Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_145755.2(TTC21A):c.3116+5G>T	TTC21A		SPERMATOGENIC FAILURE 37	Pathogenic(Last reviewed: May 13, 2019)	no assertion criteria provided	VCV000627575	3	39178003	3	39136512	627575	615930	rs148431487	NC_000003.12:39136511:G:T
NM_145755.2(TTC21A):c.2563del (p.Ala854_Val855insTer)	TTC21A		SPERMATOGENIC FAILURE 37	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000627574	3	39172566	3	39131075	627574	615929	rs1559708295	NC_000003.12:39131074:G:
NM_145755.2(TTC21A):c.341A>G (p.Tyr114Cys)	TTC21A	Y114C	SPERMATOGENIC FAILURE 37	Pathogenic(Last reviewed: May 13, 2019)	no assertion criteria provided	VCV000627573	3	39152414	3	39110923	627573	615928	rs750057655	NC_000003.12:39110922:A:G
NM_145755.2(TTC21A):c.2329C>T (p.Gln777Ter)	TTC21A	Q777*, Q729*, Q770*, Q778*	SPERMATOGENIC FAILURE 37	Pathogenic(Last reviewed: May 13, 2019)	no assertion criteria provided	VCV000627572	3	39171838	3	39130347	627572	615927	rs780431020	NC_000003.12:39130346:C:T
NM_145755.2(TTC21A):c.716+1G>A	TTC21A		SPERMATOGENIC FAILURE 37	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000627571	3	39156234	3	39114743	627571	615926	rs1559674534	NC_000003.12:39114742:G:A
NM_001025.5(RPS23):c.358T>A (p.Phe120Ile)	RPS23	F120I	MacInnes syndrome	Pathogenic(Last reviewed: Aug 11, 2017)	no assertion criteria provided	VCV000417764	5	81572002	5	82276183	417764	404665	rs1060505035	NC_000005.10:82276182:A:T
NM_001025.5(RPS23):c.200G>A (p.Arg67Lys)	RPS23	R67K	MacInnes syndrome|not provided	Pathogenic(Last reviewed: Aug 11, 2017)	no assertion criteria provided	VCV000417763	5	81572302	5	82276483	417763	404664	rs1060505034	NC_000005.10:82276482:C:T
NM_177939.3(P4HTM):c.949del (p.Val317fs)	P4HTM	V317fs	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES	Pathogenic(Last reviewed: Jul 12, 2019)	no assertion criteria provided	VCV000635798	3	49042355	3	49004922	635798	623630		NC_000003.12:49004921:G:
NM_177939.3(P4HTM):c.1411C>T (p.Gln471Ter)	P4HTM	Q532*, Q471*	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES	Pathogenic(Last reviewed: Jul 12, 2019)	no assertion criteria provided	VCV000635797	3	49044242	3	49006809	635797	623629		NC_000003.12:49006808:C:T
NM_002070.4(GNAI2):c.600T>A (p.Phe200Leu)	GNAI2	F200L, F148L, F184L, F119L, F163L	Ventricular tachycardia, somatic	Pathogenic(Last reviewed: Jun 15, 1998)	no assertion criteria provided	VCV000015906	3	50294161	3	50256729	15906	30945	rs137853228	NC_000003.12:50256728:T:A
NM_177939.3(P4HTM):c.1073G>A (p.Arg358His)	P4HTM	R358Q, R358H	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635794	3	49042479	3	49005046	635794	623626		NC_000003.12:49005045:G:A
NM_002070.4(GNAI2):c.535C>G (p.Arg179Gly)	GNAI2	R179G, R142G, R98G, R163G, R127G	Pituitary dependent hypercortisolism	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	VCV000015905	3	50293694	3	50256262	15905	30944	rs137853226	NC_000003.12:50256261:C:G
NM_002070.4(GNAI2):c.536G>A (p.Arg179His)	GNAI2	R179H, R142H, R163H, R98H, R127H	Granulosa cell tumor of the ovary|Thecoma, somatic|Adrenocortical tumor, somatic	Pathogenic(Last reviewed: Aug 26, 2014)	no assertion criteria provided	VCV000015904	3	50293695	3	50256263	15904	30943	rs137853227	NC_000003.12:50256262:G:A
NM_002070.4(GNAI2):c.535C>T (p.Arg179Cys)	GNAI2	R179C, R163C, R142C, R98C, R127C	Granulosa cell tumor of the ovary|Thecoma, somatic|Adrenocortical tumor, somatic	Pathogenic(Last reviewed: Aug 10, 1990)	no assertion criteria provided	VCV000015903	3	50293694	3	50256262	15903	30942	rs137853226	NC_000003.12:50256261:C:T
NM_133267.3(GSX2):c.752A>G (p.Gln251Arg)	GSX2	Q251R	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2	Pathogenic(Last reviewed: Oct 29, 2019)	no assertion criteria provided	VCV000694063	4	54967926	4	54101759	694063	681869		NC_000004.12:54101758:A:G
NM_133267.3(GSX2):c.26C>A (p.Ser9Ter)	GSX2	S9*	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2	Pathogenic(Last reviewed: Oct 29, 2019)	no assertion criteria provided	VCV000694062	4	54966537	4	54100370	694062	681868		NC_000004.12:54100369:C:A
NM_014415.4(ZBTB11):c.2640T>G (p.His880Gln)	ZBTB11	H880Q	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625186	3	101371344	3	101652500	625186	613529	rs1559981249	NC_000003.12:101652499:A:C
NM_014415.4(ZBTB11):c.2185C>T (p.His729Tyr)	ZBTB11	H729Y	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625185	3	101374954	3	101656110	625185	613528	rs1559982532	NC_000003.12:101656109:G:A
NM_007282.4(RNF13):c.935T>C (p.Leu312Pro)	RNF13	L312P, L193P	Rnf13-related severe early-onset epileptic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000625148	3	149678680	3	149960893	625148	613492	rs1559980785	NC_000003.12:149960892:T:C
NM_007282.4(RNF13):c.932T>C (p.Leu311Ser)	RNF13	L311S, L192S	Rnf13-related severe early-onset epileptic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000625147	3	149678677	3	149960890	625147	613491	rs1559980771	NC_000003.12:149960889:T:C
NM_003587.5(DHX16):c.2091G>T (p.Gln697His)	DHX16	Q216H, Q637H, Q697H	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES|Enlarged kidney|Reduced renal corticomedullary differentiation|Multiple renal cysts	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000691932	6	30624786	6	30657009	691932	679672		NC_000006.12:30657008:C:A
NM_003587.5(DHX16):c.2021C>T (p.Thr674Met)	DHX16	T193M, T614M, T674M	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES|Neurodevelopmental delay|Intellectual disability|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000691934	6	30624856	6	30657079	691934	679673		NC_000006.12:30657078:G:A
NM_003587.5(DHX16):c.1280G>A (p.Gly427Glu)	DHX16	G367E, G427E	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES|Neurodevelopmental delay|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000691933	6	30632615	6	30664838	691933	679675		NC_000006.12:30664837:C:T
NM_003587.5(DHX16):c.1744T>A (p.Phe582Ile)	DHX16	F101I, F522I, F582I	NEUROMUSCULAR DISEASE AND OCULAR OR AUDITORY ANOMALIES WITH OR WITHOUT SEIZURES||Seizures|Neurodevelopmental delay|Intellectual disability|Periventricular gray matter heterotopia|Chorioretinal lacunae	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	no assertion criteria provided	VCV000691931	6	30627820	6	30660043	691931	679674		NC_000006.12:30660042:A:T
NM_024574.4(NDNF):c.1406G>A (p.Trp469Ter)	NDNF	W469*	HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834071	4	121957720	4	121036565	834071	822322		NC_000004.12:121036564:C:T
NM_024574.4(NDNF):c.381del (p.Tyr128fs)	NDNF	Y128fs	HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834070	4	121958745	4	121037590	834070	822321		NC_000004.12:121037589:GG:G
NM_024574.4(NDNF):c.184A>T (p.Lys62Ter)	NDNF	K62*	HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834069	4	121966809	4	121045654	834069	822320		NC_000004.12:121045653:T:A
NM_017872.5(THG1L):c.164T>C (p.Val55Ala)	THG1L	V55A	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28|not provided	Pathogenic(Last reviewed: Mar 12, 2020)	no assertion criteria provided	VCV000441070	5	157158612	5	157731604	441070	434599	rs201920319	NC_000005.10:157731603:T:C
NM_017819.4(TRMT10C):c.814A>G (p.Thr272Ala)	TRMT10C	T272A	Combined oxidative phosphorylation deficiency 30|Mitochondrial diseases	Pathogenic(Last reviewed: Sep 10, 2019)	no assertion criteria provided	VCV000224317	3	101284439	3	101565595	224317	226045	rs875989831	NC_000003.12:101565594:A:G
NM_017819.4(TRMT10C):c.542G>T (p.Arg181Leu)	TRMT10C	R181L	Combined oxidative phosphorylation deficiency 30|Mitochondrial diseases	Pathogenic(Last reviewed: Sep 10, 2019)	no assertion criteria provided	VCV000224316	3	101284167	3	101565323	224316	226044	rs199730889	NC_000003.12:101565322:G:T
NM_198880.3(QRICH1):c.64dup (p.Val22fs)	QRICH1		VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801970	3	49114386 - 49114387	3	49076953 - 49076954	801970	790404		NC_000003.12:49076953:C:CC
NM_198880.3(QRICH1):c.1143_1144CT[2] (p.Leu383fs)	QRICH1		VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801969	3	49094483 - 49094486	3	49057050 - 49057053	801969	790403		NC_000003.12:49057049:AGAGAGAG:AGAG
NM_198880.3(QRICH1):c.1606C>T (p.Arg536Ter)	QRICH1	R536*	VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: Mar 15, 2019)	no assertion criteria provided	VCV000620666	3	49083923	3	49046490	620666	612052	rs1559930732	NC_000003.12:49046489:G:A
NM_198880.3(QRICH1):c.1378C>T (p.Gln460Ter)	QRICH1	Q460*	VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000584433	3	49084640	3	49047207	584433	575488	rs1559931177	NC_000003.12:49047206:G:A
NM_198880.3(QRICH1):c.138_139delinsTT (p.Gln46_Gln47delinsHisTer)	QRICH1		VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000523659	3	49114312 - 49114313	3	49076879 - 49076880	523659	514307	rs1553747119	NC_000003.12:49076878:GC:AA
NM_198880.3(QRICH1):c.1953dup (p.Arg652fs)	QRICH1		VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000523658	3	49070148 - 49070149	3	49032715 - 49032716	523658	514306	rs1553738605	NC_000003.12:49032715:C:CC
NM_198880.3(QRICH1):c.1954C>T (p.Arg652Ter)	QRICH1	R652*	VERVERI-BRADY SYNDROME	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000523657	3	49070148	3	49032715	523657	514305	rs1236702036	NC_000003.12:49032714:G:A
NM_001031741.3(NEK10):c.253C>T (p.Arg85Cys)	NEK10	R85C, R773C	CILIARY DYSKINESIA, PRIMARY, 44	Pathogenic(Last reviewed: Feb 24, 2020)	no assertion criteria provided	VCV000813281	3	27233708	3	27192217	813281	801526		NC_000003.12:27192216:G:A
NM_152534.4(NEK10):c.2243C>T (p.Pro748Leu)	NEK10	P748L, P60L	CILIARY DYSKINESIA, PRIMARY, 44	Pathogenic(Last reviewed: Feb 24, 2020)	no assertion criteria provided	VCV000813280	3	27243049	3	27201558	813280	801525		NC_000003.12:27201557:G:A
NM_152534.4(NEK10):c.1869dup (p.His624fs)	NEK10		CILIARY DYSKINESIA, PRIMARY, 44	Pathogenic(Last reviewed: Feb 24, 2020)	no assertion criteria provided	VCV000813279	3	27326372 - 27326373	3	27284881 - 27284882	813279	801524		NC_000003.12:27284881:A:AA
NM_152534.4(NEK10):c.1230+5G>C	NEK10		CILIARY DYSKINESIA, PRIMARY, 44	Pathogenic(Last reviewed: Feb 24, 2020)	no assertion criteria provided	VCV000813278	3	27338665	3	27297174	813278	801523		NC_000003.12:27297173:C:G
NM_138615.3(DHX30):c.1390A>G (p.Thr464Ala)	DHX30	T425A, T464A, T436A	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801964	3	47887952	3	47846462	801964	790398		NC_000003.12:47846461:A:G
NM_002184.4(IL6ST):c.1493C>T (p.Pro498Leu)	IL6ST	P498L, P166L, P209L, P437L, P197L, P428L	HYPER-IgE RECURRENT INFECTION SYNDROME 4, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Jul 31, 2019)	no assertion criteria provided	VCV000638566	5	55248137	5	55952309	638566	626353		NC_000005.10:55952308:G:A
NM_002184.4(IL6ST):c.1210A>T (p.Asn404Tyr)	IL6ST	N404Y, N115Y, N103Y, N334Y, N72Y	HYPER-IgE RECURRENT INFECTION SYNDROME 4, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Jul 31, 2019)	no assertion criteria provided	VCV000638565	5	55251910	5	55956082	638565	626352		NC_000005.10:55956081:T:A
NC_000005.10:g.55247753A>G	IL6ST		Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	no assertion criteria provided	VCV000638017	5	54543581	5	55247753	638017	625838		NC_000005.10:55247752:A:G
NM_002184.4(IL6ST):c.841C>T (p.Arg281Ter)	IL6ST	R281*, R211*	Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	no assertion criteria provided	VCV000635407	5	55256362	5	55960534	635407	623233		NC_000005.10:55960533:G:A
NM_138615.3(DHX30):c.2354G>A (p.Arg785His)	DHX30	R785H, R757H, R746H	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	VCV000453272	3	47889737	3	47848247	453272	446866	rs1553706799	NC_000003.12:47848246:G:A
NM_138615.3(DHX30):c.2342G>A (p.Gly781Asp)	DHX30	G781D, G742D, G753D	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	VCV000453269	3	47889725	3	47848235	453269	446863	rs1553706775	NC_000003.12:47848234:G:A
NM_001199198.3(TBC1D23):c.1687+1G>A	TBC1D23		PONTOCEREBELLAR HYPOPLASIA, TYPE 11	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000440764	3	100035032	3	100316188	440764	434391	rs1553731603	NC_000003.12:100316187:G:A
NM_001199198.3(TBC1D23):c.1687+2T>A	TBC1D23		PONTOCEREBELLAR HYPOPLASIA, TYPE 11	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000440763	3	100035033	3	100316189	440763	434390	rs1553731605	NC_000003.12:100316188:T:A
NM_006545.5(NPRL2):c.68_69del (p.Ile23fs)	NPRL2	I23fs	Epilepsy, familial focal, with variable foci 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254365	3	50388015 - 50388016	3	50350584 - 50350585	254365	248905	rs886037966	NC_000003.12:50350583:GA:
NM_006545.5(NPRL2):c.314T>C (p.Leu105Pro)	NPRL2	L105P	Epilepsy, familial focal, with variable foci 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254364	3	50387121	3	50349690	254364	248904	rs886037965	NC_000003.12:50349689:A:G
NM_006545.5(NPRL2):c.883C>T (p.Arg295Ter)	NPRL2	R295*	Epilepsy, familial focal, with variable foci 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254363	3	50385604	3	50348173	254363	248903	rs886037964	NC_000003.12:50348172:G:A
NM_006545.5(NPRL2):c.100C>T (p.Arg34Ter)	NPRL2	R34*	Epilepsy, familial focal, with variable foci 2	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000254362	3	50387432	3	50350001	254362	248902	rs886037963	NC_000003.12:50350000:G:A
NM_001042616.2(PIGY):c.-540G>A	PIGY		Hyperphosphatasia with mental retardation syndrome 6	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000222025	4	89444948	4	88523797	222025	223716	rs869025323	NC_000004.12:88523796:C:T
NM_001553.3(IGFBP7):c.830-1G>A	IGFBP7		Retinal arterial macroaneurysm with supravascular pulmonic stenosis	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030280	4	57897503	4	57031337	30280	39236	rs866994863	NC_000004.12:57031336:C:T
NM_002198.3(IRF1):c.22A>T (p.Met8Leu)	IRF1	M8L	Neoplasm of stomach	Pathogenic(Last reviewed: Aug 12, 1998)	no assertion criteria provided	VCV000014720	5	131825149	5	132489457	14720	29759	rs121912469	NC_000005.10:132489456:T:A
NM_138615.3(DHX30):c.2353C>T (p.Arg785Cys)	DHX30	R746C, R757C, R785C	not provided|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000426111	3	47889736	3	47848246	426111	414715	rs1085307451	NC_000003.12:47848245:C:T
NM_001199198.3(TBC1D23):c.1687+2T>G	TBC1D23		PONTOCEREBELLAR HYPOPLASIA, TYPE 11|Pontoneocerebellar hypoplasia	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000397555	3	100035033	3	100316189	397555	384450	rs1553731605	NC_000003.12:100316188:T:G
NM_001199198.3(TBC1D23):c.1526delinsAA (p.Ile509fs)	TBC1D23		PONTOCEREBELLAR HYPOPLASIA, TYPE 11|Pontoneocerebellar hypoplasia	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000397554	3	100029359	3	100310515	397554	384449	rs1553730885	NC_000003.12:100310514:T:AA
NM_001199198.3(TBC1D23):c.1473_1474TG[1] (p.Val492fs)	TBC1D23		PONTOCEREBELLAR HYPOPLASIA, TYPE 11|Pontoneocerebellar hypoplasia	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000397553	3	100029306 - 100029307	3	100310462 - 100310463	397553	384448	rs1553730872	NC_000003.12:100310461:TGTG:TG
NM_138615.3(DHX30):c.1478G>A (p.Arg493His)	DHX30	R493H, R454H, R465H	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE|Unsteady gait|Seizures|Microcephaly|Short stature|Strabismus|Oculomotor apraxia	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	VCV000375374	3	47888040	3	47846550	375374	362138	rs1057519436	NC_000003.12:47846549:G:A
NM_015895.5(GMNN):c.16A>T (p.Lys6Ter)	GMNN	K6*	Meier-gorlin syndrome 6|Meier-Gorlin syndrome	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000203999	6	24777490	6	24777262	203999	200397	rs864309486	NC_000006.12:24777261:A:T
NM_015895.5(GMNN):c.35_38del (p.Ile12fs)	GMNN	I12fs	Meier-gorlin syndrome 6|Meier-Gorlin syndrome	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000204000	6	24777507 - 24777510	6	24777279 - 24777282	204000	200398	rs864309487	NC_000006.12:24777278:AATCAA:AA
NM_002198.3(IRF1):c.31T>C (p.Trp11Arg)	IRF1	W11R	Non-small cell lung cancer	Pathogenic(Last reviewed: Jul 7, 1999)	no assertion criteria provided	VCV000014721	5	131825140	5	132489448	14721	29760	rs121912470	NC_000005.10:132489447:A:G
NM_001039111.3(TRIM71):c.2387G>A (p.Arg796His)	TRIM71	R796H	HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1	Pathogenic(Last reviewed: Nov 22, 2019)	no assertion criteria provided	VCV000694595	3	32933083	3	32891591	694595	682668		NC_000003.12:32891590:G:A
NM_001039111.3(TRIM71):c.1823G>A (p.Arg608His)	TRIM71	R608H	HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1	Pathogenic(Last reviewed: Nov 22, 2019)	no assertion criteria provided	VCV000694594	3	32932519	3	32891027	694594	682667		NC_000003.12:32891026:G:A
NM_001042646.3(TRAK1):c.287-2A>G	TRAK1		EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68	Pathogenic(Last reviewed: Nov 28, 2018)	no assertion criteria provided	VCV000590943	3	42218304	3	42176812	590943	581887	rs1559877920	NC_000003.12:42176811:A:G
NM_001042646.3(TRAK1):c.287-2A>C	TRAK1		EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68	Pathogenic(Last reviewed: Nov 28, 2018)	no assertion criteria provided	VCV000590942	3	42218304	3	42176812	590942	581886	rs1559877920	NC_000003.12:42176811:A:C
NM_005033.3(EXOSC9):c.481C>T (p.Arg161Ter)	EXOSC9	R161*	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D	Pathogenic(Last reviewed: Jul 27, 2018)	no assertion criteria provided	VCV000549846	4	122725873	4	121804718	549846	540571	rs372318863	NC_000004.12:121804717:C:T
NM_001042646.3(TRAK1):c.1759dup (p.His587fs)	TRAK1		EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000590944	3	42251272 - 42251273	3	42209780 - 42209781	590944	581888	rs1559390743	NC_000003.12:42209780:C:CC
NM_005033.3(EXOSC9):c.41T>C (p.Leu14Pro)	EXOSC9	L14P	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000549845	4	122722620	4	121801465	549845	540570	rs139632595	NC_000004.12:121801464:T:C
NM_138615.3(DHX30):c.2344C>T (p.Arg782Trp)	DHX30	R782W, R743W, R754W	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE|Hirsutism|Global developmental delay|Generalized hypotonia|Failure to thrive|Microcephaly|Short stature|Intellectual disability|EEG abnormality	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375373	3	47889727	3	47848237	375373	362139	rs753242774	NC_000003.12:47848236:C:T
NM_001664.4(RHOA):c.211C>T (p.Pro71Ser)	RHOA	P71S, P51S	ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES, SOMATIC MOSAIC	Pathogenic(Last reviewed: Jan 29, 2020)	no assertion criteria provided	VCV000801330	3	49405927	3	49368494	801330	789712		NC_000003.12:49368493:G:A
NM_001664.4(RHOA):c.139G>A (p.Glu47Lys)	RHOA	E47K	ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES, SOMATIC MOSAIC	Pathogenic(Last reviewed: Jan 29, 2020)	no assertion criteria provided	VCV000695069	3	49412884	3	49375451	695069	683186		NC_000003.12:49375450:C:T
NM_013336.4(SEC61A1):c.200T>G (p.Val67Gly)	SEC61A1	V67G	Hyperuricemic nephropathy, familial juvenile, 4	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000253147	3	127774574	3	128055731	253147	247559	rs752745051	NC_000003.12:128055730:T:G
NM_013336.4(SEC61A1):c.553A>G (p.Thr185Ala)	SEC61A1	T185A	Hyperuricemic nephropathy, familial juvenile, 4	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000253146	3	127779441	3	128060598	253146	247558	rs879255648	NC_000003.12:128060597:A:G
NM_005213.4(CSTA):c.172C>T (p.Arg58Ter)	CSTA	R58*	Peeling skin syndrome 4	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000208473	3	122060289	3	122341442	208473	204994	rs149474339	NC_000003.12:122341441:C:T
NM_002295.6(RPSA):c.172C>T (p.Leu58Phe)	RPSA	L58F	Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064677	3	39450135	3	39408644	64677	75612	rs397514763	NC_000003.12:39408643:C:T
NM_002295.6(RPSA):c.538C>T (p.Arg180Trp)	RPSA	R180W, R185W	Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064674	3	39453179	3	39411688	64674	75609	rs397514760	NC_000003.12:39411687:C:T
NM_002295.6(RPSA):c.538C>G (p.Arg180Gly)	RPSA	R180G, R185G	Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064673	3	39453179	3	39411688	64673	75608	rs397514760	NC_000003.12:39411687:C:G
NM_002295.6(RPSA):c.25C>T (p.Gln9Ter)	RPSA	Q9*	Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064671	3	39449169	3	39407678	64671	75606	rs397514759	NC_000003.12:39407677:C:T
NM_005213.4(CSTA):c.256C>T (p.Gln86Ter)	CSTA	Q86*	Peeling skin syndrome 4	Pathogenic(Last reviewed: Oct 7, 2011)	no assertion criteria provided	VCV000029893	3	122060373	3	122341526	29893	38848	rs387906689	NC_000003.12:122341525:C:T
NM_001008388.5(CISD2):c.103+1G>A	CISD2		Wolfram syndrome 2	Pathogenic(Last reviewed: Jul 30, 2019)	no assertion criteria provided	VCV000638297	4	103790345	4	102869188	638297	626087		NC_000004.12:102869187:G:A
NM_002295.6(RPSA):c.590_594dup (p.Pro199fs)	RPSA		Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064672	3	39453229 - 39453230	3	39411738 - 39411739	64672	75607	rs398122389	NC_000003.12:39411738:GTCATG:GTCATGTCATG
NM_005213.4(CSTA):c.67-2A>T	CSTA		Peeling skin syndrome 4	Pathogenic(Last reviewed: Oct 7, 2011)	no assertion criteria provided	VCV000029892	3	122056392	3	122337545	29892	38847	rs398122804	NC_000003.12:122337544:A:T
NM_002295.6(RPSA):c.161C>A (p.Thr54Asn)	RPSA	T54N	Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064676	3	39450124	3	39408633	64676	75611	rs397514762	NC_000003.12:39408632:C:A
NM_002295.6(RPSA):c.556C>T (p.Arg186Cys)	RPSA	R186C, R191C	Asplenia, isolated congenital	Pathogenic(Last reviewed: May 24, 2013)	no assertion criteria provided	VCV000064675	3	39453197	3	39411706	64675	75610	rs397514761	NC_000003.12:39411705:C:T
NM_001145319.2(PLS1):c.383T>C (p.Phe128Ser)	PLS1	F128S	DEAFNESS, AUTOSOMAL DOMINANT 76|Autosomal dominant non-syndromic sensorineural deafness type DFNA|Bilateral sensorineural hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000633603	3	142395017	3	142676175	633603	622035		NC_000003.12:142676174:T:C
NM_005213.4(CSTA):c.64A>T (p.Lys22Ter)	CSTA	K22*	Peeling skin syndrome 4|not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000208472	3	122044203	3	122325356	208472	204993	rs747711488	NC_000003.12:122325355:A:T
NM_138615.3(DHX30):c.1685A>G (p.His562Arg)	DHX30	H562R, H523R, H534R	Hearing impairment|Strabismus|Microcephaly|Muscular hypotonia of the trunk|Delayed speech and language development|Sleep disturbance|Global developmental delay|Abnormality of the cerebral white matter|Autistic disorder of childhood onset|Intellectual disability|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic	criteria provided, single submitter	VCV000402130	3	47888247	3	47846757	402130	389102	rs1060499733	NC_000003.12:47846756:A:G
NC_000003.11:g.51062402_51232768del	DOCK3		NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA	Pathogenic(Last reviewed: Jan 24, 2019)	no assertion criteria provided	VCV000617489	3	51062402 - 51232768			617489	608856		
NM_004947.5(DOCK3):c.1038-2A>G	DOCK3		Global developmental delay|Muscular hypotonia	Pathogenic(Last reviewed: Mar 31, 2017)	no assertion criteria provided	VCV000599269	3	51246203	3	51208772	599269	583203	rs1560212751	NC_000003.12:51208771:A:G
NM_004947.5(DOCK3):c.3107_3110del (p.Tyr1036fs)	DOCK3	Y1036fs	Global developmental delay|Muscular hypotonia	Pathogenic(Last reviewed: Mar 31, 2017)	no assertion criteria provided	VCV000599268	3	51349917 - 51349920	3	51312486 - 51312489	599268	583204	rs1560414254	NC_000003.12:51312485:CTTACTT:CTT
NM_016589.4(TIMMDC1):c.597-1340A>G	TIMMDC1		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000429020	3	119234712	3	119515865	429020	420976	rs781525096	NC_000003.12:119515864:A:G
GRCh38/hg38 3p21.2(chr3:50818845-51207727)x3	DOCK3		See cases	Pathogenic(Last reviewed: Sep 23, 2013)	no assertion criteria provided	VCV000144169	3	50856276 - 51245158	3	50818845 - 51207727	144169	153920		
NM_000524.3(HTR1A):c.-480del	HTR1A		Periodic fever, menstrual cycle-dependent	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000031658	5	63258026	5	63962199	31658	40333	rs367956927	NC_000005.10:63962198:TT:T
NM_005879.3(TRAIP):c.52C>T (p.Arg18Cys)	TRAIP	R18C	Seckel syndrome 9	Pathogenic(Last reviewed: May 22, 2019)	no assertion criteria provided	VCV000221233	3	49893835	3	49856402	221233	222931	rs864622784	NC_000003.12:49856401:G:A
NM_005879.3(TRAIP):c.553C>T (p.Arg185Ter)	TRAIP	R185*	Seckel syndrome 9	Pathogenic(Last reviewed: May 22, 2019)	no assertion criteria provided	VCV000221232	3	49879323	3	49841890	221232	222930	rs767664526	NC_000003.12:49841889:G:A
NM_004464.3(FGF5):c.520T>C (p.Tyr174His)	FGF5	Y174H, Y31H	Trichomegaly	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000141413	4	81207539	4	80286385	141413	151127	rs587777581	NC_000004.12:80286384:T:C
NM_004464.3(FGF5):c.160_161del (p.Met54fs)	FGF5	M54fs	Trichomegaly	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000141411	4	81188137 - 81188138	4	80266983 - 80266984	141411	151125	rs587777580	NC_000004.12:80266982:TAT:T
NM_004464.3(FGF5):c.459+1del	FGF5		Trichomegaly	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000141410	4	81196167	4	80275013	141410	151124	rs587777579	NC_000004.12:80275012:G:
NM_001206981.2(ODAPH):c.51_56delinsATGCTGGTTACTGGTA (p.Val18fs)	ODAPH		Amelogenesis imperfecta, hypomaturation type IIA4	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000037220	4	76481343 - 76481348	4	75556133 - 75556138	37220	45825	rs1560558455	NC_000004.12:75556132:GGTAAC:ATGCTGGTTACTGGTA
NM_178497.3(C4orf26):c.318G>A	ODAPH	W106*, G121D	Amelogenesis imperfecta, hypomaturation type IIA4	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000037219	4	76489574	4	75564364	37219	45824	rs146645381	NC_000004.12:75564363:G:A
NM_001206981.2(ODAPH):c.112-2A>T	ODAPH		Amelogenesis imperfecta, hypomaturation type IIA4	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000037218	4	76489322	4	75564112	37218	45823	rs1560562630	NC_000004.12:75564111:A:T
NM_001206981.2(ODAPH):c.173C>A (p.Ala58Asp)	ODAPH	C43*, A58D	Amelogenesis imperfecta, hypomaturation type IIA4	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000037217	4	76489385	4	75564175	37217	45822	rs1560562738	NC_000004.12:75564174:C:A
NM_001206981.2(ODAPH):c.273C>T (p.His91=)	ODAPH	R77*	Amelogenesis imperfecta, hypomaturation type IIA4	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000037216	4	76489485	4	75564275	37216	45821	rs866941536	NC_000004.12:75564274:C:T
NM_001134665.3(TRMT10A):c.79G>T (p.Glu27Ter)	TRMT10A	E27*	not provided	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000593751	4	100480417	4	99559260	593751	584814	rs142895837	NC_000004.12:99559259:C:A
NM_001010874.5(TECRL):c.918+3A>G	TECRL		Ventricular tachycardia, catecholaminergic polymorphic, 3	Pathogenic(Last reviewed: Feb 28, 2020)	no assertion criteria provided	VCV000814027	4	65147189	4	64281471	814027	802256		NC_000004.12:64281470:T:C
NM_001010874.5(TECRL):c.331+1G>A	TECRL		Ventricular tachycardia, catecholaminergic polymorphic, 3	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000372283	4	65194229	4	64328511	372283	359191	rs1057517699	NC_000004.12:64328510:C:T
NM_016614.3(TDP2):c.389C>G (p.Ser130Ter)	TDP2	S130*	not provided	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000620174	6	24658825	6	24658597	620174	611654	rs1562148727	NC_000006.12:24658596:G:C
NM_031956.3(TTC29):c.977+1G>T	TTC29		SPERMATOGENIC FAILURE 42	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000805961	4	147754957	4	146833805	805961	794297		NC_000004.12:146833804:C:A
NM_031956.3(TTC29):c.412_425del (p.Asp138fs)	TTC29	D164fs, D138fs	SPERMATOGENIC FAILURE 42	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000805960	4	147824857 - 147824870	4	146903705 - 146903718	805960	794296		NC_000004.12:146903704:TTATTATGTACATCTT:TT
NM_031956.3(TTC29):c.1107C>G (p.Tyr369Ter)	TTC29	Y369*, Y395*	SPERMATOGENIC FAILURE 42	Pathogenic(Last reviewed: Jan 24, 2020)	no assertion criteria provided	VCV000805959	4	147724832	4	146803680	805959	794295		NC_000004.12:146803679:G:C
NM_031956.3(TTC29):c.750C>A (p.Tyr250Ter)	TTC29	Y250*, Y276*	SPERMATOGENIC FAILURE 42	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000805958	4	147795917	4	146874765	805958	794294		NC_000004.12:146874764:G:T
NM_031956.3(TTC29):c.330_334del (p.Glu111fs)	TTC29	E137fs, E111fs	SPERMATOGENIC FAILURE 42	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000805957	4	147830244 - 147830248	4	146909092 - 146909096	805957	794293		NC_000004.12:146909091:CCTCC:
NM_031956.3(TTC29):c.*334G>A	TTC29		SPERMATOGENIC FAILURE 42	Pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000805956	4	147627976	4	146706824	805956	794292		NC_000004.12:146706823:C:T
NM_016614.3(TDP2):c.413_414delinsAA (p.Ser138Ter)	TDP2		Spinocerebellar ataxia, autosomal recessive 23	Pathogenic(Last reviewed: Dec 28, 2017)	no assertion criteria provided	VCV000226425	6	24658800 - 24658801	6	24658572 - 24658573	226425	228226	rs879255601	NC_000006.12:24658571:GG:TT
NM_016614.3(TDP2):c.425+1G>A	TDP2		Spinocerebellar ataxia, autosomal recessive 23	Pathogenic(Last reviewed: Oct 23, 2018)	no assertion criteria provided	VCV000226424	6	24658788	6	24658560	226424	228225	rs372245668	NC_000006.12:24658559:C:T
NM_001465.6(FYB1):c.393G>A (p.Trp131Ter)	FYB1	W131*, W141*	Thrombocytopenia 3	Pathogenic(Last reviewed: Apr 21, 2017)	no assertion criteria provided	VCV000417971	5	39202670	5	39202568	417971	404860	rs745672593	NC_000005.10:39202567:C:T
NM_001465.6(FYB1):c.1383_1384AT[1] (p.Thr461_Tyr462insTer)	FYB1		Thrombocytopenia 3	Pathogenic(Last reviewed: Apr 21, 2017)	no assertion criteria provided	VCV000417970	5	39138767 - 39138768	5	39138665 - 39138666	417970	404859	rs1060505056	NC_000005.10:39138664:ATAT:AT
ATXN7, (CAG)n REPEAT EXPANSION	ATXN7		Spinocerebellar ataxia 7	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000562100					562100	553276		
NM_001037333.3(CYFIP2):c.259C>T (p.Arg87Cys)	CYFIP2	R87C	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430807	5	156721843	5	157294834	430807	424352	rs1131692231	NC_000005.10:157294833:C:T
NM_020347.4(LZTFL1):c.322C>T (p.Arg108Ter)	LZTFL1	R91*, R108*, R104*	not provided	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000196497	3	45877083	3	45835591	196497	193658	rs769327864	NC_000003.12:45835590:G:A
NM_004944.4(DNASE1L3):c.441dup (p.Asp148fs)	DNASE1L3		not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000641317	3	58186828 - 58186829	3	58201101 - 58201102	641317	631767		NC_000003.12:58201101:TTT:TTTT
NM_032128.4(SLC10A7):c.388G>A (p.Gly130Arg)	SLC10A7	G130R, W84*	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623256	4	147425009	4	146503857	623256	612219	rs1560973467	NC_000004.12:146503856:C:T
NM_001317817.1(SLC10A7):c.184-6088T>C	SLC10A7	L74P	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623255	4	147431164	4	146510012	623255	612218	rs1560980659	NC_000004.12:146510011:A:G
NM_001029998.6(SLC10A7):c.553C>T (p.Gln185Ter)	SLC10A7	Q172*, Q185*	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623254	4	147227080	4	146305928	623254	612217	rs1560782372	NC_000004.12:146305927:G:A
NM_001029998.6(SLC10A7):c.335G>A (p.Gly112Asp)	SLC10A7	G112D	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623253	4	147425062	4	146503910	623253	612216	rs1560973571	NC_000004.12:146503909:C:T
NM_001029998.6(SLC10A7):c.722-16A>G	SLC10A7		SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000623252	4	147214148	4	146292996	623252	612215	rs773117913	NC_000004.12:146292995:T:C
NM_004944.4(DNASE1L3):c.643del (p.Trp215fs)	DNASE1L3	W185fs, W215fs	Systemic lupus erythematosus 16	Pathogenic(Last reviewed: Oct 23, 2011)	no assertion criteria provided	VCV000030256	3	58183609	3	58197882	30256	39212		NC_000003.12:58197881:AAA:AA
NM_020347.4(LZTFL1):c.402_406del (p.Pro136fs)	LZTFL1	P132fs, P136fs, P119fs	Bardet-Biedl syndrome 17	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000039770	3	45874592 - 45874596	3	45833100 - 45833104	39770	48369	rs431825171	NC_000003.12:45833099:GCTTTG:G
NM_020347.4(LZTFL1):c.778G>T (p.Glu260Ter)	LZTFL1	E243*, E260*	Bardet-Biedl syndrome 17|Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000126381	3	45868951	3	45827459	126381	131914	rs515726136	NC_000003.12:45827458:C:A
NM_020347.4(LZTFL1):c.260T>C (p.Leu87Pro)	LZTFL1	L70P, L87P, L83P	Bardet-Biedl syndrome 17|Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000126380	3	45877145	3	45835653	126380	131913	rs515726135	NC_000003.12:45835652:A:G
NM_002653.5(PITX1):c.765_799del (p.Ala256fs)	PITX1	A256fs	Clubfoot	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037253	5	134364615 - 134364649	5	135028925 - 135028959	37253	45846	rs730882191	NC_000005.10:135028924:GAGTGCCGTACGGGCAAGCGCCCGGCGACATGGCCGAGT:GAGT
NM_002653.5(PITX1):c.388G>A (p.Glu130Lys)	PITX1	E130K	Clubfoot	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000007505	5	134366980	5	135031290	7505	22544	rs121909109	NC_000005.10:135031289:C:T
NM_015426.5(POC1A):c.703_704CT[2] (p.Ser236fs)	POC1A		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504327	3	52172290 - 52172291	3	52138274 - 52138275	504327	495194	rs772586602	NC_000003.12:52138273:AGAGAG:AGAG
NM_000949.7(PRLR):c.635A>G (p.His212Arg)	PRLR	H188R, H212R, H111R	Hyperprolactinemia	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000089027	5	35070276	5	35070174	89027	94573	rs398122522	NC_000005.10:35070173:T:C
NM_003107.3(SOX4):c.315G>T (p.Lys105Asn)	SOX4	K105N	COFFIN-SIRIS SYNDROME 10	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635854	6	21595080	6	21594849	635854	623667		NC_000006.12:21594848:G:T
NM_003107.3(SOX4):c.176T>G (p.Ile59Ser)	SOX4	I59S	COFFIN-SIRIS SYNDROME 10	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635853	6	21594941	6	21594710	635853	623666		NC_000006.12:21594709:T:G
NM_003107.3(SOX4):c.334G>C (p.Ala112Pro)	SOX4	A112P	COFFIN-SIRIS SYNDROME 10	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635852	6	21595099	6	21594868	635852	623665		NC_000006.12:21594867:G:C
NC_000004.11:g.39350045_39350099delinsAAAGG[(400_2000)]	RFC1		Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	no assertion criteria provided	VCV000625877	4	39350045 - 39350099			625877	614179		
NC_000004.11:g.39350045_39350099delinsAAGGG[(400_2000)]	RFC1		Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	no assertion criteria provided	VCV000625876	4	39350045 - 39350099			625876	614178		
RFC1, (AAGGG)n REPEAT EXPANSION	RFC1		Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000625839					625839	614143		
NM_000949.7(PRLR):c.806C>T (p.Pro269Leu)	PRLR	P269L, P168L	Hyperprolactinemia	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599316	5	35068367	5	35068265	599316	590591	rs754974807	NC_000005.10:35068264:G:A
NM_000949.7(PRLR):c.511C>T (p.Arg171Ter)	PRLR	R171*, R70*	Hyperprolactinemia	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599315	5	35072709	5	35072607	599315	590590	rs376188691	NC_000005.10:35072606:G:A
NM_001136239.4(PRDM6):c.1385A>G (p.Gln462Arg)	PRDM6	Q462R	Patent ductus arteriosus 3	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000243051	5	122506691	5	123170997	243051	244132	rs879253872	NC_000005.10:123170996:A:G
NM_001136239.4(PRDM6):c.788G>C (p.Cys263Ser)	PRDM6	C263S	Patent ductus arteriosus 3	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000243050	5	122435544	5	123099849	243050	244131	rs879255279	NC_000005.10:123099848:G:C
NM_001136239.4(PRDM6):c.1646G>A (p.Arg549Gln)	PRDM6	R549Q	Patent ductus arteriosus 3	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000243049	5	122515990	5	123180296	243049	244130	rs879255278	NC_000005.10:123180295:G:A
NM_015426.5(POC1A):c.512T>C (p.Leu171Pro)	POC1A	L171P, L133P	Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037063	3	52181055	3	52147039	37063	45743	rs397514488	NC_000003.12:52147038:A:G
NM_015426.5(POC1A):c.241C>T (p.Arg81Ter)	POC1A	R81*, R43*	Primordial dwarfism|Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000037062	3	52183866	3	52149850	37062	45742	rs397514487	NC_000003.12:52149849:G:A
NM_001085049.3(MRAS):c.68G>T (p.Gly23Val)	MRAS	G23V	NOONAN SYNDROME 11	Pathogenic(Last reviewed: Jul 11, 2019)	no assertion criteria provided	VCV000635781	3	138091793	3	138372951	635781	623612		NC_000003.12:138372950:G:T
NM_001126128.2(PROK2):c.101G>A (p.Cys34Tyr)	PROK2	C34Y	Hypogonadotropic hypogonadism 4 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000156561	3	71830739	3	71781588	156561	166365	rs587777864	NC_000003.12:71781587:C:T
NM_001126128.2(PROK2):c.70G>C (p.Ala24Pro)	PROK2	A24P	Hypogonadotropic hypogonadism 4 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000156560	3	71834134	3	71784983	156560	166364	rs587777863	NC_000003.12:71784982:C:G
NM_030964.4(SPRY4):c.115G>A (p.Val39Ile)	SPRY4	V16I, V39I	Hypogonadotropic hypogonadism 17 with or without anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050875	5	141694628	5	142315063	50875	59861	rs587776981	NC_000005.10:142315062:C:T
PROK2, 1-BP INS, 234T	PROK2		Hypogonadotropic hypogonadism 4 with or without anosmia	Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	VCV000003602					3602	18641		
NM_001126128.2(PROK2):c.94G>C (p.Gly32Arg)	PROK2	G32R	Hypogonadotropic hypogonadism 4 with or without anosmia	Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	VCV000003601	3	71834110	3	71784959	3601	18640	rs104893767	NC_000003.12:71784958:C:G
NM_001085049.3(MRAS):c.212A>G (p.Gln71Arg)	MRAS	Q71R	NOONAN SYNDROME 11	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000635783	3	138116184	3	138397342	635783	623614		NC_000003.12:138397341:A:G
NM_001126128.2(PROK2):c.217C>T (p.Arg73Cys)	PROK2	R73C	Hypogonadotropic hypogonadism 4 with or without anosmia	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000003604	3	71830623	3	71781472	3604	18643	rs121434272	NC_000003.12:71781471:G:A
NM_002715.4(PPP2CA):c.724C>G (p.Gln242Glu)	PPP2CA	Q177E, Q242E	NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000807663	5	133536040	5	134200349	807663	798549		NC_000005.10:134200348:G:C
NM_152295.4(TARS1):c.680T>C (p.Leu227Pro)	TARS1	L227P, L260P	TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689399	5	33455796	5	33455691	689399	676991		NC_000005.10:33455690:T:C
NM_152295.4(TARS1):c.826A>G (p.Lys276Glu)	TARS1	K276E, K309E	TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689398	5	33456321	5	33456216	689398	676990		NC_000005.10:33456215:A:G
NM_152295.4(TARS1):c.1912C>T (p.Arg638Ter)	TARS1	R638*, R671*	TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000689397	5	33466979	5	33466874	689397	676989		NC_000005.10:33466873:C:T
NM_002715.4(PPP2CA):c.438del (p.Phe146fs)	PPP2CA	F146fs, F81fs	NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES	Pathogenic(Last reviewed: Mar 13, 2019)	no assertion criteria provided	VCV000620079	5	133537587	5	134201896	620079	611475	rs1561734750	NC_000005.10:134201895:AAAA:AAA
NM_001142416.2(AIMP1):c.162del (p.Lys54fs)	AIMP1	K54fs		Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000590774	4	107248658	4	106327501	590774	581710	rs750731609	NC_000004.12:106327500:AAA:AA
NM_173543.3(DZIP1L):c.1059_1060AG[1] (p.Glu354fs)	DZIP1L		POLYCYSTIC KIDNEY DISEASE 5	Pathogenic(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000431434	3	137805803 - 137805804	3	138086961 - 138086962	431434	424955	rs1135402756	NC_000003.12:138086960:CTCT:CT
NM_173543.3(DZIP1L):c.463C>T (p.Gln155Ter)	DZIP1L	Q155*	POLYCYSTIC KIDNEY DISEASE 5	Pathogenic(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000431433	3	137822351	3	138103509	431433	424954	rs1135402755	NC_000003.12:138103508:G:A
NM_173543.3(DZIP1L):c.273G>C (p.Gln91His)	DZIP1L	Q91H	POLYCYSTIC KIDNEY DISEASE 5	Pathogenic(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000431432	3	137822541	3	138103699	431432	424953	rs1135402754	NC_000003.12:138103698:C:G
NM_173543.3(DZIP1L):c.269C>T (p.Ala90Val)	DZIP1L	A90V	POLYCYSTIC KIDNEY DISEASE 5	Pathogenic(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000431431	3	137822545	3	138103703	431431	424952	rs555349004	NC_000003.12:138103702:G:A
NM_016519.6(AMBN):c.532-1G>C	AMBN		Amelogenesis imperfecta, type IF	Pathogenic(Last reviewed: Nov 22, 2016)	no assertion criteria provided	VCV000372171	4	71468340	4	70602623	372171	359076	rs146238585	NC_000004.12:70602622:G:C
NM_003118.4(SPARC):c.787G>A (p.Glu263Lys)	SPARC	E263K, E262K	Osteogenesis imperfecta, type xvii	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000372141	5	151043744	5	151664183	372141	359046	rs1057517663	NC_000005.10:151664182:C:T
NM_003118.4(SPARC):c.497G>A (p.Arg166His)	SPARC	R166H, R165H	Osteogenesis imperfecta, type xvii	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000372140	5	151047116	5	151667555	372140	359045	rs1057517662	NC_000005.10:151667554:C:T
NM_001064.4(TKT):c.952C>T (p.Arg318Cys)	TKT	R318C, R326C	Short stature, developmental delay, and congenital heart defects	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000223091	3	53264628	3	53230612	223091	224814	rs782092363	NC_000003.12:53230611:G:A
NM_001064.4(TKT):c.633G>A (p.Trp211Ter)	TKT	W211*, W219*	Short stature, developmental delay, and congenital heart defects	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000223089	3	53267287	3	53233271	223089	224816	rs868953318	NC_000003.12:53233270:C:T
NM_016519.6(AMBN):c.294+140_531+479del	AMBN		Amelogenesis imperfecta, type IF	Pathogenic(Last reviewed: Oct 15, 2014)	no assertion criteria provided	VCV000183689	4	71465502 - 71467849	4	70599785 - 70602132	183689	181588		
NM_001142416.2(AIMP1):c.292_293del (p.Gln98fs)	AIMP1	Q98fs		Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030372	4	107249300 - 107249301	4	106328143 - 106328144	30372	39329	rs387906865	NC_000004.12:106328142:ACA:A
NM_001142416.2(AIMP1):c.115C>T (p.Gln39Ter)	AIMP1	Q39*		Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000162377	4	107248613	4	106327456	162377	172080	rs724159969	NC_000004.12:106327455:C:T
NM_002715.4(PPP2CA):c.373C>T (p.Gln125Ter)	PPP2CA	Q125*, Q60*	NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000620080	5	133537652	5	134201961	620080	611476	rs1561734790	NC_000005.10:134201960:G:A
NM_001142416.2(AIMP1):c.334C>T (p.Gln112Ter)	AIMP1	Q112*		Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243083	4	107249343	4	106328186	243083	244154	rs879253867	NC_000004.12:106328185:C:T
NM_001135055.2:c.769_770insCTACCTCCTTATCTTCTG	TKT		Short stature, developmental delay, and congenital heart defects|not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000243092	3	53265545 - 53265546	3	53231529 - 53231530	243092	244175	rs781905246	NC_000003.12:53231529::CAGAAGATAAGGAGGTAG
NM_002520.6(NPM1):c.864_873delinsTTTAAGGATTCGTC (p.Trp288fs)	NPM1		Acute Myeloid Leukemia with Multilineage Dysplasia	Pathogenic(Last reviewed: Jan 7, 2020)	no assertion criteria provided	VCV000810668	5	170837548 - 170837557	5	171410544 - 171410553	810668	798954		NC_000005.10:171410543:GCAGTGGAGG:TTTAAGGATTCGTC
NM_001271838.2(RSRC1):c.205C>T (p.Arg69Ter)	RSRC1	R69*	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70	Pathogenic(Last reviewed: Apr 26, 2019)	no assertion criteria provided	VCV000626266	3	157841665	3	158123876	626266	614570	rs868818936	NC_000003.12:158123875:C:T
NM_001271838.2(RSRC1):c.268C>T (p.Arg90Ter)	RSRC1	R90*	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70	Pathogenic(Last reviewed: Apr 26, 2019)	no assertion criteria provided	VCV000626265	3	157841728	3	158123939	626265	614569	rs1183090232	NC_000003.12:158123938:C:T
GLYCTK, 1-BP DEL, 1558C	GLYCTK		Deficiency of glycerate kinase	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030837					30837	39794		
GLYCTK, 1-BP DEL, 1448T	GLYCTK		Deficiency of glycerate kinase	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030835					30835	39792		
NM_199185.3(NPM1):c.782_788delinsCCCTGGCTAGG (p.Trp261fs)	NPM1		Acute myeloid leukemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000632551	5	170837553 - 170837559	5	171410549 - 171410555	632551	620938	rs1561878500	NC_000005.10:171410548:GGAGGAA:CCCTGGCTAGG
NM_002520.6(NPM1):c.863_864insCCTG (p.Trp288fs)	NPM1		Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 20, 2005)	no assertion criteria provided	VCV000014001	5	170837544 - 170837545	5	171410540 - 171410541	14001	29040	rs1554138189	NC_000005.10:171410540:CTG:CTGCCTG
NM_002520.6(NPM1):c.863_864insCGTG (p.Trp288fs)	NPM1		Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 20, 2005)	no assertion criteria provided	VCV000014000	5	170837545 - 170837546	5	171410541 - 171410542	14000	29039	rs1554138188	NC_000005.10:171410541:TG:TGCGTG
NM_002520.6(NPM1):c.863_864insCATG (p.Trp288fs)	NPM1		Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 20, 2005)	no assertion criteria provided	VCV000013999	5	170837545 - 170837546	5	171410541 - 171410542	13999	29038	rs1554138188	NC_000005.10:171410541:TG:TGCATG
NM_000944.5(PPP3CA):c.1311_1315del (p.Ser438fs)	PPP3CA	S438fs, S396fs	Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802080	4	101953448 - 101953452	4	101032291 - 101032295	802080	790427		NC_000004.12:101032290:CAGAA:
NM_014243.3(ADAMTS3):c.280C>T (p.Arg94Ter)	ADAMTS3	R94*	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627548	4	73414419	4	72548702	627548	615903	rs747975445	NC_000004.12:72548701:G:A
NM_000944.5(PPP3CA):c.1417G>A (p.Ala473Thr)	PPP3CA	A473T, A421T, A463T	ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599241	4	101947171	4	101026014	599241	590465	rs1560567337	NC_000004.12:101026013:C:T
NM_000944.5(PPP3CA):c.1408T>C (p.Phe470Leu)	PPP3CA	F470L, F418L, F460L	ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599240	4	101947180	4	101026023	599240	590464	rs1560567347	NC_000004.12:101026022:A:G
NM_000944.5(PPP3CA):c.1290dup (p.Met431fs)	PPP3CA		Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599239	4	101953472 - 101953473	4	101032315 - 101032316	599239	590463	rs1560570541	NC_000004.12:101032315:G:GG
NM_014243.3(ADAMTS3):c.872T>C (p.Ile291Thr)	ADAMTS3	I291T	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000586988	4	73188804	4	72323087	586988	578034	rs61757480	NC_000004.12:72323086:A:G
NM_014243.3(ADAMTS3):c.503T>C (p.Leu168Pro)	ADAMTS3	L168P	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000586987	4	73414196	4	72548479	586987	578033	rs1177851177	NC_000004.12:72548478:A:G
NM_000944.5(PPP3CA):c.1308_1311dup (p.Ser438fs)	PPP3CA		Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000522802	4	101953451 - 101953452	4	101032294 - 101032295	522802	513416	rs1553920379	NC_000004.12:101032294:AAGTA:AAGTAAGTA
NM_000944.5(PPP3CA):c.843C>G (p.His281Gln)	PPP3CA	H281Q	Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000441274	4	102004360	4	101083203	441274	434928	rs199706529	NC_000004.12:101083202:G:C
NM_000944.5(PPP3CA):c.1339G>A (p.Ala447Thr)	PPP3CA	A447T, A405T	Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000441273	4	101953424	4	101032267	441273	434927	rs1553920374	NC_000004.12:101032266:C:T
NM_000944.5(PPP3CA):c.1333C>T (p.Gln445Ter)	PPP3CA	Q445*, Q403*	Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000441271	4	101953430	4	101032273	441271	434925	rs1553920376	NC_000004.12:101032272:G:A
NM_003401.5(XRCC4):c.760del (p.Asp254fs)	XRCC4	D254fs	Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: Jul 23, 2015)	no assertion criteria provided	VCV000208522	5	82554363	5	83258544	208522	205040	rs879255259	NC_000005.10:83258543:G:
NM_003401.5(XRCC4):c.482G>A (p.Arg161Gln)	XRCC4	R161Q	Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208521	5	82491755	5	83195936	208521	205039	rs797045017	NC_000005.10:83195935:G:A
NM_003401.5(XRCC4):c.246T>G (p.Asp82Glu)	XRCC4	D82E	Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000208520	5	82406953	5	83111134	208520	205038	rs879255258	NC_000005.10:83111133:T:G
NM_003401.5(XRCC4):c.481C>T (p.Arg161Ter)	XRCC4	R161*	Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000208519	5	82491754	5	83195935	208519	205037	rs779773463	NC_000005.10:83195934:C:T
NM_003401.5(XRCC4):c.-10-1G>T	XRCC4		Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000208517	5	82400728	5	83104909	208517	205035	rs869320678	NC_000005.10:83104908:G:T
NM_001281471.3(PPIP5K2):c.2510G>A (p.Arg837His)	PPIP5K2	R837H, R836H	DEAFNESS, AUTOSOMAL RECESSIVE 100	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000627521	5	102509657	5	103173953	627521	615877	rs548137246	NC_000005.10:103173952:G:A
NM_022154.5(SLC39A8):c.112G>C	SLC39A8	G38R	SLC39A8-CDG	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218895	4	103265708	4	102344551	218895	215655	rs778210210	NC_000004.12:102344550:C:G
NM_003401.5(XRCC4):c.823C>T (p.Arg275Ter)	XRCC4	R275*	Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208516	5	82554426	5	83258607	208516	205034	rs797045016	NC_000005.10:83258606:C:T
NM_003401.5(XRCC4):c.673C>T (p.Arg225Ter)	XRCC4	R225*	Short stature, microcephaly, and endocrine dysfunction	Pathogenic(Last reviewed: Jul 23, 2015)	no assertion criteria provided	VCV000208518	5	82500668	5	83204849	208518	205036	rs768825050	NC_000005.10:83204848:C:T
NM_000944.5(PPP3CA):c.275A>G (p.His92Arg)	PPP3CA	H92R	Intellectual disability|Seizures|Epileptic encephalopathy, infantile or early childhood 1	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV000441272	4	102030220	4	101109063	441272	434926	rs1553925558	NC_000004.12:101109062:T:C
NM_003401.5(XRCC4):c.25del (p.His9fs)	XRCC4	H9fs	Short stature, microcephaly, and endocrine dysfunction|not provided	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208515	5	82400762	5	83104943	208515	205033	rs869320677	NC_000005.10:83104942:CC:C
NM_016103.4(SAR1B):c.194_197dup (p.Ala67fs)	SAR1B		not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000817510	5	133948427 - 133948428	5	134612737 - 134612738	817510	805408		NC_000005.10:134612737:ATGG:ATGGATGG
NM_001270.2(CHD1):c.1379G>A (p.Arg460Lys)	CHD1	R460K	PILAROWSKI-BJORNSSON SYNDROME	Pathogenic(Last reviewed: Jun 24, 2019)	no assertion criteria provided	VCV000438821	5	98233011	5	98897307	438821	432452	rs1554078856	NC_000005.10:98897306:C:T
NM_001270.2(CHD1):c.5123G>A (p.Arg1708Gln)	CHD1	R1708Q, R1796Q	PILAROWSKI-BJORNSSON SYNDROME	Pathogenic(Last reviewed: Jun 24, 2019)	no assertion criteria provided	VCV000438820	5	98192094	5	98856390	438820	432451	rs1293161341	NC_000005.10:98856389:C:T
NM_003500.4(ACOX2):c.673C>T (p.Arg225Trp)	ACOX2	R225W	Bile acid synthesis defect, congenital, 6	Pathogenic(Last reviewed: Feb 20, 2017)	no assertion criteria provided	VCV000375691	3	58517450	3	58531723	375691	362581	rs150832314	NC_000003.12:58531722:G:A
NM_003500.4(ACOX2):c.207T>A (p.Tyr69Ter)	ACOX2	Y69*	Bile acid synthesis defect, congenital, 6	Pathogenic(Last reviewed: Feb 20, 2017)	no assertion criteria provided	VCV000375219	3	58520203	3	58534476	375219	361924	rs1057519329	NC_000003.12:58534475:A:T
NM_001128430.2(SMARCAD1):c.1281+667A>T	SMARCAD1		Basan syndrome	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000187779	4	95174825	4	94253674	187779	185677	rs895436485	NC_000004.12:94253673:A:T
NM_001128430.2(SMARCAD1):c.1281+669G>C	SMARCAD1		Adermatoglyphia	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000187778	4	95174827	4	94253676	187778	185676	rs1114167277	NC_000004.12:94253675:G:C
NM_001128430.2(SMARCAD1):c.1281+665G>A	SMARCAD1		Adermatoglyphia	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000187776	4	95174823	4	94253672	187776	185674	rs1057519613	NC_000004.12:94253671:G:A
NM_016103.4(SAR1B):c.554G>T (p.Gly185Val)	SAR1B	G185V	Chylomicron retention disease	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002929	5	133942683	5	134606993	2929	17968	rs137853126	NC_000005.10:134606992:C:A
NM_016103.4(SAR1B):c.364G>T (p.Glu122Ter)	SAR1B	E122*	Chylomicron retention disease	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002928	5	133944178	5	134608488	2928	17967	rs137853125	NC_000005.10:134608487:C:A
NM_016103.4(SAR1B):c.555_558dup (p.Gly187fs)	SAR1B		Chylomicron retention disease	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000002926	5	133942678 - 133942679	5	134606988 - 134606989	2926	17965		NC_000005.10:134606988:GTAA:GTAAGTAA
NM_016103.4(SAR1B):c.75_76del (p.Thr25_Gly26insTer)	SAR1B		Chylomicron retention disease	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000002924	5	133956725 - 133956726	5	134621035 - 134621036	2924	17963		NC_000005.10:134621034:CA:
NM_016103.4(SAR1B):c.109G>A (p.Gly37Arg)	SAR1B	G37R	Chylomicron retention disease	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000002922	5	133956692	5	134621002	2922	17961	rs121917846	NC_000005.10:134621001:C:T
NM_001128430.2(SMARCAD1):c.1281+666dup	SMARCAD1		Keratoderma with scleroatrophy of the extremities	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620664	4	95174823 - 95174824	4	94253672 - 94253673	620664	612050	rs1560542214	NC_000004.12:94253672:T:TT
NM_001128430.2(SMARCAD1):c.1281+649_1281+666del	SMARCAD1		Keratoderma with scleroatrophy of the extremities	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620663	4	95174807 - 95174824	4	94253656 - 94253673	620663	612049	rs1560542180	NC_000004.12:94253655:GAAGGCATAAGCACTGGT:
NM_016103.4(SAR1B):c.537T>A (p.Ser179Arg)	SAR1B	S179R	Chylomicron retention disease	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002925	5	133942700	5	134607010	2925	17964	rs28942110	NC_000005.10:134607009:A:T
NM_001270.2(CHD1):c.1853G>A (p.Arg618Gln)	CHD1	R618Q	PILAROWSKI-BJORNSSON SYNDROME|not provided	Pathogenic(Last reviewed: Jun 24, 2019)	no assertion criteria provided	VCV000438819	5	98229258	5	98893554	438819	432450	rs1554078349	NC_000005.10:98893553:C:T
NM_016103.4(SAR1B):c.349-1G>C	SAR1B		Chylomicron retention disease	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000002927	5	133944194	5	134608504	2927	17966		NC_000005.10:134608503:C:G
NM_001128430.2(SMARCAD1):c.1281+666T>C	SMARCAD1		Keratoderma with scleroatrophy of the extremities|Adermatoglyphia	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000187777	4	95174824	4	94253673	187777	185675	rs1114167276	NC_000004.12:94253672:T:C
NM_001128430.2(SMARCAD1):c.1281+665G>T	SMARCAD1		Adermatoglyphia|Basan syndrome	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030981	4	95174823	4	94253672	30981	39938	rs1057519613	NC_000004.12:94253671:G:T
NM_002520.6(NPM1):c.860_863dupTCTG	NPM1		Myelodysplastic syndrome progressed to acute myeloid leukemia|Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000013998	5	170837543 - 170837544	5	171410539 - 171410540	13998	29037	rs587776806	NC_000005.10:171410539:TCTG:TCTGTCTG
NM_000587.4(C7):c.2350+2T>C	C7		not provided	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000636459	5	40980013	5	40979911	636459	624774		NC_000005.10:40979910:T:C
NM_000587.4(C7):c.2350+1del	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000635449	5	40980011	5	40979909	635449	623285		NC_000005.10:40979908:GG:G
NM_000587.4(C7):c.317del (p.Asp106fs)	C7	D106fs	Complement component 7 deficiency	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000635448	5	40936476	5	40936374	635448	623284		NC_000005.10:40936373:A:
NM_000587.4(C7):c.1922_1923AG[1] (p.His643fs)	C7		not provided	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000280140	5	40972544 - 40972545	5	40972442 - 40972443	280140	264241	rs764871530	NC_000005.10:40972441:AGAG:AG
NM_005869.4(CWC27):c.77_78del (p.Ile26fs)	CWC27	I26fs	not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000843649	5	64070551 - 64070552	5	64774724 - 64774725	843649	830909		NC_000005.10:64774723:ATA:A
NM_030948.2:c.1449T>C	PHACTR1	L500P	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70	Pathogenic(Last reviewed: Jan 24, 2019)	no assertion criteria provided	VCV000617491					617491	608858	rs1562114406	
NM_005869.4(CWC27):c.617C>A (p.Ser206Ter)	CWC27	S206*	Retinitis pigmentosa with or without skeletal anomalies	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000426074	5	64084795	5	64788968	426074	414478	rs781702398	NC_000005.10:64788967:C:A
NM_005869.4(CWC27):c.1002dup (p.Val335fs)	CWC27		Retinitis pigmentosa with or without skeletal anomalies	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000426073	5	64181325 - 64181326	5	64885498 - 64885499	426073	414477	rs752159903	NC_000005.10:64885498:AAAAAAAA:AAAAAAAAA
NM_005869.4(CWC27):c.943G>T (p.Glu315Ter)	CWC27	E315*	Retinitis pigmentosa with or without skeletal anomalies	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000426072	5	64181274	5	64885447	426072	414476	rs1085307447	NC_000005.10:64885446:G:T
C7, 11-BP DEL, NT631	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000012112					12112	27151		
NM_000587.4(C7):c.1458T>A (p.Cys486Ter)	C7	C464*, C486*	Complement component 7 deficiency	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000012111	5	40958332	5	40958230	12111	27150	rs121964922	NC_000005.10:40958229:T:A
C7, 1-BP DEL, 1309A	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000012109					12109	27148		
C7, EX7-8DEL	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Jul 15, 1997)	no assertion criteria provided	VCV000012107					12107	27146		
C7, IVS1AS, G-A, -1	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Jul 15, 1997)	no assertion criteria provided	VCV000012106					12106	27145		
C7, 2-BP DEL, 2137TG	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000012104					12104	27143		
NM_000587.4(C7):c.2184T>A (p.Cys728Ter)	C7	C728*	Complement component 7 deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000012103	5	40979845	5	40979743	12103	27142	rs387906509	NC_000005.10:40979742:T:A
NM_005869.4(CWC27):c.495G>A (p.Glu165=)	CWC27		Retinitis pigmentosa with or without skeletal anomalies	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000426071	5	64081406	5	64785579	426071	414475	rs1085307446	NC_000005.10:64785578:G:A
NM_000587.4(C7):c.281-1G>T	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225308	5	40936439	5	40936337	225308	227286	rs531103546	NC_000005.10:40936336:G:T
C7, 2-BP DEL, 1922AG	C7		Complement component 7 deficiency	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000012110					12110	27149		
NM_000587.4(C7):c.1135G>C (p.Gly379Arg)	C7	G357R, G379R	Complement component 7 deficiency	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000012108	5	40955530	5	40955428	12108	27147	rs121964921	NC_000005.10:40955427:G:C
NM_005869.4(CWC27):c.1156dup (p.Leu386fs)	CWC27		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000850590	5	64272962 - 64272963	5	64977135 - 64977136	850590	830915		NC_000005.10:64977135:CCC:CCCC
NM_016103.4(SAR1B):c.409G>A (p.Asp137Asn)	SAR1B	D137N	Chylomicron retention disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002923	5	133944133	5	134608443	2923	17962	rs28942109	NC_000005.10:134608442:C:T
NM_003401.5(XRCC4):c.127T>C (p.Trp43Arg)	XRCC4	W43R	Short stature, microcephaly, and endocrine dysfunction|not provided|Ateleiotic dwarfism	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000127246	5	82400865	5	83105046	127246	132703	rs587779351	NC_000005.10:83105045:T:C
NM_000587.4(C7):c.1561C>A (p.Arg521Ser)	C7	R499S, R521S	not provided|C7 and C6 deficiency, combined subtotal|Complement component 7 deficiency	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000012105	5	40959622	5	40959520	12105	27144	rs121964920	NC_000005.10:40959519:C:A
NM_001134382.3(IQSEC1):c.962G>A (p.Arg321Gln)	IQSEC1	R321Q, R429Q, R213Q, R335Q	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Dec 4, 2019)	no assertion criteria provided	VCV000695123	3	12977554	3	12936054	695123	683226		
NM_001134382.3(IQSEC1):c.1028C>T (p.Thr343Met)	IQSEC1	T343M, T357M, T451M, T235M	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Dec 4, 2019)	no assertion criteria provided	VCV000695122	3	12977488	3	12935988	695122	683225		
NM_001017973.1(P4HA2):c.1365+96_1365+97del	P4HA2		Myopia 25, autosomal dominant	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	VCV000372167	5	131533917 - 131533918	5	132198224 - 132198225	372167	359072	rs1135402746	NC_000005.10:132198223:CACAC:CAC
NM_004199.2(P4HA2):c.419A>G (p.Gln140Arg)	P4HA2	Q140R	Myopia 25, autosomal dominant	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	VCV000372166	5	131549659	5	132213966	372166	359071	rs764211125	NC_000005.10:132213965:T:C
NM_004199.2(P4HA2):c.871G>A (p.Glu291Lys)	P4HA2	E291K	Myopia 25, autosomal dominant	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	VCV000372165	5	131544863	5	132209170	372165	359070	rs758872875	NC_000005.10:132209169:C:T
NM_181705.4(LYRM7):c.214C>T (p.Gln72Ter)	LYRM7	Q72*	Mitochondrial complex III deficiency, nuclear type 8	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000223136	5	130522772	5	131187079	223136	224862	rs869025604	NC_000005.10:131187078:C:T
NM_181705.4(LYRM7):c.190_192TTA[3] (p.Leu66dup)	LYRM7		Mitochondrial complex III deficiency, nuclear type 8	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000223135	5	130522746 - 130522747	5	131187053 - 131187054	223135	224861	rs869025603	NC_000005.10:131187053:ATTATTA:ATTATTATTA
NM_181705.4(LYRM7):c.244+5dup	LYRM7		Mitochondrial complex III deficiency, nuclear type 8	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000223134	5	130522806 - 130522807	5	131187113 - 131187114	223134	224860	rs869025602	NC_000005.10:131187113:G:GG
NM_006225.4(PLCD1):c.562T>C (p.Cys188Arg)	PLCD1	C209R, C188R	Leukonychia totalis	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030242	3	38052933	3	38011442	30242	39198	rs397514471	NC_000003.12:38011441:A:G
NM_006225.4(PLCD1):c.1657G>A (p.Ala553Thr)	PLCD1	A574T, A553T	Leukonychia totalis	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030241	3	38050599	3	38009108	30241	39197	rs375683615	NC_000003.12:38009107:C:T
NM_006225.4(PLCD1):c.1724-5_1728del	PLCD1		Leukonychia totalis	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030240	3	38050123 - 38050132	3	38008632 - 38008641	30240	39196	rs1210583991	NC_000003.12:38008631:GGCCACTACAGGC:GGC
NM_006225.4(PLCD1):c.1246C>T (p.Arg416Ter)	PLCD1	R437*, R416*	Leukonychia totalis	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030239	3	38051436	3	38009945	30239	39195	rs397514470	NC_000003.12:38009944:G:A
NM_181705.4(LYRM7):c.73G>A (p.Asp25Asn)	LYRM7	D25N	Mitochondrial complex III deficiency, nuclear type 8	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000135664	5	130515842	5	131180149	135664	139382	rs587777433	NC_000005.10:131180148:G:A
NM_173665.3(KIAA0825):c.591dup (p.Gln198fs)	KIAA0825		POLYDACTYLY, POSTAXIAL, TYPE A10|Postaxial polydactyly type A1	Pathogenic(Last reviewed: Jul 9, 2019)	no assertion criteria provided	VCV000599403	5	93856331 - 93856332	5	94520626 - 94520627	599403	590739		NC_000005.10:94520626:TT:TTT
NM_001145678.2(KIAA0825):c.2173A>T (p.Lys725Ter)	KIAA0825	K725*	POLYDACTYLY, POSTAXIAL, TYPE A10|Postaxial polydactyly type A1	Pathogenic(Last reviewed: Jul 9, 2019)	no assertion criteria provided	VCV000599402	5	93798165	5	94462460	599402	590738		NC_000005.10:94462459:T:A
NM_181705.4(LYRM7):c.37del (p.Thr13fs)	LYRM7	T13fs	Mitochondrial complex III deficiency, nuclear type 8|not provided	Pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000223137	5	130515803	5	131180110	223137	224863	rs869025605	NC_000005.10:131180109:AAAA:AAA
NM_016604.4(KDM3B):c.133C>T (p.Arg45Ter)	KDM3B	R45*	DIETS-JONGMANS SYNDROME	Pathogenic(Last reviewed: Apr 14, 2020)	no assertion criteria provided	VCV000864853	5	137688617	5	138352928	864853	855101		NC_000005.10:138352927:C:T
NM_016604.4(KDM3B):c.5191G>A (p.Glu1731Lys)	KDM3B	E1731K	DIETS-JONGMANS SYNDROME	Pathogenic(Last reviewed: Apr 14, 2020)	no assertion criteria provided	VCV000864851	5	137767234	5	138431545	864851	855099		NC_000005.10:138431544:G:A
NM_016604.4(KDM3B):c.1007A>G (p.Asp336Gly)	KDM3B	D336G	DIETS-JONGMANS SYNDROME	Pathogenic(Last reviewed: Apr 14, 2020)	no assertion criteria provided	VCV000864850	5	137721937	5	138386248	864850	855098		NC_000005.10:138386247:A:G
NM_000812.4(GABRB1):c.860C>T (p.Thr287Ile)	GABRB1	T287I	Epileptic encephalopathy, early infantile, 45	Pathogenic(Last reviewed: Oct 12, 2016)	no assertion criteria provided	VCV000265864	4	47408723	4	47406706	265864	260580	rs886039818	NC_000004.12:47406705:C:T
NM_016604.4(KDM3B):c.3095A>T (p.Asp1032Val)	KDM3B	D1032V	DIETS-JONGMANS SYNDROME	Pathogenic(Last reviewed: Apr 14, 2020)	no assertion criteria provided	VCV000864852	5	137735597	5	138399908	864852	855100		NC_000005.10:138399907:A:T
NM_016604.4(KDM3B):c.277G>T (p.Glu93Ter)	KDM3B	E93*	DIETS-JONGMANS SYNDROME	Pathogenic(Last reviewed: Apr 14, 2020)	no assertion criteria provided	VCV000864849	5	137708447	5	138372758	864849	855097		NC_000005.10:138372757:G:T
NM_000812.4(GABRB1):c.737T>C (p.Phe246Ser)	GABRB1	F246S	Epileptic encephalopathy, early infantile, 45	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000265863	4	47405630	4	47403613	265863	260579	rs886039817	NC_000004.12:47403612:T:C
ARHGAP26, 74-BP INS	ARHGAP26		Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000005054					5054	20093		
ARHGAP26, 52-BP INS	ARHGAP26		Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000005053					5053	20092		
NM_001135608.3(ARHGAP26):c.1250A>G (p.Asn417Ser)	ARHGAP26	N417S, N381S	Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000005052	5	142421420	5	143041855	5052	20091	rs121918546	NC_000005.10:143041854:A:G
NM_021964.2(ZNF148):c.1628_1629CT[1] (p.Leu544fs)	ZNF148		Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000807527	3	124951939 - 124951940	3	125233095 - 125233096	807527	798521		NC_000003.12:125233094:AGAG:AG
NM_001690.4(ATP6V1A):c.1112A>G (p.Asp371Gly)	ATP6V1A	D371G	Epileptic encephalopathy, infantile or early childhood 3	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000545527	3	113513937	3	113795090	545527	536029	rs1553710694	NC_000003.12:113795089:A:G
NM_001690.4(ATP6V1A):c.80C>G (p.Pro27Arg)	ATP6V1A	P27R	Epileptic encephalopathy, infantile or early childhood 3	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000545526	3	113497680	3	113778833	545526	536028	rs1553709380	NC_000003.12:113778832:C:G
NM_001690.4(ATP6V1A):c.1045G>A (p.Asp349Asn)	ATP6V1A	D349N	Epileptic encephalopathy, infantile or early childhood 3	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000545525	3	113513775	3	113794928	545525	536027	rs1553710664	NC_000003.12:113794927:G:A
NM_001690.4(ATP6V1A):c.298G>T (p.Asp100Tyr)	ATP6V1A	D100Y	Epileptic encephalopathy, infantile or early childhood 3	Pathogenic(Last reviewed: Jun 14, 2018)	no assertion criteria provided	VCV000545524	3	113503157	3	113784310	545524	536026	rs1553709855	NC_000003.12:113784309:G:T
NM_001690.4(ATP6V1A):c.215G>A (p.Gly72Asp)	ATP6V1A	G72D		Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000417773	3	113503074	3	113784227	417773	404674	rs1060505037	NC_000003.12:113784226:G:A
NM_021964.2(ZNF148):c.1581_1582insC (p.Lys528fs)	ZNF148		Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	Pathogenic(Last reviewed: Dec 20, 2016)	no assertion criteria provided	VCV000374845	3	124951988 - 124951989	3	125233144 - 125233145	374845	361750	rs1057519268	NC_000003.12:125233144::G
NM_021964.2(ZNF148):c.970dup (p.Ser324fs)	ZNF148		Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	Pathogenic(Last reviewed: Dec 20, 2016)	no assertion criteria provided	VCV000374844	3	124952599 - 124952600	3	125233755 - 125233756	374844	361749	rs1057519267	NC_000003.12:125233755:A:AA
NM_021964.2(ZNF148):c.1583dup (p.Ser529fs)	ZNF148		Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	Pathogenic(Last reviewed: Dec 20, 2016)	no assertion criteria provided	VCV000374843	3	124951986 - 124951987	3	125233142 - 125233143	374843	361748	rs1057519266	NC_000003.12:125233142:TT:TTT
NM_021964.2(ZNF148):c.1792A>T (p.Lys598Ter)	ZNF148	K598*, K556*	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	Pathogenic(Last reviewed: Dec 20, 2016)	no assertion criteria provided	VCV000374842	3	124951778	3	125232934	374842	361747	rs1057519265	NC_000003.12:125232933:T:A
NM_004134.7(HSPA9):c.882_883del (p.Gly295_Val296insTer)	HSPA9		Even-plus syndrome	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000224330	5	137902404 - 137902405	5	138566715 - 138566716	224330	226066	rs772570880	NC_000005.10:138566714:CT:
NM_004134.7(HSPA9):c.383A>G (p.Tyr128Cys)	HSPA9	Y128C	Even-plus syndrome	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000224329	5	137906676	5	138570987	224329	226065	rs765368797	NC_000005.10:138570986:T:C
NM_004134.7(HSPA9):c.376C>T (p.Arg126Trp)	HSPA9	R126W	Even-plus syndrome	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000224328	5	137906683	5	138570994	224328	226064	rs751478142	NC_000005.10:138570993:G:A
NM_004134.7(HSPA9):c.1373_1378del (p.Ile458_Asn459del)	HSPA9		Anemia, sideroblastic, 4	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000224070	5	137895585 - 137895590	5	138559896 - 138559901	224070	225798	rs869312659	NC_000005.10:138559895:TATTAATA:TA
NM_016474.5(CCDC174):c.1404A>G (p.Ter468Trp)	CCDC174	*468W	Hypotonia, infantile, with psychomotor retardation	Pathogenic(Last reviewed: Feb 18, 2016)	no assertion criteria provided	VCV000222080	3	14712701	3	14671194	222080	223779	rs869025342	NC_000003.12:14671193:A:G
COL25A1, 12.4-KB DEL	COL25A1		Fibrosis of extraocular muscles, congenital, 5	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180692					180692	178857		
NM_198721.4(COL25A1):c.1489G>T (p.Gly497Ter)	COL25A1	G497*, G470*	Fibrosis of extraocular muscles, congenital, 5	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180691	4	109767321	4	108846165	180691	178856	rs886037741	NC_000004.12:108846164:C:A
NM_198721.4(COL25A1):c.1144G>A (p.Gly382Arg)	COL25A1	G382R, G378R	Fibrosis of extraocular muscles, congenital, 5	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180690	4	109784483	4	108863327	180690	178855	rs780209390	NC_000004.12:108863326:C:T
NM_001690.4(ATP6V1A):c.1012C>T (p.Arg338Cys)	ATP6V1A	R338C		Pathogenic(Last reviewed: Mar 27, 2017)	no assertion criteria provided	VCV000417772	3	113513742	3	113794895	417772	404673	rs1060505036	NC_000003.12:113794894:C:T
NM_004134.7(HSPA9):c.409_410del (p.Asp136_Ile137insTer)	HSPA9		Anemia, sideroblastic, 4	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000224069	5	137906649 - 137906650	5	138570960 - 138570961	224069	225797	rs763817505	NC_000005.10:138570959:AT:
SLC36A2, IVS1, G-A, +1	SLC36A2		Iminoglycinuria|Hyperglycinuria	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002385					2385	17424		
NM_001109809.4(ZFP57):c.898_905del (p.Gly299_Thr300insTer)	ZFP57		Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000721	6	29640983 - 29640990	6	29673206 - 29673213	721	15760	rs606231123	NC_000006.12:29673205:GCCTGGGTGCCTGG:GCCTGG
NM_001109809.4(ZFP57):c.829C>A (p.His277Asn)	ZFP57	H257N, H277N, H205N	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000720	6	29641059	6	29673282	720	15759	rs78378398	NC_000006.12:29673281:G:T
NM_001109809.4(ZFP57):c.743G>A (p.Arg248His)	ZFP57	R228H, R248H, R176H	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000719	6	29641145	6	29673368	719	15758	rs77625743	NC_000006.12:29673367:C:T
NM_001109809.4(ZFP57):c.1372C>G (p.His458Asp)	ZFP57	H438D, H458D, H386D	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000718	6	29640516	6	29672739	718	15757	rs79020217	NC_000006.12:29672738:G:C
NM_001109809.4(ZFP57):c.1383del (p.Tyr462fs)	ZFP57	Y390fs, Y462fs	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000717	6	29640505	6	29672728	717	15756	rs606231122	NC_000006.12:29672727:G:
NM_001109809.4(ZFP57):c.313_314AG[2] (p.Glu106fs)	ZFP57		Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000716	6	29643197 - 29643198	6	29675420 - 29675421	716	15755	rs606231121	NC_000006.12:29675419:CTCTCTC:CTCTC
NM_001109809.2(ZFP57):c.783C>A (p.Cys261Ter)	ZFP57	C241*, C261*, C189*	Transient neonatal diabetes mellitus 1	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000000715	6	29641105	6	29673328	715	15754	rs61730328	NC_000006.12:29673327:G:T
NM_000174.4(GP9):c.337del (p.Cys113fs)	GP9	C113fs	Macrothrombocytopenia	Pathogenic(Last reviewed: Mar 22, 2019)	no assertion criteria provided	VCV000623661	3	128780919	3	129062076	623661	612487	rs1297298519	NC_000003.12:129062075:T:
NC_000003.11:g.(?_128780573)_(128781126_?)del	GP9		not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000662842	3	128780573 - 128781126	3	129061730 - 129062283	662842	650970		
NM_000174.4(GP9):c.167T>C (p.Leu56Pro)	GP9	L40P, L56P	Bernard-Soulier syndrome type C	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000013532	3	128780749	3	129061906	13532	28571	rs28933377	NC_000003.12:129061905:T:C
NM_000174.4(GP9):c.110A>G (p.Asp37Gly)	GP9	D21G, D37G	Bernard-Soulier syndrome type C	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000013530	3	128780692	3	129061849	13530	28569	rs121918036	NC_000003.12:129061848:A:G
NM_003865.3(HESX1):c.18G>C (p.Gln6His)	HESX1	Q6H	Pituitary hormone deficiency, combined 5	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000007700	3	57233929	3	57199901	7700	22739	rs121909173	NC_000003.12:57199900:C:G
NM_003865.3(HESX1):c.445G>A (p.Glu149Lys)	HESX1	E149K	Growth hormone deficiency with pituitary anomalies	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000007699	3	57232433	3	57198405	7699	22738	rs104893742	NC_000003.12:57198404:C:T
NM_003865.3(HESX1):c.357+2T>C	HESX1		Pituitary hormone deficiency, combined 5	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000007698	3	57232779	3	57198751	7698	22737	rs575112817	NC_000003.12:57198750:A:G
NM_003865.3(HESX1):c.450_451del (p.Asp150fs)	HESX1	D150fs	Pituitary hormone deficiency, combined 5	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000007697	3	57232427 - 57232428	3	57198399 - 57198400	7697	22736	rs587776664	NC_000003.12:57198398:TGT:T
NM_003865.3(HESX1):c.77T>C (p.Ile26Thr)	HESX1	I26T	Pituitary hormone deficiency, combined 5	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000007695	3	57233870	3	57199842	7695	22734	rs28936416	NC_000003.12:57199841:A:G
NM_000174.4(GP9):c.20T>C (p.Leu7Pro)	GP9	L7P	Bernard-Soulier syndrome type C	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000013534	3	128780602	3	129061759	13534	28573	rs121918038	NC_000003.12:129061758:T:C
HESX1, 1-BP DEL, 1684G	HESX1		Septo-optic dysplasia sequence	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000007696					7696	22735		
NM_003865.3(HESX1):c.301_302AG[4] (p.Leu103fs)	HESX1		Septo-optic dysplasia sequence	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000007694	3	57232831 - 57232832	3	57198803 - 57198804	7694	22733		NC_000003.12:57198803:CTCTCT:CTCTCTCT
NM_003359.4(UGDH):c.41A>G (p.Tyr14Cys)	UGDH	Y14C	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000810662	4	39523092	4	39521472	810662	798948		NC_000004.12:39521471:T:C
NM_003359.4(UGDH):c.131C>T (p.Ala44Val)	UGDH	A44V	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000810659	4	39523002	4	39521382	810659	798945		NC_000004.12:39521381:G:A
NM_003359.4(UGDH):c.193C>T (p.Arg65Ter)	UGDH	R65*	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000810658	4	39515774	4	39514154	810658	798944		NC_000004.12:39514153:G:A
NM_003359.4(UGDH):c.214T>G (p.Ser72Ala)	UGDH	S72A	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000810657	4	39515753	4	39514133	810657	798943		NC_000004.12:39514132:A:C
NM_003359.4(UGDH):c.244G>A (p.Ala82Thr)	UGDH	A82T	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000810656	4	39515723	4	39514103	810656	798942		NC_000004.12:39514102:C:T
NM_003359.4(UGDH):c.1100A>G (p.Tyr367Cys)	UGDH	Y367C, Y270C, Y300C	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2020)	no assertion criteria provided	VCV000810646	4	39506928	4	39505308	810646	798932		NC_000004.12:39505307:T:C
NM_003865.3(HESX1):c.313T>G (p.Trp105Gly)	HESX1	W105G	|Septo-optic dysplasia sequence	Pathogenic(Last reviewed: Jun 3, 2008)	no assertion criteria provided	VCV000492850	3	57232825	3	57198797	492850	485730	rs754137696	NC_000003.12:57198796:A:C
NM_003865.3(HESX1):c.240del (p.Glu81fs)	HESX1	E81fs	|Septo-optic dysplasia sequence	Pathogenic(Last reviewed: Sep 7, 2010)	no assertion criteria provided	VCV000492848	3	57232898	3	57198870	492848	485732	rs777833871	NC_000003.12:57198869:T:
NM_003865.3(HESX1):c.478C>T (p.Arg160Cys)	HESX1	R160C	Septo-optic dysplasia sequence	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000007691	3	57232305	3	57198277	7691	22730	rs28936702	NC_000003.12:57198276:G:A
NM_003359.4(UGDH):c.950G>A (p.Arg317Gln)	UGDH	R317Q, R250Q, R220Q	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 84|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000592087	4	39507325	4	39505705	592087	583092	rs775162839	NC_000004.12:39505704:C:T
NM_000174.4(GP9):c.70T>C (p.Cys24Arg)	GP9	C8R, C24R	Bernard Soulier syndrome|not provided|Bernard-Soulier syndrome type C	Pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	VCV000013533	3	128780652	3	129061809	13533	28572	rs28933378	NC_000003.12:129061808:T:C
NM_000174.4(GP9):c.212T>C (p.Phe71Ser)	GP9	F55S, F71S	Bernard-Soulier syndrome type C|Macrothrombocytopenia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000013531	3	128780794	3	129061951	13531	28570	rs121918037	NC_000003.12:129061950:T:C
NM_007208.4(MRPL3):c.629+1G>A	MRPL3		not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000489330	3	131206523	3	131487679	489330	481674	rs780595770	NC_000003.12:131487678:C:T
NM_007208.4(MRPL3):c.49del (p.Arg17fs)	MRPL3	R17fs	Combined oxidative phosphorylation deficiency 9	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000689411	3	131221617	3	131502773	689411	677003		NC_000003.12:131502772:G:
NM_016306.5(DNAJB11):c.479del (p.Ala160fs)	DNAJB11	A160fs	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Jul 27, 2018)	no assertion criteria provided	VCV000549849	3	186299182	3	186581393	549849	540574	rs1351138670	NC_000003.12:186581392:C:
NM_016306.5(DNAJB11):c.166_167insTT (p.Arg56fs)	DNAJB11		POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Jul 27, 2018)	no assertion criteria provided	VCV000549848	3	186289981 - 186289982	3	186572192 - 186572193	549848	540573	rs1553849920	NC_000003.12:186572192::TT
NM_004465.1(FGF10):c.413G>A (p.Gly138Glu)	FGF10	G138E	Congenital absence of salivary gland	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000007535	5	44310545	5	44310443	7535	22574	rs104893889	NC_000005.10:44310442:C:T
NM_004465.1(FGF10):c.467T>G (p.Ile156Arg)	FGF10	I156R	Levy-Hollister syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000007532	5	44305257	5	44305155	7532	22571	rs104893886	NC_000005.10:44305154:A:C
NC_000005.10:g.(44304226_44304232)_(44357318_44357323)del	FGF10		Congenital absence of salivary gland	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000007530			5	44304226 - 44357323	7530	22569		
NM_007208.4(MRPL3):c.950C>G (p.Pro317Arg)	MRPL3	P317R	Combined oxidative phosphorylation deficiency 9	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000030643	3	131181664	3	131462820	30643	39600	rs387906962	NC_000003.12:131462819:G:C
NM_004465.1(FGF10):c.317G>T (p.Cys106Phe)	FGF10	C106F	Levy-Hollister syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000007531	5	44388468	5	44388366	7531	22570	rs104893885	NC_000005.10:44388365:C:A
NM_016306.5(DNAJB11):c.616C>T (p.Arg206Ter)	DNAJB11	R206*	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000549851	3	186299800	3	186582011	549851	540576	rs941713150	NC_000003.12:186582010:C:T
NM_004465.1(FGF10):c.409A>T (p.Lys137Ter)	FGF10	K137*	Levy-Hollister syndrome|Congenital absence of salivary gland	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000007533	5	44310549	5	44310447	7533	22572	rs104893887	NC_000005.10:44310446:T:A
NM_004465.1(FGF10):c.577C>T (p.Arg193Ter)	FGF10	R193*	not provided|Congenital absence of salivary gland	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000007529	5	44305147	5	44305045	7529	22568	rs104893884	NC_000005.10:44305044:G:A
NM_004465.1(FGF10):c.240A>C (p.Arg80Ser)	FGF10	R80S	Levy-Hollister syndrome|Congenital absence of salivary gland	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000007534	5	44388545	5	44388443	7534	22573	rs104893888	NC_000005.10:44388442:T:G
NM_004991.4(MECOM):c.3106C>T (p.Arg1036Ter)	MECOM	R1036*, R848*, R515*, R703*, R913*, R840*, R849*, R1027*, R839*	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000620298	3	168810804	3	169093016	620298	611583	rs1560118923	NC_000003.12:169093015:G:A
NM_004991.4(MECOM):c.2816A>G (p.His939Arg)	MECOM	H751R, H939R, H606R, H742R, H743R, H752R, H816R, H418R, H930R	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218952	3	168818706	3	169100918	218952	215786	rs864309723	NC_000003.12:169100917:T:C
NM_004991.4(MECOM):c.2830A>G (p.Thr944Ala)	MECOM	T756A, T944A, T757A, T821A, T423A, T935A, T611A, T747A, T748A	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218951	3	168818692	3	169100904	218951	215785	rs864309722	NC_000003.12:169100903:T:C
NM_001190442.1(CAST):c.298A>T (p.Lys100Ter)	CAST	K142*, K100*, K127*, K183*, K78*, K161*, K59*, K164*, K168*, K81*	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000189335	5	96065427	5	96729723	189335	187224	rs786204842	NC_000005.10:96729722:A:T
NM_001190442.1(CAST):c.481dup (p.Ile161fs)	CAST		Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000189334	5	96073581 - 96073582	5	96737877 - 96737878	189334	187223	rs786205140	NC_000005.10:96737877:AA:AAA
NM_002468.5(MYD88):c.-24_-6del	MYD88		Myd88 deficiency	Pathogenic(Last reviewed: Dec 15, 2018)	criteria provided, single submitter	VCV000469578	3	38180162 - 38180180	3	38138671 - 38138689	469578	452531	rs746651350	NC_000003.12:38138670:GACCGCGCTGAGGCTCCAGGACCGC:GACCGC
NM_002468.5(MYD88):c.278T>C (p.Leu93Pro)	MYD88	L93P, L106P	Myd88 deficiency	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000007496	3	38180469	3	38138978	7496	22535	rs137853065	NC_000003.12:38138977:T:C
NM_002468.5(MYD88):c.586C>T (p.Arg196Cys)	MYD88	R196C, R164C, R209C, R151C	Myd88 deficiency	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000007495	3	38182001	3	38140510	7495	22534	rs137853064	NC_000003.12:38140509:C:T
NM_017541.4(CRYGS):c.30_31delinsAA (p.Phe10_Tyr11delinsLeuAsn)	CRYGS		Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252949	3	186257377 - 186257378	3	186539588 - 186539589	252949	247350	rs1114167312	NC_000003.12:186539587:AG:TT
NM_017541.4(CRYGS):c.124G>A (p.Val42Met)	CRYGS	V42M		Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000617601	3	186257284	3	186539495	617601	608998		NC_000003.12:186539494:C:T
NM_017541.4(CRYGS):c.116C>G (p.Ser39Cys)	CRYGS	S39C		Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000617600	3	186257292	3	186539503	617600	608997	rs1184398243	NC_000003.12:186539502:G:C
NM_003999.3(OSMR):c.2090A>C (p.Lys697Thr)	OSMR	K697T, K698T	Primary localized cutaneous amyloidosis 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030222	5	38925351	5	38925249	30222	39178	rs387906823	NC_000005.10:38925248:A:C
NM_003999.3(OSMR):c.1940A>T (p.Asp647Val)	OSMR	D647V, D648V	Primary localized cutaneous amyloidosis 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030220	5	38924593	5	38924491	30220	39176	rs387906821	NC_000005.10:38924490:A:T
NM_000065.4(C6):c.237del (p.Ile80fs)	C6	I80fs	Complement component 6 deficiency	Pathogenic(Last reviewed: Mar 15, 1996)	no assertion criteria provided	VCV000029922	5	41201723	5	41201621	29922	38877	rs398122811	NC_000005.10:41201620:GGGG:GGG
NM_017541.4(CRYGS):c.53G>T (p.Gly18Val)	CRYGS	G18V		Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000016936	3	186257355	3	186539566	16936	31975	rs104893736	NC_000003.12:186539565:C:A
C6, 1-BP DEL, 879G	C6		Complement component 6 deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000012115					12115	27154		
NM_003999.3(OSMR):c.1853G>C (p.Gly618Ala)	OSMR	G618A, G619A	Primary localized cutaneous amyloidosis 1	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007809	5	38923339	5	38923237	7809	22848	rs63750560	NC_000005.10:38923236:G:C
NM_003999.3(OSMR):c.2072T>C (p.Ile691Thr)	OSMR	I691T, I692T	Primary localized cutaneous amyloidosis 1	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007808	5	38925333	5	38925231	7808	22847	rs63750567	NC_000005.10:38925230:T:C
C6, 1-BP DEL, 1195C	C6		Complement component 6 deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000012116					12116	27155		
C6, IVS15DS, T-C, +2	C6		C6 deficiency, subtotal	Pathogenic(Last reviewed: Oct 15, 1996)	no assertion criteria provided	VCV000012114					12114	27153		
C6, 1-BP DEL, 1936G	C6		Complement component 6 deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000012117					12117	27156		
NM_006745.5(MSMO1):c.736G>C (p.Gly246Arg)	MSMO1	G115R, G246R	Microcephaly, congenital cataract, and psoriasiform dermatitis	Pathogenic(Last reviewed: Jun 17, 2016)	no assertion criteria provided	VCV000222976	4	166262952	4	165341800	222976	224697	rs869025577	NC_000004.12:165341799:G:C
NM_006745.5(MSMO1):c.519T>A (p.His173Gln)	MSMO1	H173Q, H42Q	Microcephaly, congenital cataract, and psoriasiform dermatitis	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000222974	4	166259918	4	165338766	222974	224695	rs869025576	NC_000004.12:165338765:T:A
NM_006587.4(CORIN):c.1414A>G (p.Ser472Gly)	CORIN	S472G, S368G, S435G	Preeclampsia/eclampsia 5	Pathogenic(Last reviewed: Mar 21, 2012)	no assertion criteria provided	VCV000030451	4	47667224	4	47665207	30451	39408	rs387906895	NC_000004.12:47665206:T:C
NM_006587.4(CORIN):c.949A>G (p.Lys317Glu)	CORIN	K317E, K250E	Preeclampsia/eclampsia 5	Pathogenic(Last reviewed: Mar 21, 2012)	no assertion criteria provided	VCV000030450	4	47685820	4	47683803	30450	39407	rs387906894	NC_000004.12:47683802:T:C
NM_001126128.2(PROK2):c.163del (p.Ser54_Ile55insTer)	PROK2		Hypogonadotropic hypogonadism 4 with or without anosmia|not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003603	3	71830677	3	71781526	3603	18642	rs554675432	NC_000003.12:71781525:T:
NM_001278689.2(EOGT):c.1335-1G>A	EOGT		Adams-Oliver syndrome 4	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523612	3	69027587	3	68978436	523612	514231	rs185181819	NC_000003.12:68978435:C:T
NM_015028.4(TNIK):c.538C>T (p.Arg180Ter)	TNIK	R180*	Mental retardation, autosomal recessive 54	Pathogenic(Last reviewed: Jul 26, 2016)	no assertion criteria provided	VCV000243022	3	170906592	3	171188803	243022	244104	rs886037841	NC_000003.12:171188802:G:A
NM_017563.5(IL17RD):c.1730C>A (p.Pro577Gln)	IL17RD	P577Q, P433Q	Hypogonadotropic hypogonadism 18 with anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050871	3	57132001	3	57097973	50871	59857	rs587776980	NC_000003.12:57097972:G:T
NM_017563.5(IL17RD):c.1403C>T (p.Ser468Leu)	IL17RD	S468L, S324L	Hypogonadotropic hypogonadism 18 with anosmia	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050870	3	57132328	3	57098300	50870	59856	rs145221454	NC_000003.12:57098299:G:A
NM_001278689.2(EOGT):c.78_81del (p.His27fs)	EOGT	H27fs	Adams-Oliver syndrome 4	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523593	3	69058917 - 69058920	3	69009766 - 69009769	523593	514234	rs771160630	NC_000003.12:69009765:GTGAGT:GT
NM_001278689.2(EOGT):c.404G>A (p.Cys135Tyr)	EOGT	C135Y	Adams-Oliver syndrome 4	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523580	3	69056880	3	69007729	523580	514232	rs1247059195	NC_000003.12:69007728:C:T
NM_001278689.2(EOGT):c.311+1G>T	EOGT		Adams-Oliver syndrome 4	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523579	3	69057578	3	69008427	523579	514233	rs369583084	NC_000003.12:69008426:C:A
NM_001278689.2(EOGT):c.1130G>A (p.Arg377Gln)	EOGT	R377Q, R293Q	Adams-Oliver syndrome 4	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000055818	3	69036618	3	68987467	55818	70474	rs587776995	NC_000003.12:68987466:C:T
NM_001278689.2(EOGT):c.620G>C (p.Trp207Ser)	EOGT	W207S	Adams-Oliver syndrome 4	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000055816	3	69053529	3	69004378	55816	70472	rs587776993	NC_000003.12:69004377:C:G
NM_001278689.2(EOGT):c.1074del (p.Gly359fs)	EOGT	G359fs	Adams-Oliver syndrome 4|Adams-Oliver syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000055817	3	69037455	3	68988304	55817	70473	rs587776994	NC_000003.12:68988303:TT:T
NM_004625.4(WNT7A):c.304C>T (p.Arg102Trp)	WNT7A	R102W	Schinzel phocomelia syndrome	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000253008	3	13896295	3	13854798	253008	247414	rs879255548	NC_000003.12:13854797:G:A
NM_182977.3(NNT):c.211C>T (p.Arg71Ter)	NNT	R71*	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265844	5	43613069	5	43612967	265844	260551	rs886039790	NC_000005.10:43612966:C:T
NM_182977.3(NNT):c.385C>T (p.Arg129Ter)	NNT	R129*	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265843	5	43615953	5	43615851	265843	260550	rs886039789	NC_000005.10:43615850:C:T
NM_182977.3(NNT):c.598G>A (p.Gly200Ser)	NNT	G200S, G69S	GLUCOCORTICOID DEFICIENCY 4 WITH MINERALOCORTICOID DEFICIENCY	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265842	5	43616166	5	43616064	265842	260549	rs886039788	NC_000005.10:43616063:G:A
NM_012343.3(NNT):c.(-54+1_-53-1)_(381+1_382-1)del	NNT		GLUCOCORTICOID DEFICIENCY 4 WITH MINERALOCORTICOID DEFICIENCY	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265841					265841	260548		
NM_182977.3(NNT):c.1163A>C (p.Tyr388Ser)	NNT	Y388S, Y257S	GLUCOCORTICOID DEFICIENCY 4 WITH MINERALOCORTICOID DEFICIENCY	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265840	5	43644777	5	43644675	265840	260547	rs886039787	NC_000005.10:43644674:A:C
NM_182977.3(NNT):c.644T>C (p.Phe215Ser)	NNT	F215S, F84S	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265839	5	43619178	5	43619076	265839	260546	rs886039786	NC_000005.10:43619075:T:C
NM_182977.3(NNT):c.1259dup (p.His421fs)	NNT		Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic	criteria provided, single submitter	VCV000218365	5	43644870 - 43644871	5	43644768 - 43644769	218365	215092	rs864309519	NC_000005.10:43644768:GGG:GGGG
NM_004625.4(WNT7A):c.214G>A (p.Glu72Lys)	WNT7A	E72K	Schinzel phocomelia syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000040302	3	13916528	3	13875031	40302	48778	rs397514666	NC_000003.12:13875030:C:T
NM_004625.4(WNT7A):c.664C>T (p.Arg222Trp)	WNT7A	R222W	Schinzel phocomelia syndrome	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000040130	3	13860827	3	13819330	40130	48633	rs397514643	NC_000003.12:13819329:G:A
NM_182977.3(NNT):c.3022G>C (p.Ala1008Pro)	NNT	A1008P, A877P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035543	5	43702749	5	43702647	35543	44214	rs387907234	NC_000005.10:43702646:G:C
NM_182977.3(NNT):c.3027T>G (p.Asn1009Lys)	NNT	N1009K, N878K	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035542	5	43702754	5	43702652	35542	44213	rs370273690	NC_000005.10:43702651:T:G
NM_182977.3(NNT):c.1107_1110del (p.Thr369_His370insTer)	NNT		Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035541	5	43644719 - 43644722	5	43644617 - 43644620	35541	44212	rs786205345	NC_000005.10:43644616:ACTCAC:AC
NM_182977.3(NNT):c.2930T>C (p.Leu977Pro)	NNT	L977P, L846P	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035540	5	43700274	5	43700172	35540	44211	rs387907233	NC_000005.10:43700171:T:C
NM_182977.3(NNT):c.600-1del	NNT		Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035539	5	43619133	5	43619031	35539	44210	rs786205344	NC_000005.10:43619030:G:
NM_182977.3(NNT):c.1598C>T (p.Ala533Val)	NNT	A533V, A402V	Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency	Pathogenic(Last reviewed: May 27, 2012)	no assertion criteria provided	VCV000035538	5	43649402	5	43649300	35538	44209	rs387907232	NC_000005.10:43649299:C:T
NM_004625.4(WNT7A):c.874C>T (p.Arg292Cys)	WNT7A	R292C	Schinzel phocomelia syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000008060	3	13860617	3	13819120	8060	23099	rs104893835	NC_000003.12:13819119:G:A
NM_004625.4(WNT7A):c.325G>A (p.Ala109Thr)	WNT7A	A109T	Fuhrmann syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000008061	3	13896274	3	13854777	8061	23100	rs104893832	NC_000003.12:13854776:C:T
NM_004625.4(WNT7A):c.610G>A (p.Gly204Ser)	WNT7A	G204S	Schinzel phocomelia syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000035537	3	13860881	3	13819384	35537	44208	rs387907231	NC_000003.12:13819383:C:T
NM_017644.3(KLHL24):c.1A>T (p.Met1Leu)	KLHL24	M1L	not provided	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000432253	3	183368145	3	183650357	432253	425535	rs886037956	NC_000003.12:183650356:A:T
NM_139248.3(LIPH):c.328C>T (p.Arg110Ter)	LIPH	R110*	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000280138	3	185252642	3	185534854	280138	264151	rs768448663	NC_000003.12:185534853:G:A
NM_139248.3(LIPH):c.742C>A (p.His248Asn)	LIPH	H248N	Woolly hair, autosomal recessive 2, with or without hypotrichosis	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000030669	3	185237074	3	185519286	30669	39626	rs201868115	NC_000003.12:185519285:G:T
NM_016828.2(OGG1):c.137G>A (p.Arg46Gln)	OGG1	R46Q	Clear cell carcinoma of kidney	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000007602	3	9792107	3	9750423	7602	22641	rs104893751	NC_000003.12:9750422:G:A
LIPH, 90-BP DUP, NT280	LIPH		Woolly hair, autosomal recessive 2, with or without hypotrichosis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000003306					3306	18345		
LIPH, 5-BP DEL, NT346	LIPH		Hypotrichosis 7	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000003302					3302	18341		
LIPH, EX4 DEL	LIPH		Hypotrichosis 7	Pathogenic(Last reviewed: Nov 10, 2006)	no assertion criteria provided	VCV000003301					3301	18340		
NM_139248.3(LIPH):c.322T>C (p.Trp108Arg)	LIPH	W108R	Woolly hair, autosomal recessive 2, with or without hypotrichosis	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000003305	3	185252648	3	185534860	3305	18344	rs267607219	NC_000003.12:185534859:A:G
LIPH, EXONS 7-8 DEL	LIPH		Hypotrichosis 7|Woolly hair, autosomal recessive 2, with or without hypotrichosis	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000003304					3304	18343		
NM_017644.3(KLHL24):c.2T>C (p.Met1Thr)	KLHL24	M1T	Epidermolysis bullosa simplex, generalized, with scarring and hair loss|Epidermolysis bullosa simplex, Koebner type	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000370042	3	183368146	3	183650358	370042	354282	rs1057515580	NC_000003.12:183650357:T:C
NM_017644.3(KLHL24):c.3G>T (p.Met1Ile)	KLHL24	M1I	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000264647	3	183368147	3	183650359	264647	259240	rs886037957	NC_000003.12:183650358:G:T
NM_017644.3(KLHL24):c.3G>A (p.Met1Ile)	KLHL24	M1I	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000264646	3	183368147	3	183650359	264646	259239	rs886037957	NC_000003.12:183650358:G:A
NM_139248.3(LIPH):c.659_660del (p.Ile220fs)	LIPH	I220fs	Hypotrichosis 7|Woolly hair, autosomal recessive 2, with or without hypotrichosis	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000003303	3	185241917 - 185241918	3	185524129 - 185524130	3303	18342	rs559648418	NC_000003.12:185524128:TAT:T
GRCh37/hg19 4p15.2(chr4:25668462-25681490)x1	SLC34A2		not provided	Pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000687145	4	25668462 - 25681490			687145	674737		
NM_006424.3(SLC34A2):c.212_224del (p.Asn71fs)	SLC34A2	N70fs, N71fs	PULMONARY ALVEOLAR MICROLITHIASIS	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000208162	4	25664426 - 25664438	4	25662804 - 25662816	208162	204422	rs796065044	NC_000004.12:25662803:ACCTACCCACTCT:
NM_002662.5(PLD1):c.2882+2T>C	PLD1		Cardiac valvular defect, developmental	Pathogenic(Last reviewed: May 16, 2017)	no assertion criteria provided	VCV000426091	3	171330067	3	171612277	426091	414650	rs1085307450	NC_000003.12:171612276:A:G
NM_002662.5(PLD1):c.1482_1483CA[1] (p.Thr495fs)	PLD1		Cardiac valvular defect, developmental	Pathogenic(Last reviewed: May 16, 2017)	no assertion criteria provided	VCV000426090	3	171406520 - 171406521	3	171688730 - 171688731	426090	414649	rs778311238	NC_000003.12:171688729:TGTG:TG
NM_002662.5(PLD1):c.1325A>C (p.His442Pro)	PLD1	H442P	Cardiac valvular defect, developmental	Pathogenic(Last reviewed: May 16, 2017)	no assertion criteria provided	VCV000426089	3	171410135	3	171692345	426089	414648	rs769669104	NC_000003.12:171692344:T:G
NM_003085.5(SNCB):c.368C>A (p.Pro123His)	SNCB	P123H, P109H	Lewy body dementia	Pathogenic(Last reviewed: Sep 14, 2004)	no assertion criteria provided	VCV000007026	5	176048219	5	176621218	7026	22065	rs104893937	NC_000005.10:176621217:G:T
NM_003085.5(SNCB):c.208G>A (p.Val70Met)	SNCB	V70M, V56M	Lewy body dementia	Pathogenic(Last reviewed: Sep 14, 2004)	no assertion criteria provided	VCV000007025	5	176053473	5	176626472	7025	22064	rs104893936	NC_000005.10:176626471:C:T
NM_006424.3(SLC34A2):c.316G>C (p.Gly106Arg)	SLC34A2	G106R, G105R	PULMONARY ALVEOLAR MICROLITHIASIS	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000005717	4	25665889	4	25664267	5717	20756	rs137853142	NC_000004.12:25664266:G:C
NM_006424.3(SLC34A2):c.226C>T (p.Gln76Ter)	SLC34A2	Q76*, Q75*	PULMONARY ALVEOLAR MICROLITHIASIS	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000005716	4	25664440	4	25662818	5716	20755	rs137853141	NC_000004.12:25662817:C:T
SLC34A2, 1-BP DEL, 114A	SLC34A2		PULMONARY ALVEOLAR MICROLITHIASIS	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000005715					5715	20754		
SLC34A2, 186-BP DEL	SLC34A2		PULMONARY ALVEOLAR MICROLITHIASIS	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000005714					5714	20753		
NM_002468.5(MYD88):c.154_156GAG[1] (p.Glu53del)	MYD88	E66del	Myd88 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235259	3	38180344 - 38180346	3	38138853 - 38138855	235259	236946	rs878852993	NC_000003.12:38138852:GGAGGAG:GGAG
NM_001369848.1(PRSS56):c.1186T>C (p.Cys396Arg)	PRSS56	C395R, C396R	Microphthalmia, isolated 6	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000183174	2	233388652	2	232523942	183174	181306	rs730882161	NC_000002.12:232523941:T:C
NM_001369848.1(PRSS56):c.709G>A (p.Gly237Arg)	PRSS56	G237R	Microphthalmia, isolated 6	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000183173	2	233387772	2	232523062	183173	181305	rs730882160	NC_000002.12:232523061:G:A
NM_001369848.1(PRSS56):c.833dup (p.Val279fs)	PRSS56		Microphthalmia, isolated 6	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000183172	2	233387890 - 233387891	2	232523180 - 232523181	183172	181304	rs730882159	NC_000002.12:232523180:GGGGGG:GGGGGGG
NM_001369848.1(PRSS56):c.958G>A (p.Gly320Arg)	PRSS56	G320R	Microphthalmia, isolated 6	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000183170	2	233388234	2	232523524	183170	181302	rs730882158	NC_000002.12:232523523:G:A
NM_001369848.1(PRSS56):c.526C>G (p.Arg176Gly)	PRSS56	R176G	Microphthalmia, isolated 6	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000031080	2	233387304	2	232522594	31080	40037	rs387907096	NC_000002.12:232522593:C:G
NM_199069.2(NDUFAF3):c.2T>C (p.Met1Thr)	NDUFAF3	M1T	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000424	3	49059579	3	49022146	424	15463	rs121918136	NC_000003.12:49022145:T:C
NM_199069.2(NDUFAF3):c.365G>C (p.Arg122Pro)	NDUFAF3	R122P, R65P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000423	3	49060336	3	49022903	423	15462	rs121918135	NC_000003.12:49022902:G:C
NM_199069.2(NDUFAF3):c.229G>C (p.Gly77Arg)	NDUFAF3	G77R, G20R	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000422	3	49059930	3	49022497	422	15461	rs121918134	NC_000003.12:49022496:G:C
NM_001369848.1(PRSS56):c.1558G>A (p.Gly520Arg)	PRSS56	G519R, G520R	Microphthalmia, isolated 6	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000183175	2	233389959	2	232525249	183175	181307	rs730882162	NC_000002.12:232525248:G:A
NM_001369848.1(PRSS56):c.926G>C (p.Trp309Ser)	PRSS56	W309S	Microphthalmia, isolated 6	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000031079	2	233388202	2	232523492	31079	40036	rs387907095	NC_000002.12:232523491:G:C
NM_000065.4(C6):c.1879del (p.Asp627fs)	C6	D627fs	Immunodeficiency due to a late component of complement deficiency|Complement component 6 deficiency	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000505659	5	41158865	5	41158763	505659	496803	rs61469168	NC_000005.10:41158762:C:
NM_016580.4(PCDH12):c.669dup (p.Lys224fs)	PCDH12		not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000817069	5	141336747 - 141336748	5	141957182 - 141957183	817069	805418		NC_000005.10:141957182:GGGGGGG:GGGGGGGG
NM_016580.3(PCDH12):c.922C>T (p.Arg308Ter)	PCDH12	R308*	not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000620173	5	141336495	5	141956930	620173	611626	rs370283860	NC_000005.10:141956929:G:A
PCDH12, ARG151TER	PCDH12	R151*	Diencephalic-mesencephalic junction dysplasia syndrome 1	Pathogenic(Last reviewed: Oct 30, 2019)	no assertion criteria provided	VCV000694061					694061	681867		
NM_016580.3(PCDH12):c.1060del (p.Val354fs)	PCDH12	V354fs	Diencephalic-mesencephalic junction dysplasia syndrome	Pathogenic(Last reviewed: Sep 3, 2018)	no assertion criteria provided	VCV000684720	5	141336357	5	141956792	684720	672238		NC_000005.10:141956791:C:
NM_016580.3(PCDH12):c.2299C>T (p.Gln767Ter)	PCDH12	Q767*	not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000640849	5	141335118	5	141955553	640849	633544		NC_000005.10:141955552:G:A
NM_016580.3(PCDH12):c.2515C>T (p.Arg839Ter)	PCDH12	R839*	Diencephalic-mesencephalic junction dysplasia syndrome 1	Pathogenic(Last reviewed: Oct 30, 2019)	no assertion criteria provided	VCV000440889	5	141334902	5	141955337	440889	434518	rs375346212	NC_000005.10:141955336:G:A
NM_016580.3(PCDH12):c.2765_2766del (p.Pro922fs)	PCDH12	P922fs	Diencephalic-mesencephalic junction dysplasia syndrome|Diencephalic-mesencephalic junction dysplasia syndrome 1	Pathogenic(Last reviewed: Oct 30, 2019)	no assertion criteria provided	VCV000684719	5	141334651 - 141334652	5	141955086 - 141955087	684719	672236		NC_000005.10:141955085:AG:
NM_016580.3(PCDH12):c.2511del (p.Ser838fs)	PCDH12	S838fs	Diencephalic-mesencephalic junction dysplasia syndrome|Diencephalic-mesencephalic junction dysplasia syndrome 1	Pathogenic(Last reviewed: Oct 30, 2019)	no assertion criteria provided	VCV000684718	5	141334906	5	141955341	684718	672237		NC_000005.10:141955340:C:
NM_057175.5(NAA15):c.1750del (p.Thr584fs)	NAA15	T584fs	not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000817754	4	140283088	4	139361934	817754	805382		NC_000004.12:139361933:A:
NM_057175.5(NAA15):c.1521dup (p.Cys508fs)	NAA15		not provided	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000817654	4	140281761 - 140281762	4	139360607 - 139360608	817654	805381		NC_000004.12:139360607:AAA:AAAA
NM_057175.5(NAA15):c.1268_1269AT[1] (p.Asn423_Ile424insTer)	NAA15		not provided	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000816999	4	140280907 - 140280908	4	139359753 - 139359754	816999	805380		NC_000004.12:139359752:ATAT:AT
NM_057175.5(NAA15):c.430C>T (p.Arg144Ter)	NAA15	R144*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000620471	4	140264007	4	139342853	620471	611605	rs1560966086	NC_000004.12:139342852:C:T
NM_057175.5(NAA15):c.1477C>T (p.Gln493Ter)	NAA15	Q493*	not provided	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000620403	4	140281720	4	139360566	620403	611606	rs1560973974	NC_000004.12:139360565:C:T
NM_057175.5(NAA15):c.2322C>G (p.Tyr774Ter)	NAA15	Y774*	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000268211	4	140307306	4	139386152	268211	263827	rs886041097	NC_000004.12:139386151:C:G
NM_057175.5(NAA15):c.103C>T (p.Gln35Ter)	NAA15	Q35*	not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000641161	4	140255376	4	139334222	641161	631953		NC_000004.12:139334221:C:T
NM_057175.5(NAA15):c.913A>T (p.Lys305Ter)	NAA15	K305*	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000559847	4	140272664	4	139351510	559847	550569	rs1553996072	NC_000004.12:139351509:A:T
NM_057175.5(NAA15):c.1009_1012del (p.Glu337fs)	NAA15	E337fs	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Aug 21, 2018)	no assertion criteria provided	VCV000559846	4	140272757 - 140272760	4	139351603 - 139351606	559846	550568	rs1553996086	NC_000004.12:139351602:AAAGAAA:AAA
NM_057175.5(NAA15):c.163del (p.Thr55fs)	NAA15	T55fs	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Aug 21, 2018)	no assertion criteria provided	VCV000559845	4	140258024	4	139336870	559845	550567	rs1553994814	NC_000004.12:139336869:AA:A
NM_057175.5(NAA15):c.2086A>T (p.Lys696Ter)	NAA15	K696*	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446519	4	140299939	4	139378785	446519	440037	rs1553998565	NC_000004.12:139378784:A:T
NM_057175.5(NAA15):c.1695T>A (p.Tyr565Ter)	NAA15	Y565*	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446518	4	140283033	4	139361879	446518	440036	rs1553997065	NC_000004.12:139361878:T:A
NM_057175.5(NAA15):c.239_240del (p.His80fs)	NAA15	H80fs	not provided|Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Aug 4, 2019)	criteria provided, single submitter	VCV000559844	4	140258101 - 140258102	4	139336947 - 139336948	559844	550566	rs779009256	NC_000004.12:139336946:AT:
NM_001369848.1(PRSS56):c.1069dup (p.Gln357fs)	PRSS56		Microphthalmia, isolated 6|not provided	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000031077	2	233388527 - 233388528	2	232523817 - 232523818	31077	40034	rs730882064	NC_000002.12:232523817:CCCCCCCC:CCCCCCCCC
NM_017644.3(KLHL24):c.1A>G (p.Met1Val)	KLHL24	M1V	Epidermolysis bullosa simplex, Koebner type|not provided|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000264648	3	183368145	3	183650357	264648	259241	rs886037956	NC_000003.12:183650356:A:G
NM_005862.3(STAG1):c.260del (p.Leu87fs)	STAG1	L87fs	MENTAL RETARDATION, AUTOSOMAL DOMINANT 47	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802013	3	136323188	3	136604346	802013	790338		NC_000003.12:136604345:AA:A
GRCh37/hg19 3q22.3(chr3:136193031-136305476)x1	STAG1		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000689317	3	136193031 - 136305476			689317	676909		
GRCh37/hg19 3q22.3(chr3:136192663-136396078)x1	STAG1		not provided	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000686586	3	136192663 - 136396078			686586	674178		
NM_005862.3(STAG1):c.2241G>A (p.Trp747Ter)	STAG1	W747*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	no assertion criteria provided	VCV000545081	3	136117627	3	136398785	545081	535299	rs1553801881	NC_000003.12:136398784:C:T
NM_001130105.1(CERT1):c.778T>C (p.Ser260Pro)	CERT1	S260P, S132P	not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000452039	5	74722258	5	75426433	452039	443823	rs1554039069	NC_000005.10:75426432:A:G
NM_001130105.1(CERT1):c.779C>T (p.Ser260Leu)	CERT1	S260L, S132L	not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000419654	5	74722257	5	75426432	419654	406763	rs1064794019	NC_000005.10:75426431:G:A
NC_000003.12:g.(?_136452033)_(136477412_?)del	STAG1		not provided	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000830788	3	136170875 - 136196254			830788	819329		
STAG1, 173-BP DEL	STAG1		MENTAL RETARDATION, AUTOSOMAL DOMINANT 47	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437896					437896	431518		
COL4A3BP, SER132LEU	CERT1	S132L	Mental retardation, autosomal dominant 34	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190276					190276	188110		
NM_000965.4(RARB):c.1203_1204TC[3] (p.Ile403fs)	RARB		Microphthalmia, syndromic 12	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088761	3	25637961 - 25637962	3	25596470 - 25596471	88761	94342	rs397518482	NC_000003.12:25596470:CTCTC:CTCTCTC
NM_018475.5(TMEM165):c.910G>A (p.Gly304Arg)	TMEM165	G304R	Congenital disorder of glycosylation type 2k	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035521	4	56291554	4	55425387	35521	44198	rs886037631	NC_000004.12:55425386:G:A
NM_018475.5(TMEM165):c.377G>A (p.Arg126His)	TMEM165	R126H	Congenital disorder of glycosylation type 2k	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035519	4	56277950	4	55411783	35519	44196	rs387907221	NC_000004.12:55411782:G:A
NM_018475.5(TMEM165):c.792+182G>A	TMEM165		Congenital disorder of glycosylation type 2k	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035518	4	56284334	4	55418167	35518	44195	rs793888506	NC_000004.12:55418166:G:A
NM_005862.3(STAG1):c.1736dup (p.Ser580fs)	STAG1		STAG1-related disorder|MENTAL RETARDATION, AUTOSOMAL DOMINANT 47	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437901	3	136141800 - 136141801	3	136422958 - 136422959	437901	431523	rs1553718528	NC_000003.12:136422958:A:AA
NM_005862.3(STAG1):c.1460_1464dup (p.Trp489fs)	STAG1		STAG1-related disorder|MENTAL RETARDATION, AUTOSOMAL DOMINANT 47	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437900	3	136162210 - 136162211	3	136443368 - 136443369	437900	431522	rs1553722294	NC_000003.12:136443368:TAAACT:TAAACTAAACT
NM_005862.3(STAG1):c.646A>G (p.Arg216Gly)	STAG1	R216G	STAG1-related disorder|MENTAL RETARDATION, AUTOSOMAL DOMINANT 47	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437898	3	136240085	3	136521243	437898	431520	rs1553738686	NC_000003.12:136521242:T:C
NM_005862.3(STAG1):c.1433A>C (p.His478Pro)	STAG1	H478P	STAG1-related disorder|MENTAL RETARDATION, AUTOSOMAL DOMINANT 47	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437897	3	136162242	3	136443400	437897	431519	rs1553722309	NC_000003.12:136443399:T:G
NM_000965.4(RARB):c.1159C>A (p.Arg387Ser)	RARB	R387S, R275S, R338S, R344S, R394S, R341S	Microphthalmia, syndromic 12	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088763	3	25637919	3	25596428	88763	94344	rs397518483	NC_000003.12:25596427:C:A
NM_000965.4(RARB):c.355C>T (p.Arg119Ter)	RARB	R119*, R126*, R7*, R76*, R70*	Microphthalmia, syndromic 12	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088760	3	25542721	3	25501230	88760	94341	rs397518481	NC_000003.12:25501229:C:T
NM_057175.4(NAA15):c.228_232del (p.Asp76Glufs)	NAA15	D76fs	not provided|Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446520	4	140258087 - 140258091	4	139336933 - 139336937	446520	440038	rs1380822792	NC_000004.12:139336932:TGACTTGA:TGA
NM_005321.3(H1-4):c.444_466del (p.Lys149fs)	H1-4	K149fs	not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000817681	6	26157056 - 26157078	6	26156828 - 26156850	817681	805495		NC_000006.12:26156827:CCCCAAGAAGAGCGCCAAGAAGACCCCAA:CCCCAA
NM_005321.3(H1-4):c.430delinsCC (p.Ala144fs)	H1-4		not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000817475	6	26157048	6	26156820	817475	805494		NC_000006.12:26156819:G:CC
NM_005321.3(H1-4):c.392dup (p.Ala132fs)	H1-4		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000817291	6	26157008 - 26157009	6	26156780 - 26156781	817291	805493		NC_000006.12:26156780:CC:CCC
NM_005321.3(H1-4):c.429_430del (p.Ala144fs)	H1-4	A144fs	RAHMAN SYNDROME	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801359	6	26157044 - 26157045	6	26156816 - 26156817	801359	789742		NC_000006.12:26156815:GGGGG:GGG
NM_005321.2(H1-4):c.454_455insT (p.Lys152fs)	H1-4		not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000523954	6	26157072 - 26157073	6	26156844 - 26156845	523954	514534	rs1554162894	NC_000006.12:26156844::T
NM_005321.2(H1-4):c.433dup (p.Ala145fs)	H1-4		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000503824	6	26157049 - 26157050	6	26156821 - 26156822	503824	495307	rs1554162872	NC_000006.12:26156821:GG:GGG
NM_147196.2(TMIE):c.92A>G (p.Glu31Gly)	TMIE	E31G	not provided	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	VCV000372538	3	46743069	3	46701579	372538	359531	rs1057517839	NC_000003.12:46701578:A:G
NM_001354930.2(RIPK1):c.1802G>A (p.Cys601Tyr)	RIPK1	C601Y, C555Y, C438Y	Primary immunodeficiency|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome	Pathogenic	no assertion criteria provided	VCV000598791	6	3113359	6	3113125	598791	589849	rs1561780980	NC_000006.12:3113124:G:A
NM_001354930.2(RIPK1):c.1278C>A (p.Tyr426Ter)	RIPK1	Y426*, Y263*, Y380*	Primary immunodeficiency|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome	Pathogenic	no assertion criteria provided	VCV000598789	6	3105987	6	3105753	598789	589848	rs374657927	NC_000006.12:3105752:C:A
NM_001354930.2(RIPK1):c.1934C>T (p.Thr645Met)	RIPK1	T645M, T482M, T599M	Primary immunodeficiency|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome	Pathogenic	no assertion criteria provided	VCV000598788	6	3113491	6	3113257	598788	589851	rs116040763	NC_000006.12:3113256:C:T
NM_001354930.2(RIPK1):c.1844T>C (p.Ile615Thr)	RIPK1	I615T, I452T, I569T	Primary immunodeficiency|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome	Pathogenic	no assertion criteria provided	VCV000598787	6	3113401	6	3113167	598787	589850	rs752183065	NC_000006.12:3113166:T:C
RIPK1, 2,064-BP DEL	RIPK1		IMMUNODEFICIENCY 57	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000561166					561166	552272		
RIPK1, 21-BP DEL	RIPK1		IMMUNODEFICIENCY 57	Pathogenic(Last reviewed: Sep 12, 2018)	no assertion criteria provided	VCV000561165					561165	552271		
RIPK1, 4-BP DEL	RIPK1		IMMUNODEFICIENCY 57	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000561164					561164	552270		
NM_147196.3(TMIE):c.58del (p.Val20fs)	TMIE	V20fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817378	3	46743032	3	46701542	817378	805352		NC_000003.12:46701541:GGGG:GGG
NM_005321.3(H1-4):c.464dup (p.Lys157fs)	H1-4		RAHMAN SYNDROME	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000635261	6	26157078 - 26157079	6	26156850 - 26156851	635261	623095		NC_000006.12:26156850:CCCC:CCCCC
NM_005321.3(H1-4):c.447dup (p.Ser150fs)	H1-4		RAHMAN SYNDROME	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000635260	6	26157064 - 26157065	6	26156836 - 26156837	635260	623094		NC_000006.12:26156836:G:GG
NM_005321.3(H1-4):c.425delinsAG (p.Thr142fs)	H1-4		RAHMAN SYNDROME	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000635259	6	26157043	6	26156815	635259	623092		NC_000006.12:26156814:C:AG
NM_005321.2(H1-4):c.425_431delinsAGGGGGTT (p.Thr142fs)	H1-4		RAHMAN SYNDROME	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000635258	6	26157043 - 26157049	6	26156815 - 26156821	635258	623093		NC_000006.12:26156814:CGGGGGC:AGGGGGTT
NM_005321.3(H1-4):c.414dup (p.Lys139fs)	H1-4		RAHMAN SYNDROME	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000635257	6	26157029 - 26157030	6	26156801 - 26156802	635257	623091		NC_000006.12:26156801:CCC:CCCC
NM_147196.2(TMIE):c.170G>A (p.Trp57Ter)	TMIE	W57*, W4*	Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000003394	3	46747356	3	46705866	3394	18433	rs267607120	NC_000003.12:46705865:G:A
NM_147196.2(TMIE):c.94-2_98delinsC	TMIE		Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003393	3	46747278 - 46747284	3	46705788 - 46705794	3393	18432	rs876657371	NC_000003.12:46705787:AGCCCAG:C
NM_147196.2(TMIE):c.241C>T (p.Arg81Cys)	TMIE	R81C, R28C	Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003390	3	46750645	3	46709155	3390	18429	rs28942096	NC_000003.12:46709154:C:T
NM_001370524.1(TMIE):c.-38_-35del	TMIE	P41fs	Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003389	3	46747307 - 46747310	3	46705817 - 46705820	3389	18428	rs876661301	NC_000003.12:46705816:CCGCC:C
NM_001354930.2(RIPK1):c.954del (p.Met318fs)	RIPK1	M318fs, M155fs, M272fs	Primary immunodeficiency|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome|IMMUNODEFICIENCY 57	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000598790	6	3104497	6	3104263	598790	589847	rs1561772403	NC_000006.12:3104262:G:
NM_005321.2(H1-4):c.436_458del (p.Thr146fs)	H1-4	T146fs	not provided|RAHMAN SYNDROME	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000428607	6	26157054 - 26157076	6	26156826 - 26156848	428607	420426	rs1131690807	NC_000006.12:26156825:ACCCCCAAGAAGAGCGCCAAGAA:
NM_005321.3(H1-4):c.408dup (p.Lys137fs)	H1-4		RAHMAN SYNDROME	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635256	6	26157025 - 26157026	6	26156797 - 26156798	635256	623090		NC_000006.12:26156797:G:GG
NM_147196.2(TMIE):c.250C>T (p.Arg84Trp)	TMIE	R84W, R31W	Deafness, autosomal recessive 6	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000003391	3	46750654	3	46709164	3391	18430	rs28942097	NC_000003.12:46709163:C:T
NM_024867.4(SPEF2):c.3240del (p.Phe1080fs)	SPEF2	F1080fs	SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805992	5	35740276	5	35740174	805992	794328		NC_000005.10:35740173:TTTT:TTT
NM_024867.4(SPEF2):c.4952del (p.Val1651fs)	SPEF2	V1651fs	SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805991	5	35800191	5	35800089	805991	794327		NC_000005.10:35800088:T:
NM_024867.4(SPEF2):c.2735del (p.Pro912fs)	SPEF2	P912fs	SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805990	5	35709118	5	35709016	805990	794326		NC_000005.10:35709015:CC:C
NM_024867.4(SPEF2):c.4326dup (p.Val1443fs)	SPEF2		SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805989	5	35779323 - 35779324	5	35779221 - 35779222	805989	794325		NC_000005.10:35779221:AAAA:AAAAA
NM_024867.4(SPEF2):c.4102G>T (p.Glu1368Ter)	SPEF2	E1368*	SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805988	5	35776382	5	35776280	805988	794324		NC_000005.10:35776279:G:T
NM_024867.4(SPEF2):c.1745-2A>G	SPEF2		SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805987	5	35692670	5	35692568	805987	794323		NC_000005.10:35692567:A:G
NM_024867.4(SPEF2):c.13del (p.Leu5fs)	SPEF2	L5fs	SPERMATOGENIC FAILURE 43	Pathogenic(Last reviewed: Jan 27, 2020)	no assertion criteria provided	VCV000805986	5	35618111	5	35618009	805986	794322		NC_000005.10:35618008:CC:C
NM_001190787.3(MCIDAS):c.717+2T>G	MCIDAS		CILIARY DYSKINESIA, PRIMARY, 42	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800285	5	54516842	5	55221014	800285	788391		NC_000005.10:55221013:A:C
NM_002495.4(NDUFS4):c.44G>A (p.Trp15Ter)	NDUFS4	W15*	Mitochondrial complex I deficiency, nuclear type 1	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000006890	5	52856536	5	53560706	6890	21929	rs104893899	NC_000005.10:53560705:G:A
NM_002495.4(NDUFS4):c.466_470dup (p.Lys158fs)	NDUFS4		Mitochondrial complex I deficiency, nuclear type 1	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000006887	5	52978987 - 52978988	5	53683157 - 53683158	6887	21926	rs1445075330	NC_000005.10:53683157:CAAGTC:CAAGTCAAGTC
NM_001190787.2(MCIDAS):c.135del (p.Lys46fs)	MCIDAS	K46fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000565534	5	54522745	5	55226917	565534	560480	rs1561117442	NC_000005.10:55226916:CC:C
NM_002495.4(NDUFS4):c.316C>T (p.Arg106Ter)	NDUFS4	R106*	Mitochondrial complex I deficiency|Mitochondrial complex I deficiency, nuclear type 1	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000006889	5	52942201	5	53646371	6889	21928	rs104893898	NC_000005.10:53646370:C:T
NM_002495.4(NDUFS4):c.291del (p.Lys96_Trp97insTer)	NDUFS4	W96*	Mitochondrial complex I deficiency, nuclear type 1|not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000006888	5	52942175	5	53646345	6888	21927	rs121908985	NC_000005.10:53646344:GG:G
NM_002495.4(NDUFS4):c.470_471del (p.Lys156_Ser157insTer)	NDUFS4		Leigh syndrome	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488560	5	52978993 - 52978994	5	53683163 - 53683164	488560	481428	rs1554062427	NC_000005.10:53683162:CC:
NM_002495.4(NDUFS4):c.178-2A>G	NDUFS4		Leigh syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488559	5	52942061	5	53646231	488559	481427	rs1554059248	NC_000005.10:53646230:A:G
NM_001190787.3(MCIDAS):c.1097G>A (p.Gly366Asp)	MCIDAS	G366D	CILIARY DYSKINESIA, PRIMARY, 42|Kartagener syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000209008	5	54516255	5	55220427	209008	205554	rs797045151	NC_000005.10:55220426:C:T
NM_005321.2(H1-4):c.441dup (p.Lys148fs)	H1-4		not provided|RAHMAN SYNDROME	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428606	6	26157054 - 26157055	6	26156826 - 26156827	428606	420425	rs1131690806	NC_000006.12:26156826:CCCCC:CCCCCC
NM_020928.2(ZSWIM6):c.2737C>T (p.Arg913Ter)	ZSWIM6	R913*	ZSWIM6 related intellectual disability|NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES|not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431797	5	60837744	5	61541917	431797	425299	rs1554041295	NC_000005.10:61541916:C:T
NM_001190787.3(MCIDAS):c.1142G>A (p.Arg381His)	MCIDAS	R381H	CILIARY DYSKINESIA, PRIMARY, 42|Kartagener syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000209009	5	54516210	5	55220382	209009	205553	rs797045152	NC_000005.10:55220381:C:T
NM_001190787.3(MCIDAS):c.441C>A (p.Cys147Ter)	MCIDAS	C147*	CILIARY DYSKINESIA, PRIMARY, 42|Kartagener syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000209007	5	54518169	5	55222341	209007	205555	rs777031813	NC_000005.10:55222340:G:T
NM_001012339.3(DNAJC21):c.647_666del (p.Arg216fs)	DNAJC21	R216fs	Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807409	5	34937635 - 34937654	5	34937530 - 34937549	807409	798560		NC_000005.10:34937529:AAAAGAGTGCAGGCGCATCGAAAA:AAAA
NM_001012339.3(DNAJC21):c.982del (p.Ala328fs)	DNAJC21	A328fs	Bone marrow failure syndrome 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802111	5	34941286	5	34941181	802111	790553		NC_000005.10:34941180:GG:G
NM_005630.3(SLCO2A1):c.270C>G (p.Tyr90Ter)	SLCO2A1	Y90*	not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000620392	3	133692634	3	133973790	620392	611582	rs1381150705	NC_000003.12:133973789:G:C
NM_001205254.2(OCLN):c.1014_1015AG[1] (p.Glu339fs)	OCLN		not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000503999	5	68830643 - 68830644	5	69534816 - 69534817	503999	495503	rs1303392945	NC_000005.10:69534815:AGAG:AG
NM_001012339.3(DNAJC21):c.520C>T (p.Gln174Ter)	DNAJC21	Q174*	Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jan 30, 2019)	no assertion criteria provided	VCV000617606	5	34937512	5	34937407	617606	609003	rs1561183139	NC_000005.10:34937406:C:T
NM_000856.6(GUCY1A1):c.1954G>T (p.Gly652Ter)	GUCY1A1	G652*, G417*	Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559599	4	156651264	4	155730112	559599	550320	rs1368733883	NC_000004.12:155730111:G:T
NM_001205254.2(OCLN):c.1037+1G>A	OCLN		Pseudo-TORCH syndrome 1	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000436101	5	68830667	5	69534840	436101	428464	rs748442113	NC_000005.10:69534839:G:A
NM_001012339.3(DNAJC21):c.983+1G>T	DNAJC21		Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000253171	5	34941289	5	34941184	253171	247583	rs368148362	NC_000005.10:34941183:G:T
NM_000856.6(GUCY1A1):c.1170del (p.Glu391fs)	GUCY1A1	E156fs, E391fs	Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000127096	4	156634333	4	155713181	127096	132605	rs587777322	NC_000004.12:155713180:A:
NM_000856.6(GUCY1A1):c.1045C>T (p.Arg349Ter)	GUCY1A1	R349*, R114*	Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000127095	4	156632362	4	155711210	127095	132604	rs587777321	NC_000004.12:155711209:C:T
NM_000856.6(GUCY1A1):c.1086+1G>A	GUCY1A1		Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000127094	4	156632404	4	155711252	127094	132603	rs587777320	NC_000004.12:155711251:G:A
NM_000856.6(GUCY1A1):c.488dup (p.Leu163fs)	GUCY1A1		Myocardial infarction 1	Pathogenic(Last reviewed: Sep 15, 2013)	no assertion criteria provided	VCV000065427	4	156631799 - 156631800	4	155710647 - 155710648	65427	76355	rs587777928	NC_000004.12:155710647:TTTTTT:TTTTTTT
NM_005630.3(SLCO2A1):c.253A>T (p.Ile85Phe)	SLCO2A1	I85F	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000037170	3	133692651	3	133973807	37170	45810	rs387907296	NC_000003.12:133973806:T:A
NM_005630.3(SLCO2A1):c.1259G>T (p.Cys420Phe)	SLCO2A1	C420F	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000037169	3	133666136	3	133947292	37169	45809	rs387907295	NC_000003.12:133947291:C:A
NM_005630.3(SLCO2A1):c.830dup (p.Phe278fs)	SLCO2A1		Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000037167	3	133670082 - 133670083	3	133951238 - 133951239	37167	45807	rs751192029	NC_000003.12:133951238:AAAAAAAA:AAAAAAAAA
NM_005630.3(SLCO2A1):c.1634del (p.Asn545fs)	SLCO2A1	N545fs	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030188	3	133657329	3	133938485	30188	39144	rs1559927542	NC_000003.12:133938484:TT:T
NM_005630.3(SLCO2A1):c.764G>A (p.Gly255Glu)	SLCO2A1	G255E	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030187	3	133670149	3	133951305	30187	39143	rs387906806	NC_000003.12:133951304:C:T
NM_005630.3(SLCO2A1):c.97-1G>A	SLCO2A1		Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030186	3	133698463	3	133979619	30186	39142	rs1559943990	NC_000003.12:133979618:C:T
NM_001205254.2(OCLN):c.656T>C (p.Phe219Ser)	OCLN	F219S	Pseudo-TORCH syndrome 1	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000006752	5	68805573	5	69509746	6752	21791	rs267606926	NC_000005.10:69509745:T:C
NM_001205254.2(OCLN):c.512dup (p.Tyr171Ter)	OCLN		Pseudo-TORCH syndrome 1	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000006751	5	68805428 - 68805429	5	69509601 - 69509602	6751	21790	rs749237456	NC_000005.10:69509601:A:AA
NM_012464.5(TLL1):c.1885A>G (p.Ile629Val)	TLL1	I629V	Atrial septal defect 6	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000004076	4	166981218	4	166060066	4076	19115	rs137852953	NC_000004.12:166060065:A:G
NM_012464.5(TLL1):c.713T>C (p.Val238Ala)	TLL1	V238A	Atrial septal defect 6	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000004075	4	166924623	4	166003471	4075	19114	rs137852952	NC_000004.12:166003470:T:C
NM_012464.5(TLL1):c.544A>C (p.Met182Leu)	TLL1	M182L	Atrial septal defect 6	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000004074	4	166916242	4	165995090	4074	19113	rs137852951	NC_000004.12:165995089:A:C
NM_012464.5(TLL1):c.1379-2A>G	TLL1		Atrial septal defect 6	Pathogenic	criteria provided, single submitter	VCV000690359	4	166964424	4	166043272	690359	678038		NC_000004.12:166043271:A:G
NM_001012339.3(DNAJC21):c.100A>G (p.Lys34Glu)	DNAJC21	K34E	Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jan 30, 2019)	no assertion criteria provided	VCV000617607	5	34933922	5	34933817	617607	609004	rs1561180439	NC_000005.10:34933816:A:G
NM_005630.3(SLCO2A1):c.1807C>T (p.Arg603Ter)	SLCO2A1	R603*	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225477	3	133654625	3	133935781	225477	227249	rs776813259	NC_000003.12:133935780:G:A
NM_005630.3(SLCO2A1):c.310G>T (p.Gly104Ter)	SLCO2A1	G104*	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000037171	3	133692594	3	133973750	37171	45811	rs387907297	NC_000003.12:133973749:C:A
NM_001205254.2(OCLN):c.171_193del (p.Lys57fs)	OCLN	K57fs	Pseudo-TORCH syndrome 1	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000006750	5	68805087 - 68805109	5	69509260 - 69509282	6750	21789	rs1561334604	NC_000005.10:69509259:AATGGACCTCTCCTCCAGGAGTGA:A
NM_000856.6(GUCY1A1):c.332_333GA[1] (p.Glu112fs)	GUCY1A1		Moyamoya disease 1|Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559598	4	156629401 - 156629402	4	155708249 - 155708250	559598	550319	rs781020381	NC_000004.12:155708248:AGAGA:AGA
NM_000856.6(GUCY1A1):c.1550G>A (p.Cys517Tyr)	GUCY1A1	C517Y, C282Y	Moyamoya disease 1|Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559597	4	156634713	4	155713561	559597	550318	rs751701114	NC_000004.12:155713560:G:A
NM_000856.6(GUCY1A1):c.1258C>T (p.Arg420Ter)	GUCY1A1	R42*, R420*, R185*	Moyamoya disease 1|Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559596	4	156634421	4	155713269	559596	550317	rs373182378	NC_000004.12:155713268:C:T
NM_005630.3(SLCO2A1):c.664G>A (p.Gly222Arg)	SLCO2A1	G222R	Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438675	3	133672567	3	133953723	438675	432290	rs774795340	NC_000003.12:133953722:C:T
NM_001012339.3(DNAJC21):c.793G>T (p.Glu265Ter)	DNAJC21	E265*	Inherited bone marrow failure syndrome|Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000222065	5	34939012	5	34938907	222065	223764	rs770282904	NC_000005.10:34938906:G:T
NM_001012339.3(DNAJC21):c.517C>T (p.Arg173Ter)	DNAJC21	R173*	Inherited bone marrow failure syndrome|Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000222064	5	34937509	5	34937404	222064	223763	rs150576702	NC_000005.10:34937403:C:T
NM_001012339.3(DNAJC21):c.94C>G (p.Pro32Ala)	DNAJC21	P32A	Inherited bone marrow failure syndrome|Bone marrow failure syndrome 3	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000222063	5	34930018	5	34929913	222063	223761	rs879253818	NC_000005.10:34929912:C:G
NM_001205254.2(OCLN):c.1037+5G>A	OCLN		Pseudo-TORCH syndrome 1	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	VCV000211774	5	68830671	5	69534844	211774	207280	rs797045840	NC_000005.10:69534843:G:A
NM_005630.3(SLCO2A1):c.940+1G>A	SLCO2A1		Primary hypertrophic osteoarthropathy, autosomal recessive 2	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225478	3	133667736	3	133948892	225478	227251	rs765249238	NC_000003.12:133948891:C:T
NM_001012339.3(DNAJC21):c.544C>T (p.Arg182Ter)	DNAJC21	R182*	Acute myeloid leukemia|Pectus excavatum|Cognitive impairment|Pancytopenia|Webbed neck|Abnormality of the tongue|Short stature	Pathogenic	criteria provided, single submitter	VCV000598950	5	34937536	5	34937431	598950	590056	rs771063992	NC_000005.10:34937430:C:T
NM_015312.3(KIAA1109):c.997dup (p.Ile333fs)	KIAA1109		not provided	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000280219	4	123113478 - 123113479	4	122192323 - 122192324	280219	264177	rs886041465	NC_000004.12:122192323:A:AA
NM_015312.3(KIAA1109):c.10153G>C (p.Gly3385Arg)	KIAA1109	G3385R	ALKURAYA-KUCINSKAS SYNDROME	Pathogenic(Last reviewed: Jan 11, 2018)	no assertion criteria provided	VCV000487551	4	123230520	4	122309365	487551	480600	rs1554059454	NC_000004.12:122309364:G:C
NM_015312.3(KIAA1109):c.2902C>T (p.Arg968Cys)	KIAA1109	R968C	ALKURAYA-KUCINSKAS SYNDROME	Pathogenic(Last reviewed: Jan 11, 2018)	no assertion criteria provided	VCV000487550	4	123147970	4	122226815	487550	480599	rs1051597475	NC_000004.12:122226814:C:T
NM_015312.3(KIAA1109):c.3611del (p.Asn1204fs)	KIAA1109	N1204fs	ALKURAYA-KUCINSKAS SYNDROME	Pathogenic(Last reviewed: Jan 11, 2018)	no assertion criteria provided	VCV000487549	4	123159280	4	122238125	487549	480598	rs775516790	NC_000004.12:122238124:AAAA:AAA
NM_015312.3(KIAA1109):c.5599G>A (p.Val1867Met)	KIAA1109	V1867M	ALKURAYA-KUCINSKAS SYNDROME	Pathogenic(Last reviewed: Jan 11, 2018)	no assertion criteria provided	VCV000487548	4	123170726	4	122249571	487548	480597	rs1554025656	NC_000004.12:122249570:G:A
NM_015312.3(KIAA1109):c.3986A>G (p.Tyr1329Cys)	KIAA1109	Y1329C	ALKURAYA-KUCINSKAS SYNDROME	Pathogenic(Last reviewed: Jan 11, 2018)	no assertion criteria provided	VCV000487547	4	123160823	4	122239668	487547	480596	rs770791100	NC_000004.12:122239667:A:G
NM_144499.3(GNAT1):c.386A>G (p.Asp129Gly)	GNAT1	D129G	Night blindness, congenital stationary, type 1g	Pathogenic(Last reviewed: Mar 13, 2012)	no assertion criteria provided	VCV000190968	3	50231033	3	50193600	190968	188776	rs786205854	NC_000003.12:50193599:A:G
NM_144499.3(GNAT1):c.598C>G (p.Gln200Glu)	GNAT1	Q200E	Congenital stationary night blindness, autosomal dominant 3	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000190967	3	50231544	3	50194111	190967	188775	rs786205853	NC_000003.12:50194110:C:G
NM_145261.4(DNAJC19):c.300del (p.Ala101fs)	DNAJC19	A101fs, A76fs	3-methylglutaconic aciduria type V	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000120181	3	180702479	3	180984691	120181	125789	rs587777224	NC_000003.12:180984690:T:
NM_144499.3(GNAT1):c.113G>A (p.Gly38Asp)	GNAT1	G38D	Congenital stationary night blindness, autosomal dominant 3	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000015926	3	50230572	3	50193139	15926	30965	rs104893740	NC_000003.12:50193138:G:A
NM_144499.3(GNAT1):c.460G>T (p.Asp154Tyr)	GNAT1	D154Y	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812325	3	50231196	3	50193763	812325	800493		NC_000003.12:50193762:G:T
NM_144499.3(GNAT1):c.8del (p.Ala3fs)	GNAT1	A3fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812324	3	50229166	3	50191733	812324	800492		NC_000003.12:50191732:C:
NM_015312.3(KIAA1109):c.1557T>A (p.Tyr519Ter)	KIAA1109	Y519*	ALKURAYA-KUCINSKAS SYNDROME|Dandy-Walker syndrome|Hydrocephalus|Clubfoot|Flexed deformity|Micrognathia|Pleural effusion	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183349	4	123128323	4	122207168	183349	181412	rs730882245	NC_000004.12:122207167:T:A
NM_145261.4(DNAJC19):c.130-1G>C	DNAJC19		3-methylglutaconic aciduria type V	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000001951	3	180704811	3	180987023	1951	16990	rs137854888	NC_000003.12:180987022:C:G
NM_014402.5(UQCRQ):c.134C>T (p.Ser45Phe)	UQCRQ	S45F	not provided|Mitochondrial complex III deficiency, nuclear type 4	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000000729	5	132202707	5	132867015	729	15768	rs11544803	NC_000005.10:132867014:C:T
NM_002317.7(LOX):c.604G>T (p.Gly202Ter)	LOX	G202*	Acute aortic dissection|Familial thoracic aortic aneurysm	Pathogenic(Last reviewed: Jan 12, 2016)	no assertion criteria provided	VCV000617847	5	121413077	5	122077382	617847	609199	rs1473260982	NC_000005.10:122077381:C:A
NM_014423.4(AFF4):c.761C>G (p.Thr254Ser)	AFF4	T254S	Chops syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000190330	5	132269996	5	132934304	190330	188157	rs786205679	NC_000005.10:132934303:G:C
NM_014423.4(AFF4):c.760A>G (p.Thr254Ala)	AFF4	T254A	Chops syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000190329	5	132269997	5	132934305	190329	188156	rs786205233	NC_000005.10:132934304:T:C
NM_012188.5(FOXI1):c.800G>A (p.Arg267Gln)	FOXI1	R267Q	Pendred syndrome|Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000008450	5	169535278	5	170108274	8450	23489	rs121909341	NC_000005.10:170108273:G:A
NM_016648.4(LARP7):c.298dup (p.Val100fs)	LARP7		not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426686	4	113567601 - 113567602	4	112646445 - 112646446	426686	414954	rs1085307744	NC_000004.12:112646445:G:GG
NM_153365.3(TAPT1):c.1032G>T (p.Met344Ile)	TAPT1	M344I	Osteochondrodysplasia, complex lethal, symoens-barnes-gistelinck type	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000690289	4	16177817	4	16176194	690289	677968		NC_000004.12:16176193:C:A
NM_016648.4(LARP7):c.209_210AT[4] (p.Ser72fs)	LARP7		Alazami syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000374899	4	113567512 - 113567513	4	112646356 - 112646357	374899	361804	rs1057519297	NC_000004.12:112646356:ATATAT:ATATATAT
NM_153365.3(TAPT1):c.1058A>T (p.Asp353Val)	TAPT1	D353V	Osteochondrodysplasia, complex lethal, symoens-barnes-gistelinck type	Pathogenic(Last reviewed: Apr 11, 2018)	no assertion criteria provided	VCV000224907	4	16177791	4	16176168	224907	226776	rs869312980	NC_000004.12:16176167:T:A
NM_153365.3(TAPT1):c.1108-1G>C	TAPT1		Osteochondrodysplasia, complex lethal, symoens-barnes-gistelinck type	Pathogenic(Last reviewed: Apr 11, 2018)	no assertion criteria provided	VCV000224906	4	16176353	4	16174730	224906	226775	rs869320633	NC_000004.12:16174729:C:G
LARP7, LYS276fs	LARP7		Alazami syndrome	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000041475					41475	49912		
NM_002495.4(NDUFS4):c.99-1G>A	NDUFS4		Leigh syndrome|Mitochondrial complex I deficiency, nuclear type 1	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000496165	5	52899281	5	53603451	496165	487060	rs376281345	NC_000005.10:53603450:G:A
NM_014423.4(AFF4):c.772C>T (p.Arg258Trp)	AFF4	R258W	not provided|Chops syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190331	5	132269985	5	132934293	190331	188158	rs786205680	NC_000005.10:132934292:G:A
NM_001085411.3(NADK2):c.956+6T>C	NADK2		2,4-Dienoyl-CoA reductase deficiency	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000830231	5	36207266	5	36207164	830231	818631		NC_000005.10:36207163:A:G
NM_173471.3(SLC25A26):c.33+1G>A	SLC25A26		Combined oxidative phosphorylation deficiency 28	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000222009	3	66271554	3	66221128	222009	223699	rs781798317	NC_000003.12:66221127:G:A
NM_173471.3(SLC25A26):c.596C>T (p.Pro199Leu)	SLC25A26	P199L, P111L	Combined oxidative phosphorylation deficiency 28	Pathogenic(Last reviewed: Feb 11, 2016)	no assertion criteria provided	VCV000222008	3	66419929	3	66369505	222008	223698	rs869025315	NC_000003.12:66369504:C:T
NM_173471.3(SLC25A26):c.305C>T (p.Ala102Val)	SLC25A26	A102V, A14V	Combined oxidative phosphorylation deficiency 28	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000222007	3	66312479	3	66262055	222007	223697	rs869025314	NC_000003.12:66262054:C:T
NM_173471.3(SLC25A26):c.443T>G (p.Val148Gly)	SLC25A26	V148G, V60G	Combined oxidative phosphorylation deficiency 28	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000222006	3	66313793	3	66263369	222006	223696	rs869025313	NC_000003.12:66263368:T:G
NM_014264.5(PLK4):c.1299_1303del (p.Phe433fs)	PLK4	F392fs, F401fs, F433fs	Microcephaly and chorioretinopathy, autosomal recessive, 2	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162401	4	128807824 - 128807828	4	127886669 - 127886673	162401	172104	rs724159996	NC_000004.12:127886668:TAAAG:
NM_014264.5(PLK4):c.2811-5C>G	PLK4		Microcephaly and chorioretinopathy, autosomal recessive, 2	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162400	4	128819589	4	127898434	162400	172103	rs724159995	NC_000004.12:127898433:C:G
NM_001085411.3(NADK2):c.1018C>T (p.Arg340Ter)	NADK2	R340*, R199*, R177*	2,4-Dienoyl-CoA reductase deficiency	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156239	5	36200377	5	36200275	156239	166025	rs587777772	NC_000005.10:36200274:G:A
NM_017875.4(SLC25A38):c.166C>T (p.Gln56Ter)	SLC25A38	Q56*	not provided	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000373218	3	39431082	3	39389591	373218	359522	rs866266558	NC_000003.12:39389590:C:T
NM_017875.4(SLC25A38):c.790A>T (p.Lys264Ter)	SLC25A38	K264*	Anemia, sideroblastic, 2, pyridoxine-refractory	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000001122	3	39436065	3	39394574	1122	16161	rs121918332	NC_000003.12:39394573:A:T
NM_017875.4(SLC25A38):c.277-1G>A	SLC25A38		Anemia, sideroblastic, 2, pyridoxine-refractory	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000001121	3	39432931	3	39391440	1121	16160	rs869312029	NC_000003.12:39391439:G:A
NM_017875.4(SLC25A38):c.70-2A>C	SLC25A38		Anemia, sideroblastic, 2, pyridoxine-refractory	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561108	3	39430984	3	39389493	561108	552073	rs1233124208	NC_000003.12:39389492:A:C
NM_017875.4(SLC25A38):c.349C>T (p.Arg117Ter)	SLC25A38	R117*	not provided|Anemia, sideroblastic, 2, pyridoxine-refractory	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000001118	3	39433004	3	39391513	1118	16157	rs121918330	NC_000003.12:39391512:C:T
NM_005327.7(HADH):c.587del (p.Ser196fs)	HADH	S200fs, S196fs	Deficiency of 3-hydroxyacyl-CoA dehydrogenase	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802083	4	108944670	4	108023514	802083	790430		NC_000004.12:108023513:C:
NM_005327.7(HADH):c.261+1G>A	HADH		Deficiency of 3-hydroxyacyl-CoA dehydrogenase	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802082	4	108931044	4	108009888	802082	790429		NC_000004.12:108009887:G:A
NM_005327.5(HADH):c.374_375insTTCA (p.Lys125fs)	HADH		not provided	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000432053	4	108935698 - 108935699	4	108014542 - 108014543	432053	425588	rs766656997	NC_000004.12:108014542:A:ATTCA
NM_001059.3(TACR3):c.548+2T>C	TACR3		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000373350	4	104640283	4	103719126	373350	359506	rs772508077	NC_000004.12:103719125:A:G
NM_000306.4(POU1F1):c.665+1G>T	POU1F1			Pathogenic(Last reviewed: Nov 10, 2011)	no assertion criteria provided	VCV000126542	3	87310422	3	87261272	126542	132061	rs515726221	NC_000003.12:87261271:C:A
NM_005327.5(HADH):c.171C>A (p.Asp57Glu)	HADH	D45E, D57E, D61E	Deficiency of 3-hydroxyacyl-CoA dehydrogenase	Pathogenic(Last reviewed: Aug 18, 2015)	no assertion criteria provided	VCV000008019	4	108930953	4	108009797	8019	23058	rs137853102	NC_000004.12:108009796:C:A
NM_005327.5(HADH):c.118G>A (p.Ala40Thr)	HADH	A28T, A40T	Deficiency of 3-hydroxyacyl-CoA dehydrogenase	Pathogenic(Last reviewed: Feb 4, 2013)	no assertion criteria provided	VCV000008018	4	108911206	4	107990050	8018	23057	rs137853101	NC_000004.12:107990049:G:A
NM_000306.4(POU1F1):c.537C>G (p.Ser179Arg)	POU1F1	S179R, S205R		Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000013616	3	87311288	3	87262138	13616	28655	rs104893766	NC_000003.12:87262137:G:C
NM_000306.4(POU1F1):c.775dup (p.Arg259fs)	POU1F1			Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000013615	3	87309144 - 87309145	3	87259994 - 87259995	13615	28654	rs587776799	NC_000003.12:87259994:TT:TTT
NM_000306.4(POU1F1):c.433A>T (p.Lys145Ter)	POU1F1	K145*, K171*		Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013612	3	87313444	3	87264294	13612	28651	rs104893763	NC_000003.12:87264293:T:A
NM_000306.4(POU1F1):c.577T>C (p.Trp193Arg)	POU1F1	W193R, W219R		Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000013611	3	87311248	3	87262098	13611	28650	rs104893758	NC_000003.12:87262097:A:G
NM_000306.4(POU1F1):c.747del (p.Glu250fs)	POU1F1	E276fs, E250fs		Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000013610	3	87309173	3	87260023	13610	28649	rs587776798	NC_000003.12:87260022:TT:T
NM_000306.4(POU1F1):c.715C>T (p.Pro239Ser)	POU1F1	P239S, P265S		Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000013609	3	87309205	3	87260055	13609	28648	rs104893762	NC_000003.12:87260054:G:A
NM_000306.4(POU1F1):c.748G>T (p.Glu250Ter)	POU1F1	E250*, E276*		Pathogenic(Last reviewed: Jun 1, 1995)	no assertion criteria provided	VCV000013607	3	87309172	3	87260022	13607	28646	rs104893760	NC_000003.12:87260021:C:A
NM_000306.4(POU1F1):c.428G>A (p.Arg143Gln)	POU1F1	R143Q, R169Q		Pathogenic(Last reviewed: Dec 15, 1992)	no assertion criteria provided	VCV000013606	3	87313449	3	87264299	13606	28645	rs104893759	NC_000003.12:87264298:C:T
NM_000306.4(POU1F1):c.71C>T (p.Pro24Leu)	POU1F1	P24L		Pathogenic(Last reviewed: Dec 15, 1992)	no assertion criteria provided	VCV000013605	3	87325542	3	87276392	13605	28644	rs104893757	NC_000003.12:87276391:G:A
NM_000306.4(POU1F1):c.514C>T (p.Arg172Ter)	POU1F1	R172*, R198*		Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000013602	3	87311311	3	87262161	13602	28641	rs104893754	NC_000003.12:87262160:G:A
NM_001059.3(TACR3):c.737+1G>A	TACR3		Hypogonadotropic hypogonadism 11 with or without anosmia	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV000818214	4	104579371	4	103658214	818214	806427	rs760022956	NC_000004.12:103658213:C:T
NM_001059.3(TACR3):c.766T>C (p.Tyr256His)	TACR3	Y256H	Hypogonadotropic hypogonadism 11 with or without anosmia	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000066085	4	104577473	4	103656316	66085	76987	rs397515483	NC_000004.12:103656315:A:G
HADH, EX1DEL	HADH		Hyperinsulinemic hypoglycemia, familial, 4	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000039483					39483	48082		
NM_000306.4(POU1F1):c.688G>A (p.Glu230Lys)	POU1F1	E230K, E256K		Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000013613	3	87309232	3	87260082	13613	28652	rs104893764	NC_000003.12:87260081:C:T
NM_000306.4(POU1F1):c.404T>G (p.Phe135Cys)	POU1F1	F135C, F161C		Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000013608	3	87313473	3	87264323	13608	28647	rs104893761	NC_000003.12:87264322:A:C
NM_000306.4(POU1F1):c.472G>C (p.Ala158Pro)	POU1F1	A158P, A184P		Pathogenic(Last reviewed: Aug 21, 1992)	no assertion criteria provided	VCV000013604	3	87311353	3	87262203	13604	28643	rs104893756	NC_000003.12:87262202:C:G
NM_005327.5(HADH):c.773C>T (p.Pro258Leu)	HADH	P258L, P262L, P275L	Hyperinsulinemic hypoglycemia, familial, 4	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000008020	4	108954395	4	108033239	8020	23059	rs137853103	NC_000004.12:108033238:C:T
NM_005327.5(HADH):c.636+471G>T	HADH		Hyperinsulinemic hypoglycemia, familial, 4	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039484	4	108945190	4	108024034	39484	48083	rs786200932	NC_000004.12:108024033:G:T
NM_005327.5(HADH):c.706C>T (p.Arg236Ter)	HADH	R236*, R240*	Hyperinsulinemic hypoglycemia, familial, 4	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000039482	4	108948913	4	108027757	39482	48081	rs375717077	NC_000004.12:108027756:C:T
HADH, 6-BP DEL	HADH		Hyperinsulinemic hypoglycemia, familial, 4	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000008021					8021	23060		
NM_001059.3(TACR3):c.1057C>T (p.Pro353Ser)	TACR3	P353S	not provided|Hypogonadotropic hypogonadism 11 with or without anosmia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000014026	4	104512672	4	103591515	14026	29065	rs121918125	NC_000004.12:103591514:G:A
NM_001059.3(TACR3):c.278G>A (p.Gly93Asp)	TACR3	G93D	not provided|Hypogonadotropic hypogonadism 11 with or without anosmia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000014025	4	104640555	4	103719398	14025	29064	rs121918124	NC_000004.12:103719397:C:T
GRCh37/hg19 4p13(chr4:42922101-43379430)x1	GRXCR1		not provided	Pathogenic(Last reviewed: Oct 5, 2017)	no assertion criteria provided	VCV000687258	4	42922101 - 43379430			687258	674850		
NM_001080476.2(GRXCR1):c.655G>A (p.Glu219Lys)	GRXCR1	E219K	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560891	4	43022398	4	43020381	560891	552001	rs1560690591	NC_000004.12:43020380:G:A
NM_001080476.2(GRXCR1):c.385-2A>G	GRXCR1		Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522426	4	42964907	4	42962890	522426	513051	rs771844359	NC_000004.12:42962889:A:G
NM_001017979.3(RAB28):c.565C>T (p.Gln189Ter)	RAB28	E189*, Q189*	Cone-rod dystrophy 18	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060754	4	13378177	4	13376553	60754	75294	rs786200944	NC_000004.12:13376552:G:A
NM_001080476.2(GRXCR1):c.412C>T (p.Arg138Cys)	GRXCR1	R138C	Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000196	4	42964936	4	42962919	196	15235	rs267606856	NC_000004.12:42962918:C:T
NM_001080476.2(GRXCR1):c.627+19A>T	GRXCR1		Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000194	4	42965170	4	42963153	194	15233	rs201824235	NC_000004.12:42963152:A:T
NM_001080476.2(GRXCR1):c.628-9C>A	GRXCR1		Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000193	4	43022362	4	43020345	193	15232	rs606231120	NC_000004.12:43020344:C:A
NM_001080476.2(GRXCR1):c.590_593CCCT[3] (p.Val200fs)	GRXCR1		Rare genetic deafness	Pathogenic(Last reviewed: May 1, 2016)	criteria provided, single submitter	VCV000504921	4	42965112 - 42965113	4	42963095 - 42963096	504921	496320	rs1553941938	NC_000004.12:42963095:TCCCTCCCT:TCCCTCCCTCCCT
NM_001080476.2(GRXCR1):c.229C>T (p.Gln77Ter)	GRXCR1	Q77*	Deafness, autosomal recessive 25	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000000195	4	42895512	4	42893495	195	15234	rs267606855	NC_000004.12:42893494:C:T
NM_001017979.3(RAB28):c.409C>T (p.Arg137Ter)	RAB28	R137*	Cone-rod degeneration|Cone-rod dystrophy 18	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000060755	4	13383201	4	13381577	60755	75295	rs398123044	NC_000004.12:13381576:G:A
NM_001017979.3(RAB28):c.574-1238T>G	RAB28	C217W	Cone-rod dystrophy 18	Pathogenic(Last reviewed: Feb 1, 2015)	criteria provided, single submitter	VCV000225879	4	13371512	4	13369888	225879	227691	rs751163782	NC_000004.12:13369887:A:C
NM_001017979.3(RAB28):c.172+1G>C	RAB28		Cone-rod dystrophy 18	Pathogenic(Last reviewed: Feb 1, 2015)	criteria provided, single submitter	VCV000225878	4	13481053	4	13479429	225878	227692	rs875989778	NC_000004.12:13479428:C:G
NC_000005.9:g.(?_130494966)_(130501051_?)del	HINT1		Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000659597	5	130494966 - 130501051	5	131159273 - 131165358	659597	651247		
NC_000005.9:g.(?_130495120)_(130500918_?)del	HINT1		Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000543794	5	130495120 - 130500918	5	131159427 - 131165225	543794	520582		
NM_005340.7(HINT1):c.278G>A (p.Gly93Asp)	HINT1	G93D	Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037318	5	130495243	5	131159550	37318	45893	rs397514493	NC_000005.10:131159549:C:T
NM_005340.7(HINT1):c.152A>G (p.His51Arg)	HINT1	H51R	Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037316	5	130498329	5	131162636	37316	45891	rs397514491	NC_000005.10:131162635:T:C
NM_005340.7(HINT1):c.334C>A (p.His112Asn)	HINT1	H112N	Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037315	5	130495187	5	131159494	37315	45890	rs373849532	NC_000005.10:131159493:G:T
NM_005340.7(HINT1):c.266G>T (p.Gly89Val)	HINT1	G89V	Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037314	5	130495255	5	131159562	37314	45889	rs397514490	NC_000005.10:131159561:C:A
NM_005340.7(HINT1):c.250T>C (p.Cys84Arg)	HINT1	C84R	Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037313	5	130495271	5	131159578	37313	45888	rs397514489	NC_000005.10:131159577:A:G
NM_005340.7(HINT1):c.184C>T (p.Gln62Ter)	HINT1	Q62*	Autosomal recessive axonal neuropathy with neuromyotonia	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000037317	5	130498297	5	131162604	37317	45892	rs397514492	NC_000005.10:131162603:G:A
NM_005349.3(RBPJ):c.505A>G (p.Lys169Glu)	RBPJ	K169E, K154E, K156E, K155E, K134E	Adams-Oliver syndrome 3	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037054	4	26422317	4	26420695	37054	45734	rs387907271	NC_000004.12:26420694:A:G
NM_005349.3(RBPJ):c.188A>G (p.Glu63Gly)	RBPJ	E63G, E48G, E28G, E49G, E50G	Adams-Oliver syndrome 3	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037053	4	26407886	4	26406264	37053	45733	rs387907270	NC_000004.12:26406263:A:G
NM_002700.3(POU4F3):c.374C>T (p.Pro125Leu)	POU4F3	P125L	Autosomal recessive sensorineural hearing loss	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562074	5	145719364	5	146339801	562074	553256	rs1561590396	NC_000005.10:146339800:C:T
GRCh37/hg19 3q28(chr3:190039387-190040504)	CLDN1		Neonatal ichthyosis-sclerosing cholangitis syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625822	3	190039387 - 190040504			625822	614126		
THPO, 1-BP DEL, 3252G	THPO		Thrombocythemia 1	Pathogenic(Last reviewed: Aug 15, 1998)	no assertion criteria provided	VCV000009509					9509	24548		
THPO, IVS3, G-C, +1	THPO		Thrombocythemia 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000009508					9508	24547		
NM_002700.3(POU4F3):c.662_675del (p.Gly221fs)	POU4F3	G221fs	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Jun 4, 2010)	no assertion criteria provided	VCV000101525	5	145719652 - 145719665	5	146340089 - 146340102	101525	107268	rs1064792854	NC_000005.10:146340088:GCTCGCTGAGCCAA:
NM_002700.3(POU4F3):c.977G>A (p.Arg326Lys)	POU4F3	R326K	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000096710	5	145719967	5	146340404	96710	102599	rs398123070	NC_000005.10:146340403:G:A
NM_002700.3(POU4F3):c.668T>C (p.Leu223Pro)	POU4F3	L223P	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000007080	5	145719658	5	146340095	7080	22119	rs121909057	NC_000005.10:146340094:T:C
NM_002700.3(POU4F3):c.865C>T (p.Leu289Phe)	POU4F3	L298F, L289F	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000007079	5	145719855	5	146340292	7079	22118	rs121909056	NC_000005.10:146340291:C:T
THPO, 516G-T	THPO		Thrombocythemia 1	Pathogenic(Last reviewed: Aug 20, 2009)	no assertion criteria provided	VCV000009510					9510	24549		
NM_002700.3(POU4F3):c.882_889del (p.Ile295fs)	POU4F3	I295fs	Deafness, autosomal dominant 15	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000007078	5	145719870 - 145719877	5	146340307 - 146340314	7078	22117	rs398124631	NC_000005.10:146340306:GCTATCCAGC:GC
NM_004423.4(DVL3):c.1728_1752del (p.Ser578fs)	DVL3	S578fs	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000817756	3	183888120 - 183888144	3	184170332 - 184170356	817756	805333		NC_000003.12:184170331:TGGCTCCAACCGTAGCGGCAGCGAT:
NM_004423.4(DVL3):c.1751_1754del (p.Asp584fs)	DVL3	D584fs	not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000817264	3	183888141 - 183888144	3	184170353 - 184170356	817264	805334		NC_000003.12:184170352:CGATCG:CG
NM_001063.4(TF):c.1429G>C (p.Ala477Pro)	TF	A477P, A350P, A433P	Atransferrinemia	Pathogenic(Last reviewed: Dec 15, 2000)	no assertion criteria provided	VCV000012620	3	133485220	3	133766376	12620	27659	rs121918679	NC_000003.12:133766375:G:C
TF, 10-BP DEL AND 9-BP DUP	TF		Atransferrinemia	Pathogenic(Last reviewed: Dec 15, 2000)	no assertion criteria provided	VCV000012619					12619	27658		
NM_001063.4(TF):c.1936A>G (p.Lys646Glu)	TF	K627E, K646E, K519E, K602E	Transferrin variant bv	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000012618	3	133495956	3	133777112	12618	27657	rs121918678	NC_000003.12:133777111:A:G
NM_004423.4(DVL3):c.1715-2A>C	DVL3		Robinow syndrome, autosomal dominant 1	Pathogenic	criteria provided, single submitter	VCV000694689	3	183888105	3	184170317	694689	682840		NC_000003.12:184170316:A:C
NM_004423.4(DVL3):c.1592del (p.Pro531fs)	DVL3	P531fs	Robinow syndrome, autosomal dominant 3	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689755	3	183887884	3	184170096	689755	677415		NC_000003.12:184170095:CCCC:CCC
NM_001063.4(TF):c.2012G>A (p.Gly671Glu)	TF	G652E, G671E, G627E, G544E	Transferrin variant b2	Pathogenic(Last reviewed: May 1, 1984)	no assertion criteria provided	VCV000012616	3	133496032	3	133777188	12616	27655	rs121918677	NC_000003.12:133777187:G:A
NM_001063.4(TF):c.1180G>A (p.Glu394Lys)	TF	E375K, E394K, E350K, E267K	Atransferrinemia	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000012623	3	133478150	3	133759306	12623	27662	rs121918680	NC_000003.12:133759305:G:A
NM_001063.4(TF):c.229G>A (p.Asp77Asn)	TF	D77N, D33N	Atransferrinemia	Pathogenic(Last reviewed: Oct 15, 2004)	no assertion criteria provided	VCV000012621	3	133472451	3	133753607	12621	27660	rs121918681	NC_000003.12:133753606:G:A
NM_001063.4(TF):c.830G>A (p.Gly277Asp)	TF	G277D, G150D, G233D	Transferrin variant d1	Pathogenic(Last reviewed: May 1, 1984)	no assertion criteria provided	VCV000012614	3	133475813	3	133756969	12614	27653	rs121918676	NC_000003.12:133756968:G:A
NM_001059.3(TACR3):c.824G>A (p.Trp275Ter)	TACR3	W275*	Hypogonadotropic hypogonadism 11 with or without anosmia|not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066084	4	104577415	4	103656258	66084	76986	rs144292455	NC_000004.12:103656257:C:T
NM_004423.4(DVL3):c.1749del (p.Ser583fs)	DVL3	S583fs	Robinow syndrome, autosomal dominant 3|Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219222	3	183888141	3	184170353	219222	217244	rs869025219	NC_000003.12:184170352:C:
NM_004423.4(DVL3):c.1716del (p.Ser573fs)	DVL3	S573fs	Robinow syndrome, autosomal dominant 3|Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219221	3	183888108	3	184170320	219221	217243	rs869025218	NC_000003.12:184170319:C:
NM_004423.4(DVL3):c.1715-1G>A	DVL3		Robinow syndrome, autosomal dominant 3|Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219220	3	183888106	3	184170318	219220	217242	rs869025217	NC_000003.12:184170317:G:A
NM_004423.4(DVL3):c.1715-2A>G	DVL3		Robinow syndrome, autosomal dominant 3|Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219219	3	183888105	3	184170317	219219	217241	rs869025216	NC_000003.12:184170316:A:G
NM_004423.4(DVL3):c.1585del (p.Ala529fs)	DVL3	A529fs	Robinow syndrome, autosomal dominant 3|Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219218	3	183887876	3	184170088	219218	217240	rs869025215	NC_000003.12:184170087:GGGGG:GGGG
NM_198407.2(GHSR):c.6G>A (p.Trp2Ter)	GHSR	W2*	Short stature due to growth hormone secretagogue receptor deficiency	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000007633	3	172166198	3	172448408	7633	22672	rs267606843	NC_000003.12:172448407:C:T
NM_004531.5(MOCS2):c.2T>G (p.Met1Arg)	MOCS2	M1R, Y63*	Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587508	5	52403003	5	53107173	587508	578434	rs772575104	NC_000005.10:53107172:A:C
NM_032380.5(GFM2):c.2029-1G>A	GFM2		COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39	Pathogenic(Last reviewed: Apr 19, 2019)	no assertion criteria provided	VCV000225206	5	74018387	5	74722562	225206	227134	rs869320704	NC_000005.10:74722561:C:T
NM_032380.5(GFM2):c.206+4A>G	GFM2		COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39	Pathogenic(Last reviewed: Apr 19, 2019)	no assertion criteria provided	VCV000225205	5	74055190	5	74759365	225205	227133	rs869320703	NC_000005.10:74759364:T:C
NM_004531.5(MOCS2):c.-656_-634del	MOCS2	M1fs	Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000006116	5	52405545 - 52405567	5	53109715 - 53109737	6116	21155	rs397518417	NC_000005.10:53109714:GCACAGCGGCACCATCCCGCCTAG:G
NM_004531.5(MOCS2):c.567A>C (p.Ter189Tyr)	MOCS2	*189Y	Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000006115	5	52394432	5	53098602	6115	21154	rs121908609	NC_000005.10:53098601:T:G
NM_004531.5(MOCS2):c.3G>A (p.Met1Ile)	MOCS2	M1I, V64I	Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006112	5	52403002	5	53107172	6112	21151	rs121908606	NC_000005.10:53107171:C:T
NM_015896.4(ZMYND10):c.589_590TG[2] (p.Val198fs)	ZMYND10		Ciliary dyskinesia, primary, 22	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000066025	3	50380554 - 50380555	3	50343123 - 50343124	66025	76935	rs587777045	NC_000003.12:50343122:CACACA:CACA
NM_015896.4(ZMYND10):c.967C>T (p.Gln323Ter)	ZMYND10	Q323*, Q318*	Ciliary dyskinesia, primary, 22	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000066024	3	50379478	3	50342047	66024	76934	rs397515460	NC_000003.12:50342046:G:A
NM_015896.4(ZMYND10):c.486dup (p.Ser163fs)	ZMYND10		Ciliary dyskinesia, primary, 22	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000066023	3	50380761 - 50380762	3	50343330 - 50343331	66023	76933	rs587777044	NC_000003.12:50343330:T:TT
NM_015896.4(ZMYND10):c.300del (p.Phe101fs)	ZMYND10	F101fs	Ciliary dyskinesia, primary, 22	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000066022	3	50381183	3	50343752	66022	76932	rs587777043	NC_000003.12:50343751:GG:G
NM_014043.4(CHMP2B):c.532-1G>A	CHMP2B		Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000021505	3	87302861	3	87253711	21505	34357	rs63750652	NC_000003.12:87253710:G:A
NM_002449.5(MSX2):c.548_555del (p.Glu183fs)	MSX2	E183fs	Parietal foramina 1	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000016968	5	174156327 - 174156334	5	174729324 - 174729331	16968	32007	rs1561643060	NC_000005.10:174729323:CAGAGACCCAG:CAG
NM_002449.5(MSX2):c.505_508dup (p.Ala170fs)	MSX2		Parietal foramina with cleidocranial dysplasia	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000016967	5	174156286 - 174156287	5	174729283 - 174729284	16967	32006	rs1561643029	NC_000005.10:174729283:ATTG:ATTGATTG
NM_002449.5(MSX2):c.345del (p.Ala114_Trp115insTer)	MSX2	W115*	Parietal foramina 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000016966	5	174152006	5	174725003	16966	32005	rs121912972	NC_000005.10:174725002:GG:G
NM_002449.5(MSX2):c.265_266delinsTA (p.Ala89Ter)	MSX2	A89*	Parietal foramina 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000016965	5	174151927 - 174151928	5	174724924 - 174724925	16965	32004	rs121912971	NC_000005.10:174724923:GC:TA
nsv513767	MSX2		Parietal foramina 1	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000016964					16964	32003		
NM_002449.5(MSX2):c.515G>A (p.Arg172His)	MSX2	R172H	Parietal foramina 1	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000016963	5	174156297	5	174729294	16963	32002	rs104893896	NC_000005.10:174729293:G:A
MSX2, 6-BP DEL, NT475	MSX2		Parietal foramina 1	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000016962					16962	32001		
NM_004531.5(MOCS2):c.-169G>T	MOCS2	V7F	Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Jul 11, 2003)	no assertion criteria provided	VCV000006114	5	52404473	5	53108643	6114	21153	rs121908608	NC_000005.10:53108642:C:A
NM_025139.5(ARMC9):c.1211_1334del (p.Arg405Alafs)	ARMC9		JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427938	2	232137668 - 232137791	2	231272955 - 231273078	427938	419009	rs1553611393	
NM_015896.4(ZMYND10):c.85T>C (p.Ser29Pro)	ZMYND10	S29P	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000410632	3	50382926	3	50345495	410632	393852	rs587621539	NC_000003.12:50345494:A:G
NM_004531.5(MOCS2):c.-633C>T	MOCS2	Q6*	Molybdenum cofactor deficiency, complementation group A|Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000006113	5	52405544	5	53109714	6113	21152	rs121908607	NC_000005.10:53109713:G:A
NM_004531.5(MOCS2):c.65dup (p.Leu23fs)	MOCS2		Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000006111	5	52402939 - 52402940	5	53107109 - 53107110	6111	21150	rs398122799	NC_000005.10:53107109:GGGGGGG:GGGGGGGG
NM_004531.5(MOCS2):c.502G>A (p.Glu168Lys)	MOCS2	E168K	Molybdenum cofactor deficiency, complementation group B	Pathogenic(Last reviewed: Jul 11, 2003)	no assertion criteria provided	VCV000006109	5	52394497	5	53098667	6109	21148	rs121908605	NC_000005.10:53098666:C:T
CHMP2B, IVS5AS, G-C	CHMP2B		Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000001652					1652	16691		
NM_015896.4(ZMYND10):c.510+1G>A	ZMYND10		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000645306	3	50380737	3	50343306	645306	651211		NC_000003.12:50343305:C:T
NM_014043.4(CHMP2B):c.556C>T (p.Arg186Ter)	CHMP2B	R186*, R145*	not provided|Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000021506	3	87302886	3	87253736	21506	34358	rs63751048	NC_000003.12:87253735:C:T
NM_032380.5(GFM2):c.275A>C (p.Tyr92Ser)	GFM2	Y92S, Y124S	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 19, 2019)	no assertion criteria provided	VCV000440788	5	74054703	5	74758878	440788	434404	rs1554042187	NC_000005.10:74758877:T:G
NM_032380.5(GFM2):c.636del (p.Glu213fs)	GFM2	E213fs, E245fs	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39|Mitochondrial diseases	Pathogenic(Last reviewed: Apr 19, 2019)	no assertion criteria provided	VCV000440787	5	74041963	5	74746138	440787	434403	rs746538436	NC_000005.10:74746137:T:
NM_025139.6(ARMC9):c.51+5G>T	ARMC9		ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2017)	no assertion criteria provided	VCV000427931	2	232071007	2	231206294	427931	419004	rs1114167447	NC_000002.12:231206293:G:T
NM_014043.4(CHMP2B):c.493C>T (p.Gln165Ter)	CHMP2B	Q165*, Q124*	not provided|Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001655	3	87302622	3	87253472	1655	16694	rs63750355	NC_000003.12:87253471:C:T
NM_014043.4(CHMP2B):c.442G>T (p.Asp148Tyr)	CHMP2B	D148Y, D107Y	not provided|Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001653	3	87302571	3	87253421	1653	16692	rs63750653	NC_000003.12:87253420:G:T
NM_020191.3(MRPS22):c.768_769del (p.Gly257fs)	MRPS22	G216fs, G256fs, G257fs	not provided	Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000214685	3	139071523 - 139071524	3	139352681 - 139352682	214685	210946	rs863224077	NC_000003.12:139352680:GTG:G
NM_020191.3(MRPS22):c.644T>C (p.Leu215Pro)	MRPS22	L215P, L214P, L174P	Combined oxidative phosphorylation deficiency 5	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000030524	3	139069160	3	139350318	30524	39481	rs387906924	NC_000003.12:139350317:T:C
NM_001189.4(NKX3-2):c.97_103CGCCCGG[1] (p.Ala35fs)	NKX3-2		Spondylo-megaepiphyseal-metaphyseal dysplasia	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000007493	4	13545929 - 13545935	4	13544305 - 13544311	7493	22532	rs606231354	NC_000004.12:13544304:CCGGGCGCCGGGCGCC:CCGGGCGCC
NM_001189.4(NKX3-2):c.336_337delinsT (p.Ala113fs)	NKX3-2		Spondylo-megaepiphyseal-metaphyseal dysplasia	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000007492	4	13545702 - 13545703	4	13544078 - 13544079	7492	22531	rs606231353	NC_000004.12:13544077:CC:A
NM_001189.4(NKX3-2):c.337dup (p.Ala113fs)	NKX3-2		Spondylo-megaepiphyseal-metaphyseal dysplasia	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000007491	4	13545701 - 13545702	4	13544077 - 13544078	7491	22530	rs606231352	NC_000004.12:13544077:CCCCCC:CCCCCCC
NM_001189.4(NKX3-2):c.507_508del (p.Gly171fs)	NKX3-2	G171fs	Spondylo-megaepiphyseal-metaphyseal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2019)	no assertion criteria provided	VCV000522597	4	13544111 - 13544112	4	13542487 - 13542488	522597	513210	rs1560165127	NC_000004.12:13542486:TG:
NM_021032.4(FGF12):c.341G>A (p.Arg114His)	FGF12	R114H, R52H	not provided|Epileptic encephalopathy, early infantile, 47	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000266034	3	192053223	3	192335434	266034	260857	rs886039903	NC_000003.12:192335433:C:T
NM_020191.3(MRPS22):c.605G>A (p.Arg202His)	MRPS22	R202H, R201H, R161H	OVARIAN DYSGENESIS 7|46,XX gonadal dysgenesis	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000441255	3	139069121	3	139350279	441255	434897	rs753345594	NC_000003.12:139350278:G:A
NM_002449.5(MSX2):c.443C>A (p.Pro148His)	MSX2	P148H	Craniosynostosis 2	Pathogenic(Last reviewed: Nov 8, 2012)	no assertion criteria provided	VCV000016961	5	174156225	5	174729222	16961	32000	rs104893895	NC_000005.10:174729221:C:A
NM_020191.3(MRPS22):c.509G>A (p.Arg170His)	MRPS22	R170H, R129H, R169H	Combined oxidative phosphorylation deficiency 5|not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000004753	3	139069025	3	139350183	4753	19792	rs119478059	NC_000003.12:139350182:G:A
NM_002495.4(NDUFS4):c.462del (p.Lys154fs)	NDUFS4	K154fs	Leigh syndrome|Mitochondrial complex I deficiency, nuclear type 1|not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040257	5	52978982	5	53683152	40257	48741	rs587776949	NC_000005.10:53683151:AAAA:AAA
NM_000925.4(PDHB):c.300_303+7del	PDHB		not provided	Pathogenic(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	VCV000217513	3	58417313 - 58417323	3	58431586 - 58431596	217513	214151	rs863225125	NC_000003.12:58431585:TACATACCATA:
NM_014822.4(SEC24D):c.1450C>T (p.Arg484Ter)	SEC24D	R484*, R485*	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 27, 2019)	no assertion criteria provided	VCV000638184	4	119674015	4	118752860	638184	626006		NC_000004.12:118752859:G:A
NM_014822.4(SEC24D):c.875C>T (p.Pro292Leu)	SEC24D	P292L, P293L	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 26, 2019)	no assertion criteria provided	VCV000638183	4	119727036	4	118805881	638183	626005		NC_000004.12:118805880:G:A
NM_014822.4(SEC24D):c.2842T>C (p.Ser948Pro)	SEC24D	S948P, S949P	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 27, 2019)	no assertion criteria provided	VCV000638181	4	119652497	4	118731342	638181	626003		NC_000004.12:118731341:A:G
NM_014822.4(SEC24D):c.2723G>A (p.Cys908Tyr)	SEC24D	C908Y, C909Y	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 26, 2019)	no assertion criteria provided	VCV000638180	4	119652616	4	118731461	638180	626002		NC_000004.12:118731460:C:T
NM_014822.4(SEC24D):c.2496G>T (p.Gln832His)	SEC24D	Q832H, Q833H	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 26, 2019)	no assertion criteria provided	VCV000638179	4	119659416	4	118738261	638179	626001		NC_000004.12:118738260:C:A
NM_014822.4(SEC24D):c.113dup (p.Thr39fs)	SEC24D		Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 26, 2019)	no assertion criteria provided	VCV000638178	4	119754738 - 119754739	4	118833583 - 118833584	638178	626000		NC_000004.12:118833583:GG:GGG
NM_001032280.3(TFAP2A):c.1019_1020del (p.Lys340fs)	TFAP2A	K340fs, K342fs, K346fs	Esotropia|Short neck|Lens subluxation|Hypertelorism|Epicanthus|High palate|Nystagmus|Abnormality of visual evoked potentials|Amblyopia|Microphthalmia|Iris coloboma|Low-set ears|EEG abnormality	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523459	6	10398926 - 10398927	6	10398693 - 10398694	523459	513960	rs1554110735	NC_000006.12:10398692:TTT:T
HRG, CYS223ARG	HRG	C223R	Thrombophilia, histidine-rich glycoprotein-related	Pathogenic(Last reviewed: May 16, 2018)	no assertion criteria provided	VCV000374832					374832	361737		
NM_014822.4(SEC24D):c.2933A>C (p.Gln978Pro)	SEC24D	Q978P, Q979P	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000189341	4	119649741	4	118728586	189341	187230	rs786204846	NC_000004.12:118728585:T:G
NM_014822.4(SEC24D):c.613C>T (p.Gln205Ter)	SEC24D	Q205*	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000189340	4	119736666	4	118815511	189340	187229	rs786204845	NC_000004.12:118815510:G:A
NM_014822.4(SEC24D):c.3044C>T (p.Ser1015Phe)	SEC24D	S1015F, S1016F	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000189339	4	119644725	4	118723570	189339	187228	rs760670617	NC_000004.12:118723569:G:A
NM_000412.4(HRG):c.308G>A (p.Gly103Glu)	HRG	G85E, G103E	Thrombophilia, histidine-rich glycoprotein-related	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000014914	3	186387734	3	186669945	14914	29953	rs121918122	NC_000003.12:186669944:G:A
NM_000925.4(PDHB):c.1030C>T (p.Pro344Ser)	PDHB	P344S, P326S	Pyruvate dehydrogenase E1-beta deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000013189	3	58413811	3	58428084	13189	28228	rs28933391	NC_000003.12:58428083:G:A
NM_000925.4(PDHB):c.395A>G (p.Tyr132Cys)	PDHB	Y132C, Y114C	Pyruvate dehydrogenase E1-beta deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000013188	3	58416578	3	58430851	13188	28227	rs28935769	NC_000003.12:58430850:T:C
NM_014822.4(SEC24D):c.938G>A (p.Arg313His)	SEC24D	R313H, R314H	Cole-Carpenter syndrome 2	Pathogenic(Last reviewed: Jul 27, 2019)	no assertion criteria provided	VCV000638182	4	119718941	4	118797786	638182	626004		NC_000004.12:118797785:C:T
NM_001032280.3(TFAP2A):c.749C>T (p.Ala250Val)	TFAP2A	A256V, A250V, A252V	Branchiooculofacial syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547803	6	10402841	6	10402608	547803	537796	rs151344531	NC_000006.12:10402607:G:A
NM_000412.4(HRG):c.271C>T (p.Pro91Ser)	HRG	P91S, P73S	Thrombophilia, histidine-rich glycoprotein-related|Familial early-onset deep venous thrombosis	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	no assertion criteria provided	VCV000440913	3	186386811	3	186669022	440913	434541	rs761776963	NC_000003.12:186669021:C:T
TFAP2A, 18-BP DEL/6-BP INS, NT828	TFAP2A		Branchiooculofacial syndrome	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000017941					17941	32980		
TFAP2A, PHE319SER	TFAP2A	F319S	Branchiooculofacial syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000017940					17940	32979		
TFAP2A, 12-BP DEL, NT697	TFAP2A		Branchiooculofacial syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000017939					17939	32978		
NM_000925.4(PDHB):c.301A>G (p.Met101Val)	PDHB	M101V, M83V	Pyruvate dehydrogenase E1-beta deficiency	Pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, single submitter	VCV000839569	3	58417322	3	58431595	839569	828531		NC_000003.12:58431594:T:C
NM_001032280.3(TFAP2A):c.868G>A (p.Glu290Lys)	TFAP2A	E269K, E290K, E292K, E296K	Branchiooculofacial syndrome	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000018465	6	10400820	6	10400587	18465	33504	rs267607108	NC_000006.12:10400586:C:T
NM_001032280.3(TFAP2A):c.767G>A (p.Gly256Glu)	TFAP2A	G262E, G258E, G256E	Branchiooculofacial syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000017938	6	10402823	6	10402590	17938	32977	rs121909575	NC_000006.12:10402589:C:T
NM_005340.7(HINT1):c.110G>C (p.Arg37Pro)	HINT1	R37P	Autosomal recessive axonal neuropathy with neuromyotonia|not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037312	5	130500789	5	131165096	37312	45887	rs149782619	NC_000005.10:131165095:C:G
NM_001001486.2(ATP2C1):c.1810_1811del (p.Val604fs)	ATP2C1	V588fs, V604fs, V638fs, V599fs	not provided	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000817334	3	130699493 - 130699494	3	130980649 - 130980650	817334	805325		NC_000003.12:130980648:TGT:T
NM_001001486.2(ATP2C1):c.457C>T (p.Arg153Ter)	ATP2C1	R148*, R187*, R153*, R137*	not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000816949	3	130660469	3	130941625	816949	805324		NC_000003.12:130941624:C:T
NM_183075.3(CYP2U1):c.782_785TCTG[1] (p.Ile261_Cys262insTer)	CYP2U1		not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000595276	4	108866417 - 108866420	4	107945261 - 107945264	595276	586338	rs1560701036	NC_000004.12:107945260:TCTGTCTG:TCTG
NM_014382.4(ATP2C1):c.667del (p.Val223fs)	ATP2C1	V223fs, V218fs, V257fs, V207fs	not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000503743	3	130672799	3	130953955	503743	495439	rs1553767857	NC_000003.12:130953954:GG:G
NM_014382.4(ATP2C1):c.1707del (p.Thr570fs)	ATP2C1	T570fs, T604fs, T565fs, T554fs	not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000453081	3	130698228	3	130979384	453081	443363	rs1553775581	NC_000003.12:130979383:TT:T
NM_000387.6(SLC25A20):c.199-2A>C	SLC25A20		not provided	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	VCV000449618	3	48921559	3	48884126	449618	443486	rs1553686345	NC_000003.12:48884125:T:G
NM_014382.4(ATP2C1):c.1535_1536dup (p.Glu513fs)	ATP2C1		not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000429384	3	130694296 - 130694297	3	130975452 - 130975453	429384	421421	rs1131691355	NC_000003.12:130975452:AA:AAAA
NM_014382.4(ATP2C1):c.2197C>T (p.Gln733Ter)	ATP2C1	Q733*, Q728*, Q767*, Q717*	not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379537	3	130715594	3	130996750	379537	368219	rs1057520634	NC_000003.12:130996749:C:T
NM_014382.4(ATP2C1):c.2335dup (p.Ile779fs)	ATP2C1		not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000373762	3	130716537 - 130716538	3	130997693 - 130997694	373762	359389	rs1057518594	NC_000003.12:130997693:AAAA:AAAAA
NM_000387.6(SLC25A20):c.270del (p.Phe91fs)	SLC25A20	F91fs	Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830060	3	48921486	3	48884053	830060	818386		NC_000003.12:48884052:G:
NM_183075.3(CYP2U1):c.1031_1032AT[1] (p.Ile345fs)	CYP2U1		Spastic paraplegia	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000659414	4	108866665 - 108866666	4	107945509 - 107945510	659414	631852		NC_000004.12:107945508:TATAT:TAT
NM_183075.3(CYP2U1):c.1150_1151AG[1] (p.Arg384fs)	CYP2U1		Spastic paraplegia	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000582218	4	108868555 - 108868556	4	107947399 - 107947400	582218	563364	rs759033144	NC_000004.12:107947398:AGAG:AG
NM_000387.6(SLC25A20):c.505dup (p.Tyr169fs)	SLC25A20		Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000460440	3	48900004 - 48900005	3	48862571 - 48862572	460440	452802	rs1553684897	NC_000003.12:48862571:A:AA
NM_183075.3(CYP2U1):c.943C>T (p.Gln315Ter)	CYP2U1	Q315*	Spastic paraplegia 56, autosomal recessive	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000433183	4	108866578	4	107945422	433183	426743	rs1553937522	NC_000004.12:107945421:C:T
NM_000387.6(SLC25A20):c.106-2A>T	SLC25A20		Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000126508	3	48929507	3	48892074	126508	132032	rs587777287	NC_000003.12:48892073:T:A
NM_000387.6(SLC25A20):c.576G>A (p.Trp192Ter)	SLC25A20	W192*	Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000126507	3	48897020	3	48859587	126507	132031	rs587777286	NC_000003.12:48859586:C:T
NM_183075.3(CYP2U1):c.784T>C (p.Cys262Arg)	CYP2U1	C262R	Spastic paraplegia 56, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039503	4	108866419	4	107945263	39503	48102	rs397514515	NC_000004.12:107945262:T:C
CYP2U1, 13-BP DEL, NT61	CYP2U1		Spastic paraplegia 56, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039502					39502	48101		
NM_183075.3(CYP2U1):c.1139A>G (p.Glu380Gly)	CYP2U1	E380G	Spastic paraplegia 56, autosomal recessive	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039501	4	108868544	4	107947388	39501	48100	rs397514514	NC_000004.12:107947387:A:G
SLC25A20, 110-BP DEL	SLC25A20		Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000012134					12134	27173		
NM_000387.6(SLC25A20):c.200_326+1del	SLC25A20		Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000012133	3	48921429 - 48921556	3	48883996 - 48884123	12133	27172	rs1553686314	
NM_000387.6(SLC25A20):c.897dup (p.Asn300fs)	SLC25A20		Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000012132	3	48895151 - 48895152	3	48857718 - 48857719	12132	27171	rs587776759	NC_000003.12:48857718:GGGGG:GGGGGG
NM_014382.4(ATP2C1):c.1751T>C (p.Leu584Pro)	ATP2C1	L584P, L579P, L568P, L618P	Familial benign pemphigus	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005588	3	130699435	3	130980591	5588	20627	rs137853015	NC_000003.12:130980590:T:C
NM_014382.4(ATP2C1):c.2460del (p.Met820fs)	ATP2C1	M804fs, M820fs, M815fs, M854fs	Familial benign pemphigus	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005587	3	130717206	3	130998362	5587	20626	rs1560033613	NC_000003.12:130998361:G:
NM_014382.4(ATP2C1):c.1469G>T (p.Cys490Phe)	ATP2C1	C490F, C524F, C485F, C474F	Familial benign pemphigus	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005586	3	130694231	3	130975387	5586	20625	rs137853014	NC_000003.12:130975386:G:T
NM_014382.4(ATP2C1):c.900-1G>A	ATP2C1		Familial benign pemphigus	Pathogenic(Last reviewed: Apr 12, 2000)	no assertion criteria provided	VCV000005585	3	130682814	3	130963970	5585	20624	rs1559982055	NC_000003.12:130963969:G:A
NM_014382.4(ATP2C1):c.1402C>T (p.Arg468Ter)	ATP2C1	R468*, R452*, R502*, R463*	Familial benign pemphigus	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005583	3	130688229	3	130969385	5583	20622	rs137853013	NC_000003.12:130969384:C:T
NM_014382.4(ATP2C1):c.910G>A (p.Ala304Thr)	ATP2C1	A304T, A299T, A338T, A288T	Familial benign pemphigus	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005582	3	130682825	3	130963981	5582	20621	rs137853012	NC_000003.12:130963980:G:A
NM_014382.4(ATP2C1):c.769_772dup (p.Leu258fs)	ATP2C1		Familial benign pemphigus	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005581	3	130674958 - 130674959	3	130956114 - 130956115	5581	20620	rs1559971447	NC_000003.12:130956114:CCCTC:CCCTCCCTC
NM_183075.3(CYP2U1):c.1168C>T (p.Arg390Ter)	CYP2U1	R390*	Spastic paraplegia 56, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000562229	4	108868573	4	107947417	562229	553413	rs772400670	NC_000004.12:107947416:C:T
NM_000387.6(SLC25A20):c.292A>T (p.Lys98Ter)	SLC25A20	K98*	Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000460439	3	48921464	3	48884031	460439	452806	rs1553686321	NC_000003.12:48884030:T:A
ATP2C1, IVS22, G-A, +1	ATP2C1		Familial benign pemphigus	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000005589					5589	20628		
NM_000387.6(SLC25A20):c.691G>C (p.Asp231His)	SLC25A20	D231H	Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000646763	3	48896552	3	48859119	646763	631501		NC_000003.12:48859118:C:G
NM_014382.4(ATP2C1):c.2371_2374TTGT[1] (p.Phe792fs)	ATP2C1		not provided|Familial benign pemphigus	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000372308	3	130716576 - 130716579	3	130997732 - 130997735	372308	359526	rs1057517706	NC_000003.12:130997731:TTTGTTTGT:TTTGT
NM_000387.6(SLC25A20):c.10C>T (p.Gln4Ter)	SLC25A20	Q4*	not provided|Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000203941	3	48936218	3	48898785	203941	200052	rs756998699	NC_000003.12:48898784:G:A
NM_000387.6(SLC25A20):c.496C>T (p.Arg166Ter)	SLC25A20	R166*	not provided|Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000012135	3	48900014	3	48862581	12135	27174	rs151340616	NC_000003.12:48862580:G:A
NM_025139.6(ARMC9):c.1336C>T (p.Arg446Cys)	ARMC9	R446C, R413C	JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427939	2	232141350	2	231276637	427939	419010	rs753432312	NC_000002.12:231276636:C:T
NM_025139.6(ARMC9):c.1027C>A (p.Arg343Ser)	ARMC9	R343S, R310S	JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427937	2	232127019	2	231262306	427937	419007	rs759799287	NC_000002.12:231262305:C:A
NM_025139.6(ARMC9):c.1559C>T (p.Pro520Leu)	ARMC9	P520L, P487L	JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2017)	no assertion criteria provided	VCV000427936	2	232146779	2	231282066	427936	419013	rs1114167449	NC_000002.12:231282065:C:T
NM_025139.6(ARMC9):c.1474G>A (p.Gly492Arg)	ARMC9	G492R, G459R	JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427935	2	232141488	2	231276775	427935	419011	rs780265931	NC_000002.12:231276774:G:A
NM_025139.6(ARMC9):c.1474+1G>C	ARMC9		JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427934	2	232141489	2	231276776	427934	419012	rs1114167448	NC_000002.12:231276775:G:C
NM_025139.6(ARMC9):c.259C>T (p.Arg87Ter)	ARMC9	R87*	JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427933	2	232079625	2	231214912	427933	419006	rs372770167	NC_000002.12:231214911:C:T
NM_025139.6(ARMC9):c.205G>A (p.Gly69Arg)	ARMC9	G69R	JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000427930	2	232079571	2	231214858	427930	419005	rs750247691	NC_000002.12:231214857:G:A
NM_015896.4(ZMYND10):c.797T>C (p.Leu266Pro)	ZMYND10	L266P, L66P, L261P	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 22|Kartagener syndrome	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000066026	3	50379904	3	50342473	66026	76936	rs200913791	NC_000003.12:50342472:A:G
NM_000387.6(SLC25A20):c.84del (p.His29fs)	SLC25A20	H29fs	Carnitine acylcarnitine translocase deficiency|not provided	Pathogenic(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	VCV000012136	3	48936144	3	48898711	12136	27175	rs587776760	NC_000003.12:48898710:A:
LMNB1, DUP, CHR5:126,102,443-126,199,753 SRO, GRCh37	LMNB1		Leukodystrophy, adult-onset, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000014476					14476	29515		
NM_021870.3(FGG):c.666+23T>A	FGG		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000800570	4	155530759	4	154609607	800570	789171		NC_000004.12:154609606:A:T
NM_021870.3(FGG):c.1022G>A (p.Trp341Ter)	FGG	W341*	Afibrinogenemia, congenital	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000504885	4	155527964	4	154606812	504885	496316	rs1553965519	NC_000004.12:154606811:C:T
NM_001543.5(NDST1):c.1831G>A (p.Gly611Ser)	NDST1	G611S	Mental retardation, autosomal recessive 46	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161412	5	149921213	5	150541651	161412	171255	rs606231459	NC_000005.10:150541650:G:A
NM_001543.5(NDST1):c.1918T>C (p.Phe640Leu)	NDST1	F640L	Mental retardation, autosomal recessive 46	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161411	5	149922481	5	150542919	161411	171254	rs606231458	NC_000005.10:150542918:T:C
NM_021870.3(FGG):c.307+5G>A	FGG		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000016377	4	155533165	4	154612013	16377	31416	rs587776838	NC_000004.12:154612012:C:T
NM_021870.3(FGG):c.331A>T (p.Lys111Ter)	FGG	K111*	Abnormal bleeding	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626954	4	155533027	4	154611875	626954	615391		NC_000004.12:154611874:T:A
NM_001543.5(NDST1):c.1926G>T (p.Glu642Asp)	NDST1	E642D	Mental retardation, autosomal recessive 46	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161410	5	149922489	5	150542927	161410	171253	rs606231457	NC_000005.10:150542926:G:T
NM_001543.5(NDST1):c.2126G>A (p.Arg709Gln)	NDST1	R709Q	Mental retardation, autosomal recessive 46	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161409	5	149925029	5	150545467	161409	171252	rs606231456	NC_000005.10:150545466:G:A
NM_021870.3(FGG):c.1210T>C (p.Ser404Pro)	FGG	S378P, S404P	Hypodysfibrinogenemia	Pathogenic(Last reviewed: Apr 15, 2005)	no assertion criteria provided	VCV000156105	4	155526138	4	154604986	156105	165902	rs587777720	NC_000004.12:154604985:A:G
NM_021870.3(FGG):c.667-320A>T	FGG		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000016380	4	155530122	4	154608970	16380	31419	rs587776839	NC_000004.12:154608969:T:A
NM_000387.6(SLC25A20):c.713A>G (p.Gln238Arg)	SLC25A20	Q238R	Carnitine acylcarnitine translocase deficiency|not provided	Pathogenic(Last reviewed: Dec 17, 2013)	criteria provided, multiple submitters, no conflicts	VCV000012138	3	48896530	3	48859097	12138	27177	rs28934589	NC_000003.12:48859096:T:C
NM_005429.5(VEGFC):c.362-2A>T	VEGFC		not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000392820	4	177649124	4	176727970	392820	367621	rs1057524647	NC_000004.12:176727969:T:A
NM_004407.4(DMP1):c.98G>A (p.Trp33Ter)	DMP1	W33*	not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000595958	4	88578227	4	87657075	595958	587019	rs766601503	NC_000004.12:87657074:G:A
NM_153223.3(CEP120):c.2924T>G (p.Ile975Ser)	CEP120	I949S, I975S	Short-rib thoracic dysplasia 13 with or without polydactyly	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000446143	5	122682250	5	123346556	446143	439490	rs1554098663	NC_000005.10:123346555:A:C
NM_153223.3(CEP120):c.451C>T (p.Arg151Ter)	CEP120	R151*, R125*	Short-rib thoracic dysplasia 13 with or without polydactyly	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000446142	5	122748105	5	123412411	446142	439489	rs757499322	NC_000005.10:123412410:G:A
NM_018942.3(HMX1):c.650A>C (p.Gln217Pro)	HMX1	Q217P	Oculoauricular syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000192315	4	8869816	4	8868090	192315	190108	rs876657398	NC_000004.12:8868089:T:G
NM_005429.5(VEGFC):c.628C>T (p.Arg210Ter)	VEGFC	R210*	Lymphedema, hereditary, ID	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000140737	4	177632729	4	176711575	140737	150450	rs587777567	NC_000004.12:176711574:G:A
NM_005429.5(VEGFC):c.571_572insTT (p.Pro191fs)	VEGFC		Lymphedema, hereditary, ID	Pathogenic(Last reviewed: Mar 15, 2013)	no assertion criteria provided	VCV000140736	4	177632785 - 177632786	4	176711631 - 176711632	140736	150449	rs587777566	NC_000004.12:176711631::AA
HMX1, 26-BP DEL, NT215	HMX1		Oculoauricular syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000014865					14865	29904		
NM_004407.4(DMP1):c.1485_1491del (p.Tyr496fs)	DMP1	Y480fs, Y496fs	Autosomal recessive hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000008576	4	88584414 - 88584420	4	87663262 - 87663268	8576	23615	rs587776698	NC_000004.12:87663261:CCTATCAC:C
NM_153223.3(CEP120):c.1646C>T (p.Ala549Val)	CEP120	A549V, A523V	JOUBERT SYNDROME 31	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000446148	5	122720762	5	123385068	446148	439495	rs775080726	NC_000005.10:123385067:G:A
NM_153223.3(CEP120):c.1138_1139insA (p.Ser380fs)	CEP120		JOUBERT SYNDROME 31	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000446147	5	122725734 - 122725735	5	123390040 - 123390041	446147	439494	rs1554103267	NC_000005.10:123390040::T
NM_153223.3(CEP120):c.2177T>C (p.Leu726Pro)	CEP120	L726P, L700P	JOUBERT SYNDROME 31	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000446146	5	122714049	5	123378355	446146	439493	rs1554102026	NC_000005.10:123378354:A:G
NM_153223.3(CEP120):c.581T>C (p.Val194Ala)	CEP120	V194A, V168A	JOUBERT SYNDROME 31	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000446144	5	122734861	5	123399167	446144	439491	rs1554104276	NC_000005.10:123399166:A:G
NM_153223.3(CEP120):c.595G>C (p.Ala199Pro)	CEP120	A199P, A173P	Short-rib thoracic dysplasia 13 with or without polydactyly	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000189370	5	122734847	5	123399153	189370	187258	rs367600930	NC_000005.10:123399152:C:G
NM_004407.4(DMP1):c.55-1G>C	DMP1		Autosomal recessive hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000008574	4	88578183	4	87657031	8574	23613	rs587776697	NC_000004.12:87657030:G:C
NM_004407.4(DMP1):c.362del (p.Pro121fs)	DMP1	P105fs, P121fs	Autosomal recessive hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000008573	4	88583290	4	87662138	8573	23612	rs587776696	NC_000004.12:87662137:CCC:CC
NM_015896.4(ZMYND10):c.47T>G (p.Val16Gly)	ZMYND10	V16G	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 22|Kartagener syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000066021	3	50382964	3	50345533	66021	76931	rs138815960	NC_000003.12:50345532:A:C
NM_014043.4(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	Q206H, Q165H	not provided|Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001654	3	87302948	3	87253798	1654	16693	rs63751126	NC_000003.12:87253797:A:C
NM_004407.4(DMP1):c.1A>G (p.Met1Val)	DMP1	M1V	not provided|Autosomal recessive hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000008575	4	88577645	4	87656493	8575	23614	rs104893834	NC_000004.12:87656492:A:G
NM_001134665.3(TRMT10A):c.616G>A (p.Gly206Arg)	TRMT10A	G206R	Microcephaly, short stature, and impaired glucose metabolism 1|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000156230	4	100474971	4	99553814	156230	166023	rs587777744	NC_000004.12:99553813:C:T
NM_004733.4(SLC33A1):c.1474_1482+9del	SLC33A1		Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000684760	3	155547468 - 155547485	3	155829679 - 155829696	684760	672354		NC_000003.12:155829678:CATACTTACCTCAACAGC:
NM_004733.4(SLC33A1):c.1267-1G>A	SLC33A1		Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000684759	3	155547693	3	155829904	684759	672355		NC_000003.12:155829903:C:T
NM_004733.4(SLC33A1):c.540_541TG[1] (p.Val181fs)	SLC33A1		Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000684757	3	155571244 - 155571245	3	155853455 - 155853456	684757	672353		NC_000003.12:155853454:CACA:CA
NM_020949.3(SLC7A14):c.2122T>G (p.Phe708Val)	SLC7A14	F708V	Retinitis pigmentosa 68	Pathogenic(Last reviewed: Mar 27, 2014)	no assertion criteria provided	VCV000126447	3	170185037	3	170467249	126447	131975	rs587777272	NC_000003.12:170467248:A:C
SLC33A1, 18-BP DEL, NT1474	SLC33A1		Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030379					30379	39336		
SLC33A1, IVS5AS, G-A, -1	SLC33A1		Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030376					30376	39333		
NM_004733.4(SLC33A1):c.339T>G (p.Ser113Arg)	SLC33A1	S113R	Spastic paraplegia 42, autosomal dominant	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000006132	3	155571448	3	155853659	6132	21171	rs121909484	NC_000003.12:155853658:A:C
NM_004733.4(SLC33A1):c.614dup (p.Leu205fs)	SLC33A1		Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000030378	3	155571172 - 155571173	3	155853383 - 155853384	30378	39335	rs863223316	NC_000003.12:155853383:AA:AAA
NM_000387.6(SLC25A20):c.532C>T (p.Arg178Ter)	SLC25A20	R178*	not provided|Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545967	3	48899978	3	48862545	545967	536282	rs778220325	NC_000003.12:48862544:G:A
NM_004733.4(SLC33A1):c.1098C>G (p.Tyr366Ter)	SLC33A1	H304D, Y366*	Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000684758	3	155551696	3	155833907	684758	672352		NC_000003.12:155833906:G:C
NM_000316.3(PTH1R):c.611T>A (p.Val204Glu)	PTH1R	V204E	Failure of tooth eruption, primary	Pathogenic(Last reviewed: Jun 4, 2018)	no assertion criteria provided	VCV000592121	3	46939935	3	46898445	592121	583090	rs769180471	NC_000003.12:46898444:T:A
NM_031296.3(RAB33B):c.490C>T (p.Gln164Ter)	RAB33B	Q164*	Smith-McCort dysplasia 2	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000425563	4	140394080	4	139472926	425563	413918	rs1085307131	NC_000004.12:139472925:C:T
NM_031296.3(RAB33B):c.48_55del (p.Gly17fs)	RAB33B	G17fs	Smith-McCort dysplasia 2	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000425562	4	140375394 - 140375401	4	139454240 - 139454247	425562	413917	rs1085307130	NC_000004.12:139454239:CAGCGGGGCAG:CAG
NM_031296.3(RAB33B):c.365T>C (p.Phe122Ser)	RAB33B	F122S	Smith-McCort dysplasia 2	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000425561	4	140393955	4	139472801	425561	413916	rs1085307129	NC_000004.12:139472800:T:C
NM_031296.3(RAB33B):c.211C>T (p.Arg71Ter)	RAB33B	R71*	Smith-McCort dysplasia 2	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000425560	4	140375560	4	139454406	425560	413915	rs1085307128	NC_000004.12:139454405:C:T
NM_032492.4(JAGN1):c.297C>G (p.Tyr99Ter)	JAGN1	Y99*, Y45*	Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000190481	3	9934806	3	9893122	190481	188300	rs786205705	NC_000003.12:9893121:C:G
NM_032492.4(JAGN1):c.40G>A (p.Gly14Ser)	JAGN1	G14S	Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000190480	3	9932446	3	9890762	190480	188298	rs786205704	NC_000003.12:9890761:G:A
NM_032492.4(JAGN1):c.59G>A (p.Arg20Gln)	JAGN1	R20Q	Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000190479	3	9932465	3	9890781	190479	188299	rs777966677	NC_000003.12:9890780:G:A
NM_031296.3(RAB33B):c.136A>C (p.Lys46Gln)	RAB33B	K46Q	Smith-McCort dysplasia 2	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000050230	4	140375485	4	139454331	50230	59384	rs587776958	NC_000004.12:139454330:A:C
NM_000316.3(PTH1R):c.463G>T (p.Glu155Ter)	PTH1R	E155*	Failure of tooth eruption, primary	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000013754	3	46939602	3	46898112	13754	28793	rs121434605	NC_000003.12:46898111:G:T
PTH1R, IVS8DS, G-A, +1	PTH1R		Failure of tooth eruption, primary	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000013753					13753	28792		
NM_000316.3(PTH1R):c.1050-3C>G	PTH1R		Failure of tooth eruption, primary	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000013752	3	46942901	3	46901411	13752	28791		NC_000003.12:46901410:C:G
PTH1R, IVSM4, C-T, +27	PTH1R		Chondrodysplasia Blomstrand type	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000013751					13751	28790		
NM_000316.3(PTH1R):c.1453C>T (p.Arg485Ter)	PTH1R	R485*	Eiken skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000013749	3	46944817	3	46903327	13749	28788	rs121434603	NC_000003.12:46903326:C:T
NM_000316.3(PTH1R):c.1229C>G (p.Thr410Arg)	PTH1R	T410R	Metaphyseal chondrodysplasia, Jansen type	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000013748	3	46944033	3	46902543	13748	28787	rs121434602	NC_000003.12:46902542:C:G
NM_000316.3(PTH1R):c.1373T>G (p.Ile458Arg)	PTH1R	I458R	Metaphyseal chondrodysplasia, Jansen type	Pathogenic(Last reviewed: Sep 5, 1996)	no assertion criteria provided	VCV000013747	3	46944258	3	46902768	13747	28786	rs121434600	NC_000003.12:46902767:T:G
PTH1R, 1-BP DEL, 1122G	PTH1R		Chondrodysplasia Blomstrand type	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000013746					13746	28785		
NM_000316.3(PTH1R):c.395C>T (p.Pro132Leu)	PTH1R	P132L	Chondrodysplasia Blomstrand type	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000013745	3	46939426	3	46897936	13745	28784	rs121434599	NC_000003.12:46897935:C:T
NM_000316.3(PTH1R):c.1228A>C (p.Thr410Pro)	PTH1R	T410P	Metaphyseal chondrodysplasia, Jansen type	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000013743	3	46944032	3	46902542	13743	28782	rs121434598	NC_000003.12:46902541:A:C
NM_031296.3(RAB33B):c.444T>A (p.Asn148Lys)	RAB33B	N148K	Smith-McCort dysplasia 2	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000050231	4	140394034	4	139472880	50231	59385	rs886044716	NC_000004.12:139472879:T:A
NM_000316.3(PTH1R):c.310C>T (p.Arg104Ter)	PTH1R	R104*	Chondrodysplasia Blomstrand type	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000013750	3	46937356	3	46895866	13750	28789	rs121434604	NC_000003.12:46895865:C:T
NM_000316.3(PTH1R):c.1148G>A (p.Arg383Gln)	PTH1R	R383Q	Chondrodysplasia Blomstrand type	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000013744	3	46943287	3	46901797	13744	28783	rs398122843	NC_000003.12:46901796:G:A
NM_032492.4(JAGN1):c.35_43del (p.Thr12_Gly14del)	JAGN1		Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000156117	3	9932436 - 9932444	3	9890752 - 9890760	156117	165916	rs587777731	NC_000003.12:9890751:CGGCACCGACGGCA:CGGCA
NM_032492.4(JAGN1):c.485A>G (p.Gln162Arg)	JAGN1	Q162R, Q108R	Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000156116	3	9934994	3	9893310	156116	165915	rs587777730	NC_000003.12:9893309:A:G
NM_032492.4(JAGN1):c.130C>T (p.His44Tyr)	JAGN1	H44Y	Severe congenital neutropenia|Severe congenital neutropenia 6, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000156114	3	9934639	3	9892955	156114	165913	rs587777728	NC_000003.12:9892954:C:T
NM_032492.4(JAGN1):c.3G>A (p.Met1Ile)	JAGN1	M1I	Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000156113	3	9932409	3	9890725	156113	165912	rs587777727	NC_000003.12:9890724:G:A
NM_000316.3(PTH1R):c.668A>G (p.His223Arg)	PTH1R	H223R	Metaphyseal chondrodysplasia, Jansen type	Pathogenic(Last reviewed: Sep 5, 1996)	no assertion criteria provided	VCV000013742	3	46940181	3	46898691	13742	28781	rs121434597	NC_000003.12:46898690:A:G
NM_004733.4(SLC33A1):c.328G>C (p.Ala110Pro)	SLC33A1	A110P	not provided|Congenital cataracts, hearing loss, and neurodegeneration	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000030375	3	155571459	3	155853670	30375	39332	rs281875283	NC_000003.12:155853669:C:G
NM_001163435.3(TBCK):c.1878G>T (p.Trp626Cys)	TBCK	W626C, W454C, W563C, W587C	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807703	4	107115894	4	106194737	807703	798541		NC_000004.12:106194736:C:A
NM_001163435.3(TBCK):c.1880T>G (p.Phe627Cys)	TBCK	F588C, F627C, F564C, F455C	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807702	4	107115892	4	106194735	807702	798540		NC_000004.12:106194734:A:C
GRCh37/hg19 4q24(chr4:106989610-107101268)x1	TBCK		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000686259	4	106989610 - 107101268			686259	673851		
GRCh37/hg19 4q24(chr4:107110401-107170995)x1	TBCK		not provided	Pathogenic(Last reviewed: Sep 27, 2017)	no assertion criteria provided	VCV000685817	4	107110401 - 107170995			685817	673409		
GRCh37/hg19 4q24(chr4:106989610-107101268)x1	TBCK		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000685167	4	106989610 - 107101268			685167	672759		
NM_025009.5(CEP135):c.795dup (p.Asn266fs)	CEP135		not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000503912	4	56830533 - 56830534	4	55964367 - 55964368	503912	495224	rs1553889111	NC_000004.12:55964367:CC:CCC
NM_025009.5(CEP135):c.2594G>A (p.Trp865Ter)	CEP135	W865*	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000489230	4	56877666	4	56011500	489230	481716	rs1553894675	NC_000004.12:56011499:G:A
NM_001163435.3(TBCK):c.1039C>T (p.Arg347Ter)	TBCK	R347*, R175*, R308*, R284*	not provided	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000430512	4	107165814	4	106244657	430512	421464	rs762552974	NC_000004.12:106244656:G:A
NM_001163435.3(TBCK):c.753dup (p.Lys252Ter)	TBCK		not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000429339	4	107169430 - 107169431	4	106248273 - 106248274	429339	421465	rs1131691329	NC_000004.12:106248273:A:AA
NM_174889.5(NDUFAF2):c.386_390del (p.Ile129fs)	NDUFAF2	I129fs	not provided	Pathogenic(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	VCV000214743	5	60448655 - 60448659	5	61152828 - 61152832	214743	211171	rs760647945	NC_000005.10:61152827:AAATTAAA:AAA
NM_198282.4(STING1):c.439G>C (p.Val147Leu)	STING1	V147L, V28L	Sting-associated vasculopathy, infantile-onset	Pathogenic(Last reviewed: Dec 19, 2019)	no assertion criteria provided	VCV000143863	5	138860456	5	139480871	143863	153588	rs587777611	NC_000005.10:139480870:C:G
NM_198282.4(STING1):c.461A>G (p.Asn154Ser)	STING1	N154S, N35S	Sting-associated vasculopathy, infantile-onset	Pathogenic(Last reviewed: Dec 19, 2019)	no assertion criteria provided	VCV000143861	5	138860434	5	139480849	143861	153586	rs587777609	NC_000005.10:139480848:T:C
NM_001163435.3(TBCK):c.659-1G>A	TBCK		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000638592	4	107170140	4	106248983	638592	626380		NC_000004.12:106248982:C:T
NM_001163435.3(TBCK):c.1860+1G>A	TBCK		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000636243	4	107133906	4	106212749	636243	624065		NC_000004.12:106212748:C:T
NM_001163435.3(TBCK):c.658+1G>A	TBCK		Neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635859	4	107171574	4	106250417	635859	623674		NC_000004.12:106250416:C:T
NM_001163435.3(TBCK):c.2060_2235+1del	TBCK		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000584451	4	107092251 - 107092427	4	106171094 - 106171270	584451	575514	rs1560755661	
NM_025009.5(CEP135):c.874C>T (p.Arg292Ter)	CEP135	R292*	Primary autosomal recessive microcephaly 8	Pathogenic	no assertion criteria provided	VCV000518356	4	56831855	4	55965689	518356	508795	rs752140135	NC_000004.12:55965688:C:T
NM_174889.5(NDUFAF2):c.1A>T (p.Met1Leu)	NDUFAF2	M1L	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000496596	5	60241083	5	60945256	496596	488088	rs1554076306	NC_000005.10:60945255:A:T
NM_001163435.3(TBCK):c.1370del (p.Asn457fs)	TBCK	N394fs, N418fs, N285fs, N457fs	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000225241	4	107156505	4	106235348	225241	227155	rs746860249	NC_000004.12:106235347:TTTTTTTT:TTTTTTT
NM_174889.5(NDUFAF2):c.103del (p.Ile35fs)	NDUFAF2	I35fs	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001595	5	60241185	5	60945358	1595	16634	rs1554076324	NC_000005.10:60945357:A:
NM_198282.4(STING1):c.842G>A (p.Arg281Gln)	STING1	R281Q, R162Q	Sting-associated vasculopathy, infantile-onset	Pathogenic(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV000568703	5	138857018	5	139477433	568703	564814	rs1561482476	NC_000005.10:139477432:C:T
NM_025009.5(CEP135):c.2930_2931del (p.Leu977fs)	CEP135	L977fs	Primary autosomal recessive microcephaly 8	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000433185	4	56883941 - 56883942	4	56017775 - 56017776	433185	426744	rs1553895368	NC_000004.12:56017774:TT:
NM_025009.5(CEP135):c.1473+1G>A	CEP135		Primary autosomal recessive microcephaly 8	Pathogenic(Last reviewed: Mar 29, 2017)	no assertion criteria provided	VCV000417785	4	56841136	4	55974970	417785	404686	rs1085307120	NC_000004.12:55974969:G:A
NM_001163435.3(TBCK):c.831_832insTA (p.Pro278fs)	TBCK		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000225238	4	107168395 - 107168396	4	106247238 - 106247239	225238	227152	rs869320769	NC_000004.12:106247238:T:TAT
NM_025009.5(CEP135):c.970del (p.Gln324fs)	CEP135	Q324fs	Primary autosomal recessive microcephaly 8	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031661	4	56831951	4	55965785	31661	40336	rs202247811	NC_000004.12:55965784:C:
NM_174889.5(NDUFAF2):c.9G>A (p.Trp3Ter)	NDUFAF2	W3*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000496598	5	60241091	5	60945264	496598	488090	rs1554076309	NC_000005.10:60945263:G:A
NM_001163435.3(TBCK):c.803_806del (p.Met268fs)	TBCK	M205fs, M229fs, M268fs, M96fs	not provided|Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000225240	4	107168421 - 107168424	4	106247264 - 106247267	225240	227154	rs771481304	NC_000004.12:106247263:TTCATT:TT
NM_001163435.3(TBCK):c.1532G>A (p.Arg511His)	TBCK	R511H, R339H, R448H, R472H	Syndromic Infantile Encephalopathy|Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000225237	4	107154202	4	106233045	225237	227151	rs869320711	NC_000004.12:106233044:C:T
NM_001085377.2(MCC):c.2087G>A (p.Arg696Gln)	MCC	R506Q, R696Q	Carcinoma of colon	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000014203	5	112399807	5	113064110	14203	29242	rs121917732	NC_000005.10:113064109:C:T
NM_001085377.2(MCC):c.2663C>T (p.Ala888Val)	MCC	A698V, A888V	Carcinoma of colon	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000014202	5	112379320	5	113043623	14202	29241	rs121917731	NC_000005.10:113043622:G:A
NM_174889.5(NDUFAF2):c.221G>A (p.Trp74Ter)	NDUFAF2	W74*	Leigh syndrome	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000496555	5	60394822	5	61098995	496555	487064	rs772294726	NC_000005.10:61098994:G:A
NM_001163435.3(TBCK):c.1363A>T (p.Lys455Ter)	TBCK	K455*, K392*, K283*, K416*	Syndromic Infantile Encephalopathy|not provided|Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000225236	4	107156512	4	106235355	225236	227150	rs376699648	NC_000004.12:106235354:T:A
NM_001163435.3(TBCK):c.1897+1G>A	TBCK		Hypotonia, infantile, with psychomotor retardation and characteristic facies 3|Muscular hypotonia|Dysmorphism|Ventral septal defect|Delayed reflexes|Global developmental delay|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183338	4	107115874	4	106194717	183338	181410	rs374319146	NC_000004.12:106194716:C:T
NM_001271893.4(TWIST2):c.168del (p.Ser57fs)	TWIST2	S57fs	Congenital ectodermal dysplasia of face	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000039840	2	239757021	2	238848380	39840	48439		NC_000002.12:238848379:CCCC:CCC
NM_006947.4(SRP72):c.620G>A (p.Arg207His)	SRP72	R207H	Bone marrow failure syndrome 1	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031660	4	57342846	4	56476680	31660	40335	rs387907189	NC_000004.12:56476679:G:A
NM_006947.4(SRP72):c.1060_1061CA[2] (p.Thr355fs)	SRP72		Bone marrow failure syndrome 1	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031659	4	57351004 - 57351005	4	56484838 - 56484839	31659	40334	rs587776907	NC_000004.12:56484837:CACACA:CACA
NM_001271893.4(TWIST2):c.229_234dup (p.Gln77_Arg78dup)	TWIST2		Barber-Say syndrome	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000208079	2	239757079 - 239757080	2	238848438 - 238848439	208079	204358	rs869320750	NC_000002.12:238848438:AGCGCCAGCGC:AGCGCCAGCGCCAGCGC
NM_001271893.4(TWIST2):c.224A>C (p.Glu75Ala)	TWIST2	E75A	Barber-Say syndrome	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000208076	2	239757080	2	238848439	208076	204355	rs1553565143	NC_000002.12:238848438:A:C
NM_001271893.4(TWIST2):c.193C>T (p.Gln65Ter)	TWIST2	Q65*	Congenital ectodermal dysplasia of face	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000030679	2	239757049	2	238848408	30679	39636	rs387906974	NC_000002.12:238848407:C:T
NM_001271893.4(TWIST2):c.355C>T (p.Gln119Ter)	TWIST2	Q119*	Congenital ectodermal dysplasia of face	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000030678	2	239757211	2	238848570	30678	39635	rs387906973	NC_000002.12:238848569:C:T
NM_001163435.3(TBCK):c.1771C>T (p.Gln591Ter)	TBCK	Q591*, Q528*, Q552*, Q419*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373291	4	107151523	4	106230366	373291	359599	rs1057518332	NC_000004.12:106230365:G:A
NM_031889.3(ENAM):c.123+2T>G	ENAM		Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic(Last reviewed: Dec 23, 2017)	no assertion criteria provided	VCV000517662	4	71497457	4	70631740	517662	508753	rs1553887511	NC_000004.12:70631739:T:G
NM_031889.3(ENAM):c.1842C>G (p.Tyr614Ter)	ENAM	Y614*, Y396*	Amelogenesis imperfecta, type IC	Pathogenic(Last reviewed: Dec 23, 2017)	no assertion criteria provided	VCV000488662	4	71508985	4	70643268	488662	481537	rs1553888384	NC_000004.12:70643267:C:G
NM_031889.3(ENAM):c.588+1dup	ENAM		not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000427132	4	71503554 - 71503555	4	70637837 - 70637838	427132	414976	rs752102959	NC_000004.12:70637837:GGGGGGG:GGGGGGGG
NM_031889.3(ENAM):c.2763del (p.Asp921fs)	ENAM	D703fs, D921fs	not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000418735	4	71509906	4	70644189	418735	406459	rs529979202	NC_000004.12:70644188:T:
NM_031889.3(ENAM):c.157A>T (p.Lys53Ter)	ENAM	K53*	Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000004237	4	71497599	4	70631882	4237	19276	rs121908109	NC_000004.12:70631881:A:T
NM_031889.3(ENAM):c.92T>G (p.Leu31Arg)	ENAM	L31R	Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000374930	4	71497424	4	70631707	374930	361835	rs1060499539	NC_000004.12:70631706:T:G
NM_031889.3(ENAM):c.534+1G>A	ENAM		Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000004236	4	71501612	4	70635895	4236	19275	rs587776587	NC_000004.12:70635894:G:A
NM_183040.2(DTNBP1):c.177G>A (p.Trp59Ter)	DTNBP1	W59*, W24*, W42*	Hermansky-Pudlak syndrome 7|Hermansky-Pudlak syndrome 1	Pathogenic(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000162098	6	15638020	6	15637789	162098	171814	rs727502866	NC_000006.12:15637788:C:T
NM_001271893.4(TWIST2):c.223G>C (p.Glu75Gln)	TWIST2	E75Q	Barber-Say syndrome	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000208078	2	239757079	2	238848438	208078	204357	rs1553565140	NC_000002.12:238848437:G:C
NC_000004.11:g.(?_111539205)_(111543628_?)del	PITX2		Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Jul 31, 2015)	no assertion criteria provided	VCV000375443	4	111539205 - 111543628	4	110618049 - 110622472	375443	362187		
NM_000325.6(PITX2):c.807T>A (p.Cys269Ter)	PITX2	C216*, C262*, C269*	Axenfeld-Rieger syndrome type 1	Pathogenic	no assertion criteria provided	VCV000375442	4	111539449	4	110618293	375442	362188	rs1057519489	NC_000004.12:110618292:A:T
NM_000325.6(PITX2):c.784_785del (p.Ser262fs)	PITX2	S255fs, S262fs, S209fs	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Nov 24, 2009)	no assertion criteria provided	VCV000375441	4	111539471 - 111539472	4	110618315 - 110618316	375441	362189	rs1057519488	NC_000004.12:110618314:GA:
NM_000325.6(PITX2):c.714_735del (p.Thr239fs)	PITX2	T232fs, T239fs, T186fs	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: May 11, 2015)	no assertion criteria provided	VCV000375440	4	111539521 - 111539542	4	110618365 - 110618386	375440	362190	rs1057519487	NC_000004.12:110618364:ACTGGAGCCCGGGACGCCTGTCACTG:ACTG
NM_000325.6(PITX2):c.350C>T (p.Pro117Leu)	PITX2	P64L, P110L, P117L	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	VCV000375437	4	111542381	4	110621225	375437	362194	rs1057519484	NC_000004.12:110621224:G:A
NM_000325.6(PITX2):c.343_364del (p.Arg115fs)	PITX2	R115fs, R108fs, R62fs	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Oct 12, 2015)	no assertion criteria provided	VCV000375436	4	111542367 - 111542388	4	110621211 - 110621232	375436	362193	rs1057519483	NC_000004.12:110621210:GTGTGGACATGTCCGGGTAGCGGT:GT
NM_002187.3(IL12B):c.30G>A (p.Trp10Ter)	IL12B	W10*	Immunodeficiency 29	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000847134	5	158753761	5	159326753	847134	830581		NC_000005.10:159326752:C:T
NM_002187.2(IL12B):c.259C>T (p.Gln87Ter)	IL12B	Q87*	Immunodeficiency 29	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000571326	5	158750167	5	159323159	571326	564981	rs1562113567	NC_000005.10:159323158:G:A
NM_000325.6(PITX2):c.307C>T (p.Gln103Ter)	PITX2	Q50*, Q103*, Q96*	Rieger syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000492756	4	111542424	4	110621268	492756	485734	rs1553922901	NC_000004.12:110621267:G:A
NM_002187.2(IL12B):c.298_305del (p.Ser100fs)	IL12B	S100fs	Immunodeficiency 29	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000183390	5	158750121 - 158750128	5	159323113 - 159323120	183390	181494	rs786201006	NC_000005.10:159323112:AGGAGCGAA:A
NC_000005.10:g.(159317671_159317673)_(159322312_159322314)del	IL12B		Immunodeficiency 29	Pathogenic(Last reviewed: Dec 15, 1998)	no assertion criteria provided	VCV000014053			5	159317671 - 159322314	14053	29092		
NM_000325.6(PITX2):c.344G>A (p.Arg115His)	PITX2	R62H, R108H, R115H	Ring dermoid of cornea	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000008094	4	111542387	4	110621231	8094	23133	rs104893862	NC_000004.12:110621230:C:T
PITX2, 21-BP DUP, NT713	PITX2		Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000008093					8093	23132		
NM_000325.6(PITX2):c.406G>C (p.Val136Leu)	PITX2	V45L, V83L, V136L, V129L	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000008092	4	111542325	4	110621169	8092	23131	rs121909249	NC_000004.12:110621168:C:G
NM_153427.2(PITX2):c.253-2A>T	PITX2		ANTERIOR SEGMENT DYSGENESIS 4, PETERS ANOMALY SUBTYPE	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000008091	4	111539846	4	110618690	8091	23130	rs1553922583	NC_000004.12:110618689:T:A
NM_000325.6(PITX2):c.558G>A (p.Trp186Ter)	PITX2	W133*, W179*, W186*	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008088	4	111539698	4	110618542	8088	23127	rs104893860	NC_000004.12:110618541:C:T
NM_000325.6(PITX2):c.431G>C (p.Arg144Pro)	PITX2	R91P, R144P, R137P	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008087	4	111539825	4	110618669	8087	23126	rs104893859	NC_000004.12:110618668:C:G
NM_000325.6(PITX2):c.412-11A>G	PITX2		Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008086	4	111539855	4	110618699	8086	23125	rs1198152064	NC_000004.12:110618698:T:C
NM_000325.6(PITX2):c.411+5G>C	PITX2		Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008084	4	111542315	4	110621159	8084	23123	rs1560590094	NC_000004.12:110621158:C:G
NM_000325.6(PITX2):c.320T>A (p.Leu107Gln)	PITX2	L54Q, L107Q, L100Q	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008083	4	111542411	4	110621255	8083	23122	rs104893857	NC_000004.12:110621254:A:T
NM_000325.6(PITX2):c.421A>G (p.Lys141Glu)	PITX2	K88E, K141E, K134E	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000030197	4	111539835	4	110618679	30197	39153	rs387906810	NC_000004.12:110618678:T:C
NM_000325.6(PITX2):c.409C>T (p.Arg137Trp)	PITX2	R46W, R84W, R137W, R130W		Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000008089	4	111542322	4	110621166	8089	23128	rs121909248	NC_000004.12:110621165:G:A
NM_000325.6(PITX2):c.416G>C (p.Trp139Ser)	PITX2	W139S, W86S, W132S	Axenfeld-Rieger syndrome type 1|	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000647394	4	111539840	4	110618684	647394	631862		NC_000004.12:110618683:C:G
NM_000325.6(PITX2):c.534C>G (p.Tyr178Ter)	PITX2	Y171*, Y125*, Y178*	Axenfeld-Rieger syndrome type 1|	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000639456	4	111539722	4	110618566	639456	631861		NC_000004.12:110618565:G:C
NM_000325.6(PITX2):c.361A>C (p.Thr121Pro)	PITX2	T68P, T114P, T121P	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000008085	4	111542370	4	110621214	8085	23124	rs104893858	NC_000004.12:110621213:T:G
NM_000325.6(PITX2):c.373del (p.Ile125fs)	PITX2	I118fs, I125fs, I72fs	|Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000844916	4	111542358	4	110621202	844916	828671		NC_000004.12:110621201:TTT:TT
NM_000325.6(PITX2):c.264del (p.Lys89fs)	PITX2	K36fs, K89fs, K82fs	Axenfeld-Rieger syndrome type 1|	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000837823	4	111542467	4	110621311	837823	828672		NC_000004.12:110621310:C:
NC_000004.12:g.(?_110618105)_(110633018_?)del	PITX2		Axenfeld-Rieger syndrome type 1|	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000832808	4	111539261 - 111554174			832808	819438		
NM_000325.6(PITX2):c.411+2T>G	PITX2		|Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000662470	4	111542318	4	110621162	662470	651151		NC_000004.12:110621161:A:C
NM_000325.6(PITX2):c.365G>A (p.Arg122His)	PITX2	R115H, R122H, R69H	|not provided	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000008090	4	111542366	4	110621210	8090	23129	rs104893861	NC_000004.12:110621209:C:T
NM_000387.6(SLC25A20):c.326+1del	SLC25A20		not provided|Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000345943	3	48921429	3	48883996	345943	295347	rs757552268	NC_000003.12:48883995:CC:C
NM_058172.6(ANTXR2):c.1074del (p.Ala359fs)	ANTXR2	A282fs, A359fs	not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000419342	4	80905985	4	79984831	419342	406466	rs312262693	NC_000004.12:79984830:A:
NM_058172.6(ANTXR2):c.134T>C (p.Leu45Pro)	ANTXR2	L45P	not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000280129	4	80993581	4	80072427	280129	264207	rs886041401	NC_000004.12:80072426:A:G
NM_058172.6(ANTXR2):c.903dup (p.Ser302fs)	ANTXR2		Hyaline fibromatosis syndrome	Pathogenic	no assertion criteria provided	VCV000446525	4	80940093 - 80940094	4	80018939 - 80018940	446525	440043	rs1553933367	NC_000004.12:80018939:TTTT:TTTTT
NM_014208.3(DSPP):c.3438del (p.Asp1146fs)	DSPP	D1146fs	Dentinogenesis imperfecta - Shield's type II	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000016861	4	88537252	4	87616100	16861	31900	rs1560480632	NC_000004.12:87616099:C:
NM_014208.3(DSPP):c.2040del (p.Ser680fs)	DSPP	S680fs	Denticles	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000016860	4	88535854	4	87614702	16860	31899	rs1560478758	NC_000004.12:87614701:C:
NM_014208.3(DSPP):c.16T>G (p.Tyr6Asp)	DSPP	D6Y, Y6D	Denticles	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000016857	4	88532076	4	87610924	16857	31896	rs121912988	NC_000004.12:87610923:T:G
NM_014208.3(DSPP):c.135+1G>A	DSPP		Dentinogenesis imperfecta - Shield's type II	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000016854	4	88533341	4	87612189	16854	31893	rs1560477489	NC_000004.12:87612188:G:A
NM_014208.3(DSPP):c.133C>T (p.Gln45Ter)	DSPP	Q45*	Dentinogenesis imperfecta - Shield's type II	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000016853	4	88533338	4	87612186	16853	31892	rs121912985	NC_000004.12:87612185:C:T
NM_183040.2(DTNBP1):c.307C>T (p.Gln103Ter)	DTNBP1	Q103*, Q68*, Q86*, Q22*	Hermansky-Pudlak syndrome 7	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000003432	6	15627622	6	15627391	3432	18471	rs104893945	NC_000006.12:15627390:G:A
NM_014208.3(DSPP):c.44C>T (p.Ala15Val)	DSPP	A15V	Dentinogenesis imperfecta - Shield's type II	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000016859	4	88532104	4	87610952	16859	31898	rs121912989	NC_000004.12:87610951:C:T
NM_014208.3(DSPP):c.49C>A (p.Pro17Thr)	DSPP	P17T	Deafness, autosomal dominant nonsyndromic sensorineural 39, with dentinogenesis imperfecta 1	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000016855	4	88532109	4	87610957	16855	31894	rs121912986	NC_000004.12:87610956:C:A
NM_058172.6(ANTXR2):c.658G>T (p.Glu220Ter)	ANTXR2	E220*, E143*	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000002602	4	80957165	4	80036011	2602	17641	rs137852904	NC_000004.12:80036010:C:A
NM_058172.6(ANTXR2):c.986T>G (p.Leu329Arg)	ANTXR2	L329R, L252R	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000002601	4	80929730	4	80008576	2601	17640	rs137852903	NC_000004.12:80008575:A:C
NM_058172.6(ANTXR2):c.314G>A (p.Gly105Asp)	ANTXR2	G105D, G28D	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000002600	4	80977150	4	80055996	2600	17639	rs137852902	NC_000004.12:80055995:C:T
NM_025139.6(ARMC9):c.1027C>T (p.Arg343Cys)	ARMC9	R343C, R310C	not provided|JOUBERT SYNDROME 30|ARMC9-related Joubert syndrome|Joubert syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000427932	2	232127019	2	231262306	427932	419008	rs759799287	NC_000002.12:231262305:C:T
NM_058172.6(ANTXR2):c.1305del (p.Thr436fs)	ANTXR2	T359fs, T436fs	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	VCV000209132	4	80899203	4	79978049	209132	205741	rs797045028	NC_000004.12:79978048:GGG:GG
ANTXR2, 1-BP DEL, 1074T	ANTXR2		Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000039509					39509	48108		
NM_058172.6(ANTXR2):c.566T>C (p.Ile189Thr)	ANTXR2	I189T, I112T	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000002603	4	80975496	4	80054342	2603	17642	rs137852905	NC_000004.12:80054341:A:G
NM_058172.6(ANTXR2):c.1142A>G (p.Tyr381Cys)	ANTXR2	Y381C, Y304C	Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000002599	4	80905069	4	79983915	2599	17638	rs137852901	NC_000004.12:79983914:T:C
NM_058172.6(ANTXR2):c.1179G>A (p.Glu393=)	ANTXR2		Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000002598	4	80905032	4	79983878	2598	17637	rs546102223	NC_000004.12:79983877:C:T
NM_021870.2(FGG):c.902G>A (p.Arg301His)	FGG	R275H, R301H	Hypofibrinogenemia|FIBRINOGEN HAIFA 1	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000016362	4	155528084	4	154606932	16362	31401	rs121913088	NC_000004.12:154606931:C:T
NM_021147.5(CCNO):c.716A>G (p.His239Arg)	CCNO	H239R	Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000209004	5	54527540	5	55231712	209004	205556	rs797045150	NC_000005.10:55231711:T:C
NM_021147.5(CCNO):c.259_268dup (p.Val90fs)	CCNO		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000665170	5	54529083 - 54529084	5	55233255 - 55233256	665170	633983		NC_000005.10:55233255:CGGGCTGGGCCGGGC:CGGGCTGGGCCGGGCTGGGCCGGGC
NM_021147.5(CCNO):c.302del (p.Tyr101fs)	CCNO	Y101fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000665010	5	54529050	5	55233222	665010	633982		NC_000005.10:55233221:T:
NM_021147.5(CCNO):c.538dup (p.Val180fs)	CCNO		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000525368	5	54528217 - 54528218	5	55232389 - 55232390	525368	521504	rs774393276	NC_000005.10:55232389:CCCC:CCCCC
NM_021147.5(CCNO):c.638T>C (p.Leu213Pro)	CCNO	L213P	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000411594	5	54527618	5	55231790	411594	395335	rs775051461	NC_000005.10:55231789:A:G
NM_021147.5(CCNO):c.165del (p.Gly56fs)	CCNO	G56fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000645504	5	54529187	5	55233359	645504	633985		NC_000005.10:55233358:GG:G
NM_021147.5(CCNO):c.875_897del (p.Asp292fs)	CCNO	D292fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000861050	5	54527359 - 54527381	5	55231531 - 55231553	861050	830893		NC_000005.10:55231530:CCGCGAGACCCGCAGCATGCGGTCCGC:CCGC
NM_021147.5(CCNO):c.746del (p.Gln249fs)	CCNO	Q249fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000839570	5	54527510	5	55231682	839570	830897		NC_000005.10:55231681:T:
NM_021147.5(CCNO):c.793del (p.Val265fs)	CCNO	V265fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000838130	5	54527463	5	55231635	838130	830896		NC_000005.10:55231634:CCCCCC:CCCCC
NM_021147.5(CCNO):c.775C>T (p.Gln259Ter)	CCNO	Q259*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000411596	5	54527481	5	55231653	411596	395630	rs1060503388	NC_000005.10:55231652:G:A
NM_021147.5(CCNO):c.479_480CT[1] (p.Leu161fs)	CCNO		Ciliary dyskinesia, primary, 29|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000139611	5	54528274 - 54528275	5	55232446 - 55232447	139611	143235	rs587777503	NC_000005.10:55232445:AGAG:AG
NM_021147.5(CCNO):c.961C>T (p.Gln321Ter)	CCNO	Q321*	Ciliary dyskinesia, primary, 29|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000139602	5	54527295	5	55231467	139602	143227	rs587777501	NC_000005.10:55231466:G:A
NM_021147.5(CCNO):c.926del (p.Pro309fs)	CCNO	P309fs	Ciliary dyskinesia, primary, 29|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000139601	5	54527330	5	55231502	139601	143226	rs587777500	NC_000005.10:55231501:GGG:GG
NM_003998.4(NFKB1):c.1071_1074del (p.Glu358fs)	NFKB1	E358fs, E357fs	not provided	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000817383	4	103514584 - 103514587	4	102593427 - 102593430	817383	805373		NC_000004.12:102593426:AAAGAA:AA
NM_003998.4(NFKB1):c.2083G>T (p.Glu695Ter)	NFKB1	E695*, E694*	not provided	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000452633	4	103528435	4	102607278	452633	443536	rs1553937650	NC_000004.12:102607277:G:T
NM_003998.4(NFKB1):c.702del (p.Val235fs)	NFKB1	V235fs, V234fs	not provided	Pathogenic(Last reviewed: Jul 8, 2017)	criteria provided, single submitter	VCV000450428	4	103500166	4	102579009	450428	443533	rs1553934187	NC_000004.12:102579008:CCC:CC
NM_001069.3(TUBB2A):c.580G>A (p.Glu194Lys)	TUBB2A	E194K, E109K	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000449113	6	3154855	6	3154621	449113	443943	rs1554122959	NC_000006.12:3154620:C:T
NM_003998.4(NFKB1):c.2602_2603dup (p.Thr869fs)	NFKB1		not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000432311	4	103534587 - 103534588	4	102613430 - 102613431	432311	425584	rs1553938888	NC_000004.12:102613430:GGGGG:GGGGGGG
NM_001069.3(TUBB2A):c.533C>T (p.Thr178Met)	TUBB2A	T178M, T93M	not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000265284	6	3154902	6	3154668	265284	259843	rs886039447	NC_000006.12:3154667:G:A
Single allele	NFKB1		Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827830	4	103370996 - 103528207			827830	816028		
NM_003998.4(NFKB1):c.843C>G (p.Ile281Met)	NFKB1	I281M, I280M	Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827721	4	103504030	4	102582873	827721	815902		NC_000004.12:102582872:C:G
NM_003998.4(NFKB1):c.293T>A (p.Val98Asp)	NFKB1	V97D, V98D	Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827720	4	103488178	4	102567021	827720	815900		NC_000004.12:102567020:T:A
NM_003998.4(NFKB1):c.260T>G (p.Ile87Ser)	NFKB1	I87S, I86S	Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827719	4	103488145	4	102566988	827719	815899		NC_000004.12:102566987:T:G
NM_003998.4(NFKB1):c.465dup (p.Ala156fs)	NFKB1		Immunodeficiency, common variable, 12	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000210058	4	103498088 - 103498089	4	102576931 - 102576932	210058	206681	rs869320754	NC_000004.12:102576931:AA:AAA
NM_003998.4(NFKB1):c.835+2T>G	NFKB1		Immunodeficiency, common variable, 12	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000210057	4	103501798	4	102580641	210057	206680	rs869320689	NC_000004.12:102580640:T:G
NM_003998.4(NFKB1):c.295C>T (p.Gln99Ter)	NFKB1	Q99*, Q98*	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827729	4	103488180	4	102567023	827729	815901		NC_000004.12:102567022:C:T
NM_003998.4(NFKB1):c.1621_1622del (p.Gln540_Asp541insTer)	NFKB1		Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827727	4	103518802 - 103518803	4	102597645 - 102597646	827727	815907		NC_000004.12:102597644:GA:
NM_003998.4(NFKB1):c.1539_1543del (p.His513fs)	NFKB1	H512fs, H513fs	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827724	4	103518718 - 103518722	4	102597561 - 102597565	827724	815906		NC_000004.12:102597560:CATGCCA:CA
NM_003998.4(NFKB1):c.1005del (p.Arg336fs)	NFKB1	R335fs, R336fs	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827722	4	103505915	4	102584758	827722	815904		NC_000004.12:102584757:GG:G
NM_001069.3(TUBB2A):c.728C>T (p.Pro243Leu)	TUBB2A	P243L, P158L	not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000546138	6	3154707	6	3154473	546138	536712	rs1554122947	NC_000006.12:3154472:G:A
NM_058172.6(ANTXR2):c.1073dup (p.Ala359fs)	ANTXR2		Hyaline fibromatosis syndrome	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000002604	4	80905985 - 80905986	4	79984831 - 79984832	2604	17643	rs312262690	NC_000004.12:79984831:GGGG:GGGGG
NM_003998.4(NFKB1):c.830dup (p.Lys278fs)	NFKB1		Common variable immunodeficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636694	4	103501790 - 103501791	4	102580633 - 102580634	636694	624272		NC_000004.12:102580633:A:AA
NM_003998.4(NFKB1):c.730+4A>G	NFKB1		Immunodeficiency, common variable, 12	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000210056	4	103500200	4	102579043	210056	206679	rs869320688	NC_000004.12:102579042:A:G
NM_003998.4(NFKB1):c.850C>T (p.Arg284Ter)	NFKB1	R283*, R284*	Common variable immunodeficiency|Inherited Immunodeficiency Diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827726	4	103504037	4	102582880	827726	815903		NC_000004.12:102582879:C:T
NM_003998.4(NFKB1):c.1423del (p.Ala475fs)	NFKB1	A475fs, A474fs	Common variable immunodeficiency|Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827723	4	103517416	4	102596259	827723	815905		NC_000004.12:102596258:GG:G
NM_001069.3(TUBB2A):c.1033A>T (p.Ile345Phe)	TUBB2A	I345F, I260F	Cortical dysplasia, complex, with other brain malformations 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, multiple submitters, no conflicts	VCV000212495	6	3154402	6	3154168	212495	207399	rs797046074	NC_000006.12:3154167:T:A
NM_001069.3(TUBB2A):c.741C>G (p.Asn247Lys)	TUBB2A	N247K, N162K	Cortical dysplasia, complex, with other brain malformations 5	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000127100	6	3154694	6	3154460	127100	132609	rs886037663	NC_000006.12:3154459:G:C
NM_001069.3(TUBB2A):c.292G>A (p.Gly98Arg)	TUBB2A	G98R, G13R	not provided|Cortical dysplasia, complex, with other brain malformations 5	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421739	6	3155143	6	3154909	421739	406855	rs1064795334	NC_000006.12:3154908:C:T
NM_183075.3(CYP2U1):c.947A>T (p.Asp316Val)	CYP2U1	D316V	Spastic paraplegia 56, autosomal recessive|not provided|Global developmental delay|Neurodegeneration|Spastic paraplegia	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000039500	4	108866582	4	107945426	39500	48099	rs397514513	NC_000004.12:107945425:A:T
NM_014208.3(DSPP):c.52G>T (p.Val18Phe)	DSPP	V18F	Deafness, autosomal dominant nonsyndromic sensorineural 39, with dentinogenesis imperfecta 1|Dentinogenesis imperfecta - Shield's type III|Dentinogenesis imperfecta - Shield's type II	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000016856	4	88533257	4	87612105	16856	31895	rs121912987	NC_000004.12:87612104:G:T
NM_021870.2(FGG):c.901C>T (p.Arg301Cys)	FGG	R275C, R301C	Hypofibrinogenemia|FIBRINOGEN TOKYO 2	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000016361	4	155528085	4	154606933	16361	31400	rs121913087	NC_000004.12:154606932:G:A
NM_021147.5(CCNO):c.263_267dup (p.Val90fs)	CCNO		Ciliary dyskinesia, primary, 29|Primary ciliary dyskinesia|Kartagener syndrome	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000139603	5	54529084 - 54529085	5	55233256 - 55233257	139603	143228	rs587777502	NC_000005.10:55233256:GGGCTGGGC:GGGCTGGGCTGGGC
NM_021147.5(CCNO):c.248_252dup (p.Gly85fs)	CCNO		Ciliary dyskinesia, primary, 29|Primary ciliary dyskinesia|Kartagener syndrome	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000139599	5	54529099 - 54529100	5	55233271 - 55233272	139599	143224	rs587777498	NC_000005.10:55233271:GGGCAGGG:GGGCAGGGCAGGG
NM_000436.4(OXCT1):c.1402C>T (p.Arg468Cys)	OXCT1	R438C, R475C, R282C, R466C, R468C	Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800772	5	41749646	5	41749544	800772	788779		NC_000005.10:41749543:G:A
NM_000436.4(OXCT1):c.1248+5G>A	OXCT1		Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000041497	5	41794100	5	41793998	41497	49933	rs1561081472	NC_000005.10:41793997:C:T
NM_000436.4(OXCT1):c.661G>A (p.Val221Met)	OXCT1	V221M, V228M, V35M	Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008168	5	41842787	5	41842685	8168	23207	rs121909303	NC_000005.10:41842684:C:T
NM_000436.4(OXCT1):c.656G>A (p.Gly219Glu)	OXCT1	G219E, G226E, G33E	Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008167	5	41842792	5	41842690	8167	23206	rs121909302	NC_000005.10:41842689:C:T
NM_000436.4(OXCT1):c.1367G>T (p.Cys456Phe)	OXCT1	C456F, C426F, C270F, C454F, C463F	Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000008164	5	41749681	5	41749579	8164	23203	rs121909300	NC_000005.10:41749578:C:A
NM_000436.4(OXCT1):c.971G>A (p.Gly324Glu)	OXCT1	G324E, G138E, G322E, G331E	Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008166	5	41803250	5	41803148	8166	23205	rs121909301	NC_000005.10:41803147:C:T
NM_000436.4(OXCT1):c.848C>G (p.Ser283Ter)	OXCT1	S283*, S290*, S281*, S97*	Succinyl-CoA acetoacetate transferase deficiency	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000008163	5	41805776	5	41805674	8163	23202	rs121909299	NC_000005.10:41805673:G:C
NM_003998.4(NFKB1):c.904dup (p.Ser302fs)	NFKB1		not provided|Inherited Immunodeficiency Diseases|Immunodeficiency, common variable, 12	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430907	4	103504086 - 103504087	4	102582929 - 102582930	430907	424449	rs773694113	NC_000004.12:102582929:TTTTT:TTTTTT
NM_005885.4(MARCHF6):c.19+2427TTTAT[641]	MARCHF6		Epilepsy, familial adult myoclonic, 3	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635281	5	10356455 - 10356456	5	10356343 - 10356344	635281	623115		
NC_000005.9:g.(?_150632758)_(150647221_?)del	GM2A		Tay-Sachs disease, variant AB	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000529236	5	150632758 - 150647221	5	151253197 - 151267660	529236	520161		
NM_000358.3(TGFBI):c.1998G>C (p.Arg666Ser)	TGFBI	R666S	Corneal epithelial dystrophy	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000007878	5	135398363	5	136062674	7878	22917	rs121909217	NC_000005.10:136062673:G:C
NM_000358.3(TGFBI):c.1526T>G (p.Leu509Arg)	TGFBI	L509R	Corneal epithelial dystrophy	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000007877	5	135391484	5	136055795	7877	22916	rs121909216	NC_000005.10:136055794:T:G
NM_000358.3(TGFBI):c.1619T>C (p.Phe540Ser)	TGFBI	F540S		Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000007875	5	135392425	5	136056736	7875	22914	rs121909214	NC_000005.10:136056735:T:C
NM_000358.3(TGFBI):c.370C>A (p.Arg124Ser)	TGFBI	R124S	Groenouw corneal dystrophy type I	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007873	5	135382095	5	136046406	7873	22912	rs121909210	NC_000005.10:136046405:C:A
TGFBI, 3-BP DEL, EX12	TGFBI		Reis-Bucklers' corneal dystrophy	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007870					7870	22909		
NM_000405.5(GM2A):c.160G>T (p.Glu54Ter)	GM2A	E54*	Tay-Sachs disease, variant AB	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000000394	5	150639394	5	151259833	394	15433	rs104893897	NC_000005.10:151259832:G:T
GM2A, 1-BP DEL, 410A	GM2A		Tay-Sachs disease, variant AB	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000000393					393	15432		
GM2A, 3-BP DEL, 262AAG	GM2A		Tay-Sachs disease, variant AB	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000000392					392	15431		
NM_000405.5(GM2A):c.506G>C (p.Arg169Pro)	GM2A	R169P	Tay-Sachs disease, variant AB	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000000391	5	150646936	5	151267375	391	15430	rs104893892	NC_000005.10:151267374:G:C
MARCHF6, TTTCA(n) REPEAT EXPANSION, IVS1	MARCHF6		Epilepsy, familial adult myoclonic, 3	Pathogenic(Last reviewed: Nov 15, 2019)	no assertion criteria provided	VCV000694446					694446	682370		
NM_000345.4(SNCA):c.152G>A (p.Gly51Asp)	SNCA	G51D	Parkinson disease 1	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000097000	4	90749305	4	89828154	97000	102896	rs431905511	NC_000004.12:89828153:C:T
NM_000358.3(TGFBI):c.1868G>A (p.Gly623Asp)	TGFBI	G623D	Reis-Bucklers' corneal dystrophy	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000007876	5	135396587	5	136060898	7876	22915	rs121909215	NC_000005.10:136060897:G:A
NM_000358.3(TGFBI):c.371G>A (p.Arg124His)	TGFBI	R124H	Avellino corneal dystrophy	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000007869	5	135382096	5	136046407	7869	22908	rs121909211	NC_000005.10:136046406:G:A
NM_000358.3(TGFBI):c.370C>T (p.Arg124Cys)	TGFBI	R124C	Lattice corneal dystrophy Type I	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000007868	5	135382095	5	136046406	7868	22907	rs121909210	NC_000005.10:136046405:C:T
NM_000358.3(TGFBI):c.1663C>T (p.Arg555Trp)	TGFBI	R555W	Groenouw corneal dystrophy type I	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000007866	5	135392469	5	136056780	7866	22905	rs121909208	NC_000005.10:136056779:C:T
NM_000405.5(GM2A):c.333del (p.Cys112fs)	GM2A	C112fs	Tay-Sachs disease	Pathogenic	no assertion criteria provided	VCV000100728	5	150646381	5	151266820	100728	106593	rs587779405	NC_000005.10:151266819:C:
NM_000345.4(SNCA):c.136G>A (p.Glu46Lys)	SNCA	E46K	Lewy body dementia	Pathogenic(Last reviewed: Mar 4, 2005)	no assertion criteria provided	VCV000014010	4	90749321	4	89828170	14010	29049	rs104893875	NC_000004.12:89828169:C:T
NM_000405.5(GM2A):c.412T>C (p.Cys138Arg)	GM2A	C138R	Tay-Sachs disease, variant AB	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000000390	5	150646460	5	151266899	390	15429	rs137852797	NC_000005.10:151266898:T:C
NM_000358.3(TGFBI):c.1664G>A (p.Arg555Gln)	TGFBI	R555Q	Thiel-Behnke corneal dystrophy	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000007867	5	135392470	5	136056781	7867	22906	rs121909209	NC_000005.10:136056780:G:A
NM_198506.5(LRIT3):c.1536_1537CT[1] (p.Ser513fs)	LRIT3		Congenital stationary night blindness, type 1F	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039441	4	110791441 - 110791442	4	109870285 - 109870286	39441	48040	rs397509380	NC_000004.12:109870284:CTCT:CT
NM_198506.5(LRIT3):c.1151C>G (p.Ser384Ter)	LRIT3	S384*	Congenital stationary night blindness, type 1F	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039440	4	110791056	4	109869900	39440	48039	rs397509379	NC_000004.12:109869899:C:G
NM_198506.5(LRIT3):c.1318C>T (p.Arg440Ter)	LRIT3	R440*	Congenital stationary night blindness, type 1F	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039439	4	110791223	4	109870067	39439	48038	rs397509378	NC_000004.12:109870066:C:T
NM_198506.5(LRIT3):c.983G>A (p.Cys328Tyr)	LRIT3	C328Y	Congenital stationary night blindness, type 1F	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039438	4	110790888	4	109869732	39438	48037	rs376610215	NC_000004.12:109869731:G:A
NM_000405.5(GM2A):c.164C>T (p.Pro55Leu)	GM2A	P55L	Neurodegenerative illness progressing to crippling dystonia and death with relentless cerebral atrophy|Tay-Sachs disease, variant AB	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000183275	5	150639398	5	151259837	183275	181419	rs730882196	NC_000005.10:151259836:C:T
NM_000358.3(TGFBI):c.371G>T (p.Arg124Leu)	TGFBI	R124L	Avellino corneal dystrophy|Reis-Bucklers' corneal dystrophy	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000007872	5	135382096	5	136046407	7872	22911	rs121909211	NC_000005.10:136046406:G:T
NM_000345.4(SNCA):c.88G>C (p.Ala30Pro)	SNCA	A30P	Parkinson disease 1	Pathogenic(Last reviewed: Nov 22, 2013)	no assertion criteria provided	VCV000014008	4	90756731	4	89835580	14008	29047	rs104893878	NC_000004.12:89835579:C:G
NM_001098511.3(KIF2A):c.283C>T (p.Arg95Ter)	KIF2A	R95*, R75*	Cortical dysplasia, complex, with other brain malformations 3	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800959	5	61645896	5	62350069	800959	788782		NC_000005.10:62350068:C:T
NM_004520.4(KIF2A):c.950G>A (p.Ser317Asn)	KIF2A	S317N, S297N, S298N	Cortical dysplasia, complex, with other brain malformations 3	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000065401	5	61657146	5	62361319	65401	76334	rs587777034	NC_000005.10:62361318:G:A
NM_004520.4(KIF2A):c.961C>G (p.His321Asp)	KIF2A	H321D, H301D, H302D	Cortical dysplasia, complex, with other brain malformations 3	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000065400	5	61657157	5	62361330	65400	76333	rs587777033	NC_000005.10:62361329:C:G
NM_001098511.2(KIF2A):c.959C>T (p.Thr320Ile)	KIF2A	T320I, T301I, T300I	Cortical dysplasia, complex, with other brain malformations 3	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000435642	5	61657155	5	62361328	435642	428443	rs1554042050	NC_000005.10:62361327:C:T
SNCA, TRIPLICATION	SNCA		Parkinson disease 4	Pathogenic(Last reviewed: Mar 20, 2007)	no assertion criteria provided	VCV000014009					14009	29048		
NM_021629.4(GNB4):c.265A>G (p.Lys89Glu)	GNB4	K89E	Charcot-Marie-Tooth disease, dominant intermediate F	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000041941	3	179134283	3	179416495	41941	51107	rs387907341	NC_000003.12:179416494:T:C
SOX2, DEL	SOX2		Anophthalmia/microphthalmia-esophageal atresia syndrome	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000012819					12819	27858		
SOX2, 17-BP DEL, NT70	SOX2		Anophthalmia/microphthalmia-esophageal atresia syndrome	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000012827					12827	27866		
SOX2, 1-BP INS, 60G	SOX2		Anophthalmia/microphthalmia-esophageal atresia syndrome	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000012824					12824	27863		
NM_001003694.2(BRPF1):c.2594_2597del (p.Asp865fs)	BRPF1	D859fs, D858fs, D865fs	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000818056	3	9785542 - 9785545	3	9743858 - 9743861	818056	805370		NC_000003.12:9743857:AGATAG:AG
NM_001003694.2(BRPF1):c.558_570delinsAGGTAGAGGTG (p.Asp187fs)	BRPF1		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817938	3	9776382 - 9776394	3	9734698 - 9734710	817938	805369		NC_000003.12:9734697:GGACACCCCTGAT:AGGTAGAGGTG
NM_001038603.3(MARVELD2):c.799_800del (p.Thr267fs)	MARVELD2	T267fs	not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000817776	5	68716010 - 68716011	5	69420183 - 69420184	817776	805447		NC_000005.10:69420182:CAC:C
NM_001038603.3(MARVELD2):c.866G>A (p.Trp289Ter)	MARVELD2	W289*	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000620515	5	68716078	5	69420251	620515	611637	rs1561291313	NC_000005.10:69420250:G:A
NM_001038603.3(MARVELD2):c.1160C>G (p.Ser387Ter)	MARVELD2	S387*	not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000620321	5	68720441	5	69424614	620321	611638	rs1336624126	NC_000005.10:69424613:C:G
NM_001038603.3(MARVELD2):c.1224dup (p.Val409fs)	MARVELD2		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560893	5	68728393 - 68728394	5	69432566 - 69432567	560893	552002	rs1561299289	NC_000005.10:69432566:AA:AAA
NM_001003694.2(BRPF1):c.1300del (p.Thr434fs)	BRPF1	T434fs	not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000503926	3	9781383	3	9739699	503926	495474	rs1553695254	NC_000003.12:9739698:A:
NM_001003694.2(BRPF1):c.1218C>G (p.Tyr406Ter)	BRPF1	Y406*	not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000489378	3	9781301	3	9739617	489378	481709	rs1553695222	NC_000003.12:9739616:C:G
NM_001003694.2(BRPF1):c.3G>A (p.Met1Ile)	BRPF1	M1I	not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000489079	3	9775827	3	9734143	489079	481708	rs1553693702	NC_000003.12:9734142:G:A
NC_000003.12:g.9739581_9739582del	BRPF1		Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000810669					810669	798955		
NM_001003694.2(BRPF1):c.904C>T (p.Gln302Ter)	BRPF1	Q302*	Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000559906	3	9780987	3	9739303	559906	550597	rs1553695017	NC_000003.12:9739302:C:T
NM_001003694.2(BRPF1):c.286C>T (p.Gln96Ter)	BRPF1	Q96*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000440978	3	9776110	3	9734426	440978	434588	rs1553693863	NC_000003.12:9734425:C:T
NM_001003694.2(BRPF1):c.104dup (p.Tyr35Ter)	BRPF1		Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375493	3	9775927 - 9775928	3	9734243 - 9734244	375493	362303	rs1057519517	NC_000003.12:9734243:A:AA
NM_001003694.2(BRPF1):c.1165T>C (p.Cys389Arg)	BRPF1	C389R	Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375491	3	9781248	3	9739564	375491	362301	rs1057519515	NC_000003.12:9739563:T:C
NM_001003694.2(BRPF1):c.2982C>G (p.Tyr994Ter)	BRPF1	Y994*, Y988*, Y893*, Y987*	Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375490	3	9786753	3	9745069	375490	362300	rs1057519514	NC_000003.12:9745068:C:G
NM_001003694.2(BRPF1):c.3298C>T (p.Arg1100Ter)	BRPF1	R1100*, R1093*, R1094*, R999*	Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375488	3	9787588	3	9745904	375488	362298	rs1057519513	NC_000003.12:9745903:C:T
NM_001003694.2(BRPF1):c.1108C>T (p.Pro370Ser)	BRPF1	P370S	Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375484	3	9781191	3	9739507	375484	362294	rs1057519509	NC_000003.12:9739506:C:T
NM_001038603.2(MARVELD2):c.1331+4_1331+7delAGTG	MARVELD2		Deafness, autosomal recessive 49	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000001196					1196	16235		
NM_001038603.3(MARVELD2):c.1183-1G>A	MARVELD2		Deafness, autosomal recessive 49	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000001195	5	68728353	5	69432526	1195	16234	rs200781822	NC_000005.10:69432525:G:A
NM_001003694.2(BRPF1):c.567del (p.Asp190fs)	BRPF1	D190fs	Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000375492	3	9776391	3	9734707	375492	362302	rs1057519516	NC_000003.12:9734706:T:
NM_001003694.2(BRPF1):c.2497C>T (p.Arg833Ter)	BRPF1	R833*, R827*, R826*	not provided|Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000375487	3	9785447	3	9743763	375487	362297	rs1057519512	NC_000003.12:9743762:C:T
NM_001003694.2(BRPF1):c.1363C>T (p.Arg455Ter)	BRPF1	R455*	Intellectual developmental disorder with dysmorphic facies and ptosis|not provided	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000375485	3	9781446	3	9739762	375485	362295	rs1057519510	NC_000003.12:9739761:C:T
MARVELD2, IVS4DS, T-C, +2	MARVELD2		Deafness, autosomal recessive 49	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000001197					1197	16236		
NM_139248.3(LIPH):c.736T>A (p.Cys246Ser)	LIPH	C246S	Hereditary hypotrichosis simplex|Woolly hair, autosomal recessive 2, with or without hypotrichosis|Hypotrichosis 7	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225403	3	185237080	3	185519292	225403	227256	rs201249971	NC_000003.12:185519291:A:T
NM_001003694.2(BRPF1):c.360_361AG[1] (p.Glu121fs)	BRPF1		Neurodevelopmental disorder|Intellectual developmental disorder with dysmorphic facies and ptosis	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375486	3	9776184 - 9776185	3	9734500 - 9734501	375486	362296	rs1057519511	NC_000003.12:9734499:AGAG:AG
NM_021871.4(FGA):c.327_337del (p.Met110fs)	FGA	M110fs	not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000817729	4	155509972 - 155509982	4	154588820 - 154588830	817729	805386		NC_000004.12:154588819:AAATTTCCATTA:A
NM_002887.4(RARS1):c.2T>A (p.Met1Lys)	RARS1	M1K	not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000488942	5	167913505	5	168486500	488942	481730	rs769713780	NC_000005.10:168486499:T:A
NM_002887.4(RARS1):c.1849_1850TG[2] (p.Val618fs)	RARS1		not provided	Pathogenic(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	VCV000419440	5	167945043 - 167945044	5	168518038 - 168518039	419440	406700	rs754997301	NC_000005.10:168518037:TGTGTG:TGTG
NM_002887.4(RARS1):c.1439_1442AAGA[1] (p.Arg482fs)	RARS1		not provided	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000373799	5	167937677 - 167937680	5	168510672 - 168510675	373799	359680	rs1057518618	NC_000005.10:168510671:AAAGAAAGA:AAAGA
NM_021871.4(FGA):c.811C>T (p.Arg271Ter)	FGA	R271*	Afibrinogenemia, congenital	Pathogenic	no assertion criteria provided	VCV000800649	4	155507770	4	154586618	800649	789247		NC_000004.12:154586617:G:A
NM_021871.4(FGA):c.502C>T (p.Arg168Ter)	FGA	R168*	Afibrinogenemia, congenital	Pathogenic(Last reviewed: Sep 26, 2015)	criteria provided, single submitter	VCV000402230	4	155508672	4	154587520	402230	389197	rs755117226	NC_000004.12:154587519:G:A
NM_002887.4(RARS1):c.94_95TG[1] (p.Cys32fs)	RARS1		Leukodystrophy, hypomyelinating, 9	Pathogenic(Last reviewed: Apr 29, 2014)	no assertion criteria provided	VCV000162082	5	167915655 - 167915656	5	168488650 - 168488651	162082	171798	rs672601374	NC_000005.10:168488649:TGTG:TG
NM_002887.4(RARS1):c.45+1G>T	RARS1		Leukodystrophy, hypomyelinating, 9	Pathogenic(Last reviewed: Apr 29, 2014)	no assertion criteria provided	VCV000162081	5	167913549	5	168486544	162081	171797	rs672601373	NC_000005.10:168486543:G:T
NM_021871.4(FGA):c.711dup (p.Lys238Ter)	FGA		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000016417	4	155507869 - 155507870	4	154586717 - 154586718	16417	31456	rs606231225	NC_000004.12:154586717:AAAA:AAAAA
NM_021871.4(FGA):c.1629del (p.Thr544fs)	FGA	T544fs	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: May 15, 1996)	no assertion criteria provided	VCV000016413	4	155506952	4	154585800	16413	31452	rs587777762	NC_000004.12:154585799:C:
NM_021871.4(FGA):c.1622del (p.Val541fs)	FGA	V541fs	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Dec 15, 1997)	no assertion criteria provided	VCV000016409	4	155506959	4	154585807	16409	31448	rs587777761	NC_000004.12:154585806:A:
NM_021871.4(FGA):c.1718G>T (p.Arg573Leu)	FGA	R554L, R573L	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000016408	4	155506863	4	154585711	16408	31447	rs78506343	NC_000004.12:154585710:C:A
NM_021871.4(FGA):c.104G>C (p.Arg35Pro)	FGA	R35P	Hypofibrinogenemia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627199	4	155510665	4	154589513	627199	615383		NC_000004.12:154589512:C:G
NM_021871.4(FGA):c.103C>A (p.Arg35Ser)	FGA	R35S	Hypofibrinogenemia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627196	4	155510666	4	154589514	627196	615384		NC_000004.12:154589513:G:T
NM_021871.4(FGA):c.945del (p.Gly316fs)	FGA	G316fs	Hypofibrinogenemia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627159	4	155507636	4	154586484	627159	615380		NC_000004.12:154586483:A:
NM_002887.4(RARS1):c.1846_1847del (p.Tyr616fs)	RARS1	Y616fs	Leukodystrophy, hypomyelinating, 9	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000424864	5	167945040 - 167945041	5	168518035 - 168518036	424864	354262	rs1064792894	NC_000005.10:168518034:TA:
NM_002887.4(RARS1):c.1367C>T (p.Ser456Leu)	RARS1	S456L	Leukodystrophy, hypomyelinating, 9	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000265854	5	167937606	5	168510601	265854	260554	rs139644798	NC_000005.10:168510600:C:T
NC_000004.12:g.(154580323_154580329)_(154590210_154590216)del	FGA		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000016414			4	154580323 - 154590216	16414	31453		
NM_001003694.2(BRPF1):c.1050_1051TG[1] (p.Val351fs)	BRPF1		Intellectual developmental disorder with dysmorphic facies and ptosis|Intellectual disability	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000268185	3	9781133 - 9781134	3	9739449 - 9739450	268185	263800	rs886041090	NC_000003.12:9739448:TGTG:TG
NM_002887.4(RARS1):c.1A>G (p.Met1Val)	RARS1	M1V	Leukodystrophy, hypomyelinating, 9|not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000162083	5	167913504	5	168486499	162083	171799	rs672601375	NC_000005.10:168486498:A:G
NM_002887.4(RARS1):c.2T>C (p.Met1Thr)	RARS1	M1T	Leukodystrophy, hypomyelinating, 9|not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391980	5	167913505	5	168486500	391980	368072	rs769713780	NC_000005.10:168486499:T:C
NM_021871.4(FGA):c.1634A>T (p.Glu545Val)	FGA	E526V, E545V	Familial visceral amyloidosis, Ostertag type	Pathogenic(Last reviewed: Dec 25, 2008)	no assertion criteria provided	VCV000016410	4	155506947	4	154585795	16410	31449	rs121909612	NC_000004.12:154585794:T:A
GRCh37/hg19 4q22.1(chr4:93326311-93569881)x1	GRID2		not provided	Pathogenic(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000688260	4	93326311 - 93569881			688260	675852		
GRCh37/hg19 4q22.1-22.2(chr4:93426934-93754475)x1	GRID2		not provided	Pathogenic(Last reviewed: May 18, 2018)	no assertion criteria provided	VCV000685734	4	93426934 - 93754475			685734	673326		
Single allele	GRID2		Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242880	4	93978239 - 94078203			242880	244005		
GRCh37/hg19 4q22.2(chr4:93978239-94073948)x0	GRID2		See cases	Pathogenic(Last reviewed: Jun 22, 2015)	no assertion criteria provided	VCV000442959	4	93978239 - 94073948			442959	436621		
NM_004752.3(GCM2):c.456+2_456+3insT	GCM2		not provided	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000433165	6	10876675 - 10876676	6	10876442 - 10876443	433165	426715	rs759190203	NC_000006.12:10876442:A:AA
NM_001510.4(GRID2):c.2128C>T (p.Arg710Trp)	GRID2	R710W, R615W	Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000427806	4	94436497	4	93515346	427806	418553	rs750331613	NC_000004.12:93515345:C:T
NC_000004.12:g.92491792_92826931del	GRID2		Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Oct 15, 2013)	no assertion criteria provided	VCV000180134	4	93412943 - 93748082	4	92491792 - 92826931	180134	178315		
NC_000004.12:g.92559959_92610106del	GRID2		Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Oct 15, 2013)	no assertion criteria provided	VCV000180133	4	93481112 - 93531259	4	92559959 - 92610106	180133	178314		
NM_001510.3(GRID2):c.530-12057_735+24661del36924	GRID2		Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Oct 15, 2013)	no assertion criteria provided	VCV000180132	4	94019842 - 94056765	4	93098691 - 93135614	180132	178313		
NC_000004.12:g.93013415_93157863del	GRID2		Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000180131	4	94153589 - 94298037	4	93013415 - 93157863	180131	178312		
NM_004752.3(GCM2):c.893del (p.Ile298Thrfs)	GCM2	I298fs	Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: May 15, 2010)	no assertion criteria provided	VCV000064623	6	10874856	6	10874623	64623	75587	rs886037646	NC_000006.12:10874622:A:
NM_004752.3(GCM2):c.187G>A (p.Gly63Ser)	GCM2	G63S	Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000006092	6	10877529	6	10877296	6092	21131	rs104893960	NC_000006.12:10877295:C:T
GCM2, EX1-4DEL	GCM2		Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000006090					6090	21129		
NC_000006.11:g.(?_10876124)_(10882098_?)del	GCM2		not provided	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000433163	6	10876124 - 10882098	6	10875891 - 10881865	433163	426714		
NM_004752.3(GCM2):c.140G>T (p.Arg47Leu)	GCM2	R47L	Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: May 15, 2010)	no assertion criteria provided	VCV000006091	6	10877576	6	10877343	6091	21130	rs104893959	NC_000006.12:10877342:C:A
NM_002887.4(RARS1):c.5A>G (p.Asp2Gly)	RARS1	D2G	Leukodystrophy, hypomyelinating, 9	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000162080	5	167913508	5	168486503	162080	171796	rs672601372	NC_000005.10:168486502:A:G
NM_001038603.3(MARVELD2):c.1331+1G>A	MARVELD2		Rare genetic deafness|Deafness, autosomal recessive 49	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000228359	5	68728503	5	69432676	228359	229307	rs762352115	NC_000005.10:69432675:G:A
NM_004752.3(GCM2):c.408C>A (p.Tyr136Ter)	GCM2	Y136*	not provided|Familial isolated hypoparathyroidism	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000433164	6	10876726	6	10876493	433164	426716	rs1554103179	NC_000006.12:10876492:G:T
NM_000541.5(SAG):c.571C>T (p.Gln191Ter)	SAG	Q191*	Oguchi's disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801912	2	234237182	2	233328536	801912	790212		NC_000002.12:233328535:C:T
NM_005921.2(MAP3K1):c.1408del (p.His470fs)	MAP3K1	H470fs	Ovarian Neoplasms	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000634799	5	56167842	5	56872015	634799	622530	rs1561193071	NC_000005.10:56872014:CC:C
NM_005921.2(MAP3K1):c.2111C>G (p.Ser704Ter)	MAP3K1	S704*	Ovarian Neoplasms	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000634720	5	56176561	5	56880734	634720	622531	rs1561198459	NC_000005.10:56880733:C:G
NM_005921.2(MAP3K1):c.4369_4373del (p.His1457fs)	MAP3K1	H1457fs	Ovarian Neoplasms	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000634716	5	56184163 - 56184167	5	56888336 - 56888340	634716	622534	rs1561204571	NC_000005.10:56888335:TCATCT:T
NM_005921.2(MAP3K1):c.2627_2642del (p.Thr876fs)	MAP3K1	T876fs	Ovarian Neoplasms	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000634713	5	56177651 - 56177666	5	56881824 - 56881839	634713	622533	rs1561199493	NC_000005.10:56881823:ACACTTTGGATGGTCAACA:ACA
NM_007217.4(PDCD10):c.370dup (p.Arg124fs)	PDCD10		not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000524065	3	167413408 - 167413409	3	167695620 - 167695621	524065	514477	rs1553760888	NC_000003.12:167695620:T:TT
NM_007217.4(PDCD10):c.268+1G>A	PDCD10		not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000489298	3	167414796	3	167697008	489298	481677	rs1553761217	NC_000003.12:167697007:C:T
NM_007217.4(PDCD10):c.467dup (p.Asn156fs)	PDCD10		not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000280738	3	167405409 - 167405410	3	167687621 - 167687622	280738	264116	rs886041888	NC_000003.12:167687621:TT:TTT
NC_000002.12:g.(?_233316075)_(233316135_?)del	SAG		not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000831716	2	234224721 - 234224781			831716	819144		
NM_000824.5(GLRB):c.122+1G>A	GLRB		Hyperekplexia 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802099	4	157999299	4	157078147	802099	790447		NC_000004.12:157078146:G:A
NM_007217.4(PDCD10):c.586C>T (p.Arg196Ter)	PDCD10	R196*	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000590684	3	167402149	3	167684361	590684	581296	rs1404676956	NC_000003.12:167684360:G:A
NM_007217.4(PDCD10):c.396-3C>G	PDCD10		not provided	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000590679	3	167405484	3	167687696	590679	581302	rs1559945136	NC_000003.12:167687695:G:C
NM_007217.4(PDCD10):c.283C>T (p.Arg95Ter)	PDCD10	R95*	not provided	Pathogenic(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	VCV000590675	3	167413496	3	167695708	590675	581305	rs1357917630	NC_000003.12:167695707:G:A
NM_000541.5(SAG):c.523C>T (p.Arg175Ter)	SAG	R175*	Oguchi's disease	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000102422	2	234237134	2	233328488	102422	108164	rs587777209	NC_000002.12:233328487:C:T
NM_000541.5(SAG):c.916G>T (p.Glu306Ter)	SAG	E306*	Oguchi's disease	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000041898	2	234243717	2	233335071	41898	50335	rs397514682	NC_000002.12:233335070:G:T
NM_000541.5(SAG):c.874C>T (p.Arg292Ter)	SAG	R292*	Oguchi's disease	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000041897	2	234243675	2	233335029	41897	50334	rs397514681	NC_000002.12:233335028:C:T
SOX2, 20-BP DEL, NT70	SOX2		Anophthalmia/microphthalmia-esophageal atresia syndrome	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000012823					12823	27862		
NM_000824.5(GLRB):c.24del (p.Phe9_Leu10insTer)	GLRB		Hyperekplexia 2	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000653331	4	157999199	4	157078047	653331	632061		NC_000004.12:157078046:CC:C
NM_000824.5(GLRB):c.472del (p.Gln158fs)	GLRB	Q158fs	Hyperekplexia 2	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000582806	4	158057793	4	157136641	582806	563550	rs1560962636	NC_000004.12:157136640:CCC:CC
NM_000824.5(GLRB):c.448dup (p.Ser150fs)	GLRB		Hyperekplexia 2	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000574411	4	158057765 - 158057766	4	157136613 - 157136614	574411	563549	rs1560962569	NC_000004.12:157136613:AAAAAA:AAAAAAA
NM_000824.5(GLRB):c.596T>G (p.Met199Arg)	GLRB	M177R, M199R	Hyperekplexia 2	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031539	4	158058024	4	157136872	31539	40211	rs398122856	NC_000004.12:157136871:T:G
NM_000824.5(GLRB):c.123-2A>G	GLRB		Hyperekplexia 2	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000574419	4	158041706	4	157120554	574419	559623	rs1415892964	NC_000004.12:157120553:A:G
NM_005921.2(MAP3K1):c.1760T>A (p.Leu587His)	MAP3K1	L587H	46,XY sex reversal, type 6	Pathogenic(Last reviewed: Jul 17, 2017)	no assertion criteria provided	VCV000430732	5	56170932	5	56875105	430732	424270	rs1131692186	NC_000005.10:56875104:T:A
NM_005921.2(MAP3K1):c.566T>G (p.Leu189Arg)	MAP3K1	L189R	46,XY sex reversal, type 6	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030147	5	56152510	5	56856683	30147	39103	rs387906788	NC_000005.10:56856682:T:G
NM_005921.2(MAP3K1):c.566T>C (p.Leu189Pro)	MAP3K1	L189P	46,XY sex reversal, type 6	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030146	5	56152510	5	56856683	30146	39102	rs387906788	NC_000005.10:56856682:T:C
NM_000824.5(GLRB):c.752G>A (p.Gly251Asp)	GLRB	G229D, G251D	Hyperekplexia 2	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016058	4	158064959	4	157143807	16058	31097	rs121909749	NC_000004.12:157143806:G:A
NM_007217.4(PDCD10):c.178C>T (p.Gln60Ter)	PDCD10	Q60*	Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000851434	3	167414887	3	167697099	851434	827655		NC_000003.12:167697098:G:A
NM_145860.1:c.-117+7110_20del	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000839267					839267	850918		
NC_000003.12:g.(?_167684288)_(167697146_?)del	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000833193	3	167402076 - 167414934			833193	819345		
NM_007217.4(PDCD10):c.394A>T (p.Lys132Ter)	PDCD10	K132*	Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000649296	3	167413385	3	167695597	649296	631024		NC_000003.12:167695596:T:A
NC_000003.11:g.(?_167402076)_(167437965_?)del	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000639871	3	167402076 - 167437965	3	167684288 - 167720177	639871	651039		
NM_007217.4(PDCD10):c.333dup (p.Gln112fs)	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000567872	3	167413445 - 167413446	3	167695657 - 167695658	567872	559365	rs1559952317	NC_000003.12:167695657:TTT:TTTT
NM_007217.4(PDCD10):c.557+4_557+7del	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000468332	3	167405015 - 167405018	3	167687227 - 167687230	468332	452270	rs1553759042	NC_000003.12:167687226:TACTTACTT:TACTT
NM_007217.4(PDCD10):c.301C>T (p.Gln101Ter)	PDCD10	Q101*	Cerebral cavernous malformations 3	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000468329	3	167413478	3	167695690	468329	452358	rs1303470125	NC_000003.12:167695689:G:A
NM_007217.4(PDCD10):c.160_163del (p.Glu54fs)	PDCD10	E54fs	Cerebral cavernous malformations 3	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000468328	3	167414902 - 167414905	3	167697114 - 167697117	468328	452276	rs1553761266	NC_000003.12:167697113:TTTCTTT:TTT
NM_005921.2(MAP3K1):c.634-8T>A	MAP3K1		46,XY sex reversal, type 6	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030144	5	56155534	5	56859707	30144	39100	rs1131692053	NC_000005.10:56859706:T:A
PDCD10, DEL	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000001870					1870	16909		
NM_007217.4(PDCD10):c.475-1G>A	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001869	3	167405105	3	167687317	1869	16908		NC_000003.12:167687316:C:T
PDCD10, 4-BP DEL	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001868					1868	16907		
PDCD10, 54-BP DEL	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001867					1867	16906		
PDCD10, 103C-T	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001866					1866	16905		
NM_007217.4(PDCD10):c.385C>T (p.Gln129Ter)	PDCD10	Q129*	Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001865	3	167413394	3	167695606	1865	16904		NC_000003.12:167695605:G:A
PDCD10, 586C-T	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001864					1864	16903		
NM_198282.4(STING1):c.463G>A (p.Val155Met)	STING1	V155M, V36M	not provided|Sting-associated vasculopathy, infantile-onset	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143862	5	138860432	5	139480847	143862	153587	rs587777610	NC_000005.10:139480846:C:T
NM_005141.4(FGB):c.679T>C (p.Cys227Arg)	FGB	C168R, C227R	Dysfibrinogenemia, congenital	Pathogenic	no assertion criteria provided	VCV000800648	4	155488933	4	154567781	800648	789246		NC_000004.12:154567780:T:C
NM_001199799.2(ILDR1):c.643G>T (p.Glu215Ter)	ILDR1	E215*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627449	3	121720158	3	122001311	627449	615788	rs1559875009	NC_000003.12:122001310:C:A
NM_001199799.2(ILDR1):c.1384C>T (p.Arg462Ter)	ILDR1	R462*, R373*, R418*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562073	3	121712212	3	121993365	562073	553254	rs775062249	NC_000003.12:121993364:G:A
NM_001199799.2(ILDR1):c.1161_1162del (p.Trp388fs)	ILDR1	W299fs, W344fs, W388fs	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560892	3	121712434 - 121712435	3	121993587 - 121993588	560892	552000	rs1559870857	NC_000003.12:121993586:AA:
NM_005141.4(FGB):c.974G>C (p.Gly325Ala)	FGB	G266A, G325A	Afibrinogenemia, congenital	Pathogenic(Last reviewed: Feb 27, 2016)	no assertion criteria provided	VCV000800647	4	155490681	4	154569529	800647	789245		NC_000004.12:154569528:G:C
NM_001199799.2(ILDR1):c.942C>A (p.Cys314Ter)	ILDR1	C225*, C270*, C314*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000695027	3	121712654	3	121993807	695027	683136		NC_000003.12:121993806:G:T
NM_001349750.2(PDE8B):c.36+30743G>T	PDE8B	E102*	Striatal degeneration, autosomal dominant 1	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000235863	5	76507054	5	77211229	235863	237518	rs878853158	NC_000005.10:77211228:G:T
NM_001349750.2(PDE8B):c.36+30518del	PDE8B	R27fs	Striatal degeneration, autosomal dominant 1	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000235862	5	76506826	5	77211001	235862	237517	rs878853157	NC_000005.10:77211000:CCCC:CCC
NM_001199799.2(ILDR1):c.583C>T (p.Gln195Ter)	ILDR1	Q195*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000030798	3	121720218	3	122001371	30798	39755	rs387907017	NC_000003.12:122001370:G:A
NM_001199799.2(ILDR1):c.1135G>T (p.Glu379Ter)	ILDR1	E379*, E335*, E290*	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000030796	3	121712461	3	121993614	30796	39753	rs387907015	NC_000003.12:121993613:C:A
NM_005141.4(FGB):c.605T>A (p.Leu202Gln)	FGB	L172Q, L202Q, L143Q	Afibrinogenemia, congenital	Pathogenic(Last reviewed: Apr 15, 2004)	no assertion criteria provided	VCV000016395	4	155488859	4	154567707	16395	31434	rs121909624	NC_000004.12:154567706:T:A
NM_005141.4(FGB):c.1244+1G>T	FGB		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Dec 15, 2002)	no assertion criteria provided	VCV000016393	4	155490952	4	154569800	16393	31432	rs606231224	NC_000004.12:154569799:G:T
NM_005141.4(FGB):c.958+13C>T	FGB		Afibrinogenemia, congenital	Pathogenic(Last reviewed: Dec 15, 2002)	no assertion criteria provided	VCV000016392	4	155490472	4	154569320	16392	31431	rs606231223	NC_000004.12:154569319:C:T
NM_005141.4(FGB):c.1289G>A (p.Gly430Asp)	FGB	G400D, G430D, G371D	Afibrinogenemia, congenital	Pathogenic(Last reviewed: Feb 15, 2000)	no assertion criteria provided	VCV000016390	4	155491615	4	154570463	16390	31429	rs121909622	NC_000004.12:154570462:G:A
NM_005141.4(FGB):c.1148T>G (p.Leu383Arg)	FGB	L353R, L383R, L324R	Afibrinogenemia, congenital	Pathogenic(Last reviewed: Feb 15, 2000)	no assertion criteria provided	VCV000016389	4	155490855	4	154569703	16389	31428	rs121909621	NC_000004.12:154569702:T:G
PDE8B, 94G-C AND 1-BP DEL, 95T	PDE8B		Striatal degeneration, autosomal dominant 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000006391					6391	21430		
NM_001029851.3(PDE8B):c.876+4525A>C	PDE8B	H305P, H181P, H203P, H304P, H285P, H225P, H326P	Pigmented nodular adrenocortical disease, primary, 3	Pathogenic(Last reviewed: Feb 14, 2008)	no assertion criteria provided	VCV000006390	5	76645281	5	77349456	6390	21429	rs121918360	NC_000005.10:77349455:A:C
NM_001199799.2(ILDR1):c.1032del (p.Thr345fs)	ILDR1	T256fs, T345fs, T301fs	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562090	3	121712564	3	121993717	562090	553255	rs1226171550	NC_000003.12:121993716:CC:C
NM_001199799.2(ILDR1):c.3G>A (p.Met1Ile)	ILDR1	M1I	Deafness, autosomal recessive 42	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000030797	3	121740922	3	122022075	30797	39754	rs387907016	NC_000003.12:122022074:C:T
GRCh37/hg19 3q13.31(chr3:114044158-114644245)x1	ZBTB20		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000687698	3	114044158 - 114644245			687698	675290		
GRCh37/hg19 3q13.31(chr3:114091113-114267010)x1	ZBTB20		not provided	Pathogenic(Last reviewed: Apr 26, 2017)	no assertion criteria provided	VCV000687119	3	114091113 - 114267010			687119	674711		
NM_001348803.2(ZBTB20):c.1786C>T (p.His596Tyr)	ZBTB20	H596Y, H523Y	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000375372	3	114069139	3	114350292	375372	362137	rs1057519435	NC_000003.12:114350291:G:A
NM_001348803.2(ZBTB20):c.1876G>A (p.Val626Met)	ZBTB20	V626M, V553M	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000139450	3	114058202	3	114339355	139450	143142	rs483353063	NC_000003.12:114339354:C:T
NM_001348803.2(ZBTB20):c.1802C>T (p.Thr601Ile)	ZBTB20	T601I, T528I	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000139446	3	114069123	3	114350276	139446	143138	rs483353067	NC_000003.12:114350275:G:A
NM_001348803.2(ZBTB20):c.1771C>G (p.Gln591Glu)	ZBTB20	Q591E, Q518E	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000139437	3	114069154	3	114350307	139437	143129	rs483353065	NC_000003.12:114350306:G:C
NM_001348803.2(ZBTB20):c.1939A>C (p.Ser647Arg)	ZBTB20	S647R, S574R	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638662	3	114058139	3	114339292	638662	626434		NC_000003.12:114339291:T:G
NM_001348803.2(ZBTB20):c.391_397delinsAA (p.Asp131fs)	ZBTB20		Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638661	3	114070528 - 114070534	3	114351681 - 114351687	638661	626439		NC_000003.12:114351680:GTTTGTC:TT
NM_001348803.2(ZBTB20):c.1817A>C (p.His606Pro)	ZBTB20	H606P, H533P	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638660	3	114058261	3	114339414	638660	626437		NC_000003.12:114339413:T:G
NM_001348803.2(ZBTB20):c.1955A>G (p.His652Arg)	ZBTB20	H652R, H579R	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638659	3	114058123	3	114339276	638659	626433		NC_000003.12:114339275:T:C
NM_001348803.2(ZBTB20):c.1837C>T (p.Arg613Cys)	ZBTB20	R613C, R540C	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638658	3	114058241	3	114339394	638658	626436		NC_000003.12:114339393:G:A
NM_001348803.2(ZBTB20):c.1760T>G (p.Phe587Cys)	ZBTB20	F587C, F514C	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638657	3	114069165	3	114350318	638657	626438		NC_000003.12:114350317:A:C
NM_001099287.1(NIPAL4):c.1268del (p.Asn423fs)	NIPAL4	N423fs, N404fs	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638553	5	156899831	5	157472823	638553	626339		NC_000005.10:157472822:AAAAA:AAAA
NM_001099287.1(NIPAL4):c.1014C>A (p.Ser338Arg)	NIPAL4	S338R, S319R	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638552	5	156899581	5	157472573	638552	626338		NC_000005.10:157472572:C:A
NM_001099287.1(NIPAL4):c.939C>G (p.Asn313Lys)	NIPAL4	N313K, N294K	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638551	5	156899506	5	157472498	638551	626337		NC_000005.10:157472497:C:G
NM_001099287.1(NIPAL4):c.844G>A (p.Gly282Arg)	NIPAL4	G282R, G263R	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638549	5	156899411	5	157472403	638549	626335		NC_000005.10:157472402:G:A
NM_001099287.1(NIPAL4):c.836C>T (p.Pro279Leu)	NIPAL4	P279L, P260L	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638548	5	156899403	5	157472395	638548	626334		NC_000005.10:157472394:C:T
NM_001099287.1(NIPAL4):c.709del (p.His237fs)	NIPAL4	H218fs, H237fs	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638547	5	156898762	5	157471754	638547	626332		NC_000005.10:157471753:C:
NM_001099287.1(NIPAL4):c.695C>G (p.Thr232Arg)	NIPAL4	T232R, T213R	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638545	5	156898748	5	157471740	638545	626331		NC_000005.10:157471739:C:G
NM_001099287.1(NIPAL4):c.612-3del	NIPAL4		Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638543	5	156898662	5	157471654	638543	626343		NC_000005.10:157471653:C:
NM_001099287.1(NIPAL4):c.611+1G>A	NIPAL4		Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638542	5	156895821	5	157468813	638542	626342		NC_000005.10:157468812:G:A
NM_001099287.1(NIPAL4):c.555C>G (p.Tyr185Ter)	NIPAL4	Y185*, Y166*	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638541	5	156895764	5	157468756	638541	626329		NC_000005.10:157468755:C:G
NM_001099287.1(NIPAL4):c.534A>C (p.Glu178Asp)	NIPAL4	E178D, E159D	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638540	5	156895743	5	157468735	638540	626328		NC_000005.10:157468734:A:C
NM_001099287.1(NIPAL4):c.470G>A (p.Gly157Glu)	NIPAL4	G157E	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638539	5	156894063	5	157467055	638539	626327		NC_000005.10:157467054:G:A
NM_001099287.1(NIPAL4):c.463+5G>A	NIPAL4		Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638538	5	156890346	5	157463338	638538	626341		NC_000005.10:157463337:G:A
NM_001099287.1(NIPAL4):c.407T>A (p.Val136Asp)	NIPAL4	V136D	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638536	5	156890285	5	157463277	638536	626325		NC_000005.10:157463276:T:A
NM_001099287.1(NIPAL4):c.283del (p.Leu95fs)	NIPAL4	L95fs	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638535	5	156890160	5	157463152	638535	626324		NC_000005.10:157463151:CC:C
NM_001099287.1(NIPAL4):c.223+5G>C	NIPAL4		Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638534	5	156887370	5	157460362	638534	626340		NC_000005.10:157460361:G:C
NM_001348803.2(ZBTB20):c.1800C>G (p.His600Gln)	ZBTB20	H600Q, H527Q	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000618973	3	114069125	3	114350278	618973	610373	rs1560110565	NC_000003.12:114350277:G:C
NM_032898.5(CEP19):c.232C>T (p.Arg78Ter)	CEP19	R82*, R78*	Morbid obesity and spermatogenic failure	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000120189	3	196434682	3	196707811	120189	125798	rs587777230	NC_000003.12:196707810:G:A
NM_004744.5(LRAT):c.588dup (p.Ala197fs)	LRAT		not provided	Pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	VCV000095178	4	155670181 - 155670182	4	154749029 - 154749030	95178	101078	rs398124185	NC_000004.12:154749029:TT:TTT
NM_004744.5(LRAT):c.400_401del (p.Lys134fs)	LRAT	K134fs	RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000005335	4	155665875 - 155665876	4	154744723 - 154744724	5335	20374	rs761717462	NC_000004.12:154744722:AAAAA:AAA
NM_001099287.1(NIPAL4):c.889G>A (p.Gly297Arg)	NIPAL4	G297R, G278R	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638550	5	156899456	5	157472448	638550	626336		NC_000005.10:157472447:G:A
NM_001099287.1(NIPAL4):c.709C>G (p.His237Asp)	NIPAL4	H237D, H218D	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638546	5	156898762	5	157471754	638546	626333		NC_000005.10:157471753:C:G
NM_001099287.1(NIPAL4):c.623C>T (p.Ser208Phe)	NIPAL4	S208F, S189F	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638544	5	156898676	5	157471668	638544	626330		NC_000005.10:157471667:C:T
NM_001099287.1(NIPAL4):c.425G>T (p.Gly142Val)	NIPAL4	G142V	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638537	5	156890303	5	157463295	638537	626326		NC_000005.10:157463294:G:T
NM_001099287.1(NIPAL4):c.2T>C (p.Met1Thr)	NIPAL4	M1T	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000638533	5	156887144	5	157460136	638533	626323		NC_000005.10:157460135:T:C
NM_001099287.1(NIPAL4):c.706_712del (p.Ile236fs)	NIPAL4	I217fs, I236fs	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633805	5	156898757 - 156898763	5	157471749 - 157471755	633805	622225	rs1561831443	NC_000005.10:157471748:TGATACATG:TG
NM_001099287.1(NIPAL4):c.1083C>A (p.Tyr361Ter)	NIPAL4	Y361*, Y342*	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000633804	5	156899650	5	157472642	633804	622226	rs373501601	NC_000005.10:157472641:C:A
NM_032898.5(CEP19):c.182dup (p.Tyr61Ter)	CEP19		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 5, 2017)	no assertion criteria provided	VCV000430642	3	196434731 - 196434732	3	196707860 - 196707861	430642	424022	rs1553794304	NC_000003.12:196707860:T:TT
NM_004744.5(LRAT):c.473G>A (p.Trp158Ter)	LRAT	W158*	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000236451	4	155665951	4	154744799	236451	238015	rs878853351	NC_000004.12:154744798:G:A
NM_001348803.2(ZBTB20):c.1805G>C (p.Gly602Ala)	ZBTB20	G602A, G529A	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139447	3	114058273	3	114339426	139447	143139	rs483353068	NC_000003.12:114339425:C:G
NM_001348803.2(ZBTB20):c.1787A>G (p.His596Arg)	ZBTB20	H596R, H523R	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139438	3	114069138	3	114350291	139438	143130	rs483353066	NC_000003.12:114350290:T:C
NIPAL4, ALA114ASN	NIPAL4	A114N	Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: Oct 15, 2004)	no assertion criteria provided	VCV000001730					1730	16769		
NM_001348803.2(ZBTB20):c.1862T>C (p.Leu621Pro)	ZBTB20	L621P, L548P	Marfanoid habitus and intellectual disability|Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638663	3	114058216	3	114339369	638663	626435		NC_000003.12:114339368:A:G
NM_004744.5(LRAT):c.459dup (p.Tyr154fs)	LRAT		not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503963	4	155665932 - 155665933	4	154744780 - 154744781	503963	495211	rs765063151	NC_000004.12:154744780:CCCCC:CCCCCC
NM_001348803.2(ZBTB20):c.1861C>T (p.Leu621Phe)	ZBTB20	L621F, L548F	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139449	3	114058217	3	114339370	139449	143141	rs483353070	NC_000003.12:114339369:G:A
NM_001348803.2(ZBTB20):c.1768A>C (p.Lys590Gln)	ZBTB20	K590Q, K517Q	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139436	3	114069157	3	114350310	139436	143128	rs483353064	NC_000003.12:114350309:T:G
NM_004744.5(LRAT):c.525T>A (p.Ser175Arg)	LRAT	S175R	not provided|RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000005334	4	155666003	4	154744851	5334	20373	rs104893848	NC_000004.12:154744850:T:A
NM_001099287.1(NIPAL4):c.772+1G>A	NIPAL4		Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 16, 2019)	no assertion criteria provided	VCV000001732	5	156898826	5	157471818	1732	16771	rs1561831582	NC_000005.10:157471817:G:A
NM_001099287.1(NIPAL4):c.688G>A (p.Gly230Arg)	NIPAL4	G230R, G211R	not provided|Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000372383	5	156898741	5	157471733	372383	359546	rs370356566	NC_000005.10:157471732:G:A
NM_005025.4(SERPINI1):c.1013A>G (p.His338Arg)	SERPINI1	H338R	Encephalopathy, familial, with neuroserpin inclusion bodies	Pathogenic(Last reviewed: Jun 29, 2002)	no assertion criteria provided	VCV000007088	3	167540807	3	167823019	7088	22127	rs121909052	NC_000003.12:167823018:A:G
NM_005025.4(SERPINI1):c.154A>C (p.Ser52Arg)	SERPINI1	S52R	Encephalopathy, familial, with neuroserpin inclusion bodies	Pathogenic(Last reviewed: Jul 2, 2004)	no assertion criteria provided	VCV000007087	3	167507070	3	167789282	7087	22126		NC_000003.12:167789281:A:C
NM_005025.4(SERPINI1):c.145T>C (p.Ser49Pro)	SERPINI1	S49P	Encephalopathy, familial, with neuroserpin inclusion bodies	Pathogenic(Last reviewed: Jul 2, 2004)	no assertion criteria provided	VCV000007086	3	167507061	3	167789273	7086	22125	rs121909051	NC_000003.12:167789272:T:C
NC_000003.12:g.(?_167684288)_(167687713_?)del	PDCD10		Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832908	3	167402076 - 167405501			832908	819344		
NM_007217.4(PDCD10):c.510C>G (p.Tyr170Ter)	PDCD10	Y170*	Cerebral cavernous malformations 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000536234	3	167405069	3	167687281	536234	518945	rs1553759059	NC_000003.12:167687280:G:C
NM_000541.5(SAG):c.577C>T (p.Arg193Ter)	SAG	R193*	Retinal dystrophy|not provided|Oguchi's disease	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041895	2	234237188	2	233328542	41895	50332	rs201153410	NC_000002.12:233328541:C:T
NM_005025.4(SERPINI1):c.1174G>A (p.Gly392Arg)	SERPINI1	G392R	Encephalopathy, familial, with neuroserpin inclusion bodies	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000007090	3	167543052	3	167825264	7090	22129	rs121909054	NC_000003.12:167825263:G:A
NM_005025.4(SERPINI1):c.1175G>A (p.Gly392Glu)	SERPINI1	G392E	Encephalopathy, familial, with neuroserpin inclusion bodies	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000007089	3	167543053	3	167825265	7089	22128	rs121909053	NC_000003.12:167825264:G:A
NM_001099287.1(NIPAL4):c.433C>T (p.Arg145Ter)	NIPAL4	R83*, R145*	not provided|Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000001729	5	156890311	5	157463303	1729	16768	rs199422216	NC_000005.10:157463302:C:T
NM_021871.4(FGA):c.510+1G>T	FGA		Hypodysfibrinogenemia, congenital|Hypofibrinogenemia|Afibrinogenemia, congenital	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000016415	4	155508663	4	154587511	16415	31454	rs146387238	NC_000004.12:154587510:C:A
NM_000508.3(FGA):c.103C>T (p.Arg35Cys)	FGA	R16C, R35C	Dysfibrinogenemia	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000016399	4	155510666	4	154589514	16399	31438	rs121909606	NC_000004.12:154589513:G:A
NM_024101.7(MLPH):c.70C>T (p.Arg24Ter)	MLPH	R24*	Griscelli syndrome type 3	Pathogenic(Last reviewed: Jan 8, 2018)	no assertion criteria provided	VCV000636328	2	238402139	2	237493496	636328	624151		NC_000002.12:237493495:C:T
NM_005787.6(ALG3):c.350G>C (p.Arg117Pro)	ALG3	R117P, R69P	ALG3-CDG	Pathogenic	no assertion criteria provided	VCV000617674	3	183963350	3	184245562	617674	609077	rs370434427	NC_000003.12:184245561:C:G
NM_005787.6(ALG3):c.286G>A (p.Gly96Arg)	ALG3	G96R, G48R	ALG3-CDG	Pathogenic	no assertion criteria provided	VCV000617673	3	183963511	3	184245723	617673	609076	rs367679074	NC_000003.12:184245722:C:T
NM_005787.6(ALG3):c.163_196+3del	ALG3		ALG3-CDG	Pathogenic	no assertion criteria provided	VCV000617517	3	183966530 - 183966566	3	184248742 - 184248778	617517	608880	rs1560166870	NC_000003.12:184248741:CACATGCCACCCTGTGAATGACCCAGAAGGTGATGCCCAC:CAC
NM_005787.6(ALG3):c.1263G>A (p.Trp421Ter)	ALG3	W421*, W373*	ALG3-CDG	Pathogenic	no assertion criteria provided	VCV000617476	3	183960356	3	184242568	617476	608838	rs1560161567	NC_000003.12:184242567:C:T
NM_152773.5(TCTEX1D2):c.262C>T (p.Arg88Ter)	TCTEX1D2	R88*	Short-rib thoracic dysplasia 17 with or without polydactyly	Pathogenic(Last reviewed: Mar 26, 2017)	no assertion criteria provided	VCV000417792	3	196033869	3	196306998	417792	404693	rs771373235	NC_000003.12:196306997:G:A
NM_152773.5(TCTEX1D2):c.317+4A>T	TCTEX1D2		Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic	no assertion criteria provided	VCV000266107	3	196033810	3	196306939	266107	260898	rs886039815	NC_000003.12:196306938:T:A
NM_003619.4(PRSS12):c.1355_1358del (p.Asp452fs)	PRSS12	D452fs	Mental retardation, autosomal recessive 1	Pathogenic(Last reviewed: Nov 29, 2002)	no assertion criteria provided	VCV000004101	4	119234487 - 119234490	4	118313332 - 118313335	4101	19140	rs876657372	NC_000004.12:118313331:ACGT:
NM_005787.6(ALG3):c.1037A>G (p.Asn346Ser)	ALG3	N346S, N298S	ALG3-CDG	Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	VCV000617513	3	183960718	3	184242930	617513	608876	rs1560162116	NC_000003.12:184242929:T:C
NM_024101.7(MLPH):c.103C>T (p.Arg35Trp)	MLPH	R35W	Griscelli syndrome type 3	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000004268	2	238402172	2	237493529	4268	19307	rs119473031	NC_000002.12:237493528:C:T
NM_005787.6(ALG3):c.470T>A (p.Met157Lys)	ALG3	M157K, M109K	ALG3-CDG	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000002131	3	183963121	3	184245333	2131	17170	rs119103238	NC_000003.12:184245332:A:T
NM_005787.6(ALG3):c.211T>C (p.Trp71Arg)	ALG3	W71R, W23R	ALG3-CDG	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000002130	3	183963586	3	184245798	2130	17169	rs119103237	NC_000003.12:184245797:A:G
NM_005787.6(ALG3):c.512G>A (p.Arg171Gln)	ALG3	R171Q, R123Q	ALG3-CDG	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000002129	3	183963079	3	184245291	2129	17168	rs119103236	NC_000003.12:184245290:C:T
NM_005787.6(ALG3):c.353G>A (p.Gly118Asp)	ALG3	G118D, G70D	ALG3-CDG	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000002127	3	183963347	3	184245559	2127	17166	rs28940588	NC_000003.12:184245558:C:T
NM_004744.5(LRAT):c.217_218del (p.Met73fs)	LRAT	M73fs	Leber congenital amaurosis 14|RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000005336	4	155665695 - 155665696	4	154744543 - 154744544	5336	20375	rs1560870755	NC_000004.12:154744542:AT:
NM_004826.4(ECEL1):c.278del (p.Gly93fs)	ECEL1	G93fs	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000817364	2	233351086	2	232486376	817364	805299		NC_000002.12:232486375:CC:C
NM_004826.4(ECEL1):c.1581+1G>A	ECEL1		Distal arthrogryposis type 5D	Pathogenic	no assertion criteria provided	VCV000816825	2	233347814	2	232483104	816825	805059		NC_000002.12:232483103:C:T
NM_004826.4(ECEL1):c.505_529del (p.Gly169fs)	ECEL1	G169fs	Distal arthrogryposis type 5D	Pathogenic	no assertion criteria provided	VCV000816799	2	233350835 - 233350859	2	232486125 - 232486149	816799	804993		NC_000002.12:232486124:GGGCCGCGCCGCCAGGCCCACCCCCGGGCCGCGCC:GGGCCGCGCC
NM_004826.4(ECEL1):c.2151+2T>A	ECEL1		Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488495	2	233345426	2	232480716	488495	481363	rs762979130	NC_000002.12:232480715:A:T
NM_004826.4(ECEL1):c.4G>T (p.Glu2Ter)	ECEL1	E2*	not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000373060	2	233351360	2	232486650	373060	359359	rs1057518181	NC_000002.12:232486649:C:A
NM_004826.4(ECEL1):c.1147C>T (p.Gln383Ter)	ECEL1	Q383*	Distal arthrogryposis type 5D	Pathogenic	no assertion criteria provided	VCV000816827	2	233349219	2	232484509	816827	804992		NC_000002.12:232484508:G:A
NM_000097.7(CPOX):c.478C>T (p.Gln160Ter)	CPOX	Q160*	Hereditary coproporphyria	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801990	3	98311871	3	98593027	801990	790424		NC_000003.12:98593026:G:A
NM_000097.7(CPOX):c.717T>A (p.Cys239Ter)	CPOX	C239*	not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000656587	3	98309570	3	98590726	656587	631808		NC_000003.12:98590725:A:T
NM_000097.7(CPOX):c.225del (p.Thr76fs)	CPOX	T76fs	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000650602	3	98312124	3	98593280	650602	631810		NC_000003.12:98593279:CCCC:CCC
NM_004826.4(ECEL1):c.1184G>A (p.Arg395Gln)	ECEL1	R395Q	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 8, 2013)	criteria provided, single submitter	VCV000235819	2	233349182	2	232484472	235819	237474	rs765430577	NC_000002.12:232484471:C:T
NM_000097.7(CPOX):c.980A>G (p.His327Arg)	CPOX	H327R	Harderoporphyria	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000126445	3	98304477	3	98585633	126445	131973	rs587777271	NC_000003.12:98585632:T:C
NM_004826.4(ECEL1):c.1685+1G>T	ECEL1		Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Apr 15, 2013)	no assertion criteria provided	VCV000100652	2	233347560	2	232482850	100652	106524	rs587777131	NC_000002.12:232482849:C:A
NM_004826.4(ECEL1):c.1649C>G (p.Ser550Ter)	ECEL1	S550*	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Apr 15, 2013)	no assertion criteria provided	VCV000100651	2	233347597	2	232482887	100651	106523	rs587777130	NC_000002.12:232482886:G:C
NM_004826.4(ECEL1):c.2278T>C (p.Cys760Arg)	ECEL1	C760R, C758R	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Apr 15, 2013)	no assertion criteria provided	VCV000100650	2	233344913	2	232480203	100650	106522	rs587777129	NC_000002.12:232480202:A:G
NM_004826.4(ECEL1):c.590G>A (p.Gly197Asp)	ECEL1	G197D	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039493	2	233350774	2	232486064	39493	48092	rs587776921	NC_000002.12:232486063:C:T
NM_004826.4(ECEL1):c.1252C>T (p.Arg418Cys)	ECEL1	R418C	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039492	2	233348866	2	232484156	39492	48091	rs587776919	NC_000002.12:232484155:G:A
NM_004826.4(ECEL1):c.1184+3A>T	ECEL1		Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039491	2	233349179	2	232484469	39491	48090	rs587776920	NC_000002.12:232484468:T:A
NM_004826.4(ECEL1):c.1252C>A (p.Arg418Ser)	ECEL1	R418S	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039490	2	233348866	2	232484156	39490	48089	rs587776919	NC_000002.12:232484155:G:T
NM_004826.4(ECEL1):c.344_355del (p.Asn115_Ala118del)	ECEL1		Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039489	2	233351009 - 233351020	2	232486299 - 232486310	39489	48088	rs587776918	NC_000002.12:232486298:TGGCGTCCAGGTTGGCG:TGGCG
NM_000097.7(CPOX):c.835G>C (p.Gly279Arg)	CPOX	G279R	Coproporphyria, digenic	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000000463	3	98307675	3	98588831	463	15502	rs121917874	NC_000003.12:98588830:C:G
NM_000097.7(CPOX):c.856dup (p.Thr286fs)	CPOX		Coproporphyria	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000000462	3	98307653 - 98307654	3	98588809 - 98588810	462	15501	rs1559677768	NC_000003.12:98588809:TT:TTT
NM_000097.7(CPOX):c.982C>T (p.Arg328Cys)	CPOX	R328C	Coproporphyria	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000000461	3	98304475	3	98585631	461	15500	rs121917873	NC_000003.12:98585630:G:A
NM_000097.7(CPOX):c.623C>T (p.Ser208Phe)	CPOX	S208F	Coproporphyria	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000000460	3	98309933	3	98591089	460	15499	rs121917872	NC_000003.12:98591088:G:A
NM_000097.7(CPOX):c.1277+3A>G	CPOX		Harderoporphyria	Pathogenic(Last reviewed: Feb 15, 1998)	no assertion criteria provided	VCV000000457	3	98300248	3	98581404	457	15496	rs370245685	NC_000003.12:98581403:T:C
NM_000097.7(CPOX):c.883C>G (p.His295Asp)	CPOX	H295D	Coproporphyria	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000000456	3	98307627	3	98588783	456	15495	rs121917870	NC_000003.12:98588782:G:C
NM_000097.7(CPOX):c.489_509del (p.Cys164_Val170del)	CPOX		Coproporphyria	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000000455	3	98311840 - 98311860	3	98592996 - 98593016	455	15494	rs786205054	NC_000003.12:98592995:ACCTGTGCCAGAGCCTGGCACACCTG:ACCTG
CPOX, IVS6, G-A, -1	CPOX		Coproporphyria	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000000452					452	15491		
NM_004826.4(ECEL1):c.509del (p.Gly170fs)	ECEL1	G170fs	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000435023	2	233350855	2	232486145	435023	427995	rs1553567937	NC_000002.12:232486144:CCCCC:CCCC
NM_004826.4(ECEL1):c.716dup (p.Tyr239Ter)	ECEL1	Y239*	Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jan 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000039488	2	233350647 - 233350648	2	232485937 - 232485938	39488	48087	rs587776917	NC_000002.12:232485937:T:TT
NM_000097.7(CPOX):c.122_126GCAGC[3] (p.Gly45fs)	CPOX		not provided|Coproporphyria	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000000454	3	98312217 - 98312218	3	98593373 - 98593374	454	15493	rs786205053	NC_000003.12:98593373:GCTGCGCTGCGCTG:GCTGCGCTGCGCTGCGCTG
NM_004826.4(ECEL1):c.1470G>A (p.Trp490Ter)	ECEL1	W490*	Distal arthrogryposis type 5D|not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000374305	2	233348162	2	232483452	374305	361175	rs149459910	NC_000002.12:232483451:C:T
NM_000097.7(CPOX):c.85C>T (p.Gln29Ter)	CPOX	Q29*	Coproporphyria	Pathogenic(Last reviewed: Nov 16, 1998)	no assertion criteria provided	VCV000000458	3	98312264	3	98593420	458	15497	rs121917871	NC_000003.12:98593419:G:A
NM_000097.7(CPOX):c.991C>T (p.Arg331Trp)	CPOX	R331W	Coproporphyria	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000000451	3	98304466	3	98585622	451	15490	rs121917866	NC_000003.12:98585621:G:A
NM_021147.5(CCNO):c.253_257GGCCC[3] (p.Gln88fs)	CCNO		Ciliary dyskinesia, primary, 29|not provided|Primary ciliary dyskinesia|Kartagener syndrome	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000139600	5	54529089 - 54529090	5	55233261 - 55233262	139600	143225	rs587777499	NC_000005.10:55233261:GGGCCGGGCCGGGC:GGGCCGGGCCGGGCCGGGC
NM_007217.4(PDCD10):c.322C>T (p.Arg108Ter)	PDCD10	R108*	not provided|Cerebral cavernous malformations 3	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468330	3	167413457	3	167695669	468330	452357	rs1553760900	NC_000003.12:167695668:G:A
NM_000320.3(QDPR):c.174del (p.Ser59fs)	QDPR	S59fs	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802060	4	17510918	4	17509295	802060	790460		NC_000004.12:17509294:G:
NM_000320.3(QDPR):c.421del (p.Leu141fs)	QDPR	L110fs, L141fs	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802059	4	17503357	4	17501734	802059	790459		NC_000004.12:17501733:GGG:GG
NM_000320.3(QDPR):c.661C>T (p.Arg221Ter)	QDPR	R190*, R221*	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802058	4	17488828	4	17487205	802058	790458		NC_000004.12:17487204:G:A
NM_000320.3(QDPR):c.1A>T (p.Met1Leu)	QDPR	M1L	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000503646	4	17513677	4	17512054	503646	495221	rs1034528249	NC_000004.12:17512053:T:A
NM_024592.5(SRD5A3):c.364G>T (p.Gly122Ter)	SRD5A3	G122*	not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000498853	4	56225655	4	55359488	498853	490277	rs1487808056	NC_000004.12:55359487:G:T
NM_024592.5(SRD5A3):c.66del (p.Thr23fs)	SRD5A3	T23fs	not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000423433	4	56212569	4	55346402	423433	406442	rs1064796421	NC_000004.12:55346401:G:
NM_000320.3(QDPR):c.48C>G (p.Tyr16Ter)	QDPR	Y16*	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000567509	4	17513630	4	17512007	567509	559635	rs1171544975	NC_000004.12:17512006:G:C
NM_000320.3(QDPR):c.344C>T (p.Ser115Leu)	QDPR	S115L, S84L	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000459896	4	17503434	4	17501811	459896	453349	rs1407920390	NC_000004.12:17501810:G:A
NM_005816.5(CD96):c.791C>T (p.Thr264Met)	CD96	T280M, T264M	C syndrome	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000004640	3	111304209	3	111585362	4640	19679	rs119477056	NC_000003.12:111585361:C:T
CD96, EXONIC BREAKPOINT	CD96		C syndrome	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000004639					4639	19678		
NM_000320.3(QDPR):c.270G>A (p.Trp90Ter)	QDPR	W90*, W59*	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000000495	4	17506027	4	17504404	495	15534	rs104893867	NC_000004.12:17504403:C:T
NM_000320.3(QDPR):c.449A>G (p.Tyr150Cys)	QDPR	Y150C, Y119C	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000000494	4	17493951	4	17492328	494	15533	rs104893866	NC_000004.12:17492327:T:C
QDPR, IVS3, A-G, 152-BP INS	QDPR		Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000000493					493	15532		
NM_000320.3(QDPR):c.106T>C (p.Trp36Arg)	QDPR	W36R	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000000492	4	17510986	4	17509363	492	15531	rs104893865	NC_000004.12:17509362:A:G
NM_000320.3(QDPR):c.322T>G (p.Trp108Gly)	QDPR	W108G, W77G	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000000491	4	17503456	4	17501833	491	15530	rs104893864	NC_000004.12:17501832:A:C
NM_000320.3(QDPR):c.68G>A (p.Gly23Asp)	QDPR	G23D	Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000000490	4	17513610	4	17511987	490	15529	rs104893863	NC_000004.12:17511986:C:T
QDPR, 3-BP INS, 390ACT	QDPR		Dihydropteridine reductase deficiency	Pathogenic(Last reviewed: Aug 1, 1990)	no assertion criteria provided	VCV000000489					489	15528		
NM_024592.5(SRD5A3):c.204dup (p.Phe69fs)	SRD5A3		Kahrizi syndrome	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030929	4	56212705 - 56212706	4	55346538 - 55346539	30929	39886	rs869320736	NC_000004.12:55346538:CC:CCC
NM_024592.5(SRD5A3):c.29C>A (p.Ser10Ter)	SRD5A3	S10*	Congenital disorder of glycosylation type 1Q	Pathogenic(Last reviewed: Jul 23, 2010)	no assertion criteria provided	VCV000018408	4	56212532	4	55346365	18408	33447	rs267607094	NC_000004.12:55346364:C:A
NM_024592.5(SRD5A3):c.489C>A (p.Tyr163Ter)	SRD5A3	Y163*	Congenital disorder of glycosylation type 1Q	Pathogenic(Last reviewed: Jul 23, 2010)	no assertion criteria provided	VCV000018407	4	56230365	4	55364198	18407	33446	rs267607092	NC_000004.12:55364197:C:A
NM_024592.5(SRD5A3):c.424C>T (p.Arg142Ter)	SRD5A3	R142*	Congenital disorder of glycosylation type 1Q	Pathogenic(Last reviewed: Jul 23, 2010)	no assertion criteria provided	VCV000018406	4	56230300	4	55364133	18406	33445	rs267607095	NC_000004.12:55364132:C:T
NM_024592.5(SRD5A3):c.286_288delinsTGAGTAAGGC (p.Gln96Ter)	SRD5A3		Congenital disorder of glycosylation type 1Q	Pathogenic(Last reviewed: Jul 23, 2010)	no assertion criteria provided	VCV000018404	4	56225577 - 56225579	4	55359410 - 55359412	18404	33443	rs587776521	NC_000004.12:55359409:CAA:TGAGTAAGGC
NM_004826.4(ECEL1):c.997C>T (p.Arg333Ter)	ECEL1	R333*	Distal arthrogryposis type 5D|not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210910	2	233349573	2	232484863	210910	206947	rs370167241	NC_000002.12:232484862:G:A
NM_004826.4(ECEL1):c.2023G>A (p.Ala675Thr)	ECEL1	A675T, A673T	Distal arthrogryposis type 5D	Pathogenic	criteria provided, single submitter	VCV000161451	2	233345833	2	232481123	161451	171286	rs606231471	NC_000002.12:232481122:C:T
NM_018192.4(P3H2):c.1328del (p.Gly443fs)	P3H2	G262fs, G443fs	not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000452529	3	189692471	3	189974682	452529	443398	rs778079243	NC_000003.12:189974681:CC:C
NM_018192.4(P3H2):c.1452+1G>T	P3H2		not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424202	3	189692346	3	189974557	424202	406165	rs1064796858	NC_000003.12:189974556:C:A
NM_182943.3(PLOD2):c.1127+2T>C	PLOD2		not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000391827	3	145804572	3	146086785	391827	367234	rs1057524251	NC_000003.12:146086784:A:G
NM_178012.5(TUBB2B):c.533C>T (p.Thr178Met)	TUBB2B	T178M	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000378836	6	3225790	6	3225556	378836	368900	rs1057520391	NC_000006.12:3225555:G:A
NM_018192.4(P3H2):c.1684C>T (p.Arg562Ter)	P3H2	R562*, R381*	not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000856635	3	189690678	3	189972889	856635	827785		NC_000003.12:189972888:G:A
NM_018192.4(P3H2):c.297del (p.Gly100fs)	P3H2	G100fs	Myopia, high, with cataract and vitreoretinal degeneration	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225632	3	189838224	3	190120435	225632	227466	rs875989838	NC_000003.12:190120434:GGGGGG:GGGGG
NM_018192.4(P3H2):c.556C>T (p.Gln186Ter)	P3H2	Q5*, Q186*	Myopia, high, with cataract and vitreoretinal degeneration	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162462	3	189713156	3	189995367	162462	172136	rs724160006	NC_000003.12:189995366:G:A
NM_182943.3(PLOD2):c.1559dup (p.Val523fs)	PLOD2		Bruck syndrome 2	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000041424	3	145795652 - 145795653	3	146077865 - 146077866	41424	49862	rs749709000	NC_000003.12:146077865:GGGGGG:GGGGGGG
NM_018192.4(P3H2):c.1523G>T (p.Gly508Val)	P3H2	G508V, G327V	Myopia, high, with cataract and vitreoretinal degeneration	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000030822	3	189691723	3	189973934	30822	39779	rs724159988	NC_000003.12:189973933:C:A
NM_182943.3(PLOD2):c.1856G>A (p.Arg619His)	PLOD2	R598H, R619H	Bruck syndrome 2	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000007643	3	145789203	3	146071416	7643	22682	rs121434461	NC_000003.12:146071415:C:T
NM_182943.3(PLOD2):c.1865G>T (p.Gly622Val)	PLOD2	G601V, G622V	Bruck syndrome 2	Pathogenic(Last reviewed: Oct 17, 2003)	no assertion criteria provided	VCV000007642	3	145789194	3	146071407	7642	22681	rs121434460	NC_000003.12:146071406:C:A
NM_182943.3(PLOD2):c.1886C>T (p.Thr629Ile)	PLOD2	T608I, T629I	Bruck syndrome 2	Pathogenic(Last reviewed: Oct 17, 2003)	no assertion criteria provided	VCV000007641	3	145789173	3	146071386	7641	22680	rs121434459	NC_000003.12:146071385:G:A
NM_018192.4(P3H2):c.1726del (p.Ser576fs)	P3H2	S576fs, S395fs	not provided	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000424203	3	189689770	3	189971981	424203	406164	rs767012332	NC_000003.12:189971980:T:
NM_178012.5(TUBB2B):c.1249G>A (p.Asp417Asn)	TUBB2B	D417N	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000039720	6	3225074	6	3224840	39720	48319	rs397514567	NC_000006.12:3224839:C:T
NM_178012.5(TUBB2B):c.793T>C (p.Phe265Leu)	TUBB2B	F265L	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000428	6	3225530	6	3225296	428	15467	rs137853196	NC_000006.12:3225295:A:G
NM_178012.5(TUBB2B):c.683T>C (p.Leu228Pro)	TUBB2B	L228P	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000427	6	3225640	6	3225406	427	15466	rs137853195	NC_000006.12:3225405:A:G
NM_018192.4(P3H2):c.1213C>T (p.Arg405Ter)	P3H2	R405*, R224*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812364	3	189702355	3	189984566	812364	800491		NC_000003.12:189984565:G:A
NM_182943.3(PLOD2):c.2038C>T (p.Arg680Ter)	PLOD2	R659*, R680*	Camptodactyly|Aplasia/hypoplasia of the femur|Short femur|Femoral bowing|Clubfoot|Cleft of soft palate|Ulnar bowing|Radial bowing|Bowing of the long bones|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374012	3	145788912	3	146071125	374012	360847	rs780770356	NC_000003.12:146071124:G:A
NM_178012.5(TUBB2B):c.716G>T (p.Cys239Phe)	TUBB2B	C239F	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Jun 21, 2016)	no assertion criteria provided	VCV000236255	6	3225607	6	3225373	236255	237813	rs878853284	NC_000006.12:3225372:C:A
NM_178012.5(TUBB2B):c.514T>C (p.Ser172Pro)	TUBB2B	S172P	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000426	6	3225809	6	3225575	426	15465	rs137853194	NC_000006.12:3225574:A:G
NM_004826.4(ECEL1):c.1210C>T (p.Arg404Cys)	ECEL1	R404C	not provided|Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000191152	2	233348908	2	232484198	191152	188955	rs532757890	NC_000002.12:232484197:G:A
NM_178012.5(TUBB2B):c.292G>A (p.Gly98Arg)	TUBB2B	G98R	not provided|Polymicrogyria, asymmetric	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212497	6	3226031	6	3225797	212497	207401	rs797046075	NC_000006.12:3225796:C:T
NM_178012.5(TUBB2B):c.1261G>A (p.Glu421Lys)	TUBB2B	E421K	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Dec 4, 2015)	no assertion criteria provided	VCV000088897	6	3225062	6	3224828	88897	94456	rs398122369	NC_000006.12:3224827:C:T
NM_024592.5(SRD5A3):c.320G>A (p.Trp107Ter)	SRD5A3	W107*	Congenital disorder of glycosylation type 1Q	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000018405	4	56225611	4	55359444	18405	33444	rs267607093	NC_000004.12:55359443:G:A
NM_002337.4(LRPAP1):c.199del (p.Gln67fs)	LRPAP1	Q67fs	Myopia 23, autosomal recessive	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000190230	4	3533941	4	3532214	190230	188059	rs786205216	NC_000004.12:3532213:GGG:GG
NM_002337.4(LRPAP1):c.863_864del (p.Ile288fs)	LRPAP1	I288fs	Myopia 23, autosomal recessive	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065461	4	3516626 - 3516627	4	3514899 - 3514900	65461	76377	rs398122836	NC_000004.12:3514898:GA:
NM_002337.4(LRPAP1):c.605del (p.Asn202fs)	LRPAP1	N202fs	Myopia 23, autosomal recessive	Pathogenic(Last reviewed: Aug 8, 2013)	no assertion criteria provided	VCV000065460	4	3519907	4	3518180	65460	76376	rs786205127	NC_000004.12:3518179:TT:T
NM_031889.3(ENAM):c.1259_1260insAG (p.Pro422fs)	ENAM		not provided|Amelogenesis imperfecta - hypoplastic autosomal dominant - local|Amelogenesis imperfecta, type IC	Pathogenic(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000004238	4	71508402 - 71508403	4	70642685 - 70642686	4238	19277	rs587776588	NC_000004.12:70642685::AG
NM_004637.6(RAB7A):c.471G>T (p.Lys157Asn)	RAB7A	K157N		Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000846631	3	128526457	3	128807614	846631	827519		NC_000003.12:128807613:G:T
NM_001128148.3(TFRC):c.1198+1G>T	TFRC		Immunodeficiency 46	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587621	3	195792313	3	196065442	587621	578416	rs1341988492	NC_000003.12:196065441:C:A
NM_031372.3(HNRNPDL):c.1132G>C (p.Asp378His)	HNRNPDL	D378H	Limb-girdle muscular dystrophy, type 1G	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144074	4	83347676	4	82426523	144074	153825	rs587777669	NC_000004.12:82426522:C:G
NC_000004.11:g.(?_90647315)_(90756828_?)dup	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000639372	4	90647315 - 90756828	4	89726164 - 89835677	639372	651126		
NC_000004.11:g.(?_90647315)_(90756838_?)dup	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000531846	4	90647315 - 90756838	4	89726164 - 89835687	531846	519673		
NM_139125.4(MASP1):c.518del (p.Ile173fs)	MASP1	I173fs		Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807629	3	186978558	3	187260770	807629	798525		NC_000003.12:187260769:A:
NM_005654.6(NR2F1):c.353T>G (p.Leu118Ter)	NR2F1	L118*	not provided	Pathogenic(Last reviewed: Oct 14, 2018)	criteria provided, single submitter	VCV000620402	5	92921082	5	93585376	620402	611641	rs1561523796	NC_000005.10:93585375:T:G
NM_001879.5(MASP1):c.238-2A>T	MASP1		not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000546181	3	186980510	3	187262722	546181	536643	rs1553779765	NC_000003.12:187262721:T:A
NM_016006.6(ABHD5):c.588_591del (p.Trp197fs)	ABHD5	W197fs, W156fs	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000524159	3	43753282 - 43753285	3	43711790 - 43711793	524159	514489	rs1553616447	NC_000003.12:43711789:TTGG:
NM_016006.6(ABHD5):c.340C>T (p.Arg114Ter)	ABHD5	R114*, R73*	not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000523801	3	43743913	3	43702421	523801	514488	rs752473449	NC_000003.12:43702420:C:T
NM_005654.6(NR2F1):c.290A>C (p.His97Pro)	NR2F1	H97P	not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000451033	5	92921019	5	93585313	451033	443835	rs1554074673	NC_000005.10:93585312:A:C
NM_005654.6(NR2F1):c.1A>G (p.Met1Val)	NR2F1	M1V	not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000424105	5	92920730	5	93585024	424105	406779	rs1064796799	NC_000005.10:93585023:A:G
NM_005654.6(NR2F1):c.413G>A (p.Cys138Tyr)	NR2F1	C138Y	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic	no assertion criteria provided	VCV000375371	5	92921142	5	93585436	375371	362143	rs1057519434	NC_000005.10:93585435:G:A
NM_001879.5(MASP1):c.1303+5389G>A	MASP1	W593*	not provided	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	VCV000285005	3	186953880	3	187236092	285005	269242	rs549330397	NC_000003.12:187236091:C:T
NM_005654.6(NR2F1):c.424C>T (p.Arg142Cys)	NR2F1	R142C	not provided	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000280552	5	92921153	5	93585447	280552	264255	rs886041738	NC_000005.10:93585446:C:T
NM_005654.6(NR2F1):c.417A>T (p.Gln139His)	NR2F1	Q139H	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280458	5	92921146	5	93585440	280458	264198	rs778199728	NC_000005.10:93585439:A:T
NM_005654.6(NR2F1):c.2T>C (p.Met1Thr)	NR2F1	M1T	not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000279855	5	92920731	5	93585025	279855	264248	rs886041216	NC_000005.10:93585024:T:C
NM_005654.6(NR2F1):c.262G>A (p.Val88Met)	NR2F1	V88M	not provided	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000265667	5	92920991	5	93585285	265667	259830	rs886039714	NC_000005.10:93585284:G:A
NM_005654.6(NR2F1):c.968_969del (p.Lys323fs)	NR2F1	K323fs	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	no assertion criteria provided	VCV000827802	5	92924126 - 92924127	5	93588420 - 93588421	827802	815984		NC_000005.10:93588419:AAA:A
NC_000003.11:g.(?_186953452)_(186974668_?)del	MASP1			Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000650705	3	186953452 - 186974668	3	187235664 - 187256880	650705	651110		
NM_001879.5(MASP1):c.812dup (p.Ser272fs)	MASP1			Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000572584	3	186971035 - 186971036	3	187253247 - 187253248	572584	558866	rs1560255926	NC_000003.12:187253247:T:TT
NM_005654.6(NR2F1):c.403C>T (p.Arg135Cys)	NR2F1	R135C	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000559633	5	92921132	5	93585426	559633	550359	rs1022192010	NC_000005.10:93585425:C:T
NM_002448.3(MSX1):c.661C>T (p.Gln221Ter)	MSX1	Q221*	Hypoplastic enamel-onycholysis-hypohidrosis syndrome	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000461602	4	4864619	4	4862892	461602	453942	rs1553878162	NC_000004.12:4862891:C:T
NM_001879.5(MASP1):c.1303+5669G>A	MASP1	G687R		Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000030077	3	186953600	3	187235812	30077	39032	rs533236263	NC_000003.12:187235811:C:T
NM_001879.5(MASP1):c.1303+5498T>C	MASP1	C630R		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030075	3	186953771	3	187235983	30075	39030	rs387906753	NC_000003.12:187235982:A:G
NM_001879.5(MASP1):c.1303+5099C>T	MASP1	H497Y		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030074	3	186954170	3	187236382	30074	39029	rs387906752	NC_000003.12:187236381:G:A
NM_000176.3(NR3C1):c.2209T>C (p.Phe737Leu)	NR3C1	F737L, F652L, F738L, F640L, F648L, F402L, F407L, F422L, F711L	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000016158	5	142661579	5	143282014	16158	31197	rs121909727	NC_000005.10:143282013:A:G
NM_000176.3(NR3C1):c.2318T>C (p.Leu773Pro)	NR3C1	L773P, L458P, L443P, L676P, L684P, L688P, L438P, L747P, L774P	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000016155	5	142661470	5	143281905	16155	31194	rs104893912	NC_000005.10:143281904:A:G
NM_000176.3(NR3C1):c.1712T>C (p.Val571Ala)	NR3C1	V571A, V486A, V236A, V256A, V474A, V545A, V572A, V241A, V482A	Pseudohermaphroditism, female, with hypokalemia, due to glucocorticoid resistance	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000016153	5	142680085	5	143300520	16153	31192	rs104893911	NC_000005.10:143300519:A:G
NM_000176.3(NR3C1):c.2241T>G (p.Ile747Met)	NR3C1	I747M, I412M, I432M, I417M, I650M, I662M, I658M, I721M, I748M	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016152	5	142661547	5	143281982	16152	31191	rs104893910	NC_000005.10:143281981:A:C
NM_000176.3(NR3C1):c.2259A>T (p.Leu753Phe)	NR3C1	L753F, L664F, L418F, L668F, L727F, L423F, L438F, L754F, L656F	Glucocorticoid resistance, cellular	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000016149	5	142661529	5	143281964	16149	31188	rs121909726	NC_000005.10:143281963:T:A
NM_000176.3(NR3C1):c.1891_1892+2del	NR3C1		Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000016148	5	142678231 - 142678234	5	143298666 - 143298669	16148	31187	rs587776832	NC_000005.10:143298665:ACTCA:A
NM_002448.3(MSX1):c.81dup (p.Gly28fs)	MSX1		Selective tooth agenesis 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000014887	4	4861706 - 4861707	4	4859979 - 4859980	14887	29926	rs1553877821	NC_000004.12:4859979:A:AA
NM_002448.3(MSX1):c.200T>A (p.Met67Lys)	MSX1	M6K, M67K	Selective tooth agenesis 1	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000014886	4	4861826	4	4860099	14886	29925	rs121913130	NC_000004.12:4860098:T:A
NM_002448.3(MSX1):c.365G>A (p.Gly122Glu)	MSX1	G116E, G122E	Orofacial cleft 5	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000014884	4	4861991	4	4860264	14884	29923	rs28933081	NC_000004.12:4860263:G:A
NM_002448.3(MSX1):c.251A>T (p.Glu84Val)	MSX1	E78V, E84V	Orofacial cleft 5	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000014883	4	4861877	4	4860150	14883	29922	rs28928890	NC_000004.12:4860149:A:T
NM_002448.3(MSX1):c.577C>T (p.Gln193Ter)	MSX1	Q187*, Q193*	Selective tooth agenesis 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000014881	4	4864535	4	4862808	14881	29920	rs104893850	NC_000004.12:4862807:C:T
NM_002448.3(MSX1):c.332C>A (p.Ser111Ter)	MSX1	S105*, S111*	Selective tooth agenesis 1	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000014880	4	4861958	4	4860231	14880	29919	rs104893852	NC_000004.12:4860230:C:A
NM_016006.6(ABHD5):c.594dup (p.Arg199fs)	ABHD5		Triglyceride storage disease with ichthyosis	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000005352	3	43753287 - 43753288	3	43711795 - 43711796	5352	20391	rs387906335	NC_000003.12:43711795:C:CC
NM_016006.6(ABHD5):c.134-2A>G	ABHD5		Triglyceride storage disease with ichthyosis	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000005349	3	43743705	3	43702213	5349	20388		NC_000003.12:43702212:A:G
NM_016006.6(ABHD5):c.98C>G (p.Ser33Ter)	ABHD5	S33*	Triglyceride storage disease with ichthyosis	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000005348	3	43740818	3	43699326	5348	20387	rs104893675	NC_000003.12:43699325:C:G
ABHD5, IVS6, G-A, -1	ABHD5		Triglyceride storage disease with ichthyosis	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000005347					5347	20386		
NM_002448.3(MSX1):c.655_659del (p.Trp219fs)	MSX1	W219fs	Hypoplastic enamel-onycholysis-hypohidrosis syndrome	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000845306	4	4864613 - 4864617	4	4862886 - 4862890	845306	829191		NC_000004.12:4862885:TGGTT:
NM_016006.6(ABHD5):c.811G>A (p.Gly271Arg)	ABHD5	G230R, G271R	Triglyceride storage disease with ichthyosis	Pathogenic	criteria provided, single submitter	VCV000812597	3	43759200	3	43717708	812597	800846		NC_000003.12:43717707:G:A
NM_016006.6(ABHD5):c.934C>T (p.Arg312Ter)	ABHD5	R312*, R271*	Triglyceride storage disease with ichthyosis	Pathogenic	criteria provided, single submitter	VCV000619125	3	43759323	3	43717831	619125	610515	rs761087968	NC_000003.12:43717830:C:T
NM_002448.3(MSX1):c.910_911dup (p.Ter304TyrextTer?)	MSX1		Selective tooth agenesis 1	Pathogenic(Last reviewed: Jan 13, 2014)	no assertion criteria provided	VCV000127273	4	4864866 - 4864867	4	4863139 - 4863140	127273	132730	rs515726227	NC_000004.12:4863139:ATA:ATATA
NM_001879.5(MASP1):c.870G>A (p.Trp290Ter)	MASP1	W290*		Pathogenic(Last reviewed: Oct 15, 2012)	no assertion criteria provided	VCV000030078	3	186970978	3	187253190	30078	39033	rs763360042	NC_000003.12:187253189:C:T
NM_000176.3(NR3C1):c.2035G>A (p.Gly679Ser)	NR3C1	G679S, G344S, G590S, G653S, G364S, G594S, G349S, G680S, G582S	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000016157	5	142662279	5	143282714	16157	31196	rs104893914	NC_000005.10:143282713:C:T
NM_000176.3(NR3C1):c.1430G>A (p.Arg477His)	NR3C1	R477H, R142H, R380H, R162H, R388H, R451H, R478H, R147H, R392H	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000016156	5	142689700	5	143310135	16156	31195	rs104893913	NC_000005.10:143310134:C:T
NM_000176.3(NR3C1):c.1676T>A (p.Ile559Asn)	NR3C1	I559N, I229N, I244N, I462N, I470N, I533N, I560N, I224N, I474N	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000016151	5	142680121	5	143300556	16151	31190	rs104893909	NC_000005.10:143300555:A:T
NM_002448.3(MSX1):c.623C>A (p.Ser208Ter)	MSX1	S202*, S208*	Hypoplastic enamel-onycholysis-hypohidrosis syndrome	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000014882	4	4864581	4	4862854	14882	29921	rs104893853	NC_000004.12:4862853:C:A
NM_002448.3(MSX1):c.605G>C (p.Arg202Pro)	MSX1	R31P, R202P	Selective tooth agenesis 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000014879	4	4864563	4	4862836	14879	29918	rs121913129	NC_000004.12:4862835:G:C
NM_016006.6(ABHD5):c.778G>A (p.Glu260Lys)	ABHD5	E260K, E219K	Triglyceride storage disease with ichthyosis	Pathogenic(Last reviewed: Jul 16, 2004)	no assertion criteria provided	VCV000005353	3	43759167	3	43717675	5353	20392	rs28939078	NC_000003.12:43717674:G:A
NM_016006.6(ABHD5):c.389A>C (p.Gln130Pro)	ABHD5	Q130P, Q89P	Triglyceride storage disease with ichthyosis	Pathogenic(Last reviewed: Jul 16, 2004)	no assertion criteria provided	VCV000005350	3	43743962	3	43702470	5350	20389	rs28939077	NC_000003.12:43702469:A:C
NM_001879.5(MASP1):c.1303+5607G>A	MASP1	G666E		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030076	3	186953662	3	187235874	30076	39031	rs387906754	NC_000003.12:187235873:C:T
NM_002448.3(MSX1):c.458C>A (p.Pro153Gln)	MSX1	P147Q, P153Q	Orofacial cleft 5	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000014885	4	4862084	4	4860357	14885	29924	rs104893854	NC_000004.12:4860356:C:A
NM_005654.6(NR2F1):c.339C>A (p.Ser113Arg)	NR2F1	S113R	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000126494	5	92921068	5	93585362	126494	132018	rs587777275	NC_000005.10:93585361:C:A
NM_005654.6(NR2F1):c.344G>C (p.Arg115Pro)	NR2F1	R115P	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000126493	5	92921073	5	93585367	126493	132017	rs587777274	NC_000005.10:93585366:G:C
NM_001242957.1:c.1297_1298insAlu	MAK		not provided	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000800737					800737	789357		
NM_001242957.2(MAK):c.170_171del (p.Leu57fs)	MAK	L57fs	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000286531	6	10818190 - 10818191	6	10817957 - 10817958	286531	270768	rs886043417	NC_000006.12:10817956:AA:
NM_005906.5(MAK):c.37G>A (p.Gly13Ser)	MAK	G13S	Retinitis pigmentosa 62	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000029783	6	10830845	6	10830612	29783	38738	rs387906647	NC_000006.12:10830611:C:T
NM_005906.5(MAK):c.388A>C (p.Asn130His)	MAK	N130H	Retinitis pigmentosa 62	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000029782	6	10809146	6	10808913	29782	38737	rs387906646	NC_000006.12:10808912:T:G
NM_005906.5(MAK):c.718C>T (p.Gln240Ter)	MAK	G240*, Q240*	Retinitis pigmentosa 62	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000029781	6	10802238	6	10802005	29781	38736	rs779514800	NC_000006.12:10802004:G:A
MAK, 353-BP ALU INS, EX9	MAK		Retinitis pigmentosa 62	Pathogenic(Last reviewed: Aug 23, 2011)	no assertion criteria provided	VCV000029780					29780	38735		
NM_001242957.3(MAK):c.79G>C (p.Gly27Arg)	MAK	G27R	not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000849391	6	10830803	6	10830570	849391	831368		NC_000006.12:10830569:C:G
NM_001242385.1(MAK):c.393delinsACCTT (p.Leu132fs)	MAK		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812347	6	10809141	6	10808908	812347	800508		NC_000006.12:10808907:C:AAGGT
NM_000176.3(NR3C1):c.1922A>T (p.Asp641Val)	NR3C1	D641V, D306V, D326V, D544V, D552V, D615V, D642V, D311V, D556V	Glucocorticoid resistance, generalized	Pathogenic(Last reviewed: Feb 1, 1991)	no assertion criteria provided	VCV000016147	5	142675126	5	143295561	16147	31186	rs104893908	NC_000005.10:143295560:T:A
NM_001242957.3(MAK):c.718_719del (p.Gln240fs)	MAK	Q206fs, Q240fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817732	6	10802237 - 10802238	6	10802004 - 10802005	817732	806271		NC_000006.12:10802003:TG:
NM_002111.8(HTT):c.8156T>A (p.Phe2719Tyr)	HTT	F2719L, F2719Y	Lopes-Maciel-Rodan syndrome	Pathogenic(Last reviewed: Apr 15, 2017)	no assertion criteria provided	VCV000417745	4	3231654	4	3229927	417745	404646	rs1060505028	NC_000004.12:3229926:T:A
NM_002111.8(HTT):c.2114C>T (p.Pro705Leu)	HTT	P703L, P705L	Lopes-Maciel-Rodan syndrome	Pathogenic(Last reviewed: Apr 15, 2017)	no assertion criteria provided	VCV000417742	4	3133374	4	3131647	417742	404643	rs768047421	NC_000004.12:3131646:C:T
NM_001242957.2(MAK):c.814C>T (p.Arg272Ter)	MAK	R272*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000636040	6	10802142	6	10801909	636040	623847		NC_000006.12:10801908:G:A
NM_007217.4(PDCD10):c.474+5G>A	PDCD10		not provided|Cerebral arteriovenous malformation|Seizures|Cavernous hemangioma|Hemiparesis|Cerebral cavernous malformations 3	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000468331	3	167405398	3	167687610	468331	452274	rs1553759139	NC_000003.12:167687609:C:T
NM_004172.5(SLC1A3):c.556T>A (p.Cys186Ser)	SLC1A3	C186S, C140S	Episodic ataxia, type 6	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000009442	5	36674182	5	36674080	9442	24481	rs137852620	NC_000005.10:36674079:T:A
NM_001242957.2(MAK):c.497G>A (p.Arg166His)	MAK	R166H	Retinitis pigmentosa 62|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000029784	6	10804119	6	10803886	29784	38739	rs387906648	NC_000006.12:10803885:C:T
NM_001023570.4(IQCB1):c.1108dup (p.Met370fs)	IQCB1		Senior Loken syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812337	3	121508940 - 121508941	3	121790093 - 121790094	812337	800485		NC_000003.12:121790093:T:TT
NM_005908.4(MANBA):c.1622G>A (p.Trp541Ter)	MANBA	W541*	not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000594436	4	103578921	4	102657764	594436	585499	rs771865668	NC_000004.12:102657763:C:T
NM_001023570.4(IQCB1):c.994C>T (p.Arg332Ter)	IQCB1	R332*, R199*	Retinal dystrophy	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560468	3	121509055	3	121790208	560468	551528	rs1189889920	NC_000003.12:121790207:G:A
NM_001023570.4(IQCB1):c.1632_1638dup (p.Ala547fs)	IQCB1		Retinal dystrophy	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560465	3	121489350 - 121489351	3	121770503 - 121770504	560465	551527	rs767295178	NC_000003.12:121770503:TGCCACA:TGCCACATGCCACA
NM_001023570.4(IQCB1):c.1513del (p.Gln505fs)	IQCB1	Q372fs, Q505fs	not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000419171	3	121491458	3	121772611	419171	406090	rs1064793692	NC_000003.12:121772610:G:
NM_001023570.4(IQCB1):c.817G>T (p.Glu273Ter)	IQCB1	E273*	not provided	Pathogenic(Last reviewed: Aug 4, 2014)	criteria provided, single submitter	VCV000199049	3	121516024	3	121797177	199049	196208	rs794727964	NC_000003.12:121797176:C:A
NM_001023570.4(IQCB1):c.264-2A>T	IQCB1		not provided	Pathogenic(Last reviewed: Feb 5, 2014)	criteria provided, single submitter	VCV000167198	3	121545029	3	121826182	167198	177781	rs727503969	NC_000003.12:121826181:T:A
NM_001023570.4(IQCB1):c.1520_1521GA[3] (p.Ala509fs)	IQCB1		Senior-Loken syndrome 5	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156379	3	121491447 - 121491448	3	121772600 - 121772601	156379	166160	rs587783011	NC_000003.12:121772600:TCTCT:TCTCTCT
NM_001023570.4(IQCB1):c.488-1G>A	IQCB1		Senior-Loken syndrome 5	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812120	3	121526291	3	121807444	812120	800368		NC_000003.12:121807443:C:T
NM_005908.4(MANBA):c.1540_1541del (p.Val514fs)	MANBA	V514fs	Beta-D-mannosidosis	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000542166	4	103579002 - 103579003	4	102657845 - 102657846	542166	519686	rs775574131	NC_000004.12:102657844:ACA:A
NM_001023570.4(IQCB1):c.333del (p.Ala112fs)	IQCB1	A112fs	Senior-Loken syndrome 5	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030776	3	121544958	3	121826111	30776	39733	rs786200929	NC_000003.12:121826110:A:
NM_001023570.4(IQCB1):c.1069C>T (p.Gln357Ter)	IQCB1	Q357*, Q224*	Senior-Loken syndrome 5	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000001834	3	121508980	3	121790133	1834	16873	rs121918245	NC_000003.12:121790132:G:A
NM_001023570.4(IQCB1):c.443_444CT[1] (p.Leu149fs)	IQCB1		Senior-Loken syndrome 5	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000001832	3	121527802 - 121527805	3	121808955 - 121808958	1832	16871	rs1156803164	NC_000003.12:121808954:AGAGAGA:AGA
NM_005908.4(MANBA):c.1276C>T (p.Gln426Ter)	MANBA	Q426*	Beta-D-mannosidosis	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000001682	4	103590161	4	102669004	1682	16721	rs121434336	NC_000004.12:102669003:G:A
NM_005908.4(MANBA):c.375A>G (p.Arg125=)	MANBA		Beta-D-mannosidosis	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000001680	4	103645022	4	102723865	1680	16719	rs771587242	NC_000004.12:102723864:T:C
MANBA, IVS13AS, G-A, -1	MANBA		Beta-D-mannosidosis	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001678					1678	16717		
NM_005908.4(MANBA):c.563_572dup (p.Trp192_Gly193insTer)	MANBA		Beta-D-mannosidosis	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001677	4	103635695 - 103635696	4	102714538 - 102714539	1677	16716	rs752343321	NC_000004.12:102714538:TCCCAACTAA:TCCCAACTAATCCCAACTAA
NM_005908.4(MANBA):c.960+1G>A	MANBA		Beta-D-mannosidosis	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000001676	4	103610730	4	102689573	1676	16715	rs890870104	NC_000004.12:102689572:C:T
NM_005908.4(MANBA):c.247G>T (p.Glu83Ter)	MANBA	E83*	Beta-D-mannosidosis	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000001681	4	103647771	4	102726614	1681	16720	rs121434335	NC_000004.12:102726613:C:A
NM_005908.4(MANBA):c.1513T>C (p.Ser505Pro)	MANBA	S505P	Beta-D-mannosidosis	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000001679	4	103579030	4	102657873	1679	16718	rs121434334	NC_000004.12:102657872:A:G
MANBA, IVS-AS, A-G, -2	MANBA		Beta-D-mannosidosis	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000001675					1675	16714		
NM_001023570.4(IQCB1):c.1363C>T (p.Arg455Ter)	IQCB1	R455*, R322*	Renal dysplasia and retinal aplasia	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000504877	3	121500637	3	121781790	504877	496723	rs866982675	NC_000003.12:121781789:G:A
NM_004172.5(SLC1A3):c.869C>G (p.Pro290Arg)	SLC1A3	P290R, P244R, P178R	Episodic ataxia, type 6	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000009441	5	36679737	5	36679635	9441	24480	rs137852619	NC_000005.10:36679634:C:G
NC_000003.12:g.(?_121772557)_(121781874_?)del	IQCB1		Nephronophthisis	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000830596	3	121491404 - 121500721			830596	819313		
NM_005908.4(MANBA):c.693G>A (p.Trp231Ter)	MANBA	W231*	Beta-D-mannosidosis	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000632877	4	103611909	4	102690752	632877	621166	rs763849774	NC_000004.12:102690751:C:T
NM_005908.4(MANBA):c.2158-2A>G	MANBA		Beta-D-mannosidosis	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000590928	4	103556204	4	102635047	590928	581872	rs772852668	NC_000004.12:102635046:T:C
NM_001023570.4(IQCB1):c.214C>T (p.Arg72Ter)	IQCB1	R72*	not provided|Leber congenital amaurosis	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000285623	3	121547366	3	121828519	285623	269860	rs201405662	NC_000003.12:121828518:G:A
NM_005908.4(MANBA):c.1454_1455del (p.Tyr485fs)	MANBA	Y485fs	Beta-D-mannosidosis	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000001683	4	103585872 - 103585873	4	102664715 - 102664716	1683	16722	rs1188116333	NC_000004.12:102664714:ATA:A
NM_003392.4(WNT5A):c.545G>C (p.Cys182Ser)	WNT5A	C182S, C167S	Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000162615	3	55508504	3	55474476	162615	172288	rs869312850	NC_000003.12:55474475:C:G
NM_003392.4(WNT5A):c.257A>G (p.Tyr86Cys)	WNT5A	Y86C, Y71C	Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162612	3	55513476	3	55479448	162612	172289	rs786204836	NC_000003.12:55479447:T:C
NM_003392.4(WNT5A):c.248G>C (p.Cys83Ser)	WNT5A	C83S, C68S	Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000029820	3	55513485	3	55479457	29820	38775	rs786200925	NC_000003.12:55479456:C:G
NM_003392.4(WNT5A):c.544T>C (p.Cys182Arg)	WNT5A	C182R, C167R	Robinow syndrome, autosomal dominant 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000029819	3	55508505	3	55474477	29819	38774	rs387906663	NC_000003.12:55474476:A:G
CNGA1, 1-BP DEL, FS655TER	CNGA1		Retinitis pigmentosa 49	Pathogenic(Last reviewed: Oct 24, 1995)	no assertion criteria provided	VCV000016933					16933	31972		
NC_000004.12:g.(?_47936421)_(47943412_?)del	CNGA1		not provided	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000831025	4	47938438 - 47945429			831025	819481		
NM_001023570.4(IQCB1):c.1504C>T (p.Arg502Ter)	IQCB1	R502*, R369*	Retinal dystrophy|Nephronophthisis	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569196	3	121491467	3	121772620	569196	559279	rs1280238814	NC_000003.12:121772619:G:A
NM_001023570.4(IQCB1):c.825_828del (p.Arg275fs)	IQCB1	R275fs	Senior-Loken syndrome 5|Nephronophthisis	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000001833	3	121516013 - 121516016	3	121797166 - 121797169	1833	16872	rs1474058708	NC_000003.12:121797165:CTGTCT:CT
NM_057175.5(NAA15):c.382C>T (p.Arg128Ter)	NAA15	R128*	Inborn genetic diseases|Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521938	4	140262203	4	139341049	521938	511524	rs1274633498	NC_000004.12:139341048:C:T
NM_000406.2(GNRHR):c.633T>A (p.Tyr211Ter)	GNRHR	Y211*	not provided	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000379859	4	68610395	4	67744677	379859	367687	rs1057520762	NC_000004.12:67744676:A:T
NM_018699.3(PRDM5):c.93+2T>C	PRDM5		Brittle cornea syndrome 2	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000031115	4	121843669	4	120922514	31115	40072		NC_000004.12:120922513:A:G
NM_018699.3(PRDM5):c.974del (p.Cys325fs)	PRDM5	C294fs, C325fs	Brittle cornea syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031114	4	121720872	4	120799717	31114	40071		NC_000004.12:120799716:C:
NM_001300824.1(PRDM5):c.*83C>T	PRDM5	R590*, R559*	Brittle cornea syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031111	4	121616391	4	120695236	31111	40068	rs387907110	NC_000004.12:120695235:G:A
NM_000406.2(GNRHR):c.806C>T (p.Thr269Met)	GNRHR	T269M	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000140611	4	68606379	4	67740661	140611	150302	rs369176613	NC_000004.12:67740660:G:A
NM_000406.2(GNRHR):c.392T>C (p.Met131Thr)	GNRHR	M131T	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000140610	4	68619662	4	67753944	140610	150301	rs606231406	NC_000004.12:67753943:A:G
NM_000406.2(GNRHR):c.94A>G (p.Thr32Ala)	GNRHR	T32A	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000126541	4	68619960	4	67754242	126541	132060	rs515726219	NC_000004.12:67754241:T:C
NM_000406.2(GNRHR):c.842C>T (p.Thr281Ile)	GNRHR	T281I	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000126540	4	68606343	4	67740625	126540	132059	rs515726220	NC_000004.12:67740624:G:A
NM_018699.3(PRDM5):c.320A>G (p.Tyr107Cys)	PRDM5	Y107C	Brittle cornea syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031113	4	121742481	4	120821326	31113	40070	rs387907111	NC_000004.12:120821325:T:C
NM_018699.3(PRDM5):c.93+1G>A	PRDM5		Brittle cornea syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031112	4	121843670	4	120922515	31112	40069		NC_000004.12:120922514:C:T
NM_018699.3(PRDM5):c.946_1623del	PRDM5		Brittle cornea syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031110					31110	40067		
NM_000406.2(GNRHR):c.959C>T (p.Pro320Leu)	GNRHR	P320L	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000016036	4	68606226	4	67740508	16036	31075	rs104893847	NC_000004.12:67740507:G:A
NM_000406.2(GNRHR):c.511G>A (p.Ala171Thr)	GNRHR	A171T	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000016034	4	68619543	4	67753825	16034	31073	rs74452732	NC_000004.12:67753824:C:T
NM_000406.2(GNRHR):c.523_742del	GNRHR		Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016033	4	68610506	4	67744788	16033	31072	rs797044452	NC_000004.12:67744787:C:T
NM_000406.2(GNRHR):c.941T>A (p.Leu314Ter)	GNRHR	L314*	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000016029	4	68606244	4	67740526	16029	31068	rs104893841	NC_000004.12:67740525:A:T
NM_000406.2(GNRHR):c.504T>A (p.Ser168Arg)	GNRHR	S168R	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000016028	4	68619550	4	67753832	16028	31067	rs104893840	NC_000004.12:67753831:A:T
NM_000406.2(GNRHR):c.651C>A (p.Ser217Arg)	GNRHR	S217R, L175M	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000016027	4	68610377	4	67744659	16027	31066	rs104893839	NC_000004.12:67744658:G:T
NM_000406.2(GNRHR):c.386C>A (p.Ala129Asp)	GNRHR	A129D	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000016026	4	68619668	4	67753950	16026	31065	rs104893838	NC_000004.12:67753949:G:T
NM_000406.2(GNRHR):c.851A>G (p.Tyr284Cys)	GNRHR	Y284C	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000016025	4	68606334	4	67740616	16025	31064	rs28933074	NC_000004.12:67740615:T:C
NM_000406.2(GNRHR):c.268G>A (p.Glu90Lys)	GNRHR	E90K	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000016032	4	68619786	4	67754068	16032	31071	rs104893844	NC_000004.12:67754067:C:T
NM_000406.2(GNRHR):c.350T>G (p.Leu117Arg)	GNRHR	L117R	Hypogonadotropic hypogonadism 7 with or without anosmia|Delayed puberty	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180147	4	68619704	4	67753986	180147	178331	rs727505367	NC_000004.12:67753985:A:C
GRCh37/hg19 3q29(chr3:196204149-196232328)x1	RNF168		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000688034	3	196204149 - 196232328			688034	675626		
NM_152617.4(RNF168):c.1323_1326del (p.Gln442fs)	RNF168	Q442fs	Riddle syndrome	Pathogenic(Last reviewed: Feb 6, 2009)	no assertion criteria provided	VCV000000488	3	196199080 - 196199083	3	196472209 - 196472212	488	15527		NC_000003.12:196472208:TTGTTT:TT
NM_152617.4(RNF168):c.397dup (p.Ala133fs)	RNF168		Riddle syndrome	Pathogenic(Last reviewed: Feb 6, 2009)	no assertion criteria provided	VCV000000487	3	196214430 - 196214431	3	196487559 - 196487560	487	15526		NC_000003.12:196487559:CCC:CCCC
NM_001023570.4(IQCB1):c.1090C>T (p.Arg364Ter)	IQCB1	R364*, R231*	Nephronophthisis|not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000167197	3	121508959	3	121790112	167197	177349	rs727503968	NC_000003.12:121790111:G:A
NM_176824.3(BBS7):c.1002del (p.Asn335fs)	BBS7	N335fs	Retinal dystrophy	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000866308	4	122768594	4	121847439	866308	856307		NC_000004.12:121847438:AA:A
NM_014639.4(TTC37):c.860_861del (p.Lys287fs)	TTC37	K287fs	not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000818062	5	94865824 - 94865825	5	95530120 - 95530121	818062	805457		NC_000005.10:95530119:CT:
NM_014639.4(TTC37):c.3426dup (p.Ala1143fs)	TTC37		not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000817666	5	94834210 - 94834211	5	95498506 - 95498507	817666	805456		NC_000005.10:95498506:TTTT:TTTTT
NM_018075.5(ANO10):c.1025G>A (p.Trp342Ter)	ANO10	W231*, W342*, W276*	Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000807373	3	43618321	3	43576829	807373	798534		NC_000003.12:43576828:C:T
NM_176824.3(BBS7):c.1371+2T>C	BBS7		not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000598472	4	122760784	4	121839629	598472	589533	rs1560647130	NC_000004.12:121839628:A:G
NM_014639.3(TTC37):c.3364del (p.Thr1122fs)	TTC37	T1122fs	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000501317	5	94834273	5	95498569	501317	492741	rs774405964	NC_000005.10:95498568:T:
NM_176824.3(BBS7):c.649dup (p.Ala217fs)	BBS7		not provided	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000291142	4	122775927 - 122775928	4	121854772 - 121854773	291142	275379	rs886044668	NC_000004.12:121854772:C:CC
NM_018075.5(ANO10):c.473-2A>G	ANO10		not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000446835	3	43621966	3	43580474	446835	440793	rs1553724533	NC_000003.12:43580473:T:C
NM_018075.5(ANO10):c.306C>A (p.Tyr102Ter)	ANO10	Y102*	Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000434213	3	43641907	3	43600415	434213	428190	rs1210764379	NC_000003.12:43600414:G:T
NM_018075.5(ANO10):c.337+1G>A	ANO10		Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000210186	3	43641875	3	43600383	210186	207077	rs765592794	NC_000003.12:43600382:C:T
NM_018075.5(ANO10):c.1669-2A>T	ANO10		Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000210185	3	43591342	3	43549850	210185	207076	rs797045240	NC_000003.12:43549849:T:A
NM_176824.3(BBS7):c.1967_1968delinsC (p.Leu656fs)	BBS7		Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000162088	4	122749347 - 122749348	4	121828192 - 121828193	162088	171804	rs672601379	NC_000004.12:121828191:TA:G
NM_018075.5(ANO10):c.1144G>T (p.Glu382Ter)	ANO10	E382*, E271*, E316*	Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000162018	3	43618202	3	43576710	162018	171739	rs144272231	NC_000003.12:43576709:C:A
NM_018075.5(ANO10):c.1604del (p.Ala534_Leu535insTer)	ANO10		Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031060	3	43596834	3	43555342	31060	40017	rs794726681	NC_000003.12:43555341:AA:A
NM_018075.5(ANO10):c.1476+1G>T	ANO10		Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031059	3	43602711	3	43561219	31059	40016	rs761213683	NC_000003.12:43561218:C:A
NM_018075.5(ANO10):c.1150_1151del (p.Leu384fs)	ANO10	L318fs, L384fs, L273fs	Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031058	3	43618195 - 43618196	3	43576703 - 43576704	31058	40015	rs794726680	NC_000003.12:43576702:AAAAA:AAA
NM_018075.5(ANO10):c.1529T>G (p.Leu510Arg)	ANO10	L510R, L399R, L444R, L320R	Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000031057	3	43596909	3	43555417	31057	40014	rs387907089	NC_000003.12:43555416:A:C
NM_001963.6(EGF):c.3209C>T (p.Pro1070Leu)	EGF	P1070L, P1028L, P947L, P1029L	Hypomagnesemia 4, renal	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000016614	4	110925696	4	110004540	16614	31653	rs121434567	NC_000004.12:110004539:C:T
NC_000004.12:g.121855560dup	BBS7		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000849754					849754	851584		
NC_000005.10:g.95514896G>A	TTC37		Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000816870					816870	805082		
NM_176824.3(BBS7):c.500_501insTATGAG (p.Gln168_Asp169insMetSer)	BBS7		Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812119	4	122780174 - 122780175	4	121859019 - 121859020	812119	800353		NC_000004.12:121859019:C:CTCATAC
NM_176824.3(BBS7):c.763A>T (p.Lys255Ter)	BBS7	K255*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000625451	4	122774197	4	121853042	625451	613749	rs1560658189	NC_000004.12:121853041:T:A
NM_176824.3(BBS7):c.542_543insAA (p.Met181fs)	BBS7		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000531829	4	122776702 - 122776703	4	121855547 - 121855548	531829	519988	rs1553933472	NC_000004.12:121855547::TT
NM_176824.3(BBS7):c.1413T>A (p.Tyr471Ter)	BBS7	Y471*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000531822	4	122756397	4	121835242	531822	520005	rs991365297	NC_000004.12:121835241:A:T
NM_176824.3(BBS7):c.719G>A (p.Gly240Asp)	BBS7	G240D	Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522733	4	122774241	4	121853086	522733	513267	rs761403504	NC_000004.12:121853085:C:T
NM_176824.3(BBS7):c.125G>A (p.Gly42Glu)	BBS7	G42E	Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522666	4	122784412	4	121863257	522666	513268	rs1221499782	NC_000004.12:121863256:C:T
NM_018075.5(ANO10):c.338-2A>G	ANO10		not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421009	3	43640160	3	43598668	421009	406307	rs761765455	NC_000003.12:43598667:T:C
NM_018075.5(ANO10):c.2T>C (p.Met1Thr)	ANO10	M1T	not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373298	3	43647343	3	43605851	373298	359527	rs531656357	NC_000003.12:43605850:A:G
NM_176824.3(BBS7):c.949C>G (p.Leu317Val)	BBS7	L317V	Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000217436	4	122768647	4	121847492	217436	214071	rs869025207	NC_000004.12:121847491:G:C
NM_176824.3(BBS7):c.1986_1988delinsT (p.Lys662fs)	BBS7		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000216137	4	122749327 - 122749329	4	121828172 - 121828174	216137	212349	rs863224529	NC_000004.12:121828171:TGC:A
NM_014639.3(TTC37):c.4620+1G>C	TTC37		Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000031237	5	94803569	5	95467865	31237	40194	rs370373017	NC_000005.10:95467864:C:G
NM_014639.3(TTC37):c.2515+1G>C	TTC37		Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000031235	5	94852375	5	95516671	31235	40192	rs1060499528	NC_000005.10:95516670:C:G
NM_014639.3(TTC37):c.2251C>T (p.Gln751Ter)	TTC37	Q751*	Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000031234	5	94852890	5	95517186	31234	40191	rs387907148	NC_000005.10:95517185:G:A
NM_014639.3(TTC37):c.439C>T (p.Gln147Ter)	TTC37	Q147*	Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000031233	5	94876498	5	95540794	31233	40190	rs387907147	NC_000005.10:95540793:G:A
NM_014639.3(TTC37):c.1632+1del	TTC37		Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000031232	5	94859358	5	95523654	31232	40189	rs1060499527	NC_000005.10:95523653:CC:C
TTC37, IVS28AS, G-A, -2	TTC37		Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000031231					31231	40188		
NM_176824.3(BBS7):c.1592_1597del (p.Val531_Pro532del)	BBS7		Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000030680	4	122754465 - 122754470	4	121833310 - 121833315	30680	39637	rs587777836	NC_000004.12:121833309:CTGGAACT:CT
NM_176824.3(BBS7):c.709_712del (p.Lys237fs)	BBS7	K237fs	Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003017	4	122775865 - 122775868	4	121854710 - 121854713	3017	18056	rs587777812	NC_000004.12:121854709:TCTTT:T
NM_176824.3(BBS7):c.968A>G (p.His323Arg)	BBS7	H323R	Bardet-Biedl syndrome 7	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003015	4	122768628	4	121847473	3015	18054	rs119466001	NC_000004.12:121847472:T:C
NM_176824.3(BBS7):c.1657C>T (p.Gln553Ter)	BBS7	Q553*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000859098	4	122754405	4	121833250	859098	828721		NC_000004.12:121833249:G:A
NM_014639.3(TTC37):c.409C>T (p.Arg137Ter)	TTC37	R137*	Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561159	5	94876528	5	95540824	561159	552090	rs776321294	NC_000005.10:95540823:G:A
NM_018075.5(ANO10):c.96del (p.Glu33fs)	ANO10	E33fs	not provided|Spinocerebellar ataxia, autosomal recessive 10	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000434215	3	43647249	3	43605757	434215	428192	rs758937084	NC_000003.12:43605756:TTT:TT
NM_176824.3(BBS7):c.1060_1061TA[1] (p.Tyr354_Lys355delinsTer)	BBS7		not provided|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000285609	4	122766826 - 122766827	4	121845671 - 121845672	285609	269846	rs773139166	NC_000004.12:121845670:TATA:TA
NM_006254.4(PRKCD):c.1840C>T (p.Arg614Trp)	PRKCD	R614W, R633W, R630W	Autoimmune lymphoproliferative syndrome, type III	Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000157675	3	53223985	3	53189969	157675	167524	rs606231297	NC_000003.12:53189968:C:T
NM_006254.4(PRKCD):c.1528G>A (p.Gly510Ser)	PRKCD	G510S, G526S, G529S	Autoimmune lymphoproliferative syndrome, type III	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000157674	3	53222848	3	53188832	157674	167523	rs606231296	NC_000003.12:53188831:G:A
NM_006254.4(PRKCD):c.1352+1G>A	PRKCD		Autoimmune lymphoproliferative syndrome, type III	Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000089076	3	53220712	3	53186696	89076	94618	rs398122958	NC_000003.12:53186695:G:A
NM_014639.3(TTC37):c.2808G>A (p.Trp936Ter)	TTC37	W936*	Trichohepatoenteric syndrome 1|not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000196135	5	94848293	5	95512589	196135	193296	rs534237033	NC_000005.10:95512588:C:T
NM_014639.3(TTC37):c.2578-7_2578-3del	TTC37		not provided|Trichohepatoenteric syndrome 1	Pathogenic(Last reviewed: Oct 1, 2018)	no assertion criteria provided	VCV000031236	5	94852116 - 94852120	5	95516412 - 95516416	31236	40193	rs746874042	NC_000005.10:95516411:AAAAAA:A
NM_000860.6(HPGD):c.1A>T (p.Met1Leu)	HPGD	M1L	Hypertrophic osteoarthropathy, primary, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000156026	4	175443602	4	174522451	156026	165835	rs577045722	NC_000004.12:174522450:T:A
NM_000860.6(HPGD):c.577T>C (p.Ser193Pro)	HPGD	S193P, S125P, S72P	Digital clubbing, isolated congenital	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000007920	4	175414387	4	174493236	7920	22959	rs121434481	NC_000004.12:174493235:A:G
NM_000860.6(HPGD):c.232_241delinsCA (p.Val78fs)	HPGD		Hypertrophic osteoarthropathy, primary, autosomal recessive, 1	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000007918	4	175439205 - 175439214	4	174518054 - 174518063	7918	22957	rs587776676	NC_000004.12:174518053:GGTCTACAAC:TG
NM_000860.6(HPGD):c.173_174CT[1] (p.Leu59fs)	HPGD		Hypertrophic osteoarthropathy, primary, autosomal recessive, 1	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000007919	4	175443136 - 175443137	4	174521985 - 174521986	7919	22958	rs548208942	NC_000004.12:174521984:AGAG:AG
NM_183357.2(ADCY5):c.668C>A (p.Ser223Ter)	ADCY5	S223*	not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000620203	3	123166725	3	123447878	620203	611579	rs1553751151	NC_000003.12:123447877:G:T
NM_183357.2(ADCY5):c.2931C>A (p.Cys977Ter)	ADCY5	C977*, C627*	not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000620201	3	123015063	3	123296216	620201	611966	rs1553718964	NC_000003.12:123296215:G:T
NM_005199.5(CHRNG):c.274C>T (p.Arg92Ter)	CHRNG	R92*	not provided	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000618567	2	233405345	2	232540635	618567	609473	rs1559302834	NC_000002.12:232540634:C:T
NM_183357.2(ADCY5):c.402_415CGGCGGCGGCGGCT[1] (p.Ser139fs)	ADCY5		not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000524013	3	123166964 - 123166977	3	123448117 - 123448130	524013	514475	rs1215504032	NC_000003.12:123448116:AGCCGCCGCCGCCGAGCCGCCGCCGCCG:AGCCGCCGCCGCCG
NM_005199.5(CHRNG):c.397del (p.Ser133fs)	CHRNG	S133fs	not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000431955	2	233406130	2	232541420	431955	425472	rs780249576	NC_000002.12:232541419:T:
NM_005199.5(CHRNG):c.241C>T (p.Gln81Ter)	CHRNG	Q81*	Autosomal recessive multiple pterygium syndrome	Pathogenic	no assertion criteria provided	VCV000816828	2	233405312	2	232540602	816828	804994		NC_000002.12:232540601:C:T
NM_005199.5(CHRNG):c.202C>T (p.Arg68Ter)	CHRNG	R68*	Autosomal recessive multiple pterygium syndrome|Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000548021	2	233405097	2	232540387	548021	538346	rs764266722	NC_000002.12:232540386:C:T
NM_005199.5(CHRNG):c.428C>G (p.Pro143Arg)	CHRNG	P143R	Autosomal recessive multiple pterygium syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000217751	2	233406161	2	232541451	217751	214403	rs765746795	NC_000002.12:232541450:C:G
NM_183357.2(ADCY5):c.3086T>A (p.Met1029Lys)	ADCY5	M1029K, M679K	Dyskinesia, familial, with facial myokymia	Pathogenic(Last reviewed: Oct 30, 2014)	no assertion criteria provided	VCV000162092	3	123010201	3	123291354	162092	171806	rs864309484	NC_000003.12:123291353:A:T
NM_005546.3(ITK):c.86G>A (p.Arg29His)	ITK	R29H	Lymphoproliferative syndrome 1	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000064372	5	156608074	5	157181063	64372	75337	rs397514261	NC_000005.10:157181062:G:A
NM_005199.5(CHRNG):c.136C>T (p.Arg46Ter)	CHRNG	R46*	Autosomal recessive multiple pterygium syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000018341	2	233404782	2	232540072	18341	33380	rs121912672	NC_000002.12:232540071:C:T
NM_005199.5(CHRNG):c.301_309dup (p.Arg101_Pro103dup)	CHRNG		Autosomal recessive multiple pterygium syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000018338	2	233405370 - 233405371	2	232540660 - 232540661	18338	33377	rs863223313	NC_000002.12:232540660:GAGGGTGCCG:GAGGGTGCCGAGGGTGCCG
NM_183357.2(ADCY5):c.2088+1G>A	ADCY5		Dyskinesia, familial, with facial myokymia	Pathogenic(Last reviewed: Dec 17, 2015)	no assertion criteria provided	VCV000218355	3	123044168	3	123325321	218355	215062	rs797045002	NC_000003.12:123325320:C:T
NM_005546.3(ITK):c.1764C>G (p.Tyr588Ter)	ITK	Y588*	Lymphoproliferative syndrome 1	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000064371	5	156675990	5	157248980	64371	75336	rs397514260	NC_000005.10:157248979:C:G
NM_183357.2(ADCY5):c.2088+1G>T	ADCY5		Dyskinesia, familial, with facial myokymia	Pathogenic(Last reviewed: Nov 17, 2014)	no assertion criteria provided	VCV000208485	3	123044168	3	123325321	208485	205009	rs797045002	NC_000003.12:123325320:C:A
CHRNG, 1-BP DUP, 459A	CHRNG		Autosomal recessive multiple pterygium syndrome|Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000029583					29583	38537		
NM_005199.5(CHRNG):c.320T>G (p.Val107Gly)	CHRNG	V107G	Autosomal recessive multiple pterygium syndrome|Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000018340	2	233405391	2	232540681	18340	33379	rs267606726	NC_000002.12:232540680:T:G
NM_005199.5(CHRNG):c.13C>T (p.Gln5Ter)	CHRNG	Q18*, Q5*	Autosomal recessive multiple pterygium syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000018336	2	233404470	2	232539760	18336	33375	rs267606725	NC_000002.12:232539759:C:T
NM_005546.3(ITK):c.1003C>T (p.Arg335Trp)	ITK	R335W	Lymphoproliferative syndrome 1	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000012741	5	156668673	5	157241663	12741	27780	rs121908191	NC_000005.10:157241662:C:T
NM_183357.2(ADCY5):c.1253G>A (p.Arg418Gln)	ADCY5	R418Q, R68Q	not provided|Dyskinesia, familial, with facial myokymia	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	VCV000218354	3	123071310	3	123352463	218354	215063	rs864309515	NC_000003.12:123352462:C:T
NM_005199.5(CHRNG):c.715C>T (p.Arg239Cys)	CHRNG	R217C, R239C	Lethal multiple pterygium syndrome|Autosomal recessive multiple pterygium syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000018337	2	233407702	2	232542992	18337	33376	rs121912670	NC_000002.12:232542991:C:T
NM_000860.6(HPGD):c.418G>C (p.Ala140Pro)	HPGD	A140P, A19P	Cranioosteoarthropathy|Hypertrophic osteoarthropathy, primary, autosomal recessive, 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000007917	4	175429850	4	174508699	7917	22956	rs121434480	NC_000004.12:174508698:C:G
NM_176824.3(BBS7):c.85_86CA[1] (p.His29fs)	BBS7		Bardet-Biedl syndrome|Bardet-Biedl syndrome 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804446	4	122789150 - 122789151	4	121867995 - 121867996	804446	792743		NC_000004.12:121867994:TGTGT:TGT
NM_176824.3(BBS7):c.389_390del (p.Asn130fs)	BBS7	N130fs	Bardet-Biedl syndrome 7|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216138	4	122780285 - 122780286	4	121859130 - 121859131	216138	212352	rs863224530	NC_000004.12:121859129:GT:
NM_001174150.2(ARL13B):c.131-1G>T	ARL13B		not provided	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000285657	3	93722502	3	94003658	285657	269894	rs373604132	NC_000003.12:94003657:G:T
NM_001174150.2(ARL13B):c.393_396del (p.Gln132fs)	ARL13B	Q132fs, Q25fs, Q117fs, Q29fs	Joubert syndrome 8	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000578346	3	93754185 - 93754188	3	94035341 - 94035344	578346	559535	rs1560002959	NC_000003.12:94035340:AAACAA:AA
NM_001174150.2(ARL13B):c.257A>G (p.Tyr86Cys)	ARL13B	Y86C, Y71C	Joubert syndrome 8	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000218107	3	93722629	3	94003785	218107	214762	rs863225430	NC_000003.12:94003784:A:G
NM_001174150.2(ARL13B):c.461A>G (p.Asn154Ser)	ARL13B	N154S, N51S, N139S, N47S	Joubert syndrome 8	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217552	3	93754255	3	94035411	217552	214169	rs758972393	NC_000003.12:94035410:A:G
NM_001174150.2(ARL13B):c.65T>G (p.Val22Gly)	ARL13B	V22G	Joubert syndrome 8	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217551	3	93714723	3	93995879	217551	214168	rs863225149	NC_000003.12:93995878:T:G
NM_001174150.2(ARL13B):c.236G>A (p.Arg79Gln)	ARL13B	R79Q, R64Q	Joubert syndrome 8	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000001991	3	93722608	3	94003764	1991	17030	rs121912606	NC_000003.12:94003763:G:A
NM_001174150.2(ARL13B):c.598C>T (p.Arg200Cys)	ARL13B	R200C, R185C, R93C, R97C	Joubert syndrome 8	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000001993	3	93755507	3	94036663	1993	17032	rs121912608	NC_000003.12:94036662:C:T
NM_001174150.2(ARL13B):c.246G>A (p.Trp82Ter)	ARL13B	W82*, W67*	Joubert syndrome 8	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000001992	3	93722618	3	94003774	1992	17031	rs121912607	NC_000003.12:94003773:G:A
NM_015650.4(TRAF3IP1):c.1358C>G (p.Ser453Cys)	TRAF3IP1	S453C, S387C	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446658	2	239257480	2	238348839	446658	440067	rs146820102	NC_000002.12:238348838:C:G
NM_015650.4(TRAF3IP1):c.1368-1del	TRAF3IP1		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446657	2	239257965	2	238349324	446657	440068	rs764906529	NC_000002.12:238349323:G:
NM_015650.4(TRAF3IP1):c.988-1G>C	TRAF3IP1		Short rib-polydactyly syndrome, Majewski type	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446656	2	239242600	2	238333959	446656	440066	rs372499275	NC_000002.12:238333958:G:C
NM_015650.4(TRAF3IP1):c.169G>A (p.Glu57Lys)	TRAF3IP1	E57K	Short rib-polydactyly syndrome, Majewski type	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446655	2	239233992	2	238325351	446655	440065	rs769651861	NC_000002.12:238325350:G:A
NM_015650.4(TRAF3IP1):c.51T>G (p.Ile17Met)	TRAF3IP1	I17S, I17M	Senior-Loken syndrome 9	Pathogenic(Last reviewed: Sep 6, 2016)	no assertion criteria provided	VCV000254150	2	239229354	2	238320713	254150	248622	rs886037899	NC_000002.12:238320712:T:G
NM_015650.4(TRAF3IP1):c.373G>A (p.Val125Met)	TRAF3IP1	V125M	Senior-Loken syndrome 9	Pathogenic(Last reviewed: Sep 6, 2016)	no assertion criteria provided	VCV000254149	2	239237345	2	238328704	254149	248621	rs886037898	NC_000002.12:238328703:G:A
NM_015650.4(TRAF3IP1):c.1575+6T>G	TRAF3IP1		Senior-Loken syndrome 9	Pathogenic(Last reviewed: Sep 6, 2016)	no assertion criteria provided	VCV000254148	2	239261597	2	238352956	254148	248620	rs886037897	NC_000002.12:238352955:T:G
NM_015650.4(TRAF3IP1):c.1559T>G (p.Met520Arg)	TRAF3IP1	M520R, M454R	Senior-Loken syndrome 9	Pathogenic(Last reviewed: Sep 6, 2016)	no assertion criteria provided	VCV000254147	2	239261575	2	238352934	254147	248619	rs750055952	NC_000002.12:238352933:T:G
NM_015650.4(TRAF3IP1):c.463C>T (p.Arg155Ter)	TRAF3IP1	R155*	Senior-Loken syndrome 9	Pathogenic(Last reviewed: Sep 6, 2016)	no assertion criteria provided	VCV000254146	2	239237435	2	238328794	254146	248618	rs765903345	NC_000002.12:238328793:C:T
NM_015650.4(TRAF3IP1):c.374T>C (p.Val125Ala)	TRAF3IP1	V125A	Senior-Loken syndrome 9	Pathogenic(Last reviewed: Sep 6, 2016)	no assertion criteria provided	VCV000254145	2	239237346	2	238328705	254145	248617	rs886037896	NC_000002.12:238328704:T:C
NM_000860.6(HPGD):c.308_309CT[1] (p.Leu104fs)	HPGD		Hypertrophic osteoarthropathy, primary, autosomal recessive, 1|HPGD-Related Disorders	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000156027	4	175439135 - 175439136	4	174517984 - 174517985	156027	165836	rs587777719	NC_000004.12:174517983:AGAG:AG
NM_001023570.4(IQCB1):c.897_900dup (p.Ile301fs)	IQCB1		Senior-Loken syndrome 5|Nephronophthisis|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000403963	3	121514389 - 121514390	3	121795542 - 121795543	403963	393234	rs745340459	NC_000003.12:121795542:CAAGCA:CAAGCAAGCA
NM_001023570.4(IQCB1):c.1036G>T (p.Glu346Ter)	IQCB1	E346*, E213*	Nephronophthisis|Leber congenital amaurosis|Senior-Loken syndrome 5	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000030779	3	121509013	3	121790166	30779	39736	rs387907009	NC_000003.12:121790165:C:A
NM_005199.5(CHRNG):c.401_402del (p.Pro134fs)	CHRNG	P134fs	Autosomal recessive multiple pterygium syndrome|not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419026	2	233406134 - 233406135	2	232541424 - 232541425	419026	405662	rs747067203	NC_000002.12:232541423:CT:
NM_183357.2(ADCY5):c.2176G>A (p.Ala726Thr)	ADCY5	A726T, A376T	not provided|Dyskinesia, familial, with facial myokymia	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000162091	3	123038601	3	123319754	162091	171807	rs796065306	NC_000003.12:123319753:C:T
NM_013334.3(GMPPB):c.490C>T (p.Gln164Ter)	GMPPB	Q164*	not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000620253	3	49760100	3	49722667	620253	611593	rs1559697183	NC_000003.12:49722666:G:A
NM_013334.3(GMPPB):c.260-1G>A	GMPPB		not provided	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000265184	3	49760548	3	49723115	265184	259775	rs886039382	NC_000003.12:49723114:C:T
NM_013334.3(GMPPB):c.271_283del (p.Ala91fs)	GMPPB	A91fs	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000663873	3	49760524 - 49760536	3	49723091 - 49723103	663873	631582		NC_000003.12:49723090:CACGGGCCAGCGCCA:CA
NM_021971.2:c.109C>T	GMPPB	Q37*	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000647358	3	49761051	3	49723618	647358	631585		NC_000003.12:49723617:G:A
NM_021971.2(GMPPB):c.790C>T (p.Gln264Ter)	GMPPB	Q264*	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000571713	3	49759559	3	49722126	571713	561685	rs763971677	NC_000003.12:49722125:G:A
NM_013334.3(GMPPB):c.456_457CA[1] (p.Thr153fs)	GMPPB		Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000474017	3	49760131 - 49760132	3	49722698 - 49722699	474017	453092	rs1553691918	NC_000003.12:49722697:TGTGT:TGT
NM_013334.3(GMPPB):c.365_366dup (p.Phe123fs)	GMPPB		Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000474016	3	49760440 - 49760441	3	49723007 - 49723008	474016	452860	rs1553691975	NC_000003.12:49723007:CT:CTCT
NM_007255.3(B4GALT7):c.641G>A (p.Cys214Tyr)	B4GALT7	C214Y	Ehlers-Danlos syndrome progeroid type	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000253110	5	177035541	5	177608540	253110	247521	rs753594601	NC_000005.10:177608539:G:A
NM_007255.3(B4GALT7):c.277dup (p.His93fs)	B4GALT7		Ehlers-Danlos syndrome progeroid type	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000253109	5	177031401 - 177031402	5	177604400 - 177604401	253109	247520	rs879255634	NC_000005.10:177604400:CCCCC:CCCCCC
NM_013334.3(GMPPB):c.308C>T (p.Pro103Leu)	GMPPB	P103L	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Sep 25, 2018)	no assertion criteria provided	VCV000225927	3	49760499	3	49723066	225927	227738	rs875989851	NC_000003.12:49723065:G:A
NM_007255.3(B4GALT7):c.122T>C (p.Leu41Pro)	B4GALT7	L41P	Ehlers-Danlos syndrome progeroid type	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000225691	5	177031251	5	177604250	225691	227506	rs375845310	NC_000005.10:177604249:T:C
NM_013334.3(GMPPB):c.64C>T (p.Pro22Ser)	GMPPB	P22S	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060542	3	49761096	3	49723663	60542	75123	rs397509424	NC_000003.12:49723662:G:A
NM_013334.3(GMPPB):c.220C>T (p.Arg74Ter)	GMPPB	R74*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060541	3	49760726	3	49723293	60541	75122	rs397509423	NC_000003.12:49723292:G:A
NM_007255.3(B4GALT7):c.617T>C (p.Leu206Pro)	B4GALT7	L206P	Ehlers-Danlos syndrome progeroid type	Pathogenic(Last reviewed: Oct 8, 1999)	no assertion criteria provided	VCV000005612	5	177034506	5	177607505	5612	20651	rs121917818	NC_000005.10:177607504:T:C
NM_007255.3(B4GALT7):c.557C>A (p.Ala186Asp)	B4GALT7	A186D	Ehlers-Danlos syndrome progeroid type	Pathogenic(Last reviewed: Oct 8, 1999)	no assertion criteria provided	VCV000005611	5	177034446	5	177607445	5611	20650	rs121917817	NC_000005.10:177607444:C:A
NM_021971.2(GMPPB):c.656T>C (p.Ile219Thr)	GMPPB	I219T	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000575991	3	49759776	3	49722343	575991	559054	rs761714818	NC_000003.12:49722342:A:G
NM_003280.3(TNNC1):c.91G>A (p.Ala31Thr)	TNNC1	A31T	not provided	Pathogenic(Last reviewed: May 15, 2013)	criteria provided, single submitter	VCV000181561	3	52486233	3	52452217	181561	179078	rs397514616	NC_000003.12:52452216:C:T
NM_001312673.2(PCYT1A):c.968dup (p.Ser323fs)	PCYT1A		Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101065	3	195965694 - 195965695	3	196238823 - 196238824	101065	106830	rs587777196	NC_000003.12:196238823:C:CC
NM_025265.4(TSEN2):c.691C>T (p.Gln231Ter)	TSEN2	Q231*	Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000180671	3	12545143	3	12503644	180671	178839	rs730880294	NC_000003.12:12503643:C:T
NM_025265.4(TSEN2):c.934G>A (p.Gly312Arg)	TSEN2	G312R, G253R, G286R	Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000180670	3	12558134	3	12516635	180670	178838	rs886037739	NC_000003.12:12516634:G:A
NM_025265.4(TSEN2):c.960+1_960+5del	TSEN2		Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000180669	3	12558158 - 12558162	3	12516659 - 12516663	180669	178837	rs886037738	NC_000003.12:12516658:AAGGTAAG:AAG
NM_001312673.2(PCYT1A):c.571T>C (p.Phe191Leu)	PCYT1A	F191L	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101064	3	195968956	3	196242085	101064	106829	rs587777195	NC_000003.12:196242084:A:G
NM_001312673.2(PCYT1A):c.669G>C (p.Arg223Ser)	PCYT1A	R223S	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101062	3	195968858	3	196241987	101062	106827	rs540053239	NC_000003.12:196241986:C:G
NM_001312673.2(PCYT1A):c.847C>T (p.Arg283Ter)	PCYT1A	R283*	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101060	3	195966468	3	196239597	101060	106825	rs587777192	NC_000003.12:196239596:G:A
NM_001312673.2(PCYT1A):c.448C>G (p.Pro150Ala)	PCYT1A	P150A	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101058	3	195974276	3	196247405	101058	106823	rs587777190	NC_000003.12:196247404:G:C
NM_003280.3(TNNC1):c.91G>T (p.Ala31Ser)	TNNC1	A31S	Familial hypertrophic cardiomyopathy 13	Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	VCV000039832	3	52486233	3	52452217	39832	48431	rs397514616	NC_000003.12:52452216:C:A
NM_003280.3(TNNC1):c.251G>A (p.Cys84Tyr)	TNNC1	C84Y	Familial hypertrophic cardiomyopathy 13	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000012444	3	52485826	3	52451810	12444	27483	rs267607126	NC_000003.12:52451809:C:T
NM_001312673.2(PCYT1A):c.385G>A (p.Glu129Lys)	PCYT1A	E129K	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101063	3	195974339	3	196247468	101063	106828	rs587777194	NC_000003.12:196247467:C:T
NM_001312673.2(PCYT1A):c.990del (p.Ser331fs)	PCYT1A	S331fs	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101061	3	195965673	3	196238802	101061	106826	rs587777193	NC_000003.12:196238801:GGGGG:GGGG
NM_001312673.2(PCYT1A):c.295G>A (p.Ala99Thr)	PCYT1A	A99T	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic	criteria provided, single submitter	VCV000101059	3	195975117	3	196248246	101059	106824	rs587777191	NC_000003.12:196248245:C:T
NM_000387.6(SLC25A20):c.199-10T>G	SLC25A20		not provided|Carnitine acylcarnitine translocase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012137	3	48921567	3	48884134	12137	27176	rs541208710	NC_000003.12:48884133:A:C
NM_002609.4(PDGFRB):c.1699A>G (p.Lys567Glu)	PDGFRB	K567E, K503E, K406E	Infantile myofibromatosis 1	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000375237	5	149505116	5	150125553	375237	361944	rs1554108389	NC_000005.10:150125552:T:C
NM_002609.4(PDGFRB):c.1615_1616insGAT (p.Leu539_Ala540insArg)	PDGFRB		Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000375557	5	149506141 - 149506142	5	150126578 - 150126579	375557	362367	rs1060499541	NC_000005.10:150126578::ATC
NM_002609.4(PDGFRB):c.1697_1702del (p.Trp566_Val568delinsLeu)	PDGFRB		Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000375555	5	149505113 - 149505118	5	150125550 - 150125555	375555	362365	rs1060499543	NC_000005.10:150125549:CCTTCC:
NM_002609.4(PDGFRB):c.1751C>G (p.Pro584Arg)	PDGFRB	P584R, P423R, P520R	Kosaki overgrowth syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000217122	5	149505064	5	150125501	217122	213767	rs863224946	NC_000005.10:150125500:G:C
NM_001098484.3(SLC4A4):c.254-37C>T	SLC4A4	Q29*	Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000006473	4	72205050	4	71339333	6473	21512	rs121908858	NC_000004.12:71339332:C:T
NM_001098484.3(SLC4A4):c.1661G>A (p.Arg554His)	SLC4A4	R510H, R554H	Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006472	4	72338445	4	71472728	6472	21511	rs121908857	NC_000004.12:71472727:G:A
NM_001098484.3(SLC4A4):c.1026A>C (p.Arg342Ser)	SLC4A4	R298S, R342S	Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006471	4	72313423	4	71447706	6471	21510	rs121908856	NC_000004.12:71447705:A:C
NM_002609.4(PDGFRB):c.2549A>T (p.Asp850Val)	PDGFRB	D850V, D689V, D786V	Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000375681	5	149500488	5	150120925	375681	362520	rs1060499540	NC_000005.10:150120924:T:A
NM_002609.4(PDGFRB):c.1998C>G (p.Asn666Lys)	PDGFRB	N666K, N602K, N505K	Infantile myofibromatosis	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000375556	5	149503838	5	150124275	375556	362366	rs864309711	NC_000005.10:150124274:G:C
NM_002609.4(PDGFRB):c.1978C>A (p.Pro660Thr)	PDGFRB	P660T, P596T, P499T	Infantile myofibromatosis 1	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055849	5	149503858	5	150124295	55849	70503	rs144050370	NC_000005.10:150124294:G:T
NM_002609.4(PDGFRB):c.1994T>C (p.Val665Ala)	PDGFRB	V665A, V504A, V601A	Premature aging syndrome, Penttinen type	Pathogenic(Last reviewed: Nov 21, 2017)	no assertion criteria provided	VCV000495300	5	149503842	5	150124279	495300	213768	rs1554108211	NC_000005.10:150124278:A:G
NM_002609.4(PDGFRB):c.2959C>T (p.Arg987Trp)	PDGFRB	R987W, R826W, R923W	Basal ganglia calcification, idiopathic, 4	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039589	5	149497359	5	150117796	39589	48188	rs397509382	NC_000005.10:150117795:G:A
NM_002609.4(PDGFRB):c.1973T>C (p.Leu658Pro)	PDGFRB	L658P, L497P, L594P	Basal ganglia calcification, idiopathic, 4	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039588	5	149503863	5	150124300	39588	48187	rs397509381	NC_000005.10:150124299:A:G
NM_002609.4(PDGFRB):c.1998C>A (p.Asn666Lys)	PDGFRB	N666K, N505K, N602K	Infantile myofibromatosis 1|Infantile myofibromatosis	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218935	5	149503838	5	150124275	218935	215769	rs864309711	NC_000005.10:150124274:G:T
NM_176824.3(BBS7):c.632C>T (p.Thr211Ile)	BBS7	T211I	Bardet-Biedl syndrome 1/7, digenic|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000003016	4	122775945	4	121854790	3016	18055	rs119466002	NC_000004.12:121854789:G:A
NM_025265.4(TSEN2):c.926A>G (p.Tyr309Cys)	TSEN2	Y309C, Y250C, Y283C	Pontocerebellar hypoplasia type 2B	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000002125	3	12558126	3	12516627	2125	17164	rs113994149	NC_000003.12:12516626:A:G
NM_001023570.4(IQCB1):c.1465C>T (p.Arg489Ter)	IQCB1	R489*, R356*	Retinal dystrophy|Nephronophthisis|Senior-Loken syndrome 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030778	3	121491506	3	121772659	30778	39735	rs373909351	NC_000003.12:121772658:G:A
NM_003907.3(EIF2B5):c.291G>A (p.Trp97Ter)	EIF2B5	W97*	not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000854604	3	183854495	3	184136707	854604	827769		NC_000003.12:184136706:G:A
NM_003907.3(EIF2B5):c.407G>A (p.Arg136His)	EIF2B5	R136H	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802032	3	183855494	3	184137706	802032	790369		NC_000003.12:184137705:G:A
NM_003907.3(EIF2B5):c.1590_1592delinsCC (p.Glu530fs)	EIF2B5		not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000503917	3	183860610 - 183860612	3	184142822 - 184142824	503917	495166	rs1553807905	NC_000003.12:184142821:GCA:CC
NM_003907.3(EIF2B5):c.583C>T (p.Arg195Cys)	EIF2B5	R195C	Ovarioleukodystrophy	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000005948	3	183855762	3	184137974	5948	20987	rs113994055	NC_000003.12:184137973:C:T
NM_003907.3(EIF2B5):c.1340C>T (p.Ser447Leu)	EIF2B5	S447L	Leukoencephalopathy with vanishing white matter	Pathogenic	criteria provided, single submitter	VCV000813359	3	183860062	3	184142274	813359	801606		NC_000003.12:184142273:C:T
NM_003907.3(EIF2B5):c.1016G>C (p.Arg339Pro)	EIF2B5	R339P	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000692119	3	183858378	3	184140590	692119	679862		NC_000003.12:184140589:G:C
NM_003907.3(EIF2B5):c.337C>T (p.Arg113Cys)	EIF2B5	R113C	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000692118	3	183855424	3	184137636	692118	679861		NC_000003.12:184137635:C:T
NM_003907.3(EIF2B5):c.943C>T (p.Arg315Cys)	EIF2B5	R315C	Dystonia|Developmental regression|Leukodystrophy|Abnormality of the cerebral white matter	Pathogenic	criteria provided, single submitter	VCV000598970	3	183858305	3	184140517	598970	590049	rs113994063	NC_000003.12:184140516:C:T
NM_003907.3(EIF2B5):c.241G>A (p.Glu81Lys)	EIF2B5	E81K	not provided	Pathogenic(Last reviewed: Nov 25, 2015)	criteria provided, single submitter	VCV000285116	3	183854445	3	184136657	285116	269353	rs113994047	NC_000003.12:184136656:G:A
NM_003907.3(EIF2B5):c.808G>C (p.Asp270His)	EIF2B5	D270H	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000040178	3	183857910	3	184140122	40178	48675	rs397514646	NC_000003.12:184140121:G:C
NM_003907.3(EIF2B5):c.167T>G (p.Phe56Cys)	EIF2B5	F56C	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Jul 24, 2007)	no assertion criteria provided	VCV000005952	3	183853340	3	184135552	5952	20991	rs121908541	NC_000003.12:184135551:T:G
NM_003907.3(EIF2B5):c.166T>G (p.Phe56Val)	EIF2B5	F56V	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Jul 24, 2007)	no assertion criteria provided	VCV000005951	3	183853339	3	184135551	5951	20990	rs113994043	NC_000003.12:184135550:T:G
NM_003907.3(EIF2B5):c.1157G>T (p.Gly386Val)	EIF2B5	G386V	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005944	3	183859713	3	184141925	5944	20983	rs113994074	NC_000003.12:184141924:G:T
NM_003907.3(EIF2B5):c.1882T>C (p.Trp628Arg)	EIF2B5	W628R	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005943	3	183861899	3	184144111	5943	20982	rs28937596	NC_000003.12:184144110:T:C
NM_003907.3(EIF2B5):c.1946T>C (p.Ile649Thr)	EIF2B5	I649T	Leukoencephalopathy with vanishing white matter|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420049	3	183861963	3	184144175	420049	406161	rs1064794256	NC_000003.12:184144174:T:C
NM_003907.3(EIF2B5):c.925G>C (p.Val309Leu)	EIF2B5	L309V, V309L	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000005947	3	183858287	3	184140499	5947	20986	rs113994061	NC_000003.12:184140498:G:C
NM_006261.4(PROP1):c.218G>A (p.Arg73His)	PROP1	R73H	Pituitary hormone deficiency, combined 2	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000008103	5	177421231	5	177994230	8103	23142	rs121917842	NC_000005.10:177994229:C:T
NM_006261.4(PROP1):c.263T>C (p.Phe88Ser)	PROP1	F88S	Pituitary hormone deficiency, combined 2	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000008100	5	177421186	5	177994185	8100	23139	rs121917841	NC_000005.10:177994184:A:G
NM_006261.4(PROP1):c.150_151del (p.Gly52fs)	PROP1	G52fs	Pituitary hormone deficiency, combined 2	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000008097	5	177421298 - 177421299	5	177994297 - 177994298	8097	23136	rs587776681	NC_000005.10:177994296:CTC:C
NM_001038603.3(MARVELD2):c.1498C>T (p.Arg500Ter)	MARVELD2	R500*, R488*	Deafness, autosomal recessive 49|Deafness, neurosensory, autosomal recessive 49|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001198	5	68728915	5	69433088	1198	16237	rs118203957	NC_000005.10:69433087:C:T
NM_052859.4(RFT1):c.775G>A (p.Gly259Ser)	RFT1	G259S	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807671	3	53145846	3	53111830	807671	798535		NC_000003.12:53111829:C:T
NM_052859.4(RFT1):c.1325G>A (p.Arg442Gln)	RFT1	R442Q	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000207991	3	53126518	3	53092502	207991	204233	rs749968109	NC_000003.12:53092501:C:T
NM_052859.4(RFT1):c.1222A>G (p.Met408Val)	RFT1	M408V	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000207990	3	53126621	3	53092605	207990	204232	rs796053522	NC_000003.12:53092604:T:C
NM_052859.4(RFT1):c.887T>G (p.Ile296Arg)	RFT1	I296R	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000207989	3	53139759	3	53105743	207989	204231	rs772820136	NC_000003.12:53105742:A:C
NM_052859.4(RFT1):c.887T>A (p.Ile296Lys)	RFT1	I296K	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000207988	3	53139759	3	53105743	207988	204230	rs772820136	NC_000003.12:53105742:A:T
NM_052859.4(RFT1):c.892G>A (p.Glu298Lys)	RFT1	E298K	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000207987	3	53139754	3	53105738	207987	204229	rs796053521	NC_000003.12:53105737:C:T
NM_052859.4(RFT1):c.454A>G (p.Lys152Glu)	RFT1	K152E	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000207986	3	53156392	3	53122376	207986	204228	rs763862849	NC_000003.12:53122375:T:C
NM_052859.4(RFT1):c.199C>T (p.Arg67Cys)	RFT1	R67C	Congenital disorder of glycosylation type 1N	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000000785	3	53157807	3	53123791	785	15824	rs118203913	NC_000003.12:53123790:G:A
NM_006261.4(PROP1):c.91dup (p.Thr31fs)	PROP1		not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000845240	5	177422843 - 177422844	5	177995842 - 177995843	845240	830692		NC_000005.10:177995842:T:TT
NC_000005.10:g.(?_177992699)_(177995943_?)del	PROP1		not provided	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000831587	5	177419700 - 177422944			831587	819577		
NM_006261.4(PROP1):c.295C>T (p.Arg99Ter)	PROP1	R99*	Pituitary hormone deficiency, combined 2	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000008105	5	177421154	5	177994153	8105	23144	rs121917844	NC_000005.10:177994152:G:A
NM_006261.4(PROP1):c.112_124del (p.Ser38fs)	PROP1	S38fs	Pituitary hormone deficiency, combined 2	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000008101	5	177421325 - 177421337	5	177994324 - 177994336	8101	23140	rs587776682	NC_000005.10:177994323:GTGGAGCACTCGAGT:GT
NM_020894.4(UVSSA):c.87del (p.Ile31fs)	UVSSA	I31fs	UV-sensitive syndrome 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031570	4	1341966	4	1348178	31570	40250		NC_000004.12:1348177:G:
NM_020894.4(UVSSA):c.94T>C (p.Cys32Arg)	UVSSA	C32R	UV-sensitive syndrome 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031571	4	1341973	4	1348185	31571	40251	rs387907164	NC_000004.12:1348184:T:C
NM_021871.4(FGA):c.104G>A (p.Arg35His)	FGA	R16H, R35H	Abnormal bleeding|Hypofibrinogenemia|Dysfibrinogenemia	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000016404	4	155510665	4	154589513	16404	31443	rs121909607	NC_000004.12:154589512:C:T
NM_024665.7(TBL1XR1):c.327_357dup (p.Gln120fs)	TBL1XR1		not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000818064	3	176769361 - 176769362	3	177051573 - 177051574	818064	805331		NC_000003.12:177051573:GCTGGCTGCAGCTGCGGCAGCTGCAGCAGCTGCTG:GCTGGCTGCAGCTGCGGCAGCTGCAGCAGCTGCTGGCTGCAGCTGCGGCAGCTGCAGCAGCTGCTG
NM_024665.7(TBL1XR1):c.1362_1365dup (p.Tyr456fs)	TBL1XR1		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000817137	3	176750809 - 176750810	3	177033021 - 177033022	817137	805330		NC_000003.12:177033021:CCTGCC:CCTGCCTGCC
NM_024665.7(TBL1XR1):c.799G>T (p.Gly267Cys)	TBL1XR1	G180C, G267C	Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000807509	3	176765153	3	177047365	807509	798524		NC_000003.12:177047364:C:A
NM_024665.6(TBL1XR1):c.1108G>A (p.Asp370Asn)	TBL1XR1	D370N, D283N	not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000372701	3	176755900	3	177038112	372701	359406	rs1057517933	NC_000003.12:177038111:C:T
NM_024665.7(TBL1XR1):c.626_629del (p.Leu209fs)	TBL1XR1	L209fs, L122fs	Pierpont syndrome	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000857363	3	176767858 - 176767861	3	177050070 - 177050073	857363	827712		NC_000003.12:177050069:ACTAACT:ACT
NM_024665.6(TBL1XR1):c.874dup (p.Ile292fs)	TBL1XR1		Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: Nov 24, 2017)	no assertion criteria provided	VCV000559628	3	176763967 - 176763968	3	177046179 - 177046180	559628	550354	rs1553813646	NC_000003.12:177046179:T:TT
NM_024665.6(TBL1XR1):c.1336T>G (p.Tyr446Asp)	TBL1XR1	Y446D, Y359D	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000559571	3	176750839	3	177033051	559571	550294	rs1553808301	NC_000003.12:177033050:A:C
I397SFSTER19	TBL1XR1		Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000225872					225872	227685		
NM_001321195.2(TBL1XR1):c.-53G>A	TBL1XR1	G70D	Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000191371	3	176769510	3	177051722	191371	189176	rs786205859	NC_000003.12:177051721:C:T
NM_006261.4(PROP1):c.2T>C (p.Met1Thr)	PROP1	M1T	Pituitary hormone deficiency, combined 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551288	5	177422933	5	177995932	551288	543744	rs1554182645	NC_000005.10:177995931:A:G
NM_024665.6(TBL1XR1):c.734A>G (p.Tyr245Cys)	TBL1XR1	Y245C, Y158C	Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000225873	3	176765306	3	177047518	225873	227686	rs878854401	NC_000003.12:177047517:T:C
TBL1XR1, LEU282PRO	TBL1XR1	L282P	Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000225871					225871	227684		
NC_000003.12:g.(?_160299237)_(160319939_?)del	IFT80		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000830648	3	160017025 - 160037727			830648	819343		
NM_024665.6(TBL1XR1):c.1337A>G (p.Tyr446Cys)	TBL1XR1	Y446C, Y359C	Pierpont syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000225874	3	176750838	3	177033050	225874	227687	rs878854402	NC_000003.12:177033049:T:C
NM_176824.3(BBS7):c.710_711AG[1] (p.Arg238fs)	BBS7		not provided|Bardet-Biedl syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000281626	4	122775862 - 122775865	4	121854707 - 121854710	281626	265863	rs760165634	NC_000004.12:121854706:CTCTCT:CT
NM_007217.4(PDCD10):c.103C>T (p.Arg35Ter)	PDCD10	R35*	Cerebral cavernous malformations 3|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372445	3	167422677	3	167704889	372445	359498	rs1057517786	NC_000003.12:167704888:G:A
NM_016955.4(SEPSECS):c.501G>A (p.Trp167Ter)	SEPSECS	W167*	not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000863228	4	25157705	4	25156083	863228	829059		NC_000004.12:25156082:C:T
NM_016955.4(SEPSECS):c.443dup (p.Thr149fs)	SEPSECS		not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000857931	4	25157762 - 25157763	4	25156140 - 25156141	857931	829061		NC_000004.12:25156140:A:AA
NM_016955.4(SEPSECS):c.772C>T (p.Gln258Ter)	SEPSECS	Q258*	not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000852679	4	25153614	4	25151992	852679	829058		NC_000004.12:25151991:G:A
NM_016955.4(SEPSECS):c.449dup (p.Cys151fs)	SEPSECS		not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000851642	4	25157756 - 25157757	4	25156134 - 25156135	851642	829060		NC_000004.12:25156134:A:AA
NC_000004.12:g.(?_25151950)_(25152072_?)del	SEPSECS		not provided	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000831417	4	25153572 - 25153694			831417	819476		
NC_000004.12:g.(?_25156846)_(25156984_?)del	SEPSECS		not provided	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000830459	4	25158468 - 25158606			830459	819477		
NM_198271.4(LMOD3):c.1628G>T (p.Arg543Leu)	LMOD3	R543L	Nemaline myopathy 10	Pathogenic(Last reviewed: Jul 5, 2019)	no assertion criteria provided	VCV000692211	3	69167878	3	69118727	692211	679953		NC_000003.12:69118726:C:A
NM_016955.4(SEPSECS):c.289C>T (p.Arg97Ter)	SEPSECS	R97*	not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000645393	4	25158577	4	25156955	645393	632140		NC_000004.12:25156954:G:A
NM_016955.4(SEPSECS):c.1466A>T (p.Asp489Val)	SEPSECS	D489V	Pontocerebellar hypoplasia type 2D	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000190145	4	25125593	4	25123971	190145	187972	rs773876739	NC_000004.12:25123970:T:A
NM_000187.4(HGD):c.140C>T (p.Ser47Leu)	HGD	S47L	Alkaptonuria	Pathogenic(Last reviewed: Aug 22, 2013)	no assertion criteria provided	VCV000065574	3	120393784	3	120674937	65574	76482	rs369517993	NC_000003.12:120674936:G:A
NM_016955.4(SEPSECS):c.715G>A (p.Ala239Thr)	SEPSECS	A239T	Pontocerebellar hypoplasia type 2D	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000018401	4	25153671	4	25152049	18401	33440	rs267607035	NC_000004.12:25152048:C:T
NM_000892.5(KLKB1):c.367G>A (p.Gly123Arg)	KLKB1	G104R, G123R, G85R	Prekallikrein deficiency	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000012036	4	187157973	4	186236819	12036	27075	rs121964952	NC_000004.12:186236818:G:A
NM_000892.5(KLKB1):c.1205G>A (p.Trp402Ter)	KLKB1	W383*, W402*, W200*, W364*	Prekallikrein deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000012034	4	187173231	4	186252077	12034	27073	rs121964950	NC_000004.12:186252076:G:A
NM_000892.5(KLKB1):c.337C>T (p.Arg113Ter)	KLKB1	R94*, R113*, R75*	Prekallikrein deficiency	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000012033	4	187157943	4	186236789	12033	27072	rs121964949	NC_000004.12:186236788:C:T
NM_000187.4(HGD):c.291G>A (p.Trp97Ter)	HGD	W97*	Alkaptonuria	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000855743	3	120371490	3	120652643	855743	827322		NC_000003.12:120652642:C:T
NM_000187.4(HGD):c.1039C>T (p.Arg347Ter)	HGD	R347*	Alkaptonuria	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000850435	3	120352143	3	120633296	850435	827320		NC_000003.12:120633295:G:A
NC_000003.12:g.(?_120647857)_(120647931_?)del	HGD		Alkaptonuria	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000830678	3	120366704 - 120366778			830678	819312		
NM_000187.4(HGD):c.651_652del (p.Ala218Glnfs)	HGD		Alkaptonuria	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000643931	3	120363288 - 120363289	3	120644441 - 120644442	643931	651058		NC_000003.12:120644440:CCCC:CC
NM_198271.4(LMOD3):c.476del (p.Gly159fs)	LMOD3	G159fs	Nemaline myopathy 10	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000475328	3	69169030	3	69119879	475328	453525	rs1426709672	NC_000003.12:69119878:CC:C
NM_001304418.2(LMOD3):c.357_361AAAAG[1] (p.Glu121fs)	LMOD3		Nemaline myopathy 10	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000475319	3	69169140 - 69169144	3	69119989 - 69119993	475319	453547	rs1274699363	NC_000003.12:69119988:CTTTTCTTTT:CTTTT
NC_000003.11:g.(?_69158226)_(69171557_?)del	LMOD3		Nemaline myopathy 10	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000475292	3	69158226 - 69171557			475292	451561		
NM_000187.4(HGD):c.189G>T (p.Arg63Ser)	HGD	R63S	Alkaptonuria	Pathogenic(Last reviewed: Jun 18, 2017)	criteria provided, single submitter	VCV000437464	3	120389367	3	120670520	437464	431010	rs1390061303	NC_000003.12:120670519:C:A
NM_000187.4(HGD):c.1017_1019delinsTA (p.Met339fs)	HGD		Alkaptonuria	Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000371197	3	120352163 - 120352165	3	120633316 - 120633318	371197	357270	rs1057517081	NC_000003.12:120633315:CTC:TA
NM_198271.4(LMOD3):c.1069G>T (p.Glu357Ter)	LMOD3	E357*	Nemaline myopathy 10	Pathogenic(Last reviewed: Nov 3, 2014)	no assertion criteria provided	VCV000162219	3	69168437	3	69119286	162219	171927	rs724159965	NC_000003.12:69119285:C:A
NM_198271.4(LMOD3):c.1201C>T (p.Arg401Ter)	LMOD3	R401*	Nemaline myopathy 10	Pathogenic(Last reviewed: Nov 3, 2014)	no assertion criteria provided	VCV000162217	3	69168305	3	69119154	162217	171925	rs724159964	NC_000003.12:69119153:G:A
NM_001304418.2(LMOD3):c.1100_1102ACA[1] (p.Asn368del)	LMOD3	N368del	Nemaline myopathy 10	Pathogenic(Last reviewed: Nov 3, 2014)	no assertion criteria provided	VCV000162216	3	69168401 - 69168403	3	69119250 - 69119252	162216	171924	rs727502798	NC_000003.12:69119249:TGTTGTT:TGTT
NM_198271.4(LMOD3):c.138dup (p.Ser47fs)	LMOD3		Nemaline myopathy 10	Pathogenic(Last reviewed: Apr 17, 2019)	no assertion criteria provided	VCV000162215	3	69171399 - 69171400	3	69122248 - 69122249	162215	171923	rs727502797	NC_000003.12:69122248:GGGG:GGGGG
NM_000187.4(HGD):c.16-272_87+305del	HGD		Alkaptonuria	Pathogenic	no assertion criteria provided	VCV000156275	3	120394334 - 120394982	3	120675487 - 120676135	156275	166057	rs1553721650	
NM_000187.4(HGD):c.1111dup (p.His371fs)	HGD		Alkaptonuria	Pathogenic(Last reviewed: Dec 27, 2015)	criteria provided, single submitter	VCV000065573	3	120352070 - 120352071	3	120633223 - 120633224	65573	76481	rs397515516	NC_000003.12:120633223:GGGGGG:GGGGGGG
NM_016955.4(SEPSECS):c.1001A>G (p.Tyr334Cys)	SEPSECS	Y334C	Pontocerebellar hypoplasia type 2D	Pathogenic(Last reviewed: Oct 8, 2010)	no assertion criteria provided	VCV000018400	4	25146421	4	25144799	18400	33439	rs267607036	NC_000004.12:25144798:T:C
NM_000187.4(HGD):c.1112A>G (p.His371Arg)	HGD	H371R	Alkaptonuria	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000003172	3	120352070	3	120633223	3172	18211	rs120074172	NC_000003.12:120633222:T:C
NM_000187.4(HGD):c.990G>T (p.Arg330Ser)	HGD	R330S	Alkaptonuria	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000003167	3	120357318	3	120638471	3167	18206	rs120074171	NC_000003.12:120638470:C:A
NM_020894.4(UVSSA):c.367A>T (p.Lys123Ter)	UVSSA	K123*	UV-sensitive syndrome 3	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000031569	4	1343580	4	1349792	31569	40249	rs387907163	NC_000004.12:1349791:A:T
NM_198271.4(LMOD3):c.1099_1100del (p.Asn367fs)	LMOD3	N367fs	Nemaline myopathy 10|not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000162218	3	69168406 - 69168407	3	69119255 - 69119256	162218	171926	rs727502799	NC_000003.12:69119254:TTT:T
NM_000187.4(HGD):c.16-1G>A	HGD		Alkaptonuria	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000003170	3	120394711	3	120675864	3170	18209	rs397515347	NC_000003.12:120675863:C:T
NM_052995.2(CLRN1):c.121_130del (p.Ala41fs)	CLRN1	A117fs, A41fs, S174fs	Usher syndrome, type 3A	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812272	3	150659444 - 150659453	3	150941657 - 150941666	812272	800490		NC_000003.12:150941656:TGAAGAAGGCTG:TG
NM_001195794.1(CLRN1):c.121_136dup (p.Leu46fs)	CLRN1		not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000651716	3	150690359 - 150690360	3	150972572 - 150972573	651716	631000		NC_000003.12:150972572:GCAGAGCTCCCGTTTTGCAGAG:GCAGAGCTCCCGTTTTGCAGAGCTCCCGTTTTGCAGAG
NM_052995.2(CLRN1):c.233T>G (p.Leu78Trp)	CLRN1	L154W, L167W, L78W	Retinitis pigmentosa 61	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000030574	3	150645961	3	150928174	30574	39531	rs775098953	NC_000003.12:150928173:A:C
SNCA, DUPLICATION	SNCA		Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: Oct 14, 2008)	no assertion criteria provided	VCV000014011					14011	29050		
NM_000345.4(SNCA):c.157G>A (p.Ala53Thr)	SNCA	A53T	Lewy body dementia|Parkinson disease 1|Parkinson disease 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000014007	4	90749300	4	89828149	14007	29046	rs104893877	NC_000004.12:89828148:C:T
NM_001195794.1(CLRN1):c.67G>T (p.Gly23Ter)	CLRN1	G23*	not provided	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000838097	3	150690429	3	150972642	838097	827630		NC_000003.12:150972641:C:A
NM_052995.2(CLRN1):c.26-649T>G	CLRN1		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000834124	3	150660197	3	150942410	834124	851544		NC_000003.12:150942409:A:C
NM_001195794.1(CLRN1):c.65T>A (p.Leu22His)	CLRN1	L22H	Usher syndrome, type 3A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812104	3	150690431	3	150972644	812104	800352		NC_000003.12:150972643:A:T
NM_052995.2(CLRN1):c.95T>C (p.Leu32Pro)	CLRN1	L108P, L32P	Usher syndrome, type 3A	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000633701	3	150659479	3	150941692	633701	622134	rs1559982739	NC_000003.12:150941691:A:G
NM_001195794.1(CLRN1):c.188_210del (p.Tyr63fs)	CLRN1	Y63fs	Usher syndrome, type 3A	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000004398	3	150690286 - 150690308	3	150972499 - 150972521	4398	19437	rs1553776036	NC_000003.12:150972498:ACCCTCTCCGTGGAAAAGCCCGTAC:AC
NM_052995.2(CLRN1):c.221T>C (p.Leu74Pro)	CLRN1	L150P, L163P, L74P	Usher syndrome, type 3A	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000004396	3	150645973	3	150928186	4396	19435	rs121908142	NC_000003.12:150928185:A:G
NM_052995.2(CLRN1):c.191T>A (p.Leu64Ter)	CLRN1	L140*, L64*	not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000847350	3	150659383	3	150941596	847350	827627		NC_000003.12:150941595:A:T
NM_001195794.1(CLRN1):c.617del (p.Phe206fs)	CLRN1	F206fs, F193fs	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000644615	3	150645844	3	150928057	644615	630999		NC_000003.12:150928056:AAAA:AAA
NM_052995.2(CLRN1):c.205+1G>A	CLRN1		Usher syndrome, type 3A	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000638640	3	150659368	3	150941581	638640	626415		NC_000003.12:150941580:C:T
NM_001195794.1(CLRN1):c.92C>T (p.Pro31Leu)	CLRN1	P31L	Retinitis pigmentosa 61|Retinal dystrophy	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000030575	3	150690404	3	150972617	30575	39532	rs374390376	NC_000003.12:150972616:G:A
NM_052995.2(CLRN1):c.231_233del (p.Ile77_Leu78delinsMet)	CLRN1		Usher syndrome, type 3A	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000004394	3	150645961 - 150645963	3	150928174 - 150928176	4394	19433	rs1085307049	NC_000003.12:150928173:AATA:A
NM_052995.2(CLRN1):c.131T>A (p.Met44Lys)	CLRN1	M120K, H177Q, M44K	Usher syndrome, type 3A	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000004393	3	150659443	3	150941656	4393	19432	rs121908141	NC_000003.12:150941655:A:T
NM_052995.2(CLRN1):c.73_77del (p.Val25fs)	CLRN1	C158fs, V25fs, V101fs	Usher syndrome, type 3A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, multiple submitters, no conflicts	VCV000048145	3	150659497 - 150659501	3	150941710 - 150941714	48145	57309	rs397517932	NC_000003.12:150941709:ATGACAT:AT
NM_003907.3(EIF2B5):c.1015C>T (p.Arg339Trp)	EIF2B5	R339W	not provided|Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000666195	3	183858377	3	184140589	666195	631109		NC_000003.12:184140588:C:T
NM_003907.3(EIF2B5):c.944G>A (p.Arg315His)	EIF2B5	R315H	Leukoencephalopathy with vanishing white matter|not provided	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000005950	3	183858306	3	184140518	5950	20989	rs113994064	NC_000003.12:184140517:G:A
NM_003907.3(EIF2B5):c.584G>A (p.Arg195His)	EIF2B5	R195H	not provided|Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000005946	3	183855763	3	184137975	5946	20985	rs113994054	NC_000003.12:184137974:G:A
NM_000187.4(HGD):c.1078G>C (p.Gly360Arg)	HGD	G360R	Alkaptonuria	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000640206	3	120352104	3	120633257	640206	630755		NC_000003.12:120633256:C:G
NM_016955.4(SEPSECS):c.805-1dup	SEPSECS		Pontocerebellar hypoplasia type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279890	4	25146751 - 25146752	4	25145129 - 25145130	279890	264173	rs776969714	NC_000004.12:25145129:CCCCC:CCCCCC
NM_000187.4(HGD):c.457dup (p.Asp153fs)	HGD		Alkaptonuria	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003169	3	120366735 - 120366736	3	120647888 - 120647889	3169	18208	rs397515346	NC_000003.12:120647888:CCCC:CCCCC
NM_006580.3(CLDN16):c.602G>A (p.Gly201Glu)	CLDN16	G201E	Primary hypomagnesemia	Pathogenic	no assertion criteria provided	VCV000560390	3	190126112	3	190408323	560390	551446	rs138308105	NC_000003.12:190408322:G:A
NM_006580.3(CLDN16):c.678del (p.Gly227fs)	CLDN16	G227fs	Primary hypomagnesemia	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438693	3	190126187	3	190408398	438693	432291	rs1553809654	NC_000003.12:190408397:TT:T
NM_006580.3(CLDN16):c.545_548dup (p.Lys183delinsAsnTer)	CLDN16		Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 29, 2018)	no assertion criteria provided	VCV000545703	3	190122666 - 190122667	3	190404877 - 190404878	545703	536195	rs1253995767	NC_000003.12:190404877:ATTAA:ATTAATTAA
NM_006580.3(CLDN16):c.416C>T (p.Ala139Val)	CLDN16	A139V	Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 29, 2018)	no assertion criteria provided	VCV000545702	3	190120217	3	190402428	545702	536194	rs765256758	NC_000003.12:190402427:C:T
NM_017415.3(KLHL3):c.1295G>A (p.Ser432Asn)	KLHL3	S432N, S350N, S400N	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100550	5	136973009	5	137637320	100550	106427	rs199469631	NC_000005.10:137637319:C:T
NM_017415.3(KLHL3):c.1723C>T (p.Arg575Trp)	KLHL3	R575W, R493W, R543W	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100548	5	136961454	5	137625765	100548	106425	rs199469646	NC_000005.10:137625764:G:A
NM_017415.3(KLHL3):c.1292G>A (p.Arg431Gln)	KLHL3	R431Q, R349Q, R399Q	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100545	5	136973012	5	137637323	100545	106422	rs199469643	NC_000005.10:137637322:C:T
NM_017415.3(KLHL3):c.1151G>A (p.Arg384Gln)	KLHL3	R384Q, R302Q, R352Q	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100544	5	136974710	5	137639021	100544	106421	rs199469629	NC_000005.10:137639020:C:T
NM_017415.3(KLHL3):c.926A>G (p.Gln309Arg)	KLHL3	Q309R, Q277R, Q227R	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100541	5	136975644	5	137639955	100541	106418	rs199469627	NC_000005.10:137639954:T:C
NM_017415.3(KLHL3):c.430C>T (p.Gln144Ter)	KLHL3	Q144*, Q62*, Q112*	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100540	5	137028070	5	137692381	100540	106417	rs199469637	NC_000005.10:137692380:G:A
NM_017415.3(KLHL3):c.1501C>A (p.Pro501Thr)	KLHL3	P501T, P469T, P419T	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100539	5	136964076	5	137628387	100539	106416	rs199469634	NC_000005.10:137628386:G:T
NM_017415.3(KLHL3):c.232A>G (p.Met78Val)	KLHL3	M78V, M46V	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100538	5	137045448	5	137709759	100538	106415	rs199469624	NC_000005.10:137709758:T:C
NM_017415.3(KLHL3):c.1280T>C (p.Met427Thr)	KLHL3	M427T, M345T, M395T	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100537	5	136973024	5	137637335	100537	106414	rs199469642	NC_000005.10:137637334:A:G
NM_017415.3(KLHL3):c.1160T>C (p.Leu387Pro)	KLHL3	L387P, L305P, L355P	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100536	5	136974701	5	137639012	100536	106413	rs199469630	NC_000005.10:137639011:A:G
NM_017415.3(KLHL3):c.254A>C (p.Glu85Ala)	KLHL3	E85A, E3A, E53A	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100534	5	137034085	5	137698396	100534	106411	rs199469625	NC_000005.10:137698395:T:G
NM_017415.3(KLHL3):c.491G>T (p.Cys164Phe)	KLHL3	C164F, C82F, C132F	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100533	5	137028009	5	137692320	100533	106410	rs199469626	NC_000005.10:137692319:C:A
NM_017415.3(KLHL3):c.230C>A (p.Ala77Glu)	KLHL3	A77E, A45E	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100532	5	137045450	5	137709761	100532	106409	rs199469623	NC_000005.10:137709760:G:T
NM_017415.3(KLHL3):c.1480G>A (p.Ala494Thr)	KLHL3	A494T, A412T, A462T	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100531	5	136964097	5	137628408	100531	106408	rs199469633	NC_000005.10:137628407:C:T
NM_017415.3(KLHL3):c.1019C>T (p.Ala340Val)	KLHL3	A340V, A258V, A308V	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100530	5	136975551	5	137639862	100530	106407	rs199469628	NC_000005.10:137639861:G:A
NM_017415.3(KLHL3):c.753+1G>A	KLHL3		Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100529	5	136997603	5	137661914	100529	106406	rs199469648	NC_000005.10:137661913:C:T
NM_017415.3(KLHL3):c.721del (p.Leu241fs)	KLHL3	L241fs, L159fs, L209fs	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100528	5	136997636	5	137661947	100528	106405	rs199469647	NC_000005.10:137661946:G:
NM_017415.3(KLHL3):c.1410G>A (p.Trp470Ter)	KLHL3	W470*, W388*, W438*	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100527	5	136969766	5	137634077	100527	106404	rs199469644	NC_000005.10:137634076:C:T
NM_006580.3(CLDN16):c.823A>T (p.Lys275Ter)	CLDN16	K275*	Primary hypomagnesemia	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000030405	3	190127730	3	190409941	30405	39362	rs387906880	NC_000003.12:190409940:A:T
NM_006580.3(CLDN16):c.831T>G (p.Tyr277Ter)	CLDN16	Y277*	Primary hypomagnesemia	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000005940	3	190127738	3	190409949	5940	20979	rs121908543	NC_000003.12:190409948:T:G
NM_006580.3(CLDN16):c.908C>G (p.Thr303Arg)	CLDN16	T303R	Hypercalciuria, childhood, self-limiting	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000005939	3	190127815	3	190410026	5939	20978	rs121908542	NC_000003.12:190410025:C:G
CLDN16, LEU151PRO	CLDN16	L151P	Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005938					5938	20977		
NM_006580.3(CLDN16):c.350G>A (p.Trp117Ter)	CLDN16	W117*	Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005937	3	190120151	3	190402362	5937	20976	rs104893732	NC_000003.12:190402361:G:A
NM_006580.3(CLDN16):c.434T>C (p.Leu145Pro)	CLDN16	L145P	Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005936	3	190122557	3	190404768	5936	20975	rs104893731	NC_000003.12:190404767:T:C
NM_006580.3(CLDN16):c.452T>G (p.Leu151Trp)	CLDN16	L151W	Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005935	3	190122575	3	190404786	5935	20974	rs104893730	NC_000003.12:190404785:T:G
NM_006580.3(CLDN16):c.704C>T (p.Ser235Phe)	CLDN16	S235F	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 1999)	no assertion criteria provided	VCV000005933	3	190126214	3	190408425	5933	20972	rs104893728	NC_000003.12:190408424:C:T
NM_006580.3(CLDN16):c.698G>A (p.Gly233Asp)	CLDN16	G233D	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 1999)	no assertion criteria provided	VCV000005932	3	190126208	3	190408419	5932	20971	rs104893727	NC_000003.12:190408418:G:A
NM_006580.3(CLDN16):c.500T>C (p.Leu167Pro)	CLDN16	L167P	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 1999)	no assertion criteria provided	VCV000005930	3	190122623	3	190404834	5930	20969	rs104893725	NC_000003.12:190404833:T:C
NM_006580.3(CLDN16):c.212T>G (p.Met71Arg)	CLDN16	M71R	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 1999)	no assertion criteria provided	VCV000005929	3	190106120	3	190388331	5929	20968	rs104893724	NC_000003.12:190388330:T:G
NM_006580.3(CLDN16):c.593G>A (p.Gly198Asp)	CLDN16	G198D	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 1999)	no assertion criteria provided	VCV000005928	3	190126103	3	190408314	5928	20967	rs104893723	NC_000003.12:190408313:G:A
NM_006580.3(CLDN16):c.571G>A (p.Gly191Arg)	CLDN16	G191R	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 2, 1999)	no assertion criteria provided	VCV000005927	3	190122694	3	190404905	5927	20966	rs104893722	NC_000003.12:190404904:G:A
NM_017415.3(KLHL3):c.1277C>T (p.Pro426Leu)	KLHL3	P426L, P394L, P344L	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	VCV000031546	5	136973027	5	137637338	31546	40224	rs387907156	NC_000005.10:137637337:G:A
NM_017415.3(KLHL3):c.1587C>A (p.Asn529Lys)	KLHL3	N529K, N447K, N497K	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	VCV000031545	5	136963990	5	137628301	31545	40223		NC_000005.10:137628300:G:T
NM_017415.3(KLHL3):c.1193C>T (p.Ala398Val)	KLHL3	A398V, A316V, A366V	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	VCV000031544	5	136974668	5	137638979	31544	40222	rs387907155	NC_000005.10:137638978:G:A
KLHL3, TRP470TER	KLHL3	W470*	Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030515					30515	39472		
NM_006580.3(CLDN16):c.445C>T (p.Arg149Ter)	CLDN16	R149*	Primary hypomagnesemia	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000005925	3	190122568	3	190404779	5925	20964	rs104893720	NC_000003.12:190404778:C:T
NM_006580.3(CLDN16):c.715G>A (p.Gly239Arg)	CLDN16	G239R	Primary hypomagnesemia	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005926	3	190126225	3	190408436	5926	20965	rs104893721	NC_000003.12:190408435:G:A
NM_017415.3(KLHL3):c.1298G>A (p.Ser433Asn)	KLHL3	S433N, S401N, S351N	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030523	5	136973006	5	137637317	30523	39480	rs199469632	NC_000005.10:137637316:C:T
NM_017415.3(KLHL3):c.1670A>G (p.Tyr557Cys)	KLHL3	Y557C, Y475C, Y525C	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030521	5	136961507	5	137625818	30521	39478	rs199469645	NC_000005.10:137625817:T:C
NM_017415.3(KLHL3):c.1007G>T (p.Arg336Ile)	KLHL3	R336I, R254I, R304I	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030520	5	136975563	5	137639874	30520	39477	rs199469640	NC_000005.10:137639873:C:A
NM_017415.3(KLHL3):c.718C>T (p.Arg240Ter)	KLHL3	R240*, R158*, R208*	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030519	5	136997639	5	137661950	30519	39476	rs199469638	NC_000005.10:137661949:G:A
NM_017415.3(KLHL3):c.965T>G (p.Phe322Cys)	KLHL3	F322C, F290C, F240C	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030516	5	136975605	5	137639916	30516	39473	rs199469639	NC_000005.10:137639915:A:C
NM_006580.3(CLDN16):c.695T>G (p.Phe232Cys)	CLDN16	F232C	Nephrolithiasis|Nephrocalcinosis|Primary hypomagnesemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000005931	3	190126205	3	190408416	5931	20970	rs104893726	NC_000003.12:190408415:T:G
GRCh37/hg19 4p14(chr4:39478387-39478807)x1	LIAS		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253562	4	39478387 - 39478807			253562	248010		
NM_006859.4(LIAS):c.217del (p.Arg73fs)	LIAS	R73fs	not provided	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000206046	4	39462579	4	39460959	206046	201768	rs796052703	NC_000004.12:39460958:AAA:AA
NM_006859.4(LIAS):c.363del (p.Glu122fs)	LIAS	E90fs, E122fs	Pyruvate dehydrogenase lipoic acid synthetase deficiency	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000540089	4	39465195	4	39463575	540089	519907	rs1553934199	NC_000004.12:39463574:A:
NM_006859.4(LIAS):c.64dup (p.Cys22fs)	LIAS		Pyruvate dehydrogenase lipoic acid synthetase deficiency	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000540088	4	39462423 - 39462424	4	39460803 - 39460804	540088	520185	rs960319940	NC_000004.12:39460803:TTTTT:TTTTTT
NM_006859.4(LIAS):c.645T>A (p.Asp215Glu)	LIAS	D215E, D112E	Pyruvate dehydrogenase lipoic acid synthetase deficiency	Pathogenic(Last reviewed: Mar 20, 2018)	no assertion criteria provided	VCV000224602	4	39469174	4	39467554	224602	226380	rs869312808	NC_000004.12:39467553:T:A
NM_006859.4(LIAS):c.475_477delinsAAA (p.Glu159Lys)	LIAS	E159K	Pyruvate dehydrogenase lipoic acid synthetase deficiency	Pathogenic(Last reviewed: Mar 20, 2018)	no assertion criteria provided	VCV000224601	4	39466747 - 39466749	4	39465127 - 39465129	224601	226379	rs869320760	NC_000004.12:39465126:GAG:AAA
NM_000187.4(HGD):c.360T>G (p.Cys120Trp)	HGD	C120W	Alkaptonuria	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065578	3	120369695	3	120650848	65578	76486	rs149165166	NC_000003.12:120650847:A:C
NM_017415.3(KLHL3):c.1582C>T (p.Arg528Cys)	KLHL3	R528C, R446C, R496C	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	VCV000030522	5	136963995	5	137628306	30522	39479	rs199469635	NC_000005.10:137628305:G:A
NM_017415.3(KLHL3):c.1229C>T (p.Ser410Leu)	KLHL3	S410L, S328L, S378L	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Mar 11, 2012)	no assertion criteria provided	VCV000030517	5	136973075	5	137637386	30517	39474	rs199469641	NC_000005.10:137637385:G:A
NM_016599.4(MYOZ2):c.142T>C (p.Ser48Pro)	MYOZ2	S48P	not provided|Familial hypertrophic cardiomyopathy 16	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000030508	4	120072092	4	119150937	30508	39465	rs199476398	NC_000004.12:119150936:T:C
NM_001203.3(BMPR1B):c.640C>A (p.Arg214Ser)	BMPR1B	R214S, R244S	Acromesomelic dysplasia, Demirhan type||Fibular hypoplasia and complex brachydactyly|Brachydactyly, type a1, d	Pathogenic	no assertion criteria provided	VCV000446284	4	96051067	4	95129916	446284	439689	rs1553941890	NC_000004.12:95129915:C:A
NM_015271.5(TRIM2):c.797C>A (p.Ser266Ter)	TRIM2	S239*, S114*, S256*, S257*, S266*	Charcot-Marie-Tooth disease, axonal, type 2R	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000580197	4	154216475	4	153295323	580197	559774	rs746386202	NC_000004.12:153295322:C:A
NC_000004.11:g.(?_154125663)_(154197302_?)del	TRIM2		Charcot-Marie-Tooth disease, axonal, type 2R	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000474600	4	154125663 - 154197302	4	153204511 - 153276150	474600	453606		
NM_001203.3(BMPR1B):c.975A>C (p.Lys325Asn)	BMPR1B	K325N, K355N	Brachydactyly, type a1, d	Pathogenic(Last reviewed: Mar 4, 2016)	no assertion criteria provided	VCV000223156	4	96052562	4	95131411	223156	224883	rs869025614	NC_000004.12:95131410:A:C
NM_001203.3(BMPR1B):c.447-1G>A	BMPR1B		Brachydactyly, type a1, d	Pathogenic(Last reviewed: Mar 4, 2016)	no assertion criteria provided	VCV000223155	4	96046133	4	95124982	223155	224882	rs869025613	NC_000004.12:95124981:G:A
NM_001203.3(BMPR1B):c.91C>T (p.Arg31Cys)	BMPR1B	R31C, R61C	Acromesomelic dysplasia, Demirhan type	Pathogenic(Last reviewed: Jun 24, 2015)	no assertion criteria provided	VCV000217256	4	96025666	4	95104515	217256	213899	rs745854387	NC_000004.12:95104514:C:T
NM_001203.3(BMPR1B):c.657G>A (p.Trp219Ter)	BMPR1B	W219*, W249*	Acromesomelic dysplasia, Demirhan type	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000217255	4	96051084	4	95129933	217255	213898	rs863225042	NC_000004.12:95129932:G:A
NM_001203.3(BMPR1B):c.157T>C (p.Cys53Arg)	BMPR1B	C53R, C83R	Acromesomelic dysplasia, Demirhan type	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000217254	4	96035884	4	95114733	217254	213897	rs863225041	NC_000004.12:95114732:T:C
NM_015271.5(TRIM2):c.1781del (p.Lys594fs)	TRIM2	K442fs, K567fs, K594fs, K585fs, K584fs	Charcot-Marie-Tooth disease, axonal, type 2R	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000083304	4	154237149	4	153315997	83304	94195	rs587777838	NC_000004.12:153315996:AA:A
NM_015271.5(TRIM2):c.761A>T (p.Glu254Val)	TRIM2	E227V, E244V, E102V, E245V, E254V	Charcot-Marie-Tooth disease, axonal, type 2R	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000083303	4	154215612	4	153294460	83303	94194	rs587777063	NC_000004.12:153294459:A:T
NM_001203.3(BMPR1B):c.1457G>A (p.Arg486Gln)	BMPR1B	R486Q, R516Q		Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000006558	4	96075772	4	95154621	6558	21597	rs121434419	NC_000004.12:95154620:G:A
NM_001203.3(BMPR1B):c.361_368del (p.Gly121fs)	BMPR1B	G151fs, G121fs	Acromesomelic dysplasia, Demirhan type	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006557	4	96044970 - 96044977	4	95123819 - 95123826	6557	21596	rs863223287	NC_000004.12:95123818:ATGGACCTAT:AT
NM_001203.3(BMPR1B):c.1456C>T (p.Arg486Trp)	BMPR1B	R486W, R516W		Pathogenic(Last reviewed: Oct 14, 2003)	no assertion criteria provided	VCV000006556	4	96075771	4	95154620	6556	21595	rs121434418	NC_000004.12:95154619:C:T
NM_001203.3(BMPR1B):c.599T>A (p.Ile200Lys)	BMPR1B	I200K, I230K		Pathogenic(Last reviewed: Oct 14, 2003)	no assertion criteria provided	VCV000006555	4	96051026	4	95129875	6555	21594	rs121434417	NC_000004.12:95129874:T:A
NM_001195794.1(CLRN1):c.658C>T (p.Arg220Ter)	CLRN1	R207*, R220*	Usher syndrome, type 3A|not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371628	3	150645803	3	150928016	371628	357287	rs373208120	NC_000003.12:150928015:G:A
NM_017415.3(KLHL3):c.1583G>A (p.Arg528His)	KLHL3	R528H, R446H, R496H	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2D	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000030518	5	136963994	5	137628305	30518	39475	rs199469636	NC_000005.10:137628304:C:T
NM_004237.4(TRIP13):c.673-1G>C	TRIP13		Mosaic variegated aneuploidy syndrome 3	Pathogenic(Last reviewed: Jul 27, 2017)	no assertion criteria provided	VCV000431046	5	908102	5	907987	431046	424575	rs1131692330	NC_000005.10:907986:G:C
NM_004237.4(TRIP13):c.1060C>T (p.Arg354Ter)	TRIP13	R354*	Mosaic variegated aneuploidy syndrome 3	Pathogenic(Last reviewed: Jul 27, 2017)	no assertion criteria provided	VCV000431045	5	914619	5	914504	431045	424574	rs376882637	NC_000005.10:914503:C:T
NM_001003694.2(BRPF1):c.28_29del (p.Phe10fs)	BRPF1	F10fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000522172	3	9775851 - 9775852	3	9734167 - 9734168	522172	511516	rs1553693712	NC_000003.12:9734166:TTT:T
NM_001003694.2(BRPF1):c.2812dup (p.Gln938fs)	BRPF1		Inborn genetic diseases	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000521797	3	9786077 - 9786078	3	9744393 - 9744394	521797	511518	rs762904815	NC_000003.12:9744393:CCCCCCC:CCCCCCCC
NM_001003694.2(BRPF1):c.2308_2309del (p.Asp770fs)	BRPF1	D764fs, D770fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000521076	3	9784933 - 9784934	3	9743249 - 9743250	521076	511517	rs1553696275	NC_000003.12:9743248:AGA:A
NM_001041.4(SI):c.853G>T (p.Glu285Ter)	SI	E285*	not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000489002	3	164781284	3	165063496	489002	481676	rs758259365	NC_000003.12:165063495:C:A
NM_022464.5(SIL1):c.1205del (p.Gly402fs)	SIL1	G402fs	not provided	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000285373	5	138282987	5	138947298	285373	269610	rs886043087	NC_000005.10:138947297:CCC:CC
NM_022464.5(SIL1):c.1030-9G>A	SIL1		not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280106	5	138283171	5	138947482	280106	264217	rs370290043	NC_000005.10:138947481:C:T
NM_022464.5(SIL1):c.460C>T (p.Gln154Ter)	SIL1	Q154*	not provided	Pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	VCV000198254	5	138362675	5	139026986	198254	195415	rs774441811	NC_000005.10:139026985:G:A
NM_001041.4(SI):c.3686G>A (p.Cys1229Tyr)	SI	C1229Y	Sucrase-isomaltase deficiency	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001416	3	164735409	3	165017621	1416	16455	rs121912614	NC_000003.12:165017620:C:T
NM_001041.4(SI):c.1859T>C (p.Leu620Pro)	SI	L620P	Sucrase-isomaltase deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000001415	3	164764657	3	165046869	1415	16454	rs121912613	NC_000003.12:165046868:A:G
NM_001041.4(SI):c.350A>G (p.Gln117Arg)	SI	Q117R	Sucrase-isomaltase deficiency	Pathogenic(Last reviewed: Jun 29, 2001)	no assertion criteria provided	VCV000001414	3	164786889	3	165069101	1414	16453	rs121912612	NC_000003.12:165069100:T:C
NM_001041.4(SI):c.1022T>C (p.Leu341Pro)	SI	L340P, L341P	Sucrase-isomaltase deficiency	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000001413	3	164777814	3	165060026	1413	16452	rs267607049	NC_000003.12:165060025:A:G
NM_001041.4(SI):c.3293A>C (p.Gln1098Pro)	SI	Q1098P	Sucrase-isomaltase deficiency	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000001412	3	164737520	3	165019732	1412	16451	rs121912611	NC_000003.12:165019731:T:G
nsv1197592	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000002631	5	138311134 - 138369402	5	138975444 - 139033712	2631	17670		
NM_022464.5(SIL1):c.598_602GAAGA[1] (p.Glu201fs)	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000002630	5	138362528 - 138362532	5	139026839 - 139026843	2630	17669		NC_000005.10:139026838:TCTTCTCTTC:TCTTC
NM_022464.5(SIL1):c.1370T>C (p.Leu457Pro)	SIL1	L457P	Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000002628	5	138282822	5	138947133	2628	17667		NC_000005.10:138947132:A:G
NM_022464.5(SIL1):c.1029+1G>A	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002626	5	138286859	5	138951170	2626	17665		NC_000005.10:138951169:C:T
NM_022464.5(SIL1):c.645+2T>C	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002624	5	138362488	5	139026799	2624	17663		NC_000005.10:139026798:A:G
NM_022464.5(SIL1):c.645+1G>A	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002623	5	138362489	5	139026800	2623	17662		NC_000005.10:139026799:C:T
NM_022464.5(SIL1):c.502_505AAGA[3] (p.Asp170fs)	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000002622	5	138362625 - 138362626	5	139026936 - 139026937	2622	17661		NC_000005.10:139026936:TCTTTCTT:TCTTTCTTTCTT
NC_000005.10:g.139189727_139201554del	SIL1		Global developmental delay|Generalized hypotonia|Ptosis|Cerebellar atrophy|Cataract (disease)|Constipation|Generalized hypotonia|Urinary incontinence|Strabismus|Cataract (disease)|Apraxia	Pathogenic	no assertion criteria provided	VCV000812923	5	138525416 - 138537243			812923	801079		
NM_022464.5(SIL1):c.936dup (p.Leu313fs)	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000002629	5	138286952 - 138286953	5	138951263 - 138951264	2629	17668		NC_000005.10:138951263:CCCCCC:CCCCCCC
NM_022464.5(SIL1):c.1312C>T (p.Gln438Ter)	SIL1	Q438*	Marinesco-Sjögren syndrome|not provided	Pathogenic(Last reviewed: Nov 21, 2012)	criteria provided, single submitter	VCV000002627	5	138282880	5	138947191	2627	17666	rs119456966	NC_000005.10:138947190:G:A
NM_000258.2(MYL3):c.457del (p.Leu153fs)	MYL3	L153fs	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000418813	3	46900989	3	46859499	418813	406312	rs1064793448	NC_000003.12:46859498:G:
NM_005199.5(CHRNG):c.459dup (p.Val154fs)	CHRNG		CHRNG-Related Disorders|not provided|Autosomal recessive multiple pterygium syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449338	2	233406191 - 233406192	2	232541481 - 232541482	449338	443183	rs774279192	NC_000002.12:232541481:A:AA
NM_022464.5(SIL1):c.947dup (p.Arg317fs)	SIL1		Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000631958	5	138286941 - 138286942	5	138951252 - 138951253	631958	620186		NC_000005.10:138951252:A:AA
NM_022464.5(SIL1):c.331C>T (p.Arg111Ter)	SIL1	R111*	Marinesco-Sjögren syndrome	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000002625	5	138386649	5	139050960	2625	17664		NC_000005.10:139050959:G:A
NM_000258.2(MYL3):c.463C>G (p.His155Asp)	MYL3	H155D	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031783	3	46900983	3	46859493	31783	40443	rs199474706	NC_000003.12:46859492:G:C
NM_006580.3(CLDN16):c.453G>T (p.Leu151Phe)	CLDN16	L151F	Primary hypomagnesemia	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000005934	3	190122576	3	190404787	5934	20973	rs104893729	NC_000003.12:190404786:G:T
NM_138773.4(SLC25A46):c.11_12insTG (p.Arg5fs)	SLC25A46		not provided	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000422422	5	110074830 - 110074831	5	110739129 - 110739130	422422	406471	rs1064795772	NC_000005.10:110739129:G:GTG
NM_138773.4(SLC25A46):c.185_189del (p.Pro62fs)	SLC25A46	P62fs		Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000834307	5	110075003 - 110075007	5	110739302 - 110739306	834307	829566		NC_000005.10:110739301:CCCGCCC:CC
NM_138773.4(SLC25A46):c.47del (p.Gly16fs)	SLC25A46	G16fs		Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000655776	5	110074864	5	110739163	655776	632539		NC_000005.10:110739162:GGGG:GGG
NC_000005.9:g.(?_110079421)_(110079498_?)del	SLC25A46			Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000652950	5	110079421 - 110079498	5	110743720 - 110743797	652950	651284		
NM_138773.4(SLC25A46):c.425C>T (p.Thr142Ile)	SLC25A46	T142I, T51I		Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000374894	5	110082010	5	110746309	374894	361799	rs1057519296	NC_000005.10:110746308:C:T
NM_138773.4(SLC25A46):c.413T>G (p.Leu138Arg)	SLC25A46	L138R, L47R		Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000374893	5	110081998	5	110746297	374893	361798	rs1057519295	NC_000005.10:110746296:T:G
NM_138773.4(SLC25A46):c.1022T>C (p.Leu341Pro)	SLC25A46	L341P, L250P, L260P		Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000374892	5	110097247	5	110761547	374892	361797	rs1057519294	NC_000005.10:110761546:T:C
SCL25A46, 1.897-KB DEL	SLC25A46			Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000374891					374891	361796		
NM_138773.4(SLC25A46):c.1018C>T (p.Arg340Cys)	SLC25A46	R340C, R259C, R249C		Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000372242	5	110097243	5	110761543	372242	359147	rs746681765	NC_000005.10:110761542:C:T
NM_138773.4(SLC25A46):c.998C>T (p.Pro333Leu)	SLC25A46	P333L, P252L, P242L		Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000372241	5	110097223	5	110761523	372241	359146	rs1057518750	NC_000005.10:110761522:C:T
NM_138773.4(SLC25A46):c.1005A>T (p.Glu335Asp)	SLC25A46	E335D, E244D, E254D		Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000372239	5	110097230	5	110761530	372239	359144	rs1057518748	NC_000005.10:110761529:A:T
NM_138773.4(SLC25A46):c.166dup (p.His56fs)	SLC25A46			Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000372237	5	110074985 - 110074986	5	110739284 - 110739285	372237	359142	rs1057519416	NC_000005.10:110739284:C:CC
NM_138773.4(SLC25A46):c.882_885dup (p.Asn296fs)	SLC25A46			Pathogenic(Last reviewed: Jan 14, 2017)	no assertion criteria provided	VCV000372240	5	110097104 - 110097105	5	110761404 - 110761405	372240	359145	rs1057518749	NC_000005.10:110761404:ACTTAC:ACTTACTTAC
NM_003907.3(EIF2B5):c.1016G>A (p.Arg339Gln)	EIF2B5	R339Q	not provided|Leukoencephalopathy with vanishing white matter	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381579	3	183858378	3	184140590	381579	367277	rs113994069	NC_000003.12:184140589:G:A
NM_000406.2(GNRHR):c.416G>A (p.Arg139His)	GNRHR	R139H	not provided|Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016030	4	68619638	4	67753920	16030	31069	rs104893842	NC_000004.12:67753919:C:T
GRCh37/hg19 4q31.23(chr4:149087640-149284001)x1	NR3C2		not provided	Pathogenic(Last reviewed: Nov 6, 2017)	no assertion criteria provided	VCV000686678	4	149087640 - 149284001			686678	674270		
NM_000901.5(NR3C2):c.1768C>T (p.Arg590Ter)	NR3C2	R590*	not provided	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000429751	4	149181259	4	148260107	429751	421478	rs1131691568	NC_000004.12:148260106:G:A
NM_198586.3(NHLRC1):c.468del (p.Gly158fs)	NHLRC1	G158fs	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280034	6	18122370	6	18122139	280034	264259	rs757954108	NC_000006.12:18122138:T:
NM_000901.5(NR3C2):c.1409C>A (p.Ser470Ter)	NR3C2	S470*	Pseudohypoaldosteronism	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000252501	4	149356604	4	148435452	252501	246962	rs879255348	NC_000004.12:148435451:G:T
NM_198586.3(NHLRC1):c.226del (p.Arg76fs)	NHLRC1	R76fs	not provided	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000206194	6	18122612	6	18122381	206194	201963	rs796052758	NC_000006.12:18122380:GG:G
NM_198586.3(NHLRC1):c.664G>T (p.Glu222Ter)	NHLRC1	E222*	not provided	Pathogenic(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	VCV000193517	6	18122174	6	18121943	193517	190681	rs794726964	NC_000006.12:18121942:C:A
GRCh38/hg38 4q31.23(chr4:148356485-148748029)x1	NR3C2		See cases	Pathogenic(Last reviewed: Aug 5, 2011)	no assertion criteria provided	VCV000146288	4	149277637 - 149669181	4	148356485 - 148748029	146288	156039		
NM_000901.5(NR3C2):c.2915A>G (p.Glu972Gly)	NR3C2	E972G, E855G		Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000008572	4	149002535	4	148081384	8572	23611	rs121912574	NC_000004.12:148081383:T:C
NM_000901.5(NR3C2):c.2024C>G (p.Ser675Ter)	NR3C2	S675*		Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000008570	4	149076043	4	148154892	8570	23609	rs121912572	NC_000004.12:148154891:G:C
NM_000901.5(NR3C2):c.1308T>A (p.Cys436Ter)	NR3C2	C436*		Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000008568	4	149356705	4	148435553	8568	23607	rs121912570	NC_000004.12:148435552:A:T
NM_000901.5(NR3C2):c.488C>G (p.Ser163Ter)	NR3C2	S163*		Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000008566	4	149357525	4	148436373	8566	23605	rs121912568	NC_000004.12:148436372:G:C
NM_000901.5(NR3C2):c.2936T>C (p.Leu979Pro)	NR3C2	L979P, L862P		Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000008565	4	149002514	4	148081363	8565	23604	rs121912567	NC_000004.12:148081362:A:G
NM_000901.5(NR3C2):c.1897G>A (p.Gly633Arg)	NR3C2	G633R		Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000008564	4	149181130	4	148259978	8564	23603	rs121912566	NC_000004.12:148259977:C:T
NM_000901.5(NR3C2):c.2327A>G (p.Gln776Arg)	NR3C2	Q776R		Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000008563	4	149075740	4	148154589	8563	23602	rs121912565	NC_000004.12:148154588:T:C
NM_000901.5(NR3C2):c.1935C>A (p.Cys645Ter)	NR3C2	C645*		Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000008562	4	149115976	4	148194825	8562	23601	rs121912564	NC_000004.12:148194824:G:T
NR3C2, 8-BP DEL, NT537	NR3C2			Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000008561					8561	23600		
NM_000901.5(NR3C2):c.2771T>C (p.Leu924Pro)	NR3C2	L924P, L807P		Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000008559	4	149035283	4	148114132	8559	23598	rs121912563	NC_000004.12:148114131:A:G
NM_000901.5(NR3C2):c.2429C>T (p.Ser810Leu)	NR3C2	S810L, S693L	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	Pathogenic(Last reviewed: Jul 7, 2000)	no assertion criteria provided	VCV000008557	4	149073701	4	148152550	8557	23596	rs41511344	NC_000004.12:148152549:G:A
NM_000901.5(NR3C2):c.2365+3del	NR3C2			Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000008556	4	149075699	4	148154548	8556	23595	rs1560949756	NC_000004.12:148154547:T:
NR3C2, 1-BP DEL, 1597T	NR3C2			Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000008554					8554	23593		
NR3C2, 1-BP DEL, 1226G	NR3C2			Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000008553					8553	23592		
NM_198586.3(NHLRC1):c.923A>C (p.Asp308Ala)	NHLRC1	D308A	Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Mar 22, 2005)	no assertion criteria provided	VCV000002592	6	18121915	6	18121684	2592	17631	rs137852859	NC_000006.12:18121683:T:G
NM_198586.3(NHLRC1):c.793C>T (p.Arg265Ter)	NHLRC1	R265*	Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Mar 22, 2005)	no assertion criteria provided	VCV000002590	6	18122045	6	18121814	2590	17629	rs121917875	NC_000006.12:18121813:G:A
NM_198586.3(NHLRC1):c.992del (p.Gly331fs)	NHLRC1	G331fs	Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000002589	6	18121846	6	18121615	2589	17628	rs587776543	NC_000006.12:18121614:CCC:CC
NM_000901.5(NR3C2):c.2453C>T (p.Ser818Leu)	NR3C2	S181L, S701L, S818L		Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000008571	4	149073677	4	148152526	8571	23610	rs121912573	NC_000004.12:148152525:G:A
NM_000901.5(NR3C2):c.2839C>T (p.Arg947Ter)	NR3C2	R947*, R830*		Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000008567	4	149002611	4	148081460	8567	23606	rs121912569	NC_000004.12:148081459:G:A
NM_000901.5(NR3C2):c.1131dup (p.Glu378Ter)	NR3C2			Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000008560	4	149356881 - 149356882	4	148435729 - 148435730	8560	23599	rs1560735659	NC_000004.12:148435729:A:AA
NM_000901.5(NR3C2):c.2871dup (p.Ala958fs)	NR3C2			Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000008558	4	149002578 - 149002579	4	148081427 - 148081428	8558	23597	rs1560910156	NC_000004.12:148081427:GGGG:GGGGG
NM_198586.3(NHLRC1):c.1091C>A (p.Ser364Ter)	NHLRC1	S364*	Lafora disease	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV000860910	6	18121747	6	18121516	860910	831751		NC_000006.12:18121515:G:T
NM_198586.3(NHLRC1):c.560A>C (p.His187Pro)	NHLRC1	H187P	Lafora disease	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000813783	6	18122278	6	18122047	813783	801990		NC_000006.12:18122046:T:G
NM_198586.3(NHLRC1):c.593T>A (p.Ile198Asn)	NHLRC1	I198N	Lafora disease|Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Jan 22, 2015)	no assertion criteria provided	VCV000002591	6	18122245	6	18122014	2591	17630	rs121917876	NC_000006.12:18122013:A:T
NM_198586.3(NHLRC1):c.462dup (p.Asp155Ter)	NHLRC1		Lafora disease	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000663551	6	18122375 - 18122376	6	18122144 - 18122145	663551	634780		NC_000006.12:18122144:AAAAA:AAAAAA
NM_002109.6(HARS1):c.1090G>T (p.Asp364Tyr)	HARS1	D364Y, D324Y, D344Y, D250Y, D335Y, D290Y, D304Y	Charcot-Marie-Tooth disease, axonal, type 2w	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000217509	5	140056343	5	140676758	217509	214148	rs863225124	NC_000005.10:140676757:C:A
NM_002109.6(HARS1):c.525T>G (p.Asp175Glu)	HARS1	D175E, D61E, D155E, D115E, D146E, D101E, D135E	Charcot-Marie-Tooth disease, axonal, type 2w	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000217508	5	140057598	5	140678013	217508	214147	rs863225123	NC_000005.10:140678012:A:C
NM_002109.6(HARS1):c.401C>A (p.Pro134His)	HARS1	P134H, P94H, P105H	Charcot-Marie-Tooth disease, axonal, type 2w	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000217507	5	140058708	5	140679123	217507	214146	rs863225122	NC_000005.10:140679122:G:T
NM_002109.6(HARS1):c.395C>T (p.Thr132Ile)	HARS1	T132I, T92I, T103I	Charcot-Marie-Tooth disease, axonal, type 2w	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000217506	5	140059374	5	140679789	217506	214145	rs143473232	NC_000005.10:140679788:G:A
NM_002109.6(HARS1):c.1393A>C (p.Ile465Leu)	HARS1	I351L, I391L, I405L, I425L, I436L, I445L, I465L	Pes planus|Motor delay|Microcephaly|Intellectual disability|Distal muscle weakness|Cerebellar ataxia|Urinary urgency|Hammertoe|Scoliosis|Dysarthria|Joint laxity	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000804288	5	140054329	5	140674744	804288	792641		NC_000005.10:140674743:T:G
NM_002109.6(HARS1):c.910_912dup (p.Leu305dup)	HARS1		Pes planus|Motor delay|Microcephaly|Intellectual disability|Distal muscle weakness|Cerebellar ataxia|Urinary urgency|Hammertoe|Scoliosis|Dysarthria|Joint laxity	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000804287	5	140056612 - 140056613	5	140677027 - 140677028	804287	792642		NC_000005.10:140677027:CAAC:CAACAAC
NM_002109.6:c.730delG	HARS1		Peripheral neuropathy|Dysmetria|Nystagmus|Intellectual disability|Choreoathetosis|Cerebellar atrophy|Spastic ataxia|Oculomotor apraxia|Tremor|Dysarthria	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000804286					804286	792644		
NM_002109.6(HARS1):c.616G>T (p.Asp206Tyr)	HARS1	D132Y, D146Y, D166Y, D177Y, D186Y, D206Y, D92Y	Peripheral neuropathy|Dysmetria|Nystagmus|Intellectual disability|Choreoathetosis|Cerebellar atrophy|Spastic ataxia|Oculomotor apraxia|Tremor|Dysarthria	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000804285	5	140057507	5	140677922	804285	792643		NC_000005.10:140677921:C:A
NM_001904.4(CTNNB1):c.1140_1147del (p.Asn380fs)	CTNNB1	N373fs, N380fs	not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000817965	3	41274890 - 41274897	3	41233399 - 41233406	817965	805346		NC_000003.12:41233398:CTGTCTTT:
NM_001904.4(CTNNB1):c.925del (p.Gln309fs)	CTNNB1	Q302fs, Q309fs	not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000817765	3	41267340	3	41225849	817765	805345		NC_000003.12:41225848:CC:C
NM_001904.4(CTNNB1):c.1968_1969dup (p.Ala657fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000817442	3	41278091 - 41278092	3	41236600 - 41236601	817442	805348		NC_000003.12:41236600:TG:TGTG
NM_001904.4(CTNNB1):c.2119dup (p.Leu707fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000817257	3	41279545 - 41279546	3	41238054 - 41238055	817257	805349		NC_000003.12:41238054:CCCC:CCCCC
NM_001904.4(CTNNB1):c.211dup (p.Ser71fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000817214	3	41266210 - 41266211	3	41224719 - 41224720	817214	805344		NC_000003.12:41224719:TTTT:TTTTT
NM_001904.4(CTNNB1):c.1354_1357del (p.Leu452fs)	CTNNB1	L445fs, L452fs	not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000817107	3	41275186 - 41275189	3	41233695 - 41233698	817107	805347		NC_000003.12:41233694:TCCTTC:TC
NM_001904.4(CTNNB1):c.1900G>T (p.Glu634Ter)	CTNNB1	E634*, E627*	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000807588	3	41277936	3	41236445	807588	798532		NC_000003.12:41236444:G:T
NM_001904.4(CTNNB1):c.468dup (p.Thr157fs)	CTNNB1		Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000807587	3	41266670 - 41266671	3	41225179 - 41225180	807587	798531		NC_000003.12:41225179:G:GG
NM_001904.4(CTNNB1):c.1041_1044del (p.Val349fs)	CTNNB1	V349fs, V342fs	Hepatocellular carcinoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801961	3	41268801 - 41268804	3	41227310 - 41227313	801961	790393		NC_000003.12:41227309:CTATCT:CT
NM_001904.4(CTNNB1):c.1090C>T (p.Gln364Ter)	CTNNB1	Q364*, Q357*	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000620205	3	41274840	3	41233349	620205	611586	rs1559474040	NC_000003.12:41233348:C:T
NM_001904.4(CTNNB1):c.1444C>T (p.Gln482Ter)	CTNNB1	Q482*, Q475*	not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000598543	3	41275278	3	41233787	598543	589604	rs1559474557	NC_000003.12:41233786:C:T
NM_001904.4(CTNNB1):c.959dup (p.Pro321fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000523962	3	41268719 - 41268720	3	41227228 - 41227229	523962	514484	rs1553630795	NC_000003.12:41227228:GG:GGG
NM_001904.4(CTNNB1):c.2069G>A (p.Trp690Ter)	CTNNB1	W690*, W683*	not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000523868	3	41278193	3	41236702	523868	514486	rs1553632412	NC_000003.12:41236701:G:A
NM_001904.4(CTNNB1):c.1354_1355delinsG (p.Leu452fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000504115	3	41275188 - 41275189	3	41233697 - 41233698	504115	495187	rs1553631845	NC_000003.12:41233696:CT:G
NM_001904.4(CTNNB1):c.774_775TC[1] (p.Leu259fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000503913	3	41267189 - 41267190	3	41225698 - 41225699	503913	495182	rs1553630458	NC_000003.12:41225697:CTCTC:CTC
NM_001904.4(CTNNB1):c.2076+2T>C	CTNNB1		not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000449767	3	41278202	3	41236711	449767	443455	rs1553632414	NC_000003.12:41236710:T:C
NM_001904.4(CTNNB1):c.937-2A>G	CTNNB1		not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000449750	3	41268697	3	41227206	449750	443453	rs1553630789	NC_000003.12:41227205:A:G
NM_001904.4(CTNNB1):c.285_294del (p.Ala96fs)	CTNNB1	A96fs, A89fs	not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000430017	3	41266487 - 41266496	3	41224996 - 41225005	430017	421440	rs1131691736	NC_000003.12:41224995:GAGCTGCTATG:G
NM_001904.4(CTNNB1):c.1683+5G>C	CTNNB1		not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000423828	3	41275793	3	41234302	423828	406300	rs1064796646	NC_000003.12:41234301:G:C
NM_001904.4(CTNNB1):c.791del (p.Leu264fs)	CTNNB1	L257fs, L264fs	not provided	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000419552	3	41267206	3	41225715	419552	406298	rs1064793948	NC_000003.12:41225714:TT:T
NM_001904.4(CTNNB1):c.542del (p.Lys181fs)	CTNNB1	K181fs, K174fs	not provided	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000418899	3	41266867	3	41225376	418899	406297	rs1064793509	NC_000003.12:41225375:AAAAA:AAAA
NM_001904.4(CTNNB1):c.1580T>A (p.Leu527Ter)	CTNNB1	L527*, L520*	not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000379783	3	41275685	3	41234194	379783	367572	rs1057520730	NC_000003.12:41234193:T:A
NM_001904.4(CTNNB1):c.841A>T (p.Lys281Ter)	CTNNB1	K281*, K274*	not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000379284	3	41267257	3	41225766	379284	367230	rs1057520556	NC_000003.12:41225765:A:T
NM_001904.4(CTNNB1):c.1962T>G (p.Tyr654Ter)	CTNNB1	Y654*, Y647*	not provided	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000280346	3	41278086	3	41236595	280346	264168	rs750402920	NC_000003.12:41236594:T:G
NM_001904.4(CTNNB1):c.198G>A (p.Trp66Ter)	CTNNB1	W66*, W59*	not provided	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000280325	3	41266201	3	41224710	280325	264159	rs886041553	NC_000003.12:41224709:G:A
NM_001904.4(CTNNB1):c.1043_1044del (p.Ser348fs)	CTNNB1	S348fs, S341fs	not provided	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000280194	3	41268804 - 41268805	3	41227313 - 41227314	280194	264133	rs886041444	NC_000003.12:41227312:TCT:T
NM_001904.4(CTNNB1):c.1867C>T (p.Gln623Ter)	CTNNB1	Q623*, Q616*	not provided	Pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	VCV000218599	3	41277903	3	41236412	218599	215284	rs864309577	NC_000003.12:41236411:C:T
NM_000344.3(SMN1):c.274_284del11	SMN1		not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000634945	5	70238184 - 70238194	5	70942357 - 70942367	634945	622788	rs1561499612	NC_000005.10:70942356:GTGGAAAGTTGG:G
NM_000344.3(SMN1):c.584del (p.Pro195fs)	SMN1	P195fs	not provided	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000634940	5	70238652	5	70942825	634940	622779	rs1561499748	NC_000005.10:70942824:CCC:CC
NM_000344.3(SMN1):c.570G>A (p.Trp190Ter)	SMN1	W190*	not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000634936	5	70238640	5	70942813	634936	622778	rs1561499737	NC_000005.10:70942812:G:A
NM_001904.4(CTNNB1):c.1261del (p.Ala421fs)	CTNNB1	A414fs, A421fs	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000633516	3	41275095	3	41233604	633516	621952	rs1559474311	NC_000003.12:41233603:G:
NM_001904.4(CTNNB1):c.2112dup (p.Glu705fs)	CTNNB1		not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000633501	3	41279541 - 41279542	3	41238050 - 41238051	633501	621953	rs1559478415	NC_000003.12:41238050:A:AA
NM_001904.4(CTNNB1):c.1588C>T (p.Gln530Ter)	CTNNB1	Q530*, Q523*	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000598768	3	41275693	3	41234202	598768	589831	rs1559474966	NC_000003.12:41234201:C:T
NM_001904.4(CTNNB1):c.1297A>T (p.Lys433Ter)	CTNNB1	K433*, K426*	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000560707	3	41275131	3	41233640	560707	551769	rs1559474364	NC_000003.12:41233639:A:T
NM_001904.4(CTNNB1):c.865_867delinsCC (p.Thr289fs)	CTNNB1		Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000559642	3	41267281 - 41267283	3	41225790 - 41225792	559642	550355	rs1553630507	NC_000003.12:41225789:ACA:CC
NM_001904.4(CTNNB1):c.1420C>T (p.Arg474Ter)	CTNNB1	R474*, R467*	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Mar 7, 2018)	no assertion criteria provided	VCV000559636	3	41275254	3	41233763	559636	550356	rs1553631860	NC_000003.12:41233762:C:T
NM_001904.4(CTNNB1):c.427_470dup (p.Leu159_Leu160insMetMetGlnAsnLeuProHisValGlnSerLeuAsnTerLys)	CTNNB1		Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000434868	3	41266629 - 41266630	3	41225138 - 41225139	434868	428176	rs1553630304	NC_000003.12:41225138:CAAGATGATGCAGAACTTGCCACACGTGCAATCCCTGAACTGAC:CAAGATGATGCAGAACTTGCCACACGTGCAATCCCTGAACTGACCAAGATGATGCAGAACTTGCCACACGTGCAATCCCTGAACTGAC
NM_001904.4(CTNNB1):c.1672C>T (p.Gln558Ter)	CTNNB1	Q558*, Q551*	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Mar 18, 2019)	no assertion criteria provided	VCV000430707	3	41275777	3	41234286	430707	424246	rs1131692181	NC_000003.12:41234285:C:T
NM_001904.4(CTNNB1):c.705dup (p.Gly236fs)	CTNNB1		Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000133315	3	41267033 - 41267034	3	41225542 - 41225543	133315	137052	rs587777412	NC_000003.12:41225542:A:AA
NM_001904.4(CTNNB1):c.925C>T (p.Gln309Ter)	CTNNB1	Q309*, Q302*	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039656	3	41267341	3	41225850	39656	48255	rs376393123	NC_000003.12:41225849:C:T
NM_001904.4(CTNNB1):c.1268_1271TTCT[1] (p.Ser425fs)	CTNNB1		Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039654	3	41275102 - 41275105	3	41233611 - 41233614	39654	48253	rs398122907	NC_000003.12:41233610:TTCTTTCT:TTCT
NM_001904.4(CTNNB1):c.1768dup (p.Ile590fs)	CTNNB1		Intellectual disability	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000691265	3	41277298 - 41277299	3	41235807 - 41235808	691265	678937		NC_000003.12:41235807:A:AA
NM_000344.3(SMN1):c.510_511del (p.Ser170fs)	SMN1	S170fs	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000634941	5	70238579 - 70238580	5	70942752 - 70942753	634941	622777	rs1561499720	NC_000005.10:70942751:GTG:G
NM_001904.4(CTNNB1):c.495+1G>C	CTNNB1		Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560987	3	41266699	3	41225208	560987	552074	rs1559468403	NC_000003.12:41225207:G:C
NM_001904.4(CTNNB1):c.998dup (p.Tyr333Ter)	CTNNB1		Mental retardation, autosomal dominant 19|not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000279956	3	41268759 - 41268760	3	41227268 - 41227269	279956	264142	rs886041281	NC_000003.12:41227268:A:AA
NM_001904.4(CTNNB1):c.268C>T (p.Arg90Ter)	CTNNB1	R90*, R83*	not provided|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253000	3	41266471	3	41224980	253000	247398	rs1369821061	NC_000003.12:41224979:C:T
NM_000344.3(SMN1):c.724-2A>G	SMN1		Kugelberg-Welander disease	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000634942	5	70241891	5	70946064	634942	622789	rs1561500842	NC_000005.10:70946063:A:G
NM_001904.4(CTNNB1):c.1494dup (p.His499fs)	CTNNB1		not provided|Hepatocellular carcinoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000499655	3	41275327 - 41275328	3	41233836 - 41233837	499655	491079	rs1553631896	NC_000003.12:41233836:A:AA
NM_000344.3(SMN1):c.93_96dup (p.Ile33Ter)	SMN1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448433	5	70234675 - 70234676	5	70938848 - 70938849	448433	440894	rs1554081950	NC_000005.10:70938848:CTGAC:CTGACTGAC
SMN1, DEL	SMN1		Kugelberg-Welander disease	Pathogenic(Last reviewed: Feb 21, 2012)	no assertion criteria provided	VCV000039514					39514	48113		
NM_000344.3(SMN1):c.388T>C (p.Tyr130His)	SMN1	Y130H	Kugelberg-Welander disease	Pathogenic(Last reviewed: Feb 21, 2012)	no assertion criteria provided	VCV000039513	5	70238299	5	70942472	39513	48112	rs397514518	NC_000005.10:70942471:T:C
NM_000344.3(SMN1):c.389A>G (p.Tyr130Cys)	SMN1	Y130C	Kugelberg-Welander disease	Pathogenic(Last reviewed: Feb 21, 2012)	no assertion criteria provided	VCV000039512	5	70238300	5	70942473	39512	48111	rs397514517	NC_000005.10:70942472:A:G
NM_000344.3(SMN1):c.784A>G (p.Ser262Gly)	SMN1	S262G, S230G	Kugelberg-Welander disease	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000009178	5	70241953	5	70946126	9178	24217	rs104893932	NC_000005.10:70946125:A:G
NM_000344.3(SMN1):c.131A>T (p.Asp44Val)	SMN1	D44V	Kugelberg-Welander disease	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000009172	5	70234715	5	70938888	9172	24211	rs104893931	NC_000005.10:70938887:A:T
SMN1, IVS7DS, T-G, +6	SMN1		Kugelberg-Welander disease	Pathogenic(Last reviewed: May 25, 1999)	no assertion criteria provided	VCV000009170					9170	24209		
NM_020191.3(MRPS22):c.489T>G (p.Tyr163Ter)	MRPS22	Y163*, Y122*, Y162*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000521613	3	139067151	3	139348309	521613	511461	rs201337850	NC_000003.12:139348308:T:G
NM_000344.3(SMN1):c.469C>T (p.Gln157Ter)	SMN1	Q157*	not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000805485	5	70238380	5	70942553	805485	793092		NC_000005.10:70942552:C:T
NM_000344.3(SMN1):c.835-1G>A	SMN1		Spinal muscular atrophy	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000632989	5	70247767	5	70951940	632989	621745	rs1217001154	NC_000005.10:70951939:G:A
NM_001904.4(CTNNB1):c.1981C>T (p.Arg661Ter)	CTNNB1	R661*, R654*	Mental retardation, autosomal dominant 19|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429824	3	41278105	3	41236614	429824	421442	rs748294403	NC_000003.12:41236613:C:T
NM_001904.4(CTNNB1):c.2142_2157dup (p.His720Ter)	CTNNB1		Exudative vitreoretinopathy 1|EXUDATIVE VITREORETINOPATHY 7	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000225172	3	41280628 - 41280629	3	41239137 - 41239138	225172	227080	rs1057519380	NC_000003.12:41239137:TAGCTATCGTTCTTTT:TAGCTATCGTTCTTTTTAGCTATCGTTCTTTT
NM_001904.4(CTNNB1):c.2128C>T (p.Arg710Cys)	CTNNB1	R710C, R703C	Exudative vitreoretinopathy 1|EXUDATIVE VITREORETINOPATHY 7	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000225171	3	41279558	3	41238067	225171	227079	rs748653573	NC_000003.12:41238066:C:T
NM_001904.4(CTNNB1):c.1434_1435insC (p.Glu479fs)	CTNNB1		Exudative vitreoretinopathy 1|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Mar 18, 2019)	no assertion criteria provided	VCV000225170	3	41275268 - 41275269	3	41233777 - 41233778	225170	227078	rs1057519379	NC_000003.12:41233777::C
NM_000344.3(SMN1):c.88G>A (p.Asp30Asn)	SMN1	D30N	Spinal muscular atrophy, type II	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000009175	5	70234672	5	70938845	9175	24214	rs104893930	NC_000005.10:70938844:G:A
NM_183357.2(ADCY5):c.1425C>G (p.Ile475Met)	ADCY5	I475M, I125M	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 13, 2013)	criteria provided, single submitter	VCV000208670	3	123051504	3	123332657	208670	205239	rs757156390	NC_000003.12:123332656:G:C
NM_000901.5(NR3C2):c.1609C>T (p.Arg537Ter)	NR3C2	R537*	|Autism spectrum disorder	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000008555	4	149356404	4	148435252	8555	23594	rs121912562	NC_000004.12:148435251:G:A
NC_000005.10:g.70936291_70945268del	SMN1		Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000692109					692109	679853		
NM_000344.3(SMN1):c.48_55dup (p.Val19fs)	SMN1		Spinal muscular atrophy, type II	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000634931	5	70220977 - 70220978	5	70925150 - 70925151	634931	622772	rs1561498701	NC_000005.10:70925150:GGATTCCG:GGATTCCGGGATTCCG
NM_001904.4(CTNNB1):c.1543C>T (p.Arg515Ter)	CTNNB1	R515*, R508*	not provided|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000039655	3	41275648	3	41234157	39655	48254	rs397514554	NC_000003.12:41234156:C:T
NM_000344.3(SMN1):c.406C>G (p.Gln136Glu)	SMN1	Q136E	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Jul 13, 2004)	no assertion criteria provided	VCV000009180	5	70238317	5	70942490	9180	24219	rs104893934	NC_000005.10:70942489:C:G
SMN1, 5-BP DEL, 425	SMN1		Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000009171					9171	24210		
SMN1, 11-BP DUP, 801-811	SMN1		Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000009163					9163	24202		
NM_004637.5(RAB7A):c.484G>A (p.Val162Met)	RAB7A	V162M	Charcot-Marie-Tooth disease|not provided|	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000007346	3	128526470	3	128807627	7346	22385	rs121909079	NC_000003.12:128807626:G:A
NM_023067.4(FOXL2):c.462_468del (p.Pro156fs)	FOXL2	P156fs	Premature ovarian failure 3	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000522614	3	138665097 - 138665103	3	138946255 - 138946261	522614	513226	rs1553752894	NC_000003.12:138946254:CGGCGGCCGG:CGG
NM_023067.4(FOXL2):c.988dup (p.Ala330fs)	FOXL2		Premature ovarian failure 3	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000503493	3	138664576 - 138664577	3	138945734 - 138945735	503493	494916	rs1553752779	NC_000003.12:138945734:C:CC
NM_023067.4(FOXL2):c.490A>T (p.Lys164Ter)	FOXL2	K164*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic	no assertion criteria provided	VCV000397612	3	138665075	3	138946233	397612	384478	rs1060499717	NC_000003.12:138946232:T:A
NM_023067.4(FOXL2):c.102dup (p.Gly35fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000375303	3	138665462 - 138665463	3	138946620 - 138946621	375303	362075	rs1553752945	NC_000003.12:138946620:T:TT
NM_023067.4(FOXL2):c.1011del (p.Thr338fs)	FOXL2	T338fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369938	3	138664554	3	138945712	369938	354103	rs1057516185	NC_000003.12:138945711:GGG:GG
NM_023067.4(FOXL2):c.982del (p.Ala328fs)	FOXL2	A328fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369937	3	138664583	3	138945741	369937	354104	rs1057516184	NC_000003.12:138945740:C:
NM_023067.4(FOXL2):c.951_961dup (p.Gln321fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369936	3	138664603 - 138664604	3	138945761 - 138945762	369936	354105	rs1057516183	NC_000003.12:138945761:GGCCCGGCGGCGGC:GGCCCGGCGGCGGCCCGGCGGCGGC
NM_023067.4(FOXL2):c.907_926dup (p.His312fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369935	3	138664638 - 138664639	3	138945796 - 138945797	369935	354106	rs1057516182	NC_000003.12:138945796:GGGGCAGGCGGCGGTGCGGCGG:GGGGCAGGCGGCGGTGCGGCGGGGCAGGCGGCGGTGCGGCGG
NM_023067.4(FOXL2):c.892dup (p.His298fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369934	3	138664672 - 138664673	3	138945830 - 138945831	369934	354107	rs1057516181	NC_000003.12:138945830:GG:GGG
NM_023067.4(FOXL2):c.856_857delinsA (p.Pro286fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369933	3	138664708 - 138664709	3	138945866 - 138945867	369933	354109	rs1057516180	NC_000003.12:138945865:GG:T
NM_023067.4(FOXL2):c.840_871del (p.Ala283fs)	FOXL2	A283fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369932	3	138664694 - 138664725	3	138945852 - 138945883	369932	354108	rs1057516179	NC_000003.12:138945851:GGGGGTGCGGCGGAGGCGGGGGTGCGGCCGGCGGG:GGG
NM_023067.4(FOXL2):c.827dup (p.Leu277fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369931	3	138664737 - 138664738	3	138945895 - 138945896	369931	354110	rs1057516178	NC_000003.12:138945895:CC:CCC
NM_023067.4(FOXL2):c.777dup (p.Arg260fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369928	3	138664787 - 138664788	3	138945945 - 138945946	369928	354113	rs1057516176	NC_000003.12:138945945:T:TT
NM_023067.4(FOXL2):c.748_749del (p.Gly250fs)	FOXL2	G250fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369927	3	138664816 - 138664817	3	138945974 - 138945975	369927	354114	rs1057516175	NC_000003.12:138945973:CCC:C
NM_023067.4(FOXL2):c.678_705del (p.Ala227fs)	FOXL2	A227fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369926	3	138664860 - 138664887	3	138946018 - 138946045	369926	354115	rs1057516174	NC_000003.12:138946017:GCCCGCGGCTGCAGCCGCAGCTGCTGCAGCC:GCC
NM_023067.4(FOXL2):c.674_703dup (p.Ala225_Ala234dup)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369925	3	138664861 - 138664862	3	138946019 - 138946020	369925	354116	rs1057516173	NC_000003.12:138946019:CCGCGGCTGCAGCCGCAGCTGCTGCAGCCGC:CCGCGGCTGCAGCCGCAGCTGCTGCAGCCGCCGCGGCTGCAGCCGCAGCTGCTGCAGCCGC
NM_023067.4(FOXL2):c.674_695del (p.Ala225fs)	FOXL2	A225fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369924	3	138664870 - 138664891	3	138946028 - 138946049	369924	354117	rs1057516172	NC_000003.12:138946027:GCAGCCGCAGCTGCTGCAGCCG:
NM_023067.4(FOXL2):c.662_689del (p.Ala221fs)	FOXL2	A221fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369922	3	138664876 - 138664903	3	138946034 - 138946061	369922	354119	rs1057516170	NC_000003.12:138946033:GCAGCTGCTGCAGCCGCTGCGGCTGCCG:
NM_023067.4(FOXL2):c.632C>A (p.Ser211Ter)	FOXL2	S211*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369918	3	138664933	3	138946091	369918	354124	rs1057516167	NC_000003.12:138946090:G:T
NM_023067.4(FOXL2):c.630_651dup (p.Cys218fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369917	3	138664913 - 138664914	3	138946071 - 138946072	369917	354121	rs1057516166	NC_000003.12:138946071:GGAGGCATAGGGCATGGGTGAGGGAGGC:GGAGGCATAGGGCATGGGTGAGGGAGGCATAGGGCATGGGTGAGGGAGGC
NM_023067.4(FOXL2):c.618del (p.Pro207fs)	FOXL2	P207fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369916	3	138664947	3	138946105	369916	354125	rs1057516165	NC_000003.12:138946104:T:
NM_023067.4(FOXL2):c.612G>A (p.Trp204Ter)	FOXL2	W204*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369915	3	138664953	3	138946111	369915	354126	rs1057516164	NC_000003.12:138946110:C:T
NM_023067.4(FOXL2):c.582C>G (p.Tyr194Ter)	FOXL2	Y194*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369914	3	138664983	3	138946141	369914	354127	rs1057516163	NC_000003.12:138946140:G:C
NM_023067.4(FOXL2):c.576dup (p.Lys193fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369912	3	138664988 - 138664989	3	138946146 - 138946147	369912	354129	rs1057516161	NC_000003.12:138946146:GGGGGG:GGGGGGG
NM_023067.4(FOXL2):c.353_476dup (p.His159fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369909	3	138665088 - 138665089	3	138946246 - 138946247	369909	354130	rs1553752890	
NM_023067.4(FOXL2):c.338del (p.Ile113fs)	FOXL2	I113fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369907	3	138665227	3	138946385	369907	354134	rs1057516158	NC_000003.12:138946384:A:
NM_023067.4(FOXL2):c.293G>A (p.Trp98Ter)	FOXL2	W98*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369898	3	138665272	3	138946430	369898	354143	rs1057516150	NC_000003.12:138946429:C:T
NM_023067.4(FOXL2):c.205G>T (p.Glu69Ter)	FOXL2	E69*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369893	3	138665360	3	138946518	369893	354148	rs387906920	NC_000003.12:138946517:C:A
NM_023067.4(FOXL2):c.173C>A (p.Ser58Ter)	FOXL2	S58*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369889	3	138665392	3	138946550	369889	354152	rs1057516142	NC_000003.12:138946549:G:T
NM_023067.4(FOXL2):c.171C>G (p.Tyr57Ter)	FOXL2	Y57*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369888	3	138665394	3	138946552	369888	354153	rs1057516141	NC_000003.12:138946551:G:C
NM_023067.4(FOXL2):c.43del (p.Leu15fs)	FOXL2	L15fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369887	3	138665522	3	138946680	369887	354154	rs1057516140	NC_000003.12:138946679:GGG:GG
NM_023067.4(FOXL2):c.15C>A (p.Tyr5Ter)	FOXL2	Y5*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369886	3	138665550	3	138946708	369886	354155	rs1057516139	NC_000003.12:138946707:G:T
NM_023067.4(FOXL2):c.843_865dup (p.His289fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000180599	3	138664699 - 138664700	3	138945857 - 138945858	180599	178772	rs797044530	NC_000003.12:138945857:GCGGCGGAGGCGGGGGTGCGGCCG:GCGGCGGAGGCGGGGGTGCGGCCGCGGCGGAGGCGGGGGTGCGGCCG
NM_023067.3(FOXL2):c.661GCN[15_24] (p.Ala221[(15_24)])	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000180596					180596	178778		
NM_023067.4(FOXL2):c.142_173delinsGCGCT (p.Lys48_Ser58delinsAlaLeu)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Mar 17, 2009)	no assertion criteria provided	VCV000162043	3	138665392 - 138665423	3	138946550 - 138946581	162043	171759	rs672601357	NC_000003.12:138946549:GAGTACGGGGGCTTCTGCGCCGGGTCCGGCTT:AGCGC
GRCh38/hg38 3q22.3(chr3:138945182-138946841)x1	FOXL2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057833	3	138664024 - 138665683	3	138945182 - 138946841	57833	72428		
FOXL2, 15-BP DUP, NT684	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000004870					4870	19909		
FOXL2, 30-BP DEL, NT898	FOXL2		Premature ovarian failure 3	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000004868					4868	19907		
NM_023067.4(FOXL2):c.959dup (p.Gln321fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000004867	3	138664605 - 138664606	3	138945763 - 138945764	4867	19906	rs863225453	NC_000003.12:138945763:CCC:CCCC
NM_023067.4(FOXL2):c.251T>G (p.Ile84Ser)	FOXL2	I84S	Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000004863	3	138665314	3	138946472	4863	19902	rs28937884	NC_000003.12:138946471:A:C
NM_023067.3(FOXL2):c.684684AGCTGCGGCTGCAGC[3] (p.Ala234_Gly235insAlaAlaAlaAlaAlaAlaAlaAlaAlaAla)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000004862	3	138664867	3	138946024 - 138946025	4862	19901	rs387906322	NC_000003.12:138946024:GCTGCAGCCGCAGCTGCTGCAGCCGC:GCTGCAGCCGCAGCTGCTGCAGCCGCAGCTGCTGCAGCCGCAGCTGCTGCAGCCGC
NM_023067.4(FOXL2):c.912_919dup (p.Pro307fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	VCV000004856	3	138664645 - 138664646	3	138945803 - 138945804	4856	19895	rs863225451	NC_000003.12:138945803:GCGGCGGTGCGGCGG:GCGGCGGTGCGGCGGTGCGGCGG
NM_023067.4(FOXL2):c.53_54del (p.Pro18fs)	FOXL2	P18fs	Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	VCV000004855	3	138665511 - 138665512	3	138946669 - 138946670	4855	19894	rs863225450	NC_000003.12:138946668:TG:
NM_023067.4(FOXL2):c.937_944dup (p.Ala316fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000634986	3	138664620 - 138664621	3	138945778 - 138945779	634986	622795	rs1559921849	NC_000003.12:138945778:GCGGCCCCG:GCGGCCCCGCGGCCCCG
NM_023067.4(FOXL2):c.901_911dup (p.Pro305fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000634985	3	138664653 - 138664654	3	138945811 - 138945812	634985	622796	rs1559921874	NC_000003.12:138945811:GCGGCGGCCGCG:GCGGCGGCCGCGCGGCGGCCGCG
NM_023067.4(FOXL2):c.935_997delinsGGCGGCGGCG (p.His312fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000634984	3	138664568 - 138664630	3	138945726 - 138945788	634984	622793	rs1559921800	
NM_023067.4(FOXL2):c.841_842insT (p.Pro281fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000634983	3	138664723 - 138664724	3	138945881 - 138945882	634983	622797	rs1559921944	NC_000003.12:138945881::A
NM_023067.4(FOXL2):c.818C>A (p.Ser273Ter)	FOXL2	S273*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000634982	3	138664747	3	138945905	634982	622798	rs1559921973	NC_000003.12:138945904:G:T
NM_023067.4(FOXL2):c.784C>T (p.Gln262Ter)	FOXL2	Q262*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000634981	3	138664781	3	138945939	634981	622799	rs1559922013	NC_000003.12:138945938:G:A
NM_023067.4(FOXL2):c.773del (p.Tyr258fs)	FOXL2	Y258fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000634980	3	138664792	3	138945950	634980	622800	rs1559922026	NC_000003.12:138945949:T:
NM_023067.4(FOXL2):c.675_769dup (p.Pro257fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000634978	3	138664795 - 138664796	3	138945953 - 138945954	634978	622801	rs1559922033	
NM_023067.4(FOXL2):c.669_681del (p.Ala224fs)	FOXL2	A224fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000634977	3	138664884 - 138664896	3	138946042 - 138946054	634977	622803	rs1559922136	NC_000003.12:138946041:TGCAGCCGCTGCG:
NM_023067.4(FOXL2):c.551dup (p.Asp184fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000634976	3	138665013 - 138665014	3	138946171 - 138946172	634976	622804	rs1559922257	NC_000003.12:138946171:T:TT
NM_023067.4(FOXL2):c.549dup (p.Asp184fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000634975	3	138665015 - 138665016	3	138946173 - 138946174	634975	622805	rs1559922261	NC_000003.12:138946173:GG:GGG
NM_023067.4(FOXL2):c.525del (p.Cys176fs)	FOXL2	C176fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000634974	3	138665040	3	138946198	634974	622806	rs1559922308	NC_000003.12:138946197:CCC:CC
NM_023067.4(FOXL2):c.445_469dup (p.Pro157fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000634973	3	138665095 - 138665096	3	138946253 - 138946254	634973	622807	rs1559922381	NC_000003.12:138946253:GCGGCGGCCGGAAGGGCCTCTTCATGCGGCGGC:GCGGCGGCCGGAAGGGCCTCTTCATGCGGCGGCCGGAAGGGCCTCTTCATGCGGCGGC
NM_023067.4(FOXL2):c.399del (p.Cys134fs)	FOXL2	C134fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000634972	3	138665166	3	138946324	634972	622808	rs1559922462	NC_000003.12:138946323:GG:G
NM_023067.4(FOXL2):c.387del (p.Leu130fs)	FOXL2	L130fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000634971	3	138665178	3	138946336	634971	622809	rs1559922470	NC_000003.12:138946335:C:
NM_023067.4(FOXL2):c.384G>A (p.Trp128Ter)	FOXL2	W128*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000634970	3	138665181	3	138946339	634970	622810	rs1559922472	NC_000003.12:138946338:C:T
NM_023067.4(FOXL2):c.384del (p.Tyr127_Trp128insTer)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000634969	3	138665181	3	138946339	634969	622811	rs1559922473	NC_000003.12:138946338:CC:C
NM_023067.4(FOXL2):c.377_380dup (p.Tyr127Ter)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000634968	3	138665184 - 138665185	3	138946342 - 138946343	634968	622812	rs1559922476	NC_000003.12:138946342:TAGTT:TAGTTAGTT
NM_023067.4(FOXL2):c.52_53del (p.Pro18fs)	FOXL2	P18fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000634967	3	138665512 - 138665513	3	138946670 - 138946671	634967	622826	rs1559922782	NC_000003.12:138946669:GGGG:GG
NM_023067.4(FOXL2):c.18del (p.Glu7fs)	FOXL2	E7fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000634966	3	138665547	3	138946705	634966	622827	rs1559922829	NC_000003.12:138946704:GGGG:GGG
NM_023067.4(FOXL2):c.1103del (p.Gly368fs)	FOXL2	G368fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000634965	3	138664462	3	138945620	634965	622791	rs1559921677	NC_000003.12:138945619:CC:C
NM_023067.4(FOXL2):c.998dup (p.Ala334fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000634964	3	138664566 - 138664567	3	138945724 - 138945725	634964	622792	rs1559921797	NC_000003.12:138945724:GGGGG:GGGGGG
NM_023067.4(FOXL2):c.174_186del (p.Tyr59fs)	FOXL2	Y59fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000634955	3	138665379 - 138665391	3	138946537 - 138946549	634955	622820	rs1559922628	NC_000003.12:138946536:GAGCGCCACGTACGAG:GAG
NM_023067.4(FOXL2):c.160A>G (p.Lys54Glu)	FOXL2	K54E	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000634952	3	138665405	3	138946563	634952	622824	rs1559922657	NC_000003.12:138946562:T:C
NM_023067.4(FOXL2):c.55G>T (p.Glu19Ter)	FOXL2	E19*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000634951	3	138665510	3	138946668	634951	622825	rs759236439	NC_000003.12:138946667:C:A
NM_023067.4(FOXL2):c.700_701insAGCGGCTGCAGCAGCTGCGGCTGCAGCCGC (p.Ala234delinsGluArgLeuGlnGlnLeuArgLeuGlnProPro)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000559900	3	138664864 - 138664865	3	138946022 - 138946023	559900	550591	rs1553752849	NC_000003.12:138946022::GCGGCTGCAGCCGCAGCTGCTGCAGCCGCT
NM_023067.4(FOXL2):c.854del (p.Pro285fs)	FOXL2	P285fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000180600	3	138664711	3	138945869	180600	178774	rs797044531	NC_000003.12:138945868:GGGGG:GGGG
NM_023067.4(FOXL2):c.841_857dup (p.Pro287fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000180598	3	138664707 - 138664708	3	138945865 - 138945866	180598	178773	rs797044529	NC_000003.12:138945865:GGCGGGGGTGCGGCCGG:GGCGGGGGTGCGGCCGGGGCGGGGGTGCGGCCGG
NM_023067.4(FOXL2):c.205G>A (p.Glu69Lys)	FOXL2	E69K	Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030507	3	138665360	3	138946518	30507	39464	rs387906920	NC_000003.12:138946517:C:T
NM_023067.4(FOXL2):c.586C>T (p.Gln196Ter)	FOXL2	Q196*	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004865	3	138664979	3	138946137	4865	19904	rs104893739	NC_000003.12:138946136:G:A
NM_023067.4(FOXL2):c.295C>T (p.Gln99Ter)	FOXL2	Q99*	Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000004864	3	138665270	3	138946428	4864	19903	rs121908358	NC_000003.12:138946427:G:A
NM_052995.2(CLRN1):c.274dup (p.Ile92fs)	CLRN1		not provided|Usher syndrome, type 3A|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188875	3	150645919 - 150645920	3	150928132 - 150928133	188875	186675	rs746523071	NC_000003.12:150928132:TTTTTT:TTTTTTT
NM_023067.4(FOXL2):c.940_947GCCGCCGC[1] (p.Pro317fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000634987	3	138664610 - 138664617	3	138945768 - 138945775	634987	622794		NC_000003.12:138945767:GCGGCGGCGCGGCGGC:GCGGCGGC
NM_023067.4(FOXL2):c.804del (p.Gly269fs)	FOXL2	G269fs	Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000369930	3	138664761	3	138945919	369930	354111	rs797044528	NC_000003.12:138945918:GGGGGG:GGGGG
NM_023067.4(FOXL2):c.663_692dup (p.Ala225_Ala234dup)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000369923	3	138664872 - 138664873	3	138946030 - 138946031	369923	354118	rs764243782	NC_000003.12:138946030:GCCGCAGCTGCTGCAGCCGCTGCGGCTGCCGCC:GCCGCAGCTGCTGCAGCCGCTGCGGCTGCCGCCGCAGCTGCTGCAGCCGCTGCGGCTGCCGCC
NM_023067.4(FOXL2):c.644A>G (p.Tyr215Cys)	FOXL2	Y215C	not provided|Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000369919	3	138664921	3	138946079	369919	354123	rs1057516168	NC_000003.12:138946078:T:C
NM_023067.4(FOXL2):c.965_983dup (p.Thr329fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162044	3	138664581 - 138664582	3	138945739 - 138945740	162044	171757	rs672601358	NC_000003.12:138945739:GCTGGGCTGGCAGGGCTGAGCTGG:GCTGGGCTGGCAGGGCTGAGCTGGGCTGGCAGGGCTGAGCTGG
NM_023067.4(FOXL2):c.822C>G (p.Tyr274Ter)	FOXL2	Y274*	Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000004861	3	138664743	3	138945901	4861	19900	rs104893738	NC_000003.12:138945900:G:C
NM_023067.4(FOXL2):c.157C>T (p.Gln53Ter)	FOXL2	Q53*	Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1|not provided	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000004860	3	138665408	3	138946566	4860	19899	rs104893737	NC_000003.12:138946565:G:A
NM_052985.4(IFT122):c.1301-1G>C	IFT122		not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000593588	3	129196858	3	129478015	593588	584652	rs755005244	NC_000003.12:129478014:G:C
NM_052985.4(IFT122):c.183T>G (p.Tyr61Ter)	IFT122	Y61*	not provided	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000419260	3	129170831	3	129451988	419260	406112	rs373836204	NC_000003.12:129451987:T:G
NM_052985.4(IFT122):c.2188del (p.Ser730fs)	IFT122	S529fs, S620fs, S679fs, S730fs, S568fs, S671fs, S470fs	not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000281344	3	129211026	3	129492183	281344	265581	rs886042132	NC_000003.12:129492182:A:
NM_052985.4(IFT122):c.2464_2465del (p.Tyr822fs)	IFT122	Y712fs, Y822fs, Y562fs, Y763fs, Y621fs, Y660fs, Y771fs	not provided	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000280161	3	129218847 - 129218848	3	129500004 - 129500005	280161	264115	rs886041421	NC_000003.12:129500003:TA:
NM_004174.4(SLC9A3):c.782dup (p.Thr262fs)	SLC9A3		Diarrhea 8, secretory sodium, congenital	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000224600	5	484784 - 484785	5	484669 - 484670	224600	226378	rs869320759	NC_000005.10:484669:CCCCCC:CCCCCCC
NM_004174.4(SLC9A3):c.805G>A (p.Ala269Thr)	SLC9A3	A269T	Diarrhea 8, secretory sodium, congenital	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000224599	5	484762	5	484647	224599	226377	rs869312807	NC_000005.10:484646:C:T
NM_004174.4(SLC9A3):c.1145G>A (p.Arg382Gln)	SLC9A3	R382Q	Diarrhea 8, secretory sodium, congenital	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000224597	5	483385	5	483270	224597	226375	rs766076524	NC_000005.10:483269:C:T
NM_004174.4(SLC9A3):c.341_343TCT[3] (p.Phe117del)	SLC9A3	F117del	Diarrhea 8, secretory sodium, congenital	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000224596	5	492046 - 492048	5	491931 - 491933	224596	226374	rs776026092	NC_000005.10:491930:AGAAGAAGAAGA:AGAAGAAGA
NM_004174.4(SLC9A3):c.932C>T (p.Ala311Val)	SLC9A3	A311V	Diarrhea 8, secretory sodium, congenital	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000224595	5	484635	5	484520	224595	226373	rs869312806	NC_000005.10:484519:G:A
NM_018834.6(MATR3):c.460C>T (p.Pro154Ser)	MATR3	P154S	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126563	5	138643564	5	139307875	126563	132073	rs587777302	NC_000005.10:139307874:C:T
NM_018834.6(MATR3):c.1864A>G (p.Thr622Ala)	MATR3	T622A, T284A, T334A	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126562	5	138658372	5	139322683	126562	132072	rs587777301	NC_000005.10:139322682:A:G
NM_018834.6(MATR3):c.344T>G (p.Phe115Cys)	MATR3	F115C	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126561	5	138643448	5	139307759	126561	132071	rs587777300	NC_000005.10:139307758:T:G
NM_052989.3(IFT122):c.955del (p.Glu319fs)	IFT122	E169fs, E208fs, E311fs, E260fs, E370fs, E110fs, E319fs	Cranioectodermal dysplasia 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065740	3	129195293	3	129476450	65740	76648	rs397515567	NC_000003.12:129476449:GGGG:GGG
NM_001904.4(CTNNB1):c.337C>T (p.Gln113Ter)	CTNNB1	Q113*, Q106*	Mental retardation, autosomal dominant 19|not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451713	3	41266540	3	41225049	451713	443452	rs1553630279	NC_000003.12:41225048:C:T
NM_000344.3(SMN1):c.683T>A (p.Leu228Ter)	SMN1	L228*	not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000448429	5	70240540	5	70944713	448429	440897	rs79784540	NC_000005.10:70944712:T:A
NM_000344.3(SMN1):c.346A>T (p.Ile116Phe)	SMN1	I116F	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Feb 15, 2013)	no assertion criteria provided	VCV000009179	5	70238257	5	70942430	9179	24218	rs104893933	NC_000005.10:70942429:A:T
NM_000344.3(SMN1):c.283G>C (p.Gly95Arg)	SMN1	G95R	Kugelberg-Welander disease|not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000009176	5	70238194	5	70942367	9176	24215	rs104893927	NC_000005.10:70942366:G:C
SMN1, EX8DEL	SMN1		Kugelberg-Welander disease|Spinal muscular atrophy, type II	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009169					9169	24208		
NM_001297715.1(SMN1):c.835-497G>T	SMN1	G279V, G247V	Werdnig-Hoffmann disease	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000009167	5	70247769	5	70951942	9167	24206	rs76163360	NC_000005.10:70951941:G:T
NM_052989.3(IFT122):c.21G>C (p.Trp7Cys)	IFT122	W7C	Cranioectodermal dysplasia 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000004638	3	129159194	3	129440351	4638	19677	rs267607193	NC_000003.12:129440350:G:C
NM_052989.3(IFT122):c.349+5G>A	IFT122		Cranioectodermal dysplasia 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000004637	3	129180152	3	129461309	4637	19676	rs376595844	NC_000003.12:129461308:G:A
NM_052989.3(IFT122):c.1505T>G (p.Val502Gly)	IFT122	V553G, V391G, V494G, V293G, V352G, V443G, V502G	Cranioectodermal dysplasia 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000004635	3	129200389	3	129481546	4635	19674	rs267607191	NC_000003.12:129481545:T:G
NM_023067.4(FOXL2):c.650C>T (p.Ser217Phe)	FOXL2	S217F	Blepharophimosis, ptosis, and epicanthus inversus|not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000180594	3	138664915	3	138946073	180594	178776	rs797044527	NC_000003.12:138946072:G:A
NM_023067.4(FOXL2):c.560G>A (p.Gly187Asp)	FOXL2	G187D	Blepharophimosis, ptosis, and epicanthus inversus|Premature ovarian failure 3	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000004871	3	138665005	3	138946163	4871	19910	rs121908359	NC_000003.12:138946162:C:T
NM_023067.4(FOXL2):c.178_192dup (p.Val60_Ala64dup)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000004857	3	138665372 - 138665373	3	138946530 - 138946531	4857	19896	rs863225452	NC_000003.12:138946530:GGCGATGAGCGCCACG:GGCGATGAGCGCCACGGCGATGAGCGCCACG
NM_023067.4(FOXL2):c.655C>T (p.Gln219Ter)	FOXL2	Q219*	Blepharophimosis, ptosis, and epicanthus inversus|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000004853	3	138664910	3	138946068	4853	19892	rs104893741	NC_000003.12:138946067:G:A
NM_006261.4(PROP1):c.349T>A (p.Phe117Ile)	PROP1	F117I	Pituitary hormone deficiency, combined 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008096	5	177420042	5	177993041	8096	23135	rs121917840	NC_000005.10:177993040:A:T
NM_152393.4(KLHL40):c.631del (p.Ala211fs)	KLHL40	A211fs	Nemaline myopathy 8	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000658674	3	42727740	3	42686248	658674	631412		NC_000003.12:42686247:GG:G
NM_152393.4(KLHL40):c.818dup (p.Lys275fs)	KLHL40		Nemaline myopathy 8	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000650910	3	42727926 - 42727927	3	42686434 - 42686435	650910	631413		NC_000003.12:42686434:AA:AAA
NM_152393.4(KLHL40):c.1395C>A (p.Tyr465Ter)	KLHL40	Y465*	Nemaline myopathy 8	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000541327	3	42730183	3	42688691	541327	519290	rs139588377	NC_000003.12:42688690:C:A
NM_152393.4(KLHL40):c.1612G>C (p.Ala538Pro)	KLHL40	A538P	Nemaline myopathy 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060515	3	42732355	3	42690863	60515	75102	rs397509421	NC_000003.12:42690862:G:C
NM_152393.4(KLHL40):c.602G>T (p.Trp201Leu)	KLHL40	W201L	Nemaline myopathy 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060514	3	42727712	3	42686220	60514	75101	rs397509420	NC_000003.12:42686219:G:T
NM_152393.4(KLHL40):c.1405G>T (p.Gly469Cys)	KLHL40	G469C	Nemaline myopathy 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060513	3	42730193	3	42688701	60513	75100	rs367579275	NC_000003.12:42688700:G:T
NM_152393.4(KLHL40):c.1582G>A (p.Glu528Lys)	KLHL40	E528K	Nemaline myopathy 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060512	3	42730521	3	42689029	60512	75099	rs397509419	NC_000003.12:42689028:G:A
NM_001135940.2(MYOT):c.-197+410G>T	MYOT	S95I	Myofibrillar myopathy 3	Pathogenic(Last reviewed: Apr 27, 2004)	no assertion criteria provided	VCV000005838	5	137206624	5	137870935	5838	20877	rs121908460	NC_000005.10:137870934:G:T
NM_052989.3(IFT122):c.2375+2T>C	IFT122		Cranioectodermal dysplasia|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000191185	3	129218913	3	129500070	191185	188988	rs786205567	NC_000003.12:129500069:T:C
NM_052989.3(IFT122):c.965C>T (p.Ser322Phe)	IFT122	S373F, S211F, S172F, S314F, S113F, S263F, S322F	Cranioectodermal dysplasia 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000004636	3	129195306	3	129476463	4636	19675	rs267607192	NC_000003.12:129476462:C:T
NM_032806.6(POMGNT2):c.1216G>T (p.Glu406Ter)	POMGNT2	E406*	not provided	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000419374	3	43121708	3	43080216	419374	406305	rs780525490	NC_000003.12:43080215:C:A
NM_032806.6(POMGNT2):c.511G>A (p.Asp171Asn)	POMGNT2	D171N	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000627559	3	43122413	3	43080921	627559	615915		NC_000003.12:43080920:C:T
NM_032806.6(POMGNT2):c.494T>C (p.Met165Thr)	POMGNT2	M165T	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8	Pathogenic(Last reviewed: Oct 1, 2018)	no assertion criteria provided	VCV000565308	3	43122430	3	43080938	565308	556483	rs1559414655	NC_000003.12:43080937:A:G
NM_001128929.3(ROBO2):c.3754G>A (p.Ala1252Thr)	ROBO2	A1236T, A1252T, A1240T, A643T	Vesicoureteral reflux 2	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007104	3	77671529	3	77622378	7104	22143	rs267607015	NC_000003.12:77622377:G:A
NM_001128929.3(ROBO2):c.2882T>C (p.Ile961Thr)	ROBO2	I945T, I961T, I352T, I949T	Vesicoureteral reflux 2	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007103	3	77645881	3	77596730	7103	22142	rs267607014	NC_000003.12:77596729:T:C
NM_032806.6(POMGNT2):c.1000_1003del (p.Leu334fs)	POMGNT2	L334fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000859488	3	43121921 - 43121924	3	43080429 - 43080432	859488	828168		NC_000003.12:43080428:CCAGCC:CC
NM_032806.6(POMGNT2):c.590G>A (p.Trp197Ter)	POMGNT2	W197*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000694624	3	43122334	3	43080842	694624	45819		NC_000003.12:43080841:C:T
NM_032806.6(POMGNT2):c.745C>T (p.Gln249Ter)	POMGNT2	Q249*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8	Pathogenic(Last reviewed: Sep 27, 2015)	criteria provided, single submitter	VCV000436373	3	43122179	3	43080687	436373	428185	rs1553618354	NC_000003.12:43080686:G:A
NM_032806.6(POMGNT2):c.1333C>T (p.Arg445Ter)	POMGNT2	R445*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000037207	3	43121591	3	43080099	37207	45817	rs387907299	NC_000003.12:43080098:G:A
NM_198586.3(NHLRC1):c.76T>A (p.Cys26Ser)	NHLRC1	C26S	Lafora disease|not provided|Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000002586	6	18122762	6	18122531	2586	17625	rs28940575	NC_000006.12:18122530:A:T
NM_023067.4(FOXL2):c.843_859dup (p.Pro287fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162045	3	138664705 - 138664706	3	138945863 - 138945864	162045	171758	rs672601359	NC_000003.12:138945863:GAGGCGGGGGTGCGGCCG:GAGGCGGGGGTGCGGCCGAGGCGGGGGTGCGGCCG
NM_152393.4(KLHL40):c.1498C>T (p.Arg500Cys)	KLHL40	R500C	not provided|Nemaline myopathy 8	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000423767	3	42730437	3	42688945	423767	406303	rs758188096	NC_000003.12:42688944:C:T
NM_032383.5(HPS3):c.1385C>A (p.Ser462Ter)	HPS3	S297*, S462*	not provided	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000857848	3	148871420	3	149153633	857848	827616		NC_000003.12:149153632:C:A
NM_032383.5(HPS3):c.1101C>G (p.Tyr367Ter)	HPS3	Y202*, Y367*	not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000853956	3	148863271	3	149145484	853956	827615		NC_000003.12:149145483:C:G
NM_032383.5(HPS3):c.851_852del (p.Arg284fs)	HPS3	R284fs, R119fs	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000664198	3	148858941 - 148858942	3	149141154 - 149141155	664198	630986		NC_000003.12:149141153:AGA:A
NM_032383.5(HPS3):c.1682_1683del (p.Cys561fs)	HPS3	C396fs, C561fs	not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000662551	3	148875308 - 148875309	3	149157521 - 149157522	662551	630987		NC_000003.12:149157520:TGT:T
NM_032383.5(HPS3):c.1838C>G (p.Ser613Ter)	HPS3	S613*, S448*	not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000660187	3	148876599	3	149158812	660187	630988		NC_000003.12:149158811:C:G
NM_032383.5(HPS3):c.403del (p.Ala135fs)	HPS3	A135fs	not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000653630	3	148857975	3	149140188	653630	630985		NC_000003.12:149140187:GG:G
NM_032383.5(HPS3):c.1861G>T (p.Glu621Ter)	HPS3	E621*, E456*	not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000650918	3	148876622	3	149158835	650918	630989		NC_000003.12:149158834:G:T
NC_000003.12:g.(?_149129724)_(149129940_?)del	HPS3		not provided	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000831930	3	148847511 - 148847727			831930	819335		
NC_000003.11:g.(?_148847501)_(148847737_?)del	HPS3		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000660678	3	148847501 - 148847737	3	149129714 - 149129950	660678	651036		
HPS3, 89-BP INS	HPS3		Hermansky-Pudlak syndrome 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004614					4614	19653		
NM_032383.5(HPS3):c.15C>G (p.Tyr5Ter)	HPS3	Y5*	Hermansky-Pudlak syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627248	3	148847525	3	149129738	627248	615329		NC_000003.12:149129737:C:G
NM_032383.5(HPS3):c.1691+2T>G	HPS3		Hermansky-Pudlak syndrome 3	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004610	3	148875320	3	149157533	4610	19649	rs281865093	NC_000003.12:149157532:T:G
NC_000005.10:g.(?_70951912)_(70951994_?)del	SMN1		Spinal muscular atrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000832287	5	70247739 - 70247821			832287	819603		
NC_000005.9:g.(?_70247758)_(70247828_?)del	SMN1		Spinal muscular atrophy	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000651822	5	70247758 - 70247828	5	70951931 - 70952001	651822	651260		
NC_000005.9:g.(?_70247768)_(70247818_?)del	SMN1		Spinal muscular atrophy	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000583423	5	70247768 - 70247818	5	70951941 - 70951991	583423	564114		
NM_000344.3(SMN1):c.835-21_3+17del	SMN1		Spinal muscular atrophy	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000571461	5	70247747 - 70247838	5	70951920 - 70952011	571461	563203	rs1561503058	
NC_000005.9:g.(?_70247748)_(70247838_?)del	SMN1		Spinal muscular atrophy	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000457356			5	70951921 - 70952011	457356	454067		
Single allele	SMN1		Werdnig-Hoffmann disease|Spinal muscular atrophy, type II|Kugelberg-Welander disease|Adult spinal muscular atrophy	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000431179	5	70241892 - 70242002	5	70946065 - 70946175	431179	424702	rs1554082110	
NM_001904.4(CTNNB1):c.1603C>T (p.Arg535Ter)	CTNNB1	R535*, R528*	not provided|Abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265085	3	41275708	3	41234217	265085	259765	rs886039332	NC_000003.12:41234216:C:T
NM_032383.5(HPS3):c.89_114del (p.Arg30fs)	HPS3	R30fs	not provided|Hermansky-Pudlak syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556558	3	148847595 - 148847620	3	149129808 - 149129833	556558	543092	rs1553750083	NC_000003.12:149129807:GGGCGTGACGCGCTTTTCGTGGCGGCGGGC:GGGC
NM_032383.5(HPS3):c.0_217+692del	HPS3		Hermansky-Pudlak syndrome 3	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004608	3	148844501 - 148848419	3	149126714 - 149130632	4608	19647		
NM_032806.6(POMGNT2):c.758C>T (p.Pro253Leu)	POMGNT2	P253L	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000545449	3	43122166	3	43080674	545449	535700	rs374042455	NC_000003.12:43080673:G:A
NM_032806.6(POMGNT2):c.473G>A (p.Arg158His)	POMGNT2	R158H	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8|Severe hydrocephalus|Neonatal death	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000037208	3	43122451	3	43080959	37208	45818	rs387907300	NC_000003.12:43080958:C:T
NM_001104631.2(PDE4D):c.881T>G (p.Leu294Arg)	PDE4D	L233R, L294R, L184R, L230R, L158R, L164R, L172R, L38R, L223R, L70R	not provided	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	VCV000379784	5	58334726	5	59038899	379784	368208	rs1057520731	NC_000005.10:59038898:A:C
NM_001104631.2(PDE4D):c.2033T>C (p.Ile678Thr)	PDE4D	I678T, I617T, I422T, I454T, I542T, I607T, I387T, I556T, I568T, I614T, I376T, I548T	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000101053	5	58270888	5	58975061	101053	106817	rs587777188	NC_000005.10:58975060:A:G
NM_001104631.2(PDE4D):c.677T>G (p.Phe226Cys)	PDE4D	F226C, F165C, F104C, F162C, F90C, F116C, F155C, F96C	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000101052	5	58489333	5	59193507	101052	106816	rs397514465	NC_000005.10:59193506:A:C
NM_001104631.2(PDE4D):c.911C>T (p.Ala304Val)	PDE4D	A243V, A174V, A194V, A182V, A240V, A304V, A233V, A2V, A48V, A168V, A80V	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040064	5	58334696	5	59038869	40064	48575	rs397515433	NC_000005.10:59038868:G:A
NM_001104631.2(PDE4D):c.682C>G (p.Gln228Glu)	PDE4D	Q228E, Q167E, Q157E, Q98E, Q164E, Q92E, Q106E, Q118E	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030039	5	58489328	5	59193502	30039	38994	rs397514468	NC_000005.10:59193501:G:C
NM_001104631.2(PDE4D):c.1759A>C (p.Thr587Pro)	PDE4D	T587P, T526P, T285P, T457P, T516P, T363P, T451P, T465P, T296P, T331P, T477P, T523P	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030038	5	58272248	5	58976421	30038	38993	rs397514467	NC_000005.10:58976420:T:G
NM_001104631.2(PDE4D):c.568T>G (p.Ser190Ala)	PDE4D	S190A, S129A, S119A, S126A, S60A, S68A, S80A, S54A	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030037	5	58511682	5	59215856	30037	38992	rs397514466	NC_000005.10:59215855:A:C
NM_001104631.2(PDE4D):c.677T>C (p.Phe226Ser)	PDE4D	F226S, F165S, F90S, F116S, F162S, F104S, F155S, F96S	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030036	5	58489333	5	59193507	30036	38991	rs397514465	NC_000005.10:59193506:A:G
NM_001104631.2(PDE4D):c.673C>A (p.Pro225Thr)	PDE4D	P225T, P164T, P154T, P103T, P115T, P161T, P89T, P95T	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030035	5	58489337	5	59193511	30035	38990	rs397514464	NC_000005.10:59193510:G:T
NM_001104631.2(PDE4D):c.2018G>A (p.Gly673Asp)	PDE4D	G673D, G612D, G551D, G563D, G602D, G609D, G417D, G449D, G543D, G371D, G382D, G537D	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030041	5	58270903	5	58975076	30041	38996	rs397514469	NC_000005.10:58975075:C:T
NM_001104631.2(PDE4D):c.1952A>C (p.Glu651Ala)	PDE4D	E590A, E541A, E349A, E360A, E395A, E427A, E515A, E521A, E580A, E529A, E587A, E651A	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030040	5	58271545	5	58975718	30040	38995	rs387906744	NC_000005.10:58975717:T:G
NM_001271723.1(FBXO38):c.616T>C (p.Cys206Arg)	FBXO38	C206R	Distal hereditary motor neuronopathy 2D	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000091854	5	147784271	5	148404708	91854	97331	rs398122838	NC_000005.10:148404707:T:C
NM_182925.5(FLT4):c.1622dup (p.Gln542fs)	FLT4		CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7	Pathogenic(Last reviewed: Feb 18, 2020)	no assertion criteria provided	VCV000812615	5	180049765 - 180049766	5	180622765 - 180622766	812615	800866		NC_000005.10:180622765:CCC:CCCC
NM_182925.5(FLT4):c.3574C>T (p.Gln1192Ter)	FLT4	Q1192*	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7	Pathogenic(Last reviewed: Feb 18, 2020)	no assertion criteria provided	VCV000812614	5	180038443	5	180611443	812614	800865		NC_000005.10:180611442:G:A
FLT4, EX 25-29 DEL	FLT4		CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7	Pathogenic(Last reviewed: Feb 17, 2020)	no assertion criteria provided	VCV000812613					812613	800864		
FLT4, TYR361TER	FLT4	Y361*	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7	Pathogenic(Last reviewed: Feb 17, 2020)	no assertion criteria provided	VCV000812611					812611	800862		
NM_000481.4(AMT):c.478del (p.Val160fs)	AMT	V160fs, V104fs, V116fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801972	3	49457215	3	49419782	801972	790406		NC_000003.12:49419781:CC:C
NM_000481.4(AMT):c.908del (p.Pro303fs)	AMT	P247fs, P303fs, P259fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801971	3	49455376	3	49417943	801971	790405		NC_000003.12:49417942:GGG:GG
NM_139281.2(WDR36):c.1064A>G (p.Asn355Ser)	WDR36	N355S	Glaucoma 1, open angle, G	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000001581	5	110440041	5	111104342	1581	16620	rs118204022	NC_000005.10:111104341:A:G
NM_000481.4(AMT):c.734_735del (p.Thr245fs)	AMT	T201fs, T189fs, T245fs	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000851973	3	49456546 - 49456547	3	49419113 - 49419114	851973	828321		NC_000003.12:49419112:TGT:T
NM_182925.5(FLT4):c.89del (p.Pro30fs)	FLT4	P30fs	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7	Pathogenic(Last reviewed: Feb 18, 2020)	no assertion criteria provided	VCV000812612	5	180058748	5	180631748	812612	800863		NC_000005.10:180631747:GGGGGGG:GGGGGG
NM_000481.3(AMT):c.256C>T (p.Gln86Ter)	AMT	Q86*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000660464	3	49459539	3	49422106	660464	631552		NC_000003.12:49422105:G:A
NM_000481.3(AMT):c.164G>A (p.Trp55Ter)	AMT	W55*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000565538	3	49459631	3	49422198	565538	559040	rs1559530507	NC_000003.12:49422197:C:T
NM_000481.4(AMT):c.870G>A (p.Trp290Ter)	AMT	W290*, W234*, W246*	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	VCV000208562	3	49456411	3	49418978	208562	205141	rs797045082	NC_000003.12:49418977:C:T
NM_182925.5(FLT4):c.2563G>A (p.Ala855Thr)	FLT4	A855T	Hereditary lymphedema type I	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000016269	5	180046749	5	180619749	16269	31308	rs121909657	NC_000005.10:180619748:C:T
NM_182925.5(FLT4):c.3320_3322TCT[1] (p.Phe1108del)	FLT4	F1108del	Hereditary lymphedema type I	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000016268	5	180041074 - 180041076	5	180614074 - 180614076	16268	31307	rs587776833	NC_000005.10:180614073:AGAAGA:AGA
NM_182925.5(FLT4):c.3316G>A (p.Glu1106Lys)	FLT4	E1106K	Hereditary lymphedema type I	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000016267	5	180041083	5	180614083	16267	31306	rs121909656	NC_000005.10:180614082:C:T
NM_182925.5(FLT4):c.3257T>C (p.Ile1086Thr)	FLT4	I1086T	Hereditary lymphedema type I	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016266	5	180041142	5	180614142	16266	31305	rs121909655	NC_000005.10:180614141:A:G
NM_182925.5(FLT4):c.2632G>A (p.Val878Met)	FLT4	V878M	Hereditary lymphedema type I	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016265	5	180046680	5	180619680	16265	31304	rs121909654	NC_000005.10:180619679:C:T
NM_182925.5(FLT4):c.3104A>G (p.His1035Arg)	FLT4	H1035R	Hereditary lymphedema type I	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000016263	5	180043482	5	180616482	16263	31302	rs121909653	NC_000005.10:180616481:T:C
NM_182925.5(FLT4):c.3131T>C (p.Leu1044Pro)	FLT4	L1044P	Hereditary lymphedema type I	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000016261	5	180043455	5	180616455	16261	31300	rs121909651	NC_000005.10:180616454:A:G
NM_182925.5(FLT4):c.3122G>C (p.Arg1041Pro)	FLT4	R1041P	Hereditary lymphedema type I	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000016260	5	180043464	5	180616464	16260	31299	rs121909650	NC_000005.10:180616463:C:G
NM_182925.5(FLT4):c.2569G>A (p.Gly857Arg)	FLT4	G857R	Hereditary lymphedema type I	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000016259	5	180046743	5	180619743	16259	31298	rs267606818	NC_000005.10:180619742:C:T
AMT, 1-BP DEL, 183C	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000011977					11977	27016		
NM_000481.3(AMT):c.806G>A (p.Gly269Asp)	AMT	G269D, G213D, G225D	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000011974	3	49456475	3	49419042	11974	27013	rs121964981	NC_000003.12:49419041:C:T
NM_182925.5(FLT4):c.3341C>T (p.Pro1114Leu)	FLT4	P1114L	Hereditary lymphedema type I	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000016262	5	180040101	5	180613101	16262	31301	rs121909652	NC_000005.10:180613100:G:A
NM_000481.3(AMT):c.125A>G (p.His42Arg)	AMT	H42R	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000011976	3	49459670	3	49422237	11976	27015	rs121964983	NC_000003.12:49422236:T:C
NM_023067.4(FOXL2):c.855_871del (p.Pro287fs)	FOXL2	P287fs	Blepharophimosis, ptosis, and epicanthus inversus|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000004859	3	138664694 - 138664710	3	138945852 - 138945868	4859	19898	rs797044532	NC_000003.12:138945851:GGGGGTGCGGCGGAGGCGGGGGTGCGGC:GGGGGTGCGGC
NM_021971.2(GMPPB):c.1000G>A	GMPPB	D334N, D361N	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Congenital myasthenic syndrome|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000060540	3	49759268	3	49721835	60540	75121	rs397509422	NC_000003.12:49721834:C:T
NM_000481.3(AMT):c.982dup (p.Ala328fs)	AMT		Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000554261	3	49455301 - 49455302	3	49417868 - 49417869	554261	543236	rs1553638266	NC_000003.12:49417868:CCCCC:CCCCCC
NM_000481.3(AMT):c.1033+2T>C	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551739	3	49455249	3	49417816	551739	543254	rs1553638247	NC_000003.12:49417815:A:G
NM_001164710.2(AMT):c.340-442_340-428del	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000056232	3	49457649 - 49457663	3	49420216 - 49420230	56232	70871	rs386833683	NC_000003.12:49420215:TGAGGGCCAAATCTTT:T
NM_000171.4(GLRA1):c.920A>C (p.Tyr307Ser)	GLRA1	Y307S, Y224S	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038334	5	151208621	5	151829060	38334	46897	rs121918410	NC_000005.10:151829059:T:G
NM_000171.4(GLRA1):c.892T>A (p.Ser298Thr)	GLRA1	S298T, S215T	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038333	5	151230971	5	151851410	38333	46896	rs281864920	NC_000005.10:151851409:A:T
NM_000171.4(GLRA1):c.801G>C (p.Trp267Cys)	GLRA1	W267C, W184C	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038330	5	151231062	5	151851501	38330	46894	rs281864917	NC_000005.10:151851500:C:G
NM_000171.4(GLRA1):c.737G>A (p.Arg246Gln)	GLRA1	R246Q, R163Q	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000038329	5	151231126	5	151851565	38329	46893	rs281864916	NC_000005.10:151851564:C:T
NM_000791.4(DHFR):c.238C>T (p.Leu80Phe)	DHFR	L80F, L28F	Megaloblastic anemia due to dihydrofolate reductase deficiency	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029673	5	79945212	5	80649393	29673	38628	rs387906619	NC_000005.10:80649392:G:A
NC_000005.9:g.(?_151304035)_(151304130_?)del	GLRA1		Hyperekplexia 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000583758	5	151304035 - 151304130	5	151924474 - 151924569	583758	559964		
NM_000171.3(GLRA1):c.(?_-287)_697+?del	GLRA1		Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000041004	5	151234601 - 151304397	5	151855040 - 151924836	41004	49426		
NM_000171.4(GLRA1):c.884G>A (p.Ser295Asn)	GLRA1	S267N, S295N, S212N	Hyperekplexia 1	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000016074	5	151230979	5	151851418	16074	31113	rs267606848	NC_000005.10:151851417:C:T
NM_000171.4(GLRA1):c.477-1G>A	GLRA1		Hyperekplexia 1	Pathogenic	criteria provided, single submitter	VCV000487340	5	151235945	5	151856384	487340	480412	rs762864856	NC_000005.10:151856383:C:T
NM_000171.4(GLRA1):c.777C>G (p.Ser259Arg)	GLRA1	S231R, S259R, S176R	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016071	5	151231086	5	151851525	16071	31110	rs121918417	NC_000005.10:151851524:G:C
NM_000171.4(GLRA1):c.862G>A (p.Val288Met)	GLRA1	V260M, V288M, V205M	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016070	5	151231001	5	151851440	16070	31109	rs121918416	NC_000005.10:151851439:C:T
NM_000171.4(GLRA1):c.832C>A (p.Pro278Thr)	GLRA1	P250T, P278T, P195T	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016066	5	151231031	5	151851470	16066	31105	rs121918413	NC_000005.10:151851469:G:T
NM_000171.4(GLRA1):c.882G>C (p.Gln294His)	GLRA1	Q266H, Q294H, Q211H	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016064	5	151230981	5	151851420	16064	31103	rs121918411	NC_000005.10:151851419:C:G
NM_000171.4(GLRA1):c.815T>A (p.Ile272Asn)	GLRA1	I244N, I272N, I189N	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016062	5	151231048	5	151851487	16062	31101	rs121918409	NC_000005.10:151851486:A:T
NM_000171.4(GLRA1):c.921del (p.Ser306_Tyr307insTer)	GLRA1		Hyperekplexia 1	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000038335	5	151208620	5	151829059	38335	46898	rs281864921	NC_000005.10:151829058:A:
NM_001146040.1(GLRA1):c.(?_-287)_(912+?)del	GLRA1		Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016072					16072	31111		
NM_000171.3(GLRA1):c.298delC	GLRA1	R100fs, R17fs	Hyperekplexia 1	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000016067	5	151239524	5	151859963	16067	31106	rs281864915	NC_000005.10:151859962:GGGGG:GGGG
NM_000171.4(GLRA1):c.910A>G (p.Lys304Glu)	GLRA1	K276E, K304E, K221E	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016065	5	151230953	5	151851392	16065	31104	rs121918412	NC_000005.10:151851391:T:C
NM_000481.3(AMT):c.471+2T>C	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000056233	3	49457642	3	49420209	56233	70872	rs386833684	NC_000003.12:49420208:A:G
NM_000187.4(HGD):c.175del (p.Ser59fs)	HGD	S59fs	Alkaptonuria	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003171	3	120393749	3	120674902	3171	18210	rs397515517	NC_000003.12:120674901:TT:T
NM_000187.4(HGD):c.899T>G (p.Val300Gly)	HGD	V300G	Alkaptonuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003166	3	120357409	3	120638562	3166	18205	rs120074170	NC_000003.12:120638561:A:C
NM_004553.5(NDUFS6):c.344G>A (p.Cys115Tyr)	NDUFS6	C115Y	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000006018	5	1815999	5	1815885	6018	21057	rs267606913	NC_000005.10:1815884:G:A
nsv1197507	NDUFS6		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000006017	5	1812548 - 1816722	5	1812434 - 1816608	6017	21056		
NM_004553.5(NDUFS6):c.186+2T>A	NDUFS6		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000006016	5	1802490	5	1802376	6016	21055	rs1561102614	NC_000005.10:1802375:T:A
NM_152393.4(KLHL40):c.602G>A (p.Trp201Ter)	KLHL40	W201*	Nemaline myopathy 8|not provided	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000060516	3	42727712	3	42686220	60516	75103	rs397509420	NC_000003.12:42686219:G:A
NM_198586.3(NHLRC1):c.386C>A (p.Pro129His)	NHLRC1	P129H	not provided|Lafora disease	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206187	6	18122452	6	18122221	206187	201961	rs750465793	NC_000006.12:18122220:G:T
NM_000791.4(DHFR):c.458A>T (p.Asp153Val)	DHFR	D153V, D101V	Megaloblastic anemia due to dihydrofolate reductase deficiency	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029674	5	79929723	5	80633904	29674	38629	rs121913223	NC_000005.10:80633903:T:A
NM_000171.4(GLRA1):c.690C>A (p.Tyr230Ter)	GLRA1	Y202*, Y230*, Y147*	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016069	5	151234608	5	151855047	16069	31108	rs121918415	NC_000005.10:151855046:G:T
NM_000481.3(AMT):c.886C>T (p.Arg296Cys)	AMT	R296C, R240C, R252C	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000656955	3	49455398	3	49417965	656955	631546		NC_000003.12:49417964:G:A
NM_000481.3(AMT):c.664C>T (p.Arg222Cys)	AMT	R222C, R166C, R178C	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552860	3	49456725	3	49419292	552860	543135	rs781466698	NC_000003.12:49419291:G:A
NM_000481.3(AMT):c.794G>A (p.Arg265His)	AMT	R265H, R209H, R221H	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550886	3	49456487	3	49419054	550886	543238	rs757918826	NC_000003.12:49419053:C:T
GRCh37/hg19 5q12.1(chr5:60166094-60217776)x1	ERCC8		not provided	Pathogenic(Last reviewed: May 16, 2018)	no assertion criteria provided	VCV000685742	5	60166094 - 60217776			685742	673334		
NM_000373.4(UMPS):c.670G>T (p.Glu224Ter)	UMPS	E224*	not provided	Pathogenic(Last reviewed: Oct 28, 2018)	criteria provided, single submitter	VCV000620432	3	124456774	3	124737927	620432	611580	rs1559905153	NC_000003.12:124737926:G:T
NM_000082.3(ERCC8):c.1017C>A (p.Cys339Ter)	ERCC8	C339*, C281*, C186*	not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000596166	5	60186740	5	60890913	596166	587227	rs753663016	NC_000005.10:60890912:G:T
NM_000082.4(ERCC8):c.493G>T (p.Gly165Ter)	ERCC8	G107*, G12*, G165*	not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000861599	5	60199532	5	60903705	861599	830907		NC_000005.10:60903704:C:A
NM_001007233.2(ERCC8):c.307+1G>C	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807412	5	60200618	5	60904791	807412	798562		NC_000005.10:60904790:C:G
NM_000082.3(ERCC8):c.650del (p.Arg217fs)	ERCC8	R159fs, R64fs, R217fs	not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000640063	5	60195522	5	60899695	640063	633992		NC_000005.10:60899694:C:
NM_000082.3(ERCC8):c.78-2A>T	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Sep 1, 2018)	no assertion criteria provided	VCV000586967	5	60224788	5	60928961	586967	578013	rs748379243	NC_000005.10:60928960:T:A
NM_000373.4(UMPS):c.326T>G (p.Val109Gly)	UMPS	V109G	Orotic aciduria	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000011907	3	124456430	3	124737583	11907	26946	rs121917892	NC_000003.12:124737582:T:G
NM_000082.4(ERCC8):c.802C>T (p.Arg268Ter)	ERCC8	R115*, R210*, R268*	not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000838966	5	60194144	5	60898317	838966	830906		NC_000005.10:60898316:G:A
NM_000082.3(ERCC8):c.769G>A (p.Gly257Arg)	ERCC8	G257R, G104R, G199R	Cockayne syndrome type A	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000590788	5	60194177	5	60898350	590788	581726	rs770499406	NC_000005.10:60898349:C:T
NM_000082.3(ERCC8):c.551-1G>A	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000558564	5	60198336	5	60902509	558564	543875	rs1554073316	NC_000005.10:60902508:C:T
NM_001007233.2(ERCC8):c.-252del	ERCC8	N47fs	Cockayne syndrome type A	Pathogenic(Last reviewed: Mar 15, 2012)	criteria provided, single submitter	VCV000190175	5	60224723	5	60928896	190175	187983	rs786205176	NC_000005.10:60928895:G:
ERCC8, 279-BP DEL, 81-BP DEL	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Aug 25, 1995)	no assertion criteria provided	VCV000001714					1714	16753		
NM_000082.3(ERCC8):c.618-1G>A	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000551068	5	60195555	5	60899728	551068	543438	rs201464610	NC_000005.10:60899727:C:T
NM_000082.3(ERCC8):c.647_651dup (p.Arg218Ter)	ERCC8		Cockayne syndrome type A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424544	5	60195520 - 60195521	5	60899693 - 60899694	424544	406755	rs1554073177	NC_000005.10:60899693:TCTCA:TCTCATCTCA
NM_000082.3(ERCC8):c.1083G>T (p.Trp361Cys)	ERCC8	W361C, W208C, W303C	not provided|UV-sensitive syndrome 2	Pathogenic(Last reviewed: Apr 14, 2009)	no assertion criteria provided	VCV000068752	5	60183306	5	60887479	68752	79644	rs281875221	NC_000005.10:60887478:C:A
NM_000171.4(GLRA1):c.971C>A (p.Ser324Ter)	GLRA1	S296*, S324*, S241*	Hyperekplexia 1|not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016073	5	151208570	5	151829009	16073	31112	rs121918418	NC_000005.10:151829008:G:T
NM_000082.3(ERCC8):c.1042-2A>G	ERCC8		Cockayne syndrome type A|Cockayne syndrome type A|UV-sensitive syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551594	5	60183349	5	60887522	551594	543869	rs372237310	NC_000005.10:60887521:T:C
NM_000082.4(ERCC8):c.173+1119G>C	ERCC8		Cockayne syndrome type A	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000397640	5	60223572	5	60927745	397640	384613	rs1043679457	NC_000005.10:60927744:C:G
NM_000082.3(ERCC8):c.966C>A (p.Tyr322Ter)	ERCC8	Y322*, Y264*, Y169*	Cockayne syndrome type A	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000001715	5	60186791	5	60890964	1715	16754	rs121434323	NC_000005.10:60890963:G:T
NM_003907.3(EIF2B5):c.271A>G (p.Thr91Ala)	EIF2B5	T91A	not provided|Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005942	3	183854475	3	184136687	5942	20981	rs28939717	NC_000003.12:184136686:A:G
NM_000481.3(AMT):c.230C>T (p.Ser77Leu)	AMT	S77L	Non-ketotic hyperglycinemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056229	3	49459565	3	49422132	56229	70868	rs386833680	NC_000003.12:49422131:G:A
NM_006261.4(PROP1):c.217C>T (p.Arg73Cys)	PROP1	R73C	Pituitary hormone deficiency, combined 2|not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008104	5	177421232	5	177994231	8104	23143	rs121917843	NC_000005.10:177994230:G:A
NM_002185.5(IL7R):c.230del (p.Leu77fs)	IL7R	L77fs	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000817844	5	35867416	5	35867314	817844	805438		NC_000005.10:35867313:T:
NM_002185.5(IL7R):c.340_341del (p.Lys114fs)	IL7R	K114fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000595102	5	35867524 - 35867525	5	35867422 - 35867423	595102	586164	rs1561421608	NC_000005.10:35867421:AAAA:AA
NM_021911.2(GABRB2):c.899C>T (p.Pro300Leu)	GABRB2	P300L	not provided	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000451524	5	160758068	5	161331061	451524	443737	rs1554093889	NC_000005.10:161331060:G:A
NM_021911.2(GABRB2):c.737T>C (p.Ile246Thr)	GABRB2	I246T	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000418957	5	160761854	5	161334847	418957	406677	rs1064793551	NC_000005.10:161334846:A:G
NM_021911.2(GABRB2):c.845T>C (p.Val282Ala)	GABRB2	V282A	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000265165	5	160758122	5	161331115	265165	259815	rs886039374	NC_000005.10:161331114:A:G
NM_002185.5(IL7R):c.221+1G>A	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830061	5	35861093	5	35860991	830061	818402		NC_000005.10:35860990:G:A
NM_002185.5(IL7R):c.675C>A (p.Tyr225Ter)	IL7R	Y225*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000664754	5	35873719	5	35873617	664754	633941		NC_000005.10:35873616:C:A
NM_002185.5(IL7R):c.355A>T (p.Lys119Ter)	IL7R	K119*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000642787	5	35867541	5	35867439	642787	633939		NC_000005.10:35867438:A:T
NM_002185.5(IL7R):c.707-2A>G	IL7R		Severe combined immunodeficiency disease	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000599352	5	35874549	5	35874447	599352	590646	rs1561424886	NC_000005.10:35874446:A:G
NM_002185.5(IL7R):c.291_294del (p.Lys97fs)	IL7R	K97fs	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000533056	5	35867474 - 35867477	5	35867372 - 35867375	533056	521450	rs1554066684	NC_000005.10:35867371:AAAGAAA:AAA
NM_000813.3(GABRB2):c.830T>C (p.Leu277Ser)	GABRB2	L277S	Epileptic encephalopathy, infantile or early childhood 2	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000487683	5	160761761	5	161334754	487683	480765	rs1554094145	NC_000005.10:161334753:A:G
NM_000813.3(GABRB2):c.730T>C (p.Tyr244His)	GABRB2	Y244H	Epileptic encephalopathy, infantile or early childhood 2	Pathogenic(Last reviewed: Jan 23, 2018)	no assertion criteria provided	VCV000487682	5	160761861	5	161334854	487682	480764	rs1554094149	NC_000005.10:161334853:A:G
NM_000813.3(GABRB2):c.908A>G (p.Lys303Arg)	GABRB2	K303R	Epileptic encephalopathy, infantile or early childhood 2	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000487681	5	160758059	5	161331052	487681	480763	rs1554093885	NC_000005.10:161331051:T:C
NM_000813.3(GABRB2):c.859A>C (p.Thr287Pro)	GABRB2	T287P	Epileptic encephalopathy, infantile or early childhood 2	Pathogenic(Last reviewed: Jan 22, 2018)	no assertion criteria provided	VCV000487680	5	160758108	5	161331101	487680	480762	rs1554093894	NC_000005.10:161331100:T:G
NM_002185.5(IL7R):c.753dup (p.Ser252fs)	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000464438	5	35874596 - 35874597	5	35874494 - 35874495	464438	455617	rs1554067182	NC_000005.10:35874494:C:CC
Single allele	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	VCV000224842	5	35862009 - 35867620			224842	226682		
NM_002185.5(IL7R):c.361dup (p.Ile121fs)	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	VCV000224841	5	35867540 - 35867541	5	35867438 - 35867439	224841	226681	rs869312857	NC_000005.10:35867438:AAAAAAA:AAAAAAAA
NM_000813.3(GABRB2):c.236T>C (p.Met79Thr)	GABRB2	M79T	Epileptic encephalopathy, infantile or early childhood 2	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161444	5	160972234	5	161545228	161444	171280	rs606231468	NC_000005.10:161545227:A:G
NM_002185.5(IL7R):c.394C>T (p.Pro132Ser)	IL7R	P132S	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Oct 15, 2000)	no assertion criteria provided	VCV000014843	5	35871172	5	35871070	14843	29882	rs104893894	NC_000005.10:35871069:C:T
NM_002185.5(IL7R):c.651G>A (p.Trp217Ter)	IL7R	W217*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000014842	5	35873695	5	35873593	14842	29881	rs104893893	NC_000005.10:35873592:G:A
NC_000005.9:g.(?_35860934)_(35871335_?)del	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000650715	5	35860934 - 35871335	5	35860832 - 35871233	650715	651232		
NM_002185.5(IL7R):c.333T>A (p.Val111=)	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Sep 1, 2015)	no assertion criteria provided	VCV000208851	5	35867519	5	35867417	208851	205412	rs199641706	NC_000005.10:35867416:T:A
NM_002185.5(IL7R):c.704C>G (p.Ser235Ter)	IL7R	S235*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578174	5	35873748	5	35873646	578174	565122	rs766555082	NC_000005.10:35873645:C:G
NM_002185.5(IL7R):c.437_438del (p.Phe146fs)	IL7R	F146fs	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000565662	5	35871214 - 35871215	5	35871112 - 35871113	565662	560317	rs1561423197	NC_000005.10:35871111:TTT:T
NC_000005.9:g.(?_35867388)_(35867585_?)del	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000533085	5	35867388 - 35867585	5	35867286 - 35867483	533085	520164		
NM_000813.3(GABRB2):c.904G>A (p.Val302Met)	GABRB2	V302M	Epileptic encephalopathy, infantile or early childhood 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000427157	5	160758063	5	161331056	427157	414996	rs1085307993	NC_000005.10:161331055:C:T
NM_002185.5(IL7R):c.221+2T>G	IL7R		not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265195	5	35861094	5	35860992	265195	259823	rs200044623	NC_000005.10:35860991:T:G
NM_000082.3(ERCC8):c.394_398del (p.Leu132fs)	ERCC8	I6fs, L132fs, L74fs	Cockayne syndrome type A|not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554811	5	60214093 - 60214097	5	60918266 - 60918270	554811	543879	rs774542633	NC_000005.10:60918265:TGTAATGTA:TGTA
NM_000344.3(SMN1):c.305G>A (p.Trp102Ter)	SMN1	W102*	Kugelberg-Welander disease|Spinal muscular atrophy, type II|not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000009173	5	70238216	5	70942389	9173	24212	rs77804083	NC_000005.10:70942388:G:A
NM_002185.5(IL7R):c.538-1G>A	IL7R		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000014841	5	35873581	5	35873479	14841	29880	rs1315265916	NC_000005.10:35873478:G:A
NM_001314077.1(PROS1):c.1300G>T (p.Glu434Ter)	PROS1	E402*, E434*	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000523822	3	93605299	3	93886455	523822	514493	rs1553809314	NC_000003.12:93886454:C:A
NM_001314077.1(PROS1):c.1252-1G>A	PROS1		not provided	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	VCV000429810	3	93605348	3	93886504	429810	421455	rs1131691605	NC_000003.12:93886503:C:T
NC_000003.12:g.(?_93924230)_(93973939_?)del	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000831813	3	93643074 - 93692783			831813	819423		
NM_000313.4(PROS1):c.83C>G (p.Ser28Ter)	PROS1	S28*, S60*	not provided	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000827664	3	93646245	3	93927401	827664	815866		NC_000003.12:93927400:G:C
NM_001314077.1(PROS1):c.348del (p.Lys116fs)	PROS1	K116fs, K84fs	Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000570367	3	93643091	3	93924247	570367	559531	rs1241365457	NC_000003.12:93924246:TTTT:TTT
NC_000003.11:g.(?_93598007)_(93598158_?)del	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Jun 11, 2016)	criteria provided, single submitter	VCV000417527	3	93598007 - 93598158	3	93879163 - 93879314	417527	393153		
NM_001314077.1(PROS1):c.1063delinsGG (p.Phe355fs)	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000216868	3	93611965	3	93893121	216868	212339	rs863224838	NC_000003.12:93893120:A:CC
NM_001314077.1(PROS1):c.797A>G (p.Tyr266Cys)	PROS1	Y234C, Y266C	Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000029849	3	93619674	3	93900830	29849	38804	rs387906675	NC_000003.12:93900829:T:C
PROS1, ARG410TER	PROS1	R410*	Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000029848					29848	38803		
NM_000313.4(PROS1):c.470-2A>T	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000848002	3	93624761	3	93905917	848002	851095		NC_000003.12:93905916:T:A
NC_000003.12:g.(?_93879153)_(93879331_?)del	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832790	3	93597997 - 93598175			832790	819422		
NM_001314077.1(PROS1):c.881del (p.Gly294fs)	PROS1	G294fs, G262fs	Reduced protein S activity	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627385	3	93617356	3	93898512	627385	615365		NC_000003.12:93898511:CC:C
NM_001314077.1(PROS1):c.2092T>C (p.Cys698Arg)	PROS1	C666R, C698R	Reduced protein S activity	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627030	3	93593124	3	93874280	627030	615349		NC_000003.12:93874279:A:G
NM_001314077.1(PROS1):c.2012G>A (p.Cys671Tyr)	PROS1	C639Y, C671Y	Reduced protein S activity	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627025	3	93593204	3	93874360	627025	615351		NC_000003.12:93874359:C:T
NM_001314077.1(PROS1):c.2004del (p.Phe667_Tyr668insTer)	PROS1		Reduced protein S activity	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627024	3	93593212	3	93874368	627024	615352		NC_000003.12:93874367:A:
PROS1, 1-BP INS, 146A	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000029847					29847	38802		
NM_001314077.1(PROS1):c.1159C>T (p.Arg387Cys)	PROS1	R355C, R387C		Pathogenic(Last reviewed: Dec 14, 2010)	no assertion criteria provided	VCV000029846	3	93611869	3	93893025	29846	38801	rs387906674	NC_000003.12:93893024:G:A
NM_001314077.1(PROS1):c.931C>T (p.Gln311Ter)	PROS1	Q238*, Q279*, Q311*		Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000013322	3	93617306	3	93898462	13322	28361	rs121918475	NC_000003.12:93898461:G:A
PROS1, IVS11AS, A-G, -9	PROS1			Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000013321					13321	28360		
NM_001314077.1(PROS1):c.2127A>T (p.Ter709Tyr)	PROS1	*677Y, *709Y		Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000013320	3	93593089	3	93874245	13320	28359	rs267606981	NC_000003.12:93874244:T:A
PROS1, IVS10DS, G-A, +5	PROS1			Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000013319					13319	28358		
NM_001314077.1(PROS1):c.869A>G (p.Asn290Ser)	PROS1	N217S, N258S, N290S		Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000013317	3	93617368	3	93898524	13317	28356	rs121918473	NC_000003.12:93898523:T:C
NM_001314077.1(PROS1):c.173-1G>C	PROS1		Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000581502	3	93646252	3	93927408	581502	559533	rs759677822	NC_000003.12:93927407:C:G
NM_001314077.1(PROS1):c.1447C>T (p.Arg483Ter)	PROS1	R451*, R483*	not provided|Reduced protein S activity	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503726	3	93603713	3	93884869	503726	495151	rs5017717	NC_000003.12:93884868:G:A
NM_022132.5(MCCC2):c.456dup (p.Gln153fs)	MCCC2		not provided	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000817720	5	70898399 - 70898400	5	71602572 - 71602573	817720	805449		NC_000005.10:71602572:AAAAAA:AAAAAAA
NM_022132.5(MCCC2):c.142C>T (p.Gln48Ter)	MCCC2	Q48*	not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000597111	5	70888765	5	71592938	597111	588172	rs1184301452	NC_000005.10:71592937:C:T
NM_022132.5(MCCC2):c.1412_1413del (p.Ser471fs)	MCCC2	S433fs, S471fs	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000595072	5	70945934 - 70945935	5	71650107 - 71650108	595072	586134	rs780304038	NC_000005.10:71650106:CA:
NM_022132.5(MCCC2):c.447_448TG[1] (p.Val150fs)	MCCC2		not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000449392	5	70898396 - 70898397	5	71602569 - 71602570	449392	443819	rs1554134061	NC_000005.10:71602568:TGTG:TG
NM_022132.5(MCCC2):c.214C>T (p.Arg72Ter)	MCCC2	R72*	not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000286933	5	70892124	5	71596297	286933	271170	rs147903984	NC_000005.10:71596296:C:T
NM_022132.5(MCCC2):c.1081C>T (p.Arg361Ter)	MCCC2	R361*, R323*	not provided	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000194114	5	70939654	5	71643827	194114	191277	rs763293192	NC_000005.10:71643826:C:T
NM_022132.5(MCCC2):c.994C>T (p.Arg332Ter)	MCCC2	R332*, R294*	not provided	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	VCV000167279	5	70931068	5	71635241	167279	177362	rs727504010	NC_000005.10:71635240:C:T
NM_022132.5(MCCC2):c.380C>G (p.Ser127Ter)	MCCC2	S127*	not provided	Pathogenic(Last reviewed: Aug 29, 2012)	criteria provided, single submitter	VCV000096031	5	70895584	5	71599757	96031	101925	rs398124372	NC_000005.10:71599756:C:G
NC_000005.10:g.(?_71587406)_(71656880_?)del	MCCC2		3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000832868	5	70883233 - 70952707			832868	819604		
NM_022132.5(MCCC2):c.581del (p.Thr194fs)	MCCC2	T194fs	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000649288	5	70900252	5	71604425	649288	634004		NC_000005.10:71604424:C:
NM_022132.5(MCCC2):c.891_892del (p.Lys298fs)	MCCC2	K298fs, K260fs	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000641165	5	70930856 - 70930857	5	71635029 - 71635030	641165	634006		NC_000005.10:71635028:AGA:A
NM_022132.5(MCCC2):c.735dup (p.Val247fs)	MCCC2		3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000582906	5	70922571 - 70922572	5	71626744 - 71626745	582906	560373	rs770769655	NC_000005.10:71626744:CCCCCC:CCCCCCC
NM_022132.5(MCCC2):c.987dup (p.Asp330Ter)	MCCC2		3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000467810	5	70931058 - 70931059	5	71635231 - 71635232	467810	455704	rs1554137532	NC_000005.10:71635231:TTT:TTTT
NM_022132.5(MCCC2):c.569A>G (p.His190Arg)	MCCC2	H190R	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001926	5	70900240	5	71604413	1926	16965	rs119103225	NC_000005.10:71604412:A:G
NM_022132.5(MCCC2):c.562C>T (p.Arg188Ter)	MCCC2	R188*	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000841748	5	70900233	5	71604406	841748	830937		NC_000005.10:71604405:C:T
NM_022132.5(MCCC2):c.688A>G (p.Asn230Asp)	MCCC2	N230D	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000577397	5	70922530	5	71626703	577397	565170	rs766753795	NC_000005.10:71626702:A:G
NC_000005.9:g.(?_70922447)_(70945100_?)del	MCCC2		3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000467801			5	71626620 - 71649273	467801	454072		
NM_022132.5(MCCC2):c.464G>A (p.Arg155Gln)	MCCC2	R155Q	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000001921	5	70898413	5	71602586	1921	16960	rs119103220	NC_000005.10:71602585:G:A
NM_022132.5(MCCC2):c.929C>G (p.Pro310Arg)	MCCC2	P310R, P272R	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000001922	5	70931003	5	71635176	1922	16961	rs119103221	NC_000005.10:71635175:C:G
NM_000171.4(GLRA1):c.920A>G (p.Tyr307Cys)	GLRA1	Y279C, Y307C, Y224C	Hyperekplexia 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000016063	5	151208621	5	151829060	16063	31102	rs121918410	NC_000005.10:151829059:T:C
NM_022132.5(MCCC2):c.538C>T (p.Arg180Ter)	MCCC2	R180*	not provided|3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488740	5	70900209	5	71604382	488740	481743	rs780011606	NC_000005.10:71604381:C:T
NM_153460.4(IL17RC):c.913C>T (p.Arg305Ter)	IL17RC	R376*, R305*, R290*, R265*, R292*	Candidiasis, familial, 9	Pathogenic(Last reviewed: Jul 6, 2015)	no assertion criteria provided	VCV000372244	3	9970024	3	9928340	372244	359149	rs773852926	NC_000003.12:9928339:C:T
NM_153460.4(IL17RC):c.199C>T (p.Gln67Ter)	IL17RC	Q138*, Q67*	Candidiasis, familial, 9	Pathogenic(Last reviewed: Jul 6, 2015)	no assertion criteria provided	VCV000372243	3	9959678	3	9917994	372243	359148	rs1057518751	NC_000003.12:9917993:C:T
GRM6, 1-BP INS, 720G	GRM6		Congenital stationary night blindness, type 1B	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000005845					5845	20884		
NM_000843.3(GRM6):c.(1354+1_1355-1)_(2436+1_2437-1)del	GRM6		Leber congenital amaurosis	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636145					636145	624030		
NM_000843.4(GRM6):c.577del (p.Val193fs)	GRM6	V193fs	Congenital stationary night blindness	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000437970	5	178419012	5	178992011	437970	431682	rs781463257	NC_000005.10:178992010:CCC:CC
NM_000187.4(HGD):c.808G>A (p.Gly270Arg)	HGD	G270R	Alkaptonuria	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003175	3	120360507	3	120641660	3175	18214	rs120074174	NC_000003.12:120641659:C:T
NM_000843.4(GRM6):c.448G>A (p.Gly150Ser)	GRM6	G150S	not provided|Congenital stationary night blindness, type 1B	Pathogenic(Last reviewed: Mar 29, 2005)	no assertion criteria provided	VCV000005843	5	178421498	5	178994497	5843	20882	rs62638202	NC_000005.10:178994496:C:T
NM_024996.5(GFM1):c.1596del (p.Val533fs)	GFM1	V533fs, V552fs	not provided	Pathogenic(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	VCV000214497	3	158384170	3	158666381	214497	210969	rs761095873	NC_000003.12:158666380:T:
NM_024996.5(GFM1):c.273del (p.Met92fs)	GFM1	M92fs	not provided	Pathogenic(Last reviewed: Mar 15, 2013)	criteria provided, single submitter	VCV000214496	3	158363991	3	158646202	214496	210954	rs863224033	NC_000003.12:158646201:CC:C
NM_024996.5(GFM1):c.688G>A (p.Gly230Ser)	GFM1	G230S, G230R	not provided	Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	VCV000214493	3	158366945	3	158649156	214493	210957	rs774456344	NC_000003.12:158649155:G:A
NM_024996.5(GFM1):c.3G>A (p.Met1Ile)	GFM1	M1I	not provided	Pathogenic(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000214491	3	158362426	3	158644637	214491	210949	rs863224030	NC_000003.12:158644636:G:A
NM_024996.7(GFM1):c.2008C>T (p.Arg670Ter)	GFM1	R442*, R595*, R670*, R689*, R517*, R643*, R481*, R631*	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000861346	3	158408050	3	158690261	861346	827646		NC_000003.12:158690260:C:T
NM_024996.7(GFM1):c.661C>T (p.Arg221Ter)	GFM1	R146*, R221*, R32*	not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000860673	3	158366918	3	158649129	860673	827644		NC_000003.12:158649128:C:T
NM_024996.7(GFM1):c.1255_1277dup (p.Ser427fs)	GFM1		not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000848623	3	158378695 - 158378696	3	158660906 - 158660907	848623	827645		NC_000003.12:158660906:GCATTGTTTGGCATTGACTGTGC:GCATTGTTTGGCATTGACTGTGCGCATTGTTTGGCATTGACTGTGC
NM_024996.7(GFM1):c.1571C>T (p.Ala524Val)	GFM1	A296V, A335V, A371V, A449V, A485V, A497V, A524V, A543V	Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812094	3	158384145	3	158666356	812094	800340		NC_000003.12:158666355:C:T
NM_024996.7(GFM1):c.100C>T (p.Arg34Ter)	GFM1	R34*	Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812093	3	158363436	3	158645647	812093	800333		NC_000003.12:158645646:C:T
NM_024996.7(GFM1):c.1546T>C (p.Cys516Arg)	GFM1	C288R, C327R, C363R, C441R, C477R, C489R, C516R, C535R	Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812092	3	158384120	3	158666331	812092	800339		NC_000003.12:158666330:T:C
NM_024996.7(GFM1):c.1149_1160del (p.Ile384_Thr387del)	GFM1		Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812091	3	158376772 - 158376783	3	158658983 - 158658994	812091	800336		NC_000003.12:158658982:ACACCATCTATAACAC:ACAC
NM_024996.7(GFM1):c.248A>T (p.Asp83Val)	GFM1	D83V, D8V	Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812090	3	158363967	3	158646178	812090	800334		NC_000003.12:158646177:A:T
NM_024996.7(GFM1):c.1404del (p.Gly469fs)	GFM1	G241fs, G280fs, G316fs, G394fs, G430fs, G442fs, G469fs, G488fs	Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812087	3	158383146	3	158665357	812087	800338		NC_000003.12:158665356:AAAA:AAA
NM_024996.7(GFM1):c.1297_1300del (p.Asp433fs)	GFM1	D205fs, D244fs, D280fs, D358fs, D394fs, D406fs, D433fs, D452fs	Combined oxidative phosphorylation deficiency 1	Pathogenic	criteria provided, single submitter	VCV000812086	3	158378735 - 158378738	3	158660946 - 158660949	812086	800337		NC_000003.12:158660945:ACAGACA:ACA
NM_024996.5(GFM1):c.521dup (p.Asn174fs)	GFM1		not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000662319	3	158364683 - 158364684	3	158646894 - 158646895	662319	631019		NC_000003.12:158646894:AA:AAA
NM_024996.5(GFM1):c.291_292del (p.Gly99fs)	GFM1	G99fs	not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000652079	3	158364009 - 158364010	3	158646220 - 158646221	652079	631017		NC_000003.12:158646219:AAA:A
NM_024996.5(GFM1):c.401_404dup (p.Arg136fs)	GFM1		not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000646742	3	158364564 - 158364565	3	158646775 - 158646776	646742	631018		NC_000003.12:158646775:CCCT:CCCTCCCT
NM_024996.7(GFM1):c.539del (p.Gly180fs)	GFM1	G180fs, G105fs	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000644902	3	158364701	3	158646912	644902	631020		NC_000003.12:158646911:GGG:GG
NM_024996.5(GFM1):c.193C>T (p.Arg65Ter)	GFM1	R65*	not provided	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000644188	3	158363529	3	158645740	644188	631016		NC_000003.12:158645739:C:T
NM_003664.4(AP3B1):c.1839_1842delTAGA	AP3B1			Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000224764	5	77423980 - 77423983	5	78128156 - 78128159	224764	226542	rs869312839	NC_000005.10:78128155:TCTATCTAT:TCTAT
NM_003664.4(AP3B1):c.177del (p.Lys59fs)	AP3B1	K59fs, K10fs		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000224763	5	77563371	5	78267547	224763	226545	rs869312838	NC_000005.10:78267546:TTT:TT
NM_003664.4(AP3B1):c.716G>A (p.Trp239Ter)	AP3B1	W239*, W190*		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000224762	5	77511949	5	78216125	224762	226544	rs869312837	NC_000005.10:78216124:C:T
NM_003664.4(AP3B1):c.1754del (p.Val585fs)	AP3B1	V536fs, V585fs		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000224761	5	77425028	5	78129204	224761	226543	rs869312836	NC_000005.10:78129203:A:
NM_003664.4(AP3B1):c.2702C>G (p.Ser901Cys)	AP3B1	S901C, S852C		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000224760	5	77334974	5	78039150	224760	226541	rs869312835	NC_000005.10:78039149:G:C
NM_024996.5(GFM1):c.1487T>G (p.Met496Arg)	GFM1	M496R, M515R	Combined oxidative phosphorylation deficiency 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000004162	3	158383232	3	158665443	4162	19201	rs119470020	NC_000003.12:158665442:T:G
NM_024996.5(GFM1):c.139C>T (p.Arg47Ter)	GFM1	R47*	Combined oxidative phosphorylation deficiency 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000004161	3	158363475	3	158645686	4161	19200	rs119470019	NC_000003.12:158645685:C:T
NM_003664.5(AP3B1):c.779G>A (p.Trp260Ter)	AP3B1	W211*, W260*		Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000856193	5	77511886	5	78216062	856193	830959		NC_000005.10:78216061:C:T
NM_024996.7(GFM1):c.720del (p.Glu241fs)	GFM1	E260fs, E241fs, E52fs, E166fs, E202fs, E13fs, E88fs	not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000653852	3	158369915	3	158652126	653852	631021		NC_000003.12:158652125:T:
NM_024996.5(GFM1):c.700C>T (p.Arg234Ter)	GFM1	R234*, R253*	not provided|Combined oxidative phosphorylation deficiency 1	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214495	3	158369895	3	158652106	214495	210959	rs863224032	NC_000003.12:158652105:C:T
NM_003664.4(AP3B1):c.904A>T (p.Arg302Ter)	AP3B1	R302*, R253*		Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000006376	5	77477369	5	78181545	6376	21415	rs121908905	NC_000005.10:78181544:T:A
AP3B1, IVS14DS, T-C, +6	AP3B1			Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000006374					6374	21413		
AP3B1, 1-BP INS, 1618G	AP3B1			Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000006373					6373	21412		
NC_000005.10:g.(?_78089373)_(78141339_?)del	AP3B1			Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000833024	5	77385197 - 77437163			833024	819607		
NM_003664.4(AP3B1):c.1975G>T (p.Glu659Ter)	AP3B1	E659*, E610*		Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000006378	5	77412052	5	78116228	6378	21417	rs121908907	NC_000005.10:78116227:C:A
NM_003664.4(AP3B1):c.1525C>T (p.Arg509Ter)	AP3B1	R509*, R460*		Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000006377	5	77437092	5	78141268	6377	21416	rs121908906	NC_000005.10:78141267:G:A
NM_003664.4(AP3B1):c.1739T>G (p.Leu580Arg)	AP3B1	L580R, L531R		Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000006372	5	77425043	5	78129219	6372	21411	rs121908904	NC_000005.10:78129218:A:C
NM_003664.4(AP3B1):c.1168_1230del63 (p.Leu390_Gln410del)	AP3B1			Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000006371	5	77461434 - 77461496	5	78165610 - 78165672	6371	21410	rs1554072100	
NM_003664.4(AP3B1):c.1474-7072_1650+921del	AP3B1			Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000006375	5	77436046 - 77444215	5	78140222 - 78148391	6375	21414		
NM_022132.5(MCCC2):c.463C>T (p.Arg155Trp)	MCCC2	R155W	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566363	5	70898412	5	71602585	566363	560367	rs141030969	NC_000005.10:71602584:C:T
NM_022132.5(MCCC2):c.1065A>T (p.Leu355Phe)	MCCC2	L355F, L317F	3-methylcrotonyl CoA carboxylase 2 deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203806	5	70936895	5	71641068	203806	200100	rs757052602	NC_000005.10:71641067:A:T
NM_000344.3(SMN1):c.770_780dup (p.Gly261fs)	SMN1		Werdnig-Hoffmann disease|not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586627	5	70241936 - 70241937	5	70946109 - 70946110	586627	576822	rs1561500847	NC_000005.10:70946109:TGCTGATGCTTTG:TGCTGATGCTTTGCTGATGCTTTG
NM_000344.3(SMN1):c.332C>G (p.Ala111Gly)	SMN1	A111G	Spinal muscular atrophy, type II|not provided|Werdnig-Hoffmann disease	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000009177	5	70238243	5	70942416	9177	24216	rs104893935	NC_000005.10:70942415:C:G
NM_015175.3(NBEAL2):c.6432del (p.Phe2144fs)	NBEAL2	F2110fs, F2144fs	Gray platelet syndrome	Pathogenic	no assertion criteria provided	VCV000812962	3	47046681	3	47005191	812962	801076		NC_000003.12:47005190:TTT:TT
NM_001017995.3(SH3PXD2B):c.846del (p.Leu283fs)	SH3PXD2B	L283fs	not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000280919	5	171777533	5	172350529	280919	264256	rs886042037	NC_000005.10:172350528:GGG:GG
NM_015175.2(NBEAL2):c.3592C>T (p.Gln1198Ter)	NBEAL2	Q1198*, Q1164*	not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000280483	3	47040853	3	46999363	280483	264170	rs886041677	NC_000003.12:46999362:C:T
NM_001017995.3(SH3PXD2B):c.250C>T (p.Arg84Ter)	SH3PXD2B	R84*	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000446059	5	171821626	5	172394622	446059	439331	rs61755907	NC_000005.10:172394621:G:A
NM_015175.2(NBEAL2):c.4081G>T (p.Glu1361Ter)	NBEAL2	E1361*, E1327*	Gray platelet syndrome	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000435928	3	47041670	3	47000180	435928	428196	rs1553663498	NC_000003.12:47000179:G:T
NM_015175.2(NBEAL2):c.1793G>A (p.Trp598Ter)	NBEAL2	W598*, W564*	Gray platelet syndrome	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000435927	3	47037018	3	46995528	435927	428195	rs1553659758	NC_000003.12:46995527:G:A
NM_015175.2(NBEAL2):c.5413dup (p.Ala1805fs)	NBEAL2		Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031122	3	47044240 - 47044241	3	47002750 - 47002751	31122	40079	rs794726683	NC_000003.12:47002750:GGGGGG:GGGGGGG
NM_001365116.2(NBEAL2):c.1721G>A (p.Trp574Ter)	NBEAL2	W607*, W608*, W574*	Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031121	3	47037048	3	46995558	31121	40078	rs794726682	NC_000003.12:46995557:G:A
NM_015175.2(NBEAL2):c.6299C>T (p.Pro2100Leu)	NBEAL2	P2100L, P2066L	Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031120	3	47046466	3	47004976	31120	40077	rs387907115	NC_000003.12:47004975:C:T
NM_015175.2(NBEAL2):c.1928A>T (p.Glu643Val)	NBEAL2	E643V, E609V	Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031119	3	47037233	3	46995743	31119	40076	rs387907114	NC_000003.12:46995742:A:T
NM_015175.2(NBEAL2):c.881C>G (p.Ser294Ter)	NBEAL2	S294*, S287*	Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031117	3	47033134	3	46991644	31117	40074	rs372277612	NC_000003.12:46991643:C:G
NM_015175.2(NBEAL2):c.2701C>T (p.Arg901Ter)	NBEAL2	R901*, R867*	Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031116	3	47038800	3	46997310	31116	40073	rs387907112	NC_000003.12:46997309:C:T
NM_001017995.3(SH3PXD2B):c.76-2A>C	SH3PXD2B			Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000191	5	171849502	5	172422498	191	15230	rs775217258	NC_000005.10:172422497:T:G
NM_001017995.3(SH3PXD2B):c.127C>T (p.Arg43Trp)	SH3PXD2B	R43W		Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000190	5	171849449	5	172422445	190	15229	rs267607046	NC_000005.10:172422444:G:A
NM_015175.2(NBEAL2):c.7387C>T (p.Gln2463Ter)	NBEAL2	Q2463*, Q2429*	Gray platelet syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627372	3	47049067	3	47007577	627372	615348		NC_000003.12:47007576:C:T
NM_001017995.2(SH3PXD2B):c.1188+1773_2733+6592del	SH3PXD2B			Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000217131	5	171758785 - 171771367	5	172331781 - 172344363	217131	213775		
NM_015175.2(NBEAL2):c.1163T>C (p.Leu388Pro)	NBEAL2	L388P, L354P	Gray platelet syndrome	Pathogenic(Last reviewed: Jul 17, 2011)	no assertion criteria provided	VCV000031118	3	47035476	3	46993986	31118	40075	rs387907113	NC_000003.12:46993985:T:C
NM_001017995.3(SH3PXD2B):c.147dup (p.Asp50Ter)	SH3PXD2B			Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000000188	5	171849428 - 171849429	5	172422424 - 172422425	188	15227	rs794728005	NC_000005.10:172422424:AAAAAA:AAAAAAA
NM_001017995.3(SH3PXD2B):c.401+1G>A	SH3PXD2B		|Borrone Di Rocco Crovato syndrome	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000055933	5	171809039	5	172382035	55933	70572	rs367543284	NC_000005.10:172382034:C:T
NM_000174.4(GP9):c.182A>G (p.Asn61Ser)	GP9	N45S, N61S	Bernard Soulier syndrome|Thrombocytopenia|Macrothrombocytopenia|not provided|Bernard-Soulier syndrome type C	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013529	3	128780764	3	129061921	13529	28568	rs5030764	NC_000003.12:129061920:A:G
NM_000171.3(GLRA1):c.1259G>A	GLRA1	R428H, R420H, R337H	Hyperekplexia 1|not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242680	5	151202325	5	151822764	242680	46901	rs281864919	NC_000005.10:151822763:C:T
NM_022132.5(MCCC2):c.517dup (p.Ser173fs)	MCCC2		not provided|3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001919	5	70900186 - 70900187	5	71604359 - 71604360	1919	16958	rs587776533	NC_000005.10:71604359:TT:TTT
NM_001017995.3(SH3PXD2B):c.969del (p.Arg324fs)	SH3PXD2B	R324fs		Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000000189	5	171777410	5	172350406	189	15228	rs794728006	NC_000005.10:172350405:CCC:CC
NM_000541.5(SAG):c.926del (p.Asn309fs)	SAG	N309fs	SAG-Related Disorders|Oguchi's disease|Retinitis pigmentosa 47	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012951	2	234243725	2	233335079	12951	27990	rs587776778	NC_000002.12:233335078:AAA:AA
NM_001128840.3(CACNA1D):c.1220+597C>T	CACNA1D	A376V	Sinoatrial node dysfunction and deafness	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402284	3	53707750	3	53673723	402284	389221	rs759274321	NC_000003.12:53673722:C:T
NM_001128840.3(CACNA1D):c.1220+678_1220+679insGGG	CACNA1D		Sinoatrial node dysfunction and deafness	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000039709	3	53707829 - 53707830	3	53673802 - 53673803	39709	48308	rs398122827	NC_000003.12:53673802:GG:GGGGG
NM_001128840.3(CACNA1D):c.2250C>G (p.Ile750Met)	CACNA1D	I770M, I750M	Primary aldosteronism, seizures, and neurologic abnormalities|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066073	3	53764497	3	53730470	66073	76975	rs41276445	NC_000003.12:53730469:C:G
NM_001128840.3(CACNA1D):c.1220+678G>A	CACNA1D	G403D	Primary aldosteronism, seizures, and neurologic abnormalities|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2015)	no assertion criteria provided	VCV000066072	3	53707831	3	53673804	66072	76974	rs386834264	NC_000003.12:53673803:G:A
NM_000521.4(HEXB):c.94C>T (p.Gln32Ter)	HEXB	Q32*	Sandhoff disease	Pathogenic(Last reviewed: Sep 15, 2019)	no assertion criteria provided	VCV000800874	5	73981179	5	74685354	800874	788784		NC_000005.10:74685353:C:T
GRCh37/hg19 5q13.3(chr5:73974274-74011878)x1	HEXB		not provided	Pathogenic(Last reviewed: Aug 2, 2018)	no assertion criteria provided	VCV000686915	5	73974274 - 74011878			686915	674507		
GRCh37/hg19 5q13.3(chr5:73978700-73993202)x1	HEXB		not provided	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000686857	5	73978700 - 73993202			686857	674449		
GRCh37/hg19 5q13.3(chr5:73978700-73993202)x1	HEXB		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	no assertion criteria provided	VCV000686220	5	73978700 - 73993202			686220	673812		
GRCh37/hg19 5q13.3(chr5:73978700-73993202)x1	HEXB		not provided	Pathogenic(Last reviewed: Apr 2, 2018)	no assertion criteria provided	VCV000685450	5	73978700 - 73993202			685450	673042		
NM_000521.4(HEXB):c.299G>C (p.Arg100Pro)	HEXB	R100P	Sandhoff disease	Pathogenic	no assertion criteria provided	VCV000397589	5	73981384	5	74685559	397589	384482	rs1060499701	NC_000005.10:74685558:G:C
NM_000521.4(HEXB):c.274_277dup (p.Leu93fs)	HEXB		not provided	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000373128	5	73981357 - 73981358	5	74685532 - 74685533	373128	359569	rs1057518237	NC_000005.10:74685532:CACCC:CACCCACCC
NM_000521.4(HEXB):c.170G>A (p.Trp57Ter)	HEXB	W57*	Sandhoff disease	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242876	5	73981255	5	74685430	242876	243984	rs1114167287	NC_000005.10:74685429:G:A
NM_000521.4(HEXB):c.1517_1529dup (p.Glu511fs)	HEXB		not provided	Pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	VCV000194179	5	74016473 - 74016474	5	74720648 - 74720649	194179	191342	rs797044644	NC_000005.10:74720648:GGCAAGTGCTGTTGG:GGCAAGTGCTGTTGGCAAGTGCTGTTGG
NM_000521.4(HEXB):c.1234_1238AAAGC[1] (p.Lys414fs)	HEXB	K189fs, K414fs	not provided	Pathogenic(Last reviewed: Mar 27, 2013)	criteria provided, single submitter	VCV000093196	5	74014180 - 74014184	5	74718355 - 74718359	93196	99103	rs398123445	NC_000005.10:74718354:AAAGCAAAG:AAAG
NM_000521.4(HEXB):c.1294dup (p.Glu432fs)	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000851972	5	74014671 - 74014672	5	74718846 - 74718847	851972	830946		NC_000005.10:74718846:GG:GGG
NM_000521.4(HEXB):c.1021_1023delinsTCAAA (p.Glu342fs)	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000849280	5	74011454 - 74011456	5	74715629 - 74715631	849280	830945		NC_000005.10:74715628:AGT:TCAAA
NM_000521.4(HEXB):c.451_452dup (p.Leu151fs)	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000841253	5	73989467 - 73989468	5	74693642 - 74693643	841253	830943		NC_000005.10:74693642:TTT:TTTTT
NM_000521.4(HEXB):c.1010dup (p.Lys338fs)	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000665539	5	74011438 - 74011439	5	74715613 - 74715614	665539	634011		NC_000005.10:74715613:TTTTT:TTTTTT
NM_000521.4(HEXB):c.839T>G (p.Leu280Ter)	HEXB	L55*, L280*	Sandhoff disease	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000664928	5	74009398	5	74713573	664928	634010		NC_000005.10:74713572:T:G
NM_000521.4(HEXB):c.171_176delinsCCCCC (p.Trp57fs)	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000658705	5	73981256 - 73981261	5	74685431 - 74685436	658705	634008		NC_000005.10:74685430:GCCCCT:CCCCC
NM_000521.4(HEXB):c.841C>T (p.Arg281Ter)	HEXB	R281*, R56*	Sandhoff disease	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623308	5	74009400	5	74713575	623308	612273	rs138914144	NC_000005.10:74713574:C:T
NM_000521.4(HEXB):c.333G>A (p.Trp111Ter)	HEXB	W111*	Sandhoff disease	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000557986	5	73985186	5	74689361	557986	543892	rs761117459	NC_000005.10:74689360:G:A
NM_000521.4(HEXB):c.171del (p.Trp57fs)	HEXB	W57fs	Sandhoff disease	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000557707	5	73981255	5	74685430	557707	543886	rs771973471	NC_000005.10:74685429:GG:G
HEXB, 1-BP DEL, 965T	HEXB		Sandhoff disease, infantile	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000003888					3888	18927		
NM_000521.4(HEXB):c.1082+5G>C	HEXB		Sandhoff disease, infantile	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000003885	5	74011520	5	74715695	3885	18924		NC_000005.10:74715694:G:C
HEXB, PARTIAL DEL	HEXB		Sandhoff disease, infantile type	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000003883					3883	18922		
NM_000521.4(HEXB):c.64_65del (p.Leu22fs)	HEXB	L22fs	Sandhoff disease	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000860680	5	73981149 - 73981150	5	74685324 - 74685325	860680	830942		NC_000005.10:74685323:CT:
NM_000521.4(HEXB):c.445+1G>A	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000633263	5	73985299	5	74689474	633263	621746	rs761197472	NC_000005.10:74689473:G:A
NM_000521.4(HEXB):c.298C>T (p.Arg100Ter)	HEXB	R100*	Sandhoff disease	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623479	5	73981383	5	74685558	623479	612441	rs1007338250	NC_000005.10:74685557:C:T
NM_000521.4(HEXB):c.1023_1026del (p.Ser341fs)	HEXB	S116fs, S341fs	Sandhoff disease|not provided	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000280975	5	74011454 - 74011457	5	74715629 - 74715632	280975	265212	rs776476415	NC_000005.10:74715628:AGTGAG:AG
NM_000521.4(HEXB):c.298del (p.Arg100fs)	HEXB	R100fs	Sandhoff disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265360	5	73981383	5	74685558	265360	259827	rs886039499	NC_000005.10:74685557:C:
NM_000521.4(HEXB):c.76del (p.Met26fs)	HEXB	M26fs	Sandhoff disease, infantile	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000003886	5	73981161	5	74685336	3886	18925		NC_000005.10:74685335:A:
HEXB, 18-BP INS	HEXB		Hexosaminidase B (paris)	Pathogenic(Last reviewed: Oct 15, 1990)	no assertion criteria provided	VCV000003876					3876	18915		
NC_000005.9:g.(?_73981076)_(73992941_?)del	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000644276	5	73981076 - 73992941	5	74685251 - 74697116	644276	651266		
NC_000005.9:g.(?_73981086)_(73992931_?)del	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000583659	5	73981086 - 73992931	5	74685261 - 74697106	583659	562300		
NM_000521.4(HEXB):c.1389C>G (p.Tyr463Ter)	HEXB	Y463*, Y238*	Sandhoff disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557658	5	74014768	5	74718943	557658	543817	rs1554036943	NC_000005.10:74718942:C:G
NM_000521.4(HEXB):c.965del (p.Ile322fs)	HEXB	I322fs, I97fs	Sandhoff disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557437	5	74011398	5	74715573	557437	543813	rs768438206	NC_000005.10:74715572:T:
NC_000005.9:g.(?_73981066)_(73992951_?)del	HEXB		Sandhoff disease	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000527972	5	73981066 - 73992951	5	74685241 - 74697126	527972	520537		
NM_000521.4(HEXB):c.508C>T (p.Arg170Ter)	HEXB	R170*	Sandhoff disease|not provided	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000281002	5	73989526	5	74693701	281002	265239	rs753823903	NC_000005.10:74693700:C:T
NM_000521.4(HEXB):c.1243-2A>G	HEXB		not provided|Sandhoff disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093197	5	74014620	5	74718795	93197	99104	rs398123446	NC_000005.10:74718794:A:G
NM_000521.4(HEXB):c.1510C>T (p.Pro504Ser)	HEXB	P504S, P279S	Sandhoff disease, chronic	Pathogenic(Last reviewed: Aug 14, 1998)	no assertion criteria provided	VCV000003884	5	74016469	5	74720644	3884	18923	rs121907985	NC_000005.10:74720643:C:T
HEXB, 24-BP INS	HEXB		Sandhoff disease, juvenile type	Pathogenic(Last reviewed: Oct 15, 1990)	no assertion criteria provided	VCV000003875					3875	18914		
NM_022132.5(MCCC2):c.295G>C (p.Glu99Gln)	MCCC2	E99Q	not provided|3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001920	5	70895499	5	71599672	1920	16959	rs119103219	NC_000005.10:71599671:G:C
NM_001080517.3(SETD5):c.1716_1717insC (p.Asn573fs)	SETD5		not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000818037	3	9488925 - 9488926	3	9447241 - 9447242	818037	805366		NC_000003.12:9447241::C
NM_001080517.3(SETD5):c.2113dup (p.Thr705fs)	SETD5		not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000817921	3	9490080 - 9490081	3	9448396 - 9448397	817921	805368		NC_000003.12:9448396:A:AA
NM_001080517.3(SETD5):c.1623dup (p.Asp542Ter)	SETD5		not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000817566	3	9488831 - 9488832	3	9447147 - 9447148	817566	805365		NC_000003.12:9447147:T:TT
NM_024513.4(FYCO1):c.828_829AG[1] (p.Glu277fs)	FYCO1		not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000817447	3	46009993 - 46009996	3	45968501 - 45968504	817447	805351		NC_000003.12:45968500:CTCTCT:CT
NM_001080517.3(SETD5):c.821del (p.Gly274fs)	SETD5	G176fs, G274fs	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817327	3	9483285	3	9441601	817327	805364		NC_000003.12:9441600:GGG:GG
NM_001080517.3(SETD5):c.2097dup (p.Lys700fs)	SETD5		not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000817205	3	9489682 - 9489683	3	9447998 - 9447999	817205	805367		NC_000003.12:9447998:CC:CCC
NM_001080517.3(SETD5):c.2154del (p.Val719fs)	SETD5	V719fs, V621fs	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000807684	3	9490122	3	9448438	807684	798539		NC_000003.12:9448437:T:
NM_001080517.3(SETD5):c.1566del (p.Phe522fs)	SETD5	F424fs, F522fs	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000807683	3	9488772	3	9447088	807683	798538		NC_000003.12:9447087:TTTT:TTT
NM_001080517.2(SETD5):c.3520C>T (p.Arg1174Ter)	SETD5	R1174*, R1076*	not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000620570	3	9516155	3	9474471	620570	611601	rs1559496157	NC_000003.12:9474470:C:T
NM_001080517.2(SETD5):c.1498C>T (p.Gln500Ter)	SETD5	Q500*, Q402*	not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000620539	3	9487398	3	9445714	620539	611600	rs1559427364	NC_000003.12:9445713:C:T
NM_001080517.2(SETD5):c.586C>T (p.Gln196Ter)	SETD5	Q196*, Q98*	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000620351	3	9482158	3	9440474	620351	611598	rs1559413463	NC_000003.12:9440473:C:T
NM_001292043.2(SETD5):c.2046dup (p.Lys683Ter)	SETD5		not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000597791	3	9490307 - 9490308	3	9448623 - 9448624	597791	588852	rs1559439258	NC_000003.12:9448623:T:TT
NM_001080517.2(SETD5):c.2279C>A (p.Ser760Ter)	SETD5	S760*, S662*	not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000546031	3	9490247	3	9448563	546031	536284	rs1553626575	NC_000003.12:9448562:C:A
NM_001080517.2(SETD5):c.3586G>T (p.Glu1196Ter)	SETD5	E1196*, E1098*	not provided	Pathogenic(Last reviewed: Jul 31, 2017)	no assertion criteria provided	VCV000545085	3	9516221	3	9474537	545085	535300	rs763827023	NC_000003.12:9474536:G:T
NM_001080517.2(SETD5):c.1715C>G (p.Ser572Ter)	SETD5	S572*, S474*	not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000523890	3	9488924	3	9447240	523890	514494	rs751539788	NC_000003.12:9447239:C:G
NM_001080517.2(SETD5):c.2356A>T (p.Lys786Ter)	SETD5	K786*, K688*	not provided	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000504355	3	9495432	3	9453748	504355	495209	rs1553629700	NC_000003.12:9453747:A:T
NM_001292043.2(SETD5):c.611_621dup (p.Met208fs)	SETD5		not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000503788	3	9483368 - 9483369	3	9441684 - 9441685	503788	495203	rs1553621390	NC_000003.12:9441684:TCGTGGGAAAGTC:TCGTGGGAAAGTCGTGGGAAAGTC
NM_001292043.2(SETD5):c.2463dup (p.Val822fs)	SETD5		not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000500789	3	9512171 - 9512172	3	9470487 - 9470488	500789	492213	rs1553638715	NC_000003.12:9470487:AAAA:AAAAA
NM_001080517.2(SETD5):c.1852C>T (p.Arg618Ter)	SETD5	R618*, R520*	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000489332	3	9489439	3	9447755	489332	481705	rs1218918142	NC_000003.12:9447754:C:T
NM_001080517.2(SETD5):c.1540A>T (p.Lys514Ter)	SETD5	K514*, K416*	not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000489325	3	9488749	3	9447065	489325	481704	rs1553625037	NC_000003.12:9447064:A:T
NM_001292043.2(SETD5):c.2615dup (p.Arg873fs)	SETD5		not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000453120	3	9512326 - 9512327	3	9470642 - 9470643	453120	443525	rs1553638877	NC_000003.12:9470642:T:TT
NM_001292043.2(SETD5):c.793_794del (p.Met265fs)	SETD5	M265fs, M363fs	not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000452743	3	9485001 - 9485002	3	9443317 - 9443318	452743	443522	rs1553622384	NC_000003.12:9443316:AT:
NM_001080517.2(SETD5):c.1206T>A (p.Cys402Ter)	SETD5	C402*, C304*	not provided	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000450270	3	9486750	3	9445066	450270	443524	rs1553623299	NC_000003.12:9445065:T:A
NM_001080517.2(SETD5):c.3526C>T (p.Arg1176Ter)	SETD5	R1176*, R1078*	not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000432259	3	9516161	3	9474477	432259	425581	rs1181898358	NC_000003.12:9474476:C:T
NM_024513.4(FYCO1):c.3325_3326CT[1] (p.Cys1110fs)	FYCO1			Pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000430962	3	46003826 - 46003827	3	45962334 - 45962335	430962	424504	rs747093432	NC_000003.12:45962333:AGAG:AG
NM_024513.4(FYCO1):c.4271G>A (p.Arg1424Gln)	FYCO1	R1424Q		Pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000430961	3	45965238	3	45923746	430961	424503	rs140159323	NC_000003.12:45923745:C:T
NM_001292043.2(SETD5):c.1445_1446CA[1] (p.Gln483fs)	SETD5		not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000429986	3	9488948 - 9488949	3	9447264 - 9447265	429986	421456	rs1131691711	NC_000003.12:9447263:CACA:CA
NM_001292043.2(SETD5):c.1699del (p.Ser566_Leu567insTer)	SETD5		not provided	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000423395	3	9489580	3	9447896	423395	406367	rs1064796399	NC_000003.12:9447895:C:
NM_001292043.2(SETD5):c.2970_2971CT[1] (p.Ser991fs)	SETD5		not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000423295	3	9514988 - 9514989	3	9473304 - 9473305	423295	406368	rs1064796348	NC_000003.12:9473303:CTCT:CT
NM_001292043.2(SETD5):c.3489dup (p.Phe1164fs)	SETD5		not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000419013	3	9517224 - 9517225	3	9475540 - 9475541	419013	406371	rs1553641424	NC_000003.12:9475540:CCCCC:CCCCCC
NM_001292043.2(SETD5):c.2952del (p.Ala985fs)	SETD5	A1083fs, A985fs	not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000280577	3	9514970	3	9473286	280577	264156	rs886041755	NC_000003.12:9473285:T:
NM_001080517.2(SETD5):c.1333C>T (p.Arg445Ter)	SETD5	R445*, R347*	not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000265257	3	9486877	3	9445193	265257	259779	rs886039432	NC_000003.12:9445192:C:T
NM_014049.5(ACAD9):c.1429C>T (p.Arg477Ter)	ACAD9	R477*	not provided	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000864413	3	128627886	3	128909043	864413	827523		NC_000003.12:128909042:C:T
NM_014049.5(ACAD9):c.15_40del (p.Leu6fs)	ACAD9	L6fs	not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000850643	3	128598540 - 128598565	3	128879697 - 128879722	850643	827522		NC_000003.12:128879696:CGGCTGCGGGCTCTTCCTGCGCACCACGGCTGCGG:CGGCTGCGG
NM_001080517.3(SETD5):c.2102del (p.Lys701fs)	SETD5	K603fs, K701fs	not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000845829	3	9489685	3	9448001	845829	828595		NC_000003.12:9448000:AAAAA:AAAA
NC_000003.12:g.(?_128893545)_(128896546_?)del	ACAD9		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000832867	3	128612388 - 128615389			832867	819322		
NC_000003.12:g.(?_128899277)_(128899471_?)del	ACAD9		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000831296	3	128618120 - 128618314			831296	819323		
NM_001080517.3(SETD5):c.1573_1574del (p.Leu525fs)	SETD5	L427fs, L525fs	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV000818222	3	9488782 - 9488783	3	9447098 - 9447099	818222	806435		NC_000003.12:9447097:TT:
NM_001080517.3(SETD5):c.960del (p.Lys320fs)	SETD5	K222fs, K320fs	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV000818221	3	9483421	3	9441737	818221	806434		NC_000003.12:9441736:AAAAA:AAAA
NC_000003.12:g.128904465del	ACAD9		Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000816931					816931	805079		
NM_024513.4(FYCO1):c.2505del (p.Ala836fs)	FYCO1	A836fs		Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000660217	3	46008321	3	45966829	660217	631454		NC_000003.12:45966828:TT:T
NM_014049.5(ACAD9):c.1344_1348dup (p.Thr450fs)	ACAD9		Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638407	3	128627092 - 128627093	3	128908249 - 128908250	638407	626135		NC_000003.12:128908249:GACTA:GACTAGACTA
NM_001292043.2(SETD5):c.2094_2095del (p.Ser699fs)	SETD5	S699fs, S797fs	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000619990	3	9495464 - 9495465	3	9453780 - 9453781	619990	611386	rs1559451052	NC_000003.12:9453779:AT:
NM_001292043.2(SETD5):c.1489-1G>C	SETD5		Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: May 24, 2017)	no assertion criteria provided	VCV000488444	3	9489369	3	9447685	488444	481310	rs1553625691	NC_000003.12:9447684:G:C
NM_001292043.2(SETD5):c.2214dup (p.Arg739fs)	SETD5		Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Nov 25, 2016)	no assertion criteria provided	VCV000438303	3	9506139 - 9506140	3	9464455 - 9464456	438303	431908	rs1553635477	NC_000003.12:9464455:T:TT
NM_001292043.2(SETD5):c.1599_1600insA (p.Arg534fs)	SETD5		Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Mar 15, 2017)	no assertion criteria provided	VCV000438302	3	9489480 - 9489481	3	9447796 - 9447797	438302	431907	rs1553625836	NC_000003.12:9447796::A
NM_001292043.2(SETD5):c.831dup (p.Val278fs)	SETD5		Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431105	3	9485038 - 9485039	3	9443354 - 9443355	431105	424628	rs1135401767	NC_000003.12:9443354:T:TT
NM_014049.5(ACAD9):c.509C>T (p.Ala170Val)	ACAD9	A170V	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000372249	3	128615334	3	128896491	372249	359154	rs762521317	NC_000003.12:128896490:C:T
NM_001292043.2(SETD5):c.214_234+60del	SETD5		Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Aug 20, 2014)	no assertion criteria provided	VCV000219199	3	9477566 - 9477646	3	9435882 - 9435962	219199	217225	rs1553618323	
NM_001292043.2(SETD5):c.2008C>T (p.Arg670Ter)	SETD5	R768*, R670*	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Nov 10, 2012)	no assertion criteria provided	VCV000219198	3	9490270	3	9448586	219198	217224	rs864321657	NC_000003.12:9448585:C:T
NM_001292043.2(SETD5):c.3477dup (p.Ser1160fs)	SETD5		Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000127105	3	9517216 - 9517217	3	9475532 - 9475533	127105	132614	rs587777328	NC_000003.12:9475532:G:GG
NM_001292043.2(SETD5):c.901A>T (p.Lys301Ter)	SETD5	K399*, K301*	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000127102	3	9486739	3	9445055	127102	132611	rs587777325	NC_000003.12:9445054:A:T
NM_014049.5(ACAD9):c.797G>A (p.Arg266Gln)	ACAD9	R266Q	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030882	3	128618293	3	128899450	30882	39839	rs387907042	NC_000003.12:128899449:G:A
NM_014049.5(ACAD9):c.130T>A (p.Phe44Ile)	ACAD9	F44I	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030881	3	128598664	3	128879821	30881	39838	rs387907041	NC_000003.12:128879820:T:A
NM_014049.4(ACAD9):c.1249C>T	ACAD9	R417C	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030880	3	128625063	3	128906220	30880	39837	rs368949613	NC_000003.12:128906219:C:T
NM_024513.4(FYCO1):c.4127T>C (p.Leu1376Pro)	FYCO1	L1376P		Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030649	3	45972687	3	45931195	30649	39606	rs387906965	NC_000003.12:45931194:A:G
NM_024513.4(FYCO1):c.3858_3862dup (p.Leu1288fs)	FYCO1			Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030648	3	45996822 - 45996823	3	45955330 - 45955331	30648	39605		NC_000003.12:45955330:ATTCC:ATTCCATTCC
FYCO1, IVS9DS, G-T, +1	FYCO1			Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030647					30647	39604		
NM_024513.4(FYCO1):c.2206C>T (p.Gln736Ter)	FYCO1	Q736*		Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030646	3	46008620	3	45967128	30646	39603	rs387906964	NC_000003.12:45967127:G:A
NM_024513.4(FYCO1):c.1045C>T (p.Gln349Ter)	FYCO1	Q349*		Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030645	3	46009781	3	45968289	30645	39602	rs387906963	NC_000003.12:45968288:G:A
NM_000521.4(HEXB):c.552T>G (p.Tyr184Ter)	HEXB	Y184*	Sandhoff disease|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280067	5	73992558	5	74696733	280067	264274	rs573447174	NC_000005.10:74696732:T:G
nsv513799	HEXB		Sandhoff disease	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000003873					3873	18912		
NM_001080517.2(SETD5):c.922C>T (p.Arg308Ter)	SETD5	R308*, R210*	Mental retardation, autosomal dominant 23|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620169	3	9483388	3	9441704	620169	611599	rs1421204500	NC_000003.12:9441703:C:T
NM_024513.4(FYCO1):c.1546C>T (p.Gln516Ter)	FYCO1	Q516*		Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030650	3	46009280	3	45967788	30650	39607	rs387906966	NC_000003.12:45967787:G:A
NM_014049.4(ACAD9):c.1030-1G>T	ACAD9		not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000242464	3	128623228	3	128904385	242464	214385	rs773586510	NC_000003.12:128904384:G:T
NM_001099287.1(NIPAL4):c.527C>A (p.Ala176Asp)	NIPAL4	A176D, A157D	not provided|Autosomal recessive congenital ichthyosis 6	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001731	5	156895736	5	157468728	1731	16770	rs199422217	NC_000005.10:157468727:C:A
NM_001292043.2(SETD5):c.1881_1882CA[1] (p.Thr628fs)	SETD5		Mental retardation, autosomal dominant 23|Intellectual disability	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000127103	3	9490143 - 9490144	3	9448459 - 9448460	127103	132612	rs587777326	NC_000003.12:9448458:CACA:CA
NM_001041.4(SI):c.1730T>G (p.Val577Gly)	SI	V577G	not provided|Sucrase-isomaltase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001418	3	164764786	3	165046998	1418	16457	rs121912615	NC_000003.12:165046997:A:C
NM_018297.4(NGLY1):c.1242del (p.Asn415fs)	NGLY1	N373fs, N397fs, N415fs	not provided	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000817637	3	25775381	3	25733890	817637	805337		NC_000003.12:25733889:AA:A
NM_018297.4(NGLY1):c.1789+1G>T	NGLY1		not provided	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000504346	3	25761504	3	25720013	504346	495137	rs1261363915	NC_000003.12:25720012:C:A
NM_018297.4(NGLY1):c.1570dup (p.Met524fs)	NGLY1		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000503857	3	25770664 - 25770665	3	25729173 - 25729174	503857	495447	rs1553652151	NC_000003.12:25729173:TTTT:TTTTT
NM_018297.4(NGLY1):c.1264C>T (p.Gln422Ter)	NGLY1	Q404*, Q422*, Q380*	Congenital disorder of deglycosylation	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000807449	3	25773971	3	25732480	807449	798528		NC_000003.12:25732479:G:A
NM_000521.4(HEXB):c.1082+5G>A	HEXB		Sandhoff disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000354135	5	74011520	5	74715695	354135	300240	rs5030731	NC_000005.10:74715694:G:A
NM_000521.4(HEXB):c.1531_1532GA[2] (p.Arg512fs)	HEXB		Sandhoff disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194180	5	74016490 - 74016491	5	74720665 - 74720666	194180	191343	rs794727091	NC_000005.10:74720664:GAGAGA:GAGA
NM_018297.4(NGLY1):c.726dup (p.His243fs)	NGLY1		Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000843508	3	25781222 - 25781223	3	25739731 - 25739732	843508	827844		NC_000003.12:25739731:AAAAAA:AAAAAAA
NC_000003.11:g.(?_25792569)_(25792774_?)del	NGLY1		Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000647459	3	25792569 - 25792774	3	25751078 - 25751283	647459	650984		
NM_018297.4(NGLY1):c.857_873del (p.Cys286fs)	NGLY1	C286fs, C244fs	Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000541255	3	25781076 - 25781092	3	25739585 - 25739601	541255	519229	rs1375323331	NC_000003.12:25739584:TCGATTGCTGAACTGGC:
NM_018297.4(NGLY1):c.1202_1204GAA[1] (p.Arg402del)	NGLY1	R360del	Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Mar 20, 2014)	no assertion criteria provided	VCV000126423	3	25775416 - 25775418	3	25733925 - 25733927	126423	131955	rs587777266	NC_000003.12:25733924:TTCTTCT:TTCT
NM_018297.4(NGLY1):c.730T>C (p.Trp244Arg)	NGLY1	W202R, W244R	Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000221581	3	25781219	3	25739728	221581	223314	rs1135401729	NC_000003.12:25739727:A:G
NM_018297.4(NGLY1):c.1169G>C (p.Arg390Pro)	NGLY1	R348P, R390P, R372P	Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000221580	3	25775454	3	25733963	221580	223310	rs1135401728	NC_000003.12:25733962:C:G
NM_000344.3(SMN1):c.835-2A>G	SMN1		Spinal muscular atrophy|Werdnig-Hoffmann disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000632985	5	70247766	5	70951939	632985	621743	rs141760116	NC_000005.10:70951938:A:G
NM_024996.5(GFM1):c.748C>T (p.Arg250Trp)	GFM1	R250W, R269W	Combined oxidative phosphorylation deficiency|not provided|Combined oxidative phosphorylation deficiency 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030598	3	158369943	3	158652154	30598	39555	rs139430866	NC_000003.12:158652153:C:T
NM_018297.4(NGLY1):c.1231C>T (p.Arg411Ter)	NGLY1	R411*, R369*, R393*	Congenital disorder of deglycosylation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000647531	3	25775392	3	25733901	647531	631127		NC_000003.12:25733900:G:A
NM_018297.4(NGLY1):c.871C>T (p.Arg291Ter)	NGLY1	R249*, R291*	Congenital disorder of deglycosylation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000474235	3	25781078	3	25739587	474235	452272	rs772994617	NC_000003.12:25739586:G:A
NM_018297.4(NGLY1):c.1150-1G>C	NGLY1		Congenital disorder of deglycosylation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372852	3	25775474	3	25733983	372852	359521	rs532007026	NC_000003.12:25733982:C:G
NM_018297.4(NGLY1):c.881+5G>T	NGLY1		Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000221584	3	25781063	3	25739572	221584	223313	rs1135401731	NC_000003.12:25739571:C:A
NM_018297.4(NGLY1):c.930C>T (p.Gly310=)	NGLY1		Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000221583	3	25778898	3	25737407	221583	223312	rs745814294	NC_000003.12:25737406:G:A
NM_018297.4(NGLY1):c.347C>G (p.Ser116Ter)	NGLY1	S74*, S116*	Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000221579	3	25805702	3	25764211	221579	223316	rs907852687	NC_000003.12:25764210:G:C
NM_018297.4(NGLY1):c.931G>A (p.Glu311Lys)	NGLY1	E269K, E311K	Congenital disorder of deglycosylation	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000221576	3	25778897	3	25737406	221576	223311	rs201791209	NC_000003.12:25737405:C:T
NM_001106.4(ACVR2B):c.1480G>A (p.Val494Ile)	ACVR2B	V494I	Heterotaxy, visceral, 4, autosomal	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000006859	3	38524764	3	38483273	6859	21898	rs121434438	NC_000003.12:38483272:G:A
NM_001003841.3(SLC6A19):c.718C>T (p.Arg240Ter)	SLC6A19	R240*	Neutral 1 amino acid transport defect	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002020	5	1213632	5	1213517	2020	17059	rs121434347	NC_000005.10:1213516:C:T
NM_001003841.3(SLC6A19):c.882_883TG[1] (p.Val295fs)	SLC6A19		Neutral 1 amino acid transport defect	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002018	5	1214175 - 1214176	5	1214060 - 1214061	2018	17057	rs778611489	NC_000005.10:1214059:TGTG:TG
NM_001003841.3(SLC6A19):c.1017-4G>A	SLC6A19		Hyperglycinuria|Iminoglycinuria, digenic	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002021	5	1216900	5	1216785	2021	17060	rs35329108	NC_000005.10:1216784:G:A
NM_001003841.3(SLC6A19):c.1173+2T>G	SLC6A19		Neutral 1 amino acid transport defect|not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000449553	5	1217062	5	1216947	449553	443654	rs142979576	NC_000005.10:1216946:T:G
NM_020754.4(ARHGAP31):c.2182C>T (p.Gln728Ter)	ARHGAP31	Q728*	Adams-Oliver syndrome 1	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000523589	3	119132958	3	119414111	523589	514230	rs1553768038	NC_000003.12:119414110:C:T
NM_018297.4(NGLY1):c.1604G>A (p.Trp535Ter)	NGLY1	W493*, W535*, W517*	not provided|Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000221577	3	25770631	3	25729140	221577	223309	rs767388144	NC_000003.12:25729139:C:T
NM_014049.5(ACAD9):c.1553G>A (p.Arg518His)	ACAD9	R518H	not provided	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000858760	3	128628254	3	128909411	858760	827524		NC_000003.12:128909410:G:A
NM_014049.4(ACAD9):c.1237G>A	ACAD9	E413K	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242463	3	128625051	3	128906208	242463	214386	rs149753643	NC_000003.12:128906207:G:A
NM_020754.4(ARHGAP31):c.3260del (p.Lys1087fs)	ARHGAP31	K1087fs	Adams-Oliver syndrome 1	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000030858	3	119134034	3	119415187	30858	39815	rs1559999373	NC_000003.12:119415186:AAA:AA
NM_020754.4(ARHGAP31):c.2047C>T (p.Gln683Ter)	ARHGAP31	Q683*	Adams-Oliver syndrome 1	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000030857	3	119132823	3	119413976	30857	39814	rs387907031	NC_000003.12:119413975:C:T
NM_023067.4(FOXL2):c.855_871dup (p.His291fs)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus|not provided|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004866	3	138664693 - 138664694	3	138945851 - 138945852	4866	19905	rs797044532	NC_000003.12:138945851:GGGGGTGCGGCGGAGGCGGGGGTGCGGC:GGGGGTGCGGCGGAGGCGGGGGTGCGGCGGAGGCGGGGGTGCGGC
NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)	FOXL2		Blepharophimosis, ptosis, and epicanthus inversus, type II with Duane retraction syndrome|Blepharophimosis, ptosis, and epicanthus inversus|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004854	3	138664863 - 138664864	3	138946021 - 138946022	4854	19893	rs387906321	NC_000003.12:138946021:GCGGCTGCAGCCGCAGCTGCTGCAGCCGCTGCGGCTGC:GCGGCTGCAGCCGCAGCTGCTGCAGCCGCTGCGGCTGCAGCCGCAGCTGCTGCAGCCGCTGCGGCTGC
NM_152618.3(BBS12):c.1891_1892TC[1] (p.Pro632fs)	BBS12		Retinal dystrophy	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000866623	4	123664937 - 123664938	4	122743782 - 122743783	866623	856311		NC_000004.12:122743781:CTCTC:CTC
NM_152618.3(BBS12):c.1704G>A (p.Trp568Ter)	BBS12	W568*	not provided	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000195415	4	123664751	4	122743596	195415	192576	rs747904021	NC_000004.12:122743595:G:A
NM_152618.3(BBS12):c.323C>G (p.Pro108Arg)	BBS12	P108R	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000068065	4	123663370	4	122742215	68065	78956	rs151344630	NC_000004.12:122742214:C:G
NC_000004.12:g.(?_122741883)_(122744035_?)del	BBS12		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000830786	4	123663038 - 123665190			830786	819440		
NM_152618.3(BBS12):c.670dup (p.Thr224fs)	BBS12		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585192	4	123663716 - 123663717	4	122742561 - 122742562	585192	576219	rs1339432710	NC_000004.12:122742561:A:AA
NM_152618.3(BBS12):c.65T>C (p.Phe22Ser)	BBS12	F22S	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585191	4	123663112	4	122741957	585191	576218	rs565073445	NC_000004.12:122741956:T:C
NM_152618.3(BBS12):c.787dup (p.Tyr263fs)	BBS12		Bardet-Biedl syndrome 12	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000434491	4	123663832 - 123663833	4	122742677 - 122742678	434491	428271	rs1553941312	NC_000004.12:122742677:TT:TTT
NM_152618.3(BBS12):c.1483_1484del (p.Glu495fs)	BBS12	E495fs	Bardet-Biedl syndrome 12	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001149	4	123664529 - 123664530	4	122743374 - 122743375	1149	16188	rs587777802	NC_000004.12:122743373:AGA:A
NM_152618.3(BBS12):c.337_339del (p.Val113del)	BBS12	V113del	Bardet-Biedl syndrome 12	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001148	4	123663382 - 123663384	4	122742227 - 122742229	1148	16187	rs587777801	NC_000004.12:122742226:TAGTA:TA
NM_018297.4(NGLY1):c.622C>T (p.Gln208Ter)	NGLY1	Q166*, Q208*	not provided|Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000221578	3	25792625	3	25751134	221578	223315	rs200561967	NC_000003.12:25751133:G:A
NM_018297.4(NGLY1):c.1624C>T (p.Arg542Ter)	NGLY1	R500*, R542*	Congenital disorder of deglycosylation|not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000126424	3	25761670	3	25720179	126424	131956	rs528583612	NC_000003.12:25720178:G:A
NM_152618.3(BBS12):c.1949C>G (p.Ser650Ter)	BBS12	S650*	Bardet-Biedl syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553671	4	123664996	4	122743841	553671	543387	rs1553941580	NC_000004.12:122743840:C:G
NM_152618.3(BBS12):c.104C>A (p.Ser35Ter)	BBS12	S35*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000462963	4	123663151	4	122741996	462963	452952	rs1381368546	NC_000004.12:122741995:C:A
NM_021971.4(GMPPB):c.859C>T (p.Arg287Trp)	GMPPB	R287W	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225925	3	49759490	3	49722057	225925	227736	rs142908436	NC_000003.12:49722056:G:A
NM_152618.3(BBS12):c.1267del (p.Ile423fs)	BBS12	I423fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000657227	4	123664313	4	122743158	657227	631912		NC_000004.12:122743157:AA:A
NM_152618.3(BBS12):c.682_683insT (p.Gln228fs)	BBS12		Bardet-Biedl syndrome|Bardet-Biedl syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557758	4	123663729 - 123663730	4	122742574 - 122742575	557758	543369	rs770872200	NC_000004.12:122742574::T
NM_001453.3(FOXC1):c.20dup (p.Ser8fs)	FOXC1		not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000817017	6	1610699 - 1610700	6	1610464 - 1610465	817017	805488		NC_000006.12:1610464:T:TT
GRCh37/hg19 3p12.2(chr3:81539653-81596510)x1	GBE1		not provided	Pathogenic(Last reviewed: Nov 29, 2017)	no assertion criteria provided	VCV000688091	3	81539653 - 81596510			688091	675683		
NM_001453.3(FOXC1):c.1293_1294CT[2] (p.Leu433fs)	FOXC1		not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000503971	6	1611973 - 1611974	6	1611738 - 1611739	503971	495274	rs1554101091	NC_000006.12:1611737:CTCTCT:CTCT
NM_000158.4(GBE1):c.1345G>T (p.Glu449Ter)	GBE1	E449*	not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000452861	3	81630417	3	81581266	452861	443516	rs1553683560	NC_000003.12:81581265:C:A
NM_000158.4(GBE1):c.1468del (p.Leu490fs)	GBE1	L490fs	not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000449406	3	81627226	3	81578075	449406	443515	rs774465102	NC_000003.12:81578074:G:
NM_001453.3(FOXC1):c.1491C>G (p.Tyr497Ter)	FOXC1	Y497*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000375432	6	1612171	6	1611936	375432	362208	rs760676014	NC_000006.12:1611935:C:G
NM_001453.3(FOXC1):c.1265C>A (p.Ser422Ter)	FOXC1	S422*	Axenfeld-Rieger syndrome type 3	Pathogenic	no assertion criteria provided	VCV000375431	6	1611945	6	1611710	375431	362207	rs1057519482	NC_000006.12:1611709:C:A
NM_001453.3(FOXC1):c.925_949del (p.Ser309fs)	FOXC1	S309fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Oct 15, 2014)	no assertion criteria provided	VCV000375430	6	1611604 - 1611628	6	1611369 - 1611393	375430	362206	rs1057519481	NC_000006.12:1611368:CAGCGTGGACAACATCATGACGTCGC:C
NM_001453.3(FOXC1):c.116_123del (p.Ala39fs)	FOXC1	A39fs	Axenfeld-Rieger syndrome type 3	Pathogenic	no assertion criteria provided	VCV000375421	6	1610793 - 1610800	6	1610558 - 1610565	375421	362197	rs1057519472	NC_000006.12:1610557:CCGCCATGCCG:CCG
NM_001453.3(FOXC1):c.290dup (p.Lys98fs)	FOXC1		not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000289288	6	1610968 - 1610969	6	1610733 - 1610734	289288	273525	rs886044143	NC_000006.12:1610733:AA:AAA
NM_001453.3(FOXC1):c.456G>A (p.Trp152Ter)	FOXC1	W152*	not provided	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000280066	6	1611136	6	1610901	280066	264290	rs886041355	NC_000006.12:1610900:G:A
NM_001453.3(FOXC1):c.246C>G (p.Ser82Arg)	FOXC1	S82R	not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000265158	6	1610926	6	1610691	265158	259841	rs376405759	NC_000006.12:1610690:C:G
NM_001453.3(FOXC1):c.1134_1144del (p.Gly380fs)	FOXC1	G380fs	not provided	Pathogenic	no assertion criteria provided	VCV000183252	6	1611810 - 1611820	6	1611575 - 1611585	183252	181385	rs730882054	NC_000006.12:1611574:GCGGCGGCGGCGCGG:GCGG
NM_001453.3(FOXC1):c.-429C>G	FOXC1		not provided	Pathogenic	no assertion criteria provided	VCV000183251	6	1610252	6	1610017	183251	181383	rs77888940	NC_000006.12:1610016:C:G
NM_001453.3(FOXC1):c.*734A>T	FOXC1		not provided	Pathogenic	no assertion criteria provided	VCV000183249	6	1613076	6	1612841	183249	181386	rs35717904	NC_000006.12:1612840:A:T
NM_001453.3(FOXC1):c.1337_1342dup (p.Gly448_Gly449insAspGly)	FOXC1		not provided	Pathogenic	no assertion criteria provided	VCV000132835	6	1612016 - 1612017	6	1611781 - 1611782	132835	136584	rs756037576	NC_000006.12:1611781:ACGGCG:ACGGCGACGGCG
NM_001453.3(FOXC1):c.377T>G (p.Ile126Ser)	FOXC1	I126S	not provided	Pathogenic	no assertion criteria provided	VCV000100688	6	1611057	6	1610822	100688	106554	rs483352810	NC_000006.12:1610821:T:G
NM_001453.3(FOXC1):c.405C>A (p.Cys135Ter)	FOXC1	C135*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000857470	6	1611085	6	1610850	857470	831737		NC_000006.12:1610849:C:A
NM_001453.3(FOXC1):c.752_759del (p.Ala251fs)	FOXC1	A251fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000857141	6	1611429 - 1611436	6	1611194 - 1611201	857141	831741		NC_000006.12:1611193:GCGCCGCCGCG:GCG
NM_000158.4(GBE1):c.1861_1863CTT[1] (p.Leu622del)	GBE1		Glycogen storage disease, type IV	Pathogenic	no assertion criteria provided	VCV000816842	3	81584414 - 81584416	3	81535263 - 81535265	816842	805000		NC_000003.12:81535262:AAGAAGA:AAGA
NM_000158.4(GBE1):c.993-1G>T	GBE1		Glycogen storage disease, type IV	Pathogenic	no assertion criteria provided	VCV000478912	3	81643175	3	81594024	478912	472256	rs763016962	NC_000003.12:81594023:C:A
NM_001453.3(FOXC1):c.192C>G (p.Tyr64Ter)	FOXC1	Y64*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000430705	6	1610872	6	1610637	430705	424244	rs368260972	NC_000006.12:1610636:C:G
NC_000006.11:g.(?_1610680)_(1612342_?)del	FOXC1		Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Mar 24, 2015)	no assertion criteria provided	VCV000375435	6	1610680 - 1612342	6	1610445 - 1612107	375435	362195		
NM_001453.3(FOXC1):c.666_681del (p.Ile223fs)	FOXC1	I223fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000375428	6	1611345 - 1611360	6	1611110 - 1611125	375428	362204	rs1057519479	NC_000006.12:1611109:GCATCCAGGACATCAAG:G
NM_001453.3(FOXC1):c.487G>T (p.Glu163Ter)	FOXC1	E163*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Oct 7, 2015)	no assertion criteria provided	VCV000375426	6	1611167	6	1610932	375426	362202	rs1057519477	NC_000006.12:1610931:G:T
NM_000158.4(GBE1):c.2053-3358_2053-3350delinsTGTTTTTTACATGACAGGT	GBE1		Adult polyglucosan body neuropathy	Pathogenic(Last reviewed: Apr 11, 2016)	no assertion criteria provided	VCV000225145	3	81542964 - 81542972	3	81493813 - 81493821	225145	227045	rs869320698	NC_000003.12:81493812:CCACCACAC:ACCTGTCATGTAAAAAACA
NM_001453.3(FOXC1):c.261C>G (p.Ile87Met)	FOXC1	I87M	Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000008459	6	1610941	6	1610706	8459	23498	rs104893954	NC_000006.12:1610705:C:G
FOXC1, 22-BP INS, NT26	FOXC1		Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000008457					8457	23496		
NM_001453.3(FOXC1):c.392C>T (p.Ser131Leu)	FOXC1	S131L	Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000008452	6	1611072	6	1610837	8452	23491	rs104893957	NC_000006.12:1610836:C:T
FOXC1, 11-BP DEL	FOXC1		Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000008451					8451	23490		
NM_000158.4(GBE1):c.708G>C (p.Gln236His)	GBE1	Q236H	Glycogen storage disease IV, congenital neuromuscular	Pathogenic(Last reviewed: Apr 15, 2006)	no assertion criteria provided	VCV000002790	3	81695617	3	81646466	2790	17829	rs137852892	NC_000003.12:81646465:C:G
GBE1, 253-BP DEL	GBE1		Glycogen storage disease IV, congenital neuromuscular	Pathogenic(Last reviewed: Sep 28, 2004)	no assertion criteria provided	VCV000002787					2787	17826		
NM_000158.4(GBE1):c.1245_1258del (p.Gly416fs)	GBE1	G416fs	Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000862675	3	81635320 - 81635333	3	81586169 - 81586182	862675	828571		NC_000003.12:81586168:GAGCTGGCATTCCTGA:GA
NM_000158.4(GBE1):c.202_203del (p.Lys68fs)	GBE1	K68fs	Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000849345	3	81754705 - 81754706	3	81705554 - 81705555	849345	828573		NC_000003.12:81705553:TT:
NM_000158.4(GBE1):c.1300C>T (p.Arg434Ter)	GBE1	R434*	Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000836518	3	81635278	3	81586127	836518	828570		NC_000003.12:81586126:G:A
NM_000158.4(GBE1):c.1386C>G (p.Tyr462Ter)	GBE1	Y462*	Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000834756	3	81630376	3	81581225	834756	828569		NC_000003.12:81581224:G:C
NC_000003.12:g.(?_81646382)_(81670963_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000833175	3	81695533 - 81720114			833175	819420		
NC_000003.12:g.(?_81490397)_(81761527_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000832626	3	81539548 - 81810678			832626	819416		
NC_000003.12:g.(?_81642771)_(81670963_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000832400	3	81691922 - 81720114			832400	819419		
NC_000003.12:g.(?_81591027)_(81594033_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000830797	3	81640178 - 81643184			830797	819417		
NC_000003.11:g.(?_81548241)_(81810688_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000658997	3	81548241 - 81810688	3	81499090 - 81761537	658997	651052		
NC_000003.11:g.(?_81539538)_(81810688_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000649642	3	81539538 - 81810688	3	81490387 - 81761537	649642	651147		
NC_000003.11:g.(?_81810526)_(81810668_?)del	GBE1		Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000583853	3	81810526 - 81810668	3	81761375 - 81761517	583853	559231		
NM_001453.3(FOXC1):c.957del (p.Ser320fs)	FOXC1	S320fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000537391	6	1611633	6	1611398	537391	521490	rs1241813534	NC_000006.12:1611397:GGGGG:GGGG
NM_001453.3(FOXC1):c.349del (p.Asp117fs)	FOXC1	D117fs	Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000495293	6	1611027	6	1610792	495293	486790	rs1554100953	NC_000006.12:1610791:GGG:GG
NM_001453.3(FOXC1):c.599_617del (p.Gln200fs)	FOXC1	Q200fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375427	6	1611273 - 1611291	6	1611038 - 1611056	375427	362203	rs1057519478	NC_000006.12:1611037:GCCGCCAGCCCCCGCCCGCGCCGCC:GCCGCC
NM_001453.3(FOXC1):c.100_109del (p.Gly34fs)	FOXC1	G34fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Feb 8, 2015)	no assertion criteria provided	VCV000375420	6	1610780 - 1610789	6	1610545 - 1610554	375420	362196	rs1057519471	NC_000006.12:1610544:GGGGGCGGCT:
NM_001453.3(FOXC1):c.256C>T (p.Leu86Phe)	FOXC1	L86F	Axenfeld-Rieger syndrome type 3|not provided	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000265478	6	1610936	6	1610701	265478	259842	rs886039568	NC_000006.12:1610700:C:T
NM_001453.3(FOXC1):c.67C>T (p.Gln23Ter)	FOXC1	Q23*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000008455	6	1610747	6	1610512	8455	23494	rs104893952	NC_000006.12:1610511:C:T
NM_001453.3(FOXC1):c.335T>C (p.Phe112Ser)	FOXC1	F112S	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000008454	6	1611015	6	1610780	8454	23493	rs104893951	NC_000006.12:1610779:T:C
NM_001453.3(FOXC1):c.378C>G (p.Ile126Met)	FOXC1	I126M	Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008453	6	1611058	6	1610823	8453	23492	rs104893958	NC_000006.12:1610822:C:G
NM_000158.4(GBE1):c.38dup (p.Asp13fs)	GBE1		Glycogen storage disease IV, combined hepatic and myopathic	Pathogenic(Last reviewed: Sep 28, 2004)	no assertion criteria provided	VCV000002789	3	81810630 - 81810631	3	81761479 - 81761480	2789	17828		NC_000003.12:81761479:T:TT
NM_000158.4(GBE1):c.783-1G>A	GBE1		Glycogen storage disease IV, congenital neuromuscular	Pathogenic(Last reviewed: Feb 15, 1996)	no assertion criteria provided	VCV000002776	3	81692142	3	81642991	2776	17815	rs397515342	NC_000003.12:81642990:C:T
NM_001453.3(FOXC1):c.367C>T (p.Gln123Ter)	FOXC1	Q123*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000858712	6	1611047	6	1610812	858712	831736		NC_000006.12:1610811:C:T
NM_001453.3(FOXC1):c.451dup (p.Tyr151fs)	FOXC1		Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000846457	6	1611130 - 1611131	6	1610895 - 1610896	846457	831738		NC_000006.12:1610895:T:TT
NM_001453.3(FOXC1):c.1_*1790del (p.Met1fs)	FOXC1	M1fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000568112	6	1610681 - 1614132	6	1610446 - 1613897	568112	563468		
NM_001453.3(FOXC1):c.409_411del (p.Val137del)	FOXC1	V137del	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000495292	6	1611087 - 1611089	6	1610852 - 1610854	495292	486789	rs1554100963	NC_000006.12:1610851:TCGTC:TC
NC_000006.11:g.(?_1610661)_(1613076_?)del	FOXC1		Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000469647			6	1610426 - 1612841	469647	455761		
NM_000158.4(GBE1):c.415G>T (p.Gly139Ter)	GBE1	G139*	Glycogen storage disease, type IV	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000435291	3	81720003	3	81670852	435291	428221	rs1553690406	NC_000003.12:81670851:C:A
NM_001453.3(FOXC1):c.718_719del (p.Leu240fs)	FOXC1	L240fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000375429	6	1611398 - 1611399	6	1611163 - 1611164	375429	362205	rs1057519480	NC_000006.12:1611162:CT:
NM_001453.3(FOXC1):c.245G>C (p.Ser82Thr)	FOXC1	S82T	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008458	6	1610925	6	1610690	8458	23497	rs104893953	NC_000006.12:1610689:G:C
NM_001453.3(FOXC1):c.301_331del (p.Leu101fs)	FOXC1	L101fs	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000861432	6	1610978 - 1611008	6	1610743 - 1610773	861432	831735		NC_000006.12:1610742:ACCCTGAACGGCATCTACCAGTTCATCATGGACC:ACC
NM_001453.3(FOXC1):c.316C>T (p.Gln106Ter)	FOXC1	Q106*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000375424	6	1610996	6	1610761	375424	362200	rs1057519475	NC_000006.12:1610760:C:T
NM_001453.3(FOXC1):c.141C>G (p.Tyr47Ter)	FOXC1	Y47*	Axenfeld-Rieger syndrome type 3|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000100687	6	1610821	6	1610586	100687	106553	rs372857241	NC_000006.12:1610585:C:G
FOXC1, DUP	FOXC1		Anterior segment dysgenesis 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008456					8456	23495		
NM_004387.4(NKX2-5):c.777C>G (p.Tyr259Ter)	NKX2-5	Y259*	not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000379617	5	172659770	5	173232767	379617	369775	rs1057520670	NC_000005.10:173232766:G:C
NM_004387.4(NKX2-5):c.182C>G (p.Ala61Gly)	NKX2-5	A61G	Congenital heart disease	Pathogenic(Last reviewed: Apr 24, 2013)	no assertion criteria provided	VCV000219170	5	172661905	5	173234902	219170	217188	rs864321650	NC_000005.10:173234901:G:C
NM_004387.4(NKX2-5):c.443C>A (p.Ala148Glu)	NKX2-5	A148E	Congenital heart disease	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000219169	5	172660104	5	173233101	219169	217183	rs864321649	NC_000005.10:173233100:G:T
NM_004387.4(NKX2-5):c.391G>A (p.Glu131Lys)	NKX2-5	E131K	Congenital heart disease	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000219168	5	172660156	5	173233153	219168	217184	rs864321648	NC_000005.10:173233152:C:T
NM_004387.4(NKX2-5):c.335-1G>T	NKX2-5		Congenital heart disease	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000219165	5	172660213	5	173233210	219165	217185	rs864321645	NC_000005.10:173233209:C:A
NM_004387.4(NKX2-5):c.685_686dup (p.Cys230fs)	NKX2-5		not provided	Pathogenic(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	VCV000195219	5	172659860 - 172659861	5	173232857 - 173232858	195219	192380	rs797044675	NC_000005.10:173232857:GG:GGGG
NM_004387.4(NKX2-5):c.554_555insC (p.Trp185fs)	NKX2-5		not provided	Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	VCV000190839	5	172659992 - 172659993	5	173232989 - 173232990	190839	188424	rs786205826	NC_000005.10:173232989::G
NM_004387.4(NKX2-5):c.0_334+1del	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000661150	5	172661752 - 172662314	5	173234749 - 173235311	661150	651419		
NM_004387.4(NKX2-5):c.768T>G (p.Tyr256Ter)	NKX2-5	Y256*	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000254163	5	172659779	5	173232776	254163	248630	rs104893907	NC_000005.10:173232775:A:C
NM_004387.3(NKX2-5):c.-229_*465del	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000239928	5	172659107 - 172662315	5	173232104 - 173235312	239928	239513		
NM_004387.4(NKX2-5):c.443del (p.Ala148fs)	NKX2-5	A148fs	not provided	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000235042	5	172660104	5	173233101	235042	236766	rs876661381	NC_000005.10:173233100:G:
NM_004387.4(NKX2-5):c.554G>T (p.Trp185Leu)	NKX2-5	W185L	Abnormality of cardiovascular system morphology	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211672	5	172659993	5	173232990	211672	207171	rs797045792	NC_000005.10:173232989:C:A
NM_004387.4(NKX2-5):c.512T>G (p.Leu171Arg)	NKX2-5	L171R	Abnormality of cardiovascular system morphology	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211671	5	172660035	5	173233032	211671	207172	rs797045791	NC_000005.10:173233031:A:C
NM_004387.4(NKX2-5):c.471_472del (p.Phe157fs)	NKX2-5	F157fs	Malformation of the heart and great vessels	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159255	5	172660075 - 172660076	5	173233072 - 173233073	159255	168107	rs587784066	NC_000005.10:173233071:TG:
NM_004387.4(NKX2-5):c.721_728del (p.Tyr241fs)	NKX2-5	Y241fs	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000156160	5	172659819 - 172659826	5	173232816 - 173232823	156160	165959	rs587782930	NC_000005.10:173232815:ACGCCGTA:
NM_004387.4(NKX2-5):c.618del (p.Leu207fs)	NKX2-5	L207fs	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000156159	5	172659929	5	173232926	156159	165958	rs587782929	NC_000005.10:173232925:CCCC:CCC
NM_004387.4(NKX2-5):c.461A>G (p.Glu154Gly)	NKX2-5	E154G	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000156158	5	172660086	5	173233083	156158	165957	rs587782928	NC_000005.10:173233082:T:C
NM_004387.4(NKX2-5):c.769C>G (p.Pro257Ala)	NKX2-5	P257A	Ventricular septal defect 3	Pathogenic(Last reviewed: Nov 11, 2010)	no assertion criteria provided	VCV000030117	5	172659778	5	173232775	30117	39072	rs387906776	NC_000005.10:173232774:G:C
NM_004387.4(NKX2-5):c.175C>G (p.Pro59Ala)	NKX2-5	P59A	Ventricular septal defect 3	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030116	5	172661912	5	173234909	30116	39071	rs387906775	NC_000005.10:173234908:G:C
NM_004387.4(NKX2-5):c.380C>A (p.Ala127Glu)	NKX2-5	A127E	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Nov 5, 2003)	no assertion criteria provided	VCV000030113	5	172660167	5	173233164	30113	39068	rs387906774	NC_000005.10:173233163:G:T
NM_004387.4(NKX2-5):c.44A>T (p.Lys15Ile)	NKX2-5	K15I	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Nov 5, 2003)	no assertion criteria provided	VCV000030112	5	172662043	5	173235040	30112	39067	rs387906773	NC_000005.10:173235039:T:A
NM_004387.4(NKX2-5):c.547A>G (p.Lys183Glu)	NKX2-5	K183E	Atrioventricular septal defect, somatic	Pathogenic(Last reviewed: Jul 15, 2005)	no assertion criteria provided	VCV000009020	5	172660000	5	173232997	9020	24059	rs137852686	NC_000005.10:173232996:T:C
NM_004387.4(NKX2-5):c.482G>C (p.Arg161Pro)	NKX2-5	R161P	Hypothyroidism, congenital, nongoitrous, 5	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000009019	5	172660065	5	173233062	9019	24058	rs137852685	NC_000005.10:173233061:C:G
NM_004387.4(NKX2-5):c.768T>A (p.Tyr256Ter)	NKX2-5	Y256*	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000009017	5	172659779	5	173232776	9017	24056	rs104893907	NC_000005.10:173232775:A:T
NM_004387.4(NKX2-5):c.568C>T (p.Arg190Cys)	NKX2-5	R190C	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: May 15, 2005)	no assertion criteria provided	VCV000009016	5	172659979	5	173232976	9016	24055	rs104893906	NC_000005.10:173232975:G:A
NM_004387.4(NKX2-5):c.262del (p.Ala88fs)	NKX2-5	A88fs	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: May 15, 2005)	no assertion criteria provided	VCV000009015	5	172661825	5	173234822	9015	24054	rs606231360	NC_000005.10:173234821:C:
NM_004387.4(NKX2-5):c.224_225GC[2] (p.Pro77fs)	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000009013	5	172661858 - 172661859	5	173234855 - 173234856	9013	24052	rs606231359	NC_000005.10:173234854:GCGCGCG:GCGCG
NM_004387.4(NKX2-5):c.215_221del (p.Glu72fs)	NKX2-5	E72fs	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000009012	5	172661866 - 172661872	5	173234863 - 173234869	9012	24051	rs606231358	NC_000005.10:173234862:CCCAGCTC:C
NM_004387.4(NKX2-5):c.646C>T (p.Arg216Cys)	NKX2-5	R216C	Tetralogy of Fallot	Pathogenic(Last reviewed: Nov 20, 2001)	no assertion criteria provided	VCV000009010	5	172659901	5	173232898	9010	24049	rs104893905	NC_000005.10:173232897:G:A
NM_004387.4(NKX2-5):c.491C>A (p.Ser164Ter)	NKX2-5	S164*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000519074	5	172660056	5	173233053	519074	509757	rs1554093487	NC_000005.10:173233052:G:T
NM_004387.4(NKX2-5):c.543G>C (p.Gln181His)	NKX2-5	Q181H	Atrial septal defect-atrioventricular conduction defects syndrome	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000036659	5	172660004	5	173233001	36659	45321	rs72554028	NC_000005.10:173233000:C:G
NM_004387.4(NKX2-5):c.592C>T (p.Gln198Ter)	NKX2-5	Q198*	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000009006	5	172659955	5	173232952	9006	24045	rs104893903	NC_000005.10:173232951:G:A
NC_000005.10:g.(?_173232549)_(173245300_?)del	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000832452	5	172659552 - 172672303			832452	819574		
NC_000005.10:g.(?_173232273)_(173245300_?)del	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000831434	5	172659276 - 172672303			831434	819573		
NM_004387.4(NKX2-5):c.478_480delinsGTACCGTT (p.Gln160fs)	NKX2-5		not provided|Abnormality of cardiovascular system morphology	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000211670	5	172660067 - 172660069	5	173233064 - 173233066	211670	207173	rs797045790	NC_000005.10:173233063:CTG:AACGGTAC
NM_004387.4(NKX2-5):c.896A>G (p.Asp299Gly)	NKX2-5	D299G	Atrioventricular septal defect, somatic|Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000009014	5	172659651	5	173232648	9014	24053	rs137852683	NC_000005.10:173232647:T:C
NM_004387.4(NKX2-5):c.508C>T (p.Gln170Ter)	NKX2-5	Q170*	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000009005	5	172660039	5	173233036	9005	24044	rs104893901	NC_000005.10:173233035:G:A
NM_004387.4(NKX2-5):c.310A>T (p.Lys104Ter)	NKX2-5	K104*	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000853950	5	172661777	5	173234774	853950	830669		NC_000005.10:173234773:T:A
NM_004387.4(NKX2-5):c.486C>A (p.Tyr162Ter)	NKX2-5	Y162*	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000848998	5	172660061	5	173233058	848998	830668		NC_000005.10:173233057:G:T
NM_024996.5(GFM1):c.2011C>T (p.Arg671Cys)	GFM1	R671C, R690C	not provided|Combined oxidative phosphorylation deficiency 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214500	3	158408053	3	158690264	214500	210970	rs201408725	NC_000003.12:158690263:C:T
NM_001453.3(FOXC1):c.380G>A (p.Arg127His)	FOXC1	R127H	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000537389	6	1611060	6	1610825	537389	521484	rs1085307884	NC_000006.12:1610824:G:A
NM_000158.4(GBE1):c.1643G>A (p.Trp548Ter)	GBE1	W548*	Glycogen storage disease IV, congenital neuromuscular|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Apr 2, 2009)	no assertion criteria provided	VCV000002793	3	81586222	3	81537071	2793	17832	rs137852894	NC_000003.12:81537070:C:T
NM_000158.4(GBE1):c.691+5G>C	GBE1		Glycogen storage disease IV, congenital neuromuscular|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Apr 2, 2009)	no assertion criteria provided	VCV000002792	3	81698002	3	81648851	2792	17831	rs397515344	NC_000003.12:81648850:C:G
NM_000158.4(GBE1):c.784C>T (p.Arg262Cys)	GBE1	R262C	Glycogen storage disease IV, congenital neuromuscular|Polyglucosan body disease, adult	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000002791	3	81692140	3	81642989	2791	17830	rs137852893	NC_000003.12:81642988:G:A
NM_000158.4(GBE1):c.1774G>T (p.Glu592Ter)	GBE1	E592*	Glycogen storage disease IV, congenital neuromuscular|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Apr 2, 2009)	no assertion criteria provided	VCV000002786	3	81586091	3	81536940	2786	17825	rs137852890	NC_000003.12:81536939:C:A
NM_000158.3(GBE1):c.993-?_1618+?del	GBE1		Glycogen storage disease IV, congenital neuromuscular|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Apr 2, 2009)	no assertion criteria provided	VCV000002783	3	81586246 - 81691932	3	81537095 - 81642781	2783	17822		
NM_018297.4(NGLY1):c.1370dup (p.Arg458fs)	NGLY1		Congenital disorder of deglycosylation|not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126422	3	25773864 - 25773865	3	25732373 - 25732374	126422	131954	rs587777265	NC_000003.12:25732373:CCCCC:CCCCCC
NM_032383.5(HPS3):c.1163+1G>A	HPS3		Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004609	3	148863334	3	149145547	4609	19648	rs201227603	NC_000003.12:149145546:G:A
NM_004387.4(NKX2-5):c.375dup (p.Glu126fs)	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000583193	5	172660171 - 172660172	5	173233168 - 173233169	583193	565017	rs1561619801	NC_000005.10:173233168:T:TT
NM_004387.4(NKX2-5):c.147_163delinsGCCTCCT (p.Ala50fs)	NKX2-5		Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000570031	5	172661924 - 172661940	5	173234921 - 173234937	570031	560382	rs1561621507	NC_000005.10:173234920:CCTCTGGCTTGAAGGCG:AGGAGGC
NM_152618.3(BBS12):c.1009_1010del (p.Val337fs)	BBS12	V337fs	Bardet-Biedl syndrome|Bardet-Biedl syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558010	4	123664055 - 123664056	4	122742900 - 122742901	558010	543300	rs1553941369	NC_000004.12:122742899:TGT:T
NM_152618.3(BBS12):c.1320_1326dup (p.Gln443fs)	BBS12		Bardet-Biedl syndrome 12|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555788	4	123664365 - 123664366	4	122743210 - 122743211	555788	543358	rs1553941433	NC_000004.12:122743210:GTGTGATG:GTGTGATGTGTGATG
NM_152618.3(BBS12):c.265_266del (p.Leu89fs)	BBS12	L89fs	Bardet-Biedl syndrome|Bardet-Biedl syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554330	4	123663310 - 123663311	4	122742155 - 122742156	554330	543046	rs1397714772	NC_000004.12:122742154:TTTT:TT
NM_152618.3(BBS12):c.1375C>T (p.Gln459Ter)	BBS12	Q459*	Bardet-Biedl syndrome|Bardet-Biedl syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000531820	4	123664422	4	122743267	531820	520007	rs1269565757	NC_000004.12:122743266:C:T
NM_001151.4(SLC25A4):c.523del (p.Gln175fs)	SLC25A4	Q175fs	not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000215174	4	186066328	4	185145174	215174	211024	rs863224209	NC_000004.12:185145173:CC:C
NM_001151.4(SLC25A4):c.707G>C (p.Arg236Pro)	SLC25A4	R236P	Mitochondrial DNA depletion syndrome 12b (cardiomyopathic type), autosomal recessive	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268150	4	186067021	4	185145867	268150	263777	rs770816416	NC_000004.12:185145866:G:C
NM_001151.4(SLC25A4):c.111+1G>A	SLC25A4		Mitochondrial DNA depletion syndrome 12b (cardiomyopathic type), autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000066011	4	186064638	4	185143484	66011	76919	rs398122942	NC_000004.12:185143483:G:A
NM_001151.4(SLC25A4):c.311A>G (p.Asp104Gly)	SLC25A4	D104G	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000018248	4	186066117	4	185144963	18248	33287	rs28999114	NC_000004.12:185144962:A:G
NM_001151.4(SLC25A4):c.293T>C (p.Leu98Pro)	SLC25A4	L98P	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2	Pathogenic(Last reviewed: Dec 26, 2001)	no assertion criteria provided	VCV000018247	4	186066099	4	185144945	18247	33286	rs104893876	NC_000004.12:185144944:T:C
NM_001151.4(SLC25A4):c.865G>A (p.Val289Met)	SLC25A4	V289M	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000018246	4	186068093	4	185146939	18246	33285	rs104893874	NC_000004.12:185146938:G:A
NM_000158.4(GBE1):c.1239del (p.Asp413fs)	GBE1	D413fs	Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|not provided	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449407	3	81635339	3	81586188	449407	443517	rs758504480	NC_000003.12:81586187:A:
NM_000158.4(GBE1):c.288del (p.Gly97fs)	GBE1	G97fs	Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371491	3	81754620	3	81705469	371491	357326	rs1057517315	NC_000003.12:81705468:TT:T
NM_000158.4(GBE1):c.1634A>G (p.His545Arg)	GBE1	H545R	Glycogen storage disease, type IV|Glycogen storage disease IV, fatal perinatal neuromuscular	Pathogenic(Last reviewed: Apr 2, 2009)	no assertion criteria provided	VCV000002785	3	81586231	3	81537080	2785	17824	rs137852889	NC_000003.12:81537079:T:C
NM_000158.4(GBE1):c.143+1G>A	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, fatal perinatal neuromuscular	Pathogenic(Last reviewed: Apr 2, 2009)	no assertion criteria provided	VCV000002784	3	81810525	3	81761374	2784	17823	rs397515343	NC_000003.12:81761373:C:T
NM_018075.5(ANO10):c.132dup (p.Asp45fs)	ANO10		Spinocerebellar ataxia, autosomal recessive 10|Autosomal recessive cerebellar ataxia|not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162016	3	43647212 - 43647213	3	43605720 - 43605721	162016	171737	rs540331226	NC_000003.12:43605720:TTTTTTTTT:TTTTTTTTTT
NM_001151.4(SLC25A4):c.116_137del (p.Gln39fs)	SLC25A4	Q39fs	Mitochondrial DNA depletion syndrome 12b (cardiomyopathic type), autosomal recessive	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268149	4	186065922 - 186065943	4	185144768 - 185144789	268149	263776	rs886041080	NC_000004.12:185144767:AGCATGCCAGCAAACAGATCAG:
NM_001151.4(SLC25A4):c.340G>C (p.Ala114Pro)	SLC25A4	A114P	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2	Pathogenic(Last reviewed: Aug 4, 2000)	no assertion criteria provided	VCV000018245	4	186066146	4	185144992	18245	33284	rs104893873	NC_000004.12:185144991:G:C
NM_005859.5(PURA):c.281del (p.Gly94fs)	PURA	G94fs	not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000818050	5	139494045	5	140114460	818050	805414		NC_000005.10:140114459:GGG:GG
NM_005859.5(PURA):c.66dup (p.His23fs)	PURA		not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000817752	5	139493828 - 139493829	5	140114243 - 140114244	817752	805413		NC_000005.10:140114243:GGGG:GGGGG
NM_005859.5(PURA):c.38del (p.Ala13fs)	PURA	A13fs	not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000817671	5	139493804	5	140114219	817671	805410		NC_000005.10:140114218:C:
NM_005859.5(PURA):c.407_435del (p.Gln136fs)	PURA	Q136fs	not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000817473	5	139494171 - 139494199	5	140114586 - 140114614	817473	805415		NC_000005.10:140114585:GCAGGACGAGCCGCGCCGGGCGCTCAAAAGC:GC
NM_005859.5(PURA):c.45_60dup (p.Leu21fs)	PURA		not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000817057	5	139493810 - 139493811	5	140114225 - 140114226	817057	805411		NC_000005.10:140114225:GGGTTCGGGCGGCTCC:GGGTTCGGGCGGCTCCGGGTTCGGGCGGCTCC
NM_005859.5(PURA):c.53dup (p.Gly19fs)	PURA		not provided	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	VCV000817051	5	139493816 - 139493817	5	140114231 - 140114232	817051	805412		NC_000005.10:140114231:GGG:GGGG
NM_005859.5(PURA):c.451G>T (p.Glu151Ter)	PURA	E151*	not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000504386	5	139494217	5	140114632	504386	495230	rs1554129089	NC_000005.10:140114631:G:T
NM_005859.5(PURA):c.325G>T (p.Glu109Ter)	PURA	E109*	not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000504149	5	139494091	5	140114506	504149	495240	rs1554129064	NC_000005.10:140114505:G:T
NM_005859.5(PURA):c.1A>G (p.Met1Val)	PURA	M1V	not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000489294	5	139493767	5	140114182	489294	481724	rs793888530	NC_000005.10:140114181:A:G
NM_005859.5(PURA):c.733C>T (p.Arg245Ter)	PURA	R245*	not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000452792	5	139494499	5	140114914	452792	443693	rs1554129116	NC_000005.10:140114913:C:T
NM_005859.5(PURA):c.14_25delinsC (p.Asp5fs)	PURA		not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000452213	5	139493780 - 139493791	5	140114195 - 140114206	452213	443689	rs1554129000	NC_000005.10:140114194:ACAGCGGCAGCG:C
NM_005859.5(PURA):c.163C>T (p.Gln55Ter)	PURA	Q55*	not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000426145	5	139493929	5	140114344	426145	414991	rs1085307472	NC_000005.10:140114343:C:T
NM_005859.5(PURA):c.173_174insT (p.Gln59fs)	PURA		not provided	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000421948	5	139493939 - 139493940	5	140114354 - 140114355	421948	406637	rs1064795465	NC_000005.10:140114354::T
NM_005859.5(PURA):c.303_304TC[4] (p.Met104fs)	PURA		not provided	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000419325	5	139494067 - 139494068	5	140114482 - 140114483	419325	406642	rs587782992	NC_000005.10:140114482:CTCTCTC:CTCTCTCTC
NM_005859.5(PURA):c.264del (p.Ile88fs)	PURA	I88fs	not provided	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000419271	5	139494030	5	140114445	419271	406640	rs1064793761	NC_000005.10:140114444:C:
NM_005859.5(PURA):c.267del (p.Glu90fs)	PURA	E90fs	not provided	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000419131	5	139494032	5	140114447	419131	406641	rs1064793665	NC_000005.10:140114446:CC:C
NM_005859.5(PURA):c.685A>T (p.Lys229Ter)	PURA	K229*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000392795	5	139494451	5	140114866	392795	367950	rs1057524637	NC_000005.10:140114865:A:T
NM_005859.5(PURA):c.367C>T (p.Gln123Ter)	PURA	Q123*	not provided	Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	VCV000281745	5	139494133	5	140114548	281745	265982	rs886042229	NC_000005.10:140114547:C:T
NM_005859.5(PURA):c.711dup (p.Asn238fs)	PURA		not provided	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000280894	5	139494475 - 139494476	5	140114890 - 140114891	280894	264199	rs886042017	NC_000005.10:140114890:CC:CCC
NM_005859.5(PURA):c.42_57del (p.Leu15fs)	PURA	L15fs	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000280744	5	139493803 - 139493818	5	140114218 - 140114233	280744	264238	rs886041894	NC_000005.10:140114217:GCGGCGCTGGGTTCGGGCGGC:GCGGC
NM_005859.5(PURA):c.116dup (p.Gly40fs)	PURA		not provided	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000280576	5	139493877 - 139493878	5	140114292 - 140114293	280576	264244	rs886041754	NC_000005.10:140114292:GGGGG:GGGGGG
NM_005859.5(PURA):c.804_805AC[2] (p.Thr270fs)	PURA		not provided	Pathogenic(Last reviewed: Mar 5, 2016)	criteria provided, single submitter	VCV000280386	5	139494570 - 139494571	5	140114985 - 140114986	280386	264176	rs886041600	NC_000005.10:140114984:ACACAC:ACAC
NM_005859.5(PURA):c.458G>C (p.Arg153Pro)	PURA	R153P	not provided	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000265539	5	139494224	5	140114639	265539	259811	rs886039610	NC_000005.10:140114638:G:C
NM_005859.5(PURA):c.509_515del (p.Ile170fs)	PURA	I170fs	not provided	Pathogenic(Last reviewed: Nov 26, 2015)	criteria provided, single submitter	VCV000252653	5	139494273 - 139494279	5	140114688 - 140114694	252653	246974	rs879255390	NC_000005.10:140114687:CATCCGCCA:CA
NM_005859.5(PURA):c.379dup (p.Ser127fs)	PURA		not provided	Pathogenic(Last reviewed: Feb 17, 2015)	criteria provided, single submitter	VCV000192345	5	139494144 - 139494145	5	140114559 - 140114560	192345	190127	rs793888538	NC_000005.10:140114559:A:AA
NM_005859.5(PURA):c.305T>G (p.Leu102Arg)	PURA	L102R	not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000192338	5	139494071	5	140114486	192338	190126	rs793888531	NC_000005.10:140114485:T:G
NM_005859.5(PURA):c.424dup (p.Ala142fs)	PURA		PURA Syndrome	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000692074	5	139494187 - 139494188	5	140114602 - 140114603	692074	679745		NC_000005.10:140114602:GGG:GGGG
NM_005211.3(CSF1R):c.1929C>A (p.His643Gln)	CSF1R	H643Q	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635125	5	149440465	5	150060902	635125	622960	rs184499252	NC_000005.10:150060901:G:T
NM_005211.3(CSF1R):c.1754-1G>C	CSF1R		BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635124	5	149441159	5	150061596	635124	622959	rs1561913526	NC_000005.10:150061595:C:G
NM_005211.3(CSF1R):c.1969+115_1969+116del	CSF1R		BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635123	5	149440309 - 149440310	5	150060746 - 150060747	635123	622958		NC_000005.10:150060745:CT:
NM_005211.3(CSF1R):c.1859-119G>A	CSF1R		BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635121	5	149440654	5	150061091	635121	622956	rs1561912628	NC_000005.10:150061090:C:T
NM_005211.3(CSF1R):c.395C>T (p.Pro132Leu)	CSF1R	P132L	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635119	5	149459812	5	150080249	635119	622954	rs1351319114	NC_000005.10:150080248:G:A
NM_005859.5(PURA):c.734G>C (p.Arg245Pro)	PURA	R245P	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000545025	5	139494500	5	140114915	545025	535289	rs1554129118	NC_000005.10:140114914:G:C
NM_005859.5(PURA):c.725dup (p.Phe243fs)	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488584	5	139494490 - 139494491	5	140114905 - 140114906	488584	481452	rs1554129114	NC_000005.10:140114905:T:TT
NM_005859.5(PURA):c.364_365GC[3] (p.Gln123fs)	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000488583	5	139494128 - 139494129	5	140114543 - 140114544	488583	481451	rs1554129069	NC_000005.10:140114543:CGCGC:CGCGCGC
NM_005859.5(PURA):c.675_676TG[1] (p.Val226fs)	PURA		not provided	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424155	5	139494441 - 139494442	5	140114856 - 140114857	424155	406645	rs1064796830	NC_000005.10:140114855:TGTG:TG
NM_005859.5(PURA):c.745del (p.Glu248_Val249insTer)	PURA		not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000192346	5	139494510	5	140114925	192346	190131	rs793888539	NC_000005.10:140114924:GG:G
NM_005859.5(PURA):c.4_8del (p.Ala2fs)	PURA	A2fs	not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000192344	5	139493770 - 139493774	5	140114185 - 140114189	192344	190123	rs793888537	NC_000005.10:140114184:GCGGA:
NM_005211.3(CSF1R):c.2632C>A (p.Pro878Thr)	CSF1R	P878T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038383	5	149434822	5	150055259	38383	46944	rs281860280	NC_000005.10:150055258:G:T
NM_005211.3(CSF1R):c.2603T>C (p.Leu868Pro)	CSF1R	L868P	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038382	5	149434851	5	150055288	38382	46943	rs281860278	NC_000005.10:150055287:A:G
NM_001288705.2(CSF1R):c.2543_2545TCT[1] (p.Phe849del)	CSF1R	F849del	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038381	5	149435595 - 149435597	5	150056032 - 150056034	38381	46942	rs281860276	NC_000005.10:150056031:AGAAGA:AGA
NM_005211.3(CSF1R):c.2546T>C (p.Phe849Ser)	CSF1R	F849S	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038380	5	149435597	5	150056034	38380	46941	rs281860277	NC_000005.10:150056033:A:G
NM_005211.3(CSF1R):c.2442+5G>C	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038379	5	149435777	5	150056214	38379	46940	rs281860275	NC_000005.10:150056213:C:G
NM_005211.3(CSF1R):c.2324T>A (p.Ile775Asn)	CSF1R	I775N	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038377	5	149435900	5	150056337	38377	46938	rs281860273	NC_000005.10:150056336:A:T
NM_005211.3(CSF1R):c.2320-2A>G	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038376	5	149435906	5	150056343	38376	46937	rs281860272	NC_000005.10:150056342:T:C
NM_005211.3(CSF1R):c.2308G>C (p.Ala770Pro)	CSF1R	A770P	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038375	5	149436861	5	150057298	38375	46936	rs281860271	NC_000005.10:150057297:C:G
NM_005211.3(CSF1R):c.2297T>C (p.Met766Thr)	CSF1R	M766T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038374	5	149436872	5	150057309	38374	46935	rs281860270	NC_000005.10:150057308:A:G
NM_005211.3(CSF1R):c.1766G>A (p.Gly589Glu)	CSF1R	G589E	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038373	5	149441146	5	150061583	38373	46934	rs281860268	NC_000005.10:150061582:C:T
NM_000481.3(AMT):c.878-1G>A	AMT		Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011981	3	49455407	3	49417974	11981	27020	rs181134220	NC_000003.12:49417973:C:T
NM_005859.5(PURA):c.149_156dup (p.Gly53fs)	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jun 27, 2019)	no assertion criteria provided	VCV000827803	5	139493911 - 139493912	5	140114326 - 140114327	827803	815979		NC_000005.10:140114326:GGGCCCCAGGG:GGGCCCCAGGGCCCCAGGG
NM_005859.5(PURA):c.382dup (p.Gln128fs)	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000579296	5	139494146 - 139494147	5	140114561 - 140114562	579296	564832	rs1561793211	NC_000005.10:140114561:CC:CCC
NM_005859.5(PURA):c.619_625del (p.Asp207fs)	PURA	D207fs	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000569862	5	139494385 - 139494391	5	140114800 - 140114806	569862	560274	rs1561793344	NC_000005.10:140114799:GACGACT:
NM_001288705.2(CSF1R):c.2527_2530delinsGGCA (p.Ile843_Leu844delinsGlyIle)	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	VCV000549854	5	149435613 - 149435616	5	150056050 - 150056053	549854	540579	rs1561904557	NC_000005.10:150056049:GGAT:TGCC
NM_005859.5(PURA):c.616A>T (p.Ile206Phe)	PURA	I206F	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000189318	5	139494382	5	140114797	189318	187206	rs786204834	NC_000005.10:140114796:A:T
NM_005859.5(PURA):c.724_725GT[1] (p.Phe243fs)	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000189317	5	139494490 - 139494491	5	140114905 - 140114906	189317	187205	rs786204833	NC_000005.10:140114904:GTGT:GT
NM_005211.3(CSF1R):c.2294G>A (p.Gly765Asp)	CSF1R	G765D	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162130	5	149436875	5	150057312	162130	171841	rs690016566	NC_000005.10:150057311:C:T
NM_005211.3(CSF1R):c.2562T>A (p.Asn854Lys)	CSF1R	N854K	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162129	5	149434892	5	150055329	162129	171829	rs690016565	NC_000005.10:150055328:A:T
NM_005211.3(CSF1R):c.2350G>A (p.Val784Met)	CSF1R	V784M	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162128	5	149435874	5	150056311	162128	171838	rs690016564	NC_000005.10:150056310:C:T
NM_005211.3(CSF1R):c.1745T>C (p.Leu582Pro)	CSF1R	L582P	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162127	5	149441294	5	150061731	162127	171844	rs690016563	NC_000005.10:150061730:A:G
NM_005211.3(CSF1R):c.2467C>T	CSF1R	A823V	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162126	5	149435675	5	150056112	162126	171835	rs690016562	NC_000005.10:150056111:G:A
NM_005211.3(CSF1R):c.2378A>C (p.Lys793Thr)	CSF1R	K793T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162125	5	149435846	5	150056283	162125	171837	rs690016561	NC_000005.10:150056282:T:G
NM_005211.3(CSF1R):c.2717T>C (p.Ile906Thr)	CSF1R	I906T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162124	5	149433931	5	150054368	162124	171824	rs690016560	NC_000005.10:150054367:A:G
NM_005211.3(CSF1R):c.1957T>C (p.Cys653Arg)	CSF1R	C653R	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162123	5	149440437	5	150060874	162123	171842	rs690016559	NC_000005.10:150060873:A:G
NM_005211.3(CSF1R):c.2527A>T (p.Ile843Phe)	CSF1R	I843F	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162122	5	149435616	5	150056053	162122	171832	rs690016558	NC_000005.10:150056052:T:A
NM_005211.3(CSF1R):c.2512G>C (p.Val838Leu)	CSF1R	V838L	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162121	5	149435631	5	150056068	162121	171833	rs690016557	NC_000005.10:150056067:C:G
NM_005211.3(CSF1R):c.2528T>A (p.Ile843Asn)	CSF1R	I843N	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162119	5	149435615	5	150056052	162119	171831	rs690016555	NC_000005.10:150056051:A:T
NM_005211.3(CSF1R):c.2655-2A>G	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162117	5	149433995	5	150054432	162117	171826	rs690016554	NC_000005.10:150054431:T:C
NM_005211.3(CSF1R):c.2701C>T (p.Pro901Ser)	CSF1R	P901S	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162116	5	149433947	5	150054384	162116	171825	rs690016553	NC_000005.10:150054383:G:A
NM_005211.3(CSF1R):c.2566T>C (p.Tyr856His)	CSF1R	Y856H	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162115	5	149434888	5	150055325	162115	171828	rs690016552	NC_000005.10:150055324:A:G
NM_005211.3(CSF1R):c.2541G>C (p.Glu847Asp)	CSF1R	E847D	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162114	5	149435602	5	150056039	162114	171830	rs690016551	NC_000005.10:150056038:C:G
NM_005211.3(CSF1R):c.2480T>C (p.Ile827Thr)	CSF1R	I827T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162113	5	149435663	5	150056100	162113	171834	rs690016550	NC_000005.10:150056099:A:G
NM_005211.3(CSF1R):c.2450T>C (p.Leu817Pro)	CSF1R	L817P	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162112	5	149435693	5	150056130	162112	171836	rs690016549	NC_000005.10:150056129:A:G
NM_005211.3(CSF1R):c.1889T>G (p.Leu630Arg)	CSF1R	L630R	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162110	5	149440505	5	150060942	162110	171843	rs690016547	NC_000005.10:150060941:A:C
NM_005211.3(CSF1R):c.1699del (p.Thr567fs)	CSF1R	T567fs	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162109	5	149441340	5	150061777	162109	171845	rs690016546	NC_000005.10:150061776:T:
NM_005859.5(PURA):c.263_265del (p.Ile88_Ala89delinsThr)	PURA		Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia|Seizures	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156412	5	139494029 - 139494031	5	140114444 - 140114446	156412	166191	rs587783000	NC_000005.10:140114443:TCG:
NM_005859.5(PURA):c.265G>C (p.Ala89Pro)	PURA	A89P	Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia|Seizures	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156411	5	139494031	5	140114446	156411	166190	rs587782999	NC_000005.10:140114445:G:C
NM_005859.5(PURA):c.470T>A (p.Met157Lys)	PURA	M157K	Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156410	5	139494236	5	140114651	156410	166189	rs587782998	NC_000005.10:140114650:T:A
NM_005859.5(PURA):c.783C>G (p.Tyr261Ter)	PURA	Y261*	Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia|Seizures	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156409	5	139494549	5	140114964	156409	166188	rs587782997	NC_000005.10:140114963:C:G
NM_005211.3(CSF1R):c.2483T>C (p.Phe828Ser)	CSF1R	F828S	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000065686	5	149435660	5	150056097	65686	76594	rs397515557	NC_000005.10:150056096:A:G
NM_005211.3(CSF1R):c.1958G>A (p.Cys653Tyr)	CSF1R	C653Y	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000065684	5	149440436	5	150060873	65684	76592	rs397515555	NC_000005.10:150060872:C:T
NM_005211.3(CSF1R):c.2509G>T (p.Asp837Tyr)	CSF1R	D837Y	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 25, 2011)	no assertion criteria provided	VCV000029814	5	149435634	5	150056071	29814	38769	rs387906662	NC_000005.10:150056070:C:A
NM_005859.5(PURA):c.339C>G (p.Tyr113Ter)	PURA	Y113*	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000656180	5	139494105	5	140114520	656180	633504		NC_000005.10:140114519:C:G
NM_005859.5(PURA):c.312del (p.Met104fs)	PURA	M104fs	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000645290	5	139494078	5	140114493	645290	633503		NC_000005.10:140114492:G:
NM_005859.5(PURA):c.175C>T (p.Gln59Ter)	PURA	Q59*	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000582890	5	139493941	5	140114356	582890	562878	rs1561793115	NC_000005.10:140114355:C:T
NM_005859.5(PURA):c.10C>T (p.Arg4Ter)	PURA	R4*	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000571407	5	139493776	5	140114191	571407	564817	rs1561792945	NC_000005.10:140114190:C:T
NM_005211.3(CSF1R):c.2330G>A (p.Arg777Gln)	CSF1R	R777Q	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000162111	5	149435894	5	150056331	162111	171840	rs690016548	NC_000005.10:150056330:C:T
NM_005211.3(CSF1R):c.2342C>A (p.Ala781Glu)	CSF1R	A781E	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000120324	5	149435882	5	150056319	120324	125919	rs587777247	NC_000005.10:150056318:G:T
NM_005211.3(CSF1R):c.2442+1G>T	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000120323	5	149435781	5	150056218	120323	125918	rs587777246	NC_000005.10:150056217:C:A
NM_005211.3(CSF1R):c.2060dup (p.Ser688fs)	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000120322	5	149439334 - 149439335	5	150059771 - 150059772	120322	125917	rs587777245	NC_000005.10:150059771:A:AA
NM_005211.3(CSF1R):c.2329C>T (p.Arg777Trp)	CSF1R	R777W	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000065685	5	149435895	5	150056332	65685	76593	rs397515556	NC_000005.10:150056331:G:A
NM_005211.3(CSF1R):c.1754-2A>G	CSF1R		Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000029812	5	149441160	5	150061597	29812	38767	rs281860267	NC_000005.10:150061596:T:C
NC_000005.10:g.(?_140114162)_(140115170_?)del	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831076	5	139493747 - 139494755			831076	819560		
NM_005859.5(PURA):c.119del (p.Gly40fs)	PURA	G40fs	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000649228	5	139493884	5	140114299	649228	633500		NC_000005.10:140114298:GG:G
NM_005859.5(PURA):c.640G>T (p.Glu214Ter)	PURA	E214*	Limb dystonia|Generalized hypotonia|Apnea|Mental retardation, autosomal dominant 31	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635405	5	139494406	5	140114821	635405	623231		NC_000005.10:140114820:G:T
NM_005859.5(PURA):c.494_497dup (p.Phe167fs)	PURA		Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000575389	5	139494257 - 139494258	5	140114672 - 140114673	575389	564833	rs1561793268	NC_000005.10:140114672:CGGCCG:CGGCCGGCCG
NM_005859.5(PURA):c.205C>T (p.Gln69Ter)	PURA	Q69*	not provided|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489041	5	139493971	5	140114386	489041	481725	rs1554129045	NC_000005.10:140114385:C:T
NM_005859.5(PURA):c.302_310del (p.Thr101_Ser103del)	PURA		not provided|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000192340	5	139494067 - 139494075	5	140114482 - 140114490	192340	190125	rs793888533	NC_000005.10:140114481:ACTCTCTCCA:A
NM_005859.5(PURA):c.363C>G (p.Tyr121Ter)	PURA	Y121*	Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia|Seizures|not provided	Pathogenic(Last reviewed: Dec 23, 2016)	criteria provided, single submitter	VCV000156408	5	139494129	5	140114544	156408	166187	rs587782996	NC_000005.10:140114543:C:G
NM_005211.3(CSF1R):c.2345G>A (p.Arg782His)	CSF1R	R782H	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Mar 12, 2013)	no assertion criteria provided	VCV000038378	5	149435879	5	150056316	38378	46939	rs281860281	NC_000005.10:150056315:C:T
NM_005211.3(CSF1R):c.2381T>C (p.Ile794Thr)	CSF1R	I794T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Jan 14, 2014)	no assertion criteria provided	VCV000029813	5	149435843	5	150056280	29813	38768	rs281860274	NC_000005.10:150056279:A:G
NM_005211.3(CSF1R):c.1897G>A (p.Glu633Lys)	CSF1R	E633K	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000029811	5	149440497	5	150060934	29811	38766	rs281860269	NC_000005.10:150060933:C:T
NM_005211.3(CSF1R):c.2624T>C (p.Met875Thr)	CSF1R	M875T	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000029810	5	149434830	5	150055267	29810	38765	rs281860279	NC_000005.10:150055266:A:G
NM_005859.5(PURA):c.487C>T (p.Gln163Ter)	PURA	Q163*	Mental retardation, autosomal dominant 31|not provided	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451895	5	139494253	5	140114668	451895	443692	rs1554129091	NC_000005.10:140114667:C:T
NM_005859.5(PURA):c.556C>T (p.Gln186Ter)	PURA	Q186*	Neonatal hypotonia|Global developmental delay|Seizures|Delayed speech and language development|Intellectual disability|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000156405	5	139494322	5	140114737	156405	166184	rs587782993	NC_000005.10:140114736:C:T
NM_001453.3(FOXC1):c.358C>T (p.Gln120Ter)	FOXC1	Q120*	Axenfeld-Rieger syndrome type 3	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000008461	6	1611038	6	1610803	8461	23500	rs121909339	NC_000006.12:1610802:C:T
NM_000158.4(GBE1):c.771T>A (p.Phe257Leu)	GBE1	F257L	not provided|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000002780	3	81695554	3	81646403	2780	17819	rs137852887	NC_000003.12:81646402:A:T
NM_001151.4(SLC25A4):c.703C>G (p.Arg235Gly)	SLC25A4	R235G	Mitochondrial diseases|Mitochondrial DNA depletion syndrome 12a (cardiomyopathic type), autosomal dominant	Pathogenic(Last reviewed: Nov 15, 2016)	no assertion criteria provided	VCV000253038	4	186067017	4	185145863	253038	247445	rs886041082	NC_000004.12:185145862:C:G
NM_000539.3(RHO):c.328T>C (p.Cys110Arg)	RHO	C110R	Retinal dystrophy	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000867081	3	129247904	3	129529061	867081	856280		NC_000003.12:129529060:T:C
NM_000539.3(RHO):c.512C>A (p.Pro171Gln)	RHO	P171Q	Retinal dystrophy	Pathogenic(Last reviewed: Aug 10, 2019)	criteria provided, single submitter	VCV000866418	3	129249869	3	129531026	866418	856283		NC_000003.12:129531025:C:A
NM_000539.3(RHO):c.152G>T (p.Gly51Val)	RHO	G51V	Retinal dystrophy	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000866399	3	129247728	3	129528885	866399	856276		NC_000003.12:129528884:G:T
NM_000539.3(RHO):c.341G>T (p.Gly114Val)	RHO	G114V	Retinal dystrophy	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000866113	3	129247917	3	129529074	866113	856281		NC_000003.12:129529073:G:T
NM_000539.3(RHO):c.359del (p.Gly120fs)	RHO	G120fs	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000373094	3	129247933	3	129529090	373094	359524	rs1057518210	NC_000003.12:129529089:GGG:GG
NM_000539.3(RHO):c.646del (p.Pro215_Met216insTer)	RHO		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000860227	3	129251209	3	129532366	860227	827538		NC_000003.12:129532365:A:
NM_000027.4(AGA):c.859C>T (p.Gln287Ter)	AGA	Q277*, Q287*	Aspartylglucosaminuria	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000852651	4	178354449	4	177433295	852651	828960		NC_000004.12:177433294:G:A
NM_000027.4(AGA):c.555_558del (p.Gly186fs)	AGA	G186fs	Aspartylglucosaminuria	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000835340	4	178358623 - 178358626	4	177437469 - 177437472	835340	828961		NC_000004.12:177437468:ACCA:
NM_000027.4(AGA):c.367_368AC[4] (p.Leu126fs)	AGA		Aspartylglucosaminuria	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000835213	4	178360748 - 178360749	4	177439594 - 177439595	835213	828963		NC_000004.12:177439593:GTGTGTGTGT:GTGTGTGT
NM_000539.3(RHO):c.937-2A>T	RHO		Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802007	3	129252449	3	129533606	802007	790332		NC_000003.12:129533605:A:T
NM_000539.3(RHO):c.557C>G (p.Ser186Trp)	RHO	S186W	Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802006	3	129251120	3	129532277	802006	790331		NC_000003.12:129532276:C:G
NM_000539.3(RHO):c.538C>A (p.Pro180Thr)	RHO	P180T	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000625303	3	129251101	3	129532258	625303	613635	rs1560046837	NC_000003.12:129532257:C:A
NM_000027.4(AGA):c.216del (p.Ser72_Val73insTer)	AGA		Aspartylglucosaminuria	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623289	4	178361492	4	177440338	623289	612269	rs1560950739	NC_000004.12:177440337:A:
NM_000539.3(RHO):c.549dup (p.Gln184fs)	RHO		Congenital hypomyelinating neuropathy 2	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000590911	3	129251111 - 129251112	3	129532268 - 129532269	590911	581855	rs1560046845	NC_000003.12:129532268:G:GG
NM_000539.3(RHO):c.482G>A (p.Trp161Ter)	RHO	W161*	Retinitis pigmentosa 4, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029875	3	129249839	3	129530996	29875	38830	rs869320618	NC_000003.12:129530995:G:A
NM_000539.3(RHO):c.281C>T (p.Thr94Ile)	RHO	T94I	Congenital stationary night blindness, autosomal dominant 1	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000013054	3	129247857	3	129529014	13054	28093	rs104893796	NC_000003.12:129529013:C:T
NM_000539.3(RHO):c.269G>A (p.Gly90Asp)	RHO	G90D	Congenital stationary night blindness, autosomal dominant 1	Pathogenic(Last reviewed: Feb 17, 1994)	no assertion criteria provided	VCV000013045	3	129247845	3	129529002	13045	28084	rs104893790	NC_000003.12:129529001:G:A
NM_000539.3(RHO):c.875C>A (p.Ala292Glu)	RHO	A292E	Congenital stationary night blindness, autosomal dominant 1	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000013044	3	129251554	3	129532711	13044	28083	rs104893789	NC_000003.12:129532710:C:A
RHO, IVS4AS, G-T, +1	RHO		Retinitis pigmentosa 4	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000013039					13039	28078		
NM_000027.4(AGA):c.214T>C (p.Ser72Pro)	AGA	S72P	Aspartylglucosaminuria	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000000229	4	178361494	4	177440340	229	15268	rs121964909	NC_000004.12:177440339:A:G
NM_000027.4(AGA):c.800del (p.Leu267fs)	AGA	L267fs, L257fs	Aspartylglucosaminuria	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000000228	4	178355542	4	177434388	228	15267	rs794728009	NC_000004.12:177434387:A:
NM_000027.4(AGA):c.916T>C (p.Cys306Arg)	AGA	C306R, C296R	Aspartylglucosaminuria	Pathogenic(Last reviewed: Dec 15, 1991)	no assertion criteria provided	VCV000000221	4	178354392	4	177433238	221	15260	rs121964906	NC_000004.12:177433237:A:G
NM_000027.4(AGA):c.904G>A (p.Gly302Arg)	AGA	G302R, G292R	Aspartylglucosaminuria	Pathogenic(Last reviewed: Dec 15, 1991)	no assertion criteria provided	VCV000000220	4	178354404	4	177433250	220	15259	rs121964905	NC_000004.12:177433249:C:T
NM_000027.4(AGA):c.367_371del (p.Thr123fs)	AGA	T123fs	Aspartylglucosaminuria	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000855317	4	178360753 - 178360757	4	177439599 - 177439603	855317	828964		NC_000004.12:177439598:TGTGTTGT:TGT
NM_000539.3(RHO):c.302G>T (p.Gly101Val)	RHO	G101V	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000625301	3	129247878	3	129529035	625301	613633	rs759945007	NC_000003.12:129529034:G:T
NM_000539.3(RHO):c.891C>G (p.Ser297Arg)	RHO	S297R	Rod-cone dystrophy|Abnormality of retinal pigmentation|Optic disc drusen|Nystagmus|Unilateral strabismus|Progressive visual loss|Blindness|Retinal detachment|Cataract (disease)|Retinal exudate|Exudative retinopathy	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523376	3	129251570	3	129532727	523376	513938	rs142285818	NC_000003.12:129532726:C:G
NM_000539.3(RHO):c.946del (p.Cys316fs)	RHO	C316fs	Autosomal dominant retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	VCV000419250	3	129252460	3	129533617	419250	406115	rs1064793749	NC_000003.12:129533616:T:
NM_000027.4(AGA):c.473G>A (p.Trp158Ter)	AGA	W158*	Aspartylglucosaminuria	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370266	4	178359933	4	177438779	370266	357331	rs745976989	NC_000004.12:177438778:C:T
NM_000027.4(AGA):c.367_368AC[3] (p.Thr125fs)	AGA		Aspartylglucosaminuria	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000055944	4	178360748 - 178360751	4	177439594 - 177439597	55944	70583	rs386833425	NC_000004.12:177439593:GTGTGTGTGT:GTGTGT
NM_000539.3(RHO):c.67C>G (p.Pro23Ala)	RHO	P23A	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000013055	3	129247643	3	129528800	13055	28094	rs104893797	NC_000003.12:129528799:C:G
NM_000539.3(RHO):c.1033G>C (p.Val345Leu)	RHO	V345L	Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 15, 1994)	no assertion criteria provided	VCV000013052	3	129252547	3	129533704	13052	28091	rs104893795	NC_000003.12:129533703:G:C
NM_000539.3(RHO):c.789_791CTG[1] (p.Cys264del)	RHO	C264del	Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 15, 1994)	no assertion criteria provided	VCV000013051	3	129251468 - 129251470	3	129532625 - 129532627	13051	28090	rs121918590	NC_000003.12:129532624:CTGCTG:CTG
NM_000539.3(RHO):c.491C>A (p.Ala164Glu)	RHO	A164E	Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 15, 1994)	no assertion criteria provided	VCV000013049	3	129249848	3	129531005	13049	28088	rs104893793	NC_000003.12:129531004:C:A
NM_000539.3(RHO):c.341G>A (p.Gly114Asp)	RHO	G114D	Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 15, 1994)	no assertion criteria provided	VCV000013048	3	129247917	3	129529074	13048	28087	rs104893788	NC_000003.12:129529073:G:A
NM_000539.3(RHO):c.151G>C (p.Gly51Arg)	RHO	G51R	Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 15, 1994)	no assertion criteria provided	VCV000013047	3	129247727	3	129528884	13047	28086	rs104893792	NC_000003.12:129528883:G:C
RHO, 12-BP DEL, EX1	RHO		Retinitis pigmentosa 4	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000013031					13031	28070		
NM_000539.3(RHO):c.569A>G (p.Asp190Gly)	RHO	D190G	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000013026	3	129251132	3	129532289	13026	28065	rs104893777	NC_000003.12:129532288:A:G
NM_000539.3(RHO):c.260T>A (p.Val87Asp)	RHO	V87D	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000013020	3	129247836	3	129528993	13020	28059	rs104893771	NC_000003.12:129528992:T:A
NM_000539.3(RHO):c.133T>C (p.Phe45Leu)	RHO	F45L	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000013019	3	129247709	3	129528866	13019	28058	rs104893770	NC_000003.12:129528865:T:C
RHO, 3-BP DEL, ILE255DEL	RHO	I255del	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000013017					13017	28056		
NM_005211.3(CSF1R):c.2342C>T (p.Ala781Val)	CSF1R	A781V	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	VCV000162118	5	149435882	5	150056319	162118	171839	rs587777247	NC_000005.10:150056318:G:A
NM_005859.5(PURA):c.289A>G (p.Lys97Glu)	PURA	K97E	Neonatal hypotonia|Global developmental delay|Seizures|Delayed speech and language development|Intellectual disability|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000156406	5	139494055	5	140114470	156406	166185	rs587782994	NC_000005.10:140114469:A:G
NM_000539.3(RHO):c.548_638dup (p.Ile214fs)	RHO		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812396	3	129251109 - 129251110	3	129532266 - 129532267	812396	800487		
NM_000539.3(RHO):c.562G>A (p.Gly188Arg)	RHO	G188R	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143081	3	129251125	3	129532282	143081	152799	rs527236100	NC_000003.12:129532281:G:A
NM_000539.3(RHO):c.520G>A (p.Gly174Ser)	RHO	G174S	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143080	3	129249877	3	129531034	143080	152798	rs527236103	NC_000003.12:129531033:G:A
NM_000027.4(AGA):c.336del (p.Ile112fs)	AGA	I112fs	Aspartylglucosaminuria	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000055941	4	178360788	4	177439634	55941	70580	rs386833422	NC_000004.12:177439633:AA:A
NM_000539.3(RHO):c.1040C>A (p.Pro347Gln)	RHO	P347Q	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000013053	3	129252554	3	129533711	13053	28092	rs29001566	NC_000003.12:129533710:C:A
NM_000539.3(RHO):c.886A>G (p.Lys296Glu)	RHO	K296E	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000013030	3	129251565	3	129532722	13030	28069	rs29001653	NC_000003.12:129532721:A:G
NM_000539.3(RHO):c.1039C>T (p.Pro347Ser)	RHO	P347S	Retinitis pigmentosa 4	Pathogenic(Last reviewed: Nov 26, 1996)	no assertion criteria provided	VCV000013015	3	129252553	3	129533710	13015	28054	rs29001637	NC_000003.12:129533709:C:T
NM_000027.4(AGA):c.127_128insATGCGG (p.Ala43_Trp44insAspAla)	AGA		Aspartylglucosaminuria	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000000226	4	178363402 - 178363403	4	177442248 - 177442249	226	15265	rs386833418	NC_000004.12:177442248:C:CCGCATC
NM_000027.4(AGA):c.102_108del (p.Thr33_Trp34insTer)	AGA		Aspartylglucosaminuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 1991)	no assertion criteria provided	VCV000000224	4	178363422 - 178363428	4	177442268 - 177442274	224	15263	rs386833417	NC_000004.12:177442267:AAAGGGC:
NM_000521.4(HEXB):c.115del (p.Val39fs)	HEXB	V39fs	not provided|Sandhoff disease	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093194	5	73981199	5	74685374	93194	99101	rs398123443	NC_000005.10:74685373:GG:G
NM_000539.3(RHO):c.936+1G>T	RHO		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000855043	3	129251616	3	129532773	855043	851025		NC_000003.12:129532772:G:T
NM_000539.3(RHO):c.538C>T (p.Pro180Ser)	RHO	P180S	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000838718	3	129251101	3	129532258	838718	827536		NC_000003.12:129532257:C:T
NM_000539.3(RHO):c.810C>A (p.Ser270Arg)	RHO	S270R	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636084	3	129251489	3	129532646	636084	623832		NC_000003.12:129532645:C:A
NM_000027.4(AGA):c.101_107del (p.Trp34fs)	AGA	W34fs	Aspartylglucosaminuria	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495346	4	178363423 - 178363429	4	177442269 - 177442275	495346	487014	rs759063638	NC_000004.12:177442268:AAGGGCCAAG:AAG
NM_000027.4(AGA):c.319C>T (p.Arg107Ter)	AGA	R107*	Aspartylglucosaminuria|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291257	4	178360805	4	177439651	291257	275494	rs765070743	NC_000004.12:177439650:G:A
NM_000539.3(RHO):c.329G>A (p.Cys110Tyr)	RHO	C110Y	Retinitis pigmentosa 4|Retinal dystrophy	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000013035	3	129247905	3	129529062	13035	28074	rs104893787	NC_000003.12:129529061:G:A
NM_000539.3(RHO):c.544G>A (p.Gly182Ser)	RHO	G182S	Retinitis pigmentosa 4|Retinal dystrophy	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000013033	3	129251107	3	129532264	13033	28072	rs104893780	NC_000003.12:129532263:G:A
NM_172250.3(MMAA):c.489del (p.Phe163fs)	MMAA	F163fs	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000451256	4	146563561	4	145642409	451256	443588	rs1553958143	NC_000004.12:145642408:TTTT:TTT
NM_172250.3(MMAA):c.1196_1197delinsTT (p.Gly399Val)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440811	4	146576525 - 146576526	4	145655373 - 145655374	440811	434441	rs1553959152	NC_000004.12:145655372:GG:TT
NM_172250.3(MMAA):c.875A>T (p.Asp292Val)	MMAA	D292V	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440810	4	146575201	4	145654049	440810	434440	rs1553959025	NC_000004.12:145654048:A:T
NM_172250.3(MMAA):c.860C>A (p.Ala287Asp)	MMAA	A287D	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440809	4	146575186	4	145654034	440809	434439	rs1553959024	NC_000004.12:145654033:C:A
NM_172250.3(MMAA):c.820-1G>A	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440808	4	146575145	4	145653993	440808	434438	rs1553959017	NC_000004.12:145653992:G:A
NM_172250.3(MMAA):c.728C>A (p.Thr243Asn)	MMAA	T243N	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440807	4	146567303	4	145646151	440807	434437	rs1553958417	NC_000004.12:145646150:C:A
NM_172250.3(MMAA):c.721A>T (p.Ile241Phe)	MMAA	I241F	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440806	4	146567296	4	145646144	440806	434436	rs756221585	NC_000004.12:145646143:A:T
NM_172250.3(MMAA):c.658G>A (p.Val220Met)	MMAA	V220M	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440805	4	146567233	4	145646081	440805	434435	rs150376474	NC_000004.12:145646080:G:A
NM_172250.3(MMAA):c.651dup (p.Gly218fs)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440804	4	146567225 - 146567226	4	145646073 - 145646074	440804	434434	rs1314623572	NC_000004.12:145646073:A:AA
NM_172250.3(MMAA):c.575G>A (p.Gly192Asp)	MMAA	G192D	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440803	4	146567150	4	145645998	440803	434432	rs1553958392	NC_000004.12:145645997:G:A
NM_172250.3(MMAA):c.525_526TG[1] (p.Val176fs)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440802	4	146563600 - 146563601	4	145642448 - 145642449	440802	434431	rs1553958158	NC_000004.12:145642447:TGTG:TG
NM_172250.3(MMAA):c.455del (p.Pro152fs)	MMAA	P152fs	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440801	4	146563526	4	145642374	440801	434430	rs1553958127	NC_000004.12:145642373:CCCCC:CCCC
NM_172250.3(MMAA):c.441dup (p.Leu148fs)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440800	4	146563515 - 146563516	4	145642363 - 145642364	440800	434429	rs1553958126	NC_000004.12:145642363:A:AA
NM_172250.3(MMAA):c.298_312del (p.Cys100_Ala104del)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440799	4	146560585 - 146560599	4	145639433 - 145639447	440799	434428	rs780082584	NC_000004.12:145639432:GGCCTGTTTAGCAGAGGCC:GGCC
NM_172250.3(MMAA):c.290_296del (p.Gln97fs)	MMAA	Q97fs	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440798	4	146560575 - 146560581	4	145639423 - 145639429	440798	434427	rs1553957907	NC_000004.12:145639422:AAGGGCAAAGGGC:AAGGGC
NM_172250.3(MMAA):c.267_268del (p.Thr91fs)	MMAA	T91fs	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440797	4	146560557 - 146560558	4	145639405 - 145639406	440797	434426	rs1553957906	NC_000004.12:145639404:TTT:T
NM_172250.3(MMAA):c.202C>T (p.Gln68Ter)	MMAA	Q68*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic	criteria provided, single submitter	VCV000440796	4	146560493	4	145639341	440796	434425	rs754894257	NC_000004.12:145639340:C:T
NM_172250.3(MMAA):c.1025T>G (p.Met342Arg)	MMAA	M342R	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: May 18, 2015)	no assertion criteria provided	VCV000225189	4	146576354	4	145655202	225189	227100	rs869320657	NC_000004.12:145655201:T:G
NM_172250.3(MMAA):c.1076G>A (p.Arg359Gln)	MMAA	R359Q	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218979	4	146576405	4	145655253	218979	216036	rs864309731	NC_000004.12:145655252:G:A
NM_172250.3(MMAA):c.653G>A (p.Gly218Glu)	MMAA	G218E	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218977	4	146567228	4	145646076	218977	216034	rs864309730	NC_000004.12:145646075:G:A
NM_172250.3(MMAA):c.562G>C (p.Gly188Arg)	MMAA	G188R	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000218975	4	146563637	4	145642485	218975	216031	rs864309729	NC_000004.12:145642484:G:C
NM_172250.3(MMAA):c.397C>T (p.Gln133Ter)	MMAA	Q133*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218973	4	146560688	4	145639536	218973	216029	rs754545360	NC_000004.12:145639535:C:T
NM_172250.3(MMAA):c.358C>T (p.Gln120Ter)	MMAA	Q120*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000218972	4	146560649	4	145639497	218972	216028	rs864309727	NC_000004.12:145639496:C:T
NM_172250.3(MMAA):c.762dup (p.Asp255Ter)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000849500	4	146572241 - 146572242	4	145651089 - 145651090	849500	828815		NC_000004.12:145651089:T:TT
NC_000004.12:g.(?_145639120)_(145642505_?)del	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000830599	4	146560272 - 146563657			830599	819451		
NM_172250.3(MMAA):c.137_138CT[1] (p.Leu47fs)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000570176	4	146560427 - 146560428	4	145639275 - 145639276	570176	559740	rs1560795828	NC_000004.12:145639274:TCTCT:TCT
NM_172250.3(MMAA):c.450dup (p.Pro151fs)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000551182	4	146563522 - 146563523	4	145642370 - 145642371	551182	543081	rs754973022	NC_000004.12:145642370:GGG:GGGG
NM_172250.3(MMAA):c.562+1G>A	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: May 18, 2015)	no assertion criteria provided	VCV000225188	4	146563638	4	145642486	225188	227099	rs869320656	NC_000004.12:145642485:G:A
NM_172250.3(MMAA):c.503del (p.Thr168fs)	MMAA	T168fs	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000218974	4	146563578	4	145642426	218974	216030	rs864309728	NC_000004.12:145642425:C:
NM_172250.3(MMAA):c.620A>G (p.Tyr207Cys)	MMAA	Y207C	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Nov 26, 2002)	no assertion criteria provided	VCV000003159	4	146567195	4	145646043	3159	18198	rs104893849	NC_000004.12:145646042:A:G
MMAA, 8-BP INS, NT260	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Nov 26, 2002)	no assertion criteria provided	VCV000003157					3157	18196		
NM_172250.3(MMAA):c.970-2A>T	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000555331	4	146576297	4	145655145	555331	543423	rs1553959113	NC_000004.12:145655144:A:T
NM_172250.3(MMAA):c.551dup (p.Cys184fs)	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000554640	4	146563625 - 146563626	4	145642473 - 145642474	554640	543414	rs1553958159	NC_000004.12:145642473:G:GG
NM_172250.3(MMAA):c.988C>T (p.Arg330Ter)	MMAA	R330*	Vitamin B12-responsive methylmalonic acidemia type cblA|not provided	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000203816	4	146576317	4	145655165	203816	200055	rs571038432	NC_000004.12:145655164:C:T
NM_172250.3(MMAA):c.1034del (p.Phe345fs)	MMAA	F345fs	Vitamin B12-responsive methylmalonic acidemia type cblA|not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, multiple submitters, no conflicts	VCV000096532	4	146576361	4	145655209	96532	102426	rs398124552	NC_000004.12:145655208:TTT:TT
NM_023067.4(FOXL2):c.804dup (p.Gly269fs)	FOXL2		not provided|Blepharophimosis, ptosis, and epicanthus inversus|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1|Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004858	3	138664760 - 138664761	3	138945918 - 138945919	4858	19897	rs797044528	NC_000003.12:138945918:GGGGGG:GGGGGGG
NM_172250.3(MMAA):c.72C>A (p.Tyr24Ter)	MMAA	Y24*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000440795	4	146560363	4	145639211	440795	434424	rs1553957883	NC_000004.12:145639210:C:A
NM_005506.4(SCARB2):c.1337del (p.Gly446fs)	SCARB2	G303fs, G446fs	not provided	Pathogenic(Last reviewed: Mar 29, 2013)	criteria provided, single submitter	VCV000206723	4	77084439	4	76163286	206723	201781	rs796052949	NC_000004.12:76163285:CCC:CC
NM_005506.4(SCARB2):c.134del (p.Asn45fs)	SCARB2	N45fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000807488	4	77117001	4	76195848	807488	798547		NC_000004.12:76195847:TT:T
NM_005506.4(SCARB2):c.367dup (p.Gln123fs)	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 21, 2016)	no assertion criteria provided	VCV000453288	4	77102162 - 77102163	4	76181009 - 76181010	453288	446885	rs1553948516	NC_000004.12:76181009:GG:GGG
NM_005506.4(SCARB2):c.1412A>G (p.Glu471Gly)	SCARB2	E471G, E328G	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268148	4	77082891	4	76161738	268148	263762	rs755903502	NC_000004.12:76161737:T:C
NM_005506.4(SCARB2):c.1087C>A (p.His363Asn)	SCARB2	H363N, H220N	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268143	4	77091046	4	76169893	268143	263765	rs758857853	NC_000004.12:76169892:G:T
NM_005506.4(SCARB2):c.1016dup (p.His341fs)	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268142	4	77091116 - 77091117	4	76169963 - 76169964	268142	263766	rs886041077	NC_000004.12:76169963:AAA:AAAA
NM_005506.4(SCARB2):c.704+5G>A	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268141	4	77097585	4	76176432	268141	263767	rs774271963	NC_000004.12:76176431:C:T
NM_005506.4(SCARB2):c.704+1G>C	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268140	4	77097589	4	76176436	268140	263768	rs886041076	NC_000004.12:76176435:C:G
NM_005506.4(SCARB2):c.424-2A>C	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268137	4	77100860	4	76179707	268137	263770	rs886041074	NC_000004.12:76179706:T:G
NM_005506.4(SCARB2):c.296del (p.Asn99fs)	SCARB2	N99fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268136	4	77102234	4	76181081	268136	263771	rs886041073	NC_000004.12:76181080:TTT:TT
NM_005506.4(SCARB2):c.111del (p.Ile37fs)	SCARB2	I37fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268135	4	77134586	4	76213433	268135	263772	rs886041072	NC_000004.12:76213432:G:
NM_000539.3(RHO):c.408C>A (p.Tyr136Ter)	RHO	Y136*	not provided|Retinitis pigmentosa 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635082	3	129249765	3	129530922	635082	622873	rs200248198	NC_000003.12:129530921:C:A
NM_000539.3(RHO):c.180C>A (p.Tyr60Ter)	RHO	Y60*	Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000143079	3	129247756	3	129528913	143079	152797	rs527236101	NC_000003.12:129528912:C:A
NM_000539.3(RHO):c.620T>G (p.Met207Arg)	RHO	M207R	Retinitis pigmentosa 4|Retinal dystrophy	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000013043	3	129251183	3	129532340	13043	28082	rs104893782	NC_000003.12:129532339:T:G
NM_000027.4(AGA):c.800dup (p.Pro268fs)	AGA		Aspartylglucosaminuria	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000225	4	178355541 - 178355542	4	177434387 - 177434388	225	15264	rs386833436	NC_000004.12:177434387:A:AA
NM_005506.4(SCARB2):c.1385_1390delinsATGCATGCACC (p.Gly462fs)	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268147	4	77084386 - 77084391	4	76163233 - 76163238	268147	263763	rs886041079	NC_000004.12:76163232:TGGATC:GGTGCATGCAT
NM_005506.4(SCARB2):c.1270C>T (p.Arg424Ter)	SCARB2	R424*, R281*	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268146	4	77084506	4	76163353	268146	263764	rs886041078	NC_000004.12:76163352:G:A
NM_005506.4(SCARB2):c.704+1G>A	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268139	4	77097589	4	76176436	268139	263769	rs886041076	NC_000004.12:76176435:C:T
NM_005506.4(SCARB2):c.666_670del (p.Tyr222_Asn224delinsTer)	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000268138	4	77097624 - 77097628	4	76176471 - 76176475	268138	263773	rs886041075	NC_000004.12:76176470:TAAGGTAA:TAA
NM_005506.4(SCARB2):c.1187+2dup	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000030259	4	77089553 - 77089554	4	76168400 - 76168401	30259	39215	rs727502783	NC_000004.12:76168400:A:AA
NM_005506.4(SCARB2):c.1258del (p.Glu420fs)	SCARB2	E420fs, E277fs	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000030258	4	77084518	4	76163365	30258	39214	rs727502782	NC_000004.12:76163364:C:
NM_005506.4(SCARB2):c.1114-2A>C	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000030257	4	77089631	4	76168478	30257	39213	rs727502781	NC_000004.12:76168477:T:G
NM_005506.4(SCARB2):c.533G>A (p.Trp178Ter)	SCARB2	W178*	Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000007379	4	77100749	4	76179596	7379	22418	rs121909119	NC_000004.12:76179595:C:T
NM_005506.4(SCARB2):c.1239+1G>T	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000007376	4	77087402	4	76166249	7376	22415	rs727502772	NC_000004.12:76166248:C:A
NM_014049.4(ACAD9):c.359delT	ACAD9	F120fs	not provided|Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242524	3	128614164	3	128895321	242524	213547	rs863224844	NC_000003.12:128895320:TT:T
NM_172250.3(MMAA):c.742C>T (p.Gln248Ter)	MMAA	Q248*	Methylmalonic acidemia	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000496554	4	146572222	4	145651070	496554	487063	rs757548934	NC_000004.12:145651069:C:T
NM_172250.3(MMAA):c.1075C>T (p.Arg359Ter)	MMAA	R359*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000466216	4	146576404	4	145655252	466216	453742	rs999844958	NC_000004.12:145655251:C:T
NM_172250.3(MMAA):c.733+1G>A	MMAA		Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218978	4	146567309	4	145646157	218978	216035	rs779939886	NC_000004.12:145646156:G:A
NM_172250.3(MMAA):c.387C>A (p.Tyr129Ter)	MMAA	Y129*	Vitamin B12-responsive methylmalonic acidemia type cblA|not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203814	4	146560678	4	145639526	203814	200053	rs796051992	NC_000004.12:145639525:C:A
NM_172250.3(MMAA):c.283C>T (p.Gln95Ter)	MMAA	Q95*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000003158	4	146560574	4	145639422	3158	18197	rs104893846	NC_000004.12:145639421:C:T
NC_000003.12:g.(?_81642771)_(81643000_?)del	GBE1		Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000831402	3	81691922 - 81692151			831402	819418		
NM_000158.4(GBE1):c.1909C>T (p.Arg637Ter)	GBE1	R637*	GBE1-Related Disorders|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000346785	3	81584371	3	81535220	346785	291664	rs766935302	NC_000003.12:81535219:G:A
NM_005859.5(PURA):c.303_304TC[2] (p.Ser103fs)	PURA		Neonatal hypotonia|Global developmental delay|Delayed speech and language development|Intellectual disability|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000156404	5	139494068 - 139494069	5	140114483 - 140114484	156404	166183	rs587782992	NC_000005.10:140114482:CTCTCTC:CTCTC
NM_002185.5(IL7R):c.353G>A (p.Cys118Tyr)	IL7R	C118Y	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive|Severe combined immunodeficiency disease	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036392	5	35867539	5	35867437	36392	45055	rs193922641	NC_000005.10:35867436:G:A
NM_000539.3(RHO):c.512C>T (p.Pro171Leu)	RHO	P171L	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000862966	3	129249869	3	129531026	862966	827534		NC_000003.12:129531025:C:T
NM_000539.3(RHO):c.53G>A (p.Gly18Asp)	RHO	G18D	Retinitis pigmentosa|Retinitis pigmentosa 4	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000625297	3	129247629	3	129528786	625297	613629	rs200946638	NC_000003.12:129528785:G:A
NM_000027.4(AGA):c.194_195AG[3] (p.Glu67fs)	AGA		Aspartylglucosaminuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000055939	4	178361507 - 178361508	4	177440353 - 177440354	55939	70578	rs386833420	NC_000004.12:177440352:CTCTCTCTC:CTCTCTC
NM_000539.3(RHO):c.800C>T (p.Pro267Leu)	RHO	P267L	Retinitis pigmentosa 4|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000013034	3	129251479	3	129532636	13034	28073	rs104893781	NC_000003.12:129532635:C:T
NM_000539.3(RHO):c.1030C>T (p.Gln344Ter)	RHO	Q344*	not provided|Retinitis pigmentosa 4	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000013029	3	129252544	3	129533701	13029	28068	rs104893778	NC_000003.12:129533700:C:T
NM_000539.3(RHO):c.404G>T (p.Arg135Leu)	RHO	R135L	not provided|Retinitis pigmentosa 4	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000013024	3	129249761	3	129530918	13024	28063	rs104893774	NC_000003.12:129530917:G:T
NM_000539.3(RHO):c.266G>A (p.Gly89Asp)	RHO	G89D	Retinitis pigmentosa|Retinitis pigmentosa 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000013021	3	129247842	3	129528999	13021	28060	rs104893772	NC_000003.12:129528998:G:A
NM_004387.4(NKX2-5):c.711C>A (p.Tyr237Ter)	NKX2-5	Y237*	Ventricular fibrillation|Noncompaction cardiomyopathy|Primary dilated cardiomyopathy|Atrial septal defect|Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523473	5	172659836	5	173232833	523473	513956	rs1554093433	NC_000005.10:173232832:G:T
NM_000187.4(HGD):c.688C>T (p.Pro230Ser)	HGD	P230S	Alkaptonuria	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003165	3	120363252	3	120644405	3165	18204	rs28942100	NC_000003.12:120644404:G:A
NM_004544.4(NDUFA10):c.384_385insAAT (p.Tyr129_Arg130insAsn)	NDUFA10		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22	Pathogenic(Last reviewed: Mar 12, 2019)	no assertion criteria provided	VCV000372195	2	240960689 - 240960690	2	240021272 - 240021273	372195	359100	rs1057519415	NC_000002.12:240021272:A:ATTA
NM_004544.4(NDUFA10):c.881T>C (p.Leu294Pro)	NDUFA10	L294P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22	Pathogenic(Last reviewed: Mar 12, 2019)	no assertion criteria provided	VCV000372194	2	240944636	2	240005219	372194	359099	rs1057519414	NC_000002.12:240005218:A:G
NM_004544.4(NDUFA10):c.425A>G (p.Gln142Arg)	NDUFA10	Q142R	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030393	2	240960649	2	240021232	30393	39350	rs387906873	NC_000002.12:240021231:T:C
NM_004544.4(NDUFA10):c.1A>G (p.Met1Val)	NDUFA10	M1V	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030392	2	240964718	2	240025301	30392	39349	rs387906872	NC_000002.12:240025300:T:C
NM_172250.3(MMAA):c.586C>T (p.Arg196Ter)	MMAA	R196*	Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000466217	4	146567161	4	145646009	466217	453275	rs1029096863	NC_000004.12:145646008:C:T
NM_052995.2(CLRN1):c.140C>A (p.Ala47Asp)	CLRN1	A123D, A47D, C180*	Usher syndrome, type 3A|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048146	3	150659434	3	150941647	48146	57310	rs374963432	NC_000003.12:150941646:G:T
NM_005506.4(SCARB2):c.432_433AG[3] (p.Trp146fs)	SCARB2		Epilepsy, progressive myoclonic 4, with or without renal failure|not provided	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000007377	4	77100846 - 77100847	4	76179693 - 76179694	7377	22416	rs727502773	NC_000004.12:76179693:CTCT:CTCTCT
NM_000539.3(RHO):c.563G>A (p.Gly188Glu)	RHO	G188E	not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811432	3	129251126	3	129532283	811432	799312		NC_000003.12:129532282:G:A
NM_000539.3(RHO):c.509C>G (p.Pro170Arg)	RHO	P170R	Retinitis pigmentosa|Retinitis pigmentosa 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000437997	3	129249866	3	129531023	437997	431666	rs1553781176	NC_000003.12:129531022:C:G
NM_000539.3(RHO):c.44A>G (p.Asn15Ser)	RHO	N15S	Retinitis pigmentosa 4|Retinitis pigmentosa	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000013042	3	129247620	3	129528777	13042	28081	rs104893786	NC_000003.12:129528776:A:G
NM_000539.3(RHO):c.1040C>G (p.Pro347Arg)	RHO	P347R	Retinitis pigmentosa 4|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000013032	3	129252554	3	129533711	13032	28071	rs29001566	NC_000003.12:129533710:C:G
NM_198586.3(NHLRC1):c.436G>A (p.Asp146Asn)	NHLRC1	D146N	not provided|Lafora disease	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162618	6	18122402	6	18122171	162618	172294	rs769301934	NC_000006.12:18122170:C:T
NM_004453.4(ETFDH):c.1648_1649del (p.Leu550fs)	ETFDH	L489fs, L503fs, L550fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802104	4	159627959 - 159627960	4	158706807 - 158706808	802104	790452		NC_000004.12:158706806:TCT:T
NM_004453.4(ETFDH):c.684+2T>G	ETFDH		Glutaric aciduria, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802101	4	159611579	4	158690427	802101	790449		NC_000004.12:158690426:T:G
NM_004453.4(ETFDH):c.295C>T (p.Arg99Cys)	ETFDH	R38C, R99C, R52C	Glutaric aciduria, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802100	4	159603466	4	158682314	802100	790448		NC_000004.12:158682313:C:T
NM_004453.4(ETFDH):c.171G>A (p.Trp57Ter)	ETFDH	W57*	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000488689	4	159601755	4	158680603	488689	481713	rs949249162	NC_000004.12:158680602:G:A
NM_004453.4(ETFDH):c.485_487+14delinsT	ETFDH		not provided	Pathogenic(Last reviewed: Apr 25, 2014)	criteria provided, single submitter	VCV000203728	4	159605823 - 159605839	4	158684671 - 158684687	203728	200065	rs796051963	NC_000004.12:158684670:CAGGTAAGGTATAGTGA:T
NM_004453.4(ETFDH):c.175+1G>C	ETFDH		not provided	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000203726	4	159601760	4	158680608	203726	200060	rs796051961	NC_000004.12:158680607:G:C
NM_004453.4(ETFDH):c.1809G>A (p.Trp603Ter)	ETFDH	W603*, W542*, W556*	not provided	Pathogenic(Last reviewed: May 6, 2014)	criteria provided, single submitter	VCV000203724	4	159629634	4	158708482	203724	200080	rs796051960	NC_000004.12:158708481:G:A
NM_004453.4(ETFDH):c.1073G>A (p.Arg358Lys)	ETFDH	R358K, R297K, R311K	not provided	Pathogenic(Last reviewed: Feb 4, 2013)	criteria provided, single submitter	VCV000203720	4	159620239	4	158699087	203720	200074	rs796051959	NC_000004.12:158699086:G:A
NM_004453.4(ETFDH):c.929A>G (p.Tyr310Cys)	ETFDH	Y310C, Y249C, Y263C	not provided	Pathogenic(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	VCV000203718	4	159618808	4	158697656	203718	200072	rs796051958	NC_000004.12:158697655:A:G
NM_004453.4(ETFDH):c.524G>C (p.Arg175Pro)	ETFDH	R175P, R128P, R114P	not provided	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	VCV000203713	4	159606289	4	158685137	203713	200066	rs121964955	NC_000004.12:158685136:G:C
NM_004453.4(ETFDH):c.1568_1569CT[1] (p.Leu524fs)	ETFDH		not provided	Pathogenic(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	VCV000167042	4	159627880 - 159627881	4	158706728 - 158706729	167042	177697	rs727503919	NC_000004.12:158706727:CTCT:CT
NM_004453.4(ETFDH):c.1823del (p.Gly608fs)	ETFDH	G547fs, G561fs, G608fs	not provided	Pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	VCV000095073	4	159629647	4	158708495	95073	100973	rs398124153	NC_000004.12:158708494:GG:G
NM_004453.4(ETFDH):c.2T>C (p.Met1Thr)	ETFDH	M1T	Glutaric acidemia IIC	Pathogenic(Last reviewed: May 25, 2012)	no assertion criteria provided	VCV000012026	4	159593610	4	158672458	12026	27065	rs121964953	NC_000004.12:158672457:T:C
NM_004453.4(ETFDH):c.207del (p.Asp70fs)	ETFDH	D23fs, D9fs, D70fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000857722	4	159603378	4	158682226	857722	828914		NC_000004.12:158682225:A:
NM_182916.3(TRNT1):c.501dup (p.Asp168Ter)	TRNT1		Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000848613	3	3186284 - 3186285	3	3144600 - 3144601	848613	827878		NC_000003.12:3144600:TTT:TTTT
NM_004453.4(ETFDH):c.1605_1606AC[1] (p.His536fs)	ETFDH		Glutaric aciduria, type 2	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000846966	4	159627916 - 159627917	4	158706764 - 158706765	846966	828928		NC_000004.12:158706763:CACAC:CAC
NM_004453.4(ETFDH):c.1169del (p.Gly390fs)	ETFDH	G329fs, G390fs, G343fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000844449	4	159624626	4	158703474	844449	828922		NC_000004.12:158703473:GG:G
NM_182916.3(TRNT1):c.538A>T (p.Lys180Ter)	TRNT1	K180*	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000836471	3	3186324	3	3144640	836471	827880		NC_000003.12:3144639:A:T
NM_004453.4(ETFDH):c.1555_1556del (p.Leu519fs)	ETFDH	L472fs, L458fs, L519fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000834431	4	159627867 - 159627868	4	158706715 - 158706716	834431	828927		NC_000004.12:158706714:TT:
NM_182916.3(TRNT1):c.443C>T (p.Ala148Val)	TRNT1	A148V	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000691999	3	3182294	3	3140610	691999	679744		NC_000003.12:3140609:C:T
NM_182916.3(TRNT1):c.324_330del (p.His108fs)	TRNT1	H108fs	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000662903	3	3179117 - 3179123	3	3137433 - 3137439	662903	631151		NC_000003.12:3137432:CACGGAACA:CA
NM_004453.4(ETFDH):c.1374C>A (p.Cys458Ter)	ETFDH	C411*, C397*, C458*	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000651444	4	159627429	4	158706277	651444	632074		NC_000004.12:158706276:C:A
NM_182916.3(TRNT1):c.865del (p.Ser289fs)	TRNT1	S289fs, S269fs	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000642460	3	3189192	3	3147508	642460	631161		NC_000003.12:3147507:TTTTT:TTTT
NM_004453.4(ETFDH):c.462C>G (p.Tyr154Ter)	ETFDH	Y154*, Y107*, Y93*	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000235624	4	159605800	4	158684648	235624	237305	rs878853082	NC_000004.12:158684647:C:G
NM_004453.4(ETFDH):c.157A>T (p.Lys53Ter)	ETFDH	K53*	not provided	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000235305	4	159601741	4	158680589	235305	236992	rs878853006	NC_000004.12:158680588:A:T
NM_182916.3(TRNT1):c.609-26T>C	TRNT1		Retinitis pigmentosa and erythrocytic microcytosis	Pathogenic(Last reviewed: May 26, 2016)	no assertion criteria provided	VCV000234935	3	3188088	3	3146404	234935	236732	rs876661299	NC_000003.12:3146403:T:C
NM_182916.3(TRNT1):c.1252del (p.Ser418fs)	TRNT1	S398fs, S418fs	Retinitis pigmentosa and erythrocytic microcytosis	Pathogenic(Last reviewed: May 26, 2016)	no assertion criteria provided	VCV000234933	3	3189779	3	3148095	234933	236730	rs876661298	NC_000003.12:3148094:AAAAAAA:AAAAAA
NM_182916.3(TRNT1):c.128_130del (p.Glu43del)	TRNT1	E43del	Retinitis pigmentosa and erythrocytic microcytosis	Pathogenic(Last reviewed: May 26, 2016)	no assertion criteria provided	VCV000234932	3	3170850 - 3170852	3	3129166 - 3129168	234932	236729	rs876661297	NC_000003.12:3129165:AGAAG:AG
NM_182916.3(TRNT1):c.1142_1143insATGT (p.Trp381Ter)	TRNT1		Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Oct 30, 2014)	no assertion criteria provided	VCV000157618	3	3189675 - 3189676	3	3147991 - 3147992	157618	167478	rs606231291	NC_000003.12:3147991::ATGT
NM_182916.3(TRNT1):c.461C>T (p.Thr154Ile)	TRNT1	T154I	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Oct 30, 2014)	no assertion criteria provided	VCV000157617	3	3182312	3	3140628	157617	167477	rs606231290	NC_000003.12:3140627:C:T
NM_182916.3(TRNT1):c.497T>C (p.Leu166Ser)	TRNT1	L166S	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Oct 30, 2014)	no assertion criteria provided	VCV000157616	3	3186283	3	3144599	157616	167476	rs606231289	NC_000003.12:3144598:T:C
NM_182916.3(TRNT1):c.569G>T (p.Arg190Ile)	TRNT1	R190I	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Oct 30, 2014)	no assertion criteria provided	VCV000157613	3	3186355	3	3144671	157613	167473	rs606231287	NC_000003.12:3144670:G:T
NM_004453.4(ETFDH):c.524G>A (p.Arg175His)	ETFDH	R175H, R114H, R128H	Glutaric acidemia IIC	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031576	4	159606289	4	158685137	31576	40255	rs121964955	NC_000004.12:158685136:G:A
NM_004453.4(ETFDH):c.524G>T (p.Arg175Leu)	ETFDH	R175L, R128L, R114L	Glutaric acidemia IIC	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000012029	4	159606289	4	158685137	12029	27068	rs121964955	NC_000004.12:158685136:G:T
NM_004453.4(ETFDH):c.858G>A (p.Trp286Ter)	ETFDH	W225*, W239*, W286*	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000862045	4	159618737	4	158697585	862045	828917		NC_000004.12:158697584:G:A
NM_004453.4(ETFDH):c.34G>C (p.Ala12Pro)	ETFDH	A12P, G12R	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000576973	4	159593642	4	158672490	576973	563558	rs1172887273	NC_000004.12:158672489:G:C
NM_182916.3(TRNT1):c.608+1G>T	TRNT1		Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000858224	3	3186395	3	3144711	858224	850924		NC_000003.12:3144710:G:T
NM_182916.3(TRNT1):c.1019del (p.Ser339_Ser340insTer)	TRNT1		Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852873	3	3189350	3	3147666	852873	827890		NC_000003.12:3147665:C:
NM_004453.4(ETFDH):c.121C>T (p.Arg41Ter)	ETFDH	R41*	Glutaric aciduria, type 2	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000577047	4	159601705	4	158680553	577047	559625	rs773668457	NC_000004.12:158680552:C:T
NM_004453.4(ETFDH):c.413T>G (p.Leu138Arg)	ETFDH	L138R, L91R, L77R	Glutaric aciduria, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431962	4	159605751	4	158684599	431962	425603	rs779896449	NC_000004.12:158684598:T:G
NM_004453.4(ETFDH):c.296_297GT[5] (p.Leu102fs)	ETFDH		Glutaric aciduria, type 2|not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203727	4	159603466 - 159603467	4	158682314 - 158682315	203727	200062	rs796051962	NC_000004.12:158682314:GTGTGTGT:GTGTGTGTGT
NM_004453.4(ETFDH):c.1351G>C (p.Val451Leu)	ETFDH	V451L, V404L, V390L	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000203722	4	159627406	4	158706254	203722	200076	rs558005496	NC_000004.12:158706253:G:C
NM_182916.3(TRNT1):c.668T>C (p.Ile223Thr)	TRNT1	I223T	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay|not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000157614	3	3188173	3	3146489	157614	167474	rs370011798	NC_000003.12:3146488:T:C
NM_004453.4(ETFDH):c.380T>A (p.Leu127His)	ETFDH	L127H, L66H, L80H	Glutaric acidemia IIC|Glutaric aciduria, type 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000012030	4	159603551	4	158682399	12030	27069	rs121964956	NC_000004.12:158682398:T:A
ETFDH, 1-BP DEL, 36A	ETFDH		Glutaric acidemia IIC	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000012027					12027	27066		
NM_005859.5(PURA):c.691_693TTC[2] (p.Phe233del)	PURA	F233del	Mental retardation, autosomal dominant 31|not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189319	5	139494456 - 139494458	5	140114871 - 140114873	189319	187207	rs786204835	NC_000005.10:140114870:CTTCTTCTTC:CTTCTTC
NM_005859.5(PURA):c.812_814del (p.Phe271del)	PURA	F271del	Neonatal hypotonia|Global developmental delay|Seizures|Delayed speech and language development|Intellectual disability|Mental retardation, autosomal dominant 31|not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000156403	5	139494576 - 139494578	5	140114991 - 140114993	156403	166182	rs587782991	NC_000005.10:140114990:CTTCT:CT
NM_005677.4(COLQ):c.937del (p.Ser313fs)	COLQ	S303fs, S313fs, S279fs	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000451607	3	15499710	3	15458203	451607	443373	rs1553634790	NC_000003.12:15458202:AA:A
NM_005677.4(COLQ):c.393+1G>A	COLQ		not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000426775	3	15520483	3	15478976	426775	414915	rs1085307792	NC_000003.12:15478975:C:T
NM_005677.4(COLQ):c.529-2A>G	COLQ		not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000281421	3	15516460	3	15474953	281421	265658	rs755236236	NC_000003.12:15474952:T:C
NM_005677.4(COLQ):c.219+1G>C	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801940	3	15531031	3	15489524	801940	790345		NC_000003.12:15489523:C:G
NM_004453.4(ETFDH):c.1450T>C (p.Trp484Arg)	ETFDH	W484R, W423R, W437R	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000847402	4	159627505	4	158706353	847402	828926		NC_000004.12:158706352:T:C
NM_182916.3(TRNT1):c.1038_1041dup (p.Asp348fs)	TRNT1		Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000841899	3	3189367 - 3189368	3	3147683 - 3147684	841899	827891		NC_000003.12:3147683:ATCAA:ATCAATCAA
NM_004453.4(ETFDH):c.405+3A>T	ETFDH		not provided|Glutaric aciduria, type 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203730	4	159603579	4	158682427	203730	200064	rs796051965	NC_000004.12:158682426:A:T
NM_005677.4(COLQ):c.57dup (p.Ile20fs)	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000571382	3	15563075 - 15563076	3	15521568 - 15521569	571382	562530	rs777102590	NC_000003.12:15521568:A:AA
NM_005677.4(COLQ):c.52_53CT[1] (p.Ile20fs)	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000569887	3	15563076 - 15563079	3	15521569 - 15521572	569887	561227	rs771879602	NC_000003.12:15521568:AGAGAG:AG
NM_005677.4(COLQ):c.1225dup (p.His409fs)	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000568622	3	15495408 - 15495409	3	15453901 - 15453902	568622	561225	rs1559510978	NC_000003.12:15453901:G:GG
NM_005677.4(COLQ):c.718G>T (p.Gly240Ter)	COLQ	G240*, G230*, G206*	Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Feb 26, 2002)	no assertion criteria provided	VCV000006657	3	15507944	3	15466437	6657	21696	rs104893735	NC_000003.12:15466436:C:A
NM_005677.4(COLQ):c.1298+3A>G	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000006656	3	15495333	3	15453826	6656	21695		NC_000003.12:15453825:T:C
NM_005677.4(COLQ):c.1289A>C (p.Tyr430Ser)	COLQ	Y431S, Y430S, Y396S, Y420S	Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000006654	3	15495345	3	15453838	6654	21693	rs121908923	NC_000003.12:15453837:T:G
NM_005677.4(COLQ):c.788dup (p.Pro265fs)	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Aug 4, 1998)	no assertion criteria provided	VCV000006653	3	15507873 - 15507874	3	15466366 - 15466367	6653	21692	rs759911990	NC_000003.12:15466366:GG:GGG
NM_005677.4(COLQ):c.844A>T (p.Arg282Ter)	COLQ	R282*, R248*, R272*	Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Aug 4, 1998)	no assertion criteria provided	VCV000006651	3	15499803	3	15458296	6651	21690	rs121908922	NC_000003.12:15458295:T:A
COLQ, 215-BP DEL, NT107	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Aug 4, 1998)	no assertion criteria provided	VCV000006648					6648	21687		
NM_152618.3(BBS12):c.1151del (p.Ser384fs)	BBS12	S384fs	Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550386	4	123664198	4	122743043	550386	543375	rs1553941404	NC_000004.12:122743042:G:
NC_000003.12:g.(?_15455889)_(15456589_?)del	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000831058	3	15497396 - 15498096			831058	819341		
NM_005677.4(COLQ):c.220-1G>A	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000599284	3	15529815	3	15488308	599284	590548	rs199470447	NC_000003.12:15488307:C:T
NM_005677.4(COLQ):c.506C>G (p.Ser169Ter)	COLQ	S169*, S135*, S159*	Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Aug 4, 1998)	no assertion criteria provided	VCV000006650	3	15516954	3	15475447	6650	21689	rs104893734	NC_000003.12:15475446:G:C
NM_013334.3(GMPPB):c.860G>A (p.Arg287Gln)	GMPPB	R287Q	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|not provided	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060545	3	49759489	3	49722056	60545	75126	rs202160208	NC_000003.12:49722055:C:T
NM_005677.4(COLQ):c.679C>T (p.Arg227Ter)	COLQ	R227*, R217*, R193*	not provided|Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280125	3	15512081	3	15470574	280125	264144	rs770045897	NC_000003.12:15470573:G:A
NM_005677.4(COLQ):c.640G>T (p.Glu214Ter)	COLQ	E214*, E204*, E180*	Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000006649	3	15512120	3	15470613	6649	21688	rs104893733	NC_000003.12:15470612:C:A
NM_004453.4(ETFDH):c.1832G>A (p.Gly611Glu)	ETFDH	G611E, G564E, G550E	Glutaric aciduria, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265124	4	159629657	4	158708505	265124	259784	rs761669036	NC_000004.12:158708504:G:A
NM_006371.5(CRTAP):c.8del (p.Pro3fs)	CRTAP	P3fs	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000855093	3	33155576	3	33114084	855093	827907		NC_000003.12:33114083:CC:C
NC_000003.12:g.(?_33114058)_(33124599_?)del	CRTAP		Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000832169	3	33155550 - 33166091			832169	819367		
NM_006371.4(CRTAP):c.320_321delGC	CRTAP		Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000660744	3	33155887 - 33155888	3	33114395 - 33114396	660744	631184		NC_000003.12:33114394:GCGC:GC
NM_006371.4(CRTAP):c.198C>A (p.Tyr66Ter)	CRTAP	Y66*	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000658698	3	33155767	3	33114275	658698	631183		NC_000003.12:33114274:C:A
NM_006371.4(CRTAP):c.444C>G (p.Tyr148Ter)	CRTAP	Y148*	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000465810	3	33156013	3	33114521	465810	452061	rs972668240	NC_000003.12:33114520:C:G
NM_138348.6(OTULIN):c.731A>G (p.Tyr244Cys)	OTULIN	Y244C	Autoinflammation, panniculitis, and dermatosis syndrome	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000254126	5	14690284	5	14690175	254126	248577	rs886037887	NC_000005.10:14690174:A:G
NM_138348.6(OTULIN):c.517del (p.Gly174fs)	OTULIN	G174fs	Autoinflammation, panniculitis, and dermatosis syndrome	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000254125	5	14687678	5	14687569	254125	248576	rs886037886	NC_000005.10:14687568:C:
NM_006371.4(CRTAP):c.118G>T (p.Glu40Ter)	CRTAP	E40*	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000217257	3	33155687	3	33114195	217257	213900	rs863225043	NC_000003.12:33114194:G:T
NM_006371.4(CRTAP):c.561T>G (p.Tyr187Ter)	CRTAP	Y187*	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000041923	3	33161925	3	33120433	41923	51091	rs387907334	NC_000003.12:33120432:T:G
NM_006371.5(CRTAP):c.118_133delinsTACCC (p.Glu40fs)	CRTAP		Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000041922	3	33155687 - 33155702	3	33114195 - 33114210	41922	51090	rs387907333	NC_000003.12:33114194:GAGCTGATGCCGCTCG:TACCC
CRTAP, 16-BP DUP	CRTAP		Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Dec 28, 2006)	no assertion criteria provided	VCV000004952					4952	19991		
NM_006371.4(CRTAP):c.3G>A (p.Met1Ile)	CRTAP	M1I	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Dec 28, 2006)	no assertion criteria provided	VCV000004951	3	33155572	3	33114080	4951	19990	rs72659357	NC_000003.12:33114079:G:A
NM_006371.4(CRTAP):c.471+1G>C	CRTAP		Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Dec 28, 2006)	no assertion criteria provided	VCV000004949	3	33156041	3	33114549	4949	19988	rs72659359	NC_000003.12:33114548:G:C
NM_006371.4(CRTAP):c.879del (p.Phe293fs)	CRTAP	F293fs	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	VCV000004948	3	33171514	3	33130022	4948	19987	rs72659362	NC_000003.12:33130021:TTT:TT
NM_005787.6(ALG3):c.991C>T (p.Gln331Ter)	ALG3	Q331*, Q283*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000521583	3	183961360	3	184243572	521583	511472	rs1553827968	NC_000003.12:184243571:G:A
NM_138348.6(OTULIN):c.815T>C (p.Leu272Pro)	OTULIN	L272P	Autoinflammation, panniculitis, and dermatosis syndrome	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000254124	5	14690368	5	14690259	254124	248575	rs886037885	NC_000005.10:14690258:T:C
NM_006371.4(CRTAP):c.826C>T (p.Gln276Ter)	CRTAP	Q276*	Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000004950	3	33171463	3	33129971	4950	19989	rs72659361	NC_000003.12:33129970:C:T
CRTAP, IVS1, -1021C-G	CRTAP		Osteogenesis imperfecta type 7	Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	VCV000004947					4947	19986		
NM_005677.4(COLQ):c.588del (p.Gly198fs)	COLQ	G188fs, G198fs, G164fs	Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000599286	3	15515747	3	15474240	599286	590547	rs1559519107	NC_000003.12:15474239:GGG:GG
NM_005677.4(COLQ):c.157dup (p.Leu53fs)	COLQ		Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468343	3	15531093 - 15531094	3	15489586 - 15489587	468343	452252	rs971863968	NC_000003.12:15489586:GG:GGG
NM_005677.4(COLQ):c.943C>T (p.Arg315Ter)	COLQ	R315*, R305*, R281*	not provided|Endplate acetylcholinesterase deficiency	Pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000006655	3	15499704	3	15458197	6655	21694	rs121908924	NC_000003.12:15458196:G:A
NM_014049.5(ACAD9):c.976G>C (p.Ala326Pro)	ACAD9	A326P	not provided|Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030883	3	128622922	3	128904079	30883	39840	rs115532916	NC_000003.12:128904078:G:C
NM_003900.5(SQSTM1):c.819_820AG[2] (p.Ser275fs)	SQSTM1		not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000451357	5	179260096 - 179260097	5	179833096 - 179833097	451357	443781	rs1273214757	NC_000005.10:179833095:AGAGAG:AGAG
NM_003900.5(SQSTM1):c.309_310AG[1] (p.Glu104fs)	SQSTM1		Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Oct 10, 2016)	no assertion criteria provided	VCV000265781	5	179250865 - 179250866	5	179823865 - 179823866	265781	260471	rs886039781	NC_000005.10:179823864:AGAG:AG
NM_003900.5(SQSTM1):c.2T>A (p.Met1Lys)	SQSTM1	M1K	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Oct 10, 2016)	no assertion criteria provided	VCV000265780	5	179247938	5	179820938	265780	260470	rs886039780	NC_000005.10:179820937:T:A
NM_003900.5(SQSTM1):c.1132A>T (p.Lys378Ter)	SQSTM1	K378*, K294*		Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000202210	5	179260749	5	179833749	202210	198651	rs796052213	NC_000005.10:179833748:A:T
NM_003900.5(SQSTM1):c.1224dup (p.Glu409Ter)	SQSTM1			Pathogenic(Last reviewed: Oct 15, 2002)	no assertion criteria provided	VCV000008109	5	179263493 - 179263494	5	179836493 - 179836494	8109	23148	rs796051869	NC_000005.10:179836493:T:TT
NM_004453.4(ETFDH):c.1601C>T (p.Pro534Leu)	ETFDH	P534L, P487L, P473L	not provided|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418184	4	159627913	4	158706761	418184	406420	rs200920510	NC_000004.12:158706760:C:T
NM_004453.4(ETFDH):c.1234G>T (p.Glu412Ter)	ETFDH	E412*, E365*, E351*	not provided|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095071	4	159624692	4	158703540	95071	100971	rs398124151	NC_000004.12:158703539:G:T
NM_002609.4(PDGFRB):c.1681C>T (p.Arg561Cys)	PDGFRB	R561C, R497C, R400C	not provided|Infantile myofibromatosis|Infantile myofibromatosis 1	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000055848	5	149505134	5	150125571	55848	70502	rs367543286	NC_000005.10:150125570:G:A
NM_000027.4(AGA):c.677G>A (p.Gly226Asp)	AGA	G226D	not provided|Aspartylglucosaminuria	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000055950	4	178357451	4	177436297	55950	70589	rs386833431	NC_000004.12:177436296:C:T
NM_000539.3(RHO):c.511C>T (p.Pro171Ser)	RHO	P171S	Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000013050	3	129249868	3	129531025	13050	28089	rs104893794	NC_000003.12:129531024:C:T
NM_000539.3(RHO):c.568G>T (p.Asp190Tyr)	RHO	D190Y	Retinitis pigmentosa 4|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000013040	3	129251131	3	129532288	13040	28079	rs104893779	NC_000003.12:129532287:G:T
NM_000539.3(RHO):c.533A>G (p.Tyr178Cys)	RHO	Y178C	Retinitis pigmentosa 4|Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000013025	3	129251096	3	129532253	13025	28064	rs104893776	NC_000003.12:129532252:A:G
NM_018297.4(NGLY1):c.1533_1536del (p.Asn511fs)	NGLY1	N469fs, N493fs, N511fs	Congenital disorder of deglycosylation|Peripheral neuropathy|Neuromotor delay|Intellectual disability|not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548658	3	25770699 - 25770702	3	25729208 - 25729211	548658	539127	rs765211108	NC_000003.12:25729207:TTGATTG:TTG
NM_018297.4(NGLY1):c.1891del (p.Gln631fs)	NGLY1	Q589fs, Q613fs, Q631fs	not provided|Congenital disorder of deglycosylation	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000050961	3	25761025	3	25719534	50961	65631	rs587776982	NC_000003.12:25719533:GGG:GG
GRCh37/hg19 6p25.1(chr6:5545413-5545573)	FARS2		Combined oxidative phosphorylation deficiency 14	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000813308	6	5545413 - 5545573			813308	801560		
NC_000006.12:g.(?_5545160)_(5545360_?)del	FARS2		Combined oxidative phosphorylation deficiency 14	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000833172	6	5545393 - 5545593			833172	819701		
NM_006567.5(FARS2):c.812del (p.Thr271fs)	FARS2	T271fs, T39fs	Combined oxidative phosphorylation deficiency 14	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000654274	6	5431313	6	5431080	654274	635009		NC_000006.12:5431079:C:
NM_006567.5(FARS2):c.261G>A (p.Trp87Ter)	FARS2	W87*	Combined oxidative phosphorylation deficiency 14	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000652282	6	5369064	6	5368831	652282	635004		NC_000006.12:5368830:G:A
NC_000006.11:g.(?_5368784)_(5431425_?)del	FARS2		Combined oxidative phosphorylation deficiency 14	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000540542	6	5368784 - 5431425	6	5368551 - 5431192	540542	521895		
NM_003900.5(SQSTM1):c.526_529del (p.Ser176fs)	SQSTM1	S176fs, S92fs	Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000503881	5	179251079 - 179251082	5	179824079 - 179824082	503881	495500	rs1331685476	NC_000005.10:179824078:CTGTCTG:CTG
NC_000006.11:g.(?_5368784)_(5369435_?)del	FARS2		Combined oxidative phosphorylation deficiency 14	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000473306			6	5368551 - 5369202	473306	455121		
NM_024592.5(SRD5A3):c.57G>A (p.Trp19Ter)	SRD5A3	W19*	Congenital disorder of glycosylation|Congenital disorder of glycosylation type 1Q|Global developmental delay|Cone/cone-rod dystrophy|Autistic disorder of childhood onset|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096125	4	56212560	4	55346393	96125	102019	rs398124401	NC_000004.12:55346392:G:A
NM_005506.4(SCARB2):c.862C>T (p.Gln288Ter)	SCARB2	Q288*, Q145*	Epilepsy, progressive myoclonic 4, with or without renal failure|not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000007378	4	77095429	4	76174276	7378	22417	rs121909118	NC_000004.12:76174275:G:A
NM_016247.4(IMPG2):c.3229dup (p.Cys1077fs)	IMPG2		Retinal dystrophy	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000866639	3	100951628 - 100951629	3	101232784 - 101232785	866639	856242		NC_000003.12:101232784:AAA:AAAA
NM_016247.4(IMPG2):c.1818dup (p.Gln607fs)	IMPG2		not provided	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000283184	3	100963356 - 100963357	3	101244512 - 101244513	283184	267421	rs1553681434	NC_000003.12:101244512:CCC:CCCC
NM_016247.4(IMPG2):c.946del (p.Glu316fs)	IMPG2	E316fs	not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000861700	3	100976580	3	101257736	861700	827267		NC_000003.12:101257735:C:
NM_016247.4(IMPG2):c.1802T>A (p.Leu601Ter)	IMPG2	L601*	not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000851233	3	100963373	3	101244529	851233	827259		NC_000003.12:101244528:A:T
NM_016247.4(IMPG2):c.1826del (p.Val609fs)	IMPG2	V609fs	Retinitis pigmentosa 56	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522456	3	100963349	3	101244505	522456	513045	rs1553681433	NC_000003.12:101244504:A:
NM_016247.4(IMPG2):c.85+2T>A	IMPG2		Retinitis pigmentosa 56	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522455	3	101039130	3	101320286	522455	513046	rs1553687118	NC_000003.12:101320285:A:T
NM_016247.4(IMPG2):c.3230G>T (p.Cys1077Phe)	IMPG2	C1077F	Macular dystrophy, vitelliform, 5	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162138	3	100951628	3	101232784	162138	171853	rs713993049	NC_000003.12:101232783:C:A
NM_016247.4(IMPG2):c.2716C>T (p.Arg906Ter)	IMPG2	R906*	Retinitis pigmentosa 56	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000003548	3	100962459	3	101243615	3548	18587	rs267606876	NC_000003.12:101243614:G:A
NM_016247.4(IMPG2):c.887+430_908+274del	IMPG2		Retinitis pigmentosa 56	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000003547	3	100986081 - 100987929	3	101267237 - 101269085	3547	18586		
NM_004453.4(ETFDH):c.770A>G (p.Tyr257Cys)	ETFDH	Y196C, Y257C, Y210C	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000666174	4	159616734	4	158695582	666174	632070		NC_000004.12:158695581:A:G
NM_004453.4(ETFDH):c.1001T>C (p.Leu334Pro)	ETFDH	L334P, L273P, L287P	Glutaric aciduria, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199094	4	159620167	4	158699015	199094	196253	rs377686388	NC_000004.12:158699014:T:C
NM_004453.4(ETFDH):c.51dup (p.Ala18fs)	ETFDH		Glutaric aciduria, type 2|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195222	4	159601634 - 159601635	4	158680482 - 158680483	195222	192383	rs796051964	NC_000004.12:158680482:T:TT
NM_004453.4(ETFDH):c.1448C>T (p.Pro483Leu)	ETFDH	P483L, P436L, P422L	Glutaric aciduria, type 2|Glutaric acidemia iic, late-onset	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000031602	4	159627503	4	158706351	31602	40286	rs377656387	NC_000004.12:158706350:C:T
NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	FARS2	D142Y	Spastic paraplegia 77, autosomal recessive	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000253159	6	5369227	6	5368994	253159	247571	rs145555213	NC_000006.12:5368993:G:T
NM_016247.4(IMPG2):c.2268del (p.Asn755_Tyr756insTer)	IMPG2		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000862262	3	100962907	3	101244063	862262	827255		NC_000003.12:101244062:A:
NC_000003.12:g.(?_101267511)_(101267531_?)del	IMPG2		not provided	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000832085	3	100986355 - 100986375			832085	819301		
NM_016247.4(IMPG2):c.513T>G (p.Tyr171Ter)	IMPG2	Y171*	Macular dystrophy, vitelliform, 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000191181	3	101010343	3	101291499	191181	188984	rs763295314	NC_000003.12:101291498:A:C
NM_016247.4(IMPG2):c.379C>T (p.Arg127Ter)	IMPG2	R127*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000845633	3	101023112	3	101304268	845633	827271		NC_000003.12:101304267:G:A
NM_016247.4(IMPG2):c.1680T>A (p.Tyr560Ter)	IMPG2	Y560*	Retinal dystrophy|Abnormality of the eye	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000437938	3	100963495	3	101244651	437938	431661	rs758291149	NC_000003.12:101244650:A:T
NM_182760.4(SUMF1):c.542T>G (p.Leu181Ter)	SUMF1	L181*, L156*	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488612	3	4461808	3	4420124	488612	481480	rs1553575867	NC_000003.12:4420123:A:C
NM_182760.4(SUMF1):c.339dup (p.Ala114fs)	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000847449	3	4494664 - 4494665	3	4452980 - 4452981	847449	828181		NC_000003.12:4452980:TT:TTT
NC_000003.12:g.(?_4410855)_(4467255_?)del	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000831204	3	4452539 - 4508939			831204	819403		
NC_000003.12:g.(?_4452866)_(4467255_?)del	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000831130	3	4494550 - 4508939			831130	819405		
NC_000003.12:g.(?_4362124)_(4467265_?)del	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000831018	3	4403808 - 4508949			831018	819399		
NC_000003.11:g.(?_4490940)_(4508939_?)del	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000666213	3	4490940 - 4508939	3	4449256 - 4467255	666213	651045		
NM_182760.4(SUMF1):c.266C>G (p.Ser89Ter)	SUMF1	S89*	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000646769	3	4508664	3	4466980	646769	631450		NC_000003.12:4466979:G:C
NM_182760.4(SUMF1):c.659G>A (p.Trp220Ter)	SUMF1	W220*, W195*	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000638975	3	4459760	3	4418076	638975	631449		NC_000003.12:4418075:C:T
NM_182760.4(SUMF1):c.337G>A (p.Glu113Lys)	SUMF1	E113K	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Apr 1, 2016)	no assertion criteria provided	VCV000225909	3	4494667	3	4452983	225909	227720	rs1085307107	NC_000003.12:4452982:C:T
NM_182760.4(SUMF1):c.1A>G (p.Met1Val)	SUMF1	M1V	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002679	3	4508929	3	4467245	2679	17718	rs137852855	NC_000003.12:4467244:T:C
NM_182760.4(SUMF1):c.653G>A (p.Cys218Tyr)	SUMF1	C218Y, C193Y	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002677	3	4459766	3	4418082	2677	17716	rs137852854	NC_000003.12:4418081:C:T
NM_182760.4(SUMF1):c.1042G>C (p.Ala348Pro)	SUMF1	A348P, A323P, A328P	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002676	3	4403911	3	4362227	2676	17715	rs137852853	NC_000003.12:4362226:C:G
SUMF1, 1-BP DEL, 276C	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002674					2674	17713		
NM_182760.4(SUMF1):c.2T>G (p.Met1Arg)	SUMF1	M1R	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002673	3	4508928	3	4467244	2673	17712	rs137852851	NC_000003.12:4467243:A:C
SUMF1, 1-BP DEL, 243C	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002670					2670	17709		
NM_182760.4(SUMF1):c.1076C>A (p.Ser359Ter)	SUMF1	S359*, S339*, S334*	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002664	3	4403877	3	4362193	2664	17703	rs137852844	NC_000003.12:4362192:G:T
NM_182760.4(SUMF1):c.788G>T (p.Gly263Val)	SUMF1	G263V, G238V	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Jan 3, 2019)	no assertion criteria provided	VCV000030689	3	4458864	3	4417180	30689	39646	rs387906976	NC_000003.12:4417179:C:A
NM_182760.4(SUMF1):c.1006T>C (p.Cys336Arg)	SUMF1	C336R, C311R	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002668	3	4418022	3	4376338	2668	17707	rs137852848	NC_000003.12:4376337:A:G
NM_182760.4(SUMF1):c.1046G>A (p.Arg349Gln)	SUMF1	R349Q, R329Q, R324Q	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002667	3	4403907	3	4362223	2667	17706	rs137852847	NC_000003.12:4362222:C:T
NM_152618.3(BBS12):c.1502C>T (p.Thr501Met)	BBS12	T501M	Bardet-Biedl syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585190	4	123664549	4	122743394	585190	576221	rs138011813	NC_000004.12:122743393:C:T
NM_182760.4(SUMF1):c.1033C>T (p.Arg345Cys)	SUMF1	R345C, R325C, R320C	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Jan 3, 2019)	no assertion criteria provided	VCV000002675	3	4403920	3	4362236	2675	17714	rs137852852	NC_000003.12:4362235:G:A
NM_182760.4(SUMF1):c.661del (p.Ala221fs)	SUMF1	A196fs, A221fs	Multiple sulfatase deficiency	Pathogenic(Last reviewed: May 16, 2003)	no assertion criteria provided	VCV000002671	3	4459758	3	4418074	2671	17710	rs770241913	NC_000003.12:4418073:CCC:CC
NM_182760.4(SUMF1):c.519+5_519+8del	SUMF1		Multiple sulfatase deficiency	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000002663	3	4490942 - 4490945	3	4449258 - 4449261	2663	17702	rs775324176	NC_000003.12:4449257:TTACTTACT:TTACT
NM_017755.6(NSUN2):c.1020del (p.Gly341fs)	NSUN2	G341fs, G306fs	Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828097	5	6616841	5	6616728	828097	816456		NC_000005.10:6616727:TT:T
NM_017755.6(NSUN2):c.247_251del (p.Tyr83fs)	NSUN2	Y83fs	not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000817983	5	6632715 - 6632719	5	6632602 - 6632606	817983	805446		NC_000005.10:6632601:TTGTA:
NM_000232.5(SGCB):c.366_367del (p.Leu122_Tyr123insTer)	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802073	4	52895906 - 52895907	4	52029740 - 52029741	802073	790477		NC_000004.12:52029739:AAA:A
GRCh37/hg19 5p15.31(chr5:6599369-6603435)x1	NSUN2		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	no assertion criteria provided	VCV000687967	5	6599369 - 6603435			687967	675559		
NM_000232.4(SGCB):c.391C>T (p.Arg131Ter)	SGCB	R131*	not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000523842	4	52895882	4	52029716	523842	514497	rs1013015106	NC_000004.12:52029715:G:A
NM_017755.6(NSUN2):c.749_752AGAT[1] (p.Ile251fs)	NSUN2		not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426687	5	6620278 - 6620281	5	6620165 - 6620168	426687	415009	rs1085307745	NC_000005.10:6620164:ATCTATCT:ATCT
NM_000232.4(SGCB):c.572del (p.Leu191fs)	SGCB	L191fs	not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000283057	4	52894945	4	52028779	283057	267294	rs886042546	NC_000004.12:52028778:AAA:AA
NM_000232.4(SGCB):c.32dup (p.Gln12fs)	SGCB		not provided	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000193065	4	52904393 - 52904394	4	52038227 - 52038228	193065	190230	rs796065319	NC_000004.12:52038227:T:TT
NM_000232.5(SGCB):c.-12_8dup (p.Ala4fs)	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000841552	4	52904417 - 52904418	4	52038251 - 52038252	841552	829206		NC_000004.12:52038251:GCCGCCATCTTCCCGCGCCCGCCGCC:GCCGCCATCTTCCCGCGCCCGCCGCCATCTTCCCGCGCCCGCCGCC
NM_017755.6(NSUN2):c.1725_1728del (p.Ser575fs)	NSUN2	S540fs, S575fs	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000834323	5	6605395 - 6605398	5	6605282 - 6605285	834323	830917		NC_000005.10:6605281:CTCACT:CT
NM_017755.6(NSUN2):c.1305G>A (p.Trp435Ter)	NSUN2	W400*, W435*	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000664755	5	6609957	5	6609844	664755	633994		NC_000005.10:6609843:C:T
NC_000004.11:g.(?_52890113)_(52904435_?)del	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000663428	4	52890113 - 52904435	4	52023947 - 52038269	663428	651176		
NM_000232.4(SGCB):c.82_86del (p.Glu28fs)	SGCB	E28fs	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000466608	4	52899754 - 52899758	4	52033588 - 52033592	466608	453592	rs1553940687	NC_000004.12:52033587:CTCTC:
NM_000232.4(SGCB):c.253_254del (p.Val85fs)	SGCB	V85fs	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000466602	4	52896019 - 52896020	4	52029853 - 52029854	466602	453986	rs1553940274	NC_000004.12:52029852:ACA:A
NC_000004.11:g.(?_52904373)_(52904445_?)del	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Feb 11, 2017)	criteria provided, single submitter	VCV000466600	4	52904373 - 52904445	4	52038207 - 52038279	466600	452824		
NM_017755.6(NSUN2):c.538-1G>C	NSUN2		Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037005	5	6622214	5	6622101	37005	45671	rs1560982564	NC_000005.10:6622100:C:G
NM_017755.6(NSUN2):c.2035G>A (p.Gly679Arg)	NSUN2	G679R, G644R	Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031678	5	6600308	5	6600195	31678	40340	rs587776908	NC_000005.10:6600194:C:T
NM_017755.6(NSUN2):c.1114C>T (p.Gln372Ter)	NSUN2	Q372*, Q337*	Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031676	5	6611180	5	6611067	31676	40338	rs387907191	NC_000005.10:6611066:G:A
SGCB, 4-BP DEL, 243+3GAGT	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000008720					8720	23759		
NM_000232.4(SGCB):c.323T>G (p.Leu108Arg)	SGCB	L108R	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008717	4	52895950	4	52029784	8717	23756	rs104893870	NC_000004.12:52029783:A:C
NM_000232.4(SGCB):c.272G>C (p.Arg91Pro)	SGCB	R91P	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008716	4	52896001	4	52029835	8716	23755	rs104893869	NC_000004.12:52029834:C:G
NM_000232.4(SGCB):c.466_467del (p.Glu156fs)	SGCB	E156fs	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000008715	4	52895050 - 52895051	4	52028884 - 52028885	8715	23754		NC_000004.12:52028883:TCT:T
NM_000539.3(RHO):c.448G>A (p.Glu150Lys)	RHO	E150K	Retinitis pigmentosa 4, autosomal recessive|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000013046	3	129249805	3	129530962	13046	28085	rs104893791	NC_000003.12:129530961:G:A
NM_000539.3(RHO):c.158C>G (p.Pro53Arg)	RHO	P53R	Retinitis pigmentosa 4|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000013037	3	129247734	3	129528891	13037	28076	rs28933395	NC_000003.12:129528890:C:G
NM_000539.3(RHO):c.568G>A (p.Asp190Asn)	RHO	D190N	not provided|Retinitis pigmentosa 4	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000013023	3	129251131	3	129532288	13023	28062	rs104893779	NC_000003.12:129532287:G:A
NM_000539.3(RHO):c.173C>G (p.Thr58Arg)	RHO	T58R	Retinitis pigmentosa 4|Retinal dystrophy	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013016	3	129247749	3	129528906	13016	28055	rs28933394	NC_000003.12:129528905:C:G
NM_000232.4(SGCB):c.656_657del (p.Lys219fs)	SGCB	K219fs	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000466603	4	52894230 - 52894231	4	52028064 - 52028065	466603	453976	rs775458201	NC_000004.12:52028063:TTTT:TT
NM_000232.4(SGCB):c.29_33del (p.Glu10fs)	SGCB	E10fs	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371175	4	52904393 - 52904397	4	52038227 - 52038231	371175	357359	rs1057517064	NC_000004.12:52038226:CTGTTCTG:CTG
NSUN2, IVS5, A-C	NSUN2		Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031677					31677	40339		
NM_003900.5(SQSTM1):c.1185dup (p.Glu396Ter)	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000835699	5	179263453 - 179263454	5	179836453 - 179836454	835699	830769		NC_000005.10:179836453:TT:TTT
NM_000232.5(SGCB):c.2T>C (p.Met1Thr)	SGCB	M1T	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000862654	4	52904424	4	52038258	862654	829207		NC_000004.12:52038257:A:G
NC_000004.12:g.(?_52033421)_(52033650_?)del	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000832156	4	52899587 - 52899816			832156	819484		
NM_000232.4(SGCB):c.595_598del (p.Asn199fs)	SGCB	N199fs	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556837	4	52894919 - 52894922	4	52028753 - 52028756	556837	543508	rs762114570	NC_000004.12:52028752:CATTCA:CA
NM_000232.4(SGCB):c.28G>T (p.Glu10Ter)	SGCB	E10*	Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000534947	4	52904398	4	52038232	534947	520217	rs1448040082	NC_000004.12:52038231:C:A
SGCB, 8-BP DUP, NT383	SGCB		Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000008714					8714	23753		
NM_016247.4(IMPG2):c.829-1G>T	IMPG2		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286964	3	100988418	3	101269574	286964	271201	rs776740276	NC_000003.12:101269573:C:A
NM_016247.4(IMPG2):c.2274G>A (p.Trp758Ter)	IMPG2	W758*	not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000191180	3	100962901	3	101244057	191180	188983	rs786205564	NC_000003.12:101244056:C:T
NM_016247.4(IMPG2):c.635C>G (p.Ser212Ter)	IMPG2	S212*	Retinitis pigmentosa 56|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000003546	3	100994538	3	101275694	3546	18585	rs267606874	NC_000003.12:101275693:G:C
NM_000521.4(HEXB):c.1509-26G>A	HEXB		Sandhoff disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527971	5	74016442	5	74720617	527971	521532	rs201580118	NC_000005.10:74720616:G:A
NM_182760.4(SUMF1):c.979C>T (p.Arg327Ter)	SUMF1	R327*, R302*	Multiple sulfatase deficiency	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000002665	3	4418049	3	4376365	2665	17704	rs137852845	NC_000003.12:4376364:G:A
NM_005506.4(SCARB2):c.361C>T (p.Arg121Ter)	SCARB2	R121*	not provided|Epilepsy, progressive myoclonic 4, with or without renal failure|Progressive myoclonic epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206709	4	77102169	4	76181016	206709	201795	rs200053119	NC_000004.12:76181015:G:A
NM_005546.3(ITK):c.913del (p.Tyr305fs)	ITK	Y305fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000521210	5	156667133	5	157240123	521210	511581	rs1554102738	NC_000005.10:157240122:T:
NM_016247.4(IMPG2):c.3262C>T (p.Arg1088Ter)	IMPG2	R1088*	not provided|Retinitis pigmentosa|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143151	3	100949961	3	101231117	143151	152869	rs199867882	NC_000003.12:101231116:G:A
NM_000232.4(SGCB):c.299T>A (p.Met100Lys)	SGCB	M100K	Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008718	4	52895974	4	52029808	8718	23757	rs104893871	NC_000004.12:52029807:A:T
NM_001354712.2(THRB):c.1378G>A (p.Glu460Lys)	THRB	E460K, E429K	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	VCV000492926	3	24164383	3	24122892	492926	485712	rs1553609090	NC_000003.12:24122891:C:T
NM_001354712.2(THRB):c.1358dup (p.Leu454fs)	THRB		Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Mar 23, 2009)	no assertion criteria provided	VCV000492925	3	24164402 - 24164403	3	24122911 - 24122912	492925	485713	rs1553609119	NC_000003.12:24122911:GGGGGG:GGGGGGG
NM_001354712.2(THRB):c.1357C>G (p.Pro453Ala)	THRB	P453A, P422A	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 3, 2016)	no assertion criteria provided	VCV000492924	3	24164404	3	24122913	492924	485714	rs28933408	NC_000003.12:24122912:G:C
NM_001354712.2(THRB):c.1348C>T (p.Leu450Phe)	THRB	L450F, L419F	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jun 29, 2011)	no assertion criteria provided	VCV000492923	3	24164413	3	24122922	492923	485715	rs1553609152	NC_000003.12:24122921:G:A
NM_001354712.2(THRB):c.1312del (p.Arg438fs)	THRB	R438fs, R407fs	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2013)	no assertion criteria provided	VCV000492922	3	24164449	3	24122958	492922	485717	rs1553609179	NC_000003.12:24122957:GG:G
NM_001354712.2(THRB):c.1312C>T (p.Arg438Cys)	THRB	R438C, R407C	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jan 28, 2014)	no assertion criteria provided	VCV000492921	3	24164449	3	24122958	492921	485716	rs367757240	NC_000003.12:24122957:G:A
NM_001354712.2(THRB):c.1031G>A (p.Gly344Glu)	THRB	G344E, G313E	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Feb 24, 2012)	no assertion criteria provided	VCV000492918	3	24169103	3	24127612	492918	485720	rs1553610974	NC_000003.12:24127611:C:T
NM_001354712.2(THRB):c.980C>A (p.Thr327Asn)	THRB	T327N, T296N	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Feb 12, 2014)	no assertion criteria provided	VCV000492917	3	24169154	3	24127663	492917	485721	rs1553611038	NC_000003.12:24127662:G:T
NM_001354712.2(THRB):c.941C>T (p.Ser314Phe)	THRB	S314F, S283F	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jan 12, 2016)	no assertion criteria provided	VCV000492916	3	24169193	3	24127702	492916	485722	rs1553611075	NC_000003.12:24127701:G:A
NM_001354712.2(THRB):c.938T>C (p.Met313Thr)	THRB	M313T, M282T	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jan 27, 2010)	no assertion criteria provided	VCV000492915	3	24169196	3	24127705	492915	485723	rs1553611083	NC_000003.12:24127704:A:G
NM_001354712.2(THRB):c.928A>G (p.Met310Val)	THRB	M310V, M279V	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 6, 2014)	no assertion criteria provided	VCV000492914	3	24169206	3	24127715	492914	485724	rs1553611094	NC_000003.12:24127714:T:C
NM_001354712.2(THRB):c.67C>T (p.Arg23Ter)	THRB	R23*	not provided	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000287830	3	24231781	3	24190290	287830	272067	rs886043743	NC_000003.12:24190289:G:A
NM_001354712.2(THRB):c.1286G>A (p.Arg429Gln)	THRB	R429Q, R398Q	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000548123	3	24164475	3	24122984	548123	538610	rs1553609210	NC_000003.12:24122983:C:T
NM_001354712.2(THRB):c.1326_1327delinsAT (p.Met442_Lys443delinsIleTer)	THRB		Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000545656	3	24164434 - 24164435	3	24122943 - 24122944	545656	536152	rs1553609167	NC_000003.12:24122942:TC:AT
THRB, 1-BP INS, 1590T	THRB		Thyroid hormone resistance, selective pituitary	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000012571					12571	27610		
THRB, 1-BP DEL, CODON 438, C	THRB		Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000012570					12570	27609		
NM_001354712.2(THRB):c.1009A>G (p.Thr337Ala)	THRB	T337A, T306A	Thyroid hormone resistance, selective pituitary	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000012569	3	24169125	3	24127634	12569	27608	rs121918709	NC_000003.12:24127633:T:C
NM_001354712.2(THRB):c.1336T>C (p.Cys446Arg)	THRB	C446R, C415R	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012563	3	24164425	3	24122934	12563	27602	rs121918703	NC_000003.12:24122933:A:G
NM_001354712.2(THRB):c.959G>T (p.Arg320Leu)	THRB	R320L, R289L	Thyroid hormone resistance, selective pituitary	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000012562	3	24169175	3	24127684	12562	27601	rs121918693	NC_000003.12:24127683:C:A
NM_001354712.2(THRB):c.929T>C (p.Met310Thr)	THRB	M310T, M279T	Thyroid hormone resistance, generalized	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012540	3	24169205	3	24127714	12540	27579	rs121918699	NC_000003.12:24127713:A:G
NM_001354712.2(THRB):c.1148G>A (p.Arg383His)	THRB	R383H, R352H	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000012568	3	24164613	3	24123122	12568	27607	rs121918708	NC_000003.12:24123121:C:T
NM_001354712.2(THRB):c.1376T>G (p.Phe459Cys)	THRB	F459C, F428C	Thyroid hormone resistance, generalized	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012561	3	24164385	3	24122894	12561	27600	rs121918702	NC_000003.12:24122893:A:C
THRB, 1-BP INS, 1644C	THRB		Thyroid hormone resistance, generalized	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012560					12560	27599		
NM_001354712.2(THRB):c.958C>T (p.Arg320Cys)	THRB	R320C, R289C	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Oct 20, 2010)	no assertion criteria provided	VCV000012557	3	24169176	3	24127685	12557	27596	rs121918696	NC_000003.12:24127684:G:A
THRB, LEU325PHE	THRB	L325F	Thyroid hormone resistance, selective pituitary	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000012556					12556	27595		
NM_001354712.2(THRB):c.1327A>G (p.Lys443Glu)	THRB	K443E, K412E	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012551	3	24164434	3	24122943	12551	27590	rs121918692	NC_000003.12:24122942:T:C
NM_001354712.2(THRB):c.1349T>A (p.Leu450His)	THRB	L450H, L419H	Thyroid hormone resistance, generalized	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012548	3	24164412	3	24122921	12548	27587	rs121918701	NC_000003.12:24122920:A:T
NM_001354712.2(THRB):c.1034G>A (p.Gly345Asp)	THRB	G345D, G314D	Thyroid hormone resistance, generalized	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012544	3	24169100	3	24127609	12544	27583	rs28999970	NC_000003.12:24127608:C:T
NM_001354712.2(THRB):c.964G>C (p.Asp322His)	THRB	D322H, D291H	Thyroid hormone resistance, generalized	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012541	3	24169170	3	24127679	12541	27580	rs121918700	NC_000003.12:24127678:C:G
NM_001354712.2(THRB):c.1020G>C (p.Gln340His)	THRB	Q340H, Q309H	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012536	3	24169114	3	24127623	12536	27575	rs121918688	NC_000003.12:24127622:C:G
NM_001354712.2(THRB):c.928A>T (p.Met310Leu)	THRB	M279L, M310L	not provided	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000801289	3	24169206	3	24127715	801289	789443		NC_000003.12:24127714:T:A
NM_001354712.2(THRB):c.803C>G (p.Ala268Gly)	THRB	A268G, A237G	Thyroid hormone resistance, generalized, autosomal dominant|Thyroid hormone resistance, generalized, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000492912	3	24174889	3	24133398	492912	485726	rs750905761	NC_000003.12:24133397:G:C
NM_001354712.2(THRB):c.1305T>G (p.His435Gln)	THRB	H435Q, H404Q	Thyroid hormone resistance, generalized, autosomal dominant|Thyroid hormone resistance syndrome	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000437004	3	24164456	3	24122965	437004	428167	rs1553609185	NC_000003.12:24122964:A:C
NM_001354712.2(THRB):c.947G>A (p.Arg316His)	THRB	R316H, R285H	Thyroid hormone resistance, selective pituitary	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012555	3	24169187	3	24127696	12555	27594	rs121918695	NC_000003.12:24127695:C:T
NM_001354712.2(THRB):c.1033G>A (p.Gly345Ser)	THRB	G345S, G314S	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012552	3	24169101	3	24127610	12552	27591	rs121918686	NC_000003.12:24127609:C:T
THRB, 1-BP INS, 1627C	THRB		Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Dec 18, 2001)	no assertion criteria provided	VCV000012549					12549	27588		
NM_001354712.2(THRB):c.1040G>A (p.Gly347Glu)	THRB	G347E, G316E	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000012546	3	24169094	3	24127603	12546	27585	rs28999971	NC_000003.12:24127602:C:T
THRB, EX4-10DEL	THRB		Thyroid hormone resistance, generalized, autosomal recessive	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012538					12538	27577		
NM_001354712.2(THRB):c.727C>T (p.Arg243Trp)	THRB	R243W, R212W	Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000012567	3	24185003	3	24143512	12567	27606	rs121918707	NC_000003.12:24143511:G:A
NM_001354712.2(THRB):c.1302C>A (p.Cys434Ter)	THRB	C434*, C403*	Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000012565	3	24164459	3	24122968	12565	27604	rs121918705	NC_000003.12:24122967:G:T
NM_001354712.2(THRB):c.1313G>A (p.Arg438His)	THRB	R438H, R407H	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jan 20, 2012)	no assertion criteria provided	VCV000012559	3	24164448	3	24122957	12559	27598	rs121918698	NC_000003.12:24122956:C:T
NM_001354712.2(THRB):c.1358C>A (p.Pro453His)	THRB	P453H, P422H	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000012537	3	24164403	3	24122912	12537	27576	rs121918687	NC_000003.12:24122911:G:T
NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs)	NHLRC1	G158fs	Lafora disease|not provided|Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002588	6	18122369 - 18122370	6	18122138 - 18122139	2588	17627	rs587776542	NC_000006.12:18122137:CT:
NM_145207.3(SPATA5):c.1603A>T (p.Lys535Ter)	SPATA5	K535*, K534*	not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000817552	4	123868532	4	122947377	817552	805378		NC_000004.12:122947376:A:T
GRCh37/hg19 4q28.1(chr4:124095605-124197217)x1	SPATA5		not provided	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000689265	4	124095605 - 124197217			689265	676857		
GRCh37/hg19 4q28.1(chr4:123871868-123913329)x1	SPATA5		not provided	Pathogenic(Last reviewed: Aug 7, 2018)	no assertion criteria provided	VCV000688105	4	123871868 - 123913329			688105	675697		
GRCh37/hg19 4q28.1(chr4:123959202-124003246)x1	SPATA5		not provided	Pathogenic(Last reviewed: Nov 30, 2017)	no assertion criteria provided	VCV000684932	4	123959202 - 124003246			684932	672524		
NM_145207.3(SPATA5):c.388C>T (p.Gln130Ter)	SPATA5	Q130*, Q129*	not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000620157	4	123850294	4	122929139	620157	611604	rs1560786479	NC_000004.12:122929138:C:T
NM_145207.3(SPATA5):c.700C>T (p.Gln234Ter)	SPATA5	Q234*, Q233*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488608	4	123855446	4	122934291	488608	481476	rs775269863	NC_000004.12:122934290:C:T
NM_145207.3(SPATA5):c.394C>T (p.Gln132Ter)	SPATA5	Q132*, Q131*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488607	4	123850300	4	122929145	488607	481475	rs1220351376	NC_000004.12:122929144:C:T
NM_145207.3(SPATA5):c.1069G>T (p.Gly357Ter)	SPATA5	G357*, G356*	not provided	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000265608	4	123855815	4	122934660	265608	259781	rs755744719	NC_000004.12:122934659:G:T
NM_145207.3(SPATA5):c.1612C>T (p.Arg538Ter)	SPATA5	R538*, R537*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000864697	4	123868541	4	122947386	864697	828769		NC_000004.12:122947385:C:T
NM_145207.3(SPATA5):c.1540C>T (p.Arg514Ter)	SPATA5	R513*, R514*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000856522	4	123868469	4	122947314	856522	828767		NC_000004.12:122947313:C:T
NM_145207.3(SPATA5):c.1030C>T (p.Gln344Ter)	SPATA5	Q343*, Q344*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000839145	4	123855776	4	122934621	839145	828760		NC_000004.12:122934620:C:T
NM_145207.3(SPATA5):c.1747C>T (p.Gln583Ter)	SPATA5	Q583*, Q582*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000838696	4	123900419	4	122979264	838696	828771		NC_000004.12:122979263:C:T
NM_145207.3(SPATA5):c.1963C>T (p.Arg655Ter)	SPATA5	R655*, R654*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000836262	4	123949434	4	123028279	836262	828774		NC_000004.12:123028278:C:T
NM_145207.3(SPATA5):c.2038G>T (p.Ala680Ser)	SPATA5	A679S, A680S	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000666562	4	123949509	4	123028354	666562	654124		NC_000004.12:123028353:G:T
NM_145207.3(SPATA5):c.1039_1040dup (p.Gln347fs)	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000652524	4	123855784 - 123855785	4	122934629 - 122934630	652524	631927		NC_000004.12:122934629:CA:CACA
NM_145207.3(SPATA5):c.1820del (p.Asn607fs)	SPATA5	N606fs, N607fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000651167	4	123900491	4	122979336	651167	631935		NC_000004.12:122979335:AA:A
NC_000004.11:g.(?_123977542)_(123978443_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000583652	4	123977542 - 123978443	4	123056387 - 123057288	583652	559545		
NM_145207.3(SPATA5):c.2409_2410del (p.Glu804fs)	SPATA5	E803fs, E804fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000575536	4	124177238 - 124177239	4	123256083 - 123256084	575536	561895	rs1560667008	NC_000004.12:123256082:GGG:G
NC_000004.11:g.(?_123977522)_(123978463_?)del	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000542396	4	123977522 - 123978463	4	123056367 - 123057308	542396	519936		
NM_145207.3(SPATA5):c.661C>T (p.Gln221Ter)	SPATA5	Q221*, Q220*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000542389	4	123855407	4	122934252	542389	519739	rs1553955672	NC_000004.12:122934251:C:T
NM_145207.3(SPATA5):c.1677C>A (p.Tyr559Ter)	SPATA5	Y559*, Y558*	not provided	Pathogenic(Last reviewed: Aug 3, 2015)	no assertion criteria provided	VCV000207827	4	123868606	4	122947451	207827	204063	rs139834687	NC_000004.12:122947450:C:A
NM_145207.3(SPATA5):c.298G>A (p.Ala100Thr)	SPATA5	A100T, A99T	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000203536	4	123850204	4	122929049	203536	199925	rs796051895	NC_000004.12:122929048:G:A
NM_145207.3(SPATA5):c.1343C>T (p.Ser448Leu)	SPATA5	S448L, S447L	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000203527	4	123859289	4	122938134	203527	199928	rs766034355	NC_000004.12:122938133:C:T
NM_145207.3(SPATA5):c.250C>T (p.Arg84Ter)	SPATA5	R83*, R84*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000844710	4	123848875	4	122927720	844710	828753		NC_000004.12:122927719:C:T
NM_145207.3(SPATA5):c.1714+1G>A	SPATA5		Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000207803	4	123868644	4	122947489	207803	204039	rs149688478	NC_000004.12:122947488:G:A
NM_145207.3(SPATA5):c.556C>T (p.Arg186Ter)	SPATA5	R186*, R185*	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000204306	4	123855302	4	122934147	204306	200703	rs796052095	NC_000004.12:122934146:C:T
NM_145207.3(SPATA5):c.1574_1578del (p.Asn525fs)	SPATA5	N525fs, N524fs	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000203529	4	123868503 - 123868507	4	122947348 - 122947352	203529	199929	rs796051891	NC_000004.12:122947347:ATGCT:
NM_001354712.2(THRB):c.700G>A (p.Ala234Thr)	THRB	A234T, A203T	Thyroid hormone resistance syndrome|Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000012554	3	24185030	3	24143539	12554	27593	rs121918694	NC_000003.12:24143538:C:T
NM_001354712.2(THRB):c.1034G>T (p.Gly345Val)	THRB	G345V, G314V	Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000012545	3	24169100	3	24127609	12545	27584	rs28999970	NC_000003.12:24127608:C:A
NM_001354712.2(THRB):c.1033G>C (p.Gly345Arg)	THRB	G345R, G314R	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Sep 14, 2015)	no assertion criteria provided	VCV000012535	3	24169101	3	24127610	12535	27574	rs121918686	NC_000003.12:24127609:C:G
NM_145207.3(SPATA5):c.251G>A (p.Arg84Gln)	SPATA5	R84Q, R83Q	Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203534	4	123848876	4	122927721	203534	199923	rs745858366	NC_000004.12:122927720:G:A
NM_145207.3(SPATA5):c.1883A>G (p.Asp628Gly)	SPATA5	D628G, D627G	Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203524	4	123949354	4	123028199	203524	199931	rs768528444	NC_000004.12:123028198:A:G
NM_000539.3(RHO):c.1033G>T (p.Val345Leu)	RHO	V345L	Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000636081	3	129252547	3	129533704	636081	623835		NC_000003.12:129533703:G:T
NM_000539.3(RHO):c.316G>A (p.Gly106Arg)	RHO	G106R	Retinitis pigmentosa 4|Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000013038	3	129247892	3	129529049	13038	28077	rs104893773	NC_000003.12:129529048:G:A
NM_005677.4(COLQ):c.1082del (p.Pro361fs)	COLQ	P351fs, P361fs, P327fs	Endplate acetylcholinesterase deficiency|Congenital myasthenic syndrome|not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006652	3	15497519	3	15456012	6652	21691	rs769982050	NC_000003.12:15456011:GGGG:GGG
NM_001354712.2(THRB):c.728G>A (p.Arg243Gln)	THRB	R243Q, R212Q	Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000012566	3	24185002	3	24143511	12566	27605	rs121918706	NC_000003.12:24143510:C:T
NM_152618.3(BBS12):c.2023C>T (p.Arg675Ter)	BBS12	R675*	Bardet-Biedl syndrome 12|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000347505	4	123665070	4	122743915	347505	296978	rs752202089	NC_000004.12:122743914:C:T
NM_172250.3(MMAA):c.64C>T (p.Arg22Ter)	MMAA	R22*	not provided|Vitamin B12-responsive methylmalonic acidemia type cblA|Methylmalonic acidemia	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218969	4	146560355	4	145639203	218969	216025	rs765799472	NC_000004.12:145639202:C:T
NM_004946.3(DOCK2):c.3633C>G (p.Tyr1211Ter)	DOCK2	Y1211*	Immunodeficiency 40	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000835804	5	169463527	5	170036523	835804	830647		NC_000005.10:170036522:C:G
DOCK2, 2-BP INS	DOCK2		Immunodeficiency 40	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000199262					199262	196422		
NM_004946.3(DOCK2):c.2253G>T (p.Arg751Ser)	DOCK2	R751S	Immunodeficiency 40	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000199261	5	169145781	5	169718777	199261	196421		NC_000005.10:169718776:G:T
NM_004946.3(DOCK2):c.3970C>T (p.Gln1324Ter)	DOCK2	Q1324*	Immunodeficiency 40	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000199259	5	169474517	5	170047513	199259	196419	rs762909359	NC_000005.10:170047512:C:T
DOCK2, 2-BP INS	DOCK2		Immunodeficiency 40	Pathogenic(Last reviewed: Jun 18, 2015)	no assertion criteria provided	VCV000199258					199258	196418		
NM_000158.4(GBE1):c.1544G>A (p.Arg515His)	GBE1	R515H	not provided|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180651	3	81627150	3	81577999	180651	178812	rs201958741	NC_000003.12:81577998:C:T
NM_006371.5(CRTAP):c.471+2C>A	CRTAP		Osteogenesis imperfecta type 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208570	3	33156042	3	33114550	208570	205139	rs137853943	NC_000003.12:33114549:C:A
NM_000440.3(PDE6A):c.2302G>T (p.Glu768Ter)	PDE6A	E768*	Retinal dystrophy	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000865985	5	149245789	5	149866226	865985	856375		NC_000005.10:149866225:C:A
NM_000440.3(PDE6A):c.2183G>A (p.Trp728Ter)	PDE6A	W728*	not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000593845	5	149247674	5	149868111	593845	584908	rs1561679951	NC_000005.10:149868110:C:T
NM_000440.3(PDE6A):c.1926+1G>A	PDE6A		not provided	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000194473	5	149264342	5	149884779	194473	191636	rs794727139	NC_000005.10:149884778:C:T
NM_000440.3(PDE6A):c.1843C>T (p.Gln615Ter)	PDE6A	Q615*	not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000855493	5	149264426	5	149884863	855493	830513		NC_000005.10:149884862:G:A
NM_000440.3(PDE6A):c.286del (p.Leu96fs)	PDE6A	L96fs	not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000844371	5	149323951	5	149944388	844371	830528		NC_000005.10:149944387:GG:G
NM_000440.3(PDE6A):c.2027+5G>T	PDE6A		Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427858	5	149264037	5	149884474	427858	418820	rs794727166	NC_000005.10:149884473:C:A
NM_000440.3(PDE6A):c.1966G>T (p.Glu656Ter)	PDE6A	E656*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000846489	5	149264103	5	149884540	846489	830510		NC_000005.10:149884539:C:A
NM_000440.3(PDE6A):c.1683G>A (p.Trp561Ter)	PDE6A	W561*	Retinitis pigmentosa 43	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013112	5	149274791	5	149895228	13112	28151	rs121918578	NC_000005.10:149895227:C:T
NM_000440.3(PDE6A):c.1032C>A (p.Ser344Arg)	PDE6A	S344R	Retinitis pigmentosa 43	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013111	5	149286908	5	149907345	13111	28150	rs121918577	NC_000005.10:149907344:G:T
NM_000440.3(PDE6A):c.409delinsCT (p.Asp137fs)	PDE6A		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812369	5	149323828	5	149944265	812369	800505		NC_000005.10:149944264:C:AG
NM_000440.3(PDE6A):c.1960C>T (p.Gln654Ter)	PDE6A	Q654*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812368	5	149264109	5	149884546	812368	800504		NC_000005.10:149884545:G:A
NM_000440.3(PDE6A):c.2081_2085del (p.Glu694fs)	PDE6A	E694fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812367	5	149263042 - 149263046	5	149883479 - 149883483	812367	800503		NC_000005.10:149883478:CTGTTC:C
NM_000440.3(PDE6A):c.2506+1G>A	PDE6A		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812366	5	149242681	5	149863118	812366	800689		NC_000005.10:149863117:C:T
NM_000440.3(PDE6A):c.1674C>G (p.Tyr558Ter)	PDE6A	Y558*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802165	5	149274800	5	149895237	802165	790525		NC_000005.10:149895236:G:C
NM_000440.3(PDE6A):c.2064del (p.Lys689fs)	PDE6A	K689fs	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802164	5	149263063	5	149883500	802164	790524		NC_000005.10:149883499:A:
NM_000440.3(PDE6A):c.1408-2A>G	PDE6A		Retinitis pigmentosa 43	Pathogenic(Last reviewed: Apr 7, 2016)	no assertion criteria provided	VCV000225119	5	149276341	5	149896778	225119	227005	rs1060499536	NC_000005.10:149896777:T:C
NM_004387.4(NKX2-5):c.533C>T (p.Thr178Met)	NKX2-5	T178M	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000009004	5	172660014	5	173233011	9004	24043	rs104893900	NC_000005.10:173233010:G:A
NM_007255.3(B4GALT7):c.808C>T (p.Arg270Cys)	B4GALT7	R270C	Ehlers-Danlos syndrome progeroid type|Lethal skeletal dysplasia|not provided|Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005613	5	177035995	5	177608994	5613	20652	rs28937869	NC_000005.10:177608993:C:T
NM_000440.3(PDE6A):c.1054C>T (p.Gln352Ter)	PDE6A	Q352*	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636051	5	149286886	5	149907323	636051	623842		NC_000005.10:149907322:G:A
NM_001354712.2(THRB):c.1357C>T (p.Pro453Ser)	THRB	P453S, P422S	not provided|Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Nov 19, 2016)	criteria provided, single submitter	VCV000439310	3	24164404	3	24122913	439310	432550	rs28933408	NC_000003.12:24122912:G:A
NM_001023570.4(IQCB1):c.1516_1517CA[1] (p.His506fs)	IQCB1		not provided|Retinitis pigmentosa|Nephronophthisis|Senior-Loken syndrome 5	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093469	3	121491452 - 121491453	3	121772605 - 121772606	93469	99374	rs398123538	NC_000003.12:121772604:TGTG:TG
NM_000232.4(SGCB):c.1A>G (p.Met1Val)	SGCB	M1V	Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092660	4	52904425	4	52038259	92660	98567	rs398123262	NC_000004.12:52038258:T:C
NM_000440.3(PDE6A):c.1287G>A (p.Trp429Ter)	PDE6A	W429*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000636052	5	149278046	5	149898483	636052	623841		NC_000005.10:149898482:C:T
NM_000521.4(HEXB):c.1597C>T (p.Arg533Cys)	HEXB	R533C, R308C	Sandhoff disease	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000435415	5	74016556	5	74720731	435415	428466	rs764552042	NC_000005.10:74720730:C:T
NM_020166.5(MCCC1):c.1682-3A>G	MCCC1		not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000449385	3	182743595	3	183025807	449385	443390	rs760180709	NC_000003.12:183025806:T:C
NM_020166.5(MCCC1):c.168C>G (p.Asn56Lys)	MCCC1	N56K	not provided	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000379698	3	182810302	3	183092514	379698	368298	rs1057520695	NC_000003.12:183092513:G:C
NM_020166.5(MCCC1):c.2085del (p.Val697fs)	MCCC1	V580fs, V697fs, V588fs	not provided	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	VCV000203800	3	182733319	3	183015531	203800	200043	rs772010858	NC_000003.12:183015530:C:
NM_020166.5(MCCC1):c.1363del (p.Leu455fs)	MCCC1	L338fs, L346fs, L455fs	not provided	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	VCV000203799	3	182756828	3	183039040	203799	200044	rs796051986	NC_000003.12:183039039:GG:G
NM_020166.5(MCCC1):c.205A>T (p.Lys69Ter)	MCCC1	K69*	not provided	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000196495	3	182810265	3	183092477	196495	193656	rs147741073	NC_000003.12:183092476:T:A
NM_020166.5(MCCC1):c.640-1G>A	MCCC1		not provided	Pathogenic(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	VCV000167273	3	182788909	3	183071121	167273	177825	rs727504005	NC_000003.12:183071120:C:T
NM_020166.5(MCCC1):c.1905del (p.Lys635fs)	MCCC1	K635fs, K518fs, K526fs	not provided	Pathogenic(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	VCV000167267	3	182737990	3	183020202	167267	177821	rs727504001	NC_000003.12:183020201:TTT:TT
NM_020166.5(MCCC1):c.1522_1544del (p.Leu508fs)	MCCC1	L391fs, L399fs, L508fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000841106	3	182755056 - 182755078	3	183037268 - 183037290	841106	827760		NC_000003.12:183037267:AGACCCAGGGCTGCCTGGCATAAAGAC:AGAC
NC_000003.12:g.(?_183092389)_(183092565_?)del	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000832920	3	182810177 - 182810353			832920	819358		
NC_000003.12:g.(?_183070989)_(183072497_?)del	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000831678	3	182788777 - 182790285			831678	819357		
NM_020166.5(MCCC1):c.673C>T (p.Gln225Ter)	MCCC1	Q108*, Q116*, Q225*	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000654147	3	182788875	3	183071087	654147	631100		NC_000003.12:183071086:G:A
NM_020166.5(MCCC1):c.1210dup (p.His404fs)	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000653099	3	182759411 - 182759412	3	183041623 - 183041624	653099	631095		NC_000003.12:183041623:G:GG
NM_020166.5(MCCC1):c.739_742delinsATAGCATAGC (p.Glu247_Lys248delinsIleAlaTer)	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000580668	3	182788806 - 182788809	3	183071018 - 183071021	580668	558862	rs1560256569	NC_000003.12:183071017:TCTC:GCTATGCTAT
NM_020166.5(MCCC1):c.1257_1263del (p.Val420fs)	MCCC1	V303fs, V311fs, V420fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000573746	3	182759359 - 182759365	3	183041571 - 183041577	573746	558860	rs1560224024	NC_000003.12:183041570:CCGTACTCC:CC
NM_020166.5(MCCC1):c.343C>T (p.Gln115Ter)	MCCC1	Q115*, Q6*	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000570190	3	182804507	3	183086719	570190	561302	rs920162850	NC_000003.12:183086718:G:A
NM_020166.5(MCCC1):c.987_988del (p.His329fs)	MCCC1	H212fs, H220fs, H329fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000476402	3	182763296 - 182763297	3	183045508 - 183045509	476402	452333	rs1553856095	NC_000003.12:183045507:TAT:T
NM_020166.5(MCCC1):c.1819_1832del (p.Ser607fs)	MCCC1	S490fs, S498fs, S607fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000476396	3	182740242 - 182740255	3	183022454 - 183022467	476396	451995	rs1553850609	NC_000003.12:183022453:AGCTTCGCTTTACTAGC:AGC
NM_020166.5(MCCC1):c.169_170AG[1] (p.Gly58fs)	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000476395	3	182810298 - 182810299	3	183092510 - 183092511	476395	452336	rs1311374961	NC_000003.12:183092509:CTCT:CT
NM_020166.5(MCCC1):c.137-2A>G	MCCC1		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000167274	3	182810335	3	183092547	167274	177826	rs727504006	NC_000003.12:183092546:T:C
NM_020166.5(MCCC1):c.1604C>T (p.Ser535Phe)	MCCC1	S535F, S426F, S418F	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000001933	3	182751856	3	183034068	1933	16972	rs119103216	NC_000003.12:183034067:G:A
NM_020166.5(MCCC1):c.1310T>C (p.Leu437Pro)	MCCC1	L437P, L328P, L320P	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000001932	3	182756881	3	183039093	1932	16971	rs119103215	NC_000003.12:183039092:A:G
NM_020166.5(MCCC1):c.1594G>C (p.Asp532His)	MCCC1	D532H, D423H, D415H	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000001931	3	182755006	3	183037218	1931	16970	rs119103214	NC_000003.12:183037217:C:G
NC_000003.11:g.(?_182769927)_(182770048_?)del	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000665643	3	182769927 - 182770048	3	183052139 - 183052260	665643	650979		
NM_020166.5(MCCC1):c.558del (p.Gln186fs)	MCCC1	Q186fs, Q69fs, Q77fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000654523	3	182789079	3	183071291	654523	631102		NC_000003.12:183071290:TT:T
NM_020166.5(MCCC1):c.704del (p.Ala235fs)	MCCC1	A235fs, A126fs, A118fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000643119	3	182788844	3	183071056	643119	631099		NC_000003.12:183071055:G:
NM_020166.5(MCCC1):c.639+2T>A	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000476398	3	182788996	3	183071208	476398	452001	rs199914879	NC_000003.12:183071207:A:T
NM_020166.5(MCCC1):c.1380T>G (p.Ile460Met)	MCCC1	I460M, I343M, I351M	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001935	3	182755220	3	183037432	1935	16974	rs119103218	NC_000003.12:183037431:A:C
NM_020166.5(MCCC1):c.1679dup (p.Asn560fs)	MCCC1		3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000542948	3	182751780 - 182751781	3	183033992 - 183033993	542948	519036	rs1394547323	NC_000003.12:183033992:TTTTT:TTTTTT
NM_020166.5(MCCC1):c.1191_1192TG[1] (p.Val398fs)	MCCC1		not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203798	3	182759428 - 182759429	3	183041640 - 183041641	203798	200046	rs796051985	NC_000003.12:183041639:CACA:CA
NM_020166.5(MCCC1):c.841C>T (p.Arg281Ter)	MCCC1	R281*, R164*, R172*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000203795	3	182775131	3	183057343	203795	200047	rs185741664	NC_000003.12:183057342:G:A
NM_020166.5(MCCC1):c.1074del (p.Trp358fs)	MCCC1	W249fs, W241fs, W358fs	3 Methylcrotonyl-CoA carboxylase 1 deficiency|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095938	3	182763210	3	183045422	95938	101834	rs398124350	NC_000003.12:183045421:CC:C
NM_000440.3(PDE6A):c.998+1G>A	PDE6A		not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000855351	5	149294505	5	149914942	855351	851268		NC_000005.10:149914941:C:T
NM_000440.3(PDE6A):c.2332_2335del (p.Asp778fs)	PDE6A	D778fs	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000195462	5	149245756 - 149245759	5	149866193 - 149866196	195462	192623	rs754012367	NC_000005.10:149866192:AGTCA:A
NM_000440.3(PDE6A):c.1749C>G (p.Tyr583Ter)	PDE6A	Y583*	Retinitis pigmentosa|Retinitis pigmentosa 43	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000013110	5	149265917	5	149886354	13110	28149	rs121918576	NC_000005.10:149886353:G:C
NM_020166.5(MCCC1):c.1930G>T (p.Glu644Ter)	MCCC1	E644*, E527*, E535*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503626	3	182737965	3	183020177	503626	495181	rs905321122	NC_000003.12:183020176:C:A
NM_020166.5(MCCC1):c.945T>A (p.Tyr315Ter)	MCCC1	Y315*, Y198*, Y206*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488806	3	182769957	3	183052169	488806	481681	rs150862707	NC_000003.12:183052168:A:T
NM_020166.5(MCCC1):c.1225C>T (p.Arg409Ter)	MCCC1	R409*, R292*, R300*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488805	3	182759397	3	183041609	488805	481680	rs1484347924	NC_000003.12:183041608:G:A
NM_020166.5(MCCC1):c.980C>G (p.Ser327Ter)	MCCC1	S327*, S210*, S218*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265231	3	182763304	3	183045516	265231	259755	rs750484977	NC_000003.12:183045515:G:C
NM_016247.4(IMPG2):c.2890C>T (p.Arg964Ter)	IMPG2	R964*	Macular dystrophy|not provided|Retinitis pigmentosa 56	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000003549	3	100961664	3	101242820	3549	18588	rs267606875	NC_000003.12:101242819:G:A
NM_152783.5(D2HGDH):c.1027del (p.Ser343fs)	D2HGDH	S343fs, S156fs, S209fs	D-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	VCV000210809	2	242690689	2	241751274	210809	206986	rs797045506	NC_000002.12:241751273:TT:T
NM_152783.5(D2HGDH):c.566C>T (p.Pro189Leu)	D2HGDH	P189L, P2L, P55L	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	VCV000158422	2	242683112	2	241743697	158422	168062	rs587783517	NC_000002.12:241743696:C:T
NM_152783.5(D2HGDH):c.1123G>T (p.Asp375Tyr)	D2HGDH	D375Y, D188Y, D241Y	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000001858	2	242690786	2	241751371	1858	16897	rs267606759	NC_000002.12:241751370:G:T
NM_152783.5(D2HGDH):c.325_326dup (p.Glu110fs)	D2HGDH		D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000001857	2	242680479 - 242680480	2	241741064 - 241741065	1857	16896	rs749330477	NC_000002.12:241741064:TC:TCTC
NM_152783.5(D2HGDH):c.1315A>G (p.Asn439Asp)	D2HGDH	N439D, N305D, N252D	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000001856	2	242707133	2	241767718	1856	16895	rs121434362	NC_000002.12:241767717:A:G
NM_152783.5(D2HGDH):c.685-2A>G	D2HGDH		D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000001855	2	242684122	2	241744707	1855	16894	rs753528947	NC_000002.12:241744706:A:G
NM_152783.5(D2HGDH):c.293-23A>G	D2HGDH		D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001854	2	242680425	2	241741010	1854	16893	rs145731647	NC_000002.12:241741009:A:G
NM_152783.5(D2HGDH):c.1331T>C (p.Val444Ala)	D2HGDH	V444A, V310A, V257A	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001852	2	242707149	2	241767734	1852	16891	rs121434360	NC_000002.12:241767733:T:C
NM_152783.5(D2HGDH):c.642del (p.Arg215fs)	D2HGDH	R215fs, R28fs, R81fs	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000572875	2	242683187	2	241743772	572875	560551	rs1559361049	NC_000002.12:241743771:TT:T
NM_152783.5(D2HGDH):c.440T>G (p.Ile147Ser)	D2HGDH	I147S, I13S	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001853	2	242681939	2	241742524	1853	16892	rs121434361	NC_000002.12:241742523:T:G
NC_000002.11:g.(?_242680425)_(242707404_?)del	D2HGDH		D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000539292	2	242680425 - 242707404	2	241741010 - 241767989	539292	516224		
NM_182916.3(TRNT1):c.1252dup (p.Ser418fs)	TRNT1		Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay|not provided|Retinitis pigmentosa and erythrocytic microcytosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234934	3	3189778 - 3189779	3	3148094 - 3148095	234934	236731	rs876661298	NC_000003.12:3148094:AAAAAAA:AAAAAAAA
NM_020166.5(MCCC1):c.1263dup (p.Gln422fs)	MCCC1		not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476392	3	182759358 - 182759359	3	183041570 - 183041571	476392	452330	rs762463137	NC_000003.12:183041570:CC:CCC
NM_020166.5(MCCC1):c.1526del (p.Cys509fs)	MCCC1	C392fs, C509fs, C400fs	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167269	3	182755074	3	183037286	167269	177823	rs727504002	NC_000003.12:183037285:C:
NM_001354712.2(THRB):c.1010_1012del (p.Thr337del)	THRB	T337del, T306del	Thyroid hormone resistance, generalized, autosomal recessive|not provided	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000012539	3	24169122 - 24169124	3	24127631 - 24127633	12539	27578	rs387906515	NC_000003.12:24127630:GTG:
NM_000406.2(GNRHR):c.785G>A (p.Arg262Gln)	GNRHR	R262Q	not provided|Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016024	4	68606400	4	67740682	16024	31063	rs104893837	NC_000004.12:67740681:C:T
NM_000258.2(MYL3):c.445A>G (p.Met149Val)	MYL3	M149V	not provided|Familial hypertrophic cardiomyopathy 8|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014061	3	46901001	3	46859511	14061	29100	rs104893748	NC_000003.12:46859510:T:C
NM_000440.3(PDE6A):c.1630C>T (p.Arg544Trp)	PDE6A	R544W	Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000437982	5	149274844	5	149895281	437982	431680	rs144484128	NC_000005.10:149895280:G:A
NM_003722.5(TP63):c.325-18446del	TP63	Q9fs	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000449513	3	189507615	3	189789826	449513	443396	rs1553840705	NC_000003.12:189789825:A:
NM_003722.5(TP63):c.518G>T (p.Gly173Val)	TP63	G173V, G171V, G79V	not provided	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000430080	3	189526254	3	189808465	430080	421427	rs113993965	NC_000003.12:189808464:G:T
NM_003722.5(TP63):c.1040G>T (p.Cys347Phe)	TP63	C347F, C345F, C168F, C253F	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000418520	3	189586416	3	189868627	418520	406162	rs1064793282	NC_000003.12:189868626:G:T
NM_003722.5(TP63):c.547C>T (p.Gln183Ter)	TP63	Q183*, Q89*, Q181*	not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000379830	3	189526283	3	189808494	379830	367333	rs1057520750	NC_000003.12:189808493:C:T
NM_003722.5(TP63):c.935G>A (p.Cys312Tyr)	TP63	C312Y, C218Y, C133Y, C310Y	not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379608	3	189585674	3	189867885	379608	368310	rs1057520664	NC_000003.12:189867884:G:A
NM_003722.5(TP63):c.956G>A (p.Arg319His)	TP63	R319H, R317H, R140H, R225H	not provided	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000265276	3	189585695	3	189867906	265276	259756	rs886039442	NC_000003.12:189867905:G:A
NM_003722.5(TP63):c.1837_1841del (p.Pro613fs)	TP63	P609fs, P611fs, P613fs, P519fs, P434fs	not provided	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000194382	3	189612084 - 189612088	3	189894295 - 189894299	194382	191545	rs794727122	NC_000003.12:189894294:CCCTTC:C
NM_001034850.2(RETREG1):c.321G>A (p.Trp107Ter)	RETREG1	W107*	not provided	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000843330	5	16572211	5	16572102	843330	830620		NC_000005.10:16572101:C:T
NM_001034850.2(RETREG1):c.787C>T (p.Gln263Ter)	RETREG1	Q122*, Q263*	not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000835725	5	16478980	5	16478871	835725	830614		NC_000005.10:16478870:G:A
NM_001034850.2(RETREG1):c.571C>T (p.Gln191Ter)	RETREG1	Q191*, Q50*	not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000652106	5	16483469	5	16483360	652106	633723		NC_000005.10:16483359:G:A
NM_003722.5(TP63):c.1693T>G (p.Phe565Val)	TP63	F561V, F386V, F471V, F565V, F563V	TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000650415	3	189608618	3	189890829	650415	631118		NC_000003.12:189890828:T:G
NM_003722.5(TP63):c.1350-75_1492del	TP63		Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000635754	3	189604107 - 189604324	3	189886318 - 189886535	635754	623592		
NM_003722.5(TP63):c.1794G>A (p.Trp598Ter)	TP63	W598*, W419*, W504*, W596*, W594*	Premature ovarian insufficiency	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000619066	3	189612042	3	189894253	619066	610449	rs1560311010	NC_000003.12:189894252:G:A
NM_003722.5(TP63):c.1780C>T (p.Arg594Ter)	TP63	R594*, R500*, R590*, R415*, R592*	Premature ovarian insufficiency	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000619065	3	189612028	3	189894239	619065	610448	rs900140738	NC_000003.12:189894238:C:T
NM_003722.5(TP63):c.819_820dup (p.Gln274fs)	TP63		Orofacial cleft 8	Pathogenic(Last reviewed: Oct 14, 2018)	no assertion criteria provided	VCV000585267	3	189584521 - 189584522	3	189866732 - 189866733	585267	576317	rs1560277554	NC_000003.12:189866732:CCC:CCCCC
NM_003722.5(TP63):c.698_700del (p.Lys233_Ala234delinsThr)	TP63		TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000571116	3	189582139 - 189582141	3	189864350 - 189864352	571116	562630	rs1560274283	NC_000003.12:189864349:AAG:
NM_003722.5(TP63):c.1063G>A (p.Asp355Asn)	TP63	D355N, D261N, D176N, D353N	TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000544363	3	189586439	3	189868650	544363	519041	rs1553857889	NC_000003.12:189868649:G:A
NM_000112.3(SLC26A2):c.374A>T (p.Gln125Leu)	SLC26A2	Q125L		Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000226418	5	149357589	5	149978026	226418	228215	rs875989951	NC_000005.10:149978025:A:T
NM_003722.5(TP63):c.1963del (p.Arg655fs)	TP63	R561fs, R651fs, R476fs, R653fs, R655fs	ADULT syndrome	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208082	3	189612208	3	189894419	208082	204361	rs797044843	NC_000003.12:189894418:CCCC:CCC
NM_003722.5(TP63):c.518G>A (p.Gly173Asp)	TP63	G173D, G79D, G171D	ADULT syndrome	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000038969	3	189526254	3	189808465	38969	47572	rs113993965	NC_000003.12:189808464:G:A
NM_003722.5(TP63):c.1846del (p.Leu616fs)	TP63	L612fs, L614fs, L522fs, L616fs, L437fs	ADULT syndrome	Pathogenic(Last reviewed: Jun 8, 2010)	no assertion criteria provided	VCV000038968	3	189612094	3	189894305	38968	47571	rs113993964	NC_000003.12:189894304:C:
NM_020166.5(MCCC1):c.1973_1977+28del	MCCC1		not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498130	3	182737890 - 182737922	3	183020102 - 183020134	498130	489554	rs776641008	NC_000003.12:183020101:CATCATTCTACAGATGTCATGTGATTACCTTTTCA:CA
NM_020166.5(MCCC1):c.1114C>T (p.Gln372Ter)	MCCC1	Q372*, Q263*, Q255*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193913	3	182759508	3	183041720	193913	191076	rs544349961	NC_000003.12:183041719:G:A
NC_000005.10:g.149977951del	SLC26A2		Achondrogenesis, type IB	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000816912					816912	805081		
NM_003722.5(TP63):c.1790T>C (p.Ile597Thr)	TP63	I593T, I597T, I503T, I418T, I595T	Rapp-Hodgkin ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000807713	3	189612038	3	189894249	807713	798526		NC_000003.12:189894248:T:C
NM_000112.3(SLC26A2):c.1565C>T (p.Ser522Phe)	SLC26A2	S522F		Pathogenic(Last reviewed: Mar 22, 2019)	no assertion criteria provided	VCV000623643	5	149360721	5	149981158	623643	612468	rs1561822760	NC_000005.10:149981157:C:T
TP63, ARG227PRO	TP63	R227P	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030348					30348	39304		
TP63, PRO127LEU	TP63	P127L	ADULT syndrome	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000006552					6552	21591		
TP63, 1-BP DEL, 1783C	TP63		Rapp-Hodgkin ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000006551					6551	21590		
NM_003722.5(TP63):c.289C>T (p.Arg97Cys)	TP63	R97C, R95C	Split-hand/foot malformation 4	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006549	3	189456528	3	189738739	6549	21588	rs121908848	NC_000003.12:189738738:C:T
TP63, VAL114MET	TP63	V114M	ADULT syndrome	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000006546					6546	21585		
NM_003722.5(TP63):c.1738T>C (p.Ser580Pro)	TP63	R545P, S580P, S401P, S576P, S486P, S578P	Rapp-Hodgkin ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000006545	3	189608663	3	189890874	6545	21584	rs121908846	NC_000003.12:189890873:T:C
TP63, 1-BP DEL, 1859A	TP63		Rapp-Hodgkin ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Jan 5, 2018)	no assertion criteria provided	VCV000006543					6543	21582		
TP63, 1-BP DEL, 1709A	TP63		Rapp-Hodgkin ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000006542					6542	21581		
NM_003722.5(TP63):c.955C>T (p.Arg319Cys)	TP63	R280C, R319C, R140C, R317C, R225C	Split-hand/foot malformation 4	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000006532	3	189585694	3	189867905	6532	21571	rs121908839	NC_000003.12:189867904:C:T
TP63, 1-BP INS, 1572A	TP63		Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Oct 15, 1999)	no assertion criteria provided	VCV000006530					6530	21569		
NM_003722.5(TP63):c.1033T>C (p.Cys345Arg)	TP63	C306R, C345R, C251R, C343R, C166R	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Oct 15, 1999)	no assertion criteria provided	VCV000006529	3	189586409	3	189868620	6529	21568	rs121908837	NC_000003.12:189868619:T:C
NM_000112.3(SLC26A2):c.398C>T (p.Ala133Val)	SLC26A2	A133V	Diastrophic dysplasia	Pathogenic(Last reviewed: Nov 15, 2008)	no assertion criteria provided	VCV000004100	5	149357613	5	149978050	4100	19139	rs267607055	NC_000005.10:149978049:C:T
FAM134B, IVS7DS, T-C, +2	RETREG1		Hereditary sensory and autonomic neuropathy type IIB	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000331					331	15370		
FAM134B, 2-BP DEL, 17CT	RETREG1		Hereditary sensory and autonomic neuropathy type IIB	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000329					329	15368		
NM_003722.5(TP63):c.1727T>C (p.Ile576Thr)	TP63	I576T, I397T, I572T, I482T, I574T	TP63-Related Spectrum Disorders|not provided	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372540	3	189608652	3	189890863	372540	359504	rs1057517841	NC_000003.12:189890862:T:C
NM_003722.5(TP63):c.1037C>G (p.Ala346Gly)	TP63	A346G, A252G, A167G, A344G	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	VCV000208418	3	189586413	3	189868624	208418	204641	rs797044484	NC_000003.12:189868623:C:G
NM_003722.5(TP63):c.1009C>G (p.Arg337Gly)	TP63	R298G, R337G, R243G, R335G, R158G	ADULT syndrome	Pathogenic(Last reviewed: Jun 8, 2010)	no assertion criteria provided	VCV000006548	3	189586385	3	189868596	6548	21587	rs113993966	NC_000003.12:189868595:C:G
TP63, 2-BP DEL, 1743AA	TP63		Limb-mammary syndrome	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006539					6539	21578		
NM_003722.5(TP63):c.325-18456A>C	TP63	N6H	ADULT syndrome	Pathogenic(Last reviewed: Jun 8, 2010)	no assertion criteria provided	VCV000006537	3	189507605	3	189789816	6537	21576	rs113993963	NC_000003.12:189789815:A:C
NM_003722.5(TP63):c.697A>G (p.Lys233Glu)	TP63	K194E, K233E, K231E, K139E, K54E	Split-hand/foot malformation 4	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000006531	3	189582138	3	189864349	6531	21570	rs121908838	NC_000003.12:189864348:A:G
NM_000232.4(SGCB):c.452C>G (p.Thr151Arg)	SGCB	T151R	Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008712	4	52895065	4	52028899	8712	23751	rs28936383	NC_000004.12:52028898:G:C
NM_003722.5(TP63):c.694A>G (p.Lys232Glu)	TP63	K232E, K53E, K138E, K230E	TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000573933	3	189582135	3	189864346	573933	559409	rs1560274243	NC_000003.12:189864345:A:G
TP63, 11-BP DUP, NT1716	TP63		Rapp-Hodgkin ectodermal dysplasia syndrome|Ankyloblepharon-ectodermal defects, cleft lip/palate	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000006553					6553	21592		
NM_003722.5(TP63):c.1054A>G (p.Arg352Gly)	TP63	R313G, R352G, R342G, R173G, R258G, R350G	ADULT syndrome|Orofacial cleft 8	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000006547	3	189586430	3	189868641	6547	21586	rs121908847	NC_000003.12:189868640:A:G
TP63, 2-BP DEL, 1576TT	TP63		Limb-mammary syndrome	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000006538					6538	21577		
NM_003722.5(TP63):c.1659A>T (p.Leu553Phe)	TP63	L514F, L553F, L374F, L459F, L549F, L551F	Hay-Wells syndrome of ectodermal dysplasia	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000006535	3	189608584	3	189890795	6535	21574	rs121908842	NC_000003.12:189890794:A:T
NM_003900.5(SQSTM1):c.1211T>C (p.Met404Thr)	SQSTM1	M320T, M404T	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000855037	5	179263481	5	179836481	855037	830770		NC_000005.10:179836480:T:C
NM_000112.4(SLC26A2):c.438dup (p.Ala147fs)	SLC26A2		Diastrophic dysplasia|||Achondrogenesis, type IB	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000656557	5	149357646 - 149357647	5	149978083 - 149978084	656557	633630		NC_000005.10:149978083:TTTTTTT:TTTTTTTT
NM_003722.5(TP63):c.1646T>C (p.Ile549Thr)	TP63	I510T, I549T, I455T, I545T, I547T, I370T	Rapp-Hodgkin ectodermal dysplasia syndrome|Hay-Wells syndrome of ectodermal dysplasia	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000006544	3	189607267	3	189889478	6544	21583	rs121908845	NC_000003.12:189889477:T:C
NM_000112.3(SLC26A2):c.1535C>A (p.Thr512Lys)	SLC26A2	T512K	de la Chapelle dysplasia|Diastrophic dysplasia	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000004099	5	149360691	5	149981128	4099	19138	rs121908078	NC_000005.10:149981127:C:A
NM_000112.3(SLC26A2):c.1273A>G (p.Asn425Asp)	SLC26A2	N425D	Diastrophic dysplasia|Achondrogenesis, type IB	Pathogenic(Last reviewed: Jul 18, 2013)	no assertion criteria provided	VCV000004093	5	149360429	5	149980866	4093	19132	rs104893920	NC_000005.10:149980865:A:G
NM_021072.4(HCN1):c.469C>G (p.Leu157Val)	HCN1	L157V	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635193	5	45645667	5	45645565	635193	623027	rs1561230606	NC_000005.10:45645564:G:C
NM_021072.4(HCN1):c.1240G>A (p.Val414Met)	HCN1	V414M	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635192	5	45353339	5	45353237	635192	623026	rs1561120793	NC_000005.10:45353236:C:T
NM_021072.4(HCN1):c.986G>C (p.Cys329Ser)	HCN1	C329S	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635191	5	45461973	5	45461871	635191	623025	rs1318391259	NC_000005.10:45461870:C:G
NM_021072.4(HCN1):c.1769G>A (p.Arg590Gln)	HCN1	R590Q	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635190	5	45267205	5	45267103	635190	623024	rs1561081319	NC_000005.10:45267102:C:T
NM_021072.4(HCN1):c.1171G>A (p.Gly391Ser)	HCN1	G391S	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635189	5	45396653	5	45396551	635189	623023	rs1561139569	NC_000005.10:45396550:C:T
NM_021072.4(HCN1):c.728T>G (p.Met243Arg)	HCN1	M243R	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000635188	5	45645408	5	45645306	635188	623022	rs1561230486	NC_000005.10:45645305:A:C
NM_021072.4(HCN1):c.835C>T (p.His279Tyr)	HCN1	H279Y	Epileptic encephalopathy, early infantile, 24	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000139575	5	45645301	5	45645199	139575	143205	rs587777495	NC_000005.10:45645198:G:A
NM_021072.4(HCN1):c.890G>C (p.Arg297Thr)	HCN1	R297T	Epileptic encephalopathy, early infantile, 24	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000139574	5	45462069	5	45461967	139574	143204	rs587777494	NC_000005.10:45461966:C:G
NM_021072.4(HCN1):c.1201G>C (p.Asp401His)	HCN1	D401H	Epileptic encephalopathy, early infantile, 24	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000139571	5	45396623	5	45396521	139571	143201	rs587777491	NC_000005.10:45396520:C:G
NM_021072.4(HCN1):c.814T>C (p.Ser272Pro)	HCN1	S272P	not provided|Epileptic encephalopathy, early infantile, 24	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000139573	5	45645322	5	45645220	139573	143203	rs587777493	NC_000005.10:45645219:A:G
NM_001127671.2(LIFR):c.254del (p.Asn85fs)	LIFR	N85fs	not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000280316	5	38528831	5	38528729	280316	264253	rs886041545	NC_000005.10:38528728:TTTT:TTT
NM_001127671.2(LIFR):c.1550G>A (p.Trp517Ter)	LIFR	W517*	not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000853812	5	38502789	5	38502687	853812	830864		NC_000005.10:38502686:C:T
NM_001127671.2(LIFR):c.407del (p.Pro136fs)	LIFR	P136fs	not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000841747	5	38523675	5	38523573	841747	830865		NC_000005.10:38523572:GG:G
NM_001127671.2(LIFR):c.2327del (p.Val775_Leu776insTer)	LIFR		not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000839596	5	38489188	5	38489086	839596	830863		NC_000005.10:38489085:AAAA:AAA
NC_000005.10:g.(?_38481585)_(38530657_?)del	LIFR		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000831483	5	38481687 - 38530759			831483	819591		
NM_001127671.2(LIFR):c.274C>T (p.Gln92Ter)	LIFR	Q92*	Stüve-Wiedemann syndrome	Pathogenic	no assertion criteria provided	VCV000816860	5	38527380	5	38527278	816860	805007		NC_000005.10:38527277:G:A
NM_001127671.2(LIFR):c.478_479del (p.Arg160fs)	LIFR	R160fs	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000656451	5	38523603 - 38523604	5	38523501 - 38523502	656451	633960		NC_000005.10:38523500:CT:
NM_001127671.2(LIFR):c.1273_1276del (p.Val425fs)	LIFR	V425fs	Congenital anomalies of kidney and urinary tract	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000369648	5	38506022 - 38506025	5	38505920 - 38505923	369648	353877	rs1114167358	NC_000005.10:38505919:TAACTAA:TAA
NM_001127671.2(LIFR):c.2170C>G (p.Pro724Ala)	LIFR	P724A	Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000217274	5	38489345	5	38489243	217274	213921	rs863225047	NC_000005.10:38489242:G:C
NM_001127671.2(LIFR):c.167_170TAAC[1] (p.Asn58fs)	LIFR		Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000014462	5	38528911 - 38528914	5	38528809 - 38528812	14462	29501	rs1561179853	NC_000005.10:38528808:GTTAGTTA:GTTA
NM_001127671.2(LIFR):c.2013dup (p.Met672fs)	LIFR		Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000014461	5	38493759 - 38493760	5	38493657 - 38493658	14461	29500	rs1430793861	NC_000005.10:38493657:AA:AAA
NM_020166.5(MCCC1):c.640-2A>G	MCCC1		not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198578	3	182788910	3	183071122	198578	195739	rs772395858	NC_000003.12:183071121:T:C
NM_020166.5(MCCC1):c.2079del (p.Thr693_Val694insTer)	MCCC1	V694*	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001934	3	182733325	3	183015537	1934	16973	rs119103217	NC_000003.12:183015536:T:
NM_001127671.2(LIFR):c.503C>G (p.Ser168Ter)	LIFR	S168*	Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561052	5	38523579	5	38523477	561052	552089	rs779829941	NC_000005.10:38523476:G:C
NM_021072.4(HCN1):c.299C>T (p.Ser100Phe)	HCN1	S100F	Early infantile epileptic encephalopathy|Epileptic encephalopathy, early infantile, 24	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000139572	5	45695897	5	45695795	139572	143202	rs587777492	NC_000005.10:45695794:G:A
NM_001127671.2(LIFR):c.1789C>T (p.Arg597Ter)	LIFR	R597*	Stüve-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000014460	5	38496580	5	38496478	14460	29499	rs121912501	NC_000005.10:38496477:G:A
NM_006017.3(PROM1):c.1697dup (p.Asn566fs)	PROM1		Retinal dystrophy	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000866977	4	15995679 - 15995680	4	15994056 - 15994057	866977	856321		NC_000004.12:15994056:TTTTTTTT:TTTTTTTTT
NM_006017.3(PROM1):c.981_987delinsCTGGCTTAGAG (p.Ser328fs)	PROM1		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000817898	4	16019961 - 16019967	4	16018338 - 16018344	817898	805390		NC_000004.12:16018337:GTTGCTA:CTCTAAGCCAG
NM_001145847.2(PROM1):c.262dup (p.Ile88fs)	PROM1		Cone-rod dystrophy 12	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560486	4	16040582 - 16040583	4	16038959 - 16038960	560486	551535	rs1210104601	NC_000004.12:16038959:TTTT:TTTTT
NM_001145847.2(PROM1):c.1435G>T (p.Gly479Ter)	PROM1	G488*, G479*	Usher syndrome	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560483	4	16002235	4	16000612	560483	551534	rs1560449207	NC_000004.12:16000611:C:A
NM_006017.3(PROM1):c.1276dup (p.Thr426fs)	PROM1		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000857834	4	16010596 - 16010597	4	16008973 - 16008974	857834	828935		NC_000004.12:16008973:T:TT
NC_000004.12:g.(?_16075687)_(16075906_?)del	PROM1		not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000833028	4	16077310 - 16077529			833028	819462		
NC_000004.12:g.(?_15992248)_(15994071_?)del	PROM1		not provided	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000832556	4	15993871 - 15995694			832556	819458		
NC_000004.12:g.(?_16048828)_(16075906_?)del	PROM1		not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000831446	4	16050451 - 16077529			831446	819461		
NM_006017.3(PROM1):c.652C>T (p.Gln218Ter)	PROM1	Q209*, Q218*	Retinitis pigmentosa 41	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802057	4	16025960	4	16024337	802057	790457		NC_000004.12:16024336:G:A
NM_006017.3(PROM1):c.869del (p.Ser290fs)	PROM1	S281fs, S290fs	Retinitis pigmentosa 41	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802055	4	16020079	4	16018456	802055	790455		NC_000004.12:16018455:C:
NM_001145847.2(PROM1):c.2023C>T (p.Arg675Ter)	PROM1	R684*, R675*	Retinitis pigmentosa 41	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634483	4	15991381	4	15989758	634483	622344	rs530749007	NC_000004.12:15989757:G:A
NM_001145847.2(PROM1):c.1207del (p.Tyr403fs)	PROM1	Y403fs, Y412fs	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000500442	4	16010639	4	16009016	500442	491866	rs1460604134	NC_000004.12:16009015:AAA:AA
NM_001145847.2(PROM1):c.703C>T (p.Arg235Ter)	PROM1	R244*, R235*	Retinal dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438215	4	16025003	4	16023380	438215	431670	rs373331232	NC_000004.12:16023379:G:A
NM_001145847.2(PROM1):c.1814del (p.Gly605fs)	PROM1	G614fs, G605fs	Retinitis pigmentosa 41	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005608	4	15993941	4	15992318	5608	20647	rs886037612	NC_000004.12:15992317:CC:C
NM_003722.5(TP63):c.739C>T (p.His247Tyr)	TP63	H247Y, H153Y, H245Y, H68Y	TP63-Related Spectrum Disorders|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000478110	3	189582180	3	189864391	478110	452004	rs1553856553	NC_000003.12:189864390:C:T
NM_003722.5(TP63):c.1052A>G (p.Asp351Gly)	TP63	D351G, D349G, D172G, D257G	not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000006541	3	189586428	3	189868639	6541	21580	rs121908844	NC_000003.12:189868638:A:G
NM_000158.4(GBE1):c.671T>C (p.Leu224Pro)	GBE1	L224P	Glycogen storage disease IV, nonprogressive hepatic|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002778	3	81698027	3	81648876	2778	17817	rs137852886	NC_000003.12:81648875:A:G
NM_006017.3(PROM1):c.139del (p.His47fs)	PROM1	H47fs	Leber congenital amaurosis 1	Pathogenic(Last reviewed: Aug 22, 2019)	no assertion criteria provided	VCV000694038	4	16077391	4	16075768	694038	681857	rs747512450	NC_000004.12:16075767:GGG:GG
NM_006017.3(PROM1):c.1877_1878del (p.Ile626fs)	PROM1	I626fs, I617fs	Leber congenital amaurosis 1	Pathogenic	no assertion criteria provided	VCV000694037	4	15993904 - 15993905	4	15992281 - 15992282	694037	681856	rs1300041533	NC_000004.12:15992280:TAT:T
NM_001145847.2(PROM1):c.2254-20_2254-11del	PROM1		Cone-rod degeneration|Cone-rod dystrophy 12	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000253327	4	15985989 - 15985998	4	15984366 - 15984375	253327	247775	rs886037881	NC_000004.12:15984365:GGAAACACAGGGAAAC:GGAAAC
NM_001145847.2(PROM1):c.1130T>A (p.Leu377Ter)	PROM1	L386*, L377*	Cone-rod degeneration|Cone-rod dystrophy 12	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000253326	4	16010716	4	16009093	253326	247774	rs886037880	NC_000004.12:16009092:A:T
NM_001145847.2(PROM1):c.2050-521A>G	PROM1		Cone-rod dystrophy 2|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190373	4	15989860	4	15988237	190373	188197	rs796051882	NC_000004.12:15988236:T:C
NM_181426.2(CCDC39):c.547_548del (p.Leu183fs)	CCDC39	L183fs	not provided	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000817471	3	180377526 - 180377527	3	180659738 - 180659739	817471	805332		NC_000003.12:180659737:AAA:A
NM_004628.4(XPC):c.690dup (p.Ala231fs)	XPC		not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000452115	3	14207016 - 14207017	3	14165516 - 14165517	452115	443369	rs1553606767	NC_000003.12:14165516:A:AA
NM_181426.2(CCDC39):c.1744del (p.Val582fs)	CCDC39	V582fs	not provided	Pathogenic(Last reviewed: Feb 19, 2017)	criteria provided, single submitter	VCV000423324	3	180359911	3	180642123	423324	406157	rs1064796360	NC_000003.12:180642122:C:
NM_004628.5(XPC):c.2214_2215AG[1] (p.Glu739fs)	XPC		not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000836224	3	14190347 - 14190348	3	14148847 - 14148848	836224	827590		NC_000003.12:14148846:CTCT:CT
NM_004628.5(XPC):c.2421-25_2604+301del	XPC		not provided	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000830381	3	14188489 - 14189526	3	14146989 - 14148026	830381	818757		
NM_004628.5(XPC):c.1001del (p.Pro334fs)	XPC	P328fs, P141fs, P334fs	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000644990	3	14200382	3	14158882	644990	630981		NC_000003.12:14158881:GG:G
NM_181426.2(CCDC39):c.2226C>A (p.Tyr742Ter)	CCDC39	Y742*	not provided	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000419341	3	180337086	3	180619298	419341	406156	rs772219642	NC_000003.12:180619297:G:T
NM_181426.2(CCDC39):c.493C>T (p.Gln165Ter)	CCDC39	Q165*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000846350	3	180378381	3	180660593	846350	827751		NC_000003.12:180660592:G:A
NC_000003.12:g.(?_180651381)_(180651553_?)del	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000830912	3	180369169 - 180369341			830912	819356		
NM_181426.2(CCDC39):c.1045del (p.Thr349fs)	CCDC39	T349fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000661055	3	180369311	3	180651523	661055	631078		NC_000003.12:180651522:TTTTTT:TTTTT
NM_181426.2(CCDC39):c.1833del (p.Ser612fs)	CCDC39	S612fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000652628	3	180359822	3	180642034	652628	631075		NC_000003.12:180642033:C:
NM_181426.2(CCDC39):c.945_951del (p.Lys315_Ala316insTer)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000581112	3	180370034 - 180370040	3	180652246 - 180652252	581112	562598	rs1560090006	NC_000003.12:180652245:AGTGGCT:
NM_181426.2(CCDC39):c.1756del (p.Glu586fs)	CCDC39	E586fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000573247	3	180359899	3	180642111	573247	561286	rs1285431486	NC_000003.12:180642110:C:
NM_181426.2(CCDC39):c.570_571del (p.Lys190fs)	CCDC39	K190fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000572863	3	180377503 - 180377504	3	180659715 - 180659716	572863	562604	rs1560092160	NC_000003.12:180659714:TCT:T
NM_181426.2(CCDC39):c.402T>A (p.Cys134Ter)	CCDC39	C134*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000566549	3	180378472	3	180660684	566549	559395	rs1560092440	NC_000003.12:180660683:A:T
NM_181426.2(CCDC39):c.286C>T (p.Arg96Ter)	CCDC39	R96*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000565699	3	180379720	3	180661932	565699	562608	rs778577109	NC_000003.12:180661931:G:A
NM_181426.2(CCDC39):c.1871_1872del (p.Ile624fs)	CCDC39	I624fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000565319	3	180359783 - 180359784	3	180641995 - 180641996	565319	559393	rs1560086701	NC_000003.12:180641994:TAT:T
NM_001354726.1(XPC):c.-118_-117AG[2]	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000553148	3	14212007 - 14212008	3	14170507 - 14170508	553148	543077	rs1228981894	NC_000003.12:14170506:CTCTCT:CTCT
NM_001354726.1(XPC):c.-328del	XPC	P37fs, P43fs	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000551235	3	14214538	3	14173038	551235	543087	rs1260189637	NC_000003.12:14173037:GGGGG:GGGG
NC_000003.11:g.(?_180369931)_(180370074_?)del	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000525583	3	180369931 - 180370074	3	180652143 - 180652286	525583	518659		
NM_181426.2(CCDC39):c.1159del (p.Asp387fs)	CCDC39	D387fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000525358	3	180369197	3	180651409	525358	519201	rs1275367324	NC_000003.12:180651408:C:
NM_181426.2(CCDC39):c.1242del (p.Met414fs)	CCDC39	M414fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000525328	3	180366073	3	180648285	525328	519000	rs1553804220	NC_000003.12:180648284:C:
NM_181426.2(CCDC39):c.590_591dup (p.Glu198fs)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000525309	3	180377482 - 180377483	3	180659694 - 180659695	525309	519016	rs1553805740	NC_000003.12:180659694:TGT:TGTGT
NM_181426.2(CCDC39):c.610_613del (p.Leu204Asnfs)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000525300	3	180377365 - 180377368	3	180659577 - 180659580	525300	519013	rs1415346246	NC_000003.12:180659576:CTAACT:CT
NM_181426.2(CCDC39):c.451del (p.Ala151fs)	CCDC39	A151fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000455024	3	180378423	3	180660635	455024	452318	rs1553805885	NC_000003.12:180660634:C:
NM_181426.2(CCDC39):c.1874+1G>A	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000455015	3	180359780	3	180641992	455015	452440	rs1553803540	NC_000003.12:180641991:C:T
NM_181426.2(CCDC39):c.1311dup (p.Gln438fs)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000455009	3	180366003 - 180366004	3	180648215 - 180648216	455009	452443	rs1553804209	NC_000003.12:180648215:T:TT
NM_181426.1(CCDC39):c.1035delG (p.Arg345Serfs)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000455008	3	180369321	3	180651533	455008	452461	rs1553804640	NC_000003.12:180651532:CC:C
Single allele	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	VCV000454498			3	180651381 - 180651553	454498	452010		
NM_004628.4(XPC):c.1103_1104del (p.Gln368fs)	XPC	Q362fs, Q175fs, Q368fs	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000267279	3	14200279 - 14200280	3	14158779 - 14158780	267279	262035	rs1450238352	NC_000003.12:14158778:TT:
NM_181426.2(CCDC39):c.163_164del (p.Met55fs)	CCDC39	M55fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000242169	3	180381701 - 180381702	3	180663913 - 180663914	242169	239128	rs878855280	NC_000003.12:180663912:ATA:A
NM_181426.2(CCDC39):c.1069_1072CAAA[1] (p.Thr358fs)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000242167	3	180369280 - 180369283	3	180651492 - 180651495	242167	239124	rs878855279	NC_000003.12:180651491:TTTGTTTGT:TTTGT
NM_181426.2(CCDC39):c.1644del (p.Asp548fs)	CCDC39	D548fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	VCV000216139	3	180361929	3	180644141	216139	212294	rs863224531	NC_000003.12:180644140:A:
NM_004628.4(XPC):c.2262del (p.Asn754fs)	XPC	N672fs, N748fs, N561fs, N752fs, N754fs	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Jan 27, 2011)	criteria provided, single submitter	VCV000190208	3	14190220	3	14148720	190208	187974	rs786205206	NC_000003.12:14148719:G:
NM_181426.2(CCDC39):c.524_525CT[1] (p.Leu176fs)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000188300	3	180377547 - 180377548	3	180659759 - 180659760	188300	186011	rs780175755	NC_000003.12:180659758:AGAG:AG
CCDC39, 3-BP DEL/1-BP INS, NT2357	CCDC39		Ciliary dyskinesia, primary, 14	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031068					31068	40025		
NM_004628.4(XPC):c.413-24A>G	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000000261	3	14209904	3	14168404	261	15300	rs794729657	NC_000003.12:14168403:T:C
NM_004628.4(XPC):c.413-9T>A	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000000260	3	14209889	3	14168389	260	15299	rs794729656	NC_000003.12:14168388:A:T
NM_004628.4(XPC):c.2033+2T>G	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000000257	3	14197833	3	14156333	257	15296	rs794729655	NC_000003.12:14156332:A:C
XPC, 3-BP INS, GGT, CODON 580 AND LYS822GLN	XPC	K822Q	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000000255					255	15294		
NM_004628.4(XPC):c.621_622ins83 (p.?)	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000000254					254	15293		
NM_006017.3(PROM1):c.642T>A (p.Tyr214Ter)	PROM1	Y214*, Y205*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000836421	4	16025970	4	16024347	836421	828939		NC_000004.12:16024346:A:T
NM_181426.2(CCDC39):c.1848del (p.Arg615_Tyr616insTer)	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000653672	3	180359807	3	180642019	653672	631074		NC_000003.12:180642018:A:
NM_004628.4(XPC):c.2126_2129del (p.Gly709fs)	XPC	G516fs, G627fs, G707fs, G703fs, G709fs	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635329	3	14190435 - 14190438	3	14148935 - 14148938	635329	623133		NC_000003.12:14148934:AAGC:
NM_004628.4(XPC):c.2287del (p.Leu763fs)	XPC	L681fs, L757fs, L570fs, L761fs, L763fs	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000558141	3	14190195	3	14148695	558141	542803	rs1553604559	NC_000003.12:14148694:GG:G
NM_001354726.1(XPC):c.-43-1099GA[2]	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000557065	3	14209847 - 14209848	3	14168347 - 14168348	557065	543035	rs1402162002	NC_000003.12:14168346:TCTCTC:TCTC
NM_004628.4(XPC):c.877C>T (p.Arg293Ter)	XPC	R293*, R100*, R287*	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000554485	3	14206336	3	14164836	554485	543024	rs373519125	NC_000003.12:14164835:G:A
NM_181426.2(CCDC39):c.1167+1261A>G	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000410378	3	180367928	3	180650140	410378	393390	rs577069249	NC_000003.12:180650139:T:C
NM_016247.4(IMPG2):c.3023-6_3030dup	IMPG2		Retinitis pigmentosa|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437941	3	100951827 - 100951828	3	101232983 - 101232984	437941	431658	rs754995805	NC_000003.12:101232983:TTCATCACCTAAAA:TTCATCACCTAAAATTCATCACCTAAAA
NM_181426.2(CCDC39):c.1665+1G>A	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000575428	3	180361907	3	180644119	575428	562592	rs753580394	NC_000003.12:180644118:C:T
NM_004628.4(XPC):c.1872+1G>C	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561144	3	14199510	3	14158010	561144	552070	rs1559374923	NC_000003.12:14158009:C:G
NM_004628.4(XPC):c.2218G>T (p.Glu740Ter)	XPC	E740*, E547*, E734*, E658*, E738*	not provided|Xeroderma pigmentosum, group C	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557140	3	14190346	3	14148846	557140	543005	rs770308917	NC_000003.12:14148845:C:A
NM_004628.4(XPC):c.55C>T (p.Gln19Ter)	XPC	Q19*	Xeroderma pigmentosum, group C|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551359	3	14220014	3	14178514	551359	543069	rs1553608637	NC_000003.12:14178513:G:A
NM_004628.4(XPC):c.658C>T (p.Arg220Ter)	XPC	R220*, R27*, R214*	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000550020	3	14207049	3	14165549	550020	543068	rs745679643	NC_000003.12:14165548:G:A
NM_181426.2(CCDC39):c.1034+2T>A	CCDC39		not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000455007	3	180369949	3	180652161	455007	451989	rs1210953680	NC_000003.12:180652160:A:T
NM_001145847.2(PROM1):c.409C>T (p.Arg137Ter)	PROM1	R146*, R137*	Retinitis pigmentosa 41|Retinal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000438214	4	16035000	4	16033377	438214	431671	rs780697796	NC_000004.12:16033376:G:A
NM_001145847.2(PROM1):c.1148_1149AT[1] (p.Ile384fs)	PROM1		Retinal dystrophy|Retinitis pigmentosa 41	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000208605	4	16010695 - 16010696	4	16009072 - 16009073	208605	205143	rs746174328	NC_000004.12:16009071:ATAT:AT
NM_004637.5(RAB7A):c.385C>T (p.Leu129Phe)	RAB7A	L129F	Charcot-Marie-Tooth disease|not provided|	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000007345	3	128525419	3	128806576	7345	22384	rs121909078	NC_000003.12:128806575:C:T
NM_004628.4(XPC):c.1421dup (p.Arg475fs)	XPC		Xeroderma pigmentosum, group C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555393	3	14199961 - 14199962	3	14158461 - 14158462	555393	543016	rs1553605761	NC_000003.12:14158461:T:TT
NM_004628.4(XPC):c.1243C>T (p.Arg415Ter)	XPC	R415*, R222*, R409*	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000438623	3	14200140	3	14158640	438623	432247	rs757958943	NC_000003.12:14158639:G:A
NM_004628.4(XPC):c.1677C>A (p.Tyr559Ter)	XPC	Y559*, Y366*, Y553*	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190211	3	14199706	3	14158206	190211	187978	rs767569346	NC_000003.12:14158205:G:T
NM_004628.4(XPC):c.622-2A>C	XPC		Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190209	3	14207087	3	14165587	190209	187980	rs201940931	NC_000003.12:14165586:T:G
NM_004628.4(XPC):c.1292_1293del (p.Lys431fs)	XPC	K238fs, K431fs, K425fs	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000000256	3	14200090 - 14200091	3	14158590 - 14158591	256	15295	rs794729654	NC_000003.12:14158589:TTT:T
NM_002890.3(RASA1):c.431_438del (p.Pro144fs)	RASA1	P144fs	not specified	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000811221	5	86564699 - 86564706	5	87268882 - 87268889	811221	799423		NC_000005.10:87268881:CCCCTTTG:
NM_002890.3(RASA1):c.297del (p.Ala100fs)	RASA1	A100fs	not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000452663	5	86564565	5	87268748	452663	443826	rs1554038827	NC_000005.10:87268747:T:
NM_033337.2(CAV3):c.301T>C (p.Trp101Arg)	CAV3	W101R	not provided	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000031734	3	8787398	3	8745712	31734	40394	rs199476337	NC_000003.12:8745711:T:C
NM_000112.4(SLC26A2):c.1432del (p.Leu478fs)	SLC26A2	L478fs	Achondrogenesis, type IB||Diastrophic dysplasia|	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000856738	5	149360586	5	149981023	856738	830534		NC_000005.10:149981022:CCC:CC
NM_000112.4(SLC26A2):c.1343C>G (p.Ser448Ter)	SLC26A2	S448*	Achondrogenesis, type IB|Diastrophic dysplasia||	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000835924	5	149360499	5	149980936	835924	830533		NC_000005.10:149980935:C:G
NM_003722.5(TP63):c.952C>T (p.Arg318Cys)	TP63	R316C, R139C, R224C, R318C	TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000650760	3	189585691	3	189867902	650760	631116		NC_000003.12:189867901:C:T
NM_000112.3(SLC26A2):c.1361A>C (p.Gln454Pro)	SLC26A2	Q454P	Diastrophic dysplasia, broad bone-platyspondylic variant|Diastrophic dysplasia	Pathogenic(Last reviewed: Jul 18, 2013)	no assertion criteria provided	VCV000004096	5	149360517	5	149980954	4096	19135	rs104893921	NC_000005.10:149980953:A:C
NM_001127671.2(LIFR):c.653dup (p.Glu219fs)	LIFR		Stüve-Wiedemann syndrome|not provided|	Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	VCV000281444	5	38511974 - 38511975	5	38511872 - 38511873	281444	265681	rs886042160	NC_000005.10:38511872:A:AA
NM_001127671.2(LIFR):c.2074C>T (p.Arg692Ter)	LIFR	R692*	not provided|Stüve-Wiedemann syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189235	5	38490385	5	38490283	189235	187112	rs199775294	NC_000005.10:38490282:G:A
NM_003042.4(SLC6A1):c.1595G>A (p.Trp532Ter)	SLC6A1	W532*, W354*, W412*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000588456	3	11076284	3	11034598	588456	579062	rs1559640454	NC_000003.12:11034597:G:A
NM_003042.4(SLC6A1):c.1072del (p.Ala358fs)	SLC6A1	A180fs, A358fs, A238fs	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000423617	3	11068038	3	11026352	423617	406082	rs1064796533	NC_000003.12:11026351:GG:G
NM_003042.4(SLC6A1):c.1711del (p.Val571fs)	SLC6A1	V451fs, V393fs, V571fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689789	3	11078562	3	11036876	689789	677414		NC_000003.12:11036875:GG:G
NM_003042.4(SLC6A1):c.1335dup (p.Val446fs)	SLC6A1		Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000663338	3	11072873 - 11072874	3	11031187 - 11031188	663338	630746		NC_000003.12:11031187:T:TT
NM_003042.4(SLC6A1):c.523_524insA (p.Ser175fs)	SLC6A1		Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000661842	3	11061950 - 11061951	3	11020264 - 11020265	661842	630737		NC_000003.12:11020264::A
NM_003042.4(SLC6A1):c.1328del (p.Gly443Valfs)	SLC6A1		not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000633582	3	11072862	3	11031176	633582	622007	rs1199489242	NC_000003.12:11031175:GGGGGG:GGGGG
NM_003042.4(SLC6A1):c.1435C>T (p.Arg479Ter)	SLC6A1	R479*, R301*, R359*	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000542201	3	11075333	3	11033647	542201	518714	rs745529755	NC_000003.12:11033646:C:T
NM_003042.4(SLC6A1):c.1255del (p.Arg419fs)	SLC6A1	R299fs, R241fs, R419fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000475470	3	11070969	3	11029283	475470	451927	rs1553690583	NC_000003.12:11029282:CC:C
NM_003042.4(SLC6A1):c.830G>A (p.Arg277His)	SLC6A1	R277H, R157H, R99H	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433100	3	11067250	3	11025564	433100	426663	rs752396911	NC_000003.12:11025563:G:A
NM_003042.4(SLC6A1):c.1369_1370del (p.Gly457fs)	SLC6A1	G337fs, G279fs, G457fs	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000192371	3	11072908 - 11072909	3	11031222 - 11031223	192371	190158	rs876657401	NC_000003.12:11031221:GG:
NM_003042.4(SLC6A1):c.1000G>C (p.Ala334Pro)	SLC6A1	A334P, A156P, A214P	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000192370	3	11067967	3	11026281	192370	190157	rs749240316	NC_000003.12:11026280:G:C
NM_003042.4(SLC6A1):c.1024G>A (p.Val342Met)	SLC6A1	V222M, V342M, V164M	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000844693	3	11067991	3	11026305	844693	827311		NC_000003.12:11026304:G:A
NM_003042.4(SLC6A1):c.1222del (p.Leu408fs)	SLC6A1	L288fs, L408fs, L230fs	not provided|SLC6A1-Related Disorder	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000684497	3	11070935	3	11029249	684497	672047		NC_000003.12:11029248:CCC:CC
NM_003042.4(SLC6A1):c.1377C>G (p.Ser459Arg)	SLC6A1	S459R, S281R, S339R	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000570384	3	11072916	3	11031230	570384	559277	rs1064795099	NC_000003.12:11031229:C:G
NM_001195794.1(CLRN1):c.189C>A (p.Tyr63Ter)	CLRN1	Y63*	Usher syndrome, type 3A|Rare genetic deafness|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004397	3	150690307	3	150972520	4397	19436	rs111033267	NC_000003.12:150972519:G:T
NM_003042.4(SLC6A1):c.1070C>T (p.Ala357Val)	SLC6A1	A357V, A237V, A179V	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000542198	3	11068037	3	11026351	542198	518980	rs1553689859	NC_000003.12:11026350:C:T
NM_003042.4(SLC6A1):c.889G>A (p.Gly297Arg)	SLC6A1	G297R, G119R, G177R	Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000192369	3	11067498	3	11025812	192369	190156	rs876657400	NC_000003.12:11025811:G:A
NM_054027.6(ANKH):c.13C>A (p.Pro5Thr)	ANKH	P5T	Familial calcium pyrophosphate deposition	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005199	5	14871544	5	14871435	5199	20238	rs121908410	NC_000005.10:14871434:G:T
NM_054027.6(ANKH):c.14C>T (p.Pro5Leu)	ANKH	P5L	Familial calcium pyrophosphate deposition	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000005198	5	14871543	5	14871434	5198	20237	rs121908409	NC_000005.10:14871433:G:A
NM_054027.6(ANKH):c.1001T>G (p.Leu334Arg)	ANKH	L334R	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000005202	5	14741946	5	14741837	5202	20241	rs267606657	NC_000005.10:14741836:A:C
NM_054027.6(ANKH):c.1015T>C (p.Cys339Arg)	ANKH	C339R	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000005200	5	14716941	5	14716832	5200	20239	rs267606656	NC_000005.10:14716831:A:G
ANKH, -11C-T	ANKH		Familial calcium pyrophosphate deposition	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000005196					5196	20235		
NM_054027.6(ANKH):c.143T>C (p.Met48Thr)	ANKH	M48T	Familial calcium pyrophosphate deposition	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000005195	5	14769254	5	14769145	5195	20234	rs121908407	NC_000005.10:14769144:A:G
NM_003042.4(SLC6A1):c.640_658del (p.Leu214fs)	SLC6A1	L36fs, L94fs, L214fs	not provided|Myoclonic-atonic epilepsy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000475488	3	11064071 - 11064089	3	11022385 - 11022403	475488	451621	rs1553688970	NC_000003.12:11022384:CGCTGGCCACTGGCCATCACGCTGGCCA:CGCTGGCCA
NM_003042.4(SLC6A1):c.919G>A (p.Gly307Arg)	SLC6A1	G307R, G129R, G187R	Myoclonic-atonic epilepsy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432150	3	11067528	3	11025842	432150	425516	rs1553689696	NC_000003.12:11025841:G:A
NM_004628.4(XPC):c.739C>T (p.Arg247Ter)	XPC	R247*, R54*, R241*	Xeroderma pigmentosum, group C|not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556301	3	14206968	3	14165468	556301	543026	rs764321665	NC_000003.12:14165467:G:A
NM_004628.4(XPC):c.420_423del (p.Glu141fs)	XPC	E135fs, E141fs	not provided|Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550638	3	14209870 - 14209873	3	14168370 - 14168373	550638	542815	rs1330667099	NC_000003.12:14168369:CTCACT:CT
NM_004628.4(XPC):c.2074A>T (p.Lys692Ter)	XPC	K692*, K686*, K499*, K610*, K690*	Xeroderma pigmentosum|Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000496267	3	14193876	3	14152376	496267	487043	rs374117852	NC_000003.12:14152375:T:A
NM_181426.2(CCDC39):c.610-2A>G	CCDC39		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000216140	3	180377370	3	180659582	216140	212296	rs756235547	NC_000003.12:180659581:T:C
NM_004628.4(XPC):c.1735C>T (p.Arg579Ter)	XPC	R579*, R573*, R386*	Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000000259	3	14199648	3	14158148	259	15298	rs121965088	NC_000003.12:14158147:G:A
NM_005859.5(PURA):c.159dup (p.Leu54fs)	PURA		Mental retardation, autosomal dominant 31|Intellectual disability|PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation|not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432233	5	139493919 - 139493920	5	140114334 - 140114335	432233	425622	rs1554129040	NC_000005.10:140114334:GGGGGG:GGGGGGG
NM_005859.5(PURA):c.927_940del (p.Thr310fs)	PURA	T310fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000208768	5	139494689 - 139494702	5	140115104 - 140115117	208768	205248	rs797044944	NC_000005.10:140115103:CTGCCACCCTGCTACTGC:CTGC
NM_054027.6(ANKH):c.1124_1126del (p.Ser375del)	ANKH	S375del	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000005194	5	14716830 - 14716832	5	14716721 - 14716723	5194	20233	rs121908406	NC_000005.10:14716720:AGGAG:AG
NM_002890.3(RASA1):c.261_262del (p.Gly89fs)	RASA1	G89fs	Capillary malformation-arteriovenous malformation|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503721	5	86564529 - 86564530	5	87268712 - 87268713	503721	495239	rs1384480619	NC_000005.10:87268711:AG:
NM_002397.5(MEF2C):c.728del (p.Pro243fs)	MEF2C	P261fs, P195fs, P101fs, P117fs, P241fs, P243fs	not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000817755	5	88027628	5	88731811	817755	805451		NC_000005.10:88731810:GGGGG:GGGG
XM_024446059.1:c.805_808del	MEF2C		not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000817330					817330	806283		
GRCh37/hg19 5q14.3(chr5:88054762-88271992)x1	MEF2C		not provided	Pathogenic(Last reviewed: May 29, 2019)	no assertion criteria provided	VCV000814709	5	88054762 - 88271992			814709	802919		
NM_001131005.2(MEF2C):c.703C>T (p.Gln235Ter)	MEF2C	Q235*, Q237*, Q255*, Q95*, Q111*, Q189*	not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000620546	5	88027647	5	88731830	620546	611640	rs1561698356	NC_000005.10:88731829:G:A
NM_001131005.2(MEF2C):c.45dup (p.Asn16Ter)	MEF2C		not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000523919	5	88119560 - 88119561	5	88823743 - 88823744	523919	514514	rs1554150552	NC_000005.10:88823743:A:AA
NM_002397.5(MEF2C):c.638-2A>C	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000488545	5	88027720	5	88731903	488545	481413	rs1554102556	NC_000005.10:88731902:T:G
NM_001131005.2(MEF2C):c.258+2T>G	MEF2C		not provided	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000449493	5	88100413	5	88804596	449493	443829	rs1554139674	NC_000005.10:88804595:A:C
NM_001131005.2(MEF2C):c.560_561dup (p.Pro188fs)	MEF2C		not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000424049	5	88047695 - 88047696	5	88751878 - 88751879	424049	406775	rs1554112069	NC_000005.10:88751878:TC:TCTC
NM_001131005.2(MEF2C):c.631+2T>C	MEF2C		not provided	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000419219	5	88044885	5	88749068	419219	406774	rs1064793730	NC_000005.10:88749067:A:G
NM_001131005.2(MEF2C):c.100G>T (p.Glu34Ter)	MEF2C	E34*	not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000379358	5	88100573	5	88804756	379358	368604	rs1057520584	NC_000005.10:88804755:C:A
GRCh37/hg19 5q14.3(chr5:88056500-88183698)x1	MEF2C		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253672	5	88056500 - 88183698			253672	248120		
GRCh37/hg19 5q14.3(chr5:88018116-88183698)x1	MEF2C		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253415	5	88018116 - 88183698			253415	247863		
NM_001131005.2(MEF2C):c.43C>T (p.Arg15Cys)	MEF2C	R15C	not provided	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000206129	5	88119563	5	88823746	206129	201918	rs796052728	NC_000005.10:88823745:G:A
NM_001131005.2(MEF2C):c.896dup (p.Gly300fs)	MEF2C		not provided	Pathogenic(Last reviewed: Apr 8, 2014)	no assertion criteria provided	VCV000167287	5	88025072 - 88025073	5	88729255 - 88729256	167287	177833	rs786200981	NC_000005.10:88729255:CCC:CCCC
NM_002397.5(MEF2C):c.988del (p.Leu330fs)	MEF2C	L180fs, L322fs, L340fs, L274fs, L282fs, L204fs, L320fs, L330fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000854734	5	88024422	5	88728605	854734	831249		NC_000005.10:88728604:GG:G
NM_002397.5(MEF2C):c.908dup (p.Leu303fs)	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000662628	5	88025090 - 88025091	5	88729273 - 88729274	662628	634466		NC_000005.10:88729273:AAA:AAAA
NM_002397.5(MEF2C):c.192dup (p.Val65fs)	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000639211	5	88100480 - 88100481	5	88804663 - 88804664	639211	634467		NC_000005.10:88804663:TTT:TTTT
NM_002397.5(MEF2C):c.780dup (p.Pro261fs)	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000570908	5	88027575 - 88027576	5	88731758 - 88731759	570908	563254	rs1561697465	NC_000005.10:88731758:T:TT
NM_002397.5(MEF2C):c.614_626delinsGTCTCCAC (p.Thr205fs)	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000487207	5	88044898 - 88044910	5	88749081 - 88749093	487207	455995	rs1554110298	NC_000005.10:88749080:CCTGCACCAGACG:GTGGAGAC
NC_000005.9:g.(?_88119532)_(88119625_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000478619	5	88119532 - 88119625	5	88823715 - 88823808	478619	454426		
GRCh37/hg19 5q14.3(chr5:87999726-88137439)x1	MEF2C		See cases	Pathogenic(Last reviewed: Jun 23, 2014)	no assertion criteria provided	VCV000441978	5	87999726 - 88137439			441978	435640		
NM_002397.5(MEF2C):c.9A>T (p.Arg3Ser)	MEF2C	R3S	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000218315	5	88119597	5	88823780	218315	215010	rs876661308	NC_000005.10:88823779:T:A
GRCh38/hg38 5q14.3(chr5:88744060-88749622)x1	MEF2C		See cases	Pathogenic(Last reviewed: Jul 9, 2012)	no assertion criteria provided	VCV000150368	5	88039877 - 88045439	5	88744060 - 88749622	150368	160119		
GRCh38/hg38 5q14.3(chr5:88766676-88808855)x1	MEF2C		See cases	Pathogenic(Last reviewed: Mar 12, 2012)	no assertion criteria provided	VCV000149177	5	88062493 - 88104672	5	88766676 - 88808855	149177	158928		
NM_002397.5(MEF2C):c.458del (p.Asn153fs)	MEF2C	N105fs, N151fs, N153fs, N27fs, N11fs, N171fs	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000040217	5	88047805	5	88751988	40217	48702	rs730882192	NC_000005.10:88751987:TT:T
NM_002397.5(MEF2C):c.80G>C (p.Gly27Ala)	MEF2C	G27A	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000040216	5	88100593	5	88804776	40216	48701	rs397514656	NC_000005.10:88804775:C:G
MEF2C, 1-BP DUP, 99T	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000040215					40215	48700		
NM_002397.5(MEF2C):c.113T>A (p.Leu38Gln)	MEF2C	L38Q	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000040214	5	88100560	5	88804743	40214	48699	rs397514655	NC_000005.10:88804742:A:T
NM_002397.5(MEF2C):c.683C>G (p.Ser228Ter)	MEF2C	S228*, S180*, S226*, S246*, S86*, S102*	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000008947	5	88027673	5	88731856	8947	23986	rs267607233	NC_000005.10:88731855:G:C
NC_000005.10:g.(?_88722584)_(88823808_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000832792	5	88018401 - 88119625			832792	819631		
NM_054027.6(ANKH):c.1126_1128TTC[1] (p.Phe377del)	ANKH	F377del	Craniometaphyseal dysplasia, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000005191	5	14716825 - 14716827	5	14716716 - 14716718	5191	20230	rs121908405	NC_000005.10:14716715:GAAGAAG:GAAG
NC_000005.10:g.(?_88804588)_(88884466_?)del	MEF2C		Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000831579	5	88100405 - 88180283			831579	819632		
NM_002397.5(MEF2C):c.71G>A (p.Arg24Lys)	MEF2C	R24K	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224136	5	88100602	5	88804785	224136	225866	rs869312698	NC_000005.10:88804784:C:T
NM_002397.5(MEF2C):c.2T>C (p.Met1Thr)	MEF2C	M1T	not provided|Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211494	5	88119604	5	88823787	211494	207288	rs545185248	NC_000005.10:88823786:A:G
NM_002397.5(MEF2C):c.833del (p.Leu277_Leu278insTer)	MEF2C		not provided|Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158888	5	88026029	5	88730212	158888	168541	rs587783749	NC_000005.10:88730211:AAAA:AAA
NM_001080.3(ALDH5A1):c.1323dup (p.Pro442fs)	ALDH5A1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000595206	6	24528371 - 24528372	6	24528143 - 24528144	595206	586268	rs1561879345	NC_000006.12:24528143:GGG:GGGG
NM_002397.5(MEF2C):c.403-1G>T	MEF2C		Autism spectrum disorder	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562143	5	88047861	5	88752044	562143	553316	rs1561824498	NC_000005.10:88752043:C:A
NM_002397.5(MEF2C):c.766C>T (p.Arg256Ter)	MEF2C	R254*, R256*, R208*, R114*, R130*, R274*	Autism spectrum disorder	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000206134	5	88027590	5	88731773	206134	201908	rs796052733	NC_000005.10:88731772:G:A
NM_001080.3(ALDH5A1):c.621del (p.Ser208fs)	ALDH5A1	S208fs	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000664746	6	24505105	6	24504877	664746	634795		NC_000006.12:24504876:CCCC:CCC
NM_001080.3(ALDH5A1):c.566_567insTTGCCCT (p.Val190fs)	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000663114	6	24503613 - 24503614	6	24503385 - 24503386	663114	634794		NC_000006.12:24503385:GCCCT:GCCCTTTGCCCT
NM_001080.3(ALDH5A1):c.1343+1G>A	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587401	6	24528395	6	24528167	587401	578445	rs1561879380	NC_000006.12:24528166:G:A
NM_001080.3(ALDH5A1):c.610-2A>G	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: May 7, 2017)	criteria provided, single submitter	VCV000459990	6	24505095	6	24504867	459990	456312	rs1301821497	NC_000006.12:24504866:A:G
NM_001080.3(ALDH5A1):c.1343+1_1343+3delinsTT	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 28, 2016)	no assertion criteria provided	VCV000225890	6	24528395 - 24528397	6	24528167 - 24528169	225890	227703	rs875989801	NC_000006.12:24528166:GTA:TT
NM_001080.3(ALDH5A1):c.1014+723_1173+796del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000001360	6	24521492 - 24523946	6	24521264 - 24523718	1360	16399		
NM_001080.3(ALDH5A1):c.727-3298G>A	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000001356	6	24512097	6	24511869	1356	16395	rs1561872640	NC_000006.12:24511868:G:A
NM_001080.3(ALDH5A1):c.1402+1G>A	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000838828	6	24532406	6	24532178	838828	851068		NC_000006.12:24532177:G:A
NM_001080.3(ALDH5A1):c.1506_1521dup (p.Lys508fs)	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000835064	6	24533829 - 24533830	6	24533601 - 24533602	835064	831786		NC_000006.12:24533601:GTGGAGTGCCCTTTTGGTGGAGTG:GTGGAGTGCCCTTTTGGTGGAGTGCCCTTTTGGTGGAGTG
NC_000006.11:g.(?_24528205)_(24528414_?)del	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000583913	6	24528205 - 24528414	6	24527977 - 24528186	583913	565248		
NM_001080.3(ALDH5A1):c.1343+1G>T	ALDH5A1		Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000001355	6	24528395	6	24528167	1355	16394	rs1561879380	NC_000006.12:24528166:G:T
NM_033337.2(CAV3):c.236T>G (p.Leu79Arg)	CAV3	L79R	not provided|Long QT syndrome 9	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000008296	3	8787333	3	8745647	8296	23335	rs121909282	NC_000003.12:8745646:T:G
NM_033337.2(CAV3):c.253G>A (p.Ala85Thr)	CAV3	A85T	not provided|Long QT syndrome 9	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000008294	3	8787350	3	8745664	8294	23333	rs104893715	NC_000003.12:8745663:G:A
NM_033337.2(CAV3):c.423C>G (p.Ser141Arg)	CAV3	S141R	not provided|Long QT syndrome 9	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000008291	3	8787520	3	8745834	8291	23330	rs104893713	NC_000003.12:8745833:C:G
NM_006017.3(PROM1):c.303+1G>A	PROM1		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000860340	4	16037357	4	16035734	860340	850974		NC_000004.12:16035733:C:T
NM_002397.5(MEF2C):c.3G>C (p.Met1Ile)	MEF2C	M1I	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000206137	5	88119603	5	88823786	206137	201919	rs1554150607	NC_000005.10:88823785:C:G
NM_007118.4(TRIO):c.3040_3041del (p.Val1014fs)	TRIO	V1014fs	not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000817750	5	14368981 - 14368982	5	14368872 - 14368873	817750	805419		NC_000005.10:14368871:TGT:T
NM_007118.4(TRIO):c.5328G>A (p.Trp1776Ter)	TRIO	W1776*	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000620237	5	14461252	5	14461143	620237	611627	rs1561518112	NC_000005.10:14461142:G:A
NM_007118.4(TRIO):c.4406A>G (p.His1469Arg)	TRIO	H1469R	not provided	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	VCV000545083	5	14397246	5	14397137	545083	535302	rs1554070777	NC_000005.10:14397136:A:G
NM_007118.4(TRIO):c.2987G>A (p.Trp996Ter)	TRIO	W996*	not provided	Pathogenic(Last reviewed: Jul 28, 2016)	no assertion criteria provided	VCV000545039	5	14368929	5	14368820	545039	535301	rs1554064737	NC_000005.10:14368819:G:A
NM_007118.4(TRIO):c.3262del (p.Leu1088fs)	TRIO	L1088fs	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000523976	5	14374382	5	14374273	523976	514502	rs1554065893	NC_000005.10:14374272:CC:C
NM_007118.4(TRIO):c.6888_6889dup (p.Gly2297fs)	TRIO		not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000862274	5	14487623 - 14487624	5	14487514 - 14487515	862274	830424		NC_000005.10:14487514:GCG:GCGCG
NM_007118.4(TRIO):c.7081_7084dup (p.Glu2362fs)	TRIO		not provided	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000856557	5	14487814 - 14487815	5	14487705 - 14487706	856557	830425		NC_000005.10:14487705:CAGGCAG:CAGGCAGGCAG
NM_007118.4(TRIO):c.3233G>A (p.Arg1078Gln)	TRIO	R1078Q	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000830227	5	14374354	5	14374245	830227	818627		NC_000005.10:14374244:G:A
NM_007118.4(TRIO):c.3232C>G (p.Arg1078Gly)	TRIO	R1078G	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000830226	5	14374353	5	14374244	830226	818626		NC_000005.10:14374243:C:G
NM_007118.4(TRIO):c.634G>T (p.Glu212Ter)	TRIO	E212*	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000369657	5	14290918	5	14290809	369657	353885	rs1057516029	NC_000005.10:14290808:G:T
NM_007118.4(TRIO):c.6092dup (p.Leu2031fs)	TRIO		Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000830230	5	14477003 - 14477004	5	14476894 - 14476895	830230	818630		NC_000005.10:14476894:TTTTTTTT:TTTTTTTTT
NM_007118.4(TRIO):c.3895G>A (p.Glu1299Lys)	TRIO	E1299K	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000830228	5	14388735	5	14388626	830228	818628		NC_000005.10:14388625:G:A
NM_022874.2(SMN1):c.397_398AG[1] (p.Glu134fs)	SMN1		not provided|Adult spinal muscular atrophy|Werdnig-Hoffmann disease|Spinal muscular atrophy, type II|Kugelberg-Welander disease	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000634947	5	70238308 - 70238311	5	70942481 - 70942484	634947	622775		NC_000005.10:70942480:AGAGAG:AG
NM_001904.4(CTNNB1):c.133_135del (p.Ser45del)	CTNNB1	S45del, S38del	Carcinoma of colon|Wilms Tumor	Pathogenic, other(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000017576	3	41266136 - 41266138	3	41224643 - 41224645	17576	32615	rs587776850	NC_000003.12:41224642:CTTCT:CT
NM_000112.3(SLC26A2):c.697C>T (p.Gln233Ter)	SLC26A2	Q233*	Diastrophic dysplasia|Achondrogenesis, type IB||	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000655153	5	149357912	5	149978349	655153	633631		NC_000005.10:149978348:C:T
NM_003042.4(SLC6A1):c.1648G>A (p.Gly550Arg)	SLC6A1	G550R, G372R, G430R	not provided|Global developmental delay|Myoclonic-atonic epilepsy	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280932	3	11076337	3	11034651	280932	264105	rs886042046	NC_000003.12:11034650:G:A
NM_004628.4(XPC):c.463C>T (p.Arg155Ter)	XPC	R155*, R149*	not provided|Xeroderma pigmentosum	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496268	3	14209830	3	14168330	496268	486987	rs755825264	NC_000003.12:14168329:G:A
NM_007118.4(TRIO):c.649A>T (p.Arg217Ter)	TRIO	R217*	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253082	5	14290933	5	14290824	253082	247493	rs879255624	NC_000005.10:14290823:A:T
NM_007118.4(TRIO):c.3752del (p.Asp1251fs)	TRIO	D1251fs	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253081	5	14387728	5	14387619	253081	247492	rs879255623	NC_000005.10:14387618:A:
NM_007118.4(TRIO):c.4128G>A (p.Trp1376Ter)	TRIO	W1376*	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253080	5	14390409	5	14390300	253080	247491	rs879255622	NC_000005.10:14390299:G:A
NM_007118.4(TRIO):c.4381C>A (p.Pro1461Thr)	TRIO	P1461T	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253085	5	14397221	5	14397112	253085	247496	rs879255627	NC_000005.10:14397111:C:A
NM_007118.4(TRIO):c.4466del (p.Gln1489fs)	TRIO	Q1489fs	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253083	5	14399031	5	14398922	253083	247494	rs879255625	NC_000005.10:14398921:A:
NM_000539.3(RHO):c.50C>T (p.Thr17Met)	RHO	T17M	Retinitis pigmentosa|Retinitis pigmentosa 4|Retinal dystrophy|not specified	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013018	3	129247626	3	129528783	13018	28057	rs104893769	NC_000003.12:129528782:C:T
NM_001354712.2(THRB):c.949G>A (p.Ala317Thr)	THRB	A317T, A286T	Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000012542	3	24169185	3	24127694	12542	27581	rs121918690	NC_000003.12:24127693:C:T
NM_001371623.1(TCOF1):c.4139dup (p.Glu1381fs)	TCOF1		not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000817386	5	149776195 - 149776196	5	150396632 - 150396633	817386	805426		NC_000005.10:150396632:CCCC:CCCCC
NM_001371623.1(TCOF1):c.2490_2499del (p.Val831fs)	TCOF1	V754fs, V831fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000817067	5	149758802 - 149758811	5	150379239 - 150379248	817067	805425		NC_000005.10:150379238:CAGTGAGAAAC:C
NM_000356.4(TCOF1):c.3898_3899del (p.Val1300fs)	TCOF1	V1339fs, V1340fs, V1377fs, V1300fs, V1301fs	not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000452124	5	149776191 - 149776192	5	150396628 - 150396629	452124	443727	rs1554080589	NC_000005.10:150396627:TGT:T
NM_000356.4(TCOF1):c.1759C>T (p.Gln587Ter)	TCOF1	Q587*, Q664*	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000432771	5	149755741	5	150376178	432771	425630	rs896979080	NC_000005.10:150376177:C:T
NM_000356.4(TCOF1):c.1692_1693dup (p.Lys565fs)	TCOF1		not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000432303	5	149755673 - 149755674	5	150376110 - 150376111	432303	425629	rs1554137113	NC_000005.10:150376110:CA:CACA
NM_000356.4(TCOF1):c.2800C>T (p.Gln934Ter)	TCOF1	Q1011*, Q934*	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000431983	5	149767636	5	150388073	431983	425631	rs1554077988	NC_000005.10:150388072:C:T
NM_000356.4(TCOF1):c.2444_2447delinsGCTGCCTTGGCT (p.Lys815fs)	TCOF1		not provided	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000424169	5	149759111 - 149759114	5	150379548 - 150379551	424169	406665	rs1064796835	NC_000005.10:150379547:AGAC:GCTGCCTTGGCT
NM_000356.4(TCOF1):c.3729_3730del (p.Glu1244fs)	TCOF1	E1244fs, E1283fs, E1245fs, E1284fs, E1321fs	not provided	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000423736	5	149776023 - 149776024	5	150396460 - 150396461	423736	406666	rs1064796606	NC_000005.10:150396459:TG:
NM_000356.4(TCOF1):c.1909C>T (p.Gln637Ter)	TCOF1	Q637*, Q714*	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000420948	5	149755891	5	150376328	420948	406664	rs769931291	NC_000005.10:150376327:C:T
NM_000356.4(TCOF1):c.4133_4134del (p.Lys1378fs)	TCOF1	K1378fs, K1379fs, K1417fs, K1418fs, K1455fs	not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000418795	5	149777932 - 149777933	5	150398369 - 150398370	418795	406668	rs587776585	NC_000005.10:150398368:AAAAAAAA:AAAAAA
NM_000356.4(TCOF1):c.3523_3526del (p.Ala1175fs)	TCOF1	A1175fs, A1214fs, A1215fs, A1176fs, A1252fs	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000372528	5	149773085 - 149773088	5	150393522 - 150393525	372528	359541	rs1057517834	NC_000005.10:150393521:CAGGCAG:CAG
NM_000356.4(TCOF1):c.2055_2056del (p.Ser687fs)	TCOF1	S764fs, S687fs	not provided	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000280472	5	149756129 - 149756130	5	150376566 - 150376567	280472	264254	rs886041672	NC_000005.10:150376565:TG:
NM_001371623.1(TCOF1):c.4064del (p.Pro1355fs)	TCOF1	P1278fs, P1355fs, P1316fs, P1354fs, P1277fs, P1317fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802169	5	149776123	5	150396560	802169	790529		NC_000005.10:150396559:CC:C
NM_001371623.1(TCOF1):c.633_634del (p.Val212fs)	TCOF1	V212fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802168	5	149749159 - 149749160	5	150369596 - 150369597	802168	790528		NC_000005.10:150369595:CG:
GRCh37/hg19 5q32(chr5:149731885-149738613)x1	TCOF1		See cases	Pathogenic(Last reviewed: Jun 23, 2014)	no assertion criteria provided	VCV000441658	5	149731885 - 149738613			441658	435320		
GRCh38/hg38 5q32(chr5:150368321-150396843)x3	TCOF1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058119	5	149747884 - 149776406	5	150368321 - 150396843	58119	72714		
GRCh38/hg38 5q32(chr5:150365489-150381740)x3	TCOF1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057111	5	149745052 - 149761303	5	150365489 - 150381740	57111	71706		
NM_018297.4(NGLY1):c.1201A>T (p.Arg401Ter)	NGLY1	R401*, R359*, R383*	not provided|Congenital disorder of deglycosylation	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000050962	3	25775422	3	25733931	50962	65632	rs201337954	NC_000003.12:25733930:T:A
NM_001371623.1(TCOF1):c.3091del (p.Arg1030_Ile1031insTer)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000841345	5	149769493	5	150389930	841345	830545		NC_000005.10:150389929:AA:A
NM_001371623.1(TCOF1):c.3496dup (p.Ala1166fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000836618	5	149771713 - 149771714	5	150392150 - 150392151	836618	830546		NC_000005.10:150392150:GGGGG:GGGGGG
NM_001371623.1(TCOF1):c.3352C>T (p.Gln1118Ter)	TCOF1	Q1041*, Q1080*, Q1118*	Treacher Collins syndrome 1	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000694633	5	149771574	5	150392011	694633	682733		NC_000005.10:150392010:C:T
NM_000356.4(TCOF1):c.4130_4134del (p.Lys1377fs)	TCOF1	K1416fs, K1454fs, K1377fs, K1378fs, K1417fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000660987	5	149777932 - 149777936	5	150398369 - 150398373	660987	633653		NC_000005.10:150398368:AAAAAAAA:AAA
NM_000356.4(TCOF1):c.3557_3558del (p.Lys1186fs)	TCOF1	K1186fs, K1187fs, K1225fs, K1226fs, K1263fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000658412	5	149775849 - 149775850	5	150396286 - 150396287	658412	633652		NC_000005.10:150396285:AAAA:AA
NM_001371623.1(TCOF1):c.3625del (p.Thr1209fs)	TCOF1	T1208fs, T1131fs, T1132fs, T1171fs, T1170fs, T1209fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000653704	5	149772956	5	150393393	653704	633650		NC_000005.10:150393392:A:
NM_001371623.1(TCOF1):c.1560dup (p.Ala521fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000645291	5	149754972 - 149754973	5	150375409 - 150375410	645291	633646		NC_000005.10:150375409:C:CC
NM_001371623.1(TCOF1):c.2353del (p.Ser784_Val785insTer)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000644583	5	149758480	5	150378917	644583	633648		NC_000005.10:150378916:G:
NM_000356.4(TCOF1):c.3987dup (p.Ser1330fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000575776	5	149776277 - 149776278	5	150396714 - 150396715	575776	560219	rs1561540623	NC_000005.10:150396714:GGGG:GGGGG
NM_000356.4(TCOF1):c.1146_1147del (p.Gly383fs)	TCOF1	G460fs, G383fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000575668	5	149754615 - 149754616	5	150375052 - 150375053	575668	560217	rs1562347303	NC_000005.10:150375051:AG:
NM_000356.4(TCOF1):c.1127dup (p.Ala377fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000543943	5	149754592 - 149754593	5	150375029 - 150375030	543943	520935	rs1554136123	NC_000005.10:150375029:CCCC:CCCCC
NM_000356.4(TCOF1):c.2564C>G (p.Ser855Ter)	TCOF1	S855*, S932*	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000543942	5	149759231	5	150379668	543942	521172	rs1554138811	NC_000005.10:150379667:C:G
NM_000356.4(TCOF1):c.2902dup (p.Glu968fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000543941	5	149769534 - 149769535	5	150389971 - 150389972	543941	521367	rs1554078461	NC_000005.10:150389971:GG:GGG
NM_000356.4(TCOF1):c.4175_4176del (p.Asp1391_Ser1392insTer)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000477619	5	149777979 - 149777980	5	150398416 - 150398417	477619	455619	rs1554081168	NC_000005.10:150398415:TCT:T
NM_000356.4(TCOF1):c.1915_1916del (p.Lys639fs)	TCOF1	K639fs, K716fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000477615	5	149755988 - 149755989	5	150376425 - 150376426	477615	455608	rs1554137419	NC_000005.10:150376424:AAA:A
NM_000356.4(TCOF1):c.4134dup (p.Glu1379fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000436967	5	149777931 - 149777932	5	150398368 - 150398369	436967	428360	rs587776585	NC_000005.10:150398368:AAAAAAAA:AAAAAAAAA
NM_000356.4(TCOF1):c.386_387del (p.Thr129fs)	TCOF1	T129fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jul 26, 2015)	criteria provided, single submitter	VCV000212384	5	149748285 - 149748286	5	150368722 - 150368723	212384	207167	rs797046037	NC_000005.10:150368721:ACA:A
NM_000356.4(TCOF1):c.2876dup (p.Ser959fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000127081	5	149769509 - 149769510	5	150389946 - 150389947	127081	132592	rs587777314	NC_000005.10:150389946:G:GG
NM_000356.4(TCOF1):c.376_378+15del	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000003967	5	149747475 - 149747492	5	150367912 - 150367929	3967	19006	rs587776584	NC_000005.10:150367911:GCCAAGGTGAGTGGGACTGCC:GCC
NM_000356.4(TCOF1):c.2731C>T (p.Arg911Ter)	TCOF1	R911*, R988*	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jul 15, 2004)	no assertion criteria provided	VCV000003966	5	149767567	5	150388004	3966	19005	rs119470017	NC_000005.10:150388003:C:T
NM_000356.4(TCOF1):c.149A>G (p.Tyr50Cys)	TCOF1	Y50C	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000003964	5	149740759	5	150361196	3964	19003	rs28941769	NC_000005.10:150361195:A:G
NM_000356.4(TCOF1):c.497_500del (p.Asn166fs)	TCOF1	N166fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000003962	5	149748397 - 149748400	5	150368834 - 150368837	3962	19001	rs587776581	NC_000005.10:150368833:ATAC:
NM_000356.4(TCOF1):c.422dup (p.His141fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000003961	5	149748321 - 149748322	5	150368758 - 150368759	3961	19000	rs587776580	NC_000005.10:150368758:A:AA
NM_002397.5(MEF2C):c.47_50ACAG[1] (p.Arg17_Gln18insTer)	MEF2C		MEF2C-Related Disorder|not provided|Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431933	5	88119552 - 88119555	5	88823735 - 88823738	431933	425650	rs1554150543	NC_000005.10:88823734:CTGTCTGT:CTGT
NM_000356.4(TCOF1):c.4134del (p.Glu1379fs)	TCOF1	E1380fs, E1419fs, E1456fs, E1379fs, E1418fs	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000003968	5	149777932	5	150398369	3968	19007	rs587776585	NC_000005.10:150398368:AAAAAAAA:AAAAAAA
NM_000356.4(TCOF1):c.1404_1405AG[2] (p.Ser470fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000003965	5	149755048 - 149755049	5	150375485 - 150375486	3965	19004	rs587776583	NC_000005.10:150375484:AGAGAG:AGAG
NM_000356.4(TCOF1):c.754C>T (p.Gln252Ter)	TCOF1	Q252*, Q329*	Treacher Collins syndrome 1	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000003960	5	149753851	5	150374288	3960	18999	rs119470016	NC_000005.10:150374287:C:T
NM_007118.4(TRIO):c.3239A>T (p.Asn1080Ile)	TRIO	N1080I	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY|Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253086	5	14374360	5	14374251	253086	247497	rs879255628	NC_000005.10:14374250:A:T
NM_001371623.1(TCOF1):c.3784+1G>C	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000845924	5	149773116	5	150393553	845924	851026		NC_000005.10:150393552:G:C
NC_000005.9:g.(?_149767445)_(149778631_?)del	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000543946	5	149767445 - 149778631	5	150387882 - 150399068	543946	520536		
NM_000356.4(TCOF1):c.2052_2053CT[1] (p.Asp684_Ser685insTer)	TCOF1		not provided|Treacher Collins syndrome 1	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000477616	5	149756126 - 149756127	5	150376563 - 150376564	477616	454757	rs1554137531	NC_000005.10:150376562:CTCT:CT
NM_000356.4(TCOF1):c.640-1946C>T	TCOF1	R288*	not provided|Treacher Collins syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000452929	5	149751791	5	150372228	452929	443725	rs748805008	NC_000005.10:150372227:C:T
NM_000356.4(TCOF1):c.1217_1220del (p.Asp406fs)	TCOF1	D483fs, D406fs	Treacher Collins syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000420429	5	149754683 - 149754686	5	150375120 - 150375123	420429	406663	rs1064794474	NC_000005.10:150375119:CAGACAG:CAG
NM_000356.4(TCOF1):c.50A>G (p.His17Arg)	TCOF1	H17R	not provided|Treacher Collins syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381618	5	149737359	5	150357796	381618	368456	rs1057521108	NC_000005.10:150357795:A:G
NM_002890.3(RASA1):c.471_472CT[2] (p.Leu159fs)	RASA1		not provided|Capillary malformation-arteriovenous malformation 1	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015999	5	86564739 - 86564740	5	87268922 - 87268923	15999	31038	rs797044451	NC_000005.10:87268921:CTCTCT:CTCT
NM_000404.4(GLB1):c.881_882del (p.Leu293_Tyr294insTer)	GLB1		not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817580	3	33093407 - 33093408	3	33051915 - 33051916	817580	805341		NC_000003.12:33051914:ATA:A
NM_000404.4(GLB1):c.396+2T>C	GLB1		not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000372370	3	33110310	3	33068818	372370	359420	rs1057517738	NC_000003.12:33068817:A:G
NM_000404.4(GLB1):c.169del (p.Tyr57fs)	GLB1	Y105fs, Y57fs, Y27fs	not provided	Pathogenic(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	VCV000195073	3	33114112	3	33072620	195073	192235	rs794727249	NC_000003.12:33072619:A:
NM_000404.4(GLB1):c.457+2T>C	GLB1		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092908	3	33109720	3	33068228	92908	98815	rs398123354	NC_000003.12:33068227:A:G
NM_000404.4(GLB1):c.1318C>T (p.His440Tyr)	GLB1	H410Y, H488Y, H440Y, H309Y	Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000827672	3	33059969	3	33018477	827672	815872		NC_000003.12:33018476:G:A
NM_000404.4(GLB1):c.716C>T (p.Thr239Met)	GLB1	T239M, T287M, T209M	GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807421	3	33099598	3	33058106	807421	798530		NC_000003.12:33058105:G:A
NM_000404.4(GLB1):c.922T>C (p.Phe308Leu)	GLB1	F308L, F278L, F177L, F356L	Infantile GM1 gangliosidosis	Pathogenic	no assertion criteria provided	VCV000100727	3	33093283	3	33051791	100727	106592	rs587779404	NC_000003.12:33051790:A:G
NM_000404.2:c.672_673delAT	GLB1		Infantile GM1 gangliosidosis	Pathogenic	no assertion criteria provided	VCV000100726					100726	106591		
NM_000404.4(GLB1):c.1188dup (p.Pro397fs)	GLB1		Infantile GM1 gangliosidosis	Pathogenic	no assertion criteria provided	VCV000100725	3	33063102 - 33063103	3	33021610 - 33021611	100725	106590	rs587779403	NC_000003.12:33021610:CCC:CCCC
NM_000404.4(GLB1):c.1771T>A (p.Tyr591Asn)	GLB1	Y591N, Y460N, Y639N, Y561N	GM1-gangliosidosis, type I, with cardiac involvement	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000000947	3	33038800	3	32997308	947	15986	rs72555373	NC_000003.12:32997307:A:T
NM_000404.4(GLB1):c.1292_1293CT[3] (p.Ser433fs)	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000842879	3	33059988 - 33059989	3	33018496 - 33018497	842879	827902		NC_000003.12:33018495:AGAGAGAG:AGAGAG
NM_000404.4(GLB1):c.531_534del (p.Gly178fs)	GLB1	G178fs, R107fs, G148fs, G226fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000837229	3	33106973 - 33106976	3	33065481 - 33065484	837229	827906		NC_000003.12:33065480:CCCTCC:CC
NC_000003.12:g.(?_33097001)_(33097095_?)del	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000832564	3	33138493 - 33138587			832564	819366		
NM_000404.4(GLB1):c.247T>C (p.Tyr83His)	GLB1	Y83H, Y131H, Y53H	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000000937	3	33110461	3	33068969	937	15976	rs72555364	NC_000003.12:33068968:A:G
NM_000404.4(GLB1):c.1527G>T (p.Trp509Cys)	GLB1	W509C, W378C, W557C, W479C	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000000933	3	33055755	3	33014263	933	15972	rs72555363	NC_000003.12:33014262:C:A
NM_000404.4(GLB1):c.1370G>A (p.Arg457Gln)	GLB1	R457Q, R427Q, R505Q, R326Q		Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000000930	3	33058310	3	33016818	930	15969	rs28934886	NC_000003.12:33016817:C:T
NM_000404.2(GLB1):c.1069_1233dup	GLB1		Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000000927			3	33018562 - 33046119	927	15966		
NM_000404.4(GLB1):c.163del (p.Ile55fs)	GLB1	I103fs, I25fs, I55fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000657106	3	33114118	3	33072626	657106	631178		NC_000003.12:33072625:T:
NM_000404.4(GLB1):c.553-1G>C	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000639100	3	33099762	3	33058270	639100	651170		NC_000003.12:33058269:C:G
NM_000404.4(GLB1):c.1479+1G>A	GLB1		not provided|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2||Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557669	3	33058200	3	33016708	557669	543181	rs1022476871	NC_000003.12:33016707:C:T
NM_000404.4(GLB1):c.397-1G>A	GLB1		Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2||not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092906	3	33109783	3	33068291	92906	98813	rs398123353	NC_000003.12:33068290:C:T
NM_000404.4(GLB1):c.1456_1466dup (p.Ile489fs)	GLB1		Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2||not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092898	3	33058213 - 33058214	3	33016721 - 33016722	92898	98805	rs398123349	NC_000003.12:33016721:ATATATGCACCATA:ATATATGCACCATATATGCACCATA
NM_000404.4(GLB1):c.1174_1175del (p.Leu392fs)	GLB1	L362fs, L392fs, L261fs, L440fs	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2||not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092893	3	33063116 - 33063117	3	33021624 - 33021625	92893	98800	rs398123348	NC_000003.12:33021623:AGA:A
NM_000404.4(GLB1):c.256_278dup (p.Gln95fs)	GLB1		Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000000934	3	33110429 - 33110430	3	33068937 - 33068938	934	15973	rs587776524	NC_000003.12:33068937:GGCCAGGGCTCATGAAAGTTCCAGG:GGCCAGGGCTCATGAAAGTTCCAGGCCAGGGCTCATGAAAGTTCCAGG
NM_000404.4(GLB1):c.818G>T (p.Trp273Leu)	GLB1	W273L, W243L, W142L, W321L	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000000931	3	33093471	3	33051979	931	15970	rs72555362	NC_000003.12:33051978:C:A
NM_000356.4(TCOF1):c.4124_4125del (p.Lys1375fs)	TCOF1	K1375fs, K1376fs, K1414fs, K1452fs, K1415fs	not provided|Treacher Collins syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503704	5	149777928 - 149777929	5	150398365 - 150398366	503704	495256	rs1554081108	NC_000005.10:150398364:AAA:A
NM_000356.4(TCOF1):c.2565_2566del (p.Gly856fs)	TCOF1	G856fs, G933fs	Treacher Collins syndrome 1|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000477617	5	149759232 - 149759233	5	150379669 - 150379670	477617	454758	rs1554138819	NC_000005.10:150379668:AG:
NM_000356.4(TCOF1):c.3739dup (p.Glu1247fs)	TCOF1		Treacher Collins syndrome|Crouzon syndrome|not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000419066	5	149776031 - 149776032	5	150396468 - 150396469	419066	406667	rs1554080460	NC_000005.10:150396468:GG:GGG
NM_000404.4(GLB1):c.931G>A (p.Gly311Arg)	GLB1	G180R, G311R, G281R, G359R	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000854615	3	33093274	3	33051782	854615	827904		NC_000003.12:33051781:C:T
NM_000404.4(GLB1):c.694dup (p.Ala232fs)	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis||GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552535	3	33099619 - 33099620	3	33058127 - 33058128	552535	543117	rs1553611025	NC_000003.12:33058127:CCCC:CCCCC
NM_000404.4(GLB1):c.443G>A (p.Arg148His)	GLB1	R148H, R118H, R196H	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B||Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522884	3	33109736	3	33068244	522884	513535	rs745864233	NC_000003.12:33068243:C:T
NM_007118.4(TRIO):c.4283G>A (p.Arg1428Gln)	TRIO	R1428Q	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253084	5	14394211	5	14394102	253084	247495	rs879255626	NC_000005.10:14394101:G:A
NM_181426.2(CCDC39):c.1072del (p.Thr358fs)	CCDC39	T358fs	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 14	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000065998	3	180369284	3	180651496	65998	76906	rs587778822	NC_000003.12:180651495:TTT:TT
NM_181426.2(CCDC39):c.2190del (p.Glu731fs)	CCDC39	E731fs	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 14	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000065950	3	180337122	3	180619334	65950	76858	rs587778820	NC_000003.12:180619333:TT:T
NM_181426.2(CCDC39):c.357+1G>C	CCDC39		Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 14	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000031067	3	180379648	3	180661860	31067	40024	rs397515392	NC_000003.12:180661859:C:G
NM_002397.5(MEF2C):c.565C>T (p.Arg189Ter)	MEF2C	R187*, R189*, R141*, R207*, R63*, R47*	not provided|Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158886	5	88047698	5	88751881	158886	168543	rs587783747	NC_000005.10:88751880:G:A
NM_000404.4(GLB1):c.1144-2A>G	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2||Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557226	3	33063149	3	33021657	557226	542937	rs1553607014	NC_000003.12:33021656:T:C
NM_000404.4(GLB1):c.846del (p.Thr283fs)	GLB1	T152fs, T331fs, T253fs, T283fs	GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2||Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557052	3	33093443	3	33051951	557052	543188	rs1553610382	NC_000003.12:33051950:GG:G
NM_000404.4(GLB1):c.202C>T (p.Arg68Trp)	GLB1	R68W, R116W, R38W	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000000944	3	33114079	3	33072587	944	15983	rs72555370	NC_000003.12:33072586:G:A
NM_000532.5(PCCB):c.764-2del	PCCB		not provided	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	VCV000203886	3	136016792	3	136297950	203886	200035	rs796052022	NC_000003.12:136297949:A:
NM_000532.5(PCCB):c.419_430dup (p.Lys140_Lys143dup)	PCCB		not provided	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000197156	3	135979363 - 135979364	3	136260521 - 136260522	197156	194317	rs797044729	NC_000003.12:136260521:AAAAGATCTGCAAA:AAAAGATCTGCAAAAAGATCTGCAAA
NM_000532.5(PCCB):c.3G>A (p.Met1Ile)	PCCB	M1I	not provided	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000093230	3	135969220	3	136250378	93230	99137	rs398123464	NC_000003.12:136250377:G:A
NM_000532.5(PCCB):c.386_387delinsAAC (p.Phe129Ter)	PCCB		not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000093229	3	135979334 - 135979335	3	136260492 - 136260493	93229	99136	rs398123463	NC_000003.12:136260491:TT:AAC
NM_000532.5(PCCB):c.2T>A (p.Met1Lys)	PCCB	M1K	not provided	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000093228	3	135969219	3	136250377	93228	99135	rs398123462	NC_000003.12:136250376:T:A
NM_000532.5(PCCB):c.183+1G>A	PCCB		not provided	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000093226	3	135969401	3	136250559	93226	99133	rs398123460	NC_000003.12:136250558:G:A
NM_000532.5(PCCB):c.1223del (p.Ile408fs)	PCCB	I408fs, I428fs	Propionic acidemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802012	3	136046021	3	136327179	802012	790337		NC_000003.12:136327178:T:
NM_000532.5(PCCB):c.1207C>T (p.Gln403Ter)	PCCB	Q423*, Q403*	Propionic acidemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802011	3	136046005	3	136327163	802011	790336		NC_000003.12:136327162:C:T
NM_000532.5(PCCB):c.1091-8_1091-3del	PCCB		Propionic acidemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802010	3	136045634 - 136045639	3	136326792 - 136326797	802010	790335		NC_000003.12:136326791:TCTCTTTCT:TCT
NM_000532.5(PCCB):c.1220del (p.Gly407fs)	PCCB	G407fs, G427fs	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638041	3	136046014	3	136327172	638041	625845		NC_000003.12:136327171:GGGGG:GGGG
NM_000532.5(PCCB):c.968_970TTG[1] (p.Val324del)	PCCB	V324del	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638040	3	136035783 - 136035785	3	136316941 - 136316943	638040	625865		NC_000003.12:136316940:GTTGTTG:GTTG
NM_000532.5(PCCB):c.839del (p.Leu280fs)	PCCB	L280fs, L300fs	Propionic acidemia	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000638039	3	136016869	3	136298027	638039	625844		NC_000003.12:136298026:T:
NG_008939.1:g.883_8934del8052	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Sep 4, 2012)	no assertion criteria provided	VCV000132644	3	135965049 - 135973100	3	136246207 - 136254258	132644	136392		
NM_000532.5(PCCB):c.457G>C (p.Ala153Pro)	PCCB	A153P, A173P	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038884	3	135980821	3	136261979	38884	47487	rs202247819	NC_000003.12:136261978:G:C
NM_000532.5(PCCB):c.335G>A (p.Gly112Asp)	PCCB	G112D	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038883	3	135975428	3	136256586	38883	47486	rs202247818	NC_000003.12:136256585:G:A
NM_000532.5(PCCB):c.280G>T (p.Gly94Ter)	PCCB	G94*	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038882	3	135974794	3	136255952	38882	47485	rs202247817	NC_000003.12:136255951:G:T
NM_000532.5(PCCB):c.1556T>C (p.Leu519Pro)	PCCB	L519P, L539P	Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038880	3	136048804	3	136329962	38880	47483	rs202247822	NC_000003.12:136329961:T:C
NM_000532.5(PCCB):c.152dup (p.Gln52fs)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000838787	3	135969364 - 135969365	3	136250522 - 136250523	838787	827567		NC_000003.12:136250522:GGGGG:GGGGGG
NC_000003.12:g.(?_136316921)_(136317084_?)del	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000831645	3	136035763 - 136035926			831645	819328		
NM_000532.5(PCCB):c.136_139delinsCCT (p.Ala46fs)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000666048	3	135969353 - 135969356	3	136250511 - 136250514	666048	630960		NC_000003.12:136250510:GCGC:CCT
NM_000532.5(PCCB):c.1172_1173del (p.Phe391fs)	PCCB	F411fs, F391fs	Propionic acidemia	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000659170	3	136045724 - 136045725	3	136326882 - 136326883	659170	630963		NC_000003.12:136326881:TTTT:TT
NM_000532.5(PCCB):c.184-49_188delinsTGCTTTGCTTGCTTTGCTTTGCTTT	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623324	3	135974649 - 135974702	3	136255807 - 136255860	623324	612263	rs1559995259	
NM_000532.5(PCCB):c.825dup (p.Asn276fs)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000567152	3	136016854 - 136016855	3	136298012 - 136298013	567152	562450	rs748393514	NC_000003.12:136298012:C:CC
NM_000532.5(PCCB):c.966+1G>T	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000554742	3	136019954	3	136301112	554742	542780	rs1385850128	NC_000003.12:136301111:G:T
NM_000532.5(PCCB):c.638del (p.Phe213fs)	PCCB	F213fs, F233fs	Propionic acidemia	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000459942	3	136002772	3	136283930	459942	452332	rs1196443543	NC_000003.12:136283929:TT:T
NM_000532.5(PCCB):c.1210G>A (p.Glu404Lys)	PCCB	E404K, E424K	Propionic acidemia	Pathogenic	criteria provided, single submitter	VCV000217891	3	136046008	3	136327166	217891	214552	rs777027944	NC_000003.12:136327165:G:A
NM_000532.5(PCCB):c.654+462A>G	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000012019	3	136003251	3	136284409	12019	27058		NC_000003.12:136284408:A:G
PCCB, 14-BP DEL, 12-BP INS, NT1218	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000012013					12013	27052		
PCCB, 8-BP DEL, NT3	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Oct 1, 1993)	no assertion criteria provided	VCV000012012					12012	27051		
NC_000003.11:g.(?_135969208)_(135969410_?)del	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000653524	3	135969208 - 135969410	3	136250366 - 136250568	653524	651026		
NM_000532.5(PCCB):c.517_518del (p.Leu173fs)	PCCB	L173fs, L193fs	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552452	3	135980880 - 135980881	3	136262038 - 136262039	552452	542957	rs755776820	NC_000003.12:136262037:TTT:T
NM_000532.5(PCCB):c.184-1G>A	PCCB		Propionic acidemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000289719	3	135974697	3	136255855	289719	273956	rs886044246	NC_000003.12:136255854:G:A
NM_000532.5(PCCB):c.372+2T>C	PCCB		Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217892	3	135975467	3	136256625	217892	214550	rs879253814	NC_000003.12:136256624:T:C
NM_000532.5(PCCB):c.649dup (p.Val217fs)	PCCB		Propionic acidemia|not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000203885	3	136002782 - 136002783	3	136283940 - 136283941	203885	200033	rs796052021	NC_000003.12:136283940:GG:GGG
NM_000532.5(PCCB):c.1538_1540dup (p.Arg514_Ile515insPro)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000012017	3	136048785 - 136048786	3	136329943 - 136329944	12017	27056	rs202247821	NC_000003.12:136329943:CCC:CCCCCC
NM_000356.4(TCOF1):c.4126_4129del (p.Glu1376fs)	TCOF1	E1377fs, E1415fs, E1453fs, E1376fs, E1416fs	Treacher Collins syndrome 1|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000452460	5	149777928 - 149777931	5	150398365 - 150398368	452460	443729	rs1554081112	NC_000005.10:150398364:AAAGAAA:AAA
NM_000356.4(TCOF1):c.1047+1G>A	TCOF1		not provided|Treacher Collins syndrome 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280270	5	149754375	5	150374812	280270	264246	rs886041506	NC_000005.10:150374811:G:A
NM_000356.4(TCOF1):c.1404_1405AG[1] (p.Glu469fs)	TCOF1		Treacher Collins syndrome 1	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000127080	5	149755048 - 149755051	5	150375485 - 150375488	127080	132591	rs587776583	NC_000005.10:150375484:AGAGAG:AG
NM_001080.3(ALDH5A1):c.278G>T (p.Cys93Phe)	ALDH5A1	C93F	Succinate-semialdehyde dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449408	6	24495502	6	24495274	449408	443937	rs765561257	NC_000006.12:24495273:G:T
NM_001080.3(ALDH5A1):c.1597G>A (p.Gly533Arg)	ALDH5A1	G533R, G546R, G485R	Succinate-semialdehyde dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426524	6	24533929	6	24533701	426524	415038	rs72552284	NC_000006.12:24533700:G:A
NM_001080.3(ALDH5A1):c.526G>A (p.Gly176Arg)	ALDH5A1	G176R	Succinate-semialdehyde dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379247	6	24503578	6	24503350	379247	368543	rs72552281	NC_000006.12:24503349:G:A
NM_005051.3(QARS1):c.1058G>T (p.Gly353Val)	QARS1	G342V, G353V	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828125	3	49137729	3	49100296	828125	816450		NC_000003.12:49100295:C:A
NM_005051.3(QARS1):c.1009_1012del (p.Asp337fs)	QARS1	D337fs, D326fs	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000863518	3	49137856 - 49137859	3	49100423 - 49100426	863518	828281		NC_000003.12:49100422:AGTCAG:AG
NM_005051.3(QARS1):c.1699C>T (p.Arg567Ter)	QARS1	R567*, R556*	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000860157	3	49136602	3	49099169	860157	828269		NC_000003.12:49099168:G:A
NM_005051.3(QARS1):c.1689_1690CA[1] (p.Thr564fs)	QARS1		Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000580993	3	49136609 - 49136610	3	49099176 - 49099177	580993	561642	rs1559966797	NC_000003.12:49099175:TGTGT:TGT
NM_005051.3(QARS1):c.1567C>T (p.Arg523Ter)	QARS1	R523*, R512*	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000566178	3	49136824	3	49099391	566178	563041	rs767667312	NC_000003.12:49099390:G:A
NM_005051.3(QARS1):c.1612del (p.Arg538fs)	QARS1	R527fs, R538fs	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000544142	3	49136779	3	49099346	544142	519390	rs1553751717	NC_000003.12:49099345:GGG:GG
NM_005051.3(QARS1):c.1284_1285del (p.Asp430fs)	QARS1	D419fs, D430fs	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000544132	3	49137404 - 49137405	3	49099971 - 49099972	544132	519575	rs775652214	NC_000003.12:49099970:CT:
NM_005051.3(QARS1):c.585del (p.Arg195_Leu196insTer)	QARS1		Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000477841	3	49139684	3	49102251	477841	452837	rs1241706645	NC_000003.12:49102250:CC:C
NM_005051.3(QARS1):c.169T>C (p.Tyr57His)	QARS1	Y57H	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000127117	3	49141853	3	49104420	127117	132625	rs587777333	NC_000003.12:49104419:A:G
NM_005051.3(QARS1):c.1387C>T (p.Arg463Ter)	QARS1	R463*, R452*	Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000477827	3	49137195	3	49099762	477827	452771	rs755674457	NC_000003.12:49099761:G:A
NM_000532.5(PCCB):c.838dup (p.Leu280fs)	PCCB		Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552435	3	136016864 - 136016865	3	136298022 - 136298023	552435	542927	rs769968548	NC_000003.12:136298022:CCCC:CCCCC
NM_000532.4(PCCB):c.1218_1231delGGGCATCATCCGGCins12 (p.?)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000496028	3	136046016 - 136046029	3	136327174 - 136327187	496028	487044		
NM_000532.5(PCCB):c.1498+2T>C	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217895	3	136047701	3	136328859	217895	214553	rs879253816	NC_000003.12:136328858:T:C
NM_000112.3(SLC26A2):c.1707C>G (p.Tyr569Ter)	SLC26A2	Y569*	Diastrophic dysplasia||Achondrogenesis, type IB||Osteochondrodysplasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495551	5	149360863	5	149981300	495551	487047	rs766836061	NC_000005.10:149981299:C:G
NM_001034850.2(RETREG1):c.433C>T (p.Gln145Ter)	RETREG1	Q145*	not provided|Hereditary sensory and autonomic neuropathy type IIB|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Nov 22, 2018)	criteria provided, single submitter	VCV000000330	5	16565897	5	16565788	330	15369	rs137852737	NC_000005.10:16565787:G:A
NM_000158.4(GBE1):c.1570C>T (p.Arg524Ter)	GBE1	R524*	Glycogen storage disease IV, classic hepatic|Glycogen storage disease IV, childhood neuromuscular|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002781	3	81627124	3	81577973	2781	17820	rs137852888	NC_000003.12:81577972:G:A
NM_000404.4(GLB1):c.276G>A (p.Trp92Ter)	GLB1	W92*, W62*, W140*	Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis||GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000264673	3	33110432	3	33068940	264673	244010	rs748830051	NC_000003.12:33068939:C:T
NM_000404.4(GLB1):c.1077del (p.Val360fs)	GLB1	V330fs, V408fs, V360fs, V229fs	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167146	3	33065809	3	33024317	167146	177750	rs727503952	NC_000003.12:33024316:TTTTT:TTTT
NM_033337.2(CAV3):c.189_197delCACCTTCAC (p.Thr64_Thr66del)	CAV3		not provided|Rippling muscle disease 2	Pathogenic(Last reviewed: Sep 3, 1999)	no assertion criteria provided	VCV000008277	3	8787286 - 8787294	3	8745597 - 8745605	8277	23316	rs199476331	NC_000003.12:8745596:CACCACCTTCAC:CAC
NM_000532.5(PCCB):c.331C>T (p.Arg111Ter)	PCCB	R111*	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553380	3	135975424	3	136256582	553380	542756	rs753981900	NC_000003.12:136256581:C:T
GRCh37/hg19 5q23.1(chr5:118811401-118814716)	HSD17B4		Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000813314	5	118811401 - 118814716			813314	801564		
NM_000414.4(HSD17B4):c.1993+1G>A	HSD17B4		Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802151	5	118867100	5	119531405	802151	790510		NC_000005.10:119531404:G:A
NM_000414.4(HSD17B4):c.1438-1G>A	HSD17B4		not provided	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	VCV000449589	5	118850675	5	119514980	449589	443652	rs1554067009	NC_000005.10:119514979:G:A
NM_000414.4(HSD17B4):c.1696_1702delinsAA (p.Pro566fs)	HSD17B4		not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000287722	5	118862843 - 118862849	5	119527148 - 119527154	287722	271959	rs886043708	NC_000005.10:119527147:CCAGTAT:AA
NM_000414.4(HSD17B4):c.302+3_302+6del	HSD17B4		Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000218138	5	118811423 - 118811426	5	119475728 - 119475731	218138	214785	rs863225438	NC_000005.10:119475727:GTGAGT:GT
NM_000414.4(HSD17B4):c.1147C>T (p.Gln383Ter)	HSD17B4	Q380*, Q383*, Q236*, Q408*, Q243*, Q246*, Q274*, Q359*, Q365*	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000861128	5	118835186	5	119499491	861128	829840		NC_000005.10:119499490:C:T
NM_000414.4(HSD17B4):c.1352del (p.Lys451fs)	HSD17B4	K304fs, K427fs, K448fs, K314fs, K342fs, K433fs, K476fs, K311fs, K451fs	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000854726	5	118844853	5	119509158	854726	829841		NC_000005.10:119509157:AA:A
NM_000414.4(HSD17B4):c.1578del (p.Phe526fs)	HSD17B4	F386fs, F526fs, F502fs, F508fs, F551fs	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000582190	5	118861613	5	119525918	582190	560084	rs1561485663	NC_000005.10:119525917:TTTT:TTT
NM_000414.4(HSD17B4):c.317G>C (p.Arg106Pro)	HSD17B4	R106P, R82P, R131P, R88P	Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000007657	5	118811533	5	119475838	7657	22696	rs25640	NC_000005.10:119475837:G:C
NM_000414.4(HSD17B4):c.423_424del (p.Lys142fs)	HSD17B4	K118fs, K124fs, K142fs, K167fs, K5fs	Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000007659	5	118813184 - 118813185	5	119477489 - 119477490	7659	22698		NC_000005.10:119477488:AGA:A
NM_000414.4(HSD17B4):c.974_1209+1del	HSD17B4		Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000007654	5	118835010 - 118835246	5	119499315 - 119499551	7654	22693	rs1554065254	
NM_000414.4(HSD17B4):c.1212_1261+2del	HSD17B4		Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000007653	5	118837734 - 118837785	5	119502039 - 119502090	7653	22692	rs1554065670	
NM_000414.4(HSD17B4):c.1628_1629GT[5] (p.Leu545fs)	HSD17B4		Perrault syndrome|Bifunctional peroxisomal enzyme deficiency|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371505	5	118861665 - 118861666	5	119525970 - 119525971	371505	357377	rs1057517323	NC_000005.10:119525970:GTGTGT:GTGTGTGTGT
NM_000414.4(HSD17B4):c.1715_1716CT[1] (p.Leu573fs)	HSD17B4		Bifunctional peroxisomal enzyme deficiency|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371008	5	118862862 - 118862863	5	119527167 - 119527168	371008	357378	rs1057516936	NC_000005.10:119527166:CTCT:CT
HSD17B4, 138-BP DEL	HSD17B4		Bifunctional peroxisomal enzyme deficiency	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007658					7658	22697		
NM_000414.4(HSD17B4):c.2029C>T (p.Gln677Ter)	HSD17B4	Q677*, Q653*, Q659*, Q537*, Q702*	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551750	5	118872153	5	119536458	551750	543666	rs751646311	NC_000005.10:119536457:C:T
NM_000414.4(HSD17B4):c.936_937del (p.His312_Thr313insTer)	HSD17B4		Bifunctional peroxisomal enzyme deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504023	5	118832304 - 118832305	5	119496609 - 119496610	504023	495228	rs758055753	NC_000005.10:119496608:ATA:A
NM_000414.4(HSD17B4):c.650A>G (p.Tyr217Cys)	HSD17B4	Y217C, Y77C, Y193C, Y199C, Y242C	Perrault syndrome 1	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000030228	5	118824914	5	119489219	30228	39184	rs387906825	NC_000005.10:119489218:A:G
NM_000532.5(PCCB):c.1433_1436dup (p.Glu480fs)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000645138	3	136047633 - 136047634	3	136328791 - 136328792	645138	630964		NC_000003.12:136328791:ATGT:ATGTATGT
NM_000532.5(PCCB):c.1301C>T (p.Ala434Val)	PCCB	A434V, A454V	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554490	3	136046477	3	136327635	554490	542976	rs751538672	NC_000003.12:136327634:C:T
NM_006261.4(PROP1):c.150del (p.Arg53fs)	PROP1	R53fs	Pituitary hormone deficiency, combined 2|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008102	5	177421299	5	177994298	8102	23141	rs587776683	NC_000005.10:177994297:T:
NM_000404.4(GLB1):c.902C>T (p.Ala301Val)	GLB1	A301V, A170V, A349V, A271V	Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000381567	3	33093387	3	33051895	381567	368399	rs750531880	NC_000003.12:33051894:G:A
NM_000404.4(GLB1):c.171C>G (p.Tyr57Ter)	GLB1	Y57*, Y105*, Y27*	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2||not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092900	3	33114110	3	33072618	92900	98807	rs398123350	NC_000003.12:33072617:G:C
NM_000404.4(GLB1):c.1313G>A (p.Gly438Glu)	GLB1	G438E, G408E, G486E, G307E	Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Jul 3, 2012)	criteria provided, single submitter	VCV000000940	3	33059974	3	33018482	940	15979	rs72555367	NC_000003.12:33018481:C:T
NM_000414.4(HSD17B4):c.1704T>A (p.Tyr568Ter)	HSD17B4	Y428*, Y544*, Y593*, Y550*, Y568*	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|Perrault syndrome 1	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000655256	5	118862851	5	119527156	655256	632870		NC_000005.10:119527155:T:A
NM_006017.3(PROM1):c.1142-1G>A	PROM1		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000809626	4	16010732	4	16009109	809626	795553		NC_000004.12:16009108:C:T
NM_006017.3(PROM1):c.784+1G>A	PROM1		Retinal dystrophy|not provided|Retinitis pigmentosa 41	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802056	4	16024948	4	16023325	802056	790456		NC_000004.12:16023324:C:T
NM_006017.3(PROM1):c.1984-1G>T	PROM1		not provided|Retinitis pigmentosa 41	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802053	4	15991448	4	15989825	802053	790453		NC_000004.12:15989824:C:A
NM_001145847.2(PROM1):c.595del (p.Thr199fs)	PROM1	T208fs, T199fs	Retinal dystrophy|not provided|Retinitis pigmentosa 41	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000402237	4	16026823	4	16025200	402237	389198	rs766246531	NC_000004.12:16025199:TTT:TT
NM_001145847.2(PROM1):c.1530C>A (p.Tyr510Ter)	PROM1	Y519*, Y510*	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100577	4	16002140	4	16000517	100577	106454	rs137853907	NC_000004.12:16000516:G:T
NM_000171.4(GLRA1):c.896G>A (p.Arg299Gln)	GLRA1	R271Q, R299Q, R216Q	Hyperekplexia 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016061	5	151230967	5	151851406	16061	31100	rs121918408	NC_000005.10:151851405:C:T
NM_001165928.3(DAG1):c.1771_1796del (p.Phe591fs)	DAG1	F591fs	not provided	Pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000418678	3	49569713 - 49569738	3	49532280 - 49532305	418678	406336	rs1064793360	NC_000003.12:49532279:CCTTCGAGATCCACGTCCACAGGCGCCC:CC
NM_001165928.3(DAG1):c.285+1G>A	DAG1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9|Limb-girdle muscular dystrophy-dystroglycanopathy, type C9	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000842859	3	49548253	3	49510820	842859	851464		NC_000003.12:49510819:G:A
NM_001165928.3(DAG1):c.235C>T (p.Arg79Ter)	DAG1	R79*	Limb-girdle muscular dystrophy-dystroglycanopathy, type C9|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000654870	3	49548202	3	49510769	654870	631556		NC_000003.12:49510768:C:T
NM_001165928.3(DAG1):c.440del (p.Gln147fs)	DAG1	Q147fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9|Limb-girdle muscular dystrophy-dystroglycanopathy, type C9	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000539125	3	49568384	3	49530951	539125	519660	rs1553652503	NC_000003.12:49530950:A:
NM_001165928.3(DAG1):c.743del (p.Ala248fs)	DAG1	A248fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9	Pathogenic(Last reviewed: May 26, 2015)	no assertion criteria provided	VCV000208543	3	49568687	3	49531254	208543	205060	rs869320680	NC_000003.12:49531253:C:
NM_001165928.3(DAG1):c.2006G>T (p.Cys669Phe)	DAG1	C669F	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000208542	3	49569950	3	49532517	208542	205059	rs797045023	NC_000003.12:49532516:G:T
NM_001165928.3(DAG1):c.220G>A (p.Val74Ile)	DAG1	V74I	Limb-girdle muscular dystrophy-dystroglycanopathy, type C9	Pathogenic(Last reviewed: Jan 20, 2015)	no assertion criteria provided	VCV000208540	3	49548187	3	49510754	208540	205057	rs189360006	NC_000003.12:49510753:G:A
NM_001354712.2(THRB):c.1357C>A (p.Pro453Thr)	THRB	P453T, P422T	Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: Dec 8, 2015)	criteria provided, single submitter	VCV000012550	3	24164404	3	24122913	12550	27589	rs28933408	NC_000003.12:24122912:G:T
NC_000003.12:g.(?_49530787)_(49533209_?)del	DAG1		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9|Limb-girdle muscular dystrophy-dystroglycanopathy, type C9	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000832051	3	49568220 - 49570642			832051	819410		
NM_000532.5(PCCB):c.1398+1G>T	PCCB		not provided|Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194181	3	136046575	3	136327733	194181	191344	rs794727092	NC_000003.12:136327732:G:T
NM_000532.5(PCCB):c.502G>A (p.Glu168Lys)	PCCB	E168K, E188K	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012015	3	135980866	3	136262024	12015	27054	rs121964960	NC_000003.12:136262023:G:A
NM_198903.2(GABRG2):c.351dup (p.Ala118fs)	GABRG2		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000503773	5	161524661 - 161524662	5	162097655 - 162097656	503773	495173	rs1554097873	NC_000005.10:162097655:TTTTTT:TTTTTTT
GRCh37/hg19 5q34(chr5:161493370-161531041)x1	GABRG2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253465	5	161493370 - 161531041			253465	247913		
NM_198903.2(GABRG2):c.272T>G (p.Leu91Ter)	GABRG2	L91*	not provided	Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	VCV000205561	5	161522513	5	162095507	205561	201878	rs796052518	NC_000005.10:162095506:T:G
NM_198903.2(GABRG2):c.1039T>G (p.Leu347Val)	GABRG2	L307V, L347V	not provided	Pathogenic(Last reviewed: Sep 6, 2012)	criteria provided, single submitter	VCV000205548	5	161569319	5	162142313	205548	201890	rs796052509	NC_000005.10:162142312:T:G
NM_198903.2(GABRG2):c.964C>A (p.Pro322Thr)	GABRG2	P282T, P322T	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000205546	5	161569244	5	162142238	205546	201888	rs796052508	NC_000005.10:162142237:C:A
NM_198903.2(GABRG2):c.890-1G>A	GABRG2		not provided	Pathogenic(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	VCV000205545	5	161569169	5	162142163	205545	201886	rs796052507	NC_000005.10:162142162:G:A
NM_198903.2(GABRG2):c.95C>A (p.Ser32Ter)	GABRG2	S32*, S10*	Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000855508	5	161495100	5	162068094	855508	830599		NC_000005.10:162068093:C:A
NC_000005.10:g.(?_162101215)_(162104046_?)del	GABRG2		Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831885	5	161528221 - 161531052			831885	819571		
NC_000005.10:g.(?_162067980)_(162068126_?)del	GABRG2		Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000831562	5	161494986 - 161495132			831562	819570		
NM_198903.2(GABRG2):c.1155del (p.Phe385fs)	GABRG2	F385fs, F345fs, F250fs, F344fs, F316fs, F323fs, F205fs, F342fs, F358fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000652738	5	161576224	5	162149218	652738	633708		NC_000005.10:162149217:TTT:TT
NM_198903.2(GABRG2):c.964C>T (p.Pro322Ser)	GABRG2	P282S, P322S	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74	Pathogenic(Last reviewed: Apr 19, 2019)	no assertion criteria provided	VCV000625863	5	161569244	5	162142238	625863	201889	rs796052508	NC_000005.10:162142237:C:T
NM_198903.2(GABRG2):c.1348G>T (p.Glu450Ter)	GABRG2	E402*, E450*, E410*	not provided	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000585902	5	161580174	5	162153168	585902	576802	rs1561662283	NC_000005.10:162153167:G:T
NM_198903.2(GABRG2):c.797_801del (p.Ser265_Ser266insTer)	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000536744	5	161530937 - 161530941	5	162103931 - 162103935	536744	521493	rs1554098222	NC_000005.10:162103930:GTTCTGTT:GTT
NM_198903.2(GABRG2):c.937G>T (p.Gly313Ter)	GABRG2	G273*, G313*	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Oct 21, 2017)	criteria provided, single submitter	VCV000468869	5	161569217	5	162142211	468869	455659	rs1469287853	NC_000005.10:162142210:G:T
GRCh37/hg19 5q34(chr5:161547032-161575610)x1	GABRG2		See cases	Pathogenic(Last reviewed: Aug 18, 2014)	no assertion criteria provided	VCV000443806	5	161547032 - 161575610			443806	437468		
GRCh37/hg19 5q34(chr5:161547033-161572618)x1	GABRG2		See cases	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000441747	5	161547033 - 161572618			441747	435409		
NM_198903.2(GABRG2):c.889G>A (p.Gly297Arg)	GABRG2	G297R, G257R	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433102	5	161531032	5	162104026	433102	426665	rs1554098235	NC_000005.10:162104025:G:A
NM_198903.2(GABRG2):c.1145del (p.Cys382fs)	GABRG2	C382fs, C342fs	Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000408213	5	161576216	5	162149210	408213	395098	rs1060501889	NC_000005.10:162149209:G:
NM_198903.2(GABRG2):c.530del (p.Arg177fs)	GABRG2	R177fs	Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000238189	5	161524846	5	162097840	238189	239783	rs878854144	NC_000005.10:162097839:G:
NM_198903.2(GABRG2):c.529C>G (p.Arg177Gly)	GABRG2	R139G, R177G	Familial febrile seizures 8	Pathogenic(Last reviewed: Aug 22, 2006)	no assertion criteria provided	VCV000016211	5	161524845	5	162097839	16211	31250	rs267606837	NC_000005.10:162097838:C:G
NC_000005.10:g.(?_162101225)_(162153368_?)del	GABRG2		Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000830557	5	161528231 - 161580374			830557	819572		
NM_198903.2(GABRG2):c.1103A>T (p.Lys368Met)	GABRG2	K289M, K368M, K328M	Familial febrile seizures 8	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000016207	5	161576174	5	162149168	16207	31246	rs121909672	NC_000005.10:162149167:A:T
NC_000005.10:g.(?_162066642)_(162156539_?)del	GABRG2		Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000833050	5	161493648 - 161583545			833050	819569		
NM_198903.2(GABRG2):c.889+2T>G	GABRG2		Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000016210	5	161531034	5	162104028	16210	31249	rs1561645243	NC_000005.10:162104027:T:G
NM_198903.2(GABRG2):c.1312C>T (p.Gln438Ter)	GABRG2	Q351*, Q438*, Q390*, Q398*	Familial febrile seizures 8	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000016209	5	161580138	5	162153132	16209	31248	rs121909674	NC_000005.10:162153131:C:T
NM_207352.4(CYP4V2):c.694C>T (p.Arg232Ter)	CYP4V2	R232*	Retinal dystrophy	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000866939	4	187120130	4	186198976	866939	856331		NC_000004.12:186198975:C:T
NM_207352.4(CYP4V2):c.221_222del (p.Phe74fs)	CYP4V2	F74fs	not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000596524	4	187115656 - 187115657	4	186194502 - 186194503	596524	587585	rs1561430786	NC_000004.12:186194501:TTTTTT:TTTT
NM_207352.4(CYP4V2):c.176del (p.Leu59fs)	CYP4V2	L59fs	not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000845917	4	187113153	4	186191999	845917	829017		NC_000004.12:186191998:T:
NM_207352.4(CYP4V2):c.1123del (p.Asp374_Leu375insTer)	CYP4V2		Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812305	4	187130050	4	186208896	812305	800496		NC_000004.12:186208895:CC:C
NM_207352.4(CYP4V2):c.120C>G (p.Tyr40Ter)	CYP4V2	Y40*	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812304	4	187113097	4	186191943	812304	800495		NC_000004.12:186191942:C:G
NM_207352.4(CYP4V2):c.974C>T (p.Thr325Ile)	CYP4V2	T325I	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039274	4	187122483	4	186201329	39274	47880	rs199476196	NC_000004.12:186201328:C:T
NM_207352.4(CYP4V2):c.971A>T (p.Asp324Val)	CYP4V2	D324V	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039273	4	187122480	4	186201326	39273	47879	rs199476195	NC_000004.12:186201325:A:T
NM_207352.4(CYP4V2):c.958C>T (p.Arg320Ter)	CYP4V2	R320*	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039272	4	187122467	4	186201313	39272	47878	rs199476194	NC_000004.12:186201312:C:T
NM_207352.4(CYP4V2):c.761A>G (p.His254Arg)	CYP4V2	H254R	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039270	4	187120197	4	186199043	39270	47876	rs199476193	NC_000004.12:186199042:A:G
NM_207352.4(CYP4V2):c.759dup (p.His254fs)	CYP4V2		Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039269	4	187120193 - 187120194	4	186199039 - 186199040	39269	47875	rs199476192	NC_000004.12:186199039:AA:AAA
NM_207352.4(CYP4V2):c.655T>C (p.Tyr219His)	CYP4V2	Y219H	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039268	4	187118737	4	186197583	39268	47874	rs199476191	NC_000004.12:186197582:T:C
NM_207352.4(CYP4V2):c.518T>G (p.Leu173Trp)	CYP4V2	L173W	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039266	4	187118198	4	186197044	39266	47872	rs199476190	NC_000004.12:186197043:T:G
NM_207352.4(CYP4V2):c.400G>T (p.Gly134Ter)	CYP4V2	G134*	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039265	4	187117229	4	186196075	39265	47871	rs199476189	NC_000004.12:186196074:G:T
NM_207352.4(CYP4V2):c.335T>G (p.Leu112Ter)	CYP4V2	L112*	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039263	4	187117164	4	186196010	39263	47869	rs199476188	NC_000004.12:186196009:T:G
NM_207352.4(CYP4V2):c.327+1G>A	CYP4V2		Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039262	4	187115767	4	186194613	39262	47868	rs199476182	NC_000004.12:186194612:G:A
NM_207352.4(CYP4V2):c.283G>A (p.Gly95Arg)	CYP4V2	G95R	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039261	4	187115722	4	186194568	39261	47867	rs199476187	NC_000004.12:186194567:G:A
NM_207352.4(CYP4V2):c.253C>T (p.Arg85Cys)	CYP4V2	R85C	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039260	4	187115692	4	186194538	39260	47866	rs199476186	NC_000004.12:186194537:C:T
NM_207352.4(CYP4V2):c.1526C>T (p.Pro509Leu)	CYP4V2	P509L	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039258	4	187131743	4	186210589	39258	47864	rs199476205	NC_000004.12:186210588:C:T
NM_207352.4(CYP4V2):c.1445C>A (p.Ser482Ter)	CYP4V2	S482*	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039257	4	187131662	4	186210508	39257	47863	rs146494374	NC_000004.12:186210507:C:A
NM_207352.4(CYP4V2):c.1226-6_1235del	CYP4V2		Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039255	4	187130241 - 187130256	4	186209087 - 186209102	39255	47861	rs199476184	NC_000004.12:186209086:TGACAGCAGGTTACAG:
NM_207352.4(CYP4V2):c.1187C>T (p.Pro396Leu)	CYP4V2	P396L	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039252	4	187130115	4	186208961	39252	47858	rs199476202	NC_000004.12:186208960:C:T
NM_207352.4(CYP4V2):c.1169G>A (p.Arg390His)	CYP4V2	R390H	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039251	4	187130097	4	186208943	39251	47857	rs199476201	NC_000004.12:186208942:G:A
NM_207352.4(CYP4V2):c.1157A>C (p.Lys386Thr)	CYP4V2	K386T	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039250	4	187130085	4	186208931	39250	47856	rs199476200	NC_000004.12:186208930:A:C
NM_207352.4(CYP4V2):c.1021T>C (p.Ser341Pro)	CYP4V2	S341P	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039249	4	187126387	4	186205233	39249	47855	rs199476199	NC_000004.12:186205232:T:C
NM_207352.4(CYP4V2):c.1020G>A (p.Trp340Ter)	CYP4V2	W340*	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000039248	4	187126386	4	186205232	39248	47854	rs199476198	NC_000004.12:186205231:G:A
NM_207352.4(CYP4V2):c.1396A>G (p.Asn466Asp)	CYP4V2	N466D	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Jun 14, 2013)	no assertion criteria provided	VCV000209986	4	187130417	4	186209263	209986	206572	rs797045181	NC_000004.12:186209262:A:G
NM_207352.4(CYP4V2):c.1393A>G (p.Arg465Gly)	CYP4V2	R465G	not provided	Pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	VCV000166978	4	187130414	4	186209260	166978	177092	rs144109267	NC_000004.12:186209259:A:G
NM_207352.4(CYP4V2):c.181G>A (p.Gly61Ser)	CYP4V2	G61S	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000002190	4	187113158	4	186192004	2190	17229	rs119103285	NC_000004.12:186192003:G:A
NM_207352.4(CYP4V2):c.1523G>A (p.Arg508His)	CYP4V2	R508H	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000002189	4	187131740	4	186210586	2189	17228	rs119103284	NC_000004.12:186210585:G:A
NM_207352.4(CYP4V2):c.130T>A (p.Trp44Arg)	CYP4V2	W44R	Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000002187	4	187113107	4	186191953	2187	17226	rs119103282	NC_000004.12:186191952:T:A
NM_003722.5(TP63):c.740A>G (p.His247Arg)	TP63	H247R, H153R, H245R, H68R	not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3|TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208163	3	189582181	3	189864392	208163	204424	rs864621968	NC_000003.12:189864391:A:G
NM_001034850.2(RETREG1):c.926C>G (p.Ser309Ter)	RETREG1	S309*, S168*	Hereditary sensory and autonomic neuropathy type IIA|Hereditary sensory and autonomic neuropathy type IIB|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000000328	5	16477845	5	16477736	328	15367	rs137852739	NC_000005.10:16477735:G:C
NM_000404.4(GLB1):c.1321G>A (p.Asp441Asn)	GLB1	D441N, D310N, D489N, D411N	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B||GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551496	3	33059966	3	33018474	551496	542934	rs780724173	NC_000003.12:33018473:C:T
NM_000539.3(RHO):c.404_405delinsTT (p.Arg135Leu)	RHO		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279882	3	129249761 - 129249762	3	129530918 - 129530919	279882	264132	rs886041233	NC_000003.12:129530917:GG:TT
NM_000539.3(RHO):c.1033G>A (p.Val345Met)	RHO	V345M	not provided|Retinitis pigmentosa 4	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000013056	3	129252547	3	129533704	13056	28095	rs104893795	NC_000003.12:129533703:G:A
NM_000414.4(HSD17B4):c.742C>T (p.Arg248Cys)	HSD17B4	R248C, R224C, R230C, R108C, R273C	Perrault syndrome|Bifunctional peroxisomal enzyme deficiency|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371366	5	118829515	5	119493820	371366	357368	rs969485098	NC_000005.10:119493819:C:T
NM_207352.4(CYP4V2):c.802-6_810del	CYP4V2		not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000854856	4	187122305 - 187122319	4	186201151 - 186201165	854856	851120		NC_000004.12:186201150:ATACAGGTCATCGCT:
NM_001080.3(ALDH5A1):c.1226G>A (p.Gly409Asp)	ALDH5A1	G409D, G422D, G361D	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001359	6	24528277	6	24528049	1359	16398	rs118203984	NC_000006.12:24528048:G:A
NM_001080.3(ALDH5A1):c.1234C>T (p.Arg412Ter)	ALDH5A1	R412*, R425*, R364*	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001358	6	24528285	6	24528057	1358	16397	rs118203983	NC_000006.12:24528056:C:T
NM_198903.2(GABRG2):c.406C>T (p.Arg136Ter)	GABRG2	R136*	Epilepsy, childhood absence 2|Familial febrile seizures 8|Lennox-Gastaut syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205540	5	161524722	5	162097716	205540	201881		NC_000005.10:162097715:C:T
NM_005219.5(DIAPH1):c.2905_2906dup (p.Ser970fs)	DIAPH1		not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000504168	5	140908380 - 140908381	5	141528813 - 141528814	504168	495248	rs1554201397	NC_000005.10:141528813:TT:TTTT
NM_005219.5(DIAPH1):c.1971_1972delinsT (p.Leu657fs)	DIAPH1		not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419689	5	140953445 - 140953446	5	141573878 - 141573879	419689	406648	rs1064794044	NC_000005.10:141573877:GC:A
NM_005219.5(DIAPH1):c.2794C>T (p.Arg932Ter)	DIAPH1	R923*, R932*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000391928	5	140908493	5	141528926	391928	368235	rs1057524293	NC_000005.10:141528925:G:A
GRCh37/hg19 5q31.3(chr5:140953993-140992629)	DIAPH1		Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625826	5	140953993 - 140992629			625826	614130		
NM_005219.5(DIAPH1):c.2769del (p.Phe923fs)	DIAPH1	F914fs, F923fs	Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Oct 13, 2015)	no assertion criteria provided	VCV000217753	5	140908748	5	141529181	217753	214405	rs863225242	NC_000005.10:141529180:AAA:AA
NM_005219.5(DIAPH1):c.1549C>T (p.Gln517Ter)	DIAPH1	Q508*, Q517*	Deafness, autosomal dominant 1|Seizures, cortical blindness, and microcephaly syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000839955	5	140954626	5	141575059	839955	830414		NC_000005.10:141575058:G:A
NC_000005.10:g.(?_141516831)_(141618934_?)del	DIAPH1		Seizures, cortical blindness, and microcephaly syndrome|Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831117	5	140896398 - 140998501			831117	819562		
NM_005219.5(DIAPH1):c.3624_3625del (p.Ala1210fs)	DIAPH1	A1210fs, A1201fs	Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	VCV000424874	5	140903746 - 140903747	5	141524179 - 141524180	424874	413208	rs1064797096	NC_000005.10:141524178:CT:
NM_005219.5(DIAPH1):c.3661+1G>T	DIAPH1		Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Nov 14, 1997)	no assertion criteria provided	VCV000007528	5	140903709	5	141524142	7528	22567		NC_000005.10:141524141:C:A
NM_000532.5(PCCB):c.494G>A (p.Arg165Gln)	PCCB	R165Q, R185Q	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551146	3	135980858	3	136262016	551146	542921	rs1304714042	NC_000003.12:136262015:G:A
NM_000532.5(PCCB):c.1540C>T (p.Arg514Ter)	PCCB	R514*, R534*	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217893	3	136048788	3	136329946	217893	214554	rs749908889	NC_000003.12:136329945:C:T
NM_000532.5(PCCB):c.942C>A (p.Tyr314Ter)	PCCB	Y314*, Y334*	Propionic acidemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203882	3	136019929	3	136301087	203882	200037	rs572246667	NC_000003.12:136301086:C:A
NM_000532.5(PCCB):c.1283C>T (p.Thr428Ile)	PCCB	T428I, T448I	Propionic acidemia	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012016	3	136046081	3	136327239	12016	27055	rs111033542	NC_000003.12:136327238:C:T
NM_000440.3(PDE6A):c.2053G>A (p.Val685Met)	PDE6A	V685M	Retinal dystrophy|Retinitis pigmentosa 43|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029874	5	149263074	5	149883511	29874	38829	rs121909835	NC_000005.10:149883510:C:T
NM_005219.5(DIAPH1):c.3145C>T (p.Arg1049Ter)	DIAPH1	R1049*, R1040*	Seizures, cortical blindness, and microcephaly syndrome|not provided	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000217754	5	140908023	5	141528456	217754	214406	rs863225243	NC_000005.10:141528455:G:A
NM_032682.6(FOXP1):c.1429_1442dup (p.Glu483fs)	FOXP1		not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000817189	3	71026179 - 71026180	3	70977028 - 70977029	817189	805362		NC_000003.12:70977028:GATTCGAGAATGGC:GATTCGAGAATGGCGATTCGAGAATGGC
GRCh37/hg19 3p13(chr3:71081905-71227572)x1	FOXP1		not provided	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000814453	3	71081905 - 71227572			814453	802663		
NM_032682.6(FOXP1):c.1426_1428+1del	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807605	3	71026793 - 71026796	3	70977642 - 70977645	807605	798537		NC_000003.12:70977641:CCTGCCT:CCT
NM_032682.6(FOXP1):c.870-1G>C	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801985	3	71064805	3	71015654	801985	790419		NC_000003.12:71015653:C:G
NM_032682.6(FOXP1):c.1287_1291dup (p.Thr431fs)	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801984	3	71027035 - 71027036	3	70977884 - 70977885	801984	790418		NC_000003.12:70977884:TGTGC:TGTGCTGTGC
NM_032682.5(FOXP1):c.1476T>A (p.Tyr492Ter)	FOXP1	Y492*, Y392*, Y491*, Y391*, Y416*	not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000620514	3	71026146	3	70976995	620514	611596	rs1559616778	NC_000003.12:70976994:A:T
NM_032682.5(FOXP1):c.529C>T (p.Gln177Ter)	FOXP1	Q177*, Q101*, Q76*, Q77*, Q176*	not provided	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000620469	3	71096228	3	71047077	620469	611597	rs1559807265	NC_000003.12:71047076:G:A
NM_032682.5(FOXP1):c.1717_1722+5del	FOXP1		not provided	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000504464	3	71019882 - 71019892	3	70970731 - 70970741	504464	495197	rs1553660890	NC_000003.12:70970730:CTTACCTGTAA:
NM_032682.5(FOXP1):c.1071del (p.Asp358fs)	FOXP1	D258fs, D257fs, D282fs, D357fs, D358fs	not provided	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000503998	3	71037220	3	70988069	503998	495471	rs1553678501	NC_000003.12:70988068:TTTT:TTT
NM_032682.5(FOXP1):c.1329C>A (p.Tyr443Ter)	FOXP1	Y443*, Y342*, Y343*, Y367*, Y442*	not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000502549	3	71026998	3	70977847	502549	493973	rs1064793944	NC_000003.12:70977846:G:T
NM_032682.5(FOXP1):c.1889+1G>T	FOXP1		not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000489211	3	71015040	3	70965889	489211	481702	rs1553656387	NC_000003.12:70965888:C:A
NM_032682.5(FOXP1):c.1146+5G>C	FOXP1		not provided	Pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, single submitter	VCV000449635	3	71037140	3	70987989	449635	443514	rs1553678368	NC_000003.12:70987988:C:G
NM_001244808.2(FOXP1):c.1263_1264CT[1] (p.Ser422fs)	FOXP1		not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000424328	3	71027061 - 71027062	3	70977910 - 70977911	424328	406360	rs1064796914	NC_000003.12:70977909:AGAG:AG
NM_001174051.3(CACNA2D2):c.200dup (p.His68fs)	CACNA2D2		not provided	Pathogenic(Last reviewed: Feb 19, 2017)	criteria provided, single submitter	VCV000423330	3	50540654 - 50540655	3	50503223 - 50503224	423330	406340	rs1553759256	NC_000003.12:50503223:T:TT
NM_032682.5(FOXP1):c.1329C>G (p.Tyr443Ter)	FOXP1	Y443*, Y342*, Y343*, Y367*, Y442*	not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419546	3	71026998	3	70977847	419546	406359	rs1064793944	NC_000003.12:70977846:G:C
GRCh37/hg19 3p13(chr3:71008556-71049017)x1	FOXP1		See cases	Pathogenic	no assertion criteria provided	VCV000397062	3	71008556 - 71049017			397062	383955		
NM_032682.5(FOXP1):c.574C>T (p.Gln192Ter)	FOXP1	Q192*, Q191*, Q116*, Q92*, Q91*	not provided	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000392993	3	71096183	3	71047032	392993	367380	rs1057524732	NC_000003.12:71047031:G:A
NM_032682.5(FOXP1):c.1489C>T (p.Arg497Ter)	FOXP1	R497*, R397*, R396*, R421*, R496*	not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000379850	3	71026133	3	70976982	379850	367721	rs775136381	NC_000003.12:70976981:G:A
NM_001244810.1(FOXP1):c.1531-483_1531-458dup	FOXP1		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000280654	3	71021788 - 71021789	3	70972637 - 70972638	280654	264171	rs886041821	NC_000003.12:70972637:AAAACACTTGTGAAGACTAAGATTAT:AAAACACTTGTGAAGACTAAGATTATAAAACACTTGTGAAGACTAAGATTAT
NM_032682.5(FOXP1):c.1409A>G (p.Tyr470Cys)	FOXP1	Y470C, Y370C, Y469C, Y369C, Y394C	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280463	3	71026813	3	70977662	280463	264185	rs769448730	NC_000003.12:70977661:T:C
NM_032682.5(FOXP1):c.1624C>T (p.Gln542Ter)	FOXP1	Q542*, Q441*, Q442*, Q466*, Q541*	not provided	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000194896	3	71021734	3	70972583	194896	192058	rs794727215	NC_000003.12:70972582:G:A
NM_032682.5(FOXP1):c.1317C>A (p.Tyr439Ter)	FOXP1	Y439*, Y363*, Y438*, Y338*, Y339*	not provided	Pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	VCV000194566	3	71027010	3	70977859	194566	191729	rs794727155	NC_000003.12:70977858:G:T
NM_032682.5(FOXP1):c.1146+1G>A	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000691271	3	71037144	3	70987993	691271	678957		NC_000003.12:70987992:C:T
NM_032682.5(FOXP1):c.1653-1G>A	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000691269	3	71019957	3	70970806	691269	678956		NC_000003.12:70970805:C:T
NM_001174051.3(CACNA2D2):c.851dup (p.Ala286fs)	CACNA2D2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000653393	3	50417440 - 50417441	3	50380009 - 50380010	653393	631617		NC_000003.12:50380009:T:TT
NM_001174051.3(CACNA2D2):c.1555C>T (p.Gln519Ter)	CACNA2D2	Q519*, Q450*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000578284	3	50414969	3	50377538	578284	561700	rs1559887808	NC_000003.12:50377537:G:A
NM_001174051.3(CACNA2D2):c.1956_1960del (p.Asn652fs)	CACNA2D2	N583fs, N652fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000570589	3	50412192 - 50412196	3	50374761 - 50374765	570589	561693	rs1559884460	NC_000003.12:50374760:TGAGAT:T
NM_032682.5(FOXP1):c.1394G>C (p.Arg465Thr)	FOXP1	R465T, R365T, R364T, R464T, R389T	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000559905	3	71026828	3	70977677	559905	550596	rs1553668196	NC_000003.12:70977676:C:G
NM_032682.5(FOXP1):c.975-2A>C	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000438294	3	71050212	3	71001061	438294	431906	rs1553685707	NC_000003.12:71001060:T:G
NM_032682.5(FOXP1):c.606del (p.Gly203fs)	FOXP1	G203fs, G127fs, G202fs, G102fs, G103fs	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000435248	3	71096151	3	71047000	435248	428216	rs1553709907	NC_000003.12:71046999:TT:T
NM_001244808.2(FOXP1):c.869+1G>A	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000433178	3	71090478	3	71041327	433178	426741	rs763837297	NC_000003.12:71041326:C:T
NM_032682.5(FOXP1):c.1240dup (p.Leu414fs)	FOXP1		not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000194567	3	71027086 - 71027087	3	70977935 - 70977936	194567	191730	rs797044652	NC_000003.12:70977935:GGGGGG:GGGGGGG
NM_001174051.3(CACNA2D2):c.1295del (p.Asn432fs)	CACNA2D2	N363fs, N432fs	CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000100785	3	50416390	3	50378959	100785	106650	rs587777165	NC_000003.12:50378958:TT:T
NM_032682.5(FOXP1):c.1670_1685dup (p.Ser562fs)	FOXP1		not provided	Pathogenic(Last reviewed: Jun 28, 2013)	criteria provided, single submitter	VCV000096227	3	71019923 - 71019924	3	70970772 - 70970773	96227	102121	rs398124429	NC_000003.12:70970772:CTGCTCTGCATGTTTT:CTGCTCTGCATGTTTTCTGCTCTGCATGTTTT
NC_000003.10:g.(71109689_?)_(?_71508061)del	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000018427					18427	33466		
NM_032682.5(FOXP1):c.842_843TC[1] (p.Val283fs)	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000689737	3	71090503 - 71090504	3	71041352 - 71041353	689737	677419		NC_000003.12:71041351:GAGAG:GAG
NM_032682.5(FOXP1):c.1653-2A>T	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561014	3	71019958	3	70970807	561014	552076	rs1559596756	NC_000003.12:70970806:T:A
NM_001244808.2(FOXP1):c.1289_1290AC[1] (p.Thr431fs)	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561013	3	71027035 - 71027036	3	70977884 - 70977885	561013	552077	rs1559620376	NC_000003.12:70977883:GTGTG:GTG
NM_032682.5(FOXP1):c.622C>T (p.Gln208Ter)	FOXP1	Q208*, Q108*, Q132*, Q207*, Q107*	Mental retardation with language impairment and with or without autistic features|Cerebellar vermis hypoplasia|not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000498786	3	71096135	3	71046984	498786	490210	rs1553709881	NC_000003.12:71046983:G:A
NM_032682.5(FOXP1):c.1349-5_1350del	FOXP1		Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431122	3	71026872 - 71026878	3	70977721 - 70977727	431122	424647	rs1135401796	NC_000003.12:70977720:TGCTGAAT:T
NM_032682.5(FOXP1):c.1240_1241del (p.Leu414fs)	FOXP1	L313fs, L314fs, L338fs, L413fs, L414fs	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418219	3	71027086 - 71027087	3	70977935 - 70977936	418219	406361	rs1064793130	NC_000003.12:70977934:AG:
NM_001174051.3(CACNA2D2):c.485_486del (p.Tyr161_Tyr162insTer)	CACNA2D2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 23, 2016)	criteria provided, single submitter	VCV000411003	3	50425023 - 50425024	3	50387592 - 50387593	411003	394091	rs1060503108	NC_000003.12:50387591:ATA:A
NM_032682.5(FOXP1):c.1317C>G (p.Tyr439Ter)	FOXP1	Y439*, Y338*, Y363*, Y438*, Y339*	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000217266	3	71027010	3	70977859	217266	213914	rs794727155	NC_000003.12:70977858:G:C
NM_032682.5(FOXP1):c.1540C>T (p.Arg514Cys)	FOXP1	R514C, R413C, R414C, R438C, R513C	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000217265	3	71021818	3	70972667	217265	213912	rs869025203	NC_000003.12:70972666:G:A
NM_032682.5(FOXP1):c.1393A>G (p.Arg465Gly)	FOXP1	R465G, R464G, R389G, R364G, R365G	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000217264	3	71026829	3	70977678	217264	213913	rs869025202	NC_000003.12:70977677:T:C
NM_001244810.1(FOXP1):c.1531-427T>C	FOXP1	W534R, W458R, W533R, W433R, W434R	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000156541	3	71021758	3	70972607	156541	166312	rs587777855	NC_000003.12:70972606:A:G
NM_001195794.1(CLRN1):c.149_152delinsTGTCCAAT (p.Ser50fs)	CLRN1		not provided|Usher syndrome, type 3A|Retinal dystrophy|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188726	3	150690344 - 150690347	3	150972557 - 150972560	188726	186676	rs786204428	NC_000003.12:150972556:CCTG:ATTGGACA
NM_032682.5(FOXP1):c.1348+1G>C	FOXP1		Intellectual disability|Autistic disorder of childhood onset	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000587696	3	71026978	3	70977827	587696	578654	rs1559619762	NC_000003.12:70977826:C:G
NM_032682.5(FOXP1):c.1507C>T (p.Arg503Ter)	FOXP1	R503*, R402*, R502*, R427*, R403*	not provided|Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000211038	3	71026115	3	70976964	211038	207085	rs797045584	NC_000003.12:70976963:G:A
NM_207352.4(CYP4V2):c.1348C>T (p.Gln450Ter)	CYP4V2	Q450*	not provided|Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000039256	4	187130369	4	186209215	39256	47862	rs199476204	NC_000004.12:186209214:C:T
NM_001145847.2(PROM1):c.1699C>T (p.Gln567Ter)	PROM1	Q576*, Q567*	Retinal dystrophy|Retinitis pigmentosa 41|Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000005609	4	15995651	4	15994028	5609	20648	rs137853005	NC_000004.12:15994027:G:A
NM_001244808.2(FOXP1):c.1627C>T (p.Arg543Ter)	FOXP1	R543*, R544*, R443*, R444*, R468*	Seizures|Intellectual disability|Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000626283	3	71021728	3	70972577	626283	614601	rs1559602356	NC_000003.12:70972576:G:A
NM_001003841.3(SLC6A19):c.517G>A (p.Asp173Asn)	SLC6A19	D173N	not provided|Hyperglycinuria|Neutral 1 amino acid transport defect|Iminoglycinuria|Neutral 1 amino acid transport defect	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002019	5	1212453	5	1212338	2019	17058	rs121434346	NC_000005.10:1212337:G:A
NM_005219.5(DIAPH1):c.2332C>T (p.Gln778Ter)	DIAPH1	Q769*, Q778*	Seizures, cortical blindness, and microcephaly syndrome|Microcephaly|Global developmental delay|Seizure disorder|Failure to thrive	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183344	5	140953085	5	141573518	183344	181418	rs730882242	NC_000005.10:141573517:G:A
NM_000232.4(SGCB):c.1_2del (p.Met1fs)	SGCB	M1fs	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2E|Qualitative or quantitative defects of beta-sarcoglycan	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282860	4	52904424 - 52904425	4	52038258 - 52038259	282860	267097	rs886042503	NC_000004.12:52038257:AT:
NM_181426.2(CCDC39):c.828_829CA[1] (p.Thr277fs)	CCDC39		not provided|Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 14	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242176	3	180372649 - 180372650	3	180654861 - 180654862	242176	239125	rs773801386	NC_000003.12:180654860:TGTGT:TGT
NM_032682.5(FOXP1):c.1573C>T (p.Arg525Ter)	FOXP1	R525*, R424*, R425*, R524*, R449*	not provided|Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018428	3	71021785	3	70972634	18428	33467	rs112795301	NC_000003.12:70972633:G:A
NM_000297.4(PKD2):c.572_573AG[1] (p.Arg192fs)	PKD2		not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000618826	4	88929456 - 88929457	4	88008304 - 88008305	618826	609554		NC_000004.12:88008303:GAGAG:GAG
NM_000297.4(PKD2):c.2099_2100TC[1] (p.Ser701fs)	PKD2		not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000618323	4	88983136 - 88983137	4	88061984 - 88061985	618323	609557		NC_000004.12:88061983:CTCTC:CTC
NM_000297.4(PKD2):c.2523-1G>A	PKD2		not specified	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000440150	4	88995963	4	88074811	440150	433001	rs1553928728	NC_000004.12:88074810:G:A
NM_000297.4(PKD2):c.1094+1G>A	PKD2		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000280008	4	88959654	4	88038502	280008	264213	rs58606740	NC_000004.12:88038501:G:A
NM_000297.4(PKD2):c.709+1G>A	PKD2		not provided	Pathogenic(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	VCV000092797	4	88940724	4	88019572	92797	98704	rs398123308	NC_000004.12:88019571:G:A
NM_000297.4(PKD2):c.2019+1_2019+5del	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000829998	4	88979254 - 88979258	4	88058102 - 88058106	829998	818236		NC_000004.12:88058101:TGGTATG:TG
NM_000297.4(PKD2):c.595+1G>C	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000811939	4	88929481	4	88008329	811939	799375		NC_000004.12:88008328:G:C
NM_000297.4(PKD2):c.654_655del (p.Ser219fs)	PKD2	S219fs	Polycystic kidney disease 2	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000811885	4	88940666 - 88940667	4	88019514 - 88019515	811885	799376		NC_000004.12:88019513:AAAA:AA
NM_000297.4(PKD2):c.136_210delinsGCGGG (p.Leu46fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000811862	4	88929021 - 88929095	4	88007869 - 88007943	811862	799373		
NM_000297.4(PKD2):c.2242A>T (p.Lys748Ter)	PKD2	K748*	Polycystic kidney disease 2	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000811796	4	88986915	4	88065763	811796	799384		NC_000004.12:88065762:A:T
NM_000297.4(PKD2):c.741C>G (p.Tyr247Ter)	PKD2	Y247*	Polycystic kidney disease 2	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000811568	4	88957403	4	88036251	811568	799378		NC_000004.12:88036250:C:G
NM_000297.4(PKD2):c.2051dup (p.Tyr684Ter)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000811405	4	88983088 - 88983089	4	88061936 - 88061937	811405	799382		NC_000004.12:88061936:A:AA
NM_000297.4(PKD2):c.261G>A (p.Trp87Ter)	PKD2	W87*	not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000805202	4	88929146	4	88007994	805202	793061		NC_000004.12:88007993:G:A
NM_000297.4(PKD2):c.1325del (p.Leu442fs)	PKD2	L442fs	Polycystic kidney disease 2	Pathogenic(Last reviewed: Dec 12, 2018)	no assertion criteria provided	VCV000635531	4	88967798	4	88046646	635531	623281		NC_000004.12:88046645:TT:T
NM_000297.4(PKD2):c.1047dup (p.Val350fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000635524	4	88959605 - 88959606	4	88038453 - 88038454	635524	623280		NC_000004.12:88038453:T:TT
NM_000297.4(PKD2):c.2407C>T (p.Arg803Ter)	PKD2	R803*	Polycystic kidney disease 2	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000618321	4	88989098	4	88067946	618321	609560	rs778235410	NC_000004.12:88067945:C:T
NM_000297.4(PKD2):c.999delinsAGA (p.Pro334fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000599156	4	88959558	4	88038406	599156	590274	rs1560608729	NC_000004.12:88038405:C:AGA
NM_000297.4(PKD2):c.2503dup (p.Ser835fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Apr 30, 2018)	no assertion criteria provided	VCV000599111	4	88989191 - 88989192	4	88068039 - 88068040	599111	590276	rs1560628245	NC_000004.12:88068039:TTT:TTTT
NM_000297.4(PKD2):c.1737_1746delinsAACAGG (p.Phe579Leufs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Mar 12, 2018)	no assertion criteria provided	VCV000599090	4	88977258 - 88977267	4	88056106 - 88056115	599090	590275	rs1560620277	NC_000004.12:88056105:TAACAGGACC:AACAGG
NM_000297.4(PKD2):c.596-1G>T	PKD2		not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000586315	4	88940609	4	88019457	586315	576787	rs1560597874	NC_000004.12:88019456:G:T
NM_000297.4(PKD2):c.538dup (p.Leu180fs)	PKD2		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562301	4	88929418 - 88929419	4	88008266 - 88008267	562301	553485	rs1371793191	NC_000004.12:88008266:CCCCC:CCCCCC
NM_000297.4(PKD2):c.2286C>A (p.Tyr762Ter)	PKD2	Y762*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562296	4	88986959	4	88065807	562296	553480	rs555242193	NC_000004.12:88065806:C:A
NM_000297.4(PKD2):c.2284_2287del (p.Tyr762fs)	PKD2	Y762fs	Polycystic liver disease 1|Polycystic kidney dysplasia|Multicystic kidney dysplasia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523354	4	88986956 - 88986959	4	88065804 - 88065807	523354	513954	rs1553927823	NC_000004.12:88065803:GTACG:G
NM_000297.4(PKD2):c.1088del (p.Gly363fs)	PKD2	G363fs	Polycystic kidney disease 2	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522438	4	88959646	4	88038494	522438	513058	rs1553925467	NC_000004.12:88038493:GG:G
NM_000297.4(PKD2):c.986del (p.Gly329fs)	PKD2	G329fs	Polycystic kidney disease 2	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522425	4	88959544	4	88038392	522425	513057	rs1553925459	NC_000004.12:88038391:GG:G
NM_000297.4(PKD2):c.603G>A (p.Trp201Ter)	PKD2	W201*	not provided	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000448038	4	88940617	4	88019465	448038	440851	rs1553924158	NC_000004.12:88019464:G:A
NM_000297.4(PKD2):c.1671_1678del (p.Phe558fs)	PKD2	F558fs	not provided	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000448032	4	88973262 - 88973269	4	88052110 - 88052117	448032	440854	rs1553926529	NC_000004.12:88052109:ACAGTTCAACA:ACA
NM_000297.4(PKD2):c.2524del (p.Leu842fs)	PKD2	L842fs	Polycystic kidney disease 2	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438702	4	88995964	4	88074812	438702	432293	rs1553928730	NC_000004.12:88074811:CC:C
NM_000297.4(PKD2):c.1458C>G (p.Tyr486Ter)	PKD2	Y486*	Polycystic kidney disease 2	Pathogenic	no assertion criteria provided	VCV000431056	4	88967932	4	88046780	431056	424583	rs1135401753	NC_000004.12:88046779:C:G
NM_000297.4(PKD2):c.815_816CT[1] (p.Leu273fs)	PKD2		Polycystic kidney dysplasia|Elevated systolic blood pressure|Elevated diastolic blood pressure	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000374198	4	88957477 - 88957478	4	88036325 - 88036326	374198	360863	rs1057518969	NC_000004.12:88036324:CTCT:CT
NM_000297.4(PKD2):c.145C>T (p.Gln49Ter)	PKD2	Q49*	Polycystic kidney dysplasia	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000374110	4	88929030	4	88007878	374110	360861	rs1057518906	NC_000004.12:88007877:C:T
NM_000297.4(PKD2):c.1365G>A (p.Trp455Ter)	PKD2	W455*	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000805198	4	88967839	4	88046687	805198	793063		NC_000004.12:88046686:G:A
NM_000297.4(PKD2):c.1320-2del	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000638001	4	88967792	4	88046640	638001	625831		NC_000004.12:88046639:A:
NM_000297.4(PKD2):c.2241-2A>G	PKD2		not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000562263	4	88986912	4	88065760	562263	553447	rs1560626499	NC_000004.12:88065759:A:G
NM_000297.4(PKD2):c.1249C>T (p.Arg417Ter)	PKD2	R417*	not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000562248	4	88964539	4	88043387	562248	553432	rs1324209174	NC_000004.12:88043386:C:T
NM_000297.4(PKD2):c.2159del (p.Asn720fs)	PKD2	N720fs	not specified|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000440144	4	88986559	4	88065407	440144	433000	rs757757289	NC_000004.12:88065406:AAAAAAAA:AAAAAAA
NM_000297.4(PKD2):c.306_307insAGG (p.Val103_Glu104insArg)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000040115	4	88929190 - 88929191	4	88008038 - 88008039	40115	48616	rs398122932	NC_000004.12:88008038:G:GAGG
NC_000004.11:g.88957372-?_89042944+?dup	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000040114	4	88957372			40114	48615		
NM_000297.4(PKD2):c.1934_1935delinsT (p.Asn645fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Jul 17, 2008)	no assertion criteria provided	VCV000013525	4	88979170 - 88979171	4	88058018 - 88058019	13525	28564	rs1560621750	NC_000004.12:88058017:AC:T
NM_000297.4(PKD2):c.1532A>T (p.Asp511Val)	PKD2	D511V	Polycystic kidney disease 2	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000013524	4	88968006	4	88046854	13524	28563	rs121918043	NC_000004.12:88046853:A:T
PKD2, 1-BP INS, 197_203C	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000013523					13523	28562		
NM_000297.4(PKD2):c.2159dup (p.Asn720fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000013522	4	88986558 - 88986559	4	88065406 - 88065407	13522	28561	rs757757289	NC_000004.12:88065406:AAAAAAAA:AAAAAAAAA
NM_000297.4(PKD2):c.693dup (p.Ile232fs)	PKD2		Polycystic kidney disease 2	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000013520	4	88940706 - 88940707	4	88019554 - 88019555	13520	28559	rs1560598042	NC_000004.12:88019554:C:CC
NM_000297.4(PKD2):c.1213C>T (p.Gln405Ter)	PKD2	Q405*	Polycystic kidney disease 2	Pathogenic(Last reviewed: May 31, 1996)	no assertion criteria provided	VCV000013519	4	88964503	4	88043351	13519	28558	rs121918041	NC_000004.12:88043350:C:T
NM_000297.4(PKD2):c.1139G>A (p.Trp380Ter)	PKD2	W380*	Polycystic kidney disease 2	Pathogenic(Last reviewed: May 31, 1996)	no assertion criteria provided	VCV000013517	4	88964429	4	88043277	13517	28556	rs121918039	NC_000004.12:88043276:G:A
NM_000344.3(SMN1):c.785G>T (p.Ser262Ile)	SMN1	S262I, S230I	not provided|Kugelberg-Welander disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000009165	5	70241954	5	70946127	9165	24204	rs1554066659	NC_000005.10:70946126:G:T
NM_000297.4(PKD2):c.2440G>T (p.Glu814Ter)	PKD2	E814*	not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000805201	4	88989131	4	88067979	805201	793066		NC_000004.12:88067978:G:T
NM_000297.4(PKD2):c.1081C>T (p.Arg361Ter)	PKD2	R361*	Polycystic kidney disease 2|not provided	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000636770	4	88959640	4	88038488	636770	624285		NC_000004.12:88038487:C:T
NM_000297.4(PKD2):c.481_502del (p.Gly161fs)	PKD2	G161fs	Polycystic kidney disease 2|not specified	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000440147	4	88929362 - 88929383	4	88008210 - 88008231	440147	432993	rs1553923513	NC_000004.12:88008209:CCAGGGCCCGCCGTGCCCCAGCCCAG:CCAG
NM_000297.4(PKD2):c.670del (p.Leu224fs)	PKD2	L224fs	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000434013	4	88940684	4	88019532	434013	427227	rs1553924173	NC_000004.12:88019531:C:
NM_000297.4(PKD2):c.357_364delinsTAGGACG (p.Pro120fs)	PKD2		Polycystic kidney dysplasia|Chronic kidney disease|Hypertensive disorder|Polycystic kidney dysplasia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000373955	4	88929242 - 88929249	4	88008090 - 88008097	373955	360862	rs1057518797	NC_000004.12:88008089:CCCGGGCA:TAGGACG
NM_000297.4(PKD2):c.1390C>T (p.Arg464Ter)	PKD2	R464*	Polycystic kidney disease 2	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000013521	4	88967864	4	88046712	13521	28560	rs121918042	NC_000004.12:88046711:C:T
NM_000414.4(HSD17B4):c.1516C>T (p.Arg506Cys)	HSD17B4	R506C, R366C, R488C, R531C, R482C	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495866	5	118860923	5	119525228	495866	487165	rs766199971	NC_000005.10:119525227:C:T
NM_152778.3(MFSD8):c.998+1G>A	MFSD8		not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000502262	4	128851837	4	127930682	502262	493686	rs1553946656	NC_000004.12:127930681:C:T
NM_152778.3(MFSD8):c.1061dup (p.Leu354fs)	MFSD8		not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000280638	4	128843055 - 128843056	4	127921900 - 127921901	280638	264189	rs886041806	NC_000004.12:127921900:AA:AAA
NM_152778.3(MFSD8):c.217dup (p.Thr73fs)	MFSD8		not provided	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000206175	4	128865128 - 128865129	4	127943973 - 127943974	206175	201755	rs796052752	NC_000004.12:127943973:T:TT
NM_152778.3(MFSD8):c.599G>A (p.Trp200Ter)	MFSD8	W200*	not provided	Pathogenic(Last reviewed: Feb 13, 2014)	criteria provided, single submitter	VCV000206149	4	128861107	4	127939952	206149	201748	rs558274487	NC_000004.12:127939951:C:T
NM_001371596.2(MFSD8):c.63-1G>A	MFSD8			Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802090	4	128878748	4	127957593	802090	790437		NC_000004.12:127957592:C:T
NM_001371596.2(MFSD8):c.1124del (p.Pro375fs)	MFSD8	P330fs, P337fs, P270fs, P326fs, P375fs, P281fs, P308fs, P377fs		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802088	4	128842905	4	127921750	802088	790435		NC_000004.12:127921749:GGG:GG
NC_000004.12:g.(?_127965062)_(127965143_?)del	MFSD8			Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000832802	4	128886217 - 128886298			832802	819450		
NC_000004.12:g.(?_127932965)_(127933113_?)del	MFSD8			Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000832788	4	128854120 - 128854268			832788	819447		
NC_000004.12:g.(?_127965052)_(127965153_?)del	MFSD8			Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000831882	4	128886207 - 128886308			831882	819449		
NC_000004.12:g.(?_127930663)_(127965153_?)del	MFSD8			Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000831293	4	128851818 - 128886308			831293	819446		
NC_000004.12:g.(?_127930663)_(127933113_?)del	MFSD8			Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000830961	4	128851818 - 128854268			830961	819445		
NM_152778.3(MFSD8):c.233G>A (p.Trp78Ter)	MFSD8	W78*		Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000641252	4	128865113	4	127943958	641252	631948		NC_000004.12:127943957:C:T
NM_152778.3(MFSD8):c.1086del (p.Ile364fs)	MFSD8	I297fs, I259fs, I364fs		Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000578890	4	128843031	4	127921876	578890	559585	rs1460276679	NC_000004.12:127921875:GGG:GG
NM_152778.3(MFSD8):c.64G>T (p.Glu22Ter)	MFSD8	E22*		Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000574492	4	128878746	4	127957591	574492	563471	rs1560776422	NC_000004.12:127957590:C:A
NM_152778.3(MFSD8):c.863+3_863+4insT	MFSD8			Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000162381	4	128854136 - 128854137	4	127932981 - 127932982	162381	172084	rs727502801	NC_000004.12:127932981::A
MFSD8, 2-BP DEL/2-BP INS	MFSD8			Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000001007					1007	16046		
NM_152778.3(MFSD8):c.894T>G (p.Tyr298Ter)	MFSD8	Y298*, Y193*, Y231*		Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001003	4	128851942	4	127930787	1003	16042	rs118203977	NC_000004.12:127930786:A:C
NM_000297.4(PKD2):c.2419C>T (p.Arg807Ter)	PKD2	R807*	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000805200	4	88989110	4	88067958	805200	793065		NC_000004.12:88067957:C:T
NM_000297.4(PKD2):c.473del (p.Glu158fs)	PKD2	E158fs	Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000639450	4	88929358	4	88008206	639450	632520		NC_000004.12:88008205:A:
NM_000297.4(PKD2):c.2527del (p.Leu842_Val843insTer)	PKD2		not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000586314	4	88995967	4	88074815	586314	576791	rs1560632930	NC_000004.12:88074814:GG:G
NM_000297.4(PKD2):c.443del (p.Gly148fs)	PKD2	G148fs	Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000577770	4	88929326	4	88008174	577770	562284	rs1560592253	NC_000004.12:88008173:GGG:GG
NM_000297.4(PKD2):c.1325T>A (p.Leu442Ter)	PKD2	L442*	Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000573710	4	88967799	4	88046647	573710	559819	rs1391596181	NC_000004.12:88046646:T:A
NM_000297.4(PKD2):c.1774C>T (p.Arg592Ter)	PKD2	R592*	Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000477625	4	88977295	4	88056143	477625	453855	rs1553926905	NC_000004.12:88056142:C:T
NM_000297.4(PKD2):c.1577_1578TA[1] (p.Tyr527fs)	PKD2		Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000477623	4	88973170 - 88973171	4	88052018 - 88052019	477623	453591	rs1553926509	NC_000004.12:88052017:ATATA:ATA
NC_000004.11:g.(?_88928866)_(88979275_?)del	PKD2		Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000477620	4	88928866 - 88979275	4	88007714 - 88058123	477620	453259		
NM_000297.4(PKD2):c.916C>T (p.Arg306Ter)	PKD2	R306*	not provided|Polycystic kidney disease 2	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000397507	4	88959475	4	88038323	397507	384403	rs200001068	NC_000004.12:88038322:C:T
NM_152778.3(MFSD8):c.416G>A (p.Arg139His)	MFSD8	R139H		Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431131	4	128864930	4	127943775	431131	424648	rs749704755	NC_000004.12:127943774:C:T
NM_152778.3(MFSD8):c.1286G>A (p.Gly429Asp)	MFSD8	G429D, G362D, G324D		Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001002	4	128842743	4	127921588	1002	16041	rs118203976	NC_000004.12:127921587:C:T
NM_000404.4(GLB1):c.245+1G>A	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis||Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000417873	3	33114035	3	33072543	417873	404764	rs778423653	NC_000003.12:33072542:C:T
NM_000404.4(GLB1):c.152T>C (p.Ile51Thr)	GLB1	I51T, I21T, I99T	Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000000926	3	33114129	3	33072637	926	15965	rs72555390	NC_000003.12:33072636:A:G
NM_001371596.2(MFSD8):c.103C>T (p.Arg35Ter)	MFSD8	R35*		Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000846459	4	128878707	4	127957552	846459	828811		NC_000004.12:127957551:G:A
NM_001371596.2(MFSD8):c.831dup (p.Val278fs)	MFSD8		Retinal dystrophy|	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000648978	4	128854171 - 128854172	4	127933016 - 127933017	648978	631945		NC_000004.12:127933016:AAAAAA:AAAAAAA
NM_152778.3(MFSD8):c.1036del (p.Val346fs)	MFSD8	V241fs, V346fs, V279fs	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000464776	4	128843081	4	127921926	464776	453271	rs1439582451	NC_000004.12:127921925:C:
NM_033337.2(CAV3):c.314C>T (p.Pro105Leu)	CAV3	P105L	not provided|Rippling muscle disease 2	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000008276	3	8787411	3	8745725	8276	23315	rs116840805	NC_000003.12:8745724:C:T
NM_152618.3(BBS12):c.1063C>T (p.Arg355Ter)	BBS12	R355*	Postaxial polydactyly type A1|Abnormality of cardiovascular system morphology|Inability to walk|Visual impairment|Bardet-Biedl syndrome|Bardet-Biedl syndrome 12	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001147	4	123664110	4	122742955	1147	16186	rs121918327	NC_000004.12:122742954:C:T
NC_000004.12:g.(?_88038231)_(88075714_?)del	PKD2		Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000832516	4	88959383 - 88996866			832516	819502		
NC_000004.11:g.(?_88928866)_(88996866_?)del	PKD2		Polycystic kidney disease, autosomal dominant	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000584210	4	88928866 - 88996866	4	88007714 - 88075714	584210	559706		
NM_000297.4(PKD2):c.2533C>T (p.Arg845Ter)	PKD2	R845*	not provided|Polycystic kidney disease 2	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523770	4	88995974	4	88074822	523770	514499	rs369678636	NC_000004.12:88074821:C:T
NM_004453.2(ETFDH):c.1367C>T	ETFDH	P456L, P395L, P409L	not provided|Glutaric aciduria, type 2	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095072	4	159627422	4	158706270	95072	100972	rs398124152	NC_000004.12:158706269:C:T
NM_001371596.2(MFSD8):c.863+1G>T	MFSD8			Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000856831	4	128854139	4	127932984	856831	850966		NC_000004.12:127932983:C:A
NC_000004.12:g.(?_127920610)_(127957612_?)del	MFSD8			Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000830407	4	128841765 - 128878767			830407	819443		
NM_000158.4(GBE1):c.1571G>A (p.Arg524Gln)	GBE1	R524Q	Glycogen storage disease IV, combined hepatic and myopathic|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000002782	3	81627123	3	81577972	2782	17821	rs80338673	NC_000003.12:81577971:C:T
NM_002292.4(LAMB2):c.1978_1979del (p.Lys660fs)	LAMB2	K660fs	Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Apr 2, 2019)	no assertion criteria provided	VCV000829944	3	49165930 - 49165931	3	49128497 - 49128498	829944	818226		NC_000003.12:49128496:TT:
NM_002292.4(LAMB2):c.4611_4621del (p.Thr1538fs)	LAMB2	T1538fs	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000451720	3	49159756 - 49159766	3	49122323 - 49122333	451720	443494	rs1384293775	NC_000003.12:49122322:GCACCCGTGTGGC:GC
NM_002292.4(LAMB2):c.4573+1G>A	LAMB2		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000449551	3	49160136	3	49122703	449551	443495	rs1387723456	NC_000003.12:49122702:C:T
NM_002292.4(LAMB2):c.2890C>T (p.Arg964Ter)	LAMB2	R964*	Pierson syndrome	Pathogenic(Last reviewed: Jun 16, 2014)	no assertion criteria provided	VCV000180395	3	49162353	3	49124920	180395	178530	rs730880125	NC_000003.12:49124919:G:A
NM_002292.4(LAMB2):c.4510_4552del (p.Gln1504fs)	LAMB2	Q1504fs	Pierson syndrome|Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000842232	3	49160158 - 49160200	3	49122725 - 49122767	842232	828299		NC_000003.12:49122724:TCTGGATAAGTTCTTGAAGTTCCTGGTTGGCCTGTTCCACCTGTC:TC
NM_002292.4(LAMB2):c.4762C>T (p.Gln1588Ter)	LAMB2	Q1588*	Pierson syndrome|Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000660396	3	49159615	3	49122182	660396	631509		NC_000003.12:49122181:G:A
NM_002292.4(LAMB2):c.4773dup (p.Arg1592fs)	LAMB2		Pierson syndrome|Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000472489	3	49159603 - 49159604	3	49122170 - 49122171	472489	452787	rs1553776921	NC_000003.12:49122170:CC:CCC
NM_002292.4(LAMB2):c.440A>G (p.His147Arg)	LAMB2	H147R	Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029774	3	49169568	3	49132135	29774	38729	rs387906644	NC_000003.12:49132134:T:C
NM_002292.4(LAMB2):c.4804del (p.Gln1602fs)	LAMB2	Q1602fs	Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000014538	3	49159496	3	49122063	14538	29577	rs769399002	NC_000003.12:49122062:G:
NM_002292.4(LAMB2):c.961T>C (p.Cys321Arg)	LAMB2	C321R	Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000014536	3	49168248	3	49130815	14536	29575	rs121912492	NC_000003.12:49130814:A:G
NM_002292.4(LAMB2):c.737G>A (p.Arg246Gln)	LAMB2	R246Q	Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000014534	3	49168561	3	49131128	14534	29573	rs121912491	NC_000003.12:49131127:C:T
NM_002292.4(LAMB2):c.1122T>A (p.Cys374Ter)	LAMB2	C374*	Pierson syndrome	Pathogenic(Last reviewed: Sep 15, 2005)	no assertion criteria provided	VCV000014533	3	49167767	3	49130334	14533	29572	rs121912490	NC_000003.12:49130333:A:T
NM_002292.4(LAMB2):c.5258dup (p.Glu1754fs)	LAMB2		Pierson syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000014531	3	49158867 - 49158868	3	49121434 - 49121435	14531	29570	rs1560063136	NC_000003.12:49121434:T:TT
NM_002292.4(LAMB2):c.1478del (p.Cys493fs)	LAMB2	C493fs	Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000014537	3	49167077	3	49129644	14537	29576	rs1560075787	NC_000003.12:49129643:C:
NM_002292.4(LAMB2):c.736C>T (p.Arg246Trp)	LAMB2	R246W	Pierson syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000014530	3	49168562	3	49131129	14530	29569	rs121912488	NC_000003.12:49131128:G:A
NM_002292.4(LAMB2):c.3015del (p.Gln1006fs)	LAMB2	Q1006fs	Pierson syndrome	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000014529	3	49162228	3	49124795	14529	29568	rs1560072794	NC_000003.12:49124794:CCCC:CCC
NM_000532.5(PCCB):c.1316A>G (p.Tyr439Cys)	PCCB	Y439C, Y459C	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225429	3	136046492	3	136327650	225429	227253	rs769521436	NC_000003.12:136327649:A:G
NM_002292.4(LAMB2):c.1477del (p.Cys493fs)	LAMB2	C493fs	Nephrotic syndrome, type 5, with or without ocular abnormalities|Pierson syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000848378	3	49167078	3	49129645	848378	828312		NC_000003.12:49129644:A:
NM_002292.4(LAMB2):c.2067C>G (p.Tyr689Ter)	LAMB2	Y689*	Pierson syndrome|Nephrotic syndrome, type 5, with or without ocular abnormalities	Pathogenic(Last reviewed: Sep 3, 2018)	no assertion criteria provided	VCV000014532	3	49163882	3	49126449	14532	29571	rs121912489	NC_000003.12:49126448:G:C
NM_000112.3(SLC26A2):c.699+2T>C	SLC26A2		||Achondrogenesis, type IB|Diastrophic dysplasia	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000371684	5	149357916	5	149978353	371684	357398	rs1057517461	NC_000005.10:149978352:T:C
NM_003722.5(TP63):c.1027C>T (p.Arg343Trp)	TP63	R343W, R249W, R341W, R164W	not provided|TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279913	3	189586403	3	189868614	279913	264162	rs886041251	NC_000003.12:189868613:C:T
NM_001080.3(ALDH5A1):c.803G>A (p.Gly268Glu)	ALDH5A1	G281E, G268E	Succinate-semialdehyde dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235512	6	24515471	6	24515243	235512	237193	rs375628463	NC_000006.12:24515242:G:A
NM_145207.3(SPATA5):c.983_985CAA[2] (p.Thr330del)	SPATA5	T330del	Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207828	4	123855729 - 123855731	4	122934574 - 122934576	207828	204062	rs796052243	NC_000004.12:122934573:CAACAACAA:CAACAA
NM_207352.4(CYP4V2):c.332T>C (p.Ile111Thr)	CYP4V2	I111T	not provided|Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000002188	4	187117161	4	186196007	2188	17227	rs119103283	NC_000004.12:186196006:T:C
NM_021971.4(GMPPB):c.79G>C (p.Asp27His)	GMPPB	D27H	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|not provided|Muscular dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060546	3	49761081	3	49723648	60546	75127	rs142336618	NC_000003.12:49723647:C:G
NM_003900.5(SQSTM1):c.1165+1G>A	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset||GNE myopathy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000008110	5	179260783	5	179833783	8110	23149	rs796051870	NC_000005.10:179833782:G:A
NM_000297.4(PKD2):c.514del (p.Asp172fs)	PKD2	D172fs	Polycystic kidney disease, autosomal dominant|not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448037	4	88929396	4	88008244	448037	440850	rs1232369409	NC_000004.12:88008243:GGGG:GGG
NM_000297.4(PKD2):c.1898+5G>A	PKD2		not provided|Polycystic kidney disease 2	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448033	4	88977424	4	88056272	448033	440855	rs1553926929	NC_000004.12:88056271:G:A
NM_152778.3(MFSD8):c.1141G>T (p.Glu381Ter)	MFSD8	E381*, E314*, E276*	Macular dystrophy with central cone involvement||not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000162379	4	128842888	4	127921733	162379	172082	rs724159970	NC_000004.12:127921732:C:A
NM_152778.3(MFSD8):c.1235C>T (p.Pro412Leu)	MFSD8	P412L, P307L, P345L	Seizures|	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001005	4	128842794	4	127921639	1005	16044	rs267607235	NC_000004.12:127921638:G:A
NM_001041.4(SI):c.3370C>T (p.Arg1124Ter)	SI	R1124*	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000432014	3	164737443	3	165019655	432014	425532	rs200451408	NC_000003.12:165019654:G:A
NM_000481.3(AMT):c.959G>A (p.Arg320His)	AMT	R320H, R264H, R276H	Non-ketotic hyperglycinemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011979	3	49455325	3	49417892	11979	27018	rs121964985	NC_000003.12:49417891:C:T
NM_000404.4(GLB1):c.1480-2A>G	GLB1		GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1-gangliosidosis, type I, with cardiac involvement|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000946	3	33055804	3	33014312	946	15985	rs587776526	NC_000003.12:33014311:T:C
NM_001023570.4(IQCB1):c.424_425del (p.Phe142fs)	IQCB1	F142fs	Senior-Loken syndrome 5|Nephronophthisis|Retinal dystrophy|Leber congenital amaurosis	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001831	3	121527825 - 121527826	3	121808978 - 121808979	1831	16870	rs750962965	NC_000003.12:121808977:AAAAA:AAA
NM_001291303.1(FAT4):c.11800+1G>T	FAT4		Van Maldergem syndrome 2	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623344	4	126373966	4	125452811	623344	612350	rs963302668	NC_000004.12:125452810:G:T
NM_024582.4(FAT4):c.7200-2A>C	FAT4		Hennekam lymphangiectasia-lymphedema syndrome 2	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000156112	4	126367452	4	125446297	156112	165911	rs587777726	NC_000004.12:125446296:A:C
NM_024582.4(FAT4):c.1195del (p.Leu399fs)	FAT4	L399fs	Hennekam lymphangiectasia-lymphedema syndrome 2	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000156110	4	126238761	4	125317606	156110	165909	rs587777725	NC_000004.12:125317605:C:
NM_024582.4(FAT4):c.11455C>T (p.Arg3819Ter)	FAT4	R3819*, R3821*	Van Maldergem syndrome 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089009	4	126373626	4	125452471	89009	94563	rs398122957	NC_000004.12:125452470:C:T
NM_024582.4(FAT4):c.9481G>T (p.Glu3161Ter)	FAT4	E3161*, E3163*	Van Maldergem syndrome 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089007	4	126371652	4	125450497	89007	94561	rs370088878	NC_000004.12:125450496:G:T
NM_024582.4(FAT4):c.13193G>A (p.Cys4398Tyr)	FAT4	C4398Y, C4400Y, C4399Y	Van Maldergem syndrome 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089005	4	126411170	4	125490015	89005	94559	rs398122954	NC_000004.12:125490014:G:A
NM_001291285.1(FAT4):c.7035_7040TGGAAC[3] (p.2346_2347GT[3])	FAT4		Hennekam lymphangiectasia-lymphedema syndrome 2	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000156109	4	126355413 - 126355414	4	125434258 - 125434259	156109	165908	rs587777724	NC_000004.12:125434258:ACTGGAACTGGAAC:ACTGGAACTGGAACTGGAAC
NM_024582.4(FAT4):c.14512_14513del (p.Ser4838fs)	FAT4	S4838fs, S4840fs, S4839fs	Van Maldergem syndrome 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089008	4	126412489 - 126412490	4	125491334 - 125491335	89008	94562	rs398122956	NC_000004.12:125491333:TC:
NM_024582.4(FAT4):c.12476G>T (p.Cys4159Phe)	FAT4	C4159F, C4161F	Van Maldergem syndrome 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089004	4	126400898	4	125479743	89004	94558	rs398122953	NC_000004.12:125479742:G:T
NM_000532.5(PCCB):c.493C>T (p.Arg165Trp)	PCCB	R165W, R185W	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217894	3	135980857	3	136262015	217894	214551	rs879253815	NC_000003.12:136262014:C:T
NM_000532.5(PCCB):c.1495C>T (p.Arg499Ter)	PCCB	R499*, R519*	Propionic acidemia	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000038878	3	136047696	3	136328854	38878	47481	rs202247820	NC_000003.12:136328853:C:T
NM_000532.5(PCCB):c.1173dup (p.Val392fs)	PCCB		Propionic acidemia	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012014	3	136045723 - 136045724	3	136326881 - 136326882	12014	27053	rs587776758	NC_000003.12:136326881:TTTT:TTTTT
NM_207352.4(CYP4V2):c.1091-2A>G	CYP4V2		Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000002191	4	187130017	4	186208863	2191	17230	rs199476183	NC_000004.12:186208862:A:G
NM_152778.3(MFSD8):c.1102G>C (p.Asp368His)	MFSD8	D368H, D263H, D301H	Macular dystrophy with central cone involvement|	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000162380	4	128843015	4	127921860	162380	172083	rs727502800	NC_000004.12:127921859:C:G
NM_000232.4(SGCB):c.31C>T (p.Gln11Ter)	SGCB	Q11*	Qualitative or quantitative defects of beta-sarcoglycan|not provided|Limb-Girdle Muscular Dystrophy, Recessive|Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284502	4	52904395	4	52038229	284502	268739	rs752492870	NC_000004.12:52038228:G:A
NM_006846.4(SPINK5):c.2901del (p.Glu968fs)	SPINK5	E968fs, E998fs	not provided	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000817255	5	147506578	5	148127015	817255	805423		NC_000005.10:148127014:AA:A
NM_021942.6(TRAPPC11):c.3193C>T (p.Arg1065Ter)	TRAPPC11	R1065*	not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000620376	4	184629563	4	183708410	620376	611610	rs750976634	NC_000004.12:183708409:C:T
NM_006846.3(SPINK5):c.1530C>A (p.Cys510Ter)	SPINK5	C510*	not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000523881	5	147486650	5	148107087	523881	514504	rs1554105045	NC_000005.10:148107086:C:A
NM_006846.3(SPINK5):c.649C>T (p.Arg217Ter)	SPINK5	R217*	not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000523773	5	147470774	5	148091211	523773	514503	rs367958902	NC_000005.10:148091210:C:T
NM_006846.3(SPINK5):c.2215C>T (p.Gln739Ter)	SPINK5	Q739*	not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000452099	5	147498102	5	148118539	452099	443706	rs766028970	NC_000005.10:148118538:C:T
NM_006846.3(SPINK5):c.1615_1619del (p.Glu539fs)	SPINK5	E539fs	not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000451204	5	147488323 - 147488327	5	148108760 - 148108764	451204	443703	rs1554105205	NC_000005.10:148108759:GAAGA:
NM_006846.3(SPINK5):c.1048C>T (p.Arg350Ter)	SPINK5	R350*	not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000449101	5	147478834	5	148099271	449101	443699	rs373463881	NC_000005.10:148099270:C:T
NM_006846.3(SPINK5):c.2326del (p.Glu776fs)	SPINK5	E776fs	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430175	5	147499584	5	148120021	430175	421528	rs1131691815	NC_000005.10:148120020:G:
NM_006846.3(SPINK5):c.389_392dup (p.Leu132fs)	SPINK5		not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000418503	5	147466073 - 147466074	5	148086510 - 148086511	418503	406655	rs756874525	NC_000005.10:148086510:GTGC:GTGCGTGC
NM_006846.3(SPINK5):c.2667-1G>A	SPINK5		not provided	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000392407	5	147504327	5	148124764	392407	367974	rs1057524476	NC_000005.10:148124763:G:A
NM_006846.3(SPINK5):c.2622T>A (p.Tyr874Ter)	SPINK5	Y874*	not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000379560	5	147503479	5	148123916	379560	368431	rs1057520643	NC_000005.10:148123915:T:A
NM_021942.6(TRAPPC11):c.2407C>T (p.Gln803Ter)	TRAPPC11	Q803*	not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000373300	4	184615090	4	183693937	373300	359611	rs780139133	NC_000004.12:183693936:C:T
NM_006846.3(SPINK5):c.882+2T>C	SPINK5		not provided	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000373039	5	147475470	5	148095907	373039	359551	rs1057518161	NC_000005.10:148095906:T:C
NM_006846.3(SPINK5):c.2240+1G>A	SPINK5		not provided	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000372517	5	147498128	5	148118565	372517	359556	rs775341740	NC_000005.10:148118564:G:A
NM_006846.3(SPINK5):c.2467A>T (p.Lys823Ter)	SPINK5	K823*	not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000280272	5	147499883	5	148120320	280272	264222	rs886041508	NC_000005.10:148120319:A:T
NM_006846.3(SPINK5):c.2264dup (p.Asn755fs)	SPINK5		not provided	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000279899	5	147498566 - 147498567	5	148119003 - 148119004	279899	264220	rs748978134	NC_000005.10:148119003:AAAAAA:AAAAAAA
NM_006846.3(SPINK5):c.136C>T (p.Gln46Ter)	SPINK5	Q46*	not provided	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000265441	5	147449940	5	148070377	265441	259812	rs886039547	NC_000005.10:148070376:C:T
NM_006846.4(SPINK5):c.2671C>T (p.Arg891Ter)	SPINK5	R891*	Netherton syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000852460	5	147504332	5	148124769	852460	830450		NC_000005.10:148124768:C:T
NM_006846.4(SPINK5):c.1825C>T (p.Gln609Ter)	SPINK5	Q609*	Netherton syndrome	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000843075	5	147492435	5	148112872	843075	830444		NC_000005.10:148112871:C:T
NM_006846.4(SPINK5):c.1012C>T (p.Gln338Ter)	SPINK5	Q338*	Netherton syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000835174	5	147478798	5	148099235	835174	830434		NC_000005.10:148099234:C:T
NC_000004.12:g.(?_183663858)_(183712654_?)del	TRAPPC11		Limb-girdle muscular dystrophy, type 2S	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832412	4	184585011 - 184633807			832412	819466		
NM_006846.4(SPINK5):c.2579del (p.Lys860fs)	SPINK5	K860fs	Netherton syndrome	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000664791	5	147503434	5	148123871	664791	633572		NC_000005.10:148123870:AAA:AA
NM_006846.3(SPINK5):c.355_371delinsGACAACATATGACAACAGATGAC (p.Cys119_Lys124delinsAspAsnIleTer)	SPINK5		Netherton syndrome	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000661320	5	147466040 - 147466056	5	148086477 - 148086493	661320	633556		NC_000005.10:148086476:TGTGGCACAGATGGGAA:GACAACATATGACAACAGATGAC
NM_006846.4(SPINK5):c.374del (p.Thr125fs)	SPINK5	T125fs	Netherton syndrome	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000654217	5	147466059	5	148086496	654217	633557		NC_000005.10:148086495:C:
NM_006846.3(SPINK5):c.1915_1916del (p.Leu639fs)	SPINK5	L639fs	Netherton syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000645505	5	147493950 - 147493951	5	148114387 - 148114388	645505	633567		NC_000005.10:148114386:TTTT:TT
NM_006846.4(SPINK5):c.850del (p.Glu284fs)	SPINK5	E284fs	Netherton syndrome	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000639460	5	147475436	5	148095873	639460	633561		NC_000005.10:148095872:G:
NM_006846.3(SPINK5):c.995del (p.Met332fs)	SPINK5	M332fs	Netherton syndrome	Pathogenic(Last reviewed: Apr 8, 2019)	no assertion criteria provided	VCV000625167	5	147477542	5	148097979	625167	613510	rs1561686960	NC_000005.10:148097978:T:
NM_006846.3(SPINK5):c.1816_1820+21delinsCT	SPINK5		Netherton syndrome	Pathogenic(Last reviewed: Apr 8, 2019)	no assertion criteria provided	VCV000625166	5	147491454 - 147491479	5	148111891 - 148111916	625166	613509	rs1561695740	NC_000005.10:148111890:TTCTTGTGAGTGGGCGGCAGCCACTG:CT
NM_006846.3(SPINK5):c.354_357del (p.Cys119fs)	SPINK5	C119fs	Netherton syndrome	Pathogenic(Last reviewed: Apr 8, 2019)	no assertion criteria provided	VCV000625164	5	147466036 - 147466039	5	148086473 - 148086476	625164	613507	rs1561680487	NC_000005.10:148086472:TGTTTGT:TGT
NM_006846.3(SPINK5):c.690del (p.Lys230fs)	SPINK5	K230fs	Netherton syndrome	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000570884	5	147473936	5	148094373	570884	564888	rs1561684604	NC_000005.10:148094372:AAAAA:AAAA
NM_006846.3(SPINK5):c.1437del (p.Glu480fs)	SPINK5	E480fs	Netherton syndrome	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000529155	5	147484520	5	148104957	529155	521106	rs1554104853	NC_000005.10:148104956:AA:A
NM_021942.6(TRAPPC11):c.1893+3A>G	TRAPPC11		Limb-girdle muscular dystrophy, type 2S	Pathogenic(Last reviewed: Sep 25, 2018)	no assertion criteria provided	VCV000268055	4	184607904	4	183686751	268055	263498	rs886041053	NC_000004.12:183686750:A:G
NM_021942.6(TRAPPC11):c.661-1G>T	TRAPPC11		Limb-girdle muscular dystrophy, type 2S	Pathogenic(Last reviewed: Sep 25, 2018)	no assertion criteria provided	VCV000268054	4	184596316	4	183675163	268054	263497	rs886041052	NC_000004.12:183675162:G:T
NM_006846.3(SPINK5):c.283-2A>T	SPINK5		Netherton syndrome	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005267	5	147465966	5	148086403	5267	20306	rs587777749	NC_000005.10:148086402:A:T
NM_006846.3(SPINK5):c.2368C>T (p.Arg790Ter)	SPINK5	R790*	Netherton syndrome	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000005266	5	147499626	5	148120063	5266	20305	rs121908387	NC_000005.10:148120062:C:T
NM_006846.3(SPINK5):c.1089T>G (p.Tyr363Ter)	SPINK5	Y363*	Netherton syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000646119	5	147478875	5	148099312	646119	633562		NC_000005.10:148099311:T:G
NM_006846.3(SPINK5):c.2468del (p.Lys823fs)	SPINK5	K823fs	not provided|Netherton syndrome	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000523932	5	147499875	5	148120312	523932	514505	rs565782662	NC_000005.10:148120311:AAAAAAAAAA:AAAAAAAAA
NM_021942.6(TRAPPC11):c.142C>T (p.Arg48Ter)	TRAPPC11	R48*	Limb-girdle muscular dystrophy, type 2S	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000375391	4	184585162	4	183664009	375391	362142	rs150331292	NC_000004.12:183664008:C:T
NM_024582.4(FAT4):c.7123G>A (p.Glu2375Lys)	FAT4	E2375K	Hennekam lymphangiectasia-lymphedema syndrome 2|Van Maldergem syndrome 2	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000089006	4	126355504	4	125434349	89006	94560	rs398122955	NC_000004.12:125434348:G:A
NM_006846.3(SPINK5):c.1888-1G>A	SPINK5		Netherton syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000654917	5	147493924	5	148114361	654917	651315		NC_000005.10:148114360:G:A
NM_021942.6(TRAPPC11):c.2168dup (p.Lys724fs)	TRAPPC11		Limb-girdle muscular dystrophy, type 2S|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000450724	4	184614228 - 184614229	4	183693075 - 183693076	450724	443602	rs1554009901	NC_000004.12:183693075:TTT:TTTT
NM_006846.3(SPINK5):c.652C>T (p.Arg218Ter)	SPINK5	R218*	Netherton syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000351517	5	147470777	5	148091214	351517	301638	rs199757347	NC_000005.10:148091213:C:T
NM_006846.3(SPINK5):c.2468dup (p.Lys824fs)	SPINK5		not provided|Netherton syndrome	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000005268	5	147499874 - 147499875	5	148120311 - 148120312	5268	20307	rs565782662	NC_000005.10:148120311:AAAAAAAAAA:AAAAAAAAAAA
NM_020928.2(ZSWIM6):c.3487C>T (p.Arg1163Trp)	ZSWIM6	R1163W	Inborn genetic diseases|Acromelic frontonasal dysostosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000155772	5	60839983	5	61544156	155772	165524	rs587777695	NC_000005.10:61544155:C:T
NM_001127698.2(SPINK5):c.2557C>T (p.Arg853Ter)	SPINK5	R853*	Netherton syndrome	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623372	5	147503414	5	148123851	623372	612271	rs753621591	NC_000005.10:148123850:C:T
NM_006846.3(SPINK5):c.81+2T>A	SPINK5		not provided|Netherton syndrome	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429608	5	147444937	5	148065374	429608	421527	rs1131691490	NC_000005.10:148065373:T:A
NM_001371596.2(MFSD8):c.863+1G>A	MFSD8		|Late-infantile neuronal ceroid lipofuscinosis	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504888	4	128854139	4	127932984	504888	496375	rs200319160	NC_000004.12:127932983:C:T
NM_152778.3(MFSD8):c.881C>A (p.Thr294Lys)	MFSD8	T294K, T189K, T227K		Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001006	4	128851955	4	127930800	1006	16045	rs140948465	NC_000004.12:127930799:G:T
NM_005321.2(H1-4):c.430dup (p.Ala144fs)	H1-4		Inborn genetic diseases|not provided|RAHMAN SYNDROME	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428605	6	26157043 - 26157044	6	26156815 - 26156816	428605	420424	rs1131690805	NC_000006.12:26156815:GGGGG:GGGGGG
NM_006846.3(SPINK5):c.1302+4A>T	SPINK5		not provided|Netherton syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279898	5	147481003	5	148101440	279898	264202	rs201269335	NC_000005.10:148101439:A:T
NM_000404.4(GLB1):c.817_818delinsCT (p.Trp273Leu)	GLB1		Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000568792	3	33093471 - 33093472	3	33051979 - 33051980	568792	559427	rs1559401428	NC_000003.12:33051978:CA:AG
NM_000404.4(GLB1):c.1646C>T (p.Pro549Leu)	GLB1	P549L, P519L, P418L, P597L	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426185	3	33055636	3	33014144	426185	414933	rs776327443	NC_000003.12:33014143:G:A
NM_016955.4(SEPSECS):c.612dup (p.Val205fs)	SEPSECS		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000522119	4	25156708 - 25156709	4	25155086 - 25155087	522119	511536	rs1553881510	NC_000004.12:25155086:T:TT
NM_000187.4(HGD):c.1102A>G (p.Met368Val)	HGD	M368V	Alkaptonuria	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003173	3	120352080	3	120633233	3173	18212	rs120074173	NC_000003.12:120633232:T:C
NM_152618.3(BBS12):c.1115_1116del (p.Gly371_Phe372insTer)	BBS12		Retinal dystrophy|not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001151	4	123664161 - 123664162	4	122743006 - 122743007	1151	16190	rs587777803	NC_000004.12:122743005:TTT:T
NM_052995.2(CLRN1):c.300T>G (p.Tyr100Ter)	CLRN1	Y176*, Y100*, Y189*	Usher syndrome, type 3A|not provided|Rare genetic deafness	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004392	3	150645894	3	150928107	4392	19431	rs121908140	NC_000003.12:150928106:A:C
NM_000532.5(PCCB):c.1534C>T (p.Arg512Cys)	PCCB	R512C, R532C	Propionic acidemia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000038879	3	136048782	3	136329940	38879	47482	rs186710233	NC_000003.12:136329939:C:T
NM_000440.3(PDE6A):c.769C>T (p.Arg257Ter)	PDE6A	R257*	Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437984	5	149310680	5	149931117	437984	431681	rs146591309	NC_000005.10:149931116:G:A
NM_018834.6(MATR3):c.254C>G (p.Ser85Cys)	MATR3	S85C	Amyotrophic lateral sclerosis 21|not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014002	5	138643358	5	139307669	14002	29041	rs121434591	NC_000005.10:139307668:C:G
NM_000297.4(PKD2):c.203dup (p.Ala69fs)	PKD2		Polycystic kidney disease, autosomal dominant|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000477627	4	88929082 - 88929083	4	88007930 - 88007931	477627	454029	rs1187336837	NC_000004.12:88007930:CCCCCC:CCCCCCC
NM_006790.2(MYOT):c.179C>T (p.Ser60Phe)	MYOT	S60F	not provided|Myofibrillar myopathy 3	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005837	5	137206519	5	137870830	5837	20876	rs121908458	NC_000005.10:137870829:C:T
NM_006790.2(MYOT):c.179C>G (p.Ser60Cys)	MYOT	S60C	Myofibrillar myopathy|not provided|Myofibrillar myopathy 3	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005836	5	137206519	5	137870830	5836	20875	rs121908458	NC_000005.10:137870829:C:G
NM_021942.6(TRAPPC11):c.1192C>T (p.Arg398Ter)	TRAPPC11	R398*	Limb-girdle muscular dystrophy, type 2S|Limb-girdle muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000474342	4	184603963	4	183682810	474342	453359	rs140403642	NC_000004.12:183682809:C:T
NM_021942.6(TRAPPC11):c.2938G>A (p.Gly980Arg)	TRAPPC11	G980R	Limb-girdle muscular dystrophy, type 2S	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000060510	4	184622936	4	183701783	60510	75097	rs397509417	NC_000004.12:183701782:G:A
FANCD2, EX17 DEL	FANCD2		Fanconi anemia, complementation group D2	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000012042					12042	27081		
FANCD2, 376A-G	FANCD2		Fanconi anemia, complementation group D2	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000012039					12039	27078		
NM_172250.3(MMAA):c.593_596del (p.Thr198fs)	MMAA	T198fs	Vitamin B12-responsive methylmalonic acidemia type cblA|not provided|Methylmalonic acidemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203815	4	146567165 - 146567168	4	145646013 - 145646016	203815	200054	rs796051993	NC_000004.12:145646012:TGACTGA:TGA
NM_033084.4(FANCD2):c.-33-?_1098+?del	FANCD2		Fanconi anemia	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000254088					254088	248486		
NM_003722.5(TP63):c.1010G>A (p.Arg337Gln)	TP63	R298Q, R337Q, R158Q, R243Q, R335Q	ADULT syndrome|TP63-Related Spectrum Disorders	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000006540	3	189586386	3	189868597	6540	21579	rs113993967	NC_000003.12:189868596:G:A
NM_000404.4(GLB1):c.1768C>T (p.Arg590Cys)	GLB1	R590C, R560C, R459C, R638C	Infantile GM1 gangliosidosis|not provided|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194596	3	33038803	3	32997311	194596	191759	rs794727165	NC_000003.12:32997310:G:A
NM_000404.4(GLB1):c.1051C>T (p.Arg351Ter)	GLB1	R351*, R321*, R399*, R220*	Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|GM1-gangliosidosis, type I, with cardiac involvement|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000941	3	33087629	3	33046137	941	15980	rs72555372	NC_000003.12:33046136:G:A
NM_000404.4(GLB1):c.1369C>T (p.Arg457Ter)	GLB1	R457*, R427*, R326*, R505*	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000924	3	33058311	3	33016819	924	15963	rs72555359	NC_000003.12:33016818:G:A
NM_001127698.2(SPINK5):c.891C>T (p.Cys297=)	SPINK5		not provided|Netherton syndrome|Increased IgE level|Erythroderma	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374066	5	147477438	5	148097875	374066	360867	rs752941297	NC_000005.10:148097874:C:T
NM_005219.5(DIAPH1):c.3637C>T (p.Arg1213Ter)	DIAPH1	R1213*, R1204*	Rare genetic deafness|not provided|Deafness, autosomal dominant 1	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228577	5	140903734	5	141524167	228577	229284	rs876657776	NC_000005.10:141524166:G:A
NM_000532.5(PCCB):c.337C>T (p.Arg113Ter)	PCCB	R113*	Propionic acidemia|not provided	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265422	3	135975430	3	136256588	265422	259751	rs186031457	NC_000003.12:136256587:C:T
NM_000337.5(SGCD):c.443T>A (p.Leu148Ter)	SGCD	L148*, L147*	not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000286720	5	156022002	5	156594992	286720	270957	rs886043460	NC_000005.10:156594991:T:A
NM_000337.5(SGCD):c.65dup (p.Tyr23fs)	SGCD		not provided	Pathogenic(Last reviewed: Dec 9, 2015)	criteria provided, single submitter	VCV000285158	5	155771559 - 155771560	5	156344549 - 156344550	285158	269395	rs886043031	NC_000005.10:156344549:T:TT
SGCD, 3-BP DEL, 710AGA/711GAA	SGCD		Dilated cardiomyopathy 1L	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008175					8175	23214		
NC_000005.9:g.(?_155338082)_(156186411_?)del	SGCD		Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000832673	5	155338082 - 156186411			832673	819640		
NM_000337.5(SGCD):c.74_77dup (p.Ile27fs)	SGCD		Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000411697	5	155771566 - 155771567	5	156344556 - 156344557	411697	394836	rs1554094947	NC_000005.10:156344556:GGTGGG:GGTGGGTGGG
NM_000337.5(SGCD):c.391G>C (p.Ala131Pro)	SGCD	A131P, A130P	Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008177	5	156021950	5	156594940	8177	23216	rs267607045	NC_000005.10:156594939:G:C
NM_000337.5(SGCD):c.784G>A (p.Glu262Lys)	SGCD	E262K, E261K	Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000008174	5	156186312	5	156759301	8174	23213	rs121909297	NC_000005.10:156759300:G:A
NM_000337.5(SGCD):c.89G>A (p.Trp30Ter)	SGCD	W30*, W29*	Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000008173	5	155771584	5	156344574	8173	23212	rs121909296	NC_000005.10:156344573:G:A
NM_000337.5(SGCD):c.657del (p.Thr220fs)	SGCD	T219fs, T220fs	Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000008171	5	156184672	5	156757661	8171	23210		NC_000005.10:156757660:CC:C
NC_000005.9:g.(?_156184572)_(156186421_?)del	SGCD		Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000584277	5	156184572 - 156186421	5	156757561 - 156759410	584277	559835		
NC_000005.10:g.(?_156329567)_(156344687_?)del	SGCD		Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000831480	5	155756577 - 155771697			831480	819568		
NM_000297.4(PKD2):c.973C>T (p.Arg325Ter)	PKD2	R325*	Polycystic kidney disease, autosomal dominant|not provided|Polycystic kidney disease 2	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411870	4	88959532	4	88038380	411870	394265	rs1060503526	NC_000004.12:88038379:C:T
NM_152778.3(MFSD8):c.754+2T>A	MFSD8		|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065897	4	128859936	4	127938781	65897	76805	rs587778809	NC_000004.12:127938780:A:T
NM_004453.4(ETFDH):c.250G>A (p.Ala84Thr)	ETFDH	A84T, A23T, A37T	Glutaric aciduria, type 2|Glutaric acidemia IIC|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012028	4	159603421	4	158682269	12028	27067	rs121964954	NC_000004.12:158682268:G:A
NM_001127178.3(PIGG):c.1579_1580delinsG (p.Thr527fs)	PIGG		not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000817494	4	515695 - 515696	4	521906 - 521907	817494	805399		NC_000004.12:521905:AC:G
NM_001127178.3(PIGG):c.1163G>A (p.Trp388Ter)	PIGG	W388*, W255*, W45*, W266*, W299*, W30*	not provided	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000620287	4	514893	4	521104	620287	611613	rs1560330387	NC_000004.12:521103:G:A
NM_001127178.3(PIGG):c.342dup (p.Thr115fs)	PIGG		not provided	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	VCV000280494	4	494370 - 494371	4	500581 - 500582	280494	264209	rs886041687	NC_000004.12:500581:TT:TTT
NM_001127178.3(PIGG):c.1740_1743del (p.Phe580fs)	PIGG	F237fs, F447fs, F491fs, F572fs, F69fs, F214fs, F483fs, F580fs	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000837041	4	517370 - 517373	4	523581 - 523584	837041	829214		NC_000004.12:523580:CTTCCTT:CTT
NM_001127178.3(PIGG):c.1489dup (p.Ser497fs)	PIGG		Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000661596	4	515603 - 515604	4	521814 - 521815	661596	632245		NC_000004.12:521814:TT:TTT
NM_001127178.3(PIGG):c.2569C>T (p.Gln857Ter)	PIGG	Q724*, Q346*, Q849*, Q514*, Q491*, Q760*, Q768*, Q857*	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000654965	4	524532	4	530743	654965	632255		NC_000004.12:530742:C:T
NM_001127178.3(PIGG):c.2261+1G>C	PIGG		Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225639	4	521020	4	527231	225639	227473	rs869320773	NC_000004.12:527230:G:C
NM_001127178.3(PIGG):c.928C>T (p.Gln310Ter)	PIGG	Q310*, Q188*, Q221*, Q177*	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225637	4	509788	4	515999	225637	227471	rs869320772	NC_000004.12:515998:C:T
NM_001127178.3(PIGG):c.910C>T (p.Arg304Ter)	PIGG	R215*, R171*, R182*, R304*	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000807654	4	509770	4	515981	807654	798542		NC_000004.12:515980:C:T
NM_001127178.3(PIGG):c.2624_2625del (p.Gly874_Leu875insTer)	PIGG		not provided|Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000646604	4	527659 - 527660	4	533870 - 533871	646604	632257		NC_000004.12:533869:TA:
NM_001127178.3(PIGG):c.1515G>A (p.Trp505Ter)	PIGG	W505*, W139*, W162*, W408*, W497*, W372*, W416*	not provided|Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476318	4	515631	4	521842	476318	453992	rs150259543	NC_000004.12:521841:G:A
NM_001127178.3(PIGG):c.2005C>T (p.Arg669Cys)	PIGG	R669C, R303C, R326C, R661C, R158C, R536C, R572C, R580C	Hyperphosphatasia with mental retardation syndrome 1|Mental retardation, autosomal recessive 53	Pathogenic	criteria provided, single submitter	VCV000225638	4	517638	4	523849	225638	227472	rs372392424	NC_000004.12:523848:C:T
NM_198586.3(NHLRC1):c.205C>G (p.Pro69Ala)	NHLRC1	P69A	not provided|Lafora disease|Epilepsy, progressive myoclonic 2b	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002587	6	18122633	6	18122402	2587	17626	rs28940576	NC_000006.12:18122401:G:C
NM_000440.3(PDE6A):c.1268del (p.Ser422_Leu423insTer)	PDE6A		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000521415	5	149278065	5	149898502	521415	511577	rs1456336365	NC_000005.10:149898501:AAA:AA
NM_006218.4(PIK3CA):c.2646dup (p.Asp883fs)	PIK3CA		not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000422905	3	178947207 - 178947208	3	179229419 - 179229420	422905	406152	rs1553825266	NC_000003.12:179229419:AAA:AAAA
NM_006218.4(PIK3CA):c.3131A>G (p.Asn1044Ser)	PIK3CA	N1044S	not provided	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000419390	3	178952076	3	179234288	419390	406155	rs1064793838	NC_000003.12:179234287:A:G
NM_006218.4(PIK3CA):c.278G>A (p.Arg93Gln)	PIK3CA	R93Q	not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000419128	3	178916891	3	179199103	419128	406148	rs1064793663	NC_000003.12:179199102:G:A
NM_006218.4(PIK3CA):c.323G>A (p.Arg108His)	PIK3CA	R108H	not provided	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000280875	3	178916936	3	179199148	280875	264121	rs886042002	NC_000003.12:179199147:G:A
NM_006218.4(PIK3CA):c.248T>C (p.Phe83Ser)	PIK3CA	F83S	Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth	Pathogenic(Last reviewed: Oct 9, 2018)	no assertion criteria provided	VCV000585023	3	178916861	3	179199073	585023	576075	rs1560137208	NC_000003.12:179199072:T:C
NM_006218.4(PIK3CA):c.335T>A (p.Ile112Asn)	PIK3CA	I112N		Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218236	3	178916948	3	179199160	218236	214867	rs863225460	NC_000003.12:179199159:T:A
NM_006218.4(PIK3CA):c.1895T>G (p.Leu632Ter)	PIK3CA	L632*	Cowden syndrome 5	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000156452	3	178937507	3	179219719	156452	166224	rs587777796	NC_000003.12:179219718:T:G
NM_006218.4(PIK3CA):c.1066G>A (p.Val356Ile)	PIK3CA	V356I	Cowden syndrome 5	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000156449	3	178922297	3	179204509	156449	166221	rs587777793	NC_000003.12:179204508:G:A
NM_006218.4(PIK3CA):c.652G>A (p.Glu218Lys)	PIK3CA	E218K	Cowden syndrome 5	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000156448	3	178919167	3	179201379	156448	166220	rs587777792	NC_000003.12:179201378:G:A
NM_006218.4(PIK3CA):c.403G>A (p.Glu135Lys)	PIK3CA	E135K	Cowden syndrome 5	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000156447	3	178917528	3	179199740	156447	166219	rs587777791	NC_000003.12:179199739:G:A
NM_021942.6(TRAPPC11):c.1287+5G>A	TRAPPC11		Limb-girdle muscular dystrophy, type 2S|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060511	4	184605212	4	183684059	60511	75098	rs397509418	NC_000004.12:183684058:G:A
NM_198903.2(GABRG2):c.316G>A (p.Ala106Thr)	GABRG2	A106T	not provided|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74|Epilepsy, childhood absence 2|Familial febrile seizures 8	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205541	5	161522557	5	162095551	205541	201880	rs796052505	NC_000005.10:162095550:G:A
PIK3CA, ARG115PRO	PIK3CA	R115P	Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|MACRODACTYLY, SOMATIC	Pathogenic(Last reviewed: Oct 10, 2018)	no assertion criteria provided	VCV000585022					585022	576074		
NM_006218.4(PIK3CA):c.1356_1358AGA[1] (p.Glu453del)	PIK3CA	E453del	|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000039706	3	178928078 - 178928080	3	179210290 - 179210292	39706	48305	rs587776933	NC_000003.12:179210289:AGAAGA:AGA
NM_006218.4(PIK3CA):c.3203dup (p.Asn1068fs)	PIK3CA		Neoplasm of stomach|Hepatocellular carcinoma	Pathogenic(Last reviewed: Feb 17, 2005)	no assertion criteria provided	VCV000013658	3	178952146 - 178952147	3	179234358 - 179234359	13658	28697	rs587776802	NC_000003.12:179234358:AA:AAA
NM_006567.5(FARS2):c.801C>G (p.Tyr267Ter)	FARS2	Y267*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000522083	6	5431302	6	5431069	522083	511685	rs761709212	NC_000006.12:5431068:C:G
NM_000337.5(SGCD):c.493C>T (p.Arg165Ter)	SGCD	R165*, R164*	Dilated cardiomyopathy 1L|Autosomal recessive limb-girdle muscular dystrophy type 2F|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2F	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008172	5	156022052	5	156595042	8172	23211	rs121909295	NC_000005.10:156595041:C:T
NM_006218.4(PIK3CA):c.3073A>G (p.Thr1025Ala)	PIK3CA	T1025A	Non-small cell lung cancer	Pathogenic(Last reviewed: Aug 10, 2011)	criteria provided, single submitter	VCV000045467	3	178952018	3	179234230	45467	54634	rs397517202	NC_000003.12:179234229:A:G
NM_000128.4(F11):c.1449del (p.Leu483fs)	F11	L483fs	not provided	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000838891	4	187206936	4	186285782	838891	829030		NC_000004.12:186285781:G:
NM_000128.4(F11):c.449_450del (p.Thr150fs)	F11	T150fs	not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000835116	4	187195393 - 187195394	4	186274239 - 186274240	835116	829029		NC_000004.12:186274238:CG:
NC_000004.12:g.(?_186265841)_(186288624_?)del	F11		not provided	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000833376	4	187186995 - 187209778			833376	819473		
NM_000128.3(F11):c.1275_1281dup (p.Thr428fs)	F11		not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000659228	4	187205384 - 187205385	4	186284230 - 186284231	659228	632139		NC_000004.12:186284230:GATATTA:GATATTAGATATTA
NM_000128.3(F11):c.326-1G>A	F11		Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000371555	4	187195269	4	186274115	371555	357341	rs1057517364	NC_000004.12:186274114:G:A
F11, DEL	F11		Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000011905					11905	26944		
NM_000128.3(F11):c.1289C>T (p.Ala430Val)	F11	A412V, A430V	Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000011899	4	187205399	4	186284245	11899	26938	rs121965068	NC_000004.12:186284244:C:T
NM_000128.3(F11):c.1211C>A (p.Thr404Asn)	F11	T386N, T404N	Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000011897	4	187205321	4	186284167	11897	26936	rs121965067	NC_000004.12:186284166:C:A
NM_000128.3(F11):c.1378T>G (p.Phe460Val)	F11	F442V, F460V	Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000011895	4	187206865	4	186285711	11895	26934	rs121965065	NC_000004.12:186285710:T:G
NM_001354804.2(F11):c.*1G>C	F11		Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Mar 15, 1995)	no assertion criteria provided	VCV000011894	4	187195434	4	186274280	11894	26933		NC_000004.12:186274279:G:C
NM_000128.3:c.1029-2A>G	F11		Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Mar 15, 1995)	no assertion criteria provided	VCV000011893	4	187201626	4	186280472	11893	26932		NC_000004.12:186280471:A:G
NM_000128.3(F11):c.365G>A (p.Gly122Asp)	F11	G122D	Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627202	4	187195309	4	186274155	627202	615397		NC_000004.12:186274154:G:A
NM_000128.3(F11):c.802C>T (p.Arg268Cys)	F11	R268C	Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627142	4	187201212	4	186280058	627142	615401		NC_000004.12:186280057:C:T
NM_000128.3(F11):c.1234C>T (p.Gln412Ter)	F11	Q412*	Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554679	4	187205344	4	186284190	554679	543410	rs538083600	NC_000004.12:186284189:C:T
NM_000128.3(F11):c.755+2T>C	F11		Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552888	4	187197546	4	186276392	552888	543401	rs1220869989	NC_000004.12:186276391:T:C
NM_000128.3(F11):c.1107C>A (p.Tyr369Ter)	F11	Y369*	Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189115	4	187201706	4	186280552	189115	186690	rs773905328	NC_000004.12:186280551:C:A
NM_000356.4(TCOF1):c.4133_4137AAGAA[1] (p.Lys1380fs)	TCOF1		Treacher Collins syndrome 1|not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003963	5	149777936 - 149777940	5	150398373 - 150398377	3963	19002	rs587776582	NC_000005.10:150398372:AAAAGAAAAGAA:AAAAGAA
NM_000187.4(HGD):c.481G>A (p.Gly161Arg)	HGD	G161R	Alkaptonuria	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003168	3	120365888	3	120647041	3168	18207	rs28941783	NC_000003.12:120647040:C:T
NM_000128.3(F11):c.1288G>A (p.Ala430Thr)	F11	A430T	not provided|Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291081	4	187205398	4	186284244	291081	275318	rs753909969	NC_000004.12:186284243:G:A
NM_000128.3(F11):c.67C>T (p.Gln23Ter)	F11	Q23*	not provided|Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189122	4	187192774	4	186271620	189122	186680	rs768409400	NC_000004.12:186271619:C:T
NM_000344.3(SMN1):c.5C>G (p.Ala2Gly)	SMN1	A2G	Kugelberg-Welander disease|not provided|Spinal muscular atrophy, type II	Pathogenic(Last reviewed: Dec 31, 2016)	criteria provided, multiple submitters, no conflicts	VCV000009168	5	70220935	5	70925108	9168	24207	rs1554066397	NC_000005.10:70925107:C:G
NM_000128.3(F11):c.841C>T (p.Gln281Ter)	F11	Q281*	not provided|Hereditary factor XI deficiency disease	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449563	4	187201251	4	186280097	449563	443610	rs770505620	NC_000004.12:186280096:C:T
NM_000404.4(GLB1):c.1325G>A (p.Arg442Gln)	GLB1	R442Q, R311Q, R490Q, R412Q	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000528328	3	33059962	3	33018470	528328	519256	rs564428355	NC_000003.12:33018469:C:T
NM_000404.4(GLB1):c.841C>T (p.His281Tyr)	GLB1	H281Y, H329Y, H150Y, H251Y	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372371	3	33093448	3	33051956	372371	359418	rs745386663	NC_000003.12:33051955:G:A
NM_000404.4(GLB1):c.1733A>G (p.Lys578Arg)	GLB1	K578R, K548R, K626R, K447R	GM1 gangliosidosis type 2||Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252985	3	33055549	3	33014057	252985	247388	rs371582179	NC_000003.12:33014056:T:C
NM_000404.4(GLB1):c.1577dup (p.Trp527fs)	GLB1		GLB1-Related Disorders|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000202191	3	33055704 - 33055705	3	33014212 - 33014213	202191	198618	rs794729217	NC_000003.12:33014212:CCCCCC:CCCCCCC
NM_003722.5(TP63):c.797G>A (p.Arg266Gln)	TP63	R227Q, R266Q, R264Q, R172Q, R87Q	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3|not provided|ADULT syndrome	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000006550	3	189584501	3	189866712	6550	21589	rs121908849	NC_000003.12:189866711:G:A
NM_000128.3(F11):c.1136-7_1136-4del	F11		Hereditary factor XI deficiency disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555987	4	187205239 - 187205242	4	186284085 - 186284088	555987	543105	rs1439195599	NC_000004.12:186284084:GTTG:
NM_000128.3(F11):c.408C>A (p.Cys136Ter)	F11	C136*	Hereditary factor XI deficiency disease|Abnormal bleeding	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188914	4	187195352	4	186274198	188914	186683	rs143648758	NC_000004.12:186274197:C:A
NM_005199.5(CHRNG):c.117dup (p.Asn40fs)	CHRNG		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000195239	2	233404759 - 233404760	2	232540049 - 232540050	195239	192400	rs797044677	NC_000002.12:232540049:CCCC:CCCCC
NM_000532.5(PCCB):c.1218_1231delinsTAGAGCACAGGA (p.Gly407fs)	PCCB		Propionic acidemia|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038875	3	136046016 - 136046029	3	136327174 - 136327187	38875	47478	rs397507445	NC_000003.12:136327173:GGGCATCATCCGGC:TAGAGCACAGGA
NM_000532.5(PCCB):c.1304A>G (p.Tyr435Cys)	PCCB	Y435C, Y455C	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012018	3	136046480	3	136327638	12018	27057	rs121964961	NC_000003.12:136327637:A:G
NM_014159.7(SETD2):c.1046_1047GA[1] (p.Asp350fs)	SETD2		not provided	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000817106	3	47165077 - 47165078	3	47123587 - 47123588	817106	805353		NC_000003.12:47123586:TCTCT:TCT
NM_014159.6(SETD2):c.4997A>G (p.Tyr1666Cys)	SETD2	Y1666C, Y1622C	Luscan-lumish syndrome|Genetic syndrome with a Dandy-Walker malformation as major feature|Ventriculomegaly	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632591	3	47142966	3	47101476	632591	621022	rs1559720382	NC_000003.12:47101475:T:C
NM_014159.6(SETD2):c.2742_2743dup (p.Lys915fs)	SETD2		not provided	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000418818	3	47163382 - 47163383	3	47121892 - 47121893	418818	406315	rs1553700642	NC_000003.12:47121892:TA:TATA
NM_014159.6(SETD2):c.4774C>T (p.Arg1592Ter)	SETD2	R1592*, R1548*	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000373426	3	47147552	3	47106062	373426	359539	rs1057518410	NC_000003.12:47106061:G:A
NM_014159.6(SETD2):c.7438_7439insG (p.Gln2480fs)	SETD2		not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000633526	3	47059222 - 47059223	3	47017732 - 47017733	633526	621955	rs1559634490	NC_000003.12:47017732::C
NM_014159.6(SETD2):c.2028del (p.Pro677fs)	SETD2	P633fs, P677fs	Luscan-lumish syndrome	Pathogenic(Last reviewed: Oct 21, 2016)	no assertion criteria provided	VCV000222956	3	47164098	3	47122608	222956	224675	rs869025572	NC_000003.12:47122607:A:
NM_014159.6(SETD2):c.820C>T (p.Gln274Ter)	SETD2	Q274*, Q230*	Luscan-lumish syndrome	Pathogenic(Last reviewed: Oct 21, 2016)	no assertion criteria provided	VCV000222955	3	47165306	3	47123816	222955	224674	rs869025571	NC_000003.12:47123815:G:A
NM_014159.6(SETD2):c.5444T>G (p.Leu1815Trp)	SETD2	L1815W, L1771W	Luscan-lumish syndrome	Pathogenic(Last reviewed: Oct 21, 2016)	no assertion criteria provided	VCV000222954	3	47125826	3	47084336	222954	224673	rs869025570	NC_000003.12:47084335:A:C
NM_014159.6(SETD2):c.6341del (p.Asn2114fs)	SETD2	N2070fs, N2114fs	Luscan-lumish syndrome	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000222953	3	47098933	3	47057443	222953	224672	rs869025569	NC_000003.12:47057442:TT:T
NM_152778.3(MFSD8):c.1444C>T (p.Arg482Ter)	MFSD8	R482*, R377*, R415*	|not provided|Macular dystrophy with central cone involvement|	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162382	4	128841898	4	127920743	162382	172085	rs724159971	NC_000004.12:127920742:G:A
NM_006790.2(MYOT):c.164C>T (p.Ser55Phe)	MYOT	S55F	Progressive distal muscle weakness|Progressive proximal muscle weakness|Lower limb pain|Foot dorsiflexor weakness|Distal lower limb muscle weakness|Distal amyotrophy|EMG: myopathic abnormalities|Urinary bladder sphincter dysfunction|Muscle fiber inclusion bodies|Fatty replacement of skeletal muscle|Myofibrillar myopathy 3	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005835	5	137206504	5	137870815	5835	20874	rs121908457	NC_000005.10:137870814:C:T
NM_006790.2(MYOT):c.170C>T (p.Thr57Ile)	MYOT	T57I	not provided|Myofibrillar myopathy 3	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005834	5	137206510	5	137870821	5834	20873	rs28937597	NC_000005.10:137870820:C:T
NM_000539.3(RHO):c.491C>T (p.Ala164Val)	RHO	A164V	Congenital stationary night blindness, autosomal dominant 1|Retinitis pigmentosa|Cone-rod dystrophy	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000417867	3	129249848	3	129531005	417867	404762	rs104893793	NC_000003.12:129531004:C:T
NM_001145291.1(PDE6B):c.2116A>T (p.Lys706Ter)	PDE6B	K427*, K321*, K706*	Retinal dystrophy	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000866937	4	657997	4	664208	866937	856367		NC_000004.12:664207:A:T
NM_001145291.1(PDE6B):c.1954C>T (p.Gln652Ter)	PDE6B	Q652*, Q267*, Q373*	Retinal dystrophy	Pathogenic(Last reviewed: Feb 16, 2019)	criteria provided, single submitter	VCV000866296	4	657592	4	663803	866296	856365		NC_000004.12:663802:C:T
NM_001145291.1(PDE6B):c.2115_2116delinsAT (p.Lys706Ter)	PDE6B		Retinal dystrophy	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000865916	4	657996 - 657997	4	664207 - 664208	865916	856366		NC_000004.12:664206:GA:AT
NM_000283.3(PDE6B):c.1280G>A (p.Trp427Ter)	PDE6B	W427*, W42*, W148*	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000449303	4	651162	4	657373	449303	443631	rs771148614	NC_000004.12:657372:G:A
NC_000004.12:g.(?_625627)_(626094_?)del	PDE6B		not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000831390	4	619416 - 619883			831390	819497		
NM_000283.3(PDE6B):c.583A>T (p.Lys195Ter)	PDE6B	K195*	Retinitis pigmentosa 40	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560481	4	628580	4	634791	560481	551536	rs1212998897	NC_000004.12:634790:A:T
NM_001145291.1(PDE6B):c.1923_1971delinsTCTGGGTA (p.Asn643fs)	PDE6B		Retinitis pigmentosa 40	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560479	4	657561 - 657609	4	663772 - 663820	560479	551540	rs1560134806	NC_000004.12:663771:CCTGAACATCTACCAGAACCTGAACCGGCGGCAGCACGAGCACGTGATC:TCTGGGTA
NM_000283.3(PDE6B):c.1107+2dup	PDE6B		Retinitis pigmentosa 40	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560478	4	650082 - 650083	4	656293 - 656294	560478	551539	rs1560122302	NC_000004.12:656293:T:TT
NM_000283.3(PDE6B):c.1832+1G>T	PDE6B		Retinitis pigmentosa 40	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522405	4	656408	4	662619	522405	513054	rs370758397	NC_000004.12:662618:G:T
NM_001145291.1(PDE6B):c.169_239dup (p.Leu83fs)	PDE6B		Retinitis pigmentosa 40	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000013108	4	619583 - 619584	4	625794 - 625795	13108	28147	rs1553801591	
NM_000283.3(PDE6B):c.1488del (p.Thr497fs)	PDE6B	T112fs, T218fs, T497fs	Retinitis pigmentosa 40	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000013105	4	654274	4	660485	13105	28144	rs730880317	NC_000004.12:660484:CCC:CC
NM_000283.3(PDE6B):c.1591C>T (p.Arg531Ter)	PDE6B	R531*, R146*, R252*	Retinitis pigmentosa 40	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000013104	4	654379	4	660590	13104	28143	rs121918580	NC_000004.12:660589:C:T
NM_000283.3(PDE6B):c.1921-9C>G	PDE6B		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812372	4	657550	4	663761	812372	800688		NC_000004.12:663760:C:G
NM_000283.3(PDE6B):c.1417del (p.Leu473fs)	PDE6B	L88fs, L194fs, L473fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812371	4	652755	4	658966	812371	800502		NC_000004.12:658965:CC:C
NM_000283.3(PDE6B):c.428C>A (p.Ala143Asp)	PDE6B	A143D	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812370	4	619843	4	626054	812370	800501		NC_000004.12:626053:C:A
NM_001350154.2(PDE6B):c.1601+4T>A	PDE6B	Y535*, Y814*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802045	4	661734	4	667945	802045	790482		NC_000004.12:667944:T:A
NM_000283.3(PDE6B):c.2021+2T>G	PDE6B		Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802044	4	657661	4	663872	802044	790481		NC_000004.12:663871:T:G
NM_000283.3(PDE6B):c.2401C>T (p.Gln801Ter)	PDE6B	Q801*, Q522*, Q416*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620165	4	661693	4	667904	620165	611618	rs559964930	NC_000004.12:667903:C:T
NM_000283.3(PDE6B):c.1604T>A (p.Ile535Asn)	PDE6B	I535N, I150N, I256N	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143067	4	654392	4	660603	143067	152785	rs527236088	NC_000004.12:660602:T:A
NM_000283.3(PDE6B):c.1467+1G>C	PDE6B		Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143065	4	652807	4	659018	143065	152783	rs527236089	NC_000004.12:659017:G:C
NM_000283.3(PDE6B):c.2419T>A (p.Trp807Arg)	PDE6B	W807R, W422R, W528R	Retinitis pigmentosa 40	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000013109	4	661711	4	667922	13109	28148	rs121918583	NC_000004.12:667921:T:A
NM_000283.3(PDE6B):c.1699C>T (p.Gln567Ter)	PDE6B	Q567*, Q182*, Q288*	PDE6B-Related Disorders|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000632445	4	656007	4	662218	632445	620172	rs772057239	NC_000004.12:662217:C:T
NM_000283.3(PDE6B):c.1060-1G>T	PDE6B		Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191354	4	650033	4	656244	191354	189159	rs863223339	NC_000004.12:656243:G:T
NM_000283.3(PDE6B):c.1540del (p.Leu514fs)	PDE6B	L129fs, L514fs, L235fs	not provided	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092766	4	654328	4	660539	92766	98673	rs398123298	NC_000004.12:660538:C:
NM_000128.3(F11):c.1247G>A (p.Cys416Tyr)	F11	C416Y	Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371565	4	187205357	4	186284203	371565	357346	rs779802284	NC_000004.12:186284202:G:A
NM_014159.6(SETD2):c.5218C>T (p.Arg1740Trp)	SETD2	R1740W, R1696W	not provided|Luscan-lumish syndrome|Luscan-lumish syndrome||Cerebellar vermis hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000388568	3	47129662	3	47088172	388568	367600	rs1057523157	NC_000003.12:47088171:G:A
NM_024334.2(TMEM43):c.253G>A (p.Glu85Lys)	TMEM43	E85K	Emery-Dreifuss muscular dystrophy 7, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000040870	3	14172412	3	14130912	40870	49356	rs397514044	NC_000003.12:14130911:G:A
NM_001122681.2(SH3BP2):c.1258G>A (p.Gly420Arg)	SH3BP2	G420R, G448R, G477R	not provided	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000372503	4	2833314	4	2831587	372503	359622	rs28938170	NC_000004.12:2831586:G:A
NM_001122681.2(SH3BP2):c.1252C>T (p.Pro418Ser)	SH3BP2	P418S, P446S, P475S	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000280675	4	2833308	4	2831581	280675	264193	rs757336022	NC_000004.12:2831580:C:T
NM_001122681.2(SH3BP2):c.1259G>A (p.Gly420Glu)	SH3BP2	G420E, G448E, G477E	Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000007553	4	2833315	4	2831588	7553	22592	rs28938171	NC_000004.12:2831587:G:A
NM_001122681.2(SH3BP2):c.1244G>C (p.Arg415Pro)	SH3BP2	R415P, R443P, R472P	Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000007550	4	2833300	4	2831573	7550	22589	rs121909149	NC_000004.12:2831572:G:C
NM_001122681.2(SH3BP2):c.1253C>A (p.Pro418His)	SH3BP2	P418H, P446H, P475H	Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000007549	4	2833309	4	2831582	7549	22588	rs121909146	NC_000004.12:2831581:C:A
NM_004628.4(XPC):c.2251-1G>C	XPC		Xeroderma pigmentosum, group C|not provided|Xeroderma pigmentosum	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190213	3	14190232	3	14148732	190213	187975	rs754673606	NC_000003.12:14148731:C:G
NM_001122681.2(SH3BP2):c.1258G>C (p.Gly420Arg)	SH3BP2	G420R, G448R, G477R	Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Aug 15, 2003)	no assertion criteria provided	VCV000007552	4	2833314	4	2831587	7552	22591	rs28938170	NC_000004.12:2831586:G:C
NM_000283.3(PDE6B):c.2395C>T (p.Arg799Ter)	PDE6B	R799*, R520*, R414*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620164	4	661687	4	667898	620164	611617	rs970990957	NC_000004.12:667897:C:T
NM_000521.4(HEXB):c.850C>T (p.Arg284Ter)	HEXB	R284*, R59*	Sandhoff disease|not provided|Sandhoff disease, infantile	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003887	5	74009409	5	74713584	3887	18926	rs121907986	NC_000005.10:74713583:C:T
NM_000283.3(PDE6B):c.385G>A (p.Glu129Lys)	PDE6B	E129K	Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000636062	4	619800	4	626011	636062	623839		NC_000004.12:626010:G:A
NM_000283.3(PDE6B):c.291C>A (p.Tyr97Ter)	PDE6B	Y97*	Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000228390	4	619706	4	625917	228390	229178	rs876657718	NC_000004.12:625916:C:A
NM_000283.3(PDE6B):c.1669C>T (p.His557Tyr)	PDE6B	H557Y, H172Y, H278Y	Retinitis pigmentosa|Retinitis pigmentosa 40	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000013106	4	655977	4	662188	13106	28145	rs121918581	NC_000004.12:662187:C:T
NM_001122681.2(SH3BP2):c.1252C>A (p.Pro418Thr)	SH3BP2	P418T, P446T, P475T	Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000863669	4	2833308	4	2831581	863669	829071		NC_000004.12:2831580:C:A
NC_000003.12:g.(?_132681890)_(132684814_?)del	NPHP3		Nephronophthisis	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832293	3	132400734 - 132403658			832293	819327		
NM_001271893.4(TWIST2):c.223G>A (p.Glu75Lys)	TWIST2	E75K	Inborn genetic diseases|Ablepharon macrostomia syndrome	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000208077	2	239757079	2	238848438	208077	204356	rs1553565140	NC_000002.12:238848437:G:A
NM_000283.3(PDE6B):c.1860del (p.His620fs)	PDE6B	H620fs, H235fs, H341fs	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419959	4	656916	4	663127	419959	406457	rs769671323	NC_000004.12:663126:C:
NM_001370658.1(BTD):c.1387G>T (p.Glu463Ter)	BTD	E483*, E485*, E463*	not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000617999	3	15686810	3	15645303	617999	609502	rs1559600871	NC_000003.12:15645302:G:T
NM_000060.2(BTD):c.266delA (p.Asn89Thrfs)	BTD		not provided	Pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	VCV000419267	3	15677152	3	15635644	419267	406134	rs1064793757	
NM_001370658.1(BTD):c.1465C>T (p.Pro489Ser)	BTD	P489S	Biotinidase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801948	3	15686888	3	15645381	801948	790353		NC_000003.12:15645380:C:T
NM_001370658.1(BTD):c.798del (p.Ala267fs)	BTD	A267fs	Biotinidase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801947	3	15686219	3	15644712	801947	790352		NC_000003.12:15644711:AAA:AA
NM_001370658.1(BTD):c.203del (p.Gln68fs)	BTD	Q68fs, Q88fs	Biotinidase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801943	3	15677149	3	15635642	801943	790348		NC_000003.12:15635641:A:
NM_001370658.1(BTD):c.44_45del (p.Cys15fs)	BTD	C15fs, C35fs	Biotinidase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801942	3	15676989 - 15676990	3	15635482 - 15635483	801942	790347		NC_000003.12:15635481:TGT:T
NC_000003.12:g.(?_15601831)_(15601914_?)del	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000833362	3	15643338 - 15643421			833362	819342		
Single allele	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000641018					641018	650316		
NM_000060.4(BTD):c.594del (p.Val199Cysfs)	BTD	V198fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587754	3	15685957	3	15644450	587754	578677	rs397514374	
NM_001370658.1(BTD):c.1556dup (p.Leu519fs)	BTD	L539fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587753	3	15686977 - 15686978	3	15645470 - 15645471	587753	36434	rs397514430	NC_000003.12:15645470:TT:TTT
NM_000060.4(BTD):c.1384del (p.Arg462Glyfs)	BTD	V461fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587751	3	15686747	3	15645240	587751	578694	rs397514420	
NM_000060.4(BTD):c.246_254del (p.Leu83_Leu85del)	BTD	L85del	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587750	3	15677132 - 15677140	3	15635625 - 15635633	587750	578666	rs397514346	
NM_000060.4(BTD):c.594_596del (p.Val199del)	BTD	V199del	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587749	3	15685957 - 15685959	3	15644450 - 15644452	587749	578676	rs397514373	
NM_000060.4(BTD):c.544del (p.Ser182Valfs)	BTD	S182fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587748	3	15685907	3	15644400	587748	578673	rs397514368	
NM_000060.4(BTD):c.490_491del (p.Arg164Glyfs)	BTD	R164fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587747	3	15685853 - 15685854	3	15644346 - 15644347	587747	578672	rs397514365	
NM_000060.4(BTD):c.393del (p.Phe131Leufs)	BTD	F131fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587746	3	15683498	3	15641991	587746	578669	rs397514356	
NM_000060.4(BTD):c.1239del (p.Tyr414Ilefs)	BTD	G413fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587745	3	15686602	3	15645095	587745	578690	rs397514407	
NM_000060.4(BTD):c.1264dup (p.Leu422Profs)	BTD	G421fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587744	3	15686627	3	15645120	587744	578691	rs397514411	
NM_000060.4(BTD):c.1191_1192del (p.Glu397Aspfs)	BTD	E397fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587743	3	15686554 - 15686555	3	15645047 - 15645048	587743	578689	rs397514403	
NM_000060.4(BTD):c.1049del (p.Ala350Glufs)	BTD	A350fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587742	3	15686412	3	15644905	587742	578687	rs397514397	
NM_001370658.1(BTD):c.1568A>T (p.Asp523Val)	BTD	D543V, D523V, D545V	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587741	3	15686991	3	15645484	587741	578700	rs1050035768	NC_000003.12:15645483:A:T
NM_001370658.1(BTD):c.1497T>G (p.Tyr499Ter)	BTD	Y519*, Y499*, Y521*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587739	3	15686920	3	15645413	587739	578698	rs1559601106	NC_000003.12:15645412:T:G
NM_001370658.1(BTD):c.1466C>G (p.Pro489Arg)	BTD	P509R, P489R, P511R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587738	3	15686889	3	15645382	587738	578697	rs1559601041	NC_000003.12:15645381:C:G
NM_001370658.1(BTD):c.1398del (p.Trp467fs)	BTD	W467fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587736	3	15686821	3	15645314	587736	578695	rs1559600895	NC_000003.12:15645313:G:
NM_001370658.1(BTD):c.1036_1037dup (p.Gly347fs)	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587729	3	15686458 - 15686459	3	15644951 - 15644952	587729	578688	rs1004027979	NC_000003.12:15644951:TC:TCTC
NM_001370658.1(BTD):c.796A>G (p.Lys266Glu)	BTD	K286E, K266E, K288E	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587727	3	15686219	3	15644712	587727	578686	rs1559599682	NC_000003.12:15644711:A:G
NM_001370658.1(BTD):c.776T>A (p.Leu259Ter)	BTD	L279*, L259*, L281*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587726	3	15686199	3	15644692	587726	578685	rs397514390	NC_000003.12:15644691:T:A
NM_001370658.1(BTD):c.723C>G (p.Tyr241Ter)	BTD	Y261*, Y241*, Y263*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587724	3	15686146	3	15644639	587724	578683	rs372687866	NC_000003.12:15644638:C:G
NM_001370658.1(BTD):c.710T>A (p.Val237Asp)	BTD	V257D, V237D, V259D	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587723	3	15686133	3	15644626	587723	578682	rs1190721481	NC_000003.12:15644625:T:A
NM_001370658.1(BTD):c.635T>C (p.Phe212Ser)	BTD	F232S, F212S, F234S	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587722	3	15686058	3	15644551	587722	578681	rs768097543	NC_000003.12:15644550:T:C
NM_001370658.1(BTD):c.633del (p.Phe212fs)	BTD	F212fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587721	3	15686055	3	15644548	587721	578680	rs1559599378	NC_000003.12:15644547:CC:C
NM_001370658.1(BTD):c.586T>A (p.Tyr196Asn)	BTD	Y216N, Y196N, Y218N	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587720	3	15686009	3	15644502	587720	578679	rs1559599267	NC_000003.12:15644501:T:A
NM_001370658.1(BTD):c.571del (p.Arg191fs)	BTD	R191fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587719	3	15685993	3	15644486	587719	578678	rs1559599230	NC_000003.12:15644485:CC:C
NM_001370658.1(BTD):c.346del (p.Gln116fs)	BTD	Q116fs, Q136fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587711	3	15683508	3	15642001	587711	578670	rs1404904752	NC_000003.12:15642000:CCCC:CCC
NM_001370658.1(BTD):c.266dup (p.Phe90fs)	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000587709	3	15683430 - 15683431	3	15641923 - 15641924	587709	578668	rs1559596828	NC_000003.12:15641923:T:TT
NM_001370658.1(BTD):c.261_262TA[3] (p.Val89Ter)	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000587708	3	15683425 - 15683426	3	15641918 - 15641919	587708	578667	rs1559596792	NC_000003.12:15641918:TATA:TATATA
NM_001370658.1(BTD):c.100G>T (p.Glu34Ter)	BTD	E54*, E34*, E56*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000242759	3	15677046	3	15635539	242759	36317	rs397514338	NC_000003.12:15635538:G:T
NM_001370658.1(BTD):c.223C>T (p.Gln75Ter)	BTD	Q95*, Q75*, Q97*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000242758	3	15677169	3	15635662	242758	36332	rs397514349	NC_000003.12:15635661:C:T
NM_001370658.1(BTD):c.805G>C (p.Ala269Pro)	BTD	A289P, A269P, A291P	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000050884	3	15686228	3	15644721	50884	46848	rs397514334	NC_000003.12:15644720:G:C
NM_000060.4(BTD):c.407dup (p.Val137Glyfs)	BTD	Q136fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000038578	3	15683511 - 15683512	3	15642004 - 15642005	38578	47167	rs397514439	NC_000003.12:15642004:A:AA
NM_001370658.1(BTD):c.698C>T (p.Pro233Leu)	BTD	P253L, P233L, P255L	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000038576	3	15686121	3	15644614	38576	47165	rs397514438	NC_000003.12:15644613:C:T
NM_001370658.1(BTD):c.185C>A (p.Ala62Asp)	BTD	A82D, A62D, A84D	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000038484	3	15677131	3	15635624	38484	46852	rs397507171	NC_000003.12:15635623:C:A
NM_001370658.1(BTD):c.266T>G (p.Val89Gly)	BTD	V109G, V111G, V89G	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000038289	3	15683431	3	15641924	38289	46844	rs397507172	NC_000003.12:15641923:T:G
NM_001370658.1(BTD):c.499C>T (p.Pro167Ser)	BTD	P187S, P167S, P189S	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000038274	3	15685922	3	15644415	38274	46832	rs397507173	NC_000003.12:15644414:C:T
NM_001370658.1(BTD):c.941T>A (p.Ile314Asn)	BTD	I334N, I314N, I336N	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000025106	3	15686364	3	15644857	25106	36440	rs397514433	NC_000003.12:15644856:T:A
NM_001370658.1(BTD):c.604G>C (p.Asp202His)	BTD	D222H, D202H, D224H	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000025105	3	15686027	3	15644520	25105	36439	rs200337373	NC_000003.12:15644519:G:C
NM_001370658.1(BTD):c.1567G>C (p.Asp523His)	BTD	D543H, D523H, D545H	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025102	3	15686990	3	15645483	25102	36436	rs397514432	NC_000003.12:15645482:G:C
NM_001370658.1(BTD):c.1553G>A (p.Arg518His)	BTD	R538H, R518H, R540H	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000025099	3	15686976	3	15645469	25099	36433	rs397514429	NC_000003.12:15645468:G:A
NM_001370658.1(BTD):c.1550G>A (p.Gly517Glu)	BTD	G537V, G537E, G517E, G539E	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025098	3	15686973	3	15645466	25098	36432	rs397514428	NC_000003.12:15645465:G:A
NM_001370658.1(BTD):c.1451T>A (p.Met484Lys)	BTD	M504K, M484K, M506K	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025096	3	15686874	3	15645367	25096	36430	rs397514426	NC_000003.12:15645366:T:A
NM_001370658.1(BTD):c.1403G>A (p.Gly468Asp)	BTD	G488D, G468D, G490D	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025093	3	15686826	3	15645319	25093	36427	rs397514424	NC_000003.12:15645318:G:A
NM_001370658.1(BTD):c.1309G>A (p.Val437Met)	BTD	V457M, V437M, V459M	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025085	3	15686732	3	15645225	25085	36419	rs146600671	NC_000003.12:15645224:G:A
NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)	BTD	G451D, G431D, G453D	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025084	3	15686715	3	15645208	25084	36418	rs397514419	NC_000003.12:15645207:G:A
NM_001370658.1(BTD):c.1273G>A (p.Gly425Arg)	BTD	G445R, G425R, G447R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025081	3	15686696	3	15645189	25081	36416	rs397514417	NC_000003.12:15645188:G:A
NM_001370658.1(BTD):c.1253A>G (p.Tyr418Cys)	BTD	Y438C, Y418C, Y440C	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025079	3	15686676	3	15645169	25079	36414	rs397514415	NC_000003.12:15645168:A:G
NM_001370658.1(BTD):c.1224C>A (p.Tyr408Ter)	BTD	Y428*, Y408*, Y430*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025078	3	15686647	3	15645140	25078	36413	rs35145938	NC_000003.12:15645139:C:A
NM_001370658.1(BTD):c.1215T>G (p.Tyr405Ter)	BTD	Y425*, Y405*, Y427*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025077	3	15686638	3	15645131	25077	36412	rs397514414	NC_000003.12:15645130:T:G
NM_001370658.1(BTD):c.1211G>C (p.Cys404Ser)	BTD	C424S, C404S, C426S	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025076	3	15686634	3	15645127	25076	36314	rs397514335	NC_000003.12:15645126:G:C
NM_001370658.1(BTD):c.1208G>C (p.Cys403Ser)	BTD	C423W, C423S, C403S, C425S	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025074	3	15686631	3	15645124	25074	36410	rs397514413	NC_000003.12:15645123:G:C
NM_001370658.1(BTD):c.1193G>C (p.Cys398Ser)	BTD	C418S, C398S, C420S	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025071	3	15686616	3	15645109	25071	36407	rs397514410	NC_000003.12:15645108:G:C
NM_001370658.1(BTD):c.1189G>T (p.Val397Phe)	BTD	V417F, V397F, V419F	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025070	3	15686612	3	15645105	25070	36406	rs397514409	NC_000003.12:15645104:G:T
NM_001370658.1(BTD):c.1154T>C (p.Leu385Pro)	BTD	L405P, L385P, L407P	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025066	3	15686577	3	15645070	25066	36402	rs397514406	NC_000003.12:15645069:T:C
NM_001370658.1(BTD):c.1036T>C (p.Ser346Pro)	BTD	S366P, S346P, S368P	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025058	3	15686459	3	15644952	25058	36394	rs397514399	NC_000003.12:15644951:T:C
NM_001370658.1(BTD):c.873T>G (p.Ser291Arg)	BTD	S311R, S291R, S313R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025053	3	15686296	3	15644789	25053	36379	rs397514386	NC_000003.12:15644788:T:G
NM_001370658.1(BTD):c.872G>A (p.Ser291Asn)	BTD	S311N, S291N, S313N	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025051	3	15686295	3	15644788	25051	36388	rs397514394	NC_000003.12:15644787:G:A
NM_001370658.1(BTD):c.869G>A (p.Gly290Glu)	BTD	G310E, G290E, G312E	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025050	3	15686292	3	15644785	25050	36387	rs397514393	NC_000003.12:15644784:G:A
NM_001370658.1(BTD):c.836C>T (p.Ala279Val)	BTD	A299V, A279V, A301V	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025049	3	15686259	3	15644752	25049	36386	rs397514392	NC_000003.12:15644751:C:T
NM_001370658.1(BTD):c.827T>G (p.Val276Gly)	BTD	V296G, V276G, V298G	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025048	3	15686250	3	15644743	25048	36385	rs397514391	NC_000003.12:15644742:T:G
NM_001370658.1(BTD):c.776T>G (p.Leu259Trp)	BTD	L279W, L259W, L281W	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025046	3	15686199	3	15644692	25046	36383	rs397514390	NC_000003.12:15644691:T:G
NM_001370658.1(BTD):c.734A>T (p.His245Leu)	BTD	H265L, H245L, H267L	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025041	3	15686157	3	15644650	25041	36378	rs397514385	NC_000003.12:15644649:A:T
NM_001370658.1(BTD):c.649G>A (p.Ala217Thr)	BTD	A237T, A217T, A239T	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000025036	3	15686072	3	15644565	25036	36373	rs397514381	NC_000003.12:15644564:G:A
NM_001370658.1(BTD):c.594G>C (p.Glu198Asp)	BTD	E218D, E198D, E220D	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025034	3	15686017	3	15644510	25034	36371	rs397514379	NC_000003.12:15644509:G:C
NM_001370658.1(BTD):c.592G>C (p.Glu198Gln)	BTD	E218Q, E198Q, E220Q	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025033	3	15686015	3	15644508	25033	36370	rs397514378	NC_000003.12:15644507:G:C
NM_001370658.1(BTD):c.545A>T (p.Asn182Ile)	BTD	N202I, N182I, N204I	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025027	3	15685968	3	15644461	25027	36364	rs397514376	NC_000003.12:15644460:A:T
NM_001370658.1(BTD):c.527C>G (p.Thr176Arg)	BTD	T196R, T176R, T198R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025023	3	15685950	3	15644443	25023	36360	rs397514372	NC_000003.12:15644442:C:G
NM_001370658.1(BTD):c.524A>G (p.Asn175Ser)	BTD	N195S, N175S, N197S	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025022	3	15685947	3	15644440	25022	36359	rs397514371	NC_000003.12:15644439:A:G
NM_001370658.1(BTD):c.394A>C (p.Thr132Pro)	BTD	T152P, T132P, T154P	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025008	3	15683559	3	15642052	25008	36346	rs374681173	NC_000003.12:15642051:A:C
NM_001370658.1(BTD):c.385T>C (p.Phe129Leu)	BTD	F149L, F129L, F151L	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025007	3	15683550	3	15642043	25007	36345	rs397514359	NC_000003.12:15642042:T:C
NM_001370658.1(BTD):c.322T>G (p.Phe108Val)	BTD	F128V, F108V, F130V	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000025002	3	15683487	3	15641980	25002	36340	rs397514355	NC_000003.12:15641979:T:G
NM_001370658.1(BTD):c.274G>A (p.Glu92Lys)	BTD	E112K, E114K, E92K	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024998	3	15683439	3	15641932	24998	36336	rs397514352	NC_000003.12:15641931:G:A
NM_001370658.1(BTD):c.250G>T (p.Asp84Tyr)	BTD	D104Y, D106Y, D84Y	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024996	3	15683415	3	15641908	24996	36334	rs397514351	NC_000003.12:15641907:G:T
NM_001370658.1(BTD):c.238G>A (p.Ala80Thr)	BTD	A100T, A102T, A80T	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024995	3	15677184	3	15635677	24995	36333	rs397514350	NC_000003.12:15635676:G:A
NM_001370658.1(BTD):c.202C>T (p.Gln68Ter)	BTD	Q88*, Q68*, Q90*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024992	3	15677148	3	15635641	24992	36330	rs151071780	NC_000003.12:15635640:C:T
NM_001370658.1(BTD):c.134A>G (p.His45Arg)	BTD	H65R, H45R, H67R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024982	3	15677080	3	15635573	24982	36322	rs397514341	NC_000003.12:15635572:A:G
NM_001370658.1(BTD):c.130G>A (p.Glu44Lys)	BTD	E64K, E44K, E66K	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024980	3	15677076	3	15635569	24980	36320	rs397514340	NC_000003.12:15635568:G:A
NM_001370658.1(BTD):c.111T>G (p.Tyr37Ter)	BTD	Y57*, Y37*, Y59*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024978	3	15677057	3	15635550	24978	36318	rs397514339	NC_000003.12:15635549:T:G
NM_001370658.1(BTD):c.76G>T (p.Glu26Ter)	BTD	E46*, E26*, E48*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024976	3	15677022	3	15635515	24976	36315	rs397514336	NC_000003.12:15635514:G:T
NM_000060.3:c.*159G>A	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000641134					641134	650323		
NM_001370658.1(BTD):c.1419del (p.Tyr474fs)	BTD	Y474fs	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000574460	3	15686841	3	15645334	574460	559363	rs1559600938	NC_000003.12:15645333:CC:C
NM_001370658.1(BTD):c.1292_1293del (p.Gly431fs)	BTD	G431fs	Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558367	3	15686715 - 15686716	3	15645208 - 15645209	558367	543119	rs1553654142	NC_000003.12:15645207:GC:
NM_001370658.1(BTD):c.1066C>T (p.Gln356Ter)	BTD	Q376*, Q356*, Q378*	Biotinidase deficiency	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000552232	3	15686489	3	15644982	552232	542888	rs760612966	NC_000003.12:15644981:C:T
NM_001370658.1(BTD):c.1350dup (p.Cys451fs)	BTD		not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Feb 13, 2016)	criteria provided, single submitter	VCV000280333	3	15686771 - 15686772	3	15645264 - 15645265	280333	264145	rs886041559	NC_000003.12:15645264:CC:CCC
NM_001370658.1(BTD):c.1312dup (p.Cys438fs)	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000156005	3	15686734 - 15686735	3	15645227 - 15645228	156005	165809	rs587783007	NC_000003.12:15645227:T:TT
NM_001370658.1(BTD):c.623A>G (p.Asp208Gly)	BTD	D228G, D208G, D230G	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000156002	3	15686046	3	15644539	156002	165806	rs587783004	NC_000003.12:15644538:A:G
NM_001370658.1(BTD):c.197T>G (p.Met66Arg)	BTD	M86R, M66R, M88R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000156000	3	15677143	3	15635636	156000	165804	rs587783002	NC_000003.12:15635635:T:G
NM_001370658.1(BTD):c.458T>G (p.Leu153Arg)	BTD	L173R, L153R, L175R	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000038575	3	15685881	3	15644374	38575	47164	rs397514437	NC_000003.12:15644373:T:G
NM_001370658.1(BTD):c.1399del (p.Trp467fs)	BTD	L486fs, W467fs	Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025092	3	15686822	3	15645315	25092	36426	rs397514423	NC_000003.12:15645314:T:
NM_001370658.1(BTD):c.772C>G (p.Leu258Val)	BTD	L278V, L258V, L280V	Biotinidase deficiency	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000025044	3	15686195	3	15644688	25044	36381	rs397514388	NC_000003.12:15644687:C:G
NM_001370658.1(BTD):c.406C>T (p.Gln136Ter)	BTD	Q156*, Q136*, Q158*	Biotinidase deficiency	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000025011	3	15685829	3	15644322	25011	36349	rs397514362	NC_000003.12:15644321:C:T
NM_001370658.1(BTD):c.124G>T (p.Val42Leu)	BTD	V62L, V42L, V64L	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024979	3	15677070	3	15635563	24979	36319	rs397507170	NC_000003.12:15635562:G:T
NM_001370658.1(BTD):c.1097G>A (p.Trp366Ter)	BTD	T386*, W386*, W366*, W388*	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000024841	3	15686520	3	15645013	24841	36182	rs397514401	NC_000003.12:15645012:G:A
BTD, 15-BP DEL/11-BP INS	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000001896					1896	16935		
NM_001349253.2(SCN11A):c.1142T>C (p.Ile381Thr)	SCN11A	I381T	Episodic pain syndrome, familial, 3	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000157600	3	38950645	3	38909154	157600	167461	rs606231280	NC_000003.12:38909153:A:G
NM_001349253.2(SCN11A):c.2423C>G (p.Ala808Gly)	SCN11A	A808G	Episodic pain syndrome, familial, 3	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000089013	3	38936436	3	38894945	89013	94567	rs483352921	NC_000003.12:38894944:G:C
NM_001349253.2(SCN11A):c.673C>T (p.Arg225Cys)	SCN11A	R225C	Episodic pain syndrome, familial, 3	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000069850	3	38966945	3	38925454	69850	80741	rs138607170	NC_000003.12:38925453:G:A
NM_001349253.2(SCN11A):c.3904C>T (p.Leu1302Phe)	SCN11A	L1302F	Neuropathy, hereditary sensory and autonomic, type VII	Pathogenic(Last reviewed: Nov 9, 2017)	no assertion criteria provided	VCV000504488	3	38908859	3	38867368	504488	496112	rs1553633131	NC_000003.12:38867367:G:A
NM_020166.5(MCCC1):c.974T>G (p.Met325Arg)	MCCC1	M325R, M208R, M216R	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency|Methylcrotonyl-CoA carboxylase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001929	3	182763310	3	183045522	1929	16968	rs119103212	NC_000003.12:183045521:A:C
NM_001370658.1(BTD):c.40_41del (p.Gly14fs)	BTD	G14fs, G34fs	Biotinidase deficiency|Cryptorchidism|Global developmental delay|Macrocephalus|Generalized hypotonia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000373906	3	15676986 - 15676987	3	15635479 - 15635480	373906	360849	rs765906887	NC_000003.12:15635478:GG:
NM_001370658.1(BTD):c.1448_1452del (p.Gly483fs)	BTD	G483fs	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092399	3	15686870 - 15686874	3	15645363 - 15645367	92399	98310	rs398123138	NC_000003.12:15645362:GGGATG:G
NM_001370658.1(BTD):c.132G>C (p.Glu44Asp)	BTD	E64D, E66D, E44D	not specified|Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000038574	3	15677078	3	15635571	38574	47163	rs397514436	NC_000003.12:15635570:G:C
NM_001370658.1(BTD):c.1399T>C (p.Trp467Arg)	BTD	W487R, W467R, W489R	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000025091	3	15686822	3	15645315	25091	36425	rs397514422	NC_000003.12:15645314:T:C
NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	FARS2	Y144C	not provided|Global developmental delay|Mitochondrial encephalomyopathy|Combined oxidative phosphorylation deficiency 14	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039824	6	5369234	6	5369001	39824	48423	rs397514610	NC_000006.12:5369000:A:G
NM_000297.4(PKD2):c.637C>T (p.Arg213Ter)	PKD2	R213*	Polycystic kidney disease, autosomal dominant|not provided|Polycystic kidney disease 2	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000543947	4	88940651	4	88019499	543947	520284	rs1302726543	NC_000004.12:88019498:C:T
NM_001349253.2(SCN11A):c.1187T>C (p.Leu396Pro)	SCN11A	L396P	Neuropathy, hereditary sensory and autonomic, type VII|not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426113	3	38950600	3	38909109	426113	414717	rs1085307142	NC_000003.12:38909108:A:G
NM_001349253.2(SCN11A):c.2432T>C (p.Leu811Pro)	SCN11A	L811P	Neuropathy, hereditary sensory and autonomic, type VII	Pathogenic(Last reviewed: Nov 9, 2017)	no assertion criteria provided	VCV000089011	3	38936427	3	38894936	89011	94565	rs483352920	NC_000003.12:38894935:A:G
NM_000046.5(ARSB):c.123_139dup (p.Leu47fs)	ARSB		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000453065	5	78280932 - 78280933	5	78985109 - 78985110	453065	443825	rs766772376	NC_000005.10:78985109:GGTGGGGCGGCCGGCTGG:GGTGGGGCGGCCGGCTGGGTGGGGCGGCCGGCTGG
NM_001256545.2(MEGF10):c.625G>T (p.Glu209Ter)	MEGF10	E209*	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000419378	5	126732436	5	127396744	419378	406613	rs1064793831	NC_000005.10:127396743:G:T
NM_001256545.2(MEGF10):c.1557del (p.Trp520fs)	MEGF10	W520fs	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Apr 10, 2015)	no assertion criteria provided	VCV000374300	5	126755866	5	127420174	374300	361182	rs1057518682	NC_000005.10:127420173:A:
NM_000046.5(ARSB):c.118_134del (p.Gly40fs)	ARSB	G40fs	not provided	Pathogenic(Last reviewed: Jul 25, 2013)	criteria provided, single submitter	VCV000092353	5	78280938 - 78280954	5	78985115 - 78985131	92353	98264	rs398123123	NC_000005.10:78985114:GGCGGCCGGCTGGCCCCGGCG:GGCG
NM_001256545.2(MEGF10):c.550C>T (p.Gln184Ter)	MEGF10	Q184*	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000864627	5	126732361	5	127396669	864627	829903		NC_000005.10:127396668:C:T
NM_001256545.2(MEGF10):c.198delinsACATTC (p.Trp66Ter)	MEGF10		Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000643447	5	126674893	5	127339201	643447	632913		NC_000005.10:127339200:G:ACATTC
NM_001256545.2(MEGF10):c.3166C>T (p.Arg1056Ter)	MEGF10	R1056*	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000472740	5	126791233	5	127455541	472740	454701	rs989552169	NC_000005.10:127455540:C:T
NM_000046.3:c.384_386delCTC	ARSB		Mucopolysaccharidosis type 6	Pathogenic	no assertion criteria provided	VCV000100718					100718	106583		
NM_001256545.2(MEGF10):c.211C>T (p.Arg71Trp)	MEGF10	R71W	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000030967	5	126674906	5	127339214	30967	39924	rs387907074	NC_000005.10:127339213:C:T
NM_001256545.2(MEGF10):c.976T>C (p.Cys326Arg)	MEGF10	C326R	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000030966	5	126746139	5	127410447	30966	39923	rs387907073	NC_000005.10:127410446:T:C
NM_001256545.2(MEGF10):c.1325del (p.Pro442fs)	MEGF10	P442fs	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000030964	5	126754828	5	127419136	30964	39921	rs794726679	NC_000005.10:127419135:CCCC:CCC
NM_032446.3(MEGF10):c.3144T>G (p.Tyr1048Ter)	MEGF10	Y1048*	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000030963	5	126791211	5	127455519	30963	39920	rs794726678	NC_000005.10:127455518:T:G
MEGF10, 10-BP DUP, NT2288	MEGF10		Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000030960					30960	39917		
NM_000046.5(ARSB):c.1036G>T (p.Glu346Ter)	ARSB	E346*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000862387	5	78181513	5	78885690	862387	830970		NC_000005.10:78885689:C:A
NM_000046.5(ARSB):c.823G>T (p.Glu275Ter)	ARSB	E275*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000644772	5	78251193	5	78955370	644772	634037		NC_000005.10:78955369:C:A
NM_000046.5(ARSB):c.152T>C (p.Leu51Pro)	ARSB	L51P	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000445289	5	78280920	5	78985097	445289	438565	rs1554032220	NC_000005.10:78985096:A:G
NM_000046.5(ARSB):c.189_190insA (p.Gly64fs)	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000445288	5	78280882 - 78280883	5	78985059 - 78985060	445288	438564	rs1554032196	NC_000005.10:78985059::T
NM_000046.5(ARSB):c.281C>T (p.Ser94Leu)	ARSB	S94L	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000445287	5	78280791	5	78984968	445287	438561	rs1554032099	NC_000005.10:78984967:G:A
NM_000046.5(ARSB):c.257del (p.Tyr86fs)	ARSB	Y86fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000445286	5	78280815	5	78984992	445286	438562	rs1554032122	NC_000005.10:78984991:T:
NM_032446.3(MEGF10):c.1559G>A (p.Trp520Ter)	MEGF10	W520*	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: Nov 20, 2011)	no assertion criteria provided	VCV000030961	5	126755868	5	127420176	30961	39918	rs794726677	NC_000005.10:127420175:G:A
NC_000005.10:g.(?_78885574)_(78885837_?)del	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000832751	5	78181397 - 78181660			832751	819611		
NM_000046.5(ARSB):c.899-1337_1142+1055del	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559818	5	78180352 - 78182987	5	78884529 - 78887164	559818	550430		
NM_000046.5(ARSB):c.498del (p.Phe166fs)	ARSB	F166fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559791	5	78264830	5	78969007	559791	550488	rs1554088002	NC_000005.10:78969006:AAA:AA
NM_000046.5(ARSB):c.270_274del (p.Cys91fs)	ARSB	C91fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559755	5	78280798 - 78280802	5	78984975 - 78984979	559755	550522	rs1554032110	NC_000005.10:78984974:TGCAC:
NM_000046.5(ARSB):c.208_215del (p.Pro70fs)	ARSB	P70fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559738	5	78280857 - 78280864	5	78985034 - 78985041	559738	550541	rs1554032155	NC_000005.10:78985033:AGGTGCGG:
NM_000046.5(ARSB):c.1261G>T (p.Glu421Ter)	ARSB	E421*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559694	5	78077750	5	78781927	559694	550418	rs1554069793	NC_000005.10:78781926:C:A
NM_000046.5(ARSB):c.1208del (p.Ser403fs)	ARSB	S403fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559690	5	78135184	5	78839361	559690	550423	rs1554074124	NC_000005.10:78839360:G:
NM_000046.5(ARSB):c.1208C>G (p.Ser403Ter)	ARSB	S403*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559689	5	78135184	5	78839361	559689	550422	rs771296632	NC_000005.10:78839360:G:C
NM_000046.5(ARSB):c.1142+1G>T	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559678	5	78181406	5	78885583	559678	550433	rs746396210	NC_000005.10:78885582:C:A
NM_000046.5(ARSB):c.1059G>A (p.Trp353Ter)	ARSB	W353*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559671	5	78181490	5	78885667	559671	550438	rs1554079296	NC_000005.10:78885666:C:T
NC_000005.10:g.(78885828_78955294)_(78955503_78964415)del	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559662			5	78885828 - 78964415	559662	550384		
NM_001256545.2(MEGF10):c.2301C>A (p.Cys767Ter)	MEGF10	C767*	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset|not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000030962	5	126776498	5	127440806	30962	39919	rs387907071	NC_000005.10:127440805:C:A
NM_000060.3:c.1447G>T	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000859384					859384	850376		
NM_000060.3:c.1085T>A	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000844380					844380	850367		
NM_000060.3:c.1410dup	BTD		Biotinidase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000834119					834119	850374		
NM_003722.5(TP63):c.728G>A (p.Arg243Gln)	TP63	R204Q, R243Q, R149Q, R241Q, R64Q	TP63-Related Spectrum Disorders|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000006528	3	189582169	3	189864380	6528	21567	rs121908836	NC_000003.12:189864379:G:A
NM_003722.5(TP63):c.727C>T (p.Arg243Trp)	TP63	R204W, R243W, R64W, R149W, R241W	TP63-Related Spectrum Disorders|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3|not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006527	3	189582168	3	189864379	6527	21566	rs121908835	NC_000003.12:189864378:C:T
NM_000046.5(ARSB):c.1299dup (p.Arg434Ter)	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000852181	5	78077711 - 78077712	5	78781888 - 78781889	852181	830968		NC_000005.10:78781888:AA:AAA
NM_000046.5(ARSB):c.307_312+147del	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559767	5	78280613 - 78280765	5	78984790 - 78984942	559767	550511	rs1554089838	
NM_000046.5(ARSB):c.262C>T (p.Gln88Ter)	ARSB	Q88*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559752	5	78280810	5	78984987	559752	550527	rs1299207831	NC_000005.10:78984986:G:A
NM_000046.5(ARSB):c.1366C>T (p.Gln456Ter)	ARSB	Q456*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559709	5	78076456	5	78780633	559709	550403	rs200188234	NC_000005.10:78780632:G:A
NM_000046.5(ARSB):c.1213+6T>C	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559692	5	78135173	5	78839350	559692	550420	rs1554074118	NC_000005.10:78839349:A:G
NM_000046.5(ARSB):c.116_123del (p.Ala39fs)	ARSB	A39fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495377	5	78280949 - 78280956	5	78985126 - 78985133	495377	487135	rs1554032243	NC_000005.10:78985125:GGCCCCGG:
NM_001256545.2(MEGF10):c.2320T>C (p.Cys774Arg)	MEGF10	C774R	Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant|Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000030965	5	126776517	5	127440825	30965	39922	rs387907072	NC_000005.10:127440824:T:C
NM_000030.3(AGXT):c.67C>T (p.Gln23Ter)	AGXT	Q23*	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000654767	2	241808349	2	240868932	654767	629745		NC_000002.12:240868931:C:T
NM_000030.3(AGXT):c.841G>T (p.Glu281Ter)	AGXT	E281*	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000641162	2	241815416	2	240875999	641162	629746		NC_000002.12:240875998:G:T
NM_000030.3(AGXT):c.466G>C (p.Gly156Arg)	AGXT	G156R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000552979	2	241810808	2	240871391	552979	542075	rs121908530	NC_000002.12:240871390:G:C
NM_000030.3(AGXT):c.1108_1109CG[1] (p.Asn372fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204211	2	241818167 - 241818168	2	240878750 - 240878751	204211	200603	rs796052075	NC_000002.12:240878749:CGCG:CG
NM_000030.3(AGXT):c.957_958CA[1] (p.Thr320fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204208	2	241817453 - 241817454	2	240878036 - 240878037	204208	200589	rs796052074	NC_000002.12:240878035:CACA:CA
NM_000030.3(AGXT):c.662_664del (p.Ser221del)	AGXT	S221del	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204194	2	241813459 - 241813461	2	240874042 - 240874044	204194	200529	rs796052071	NC_000002.12:240874041:CTCCT:CT
NM_000030.3(AGXT):c.557_562delinsATCGGT (p.Ala186_Ser187delinsAspArg)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204189	2	241812428 - 241812433	2	240873011 - 240873016	204189	200512	rs180177237	NC_000002.12:240873010:CATCCC:ATCGGT
NM_000030.3(AGXT):c.519_520delinsGA (p.Cys173_His174delinsTrpAsn)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204188	2	241810861 - 241810862	2	240871444 - 240871445	204188	200507	rs180177233	NC_000002.12:240871443:CC:GA
NM_000030.3(AGXT):c.359-1_382del	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204183	2	241810057 - 241810081	2	240870640 - 240870664	204183	200481	rs796052070	NC_000002.12:240870639:CCAGGAGCCCGAGTGCACCCGATGACCA:CCA
NM_000030.3(AGXT):c.215dup (p.Asn72fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204177	2	241808634 - 241808635	2	240869217 - 240869218	204177	200453	rs796052069	NC_000002.12:240869217:AA:AAA
NM_000030.3(AGXT):c.943-1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204171	2	241817438	2	240878021	204171	200585	rs180177298	NC_000002.12:240878020:G:A
NM_000030.3(AGXT):c.777-2A>G	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204167	2	241815350	2	240875933	204167	200552	rs796052068	NC_000002.12:240875932:A:G
NM_000030.3(AGXT):c.680+2T>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204155	2	241813481	2	240874064	204155	200532	rs111742810	NC_000002.12:240874063:T:A
NM_000030.3(AGXT):c.1148C>A (p.Ala383Asp)	AGXT	A383D	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204149	2	241818207	2	240878790	204149	200606	rs796052066	NC_000002.12:240878789:C:A
NM_000030.3(AGXT):c.1045G>A (p.Gly349Ser)	AGXT	G349S	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204145	2	241817541	2	240878124	204145	200597	rs796052065	NC_000002.12:240878123:G:A
NM_000030.3(AGXT):c.1014C>G (p.Tyr338Ter)	AGXT	Y338*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204144	2	241817510	2	240878093	204144	200596	rs756437332	NC_000002.12:240878092:C:G
NM_000030.3(AGXT):c.947T>C (p.Leu316Pro)	AGXT	L316P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204139	2	241817443	2	240878026	204139	200587	rs796052063	NC_000002.12:240878025:T:C
NM_000030.3(AGXT):c.922C>T (p.Gln308Ter)	AGXT	Q308*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204138	2	241817029	2	240877612	204138	200582	rs180177296	NC_000002.12:240877611:C:T
NM_000030.3(AGXT):c.628G>C (p.Ala210Pro)	AGXT	A210P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204120	2	241813427	2	240874010	204120	200525	rs180177250	NC_000002.12:240874009:G:C
NM_000030.3(AGXT):c.595G>A (p.Gly199Ser)	AGXT	G199S	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204114	2	241812466	2	240873049	204114	200518	rs796052062	NC_000002.12:240873048:G:A
NM_000030.3(AGXT):c.423G>T (p.Glu141Asp)	AGXT	E141D	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204100	2	241810125	2	240870708	204100	200487	rs180177217	NC_000002.12:240870707:G:T
NM_000030.3(AGXT):c.371A>C (p.His124Pro)	AGXT	H124P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204098	2	241810073	2	240870656	204098	200483	rs180177211	NC_000002.12:240870655:A:C
NM_000030.3(AGXT):c.353G>A (p.Arg118His)	AGXT	R118H	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204096	2	241808774	2	240869357	204096	200476	rs138025751	NC_000002.12:240869356:G:A
NM_000030.3(AGXT):c.349G>T (p.Glu117Ter)	AGXT	E117*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204094	2	241808770	2	240869353	204094	200474	rs180177208	NC_000002.12:240869352:G:T
NM_000030.3(AGXT):c.324G>T (p.Trp108Cys)	AGXT	W108C	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204089	2	241808745	2	240869328	204089	200468	rs796052060	NC_000002.12:240869327:G:T
NM_000030.3(AGXT):c.254C>A (p.Ala85Asp)	AGXT	A85D	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204086	2	241808675	2	240869258	204086	200459	rs796052059	NC_000002.12:240869257:C:A
NM_000030.3(AGXT):c.209C>A (p.Thr70Asn)	AGXT	T70N	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204081	2	241808630	2	240869213	204081	200452	rs796052058	NC_000002.12:240869212:C:A
NM_000030.3(AGXT):c.175G>A (p.Glu59Lys)	AGXT	E59K	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204078	2	241808596	2	240869179	204078	200449	rs767586362	NC_000002.12:240869178:G:A
NM_000030.3(AGXT):c.22G>C (p.Val8Leu)	AGXT	V8L	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204067	2	241808304	2	240868887	204067	200419	rs796052057	NC_000002.12:240868886:G:C
NG_008005.1:g.(7706_9235)_(15375_?)del	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204216	2	241810867 - 241818536	2	240871450 - 240879119	204216	200411		
NG_008005.1:g.(?_5001)_(11460_12190)del	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204215	2	241808162 - 241815351	2	240868745 - 240875934	204215	200415		
NG_008005.1:g.(?_5001)_(9305_10233)del	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204214	2	241808162 - 241813394	2	240868745 - 240873977	204214	200414		
NG_008005.1:g.(14407_14970)_(15375_?)del	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204213	2	241817568 - 241818536	2	240878151 - 240879119	204213	200412		
NM_000030.3(AGXT):c.1123_1124CG[1] (p.Val376fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204212	2	241818182 - 241818183	2	240878765 - 240878766	204212	200604	rs180177164	NC_000002.12:240878764:CGCG:CG
NM_000030.3(AGXT):c.983_988del (p.Ala328_Tyr330delinsAsp)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204210	2	241817479 - 241817484	2	240878062 - 240878067	204210	200592	rs180177302	NC_000002.12:240878061:CTGGCT:
NM_000030.3(AGXT):c.969_970TG[1] (p.Val324fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204209	2	241817465 - 241817466	2	240878048 - 240878049	204209	200590	rs180177300	NC_000002.12:240878047:TGTG:TG
NM_000030.3(AGXT):c.919del (p.Leu307fs)	AGXT	L307fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204207	2	241817026	2	240877609	204207	200581	rs180177295	NC_000002.12:240877608:C:
NM_000030.3(AGXT):c.883_885GCG[1] (p.Ala296del)	AGXT	A296del	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204206	2	241816990 - 241816992	2	240877573 - 240877575	204206	200577	rs180177291	NC_000002.12:240877572:GCGGCG:GCG
NM_000030.3(AGXT):c.846+646_942+139del	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204204	2	241816067 - 241817188	2	240876650 - 240877771	204204	200570		
NM_000030.3(AGXT):c.834del (p.Ile279fs)	AGXT	I279fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204203	2	241815409	2	240875992	204203	200561	rs180177276	NC_000002.12:240875991:C:
NM_000030.3(AGXT):c.798_802delinsACAATCTCAG (p.Ile267fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204200	2	241815373 - 241815377	2	240875956 - 240875960	204200	200554	rs180177270	NC_000002.12:240875955:CATCA:ACAATCTCAG
NM_000030.3(AGXT):c.751_752delinsAA (p.Trp251Lys)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204199	2	241814596 - 241814597	2	240875179 - 240875180	204199	200545	rs796052072	NC_000002.12:240875178:TG:AA
NM_000030.3(AGXT):c.744del (p.Asn249fs)	AGXT	N249fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204198	2	241814588	2	240875171	204198	200544	rs180177261	NC_000002.12:240875170:CC:C
NM_000030.3(AGXT):c.725dup (p.Asp243fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204197	2	241814569 - 241814570	2	240875152 - 240875153	204197	200541	rs180177257	NC_000002.12:240875152:T:TT
NM_000030.3(AGXT):c.680+480_776+69delinsTGAGA	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204196	2	241813959 - 241814690	2	240874542 - 240875273	204196	200537	rs1553648931	
NM_000030.3(AGXT):c.642_645del (p.Pro215fs)	AGXT	P215fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204193	2	241813441 - 241813444	2	240874024 - 240874027	204193	200526	rs180177251	NC_000002.12:240874023:TCCA:
NM_000030.3(AGXT):c.577dup (p.Leu193fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204192	2	241812442 - 241812443	2	240873025 - 240873026	204192	200515	rs180177241	NC_000002.12:240873025:CCCCCC:CCCCCCC
NM_000030.3(AGXT):c.570del (p.Thr191fs)	AGXT	T191fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204190	2	241812439	2	240873022	204190	200513	rs180177240	NC_000002.12:240873021:GGG:GG
NM_000030.3(AGXT):c.460del (p.Thr154fs)	AGXT	T154fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204187	2	241810801	2	240871384	204187	200498	rs180177224	NC_000002.12:240871383:AA:A
NM_000030.3(AGXT):c.445del (p.Val149fs)	AGXT	V149fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204186	2	241810787	2	240871370	204186	200494	rs180177220	NC_000002.12:240871369:G:
NM_000030.3(AGXT):c.416_418del (p.Val139del)	AGXT	V139del	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204184	2	241810116 - 241810118	2	240870699 - 240870701	204184	200486	rs180177215	NC_000002.12:240870698:GGTGG:GG
NM_000030.3(AGXT):c.327del (p.Gln110fs)	AGXT	Q110fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204182	2	241808744	2	240869327	204182	200470	rs180177200	NC_000002.12:240869326:GGGGG:GGGG
NM_000030.3(AGXT):c.283_285dup (p.Glu95dup)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204180	2	241808702 - 241808703	2	240869285 - 240869286	204180	200463	rs180177190	NC_000002.12:240869285:GGAG:GGAGGAG
NM_000030.3(AGXT):c.276del (p.Asn92fs)	AGXT	N92fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204179	2	241808697	2	240869280	204179	200461	rs180177187	NC_000002.12:240869279:T:
NM_000030.3(AGXT):c.126del (p.Leu43fs)	AGXT	L43fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204176	2	241808403	2	240868986	204176	200435	rs180177171	NC_000002.12:240868985:GGGGGG:GGGGG
NM_000030.3(AGXT):c.83del (p.Pro28fs)	AGXT	P28fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204174	2	241808364	2	240868947	204174	200430	rs180177278	NC_000002.12:240868946:CC:C
NM_000030.3(AGXT):c.32_33del (p.Pro11fs)	AGXT	P11fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204173	2	241808308 - 241808309	2	240868891 - 240868892	204173	200425	rs180177201	NC_000002.12:240868890:CCCCCCCC:CCCCCC
NM_000030.3(AGXT):c.2_3delinsAT (p.Met1Asn)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204172	2	241808284 - 241808285	2	240868867 - 240868868	204172	200417	rs180177194	NC_000002.12:240868866:TG:AT
NM_000030.3(AGXT):c.424-2A>G	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204164	2	241810764	2	240871347	204164	200493	rs180177219	NC_000002.12:240871346:A:G
NM_000030.3(AGXT):c.166-1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204163	2	241808586	2	240869169	204163	200447	rs180177177	NC_000002.12:240869168:G:A
NM_000030.3(AGXT):c.1071+1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204162	2	241817568	2	240878151	204162	200598	rs180177158	NC_000002.12:240878150:G:A
NM_000030.3(AGXT):c.942+1G>T	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204161	2	241817050	2	240877633	204161	200583	rs180177297	NC_000002.12:240877632:G:T
NM_000030.3(AGXT):c.846+1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204160	2	241815422	2	240876005	204160	200567	rs180177281	NC_000002.12:240876004:G:A
NM_000030.3(AGXT):c.776+1G>C	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204158	2	241814622	2	240875205	204158	200549	rs180177265	NC_000002.12:240875204:G:C
NM_000030.3(AGXT):c.680+5G>C	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204156	2	241813484	2	240874067	204156	200533	rs180177256	NC_000002.12:240874066:G:C
NM_000030.3(AGXT):c.680+1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204154	2	241813480	2	240874063	204154	200530	rs111996685	NC_000002.12:240874062:G:A
NM_000030.3(AGXT):c.680+1G>C	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204153	2	241813480	2	240874063	204153	200531	rs111996685	NC_000002.12:240874062:G:C
NM_000030.3(AGXT):c.358+2T>G	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204152	2	241808781	2	240869364	204152	200478	rs113681235	NC_000002.12:240869363:T:G
NM_000030.3(AGXT):c.358+1G>T	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204151	2	241808780	2	240869363	204151	200477	rs796052067	NC_000002.12:240869362:G:T
NM_000030.3(AGXT):c.1076T>C (p.Leu359Pro)	AGXT	L359P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204146	2	241818135	2	240878718	204146	200600	rs180177160	NC_000002.12:240878717:T:C
NM_000030.3(AGXT):c.997A>T (p.Arg333Ter)	AGXT	R333*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204142	2	241817493	2	240878076	204142	200594	rs180177303	NC_000002.12:240878075:A:T
NM_000030.3(AGXT):c.853G>T (p.Glu285Ter)	AGXT	E285*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204134	2	241816960	2	240877543	204134	200574	rs180177288	NC_000002.12:240877542:G:T
NM_000030.3(AGXT):c.846G>C (p.Gln282His)	AGXT	Q282H	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204132	2	241815421	2	240876004	204132	200566	rs180177284	NC_000002.12:240876003:G:C
NM_000030.3(AGXT):c.844C>T (p.Gln282Ter)	AGXT	Q282*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204131	2	241815419	2	240876002	204131	200564	rs180177279	NC_000002.12:240876001:C:T
NM_000030.3(AGXT):c.753G>A (p.Trp251Ter)	AGXT	W251*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204125	2	241814598	2	240875181	204125	200546	rs180177263	NC_000002.12:240875180:G:A
NM_000030.3(AGXT):c.698G>T (p.Arg233Leu)	AGXT	R233L	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204123	2	241814543	2	240875126	204123	200539	rs121908527	NC_000002.12:240875125:G:T
NM_000030.3(AGXT):c.661T>C (p.Ser221Pro)	AGXT	S221P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204122	2	241813460	2	240874043	204122	200528	rs180177254	NC_000002.12:240874042:T:C
NM_000030.3(AGXT):c.646G>A (p.Gly216Arg)	AGXT	G216R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204121	2	241813445	2	240874028	204121	200527	rs180177252	NC_000002.12:240874027:G:A
NM_000030.3(AGXT):c.614C>A (p.Ser205Ter)	AGXT	S205*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204119	2	241813413	2	240873996	204119	200523	rs180177248	NC_000002.12:240873995:C:A
NM_000030.3(AGXT):c.614C>T (p.Ser205Leu)	AGXT	S205L	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204118	2	241813413	2	240873996	204118	200524	rs180177248	NC_000002.12:240873995:C:T
NM_000030.3(AGXT):c.612C>A (p.Tyr204Ter)	AGXT	Y204*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204117	2	241813411	2	240873994	204117	200522	rs180177247	NC_000002.12:240873993:C:A
NM_000030.3(AGXT):c.605T>A (p.Ile202Asn)	AGXT	I202N	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204116	2	241813404	2	240873987	204116	200521	rs536352238	NC_000002.12:240873986:T:A
NM_000030.3(AGXT):c.519C>A (p.Cys173Ter)	AGXT	C173*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204109	2	241810861	2	240871444	204109	200506	rs180177232	NC_000002.12:240871443:C:A
NM_000030.3(AGXT):c.497T>C (p.Leu166Pro)	AGXT	L166P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204107	2	241810839	2	240871422	204107	200504	rs180177230	NC_000002.12:240871421:T:C
NM_000030.3(AGXT):c.473C>A (p.Ser158Ter)	AGXT	S158*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204104	2	241810815	2	240871398	204104	200499	rs180177225	NC_000002.12:240871397:C:A
NM_000030.3(AGXT):c.449T>C (p.Leu150Pro)	AGXT	L150P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204101	2	241810791	2	240871374	204101	200496	rs180177222	NC_000002.12:240871373:T:C
NM_000030.3(AGXT):c.409C>T (p.Gln137Ter)	AGXT	Q137*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204099	2	241810111	2	240870694	204099	200485	rs180177214	NC_000002.12:240870693:C:T
NM_000030.3(AGXT):c.335C>A (p.Ala112Asp)	AGXT	A112D	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204093	2	241808756	2	240869339	204093	200473	rs796052061	NC_000002.12:240869338:C:A
NM_000030.3(AGXT):c.331C>T (p.Arg111Ter)	AGXT	R111*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204091	2	241808752	2	240869335	204091	200471	rs180177202	NC_000002.12:240869334:C:T
NM_000030.3(AGXT):c.323G>A (p.Trp108Ter)	AGXT	W108*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204088	2	241808744	2	240869327	204088	200467	rs180177198	NC_000002.12:240869326:G:A
NM_000030.3(AGXT):c.242C>T (p.Ser81Leu)	AGXT	S81L	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204083	2	241808663	2	240869246	204083	200456	rs180177184	NC_000002.12:240869245:C:T
NM_000030.3(AGXT):c.242C>A (p.Ser81Ter)	AGXT	S81*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204082	2	241808663	2	240869246	204082	200455	rs180177184	NC_000002.12:240869245:C:A
NM_000030.3(AGXT):c.205C>T (p.Gln69Ter)	AGXT	Q69*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204080	2	241808626	2	240869209	204080	200451	rs180177182	NC_000002.12:240869208:C:T
NM_000030.3(AGXT):c.187G>C (p.Gly63Arg)	AGXT	G63R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204079	2	241808608	2	240869191	204079	200450	rs180177181	NC_000002.12:240869190:G:C
NM_000030.3(AGXT):c.125G>A (p.Gly42Glu)	AGXT	G42E	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204074	2	241808407	2	240868990	204074	200434	rs180177170	NC_000002.12:240868989:G:A
NM_000030.3(AGXT):c.122G>A (p.Gly41Glu)	AGXT	G41E	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204073	2	241808404	2	240868987	204073	200433	rs180177168	NC_000002.12:240868986:G:A
NM_000030.3(AGXT):c.77T>C (p.Leu26Pro)	AGXT	L26P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204071	2	241808359	2	240868942	204071	200429	rs180177268	NC_000002.12:240868941:T:C
NM_000030.3(AGXT):c.28C>T (p.Pro10Ser)	AGXT	P10S	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204068	2	241808310	2	240868893	204068	200422	rs180177191	NC_000002.12:240868892:C:T
NM_000030.3(AGXT):c.3G>T (p.Met1Ile)	AGXT	M1I	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204066	2	241808285	2	240868868	204066	200418	rs180177213	NC_000002.12:240868867:G:T
AGXT, 1-BP INS, 33C	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000039487					39487	48086		
NM_006218.4(PIK3CA):c.1093G>A (p.Glu365Lys)	PIK3CA	E365K	Ovarian Neoplasms|not provided|Cowden syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419222	3	178922324	3	179204536	419222	406150	rs1064793732	NC_000003.12:179204535:G:A
NM_006218.4(PIK3CA):c.1133G>A (p.Cys378Tyr)	PIK3CA	C378Y	|Cowden syndrome|PIK3CA related overgrowth spectrum	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000039704	3	178922364	3	179204576	39704	48303	rs397514565	NC_000003.12:179204575:G:A
NM_006218.4(PIK3CA):c.2740G>A (p.Gly914Arg)	PIK3CA	G914R	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039703	3	178947865	3	179230077	39703	48302	rs587776932	NC_000003.12:179230076:G:A
NM_000046.5(ARSB):c.589C>T (p.Arg197Ter)	ARSB	R197*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559799	5	78260340	5	78964517	559799	550480	rs773460207	NC_000005.10:78964516:G:A
NM_000046.5(ARSB):c.1577del (p.Thr526fs)	ARSB	T526fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559724	5	78076245	5	78780422	559724	550389	rs1554069660	NC_000005.10:78780421:G:
NM_000046.5(ARSB):c.1142+2T>C	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559680	5	78181405	5	78885582	559680	550431	rs781510986	NC_000005.10:78885581:A:G
NM_000046.5(ARSB):c.743del (p.Pro248fs)	ARSB	P248fs	Mucopolysaccharidosis type 6|Mucopolysaccharidosis, type vi, severe	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000000882	5	78251273	5	78955450	882	15921	rs431905494	NC_000005.10:78955449:GGG:GG
NM_000030.3(AGXT):c.406_410dup (p.Gln137fs)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000557281	2	241810105 - 241810106	2	240870688 - 240870689	557281	542186	rs1553648488	NC_000002.12:240870688:CACTGCA:CACTGCACTGCA
NM_000030.3(AGXT):c.860_861delinsCG (p.Ser287Thr)	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204205	2	241816967 - 241816968	2	240877550 - 240877551	204205	200614	rs180177289	NC_000002.12:240877549:GC:CG
NM_000030.3(AGXT):c.447_454del (p.Leu151fs)	AGXT	L151fs	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000204185	2	241810787 - 241810794	2	240871370 - 240871377	204185	200495	rs180177221	NC_000002.12:240871369:GTGCTGCTGT:GT
NM_000030.3(AGXT):c.596-2A>G	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000204166	2	241813393	2	240873976	204166	200519	rs180177245	NC_000002.12:240873975:A:G
NM_000030.3(AGXT):c.776+1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204157	2	241814622	2	240875205	204157	200548	rs180177265	NC_000002.12:240875204:G:A
NM_000030.3(AGXT):c.1151T>C (p.Leu384Pro)	AGXT	L384P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204150	2	241818210	2	240878793	204150	200607	rs180177165	NC_000002.12:240878792:T:C
NM_000030.3(AGXT):c.1102G>A (p.Ala368Thr)	AGXT	A368T	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204148	2	241818161	2	240878744	204148	200602	rs180177163	NC_000002.12:240878743:G:A
NM_000030.3(AGXT):c.1007T>A (p.Val336Asp)	AGXT	V336D	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204143	2	241817503	2	240878086	204143	200595	rs180177155	NC_000002.12:240878085:T:A
NM_000030.3(AGXT):c.956C>T (p.Pro319Leu)	AGXT	P319L	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204140	2	241817452	2	240878035	204140	200588	rs180177299	NC_000002.12:240878034:C:T
NM_000030.3(AGXT):c.893T>C (p.Leu298Pro)	AGXT	L298P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204136	2	241817000	2	240877583	204136	200579	rs180177293	NC_000002.12:240877582:T:C
NM_000030.3(AGXT):c.851T>C (p.Leu284Pro)	AGXT	L284P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204133	2	241816958	2	240877541	204133	200573	rs180177287	NC_000002.12:240877540:T:C
NM_000030.3(AGXT):c.823A>C (p.Ser275Arg)	AGXT	S275R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204130	2	241815398	2	240875981	204130	200557	rs180177272	NC_000002.12:240875980:A:C
NM_000030.3(AGXT):c.806T>C (p.Leu269Pro)	AGXT	L269P	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204128	2	241815381	2	240875964	204128	200555	rs180177271	NC_000002.12:240875963:T:C
NM_000030.3(AGXT):c.783T>A (p.His261Gln)	AGXT	H261Q	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204127	2	241815358	2	240875941	204127	200553	rs180177269	NC_000002.12:240875940:T:A
NM_000030.3(AGXT):c.727G>C (p.Asp243His)	AGXT	D243H	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204124	2	241814572	2	240875155	204124	200542	rs180177258	NC_000002.12:240875154:G:C
NM_000030.3(AGXT):c.583A>C (p.Met195Leu)	AGXT	M195L	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204112	2	241812454	2	240873037	204112	200516	rs180177243	NC_000002.12:240873036:A:C
NM_000030.3(AGXT):c.547G>A (p.Asp183Asn)	AGXT	D183N	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204111	2	241812418	2	240873001	204111	200511	rs180177236	NC_000002.12:240873000:G:A
NM_000030.3(AGXT):c.518G>A (p.Cys173Tyr)	AGXT	C173Y	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204108	2	241810860	2	240871443	204108	200505	rs180177231	NC_000002.12:240871442:G:A
NM_000030.3(AGXT):c.481G>C (p.Gly161Arg)	AGXT	G161R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204106	2	241810823	2	240871406	204106	200502	rs180177227	NC_000002.12:240871405:G:C
NM_000030.3(AGXT):c.457T>G (p.Leu153Val)	AGXT	L153V	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204102	2	241810799	2	240871382	204102	200497	rs180177223	NC_000002.12:240871381:T:G
NM_000030.3(AGXT):c.332G>A (p.Arg111Gln)	AGXT	R111Q	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204092	2	241808753	2	240869336	204092	200472	rs180177203	NC_000002.12:240869335:G:A
NM_000030.3(AGXT):c.326G>T (p.Gly109Val)	AGXT	G109V	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204090	2	241808747	2	240869330	204090	200469	rs180177199	NC_000002.12:240869329:G:T
NM_000030.3(AGXT):c.283G>A (p.Glu95Lys)	AGXT	E95K	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204087	2	241808704	2	240869287	204087	200462	rs180177189	NC_000002.12:240869286:G:A
NM_000030.3(AGXT):c.248A>G (p.His83Arg)	AGXT	H83R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204085	2	241808669	2	240869252	204085	200458	rs180177186	NC_000002.12:240869251:A:G
NM_000030.3(AGXT):c.167T>A (p.Ile56Asn)	AGXT	I56N	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204077	2	241808588	2	240869171	204077	200448	rs180177180	NC_000002.12:240869170:T:A
NM_000030.3(AGXT):c.107G>A (p.Arg36His)	AGXT	R36H	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000204072	2	241808389	2	240868972	204072	200431	rs180177162	NC_000002.12:240868971:G:A
NM_000030.3(AGXT):c.74T>G (p.Leu25Arg)	AGXT	L25R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204070	2	241808356	2	240868939	204070	200428	rs180177262	NC_000002.12:240868938:T:G
NM_000030.3(AGXT):c.525-1G>A	AGXT		Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000204165	2	241812395	2	240872978	204165	200509	rs180177234	NC_000002.12:240872977:G:A
NM_000030.3(AGXT):c.757T>C (p.Cys253Arg)	AGXT	C253R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204126	2	241814602	2	240875185	204126	200547	rs180177264	NC_000002.12:240875184:T:C
NM_000030.3(AGXT):c.244G>C (p.Gly82Arg)	AGXT	G82R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000204084	2	241808665	2	240869248	204084	200457	rs180177185	NC_000002.12:240869247:G:C
NM_000030.3(AGXT):c.738G>A (p.Trp246Ter)	AGXT	W246*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000005649	2	241814583	2	240875166	5649	20688	rs121908528	NC_000002.12:240875165:G:A
NM_000030.3(AGXT):c.198C>G (p.Tyr66Ter)	AGXT	Y66*	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 27, 2014)	no assertion criteria provided	VCV000005642	2	241808619	2	240869202	5642	20681	rs121908521	NC_000002.12:240869201:C:G
NM_001370658.1(BTD):c.1433dup (p.Leu478fs)	BTD	P498fs	Biotinidase deficiency	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000587752	3	15686853 - 15686854	3	15645346 - 15645347	587752	36429	rs397514425	NC_000003.12:15645346:TTT:TTTT
NM_001370658.1(BTD):c.835G>C (p.Ala279Pro)	BTD	A299P, A279P, A301P	not provided|Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000439039	3	15686258	3	15644751	439039	432546	rs1157567876	NC_000003.12:15644750:G:C
NM_001370658.1(BTD):c.175C>T (p.Arg59Cys)	BTD	R79C, R59C, R81C	Biotinidase deficiency	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000001905	3	15677121	3	15635614	1905	16944	rs104893687	NC_000003.12:15635613:C:T
NM_000046.5(ARSB):c.1036del (p.Glu346fs)	ARSB	E346fs	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559667	5	78181513	5	78885690	559667	550442	rs1554079302	NC_000005.10:78885689:CCC:CC
NM_000030.3(AGXT):c.679_680+2del	AGXT		Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000204195	2	241813478 - 241813481	2	240874061 - 240874064	204195	200613	rs180177255	NC_000002.12:240874060:AAGT:
NM_000030.3(AGXT):c.603C>A (p.Asp201Glu)	AGXT	D201E	Primary hyperoxaluria, type I	Pathogenic	criteria provided, single submitter	VCV000204115	2	241813402	2	240873985	204115	200520	rs180177246	NC_000002.12:240873984:C:A
NM_000027.4(AGA):c.488G>C (p.Cys163Ser)	AGA	C163S	Aspartylglucosaminuria, finnish type|Aspartylglucosaminuria	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000219	4	178359918	4	177438764	219	15258	rs121964904	NC_000004.12:177438763:C:G
NM_001163213.1(FGFR3):c.1888G>A (p.Asp630Asn)	FGFR3	D628N, D630N, D516N, D629N	Levy-Hollister syndrome	Pathogenic(Last reviewed: Jun 6, 2018)	no assertion criteria provided	VCV000545425	4	1807823	4	1806096	545425	535686	rs1453271838	NC_000004.12:1806095:G:A
NM_001163213.1(FGFR3):c.1643C>A (p.Thr548Lys)	FGFR3	T546K, T548K, T547K, T434K	Camptodactyly-tall stature-scoliosis-hearing loss syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000156545	4	1807388	4	1805661	156545	166328	rs587777857	NC_000004.12:1805660:C:A
NM_001163213.1(FGFR3):c.1082-586A>T	FGFR3	N328I	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065916	4	1805471	4	1803744	65916	76824	rs587778817	NC_000004.12:1803743:A:T
NM_001163213.1(FGFR3):c.1082-599C>G	FGFR3	L324V	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065915	4	1805458	4	1803731	65915	76823	rs587778816	NC_000004.12:1803730:C:G
NM_001163213.1(FGFR3):c.801G>T (p.Leu267=)	FGFR3		Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065901	4	1803623	4	1801896	65901	76809	rs587778811	NC_000004.12:1801895:G:T
NM_001163213.1(FGFR3):c.597C>T (p.His199=)	FGFR3		Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065880	4	1803245	4	1801518	65880	76788	rs587778801	NC_000004.12:1801517:C:T
NM_001163213.1(FGFR3):c.1148T>A (p.Val383Glu)	FGFR3	V381E, V383E	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065829	4	1806123	4	1804396	65829	76737	rs587778776	NC_000004.12:1804395:T:A
NM_001163213.1(FGFR3):c.791C>T (p.Thr264Met)	FGFR3	T264M	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065823	4	1803613	4	1801886	65823	76731	rs587778773	NC_000004.12:1801885:C:T
NM_001163213.1(FGFR3):c.2427A>C (p.Ter809Cys)	FGFR3	K785Q, *809C, *807C, *808C, *695C	Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065563	4	1808989	4	1807262	65563	76471	rs121913103	NC_000004.12:1807261:A:C
NM_001163213.1(FGFR3):c.2425T>C (p.Ter809Arg)	FGFR3	V784A, *807R, *809R, *695R, *808R	Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065561	4	1808987	4	1807260	65561	76469	rs121913101	NC_000004.12:1807259:T:C
NM_001163213.1(FGFR3):c.344A>T (p.Gln115Leu)	FGFR3	Q115L	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065526	4	1801215	4	1799488	65526	76434	rs587778769	NC_000004.12:1799487:A:T
NM_001163213.1(FGFR3):c.1543G>A (p.Asp515Asn)	FGFR3	D513N, D515N, D401N, D514N	Levy-Hollister syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000016354	4	1807288	4	1805561	16354	31393	rs121913112	NC_000004.12:1805560:G:A
FGFR3, FGFR3/IGH FUSION	FGFR3		Multiple myeloma	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000016343					16343	31382		
NM_001163213.1(FGFR3):c.1082-517C>T	FGFR3	S351F	Craniosynostosis	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000649812	4	1805540	4	1803813	649812	632094		NC_000004.12:1803812:C:T
NM_001163213.1(FGFR3):c.1082-545G>T	FGFR3	G342C	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000065826	4	1805512	4	1803785	65826	76734	rs587778775	NC_000004.12:1803784:G:T
NM_001163213.1(FGFR3):c.1956G>T (p.Lys652Asn)	FGFR3	K650N, K652N, K538N, K651N	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000016346	4	1807891	4	1806164	16346	31385	rs28928868	NC_000004.12:1806163:G:T
NM_001163213.1(FGFR3):c.1618A>G (p.Ile540Val)	FGFR3	I538V, I540V, I426V, I539V	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000016345	4	1807363	4	1805636	16345	31384	rs80053154	NC_000004.12:1805635:A:G
NM_001163213.1(FGFR3):c.1625A>C (p.Asn542Thr)	FGFR3	N540T, N542T, N428T, N541T	Hypochondroplasia	Pathogenic(Last reviewed: Sep 26, 2013)	no assertion criteria provided	VCV000016344	4	1807370	4	1805643	16344	31383	rs77722678	NC_000004.12:1805642:A:C
NM_004826.4(ECEL1):c.110_155del (p.Phe37fs)	ECEL1	F37fs	Inborn genetic diseases|not provided|Distal arthrogryposis type 5D	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000435024	2	233351209 - 233351254	2	232486499 - 232486544	435024	427996	rs1341894581	NC_000002.12:232486498:AGCCCGGACCGGGCCCCGGTGGCGCTGCGCGCAGCGCCCAACGGGAAGCCCGG:AGCCCGG
NM_001163213.1(FGFR3):c.2427A>T (p.Ter809Cys)	FGFR3	K785*, *807C, *809C, *695C, *808C	Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000016336	4	1808989	4	1807262	16336	31375	rs121913103	NC_000004.12:1807261:A:T
NM_001163213.1(FGFR3):c.2427A>G (p.Ter809Trp)	FGFR3	K785E, *807W, *809W, *695W, *808W	Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000065564	4	1808989	4	1807262	65564	76472	rs121913103	NC_000004.12:1807261:A:G
NM_001163213.1(FGFR3):c.1868G>A (p.Arg623His)	FGFR3	R621H, R623H, R509H, R622H	Craniosynostosis|Camptodactyly-tall stature-scoliosis-hearing loss syndrome	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000016355	4	1807803	4	1806076	16355	31394	rs121913113	NC_000004.12:1806075:G:A
NM_001163213.1(FGFR3):c.2425T>A (p.Ter809Arg)	FGFR3	V784E, *809R, *807R, *695R, *808R	not provided|Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000016335	4	1808987	4	1807260	16335	31374	rs121913101	NC_000004.12:1807259:T:A
NM_001163213.1(FGFR3):c.1129G>T (p.Gly377Cys)	FGFR3	G375C, G377C	Achondroplasia	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000016330	4	1806104	4	1804377	16330	31369	rs75790268	NC_000004.12:1804376:G:T
NM_003242.6(TGFBR2):c.1136A>T (p.Asp379Val)	TGFBR2	D379V, D404V	Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	VCV000263559	3	30713811	3	30672319	263559	258300	rs886038847	NC_000003.12:30672318:A:T
NM_003242.6(TGFBR2):c.831G>T (p.Lys277Asn)	TGFBR2	K277N, K302N	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	VCV000263412	3	30713506	3	30672014	263412	258297	rs886038794	NC_000003.12:30672013:G:T
NM_003242.6(TGFBR2):c.1261A>G (p.Thr421Ala)	TGFBR2	T421A, T446A	Cardiovascular phenotype	Pathogenic(Last reviewed: Jul 1, 2013)	criteria provided, single submitter	VCV000263399	3	30715603	3	30674111	263399	258304	rs886038787	NC_000003.12:30674110:A:G
NM_003242.6(TGFBR2):c.1279C>T (p.Pro427Ser)	TGFBR2	P427S, P452S	not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000213931	3	30715621	3	30674129	213931	209625	rs863223850	NC_000003.12:30674128:C:T
NM_003242.6(TGFBR2):c.1277C>A (p.Ala426Asp)	TGFBR2	A426D, A451D	not provided	Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	VCV000213930	3	30715619	3	30674127	213930	209624	rs730880224	NC_000003.12:30674126:C:A
NM_003242.6(TGFBR2):c.1276G>A (p.Ala426Thr)	TGFBR2	A426T, A451T	not provided	Pathogenic(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	VCV000213929	3	30715618	3	30674126	213929	209623	rs863223849	NC_000003.12:30674125:G:A
NM_003242.6(TGFBR2):c.1066C>G (p.Arg356Gly)	TGFBR2	R356G, R381G	not provided	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000213920	3	30713741	3	30672249	213920	209612	rs199660234	NC_000003.12:30672248:C:G
NM_003242.6(TGFBR2):c.1597_1598TG[4] (p.Ala535fs)	TGFBR2		Hereditary nonpolyposis colorectal cancer type 6	Pathogenic(Last reviewed: Jun 2, 1995)	no assertion criteria provided	VCV000012501	3	30732982 - 30732983	3	30691490 - 30691491	12501	27540	rs587776769	NC_000003.12:30691490:GTGTGTG:GTGTGTGTG
NC_000005.10:g.(78839427_78885583)_(78885828_78955294)del	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559663			5	78839427 - 78955294	559663	550383		
NM_000046.5(ARSB):c.238del (p.Val80fs)	ARSB	V80fs	Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000000881	5	78280834	5	78985011	881	15920	rs431905493	NC_000005.10:78985010:CCCC:CCC
NM_003242.6(TGFBR2):c.1524+1G>T	TGFBR2		Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517118	3	30730004	3	30688512	517118	508711	rs727503475	NC_000003.12:30688511:G:T
NM_001163213.1(FGFR3):c.2426G>T (p.Ter809Leu)	FGFR3	*809L, *807L, *695L, *808L	not provided|Craniosynostosis|Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000065562	4	1808988	4	1807261	65562	76470	rs397515514	NC_000004.12:1807260:G:T
NM_001163213.1(FGFR3):c.833A>G (p.Tyr278Cys)	FGFR3	Y278C	Hypochondroplasia|Short stature	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000016357	4	1803655	4	1801928	16357	31396	rs121913115	NC_000004.12:1801927:A:G
NM_001163213.1(FGFR3):c.2425T>G (p.Ter809Gly)	FGFR3	V784G, *807G, *809G, *808G, *695G	not provided|Thanatophoric dysplasia type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000016334	4	1808987	4	1807260	16334	31373	rs121913101	NC_000004.12:1807259:T:G
NM_003242.6(TGFBR2):c.1346C>G (p.Ser449Cys)	TGFBR2	S449C, S474C	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000408444	3	30715688	3	30674196	408444	393646	rs104893807	NC_000003.12:30674195:C:G
NM_003242.6(TGFBR2):c.1271A>G (p.Tyr424Cys)	TGFBR2	Y424C, Y449C	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 23, 2016)	criteria provided, single submitter	VCV000239528	3	30715613	3	30674121	239528	239135	rs878854610	NC_000003.12:30674120:A:G
NM_173660.5(DOK7):c.1143del (p.Glu382fs)	DOK7	E238fs, E72fs, E382fs	Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802049	4	3494852	4	3493125	802049	790469		NC_000004.12:3493124:CCCCC:CCCC
NM_173660.5(DOK7):c.957del (p.Lys320fs)	DOK7	K176fs, K320fs, K10fs	not provided	Pathogenic(Last reviewed: Jan 22, 2015)	criteria provided, single submitter	VCV000198626	4	3494665	4	3492938	198626	195787	rs794727884	NC_000004.12:3492937:CCCCCC:CCCCC
NM_173660.5(DOK7):c.1358dup (p.Leu454fs)	DOK7		not provided	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000804760	4	3495067 - 3495068	4	3493340 - 3493341	804760	793054		NC_000004.12:3493340:GGGG:GGGGG
NM_173660.5(DOK7):c.1061C>T (p.Ser354Phe)	DOK7	S354F, S44F, S210F	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000544830	4	3494774	4	3493047	544830	535270	rs756015202	NC_000004.12:3493046:C:T
NM_173660.5(DOK7):c.199C>T (p.Pro67Ser)	DOK7	P67S	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000544694	4	3475231	4	3473504	544694	535238	rs1553846331	NC_000004.12:3473503:C:T
NM_001370658.1(BTD):c.134_137ATCC[4] (p.Leu49fs)	BTD		Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189072	3	15677078 - 15677079	3	15635571 - 15635572	189072	186677	rs1205964567	NC_000003.12:15635571:CATCCATCCATCC:CATCCATCCATCCATCC
NM_001370658.1(BTD):c.1167_1181delinsTTCCAATGGCC (p.Trp389fs)	BTD		not provided|Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188805	3	15686590 - 15686604	3	15645083 - 15645097	188805	186678	rs672601248	NC_000003.12:15645082:GGGAAAGGAAGGCTA:TTCCAATGGCC
NM_173660.5(DOK7):c.457A>T (p.Lys153Ter)	DOK7	K153*	Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000853396	4	3478194	4	3476467	853396	829077		NC_000004.12:3476466:A:T
NC_000004.12:g.(?_3463366)_(3493511_?)del	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000831089	4	3465093 - 3495238			831089	819479		
NM_173660.5(DOK7):c.1296_1311del (p.Asp433fs)	DOK7	D123fs, D433fs, D289fs	Myasthenia, limb-girdle, familial	Pathogenic	criteria provided, single submitter	VCV000813360	4	3495001 - 3495016	4	3493274 - 3493289	813360	801607		NC_000004.12:3493273:GCGGCCAGGGACTCAGGCGGCCAG:GCGGCCAG
NM_173660.5(DOK7):c.483_484dup (p.Ala162fs)	DOK7		Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000812703	4	3478217 - 3478218	4	3476490 - 3476491	812703	800954		NC_000004.12:3476490:GGGG:GGGGGG
NM_173660.5(DOK7):c.28del (p.Gln10fs)	DOK7	Q10fs	Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000654355	4	3465129	4	3463402	654355	632159		NC_000004.12:3463401:CC:C
NC_000004.11:g.(?_3487246)_(3495248_?)del	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000465669	4	3487246 - 3495248	4	3485519 - 3493521	465669	452822		
NC_000004.11:g.(?_3475113)_(3491543_?)del	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000465668	4	3475113 - 3491543	4	3473386 - 3489816	465668	453610		
NM_173660.5(DOK7):c.1021_1039dup (p.Ser347fs)	DOK7		Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000434960	4	3494733 - 3494734	4	3493006 - 3493007	434960	428296	rs1553850100	NC_000004.12:3493006:GCCACTGGCAGCCACTCCT:GCCACTGGCAGCCACTCCTGCCACTGGCAGCCACTCCT
NM_173660.5(DOK7):c.596del (p.Ile199fs)	DOK7	I199fs, I55fs, R196fs	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000210856	4	3487329	4	3485602	210856	207118	rs797045528	NC_000004.12:3485601:T:
NM_173660.5(DOK7):c.55-1G>T	DOK7		Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Sep 29, 2006)	no assertion criteria provided	VCV000001280	4	3465232	4	3463505	1280	16319	rs863223277	NC_000004.12:3463504:G:T
NM_173660.5(DOK7):c.601C>T (p.Arg201Ter)	DOK7	P197L, R57*, R201*	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Sep 29, 2006)	no assertion criteria provided	VCV000001279	4	3487334	4	3485607	1279	16318	rs118203995	NC_000004.12:3485606:C:T
NM_173660.5(DOK7):c.539G>C (p.Gly180Ala)	DOK7	G180A, G36A, W176C	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Sep 29, 2006)	no assertion criteria provided	VCV000001278	4	3487272	4	3485545	1278	16317	rs118203994	NC_000004.12:3485544:G:C
NM_173660.5(DOK7):c.548_551del (p.Phe183fs)	DOK7	F183fs, F39fs, P180fs	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Sep 29, 2006)	no assertion criteria provided	VCV000001275	4	3487279 - 3487282	4	3485552 - 3485555	1275	16314	rs606231130	NC_000004.12:3485551:CTTCCT:CT
NM_173660.5(DOK7):c.1408_1412dup (p.Gly472fs)	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000854520	4	3495120 - 3495121	4	3493393 - 3493394	854520	829095		NC_000004.12:3493393:GCCCC:GCCCCGCCCC
NC_000004.12:g.(?_3485529)_(3485668_?)del	DOK7		Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000832528	4	3487256 - 3487395			832528	819480		
NM_173660.5(DOK7):c.514G>A (p.Gly172Arg)	DOK7	G172R	Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560992	4	3478251	4	3476524	560992	552080	rs768892432	NC_000004.12:3476523:G:A
NM_173660.5(DOK7):c.437C>T (p.Pro146Leu)	DOK7	P146L	Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560990	4	3478174	4	3476447	560990	552078	rs770987150	NC_000004.12:3476446:C:T
NM_173660.5(DOK7):c.1476_1485dup (p.Gly496fs)	DOK7		Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000209148	4	3495188 - 3495189	4	3493461 - 3493462	209148	205738	rs797045040	NC_000004.12:3493461:TCCAGTCTGT:TCCAGTCTGTTCCAGTCTGT
NC_000004.11:g.(?_3487256)_(3495238_?)del	DOK7		Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000644832	4	3487256 - 3495238	4	3485529 - 3493511	644832	651111		
NM_173660.5(DOK7):c.1143dup (p.Glu382fs)	DOK7		Myasthenia, limb-girdle, familial|not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000001277	4	3494851 - 3494852	4	3493124 - 3493125	1277	16316	rs606231132	NC_000004.12:3493124:CCCCC:CCCCCC
GRCh37/hg19 3p26.1(chr3:4513497-4612609)x1	ITPR1		not provided	Pathogenic(Last reviewed: Apr 10, 2018)	no assertion criteria provided	VCV000687590	3	4513497 - 4612609			687590	675182		
NM_001168272.1(ITPR1):c.1207-2A>T	ITPR1		Gillespie syndrome	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617623	3	4703764	3	4662080	617623	609019	rs1559638068	NC_000003.12:4662079:A:T
NM_001168272.1(ITPR1):c.1207-1G>C	ITPR1		not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000423275	3	4703765	3	4662081	423275	406310	rs1064796337	NC_000003.12:4662080:G:C
NM_001168272.1(ITPR1):c.7748T>C (p.Ile2583Thr)	ITPR1	I2535T, I2583T, I2550T	ITPR1-associated cerebellar ataxia spectrum disorder	Pathogenic(Last reviewed: Dec 15, 2017)	no assertion criteria provided	VCV000559630	3	4856828	3	4815144	559630	550357	rs1553758021	NC_000003.12:4815143:T:C
NM_001168272.1(ITPR1):c.7748T>A (p.Ile2583Asn)	ITPR1	I2550N, I2583N, I2535N	Gillespie syndrome	Pathogenic(Last reviewed: Apr 18, 2018)	no assertion criteria provided	VCV000522562	3	4856828	3	4815144	522562	513174	rs1553758021	NC_000003.12:4815143:T:A
NM_001168272.1(ITPR1):c.2934_2935insTATA (p.Val979fs)	ITPR1		Gillespie syndrome	Pathogenic	criteria provided, single submitter	VCV000438828	3	4722248 - 4722249	3	4680564 - 4680565	438828	432459	rs1553689752	NC_000003.12:4680564::TATA
NM_001168272.1(ITPR1):c.279+4_279+7del	ITPR1		Gillespie syndrome	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000437908	3	4669561 - 4669564	3	4627877 - 4627880	437908	431536	rs1553654413	NC_000003.12:4627876:ACGTACGTA:ACGTA
NM_001168272.1(ITPR1):c.7615G>C (p.Gly2539Arg)	ITPR1	G2539R, G2506R, G2491R	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235923	3	4856205	3	4814521	235923	237581	rs752281590	NC_000003.12:4814520:G:C
NM_001168272.1(ITPR1):c.7758T>G (p.Phe2586Leu)	ITPR1	F2553L, F2586L, F2538L	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235920	3	4856838	3	4815154	235920	237578	rs878853176	NC_000003.12:4815153:T:G
NM_001168272.1(ITPR1):c.6763+5G>T	ITPR1		Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235918	3	4829828	3	4788144	235918	237576	rs878853174	NC_000003.12:4788143:G:T
NM_001168272.1(ITPR1):c.6465+3A>T	ITPR1		Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235917	3	4824428	3	4782744	235917	237575	rs878853173	NC_000003.12:4782743:A:T
NM_001168272.1(ITPR1):c.4654C>T (p.Gln1552Ter)	ITPR1	Q1558*, Q1552*, Q1543*	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235915	3	4747892	3	4706208	235915	237573	rs878853171	NC_000003.12:4706207:C:T
NM_003242.6(TGFBR2):c.1178G>A (p.Cys393Tyr)	TGFBR2	C393Y, C418Y	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000264260	3	30713853	3	30672361	264260	258303	rs886039106	NC_000003.12:30672360:G:A
NM_003242.6(TGFBR2):c.1280C>T (p.Pro427Leu)	TGFBR2	P427L, P452L	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Aug 24, 2006)	no assertion criteria provided	VCV000012518	3	30715622	3	30674130	12518	27557	rs104893818	NC_000003.12:30674129:C:T
NM_003242.6(TGFBR2):c.1273A>G (p.Met425Val)	TGFBR2	M425V, M450V	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000012517	3	30715615	3	30674123	12517	27556	rs104893817	NC_000003.12:30674122:A:G
NM_003242.6(TGFBR2):c.1397-2A>G	TGFBR2		Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000012516	3	30729874	3	30688382	12516	27555	rs587776770	NC_000003.12:30688381:A:G
NM_003242.6(TGFBR2):c.95-2A>G	TGFBR2		Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000012513	3	30686237	3	30644745	12513	27552		NC_000003.12:30644744:A:G
NM_003242.6(TGFBR2):c.1069G>T (p.Gly357Trp)	TGFBR2	G357W, G382W	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000012510	3	30713744	3	30672252	12510	27549	rs104893814	NC_000003.12:30672251:G:T
NM_003242.6(TGFBR2):c.1063G>C (p.Ala355Pro)	TGFBR2	A355P, A380P	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000012509	3	30713738	3	30672246	12509	27548	rs104893813	NC_000003.12:30672245:G:C
NM_003242.6(TGFBR2):c.1006T>A (p.Tyr336Asn)	TGFBR2	Y336N, Y361N	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000012508	3	30713681	3	30672189	12508	27547	rs104893812	NC_000003.12:30672188:T:A
NM_003242.6(TGFBR2):c.1346C>T (p.Ser449Phe)	TGFBR2	S449F, S474F	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000012506	3	30715688	3	30674196	12506	27545	rs104893807	NC_000003.12:30674195:C:T
NM_001168272.1(ITPR1):c.6281A>G (p.Glu2094Gly)	ITPR1	E2094G, E2061G, E2046G	Gillespie syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000235921	3	4821268	3	4779584	235921	237579	rs878853177	NC_000003.12:4779583:A:G
NM_001168272.1(ITPR1):c.2137C>T (p.Arg713Ter)	ITPR1	R728*, R713*	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235916	3	4712588	3	4670904	235916	237574	rs878853172	NC_000003.12:4670903:C:T
NM_001168272.1(ITPR1):c.7307T>C (p.Leu2436Pro)	ITPR1	L2436P, L2388P, L2403P		Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000503525	3	4853028	3	4811344	503525	494950	rs1553756062	NC_000003.12:4811343:T:C
NM_001168272.1(ITPR1):c.1657A>G (p.Arg553Gly)	ITPR1	R553G, R568G		Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000503523	3	4706969	3	4665285	503523	494946	rs1322796318	NC_000003.12:4665284:A:G
NM_001168272.1(ITPR1):c.5459T>C (p.Leu1820Pro)	ITPR1	L1787P, L1820P, L1772P		Pathogenic(Last reviewed: Aug 1, 2016)	no assertion criteria provided	VCV000253023	3	4776998	3	4735314	253023	247430	rs1114167316	NC_000003.12:4735313:T:C
NM_001168272.1(ITPR1):c.7739G>A (p.Gly2580Glu)	ITPR1	G2580E, G2532E, G2547E		Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000224119	3	4856819	3	4815135	224119	225849	rs869312685	NC_000003.12:4815134:G:A
NM_001168272.1(ITPR1):c.7783_7785AAG[1] (p.Lys2596del)	ITPR1	K2563del, K2596del	Gillespie syndrome	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000235919	3	4856861 - 4856863	3	4815177 - 4815179	235919	237577	rs878853175	NC_000003.12:4815176:AGAAGAAG:AGAAG
NM_001168272.1(ITPR1):c.1759A>G (p.Asn587Asp)	ITPR1	N602D, N587D		Pathogenic(Last reviewed: Sep 17, 2012)	no assertion criteria provided	VCV000039572	3	4709151	3	4667467	39572	48171	rs397514536	NC_000003.12:4667466:A:G
NM_000030.3(AGXT):c.584T>G (p.Met195Arg)	AGXT	M195R	Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000204113	2	241812455	2	240873038	204113	200517	rs180177244	NC_000002.12:240873037:T:G
NM_000030.3(AGXT):c.364C>T (p.Arg122Ter)	AGXT	R122*	Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000204097	2	241810066	2	240870649	204097	200482	rs180177210	NC_000002.12:240870648:C:T
NM_000297.4(PKD2):c.958C>T (p.Arg320Ter)	PKD2	R320*	Polycystic kidney disease, autosomal dominant|not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000562318	4	88959517	4	88038365	562318	553502	rs749004212	NC_000004.12:88038364:C:T
NM_003242.6(TGFBR2):c.1381T>C (p.Cys461Arg)	TGFBR2	C461R, C486R	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000393299	3	30715723	3	30674231	393299	380155	rs1553630457	NC_000003.12:30674230:T:C
NM_003242.6(TGFBR2):c.923T>C (p.Leu308Pro)	TGFBR2	L308P, L333P	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000012505	3	30713598	3	30672106	12505	27544	rs28934568	NC_000003.12:30672105:T:C
NM_173660.5(DOK7):c.54+25_55-38del	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000835508	4	3465170 - 3465184	4	3463443 - 3463457	835508	851602		NC_000004.12:3463442:GGGGGCGCGGGGGGGGGGGGCGCGGG:GGGGGCGCGGG
NM_000404.4(GLB1):c.175C>T (p.Arg59Cys)	GLB1	R59C, R29C, R107C	GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis||GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496895	3	33114106	3	33072614	496895	488319	rs756878418	NC_000003.12:33072613:G:A
NM_000404.4(GLB1):c.464T>G (p.Leu155Arg)	GLB1	L155R, L203R, L125R	Infantile GM1 gangliosidosis||GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265179	3	33107043	3	33065551	265179	259759	rs376710410	NC_000003.12:33065550:A:C
NM_000404.4(GLB1):c.1498A>G (p.Thr500Ala)	GLB1	T500A, T369A, T470A, T548A	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000942	3	33055784	3	33014292	942	15981	rs72555368	NC_000003.12:33014291:T:C
NM_018297.4(NGLY1):c.39del (p.Ser14fs)	NGLY1	S14fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000521914	3	25824843	3	25783352	521914	511479	rs1553666033	NC_000003.12:25783351:C:
NM_001168272.1(ITPR1):c.3203C>T (p.Pro1068Leu)	ITPR1	P1059L, P1068L, P1074L		Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000014801	3	4725156	3	4683472	14801	29840	rs121912425	NC_000003.12:4683471:C:T
NM_000046.5(ARSB):c.966G>A (p.Trp322Ter)	ARSB	W322*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559831	5	78181583	5	78885760	559831	550448	rs1554079318	NC_000005.10:78885759:C:T
NM_000046.5(ARSB):c.571C>T (p.Arg191Ter)	ARSB	R191*	not provided|Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488679	5	78260358	5	78964535	488679	481745	rs371886102	NC_000005.10:78964534:G:A
NM_000046.5(ARSB):c.245T>G (p.Leu82Arg)	ARSB	L82R	Mucopolysaccharidosis type 6	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000445290	5	78280827	5	78985004	445290	438563	rs749465732	NC_000005.10:78985003:A:C
NM_000046.5(ARSB):c.971G>T (p.Gly324Val)	ARSB	G324V	not provided|Mucopolysaccharidosis type 6	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092356	5	78181578	5	78885755	92356	98267	rs398123125	NC_000005.10:78885754:C:A
NM_001182.5(ALDH7A1):c.1317+2T>C	ALDH7A1		not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000593457	5	125887711	5	126552019	593457	584521	rs1389460034	NC_000005.10:126552018:A:G
NM_001182.5(ALDH7A1):c.50dup (p.Leu18fs)	ALDH7A1		Seizures	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000588446	5	125930840 - 125930841	5	126595148 - 126595149	588446	579107	rs1444879414	NC_000005.10:126595148:TT:TTT
NM_001182.5(ALDH7A1):c.177G>A (p.Trp59Ter)	ALDH7A1	W59*, W31*	not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000420019	5	125930714	5	126595022	420019	406610	rs1064794242	NC_000005.10:126595021:C:T
NM_001182.5(ALDH7A1):c.901_902del (p.Asn301fs)	ALDH7A1	N273fs, N301fs	not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000420017	5	125896786 - 125896787	5	126561094 - 126561095	420017	406607	rs1064794240	NC_000005.10:126561093:TT:
NM_001182.5(ALDH7A1):c.394-1G>C	ALDH7A1		not provided	Pathogenic(Last reviewed: Aug 22, 2015)	criteria provided, single submitter	VCV000419701	5	125918667	5	126582975	419701	406609	rs1064794053	NC_000005.10:126582974:C:G
NM_001182.5(ALDH7A1):c.1565+1G>T	ALDH7A1		not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000419377	5	125882015	5	126546323	419377	406605	rs1064793830	NC_000005.10:126546322:C:A
NM_001182.5(ALDH7A1):c.1281G>T (p.Glu427Asp)	ALDH7A1	E427D, E399D, E363D	not provided	Pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	VCV000204865	5	125887749	5	126552057	204865	201811	rs796052271	NC_000005.10:126552056:C:A
NM_001182.5(ALDH7A1):c.189_190AG[3] (p.Val65fs)	ALDH7A1		not provided	Pathogenic(Last reviewed: Sep 4, 2013)	criteria provided, single submitter	VCV000204862	5	125930698 - 125930699	5	126595006 - 126595007	204862	201838	rs796052270	NC_000005.10:126595006:CTCTC:CTCTCTC
NM_001182.5(ALDH7A1):c.1468del (p.Ala490fs)	ALDH7A1	A462fs, A490fs, A426fs	not provided	Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	VCV000204859	5	125885642	5	126549950	204859	201806	rs796052267	NC_000005.10:126549949:CCCC:CCC
NM_001182.5(ALDH7A1):c.607T>G (p.Trp203Gly)	ALDH7A1	W203G, W175G	not provided	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000204831	5	125912814	5	126577122	204831	201828	rs555896752	NC_000005.10:126577121:A:C
NM_001182.5(ALDH7A1):c.1093+1G>A	ALDH7A1		not provided	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000194033	5	125891622	5	126555930	194033	191196	rs794727058	NC_000005.10:126555929:C:T
NM_001182.5(ALDH7A1):c.1348G>T (p.Glu450Ter)	ALDH7A1	E386*, E422*, E450*	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000837711	5	125885955	5	126550263	837711	829859		NC_000005.10:126550262:C:A
NC_000005.10:g.(?_126582831)_(126584032_?)del	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jul 27, 2019)	criteria provided, single submitter	VCV000832420	5	125918523 - 125919724			832420	819531		
NM_001182.5(ALDH7A1):c.947dup (p.Ser317fs)	ALDH7A1		Seizures|not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000590098	5	125894992 - 125894993	5	126559300 - 126559301	590098	579106	rs778003597	NC_000005.10:126559300:GG:GGG
NM_001182.5(ALDH7A1):c.43_46dup (p.Ser16fs)	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000574950	5	125930844 - 125930845	5	126595152 - 126595153	574950	559979	rs767805540	NC_000005.10:126595152:TGGT:TGGTTGGT
NM_001182.5(ALDH7A1):c.532_542del (p.Leu178fs)	ALDH7A1	L150fs, L178fs	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000465331	5	125912879 - 125912889	5	126577187 - 126577197	465331	454973	rs765119568	NC_000005.10:126577186:TGCTCAATCAGTGC:TGC
NM_001182.5(ALDH7A1):c.530C>A (p.Ala177Glu)	ALDH7A1	A177E, A149E	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: May 7, 2016)	criteria provided, single submitter	VCV000410537	5	125912891	5	126577199	410537	395016	rs764417585	NC_000005.10:126577198:G:T
NM_001182.5(ALDH7A1):c.986G>A (p.Arg329Lys)	ALDH7A1	R329K, R301K	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000220512	5	125894954	5	126559262	220512	221554	rs864622558	NC_000005.10:126559261:C:T
NM_001182.5(ALDH7A1):c.1193G>T (p.Gly398Val)	ALDH7A1	G398V, G370V	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000220511	5	125889986	5	126554294	220511	221553	rs864622557	NC_000005.10:126554293:C:A
NM_001182.5(ALDH7A1):c.902A>T (p.Asn301Ile)	ALDH7A1	N273I, N301I, N328I	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000018001	5	125896786	5	126561094	18001	33040	rs121912711	NC_000005.10:126561093:T:A
NM_001182.5(ALDH7A1):c.1597del (p.Ala533fs)	ALDH7A1	A469fs, A505fs, A533fs	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000017999	5	125880680	5	126544988	17999	33038	rs387906574	NC_000005.10:126544987:CC:C
NM_001182.5(ALDH7A1):c.596C>T (p.Ala199Val)	ALDH7A1	A171V, A199V, A226V	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000017998	5	125912825	5	126577133	17998	33037	rs121912709	NC_000005.10:126577132:G:A
NM_001182.5(ALDH7A1):c.312+2T>A	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000017997	5	125928354	5	126592662	17997	33036	rs1561672504	NC_000005.10:126592661:A:T
NM_003242.6(TGFBR2):c.1379G>T (p.Arg460Leu)	TGFBR2	R460L, R485L	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000543900	3	30715721	3	30674229	543900	519234	rs104893816	NC_000003.12:30674228:G:T
NM_000532.5(PCCB):c.683C>T (p.Pro228Leu)	PCCB	P228L, P248L	not specified|Propionic acidemia|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198428	3	136012626	3	136293784	198428	195589	rs374722096	NC_000003.12:136293783:C:T
NM_000532.5(PCCB):c.990dup (p.Glu331Ter)	PCCB		Propionic acidemia|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167423	3	136035800 - 136035801	3	136316958 - 136316959	167423	177910	rs786200983	NC_000003.12:136316958:TTTTTT:TTTTTTT
NM_000532.5(PCCB):c.1228C>T (p.Arg410Trp)	PCCB	R412W, R410W, R430W	Propionic acidemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012011	3	136046026	3	136327184	12011	27050	rs121964959	NC_000003.12:136327183:C:T
NM_001182.5(ALDH7A1):c.312+1G>A	ALDH7A1		neonatal seizures|not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265384	5	125928355	5	126592663	265384	259807	rs199497486	NC_000005.10:126592662:C:T
NM_001182.5(ALDH7A1):c.1301_1302del (p.Tyr434fs)	ALDH7A1	Y370fs, Y406fs, Y434fs	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000863921	5	125887728 - 125887729	5	126552036 - 126552037	863921	829860		NC_000005.10:126552035:ATA:A
NC_000005.9:g.(?_125911092)_(125911176_?)del	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000584164	5	125911092 - 125911176	5	126575400 - 126575484	584164	559827		
NM_001182.5(ALDH7A1):c.796C>T (p.Arg266Ter)	ALDH7A1	R266*, R238*	not provided|Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000465333	5	125904026	5	126568334	465333	454970	rs1270423610	NC_000005.10:126568333:G:A
NM_001182.5(ALDH7A1):c.584A>G (p.Asn195Ser)	ALDH7A1	N195S, N167S	Pyridoxine-dependent epilepsy|not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000219413	5	125912837	5	126577145	219413	221555	rs372660425	NC_000005.10:126577144:T:C
NM_001182.5(ALDH7A1):c.1224T>G (p.Tyr408Ter)	ALDH7A1	Y380*, Y371*, Y408*, Y344*	Pyridoxine-dependent epilepsy|not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000018000	5	125887806	5	126552114	18000	33039	rs121912710	NC_000005.10:126552113:A:C
NM_001163213.1(FGFR3):c.835A>T (p.Ser279Cys)	FGFR3	S279C	Hypochondroplasia|not provided|Achondroplasia	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000016356	4	1803657	4	1801930	16356	31395	rs121913114	NC_000004.12:1801929:A:T
NM_001163213.1(FGFR3):c.1956G>C (p.Lys652Asn)	FGFR3	K650N, K652N, K651N, K538N	Craniosynostosis|Hypochondroplasia	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000016347	4	1807891	4	1806164	16347	31386	rs28928868	NC_000004.12:1806163:G:C
NM_001163213.1(FGFR3):c.1955A>T (p.Lys652Met)	FGFR3	K650M, K652M, K538M, K651M	Thanatophoric dysplasia type 1|SEVERE ACHONDRODYSPLASIA WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000016341	4	1807890	4	1806163	16341	31380	rs121913105	NC_000004.12:1806162:A:T
NM_173660.5(DOK7):c.810_811del (p.His272fs)	DOK7	H128fs, H272fs	Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000841000	4	3494523 - 3494524	4	3492796 - 3492797	841000	829082		NC_000004.12:3492795:CA:
NM_173660.5(DOK7):c.743_744TC[4] (p.His250fs)	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000583395	4	3491492 - 3491493	4	3489765 - 3489766	583395	559659	rs1560224831	NC_000004.12:3489765:CTCTC:CTCTCTCTC
NM_173660.5(DOK7):c.331+1G>T	DOK7		not provided|Myasthenia, limb-girdle, familial|FETAL AKINESIA DEFORMATION SEQUENCE 3	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000449547	4	3475364	4	3473637	449547	443612	rs1349476281	NC_000004.12:3473636:G:T
NM_001370658.1(BTD):c.641C>T (p.Thr214Ile)	BTD	T234I, T214I, T236I	Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000156003	3	15686064	3	15644557	156003	165807	rs587783005	NC_000003.12:15644556:C:T
NM_001370658.1(BTD):c.1274G>T (p.Gly425Val)	BTD	G445V, G425V, G447V	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025082	3	15686697	3	15645190	25082	36396	rs397514402	NC_000003.12:15645189:G:T
NM_001370658.1(BTD):c.583C>T (p.Leu195Phe)	BTD	L215F, L195F, L217F	Biotinidase deficiency	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000025031	3	15686006	3	15644499	25031	36368	rs190386869	NC_000003.12:15644498:C:T
NM_001182.5(ALDH7A1):c.1003C>T (p.Arg335Ter)	ALDH7A1	R335*, R307*	Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000652356	5	125894937	5	126559245	652356	632898		NC_000005.10:126559244:G:A
NM_001182.5(ALDH7A1):c.503_506del (p.Ile168fs)	ALDH7A1	I168fs, I140fs	Pyridoxine-dependent epilepsy|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420018	5	125918554 - 125918557	5	126582862 - 126582865	420018	406608	rs1064794241	NC_000005.10:126582861:AAGA:
NM_001182.5(ALDH7A1):c.518-1G>C	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000017996	5	125912904	5	126577212	17996	33035	rs779494572	NC_000005.10:126577211:C:G
NM_003060.4(SLC22A5):c.56_57delinsCT (p.Arg19Pro)	SLC22A5		not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000595954	5	131705720 - 131705721	5	132370028 - 132370029	595954	587015	rs1561560424	NC_000005.10:132370027:GC:CT
NM_001457.4(FLNB):c.1082G>A (p.Gly361Asp)	FLNB	G361D	not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000432006	3	58083639	3	58097912	432006	425576	rs794727854	NC_000003.12:58097911:G:A
NM_003060.4(SLC22A5):c.77G>A (p.Ser26Asn)	SLC22A5	S26N	not provided	Pathogenic(Last reviewed: Mar 7, 2015)	criteria provided, single submitter	VCV000379259	5	131705741	5	132370049	379259	368341	rs772578415	NC_000005.10:132370048:G:A
NM_001457.4(FLNB):c.6616G>T (p.Gly2206Ter)	FLNB	G2206*, G2237*, G2182*, G2195*	not provided	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000285620	3	58139350	3	58153623	285620	269857	rs886043158	NC_000003.12:58153622:G:T
NM_003060.4(SLC22A5):c.1053-3_1053-2delinsTC	SLC22A5		not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000280829	5	131726379 - 131726380	5	132390687 - 132390688	280829	264197	rs886041967	NC_000005.10:132390686:CA:TC
NM_003060.4(SLC22A5):c.395G>A (p.Trp132Ter)	SLC22A5	W132*, W156*	not provided	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000279949	5	131714071	5	132378379	279949	264226	rs886041277	NC_000005.10:132378378:G:A
NM_003060.4(SLC22A5):c.1595_1604dup (p.Pro536fs)	SLC22A5		not provided	Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	VCV000203937	5	131729880 - 131729881	5	132394188 - 132394189	203937	200094	rs796052040	NC_000005.10:132394188:AAACACAGAAAAAC:AAACACAGAAAAACACAGAAAAAC
NM_003060.4(SLC22A5):c.42G>A (p.Trp14Ter)	SLC22A5	W14*	not provided	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000203933	5	131705706	5	132370014	203933	200082	rs796052036	NC_000005.10:132370013:G:A
NM_003060.4(SLC22A5):c.394-2A>C	SLC22A5		not provided	Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	VCV000167697	5	131714068	5	132378376	167697	178075	rs377724489	NC_000005.10:132378375:A:C
NM_001457.4(FLNB):c.5555-5_5561del	FLNB		Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000807602	3	58132540 - 58132551	3	58146813 - 58146824	807602	798536		NC_000003.12:58146812:CTTGTAGGTGGTCT:CT
NM_003060.4(SLC22A5):c.1188T>G (p.Tyr396Ter)	SLC22A5	Y396*, Y420*	Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 1, 2016)	no assertion criteria provided	VCV000375238	5	131726517	5	132390825	375238	361941	rs1057519051	NC_000005.10:132390824:T:G
NM_003060.4(SLC22A5):c.1365dup (p.Thr456fs)	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: May 26, 2016)	no assertion criteria provided	VCV000236194	5	131728219 - 131728220	5	132392527 - 132392528	236194	237755	rs878853248	NC_000005.10:132392527:CCC:CCCC
NM_001457.4(FLNB):c.502G>A (p.Gly168Ser)	FLNB	G168S	FLNB-Related Disorders	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000038961	3	58062982	3	58077255	38961	47564	rs80356504	NC_000003.12:58077254:G:A
NM_001457.4(FLNB):c.4835G>A (p.Gly1612Asp)	FLNB	G1612D, G1643D	FLNB-Related Disorders	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000038960	3	58121869	3	58136142	38960	47563	rs80356505	NC_000003.12:58136141:G:A
NM_001457.4(FLNB):c.512T>A (p.Leu171Gln)	FLNB	L171Q	Atelosteogenesis type 1	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000038344	3	58062992	3	58077265	38344	46907	rs80356494	NC_000003.12:58077264:T:A
NM_001457.4(FLNB):c.700C>G (p.Leu234Val)	FLNB	L234V	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021296	3	58067416	3	58081689	21296	34148	rs80356507	NC_000003.12:58081688:C:G
NM_001457.4(FLNB):c.629G>T (p.Gly210Val)	FLNB	G210V		Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021295	3	58064531	3	58078804	21295	34147	rs80356500	NC_000003.12:58078803:G:T
NM_001457.4(FLNB):c.608A>C (p.Gln203Pro)	FLNB	Q203P	Atelosteogenesis type 1	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021294	3	58064510	3	58078783	21294	34146	rs80356497	NC_000003.12:58078782:A:C
NM_001457.4(FLNB):c.602C>T (p.Ala201Val)	FLNB	A201V		Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021293	3	58064504	3	58078777	21293	34145	rs80356499	NC_000003.12:58078776:C:T
NM_001457.4(FLNB):c.549C>G (p.Cys183Trp)	FLNB	C183W	Atelosteogenesis type 1	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021291	3	58064451	3	58078724	21291	34143	rs80356496	NC_000003.12:58078723:C:G
NM_001457.4(FLNB):c.542G>T (p.Gly181Val)	FLNB	G181V	Atelosteogenesis type 1	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021290	3	58064444	3	58078717	21290	34142	rs80356495	NC_000003.12:58078716:G:T
NM_001457.4(FLNB):c.4927G>T (p.Ala1643Ser)	FLNB	A1643S, A1674S		Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021288	3	58124074	3	58138347	21288	34140	rs80356502	NC_000003.12:58138346:G:T
NM_001457.4(FLNB):c.4808C>T (p.Pro1603Leu)	FLNB	P1603L, P1634L	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021287	3	58121842	3	58136115	21287	34139	rs80356515	NC_000003.12:58136114:C:T
NM_001457.4(FLNB):c.4804T>C (p.Ser1602Pro)	FLNB	S1602P, S1633P		Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021286	3	58121838	3	58136111	21286	34138	rs80356501	NC_000003.12:58136110:T:C
NM_001457.4(FLNB):c.4775T>A (p.Val1592Asp)	FLNB	V1592D, V1623D	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021285	3	58121809	3	58136082	21285	34137	rs80356514	NC_000003.12:58136081:T:A
NM_001457.4(FLNB):c.4747_4749del (p.Asp1583del)	FLNB	D1583del, D1614del	Atelosteogenesis type 1	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021284	3	58121780 - 58121782	3	58136053 - 58136055	21284	34136	rs80356498	NC_000003.12:58136052:CGAC:C
NM_001457.4(FLNB):c.4713_4715del (p.Asn1571del)	FLNB	N1571del, N1602del	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021283	3	58121745 - 58121747	3	58136018 - 58136020	21283	34135	rs80356512	NC_000003.12:58136017:AATAA:AA
NM_001457.4(FLNB):c.442T>A (p.Trp148Arg)	FLNB	W148R	Atelosteogenesis type 1	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021282	3	58062922	3	58077195	21282	34134	rs80356493	NC_000003.12:58077194:T:A
NM_001457.4(FLNB):c.4292T>G (p.Leu1431Arg)	FLNB	L1431R	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021281	3	58116537	3	58130810	21281	34133	rs80356511	NC_000003.12:58130809:T:G
NM_001457.4(FLNB):c.1088G>A (p.Gly363Glu)	FLNB	G363E	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021279	3	58083645	3	58097918	21279	34131	rs80356510	NC_000003.12:58097917:G:A
NM_001457.4(FLNB):c.1081G>A (p.Gly361Ser)	FLNB	G361S	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021278	3	58083638	3	58097911	21278	34130	rs80356509	NC_000003.12:58097910:G:A
NC_000005.10:g.(?_132368084)_(132370375_?)del	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000833197	5	131703776 - 131706067			833197	819536		
NM_001457.4(FLNB):c.4928C>T (p.Ala1643Val)	FLNB	A1643V, A1674V	Larsen syndrome, dominant type	Pathogenic	criteria provided, single submitter	VCV000694710	3	58124075	3	58138348	694710	682802		NC_000003.12:58138347:C:T
NM_003060.4(SLC22A5):c.845dup (p.Trp283fs)	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000659511	5	131722736 - 131722737	5	132387044 - 132387045	659511	633063		NC_000005.10:132387044:G:GG
NC_000005.9:g.(?_131719819)_(131728327_?)del	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000649071	5	131719819 - 131728327	5	132384127 - 132392635	649071	651249		
NM_003060.4(SLC22A5):c.1158del (p.Tyr387fs)	SLC22A5	Y387fs, Y411fs	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645158	5	131726487	5	132390795	645158	633072		NC_000005.10:132390794:A:
NM_001457.4(FLNB):c.1592dup (p.His532fs)	FLNB		Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	no assertion criteria provided	VCV000633651	3	58089787 - 58089788	3	58104060 - 58104061	633651	622083	rs746105983	NC_000003.12:58104060:GGGGGGG:GGGGGGGG
NM_003060.4(SLC22A5):c.361C>T (p.Gln121Ter)	SLC22A5	Q121*	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522874	5	131706025	5	132370333	522874	513554	rs1554086010	NC_000005.10:132370332:C:T
NM_003060.4(SLC22A5):c.881del (p.Glu294fs)	SLC22A5	E294fs, E318fs	Renal carnitine transport defect	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000460418	5	131722773	5	132387081	460418	454857	rs1554087719	NC_000005.10:132387080:A:
NM_003060.4(SLC22A5):c.818T>C (p.Leu273Pro)	SLC22A5	L273P, L297P	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000460417	5	131721185	5	132385493	460417	454358	rs760320629	NC_000005.10:132385492:T:C
NM_003060.4(SLC22A5):c.755del (p.Phe252fs)	SLC22A5	F252fs, F276fs	Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000460413	5	131721121	5	132385429	460413	454354	rs1554087491	NC_000005.10:132385428:TT:T
NM_003060.4(SLC22A5):c.1172G>A (p.Trp391Ter)	SLC22A5	W391*, W415*	Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000460392	5	131726501	5	132390809	460392	454864	rs1554088165	NC_000005.10:132390808:G:A
NM_001457.4(FLNB):c.517G>A (p.Ala173Thr)	FLNB	A173T	Atelosteogenesis type 1	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000126375	3	58062997	3	58077270	126375	131909	rs587777259	NC_000003.12:58077269:G:A
NM_003060.3:c.654_825del	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 18, 1998)	no assertion criteria provided	VCV000006415					6415	21454		
NM_003060.4(SLC22A5):c.653_654insTATGGCCATCAGGTTGGAG (p.Thr219fs)	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 18, 1998)	no assertion criteria provided	VCV000006414	5	131721019 - 131721020	5	132385327 - 132385328	6414	21453	rs1554087461	NC_000005.10:132385327:G:GTATGGCCATCAGGTTGGAG
SLC22A5, IVS8AS, G-A, -1	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000006412					6412	21451		
NM_001457.4(FLNB):c.5548G>T (p.Gly1850Ter)	FLNB	G1850*, G1839*, G1881*, G1826*	Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000006408	3	58131770	3	58146043	6408	21447	rs121908898	NC_000003.12:58146042:G:T
NM_001457.4(FLNB):c.6010C>T (p.Arg2004Ter)	FLNB	R2004*, R1993*, R2035*, R1980*	Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: Mar 15, 2008)	no assertion criteria provided	VCV000006407	3	58134498	3	58148771	6407	21446	rs121908897	NC_000003.12:58148770:C:T
NM_001457.4(FLNB):c.518C>T (p.Ala173Val)	FLNB	A173V	Atelosteogenesis type 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000006400	3	58062998	3	58077271	6400	21439	rs121908894	NC_000003.12:58077270:C:T
NM_000030.3(AGXT):c.817_818AG[5] (p.Ser275fs)	AGXT		Primary hyperoxaluria|Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000204201	2	241815390 - 241815391	2	240875973 - 240875974	204201	200558	rs180177273	NC_000002.12:240875973:GAGAGAGAG:GAGAGAGAGAG
NM_000030.3(AGXT):c.846+1G>T	AGXT		not provided|Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000204159	2	241815422	2	240876005	204159	200568	rs180177281	NC_000002.12:240876004:G:T
NM_000030.3(AGXT):c.613T>C (p.Ser205Pro)	AGXT	S205P	Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000005640	2	241813412	2	240873995	5640	20679	rs121908520	NC_000002.12:240873994:T:C
NM_003060.4(SLC22A5):c.825-52G>A	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000842614	5	131722665	5	132386973	842614	851850		NC_000005.10:132386972:G:A
NM_003060.4(SLC22A5):c.71del (p.Leu24fs)	SLC22A5	L24fs	not provided|Renal carnitine transport defect	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000423731	5	131705735	5	132370043	423731	406630	rs775502377	NC_000005.10:132370042:T:
NM_003060.4(SLC22A5):c.160_166dup (p.Ala56fs)	SLC22A5		Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370825	5	131705819 - 131705820	5	132370127 - 132370128	370825	357381	rs1057516797	NC_000005.10:132370127:GCCGGACGCCG:GCCGGACGCCGGACGCCG
NM_001457.4(FLNB):c.5500G>A (p.Gly1834Arg)	FLNB	G1834R, G1810R, G1823R, G1865R	Larsen syndrome, dominant type	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000021292	3	58131722	3	58145995	21292	34144	rs80356516	NC_000003.12:58145994:G:A
NM_003060.4(SLC22A5):c.1051T>C (p.Trp351Arg)	SLC22A5	W351R, W375R	Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006423	5	131724712	5	132389020	6423	21462	rs68018207	NC_000005.10:132389019:T:C
NM_003060.4(SLC22A5):c.1304del (p.Gly435fs)	SLC22A5	G434AfsX24, G459fs, G435fs	Renal carnitine transport defect	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000006418	5	131728159	5	132392467	6418	21457	rs386134217	NC_000005.10:132392466:GGG:GG
SLC22A5, 1394-BP DEL	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 18, 1998)	no assertion criteria provided	VCV000006413					6413	21452		
SLC22A5, 1-BP INS, 226C	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000006410					6410	21449		
SLC22A5, 113-BP DEL	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000006409					6409	21448		
NM_001457.4(FLNB):c.703T>C (p.Ser235Pro)	FLNB	S235P	Boomerang dysplasia	Pathogenic(Last reviewed: Jul 15, 2007)	no assertion criteria provided	VCV000006404	3	58067419	3	58081692	6404	21443	rs121908896	NC_000003.12:58081691:T:C
NM_001457.4(FLNB):c.512T>G (p.Leu171Arg)	FLNB	L171R	Boomerang dysplasia	Pathogenic(Last reviewed: Jul 15, 2007)	no assertion criteria provided	VCV000006403	3	58062992	3	58077265	6403	21442	rs80356494	NC_000003.12:58077264:T:G
NM_001457.4(FLNB):c.4819C>T (p.Arg1607Ter)	FLNB	R1607*, R1638*	Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000006397	3	58121853	3	58136126	6397	21436	rs80356520	NC_000003.12:58136125:C:T
NM_001457.4(FLNB):c.2452C>T (p.Arg818Ter)	FLNB	R818*	Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000006396	3	58095865	3	58110138	6396	21435	rs80356519	NC_000003.12:58110137:C:T
NM_001457.4(FLNB):c.6408del (p.Ser2137fs)	FLNB	S2137*, S2113fs, S2126fs, S2137fs, S2168fs	Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000006395	3	58139139	3	58153412	6395	21434	rs80356521	NC_000003.12:58153411:CCCC:CCC
NM_000112.3(SLC26A2):c.485_486delTG	SLC26A2		||Achondrogenesis, type IB|Diastrophic dysplasia||Achondrogenesis, type IB||Diastrophic dysplasia|Osteochondrodysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371777	5	149357698 - 149357699	5	149978135 - 149978136	371777	357396	rs763198695	NC_000005.10:149978134:TGTG:TG
NM_003722.5(TP63):c.1028G>A (p.Arg343Gln)	TP63	R304Q, R343Q, R164Q, R249Q, R341Q	TP63-Related Spectrum Disorders|not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006534	3	189586404	3	189868615	6534	21573	rs121908841	NC_000003.12:189868614:G:A
NM_003060.4(SLC22A5):c.797C>T (p.Pro266Leu)	SLC22A5	P290L, P266L	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000846688	5	131721164	5	132385472	846688	830065		NC_000005.10:132385471:C:T
NM_003060.4(SLC22A5):c.148del (p.Cys50fs)	SLC22A5	C50PfsX9, C50fs	Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038795	5	131705812	5	132370120	38795	47400	rs386134227	NC_000005.10:132370119:T:
NM_003060.4(SLC22A5):c.844del (p.Arg282fs)	SLC22A5	R282NfsX14, R282fs, R306fs	Renal carnitine transport defect	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000025399	5	131722731	5	132387039	25399	36733	rs386134209	NC_000005.10:132387038:CCCCCC:CCCCC
NM_001457.4(FLNB):c.1945C>T (p.Arg649Ter)	FLNB	R649*	Spondylocarpotarsal synostosis syndrome	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021280	3	58094188	3	58108461	21280	34132	rs80356517	NC_000003.12:58108460:C:T
NM_001457.4(FLNB):c.604A>G (p.Met202Val)	FLNB	M202V	Atelosteogenesis type 1|	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000006401	3	58064506	3	58078779	6401	21440	rs121908895	NC_000003.12:58078778:A:G
NM_001457.4(FLNB):c.4756G>A (p.Gly1586Arg)	FLNB	G1586R, G1617R	Larsen syndrome, dominant type|Larsen syndrome	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000006399	3	58121790	3	58136063	6399	21438	rs80356513	NC_000003.12:58136062:G:A
NM_001457.4(FLNB):c.482T>G (p.Phe161Cys)	FLNB	F161C	Larsen syndrome, dominant type|Larsen syndrome	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000006398	3	58062962	3	58077235	6398	21437	rs80356506	NC_000003.12:58077234:T:G
NM_001182.5(ALDH7A1):c.1008+1G>A	ALDH7A1		Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000856181	5	125894931	5	126559239	856181	851833		NC_000005.10:126559238:C:T
NM_001182.5(ALDH7A1):c.1004G>A (p.Arg335Gln)	ALDH7A1	R335Q, R307Q	not provided|Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204832	5	125894936	5	126559244	204832	201822	rs754449549	NC_000005.10:126559243:C:T
NM_003060.4(SLC22A5):c.1554del (p.Asp519fs)	SLC22A5	D519fs, D543fs	Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551727	5	131729471	5	132393779	551727	543685	rs1554088578	NC_000005.10:132393778:A:
NM_003060.4(SLC22A5):c.1252C>T (p.Gln418Ter)	SLC22A5	Q418*, Q442*	Renal carnitine transport defect|not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373229	5	131726581	5	132390889	373229	359638	rs1057518297	NC_000005.10:132390888:C:T
NM_003060.4(SLC22A5):c.1053-2A>C	SLC22A5		Renal carnitine transport defect|not specified|not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203929	5	131726380	5	132390688	203929	200090	rs777004046	NC_000005.10:132390687:A:C
NM_003060.4(SLC22A5):c.1556_1557AC[4] (p.Ile521fs)	SLC22A5		Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000025429	5	131729472 - 131729473	5	132393780 - 132393781	25429	36763	rs386134225	NC_000005.10:132393780:ACAC:ACACACAC
NM_001457.4(FLNB):c.679G>A (p.Glu227Lys)	FLNB	E227K	Larsen syndrome, dominant type|Larsen syndrome	Pathogenic(Last reviewed: Oct 9, 2008)	no assertion criteria provided	VCV000006405	3	58067395	3	58081668	6405	21444	rs80356508	NC_000003.12:58081667:G:A
NM_003242.6(TGFBR2):c.1409A>G (p.Tyr470Cys)	TGFBR2	Y470C, Y495C	Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000834654	3	30729888	3	30688396	834654	827866		NC_000003.12:30688395:A:G
NM_003242.6(TGFBR2):c.1512G>A (p.Trp504Ter)	TGFBR2	W504*, W529*	Loeys-Dietz syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694685	3	30729991	3	30688499	694685	682801		NC_000003.12:30688498:G:A
NM_003242.6(TGFBR2):c.1397-1G>A	TGFBR2		Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000477538	3	30729875	3	30688383	477538	452525	rs1553631693	NC_000003.12:30688382:G:A
NM_003242.6(TGFBR2):c.1524G>A (p.Gln508=)	TGFBR2	Q508Q	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000012504	3	30730003	3	30688511	12504	27543	rs121918715	NC_000003.12:30688510:G:A
NM_003060.4(SLC22A5):c.1412G>A (p.Arg471His)	SLC22A5	R471H, R495H	Renal carnitine transport defect	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000025426	5	131728269	5	132392577	25426	36760	rs386134223	NC_000005.10:132392576:G:A
NM_003060.4(SLC22A5):c.652+1G>A	SLC22A5		Renal carnitine transport defect	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025381	5	131719994	5	132384302	25381	36715	rs386134200	NC_000005.10:132384301:G:A
NM_003060.4(SLC22A5):c.83G>T (p.Ser28Ile)	SLC22A5	S28I	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000025354	5	131705747	5	132370055	25354	36688	rs72552724	NC_000005.10:132370054:G:T
NM_003060.4(SLC22A5):c.12C>G (p.Tyr4Ter)	SLC22A5	Y4*	Renal carnitine transport defect	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025347	5	131705676	5	132369984	25347	36681	rs72552722	NC_000005.10:132369983:C:G
NM_002880.3(RAF1):c.1279A>G (p.Ser427Gly)	RAF1	S427G, S346G, S313G, S366G, S394G, S447G	not provided	Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	VCV000040616	3	12632388	3	12590889	40616	49086	rs730881002	NC_000003.12:12590888:T:C
NM_002880.3(RAF1):c.785A>T (p.Asn262Ile)	RAF1	N262I, N148I, N181I, N229I	not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181517	3	12645684	3	12604185	181517	179053	rs730881010	NC_000003.12:12604184:T:A
NM_002880.3(RAF1):c.709G>A (p.Ala237Thr)	RAF1	A237T, A156T, A123T, A204T	Cardiomyopathy, dilated, 1NN	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000142299	3	12645760	3	12604261	142299	152013	rs587777588	NC_000003.12:12604260:C:T
NM_002880.3(RAF1):c.1808T>C (p.Leu603Pro)	RAF1	L603P, L623P, L522P, L542P, L489P, L570P	Cardiomyopathy, dilated, 1NN	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000142296	3	12626152	3	12584653	142296	152010	rs587777586	NC_000003.12:12584652:A:G
NM_002880.3(RAF1):c.1456G>A (p.Asp486Asn)	RAF1	D486N, D425N, D506N, D372N, D405N, D453N	Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Nov 16, 2010)	no assertion criteria provided	VCV000021341	3	12627260	3	12585761	21341	34193	rs80338798	NC_000003.12:12585760:C:T
NM_001182.5(ALDH7A1):c.589C>T (p.Pro197Ser)	ALDH7A1	P197S, P169S	not provided|Pyridoxine-dependent epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426363	5	125912832	5	126577140	426363	414979	rs779652673	NC_000005.10:126577139:G:A
NC_000005.10:g.(?_78964406)_(78969202_?)del	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000831749	5	78260229 - 78265025			831749	819612		
NM_000046.5(ARSB):c.478C>T (p.Arg160Ter)	ARSB	R160*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000445291	5	78264850	5	78969027	445291	438559	rs1255777033	NC_000005.10:78969026:G:A
NM_000046.5(ARSB):c.284G>A (p.Arg95Gln)	ARSB	R95Q	Mucopolysaccharidosis type 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000884	5	78280788	5	78984965	884	15923	rs118203942	NC_000005.10:78984964:C:T
NM_001023570.4(IQCB1):c.1381C>T (p.Arg461Ter)	IQCB1	R461*, R328*	not provided|Senior-Loken syndrome 5|Senior Loken syndrome|Nephronophthisis|Retinal dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001830	3	121500619	3	121781772	1830	16869	rs121918244	NC_000003.12:121781771:G:A
NM_002880.3(RAF1):c.1922C>T (p.Thr641Met)	RAF1	T641M, T580M, T608M, T560M, T661M, T527M	Dilated cardiomyopathy|Cardiomyopathy, dilated, 1NN	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000142298	3	12626038	3	12584539	142298	152012	rs587777587	NC_000003.12:12584538:G:A
NM_001354730.1(XPC):c.1626+13TG[2]	XPC		not provided|Xeroderma pigmentosum|Xeroderma pigmentosum, group C	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000262	3	14199739 - 14199740	3	14158239 - 14158240	262	15301	rs754532049	NC_000003.12:14158238:CACACA:CACA
NM_003060.4(SLC22A5):c.1462C>T (p.Arg488Cys)	SLC22A5	R488C, R512C	not provided|Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000460399	5	131729379	5	132393687	460399	455126	rs377216516	NC_000005.10:132393686:C:T
NM_003060.4(SLC22A5):c.1411C>T (p.Arg471Cys)	SLC22A5	R471C, R495C	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000460398	5	131728268	5	132392576	460398	455119	rs749282641	NC_000005.10:132392575:C:T
NM_000030.3(AGXT):c.139G>A (p.Gly47Arg)	AGXT	G47R	not provided|Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000204076	2	241808421	2	240869004	204076	200437	rs180177173	NC_000002.12:240869003:G:A
NM_002880.3(RAF1):c.505G>C (p.Gly169Arg)	RAF1	G169R, G88R	not provided|LEOPARD syndrome 2|Noonan syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265535	3	12650341	3	12608842	265535	259750	rs886039607	NC_000003.12:12608841:C:G
NM_001354689.3(RAF1):c.1483T>C (p.Phe495Leu)	RAF1	F475L, F495L, F394L, F361L, F414L, F442L	not provided|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040617	3	12627293	3	12585794	40617	49087	rs730881003	NC_000003.12:12585793:A:G
NM_001354689.3(RAF1):c.524A>G (p.His175Arg)	RAF1	H175R, H94R	Noonan syndrome|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040594	3	12650322	3	12608823	40594	49064	rs397516822	NC_000003.12:12608822:T:C
NM_173660.5(DOK7):c.513C>T (p.Gly171=)	DOK7		Myasthenia, limb-girdle, familial|not provided|Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429791	4	3478250	4	3476523	429791	421486	rs775583136	NC_000004.12:3476522:C:T
NM_001370658.1(BTD):c.527del (p.Thr176fs)	BTD	T176fs	Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000528478	3	15685950	3	15644443	528478	518948	rs1553653680	NC_000003.12:15644442:C:
NM_001370658.1(BTD):c.1181_1192del (p.Tyr394_Val397del)	BTD	p.Y414-V417del	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000038573	3	15686602 - 15686613	3	15645095 - 15645106	38573	47162	rs397514404	NC_000003.12:15645094:CTATCTCCACGTCT:CT
NM_001370658.1(BTD):c.124G>A (p.Val42Met)	BTD	V62M, V42M, V64M	Biotinidase deficiency	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038487	3	15677070	3	15635563	38487	46846	rs397507170	NC_000003.12:15635562:G:A
NM_001370658.1(BTD):c.399G>A (p.Glu133=)	BTD	E153E	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025009	3	15683564	3	15642057	25009	36347	rs397514360	NC_000003.12:15642056:G:A
NM_000539.3(RHO):c.1040C>T (p.Pro347Leu)	RHO	P347L	not provided|Retinitis pigmentosa|Retinitis pigmentosa 4|Blurred vision|Peripheral visual field loss|Nyctalopia|Retinal dystrophy	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013014	3	129252554	3	129533711	13014	28053	rs29001566	NC_000003.12:129533710:C:T
NM_001354689.3(RAF1):c.766A>G (p.Arg256Gly)	RAF1	R256G, R142G, R175G, R223G	Noonan syndrome|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044631	3	12645703	3	12604204	44631	53798	rs397516825	NC_000003.12:12604203:T:C
NM_003060.4(SLC22A5):c.338G>A (p.Cys113Tyr)	SLC22A5	C113Y	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167696	5	131706002	5	132370310	167696	177225	rs727504159	NC_000005.10:132370309:G:A
NM_003060.4(SLC22A5):c.1175_1177TGC[2] (p.Leu394del)	SLC22A5	L394del	not provided|Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025410	5	131726502 - 131726504	5	132390810 - 132390812	25410	36744	rs386134215	NC_000005.10:132390809:GCTGCTGCTGC:GCTGCTGC
NM_003060.4(SLC22A5):c.865C>T (p.Arg289Ter)	SLC22A5	R289*, R313*	Renal carnitine transport defect	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000025404	5	131722757	5	132387065	25404	36738	rs386134212	NC_000005.10:132387064:C:T
NM_001163213.1(FGFR3):c.251C>T (p.Ser84Leu)	FGFR3	S84L	Thanatophoric dysplasia type 1|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Thanatophoric dysplasia, type 2|Hypochondroplasia|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Hypochondroplasia	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000016358	4	1801122	4	1799395	16358	31397	rs121913116	NC_000004.12:1799394:C:T
NM_000046.5(ARSB):c.979C>T (p.Arg327Ter)	ARSB	R327*	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000559832	5	78181570	5	78885747	559832	550447	rs773492223	NC_000005.10:78885746:G:A
NM_000046.5(ARSB):c.962T>C (p.Leu321Pro)	ARSB	L321P	Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000559830	5	78181587	5	78885764	559830	550449	rs1554079320	NC_000005.10:78885763:A:G
NM_000046.5(ARSB):c.430G>A (p.Gly144Arg)	ARSB	G144R	Mucopolysaccharidosis type 6	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559783	5	78264898	5	78969075	559783	550496	rs746206847	NC_000005.10:78969074:C:T
NM_000046.5(ARSB):c.753C>G (p.Tyr251Ter)	ARSB	Y251*	Mucopolysaccharidosis type 6|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488822	5	78251263	5	78955440	488822	481744	rs765711776	NC_000005.10:78955439:G:C
NM_001182.5(ALDH7A1):c.1566-1G>T	ALDH7A1		not provided|Pyridoxine-dependent epilepsy|Seizures|Ventriculomegaly	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374140	5	125880712	5	126545020	374140	360865	rs140845195	NC_000005.10:126545019:C:A
NM_001354689.3(RAF1):c.786T>A (p.Asn262Lys)	RAF1	N262K, N148K, N229K, N181K	not provided|Noonan syndrome	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044634	3	12645683	3	12604184	44634	53801	rs397516829	NC_000003.12:12604183:A:T
NM_002880.3(RAF1):c.776C>T (p.Ser259Phe)	RAF1	S259F, S226F, S145F, S178F	Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000040603	3	12645693	3	12604194	40603	49073	rs397516827	NC_000003.12:12604193:G:A
NM_003242.6(TGFBR2):c.1408T>G (p.Tyr470Asp)	TGFBR2	Y470D, Y495D	Loeys-Dietz syndrome 2|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	VCV000217016	3	30729887	3	30688395	217016	213550	rs863224935	NC_000003.12:30688394:T:G
NM_004453.4(ETFDH):c.1130T>C (p.Leu377Pro)	ETFDH	L377P, L316P, L330P	Glutaric acidemia iic, late-onset|Glutaric aciduria, type 2|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000031601	4	159624588	4	158703436	31601	40285	rs387907170	NC_000004.12:158703435:T:C
NM_020166.5(MCCC1):c.1155A>C (p.Arg385Ser)	MCCC1	R385S, R276S, R268S	not provided|3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001930	3	182759467	3	183041679	1930	16969	rs119103213	NC_000003.12:183041678:T:G
NM_003060.4(SLC22A5):c.845G>A (p.Arg282Gln)	SLC22A5	R282Q, R306Q	not provided|Renal carnitine transport defect	Pathogenic(Last reviewed: Nov 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025401	5	131722737	5	132387045	25401	36735	rs386134210	NC_000005.10:132387044:G:A
NM_003060.4(SLC22A5):c.806del (p.Leu269fs)	SLC22A5	L269HfsX27, L293fs, L269fs	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025392	5	131721173	5	132385481	25392	36726	rs386134204	NC_000005.10:132385480:T:
NM_003060.4(SLC22A5):c.1196G>A (p.Arg399Gln)	SLC22A5	R399Q, R423Q	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000006424	5	131726525	5	132390833	6424	21463	rs121908891	NC_000005.10:132390832:G:A
NM_000030.3(AGXT):c.106C>T (p.Arg36Cys)	AGXT	R36C	Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188957	2	241808388	2	240868971	188957	186651	rs180177157	NC_000002.12:240868970:C:T
NM_000965.4(RARB):c.1159C>T (p.Arg387Cys)	RARB	R387C, R338C, R344C, R394C, R275C, R341C	Microphthalmia, syndromic 12|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000088762	3	25637919	3	25596428	88762	94343	rs397518483	NC_000003.12:25596427:C:T
NM_000128.3(F11):c.1432G>A (p.Gly478Arg)	F11	G478R	not provided|Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285379	4	187206919	4	186285765	285379	269616	rs542967227	NC_000004.12:186285764:G:A
NM_002880.3(RAF1):c.788T>A (p.Val263Asp)	RAF1	V263D, V149D, V230D, V182D	Cardiomyopathy, dilated, 1NN|Noonan syndrome 5|LEOPARD syndrome 2|not provided|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496189	3	12645681	3	12604182	496189	487033	rs397516830	NC_000003.12:12604181:A:T
NM_001354689.3(RAF1):c.768G>T (p.Arg256Ser)	RAF1	R256S, R142S, R223S, R175S	Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040599	3	12645701	3	12604202	40599	49069	rs397516826	NC_000003.12:12604201:C:A
NM_001163213.1(FGFR3):c.1117A>T (p.Ser373Cys)	FGFR3	S371C, S373C	not specified|Thanatophoric dysplasia type 1|Carcinoma|Bladder carcinoma	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000016333	4	1806092	4	1804365	16333	31372	rs121913484	NC_000004.12:1804364:A:T
NM_000258.3(MYL3):c.281G>A (p.Arg94His)	MYL3	R94H	Familial hypertrophic cardiomyopathy 8|Cardiomyopathy|Hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031777	3	46902192	3	46860702	31777	40437	rs199474703	NC_000003.12:46860701:C:T
NM_182760.4(SUMF1):c.463T>C (p.Ser155Pro)	SUMF1	S155P	not provided|Multiple sulfatase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002672	3	4491006	3	4449322	2672	17711	rs137852850	NC_000003.12:4449321:A:G
NM_014244.5(ADAMTS2):c.1513dup (p.Ala505fs)	ADAMTS2		Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000841489	5	178580493 - 178580494	5	179153492 - 179153493	841489	830748		NC_000005.10:179153492:CC:CCC
NC_000005.10:g.179207713del	ADAMTS2		Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000836198					836198	852200		
NM_014244.5(ADAMTS2):c.32del (p.Leu11fs)	ADAMTS2	L11fs	Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000658082	5	178772298	5	179345297	658082	633829		NC_000005.10:179345296:A:
NM_014244.5(ADAMTS2):c.3088C>T (p.Arg1030Ter)	ADAMTS2	R1030*	Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000581454	5	178549645	5	179122644	581454	560285	rs966437723	NC_000005.10:179122643:G:A
NM_014244.5(ADAMTS2):c.2385G>A (p.Trp795Ter)	ADAMTS2	W795*	Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000838442	5	178557005	5	179130004	838442	830744		NC_000005.10:179130003:C:T
NC_000005.10:g.(?_179272901)_(179273074_?)del	ADAMTS2		Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000831963	5	178699902 - 178700075			831963	819583		
NM_003060.4(SLC22A5):c.680G>A (p.Arg227His)	SLC22A5	R227H, R251H	not provided|Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000378583	5	131721047	5	132385355	378583	367924	rs185551386	NC_000005.10:132385354:G:A
NM_003060.4(SLC22A5):c.1193C>T (p.Pro398Leu)	SLC22A5	P398L, P422L	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025411	5	131726522	5	132390830	25411	36745	rs144547521	NC_000005.10:132390829:C:T
NM_003060.4(SLC22A5):c.1324_1325delinsAT (p.Ala442Ile)	SLC22A5	A442I	not provided|Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006428	5	131728181 - 131728182	5	132392489 - 132392490	6428	21467	rs267607053	NC_000005.10:132392488:GC:AT
NM_003060.3(SLC22A5):c.1202dupA (p.Tyr401Terfs)	SLC22A5	Y401*	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006417	5	131726530 - 131726531	5	132390838 - 132390839	6417	21456	rs121908887	NC_000005.10:132390838:A:AA
NM_000046.5(ARSB):c.427del (p.Val143fs)	ARSB	V143fs	Metachromatic leukodystrophy|Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000559782	5	78264901	5	78969078	559782	550497	rs766914147	NC_000005.10:78969077:CC:C
NM_000046.5(ARSB):c.1197C>G (p.Phe399Leu)	ARSB	F399L	Mucopolysaccharidosis type 6	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559688	5	78135195	5	78839372	559688	550424	rs200793396	NC_000005.10:78839371:G:C
NM_000046.5(ARSB):c.479G>A (p.Arg160Gln)	ARSB	R160Q	Mucopolysaccharidosis type 6	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000445292	5	78264849	5	78969026	445292	438558	rs1196325597	NC_000005.10:78969025:C:T
NM_000046.5(ARSB):c.944G>A (p.Arg315Gln)	ARSB	R315Q	Mucopolysaccharidosis type 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000166694	5	78181605	5	78885782	166694	177363	rs727503809	NC_000005.10:78885781:C:T
NM_001312673.2(PCYT1A):c.296C>T (p.Ala99Val)	PCYT1A	A99V	Inborn genetic diseases|Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000101057	3	195975116	3	196248245	101057	106822	rs587777189	NC_000003.12:196248244:G:A
NM_017755.6(NSUN2):c.679C>T (p.Gln227Ter)	NSUN2	Q227*, Q192*	Mental retardation, autosomal recessive 5|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000031675	5	6620355	5	6620242	31675	40337	rs387907190	NC_000005.10:6620241:G:A
NM_173660.5(DOK7):c.1138dup (p.Ala380fs)	DOK7		Myasthenia, limb-girdle, familial|Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I|not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000209149	4	3494846 - 3494847	4	3493119 - 3493120	209149	205737	rs761899995	NC_000004.12:3493119:GGGGG:GGGGGG
NM_001080522.2(CC2D2A):c.4295_4298del (p.Gly1431_Cys1432insTer)	CC2D2A		not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000598583	4	15591282 - 15591285	4	15589659 - 15589662	598583	589644	rs1560196436	NC_000004.12:15589658:TGTTT:T
NM_001080522.2(CC2D2A):c.1696G>T (p.Glu566Ter)	CC2D2A	E566*	not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000597947	4	15538631	4	15537008	597947	589008	rs780814559	NC_000004.12:15537007:G:T
NM_001080522.2(CC2D2A):c.1666del (p.Glu555_Ile556insTer)	CC2D2A		not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000596555	4	15538599	4	15536976	596555	587616	rs773740057	NC_000004.12:15536975:AAA:AA
NM_001080522.2(CC2D2A):c.4065+2T>C	CC2D2A		not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000594430	4	15587871	4	15586248	594430	585493	rs1179041639	NC_000004.12:15586247:T:C
NM_001080522.2(CC2D2A):c.3545G>A (p.Trp1182Ter)	CC2D2A	W1182*	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000594152	4	15572070	4	15570447	594152	585215	rs1560188288	NC_000004.12:15570446:G:A
NM_001080522.2(CC2D2A):c.1297_1299delinsAA (p.Gln433fs)	CC2D2A		not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000593430	4	15529217 - 15529219	4	15527594 - 15527596	593430	584494	rs1560166511	NC_000004.12:15527593:CAG:AA
NM_001080522.2(CC2D2A):c.4489C>T (p.Gln1497Ter)	CC2D2A	Q1497*	not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000501322	4	15599081	4	15597458	501322	492746	rs1553845302	NC_000004.12:15597457:C:T
NM_001080522.2(CC2D2A):c.1370T>A (p.Leu457Ter)	CC2D2A	L457*	not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000429902	4	15530253	4	15528630	429902	421480	rs1131691659	NC_000004.12:15528629:T:A
NM_020785.2(CC2D2A):c.282del (p.Gln94fs)	CC2D2A	N59fs, Q94fs	not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000419063	4	15482379	4	15480755	419063	406404	rs1064793618	NC_000004.12:15480754:AA:A
NM_001080522.2(CC2D2A):c.4179+1G>A	CC2D2A		not provided	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000289869	4	15589553	4	15587930	289869	274106	rs886044295	NC_000004.12:15587929:G:A
NM_001080522.2(CC2D2A):c.1017dup (p.Glu340Argfs)	CC2D2A		not provided	Pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000193831	4	15517623 - 15517624	4	15516000 - 15516001	193831	190994	rs797044636	NC_000004.12:15516000:CCCC:CCCCC
NM_001080522.2(CC2D2A):c.2561G>A (p.Trp854Ter)	CC2D2A	W854*	not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634560	4	15556769	4	15555146	634560	622341	rs1560180188	NC_000004.12:15555145:G:A
NM_001080522.2(CC2D2A):c.1468C>T (p.Gln490Ter)	CC2D2A	Q490*	not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634448	4	15534817	4	15533194	634448	622339	rs1288358527	NC_000004.12:15533193:C:T
NM_001080522.2(CC2D2A):c.1149+1G>A	CC2D2A		Clubfoot|Postaxial polydactyly type A1|Oligohydramnios|Polycystic kidney dysplasia|Narrow chest|Encephalocele|Microcephaly	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523401	4	15518380	4	15516757	523401	513950	rs1553827236	NC_000004.12:15516756:G:A
NC_000004.11:g.15601250_15601251delCT	CC2D2A		Joubert syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000242584	4	15601250 - 15601251	4	15599627 - 15599628	242584	198621	rs794729226	NC_000004.12:15599626:CTCT:CT
NM_001080522.2(CC2D2A):c.4019_4020AC[1] (p.Thr1341fs)	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000637997	4	15587823 - 15587824	4	15586200 - 15586201	637997	625795		NC_000004.12:15586199:ACAC:AC
NM_001080522.2(CC2D2A):c.4483G>T (p.Glu1495Ter)	CC2D2A	E1495*	Joubert syndrome with hepatic defect	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522909	4	15599075	4	15597452	522909	513544	rs1553845300	NC_000004.12:15597451:G:T
NM_020785.2(CC2D2A):c.100C>T (p.Arg34Ter)	CC2D2A	R34*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377067	4	15480407	4	15478783	377067	363945	rs896947430	NC_000004.12:15478782:C:T
NM_001080522.2(CC2D2A):c.4491A>C (p.Gln1497His)	CC2D2A	Q1497H	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217616	4	15599083	4	15597460	217616	214192	rs863225179	NC_000004.12:15597459:A:C
NM_001080522.2(CC2D2A):c.2671G>A (p.Glu891Lys)	CC2D2A	E891K	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217615	4	15558972	4	15557349	217615	214175	rs863225178	NC_000004.12:15557348:G:A
NM_001080522.2(CC2D2A):c.1503_1505del (p.Lys501_Asp502delinsAsn)	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217613	4	15534851 - 15534853	4	15533228 - 15533230	217613	214171	rs863225177	NC_000004.12:15533227:AAGA:A
NM_001080522.2(CC2D2A):c.1263_1264insGGCATGTTTTGGCAGCGA (p.Ser422_Arg423insGlyMetPheTrpGlnArg)	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217611	4	15529183 - 15529184	4	15527560 - 15527561	217611	214170	rs762998472	NC_000004.12:15527560::GGCATGTTTTGGCAGCGA
NM_001080522.2(CC2D2A):c.1676T>C (p.Leu559Pro)	CC2D2A	L559P	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217610	4	15538611	4	15536988	217610	214173	rs754221308	NC_000004.12:15536987:T:C
NM_001080522.2(CC2D2A):c.4226T>C (p.Ile1409Thr)	CC2D2A	I1409T	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217609	4	15591214	4	15589591	217609	214190	rs863225176	NC_000004.12:15589590:T:C
NM_001080522.2(CC2D2A):c.2624C>A (p.Ser875Ter)	CC2D2A	S875*	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217605	4	15556832	4	15555209	217605	214174	rs200904521	NC_000004.12:15555208:C:A
NM_001080522.2(CC2D2A):c.2999A>T (p.Glu1000Val)	CC2D2A	E1000V	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217604	4	15562230	4	15560607	217604	214176	rs773881370	NC_000004.12:15560606:A:T
NM_001080522.2(CC2D2A):c.4741A>G (p.Thr1581Ala)	CC2D2A	T1581A	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217603	4	15602926	4	15601303	217603	214195	rs863225174	NC_000004.12:15601302:A:G
NM_001080522.2(CC2D2A):c.3134T>C (p.Val1045Ala)	CC2D2A	V1045A	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217601	4	15565097	4	15563474	217601	214178	rs863225173	NC_000004.12:15563473:T:C
NM_001080522.2(CC2D2A):c.3772-1G>T	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217600	4	15581590	4	15579967	217600	214184	rs863225172	NC_000004.12:15579966:G:T
NM_001080522.2(CC2D2A):c.3744_3747dup (p.Pro1250fs)	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217599	4	15575920 - 15575921	4	15574297 - 15574298	217599	214183	rs863225171	NC_000004.12:15574297:TGGTT:TGGTTGGTT
NM_001080522.2(CC2D2A):c.3452T>C (p.Val1151Ala)	CC2D2A	V1151A	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217598	4	15570969	4	15569346	217598	214180	rs863225170	NC_000004.12:15569345:T:C
NM_001080522.2(CC2D2A):c.3850C>T (p.Arg1284Cys)	CC2D2A	R1284C	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217597	4	15581669	4	15580046	217597	214185	rs779823379	NC_000004.12:15580045:C:T
NM_001080522.2(CC2D2A):c.3892_3893del (p.Val1298fs)	CC2D2A	V1298fs	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217596	4	15581710 - 15581711	4	15580087 - 15580088	217596	214186	rs763735590	NC_000004.12:15580086:TGT:T
NM_001080522.2(CC2D2A):c.3288G>C (p.Gln1096His)	CC2D2A	Q1096H	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217595	4	15569105	4	15567482	217595	214179	rs863225169	NC_000004.12:15567481:G:C
NM_001080522.2(CC2D2A):c.4289T>C (p.Val1430Ala)	CC2D2A	V1430A	Joubert syndrome 9	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217594	4	15591277	4	15589654	217594	214191	rs863225168	NC_000004.12:15589653:T:C
CC2D2A, 1-BP DEL, 3289G	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000746					746	15785		
NM_001080522.2(CC2D2A):c.1762C>T (p.Gln588Ter)	CC2D2A	Q588*	Meckel syndrome type 6	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000000742	4	15538697	4	15537074	742	15781		NC_000004.12:15537073:C:T
NM_001122681.2(SH3BP2):c.1244G>A (p.Arg415Gln)	SH3BP2	R415Q, R443Q, R472Q	Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000007551	4	2833300	4	2831573	7551	22590	rs121909149	NC_000004.12:2831572:G:A
NM_001080522.2(CC2D2A):c.2222_2229dup (p.Phe744fs)	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000864745	4	15552485 - 15552486	4	15550862 - 15550863	864745	828901		NC_000004.12:15550862:GCAGAAGTG:GCAGAAGTGCAGAAGTG
NM_001080522.2(CC2D2A):c.3325C>T (p.Arg1109Ter)	CC2D2A	R1109*, R1060*	Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000839976	4	15569336	4	15567713	839976	828907		NC_000004.12:15567712:C:T
NC_000004.11:g.(?_15477537)_(15603068_?)del	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000832901	4	15477537 - 15603068			832901	819429		
NC_000004.12:g.(?_15540837)_(15541014_?)del	CC2D2A		Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000831556	4	15542460 - 15542637			831556	819457		
NM_001080522.2(CC2D2A):c.4084dup (p.Ala1362fs)	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000640187	4	15589455 - 15589456	4	15587832 - 15587833	640187	632059		NC_000004.12:15587832:GG:GGG
NM_001080522.2(CC2D2A):c.964del (p.Val322fs)	CC2D2A	V322fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000639409	4	15517573	4	15515950	639409	632055		NC_000004.12:15515949:GG:G
NM_001080522.2(CC2D2A):c.3988C>T (p.Arg1330Ter)	CC2D2A	R1330*	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000461750	4	15587792	4	15586169	461750	453806	rs758036385	NC_000004.12:15586168:C:T
NC_000004.11:g.(?_15480347)_(15482451_?)del	CC2D2A		Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000417568	4	15480347 - 15482451	4	15478723 - 15480827	417568	393999		
CC2D2A, IVS19DS, G-C, +1	CC2D2A		Joubert syndrome 9	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000000741					741	15780		
GRCh37/hg19 5p13.2(chr5:37196421-37219882)x1	CPLANE1		not provided	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000686340	5	37196421 - 37219882			686340	673932		
NM_023073.3(CPLANE1):c.702G>A (p.Trp234Ter)	CPLANE1	W234*	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000489165	5	37239947	5	37239845	489165	481740	rs1554114025	NC_000005.10:37239844:C:T
NM_023073.3(CPLANE1):c.7079del (p.Pro2360fs)	CPLANE1	P2360fs	not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000426780	5	37169047	5	37168945	426780	415007	rs1085307795	NC_000005.10:37168944:GG:G
NM_023073.3(CPLANE1):c.8510_8516delinsAT (p.Val2837fs)	CPLANE1		not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000422968	5	37138936 - 37138942	5	37138834 - 37138840	422968	406749	rs1064796131	NC_000005.10:37138833:GGATGTA:AT
NM_023073.3(CPLANE1):c.1372-2A>G	CPLANE1		not provided	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000288021	5	37227496	5	37227394	288021	272258	rs886043786	NC_000005.10:37227393:T:C
NM_023073.3(CPLANE1):c.57G>A (p.Trp19Ter)	CPLANE1	W19*	not provided	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000280828	5	37247744	5	37247642	280828	264272	rs886041966	NC_000005.10:37247641:C:T
NM_023073.3(CPLANE1):c.677+2T>C	CPLANE1		not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000280714	5	37243113	5	37243011	280714	264196	rs886041870	NC_000005.10:37243010:A:G
NM_023073.3(CPLANE1):c.8630+1G>T	CPLANE1		not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000280579	5	37138821	5	37138719	280579	264233	rs886041757	NC_000005.10:37138718:C:A
NM_023073.3(CPLANE1):c.3673-1G>C	CPLANE1		not provided	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000280495	5	37196099	5	37195997	280495	264192	rs886041688	NC_000005.10:37195996:C:G
NM_023073.3(CPLANE1):c.3380C>A (p.Ser1127Ter)	CPLANE1	S1127*	not provided	Pathogenic(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	VCV000279720	5	37201820	5	37201718	279720	264194	rs375009168	NC_000005.10:37201717:G:T
NM_023073.3(CPLANE1):c.8923del (p.Ser2975fs)	CPLANE1	S2975fs	not provided	Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	VCV000197596	5	37121819	5	37121717	197596	194757	rs794727691	NC_000005.10:37121716:A:
NM_023073.3(CPLANE1):c.1819dup (p.Tyr607fs)	CPLANE1		not provided	Pathogenic(Last reviewed: Dec 19, 2014)	criteria provided, single submitter	VCV000194120	5	37226877 - 37226878	5	37226775 - 37226776	194120	191283	rs777686211	NC_000005.10:37226775:AAAAAAAA:AAAAAAAAA
NM_023073.3(CPLANE1):c.2932C>T (p.Arg978Ter)	CPLANE1	R978*	not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000846826	5	37206516	5	37206414	846826	830862		NC_000005.10:37206413:G:A
NM_023073.3(CPLANE1):c.1394del (p.Leu465fs)	CPLANE1	L465fs	Joubert syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802118	5	37227472	5	37227370	802118	790560		NC_000005.10:37227369:AA:A
NM_023073.3(CPLANE1):c.2898del (p.Pro968fs)	CPLANE1	P968fs	Joubert syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802117	5	37213683	5	37213581	802117	790559		NC_000005.10:37213580:AA:A
NM_000030.3(AGXT):c.2T>C (p.Met1Thr)	AGXT	M1T	not provided|Primary hyperoxaluria, type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204065	2	241808284	2	240868867	204065	200416	rs138584408	NC_000002.12:240868866:T:C
NM_000030.3(AGXT):c.33del (p.Lys12fs)	AGXT	K12fs	Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188775	2	241808308	2	240868891	188775	186650	rs180177201	NC_000002.12:240868890:CCCCCCCC:CCCCCCC
NM_000030.3(AGXT):c.466G>A (p.Gly156Arg)	AGXT	G156R	Primary hyperoxaluria, type I	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000005650	2	241810808	2	240871391	5650	20689	rs121908530	NC_000002.12:240871390:G:A
NM_000030.3(AGXT):c.121G>A (p.Gly41Arg)	AGXT	G41R	Nephrolithiasis|Nephrocalcinosis|Primary hyperoxaluria, type I	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000005644	2	241808403	2	240868986	5644	20683	rs121908523	NC_000002.12:240868985:G:A
NM_001080522.2(CC2D2A):c.541-1G>A	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000844616	4	15512869	4	15511246	844616	851493		NC_000004.12:15511245:G:A
NM_001080522.2(CC2D2A):c.650del (p.Gly217fs)	CC2D2A	G217fs	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000652726	4	15512977	4	15511354	652726	632054		NC_000004.12:15511353:GGG:GG
NM_001080522.2(CC2D2A):c.2625+1G>A	CC2D2A		Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000644347	4	15556834	4	15555211	644347	651183		NC_000004.12:15555210:G:A
NM_001080522.2(CC2D2A):c.834del (p.Leu279fs)	CC2D2A	L279fs	not provided|Meckel syndrome type 6	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	VCV000056317	4	15516445	4	15514822	56317	70956	rs386833765	NC_000004.12:15514821:GG:G
NM_001080522.2(CC2D2A):c.517C>T (p.Arg173Ter)	CC2D2A	R173*	Meckel syndrome type 6	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000056315	4	15511840	4	15510217	56315	70954	rs386833763	NC_000004.12:15510216:C:T
NM_023073.3(CPLANE1):c.5557C>T (p.Gln1853Ter)	CPLANE1	Q1853*	not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000838000	5	37180972	5	37180870	838000	830860		NC_000005.10:37180869:G:A
NM_023073.3(CPLANE1):c.3507+1G>A	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813949	5	37201692	5	37201590	813949	802157		NC_000005.10:37201589:C:T
NM_023073.3(CPLANE1):c.8986dup (p.Gln2996fs)	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813948	5	37121755 - 37121756	5	37121653 - 37121654	813948	802155		NC_000005.10:37121653:G:GG
NM_023073.3(CPLANE1):c.8501+1G>T	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813945	5	37139441	5	37139339	813945	802156		NC_000005.10:37139338:C:A
NM_023073.3(CPLANE1):c.8834del (p.Lys2945fs)	CPLANE1	K2945fs	Joubert syndrome 17	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000473150	5	37122553	5	37122451	473150	455638	rs1554050342	NC_000005.10:37122450:TTTT:TTT
NM_023073.3(CPLANE1):c.7936_7937del (p.Pro2646fs)	CPLANE1	P2646fs	Joubert syndrome 17	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000473149	5	37157792 - 37157793	5	37157690 - 37157691	473149	455643	rs1554068790	NC_000005.10:37157689:GGGGG:GGG
NM_023073.3(CPLANE1):c.4890dup (p.Ser1631fs)	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000473148	5	37183392 - 37183393	5	37183290 - 37183291	473148	455192	rs1554083251	NC_000005.10:37183290:TTTTT:TTTTTT
NM_023073.3(CPLANE1):c.2422_2423del (p.Leu808fs)	CPLANE1	L808fs	Joubert syndrome 17	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000473147	5	37224711 - 37224712	5	37224609 - 37224610	473147	455896	rs1242532564	NC_000005.10:37224608:AG:
NM_023073.3(CPLANE1):c.1877del (p.Ser626fs)	CPLANE1	S626fs	Joubert syndrome 17	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000473146	5	37226820	5	37226718	473146	455647	rs1327245073	NC_000005.10:37226717:C:
NM_023073.3(CPLANE1):c.2611C>T (p.Arg871Cys)	CPLANE1	R871C	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217589	5	37221561	5	37221459	217589	214220	rs760906097	NC_000005.10:37221458:G:A
NM_023073.3(CPLANE1):c.8855+1G>T	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217588	5	37122531	5	37122429	217588	214198	rs863225154	NC_000005.10:37122428:C:A
NM_023073.3(CPLANE1):c.2923C>T (p.Gln975Ter)	CPLANE1	Q975*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217587	5	37206525	5	37206423	217587	214217	rs863225166	NC_000005.10:37206422:G:A
NM_023073.3(CPLANE1):c.2831G>A (p.Arg944His)	CPLANE1	R944H	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217586	5	37213750	5	37213648	217586	214218	rs863225165	NC_000005.10:37213647:C:T
NM_023073.3(CPLANE1):c.2709G>A (p.Trp903Ter)	CPLANE1	W903*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217585	5	37221463	5	37221361	217585	214219	rs863225164	NC_000005.10:37221360:C:T
NM_023073.3(CPLANE1):c.2377C>T (p.Gln793Ter)	CPLANE1	Q793*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217583	5	37224757	5	37224655	217583	214221	rs776886962	NC_000005.10:37224654:G:A
NM_023073.3(CPLANE1):c.2999G>T (p.Trp1000Leu)	CPLANE1	W1000L	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217582	5	37206449	5	37206347	217582	214216	rs773362418	NC_000005.10:37206346:C:A
NM_023073.3(CPLANE1):c.3007G>T (p.Glu1003Ter)	CPLANE1	E1003*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217581	5	37206441	5	37206339	217581	214215	rs863225162	NC_000005.10:37206338:C:A
NM_023073.3(CPLANE1):c.6267_6268TG[1] (p.Val2090fs)	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217579	5	37170335 - 37170336	5	37170233 - 37170234	217579	214211	rs768675259	NC_000005.10:37170232:CACA:CA
NM_023073.3(CPLANE1):c.3130_3131insA (p.Arg1044fs)	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217577	5	37206317 - 37206318	5	37206215 - 37206216	217577	214214	rs863225161	NC_000005.10:37206215::T
NM_023073.3(CPLANE1):c.510dup (p.Leu171fs)	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217576	5	37244536 - 37244537	5	37244434 - 37244435	217576	214228	rs779680371	NC_000005.10:37244434:AA:AAA
NM_023073.3(CPLANE1):c.2275C>T (p.Gln759Ter)	CPLANE1	Q759*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217573	5	37226422	5	37226320	217573	214223	rs863225158	NC_000005.10:37226319:G:A
NM_023073.3(CPLANE1):c.3632_3633AT[2] (p.Leu1213fs)	CPLANE1		Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217572	5	37198839 - 37198840	5	37198737 - 37198738	217572	214212	rs863225157	NC_000005.10:37198736:ATATATA:ATATA
NM_023073.3(CPLANE1):c.7190del (p.Pro2397fs)	CPLANE1	P2397fs	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217568	5	37168936	5	37168834	217568	214210	rs863225156	NC_000005.10:37168833:GGG:GG
NM_023073.3(CPLANE1):c.7978C>T (p.Arg2660Ter)	CPLANE1	R2660*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217566	5	37154075	5	37153973	217566	214207	rs147416429	NC_000005.10:37153972:G:A
NM_023073.3(CPLANE1):c.8716G>T (p.Glu2906Ter)	CPLANE1	E2906*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217563	5	37125426	5	37125324	217563	214201	rs863225153	NC_000005.10:37125323:C:A
NM_023073.3(CPLANE1):c.8167C>T (p.Gln2723Ter)	CPLANE1	Q2723*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217562	5	37153886	5	37153784	217562	214206	rs863225152	NC_000005.10:37153783:G:A
NM_023073.3(CPLANE1):c.8725del (p.Ala2909fs)	CPLANE1	A2909fs	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217561	5	37125417	5	37125315	217561	214200	rs770758833	NC_000005.10:37125314:CC:C
NM_023073.3(CPLANE1):c.3859G>C (p.Asp1287His)	CPLANE1	D1287H		Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000157516	5	37187897	5	37187795	157516	167377	rs606231261	NC_000005.10:37187794:C:G
NM_023073.3(CPLANE1):c.3290-2A>G	CPLANE1			Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000157514	5	37201912	5	37201810	157514	167375	rs606231260	NC_000005.10:37201809:T:C
NM_023073.3(CPLANE1):c.3150-1G>T	CPLANE1			Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000157512	5	37205557	5	37205455	157512	167373	rs606231258	NC_000005.10:37205454:C:A
NM_001354689.3(RAF1):c.775T>A (p.Ser259Thr)	RAF1	S259T, S145T, S178T, S226T	Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040601	3	12645694	3	12604195	40601	49071	rs3730271	NC_000003.12:12604194:A:T
NM_023073.3(CPLANE1):c.2556dup (p.Ala853fs)	CPLANE1		Joubert syndrome 17|	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000578049	5	37224379 - 37224380	5	37224277 - 37224278	578049	560464	rs1561655920	NC_000005.10:37224277:TTTTTT:TTTTTTT
NM_023073.3(CPLANE1):c.3405_3406CT[1] (p.Ser1136fs)	CPLANE1		Joubert syndrome 17|	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000570974	5	37201792 - 37201793	5	37201690 - 37201691	570974	560339	rs1228082731	NC_000005.10:37201689:AGAG:AG
NM_023073.3(CPLANE1):c.709C>T (p.Gln237Ter)	CPLANE1	Q237*	Joubert syndrome 17|	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000570888	5	37239940	5	37239838	570888	565158	rs957588958	NC_000005.10:37239837:G:A
NM_023073.3(CPLANE1):c.907_908del (p.Lys303fs)	CPLANE1	K303fs	Joubert syndrome 17|	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000569663	5	37238989 - 37238990	5	37238887 - 37238888	569663	560343	rs1187142382	NC_000005.10:37238886:TT:
NM_023073.3(CPLANE1):c.3407del (p.Ser1136fs)	CPLANE1	S1136fs	Joubert syndrome 17|	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000569087	5	37201793	5	37201691	569087	560341	rs1561584225	NC_000005.10:37201690:G:
NM_023073.3(CPLANE1):c.8263del (p.Thr2755fs)	CPLANE1	T2755fs	Joubert syndrome 17|	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000567531	5	37148319	5	37148217	567531	565136	rs775263897	NC_000005.10:37148216:TTTTTTT:TTTTTT
NM_023073.3(CPLANE1):c.8785A>T (p.Arg2929Ter)	CPLANE1	R2929*	Joubert syndrome 17|	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000537711	5	37125357	5	37125255	537711	521461	rs1345413118	NC_000005.10:37125254:T:A
NM_023073.3(CPLANE1):c.4314del (p.Glu1439fs)	CPLANE1	E1439fs	Joubert syndrome 17	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000427894	5	37185057	5	37184955	427894	418967	rs1554084360	NC_000005.10:37184954:TT:T
NM_023073.3(CPLANE1):c.5733T>G (p.Tyr1911Ter)	CPLANE1	Y1911*	Joubert syndrome 17	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000427893	5	37180123	5	37180021	427893	418964	rs770770257	NC_000005.10:37180020:A:C
NM_023073.3(CPLANE1):c.7778G>A (p.Trp2593Ter)	CPLANE1	W2593*	Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217574	5	37158360	5	37158258	217574	214209	rs863225159	NC_000005.10:37158257:C:T
NM_023073.3(CPLANE1):c.6407del (p.Pro2136fs)	CPLANE1	P2136fs	Joubert syndrome 17	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000031221	5	37170198	5	37170096	31221	40178	rs367543064	NC_000005.10:37170095:GGG:GG
NM_023073.3(CPLANE1):c.8471-1G>C	CPLANE1		|Joubert syndrome 17	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000575938	5	37139473	5	37139371	575938	560458	rs1561376123	NC_000005.10:37139370:C:G
NM_023073.3(CPLANE1):c.1784T>G (p.Leu595Ter)	CPLANE1	L595*	not provided|Joubert syndrome 17	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217580	5	37226913	5	37226811	217580	214225	rs530569572	NC_000005.10:37226810:A:C
NM_023073.3(CPLANE1):c.8608G>T (p.Glu2870Ter)	CPLANE1	E2870*	not provided|Joubert syndrome 17	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217567	5	37138844	5	37138742	217567	214203	rs863225155	NC_000005.10:37138741:C:A
NM_023073.3(CPLANE1):c.8855+1G>A	CPLANE1		Joubert syndrome 17|Joubert syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217564	5	37122531	5	37122429	217564	214199	rs863225154	NC_000005.10:37122428:C:T
NM_023073.3(CPLANE1):c.4804C>T (p.Arg1602Ter)	CPLANE1	R1602*	Joubert syndrome 17	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000031222	5	37183479	5	37183377	31222	40179	rs367543063	NC_000005.10:37183376:G:A
NM_020785.2(CC2D2A):c.305del (p.Gly102fs)	CC2D2A	G102fs, E67fs	not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595006	4	15482402	4	15480778	595006	586068	rs1433294475	NC_000004.12:15480777:GG:G
NM_001080522.2(CC2D2A):c.1267C>T (p.Arg423Ter)	CC2D2A	R423*	Joubert syndrome 1|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411851	4	15529187	4	15527564	411851	394140	rs757208121	NC_000004.12:15527563:C:T
NM_001080522.2(CC2D2A):c.3652C>T (p.Arg1218Ter)	CC2D2A	R1218*	not provided|Joubert syndrome	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000238273	4	15575830	4	15574207	238273	239337	rs375278294	NC_000004.12:15574206:C:T
NM_000297.4(PKD2):c.1094+3_1094+6del	PKD2		Polycystic kidney disease 2|Polycystic kidney disease, autosomal dominant|Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000434014	4	88959654 - 88959657	4	88038502 - 88038505	434014	427228	rs1553925470	NC_000004.12:88038501:GTAAGT:GT
NM_001080.3(ALDH5A1):c.612G>A (p.Trp204Ter)	ALDH5A1	W204*	not provided|Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001357	6	24505099	6	24504871	1357	16396	rs118203982	NC_000006.12:24504870:G:A
NM_023073.3(CPLANE1):c.1270C>T (p.Arg424Ter)	CPLANE1	R424*	Joubert syndrome 17||not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000392297	5	37227771	5	37227669	392297	368487	rs755097302	NC_000005.10:37227668:G:A
NM_023073.3(CPLANE1):c.2353C>T (p.Arg785Ter)	CPLANE1	R785*	not provided|Joubert syndrome 17	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217584	5	37224781	5	37224679	217584	214222	rs863225163	NC_000005.10:37224678:G:A
NM_023073.3(CPLANE1):c.510del (p.Leu171fs)	CPLANE1	L171fs	not provided|Joubert syndrome 17	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217578	5	37244537	5	37244435	217578	214227	rs779680371	NC_000005.10:37244434:AA:A
NM_001080522.2(CC2D2A):c.4582C>T (p.Arg1528Cys)	CC2D2A	R1528C	not provided|Joubert syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000744	4	15601237	4	15599614	744	15783	rs118204052	NC_000004.12:15599613:C:T
NM_023073.3(CPLANE1):c.8263dup (p.Thr2755fs)	CPLANE1		Global developmental delay|Jaundice|Joubert syndrome 17	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000217570	5	37148318 - 37148319	5	37148216 - 37148217	217570	214205	rs775263897	NC_000005.10:37148216:TTTTTTT:TTTTTTTT
NM_023073.3(CPLANE1):c.8263_8264insG (p.Thr2755fs)	CPLANE1		Joubert syndrome 17||Joubert syndrome 17	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217565	5	37148318 - 37148319	5	37148216 - 37148217	217565	214204	rs1554064102	NC_000005.10:37148216::C
NM_006218.4(PIK3CA):c.3129G>T (p.Met1043Ile)	PIK3CA	M1043I	PIK3CA related overgrowth spectrum|Neoplasm of the large intestine|Cowden syndrome	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000217292	3	178952074	3	179234286	217292	213942	rs121913283	NC_000003.12:179234285:G:T
NM_025074.7(FRAS1):c.2791del (p.Val931fs)	FRAS1	V931fs	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000817271	4	79291059	4	78369905	817271	805401		NC_000004.12:78369904:GG:G
GRCh37/hg19 4q21.21(chr4:79214098-79261919)x1	FRAS1		not provided	Pathogenic(Last reviewed: Aug 9, 2018)	no assertion criteria provided	VCV000687766	4	79214098 - 79261919			687766	675358		
NM_025074.7(FRAS1):c.11897dup (p.Asn3967fs)	FRAS1		Fraser syndrome 1	Pathogenic(Last reviewed: Jun 5, 2019)	no assertion criteria provided	VCV000633784	4	79462135 - 79462136	4	78540981 - 78540982	633784	622216	rs1560433104	NC_000004.12:78540981:T:TT
NM_025074.7(FRAS1):c.10820C>G (p.Ser3607Ter)	FRAS1	S3607*	Fraser syndrome 1	Pathogenic	no assertion criteria provided	VCV000633615	4	79447706	4	78526552	633615	622047	rs1006839535	NC_000004.12:78526551:C:G
NM_025074.7(FRAS1):c.11266_11269AACA[1] (p.Lys3757fs)	FRAS1		Fraser syndrome 1	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided	VCV000626320	4	79458320 - 79458323	4	78537166 - 78537169	626320	614652		NC_000004.12:78537165:CAAACAAACA:CAAACA
NM_025074.7(FRAS1):c.880C>T (p.Gln294Ter)	FRAS1	Q294*	not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000620296	4	79188485	4	78267331	620296	611619	rs372184784	NC_000004.12:78267330:C:T
NM_025074.7(FRAS1):c.5125C>T (p.Arg1709Ter)	FRAS1	R1709*	not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000499147	4	79353666	4	78432512	499147	490571	rs775517752	NC_000004.12:78432511:C:T
NM_025074.7(FRAS1):c.7005del (p.Lys2336fs)	FRAS1	K2336fs	not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000429758	4	79385712	4	78464558	429758	421499	rs1131691572	NC_000004.12:78464557:TT:T
NM_025074.7(FRAS1):c.469+5G>T	FRAS1		not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	VCV000419757	4	79173710	4	78252556	419757	406464	rs760212654	NC_000004.12:78252555:G:T
NM_025074.7(FRAS1):c.370C>T (p.Arg124Ter)	FRAS1	R124*	not provided	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	VCV000197861	4	79173606	4	78252452	197861	195022	rs377046630	NC_000004.12:78252451:C:T
NM_025074.7(FRAS1):c.3370dup (p.Ser1124fs)	FRAS1		not provided	Pathogenic(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	VCV000196043	4	79300952 - 79300953	4	78379798 - 78379799	196043	193204	rs797044696	NC_000004.12:78379798:TTTTT:TTTTTT
NM_025074.7(FRAS1):c.1931del (p.Gly644fs)	FRAS1	G644fs	not provided	Pathogenic(Last reviewed: Feb 18, 2015)	criteria provided, single submitter	VCV000194789	4	79238631	4	78317477	194789	191952	rs794727195	NC_000004.12:78317476:GGG:GG
NM_001163213.1(FGFR3):c.850del (p.His284fs)	FGFR3	H284fs	Carcinoma of colon	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000016352	4	1803669	4	1801942	16352	31391	rs587776836	NC_000004.12:1801941:CCCC:CCC
NM_001163213.1(FGFR3):c.1082-605G>A	FGFR3	E322K	Carcinoma of colon	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000016351	4	1805452	4	1803725	16351	31390	rs121913111	NC_000004.12:1803724:G:A
NC_000004.11:g.(?_79420875)_(79447811_?)del	FRAS1		not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000662841	4	79420875 - 79447811	4	78499721 - 78526657	662841	651177		
NM_025074.7(FRAS1):c.10948C>T (p.Gln3650Ter)	FRAS1	Q3650*	not provided	Pathogenic(Last reviewed: Jan 30, 2015)	criteria provided, single submitter	VCV000235316	4	79455625	4	78534471	235316	237003	rs878853009	NC_000004.12:78534470:C:T
NM_025074.7(FRAS1):c.5664_5665+19delinsT	FRAS1		Fraser syndrome 1	Pathogenic	no assertion criteria provided	VCV000219183	4	79362450 - 79362470	4	78441296 - 78441316	219183	217208	rs886037766	NC_000004.12:78441295:AGGTACTACTTCCTGTAAAAC:T
NM_025074.7(FRAS1):c.10287del (p.Leu3428_Tyr3429insTer)	FRAS1		Fraser syndrome 1	Pathogenic	no assertion criteria provided	VCV000219182	4	79437065	4	78515911	219182	217209	rs886037765	NC_000004.12:78515910:C:
NM_025074.7(FRAS1):c.6963_6964dup (p.Val2322fs)	FRAS1		Fraser syndrome 1	Pathogenic(Last reviewed: Sep 15, 2006)	no assertion criteria provided	VCV000002815	4	79385669 - 79385670	4	78464515 - 78464516	2815	17854	rs730882179	NC_000004.12:78464515:GGG:GGGGG
NM_025074.7(FRAS1):c.4271C>G (p.Ser1424Ter)	FRAS1	S1423*, S1424*	Fraser syndrome 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002813	4	79328958	4	78407804	2813	17852	rs120074159	NC_000004.12:78407803:C:G
NM_025074.7(FRAS1):c.3799C>T (p.Gln1267Ter)	FRAS1	Q1266*, Q1267*	Fraser syndrome 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002812	4	79308679	4	78387525	2812	17851	rs120074158	NC_000004.12:78387524:C:T
FRAS1, 1-BP INS, 5605T	FRAS1		Fraser syndrome 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002811					2811	17850		
NM_025074.7(FRAS1):c.9013C>T (p.Gln3005Ter)	FRAS1	Q3000*, Q3005*	Fraser syndrome 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002810	4	79418013	4	78496859	2810	17849	rs120074157	NC_000004.12:78496858:C:T
NM_025074.7(FRAS1):c.8602C>T (p.Gln2868Ter)	FRAS1	Q2863*, Q2868*	Fraser syndrome 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002809	4	79403116	4	78481962	2809	17848	rs120074156	NC_000004.12:78481961:C:T
NM_025074.7(FRAS1):c.516G>A (p.Trp172Ter)	FRAS1	W172*	Fraser syndrome 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635334	4	79176442	4	78255288	635334	623139		NC_000004.12:78255287:G:A
NM_025074.7(FRAS1):c.2719C>T (p.Gln907Ter)	FRAS1	Q907*	Fraser syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000435260	4	79285205	4	78364051	435260	428320	rs755750961	NC_000004.12:78364050:C:T
NM_025074.7(FRAS1):c.2722+1G>A	FRAS1		not provided	Pathogenic(Last reviewed: Dec 19, 2014)	criteria provided, multiple submitters, no conflicts	VCV000195697	4	79285209	4	78364055	195697	192858	rs794727365	NC_000004.12:78364054:G:A
NM_025074.7(FRAS1):c.7522+1G>T	FRAS1		Fraser syndrome 1	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000002816	4	79393485	4	78472331	2816	17855	rs730882180	NC_000004.12:78472330:G:T
NM_147127.5(EVC2):c.3779del (p.Ala1260fs)	EVC2	A1260fs, A1180fs	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000817357	4	5564723	4	5562996	817357	805400		NC_000004.12:5562995:G:
NM_147127.5(EVC2):c.645G>A (p.Trp215Ter)	EVC2	W215*, W135*	not specified	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000439673	4	5690945	4	5689218	439673	433541	rs779857359	NC_000004.12:5689217:C:T
NM_147127.5(EVC2):c.1110del (p.Glu371fs)	EVC2	E291fs, E371fs	not specified	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000439672	4	5664869	4	5663142	439672	433540	rs1553846613	NC_000004.12:5663141:GG:G
NM_147127.5(EVC2):c.850del (p.Thr284fs)	EVC2	T204fs, T284fs	not provided	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000290667	4	5683007	4	5681280	290667	274904	rs886044525	NC_000004.12:5681279:TT:T
NM_147127.5(EVC2):c.2398C>T (p.Gln800Ter)	EVC2	Q720*, Q800*	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000855091	4	5624367	4	5622640	855091	829408		NC_000004.12:5622639:G:A
NM_147127.5(EVC2):c.824_825CA[1] (p.Gln276fs)	EVC2		Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000854827	4	5683030 - 5683031	4	5681303 - 5681304	854827	829412		NC_000004.12:5681302:TGTGT:TGT
NM_147127.5(EVC2):c.3446_3453CAGCCTCA[3] (p.Gln1154fs)	EVC2		Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000854737	4	5570266 - 5570267	4	5568539 - 5568540	854737	829403		NC_000004.12:5568539:TGAGGCTGTGAGGCTGTG:TGAGGCTGTGAGGCTGTGAGGCTGTG
NM_147127.5(EVC2):c.3346dup (p.Thr1116fs)	EVC2		Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000851655	4	5576425 - 5576426	4	5574698 - 5574699	851655	829405		NC_000004.12:5574698:TT:TTT
NM_147127.5(EVC2):c.668C>A (p.Ser223Ter)	EVC2	S143*, S223*	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000851235	4	5690922	4	5689195	851235	829413		NC_000004.12:5689194:G:T
NM_147127.5(EVC2):c.1606G>T (p.Glu536Ter)	EVC2	E536*, E456*	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000848665	4	5633624	4	5631897	848665	829410		NC_000004.12:5631896:C:A
NM_147127.5(EVC2):c.3140G>A (p.Trp1047Ter)	EVC2	W1047*, W967*	Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000846041	4	5578099	4	5576372	846041	829406		NC_000004.12:5576371:C:T
NM_147127.5(EVC2):c.2539G>T (p.Glu847Ter)	EVC2	E767*, E847*	Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000845073	4	5620372	4	5618645	845073	829407		NC_000004.12:5618644:C:A
NM_147127.5(EVC2):c.3446_3455dup (p.Gln1152fs)	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000838376	4	5570272 - 5570273	4	5568545 - 5568546	838376	829404		NC_000004.12:5568545:TGTGAGGCTGTG:TGTGAGGCTGTGTGAGGCTGTG
NC_000004.12:g.(?_5568434)_(5568650_?)del	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000830445	4	5570161 - 5570377			830445	819495		
NM_147127.5(EVC2):c.2368C>T (p.Gln790Ter)	EVC2	Q790*, Q710*	Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000658689	4	5624397	4	5622670	658689	632444		NC_000004.12:5622669:G:A
NM_147127.5(EVC2):c.2092C>T (p.Arg698Ter)	EVC2	R698*, R618*	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000656440	4	5624673	4	5622946	656440	632445		NC_000004.12:5622945:G:A
NC_000004.11:g.(?_5690874)_(5691080_?)del	EVC2		Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000647967	4	5690874 - 5691080	4	5689147 - 5689353	647967	651117		
NM_147127.5(EVC2):c.3205C>T (p.Gln1069Ter)	EVC2	Q989*, Q1069*	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000647337	4	5578034	4	5576307	647337	632442		NC_000004.12:5576306:G:A
NM_147127.5(EVC2):c.341C>G (p.Ser114Ter)	EVC2	S114*, S34*	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000580714	4	5696171	4	5694444	580714	559805	rs748820015	NC_000004.12:5694443:G:C
NM_147127.5(EVC2):c.392dup (p.Pro132fs)	EVC2		Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000575995	4	5696119 - 5696120	4	5694392 - 5694393	575995	562238	rs774416029	NC_000004.12:5694392:A:AA
NM_147127.5(EVC2):c.3660del (p.Ser1220fs)	EVC2	S1140fs, S1220fs	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000553833	4	5564842	4	5563115	553833	543136	rs753581033	NC_000004.12:5563114:G:
NM_147127.5(EVC2):c.3634delinsGA (p.Leu1212fs)	EVC2		Ellis-van Creveld syndrome	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000455997	4	5567010	4	5565283	455997	454331	rs1553812417	NC_000004.12:5565282:G:TC
NM_147127.5(EVC2):c.1713dup (p.Asn572fs)	EVC2		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446665	4	5630458 - 5630459	4	5628731 - 5628732	446665	440099	rs1553836165	NC_000004.12:5628731:C:CC
NM_147127.5(EVC2):c.3805G>T (p.Gly1269Ter)	EVC2	G1269*, G1189*	Curry-Hall syndrome	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000102432	4	5564697	4	5562970	102432	108174	rs1560121645	NC_000004.12:5562969:C:A
NM_147127.5(EVC2):c.3797T>A (p.Leu1266Ter)	EVC2	L1266*, L1186*	Curry-Hall syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000102431	4	5564705	4	5562978	102431	108173		NC_000004.12:5562977:A:T
NM_147127.5(EVC2):c.707-2A>G	EVC2		Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000030664	4	5687208	4	5685481	30664	39621		NC_000004.12:5685480:T:C
NM_147127.5(EVC2):c.848T>G (p.Ile283Arg)	EVC2	I283R, I203R	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003385	4	5683009	4	5681282	3385	18424	rs137852926	NC_000004.12:5681281:A:C
NM_147127.5(EVC2):c.1855C>T (p.Gln619Ter)	EVC2	Q619*, Q539*	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003384	4	5630317	4	5628590	3384	18423	rs137852925	NC_000004.12:5628589:G:A
EVC2, 1-BP DEL, 3660C	EVC2		Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003380					3380	18419		
NM_147127.5(EVC2):c.3640del (p.Ala1214fs)	EVC2	A1214fs, A1134fs	Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000650524	4	5567004	4	5565277	650524	632440		NC_000004.12:5565276:CCC:CC
NM_147127.5(EVC2):c.745C>T (p.Gln249Ter)	EVC2	Q249*, Q169*	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000552093	4	5687168	4	5685441	552093	543556	rs1236566474	NC_000004.12:5685440:G:A
NM_147127.5(EVC2):c.2029C>T (p.Arg677Ter)	EVC2	R677*, R597*	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000550579	4	5627493	4	5625766	550579	543528	rs73198165	NC_000004.12:5625765:G:A
NM_147127.5(EVC2):c.1024A>T (p.Lys342Ter)	EVC2	K342*, K262*	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000550367	4	5664955	4	5663228	550367	543152	rs767072839	NC_000004.12:5663227:T:A
NM_147127.5(EVC2):c.2746del (p.Ser916fs)	EVC2	S836fs, S916fs	Ellis-van Creveld syndrome	Pathogenic	no assertion criteria provided	VCV000219180	4	5617232	4	5615505	219180	217207	rs886037763	NC_000004.12:5615504:TTTT:TTT
NM_147127.5(EVC2):c.3797T>G (p.Leu1266Ter)	EVC2	L1266*, L1186*	Curry-Hall syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000102430	4	5564705	4	5562978	102430	108172		NC_000004.12:5562977:A:C
EVC2, 5-BP INS, NT198	EVC2		Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000003381					3381	18420		
NM_003060.4(SLC22A5):c.456_457TG[1] (p.Val153fs)	SLC22A5	V153AfsX41	Renal carnitine transport defect|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025376	5	131714131 - 131714132	5	132378439 - 132378440	25376	36710	rs386134195	NC_000005.10:132378438:GTGTG:GTG
NM_003060.4(SLC22A5):c.43G>T (p.Gly15Trp)	SLC22A5	G15W	not provided|Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006429	5	131705707	5	132370015	6429	21468	rs267607052	NC_000005.10:132370014:G:T
NM_003060.4(SLC22A5):c.396G>A (p.Trp132Ter)	SLC22A5	W132*, W156*	Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006411	5	131714072	5	132378380	6411	21450	rs72552727	NC_000005.10:132378379:G:A
NM_001457.4(FLNB):c.5071G>A (p.Gly1691Ser)	FLNB	G1691S, G1722S	Larsen syndrome|Larsen syndrome, dominant type|not provided	Pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000006406	3	58124218	3	58138491	6406	21445	rs80356503	NC_000003.12:58138490:G:A
NM_147127.5(EVC2):c.105_126dup (p.Gly43fs)	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555651	4	5710114 - 5710115	4	5708387 - 5708388	555651	543529	rs1553855127	NC_000004.12:5708387:GAGGGGGCGCCAGCGGGGACGTGAG:GAGGGGGCGCCAGCGGGGACGTGAGGGGGCGCCAGCGGGGACGTGAG
NM_147127.5(EVC2):c.199_208del (p.Ser67fs)	EVC2	S67fs	Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555475	4	5710033 - 5710042	4	5708306 - 5708315	555475	543569	rs1420414097	NC_000004.12:5708305:CCGCCCCGCTCCGCCCCG:CCGCCCCG
NM_147127.5(EVC2):c.142_151del (p.Asp49fs)	EVC2	D49fs	Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000550552	4	5710090 - 5710099	4	5708363 - 5708372	550552	543571	rs1221185345	NC_000004.12:5708362:GGGGATCCCGGGG:GGG
NM_147127.5(EVC2):c.2653C>T (p.Arg885Ter)	EVC2	R884*, R885*, R805*	Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000030665	4	5620258	4	5618531	30665	39622	rs146538906	NC_000004.12:5618530:G:A
NM_147127.5(EVC2):c.3793del (p.Leu1265fs)	EVC2	L1265fs, L1185fs	Curry-Hall syndrome	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000003388	4	5564709	4	5562982	3388	18427	rs587776568	NC_000004.12:5562981:G:
NM_001080522.2(CC2D2A):c.2848C>T (p.Arg950Ter)	CC2D2A	R950*	not provided|Joubert syndrome 9	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000745	4	15560806	4	15559183	745	15784	rs118204053	NC_000004.12:15559182:C:T
NM_147127.5(EVC2):c.707-2A>C	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000653886	4	5687208	4	5685481	653886	651203		NC_000004.12:5685480:T:G
NM_147127.5(EVC2):c.3762del (p.Val1255fs)	EVC2	V1175fs, V1255fs	Ellis-van Creveld syndrome|Curry-Hall syndrome	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000639672	4	5564740	4	5563013	639672	632439		NC_000004.12:5563012:A:
NM_147127.5(EVC2):c.871-2_894del	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553798	4	5667353 - 5667378	4	5665626 - 5665651	553798	543496	rs755789146	NC_000004.12:5665625:GTGGAGGCCGTGGTGCGGCAGAACCTGTGGAG:GTGGAG
NM_147127.5(EVC2):c.2484G>A (p.Trp828Ter)	EVC2	W828*, W748*	Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553315	4	5624281	4	5622554	553315	543440	rs770918273	NC_000004.12:5622553:C:T
NM_147127.5(EVC2):c.3405_3411del (p.Gly1136fs)	EVC2	G1136fs, G1056fs	Jeune thoracic dystrophy|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000195541	4	5570317 - 5570323	4	5568590 - 5568596	195541	192702	rs750396637	NC_000004.12:5568589:GGCCCCGGGC:GGC
NM_147127.5(EVC2):c.2056dup (p.Gln686fs)	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000003382	4	5624708 - 5624709	4	5622981 - 5622982	3382	18421		NC_000004.12:5622981:G:GG
NM_023073.3(CPLANE1):c.8710C>T (p.Arg2904Ter)	CPLANE1	R2904*	not provided|Joubert syndrome 17	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217571	5	37125432	5	37125330	217571	214202	rs141507441	NC_000005.10:37125329:G:A
NC_000004.12:g.(?_5562848)_(5565369_?)del	EVC2		Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000830808	4	5564575 - 5567096			830808	819494		
NM_147127.5(EVC2):c.2620C>T (p.Arg874Ter)	EVC2	R874*, R794*	Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554547	4	5620291	4	5618564	554547	543520	rs760382778	NC_000004.12:5618563:G:A
NM_173660.4(DOK7):c.1263dupC	DOK7		Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial|Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I|FETAL AKINESIA DEFORMATION SEQUENCE 3	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001274	4	3494969 - 3494970	4	3493242 - 3493243	1274	16313	rs606231129	NC_000004.12:3493242:CCCCCCC:CCCCCCCC
NM_001364905.1(LRBA):c.6709del (p.Trp2237fs)	LRBA	W2237fs, W2248fs	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802092	4	151388896	4	150467744	802092	790440		NC_000004.12:150467743:AA:A
NM_001364905.1(LRBA):c.2479C>T (p.Arg827Ter)	LRBA	R827*	not specified	Pathogenic(Last reviewed: Jan 7, 2017)	criteria provided, single submitter	VCV000439868	4	151789428	4	150868276	439868	433672	rs779575307	NC_000004.12:150868275:G:A
NM_001364905.1(LRBA):c.2963del (p.Asn988fs)	LRBA	N988fs	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000864696	4	151773899	4	150852747	864696	828857		NC_000004.12:150852746:TTT:TT
NM_001364905.1(LRBA):c.1931dup (p.Arg645fs)	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000863113	4	151818963 - 151818964	4	150897811 - 150897812	863113	828868		NC_000004.12:150897811:GG:GGG
NC_000004.12:g.(?_150761763)_(150761867_?)del	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000833337	4	151682915 - 151683019			833337	819455		
NC_000004.12:g.(?_150683531)_(150761867_?)del	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000832311	4	151604683 - 151683019			832311	819453		
NC_000004.12:g.(?_150893032)_(150897838_?)del	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000832310	4	151814184 - 151818990			832310	819456		
NC_000004.12:g.(?_150735238)_(150735386_?)del	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000831876	4	151656390 - 151656538			831876	819454		
NM_001364905.1(LRBA):c.4522C>T (p.Gln1508Ter)	LRBA	Q1508*	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827717	4	151765299	4	150844147	827717	815909		NC_000004.12:150844146:G:A
NM_001364905.1(LRBA):c.7007G>A (p.Trp2336Ter)	LRBA	W2347*, W2336*	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000663178	4	151356775	4	150435623	663178	631971		NC_000004.12:150435622:C:T
NM_001364905.1(LRBA):c.8332C>T (p.Arg2778Ter)	LRBA	R2777*, R2789*, R2778*, R2783*	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000648944	4	151199141	4	150277989	648944	631959		NC_000004.12:150277988:G:A
NC_000004.11:g.(?_151231361)_(151271331_?)del	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000584033	4	151231361 - 151271331	4	150310209 - 150350179	584033	559549		
NM_001364905.1(LRBA):c.2563_2564delinsTG (p.Glu855Ter)	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000571049	4	151789343 - 151789344	4	150868191 - 150868192	571049	561933	rs1560938296	NC_000004.12:150868190:TC:CA
NM_001364905.1(LRBA):c.4_16dup (p.Asn6delinsSerTer)	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000540378	4	151935778 - 151935779	4	151014626 - 151014627	540378	520094	rs1554020278	NC_000004.12:151014626:TGTCTTCGCTAGC:TGTCTTCGCTAGCTGTCTTCGCTAGC
NC_000004.11:g.(?_151509180)_(151656538_?)del	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000473163	4	151509180 - 151656538	4	150588028 - 150735386	473163	453234		
NM_001364905.1(LRBA):c.2032C>T (p.Gln678Ter)	LRBA	Q678*	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162667	4	151817581	4	150896429	162667	172321	rs727503780	NC_000004.12:150896428:G:A
NM_001364905.1(LRBA):c.6620_6621GA[2] (p.Glu2208fs)	LRBA		Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000162666	4	151392818 - 151392819	4	150471666 - 150471667	162666	172320	rs727503779	NC_000004.12:150471665:TCTCTCT:TCTCT
NM_001364905.1(LRBA):c.175G>T (p.Glu59Ter)	LRBA	E59*	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000035457	4	151935620	4	151014468	35457	44122	rs199469664	NC_000004.12:151014467:C:A
NM_001364905.1(LRBA):c.5047C>T (p.Arg1683Ter)	LRBA	R1683*	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000035456	4	151749456	4	150828304	35456	44121	rs199469662	NC_000004.12:150828303:G:A
NM_001364905.1(LRBA):c.7937T>G (p.Ile2646Ser)	LRBA	I2657S, I2646S, I2651S	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000035455	4	151223857	4	150302705	35455	44120	rs199469663	NC_000004.12:150302704:A:C
NM_001364905.1(LRBA):c.3811C>T (p.Arg1271Ter)	LRBA	R1271*	Common variable immunodeficiency 8, with autoimmunity	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000574254	4	151773051	4	150851899	574254	559605	rs1560914625	NC_000004.12:150851898:G:A
NM_001354689.3(RAF1):c.1517A>G (p.Asp506Gly)	RAF1	D486G, D506G, D405G, D425G, D372G, D453G	Rasopathy|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040618	3	12627259	3	12585760	40618	49088	rs397516815	NC_000003.12:12585759:T:C
NM_001364905.1(LRBA):c.6607C>T (p.Arg2203Ter)	LRBA	R2203*, R2214*	not provided|Common variable immunodeficiency 8, with autoimmunity	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000809688	4	151392836	4	150471684	809688	795537		NC_000004.12:150471683:G:A
NM_000046.5(ARSB):c.574T>C (p.Cys192Arg)	ARSB	C192R	Mucopolysaccharidosis type 6	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559798	5	78260355	5	78964532	559798	550481	rs1554087423	NC_000005.10:78964531:A:G
NM_000046.5(ARSB):c.1143-1G>C	ARSB		Mucopolysaccharidosis type 6	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000887	5	78135250	5	78839427	887	15926	rs431905495	NC_000005.10:78839426:C:G
NM_001080522.2(CC2D2A):c.2683C>T (p.Gln895Ter)	CC2D2A	Q895*	Joubert syndrome with hepatic defect|Joubert syndrome 9|Meckel syndrome type 6|Joubert syndrome 9	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210609	4	15558984	4	15557361	210609	207110	rs764719093	NC_000004.12:15557360:C:T
NM_023073.3(CPLANE1):c.9058C>T (p.Arg3020Ter)	CPLANE1	R3020*	not provided|Joubert syndrome 17||Joubert syndrome 17	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217569	5	37120408	5	37120306	217569	214197	rs374144275	NC_000005.10:37120305:G:A
NM_147127.5(EVC2):c.1708C>T (p.Gln570Ter)	EVC2	Q570*, Q490*	Ellis-van Creveld syndrome|Short rib-polydactyly syndrome, Majewski type|Type IV short rib polydactyly syndrome	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000446664	4	5633522	4	5631795	446664	440100	rs769864196	NC_000004.12:5631794:G:A
NM_147127.5(EVC2):c.2476C>T (p.Arg826Ter)	EVC2	R826*, R746*	not provided|Ellis-van Creveld syndrome|Curry-Hall syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280117	4	5624289	4	5622562	280117	264195	rs548681312	NC_000004.12:5622561:G:A
NM_147127.5(EVC2):c.2263C>T (p.Gln755Ter)	EVC2	Q755*, Q675*	Ellis-van Creveld syndrome|Curry-Hall syndrome|Ellis-van Creveld syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194442	4	5624502	4	5622775	194442	191605	rs751356206	NC_000004.12:5622774:G:A
NM_001145291.1(PDE6B):c.1923_1969delinsTCTGGG (p.Asn643fs)	PDE6B		not provided|Retinitis pigmentosa|Retinitis pigmentosa 40	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224742	4	657561 - 657607	4	663772 - 663818	224742	226525	rs869312177	NC_000004.12:663771:CCTGAACATCTACCAGAACCTGAACCGGCGGCAGCACGAGCACGTGA:TCTGGG
NM_000030.3(AGXT):c.481G>A (p.Gly161Ser)	AGXT	G161S	Primary hyperoxaluria, type I|Nephrolithiasis|Nephrocalcinosis|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000204105	2	241810823	2	240871406	204105	200501	rs180177227	NC_000002.12:240871405:G:A
NM_000030.3(AGXT):c.777-1G>C	AGXT		Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188774	2	241815351	2	240875934	188774	186661	rs180177267	NC_000002.12:240875933:G:C
NM_000030.3(AGXT):c.481G>T (p.Gly161Cys)	AGXT	G161C	Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188738	2	241810823	2	240871406	188738	186656	rs180177227	NC_000002.12:240871405:G:T
NM_001182.5(ALDH7A1):c.1513G>C (p.Gly505Arg)	ALDH7A1	G505R, G477R, G441R	Pyridoxine-dependent epilepsy|not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204852	5	125882068	5	126546376	204852	201803	rs556400964	NC_000005.10:126546375:C:G
NM_198903.2(GABRG2):c.1088G>A (p.Arg363Gln)	GABRG2	R323Q, R363Q	Rolandic epilepsy|Generalized epilepsy with febrile seizures plus 3|not provided|Seizures|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74|Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060708	5	161576159	5	162149153	60708	75270	rs397514737	NC_000005.10:162149152:G:A
NM_001080522.2(CC2D2A):c.1017+1G>A	CC2D2A		not provided|Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 9	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000166801	4	15517628	4	15516005	166801	177556	rs200407856	NC_000004.12:15516004:G:A
NM_003060.4(SLC22A5):c.1340A>G (p.Tyr447Cys)	SLC22A5	Y447C, Y471C	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025418	5	131728197	5	132392505	25418	36752	rs386134218	NC_000005.10:132392504:A:G
NM_003060.4(SLC22A5):c.64_66TTC[1] (p.Phe23del)	SLC22A5	F23del	Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025353	5	131705726 - 131705728	5	132370034 - 132370036	25353	36687	rs377767444	NC_000005.10:132370033:TCTTCTTC:TCTTC
NM_003060.4(SLC22A5):c.632A>G (p.Tyr211Cys)	SLC22A5	Y211C, Y235C	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006420	5	131719973	5	132384281	6420	21459	rs121908888	NC_000005.10:132384280:A:G
NM_023073.3(CPLANE1):c.7400+1G>A	CPLANE1		|Joubert syndrome 17|Joubert syndrome 17	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031220	5	37167148	5	37167046	31220	40177	rs367543062	NC_000005.10:37167045:C:T
NM_023073.3(CPLANE1):c.4006C>T (p.Arg1336Trp)	CPLANE1	R1336W	Joubert syndrome 17|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000031219	5	37187590	5	37187488	31219	40176	rs367543061	NC_000005.10:37187487:G:A
NM_000203.5(IDUA):c.972+1G>A	IDUA		not provided	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000198406	4	995950	4	1002162	198406	195567	rs794727840	NC_000004.12:1002161:G:A
NM_000203.5(IDUA):c.494-1G>C	IDUA		not provided	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	VCV000197644	4	995255	4	1001467	197644	194805	rs794727701	NC_000004.12:1001466:G:C
NM_000203.5(IDUA):c.501C>G (p.Tyr167Ter)	IDUA	Y167*, Y35*	not provided	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	VCV000092644	4	995263	4	1001475	92644	98551	rs200726100	NC_000004.12:1001474:C:G
NM_000203.5(IDUA):c.1402+1G>C	IDUA		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092631	4	996733	4	1002945	92631	98538	rs398123254	NC_000004.12:1002944:G:C
NM_000203.5(IDUA):c.1045G>A (p.Asp349Asn)	IDUA	D349N, D217N	not provided	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	VCV000092623	4	996129	4	1002341	92623	98531	rs368454909	NC_000004.12:1002340:G:A
NM_000203.5(IDUA):c.1163del (p.Thr388fs)	IDUA	T388fs, T256fs	Hurler syndrome	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000828094	4	996247	4	1002459	828094	816406		NC_000004.12:1002458:C:
NM_000203.5(IDUA):c.612_615dup (p.Ser206fs)	IDUA		Hurler syndrome	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000226413	4	995485 - 995486	4	1001697 - 1001698	226413	228214	rs875989947	NC_000004.12:1001697:TGCCTGC:TGCCTGCCTGC
NM_000203.5(IDUA):c.1029C>A (p.Tyr343Ter)	IDUA	Y343*, Y211*	Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Feb 11, 2016)	no assertion criteria provided	VCV000222997	4	996113	4	1002325	222997	224718	rs764196171	NC_000004.12:1002324:C:A
NM_000203.5(IDUA):c.1874A>G (p.Tyr625Cys)	IDUA	Y625C, Y493C	Hurler syndrome	Pathogenic	no assertion criteria provided	VCV000100723	4	998093	4	1004305	100723	106588	rs587779401	NC_000004.12:1004304:A:G
NM_000203.5(IDUA):c.1561_1570del (p.Ala520_Gly521insTer)	IDUA		Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000860010	4	997164 - 997173	4	1003376 - 1003385	860010	828640		NC_000004.12:1003375:CCGCCGGCGGCCGCC:CCGCC
NM_000203.5(IDUA):c.615C>A (p.Cys205Ter)	IDUA	C205*, C73*	Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000853816	4	995492	4	1001704	853816	828632		NC_000004.12:1001703:C:A
NM_000203.5(IDUA):c.1395dup (p.Gly466fs)	IDUA		Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000845547	4	996719 - 996720	4	1002931 - 1002932	845547	828638		NC_000004.12:1002931:CCCCCC:CCCCCCC
NM_000203.5(IDUA):c.494-1G>A	IDUA		Hurler syndrome	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000557942	4	995255	4	1001467	557942	543275	rs794727701	NC_000004.12:1001466:G:A
NM_000203.5(IDUA):c.1206G>A (p.Trp402Ter)	IDUA	W402*, W270*	Hurler syndrome	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000555230	4	996536	4	1002748	555230	543343	rs991612107	NC_000004.12:1002747:G:A
NM_000203.5(IDUA):c.1854C>A (p.Tyr618Ter)	IDUA	Y618*, Y486*	Hurler syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000554826	4	998073	4	1004285	554826	543218	rs746936485	NC_000004.12:1004284:C:A
NM_000203.5(IDUA):c.1898C>G (p.Ser633Trp)	IDUA	S633W, S501W	not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000286242	4	998117	4	1004329	286242	270479	rs886043347	NC_000004.12:1004328:C:G
NM_000203.5(IDUA):c.1475G>C (p.Arg492Pro)	IDUA	R492P, R360P	Mucopolysaccharidosis, MPS-I-S	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000011918	4	996896	4	1003108	11918	26957	rs121965026	NC_000004.12:1003107:G:C
NM_000203.5(IDUA):c.1096A>C (p.Thr366Pro)	IDUA	T366P, T234P	Hurler syndrome	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000011916	4	996180	4	1002392	11916	26955	rs121965024	NC_000004.12:1002391:A:C
NM_000203.5(IDUA):c.928C>T (p.Gln310Ter)	IDUA	Q310*, Q178*	Hurler syndrome	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000011915	4	995905	4	1002117	11915	26954	rs121965023	NC_000004.12:1002116:C:T
IDUA, 1-BP DEL, 1702G	IDUA		Hurler syndrome	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011912					11912	26951		
NM_000203.5(IDUA):c.1695_1705del (p.Leu566fs)	IDUA	L566fs, L434fs	Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000862097	4	997376 - 997386	4	1003588 - 1003598	862097	828642		NC_000004.12:1003587:CTGGTTCTGGTCTGGT:CTGGT
NM_000203.5(IDUA):c.936G>A (p.Trp312Ter)	IDUA	W312*, W180*	Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000855322	4	995913	4	1002125	855322	828634		NC_000004.12:1002124:G:A
NM_000203.5(IDUA):c.1750C>T (p.Gln584Ter)	IDUA	Q584*, Q452*	Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000846228	4	997822	4	1004034	846228	828643		NC_000004.12:1004033:C:T
NM_000203.5(IDUA):c.1456G>T (p.Glu486Ter)	IDUA	E354*, E486*	Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000651168	4	996877	4	1003089	651168	631845		NC_000004.12:1003088:G:T
NM_000203.5(IDUA):c.1728-1G>C	IDUA		Hurler syndrome	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000556064	4	997799	4	1004011	556064	543039	rs1249951282	NC_000004.12:1004010:G:C
NM_000203.5(IDUA):c.606C>A (p.Tyr202Ter)	IDUA	Y202*, Y70*	Hurler syndrome	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000552333	4	995483	4	1001695	552333	543285	rs1033313360	NC_000004.12:1001694:C:A
NM_000158.4(GBE1):c.1543C>T (p.Arg515Cys)	GBE1	R515C	Inborn genetic diseases|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Aug 30, 2013)	criteria provided, single submitter	VCV000002779	3	81627151	3	81578000	2779	17818	rs80338672	NC_000003.12:81577999:G:A
NM_000203.5(IDUA):c.1422_1423dup (p.Tyr475fs)	IDUA		Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554471	4	996842 - 996843	4	1003054 - 1003055	554471	543037	rs761793564	NC_000004.12:1003054:CT:CTCT
NM_000203.5(IDUA):c.385+1G>C	IDUA		Hurler syndrome|not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000551966	4	994486	4	1000698	551966	543267	rs780615798	NC_000004.12:1000697:G:C
NM_000203.5(IDUA):c.1743C>G (p.Tyr581Ter)	IDUA	Y581*, Y449*	Hurler syndrome	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000550883	4	997815	4	1004027	550883	543319	rs776787370	NC_000004.12:1004026:C:G
NM_000203.5(IDUA):c.1799del (p.Pro599_Ser600insTer)	IDUA		not provided|Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000092636	4	997871	4	1004083	92636	98543	rs398123258	NC_000004.12:1004082:C:
NM_001370658.1(BTD):c.571C>T (p.Arg191Cys)	BTD	R211C, R191C, R213C	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000025028	3	15685994	3	15644487	25028	36365	rs372844636	NC_000003.12:15644486:C:T
NM_001370658.1(BTD):c.281G>T (p.Gly94Val)	BTD	G114V, G116V, G94V	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024999	3	15683446	3	15641939	24999	36337	rs375712490	NC_000003.12:15641938:G:T
NM_000203.5(IDUA):c.1614del (p.His539fs)	IDUA	H539fs, H407fs	not provided|Hurler syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000167191	4	997222	4	1003434	167191	177778	rs727503967	NC_000004.12:1003433:G:
NM_000203.4(IDUA):c.1960T>G (p.Ter654Gly)	IDUA	*654G, *522G	Mucopolysaccharidosis type 1|Mucopolysaccharidosis, MPS-I-H/S	Pathogenic(Last reviewed: Feb 11, 2016)	no assertion criteria provided	VCV000011920	4	998179	4	1004391	11920	26959	rs387906504	NC_000004.12:1004390:T:G
NM_001354689.3(RAF1):c.782C>T (p.Pro261Leu)	RAF1	P261L, P180L, P228L, P147L	Noonan syndrome 5|not provided|Noonan syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000120246	3	12645687	3	12604188	120246	125840	rs397516828	NC_000003.12:12604187:G:A
NM_002880.3(RAF1):c.776C>G (p.Ser259Cys)	RAF1	S259C, S178C, S145C, S226C	not provided|Rasopathy|Noonan syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040602	3	12645693	3	12604194	40602	49072	rs397516827	NC_000003.12:12604193:G:C
NM_003042.4(SLC6A1):c.1189C>T (p.Gln397Ter)	SLC6A1	Q397*, Q277*, Q219*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000521437	3	11070531	3	11028845	521437	511442	rs1553690452	NC_000003.12:11028844:C:T
NM_003042.4(SLC6A1):c.967G>A (p.Val323Ile)	SLC6A1	V323I, V145I, V203I	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000521027	3	11067934	3	11026248	521027	511441	rs1403165900	NC_000003.12:11026247:G:A
NM_003042.4(SLC6A1):c.850-2A>G	SLC6A1		Inborn genetic diseases	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000520889	3	11067457	3	11025771	520889	511440	rs1553689664	NC_000003.12:11025770:A:G
NM_003042.4(SLC6A1):c.809T>C (p.Phe270Ser)	SLC6A1	F270S, F150S, F92S	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000520878	3	11067229	3	11025543	520878	511439	rs1553689580	NC_000003.12:11025542:T:C
NM_000094.4(COL7A1):c.1450_1451CT[1] (p.Tyr485fs)	COL7A1		not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000817806	3	48629160 - 48629161	3	48591727 - 48591728	817806	805358		NC_000003.12:48591726:AGAG:AG
NM_000094.4(COL7A1):c.6041del (p.Gln2014fs)	COL7A1	Q2014fs	not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000817763	3	48612911	3	48575478	817763	805357		NC_000003.12:48575477:T:
NM_000094.4(COL7A1):c.6081dup (p.Gly2028fs)	COL7A1		not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000817592	3	48612870 - 48612871	3	48575437 - 48575438	817592	805356		NC_000003.12:48575437:GGGGGGG:GGGGGGGG
NM_000094.4(COL7A1):c.6351delinsAT (p.Gly2117_Glu2118insTer)	COL7A1		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817015	3	48612152	3	48574719	817015	805355		NC_000003.12:48574718:C:AT
NM_000094.3(COL7A1):c.5585C>G (p.Ser1862Ter)	COL7A1	S1862*	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000620163	3	48614336	3	48576903	620163	611589	rs1013627013	NC_000003.12:48576902:G:C
NM_000094.3(COL7A1):c.2699G>A (p.Trp900Ter)	COL7A1	W900*	not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000620133	3	48625726	3	48588293	620133	611591	rs1349541188	NC_000003.12:48588292:C:T
NM_000094.3(COL7A1):c.7234C>T (p.Arg2412Ter)	COL7A1	R2412*	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000620089	3	48608332	3	48570899	620089	611588	rs1342522878	NC_000003.12:48570898:G:A
NM_000094.3(COL7A1):c.4894C>T (p.Arg1632Ter)	COL7A1	R1632*	not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000620088	3	48618698	3	48581265	620088	611590	rs751535193	NC_000003.12:48581264:G:A
NM_000094.3(COL7A1):c.8272del (p.Val2758fs)	COL7A1	V2758fs	not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000503806	3	48604125	3	48566692	503806	495453	rs1553849789	NC_000003.12:48566691:CCCC:CCC
NM_000094.3(COL7A1):c.6864_6879del (p.Lys2289fs)	COL7A1	K2289fs	not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000503708	3	48610125 - 48610140	3	48572692 - 48572707	503708	495145	rs1553853022	NC_000003.12:48572691:GCCAGGTTCTCCTTTAG:G
NM_000094.3(COL7A1):c.7462C>T (p.Gln2488Ter)	COL7A1	Q2488*	not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000488686	3	48607590	3	48570157	488686	481695	rs1553851245	NC_000003.12:48570156:G:A
NM_000094.3(COL7A1):c.751C>T (p.Gln251Ter)	COL7A1	Q251*	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000488684	3	48630303	3	48592870	488684	481698	rs1211890738	NC_000003.12:48592869:G:A
NM_000094.3(COL7A1):c.2715_2722dup (p.Gln908fs)	COL7A1		not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000452542	3	48625360 - 48625361	3	48587927 - 48587928	452542	443481	rs1553613303	NC_000003.12:48587927:GTTCCTGG:GTTCCTGGGTTCCTGG
NM_000094.3(COL7A1):c.5273G>T (p.Gly1758Val)	COL7A1	G1758V	not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452096	3	48616836	3	48579403	452096	443478	rs1553857986	NC_000003.12:48579402:C:A
NM_000094.3(COL7A1):c.2291del (p.Pro764fs)	COL7A1	P764fs	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000451065	3	48626783	3	48589350	451065	443482	rs775496394	NC_000003.12:48589349:GGGGG:GGGG
NM_000094.3(COL7A1):c.5173G>A (p.Gly1725Arg)	COL7A1	G1725R	not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000450451	3	48617083	3	48579650	450451	443479	rs772195825	NC_000003.12:48579649:C:T
NM_000094.3(COL7A1):c.4011+1G>A	COL7A1		not provided	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000449650	3	48622342	3	48584909	449650	443480	rs1553862581	NC_000003.12:48584908:C:T
NM_000094.3(COL7A1):c.1781-1G>C	COL7A1		not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000449471	3	48628018	3	48590585	449471	443483	rs1553614878	NC_000003.12:48590584:C:G
NM_000094.3(COL7A1):c.5932C>T (p.Arg1978Ter)	COL7A1	R1978*	not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000449469	3	48613106	3	48575673	449469	443475	rs1368134215	NC_000003.12:48575672:G:A
NM_000094.3(COL7A1):c.5869C>T (p.Arg1957Trp)	COL7A1	R1957W	not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000449003	3	48613169	3	48575736	449003	443476	rs747081862	NC_000003.12:48575735:G:A
NM_000094.3(COL7A1):c.5425-1G>C	COL7A1		not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000432365	3	48615949	3	48578516	432365	425567	rs112850769	NC_000003.12:48578515:C:G
NM_000094.3(COL7A1):c.2710+2T>C	COL7A1		not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000431993	3	48625713	3	48588280	431993	425569	rs1553613528	NC_000003.12:48588279:A:G
NM_000094.3(COL7A1):c.5701-1G>T	COL7A1		not provided	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000431992	3	48613991	3	48576558	431992	425566	rs1553855868	NC_000003.12:48576557:C:A
NM_000094.3(COL7A1):c.6164G>A (p.Gly2055Glu)	COL7A1	G2055E	not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000431991	3	48612788	3	48575355	431991	425564	rs1553854678	NC_000003.12:48575354:C:T
NM_000094.3(COL7A1):c.6656dup (p.Thr2220fs)	COL7A1		not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000431811	3	48610664 - 48610665	3	48573231 - 48573232	431811	425563	rs757406252	NC_000003.12:48573231:A:AA
NM_000094.3(COL7A1):c.5035G>A (p.Gly1679Arg)	COL7A1	G1679R	not provided	Pathogenic(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	VCV000429804	3	48618031	3	48580598	429804	421448	rs1131691601	NC_000003.12:48580597:C:T
NM_000094.3(COL7A1):c.6394G>C (p.Gly2132Arg)	COL7A1	G2132R	not provided	Pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, single submitter	VCV000429738	3	48611983	3	48574550	429738	421447	rs1131691559	NC_000003.12:48574549:C:G
NM_000094.3(COL7A1):c.887del (p.Gly296fs)	COL7A1	G296fs	not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000429443	3	48630092	3	48592659	429443	421449	rs1131691385	NC_000003.12:48592658:CCCC:CCC
NM_000094.3(COL7A1):c.2607_2608del (p.Leu870fs)	COL7A1	L870fs	not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000426903	3	48625817 - 48625818	3	48588384 - 48588385	426903	414944	rs1085307849	NC_000003.12:48588383:GGG:G
NM_000094.3(COL7A1):c.3751_3752insACCA (p.Cys1251fs)	COL7A1		not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000422653	3	48623380 - 48623381	3	48585947 - 48585948	422653	406327	rs1064795917	NC_000003.12:48585947::TGGT
NM_000094.3(COL7A1):c.3631C>T (p.Gln1211Ter)	COL7A1	Q1211*	not provided	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000420110	3	48623599	3	48586166	420110	406328	rs747522386	NC_000003.12:48586165:G:A
NM_000094.3(COL7A1):c.6127G>T (p.Gly2043Trp)	COL7A1	G2043W	not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000419628	3	48612825	3	48575392	419628	406323	rs121912836	NC_000003.12:48575391:C:A
NM_000094.3(COL7A1):c.7828C>T (p.Arg2610Ter)	COL7A1	R2610*	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000419502	3	48605570	3	48568137	419502	406319	rs1064793916	NC_000003.12:48568136:G:A
NM_000094.3(COL7A1):c.6842G>C (p.Gly2281Ala)	COL7A1	G2281A	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000419501	3	48610162	3	48572729	419501	406322	rs1064793915	NC_000003.12:48572728:C:G
NM_000094.3(COL7A1):c.6900+1G>A	COL7A1		not provided	Pathogenic(Last reviewed: Aug 16, 2015)	criteria provided, single submitter	VCV000419491	3	48610103	3	48572670	419491	406321	rs1064793908	NC_000003.12:48572669:C:T
NM_000094.3(COL7A1):c.7688G>A (p.Gly2563Asp)	COL7A1	G2563D	not provided	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000419484	3	48606287	3	48568854	419484	406320	rs1064793904	NC_000003.12:48568853:C:T
NM_000094.3(COL7A1):c.5659_5666dup (p.Pro1892fs)	COL7A1		not provided	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000418886	3	48614142 - 48614143	3	48576709 - 48576710	418886	406325	rs1553855974	NC_000003.12:48576709:GGAGGCCC:GGAGGCCCGGAGGCCC
NM_000094.3(COL7A1):c.5015del (p.Lys1672fs)	COL7A1	K1672fs	not provided	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000418885	3	48618051	3	48580618	418885	406326	rs1064793499	NC_000003.12:48580617:TTTT:TTT
NM_000094.3(COL7A1):c.6751G>A (p.Gly2251Arg)	COL7A1	G2251R	not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000392725	3	48610375	3	48572942	392725	367602	rs765034336	NC_000003.12:48572941:C:T
NM_000094.3(COL7A1):c.5388+5G>A	COL7A1		not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000390381	3	48616625	3	48579192	390381	368619	rs1057523751	NC_000003.12:48579191:C:T
NM_000094.3(COL7A1):c.8102G>T (p.Gly2701Val)	COL7A1	G2701V	not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000379696	3	48604568	3	48567135	379696	368612	rs1057520693	NC_000003.12:48567134:C:A
NM_000094.3(COL7A1):c.7219G>A (p.Gly2407Ser)	COL7A1	G2407S	not provided	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000379479	3	48608347	3	48570914	379479	367265	rs774332349	NC_000003.12:48570913:C:T
NM_000094.3(COL7A1):c.6109G>A (p.Gly2037Arg)	COL7A1	G2037R	not provided	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000379455	3	48612843	3	48575410	379455	367268	rs1057520599	NC_000003.12:48575409:C:T
NM_000094.3(COL7A1):c.5291G>C (p.Gly1764Ala)	COL7A1	G1764A	not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000379309	3	48616818	3	48579385	379309	367609	rs1057520568	NC_000003.12:48579384:C:G
NM_000094.3(COL7A1):c.4928G>A (p.Gly1643Asp)	COL7A1	G1643D	not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379308	3	48618562	3	48581129	379308	367271	rs1057520567	NC_000003.12:48581128:C:T
NM_000094.3(COL7A1):c.4670G>A (p.Gly1557Glu)	COL7A1	G1557E	not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000379307	3	48619191	3	48581758	379307	368627	rs1057520566	NC_000003.12:48581757:C:T
NM_000094.3(COL7A1):c.6101G>C (p.Gly2034Ala)	COL7A1	G2034A	not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000379224	3	48612851	3	48575418	379224	368613	rs1057520530	NC_000003.12:48575417:C:G
NM_000094.3(COL7A1):c.6770G>C (p.Gly2257Ala)	COL7A1	G2257A	not provided	Pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000372763	3	48610356	3	48572923	372763	359553	rs1057517969	NC_000003.12:48572922:C:G
NM_000094.3(COL7A1):c.7485+5G>A	COL7A1		not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000372350	3	48607562	3	48570129	372350	359563	rs988031901	NC_000003.12:48570128:C:T
NM_000094.3(COL7A1):c.7078G>A (p.Gly2360Arg)	COL7A1	G2360R	not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000372348	3	48608702	3	48571269	372348	359543	rs916512411	NC_000003.12:48571268:C:T
NM_000094.3(COL7A1):c.6781C>T (p.Arg2261Ter)	COL7A1	R2261*	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000372346	3	48610345	3	48572912	372346	359550	rs772381373	NC_000003.12:48572911:G:A
NM_000094.3(COL7A1):c.6262G>A (p.Gly2088Arg)	COL7A1	G2088R	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000372344	3	48612514	3	48575081	372344	359555	rs573432153	NC_000003.12:48575080:C:T
NM_000094.3(COL7A1):c.6176A>G (p.Glu2059Gly)	COL7A1	E2059G	not provided	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000372343	3	48612776	3	48575343	372343	359572	rs1057517726	NC_000003.12:48575342:T:C
NM_000094.3(COL7A1):c.5720_5721delinsAT (p.Gly1907Asp)	COL7A1		not provided	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000372342	3	48613970 - 48613971	3	48576537 - 48576538	372342	359574	rs1057517725	NC_000003.12:48576536:TC:AT
NM_000094.3(COL7A1):c.5499C>T (p.Gly1833=)	COL7A1		not provided	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000372340	3	48615787	3	48578354	372340	359437	rs758886532	NC_000003.12:48578353:G:A
NM_000094.3(COL7A1):c.5344G>A (p.Gly1782Arg)	COL7A1	G1782R	not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000372339	3	48616674	3	48579241	372339	359576	rs374718902	NC_000003.12:48579240:C:T
NM_000094.3(COL7A1):c.4919del (p.Gly1640fs)	COL7A1	G1640fs	not provided	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000372336	3	48618571	3	48581138	372336	359579	rs1057517722	NC_000003.12:48581137:CC:C
NM_000094.3(COL7A1):c.4767del (p.Asp1590fs)	COL7A1	D1590fs	not provided	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	VCV000372335	3	48619021	3	48581588	372335	359581	rs1057517721	NC_000003.12:48581587:T:
NM_000094.3(COL7A1):c.4568del (p.Pro1523fs)	COL7A1	P1523fs	not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000372334	3	48619942	3	48582509	372334	359439	rs778165989	NC_000003.12:48582508:GG:G
NM_000094.3(COL7A1):c.2219_2222TGGA[3] (p.Leu743fs)	COL7A1		not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000372331	3	48626847 - 48626848	3	48589414 - 48589415	372331	359440	rs1057517720	NC_000003.12:48589414:TCCATCCA:TCCATCCATCCA
NM_000094.3(COL7A1):c.4466del (p.Gly1489fs)	COL7A1	G1489fs	not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000280735	3	48620576	3	48583143	280735	264155	rs886041885	NC_000003.12:48583142:CCC:CC
NM_000094.3(COL7A1):c.6074del (p.Gly2025fs)	COL7A1	G2025fs	not provided	Pathogenic(Last reviewed: Nov 22, 2015)	criteria provided, single submitter	VCV000280157	3	48612878	3	48575445	280157	264175	rs886041417	NC_000003.12:48575444:CCCC:CCC
NM_000094.3(COL7A1):c.6769G>A (p.Gly2257Arg)	COL7A1	G2257R	not provided	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000279791	3	48610357	3	48572924	279791	264135	rs886041189	NC_000003.12:48572923:C:T
NM_000094.3(COL7A1):c.6190G>A (p.Gly2064Arg)	COL7A1	G2064R	not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000279790	3	48612666	3	48575233	279790	264153	rs866061439	NC_000003.12:48575232:C:T
NM_000094.3(COL7A1):c.5027G>A (p.Gly1676Glu)	COL7A1	G1676E	not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000279789	3	48618039	3	48580606	279789	264181	rs886041188	NC_000003.12:48580605:C:T
NM_000094.3(COL7A1):c.4448G>A (p.Gly1483Asp)	COL7A1	G1483D	not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000279788	3	48620594	3	48583161	279788	264183	rs756217590	NC_000003.12:48583160:C:T
NM_000094.3(COL7A1):c.3140-1G>A	COL7A1		not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000279786	3	48624542	3	48587109	279786	264137	rs886041187	NC_000003.12:48587108:C:T
NM_000094.3(COL7A1):c.5300G>A (p.Gly1767Glu)	COL7A1	G1767E	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000265673	3	48616809	3	48579376	265673	259773	rs886039720	NC_000003.12:48579375:C:T
NM_000094.3(COL7A1):c.58C>T (p.Arg20Ter)	COL7A1	R20*	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000265469	3	48632535	3	48595102	265469	259774	rs886039562	NC_000003.12:48595101:G:A
NM_000094.3(COL7A1):c.8329C>T (p.Arg2777Ter)	COL7A1	R2777*	not provided	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000265081	3	48603972	3	48566539	265081	259768	rs886039330	NC_000003.12:48566538:G:A
NM_000094.3(COL7A1):c.8012G>A (p.Gly2671Glu)	COL7A1	G2671E	not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000265080	3	48605041	3	48567608	265080	259769	rs886039329	NC_000003.12:48567607:C:T
NM_000094.3(COL7A1):c.7865G>A (p.Arg2622Gln)	COL7A1	R2622Q	not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000265079	3	48605533	3	48568100	265079	259770	rs368529673	NC_000003.12:48568099:C:T
NM_000094.3(COL7A1):c.7723G>A (p.Gly2575Arg)	COL7A1	G2575R	not provided	Pathogenic(Last reviewed: Feb 27, 2016)	criteria provided, single submitter	VCV000265078	3	48606252	3	48568819	265078	259771	rs760891216	NC_000003.12:48568818:C:T
NM_000094.3(COL7A1):c.7442G>A (p.Gly2481Asp)	COL7A1	G2481D	not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000265077	3	48607610	3	48570177	265077	259772	rs886039328	NC_000003.12:48570176:C:T
NM_000094.4(COL7A1):c.6528del (p.Gly2177fs)	COL7A1	G2177fs	not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000858020	3	48611297	3	48573864	858020	828248		NC_000003.12:48573863:A:
NM_000094.4(COL7A1):c.4478del (p.Glu1493fs)	COL7A1	E1493fs	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000853700	3	48620564	3	48583131	853700	828250		NC_000003.12:48583130:T:
NM_000094.4(COL7A1):c.5656C>T (p.Gln1886Ter)	COL7A1	Q1886*	not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000851290	3	48614153	3	48576720	851290	828249		NC_000003.12:48576719:G:A
NM_000094.4(COL7A1):c.2463dup (p.Leu822fs)	COL7A1		not provided	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000849691	3	48626198 - 48626199	3	48588765 - 48588766	849691	828252		NC_000003.12:48588765:T:TT
NM_000094.4(COL7A1):c.639del (p.Arg214fs)	COL7A1	R214fs	not provided	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000841727	3	48630578	3	48593145	841727	828254		NC_000003.12:48593144:CC:C
NM_000094.4(COL7A1):c.1953_1954dup (p.Ile652fs)	COL7A1		not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000841373	3	48627741 - 48627742	3	48590308 - 48590309	841373	828253		NC_000003.12:48590308:TGT:TGTGT
NM_000094.3(COL7A1):c.4128del (p.Gly1377fs)	COL7A1	G1377fs	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000663385	3	48621800	3	48584367	663385	631497		NC_000003.12:48584366:A:
NM_000094.3(COL7A1):c.3515_3524dup (p.Ser1175fs)	COL7A1		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000651532	3	48623790 - 48623791	3	48586357 - 48586358	651532	631498		NC_000003.12:48586357:CTGAATATGTC:CTGAATATGTCTGAATATGTC
NM_000094.3(COL7A1):c.5767del (p.Glu1923fs)	COL7A1	E1923fs	not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000647209	3	48613838	3	48576405	647209	631495		NC_000003.12:48576404:CCCC:CCC
NM_000094.3(COL7A1):c.5344G>T (p.Gly1782Ter)	COL7A1	G1782*	not provided	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000643748	3	48616674	3	48579241	643748	631496		NC_000003.12:48579240:C:A
NM_000094.3(COL7A1):c.3971del (p.Leu1324fs)	COL7A1	L1324fs	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000291012	3	48622473	3	48585040	291012	275249	rs886044621	NC_000003.12:48585039:A:
NM_000094.3(COL7A1):c.8479C>T (p.Gln2827Ter)	COL7A1	Q2827*	Epidermolysis bullosa dystrophica inversa, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000029634	3	48602891	3	48565458	29634	38588	rs387906604	NC_000003.12:48565457:G:A
NM_000094.3(COL7A1):c.6946G>A (p.Gly2316Arg)	COL7A1	G2316R	Epidermolysis bullosa dystrophica inversa, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000029633	3	48609845	3	48572412	29633	38587		NC_000003.12:48572411:C:T
NM_000094.3(COL7A1):c.6218G>T (p.Gly2073Val)	COL7A1	G2073V	Epidermolysis bullosa pruriginosa, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000017455	3	48612558	3	48575125	17455	32494	rs121912848	NC_000003.12:48575124:C:A
NM_000094.3(COL7A1):c.267-1G>C	COL7A1		Epidermolysis bullosa, pretibial, autosomal recessive	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000017452	3	48631130	3	48593697	17452	32491		NC_000003.12:48593696:C:G
NM_000094.3(COL7A1):c.5096C>T (p.Pro1699Leu)	COL7A1	P1699L	Epidermolysis bullosa, pretibial, autosomal recessive	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000017451	3	48617734	3	48580301	17451	32490	rs121912845	NC_000003.12:48580300:G:A
NM_000094.3(COL7A1):c.7787del (p.Gly2596fs)	COL7A1	G2596fs	Epidermolysis bullosa pruriginosa, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000017441	3	48605939	3	48568506	17441	32480		NC_000003.12:48568505:CC:C
COL7A1, IVS64DS, G-A, +1	COL7A1		Epidermolysis bullosa pruriginosa, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000017440					17440	32479		
COL7A1, 5820G-A	COL7A1		Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000017432					17432	32471		
NM_000094.4(COL7A1):c.8233C>T (p.Arg2745Ter)	COL7A1	R2745*	not provided	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000850546	3	48604164	3	48566731	850546	828246		NC_000003.12:48566730:G:A
NM_000094.4(COL7A1):c.6745C>T (p.Gln2249Ter)	COL7A1	Q2249*	not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000848235	3	48610459	3	48573026	848235	828247		NC_000003.12:48573025:G:A
NM_000094.3(COL7A1):c.657del (p.Gly220fs)	COL7A1	G220fs	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801967	3	48630560	3	48593127	801967	790401		NC_000003.12:48593126:A:
NC_000003.12:g.48589471del	COL7A1		Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801966	3	48626903	3	48589470	801966	790400		NC_000003.12:48589469:CC:C
NM_000094.3(COL7A1):c.84A>G (p.Arg28=)	COL7A1		Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000590762	3	48632509	3	48595076	590762	581699	rs1559444716	NC_000003.12:48595075:T:C
NM_000094.3(COL7A1):c.4233del (p.Gly1412fs)	COL7A1	G1412fs	Dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587424	3	48621378	3	48583945	587424	578420	rs1560241522	NC_000003.12:48583944:A:
NM_000094.3(COL7A1):c.5048_5051dup (p.Asn1684fs)	COL7A1		not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503615	3	48618014 - 48618015	3	48580581 - 48580582	503615	495456	rs1276678432	NC_000003.12:48580581:TTTC:TTTCTTTC
NM_000094.3(COL7A1):c.4871del (p.Pro1624fs)	COL7A1	P1624fs	Recessive dystrophic epidermolysis bullosa	Pathogenic	no assertion criteria provided	VCV000424629	3	48618721	3	48581288	424629	411521	rs1064797082	NC_000003.12:48581287:GGGGGG:GGGGG
NM_000094.3(COL7A1):c.8278G>A (p.Gly2760Arg)	COL7A1	G2760R	Recessive dystrophic epidermolysis bullosa	Pathogenic	no assertion criteria provided	VCV000424628	3	48604119	3	48566686	424628	411519	rs1064797081	NC_000003.12:48566685:C:T
NM_000094.3(COL7A1):c.5924_5927del (p.Glu1975fs)	COL7A1	E1975fs	Recessive dystrophic epidermolysis bullosa	Pathogenic	no assertion criteria provided	VCV000424627	3	48613111 - 48613114	3	48575678 - 48575681	424627	411520	rs1064797080	NC_000003.12:48575677:CGTTCG:CG
NM_000094.3(COL7A1):c.2318_2321dup (p.Glu774delinsAspTer)	COL7A1		Recessive dystrophic epidermolysis bullosa	Pathogenic	no assertion criteria provided	VCV000424626	3	48626421 - 48626422	3	48588988 - 48588989	424626	411522	rs1064797079	NC_000003.12:48588988:TCAG:TCAGTCAG
NM_000094.3(COL7A1):c.6900+4A>G	COL7A1		Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374314	3	48610100	3	48572667	374314	361178	rs1057518706	NC_000003.12:48572666:T:C
NM_000094.3(COL7A1):c.4565G>A (p.Gly1522Glu)	COL7A1	G1522E	Transient bullous dermolysis of the newborn	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000029635	3	48619945	3	48582512	29635	38589	rs387906605	NC_000003.12:48582511:C:T
NM_000094.3(COL7A1):c.6227G>A (p.Gly2076Asp)	COL7A1	G2076D	Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000017457	3	48612549	3	48575116	17457	32496	rs121912850	NC_000003.12:48575115:C:T
NM_000094.3(COL7A1):c.6724G>A (p.Gly2242Arg)	COL7A1	G2242R	Epidermolysis bullosa pruriginosa, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000017439	3	48610480	3	48573047	17439	32478	rs121912837	NC_000003.12:48573046:C:T
NM_000094.3(COL7A1):c.4556G>A (p.Gly1519Asp)	COL7A1	G1519D	Transient bullous dermolysis of the newborn	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000017437	3	48620049	3	48582616	17437	32476	rs121912835	NC_000003.12:48582615:C:T
NM_000094.3(COL7A1):c.7867G>T (p.Gly2623Cys)	COL7A1	G2623C	Pretibial epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000017429	3	48605531	3	48568098	17429	32468	rs121912831	NC_000003.12:48568097:C:A
NM_000297.4(PKD2):c.2224C>T (p.Arg742Ter)	PKD2	R742*	Polycystic kidney disease, autosomal dominant|not provided|Polycystic kidney disease 2	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013518	4	88986631	4	88065479	13518	28557	rs121918040	NC_000004.12:88065478:C:T
NM_000094.4(COL7A1):c.4018C>T (p.Arg1340Ter)	COL7A1	R1340*	not provided	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000864784	3	48622196	3	48584763	864784	828251		NC_000003.12:48584762:G:A
NM_000094.3(COL7A1):c.3376_3386del (p.Tyr1126fs)	COL7A1	Y1126fs	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000689616	3	48624013 - 48624023	3	48586580 - 48586590	689616	677289		NC_000003.12:48586579:GGGTCCATGTAGGG:GGG
NM_000094.3(COL7A1):c.1319del (p.Glu440fs)	COL7A1	E440fs	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000634903	3	48629369	3	48591936	634903	622742	rs1559435706	NC_000003.12:48591935:T:
NM_000094.3(COL7A1):c.2989C>T (p.Gln997Ter)	COL7A1	Q997*	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623379	3	48624856	3	48587423	623379	612265	rs1559423385	NC_000003.12:48587422:G:A
NM_000094.3(COL7A1):c.4120-1G>C	COL7A1		Transient bullous dermolysis of the newborn	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000017461	3	48621809	3	48584376	17461	32500		NC_000003.12:48584375:C:G
NM_000094.3(COL7A1):c.8245G>A (p.Gly2749Arg)	COL7A1	G2749R	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000017460	3	48604152	3	48566719	17460	32499	rs121912853	NC_000003.12:48566718:C:T
NM_000094.3(COL7A1):c.7957G>A (p.Gly2653Arg)	COL7A1	G2653R	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000017458	3	48605169	3	48567736	17458	32497	rs121912851	NC_000003.12:48567735:C:T
NM_000094.3(COL7A1):c.4888C>T (p.Arg1630Ter)	COL7A1	R1630*	not provided|Epidermolysis bullosa pruriginosa, autosomal recessive	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000017454	3	48618704	3	48581271	17454	32493	rs121912847	NC_000003.12:48581270:G:A
NM_000094.3(COL7A1):c.6017G>A (p.Gly2006Asp)	COL7A1	G2006D	Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Jul 24, 1998)	no assertion criteria provided	VCV000017448	3	48612935	3	48575502	17448	32487	rs121912842	NC_000003.12:48575501:C:T
COL7A1, 16-BP DEL, NT6863	COL7A1		Epidermolysis bullosa pruriginosa, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000017442					17442	32481		
NM_000094.3(COL7A1):c.4119+1G>T	COL7A1		Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000017435	3	48621917	3	48584484	17435	32474		NC_000003.12:48584483:C:A
NM_000094.3(COL7A1):c.4039G>C (p.Gly1347Arg)	COL7A1	G1347R	not provided|Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000017434	3	48622175	3	48584742	17434	32473	rs121912833	NC_000003.12:48584741:C:G
NM_000094.3(COL7A1):c.933C>A (p.Tyr311Ter)	COL7A1	Y311*	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Mar 1, 1995)	no assertion criteria provided	VCV000017427	3	48630046	3	48592613	17427	32466	rs121912830	NC_000003.12:48592612:G:T
NM_000094.3(COL7A1):c.3861del (p.Pro1289fs)	COL7A1	P1289fs	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000017426	3	48623023	3	48585590	17426	32465		NC_000003.12:48585589:CCCC:CCC
NM_000094.3(COL7A1):c.2471dup (p.Asn825fs)	COL7A1		Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000017425	3	48626190 - 48626191	3	48588757 - 48588758	17425	32464		NC_000003.12:48588757:CC:CCC
NM_000094.3(COL7A1):c.6118G>A (p.Gly2040Ser)	COL7A1	G2040S	Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Apr 26, 1994)	no assertion criteria provided	VCV000017424	3	48612834	3	48575401	17424	32463	rs121912829	NC_000003.12:48575400:C:T
NM_000094.3(COL7A1):c.8393T>A (p.Met2798Lys)	COL7A1	M2798K	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000017423	3	48603714	3	48566281	17423	32462	rs121912828	NC_000003.12:48566280:A:T
NM_147127.5(EVC2):c.3659+2T>C	EVC2		Ellis-van Creveld syndrome|Curry-Hall syndrome|Ellis-van Creveld syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348980	4	5566983	4	5565256	348980	293703	rs200300612	NC_000004.12:5565255:A:G
NM_000203.5(IDUA):c.793-1G>A	IDUA		Hurler syndrome|Mucopolysaccharidosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557472	4	995769	4	1001981	557472	543284	rs762779421	NC_000004.12:1001980:G:A
NM_000203.5(IDUA):c.1210G>T (p.Glu404Ter)	IDUA	E404*, E272*	Hurler syndrome|Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552095	4	996540	4	1002752	552095	543021	rs1340421020	NC_000004.12:1002751:G:T
NM_000203.5(IDUA):c.876del (p.Asp292fs)	IDUA	D160fs, D292fs	Hurler syndrome|Mucopolysaccharidosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000456720	4	995853	4	1002065	456720	453630	rs1553917209	NC_000004.12:1002064:C:
NM_000203.5(IDUA):c.1855C>T (p.Arg619Ter)	IDUA	R619*, R487*	not provided|Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280976	4	998074	4	1004286	280976	265213	rs121965031	NC_000004.12:1004285:C:T
NM_000203.5(IDUA):c.1650+5G>A	IDUA		not provided|Hurler syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092634	4	997263	4	1003475	92634	98541	rs398123256	NC_000004.12:1003474:G:A
NM_000094.3(COL7A1):c.7012C>T (p.Arg2338Ter)	COL7A1	R2338*	not provided	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372347	3	48609571	3	48572138	372347	359547	rs745874032	NC_000003.12:48572137:G:A
NM_000094.3(COL7A1):c.6110G>A (p.Gly2037Glu)	COL7A1	G2037E	not provided|Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000017453	3	48612842	3	48575409	17453	32492	rs121912846	NC_000003.12:48575408:C:T
NM_000094.3(COL7A1):c.6127G>A (p.Gly2043Arg)	COL7A1	G2043R	Generalized dominant dystrophic epidermolysis bullosa|not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000017438	3	48612825	3	48575392	17438	32477	rs121912836	NC_000003.12:48575391:C:T
COL7A1, IVS95DS, G-A, -1	COL7A1		Epidermolysis bullosa pruriginosa, autosomal recessive|Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000017433					17433	32472		
COL7A1, IVS3DS, A-G, -2	COL7A1		Epidermolysis bullosa pruriginosa, autosomal recessive|Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000017431					17431	32470		
NM_000094.3(COL7A1):c.5819del (p.Pro1940fs)	COL7A1	P1940fs	Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000017428	3	48613683	3	48576250	17428	32467		NC_000003.12:48576249:GG:G
NM_000094.3(COL7A1):c.6022C>T (p.Arg2008Cys)	COL7A1	R2008C	Dystrophic epidermolysis bullosa|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522791	3	48612930	3	48575497	522791	513263	rs1055680335	NC_000003.12:48575496:G:A
NM_000094.3(COL7A1):c.4027C>T (p.Arg1343Ter)	COL7A1	R1343*	not provided|Epidermolysis bullosa pruriginosa|Pretibial epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8|Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Transient bullous dermolysis of the newborn|Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503709	3	48622187	3	48584754	503709	495459	rs761234904	NC_000003.12:48584753:G:A
NM_000094.3(COL7A1):c.5532+1G>A	COL7A1		not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488825	3	48615753	3	48578320	488825	481696	rs767182886	NC_000003.12:48578319:C:T
NM_000094.3(COL7A1):c.409C>T (p.Arg137Ter)	COL7A1	R137*	not provided|Pretibial epidermolysis bullosa|Epidermolysis bullosa pruriginosa|Nail disorder, nonsyndromic congenital, 8|Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Transient bullous dermolysis of the newborn|Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449472	3	48630987	3	48593554	449472	443485	rs1203706188	NC_000003.12:48593553:G:A
NM_000094.3(COL7A1):c.6081del (p.Pro2029fs)	COL7A1	P2029fs	not provided	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418654	3	48612871	3	48575438	418654	406324	rs780623622	NC_000003.12:48575437:GGGGGGG:GGGGGG
NM_000094.3(COL7A1):c.6082G>A (p.Gly2028Arg)	COL7A1	G2028R	not provided|Epidermolysis bullosa pruriginosa|Pretibial epidermolysis bullosa|Generalized dominant dystrophic epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8|Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Transient bullous dermolysis of the newborn	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379476	3	48612870	3	48575437	379476	367608	rs762162799	NC_000003.12:48575436:C:T
NM_000094.3(COL7A1):c.5605G>C (p.Gly1869Arg)	COL7A1	G1869R	not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372341	3	48614204	3	48576771	372341	359560	rs1057517724	NC_000003.12:48576770:C:G
NM_000094.3(COL7A1):c.5047C>T (p.Arg1683Ter)	COL7A1	R1683*	not provided	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372337	3	48618019	3	48580586	372337	359486	rs760063197	NC_000003.12:48580585:G:A
NM_000094.3(COL7A1):c.1573C>T (p.Arg525Ter)	COL7A1	R525*	not provided|Pretibial epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8|Dominant dystrophic epidermolysis bullosa with absence of skin|Epidermolysis bullosa pruriginosa|Transient bullous dermolysis of the newborn|Recessive dystrophic epidermolysis bullosa|Generalized dominant dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279785	3	48628960	3	48591527	279785	264139	rs368007918	NC_000003.12:48591526:G:A
NM_000094.3(COL7A1):c.497dup (p.Val168fs)	COL7A1		not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279784	3	48630811 - 48630812	3	48593378 - 48593379	279784	264169	rs766902987	NC_000003.12:48593378:T:TT
NM_000094.3(COL7A1):c.553C>T (p.Arg185Ter)	COL7A1	R185*	not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279783	3	48630664	3	48593231	279783	264158	rs886041186	NC_000003.12:48593230:G:A
NM_000094.3(COL7A1):c.7411C>T (p.Arg2471Ter)	COL7A1	R2471*	not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000017459	3	48607737	3	48570304	17459	32498	rs121912852	NC_000003.12:48570303:G:A
NM_000094.3(COL7A1):c.4783G>C (p.Gly1595Arg)	COL7A1	G1595R	Recessive dystrophic epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000017443	3	48618916	3	48581483	17443	32482	rs121912840	NC_000003.12:48581482:C:G
NM_001080522.2(CC2D2A):c.1558C>T (p.Arg520Ter)	CC2D2A	R520*	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 9|Meckel syndrome type 6|Joubert syndrome 9|Joubert syndrome with hepatic defect	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217618	4	15534907	4	15533284	217618	214172	rs781252161	NC_000004.12:15533283:C:T
NM_001080522.2(CC2D2A):c.3975+4_3975+7del	CC2D2A		Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome type 6|Joubert syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217617	4	15581794 - 15581797	4	15580171 - 15580174	217617	214187	rs386833759	NC_000004.12:15580170:AGTAAGTA:AGTA
NM_001080522.2(CC2D2A):c.394C>T (p.Arg132Ter)	CC2D2A	R132*	Joubert syndrome|Meckel-Gruber syndrome|Meckel-Gruber syndrome|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126242	4	15504502	4	15502879	126242	131774	rs377177061	NC_000004.12:15502878:C:T
NM_000203.5(IDUA):c.1044C>G (p.Asn348Lys)	IDUA	N348K, N216K	Hurler syndrome|Mucopolysaccharidosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557870	4	996128	4	1002340	557870	543182	rs746766617	NC_000004.12:1002339:C:G
NM_000203.5(IDUA):c.1898C>T (p.Ser633Leu)	IDUA	S633L, S501L	Hurler syndrome	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000556406	4	998117	4	1004329	556406	543239	rs886043347	NC_000004.12:1004328:C:T
NM_000203.5(IDUA):c.1402+2T>G	IDUA		Hurler syndrome|Mucopolysaccharidosis type 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553131	4	996734	4	1002946	553131	543203	rs1553917428	NC_000004.12:1002945:T:G
NM_000094.3(COL7A1):c.1A>G (p.Met1Val)	COL7A1	M1V	not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424625	3	48632592	3	48595159	424625	411523	rs1064797078	NC_000003.12:48595158:T:C
NM_000094.3(COL7A1):c.5261dup (p.Gly1755fs)	COL7A1		not provided|Dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372338	3	48616922 - 48616923	3	48579489 - 48579490	372338	359480	rs1057517723	NC_000003.12:48579489:GGGGG:GGGGGG
NM_000094.3(COL7A1):c.8440C>T (p.Arg2814Ter)	COL7A1	R2814*	not provided	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265082	3	48603069	3	48565636	265082	259767	rs143457874	NC_000003.12:48565635:G:A
NM_000094.3(COL7A1):c.6187C>T (p.Arg2063Trp)	COL7A1	R2063W	not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000017456	3	48612669	3	48575236	17456	32495	rs121912849	NC_000003.12:48575235:G:A
NM_000094.3(COL7A1):c.6044G>A (p.Gly2015Glu)	COL7A1	G2015E	Generalized dominant dystrophic epidermolysis bullosa|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000017449	3	48612908	3	48575475	17449	32488	rs121912843	NC_000003.12:48575474:C:T
COL7A1, 14-BP DEL, NT33563	COL7A1		Epidermolysis bullosa, pretibial, autosomal recessive|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000017445					17445	32484		
NM_000404.4(GLB1):c.442C>A (p.Arg148Ser)	GLB1	R148S, R118S, R196S	Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B||GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551757	3	33109737	3	33068245	551757	543207	rs192732174	NC_000003.12:33068244:G:T
NM_000404.4(GLB1):c.442C>T (p.Arg148Cys)	GLB1	R148C, R118C, R196C	not provided|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2||Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092907	3	33109737	3	33068245	92907	98814	rs192732174	NC_000003.12:33068244:G:A
NM_000094.3(COL7A1):c.5443G>A (p.Gly1815Arg)	COL7A1	G1815R	Dominant dystrophic epidermolysis bullosa with absence of skin|Nail disorder, nonsyndromic congenital, 8|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000156289	3	48615930	3	48578497	156289	166069	rs121912841	NC_000003.12:48578496:C:T
NM_000094.3(COL7A1):c.6752G>A (p.Gly2251Glu)	COL7A1	G2251E	Epidermolysis bullosa pruriginosa, autosomal dominant|Transient bullous dermolysis of the newborn|Nail disorder, nonsyndromic congenital, 8	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000017436	3	48610374	3	48572941	17436	32475	rs121912834	NC_000003.12:48572940:C:T
NM_006514.3(SCN10A):c.3910G>A (p.Ala1304Thr)	SCN10A	A1304T, A1206T, A1303T	Episodic pain syndrome, familial, 2	Pathogenic(Last reviewed: Nov 20, 2012)	no assertion criteria provided	VCV000089015	3	38753831	3	38712340	89015	94569	rs142173735	NC_000003.12:38712339:C:T
NM_000203.5(IDUA):c.1727+1G>A	IDUA		Mucopolysaccharidosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638077	4	997414	4	1003626	638077	625915		NC_000004.12:1003625:G:A
NM_000203.5(IDUA):c.1139A>G (p.Gln380Arg)	IDUA	Q380R, Q248R	Hurler syndrome	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000550799	4	996223	4	1002435	550799	543015	rs762903007	NC_000004.12:1002434:A:G
NM_000203.5(IDUA):c.653T>C (p.Leu218Pro)	IDUA	L218P, L86P	Mucopolysaccharidosis type 1|Hurler syndrome|not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222995	4	995530	4	1001742	222995	224716	rs869025584	NC_000004.12:1001741:T:C
NM_000203.5(IDUA):c.1037T>G (p.Leu346Arg)	IDUA	L346R, L214R	Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000011927	4	996121	4	1002333	11927	26966	rs121965033	NC_000004.12:1002332:T:G
NM_000203.5(IDUA):c.1861C>T (p.Arg621Ter)	IDUA	R621*, R489*	Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011917	4	998080	4	1004292	11917	26956	rs121965025	NC_000004.12:1004291:C:T
NM_000532.5(PCCB):c.1606A>G (p.Asn536Asp)	PCCB	N536D, N556D	Propionic acidemia|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038881	3	136048854	3	136330012	38881	47484	rs202247823	NC_000003.12:136330011:A:G
NM_003060.4(SLC22A5):c.254_264dup (p.Ile89fs)	SLC22A5	I89GfsX45	Renal carnitine transport defect|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038790	5	131705914 - 131705915	5	132370222 - 132370223	38790	47395	rs377767449	NC_000005.10:132370222:ACCGGCTCGCCACC:ACCGGCTCGCCACCGGCTCGCCACC
NM_000094.3(COL7A1):c.5820G>A (p.Pro1940=)	COL7A1		Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Transient bullous dermolysis of the newborn|Pretibial epidermolysis bullosa|Generalized dominant dystrophic epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8|Epidermolysis bullosa pruriginosa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431810	3	48613682	3	48576249	431810	425565	rs200972872	NC_000003.12:48576248:C:T
NM_000094.3(COL7A1):c.706C>T (p.Arg236Ter)	COL7A1	R109*, R236*	Recessive dystrophic epidermolysis bullosa|Nail dystrophy|Hyperpigmentation of the skin|Distal muscle weakness|Failure to thrive|Abnormal blistering of the skin|Scarring|Microcephaly|EMG abnormality|Decreased body weight|Abnormality of dental enamel|Scarring alopecia of scalp|Short stature|Abnormality of the dentition|Alopecia of scalp|Epidermolysis bullosa dystrophica inversa, autosomal recessive	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000017462	3	48630348	3	48592915	17462	32501	rs121912854	NC_000003.12:48592914:G:A
NM_000094.3(COL7A1):c.6100G>A (p.Gly2034Arg)	COL7A1	G2034R	Generalized dominant dystrophic epidermolysis bullosa|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000017450	3	48612852	3	48575419	17450	32489	rs121912844	NC_000003.12:48575418:C:T
NM_001163213.1(FGFR3):c.1114G>T (p.Gly372Cys)	FGFR3	G370C, G372C	not specified|Thanatophoric dysplasia type 1|not provided|Epidermal nevus|Bladder carcinoma	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016359	4	1806089	4	1804362	16359	31398	rs121913479	NC_000004.12:1804361:G:T
NM_001080522.2(CC2D2A):c.4465_4468del (p.Asp1489fs)	CC2D2A	D1489fs	Joubert syndrome 9|not provided|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210612	4	15599055 - 15599058	4	15597432 - 15597435	210612	207113	rs797045437	NC_000004.12:15597431:CAGACA:CA
NM_001080522.2(CC2D2A):c.3774dup (p.Glu1259Ter)	CC2D2A		not provided|Joubert syndrome 9|Meckel syndrome type 6	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056309	4	15581590 - 15581591	4	15579967 - 15579968	56309	70948	rs386833757	NC_000004.12:15579967:TTT:TTTT
NM_001080522.2(CC2D2A):c.3084del (p.Lys1029fs)	CC2D2A	K1029fs	not provided|Meckel syndrome type 6|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056301	4	15565046	4	15563423	56301	70940	rs386833749	NC_000004.12:15563422:GG:G
NM_023073.3(CPLANE1):c.7988_7989del (p.Gly2663fs)	CPLANE1	G2663fs	not provided|Typical Joubert syndrome MRI findings|Global developmental delay|Joubert syndrome 17	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000183307	5	37154064 - 37154065	5	37153962 - 37153963	183307	181421	rs730882217	NC_000005.10:37153961:TC:
NM_001354689.3(RAF1):c.1142G>C (p.Gly381Ala)	RAF1	G361A, G381A, G247A, G280A, G328A, G300A	Rasopathy|Noonan syndrome|not provided|LEOPARD syndrome 2	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040613	3	12641216	3	12599717	40613	49083	rs397516813	NC_000003.12:12599716:C:G
NM_002880.3(RAF1):c.788T>C (p.Val263Ala)	RAF1	V263A, V182A, V149A, V230A	Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040608	3	12645681	3	12604182	40608	49078	rs397516830	NC_000003.12:12604181:A:G
NM_000203.5(IDUA):c.1045G>T (p.Asp349Tyr)	IDUA	D349Y, D217Y	Mucopolysaccharidosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638075	4	996129	4	1002341	638075	625881		NC_000004.12:1002340:G:T
NM_000203.5(IDUA):c.713T>A (p.Leu238Gln)	IDUA	L238Q, L106Q	Hurler syndrome|Mucopolysaccharidosis type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265418	4	995590	4	1001802	265418	259780	rs148789453	NC_000004.12:1001801:T:A
NM_000203.5(IDUA):c.613_617dup (p.Glu207fs)	IDUA		Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011921	4	995488 - 995489	4	1001700 - 1001701	11921	26960	rs786200915	NC_000004.12:1001700:CTGCTC:CTGCTCTGCTC
NM_198903.2(GABRG2):c.245G>A (p.Arg82Gln)	GABRG2	R43Q, R82Q	not provided|Familial febrile seizures 8|Epilepsy, childhood absence 2|Familial febrile seizures 8|Epilepsy, childhood absence 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016208	5	161520971	5	162093965	16208	31247	rs121909673	NC_000005.10:162093964:G:A
NM_000112.3(SLC26A2):c.1724del (p.Lys575fs)	SLC26A2	K575fs	Osteochondrodysplasia||Diastrophic dysplasia|Achondrogenesis, type IB|Achondrogenesis, type IB|||Diastrophic dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004087	5	149360879	5	149981316	4087	19126	rs386833498	NC_000005.10:149981315:AA:A
NM_001370658.1(BTD):c.1569C>A (p.Asp523Glu)	BTD	D543E, D523E, D545E	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025103	3	15686992	3	15645485	25103	36437	rs146136265	NC_000003.12:15645484:C:A
NM_173660.5(DOK7):c.1331_1334CTGG[4] (p.Gly448fs)	DOK7		Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001276	4	3495043 - 3495044	4	3493316 - 3493317	1276	16315	rs606231131	NC_000004.12:3493316:CTGGCTGGCTGG:CTGGCTGGCTGGCTGG
NM_000094.3(COL7A1):c.6527dup (p.Gly2177fs)	COL7A1		not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372345	3	48611297 - 48611298	3	48573864 - 48573865	372345	359567	rs768128088	NC_000003.12:48573864:GGGGGG:GGGGGGG
NM_000094.3(COL7A1):c.3840del (p.Gly1281fs)	COL7A1	G1281fs	not provided|Transient bullous dermolysis of the newborn	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372332	3	48623044	3	48585611	372332	359584	rs757688782	NC_000003.12:48585610:GG:G
NM_147127.5(EVC2):c.3265C>T (p.Gln1089Ter)	EVC2	Q1009*, Q1089*	Curry-Hall syndrome|Ellis-van Creveld syndrome|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003386	4	5577974	4	5576247	3386	18425	rs137852927	NC_000004.12:5576246:G:A
NM_001182.5(ALDH7A1):c.328C>T (p.Arg110Ter)	ALDH7A1	R82*, R110*, R137*	Pyridoxine-dependent epilepsy|not provided|Seizures|Ventriculomegaly	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017995	5	125919689	5	126583997	17995	33034	rs121912708	NC_000005.10:126583996:G:A
NM_000203.5(IDUA):c.1882C>T (p.Arg628Ter)	IDUA	R628*, R496*	Hurler syndrome	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000550421	4	998101	4	1004313	550421	543325	rs756572099	NC_000004.12:1004312:C:T
NM_000203.5(IDUA):c.878_889dup (p.Thr293_Tyr296dup)	IDUA		Hurler syndrome|Mucopolysaccharidosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550382	4	995851 - 995852	4	1002063 - 1002064	550382	543176	rs779762183	NC_000004.12:1002063:ACACCCCCATTTACA:ACACCCCCATTTACACCCCCATTTACA
NM_000203.5(IDUA):c.1469T>C (p.Leu490Pro)	IDUA	L490P, L358P	Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011919	4	996890	4	1003102	11919	26958	rs121965027	NC_000004.12:1003101:T:C
NM_023073.3(CPLANE1):c.3577C>T (p.Arg1193Cys)	CPLANE1	R1193C	not provided|Joubert syndrome 17|Joubert syndrome 17|	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265062	5	37198899	5	37198797	265062	259826	rs149170427	NC_000005.10:37198796:G:A
NM_023073.3(CPLANE1):c.7477C>T (p.Arg2493Ter)	CPLANE1	R2493*	|Joubert syndrome 17|Joubert syndrome 17	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031223	5	37165697	5	37165595	31223	40180	rs139675596	NC_000005.10:37165594:G:A
NM_000094.3(COL7A1):c.6859G>A (p.Gly2287Arg)	COL7A1	G2287R	Generalized dominant dystrophic epidermolysis bullosa|not provided|Recessive dystrophic epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000017447	3	48610145	3	48572712	17447	32486	rs121912839	NC_000003.12:48572711:C:T
NM_001354689.3(RAF1):c.781C>A (p.Pro261Thr)	RAF1	P261T, P147T, P180T, P228T	Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040604	3	12645688	3	12604189	40604	49074	rs121434594	NC_000003.12:12604188:G:T
NM_001314077.1(PROS1):c.682A>G (p.Lys228Glu)	PROS1	K155E, K196E, K228E	|Thrombophilia due to protein S deficiency, autosomal recessive	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013318	3	93624643	3	93905799	13318	28357	rs121918474	NC_000003.12:93905798:T:C
NM_000414.4(HSD17B4):c.1369A>T (p.Asn457Tyr)	HSD17B4	N457Y, N317Y, N482Y, N433Y, N439Y	Bifunctional peroxisomal enzyme deficiency|Perrault syndrome 1|not specified|not provided|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007656	5	118844871	5	119509176	7656	22695	rs137853097	NC_000005.10:119509175:A:T
NM_000094.3(COL7A1):c.7344G>A (p.Val2448=)	COL7A1		not provided|Generalized dominant dystrophic epidermolysis bullosa|Pretibial epidermolysis bullosa|Epidermolysis bullosa pruriginosa|Transient bullous dermolysis of the newborn|Nail disorder, nonsyndromic congenital, 8|Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372349	3	48608072	3	48570639	372349	359566	rs201728948	NC_000003.12:48570638:C:T
NM_000060.2(BTD):c.1052delC (p.Thr351Lysfs)	BTD		not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025057	3	15686415	3	15644908	25057	36393	rs397514398	
NM_001370658.1(BTD):c.38_44delinsTCC (p.Cys13fs)	BTD	C33fs	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001895	3	15676984 - 15676990	3	15635477 - 15635483	1895	16934	rs80338684	NC_000003.12:15635476:GCGGCTG:TCC
NM_023073.3(CPLANE1):c.7817T>A (p.Leu2606Ter)	CPLANE1	L2606*	not provided|Joubert syndrome 17||Global developmental delay|Jaundice|Joubert syndrome 17	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217575	5	37157912	5	37157810	217575	214208	rs749523755	NC_000005.10:37157809:A:T
NM_207352.4(CYP4V2):c.992A>C (p.His331Pro)	CYP4V2	H331P	not provided|Retinal dystrophy|Bietti crystalline corneoretinal dystrophy	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039275	4	187126358	4	186205204	39275	47881	rs199476197	NC_000004.12:186205203:A:C
NM_003060.4(SLC22A5):c.505C>T (p.Arg169Trp)	SLC22A5	R169W, R193W	Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006422	5	131719846	5	132384154	6422	21461	rs121908890	NC_000005.10:132384153:C:T
NM_000030.3(AGXT):c.568G>A (p.Gly190Arg)	AGXT	G190R	not provided|Primary hyperoxaluria, type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189047	2	241812439	2	240873022	189047	186657	rs180177239	NC_000002.12:240873021:G:A
NM_000203.5(IDUA):c.1091C>T (p.Thr364Met)	IDUA	T364M, T232M	Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000011925	4	996175	4	1002387	11925	26964	rs121965032	NC_000004.12:1002386:C:T
NM_000094.3(COL7A1):c.1637-1G>A	COL7A1		Recessive dystrophic epidermolysis bullosa|Pretibial epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Transient bullous dermolysis of the newborn|Epidermolysis bullosa pruriginosa|Nail disorder, nonsyndromic congenital, 8|Generalized dominant dystrophic epidermolysis bullosa|not provided|Dystrophic epidermolysis bullosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000345869	3	48628250	3	48590817	345869	295323	rs886058642	NC_000003.12:48590816:C:T
NM_000094.3(COL7A1):c.6724G>C (p.Gly2242Arg)	COL7A1	G2242R	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 4, 2012)	criteria provided, single submitter	VCV000208679	3	48610480	3	48573047	208679	205243	rs121912837	NC_000003.12:48573046:C:G
NM_000094.3(COL7A1):c.6205C>T (p.Arg2069Cys)	COL7A1	R2069C	not provided|Abnormal blistering of the skin|Nail dystrophy|Hyperpigmentation of the skin|Distal muscle weakness|Failure to thrive|Abnormal blistering of the skin|Scarring|Microcephaly|EMG abnormality|Decreased body weight|Abnormality of dental enamel|Scarring alopecia of scalp|Short stature|Abnormality of the dentition|Alopecia of scalp|Epidermolysis bullosa dystrophica inversa, autosomal recessive	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017463	3	48612651	3	48575218	17463	32502	rs121912855	NC_000003.12:48575217:G:A
NM_001163213.1(FGFR3):c.1144G>C (p.Gly382Arg)	FGFR3	G380R, G382R	Hypochondroplasia|not provided|Craniosynostosis|Achondroplasia	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016328	4	1806119	4	1804392	16328	31367	rs28931614	NC_000004.12:1804391:G:C
NM_014244.5(ADAMTS2):c.673C>T (p.Gln225Ter)	ADAMTS2	Q225*	not provided|Ehlers-Danlos syndrome dermatosparaxis type	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005502	5	178699927	5	179272926	5502	20541	rs137853146	NC_000005.10:179272925:G:A
NM_001903.5(CTNNA1):c.919G>A (p.Glu307Lys)	CTNNA1	E307K, E184K, E204K	Macular dystrophy, patterned, 2	Pathogenic(Last reviewed: Apr 8, 2016)	no assertion criteria provided	VCV000225128	5	138163264	5	138827575	225128	227015	rs869320697	NC_000005.10:138827574:G:A
NM_001903.5(CTNNA1):c.1293T>G (p.Ile431Met)	CTNNA1	I431M, I328M, I61M, I308M	Macular dystrophy, patterned, 2	Pathogenic(Last reviewed: Apr 8, 2016)	no assertion criteria provided	VCV000225127	5	138223328	5	138887639	225127	227014	rs755215402	NC_000005.10:138887638:T:G
NM_001903.5(CTNNA1):c.953T>C (p.Leu318Ser)	CTNNA1	L318S, L215S, L195S	Macular dystrophy, patterned, 2	Pathogenic(Last reviewed: Apr 8, 2016)	no assertion criteria provided	VCV000225126	5	138163298	5	138827609	225126	227013	rs869320696	NC_000005.10:138827608:T:C
NM_001354712.2(THRB):c.1012C>T (p.Arg338Trp)	THRB	R338W, R307W	Thyroid hormone resistance, selective pituitary|Thyroid hormone resistance, generalized, autosomal dominant|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000012558	3	24169122	3	24127631	12558	27597	rs121918697	NC_000003.12:24127630:G:A
NM_001151.4(SLC25A4):c.239G>A (p.Arg80His)	SLC25A4	R80H	not provided|Mitochondrial diseases|Mitochondrial DNA depletion syndrome 12a (cardiomyopathic type), autosomal dominant|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000253037	4	186066045	4	185144891	253037	247444	rs886041081	NC_000004.12:185144890:G:A
NM_000060.2(BTD):c.933delT (p.Ser311Argfs)	BTD	S311fs	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025052	3	15686296	3	15644789	25052	36389	rs397514395	
NM_001370658.1(BTD):c.497G>A (p.Cys166Tyr)	BTD	C186Y, C166Y, C188Y	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025020	3	15685920	3	15644413	25020	36357	rs397514369	NC_000003.12:15644412:G:A
NM_000203.5(IDUA):c.386-2A>G	IDUA		Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222994	4	994668	4	1000880	222994	224714	rs777295041	NC_000004.12:1000879:A:G
NM_000539.3(RHO):c.541G>A (p.Glu181Lys)	RHO	E181K	Retinitis pigmentosa|Retinitis pigmentosa 4|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000196282	3	129251104	3	129532261	196282	193443	rs775557680	NC_000003.12:129532260:G:A
NM_001182.5(ALDH7A1):c.834G>A (p.Val278=)	ALDH7A1		not provided|Pyridoxine-dependent epilepsy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018002	5	125903988	5	126568296	18002	33041	rs201948406	NC_000005.10:126568295:C:T
NM_000094.3(COL7A1):c.682+1G>A	COL7A1		not provided|Recessive dystrophic epidermolysis bullosa	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372329	3	48630534	3	48593101	372329	359487	rs775288140	NC_000003.12:48593100:C:T
NM_000094.3(COL7A1):c.5797C>T (p.Arg1933Ter)	COL7A1	R1933*	Dystrophic epidermolysis bullosa|not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000345830	3	48613705	3	48576272	345830	295241	rs757415879	NC_000003.12:48576271:G:A
NM_003060.4(SLC22A5):c.506G>A (p.Arg169Gln)	SLC22A5	R169Q, R193Q	Renal carnitine transport defect|not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006421	5	131719847	5	132384155	6421	21460	rs121908889	NC_000005.10:132384154:G:A
NM_003060.4(SLC22A5):c.844C>T (p.Arg282Ter)	SLC22A5	R282*, R306*	not provided|Renal carnitine transport defect	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006416	5	131722736	5	132387044	6416	21455	rs121908886	NC_000005.10:132387043:C:T
NM_001163435.3(TBCK):c.376C>T (p.Arg126Ter)	TBCK	R126*	Syndromic Infantile Encephalopathy|Inborn genetic diseases|not provided|Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225235	4	107183260	4	106262103	225235	227149	rs575822089	NC_000004.12:106262102:G:A
GRCh37/hg19 2q37.1(chr2:232873876-232947601)x1	DIS3L2		not provided	Pathogenic(Last reviewed: Apr 4, 2018)	no assertion criteria provided	VCV000685856	2	232873876 - 232947601			685856	673448		
NM_152383.5(DIS3L2):c.1162C>T (p.Arg388Ter)	DIS3L2	R388*	Perlman syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000860912	2	233075073	2	232210363	860912	825891		NC_000002.12:232210362:C:T
NM_152383.5(DIS3L2):c.1573del (p.Val525fs)	DIS3L2	V525fs	Perlman syndrome	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000849174	2	233128063	2	232263353	849174	825908		NC_000002.12:232263352:GG:G
NM_152383.5(DIS3L2):c.325dup (p.Asp109fs)	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000844772	2	232894745 - 232894746	2	232030035 - 232030036	844772	825858		NC_000002.12:232030035:GGGG:GGGGG
NM_152383.5(DIS3L2):c.1096G>T (p.Glu366Ter)	DIS3L2	E366*	Perlman syndrome	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000844346	2	233028314	2	232163604	844346	825889		NC_000002.12:232163603:G:T
NM_152383.5(DIS3L2):c.505C>T (p.Gln169Ter)	DIS3L2	Q169*	Perlman syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000844242	2	232952335	2	232087625	844242	825864		NC_000002.12:232087624:C:T
NM_152383.5(DIS3L2):c.2041C>T (p.Gln681Ter)	DIS3L2	Q681*	Perlman syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000836527	2	233198580	2	232333870	836527	825925		NC_000002.12:232333869:C:T
NC_000002.12:g.(?_232130609)_(232130729_?)del	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000830871	2	232995319 - 232995439			830871	819137		
NC_000002.12:g.(?_232130609)_(232136729_?)del	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Jul 13, 2019)	criteria provided, single submitter	VCV000830733	2	232995319 - 233001439			830733	819138		
NM_152383.4(DIS3L2):c.1556_1565del (p.Glu519fs)	DIS3L2	E519fs	Perlman syndrome	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000652833	2	233128044 - 233128053	2	232263334 - 232263343	652833	629586		NC_000002.12:232263333:CAGAGCATAGCAG:CAG
NC_000002.11:g.(?_233113939)_(233164839_?)del	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000649080	2	233113939 - 233164839	2	232249229 - 232300129	649080	650801		
NM_152383.4(DIS3L2):c.1610_1617delinsG (p.Lys537fs)	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000643481	2	233128101 - 233128108	2	232263391 - 232263398	643481	629589		NC_000002.12:232263390:AGCAGTTA:G
NC_000002.11:g.(?_233001172)_(233001439_?)del	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000584149	2	233001172 - 233001439	2	232136462 - 232136729	584149	558082		
NM_152383.4(DIS3L2):c.733C>T (p.Arg245Ter)	DIS3L2	R245*	Perlman syndrome	Pathogenic(Last reviewed: Jan 28, 2018)	criteria provided, single submitter	VCV000581845	2	233001212	2	232136502	581845	557910	rs199648534	NC_000002.12:232136501:C:T
NM_152383.4(DIS3L2):c.799_800del (p.Leu267fs)	DIS3L2	L267fs	Perlman syndrome	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000463129	2	233001278 - 233001279	2	232136568 - 232136569	463129	450564	rs1553610371	NC_000002.12:232136567:CT:
NC_000002.11:g.(?_232995329)_(232995429_?)del	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000417536	2	232995329 - 232995429	2	232130619 - 232130719	417536	391549		
NM_152383.4(DIS3L2):c.951-?_1124+?del	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000254078	2	233028169 - 233028342	2	232163459 - 232163632	254078	248479		
NM_001257281.2(DIS3L2):c.1582-8865del	DIS3L2	F757fs	Perlman syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000241972	2	233199189	2	232334479	241972	238691	rs878855224	NC_000002.12:232334478:TT:T
NM_152383.4(DIS3L2):c.1466G>A (p.Cys489Tyr)	DIS3L2	C489Y	Perlman syndrome	Pathogenic(Last reviewed: Feb 5, 2012)	no assertion criteria provided	VCV000031125	2	233127957	2	232263247	31125	40082	rs387907116	NC_000002.12:232263246:G:A
DIS3L2, 82.8-KB DEL, EX6DEL	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Feb 5, 2012)	no assertion criteria provided	VCV000031123					31123	40080		
NM_133433.4(NIPBL):c.1048_1049TC[1] (p.Pro351fs)	NIPBL		not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000817425	5	36976057 - 36976058	5	36975955 - 36975956	817425	805439		NC_000005.10:36975954:TCTC:TC
NM_133433.4(NIPBL):c.927delinsACA (p.Asp309fs)	NIPBL		not provided	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000596965	5	36975936	5	36975834	596965	588026	rs1561101302	NC_000005.10:36975833:T:ACA
NM_133433.4(NIPBL):c.3084dup (p.Lys1029Ter)	NIPBL		not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000595639	5	36986364 - 36986365	5	36986262 - 36986263	595639	586701	rs1561119439	NC_000005.10:36986262:TT:TTT
NM_133433.4(NIPBL):c.5262C>A (p.Cys1754Ter)	NIPBL	C1754*	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000546560	5	37020913	5	37020811	546560	536692	rs1554025252	NC_000005.10:37020810:C:A
NM_133433.4(NIPBL):c.5829dup (p.Gly1944fs)	NIPBL		not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000524068	5	37027480 - 37027481	5	37027378 - 37027379	524068	514510	rs1554027083	NC_000005.10:37027378:T:TT
NM_133433.4(NIPBL):c.5509C>T (p.Arg1837Ter)	NIPBL	R1837*	not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000523876	5	37022427	5	37022325	523876	514509	rs1554025780	NC_000005.10:37022324:C:T
NM_133433.4(NIPBL):c.7855del (p.Tyr2618_Leu2619insTer)	NIPBL		not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000504042	5	37061115	5	37061013	504042	495285	rs1554035316	NC_000005.10:37061012:C:
NM_133433.4(NIPBL):c.4512dup (p.Pro1505fs)	NIPBL		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000503986	5	37010278 - 37010279	5	37010176 - 37010177	503986	495175	rs1554022466	NC_000005.10:37010176:A:AA
NM_133433.4(NIPBL):c.4760_4763del (p.Ser1586_Leu1587insTer)	NIPBL		not provided	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000498247	5	37016253 - 37016256	5	37016151 - 37016154	498247	489671	rs1554024009	NC_000005.10:37016150:GTTTGTT:GTT
NM_133433.4(NIPBL):c.6712del (p.Gln2238fs)	NIPBL	Q2238fs	not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000451659	5	37048725	5	37048623	451659	443790	rs1554032826	NC_000005.10:37048622:CC:C
NM_133433.4(NIPBL):c.2315del (p.Ser772fs)	NIPBL	S772fs	not provided	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000423537	5	36985597	5	36985495	423537	406745	rs1064796481	NC_000005.10:36985494:C:
NM_133433.4(NIPBL):c.6082C>T (p.Gln2028Ter)	NIPBL	Q2028*	not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000290119	5	37038814	5	37038712	290119	274356	rs886044351	NC_000005.10:37038711:C:T
NM_133433.4(NIPBL):c.592del (p.His198fs)	NIPBL	H198fs	not provided	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000287409	5	36962358	5	36962256	287409	271646	rs886043629	NC_000005.10:36962255:C:
NM_133433.4(NIPBL):c.3855+2T>C	NIPBL		not provided	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000285212	5	37003451	5	37003349	285212	269449	rs886043046	NC_000005.10:37003348:T:C
NM_133433.4(NIPBL):c.40dup (p.Ala14fs)	NIPBL		not provided	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	VCV000279947	5	36953837 - 36953838	5	36953735 - 36953736	279947	264251	rs886041275	NC_000005.10:36953735:G:GG
NM_133433.4(NIPBL):c.1942_1954delinsCTT (p.Thr648fs)	NIPBL		not provided	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000279946	5	36985224 - 36985236	5	36985122 - 36985134	279946	264190	rs886041274	NC_000005.10:36985121:ACAGAAGAACTTA:CTT
NM_133433.4(NIPBL):c.6156G>C (p.Glu2052Asp)	NIPBL	E2052D	not provided	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000265409	5	37044496	5	37044394	265409	259824	rs886039531	NC_000005.10:37044393:G:C
NM_133433.4(NIPBL):c.7861-2del	NIPBL		not provided	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000265312	5	37063890	5	37063788	265312	259825	rs886039468	NC_000005.10:37063787:A:
NM_133433.4(NIPBL):c.6108+1G>C	NIPBL		not provided	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000196931	5	37038841	5	37038739	196931	194092	rs587783994	NC_000005.10:37038738:G:C
NM_133433.4(NIPBL):c.5808+2T>G	NIPBL		not provided	Pathogenic(Last reviewed: Feb 13, 2015)	criteria provided, single submitter	VCV000196715	5	37026431	5	37026329	196715	193876	rs794727556	NC_000005.10:37026328:T:G
NM_133433.4(NIPBL):c.6701T>G (p.Leu2234Ter)	NIPBL	L2234*	not provided	Pathogenic(Last reviewed: Dec 30, 2013)	criteria provided, single submitter	VCV000167361	5	37048715	5	37048613	167361	177876	rs727504047	NC_000005.10:37048612:T:G
NM_133433.4(NIPBL):c.7047T>G (p.Tyr2349Ter)	NIPBL	Y2349*	not provided	Pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	VCV000096351	5	37051973	5	37051871	96351	102245	rs398124470	NC_000005.10:37051870:T:G
NM_133433.4(NIPBL):c.226del (p.His76fs)	NIPBL	H76fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802112	5	36955735	5	36955633	802112	790554		NC_000005.10:36955632:C:
NM_133433.4(NIPBL):c.7459del (p.Glu2487fs)	NIPBL	E2487fs	Tetralogy of Fallot|Cleft palate|Microcephaly	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523556	5	37059040	5	37058938	523556	513958	rs1554034812	NC_000005.10:37058937:GG:G
GRCh37/hg19 5p13.2(chr5:36916860-36960224)x1	NIPBL		See cases	Pathogenic(Last reviewed: Dec 14, 2014)	no assertion criteria provided	VCV000443203	5	36916860 - 36960224			443203	436865		
GRCh37/hg19 5p13.2(chr5:36916860-36960223)x1	NIPBL		See cases	Pathogenic(Last reviewed: Feb 24, 2015)	no assertion criteria provided	VCV000441862	5	36916860 - 36960223			441862	435524		
NM_133433.4(NIPBL):c.2626dup (p.Asp876fs)	NIPBL		not provided	Pathogenic(Last reviewed: May 30, 2013)	criteria provided, single submitter	VCV000096338	5	36985904 - 36985905	5	36985802 - 36985803	96338	102232	rs398124467	NC_000005.10:36985802:GGGG:GGGGG
DIS3L2, 22-KB DEL, EX9DEL	DIS3L2		Perlman syndrome	Pathogenic(Last reviewed: Feb 5, 2012)	no assertion criteria provided	VCV000031124					31124	40081		
NM_133433.4(NIPBL):c.7850_7851del (p.Gln2617fs)	NIPBL	Q2617fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000862863	5	37061110 - 37061111	5	37061008 - 37061009	862863	830856		NC_000005.10:37061007:AG:
NM_133433.4(NIPBL):c.241del (p.Asp81fs)	NIPBL	D81fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000861409	5	36958216	5	36958114	861409	830848		NC_000005.10:36958113:G:
NM_133433.4(NIPBL):c.7967dup (p.Gly2657fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000837908	5	37063996 - 37063997	5	37063894 - 37063895	837908	830857		NC_000005.10:37063894:GG:GGG
NC_000005.10:g.(?_36953616)_(37017182_?)del	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000832382	5	36953718 - 37017284			832382	819589		
NM_133433.4(NIPBL):c.2291del (p.Asn764fs)	NIPBL	N764fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000692070	5	36985572	5	36985470	692070	679747		NC_000005.10:36985469:AA:A
NM_133433.4(NIPBL):c.1320del (p.Asn440fs)	NIPBL	N440fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000666576	5	36976329	5	36976227	666576	654126		NC_000005.10:36976226:C:
NM_133433.4(NIPBL):c.3455C>G (p.Ser1152Ter)	NIPBL	S1152*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000664886	5	37000625	5	37000523	664886	633949		NC_000005.10:37000522:C:G
NM_133433.4(NIPBL):c.2120del (p.Gly707fs)	NIPBL	G707fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000662787	5	36985400	5	36985298	662787	633947		NC_000005.10:36985297:GGG:GG
NM_133433.4(NIPBL):c.4550C>G (p.Ser1517Ter)	NIPBL	S1517*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000662635	5	37010317	5	37010215	662635	633951		NC_000005.10:37010214:C:G
NM_133433.4(NIPBL):c.3895del (p.Ile1300fs)	NIPBL	I1300fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000651452	5	37006497	5	37006395	651452	633950		NC_000005.10:37006394:CC:C
NM_133433.4(NIPBL):c.3253del (p.Tyr1085fs)	NIPBL	Y1085fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000647925	5	36995855	5	36995753	647925	633948		NC_000005.10:36995752:T:
NM_133433.4(NIPBL):c.230+5G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000642705	5	36955744	5	36955642	642705	651347		NC_000005.10:36955641:G:A
NM_133433.4(NIPBL):c.3988G>T (p.Glu1330Ter)	NIPBL	E1330*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000580541	5	37006591	5	37006489	580541	560325	rs1561145912	NC_000005.10:37006488:G:T
NM_133433.4(NIPBL):c.1451C>G (p.Ser484Ter)	NIPBL	S484*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000572591	5	36976460	5	36976358	572591	560321	rs1561102868	NC_000005.10:36976357:C:G
NM_133433.4(NIPBL):c.6998del (p.Ala2333fs)	NIPBL	A2333fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000567873	5	37051924	5	37051822	567873	560456	rs1561214997	NC_000005.10:37051821:C:
NM_133433.4(NIPBL):c.5567G>T (p.Arg1856Ile)	NIPBL	R1856I	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000558736	5	37022485	5	37022383	558736	549466	rs1554025796	NC_000005.10:37022382:G:T
NM_133433.4(NIPBL):c.1956dup (p.Gln653fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000543049	5	36985235 - 36985236	5	36985133 - 36985134	543049	521794	rs1554017175	NC_000005.10:36985133:AAA:AAAA
NM_133433.4(NIPBL):c.6796G>T (p.Glu2266Ter)	NIPBL	E2266*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000543048	5	37049245	5	37049143	543048	521451	rs1554032954	NC_000005.10:37049142:G:T
NM_133433.4(NIPBL):c.7702del (p.Ser2568fs)	NIPBL	S2568fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000543047	5	37060962	5	37060860	543047	521795	rs1554035266	NC_000005.10:37060859:T:
NM_133433.4(NIPBL):c.6589+5G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000476595	5	37046306	5	37046204	476595	455181	rs1554032266	NC_000005.10:37046203:G:A
NM_133433.4(NIPBL):c.6086_6087insT (p.Tyr2030fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000476594	5	37038818 - 37038819	5	37038716 - 37038717	476594	455179	rs1554030285	NC_000005.10:37038716::T
NM_133433.4(NIPBL):c.4686del (p.Phe1562fs)	NIPBL	F1562fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000476591	5	37016180	5	37016078	476591	455877	rs1554023967	NC_000005.10:37016077:TTT:TT
NM_133433.4(NIPBL):c.3248del (p.Pro1083fs)	NIPBL	P1083fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 22, 2017)	criteria provided, single submitter	VCV000476587	5	36995849	5	36995747	476587	454998	rs1554019698	NC_000005.10:36995746:CC:C
NM_133433.4(NIPBL):c.3148G>T (p.Glu1050Ter)	NIPBL	E1050*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000476586	5	36995750	5	36995648	476586	455620	rs1554019667	NC_000005.10:36995647:G:T
NM_133433.4(NIPBL):c.2595dup (p.Leu866fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000476585	5	36985874 - 36985875	5	36985772 - 36985773	476585	455170	rs1554017441	NC_000005.10:36985772:AAA:AAAA
NM_133433.4(NIPBL):c.169del (p.Arg57fs)	NIPBL	R57fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000476584	5	36955678	5	36955576	476584	454996	rs1554011046	NC_000005.10:36955575:A:
NM_133433.4(NIPBL):c.1145del (p.Asn382fs)	NIPBL	N382fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000476581	5	36976151	5	36976049	476581	455875	rs1554015145	NC_000005.10:36976048:AAAA:AAA
Single allele	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000476580			5	37038582 - 37038758	476580	454421		
NM_133433.4(NIPBL):c.6635T>A (p.Val2212Glu)	NIPBL	V2212E	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000446367	5	37048649	5	37048547	446367	439808	rs1554032789	NC_000005.10:37048546:T:A
NM_133433.4(NIPBL):c.6262_6263TG[1] (p.His2087_Cys2088insTer)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000436015	5	37044750 - 37044753	5	37044648 - 37044651	436015	428428	rs1554031864	NC_000005.10:37044647:TGTGTG:TG
NM_133433.4(NIPBL):c.3107C>G (p.Ser1036Ter)	NIPBL	S1036*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000436014	5	36986389	5	36986287	436014	428420	rs1554017661	NC_000005.10:36986286:C:G
NM_133433.4(NIPBL):c.2464_2467del (p.Gln822fs)	NIPBL	Q822fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000436012	5	36985743 - 36985746	5	36985641 - 36985644	436012	428418	rs1554017345	NC_000005.10:36985640:AAACAAA:AAA
NM_133433.4(NIPBL):c.6401_6404dup (p.Pro2138fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000436010	5	37045600 - 37045601	5	37045498 - 37045499	436010	428429	rs1554032085	NC_000005.10:37045498:CTAAC:CTAACTAAC
NM_133433.4(NIPBL):c.3698T>G (p.Leu1233Ter)	NIPBL	L1233*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000436009	5	37002797	5	37002695	436009	428423	rs1554020997	NC_000005.10:37002694:T:G
NM_133433.4(NIPBL):c.7913dup (p.Val2639fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211664	5	37063943 - 37063944	5	37063841 - 37063842	211664	207258	rs797045786	NC_000005.10:37063841:A:AA
NM_133433.4(NIPBL):c.7912dup (p.Glu2638fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211663	5	37063939 - 37063940	5	37063837 - 37063838	211663	207257	rs797045785	NC_000005.10:37063837:GGGG:GGGGG
NM_133433.4(NIPBL):c.7839_7840TA[3] (p.Val2615Ter)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211662	5	37061098 - 37061099	5	37060996 - 37060997	211662	207256	rs797045784	NC_000005.10:37060996:TATA:TATATA
NM_133433.4(NIPBL):c.7816dup (p.Ile2606fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211661	5	37061072 - 37061073	5	37060970 - 37060971	211661	207255	rs797045783	NC_000005.10:37060970:AAAA:AAAAA
NM_133433.3(NIPBL):c.7301_7308delATCTAGCCins13	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211660	5	37057325 - 37057332	5	37057223 - 37057230	211660	207254		
NM_133433.4(NIPBL):c.6811dup (p.Ser2271fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211658	5	37049257 - 37049258	5	37049155 - 37049156	211658	207252	rs797045780	NC_000005.10:37049155:TTT:TTTT
NM_133433.4(NIPBL):c.6707dup (p.Asn2236fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211656	5	37048715 - 37048716	5	37048613 - 37048614	211656	207250	rs797045778	NC_000005.10:37048613:AAAAAA:AAAAAAA
NM_133433.4(NIPBL):c.6249+2dup	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211654	5	37044590 - 37044591	5	37044488 - 37044489	211654	207248	rs797045776	NC_000005.10:37044488:T:TT
NM_133433.4(NIPBL):c.6108+2T>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, single submitter	VCV000211653	5	37038842	5	37038740	211653	207247	rs797045775	NC_000005.10:37038739:T:C
NM_133433.4(NIPBL):c.5737_5738CT[1] (p.Trp1914fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000211649	5	37026358 - 37026359	5	37026256 - 37026257	211649	207243	rs797045773	NC_000005.10:37026255:CTCT:CT
NM_133433.4(NIPBL):c.5679dup (p.Arg1894fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211648	5	37024789 - 37024790	5	37024687 - 37024688	211648	207242	rs797045772	NC_000005.10:37024687:TT:TTT
NM_133433.4(NIPBL):c.5580dup (p.Gly1861fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000211647	5	37024691 - 37024692	5	37024589 - 37024590	211647	207241	rs797045771	NC_000005.10:37024589:T:TT
NM_133433.4(NIPBL):c.5046_5047insTG (p.Asp1683fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	VCV000211646	5	37020596 - 37020597	5	37020494 - 37020495	211646	207240	rs797045770	NC_000005.10:37020494::TG
NM_133433.4(NIPBL):c.5044C>T (p.Arg1682Ter)	NIPBL	R1682*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000211645	5	37020594	5	37020492	211645	207239	rs797045769	NC_000005.10:37020491:C:T
NM_133433.4(NIPBL):c.4988_4991dup (p.Glu1664delinsAspTer)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211644	5	37019478 - 37019479	5	37019376 - 37019377	211644	207238	rs797045768	NC_000005.10:37019376:ACTGA:ACTGACTGA
NM_133433.4(NIPBL):c.4965_4972del (p.Asp1657fs)	NIPBL	D1657fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000211643	5	37019454 - 37019461	5	37019352 - 37019359	211643	207237	rs797045767	NC_000005.10:37019351:ATTGCTTGATT:ATT
NM_133433.4(NIPBL):c.4893dup (p.Gly1632fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211642	5	37017235 - 37017236	5	37017133 - 37017134	211642	207236	rs797045766	NC_000005.10:37017133:AA:AAA
NM_133433.4(NIPBL):c.4580_4581insCCTGTCAACTAACATGT (p.Thr1528fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211640	5	37014803 - 37014804	5	37014701 - 37014702	211640	207234	rs797045764	NC_000005.10:37014701:T:TCCTGTCAACTAACATGT
NM_133433.4(NIPBL):c.458+1_458+2dup	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	VCV000211639	5	36961685 - 36961686	5	36961583 - 36961584	211639	207217	rs797045763	NC_000005.10:36961583:GT:GTGT
NM_133433.4(NIPBL):c.4530_4531CT[1] (p.Asp1510_Ser1511insTer)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000211638	5	37010297 - 37010298	5	37010195 - 37010196	211638	207233	rs797045762	NC_000005.10:37010194:CTCT:CT
NM_133433.4(NIPBL):c.4529dup (p.Asp1510fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211637	5	37010295 - 37010296	5	37010193 - 37010194	211637	207232	rs797045761	NC_000005.10:37010193:A:AA
NM_133433.4(NIPBL):c.4495C>T (p.Gln1499Ter)	NIPBL	Q1499*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000211636	5	37010262	5	37010160	211636	207231	rs797045760	NC_000005.10:37010159:C:T
NM_133433.4(NIPBL):c.3264del (p.Ser1089fs)	NIPBL	S1089fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	VCV000211632	5	36995866	5	36995764	211632	207227	rs797045756	NC_000005.10:36995763:C:
NM_133433.4(NIPBL):c.314dup (p.Asn105fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211631	5	36958287 - 36958288	5	36958185 - 36958186	211631	207216	rs797045755	NC_000005.10:36958185:AA:AAA
NM_133433.4(NIPBL):c.2965dup (p.Ile989fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211630	5	36986241 - 36986242	5	36986139 - 36986140	211630	207226	rs797045754	NC_000005.10:36986139:AAAAAA:AAAAAAA
NM_133433.4(NIPBL):c.286_287insG (p.Leu96fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211629	5	36958261 - 36958262	5	36958159 - 36958160	211629	207215	rs797045753	NC_000005.10:36958159::G
NM_133433.4(NIPBL):c.2521C>T (p.Arg841Ter)	NIPBL	R841*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000211628	5	36985803	5	36985701	211628	207225	rs797045752	NC_000005.10:36985700:C:T
NM_133433.4(NIPBL):c.2464del (p.Gln822fs)	NIPBL	Q822fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	VCV000211627	5	36985746	5	36985644	211627	207224	rs797045751	NC_000005.10:36985643:C:
NM_133433.4(NIPBL):c.2394_2397dup (p.Ala800Ter)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211626	5	36985675 - 36985676	5	36985573 - 36985574	211626	207223	rs797045750	NC_000005.10:36985573:TGAA:TGAATGAA
NM_133433.4(NIPBL):c.212_213dup (p.Val72fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211625	5	36955720 - 36955721	5	36955618 - 36955619	211625	207214	rs797045749	NC_000005.10:36955618:AG:AGAG
NM_133433.4(NIPBL):c.1992dup (p.Glu665fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211624	5	36985273 - 36985274	5	36985171 - 36985172	211624	207222	rs797045748	NC_000005.10:36985171:C:CC
NM_133433.4(NIPBL):c.1448_1449delinsCTCCCTT (p.Glu483fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000211622	5	36976457 - 36976458	5	36976355 - 36976356	211622	207220	rs797045746	NC_000005.10:36976354:AA:CTCCCTT
NM_133433.4(NIPBL):c.1146dup (p.Ser383Ter)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211620	5	36976154 - 36976155	5	36976052 - 36976053	211620	207218	rs797045745	NC_000005.10:36976052:T:TT
NM_133433.4(NIPBL):c.7637T>C (p.Leu2546Pro)	NIPBL	L2546P	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180196	5	37059219	5	37059117	180196	178378	rs727503772	NC_000005.10:37059116:T:C
NM_133433.4(NIPBL):c.7903_7940del (p.Glu2635fs)	NIPBL	E2635fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180195	5	37063931 - 37063968	5	37063829 - 37063866	180195	178379	rs727503771	NC_000005.10:37063828:GAAGAAGAAGGGGAGGTTTCAGCTAGCACAAATGCTCGGAA:GAA
NM_133433.4(NIPBL):c.914C>A (p.Ser305Ter)	NIPBL	S305*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180194	5	36975923	5	36975821	180194	178373	rs727503770	NC_000005.10:36975820:C:A
NM_133433.4(NIPBL):c.65-3T>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180192	5	36955571	5	36955469	180192	178372	rs727503768	NC_000005.10:36955468:T:G
NM_133433.4(NIPBL):c.1808del (p.Lys603fs)	NIPBL	K603fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180191	5	36985083	5	36984981	180191	178374	rs727503767	NC_000005.10:36984980:AAAAAAAA:AAAAAAA
NM_133433.4(NIPBL):c.2149_2150del (p.Lys717fs)	NIPBL	K717fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180190	5	36985429 - 36985430	5	36985327 - 36985328	180190	178375	rs727503766	NC_000005.10:36985326:AAAA:AA
NM_133433.4(NIPBL):c.5214dup (p.Ser1739Ter)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180189	5	37020761 - 37020762	5	37020659 - 37020660	180189	178377	rs730880331	NC_000005.10:37020659:TTT:TTTT
NM_133433.4(NIPBL):c.922C>T (p.Arg308Ter)	NIPBL	R308*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159254	5	36975931	5	36975829	159254	168329	rs587784065	NC_000005.10:36975828:C:T
NM_133433.4(NIPBL):c.892del (p.Gln298fs)	NIPBL	Q298fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159252	5	36975901	5	36975799	159252	168327	rs587784063	NC_000005.10:36975798:C:
NM_133433.4(NIPBL):c.892C>T (p.Gln298Ter)	NIPBL	Q298*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159251	5	36975901	5	36975799	159251	168326	rs587784062	NC_000005.10:36975798:C:T
NM_133433.4(NIPBL):c.869-1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159248	5	36975877	5	36975775	159248	168325	rs587784059	NC_000005.10:36975774:G:A
NM_133433.4(NIPBL):c.7849C>T (p.Gln2617Ter)	NIPBL	Q2617*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159239	5	37061109	5	37061007	159239	168520	rs587784050	NC_000005.10:37061006:C:T
NM_133433.4(NIPBL):c.772-1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159236	5	36972046	5	36971944	159236	168323	rs587784049	NC_000005.10:36971943:G:A
NM_133433.4(NIPBL):c.7701_7725del (p.Ser2568fs)	NIPBL	S2568fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159234	5	37060956 - 37060980	5	37060854 - 37060878	159234	168518	rs587784047	NC_000005.10:37060853:AAGTACTCTCCATCTGAATCTGCAAAAGTA:AAGTA
NM_133433.4(NIPBL):c.737A>G (p.Asp246Gly)	NIPBL	D246G	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159229	5	36971104	5	36971002	159229	168321	rs587784042	NC_000005.10:36971001:A:G
NM_133433.4(NIPBL):c.7264-6T>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159225	5	37057282	5	37057180	159225	168510	rs587784038	NC_000005.10:37057179:T:G
NM_133433.4(NIPBL):c.7198del (p.Arg2400fs)	NIPBL	R2400fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159224	5	37052602	5	37052500	159224	168509	rs587784037	NC_000005.10:37052499:CC:C
NM_133433.4(NIPBL):c.7106del (p.Gln2369fs)	NIPBL	Q2369fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159221	5	37052511	5	37052409	159221	168506	rs587784034	NC_000005.10:37052408:A:
NM_133433.4(NIPBL):c.7102C>T (p.Gln2368Ter)	NIPBL	Q2368*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159220	5	37052507	5	37052405	159220	168505	rs587784033	NC_000005.10:37052404:C:T
NM_133433.4(NIPBL):c.7062+2T>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159219	5	37051990	5	37051888	159219	168504	rs587784032	NC_000005.10:37051887:T:C
NM_133433.4(NIPBL):c.7011_7012del (p.Lys2337fs)	NIPBL	K2337fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159216	5	37051937 - 37051938	5	37051835 - 37051836	159216	168501	rs587784029	NC_000005.10:37051834:GG:
NM_133433.4(NIPBL):c.6954+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159214	5	37049404	5	37049302	159214	168499	rs587784027	NC_000005.10:37049301:G:A
NM_133433.4(NIPBL):c.6952C>T (p.Gln2318Ter)	NIPBL	Q2318*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159213	5	37049401	5	37049299	159213	168498	rs587784026	NC_000005.10:37049298:C:T
NM_133433.4(NIPBL):c.6647_6649ATA[2] (p.Asn2218del)	NIPBL	N2218del	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	VCV000159207	5	37048661 - 37048663	5	37048559 - 37048561	159207	168493	rs587784022	NC_000005.10:37048558:ATAATAATA:ATAATA
NM_133433.4(NIPBL):c.6644_6645TA[2] (p.Tyr2216_Asn2217delinsTer)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159206	5	37048658 - 37048659	5	37048556 - 37048557	159206	168492	rs587784021	NC_000005.10:37048555:TATATA:TATA
NM_133433.4(NIPBL):c.6590G>A (p.Gly2197Glu)	NIPBL	G2197E	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159202	5	37048604	5	37048502	159202	168488	rs587784017	NC_000005.10:37048501:G:A
NM_133433.4(NIPBL):c.6590-2A>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159201	5	37048602	5	37048500	159201	168487	rs587784016	NC_000005.10:37048499:A:C
NM_133433.4(NIPBL):c.6571A>T (p.Lys2191Ter)	NIPBL	K2191*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159199	5	37046283	5	37046181	159199	168485	rs587784015	NC_000005.10:37046180:A:T
NM_133433.4(NIPBL):c.6565C>T (p.Gln2189Ter)	NIPBL	Q2189*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159197	5	37046277	5	37046175	159197	168483	rs587784013	NC_000005.10:37046174:C:T
NM_133433.4(NIPBL):c.64+3A>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159192	5	36953865	5	36953763	159192	168300	rs587784010	NC_000005.10:36953762:A:C
NM_133433.4(NIPBL):c.6315_6316TG[1] (p.Val2106fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159186	5	37044803 - 37044806	5	37044701 - 37044704	159186	168476	rs587784005	NC_000005.10:37044700:TGTGTG:TG
NM_133433.4(NIPBL):c.6108+1G>T	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159173	5	37038841	5	37038739	159173	168465	rs587783994	NC_000005.10:37038738:G:T
NM_133433.4(NIPBL):c.610+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159172	5	36962377	5	36962275	159172	168317	rs587783993	NC_000005.10:36962274:G:A
NM_133433.4(NIPBL):c.598C>T (p.Gln200Ter)	NIPBL	Q200*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	VCV000159167	5	36962364	5	36962262	159167	168316	rs587783988	NC_000005.10:36962261:C:T
NM_133433.4(NIPBL):c.5862+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159162	5	37027515	5	37027413	159162	168456	rs587783985	NC_000005.10:37027412:G:A
NM_133433.4(NIPBL):c.5808+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159161	5	37026430	5	37026328	159161	168455	rs587783984	NC_000005.10:37026327:G:A
NM_133433.4(NIPBL):c.5709+2T>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	VCV000159157	5	37024823	5	37024721	159157	168451	rs587783980	NC_000005.10:37024720:T:G
NM_133433.4(NIPBL):c.5709+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159156	5	37024822	5	37024720	159156	168450	rs587783979	NC_000005.10:37024719:G:A
NM_133433.4(NIPBL):c.5482C>T (p.Arg1828Ter)	NIPBL	R1828*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159153	5	37022400	5	37022298	159153	168447	rs62654864	NC_000005.10:37022297:C:T
NM_133433.4(NIPBL):c.5455C>T (p.Arg1819Ter)	NIPBL	R1819*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159150	5	37022373	5	37022271	159150	168444	rs587783975	NC_000005.10:37022270:C:T
NM_133433.4(NIPBL):c.5428-2A>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159149	5	37022344	5	37022242	159149	168443	rs587783974	NC_000005.10:37022241:A:G
NM_133433.4(NIPBL):c.5389_5392del (p.Ser1797fs)	NIPBL	S1797fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159148	5	37022211 - 37022214	5	37022109 - 37022112	159148	168442	rs587783973	NC_000005.10:37022108:TGTCTG:TG
NM_133433.4(NIPBL):c.5365C>T (p.Arg1789Ter)	NIPBL	R1789*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000159147	5	37022189	5	37022087	159147	168441	rs587783972	NC_000005.10:37022086:C:T
NM_133433.4(NIPBL):c.5335C>T (p.Arg1779Ter)	NIPBL	R1779*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159145	5	37022159	5	37022057	159145	168440	rs587783971	NC_000005.10:37022056:C:T
NM_133433.4(NIPBL):c.5329-1G>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159143	5	37022152	5	37022050	159143	168438	rs587783969	NC_000005.10:37022049:G:C
NM_133433.4(NIPBL):c.5328+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159141	5	37020980	5	37020878	159141	168436	rs587783967	NC_000005.10:37020877:G:A
NM_133433.4(NIPBL):c.5174del (p.Lys1725fs)	NIPBL	K1725fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159135	5	37020719	5	37020617	159135	168430	rs587783961	NC_000005.10:37020616:AAAAAA:AAAAA
NM_133433.4(NIPBL):c.5033_5039del (p.Ala1678fs)	NIPBL	A1678fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159134	5	37020582 - 37020588	5	37020480 - 37020486	159134	168429	rs587783960	NC_000005.10:37020479:GCCCAGTG:G
NM_133433.4(NIPBL):c.4816_4817AG[1] (p.Arg1606fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159131	5	37017160 - 37017161	5	37017058 - 37017059	159131	168426	rs587783959	NC_000005.10:37017057:AGAG:AG
NM_133433.4(NIPBL):c.4712C>A (p.Ser1571Ter)	NIPBL	S1571*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159127	5	37016208	5	37016106	159127	168422	rs77632238	NC_000005.10:37016105:C:A
NM_133433.4(NIPBL):c.4684_4687del (p.Phe1562fs)	NIPBL	F1562fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159126	5	37016178 - 37016181	5	37016076 - 37016079	159126	168421	rs587783957	NC_000005.10:37016075:TGTTTG:TG
NM_133433.4(NIPBL):c.4663del (p.Glu1555fs)	NIPBL	E1555fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159124	5	37016159	5	37016057	159124	168419	rs587783955	NC_000005.10:37016056:G:
NM_133433.4(NIPBL):c.4643+1G>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	VCV000159123	5	37014868	5	37014766	159123	168418	rs587783954	NC_000005.10:37014765:G:C
NM_133433.4(NIPBL):c.4636del (p.Lys1548fs)	NIPBL	K1548fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159122	5	37014859	5	37014757	159122	168417	rs587783953	NC_000005.10:37014756:CC:C
NM_133433.4(NIPBL):c.456del (p.Ser153fs)	NIPBL	S153fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159120	5	36961682	5	36961580	159120	168314	rs587783951	NC_000005.10:36961579:CC:C
NM_133433.4(NIPBL):c.4543G>T (p.Glu1515Ter)	NIPBL	E1515*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159118	5	37010310	5	37010208	159118	168414	rs587783950	NC_000005.10:37010207:G:T
NM_133433.4(NIPBL):c.4320+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159113	5	37008191	5	37008089	159113	168408	rs587783945	NC_000005.10:37008088:G:A
NM_133433.4(NIPBL):c.4275_4287del (p.Glu1425fs)	NIPBL	E1425fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159111	5	37008144 - 37008156	5	37008042 - 37008054	159111	168407	rs587783944	NC_000005.10:37008041:AAAATGTCAGTGAA:A
NM_133433.4(NIPBL):c.4240-1G>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159109	5	37008109	5	37008007	159109	168406	rs587783942	NC_000005.10:37008006:G:C
NM_133433.4(NIPBL):c.4139_4140AG[2] (p.Arg1381fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159107	5	37007476 - 37007477	5	37007374 - 37007375	159107	168403	rs587783941	NC_000005.10:37007373:AGAGAG:AGAG
NM_133433.4(NIPBL):c.4098_4101del (p.Leu1366fs)	NIPBL	L1366fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159106	5	37007434 - 37007437	5	37007332 - 37007335	159106	168402	rs587783940	NC_000005.10:37007331:TAAGT:T
NM_133433.4(NIPBL):c.4088-2A>T	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	VCV000159105	5	37007423	5	37007321	159105	168401	rs587783939	NC_000005.10:37007320:A:T
NM_133433.4(NIPBL):c.4017C>A (p.Tyr1339Ter)	NIPBL	Y1339*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 10, 2013)	criteria provided, single submitter	VCV000159104	5	37006620	5	37006518	159104	168400	rs587783938	NC_000005.10:37006517:C:A
NM_133433.4(NIPBL):c.3G>T (p.Met1Ile)	NIPBL	M1I	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159103	5	36953801	5	36953699	159103	168298	rs587783937	NC_000005.10:36953698:G:T
NM_133433.4(NIPBL):c.3874G>T (p.Glu1292Ter)	NIPBL	E1292*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159102	5	37006477	5	37006375	159102	168399	rs587783936	NC_000005.10:37006374:G:T
NM_133433.4(NIPBL):c.3866_3869del (p.Thr1289fs)	NIPBL	T1289fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159100	5	37006468 - 37006471	5	37006366 - 37006369	159100	168397	rs587783934	NC_000005.10:37006365:ACTGA:A
NM_133433.4(NIPBL):c.3855+1G>T	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159097	5	37003450	5	37003348	159097	168394	rs587783933	NC_000005.10:37003347:G:T
NM_133433.4(NIPBL):c.3786_3787TG[1] (p.Val1263fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159093	5	37003380 - 37003381	5	37003278 - 37003279	159093	168390	rs587783930	NC_000005.10:37003277:TGTG:TG
NM_133433.4(NIPBL):c.358+1G>T	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159089	5	36958334	5	36958232	159089	168312	rs587783927	NC_000005.10:36958231:G:T
NM_133433.4(NIPBL):c.3575-3C>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159088	5	37001088	5	37000986	159088	168387	rs587783926	NC_000005.10:37000985:C:G
NM_133433.4(NIPBL):c.3526_3530del (p.Glu1176fs)	NIPBL	E1176fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159086	5	37000938 - 37000942	5	37000836 - 37000840	159086	168385	rs587783925	NC_000005.10:37000835:AAAAGAAAA:AAAA
NM_133433.4(NIPBL):c.3461_3462del (p.Asp1153_Ser1154insTer)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159084	5	37000630 - 37000631	5	37000528 - 37000529	159084	168383	rs587783923	NC_000005.10:37000527:TCT:T
NM_133433.4(NIPBL):c.3322A>T (p.Lys1108Ter)	NIPBL	K1108*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	VCV000159078	5	37000492	5	37000390	159078	168379	rs587783919	NC_000005.10:37000389:A:T
NM_133433.4(NIPBL):c.3305-1G>T	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159077	5	37000474	5	37000372	159077	168378	rs80358375	NC_000005.10:37000371:G:T
NM_133433.4(NIPBL):c.310_317del (p.Pro104fs)	NIPBL	P104fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159073	5	36958283 - 36958290	5	36958181 - 36958188	159073	168309	rs587783917	NC_000005.10:36958180:GTCCTAATGT:GT
NM_133433.4(NIPBL):c.2903del (p.Asn968fs)	NIPBL	N968fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159067	5	36986184	5	36986082	159067	168370	rs587783912	NC_000005.10:36986081:AA:A
NM_133433.4(NIPBL):c.2832T>A (p.Tyr944Ter)	NIPBL	Y944*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159065	5	36986114	5	36986012	159065	168368	rs587783911	NC_000005.10:36986011:T:A
NM_133433.4(NIPBL):c.2773_2774del (p.Lys925fs)	NIPBL	K925fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 7, 2014)	criteria provided, single submitter	VCV000159064	5	36986055 - 36986056	5	36985953 - 36985954	159064	168367	rs587783910	NC_000005.10:36985952:AA:
NM_133433.4(NIPBL):c.2711del (p.Arg904fs)	NIPBL	R904fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159062	5	36985993	5	36985891	159062	168365	rs587783909	NC_000005.10:36985890:G:
NM_133433.4(NIPBL):c.2500C>T (p.Arg834Ter)	NIPBL	R834*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159059	5	36985782	5	36985680	159059	168362	rs587783907	NC_000005.10:36985679:C:T
NM_133433.4(NIPBL):c.2494C>T (p.Arg832Ter)	NIPBL	R832*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159058	5	36985776	5	36985674	159058	168361	rs587783906	NC_000005.10:36985673:C:T
NM_133433.4(NIPBL):c.2489C>G (p.Ser830Ter)	NIPBL	S830*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	VCV000159057	5	36985771	5	36985669	159057	168360	rs587783905	NC_000005.10:36985668:C:G
NM_133433.4(NIPBL):c.2422C>T (p.Arg808Ter)	NIPBL	R808*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159054	5	36985704	5	36985602	159054	168357	rs587783902	NC_000005.10:36985601:C:T
NM_133433.4(NIPBL):c.2389C>T (p.Arg797Ter)	NIPBL	R797*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159053	5	36985671	5	36985569	159053	168356	rs587783901	NC_000005.10:36985568:C:T
NM_133433.4(NIPBL):c.2260C>T (p.Arg754Ter)	NIPBL	R754*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159050	5	36985542	5	36985440	159050	168353	rs587783899	NC_000005.10:36985439:C:T
NM_133433.4(NIPBL):c.2108del (p.Pro703fs)	NIPBL	P703fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159048	5	36985387	5	36985285	159048	168351	rs587783897	NC_000005.10:36985284:CCCC:CCC
NM_133433.4(NIPBL):c.2107_2108del (p.Pro703fs)	NIPBL	P703fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159047	5	36985387 - 36985388	5	36985285 - 36985286	159047	168350	rs587783897	NC_000005.10:36985284:CCCC:CC
NM_133433.4(NIPBL):c.2093C>G (p.Ser698Ter)	NIPBL	S698*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159046	5	36985375	5	36985273	159046	168349	rs587783896	NC_000005.10:36985272:C:G
NM_133433.4(NIPBL):c.2046del (p.Lys682fs)	NIPBL	K682fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159043	5	36985325	5	36985223	159043	168347	rs587783894	NC_000005.10:36985222:AAAA:AAA
NM_133433.4(NIPBL):c.1753del (p.Ile585fs)	NIPBL	I585fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159040	5	36985035	5	36984933	159040	168345	rs587783891	NC_000005.10:36984932:A:
NM_133433.4(NIPBL):c.1576C>T (p.Gln526Ter)	NIPBL	Q526*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159038	5	36984858	5	36984756	159038	168343	rs587783889	NC_000005.10:36984755:C:T
NM_133433.4(NIPBL):c.1514_1517del (p.Arg505fs)	NIPBL	R505fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159037	5	36984793 - 36984796	5	36984691 - 36984694	159037	168342	rs587783888	NC_000005.10:36984690:AAAGAAA:AAA
NM_133433.4(NIPBL):c.145G>T (p.Glu49Ter)	NIPBL	E49*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159035	5	36955654	5	36955552	159035	168305	rs587783886	NC_000005.10:36955551:G:T
NM_133433.4(NIPBL):c.1441_1442GA[3] (p.Glu483fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: May 30, 2013)	criteria provided, single submitter	VCV000159034	5	36976449 - 36976450	5	36976347 - 36976348	159034	168340	rs80358382	NC_000005.10:36976346:AGAGAGAGA:AGAGAGA
NM_133433.4(NIPBL):c.1372C>T (p.Gln458Ter)	NIPBL	Q458*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159033	5	36976381	5	36976279	159033	168339	rs587783884	NC_000005.10:36976278:C:T
NM_133433.4(NIPBL):c.1297C>T (p.Gln433Ter)	NIPBL	Q433*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159032	5	36976306	5	36976204	159032	168338	rs587783883	NC_000005.10:36976203:C:T
NM_133433.4(NIPBL):c.1183C>T (p.Gln395Ter)	NIPBL	Q395*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jul 10, 2013)	criteria provided, single submitter	VCV000159031	5	36976192	5	36976090	159031	168337	rs587783882	NC_000005.10:36976089:C:T
NM_133433.4(NIPBL):c.1086_1087del (p.Arg364fs)	NIPBL	R364fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159028	5	36976094 - 36976095	5	36975992 - 36975993	159028	168334	rs587783880	NC_000005.10:36975991:TTT:T
NM_133433.4(NIPBL):c.1057A>T (p.Lys353Ter)	NIPBL	K353*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159027	5	36976066	5	36975964	159027	168333	rs587783879	NC_000005.10:36975963:A:T
NM_133433.4(NIPBL):c.1033_1036del (p.Tyr345fs)	NIPBL	Y345fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159025	5	36976039 - 36976042	5	36975937 - 36975940	159025	168331	rs587783878	NC_000005.10:36975936:ATGTATG:ATG
NM_133433.4(NIPBL):c.1003del (p.Glu335fs)	NIPBL	E335fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159024	5	36976012	5	36975910	159024	168330	rs587783877	NC_000005.10:36975909:G:
NM_133433.4(NIPBL):c.7806dup (p.Asn2603Ter)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099943	5	37061065 - 37061066	5	37060963 - 37060964	99943	105832	rs80358371	NC_000005.10:37060963:T:TT
NM_133433.4(NIPBL):c.7327C>T (p.Gln2443Ter)	NIPBL	Q2443*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099940	5	37057351	5	37057249	99940	105829	rs80358370	NC_000005.10:37057248:C:T
NM_133433.4(NIPBL):c.6892C>G (p.Arg2298Gly)	NIPBL	R2298G	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099938	5	37049341	5	37049239	99938	105827	rs80358376	NC_000005.10:37049238:C:G
NM_133433.4(NIPBL):c.6641_6647del (p.Asn2214fs)	NIPBL	N2214fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099937	5	37048654 - 37048660	5	37048552 - 37048558	99937	105826	rs80358361	NC_000005.10:37048551:AATCTATA:A
NM_133433.4(NIPBL):c.6631G>T (p.Glu2211Ter)	NIPBL	E2211*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099936	5	37048645	5	37048543	99936	105825	rs80358363	NC_000005.10:37048542:G:T
NM_133433.4(NIPBL):c.585C>G (p.Tyr195Ter)	NIPBL	Y195*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099935	5	36962351	5	36962249	99935	105824	rs80358360	NC_000005.10:36962248:C:G
NM_133433.4(NIPBL):c.4804_4805GA[1] (p.Glu1602fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099931	5	37017147 - 37017148	5	37017045 - 37017046	99931	105820	rs80358372	NC_000005.10:37017044:AGAGA:AGA
NM_133433.4(NIPBL):c.4511T>A (p.Leu1504Ter)	NIPBL	L1504*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099930	5	37010278	5	37010176	99930	105819	rs80358369	NC_000005.10:37010175:T:A
NM_133433.4(NIPBL):c.4285_4294del (p.Glu1429fs)	NIPBL	E1429fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099928	5	37008151 - 37008160	5	37008049 - 37008058	99928	105817	rs80358386	NC_000005.10:37008048:CAGTGAACTACAGT:CAGT
NM_133433.4(NIPBL):c.3445C>T (p.Arg1149Ter)	NIPBL	R1149*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099926	5	37000615	5	37000513	99926	105815	rs80358374	NC_000005.10:37000512:C:T
NM_133433.4(NIPBL):c.192del (p.Gln64fs)	NIPBL	Q64fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099923	5	36955701	5	36955599	99923	105812	rs80358364	NC_000005.10:36955598:G:
NM_133433.4(NIPBL):c.1441_1442GA[2] (p.Arg482fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000099921	5	36976449 - 36976452	5	36976347 - 36976350	99921	105810	rs80358382	NC_000005.10:36976346:AGAGAGAGA:AGAGA
NM_133433.4(NIPBL):c.-321_-320delinsA	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000002151	5	36877039 - 36877040	5	36876937 - 36876938	2151	17190	rs724159980	NC_000005.10:36876936:CC:A
NM_133433.4(NIPBL):c.7861-1G>C	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002148	5	37063891	5	37063789	2148	17187	rs1561231553	NC_000005.10:37063788:G:C
NM_133433.4(NIPBL):c.3616_3618del (p.Ile1206del)	NIPBL	I1206del	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002144	5	37001131 - 37001133	5	37001029 - 37001031	2144	17183	rs121918266	NC_000005.10:37001028:AATA:A
NM_133433.4(NIPBL):c.1547dup (p.Ala517fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002143	5	36984824 - 36984825	5	36984722 - 36984723	2143	17182	rs1554016981	NC_000005.10:36984722:GGGGG:GGGGGG
NM_133433.4(NIPBL):c.7306dup (p.Ala2436fs)	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002142	5	37057329 - 37057330	5	37057227 - 37057228	2142	17181	rs1561222491	NC_000005.10:37057227:G:GG
NM_133433.4(NIPBL):c.150del (p.Asn51fs)	NIPBL	N51fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002141	5	36955659	5	36955557	2141	17180	rs1554011042	NC_000005.10:36955556:G:
NM_133433.4(NIPBL):c.7289A>G (p.Tyr2430Cys)	NIPBL	Y2430C	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002140	5	37057313	5	37057211	2140	17179	rs121918265	NC_000005.10:37057210:A:G
NM_133433.4(NIPBL):c.2T>A (p.Met1Lys)	NIPBL	M1K	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002139	5	36953800	5	36953698	2139	17178	rs121918264	NC_000005.10:36953697:T:A
NM_133433.4(NIPBL):c.3439C>T (p.Arg1147Ter)	NIPBL	R1147*	De Lange syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000627581	5	37000609	5	37000507	627581	615936	rs866740147	NC_000005.10:37000506:C:T
NM_133433.4(NIPBL):c.459-2A>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000523203	5	36962223	5	36962121	523203	513817	rs1561083229	NC_000005.10:36962120:A:G
NM_133433.4(NIPBL):c.7150C>T (p.Gln2384Ter)	NIPBL	Q2384*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 3, 2014)	criteria provided, single submitter	VCV000369665	5	37052555	5	37052453	369665	353895	rs1057516034	NC_000005.10:37052452:C:T
NM_133433.4(NIPBL):c.5440C>T (p.Arg1814Ter)	NIPBL	R1814*	not provided|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	VCV000096344	5	37022358	5	37022256	96344	102238	rs80358362	NC_000005.10:37022255:C:T
NIPBL, IVS44DS, A-G, +4	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002149					2149	17188		
NM_133433.4(NIPBL):c.3737C>G (p.Ala1246Gly)	NIPBL	A1246G	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002147	5	37002836	5	37002734	2147	17186	rs121918268	NC_000005.10:37002733:C:G
NM_000030.3(AGXT):c.847-3C>G	AGXT		Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204169	2	241816951	2	240877534	204169	200571	rs180177286	NC_000002.12:240877533:C:G
NM_133433.4(NIPBL):c.1660C>T (p.Gln554Ter)	NIPBL	Q554*	Cornelia de Lange syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817551	5	36984942	5	36984840	817551	805440		NC_000005.10:36984839:C:T
NM_133433.4(NIPBL):c.3304+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000543051	5	36995907	5	36995805	543051	521193	rs1554019712	NC_000005.10:36995804:G:A
NM_133433.4(NIPBL):c.4782_4786TCAGT[1] (p.Gln1595_Phe1596insTer)	NIPBL		Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280642	5	37017126 - 37017130	5	37017024 - 37017028	280642	264212	rs886041810	NC_000005.10:37017023:TCAGTTCAGT:TCAGT
NM_133433.4(NIPBL):c.86del (p.Pro29fs)	NIPBL	P29fs	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159249	5	36955594	5	36955492	159249	168303	rs587784060	NC_000005.10:36955491:CC:C
NM_133433.4(NIPBL):c.7012G>C (p.Ala2338Pro)	NIPBL	A2338P	not provided|Cornelia de Lange syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159217	5	37051938	5	37051836	159217	168502	rs587784030	NC_000005.10:37051835:G:C
NM_133433.4(NIPBL):c.5483G>A (p.Arg1828Gln)	NIPBL	R1828Q	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 21, 2014)	criteria provided, multiple submitters, no conflicts	VCV000159154	5	37022401	5	37022299	159154	168448	rs587783978	NC_000005.10:37022298:G:A
NM_133433.4(NIPBL):c.4593T>G (p.Tyr1531Ter)	NIPBL	Y1531*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159121	5	37014817	5	37014715	159121	168416	rs587783952	NC_000005.10:37014714:T:G
NM_133433.4(NIPBL):c.3058_3059AG[1] (p.Glu1021fs)	NIPBL		Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159070	5	36986340 - 36986343	5	36986238 - 36986241	159070	168372	rs587783914	NC_000005.10:36986237:AGAGAG:AG
NM_133433.4(NIPBL):c.1885C>T (p.Arg629Ter)	NIPBL	R629*	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, multiple submitters, no conflicts	VCV000159041	5	36985167	5	36985065	159041	168346	rs587783892	NC_000005.10:36985064:C:T
NM_133433.4(NIPBL):c.7789del (p.Leu2597fs)	NIPBL	L2597fs	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000099942	5	37061048	5	37060946	99942	105831	rs80358368	NC_000005.10:37060945:CC:C
NM_133433.4(NIPBL):c.2602C>T (p.Arg868Ter)	NIPBL	R868*	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000096337	5	36985884	5	36985782	96337	102231	rs398124466	NC_000005.10:36985781:C:T
NM_133433.4(NIPBL):c.4606C>T (p.Arg1536Ter)	NIPBL	R1536*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000002150	5	37014830	5	37014728	2150	17189	rs121918269	NC_000005.10:37014727:C:T
NM_133433.4(NIPBL):c.7435_7436GA[2] (p.Arg2480fs)	NIPBL		Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159230	5	37059016 - 37059017	5	37058914 - 37058915	159230	168514	rs587784043	NC_000005.10:37058913:AGAGAGA:AGAGA
NM_133433.4(NIPBL):c.5167C>T (p.Arg1723Ter)	NIPBL	R1723*	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	VCV000002146	5	37020717	5	37020615	2146	17185	rs121918267	NC_000005.10:37020614:C:T
NM_003722.5(TP63):c.953G>A (p.Arg318His)	TP63	R279H, R318H, R316H, R139H, R224H	Rapp-Hodgkin ectodermal dysplasia syndrome|TP63-Related Spectrum Disorders|not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006533	3	189585692	3	189867903	6533	21572	rs121908840	NC_000003.12:189867902:G:A
NM_133433.4(NIPBL):c.64+1G>A	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159191	5	36953863	5	36953761	159191	168299	rs587784009	NC_000005.10:36953760:G:A
NM_133433.4(NIPBL):c.7219C>T (p.Arg2407Ter)	NIPBL	R2407*	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096352	5	37052624	5	37052522	96352	102246	rs398124471	NC_000005.10:37052521:C:T
NM_000297.4(PKD2):c.964C>T (p.Arg322Trp)	PKD2	R322W	not provided|Polycystic kidney disease, autosomal dominant|Polycystic kidney disease 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448039	4	88959523	4	88038371	448039	440852	rs1553925453	NC_000004.12:88038370:C:T
NM_133433.4(NIPBL):c.65-5A>G	NIPBL		Cornelia de Lange syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159196	5	36955569	5	36955467	159196	168302	rs587784012	NC_000005.10:36955466:A:G
NM_003242.6(TGFBR2):c.1379G>A (p.Arg460His)	TGFBR2	R460H, R485H	Thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome 2|not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012515	3	30715721	3	30674229	12515	27554	rs104893816	NC_000003.12:30674228:G:A
NM_000203.5(IDUA):c.1487C>G (p.Pro496Arg)	IDUA	P496R, P364R	not provided|Mucopolysaccharidosis type 1|Hurler syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496861	4	996908	4	1003120	496861	488285	rs772416503	NC_000004.12:1003119:C:G
NC_000005.9:g.(?_37044429)_(37049423_?)del	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000543053	5	37044429 - 37049423	5	37044327 - 37049321	543053	520593		
NM_133433.4(NIPBL):c.7168G>A (p.Ala2390Thr)	NIPBL	A2390T	Cornelia de Lange syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159223	5	37052573	5	37052471	159223	168508	rs587784036	NC_000005.10:37052470:G:A
NM_133433.4(NIPBL):c.6893G>A (p.Arg2298His)	NIPBL	R2298H	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159211	5	37049342	5	37049240	159211	168496	rs587784024	NC_000005.10:37049239:G:A
NM_133433.4(NIPBL):c.133C>T (p.Arg45Ter)	NIPBL	R45*	not provided|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000099920	5	36955642	5	36955540	99920	105809	rs80358367	NC_000005.10:36955539:C:T
NM_000094.3(COL7A1):c.2005C>T (p.Arg669Ter)	COL7A1	R669*	Abnormal blistering of the skin|not provided|Anonychia|Skin erosion|Nail dystrophy|Abnormality of the skin|Finger syndactyly|Short stature|Toe syndactyly|Palmoplantar blistering	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374052	3	48627691	3	48590258	374052	360853	rs780261665	NC_000003.12:48590257:G:A
NM_007118.4(TRIO):c.3119G>A (p.Trp1040Ter)	TRIO	W1040*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000520910	5	14369535	5	14369426	520910	511571	rs1554064863	NC_000005.10:14369425:G:A
NM_001370658.1(BTD):c.566G>A (p.Arg189His)	BTD	R209H, R211H, R189H	not provided|not specified|Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092400	3	15685989	3	15644482	92400	98311	rs398123139	NC_000003.12:15644481:G:A
NM_053025.4(MYLK):c.3985+5G>T	MYLK		Visceral myopathy	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000427851	3	123382947	3	123664100	427851	418808	rs1553787619	NC_000003.12:123664099:C:A
NM_053025.4(MYLK):c.3838_3844dup (p.Glu1282fs)	MYLK		Visceral myopathy	Pathogenic(Last reviewed: Nov 7, 2019)	no assertion criteria provided	VCV000264987	3	123383092 - 123383093	3	123664245 - 123664246	264987	259621	rs1553787823	NC_000003.12:123664245:CGCTTTCC:CGCTTTCCGCTTTCC
NM_053025.4(MYLK):c.4471G>T (p.Ala1491Ser)	MYLK	A1491S, A1315S, A1422S	Aortic aneurysm, familial thoracic 7	Pathogenic(Last reviewed: Dec 23, 2019)	no assertion criteria provided	VCV000694344	3	123366219	3	123647372	694344	682238		NC_000003.12:123647371:C:A
NM_053025.4(MYLK):c.4459C>T (p.Arg1487Ter)	MYLK	R1487*, R1311*, R1418*	Aortic aneurysm, familial thoracic 7	Pathogenic(Last reviewed: Nov 3, 2016)	no assertion criteria provided	VCV000268203	3	123366231	3	123647384	268203	263818	rs886229659	NC_000003.12:123647383:G:A
NM_053025.4(MYLK):c.4372C>T (p.Gln1458Ter)	MYLK	Q1458*, Q1389*, Q1282*	Aortic aneurysm, familial thoracic 7	Pathogenic(Last reviewed: Nov 3, 2016)	no assertion criteria provided	VCV000268202	3	123367861	3	123649014	268202	263819	rs1553781304	NC_000003.12:123649013:G:A
NM_053025.4(MYLK):c.4438C>T (p.Arg1480Ter)	MYLK	R1480*, R1304*, R1411*	Aortic aneurysm, familial thoracic 7	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000030134	3	123366252	3	123647405	30134	39090	rs387906782	NC_000003.12:123647404:G:A
NM_133433.4(NIPBL):c.771+1G>A	NIPBL		Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159235	5	36971139	5	36971037	159235	168322	rs587784048	NC_000005.10:36971036:G:A
NM_133433.4(NIPBL):c.6892C>T (p.Arg2298Cys)	NIPBL	R2298C	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159210	5	37049341	5	37049239	159210	168495	rs80358376	NC_000005.10:37049238:C:T
NM_053025.4(MYLK):c.3823C>T (p.Arg1275Ter)	MYLK	R1275*, R1206*, R1099*	Aortic aneurysm, familial thoracic 7	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000539075	3	123385074	3	123666227	539075	519056	rs1382893400	NC_000003.12:123666226:G:A
NM_000046.5(ARSB):c.454C>T (p.Arg152Trp)	ARSB	R152W	Mucopolysaccharidosis type 6|not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496789	5	78264874	5	78969051	496789	488214	rs991104525	NC_000005.10:78969050:G:A
NM_024577.3(SH3TC2):c.1351G>T (p.Glu451Ter)	SH3TC2	E451*	not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000620528	5	148407944	5	149028381	620528	611628	rs1308058909	NC_000005.10:149028380:C:A
NM_024577.3(SH3TC2):c.2128C>T (p.Gln710Ter)	SH3TC2	Q710*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488926	5	148407167	5	149027604	488926	481727	rs753287764	NC_000005.10:149027603:G:A
NM_024577.3(SH3TC2):c.2488G>T (p.Glu830Ter)	SH3TC2	E830*	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000246578	5	148406807	5	149027244	246578	244467	rs879254317	NC_000005.10:149027243:C:A
NM_024577.3(SH3TC2):c.1797_1800dup (p.Cys601fs)	SH3TC2		not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000246532	5	148407494 - 148407495	5	149027931 - 149027932	246532	244469	rs749963147	NC_000005.10:149027931:GGCC:GGCCGGCC
NM_024577.4(SH3TC2):c.2989del (p.Arg997fs)	SH3TC2	R997fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637410	5	148406199	5	149026636	637410	625118		NC_000005.10:149026635:GG:G
NM_024577.4(SH3TC2):c.688del (p.Val230fs)	SH3TC2	V230fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637409	5	148421022	5	149041459	637409	625127		NC_000005.10:149041458:CC:C
NM_024577.4(SH3TC2):c.2004del (p.Ser669fs)	SH3TC2	S669fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000843467	5	148407291	5	149027728	843467	830482		NC_000005.10:149027727:GG:G
NM_024577.4(SH3TC2):c.1804del (p.Leu602fs)	SH3TC2	L602fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000843466	5	148407491	5	149027928	843466	830484		NC_000005.10:149027927:GG:G
NC_000005.10:g.(?_149040594)_(149040687_?)del	SH3TC2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000832090	5	148420157 - 148420250			832090	819566		
NM_024577.4(SH3TC2):c.974del (p.Asn325fs)	SH3TC2	N325fs	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802163	5	148417885	5	149038322	802163	790523		NC_000005.10:149038321:TT:T
NM_024577.4(SH3TC2):c.2189del (p.Gly730fs)	SH3TC2	G730fs	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802162	5	148407106	5	149027543	802162	790522		NC_000005.10:149027542:CCCC:CCC
NM_024577.4(SH3TC2):c.1366del (p.Asp455_Leu456insTer)	SH3TC2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000655644	5	148407929	5	149028366	655644	633613		NC_000005.10:149028365:GG:G
NC_000005.9:g.(?_148427405)_(148427572_?)del	SH3TC2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000643156	5	148427405 - 148427572	5	149047842 - 149048009	643156	651231		
NM_024577.3(SH3TC2):c.58G>T (p.Glu20Ter)	SH3TC2	E20*	Charcot-Marie-Tooth disease, type 4C	Pathogenic	no assertion criteria provided	VCV000637956	5	148431798	5	149052235	637956	625777		NC_000005.10:149052234:C:A
NM_024577.3(SH3TC2):c.2146C>T (p.Gln716Ter)	SH3TC2	Q716*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000583373	5	148407149	5	149027586	583373	562944	rs1561764925	NC_000005.10:149027585:G:A
NM_024577.3(SH3TC2):c.2418T>G (p.Tyr806Ter)	SH3TC2	Y806*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000566412	5	148406877	5	149027314	566412	560199	rs1561764735	NC_000005.10:149027313:A:C
NM_024577.3(SH3TC2):c.3675+2dup	SH3TC2		Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Feb 6, 2018)	no assertion criteria provided	VCV000545475	5	148386441 - 148386442	5	149006878 - 149006879	545475	535735	rs1554120215	NC_000005.10:149006878:A:AA
NM_024577.3(SH3TC2):c.1978C>T (p.Gln660Ter)	SH3TC2	Q660*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000543354	5	148407317	5	149027754	543354	521157	rs1554121665	NC_000005.10:149027753:G:A
NM_024577.3(SH3TC2):c.1868_1869del (p.Gly623fs)	SH3TC2	G623fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000476892	5	148407426 - 148407427	5	149027863 - 149027864	476892	455581	rs1554121691	NC_000005.10:149027862:CCCC:CC
NM_024577.3(SH3TC2):c.2072_2090del (p.Ala691fs)	SH3TC2	A691fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000241502	5	148407205 - 148407223	5	149027642 - 149027660	241502	239777	rs878855092	NC_000005.10:149027641:CCATGTTGCTGGACAGAGGCCA:CCA
NM_024577.3(SH3TC2):c.1662del (p.Ile555fs)	SH3TC2	I555fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000216119	5	148407633	5	149028070	216119	212507	rs863224520	NC_000005.10:149028069:GG:G
NM_024577.3(SH3TC2):c.2191del (p.Glu731fs)	SH3TC2	E731fs	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Mar 31, 2008)	no assertion criteria provided	VCV000021693	5	148407104	5	149027541	21693	34545	rs80338928	NC_000005.10:149027540:C:
NM_024577.4(SH3TC2):c.375C>A (p.Tyr125Ter)	SH3TC2	Y125*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000842178	5	148424106	5	149044543	842178	830499		NC_000005.10:149044542:G:T
NM_024577.3(SH3TC2):c.1520_1523del (p.Phe507fs)	SH3TC2	F507fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000570428	5	148407772 - 148407775	5	149028209 - 149028212	570428	560318	rs1561765311	NC_000005.10:149028208:ACAAAC:AC
NM_024577.3(SH3TC2):c.211C>T (p.Gln71Ter)	SH3TC2	Q71*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000220821	5	148427493	5	149047930	220821	221614	rs864622663	NC_000005.10:149047929:G:A
NM_024577.3(SH3TC2):c.3341del (p.Pro1114fs)	SH3TC2	P1114fs	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Mar 31, 2008)	no assertion criteria provided	VCV000021699	5	148388551	5	149008988	21699	34551	rs80338936	NC_000005.10:149008987:GG:G
NM_024577.3(SH3TC2):c.2491_2492delAG	SH3TC2		Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Mar 31, 2008)	no assertion criteria provided	VCV000021694	5	148406803 - 148406804	5	149027240 - 149027241	21694	34546	rs80338929	NC_000005.10:149027239:CTCTCT:CTCT
NM_000030.3(AGXT):c.322T>C (p.Trp108Arg)	AGXT	W108R	Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188891	2	241808743	2	240869326	188891	186654	rs180177197	NC_000002.12:240869325:T:C
NM_024577.3(SH3TC2):c.3596G>A (p.Trp1199Ter)	SH3TC2	W1199*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000579413	5	148386523	5	149006960	579413	560193	rs761972717	NC_000005.10:149006959:C:T
NM_024577.3(SH3TC2):c.496G>T (p.Glu166Ter)	SH3TC2	E166*	not provided|Charcot-Marie-Tooth disease type 4	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450991	5	148422290	5	149042727	450991	443716	rs1554122847	NC_000005.10:149042726:C:A
NM_024577.3(SH3TC2):c.957del (p.Phe320fs)	SH3TC2	F320fs	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000448371	5	148417902	5	149038339	448371	440877	rs1554122541	NC_000005.10:149038338:G:
NM_024577.3(SH3TC2):c.3601C>T (p.Gln1201Ter)	SH3TC2	Q1201*	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV000021700	5	148386518	5	149006955	21700	34552	rs80338937	NC_000005.10:149006954:G:A
NM_024577.3(SH3TC2):c.2829T>G (p.Tyr943Ter)	SH3TC2	Y943*	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Mar 31, 2008)	no assertion criteria provided	VCV000002481	5	148406466	5	149026903	2481	17520	rs80338932	NC_000005.10:149026902:A:C
NM_024577.3(SH3TC2):c.1747_1748delAG	SH3TC2		Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Mar 31, 2008)	no assertion criteria provided	VCV000002479	5	148407547 - 148407548	5	149027984 - 149027985	2479	17518	rs80338924	NC_000005.10:149027983:CTCT:CT
NM_005654.6(NR2F1):c.425G>A (p.Arg142His)	NR2F1	R142H	Inborn genetic diseases|Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000520777	5	92921154	5	93585448	520777	511613	rs1554074684	NC_000005.10:93585447:G:A
NM_000128.3(F11):c.901T>C (p.Phe301Leu)	F11	F283L, F301L	not provided|Hereditary factor XI deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011892	4	187201412	4	186280258	11892	26931	rs121965064	NC_000004.12:186280257:T:C
NM_000128.3(F11):c.403G>T (p.Glu135Ter)	F11	E117*, E135*	Hereditary factor XI deficiency disease|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011891	4	187195347	4	186274193	11891	26930	rs121965063	NC_000004.12:186274192:G:T
NM_024577.3(SH3TC2):c.1378C>T (p.Gln460Ter)	SH3TC2	Q460*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 19, 2019)	criteria provided, single submitter	VCV000637510	5	148407917	5	149028354	637510	625125		NC_000005.10:149028353:G:A
NM_024577.3(SH3TC2):c.3425_3435del (p.Tyr1142fs)	SH3TC2	Y1142fs	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000543408	5	148388457 - 148388467	5	149008894 - 149008904	543408	520902	rs1222150652	NC_000005.10:149008893:AGCCTTCTCATAGCCTTC:AGCCTTC
NM_024577.3(SH3TC2):c.820_821insT (p.Lys274fs)	SH3TC2		Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243068	5	148418038 - 148418039	5	149038475 - 149038476	243068	244156	rs879253859	NC_000005.10:149038475::A
NM_024577.3(SH3TC2):c.3154C>T (p.Arg1052Ter)	SH3TC2	R1052*	not provided|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220408	5	148392197	5	149012634	220408	221609	rs370115218	NC_000005.10:149012633:G:A
NM_133433.4(NIPBL):c.64+2_64+134del	NIPBL		Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000841447	5	36953863 - 36953995	5	36953761 - 36953893	841447	852213		
NM_133433.4(NIPBL):c.4321G>T (p.Val1441Leu)	NIPBL	V1441L	not provided|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000180193	5	37008725	5	37008623	180193	178376	rs727503769	NC_000005.10:37008622:G:T
NM_001080522.2(CC2D2A):c.3145C>T (p.Arg1049Ter)	CC2D2A	R1049*	Joubert syndrome 9|Joubert syndrome with hepatic defect|Meckel syndrome type 6|Joubert syndrome 9/15, digenic|Joubert syndrome with hepatic defect|not provided|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000747	4	15565108	4	15563485	747	15786	rs386833750	NC_000004.12:15563484:C:T
NM_023073.3(CPLANE1):c.1819del (p.Tyr607fs)	CPLANE1	Y607fs	not provided|Joubert syndrome 17||Global developmental delay|Jaundice|Joubert syndrome 17|Joubert syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217590	5	37226878	5	37226776	217590	214224	rs777686211	NC_000005.10:37226775:AAAAAAAA:AAAAAAA
NM_053025.4(MYLK):c.3715del (p.Gln1239fs)	MYLK	Q1239fs, Q1063fs, Q1170fs	Aortic aneurysm, familial thoracic 7	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000859691	3	123385182	3	123666335	859691	827421		NC_000003.12:123666334:G:
NM_003242.6(TGFBR2):c.1067G>C (p.Arg356Pro)	TGFBR2	R356P, R381P	Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177704	3	30713742	3	30672250	177704	173913	rs727504292	NC_000003.12:30672249:G:C
NM_001122681.2(SH3BP2):c.1253C>G (p.Pro418Arg)	SH3BP2	P418R, P446R, P475R	not provided|Fibrous dysplasia of jaw	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007548	4	2833309	4	2831582	7548	22587	rs121909146	NC_000004.12:2831581:C:G
NM_000521.4(HEXB):c.1250C>T (p.Pro417Leu)	HEXB	P417L, P405L, P192L	Sandhoff disease, juvenile type|Sandhoff disease|not provided|Sandhoff disease, adult type	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003878	5	74014629	5	74718804	3878	18917	rs28942073	NC_000005.10:74718803:C:T
NM_024577.3(SH3TC2):c.3303del (p.Arg1101fs)	SH3TC2	R1101fs	Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000220822	5	148389857	5	149010294	220822	221608	rs864622664	NC_000005.10:149010293:CC:C
NM_024577.3(SH3TC2):c.1A>G (p.Met1Val)	SH3TC2	M1V	Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease type 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218918	5	148442585	5	149063022	218918	215727	rs864309709	NC_000005.10:149063021:T:C
NM_024577.3(SH3TC2):c.279G>A (p.Lys93=)	SH3TC2		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000216120	5	148427425	5	149047862	216120	212513	rs776221160	NC_000005.10:149047861:C:T
NM_033337.2(CAV3):c.136G>A (p.Ala46Thr)	CAV3	A46T	not provided|Elevated serum creatine phosphokinase|Rippling muscle disease 2	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000008281	3	8787233	3	8745547	8281	23320	rs116840789	NC_000003.12:8745546:G:A
NM_002397.5(MEF2C):c.113T>C (p.Leu38Pro)	MEF2C	L38P	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000520592	5	88100560	5	88804743	520592	511611	rs397514655	NC_000005.10:88804742:A:G
NM_002397.5(MEF2C):c.121_122TG[1] (p.Cys41_Glu42delinsTer)	MEF2C		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000520573	5	88100549 - 88100550	5	88804732 - 88804733	520573	511610	rs1554139771	NC_000005.10:88804731:CACA:CA
NM_001370658.1(BTD):c.535G>A (p.Val179Met)	BTD	V199M, V179M, V201M	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025026	3	15685958	3	15644451	25026	36363	rs397514375	NC_000003.12:15644450:G:A
NM_024577.3(SH3TC2):c.1586_1587delinsAG (p.Arg529Gln)	SH3TC2		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000216005	5	148407708 - 148407709	5	149028145 - 149028146	216005	212508	rs863224454	NC_000005.10:149028144:AC:CT
NM_003060.4(SLC22A5):c.95A>G (p.Asn32Ser)	SLC22A5	N32S	not provided|Renal carnitine transport defect|not specified	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025355	5	131705759	5	132370067	25355	36689	rs72552725	NC_000005.10:132370066:A:G
NM_022455.5(NSD1):c.5721dup (p.Asp1908fs)	NSD1		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000817710	5	176707663 - 176707664	5	177280662 - 177280663	817710	805436		NC_000005.10:177280662:A:AA
NM_022455.5(NSD1):c.5342del (p.Pro1781fs)	NSD1	P1512fs, P1781fs	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000817623	5	176696640	5	177269639	817623	805435		NC_000005.10:177269638:CC:C
NM_022455.5(NSD1):c.2047_2048del (p.Lys683fs)	NSD1	K414fs, K683fs	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817335	5	176637445 - 176637446	5	177210444 - 177210445	817335	805430		NC_000005.10:177210443:AAAA:AA
NM_022455.5(NSD1):c.1327_1328del (p.Ile443fs)	NSD1	I174fs, I443fs	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000817196	5	176636726 - 176636727	5	177209725 - 177209726	817196	805429		NC_000005.10:177209724:TAT:T
NM_022455.5(NSD1):c.3580_3581insT (p.Asp1194fs)	NSD1		not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000817177	5	176638980 - 176638981	5	177211979 - 177211980	817177	805433		NC_000005.10:177211979::T
NM_022455.5(NSD1):c.2998del (p.Ser1000fs)	NSD1	S1000fs, S731fs	not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000817122	5	176638398	5	177211397	817122	805432		NC_000005.10:177211396:T:
NM_022455.5(NSD1):c.2615T>G (p.Leu872Ter)	NSD1	L603*, L872*	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000816979	5	176638015	5	177211014	816979	805431		NC_000005.10:177211013:T:G
NM_022455.5(NSD1):c.5296C>T (p.Arg1766Ter)	NSD1	R1497*, R1766*	not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000816943	5	176694712	5	177267711	816943	805434		NC_000005.10:177267710:C:T
NM_022455.4:c.1926_1927insAlu	NSD1		not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000800738					800738	789358		
NM_022455.4(NSD1):c.2494A>T (p.Lys832Ter)	NSD1	K832*, K563*	not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000620571	5	176637894	5	177210893	620571	611632	rs1562209222	NC_000005.10:177210892:A:T
NM_022455.4(NSD1):c.5502T>A (p.Tyr1834Ter)	NSD1	Y1834*, Y1565*	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000620496	5	176696801	5	177269800	620496	611635	rs369086894	NC_000005.10:177269799:T:A
NM_022455.4(NSD1):c.3274C>T (p.Gln1092Ter)	NSD1	Q1092*, Q823*	not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000620385	5	176638674	5	177211673	620385	611633	rs1562212423	NC_000005.10:177211672:C:T
NM_022455.4(NSD1):c.3290T>A (p.Leu1097Ter)	NSD1	L1097*, L828*	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000620138	5	176638690	5	177211689	620138	611634	rs1562212484	NC_000005.10:177211688:T:A
NM_022455.4(NSD1):c.3548_3549insG (p.Ser1183_Glu1184insTer)	NSD1		not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000546061	5	176638948 - 176638949	5	177211947 - 177211948	546061	536308	rs878855075	NC_000005.10:177211947::G
NM_022455.4(NSD1):c.6010-14_6016delinsC	NSD1		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504335	5	176710774 - 176710794	5	177283773 - 177283793	504335	495264	rs1554204905	NC_000005.10:177283772:TTTTGGAATTCTAGGACCGAA:C
NM_022455.4(NSD1):c.5851C>T (p.Gln1951Ter)	NSD1	Q1951*, Q1682*	not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000504283	5	176707794	5	177280793	504283	495260	rs1554204165	NC_000005.10:177280792:C:T
NM_022455.4(NSD1):c.4058_4061del (p.Glu1353fs)	NSD1	E1353fs, E1084fs	not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000500852	5	176665372 - 176665375	5	177238371 - 177238374	500852	492276	rs1554195857	NC_000005.10:177238370:GGAGGG:GG
NM_022455.4(NSD1):c.2915del (p.Thr972fs)	NSD1	T703fs, T972fs	not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000497291	5	176638315	5	177211314	497291	488715	rs1554189879	NC_000005.10:177211313:C:
NM_022455.4(NSD1):c.5862G>A (p.Trp1954Ter)	NSD1	W1954*, W1685*	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000489233	5	176707805	5	177280804	489233	481735	rs587784160	NC_000005.10:177280803:G:A
NM_022455.4(NSD1):c.5229G>A (p.Trp1743Ter)	NSD1	W1743*, W1474*	not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000488836	5	176694645	5	177267644	488836	481734	rs1554201740	NC_000005.10:177267643:G:A
NM_022455.4(NSD1):c.3457C>T (p.Gln1153Ter)	NSD1	Q1153*, Q884*	not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000488749	5	176638857	5	177211856	488749	481731	rs1554190269	NC_000005.10:177211855:C:T
NM_022455.4(NSD1):c.3481C>T (p.Gln1161Ter)	NSD1	Q1161*, Q892*	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000488708	5	176638881	5	177211880	488708	481732	rs1554190292	NC_000005.10:177211879:C:T
NM_022455.4(NSD1):c.2892_2914dup (p.Thr972fs)	NSD1		not provided	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000452786	5	176638290 - 176638291	5	177211289 - 177211290	452786	443759	rs1554189871	NC_000005.10:177211289:ATTCAGAGAAAAAGGGAGATGGCA:ATTCAGAGAAAAAGGGAGATGGCATTCAGAGAAAAAGGGAGATGGCA
NM_022455.4(NSD1):c.5898_5899insG (p.Phe1967fs)	NSD1		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000450647	5	176709471 - 176709472	5	177282470 - 177282471	450647	443765	rs1554204587	NC_000005.10:177282470::G
NM_172349.2(NSD1):c.1827_1828CT[1] (p.Ser610fs)	NSD1		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000450499	5	176638034 - 176638035	5	177211033 - 177211034	450499	443758	rs1554189720	NC_000005.10:177211032:CTCT:CT
NM_022455.4(NSD1):c.6170A>G (p.Asn2057Ser)	NSD1	N2057S, N1788S	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000449076	5	176715838	5	177288837	449076	443767	rs1554205939	NC_000005.10:177288836:A:G
NM_022455.4(NSD1):c.2054dup (p.Tyr686fs)	NSD1		not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000432997	5	176637451 - 176637452	5	177210450 - 177210451	432997	425635	rs1554189269	NC_000005.10:177210450:AAA:AAAA
NM_172349.2(NSD1):c.3825_3828TGTC[1] (p.Cys1277fs)	NSD1		not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000432790	5	176675316 - 176675319	5	177248315 - 177248318	432790	425636	rs1554197794	NC_000005.10:177248314:TGTCTGTC:TGTC
NM_022455.4(NSD1):c.5951G>C (p.Arg1984Pro)	NSD1	R1984P, R1715P	not provided	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000426653	5	176709524	5	177282523	426653	415001	rs587784169	NC_000005.10:177282522:G:C
NM_022455.4(NSD1):c.2276C>A (p.Ser759Ter)	NSD1	S759*, S490*	not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000424367	5	176637676	5	177210675	424367	406703	rs587784084	NC_000005.10:177210674:C:A
NM_022455.4(NSD1):c.1739_1740del (p.Lys580fs)	NSD1	K311fs, K580fs	not provided	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000423091	5	176637138 - 176637139	5	177210137 - 177210138	423091	406701	rs1064796222	NC_000005.10:177210136:AAA:A
NM_022455.4(NSD1):c.5036C>G (p.Ser1679Ter)	NSD1	S1679*, S1410*	not provided	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000423035	5	176687059	5	177260058	423035	406713	rs1064796184	NC_000005.10:177260057:C:G
NM_022455.4(NSD1):c.4819_4820dup (p.Leu1608fs)	NSD1		not provided	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000423028	5	176684004 - 176684005	5	177257003 - 177257004	423028	406711	rs1554199392	NC_000005.10:177257003:CT:CTCT
NM_172349.2(NSD1):c.1343_1344AG[1] (p.Ser449fs)	NSD1		not provided	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000423009	5	176637550 - 176637551	5	177210549 - 177210550	423009	406702	rs1064796161	NC_000005.10:177210548:AGAG:AG
NM_022455.4(NSD1):c.3575del (p.Pro1192fs)	NSD1	P1192fs, P923fs	not provided	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000422944	5	176638974	5	177211973	422944	406708	rs1064796114	NC_000005.10:177211972:CC:C
NM_022455.4(NSD1):c.3423_3424insCC (p.Asn1142fs)	NSD1		not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000422904	5	176638823 - 176638824	5	177211822 - 177211823	422904	406707	rs1064796081	NC_000005.10:177211822::CC
NM_022455.4(NSD1):c.5110dup (p.His1704fs)	NSD1		not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000422784	5	176687132 - 176687133	5	177260131 - 177260132	422784	406714	rs1554200214	NC_000005.10:177260131:C:CC
NM_022455.4(NSD1):c.2760_2763del (p.Ser920fs)	NSD1	S651fs, S920fs	not provided	Pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	VCV000419698	5	176638158 - 176638161	5	177211157 - 177211160	419698	406704	rs1064794051	NC_000005.10:177211156:AGTAAG:AG
NM_022455.4(NSD1):c.8034del (p.Pro2679fs)	NSD1	P2410fs, P2679fs	not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000419672	5	176722402	5	177295401	419672	406722	rs1064794033	NC_000005.10:177295400:TT:T
NM_022455.4(NSD1):c.3230C>G (p.Ser1077Ter)	NSD1	S1077*, S808*	not provided	Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	VCV000419395	5	176638630	5	177211629	419395	406706	rs1064793843	NC_000005.10:177211628:C:G
NM_022455.4(NSD1):c.5699del (p.Thr1900fs)	NSD1	T1900fs, T1631fs	not provided	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000419189	5	176707642	5	177280641	419189	406716	rs1064793705	NC_000005.10:177280640:C:
NM_022455.4(NSD1):c.2996_2997insTTAA (p.Ser1000_Asp1001insTer)	NSD1		not provided	Pathogenic(Last reviewed: May 12, 2015)	criteria provided, single submitter	VCV000419060	5	176638396 - 176638397	5	177211395 - 177211396	419060	406705	rs1064793616	NC_000005.10:177211395::TTAA
NM_022455.4(NSD1):c.5892+1del	NSD1		not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000418679	5	176707835	5	177280834	418679	406718	rs1064793361	NC_000005.10:177280833:GG:G
NM_022455.4(NSD1):c.4801del (p.Glu1601fs)	NSD1	E1332fs, E1601fs	not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000418638	5	176683984	5	177256983	418638	406710	rs1064793336	NC_000005.10:177256982:GGGG:GGG
NM_022455.4(NSD1):c.4378+5G>C	NSD1		not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000418390	5	176671276	5	177244275	418390	406709	rs1064793218	NC_000005.10:177244274:G:C
NM_022455.4(NSD1):c.5182G>C (p.Ala1728Pro)	NSD1	A1728P, A1459P	not provided	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000379717	5	176694598	5	177267597	379717	368398	rs1057520710	NC_000005.10:177267596:G:C
NM_022455.4(NSD1):c.4765+1G>A	NSD1		not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000379620	5	176678855	5	177251854	379620	368396	rs1057520671	NC_000005.10:177251853:G:A
NM_022455.4(NSD1):c.6010-1G>A	NSD1		not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000379496	5	176710787	5	177283786	379496	368570	rs1057520620	NC_000005.10:177283785:G:A
NM_022455.4(NSD1):c.1397C>G (p.Ser466Ter)	NSD1	S466*, S197*	not provided	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000379349	5	176636797	5	177209796	379349	369785	rs1057520581	NC_000005.10:177209795:C:G
NM_022455.4(NSD1):c.4825delinsGA (p.Pro1609fs)	NSD1		not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000373063	5	176684011	5	177257010	373063	359667	rs1057518184	NC_000005.10:177257009:C:GA
NM_022455.4(NSD1):c.6463+5G>C	NSD1		not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000373053	5	176719164	5	177292163	373053	359669	rs1057518175	NC_000005.10:177292162:G:C
NM_022455.4(NSD1):c.6152-1G>A	NSD1		not provided	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000289994	5	176715819	5	177288818	289994	274231	rs886044326	NC_000005.10:177288817:G:A
NM_022455.4(NSD1):c.3382dup (p.Ser1128fs)	NSD1		not provided	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000288002	5	176638781 - 176638782	5	177211780 - 177211781	288002	272239	rs886043780	NC_000005.10:177211780:T:TT
NM_022455.4(NSD1):c.6440dup (p.Asn2148fs)	NSD1		not provided	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	VCV000283860	5	176719135 - 176719136	5	177292134 - 177292135	283860	268097	rs886042725	NC_000005.10:177292134:T:TT
NM_022455.4(NSD1):c.1288C>T (p.Gln430Ter)	NSD1	Q430*, Q161*	not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000280938	5	176636688	5	177209687	280938	264180	rs367809750	NC_000005.10:177209686:C:T
NM_022455.4(NSD1):c.3631_3632delinsA (p.Ala1211fs)	NSD1		not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000280933	5	176639031 - 176639032	5	177212030 - 177212031	280933	264227	rs886042047	NC_000005.10:177212029:GC:A
NM_022455.4(NSD1):c.5842C>T (p.Arg1948Cys)	NSD1	R1948C, R1679C	not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000280800	5	176707785	5	177280784	280800	264186	rs886041941	NC_000005.10:177280783:C:T
NM_022455.4(NSD1):c.2163_2169del (p.Gly722fs)	NSD1	G453fs, G722fs	not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000280665	5	176637561 - 176637567	5	177210560 - 177210566	280665	264268	rs886041832	NC_000005.10:177210559:CCTGGAACC:CC
NM_022455.4(NSD1):c.5943del (p.Glu1980_Cys1981insTer)	NSD1		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000280548	5	176709516	5	177282515	280548	264229	rs886041734	NC_000005.10:177282514:C:
NM_022455.4(NSD1):c.4658del (p.Gly1553fs)	NSD1	G1284fs, G1553fs	not provided	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000280401	5	176678745	5	177251744	280401	264184	rs886041615	NC_000005.10:177251743:GGG:GG
NM_022455.4(NSD1):c.2108del (p.Leu703fs)	NSD1	L434fs, L703fs	not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000280321	5	176637508	5	177210507	280321	264266	rs886041550	NC_000005.10:177210506:T:
NM_022455.4(NSD1):c.3581_3582delinsG (p.Asp1194fs)	NSD1		not provided	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000280276	5	176638981 - 176638982	5	177211980 - 177211981	280276	264182	rs886041512	NC_000005.10:177211979:AC:G
NM_022455.4(NSD1):c.1212_1213del (p.Lys405fs)	NSD1	K136fs, K405fs	not provided	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000279856	5	176631268 - 176631269	5	177204267 - 177204268	279856	264258	rs886041217	NC_000005.10:177204266:AGA:A
NM_022455.4(NSD1):c.3387_3389delinsGG (p.Phe1129fs)	NSD1		not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000265670	5	176638787 - 176638789	5	177211786 - 177211788	265670	259820	rs886039717	NC_000005.10:177211785:TGA:GG
NM_022455.4(NSD1):c.5892+1G>T	NSD1		not provided	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000265497	5	176707836	5	177280835	265497	259822	rs886039579	NC_000005.10:177280834:G:T
NM_172349.2(NSD1):c.2739_2740CT[1] (p.Asn913_Ser914insTer)	NSD1		not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000265496	5	176638946 - 176638947	5	177211945 - 177211946	265496	259821	rs886039578	NC_000005.10:177211944:CTCT:CT
GRCh38/hg38 5q35.3(chr5:177239706-177291908)x1	NSD1		See cases	Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	VCV000145970	5	176666707 - 176718909	5	177239706 - 177291908	145970	155721		
NM_022455.4(NSD1):c.6538_6539insC (p.Ser2180fs)	NSD1		not provided	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000096069	5	176720907 - 176720908	5	177293906 - 177293907	96069	101963	rs398124383	NC_000005.10:177293906::C
NM_022455.4(NSD1):c.6463+1G>A	NSD1		not provided	Pathogenic(Last reviewed: Jun 10, 2013)	criteria provided, single submitter	VCV000096067	5	176719160	5	177292159	96067	101961	rs398124381	NC_000005.10:177292158:G:A
NM_022455.4(NSD1):c.2349del (p.Lys783fs)	NSD1	K514fs, K783fs	not provided	Pathogenic(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	VCV000096044	5	176637747	5	177210746	96044	101938	rs398124374	NC_000005.10:177210745:AAA:AA
GRCh38/hg38 5q35.3(chr5:177228604-177246556)x1	NSD1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058404	5	176655605 - 176673557	5	177228604 - 177246556	58404	72999		
NM_022455.4(NSD1):c.4766-2A>G	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000807641	5	176683950	5	177256949	807641	798559		NC_000005.10:177256948:A:G
NM_022455.4(NSD1):c.2289_2317dup (p.Ala773delinsValArgThrArgTer)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000807640	5	176637685 - 176637686	5	177210684 - 177210685	807640	798558		NC_000005.10:177210684:CAGTGAGAACTCGTTAATAAAGGGTGGGGCAG:CAGTGAGAACTCGTTAATAAAGGGTGGGGCAGTGAGAACTCGTTAATAAAGGGTGGGGCAG
NM_022455.4(NSD1):c.6553C>T (p.Gln2185Ter)	NSD1	Q2185*, Q1916*	Sotos syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802187	5	176720922	5	177293921	802187	790547		NC_000005.10:177293920:C:T
NM_022455.4(NSD1):c.6086_6087CA[1] (p.Gln2030fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802186	5	176710863 - 176710864	5	177283862 - 177283863	802186	790546		NC_000005.10:177283861:ACACA:ACA
NM_022455.4(NSD1):c.5812A>T (p.Lys1938Ter)	NSD1	K1669*, K1938*	Sotos syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802185	5	176707755	5	177280754	802185	790545		NC_000005.10:177280753:A:T
NM_022455.4(NSD1):c.4108C>T (p.Gln1370Ter)	NSD1	Q1370*, Q1101*	Sotos syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802182	5	176665424	5	177238423	802182	790542		NC_000005.10:177238422:C:T
NM_022455.4(NSD1):c.3922-1G>C	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802181	5	176665237	5	177238236	802181	790541		NC_000005.10:177238235:G:C
NM_022455.4(NSD1):c.3038C>G (p.Ser1013Ter)	NSD1	S1013*, S744*	Sotos syndrome 1	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488565	5	176638438	5	177211437	488565	481433	rs1006906224	NC_000005.10:177211436:C:G
NM_022455.4(NSD1):c.4217_4220del (p.Arg1406fs)	NSD1	R1137fs, R1406fs	not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198903	5	176666778 - 176666781	5	177239777 - 177239780	198903	196063	rs794727930	NC_000005.10:177239776:AAAGAAA:AAA
NM_000404.4(GLB1):c.622C>T (p.Arg208Cys)	GLB1	R208C, R178C, R256C	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000939	3	33099692	3	33058200	939	15978	rs72555366	NC_000003.12:33058199:G:A
NM_022455.4(NSD1):c.2613del (p.Ser871_Leu872insTer)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000638012	5	176638012	5	177211011	638012	625796		NC_000005.10:177211010:CC:C
NM_022455.4(NSD1):c.2137dup (p.Met713fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000637041	5	176637535 - 176637536	5	177210534 - 177210535	637041	624848		NC_000005.10:177210534:AA:AAA
NM_022455.4(NSD1):c.6358G>T (p.Glu2120Ter)	NSD1	E2120*, E1851*	Sotos syndrome 1	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000637037	5	176719054	5	177292053	637037	624849		NC_000005.10:177292052:G:T
NM_022455.4(NSD1):c.2314del (p.Ala772fs)	NSD1	A503fs, A772fs	Sotos syndrome 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547719	5	176637711	5	177210710	547719	537776	rs1554189482	NC_000005.10:177210709:GGGG:GGG
NM_172349.2(NSD1):c.1066G>T (p.Gly356Ter)	NSD1	G356*, G625*	Sotos syndrome 1	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000547168	5	176637273	5	177210272	547168	537656	rs1286331975	NC_000005.10:177210271:G:T
NM_172349.2(NSD1):c.3964C>T (p.His1322Tyr)	NSD1	H1322Y, H1591Y	Sotos syndrome 1	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000488392	5	176683957	5	177256956	488392	481233	rs1554199368	NC_000005.10:177256955:C:T
NM_022455.4(NSD1):c.3922-2_3925delinsG	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000436066	5	176665236 - 176665241	5	177238235 - 177238240	436066	428387	rs1554195815	NC_000005.10:177238234:AGGTAA:G
NM_022455.4(NSD1):c.1549C>T (p.Gln517Ter)	NSD1	Q517*, Q248*	Sotos syndrome 1	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000431037	5	176636949	5	177209948	431037	424561	rs1131692328	NC_000005.10:177209947:C:T
NM_022455.4(NSD1):c.7783A>T (p.Lys2595Ter)	NSD1	K2595*, K2326*	Sotos syndrome 1	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000211747	5	176722152	5	177295151	211747	207207	rs797045834	NC_000005.10:177295150:A:T
NM_022455.4(NSD1):c.6459_6463+5del	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211745	5	176719155 - 176719164	5	177292154 - 177292163	211745	207205	rs797045832	NC_000005.10:177292153:AGCAGGTTGG:
NM_022455.4(NSD1):c.6344dup (p.Glu2116fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211744	5	176719037 - 176719038	5	177292036 - 177292037	211744	207204	rs797045831	NC_000005.10:177292036:AAA:AAAA
NM_022455.4(NSD1):c.6307_6308insTGTGC (p.Gln2103fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211743	5	176719001 - 176719002	5	177292000 - 177292001	211743	207203	rs797045830	NC_000005.10:177292000:GC:GCTGTGC
NM_022455.4(NSD1):c.6290dup (p.Lys2098fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211742	5	176718983 - 176718984	5	177291982 - 177291983	211742	207202	rs797045829	NC_000005.10:177291982:AAA:AAAA
NM_022455.4(NSD1):c.6218dup (p.Ala2074fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211741	5	176715884 - 176715885	5	177288883 - 177288884	211741	207201	rs797045828	NC_000005.10:177288883:GG:GGG
NM_022455.4(NSD1):c.6112dup (p.Thr2038fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211740	5	176710889 - 176710890	5	177283888 - 177283889	211740	207200	rs797045827	NC_000005.10:177283888:A:AA
NM_022455.4(NSD1):c.6094_6095dup (p.Trp2032fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211739	5	176710870 - 176710871	5	177283869 - 177283870	211739	207199	rs797045826	NC_000005.10:177283869:GTG:GTGTG
NM_022455.4(NSD1):c.5990A>G (p.Tyr1997Cys)	NSD1	Y1997C, Y1728C	Sotos syndrome 1	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000211738	5	176709563	5	177282562	211738	207198	rs797045825	NC_000005.10:177282561:A:G
NM_022455.4(NSD1):c.5790dup (p.Cys1931fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211737	5	176707732 - 176707733	5	177280731 - 177280732	211737	207197	rs797045824	NC_000005.10:177280731:C:CC
NM_022455.4(NSD1):c.5407_5410dup (p.Tyr1804Ter)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211736	5	176696704 - 176696705	5	177269703 - 177269704	211736	207196	rs797045823	NC_000005.10:177269703:TGACT:TGACTGACT
NM_022455.4(NSD1):c.5408_5411delACTAins9	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211735	5	176696707 - 176696710	5	177269706 - 177269709	211735	207195		
NM_022455.4(NSD1):c.4882_4883insAA (p.Met1628fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211734	5	176684067 - 176684068	5	177257066 - 177257067	211734	207194	rs797045821	NC_000005.10:177257066:A:AAA
NM_022455.4(NSD1):c.4732dup (p.Arg1578fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211733	5	176678819 - 176678820	5	177251818 - 177251819	211733	207193	rs797045820	NC_000005.10:177251818:AA:AAA
NM_022455.4(NSD1):c.4479_4488dup (p.Gly1497fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211732	5	176673777 - 176673778	5	177246776 - 177246777	211732	207192	rs797045819	NC_000005.10:177246776:AAGAGATTCCA:AAGAGATTCCAAGAGATTCCA
NM_022455.4(NSD1):c.4301dup (p.Cys1435fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211731	5	176666860 - 176666861	5	177239859 - 177239860	211731	207191	rs587784112	NC_000005.10:177239859:AAAAA:AAAAAA
NM_022455.4(NSD1):c.4282dup (p.Asp1428fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211730	5	176666841 - 176666842	5	177239840 - 177239841	211730	207190	rs797045817	NC_000005.10:177239840:GGGGG:GGGGGG
NM_022455.4(NSD1):c.4020del (p.Glu1341fs)	NSD1	E1072fs, E1341fs	Sotos syndrome 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000211729	5	176665335	5	177238334	211729	207189	rs797045816	NC_000005.10:177238333:AA:A
NM_022455.4(NSD1):c.3939dup (p.Glu1314fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211728	5	176665253 - 176665254	5	177238252 - 177238253	211728	207188	rs797045815	NC_000005.10:177238252:AA:AAA
NM_022455.4(NSD1):c.3578dup (p.Ser1193fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211727	5	176638977 - 176638978	5	177211976 - 177211977	211727	207187	rs797045814	NC_000005.10:177211976:G:GG
NM_022455.4(NSD1):c.3316dup (p.Ser1106fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211725	5	176638711 - 176638712	5	177211710 - 177211711	211725	207185	rs797045812	NC_000005.10:177211710:TTTTT:TTTTTT
NM_022455.4(NSD1):c.3260_3266del (p.Lys1087fs)	NSD1	K1087fs, K818fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211724	5	176638659 - 176638665	5	177211658 - 177211664	211724	207184	rs797045811	NC_000005.10:177211657:AAAGAGGA:A
NM_022455.4(NSD1):c.3146dup (p.Thr1050fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211723	5	176638543 - 176638544	5	177211542 - 177211543	211723	207183	rs797045810	NC_000005.10:177211542:AAA:AAAA
NM_022455.4(NSD1):c.2859dup (p.Lys954Ter)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211722	5	176638258 - 176638259	5	177211257 - 177211258	211722	207182	rs797045809	NC_000005.10:177211257:T:TT
NM_172349.2(NSD1):c.1383_1384delinsG (p.Ser462fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211721	5	176637590 - 176637591	5	177210589 - 177210590	211721	207181	rs797045808	NC_000005.10:177210588:CT:G
NM_022455.4(NSD1):c.2167dup (p.Thr723fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211720	5	176637565 - 176637566	5	177210564 - 177210565	211720	207180	rs797045807	NC_000005.10:177210564:AA:AAA
NM_022455.4(NSD1):c.1802dup (p.Cys602fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211718	5	176637199 - 176637200	5	177210198 - 177210199	211718	207178	rs797045805	NC_000005.10:177210198:AAA:AAAA
NM_022455.4(NSD1):c.1264dup (p.Glu422fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211717	5	176636661 - 176636662	5	177209660 - 177209661	211717	207177	rs797045804	NC_000005.10:177209660:GGG:GGGG
NM_022455.4(NSD1):c.(?_-138)_(7458_?)del	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	VCV000211716					211716	209314		
NM_022455.4(NSD1):c.1743del (p.Glu581fs)	NSD1	E312fs, E581fs	Sotos syndrome 1	Pathogenic(Last reviewed: Jan 3, 2014)	no assertion criteria provided	VCV000202207	5	176637142	5	177210141	202207	198625	rs794729232	NC_000005.10:177210140:AA:A
NM_022455.4(NSD1):c.8043del (p.Asn2682fs)	NSD1	N2413fs, N2682fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159447	5	176722411	5	177295410	159447	168297	rs587784221	NC_000005.10:177295409:TT:T
NM_022455.4(NSD1):c.8036del (p.Pro2679fs)	NSD1	P2679fs, P2410fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159446	5	176722404	5	177295403	159446	168296	rs587784220	NC_000005.10:177295402:CC:C
NM_172349.2(NSD1):c.7130_7131CA[1] (p.Gln2378fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159445	5	176722306 - 176722307	5	177295305 - 177295306	159445	168295	rs587784219	NC_000005.10:177295304:CACA:CA
NM_022455.4(NSD1):c.6656G>A (p.Arg2219His)	NSD1	R2219H, R1950H	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159436	5	176721025	5	177294024	159436	168288	rs587784214	NC_000005.10:177294023:G:A
NM_022455.4(NSD1):c.6604T>A (p.Cys2202Ser)	NSD1	C2202S, C1933S	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159432	5	176720973	5	177293972	159432	168284	rs587784210	NC_000005.10:177293971:T:A
NM_022455.4(NSD1):c.6559C>T (p.Arg2187Ter)	NSD1	R2187*, R1918*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159431	5	176720928	5	177293927	159431	168283	rs587784209	NC_000005.10:177293926:C:T
NM_022455.4(NSD1):c.6539_6557del (p.Ser2180fs)	NSD1	S1911fs, S2180fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159429	5	176720906 - 176720924	5	177293905 - 177293923	159429	168281	rs587784207	NC_000005.10:177293904:CAGCTCCTTTTGTAAGCAGCA:CA
NM_022455.4(NSD1):c.6476G>A (p.Cys2159Tyr)	NSD1	C2159Y, C1890Y	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159424	5	176720845	5	177293844	159424	168276	rs587784202	NC_000005.10:177293843:G:A
NM_022455.4(NSD1):c.6472G>T (p.Glu2158Ter)	NSD1	E2158*, E1889*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159423	5	176720841	5	177293840	159423	168275	rs587784201	NC_000005.10:177293839:G:T
NM_022455.4(NSD1):c.6455G>A (p.Arg2152Gln)	NSD1	R2152Q, R1883Q	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159422	5	176719151	5	177292150	159422	168274	rs587784200	NC_000005.10:177292149:G:A
NM_022455.4(NSD1):c.6431del (p.Ala2144fs)	NSD1	A2144fs, A1875fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159420	5	176719127	5	177292126	159420	168272	rs587784198	NC_000005.10:177292125:C:
NM_022455.4(NSD1):c.6377A>T (p.Asp2126Val)	NSD1	D2126V, D1857V	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159415	5	176719073	5	177292072	159415	168267	rs587784193	NC_000005.10:177292071:A:T
NM_022455.4(NSD1):c.6366del (p.Phe2122fs)	NSD1	F2122fs, F1853fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159414	5	176719059	5	177292058	159414	168266	rs587784192	NC_000005.10:177292057:TTTT:TTT
NM_022455.4(NSD1):c.6311_6312del (p.Gln2104fs)	NSD1	Q1835fs, Q2104fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159411	5	176719007 - 176719008	5	177292006 - 177292007	159411	168263	rs587784189	NC_000005.10:177292005:AG:
NM_022455.4(NSD1):c.6310C>T (p.Gln2104Ter)	NSD1	Q2104*, Q1835*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159410	5	176719006	5	177292005	159410	168262	rs587784188	NC_000005.10:177292004:C:T
NM_022455.4(NSD1):c.6307C>T (p.Gln2103Ter)	NSD1	Q2103*, Q1834*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159409	5	176719003	5	177292002	159409	168261	rs587784187	NC_000005.10:177292001:C:T
NM_022455.4(NSD1):c.6291del (p.Lys2098fs)	NSD1	K2098fs, K1829fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159408	5	176718987	5	177291986	159408	168260	rs587784186	NC_000005.10:177291985:G:
NM_022455.4(NSD1):c.6258+1G>A	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159406	5	176715927	5	177288926	159406	168258	rs587784185	NC_000005.10:177288925:G:A
NM_022455.4(NSD1):c.6165del (p.Phe2056fs)	NSD1	F1787fs, F2056fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159405	5	176715832	5	177288831	159405	168257	rs587784184	NC_000005.10:177288830:CC:C
NM_022455.4(NSD1):c.6157G>T (p.Glu2053Ter)	NSD1	E2053*, E1784*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159404	5	176715825	5	177288824	159404	168256	rs587784183	NC_000005.10:177288823:G:T
NM_022455.4(NSD1):c.6059A>G (p.Asn2020Ser)	NSD1	N2020S, N1751S	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159399	5	176710837	5	177283836	159399	168251	rs587784178	NC_000005.10:177283835:A:G
NM_022455.4(NSD1):c.5938G>T (p.Glu1980Ter)	NSD1	E1980*, E1711*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159389	5	176709511	5	177282510	159389	168241	rs587784168	NC_000005.10:177282509:G:T
NM_022455.4(NSD1):c.5911del (p.Tyr1971fs)	NSD1	Y1702fs, Y1971fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159386	5	176709484	5	177282483	159386	168238	rs587784165	NC_000005.10:177282482:T:
NM_022455.4(NSD1):c.5903del (p.Val1968fs)	NSD1	V1968fs, V1699fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159385	5	176709476	5	177282475	159385	168237	rs587784164	NC_000005.10:177282474:T:
NM_022455.4(NSD1):c.5893-2A>G	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159384	5	176709464	5	177282463	159384	168236	rs587784163	NC_000005.10:177282462:A:G
NM_022455.4(NSD1):c.5862G>C (p.Trp1954Cys)	NSD1	W1954C, W1685C	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159381	5	176707805	5	177280804	159381	168233	rs587784160	NC_000005.10:177280803:G:C
NM_022455.4(NSD1):c.5805C>A (p.Cys1935Ter)	NSD1	C1935*, C1666*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159379	5	176707748	5	177280747	159379	168231	rs587784158	NC_000005.10:177280746:C:A
NM_022455.4(NSD1):c.5800C>T (p.Gln1934Ter)	NSD1	Q1934*, Q1665*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159378	5	176707743	5	177280742	159378	168230	rs587784157	NC_000005.10:177280741:C:T
NM_022455.4(NSD1):c.5712del (p.Cys1905fs)	NSD1	C1636fs, C1905fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159374	5	176707652	5	177280651	159374	168226	rs587784153	NC_000005.10:177280650:CCCC:CCC
NM_022455.4(NSD1):c.5566C>T (p.Gln1856Ter)	NSD1	Q1856*, Q1587*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159372	5	176700729	5	177273728	159372	168224	rs587784151	NC_000005.10:177273727:C:T
NM_022455.4(NSD1):c.5432G>A (p.Arg1811Gln)	NSD1	R1811Q, R1542Q	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159370	5	176696731	5	177269730	159370	168222	rs587784149	NC_000005.10:177269729:G:A
NM_022455.4(NSD1):c.5425C>T (p.Gln1809Ter)	NSD1	Q1809*, Q1540*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159368	5	176696724	5	177269723	159368	168220	rs587784147	NC_000005.10:177269722:C:T
NM_022455.4(NSD1):c.5392_5398del (p.Phe1798fs)	NSD1	F1798fs, F1529fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159366	5	176696691 - 176696697	5	177269690 - 177269696	159366	168218	rs587784145	NC_000005.10:177269689:TTTTTTG:
NM_022455.4(NSD1):c.5375G>A (p.Gly1792Glu)	NSD1	G1792E, G1523E	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159364	5	176696674	5	177269673	159364	168216	rs587784143	NC_000005.10:177269672:G:A
NM_022455.4(NSD1):c.5146+1G>A	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159360	5	176687170	5	177260169	159360	168212	rs587784139	NC_000005.10:177260168:G:A
NM_022455.4(NSD1):c.5141C>G (p.Ser1714Ter)	NSD1	S1714*, S1445*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159359	5	176687164	5	177260163	159359	168211	rs587784138	NC_000005.10:177260162:C:G
NM_022455.4(NSD1):c.4987C>T (p.Arg1663Cys)	NSD1	R1663C, R1394C	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159355	5	176687010	5	177260009	159355	168207	rs587784134	NC_000005.10:177260008:C:T
NM_022455.4(NSD1):c.4967-2A>T	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159354	5	176686988	5	177259987	159354	168206	rs587784133	NC_000005.10:177259986:A:T
NM_022455.4(NSD1):c.4966G>T (p.Gly1656Cys)	NSD1	G1656C, G1387C	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159353	5	176684152	5	177257151	159353	168203	rs587784132	NC_000005.10:177257150:G:T
NM_022455.4(NSD1):c.4966+1G>A	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159352	5	176684153	5	177257152	159352	168204	rs587784131	NC_000005.10:177257151:G:A
NM_022455.4(NSD1):c.4907C>T (p.Ser1636Phe)	NSD1	S1636F, S1367F	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159350	5	176684093	5	177257092	159350	168202	rs587784129	NC_000005.10:177257091:C:T
NM_022455.4(NSD1):c.4855T>G (p.Cys1619Gly)	NSD1	C1619G, C1350G	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159348	5	176684041	5	177257040	159348	168200	rs587784128	NC_000005.10:177257039:T:G
NM_022455.4(NSD1):c.4855T>A (p.Cys1619Ser)	NSD1	C1619S, C1350S	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159347	5	176684041	5	177257040	159347	168199	rs587784128	NC_000005.10:177257039:T:A
NM_022455.4(NSD1):c.4745del (p.Ile1582fs)	NSD1	I1582fs, I1313fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159343	5	176678834	5	177251833	159343	168195	rs587784125	NC_000005.10:177251832:T:
NM_022455.4(NSD1):c.4731_4732del (p.Gly1579fs)	NSD1	G1310fs, G1579fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159342	5	176678820 - 176678821	5	177251819 - 177251820	159342	168194	rs587784124	NC_000005.10:177251818:AA:
NM_022455.4(NSD1):c.4705del (p.Glu1569fs)	NSD1	E1300fs, E1569fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159341	5	176678793	5	177251792	159341	168193	rs587784123	NC_000005.10:177251791:GG:G
NM_022455.4(NSD1):c.4681C>T (p.Gln1561Ter)	NSD1	Q1561*, Q1292*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159340	5	176678770	5	177251769	159340	168192	rs587784122	NC_000005.10:177251768:C:T
NM_022455.4(NSD1):c.4529del (p.Ser1510fs)	NSD1	S1241fs, S1510fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159336	5	176675213	5	177248212	159336	168188	rs587784121	NC_000005.10:177248211:G:
NM_022455.4(NSD1):c.4498-3A>G	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159334	5	176675179	5	177248178	159334	168186	rs587784120	NC_000005.10:177248177:A:G
NM_022455.4(NSD1):c.4493C>G (p.Ser1498Ter)	NSD1	S1498*, S1229*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159333	5	176673793	5	177246792	159333	168185	rs587784119	NC_000005.10:177246791:C:G
NM_022455.4(NSD1):c.4444C>T (p.Gln1482Ter)	NSD1	Q1482*, Q1213*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159332	5	176673744	5	177246743	159332	168184	rs587784118	NC_000005.10:177246742:C:T
NM_022455.4(NSD1):c.4376del (p.Gly1459fs)	NSD1	G1190fs, G1459fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159327	5	176671268	5	177244267	159327	168179	rs587784114	NC_000005.10:177244266:GG:G
NM_022455.4(NSD1):c.4192+2T>G	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159323	5	176665510	5	177238509	159323	168175	rs587784111	NC_000005.10:177238508:T:G
NM_022455.4(NSD1):c.4076C>G (p.Ser1359Ter)	NSD1	S1359*, S1090*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159322	5	176665392	5	177238391	159322	168174	rs587784110	NC_000005.10:177238390:C:G
NM_022455.4(NSD1):c.4057G>T (p.Glu1353Ter)	NSD1	E1353*, E1084*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159320	5	176665373	5	177238372	159320	168172	rs587784109	NC_000005.10:177238371:G:T
NM_022455.4(NSD1):c.3578_3582del (p.Ser1193fs)	NSD1	S1193fs, S924fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159311	5	176638978 - 176638982	5	177211977 - 177211981	159311	168164	rs587784103	NC_000005.10:177211976:GTGAC:
NM_172349.2(NSD1):c.2572_2573CT[2] (p.Ser859fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159307	5	176638779 - 176638780	5	177211778 - 177211779	159307	168162	rs587784101	NC_000005.10:177211777:CTCTCT:CTCT
NM_022455.4(NSD1):c.3295del (p.Ser1099fs)	NSD1	S1099fs, S830fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159306	5	176638694	5	177211693	159306	168161	rs587784100	NC_000005.10:177211692:AA:A
NM_022455.4(NSD1):c.3293del (p.Thr1098fs)	NSD1	T1098fs, T829fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159305	5	176638693	5	177211692	159305	168160	rs587784099	NC_000005.10:177211691:C:
NM_172349.2(NSD1):c.2376_2377TG[1] (p.Val793fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159302	5	176638582 - 176638583	5	177211581 - 177211582	159302	168157	rs587784097	NC_000005.10:177211580:GTGTG:GTG
NM_172349.2(NSD1):c.2237_2238GT[1] (p.Val747fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159297	5	176638443 - 176638444	5	177211442 - 177211443	159297	168152	rs587784094	NC_000005.10:177211441:TGTGT:TGT
NM_022455.4(NSD1):c.2956del (p.Ala986fs)	NSD1	A986fs, A717fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159295	5	176638356	5	177211355	159295	168150	rs587784093	NC_000005.10:177211354:G:
NM_022455.4(NSD1):c.2827del (p.Asp943fs)	NSD1	D943fs, D674fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159291	5	176638224	5	177211223	159291	168146	rs587784089	NC_000005.10:177211222:GGGG:GGG
NM_022455.4(NSD1):c.2654C>A (p.Ser885Ter)	NSD1	S885*, S616*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159289	5	176638054	5	177211053	159289	168144	rs587784088	NC_000005.10:177211052:C:A
NM_022455.4(NSD1):c.2639del (p.Gly880fs)	NSD1	G880fs, G611fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159288	5	176638038	5	177211037	159288	168143	rs587784087	NC_000005.10:177211036:GG:G
NM_022455.4(NSD1):c.2339C>A (p.Ser780Ter)	NSD1	S780*, S511*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159286	5	176637739	5	177210738	159286	168141	rs201327209	NC_000005.10:177210737:C:A
NM_022455.4(NSD1):c.2295del (p.Ser766fs)	NSD1	S497fs, S766fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159285	5	176637695	5	177210694	159285	168140	rs587784085	NC_000005.10:177210693:C:
NM_022455.4(NSD1):c.2276C>G (p.Ser759Ter)	NSD1	S759*, S490*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159283	5	176637676	5	177210675	159283	168138	rs587784084	NC_000005.10:177210674:C:G
NM_022455.4(NSD1):c.2124_2127del (p.His708fs)	NSD1	H439fs, H708fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159280	5	176637521 - 176637524	5	177210520 - 177210523	159280	168135	rs587784082	NC_000005.10:177210519:ACATACA:ACA
NM_022455.4(NSD1):c.2064del (p.Arg688fs)	NSD1	R419fs, R688fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159278	5	176637463	5	177210462	159278	168133	rs587784081	NC_000005.10:177210461:GG:G
NM_022455.4(NSD1):c.2048del (p.Lys683fs)	NSD1	K414fs, K683fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159276	5	176637445	5	177210444	159276	168131	rs587784079	NC_000005.10:177210443:AAAA:AAA
NM_022455.4(NSD1):c.2014_2018del (p.Thr672fs)	NSD1	T672fs, T403fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159275	5	176637411 - 176637415	5	177210410 - 177210414	159275	168130	rs587784078	NC_000005.10:177210409:AGAACAGA:AGA
NM_022455.4(NSD1):c.1456del (p.Ser486fs)	NSD1	S217fs, S486fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159266	5	176636855	5	177209854	159266	168121	rs587784073	NC_000005.10:177209853:TT:T
NM_022455.4(NSD1):c.1262G>A (p.Trp421Ter)	NSD1	W421*, W152*	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159263	5	176636662	5	177209661	159263	168119	rs587784071	NC_000005.10:177209660:G:A
NM_022455.4(NSD1):c.1077del (p.Arg359fs)	NSD1	R359fs, R90fs	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159258	5	176631133	5	177204132	159258	168115	rs587784068	NC_000005.10:177204131:GG:G
NM_022455.4(NSD1):c.7968_7971del (p.Gln2656fs)	NSD1	Q2656fs, Q2387fs	Sotos syndrome 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000004145	5	176722334 - 176722337	5	177295333 - 177295336	4145	19184	rs1562312238	NC_000005.10:177295332:ACAGACA:ACA
NM_022455.4(NSD1):c.4977dup (p.Arg1660fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000004144	5	176686999 - 176687000	5	177259998 - 177259999	4144	19183	rs1562269320	NC_000005.10:177259998:G:GG
NM_022455.4(NSD1):c.896del (p.Ser299fs)	NSD1	S30fs, S299fs	Sotos syndrome 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004142	5	176563000	5	177135999	4142	19181	rs1562099585	NC_000005.10:177135998:C:
NM_022455.5(NSD1):c.4702del (p.Leu1568fs)	NSD1	L1299fs, L1568fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000864119	5	176678790	5	177251789	864119	830678		NC_000005.10:177251788:CC:C
NM_022455.5(NSD1):c.4216del (p.Arg1406fs)	NSD1	R1137fs, R1406fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000859995	5	176666778	5	177239777	859995	830676		NC_000005.10:177239776:AAA:AA
NM_022455.5(NSD1):c.6543del (p.Cys2183fs)	NSD1	C2183fs, C1914fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000859553	5	176720911	5	177293910	859553	830688		NC_000005.10:177293909:CC:C
NC_000005.10:g.(?_177288799)_(177288945_?)del	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000832417	5	176715800 - 176715946			832417	819575		
NM_172349.2(NSD1):c.1443_1444TC[3] (p.Pro484fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000665380	5	176637649 - 176637650	5	177210648 - 177210649	665380	633773		NC_000005.10:177210647:CTCTCTCTC:CTCTCTC
NM_022455.4(NSD1):c.1046_1048delinsT (p.Thr349fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000664693	5	176619003 - 176619005	5	177192002 - 177192004	664693	633764		NC_000005.10:177192001:CAC:T
NM_022455.4(NSD1):c.1760del (p.Gly587fs)	NSD1	G318fs, G587fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000663102	5	176637159	5	177210158	663102	633768		NC_000005.10:177210157:GG:G
NM_022455.4(NSD1):c.5849T>G (p.Leu1950Ter)	NSD1	L1950*, L1681*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000659145	5	176707792	5	177280791	659145	633785		NC_000005.10:177280790:T:G
NM_022455.4(NSD1):c.1492C>T (p.Arg498Ter)	NSD1	R498*, R229*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000646362	5	176636892	5	177209891	646362	633766		NC_000005.10:177209890:C:T
NM_022455.4(NSD1):c.4213C>T (p.Gln1405Ter)	NSD1	Q1405*, Q1136*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000643318	5	176666777	5	177239776	643318	633778		NC_000005.10:177239775:C:T
NC_000005.9:g.(?_176662802)_(176666886_?)del	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000583767	5	176662802 - 176666886	5	177235801 - 177239885	583767	559839		
NM_022455.4(NSD1):c.7690G>T (p.Glu2564Ter)	NSD1	E2564*, E2295*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000579858	5	176722059	5	177295058	579858	563076	rs749416834	NC_000005.10:177295057:G:T
NM_022455.4(NSD1):c.3570dup (p.Leu1191fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000578218	5	176638969 - 176638970	5	177211968 - 177211969	578218	563069	rs1562213553	NC_000005.10:177211968:A:AA
NM_022455.4(NSD1):c.207C>A (p.Tyr69Ter)	NSD1	Y69*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000575024	5	176562311	5	177135310	575024	563063	rs1562097849	NC_000005.10:177135309:C:A
NM_022455.4(NSD1):c.6152-5T>G	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000573155	5	176715815	5	177288814	573155	560277	rs755758018	NC_000005.10:177288813:T:G
NM_022455.4(NSD1):c.3513dup (p.Lys1172Ter)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000572874	5	176638912 - 176638913	5	177211911 - 177211912	572874	565037	rs1562213291	NC_000005.10:177211911:T:TT
NM_022455.4(NSD1):c.4932dup (p.Ala1645fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000567446	5	176684117 - 176684118	5	177257116 - 177257117	567446	565047	rs1562265336	NC_000005.10:177257116:T:TT
NM_172349.2(NSD1):c.702delinsGA (p.Asp235fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, single submitter	VCV000565855	5	176636909	5	177209908	565855	563065	rs1562205351	NC_000005.10:177209907:T:GA
NM_022455.4(NSD1):c.5724del (p.Ser1909fs)	NSD1	S1640fs, S1909fs	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561070	5	176707667	5	177280666	561070	552087	rs1562292879	NC_000005.10:177280665:C:
NM_022455.4(NSD1):c.4302+1G>A	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561069	5	176666867	5	177239866	561069	552086	rs1562246533	NC_000005.10:177239865:G:A
NM_022455.4(NSD1):c.5437_5440del (p.Phe1813fs)	NSD1	F1813fs, F1544fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000524706	5	176696735 - 176696738	5	177269734 - 177269737	524706	521579	rs1554202205	NC_000005.10:177269733:CTTCC:C
NM_022455.4(NSD1):c.3868del (p.Gln1290fs)	NSD1	Q1021fs, Q1290fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000524705	5	176662893	5	177235892	524705	521330	rs1554195302	NC_000005.10:177235891:C:
NM_022455.4(NSD1):c.983G>A (p.Trp328Ter)	NSD1	W328*, W59*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000524691	5	176618940	5	177191939	524691	521570	rs1554185405	NC_000005.10:177191938:G:A
NM_022455.4(NSD1):c.6020_6021dup (p.Asp2008fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000454057	5	176710797 - 176710798	5	177283796 - 177283797	454057	455440	rs1554204923	NC_000005.10:177283796:TT:TTTT
NM_022455.4(NSD1):c.5177C>G (p.Pro1726Arg)	NSD1	P1726R, P1457R	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000454055	5	176694593	5	177267592	454055	455436	rs1554201713	NC_000005.10:177267591:C:G
NM_022455.4(NSD1):c.3968_3969dup (p.Ser1324fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000454050	5	176665282 - 176665283	5	177238281 - 177238282	454050	455690	rs1554195840	NC_000005.10:177238281:TCT:TCTCT
NM_022455.4(NSD1):c.3422del (p.Met1141fs)	NSD1	M1141fs, M872fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	VCV000454049	5	176638822	5	177211821	454049	454958	rs1554190247	NC_000005.10:177211820:T:
NM_022455.4(NSD1):c.3386_3387del (p.Ser1128_Phe1129insTer)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000454048	5	176638784 - 176638785	5	177211783 - 177211784	454048	454844	rs1554190214	NC_000005.10:177211782:TTTT:TT
NM_022455.4(NSD1):c.1816A>T (p.Lys606Ter)	NSD1	K606*, K337*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000454044	5	176637216	5	177210215	454044	455685	rs1554189131	NC_000005.10:177210214:A:T
Single allele	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000453988			5	177280545 - 177283948	453988	453624		
NM_022455.4(NSD1):c.1654del (p.Ser552fs)	NSD1	S283fs, S552fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000407367	5	176637052	5	177210051	407367	394933	rs1060501497	NC_000005.10:177210050:TTT:TT
NM_022455.4(NSD1):c.6487C>T (p.Gln2163Ter)	NSD1	Q2163*, Q1894*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 17, 2016)	criteria provided, single submitter	VCV000407364	5	176720856	5	177293855	407364	395141	rs1060501494	NC_000005.10:177293854:C:T
NM_022455.4(NSD1):c.6426C>G (p.Tyr2142Ter)	NSD1	Y2142*, Y1873*	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000407363	5	176719122	5	177292121	407363	394967	rs1060501493	NC_000005.10:177292120:C:G
NM_022455.4(NSD1):c.880_881del (p.Glu294fs)	NSD1	E25fs, E294fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000407362	5	176562983 - 176562984	5	177135982 - 177135983	407362	394921	rs1060501492	NC_000005.10:177135981:AGA:A
NM_022455.4(NSD1):c.2619_2623del (p.Glu874fs)	NSD1	E605fs, E874fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000407360	5	176638016 - 176638020	5	177211015 - 177211019	407360	394936	rs1060501490	NC_000005.10:177211014:AGGTGAGG:AGG
NM_022455.4(NSD1):c.2316_2329dup (p.Leu777fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000407358	5	176637714 - 176637715	5	177210713 - 177210714	407358	394847	rs1554189490	NC_000005.10:177210713:CAGCAAATCAAGCTC:CAGCAAATCAAGCTCAGCAAATCAAGCTC
NM_022455.4(NSD1):c.5994del (p.Met1998fs)	NSD1	M1729fs, M1998fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000241436	5	176709567	5	177282566	241436	239791	rs878855077	NC_000005.10:177282565:G:
NM_022455.4(NSD1):c.3548_3549insGA (p.Glu1184fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000241434	5	176638948 - 176638949	5	177211947 - 177211948	241434	239789	rs878855075	NC_000005.10:177211947::GA
NM_022455.4(NSD1):c.7966C>T (p.Gln2656Ter)	NSD1	Q2656*, Q2387*	Sotos syndrome 1	Pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000209176	5	176722335	5	177295334	209176	205744	rs797045058	NC_000005.10:177295333:C:T
NM_022455.4(NSD1):c.4817G>A (p.Cys1606Tyr)	NSD1	C1606Y, C1337Y	Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159345	5	176684003	5	177257002	159345	168197	rs587784127	NC_000005.10:177257001:G:A
NM_022455.4(NSD1):c.6450dup (p.Lys2151fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000004141	5	176719144 - 176719145	5	177292143 - 177292144	4141	19180	rs864309639	NC_000005.10:177292143:CC:CCC
NM_022455.4(NSD1):c.6548G>C (p.Cys2183Ser)	NSD1	C2183S, C1914S	Sotos syndrome 1	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000004140	5	176720917	5	177293916	4140	19179	rs121908069	NC_000005.10:177293915:G:C
NM_022455.4(NSD1):c.6429C>G (p.His2143Gln)	NSD1	H2143Q, H1874Q	Sotos syndrome 1	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000004139	5	176719125	5	177292124	4139	19178	rs121908068	NC_000005.10:177292123:C:G
NM_022455.4(NSD1):c.6151+1G>A	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000004138	5	176710930	5	177283929	4138	19177	rs1562296511	NC_000005.10:177283928:G:A
NM_022455.4(NSD1):c.5997_5998insT (p.Thr2000fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000004137	5	176709570 - 176709571	5	177282569 - 177282570	4137	19176	rs1562295135	NC_000005.10:177282569::T
NM_022455.4(NSD1):c.3536del (p.Glu1179fs)	NSD1	E910fs, E1179fs	Sotos syndrome 1	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000004136	5	176638936	5	177211935	4136	19175	rs1562213381	NC_000005.10:177211934:A:
NM_022455.4(NSD1):c.1310C>G (p.Ser437Ter)	NSD1	S437*, S168*	Sotos syndrome 1	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000004135	5	176636710	5	177209709	4135	19174	rs121908067	NC_000005.10:177209708:C:G
NM_022455.4(NSD1):c.4378+3_4378+6del	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000565696	5	176671272 - 176671275	5	177244271 - 177244274	565696	560386	rs1562251194	NC_000005.10:177244270:GTGAGT:GT
NM_022455.4(NSD1):c.2334dup (p.His779fs)	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000524715	5	176637733 - 176637734	5	177210732 - 177210733	524715	521578	rs1554189512	NC_000005.10:177210732:A:AA
NM_172349.2(NSD1):c.2197_2198del (p.Lys733fs)	NSD1	K1002fs, K733fs	not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000436061	5	176638404 - 176638405	5	177211403 - 177211404	436061	428385	rs1554189941	NC_000005.10:177211402:AA:
NM_022455.4(NSD1):c.5854C>T (p.Arg1952Trp)	NSD1	R1952W, R1683W	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000279858	5	176707797	5	177280796	279858	264188	rs886041219	NC_000005.10:177280795:C:T
NM_022455.4(NSD1):c.6537dup (p.Ser2180fs)	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243070	5	176720902 - 176720903	5	177293901 - 177293902	243070	244157	rs879253860	NC_000005.10:177293901:CCCC:CCCCC
NM_022455.4(NSD1):c.3549dup (p.Glu1184Ter)	NSD1		not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211726	5	176638948 - 176638949	5	177211947 - 177211948	211726	207186	rs797045813	NC_000005.10:177211947:T:TT
NM_022455.4(NSD1):c.5950C>T (p.Arg1984Ter)	NSD1	R1984*, R1715*	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2014)	criteria provided, single submitter	VCV000209175	5	176709523	5	177282522	209175	205743	rs797045057	NC_000005.10:177282521:C:T
NM_172349.2(NSD1):c.5714_5716del (p.Phe1905del)	NSD1	F2174del, F1905del	not provided|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159428	5	176720888 - 176720890	5	177293887 - 177293889	159428	168280	rs587784206	NC_000005.10:177293886:CTTCT:CT
NM_172349.2(NSD1):c.5614del (p.Val1872fs)	NSD1	V1872fs, V2141fs	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159419	5	176719117	5	177292116	159419	168271	rs587784197	NC_000005.10:177292115:G:
NM_022455.4(NSD1):c.6070C>T (p.Gln2024Ter)	NSD1	Q2024*, Q1755*	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159400	5	176710848	5	177283847	159400	168252	rs587784179	NC_000005.10:177283846:C:T
NM_022455.4(NSD1):c.5989T>C (p.Tyr1997His)	NSD1	Y1997H, Y1728H	Sotos syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159392	5	176709562	5	177282561	159392	168244	rs587784171	NC_000005.10:177282560:T:C
NM_022455.4(NSD1):c.5740C>T (p.Arg1914Cys)	NSD1	R1914C, R1645C	not provided|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159375	5	176707683	5	177280682	159375	168227	rs587784154	NC_000005.10:177280681:C:T
NM_172349.2(NSD1):c.4809_4810TA[1] (p.Ile1604fs)	NSD1		not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, multiple submitters, no conflicts	VCV000159373	5	176700778 - 176700779	5	177273777 - 177273778	159373	168225	rs587784152	NC_000005.10:177273776:ATATA:ATA
NM_022455.4(NSD1):c.5309G>A (p.Trp1770Ter)	NSD1	W1770*, W1501*	not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159363	5	176696608	5	177269607	159363	168215	rs587784142	NC_000005.10:177269606:G:A
NM_022455.4(NSD1):c.4753G>T (p.Glu1585Ter)	NSD1	E1585*, E1316*	not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159344	5	176678842	5	177251841	159344	168196	rs587784126	NC_000005.10:177251840:G:T
NM_172349.2(NSD1):c.3494del (p.Lys1165fs)	NSD1	K1165fs, K1434fs	not provided|Sotos syndrome 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159324	5	176666861	5	177239860	159324	168176	rs587784112	NC_000005.10:177239859:AAAAA:AAAA
NM_022455.4(NSD1):c.3091C>T (p.Arg1031Ter)	NSD1	R1031*, R762*	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Apr 11, 2015)	criteria provided, multiple submitters, no conflicts	VCV000159300	5	176638491	5	177211490	159300	168155	rs587784096	NC_000005.10:177211489:C:T
NM_172349.2(NSD1):c.2145_2146CT[1] (p.Ser716fs)	NSD1		Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159294	5	176638352 - 176638353	5	177211351 - 177211352	159294	168149	rs587784092	NC_000005.10:177211350:CTCT:CT
NM_172349.2(NSD1):c.4472_4475del (p.Val1491fs)	NSD1	V1760fs, V1491fs	not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Jun 11, 2013)	criteria provided, multiple submitters, no conflicts	VCV000096062	5	176694693 - 176694696	5	177267692 - 177267695	96062	101956	rs398124379	NC_000005.10:177267691:TGTCTG:TG
NSD1, 1.9-MB DEL	NSD1		Sotos syndrome 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000004134					4134	19173		
NM_004321.7(KIF1A):c.1187dup (p.Asn396fs)	KIF1A		Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807620	2	241710514 - 241710515	2	240771097 - 240771098	807620	798507		NC_000002.12:240771097:TT:TTT
NM_004321.7(KIF1A):c.595G>A (p.Gly199Arg)	KIF1A	G199R	not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000449043	2	241725765	2	240786348	449043	443215	rs1553638614	NC_000002.12:240786347:C:T
NM_004321.7(KIF1A):c.308A>C (p.Lys103Thr)	KIF1A	K103T	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000432272	2	241727523	2	240788106	432272	425481	rs1553639011	NC_000002.12:240788105:T:G
NM_004321.7(KIF1A):c.222_223insGAC (p.Arg75_Asp76insAsp)	KIF1A		not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000422856	2	241727608 - 241727609	2	240788191 - 240788192	422856	405687	rs1064796046	NC_000002.12:240788191:GT:GTCGT
NM_004321.7(KIF1A):c.761G>C (p.Arg254Pro)	KIF1A	R254P	not provided	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000392042	2	241723193	2	240783776	392042	367146	rs886041692	NC_000002.12:240783775:C:G
NM_004321.7(KIF1A):c.1040A>G (p.Tyr347Cys)	KIF1A	Y347C	not provided	Pathogenic(Last reviewed: Sep 20, 2015)	criteria provided, single submitter	VCV000245928	2	241712671	2	240773254	245928	244359	rs879254004	NC_000002.12:240773253:T:C
NM_004321.7(KIF1A):c.650C>G (p.Ser217Cys)	KIF1A	S217C	not provided	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000234758	2	241724476	2	240785059	234758	231516	rs876661202	NC_000002.12:240785058:G:C
NM_004321.7(KIF1A):c.512A>C (p.His171Pro)	KIF1A	H171P	not provided	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000234716	2	241725848	2	240786431	234716	231519	rs876661180	NC_000002.12:240786430:T:G
NM_004321.7(KIF1A):c.506G>A (p.Arg169Lys)	KIF1A	R169K	not provided	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	VCV000234697	2	241725854	2	240786437	234697	231525	rs876661168	NC_000002.12:240786436:C:T
NM_004321.7(KIF1A):c.265T>G (p.Tyr89Asp)	KIF1A	Y89D	Mental retardation, autosomal dominant 9	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224157	2	241727566	2	240788149	224157	225885	rs869312711	NC_000002.12:240788148:A:C
NC_000002.12:g.240797746del	KIF1A	A4fs	Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000850864	2	241737160	2	240797743	850864	826106		NC_000002.12:240797742:CCCC:CCC
NC_000002.12:g.(?_240717364)_(240797752_?)del	KIF1A		Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000832086	2	241656781 - 241737169			832086	819147		
NM_004321.7(KIF1A):c.4678C>T (p.Gln1560Ter)	KIF1A	Q1560*, Q1594*, Q1578*, Q1569*, Q1661*	Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Mental retardation, autosomal dominant 9	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000664959	2	241659231	2	240719814	664959	629704		NC_000002.12:240719813:G:A
NM_004321.7(KIF1A):c.3523C>T (p.Arg1175Ter)	KIF1A	R1175*, R1276*, R1184*, R1209*	Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000576241	2	241679550	2	240740133	576241	558320	rs368078424	NC_000002.12:240740132:G:A
NM_004321.7(KIF1A):c.1927C>T (p.Gln643Ter)	KIF1A	Q643*, Q652*, Q677*	Spastic paraplegia 30, autosomal recessive|Mental retardation, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000568993	2	241702504	2	240763087	568993	561233	rs748477031	NC_000002.12:240763086:G:A
NM_004321.7(KIF1A):c.4968dup (p.Ser1657fs)	KIF1A		Hereditary sensory and autonomic neuropathy type IIA	Pathogenic(Last reviewed: Nov 23, 2010)	no assertion criteria provided	VCV000065875	2	241657528 - 241657529	2	240718111 - 240718112	65875	76783	rs587778798	NC_000002.12:240718111:GG:GGG
KIF1A, 1-BP DUP, 5271C	KIF1A		Hereditary sensory and autonomic neuropathy type IIC	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030168					30168	39124		
KIF1A, 1-BP DEL, 2840T	KIF1A		Hereditary sensory and autonomic neuropathy type IIC	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030167					30167	39123		
NM_004321.7(KIF1A):c.773C>T (p.Thr258Met)	KIF1A	T258M	Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000464261	2	241723181	2	240783764	464261	450732	rs1553638086	NC_000002.12:240783763:G:A
NM_004321.7(KIF1A):c.1048C>G (p.Arg350Gly)	KIF1A	R350G	Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Sep 29, 2014)	no assertion criteria provided	VCV000037004	2	241712663	2	240773246	37004	45670	rs387907259	NC_000002.12:240773245:G:C
NM_000030.3(AGXT):c.697C>T (p.Arg233Cys)	AGXT	R233C	Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005647	2	241814542	2	240875125	5647	20686	rs121908526	NC_000002.12:240875124:C:T
NM_001080522.2(CC2D2A):c.3289delG	CC2D2A		not provided|Meckel syndrome type 6|Joubert syndrome 9|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056303	4	15569299	4	15567676	56303	70942	rs386833751	NC_000004.12:15567675:GG:G
NM_022455.5(NSD1):c.4847A>G (p.His1616Arg)	NSD1	H1347R, H1616R	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000840198	5	176684033	5	177257032	840198	830679		NC_000005.10:177257031:A:G
NM_022455.4(NSD1):c.5020del (p.Cys1674fs)	NSD1	C1405fs, C1674fs	Beckwith-Wiedemann syndrome|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000657642	5	176687040	5	177260039	657642	633782		NC_000005.10:177260038:TTTT:TTT
NM_022455.4(NSD1):c.1854del (p.Lys618_Val619insTer)	NSD1		Sotos syndrome 1|Acute myeloid leukemia	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000620071	5	176637251	5	177210250	620071	611388	rs1562206791	NC_000005.10:177210249:AAAA:AAA
NM_022455.4(NSD1):c.6317del (p.Lys2106fs)	NSD1	K1837fs, K2106fs	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000566324	5	176719011	5	177292010	566324	565048	rs1562305497	NC_000005.10:177292009:AAA:AA
NM_022455.4(NSD1):c.6437G>A (p.Cys2146Tyr)	NSD1	C2146Y, C1877Y	Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000524707	5	176719133	5	177292132	524707	521446	rs1554206834	NC_000005.10:177292131:G:A
NM_022455.4(NSD1):c.2362C>T (p.Arg788Ter)	NSD1	R788*, R519*	Beckwith-Wiedemann syndrome|not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000378304	5	176637762	5	177210761	378304	368565	rs1057520339	NC_000005.10:177210760:C:T
NM_004321.7(KIF1A):c.2323C>T (p.Arg775Ter)	KIF1A	R809*, R784*, R775*	not provided|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Mental retardation, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000665003	2	241700176	2	240760759	665003	629727		NC_000002.12:240760758:G:A
NM_004321.7(KIF1A):c.914C>T (p.Pro305Leu)	KIF1A	P305L	Mental retardation, autosomal dominant 9|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428604	2	241715312	2	240775895	428604	420290	rs1131690804	NC_000002.12:240775894:G:A
NM_004321.7(KIF1A):c.643A>C (p.Ser215Arg)	KIF1A	S215R	Mental retardation, autosomal dominant 9	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000162057	2	241724483	2	240785066	162057	171775	rs672601367	NC_000002.12:240785065:T:G
NM_004321.7(KIF1A):c.604G>C (p.Ala202Pro)	KIF1A	A202P	Mental retardation, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2016)	no assertion criteria provided	VCV000162056	2	241725756	2	240786339	162056	171776	rs672601366	NC_000002.12:240786338:C:G
NM_004321.7(KIF1A):c.764C>T (p.Ala255Val)	KIF1A	A255V	Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000030166	2	241723190	2	240783773	30166	39122	rs387906798	NC_000002.12:240783772:G:A
NM_133433.4(NIPBL):c.2479_2480del (p.Arg827fs)	NIPBL	R827fs	not provided|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096336	5	36985761 - 36985762	5	36985659 - 36985660	96336	102230	rs398124465	NC_000005.10:36985658:AG:
NM_004321.7(KIF1A):c.304G>A (p.Gly102Ser)	KIF1A	G102S	Spastic paraplegia 30, autosomal recessive|Mental retardation, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422067	2	241727527	2	240788110	422067	405686	rs1064795534	NC_000002.12:240788109:C:T
NM_004321.7(KIF1A):c.761G>A (p.Arg254Gln)	KIF1A	R254Q	Mental retardation, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|not provided	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280500	2	241723193	2	240783776	280500	264094	rs886041692	NC_000002.12:240783775:C:T
NM_004321.7(KIF1A):c.2555+1023del	KIF1A	L947fs	Hereditary sensory and autonomic neuropathy type IIA|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000065859	2	241696754	2	240757337	65859	76767	rs587778791	NC_000002.12:240757336:A:
NM_000539.3(RHO):c.68C>A (p.Pro23His)	RHO	P23H	not provided|Retinitis pigmentosa 4|Retinal dystrophy|Retinitis pigmentosa 4|Congenital stationary night blindness, autosomal dominant 1|Pigmentary retinal dystrophy	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013013	3	129247644	3	129528801	13013	28052	rs104893768	NC_000003.12:129528800:C:A
NM_013334.3(GMPPB):c.553C>T (p.Arg185Cys)	GMPPB	R185C	Inborn genetic diseases|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000060543	3	49760037	3	49722604	60543	75124	rs397509425	NC_000003.12:49722603:G:A
NC_000005.9:g.(?_176562095)_(176722470_?)del	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000652389	5	176562095 - 176722470	5	177135094 - 177295469	652389	651238		
Single allele	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000453987			5	177135084 - 177295479	453987	454419		
NM_022455.4(NSD1):c.5098C>T (p.Arg1700Ter)	NSD1	R1700*, R1431*	Sotos syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159358	5	176687121	5	177260120	159358	168210	rs587784137	NC_000005.10:177260119:C:T
NM_022455.4(NSD1):c.3839G>A (p.Trp1280Ter)	NSD1	W1280*, W1011*	Disproportionate tall stature|Scoliosis|Cognitive impairment|Overfolding of the superior helices|Cleft palate|Cryptorchidism|Pectus carinatum|Hypermetropia|Highly arched eyebrow|Seizures|Patent foramen ovale|Prominent supraorbital ridges|Talipes valgus|Autistic disorder of childhood onset|Midface retrusion|Chronic lung disease|Hypertelorism|Cleft uvula|Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000159315	5	176662864	5	177235863	159315	168168	rs587784105	NC_000005.10:177235862:G:A
NM_022455.4(NSD1):c.3214C>T (p.Arg1072Ter)	NSD1	R1072*, R803*	not provided|Sotos syndrome 1	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159303	5	176638614	5	177211613	159303	168158	rs587784098	NC_000005.10:177211612:C:T
NM_022455.4(NSD1):c.3958C>T (p.Arg1320Ter)	NSD1	R1320*, R1051*	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004143	5	176665274	5	177238273	4143	19182	rs121908070	NC_000005.10:177238272:C:T
NM_004321.7(KIF1A):c.173C>T (p.Ser58Leu)	KIF1A	S58L	Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162052	2	241728663	2	240789246	162052	171780	rs672601362	NC_000002.12:240789245:G:A
NM_172250.3(MMAA):c.433C>T (p.Arg145Ter)	MMAA	R145*	not provided|Methylmalonic acidemia|Vitamin B12-responsive methylmalonic acidemia type cblA	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003160	4	146560724	4	145639572	3160	18199	rs104893851	NC_000004.12:145639571:C:T
NM_147127.5(EVC2):c.1195C>T (p.Arg399Ter)	EVC2	R399*, R319*	Short rib-polydactyly syndrome, Majewski type|Curry-Hall syndrome|Ellis-van Creveld syndrome|not provided|Ellis-van Creveld syndrome	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003383	4	5642516	4	5640789	3383	18422	rs137852924	NC_000004.12:5640788:G:A
NM_004321.7(KIF1A):c.821C>T (p.Ser274Leu)	KIF1A	S274L	Mental retardation, autosomal dominant 9|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211298	2	241722504	2	240783087	211298	206978	rs797045655	NC_000002.12:240783086:G:A
NM_001244008.1(KIF1A):c.647G>A (p.Arg216His)	KIF1A	R216H	not provided|Mental retardation, autosomal dominant 9|PEHO syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208161	2	241724479	2	240785062	208161	204420	rs672601368	NC_000002.12:240785061:C:T
NM_004321.7(KIF1A):c.646C>T (p.Arg216Cys)	KIF1A	R216C	Mental retardation, autosomal dominant 9|PEHO syndrome	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208160	2	241724480	2	240785063	208160	204421	rs797045164	NC_000002.12:240785062:G:A
NM_022455.5(NSD1):c.5509+2T>G	NSD1		Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000856456	5	176696810	5	177269809	856456	851899		NC_000005.10:177269808:T:G
NM_022455.4(NSD1):c.4411C>T (p.Arg1471Ter)	NSD1	R1471*, R1202*	Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159330	5	176673711	5	177246710	159330	168182	rs570278338	NC_000005.10:177246709:C:T
NM_172349.2(NSD1):c.2850_2851AG[1] (p.Glu951fs)	NSD1		Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159312	5	176639057 - 176639058	5	177212056 - 177212057	159312	168165	rs587784104	NC_000005.10:177212055:AGAG:AG
NM_022455.4(NSD1):c.1831C>T (p.Arg611Ter)	NSD1	R611*, R342*	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159273	5	176637231	5	177210230	159273	168128	rs587784077	NC_000005.10:177210229:C:T
NM_003242.6(TGFBR2):c.1609C>T (p.Arg537Cys)	TGFBR2	R537C, R562C	Loeys-Dietz syndrome 2|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012507	3	30732996	3	30691504	12507	27546	rs104893809	NC_000003.12:30691503:C:T
NM_024577.3(SH3TC2):c.2710C>T (p.Arg904Ter)	SH3TC2	R904*	Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000021696	5	148406585	5	149027022	21696	34548	rs80338931	NC_000005.10:149027021:G:A
NM_024577.3(SH3TC2):c.1969G>A (p.Glu657Lys)	SH3TC2	E657K	Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000021689	5	148407326	5	149027763	21689	34541	rs80338925	NC_000005.10:149027762:C:T
NM_001904.4(CTNNB1):c.122C>T (p.Thr41Ile)	CTNNB1	T41I, T34I	Lung adenocarcinoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Malignant melanoma of skin|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adrenocortical carcinoma|Pilomatrixoma|Hepatocellular carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017587	3	41266125	3	41224634	17587	32626	rs121913413	NC_000003.12:41224633:C:T
NM_022455.4(NSD1):c.5965C>T (p.Gln1989Ter)	NSD1	Q1989*, Q1720*	Sotos syndrome 1|Acute myeloid leukemia|Sotos syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159391	5	176709538	5	177282537	159391	168243	rs587784170	NC_000005.10:177282536:C:T
NM_022455.4(NSD1):c.4378+1G>A	NSD1		Sotos syndrome 1|Acute myeloid leukemia|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159328	5	176671272	5	177244271	159328	168180	rs587784115	NC_000005.10:177244270:G:A
NM_022455.4(NSD1):c.2049_2053del (p.Ile684fs)	NSD1	I415fs, I684fs	Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159277	5	176637447 - 176637451	5	177210446 - 177210450	159277	168132	rs587784080	NC_000005.10:177210445:AAGATAA:AA
NM_000222.2(KIT):c.2591_2594del (p.Phe863_Ser864insTer)	KIT		not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000280912	4	55602769 - 55602772	4	54736603 - 54736606	280912	264211	rs886042030	NC_000004.12:54736602:TCTTT:T
NM_000222.2(KIT):c.1925_1926del (p.Lys642fs)	KIT	K638fs, K642fs	Partial albinism	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000013847	4	55594221 - 55594222	4	54728055 - 54728056	13847	28886	rs794726672	NC_000004.12:54728054:AAA:A
NM_000222.2(KIT):c.1752T>G (p.Phe584Leu)	KIT	F584L, F580L	Partial albinism	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000013845	4	55593686	4	54727520	13845	28884	rs794726671	NC_000004.12:54727519:T:G
KIT, ASN822ILE	KIT	N822I	Cutaneous mastocytosis	Pathogenic(Last reviewed: Jun 25, 2018)	no assertion criteria provided	VCV000545644					545644	536140		
NM_000222.2(KIT):c.1598C>A (p.Ala533Asp)	KIT	A533D, A529D	Cutaneous mastocytosis	Pathogenic(Last reviewed: Jun 25, 2018)	no assertion criteria provided	VCV000545643	4	55593441	4	54727275	545643	536139	rs753212327	NC_000004.12:54727274:C:A
GRCh37/hg19 4q12(chr4:55587786-55614038)x1	KIT		See cases	Pathogenic(Last reviewed: Sep 22, 2014)	no assertion criteria provided	VCV000441548	4	55587786 - 55614038			441548	435210		
NM_000222.2(KIT):c.1730_1738del (p.Pro577_Asp579del)	KIT		Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375920	4	55593662 - 55593670	4	54727496 - 54727504	375920	362799	rs1131692239	NC_000004.12:54727495:TCCTTATGATC:TC
NM_000222.2(KIT):c.1859T>C (p.Val620Ala)	KIT	V620A, V616A	Piebaldism, progressive	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000035502	4	55594073	4	54727907	35502	44177	rs387907217	NC_000004.12:54727906:T:C
NM_000222.2(KIT):c.1751T>G (p.Phe584Cys)	KIT	F584C, F580C	Partial albinism	Pathogenic(Last reviewed: Nov 6, 2000)	no assertion criteria provided	VCV000013864	4	55593685	4	54727519	13864	28903	rs28933371	NC_000004.12:54727518:T:G
NM_000222.2(KIT):c.2539A>C (p.Thr847Pro)	KIT	T847P, T843P	Partial albinism	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000013861	4	55602718	4	54736552	13861	28900	rs121913687	NC_000004.12:54736551:A:C
NM_000222.2(KIT):c.2386A>G (p.Arg796Gly)	KIT	R796G, R792G	Piebaldism with sensorineural deafness	Pathogenic(Last reviewed: Jan 6, 1998)	no assertion criteria provided	VCV000013858	4	55599260	4	54733094	13858	28897	rs121913684	NC_000004.12:54733093:A:G
NM_000222.2(KIT):c.2459A>G (p.Asp820Gly)	KIT	D820G, D816G	MASTOCYTOSIS, SYSTEMIC, SOMATIC	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000013853	4	55599333	4	54733167	13853	28892	rs121913682	NC_000004.12:54733166:A:G
NM_000222.2(KIT):c.1879+1G>A	KIT		Partial albinism	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000013851	4	55594094	4	54727928	13851	28890	rs794726675	NC_000004.12:54727927:G:A
NM_000222.2(KIT):c.253del (p.Glu85fs)	KIT	E85fs	Partial albinism	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000013850	4	55561862	4	54695696	13850	28889	rs794726674	NC_000004.12:54695695:GG:G
NM_000222.2(KIT):c.1681dup (p.Glu561fs)	KIT		Partial albinism	Pathogenic(Last reviewed: Nov 1, 1977)	no assertion criteria provided	VCV000013848	4	55593614 - 55593615	4	54727448 - 54727449	13848	28887	rs794726673	NC_000004.12:54727448:G:GG
KIT, DEL	KIT		Partial albinism	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000013844					13844	28883		
NM_000222.2(KIT):c.1468G>A (p.Glu490Lys)	KIT	E490K	Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375903	4	55592144	4	54725978	375903	362782	rs1057519701	NC_000004.12:54725977:G:A
NM_000222.2(KIT):c.1747G>A (p.Glu583Lys)	KIT	E583K, E579K	Partial albinism	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000013849	4	55593681	4	54727515	13849	28888	rs121913680	NC_000004.12:54727514:G:A
NM_000222.2(KIT):c.1990G>A (p.Gly664Arg)	KIT	G664R, G660R	Partial albinism	Pathogenic(Last reviewed: Feb 1, 1992)	no assertion criteria provided	VCV000013843	4	55594287	4	54728121	13843	28882	rs121913679	NC_000004.12:54728120:G:A
NM_000222.2(KIT):c.2460T>A (p.Asp820Glu)	KIT	D820E, D816E	Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375929	4	55599334	4	54733168	375929	362808	rs1057519711	NC_000004.12:54733167:T:A
NM_000222.2(KIT):c.2152_2153del (p.Ser717_Thr718insTer)	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000580901	4	55597504 - 55597505	4	54731338 - 54731339	580901	563962	rs1560420761	NC_000004.12:54731337:AC:
NM_000222.2(KIT):c.389del (p.Asn130fs)	KIT	N130fs	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000569047	4	55564500	4	54698334	569047	559773	rs1560395607	NC_000004.12:54698333:AA:A
NM_000222.2(KIT):c.753_756del (p.Ser251fs)	KIT	S251fs	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000458966	4	55565926 - 55565929	4	54699760 - 54699763	458966	454197	rs1553887960	NC_000004.12:54699759:CAGTCAG:CAG
NM_000222.2(KIT):c.108_109insT (p.Pro37fs)	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000458850	4	55561718 - 55561719	4	54695552 - 54695553	458850	453401	rs1553887262	NC_000004.12:54695552::T
NM_000222.2(KIT):c.2454del (p.Asn819fs)	KIT	N815fs, N819fs	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000409664	4	55599328	4	54733162	409664	394112	rs1060502521	NC_000004.12:54733161:G:
KIT, 15-BP DEL AND LYS550ILE	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 23, 1998)	no assertion criteria provided	VCV000013855					13855	28894		
NM_000222.2(KIT):c.1652_1666del (p.Pro551_Val555del)	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 23, 1998)	no assertion criteria provided	VCV000013854	4	55593584 - 55593598	4	54727418 - 54727432	13854	28893	rs587776804	NC_000004.12:54727417:ACCCATGTATGAAGTAC:AC
NM_000222.2(KIT):c.1676_1681del (p.Val559_Val560del)	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 23, 1998)	no assertion criteria provided	VCV000013846	4	55593609 - 55593614	4	54727443 - 54727448	13846	28885	rs121913685	NC_000004.12:54727442:GTTGTTG:G
NM_000222.2(KIT):c.2446_2447delinsAT (p.Asp816Ile)	KIT		Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375926	4	55599320 - 55599321	4	54733154 - 54733155	375926	362805	rs1057519709	NC_000004.12:54733153:GA:AT
NM_000222.2(KIT):c.1679T>C (p.Val560Ala)	KIT	V560A, V556A	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375915	4	55593613	4	54727447	375915	362794	rs121913521	NC_000004.12:54727446:T:C
NM_000222.2(KIT):c.1674G>C (p.Lys558Asn)	KIT	K558N, K554N	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375910	4	55593608	4	54727442	375910	362789	rs200375589	NC_000004.12:54727441:G:C
NM_000222.2(KIT):c.1510T>C (p.Phe504Leu)	KIT	F504L	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375904	4	55592186	4	54726020	375904	362783	rs1057519702	NC_000004.12:54726019:T:C
NM_000222.2(KIT):c.1648_1674del	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jun 16, 2005)	no assertion criteria provided	VCV000013857	4	55593580 - 55593606	4	54727414 - 54727440	13857	28896	rs121913234	NC_000004.12:54727413:AGAAACCCATGTATGAAGTACAGTGGAAG:AG
NM_004321.7(KIF1A):c.38G>A (p.Arg13His)	KIF1A	R13H	Spastic paraplegia|Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209165	2	241737132	2	240797715	209165	205730	rs797045050	NC_000002.12:240797714:C:T
NM_004321.7(KIF1A):c.206C>T (p.Ser69Leu)	KIF1A	S69L	Hereditary spastic paraplegia|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Mental retardation, autosomal dominant 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188057	2	241727625	2	240788208	188057	185949	rs786200949	NC_000002.12:240788207:G:A
NM_003060.4(SLC22A5):c.1400C>G (p.Ser467Cys)	SLC22A5	S467C, S491C	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000025423	5	131728257	5	132392565	25423	36757	rs60376624	NC_000005.10:132392564:C:G
NM_003060.4(SLC22A5):c.1195C>T (p.Arg399Trp)	SLC22A5	R399W, R423W	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006427	5	131726524	5	132390832	6427	21466	rs267607054	NC_000005.10:132390831:C:T
NM_000551.3(VHL):c.329del (p.His110fs)	VHL	H110fs	not provided	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000560741	3	10183860	3	10142176	560741	551816	rs1559426199	NC_000003.12:10142175:A:
NM_000551.3(VHL):c.286C>T (p.Gln96Ter)	VHL	Q96*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 27, 2014)	criteria provided, single submitter	VCV000428804	3	10183817	3	10142133	428804	420442	rs1131690959	NC_000003.12:10142132:C:T
NM_000551.3(VHL):c.219_220del (p.Gln73fs)	VHL	Q73fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000182988	3	10183750 - 10183751	3	10142066 - 10142067	182988	180113	rs730882039	NC_000003.12:10142065:GG:
NM_000551.3(VHL):c.180del (p.Val62fs)	VHL	V62fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000182986	3	10183710	3	10142026	182986	180110	rs730882037	NC_000003.12:10142025:GG:G
NM_000551.4(VHL):c.222C>A (p.Val74=)	VHL	V75V	Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Mar 5, 2020)	no assertion criteria provided	VCV000635350	3	10183753	3	10142069	635350	623184		NC_000003.12:10142068:C:A
NM_000222.2(KIT):c.1706T>G (p.Val569Gly)	KIT	V569G, V565G	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375918	4	55593640	4	54727474	375918	362797	rs1057519706	NC_000004.12:54727473:T:G
NM_000222.2(KIT):c.1696A>G (p.Asn566Asp)	KIT	N566D, N562D	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375917	4	55593630	4	54727464	375917	362796	rs1057519705	NC_000004.12:54727463:A:G
NM_000222.2(KIT):c.1650A>T (p.Lys550Asn)	KIT	K550N, K546N	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375906	4	55593584	4	54727418	375906	362785	rs1057519703	NC_000004.12:54727417:A:T
NM_000222.2(KIT):c.1650A>C (p.Lys550Asn)	KIT	K550N, K546N	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375905	4	55593584	4	54727418	375905	362784	rs1057519703	NC_000004.12:54727417:A:C
NM_001080.3(ALDH5A1):c.819del (p.Asp274fs)	ALDH5A1	D274fs, D287fs	Succinate-semialdehyde dehydrogenase deficiency|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000521941	6	24515487	6	24515259	521941	511649	rs778127154	NC_000006.12:24515258:T:
NM_000551.3(VHL):c.163del (p.Glu55fs)	VHL	E55fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000428800	3	10183693	3	10142009	428800	420437	rs869025615	NC_000003.12:10142008:GG:G
NM_007118.4(TRIO):c.2359C>T (p.Gln787Ter)	TRIO	Q787*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000522014	5	14359608	5	14359499	522014	511570	rs1554062588	NC_000005.10:14359498:C:T
NM_022455.4(NSD1):c.5581C>T (p.Arg1861Ter)	NSD1	R1861*, R1592*	not provided|Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000279857	5	176700744	5	177273743	279857	264205	rs886041218	NC_000005.10:177273742:C:T
NM_022455.4(NSD1):c.6356A>G (p.Asp2119Gly)	NSD1	D2119G, D1850G	Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159413	5	176719052	5	177292051	159413	168265	rs587784191	NC_000005.10:177292050:A:G
NM_022455.4(NSD1):c.5951G>A (p.Arg1984Gln)	NSD1	R1984Q, R1715Q	not provided|Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159390	5	176709524	5	177282523	159390	168242	rs587784169	NC_000005.10:177282522:G:A
NM_022455.4(NSD1):c.3067C>T (p.Arg1023Ter)	NSD1	R1023*, R754*	Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159298	5	176638467	5	177211466	159298	168153	rs587784095	NC_000005.10:177211465:C:T
NM_022455.4(NSD1):c.1810C>T (p.Arg604Ter)	NSD1	R604*, R335*	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159271	5	176637210	5	177210209	159271	168126	rs587784076	NC_000005.10:177210208:C:T
NC_000004.11:g.(?_55524176)_(55604729_?)del	KIT		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000583798	4	55524176 - 55604729			583798	563336		
NM_000222.2(KIT):c.1670G>A (p.Trp557Ter)	KIT	W557*, W553*	B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000458885	4	55593604	4	54727438	458885	453713	rs1057520032	NC_000004.12:54727437:G:A
NM_000222.2(KIT):c.2458G>T (p.Asp820Tyr)	KIT	D820Y, D816Y	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375928	4	55599332	4	54733166	375928	362807	rs1057519710	NC_000004.12:54733165:G:T
NM_001080522.2(CC2D2A):c.3055C>T (p.Arg1019Ter)	CC2D2A	R1019*	not provided|Joubert syndrome|Meckel-Gruber syndrome|CC2D2A-Related Disorders|Joubert syndrome 9|Meckel syndrome type 6|Joubert syndrome 9|Joubert syndrome with hepatic defect	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217602	4	15565018	4	15563395	217602	214177	rs370880399	NC_000004.12:15563394:C:T
NM_023073.3(CPLANE1):c.247G>T (p.Gly83Ter)	CPLANE1	G83*	Inborn genetic diseases	Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	VCV000520682	5	37245671	5	37245569	520682	511601	rs1554117456	NC_000005.10:37245568:C:A
NM_023073.3(CPLANE1):c.493del (p.Ile165fs)	CPLANE1	I165fs	|Joubert syndrome 17|not provided||Joubert syndrome 17	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000157513	5	37244554	5	37244452	157513	167374	rs606231259	NC_000005.10:37244451:T:
NM_005199.5(CHRNG):c.753_754del (p.Val253fs)	CHRNG	V253fs	not provided|Autosomal recessive multiple pterygium syndrome|Lethal multiple pterygium syndrome|CHRNG-Related Disorders|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000018342	2	233407740 - 233407741	2	232543030 - 232543031	18342	33381	rs767503038	NC_000002.12:232543029:CT:
NM_000404.4(GLB1):c.1445G>A (p.Arg482His)	GLB1	R482H, R351H, R452H, R530H	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis|not provided|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000932	3	33058235	3	33016743	932	15971	rs72555391	NC_000003.12:33016742:C:T
NM_004321.7(KIF1A):c.757G>A (p.Glu253Lys)	KIF1A	E253K	Mental retardation, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|not provided	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000162059	2	241723197	2	240783780	162059	171772	rs672601369	NC_000002.12:240783779:C:T
NM_004656.4(BAP1):c.855dup (p.Lys286fs)	BAP1		not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000545892	3	52439856 - 52439857	3	52405840 - 52405841	545892	536283	rs1553645486	NC_000003.12:52405840:GG:GGG
NM_004656.4(BAP1):c.1254T>A (p.Tyr418Ter)	BAP1	Y418*	not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000422448	3	52437907	3	52403891	422448	406344	rs1064795786	NC_000003.12:52403890:A:T
NM_004656.4(BAP1):c.619del (p.Arg207fs)	BAP1	R207fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000826235	3	52440885	3	52406869	826235	807681		NC_000003.12:52406868:GGG:GG
NM_004656.4(BAP1):c.519_520insA (p.Val174fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000825526	3	52441250 - 52441251	3	52407234 - 52407235	825526	807686		NC_000003.12:52407234::T
NM_004656.4(BAP1):c.320del (p.Asp107fs)	BAP1	D107fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000823198	3	52442029	3	52408013	823198	807691		NC_000003.12:52408012:T:
NM_004656.4(BAP1):c.2T>C (p.Met1Thr)	BAP1	M1T	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000822547	3	52443893	3	52409877	822547	807704		NC_000003.12:52409876:A:G
NM_004656.4(BAP1):c.261dup (p.Pro88fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000821579	3	52442087 - 52442088	3	52408071 - 52408072	821579	807694		NC_000003.12:52408071:T:TT
NM_004656.4(BAP1):c.1993C>T (p.Gln665Ter)	BAP1	Q665*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000820463	3	52436681	3	52402665	820463	807647		NC_000003.12:52402664:G:A
NM_004656.4(BAP1):c.1587_1594delinsCACACCTCCCACA (p.Lys529fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000819549	3	52437567 - 52437574	3	52403551 - 52403558	819549	807652		NC_000003.12:52403550:AAAGCACC:TGTGGGAGGTGTG
NM_004656.4(BAP1):c.1513_1514del (p.Ser505fs)	BAP1	S505fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000819430	3	52437647 - 52437648	3	52403631 - 52403632	819430	807655		NC_000003.12:52403630:GAG:G
NM_004656.4(BAP1):c.1169dup (p.Pro391fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000818479	3	52438549 - 52438550	3	52404533 - 52404534	818479	807664		NC_000003.12:52404533:GGG:GGGG
NM_004656.4(BAP1):c.932-8_960del	BAP1		Uveal melanoma	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000633598	3	52439282 - 52439318	3	52405266 - 52405302	633598	622030	rs1559588632	NC_000003.12:52405265:GCATGAACCAGCCGCCTCCTCTGCACCATCTGAGACAG:G
NM_004656.4(BAP1):c.771_772insTACTA (p.Ala258delinsTyrTer)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000480812	3	52440280 - 52440281	3	52406264 - 52406265	480812	473570	rs1553645586	NC_000003.12:52406264::TAGTA
NM_004656.4(BAP1):c.1098T>G (p.Tyr366Ter)	BAP1	Y366*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000862537	3	52439144	3	52405128	862537	828483		NC_000003.12:52405127:A:C
NM_004656.4(BAP1):c.1437del (p.Thr480fs)	BAP1	T480fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000856406	3	52437724	3	52403708	856406	828475		NC_000003.12:52403707:GGG:GG
NM_004656.4(BAP1):c.852del (p.Glu284fs)	BAP1	E284fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000854952	3	52439860	3	52405844	854952	828491		NC_000003.12:52405843:C:
NM_004656.4(BAP1):c.175del (p.Arg59fs)	BAP1	R59fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000851433	3	52442570	3	52408554	851433	828506		NC_000003.12:52408553:GGG:GG
NM_004656.4(BAP1):c.1729G>T (p.Glu577Ter)	BAP1	E577*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000845141	3	52437432	3	52403416	845141	828468		NC_000003.12:52403415:C:A
NM_004656.4(BAP1):c.186_187CT[3] (p.Thr64fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000841989	3	52442555 - 52442556	3	52408539 - 52408540	841989	828505		NC_000003.12:52408539:AGAGA:AGAGAGA
NM_004656.4(BAP1):c.133G>T (p.Gly45Ter)	BAP1	G45*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835021	3	52442612	3	52408596	835021	828507		NC_000003.12:52408595:C:A
NM_004656.4(BAP1):c.898_917del (p.Arg300fs)	BAP1	R300fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000663672	3	52439795 - 52439814	3	52405779 - 52405798	663672	631725		NC_000003.12:52405778:TCAGAGGCTGCAGGGGCCCT:
NM_004656.4(BAP1):c.706dup (p.Asp236fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000651690	3	52440345 - 52440346	3	52406329 - 52406330	651690	631730		NC_000003.12:52406329:C:CC
NM_004656.4(BAP1):c.1379C>G (p.Ser460Ter)	BAP1	S460*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000650623	3	52437782	3	52403766	650623	631712		NC_000003.12:52403765:G:C
NM_004656.4(BAP1):c.1110dup (p.Met371fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000640282	3	52439131 - 52439132	3	52405115 - 52405116	640282	631720		NC_000003.12:52405115:GGGGG:GGGGGG
NM_004656.4(BAP1):c.1896_1900dup (p.Ala634fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000629185	3	52436877 - 52436878	3	52402861 - 52402862	629185	616950	rs1559585465	NC_000003.12:52402861:CCAGC:CCAGCCCAGC
NM_004656.4(BAP1):c.155G>A (p.Trp52Ter)	BAP1	W52*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000629139	3	52442590	3	52408574	629139	617029	rs1559591728	NC_000003.12:52408573:C:T
NM_004656.4(BAP1):c.1381del (p.Ile461fs)	BAP1	I461fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000628351	3	52437780	3	52403764	628351	616976	rs1559586965	NC_000003.12:52403763:TT:T
NM_004656.4(BAP1):c.1882_1885del (p.Ser628fs)	BAP1	S628fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000628182	3	52437159 - 52437162	3	52403143 - 52403146	628182	616952	rs1559585778	NC_000003.12:52403142:GTGAGT:GT
NM_004656.4(BAP1):c.458_459del (p.Pro153fs)	BAP1	P153fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000628120	3	52441311 - 52441312	3	52407295 - 52407296	628120	617014	rs1559590613	NC_000003.12:52407294:AG:
NM_004656.4(BAP1):c.15G>A (p.Trp5Ter)	BAP1	W5*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000575817	3	52443880	3	52409864	575817	559656	rs916069743	NC_000003.12:52409863:C:T
NM_004656.4(BAP1):c.1472_1473AG[1] (p.Ser492fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000570763	3	52437686 - 52437687	3	52403670 - 52403671	570763	563224	rs1559586782	NC_000003.12:52403669:CTCTC:CTC
NM_004656.4(BAP1):c.11del (p.Gly4fs)	BAP1	G4fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000566165	3	52443884	3	52409868	566165	559658	rs1559593389	NC_000003.12:52409867:CCC:CC
NM_004656.4(BAP1):c.824del (p.Lys275fs)	BAP1	K275fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000565856	3	52439888	3	52405872	565856	559112	rs1559589252	NC_000003.12:52405871:TT:T
NM_004656.4(BAP1):c.1203_1214del (p.Tyr401_Glu405delinsTer)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000539923	3	52438505 - 52438516	3	52404489 - 52404500	539923	519805	rs1553645117	NC_000003.12:52404488:TCGTCATCCTCAT:T
NM_004656.4(BAP1):c.837dup (p.Gln280fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000539922	3	52439874 - 52439875	3	52405858 - 52405859	539922	519604	rs1553645492	NC_000003.12:52405858:T:TT
NM_004656.4(BAP1):c.1464del (p.Ser489fs)	BAP1	S489fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000539913	3	52437697	3	52403681	539913	519824	rs1553644922	NC_000003.12:52403680:GGGGG:GGGG
NM_004656.4(BAP1):c.118C>T (p.Gln40Ter)	BAP1	Q40*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000539912	3	52443574	3	52409558	539912	519835	rs1553646284	NC_000003.12:52409557:G:A
NM_004656.4(BAP1):c.831dup (p.Glu278fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000539903	3	52439880 - 52439881	3	52405864 - 52405865	539903	519820	rs1553645497	NC_000003.12:52405864:TT:TTT
NM_004656.4(BAP1):c.91del (p.Glu31fs)	BAP1	E31fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000539900	3	52443601	3	52409585	539900	519836	rs1553646294	NC_000003.12:52409584:CC:C
NM_004656.4(BAP1):c.956C>G (p.Ser319Ter)	BAP1	S319*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000490911	3	52439286	3	52405270	490911	483710	rs1553645329	NC_000003.12:52405269:G:C
NM_004656.4(BAP1):c.127dup (p.Val43fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000490788	3	52442617 - 52442618	3	52408601 - 52408602	490788	483781	rs1553646061	NC_000003.12:52408601:C:CC
NM_004656.4(BAP1):c.1174C>T (p.Gln392Ter)	BAP1	Q392*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000490777	3	52438545	3	52404529	490777	483643	rs1553645146	NC_000003.12:52404528:G:A
NM_004656.4(BAP1):c.79dup (p.Val27fs)	BAP1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000485291	3	52443612 - 52443613	3	52409596 - 52409597	485291	473745	rs397509413	NC_000003.12:52409596:CCCCC:CCCCCC
NM_004656.4(BAP1):c.758dup (p.Thr254fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000472715	3	52440293 - 52440294	3	52406277 - 52406278	472715	453035	rs1553645591	NC_000003.12:52406277:T:TT
NM_004656.4(BAP1):c.1379C>A (p.Ser460Ter)	BAP1	S460*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000472667	3	52437782	3	52403766	472667	453362	rs1553644949	NC_000003.12:52403765:G:T
NC_000003.11:g.(?_52436298)_(52443900_?)del	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000472655	3	52436298 - 52443900			472655	451811		
NM_004656.4(BAP1):c.517dup (p.Tyr173fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000412449	3	52441252 - 52441253	3	52407236 - 52407237	412449	393734	rs1553645806	NC_000003.12:52407236:A:AA
NM_004656.4(BAP1):c.181A>T (p.Lys61Ter)	BAP1	K61*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000412435	3	52442564	3	52408548	412435	393739	rs1060503744	NC_000003.12:52408547:T:A
NM_004656.4(BAP1):c.1835del (p.Lys612fs)	BAP1	K612fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000412434	3	52437209	3	52403193	412434	393674	rs1060503743	NC_000003.12:52403192:TT:T
NM_004656.4(BAP1):c.1185dup (p.Asp396fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000412415	3	52438533 - 52438534	3	52404517 - 52404518	412415	394143	rs1553645136	NC_000003.12:52404517:T:TT
NM_004656.4(BAP1):c.1416del (p.Ser473fs)	BAP1	S473fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000412409	3	52437745	3	52403729	412409	393694	rs1060503731	NC_000003.12:52403728:CCC:CC
NM_004656.4(BAP1):c.644del (p.Gly215fs)	BAP1	G215fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Sep 4, 2016)	criteria provided, single submitter	VCV000412400	3	52440860	3	52406844	412400	393923	rs1060503727	NC_000003.12:52406843:CC:C
NM_004656.4(BAP1):c.544G>T (p.Glu182Ter)	BAP1	E182*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000412399	3	52441226	3	52407210	412399	393928	rs1060503726	NC_000003.12:52407209:C:A
NM_004656.4(BAP1):c.778C>T (p.Gln260Ter)	BAP1	Q260*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000220590	3	52440274	3	52406258	220590	221422	rs864622592	NC_000003.12:52406257:G:A
NM_004656.4(BAP1):c.1654del (p.Asp552fs)	BAP1	D552fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055880	3	52437507	3	52403491	55880	70528	rs397509414	NC_000003.12:52403490:C:
NM_004656.4(BAP1):c.277A>G (p.Thr93Ala)	BAP1	T93A	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055879	3	52442072	3	52408056	55879	70527	rs375129361	NC_000003.12:52408055:T:C
NM_004656.4(BAP1):c.78_79del (p.Val27fs)	BAP1	V27fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000055878	3	52443613 - 52443614	3	52409597 - 52409598	55878	70526	rs397509413	NC_000003.12:52409596:CCCCC:CCC
BAP1, 4-BP DEL, 2008TCAC	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 28, 2011)	no assertion criteria provided	VCV000030304					30304	39260		
BAP1, 1-BP DEL, 1832C	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 28, 2011)	no assertion criteria provided	VCV000030303					30303	39259		
NM_004656.4(BAP1):c.438-2A>G	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 28, 2011)	no assertion criteria provided	VCV000030301	3	52441334	3	52407318	30301	39257	rs587776879	NC_000003.12:52407317:T:C
NM_004656.4(BAP1):c.2057-2A>G	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 28, 2011)	no assertion criteria provided	VCV000030300	3	52436439	3	52402423	30300	39256	rs587776878	NC_000003.12:52402422:T:C
NM_004656.4(BAP1):c.1305del (p.Gln436fs)	BAP1	Q436fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 28, 2011)	no assertion criteria provided	VCV000030299	3	52437856	3	52403840	30299	39255	rs587776877	NC_000003.12:52403839:CCC:CC
NM_004656.4(BAP1):c.898_899del (p.Arg300fs)	BAP1	R300fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000822865	3	52439813 - 52439814	3	52405797 - 52405798	822865	807674		NC_000003.12:52405796:CT:
NM_004656.4(BAP1):c.959dup (p.Cys320fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000661010	3	52439282 - 52439283	3	52405266 - 52405267	661010	631724		NC_000003.12:52405266:C:CC
NM_004656.4(BAP1):c.592G>T (p.Glu198Ter)	BAP1	E198*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000539909	3	52440912	3	52406896	539909	519826	rs1553645720	NC_000003.12:52406895:C:A
NM_004656.4(BAP1):c.1203dup (p.Glu402Ter)	BAP1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Feb 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449856	3	52438515 - 52438516	3	52404499 - 52404500	449856	443501	rs1553645126	NC_000003.12:52404499:A:AA
NM_004656.4(BAP1):c.519T>G (p.Tyr173Ter)	BAP1	Y173*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000412451	3	52441251	3	52407235	412451	393726	rs143901408	NC_000003.12:52407234:A:C
NM_004656.4(BAP1):c.510dup (p.Val171fs)	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000412430	3	52441259 - 52441260	3	52407243 - 52407244	412430	393738	rs1553645809	NC_000003.12:52407243:AAA:AAAA
NM_004656.4(BAP1):c.1975A>T (p.Lys659Ter)	BAP1	K659*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000539901	3	52436803	3	52402787	539901	519809	rs1553644659	NC_000003.12:52402786:T:A
NM_004656.4(BAP1):c.587G>A (p.Trp196Ter)	BAP1	W196*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000472707	3	52440917	3	52406901	472707	453057	rs1553645725	NC_000003.12:52406900:C:T
NM_004656.4(BAP1):c.1358_1359del (p.Lys453fs)	BAP1	K453fs	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434478	3	52437802 - 52437803	3	52403786 - 52403787	434478	428209	rs1351986946	NC_000003.12:52403785:TTT:T
NM_000222.2(KIT):c.1526A>T (p.Lys509Ile)	KIT	K509I	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000651292	4	55592202	4	54726036	651292	632398		NC_000004.12:54726035:A:T
NM_000222.2(KIT):c.2515G>A (p.Glu839Lys)	KIT	E839K, E835K	Gastrointestinal stromal tumor|Mastocytosis	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000013862	4	55602694	4	54736528	13862	28901	rs121913509	NC_000004.12:54736527:G:A
NM_004656.4(BAP1):c.1891-1G>A	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000838659	3	52436888	3	52402872	838659	851471		NC_000003.12:52402871:C:T
NM_004656.4(BAP1):c.1729+1G>A	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000654973	3	52437431	3	52403415	654973	651112		NC_000003.12:52403414:C:T
NM_004656.4(BAP1):c.639dup (p.Ile214fs)	BAP1		Hereditary cancer-predisposing syndrome|Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000654284	3	52440864 - 52440865	3	52406848 - 52406849	654284	631731		NC_000003.12:52406848:A:AA
NM_004656.4(BAP1):c.178C>T (p.Arg60Ter)	BAP1	R60*	Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000580226	3	52442567	3	52408551	580226	559652	rs1253151209	NC_000003.12:52408550:G:A
NM_004656.4(BAP1):c.1729+1del	BAP1		Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000578825	3	52437431	3	52403415	578825	559640	rs1559586374	NC_000003.12:52403414:CC:C
NM_004656.4(BAP1):c.1695dup (p.Glu566Ter)	BAP1		Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485270	3	52437465 - 52437466	3	52403449 - 52403450	485270	473521	rs1553644815	NC_000003.12:52403449:A:AA
NM_004656.4(BAP1):c.799C>T (p.Gln267Ter)	BAP1	Q267*	Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000030305	3	52439913	3	52405897	30305	39261	rs387906849	NC_000003.12:52405896:G:A
NM_000414.4(HSD17B4):c.46G>A (p.Gly16Ser)	HSD17B4	G16S	HSD17B4-Related Disorders|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|not provided|Bifunctional peroxisomal enzyme deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007655	5	118788316	5	119452621	7655	22694	rs137853096	NC_000005.10:119452620:G:A
NM_004656.4(BAP1):c.1321C>T (p.Gln441Ter)	BAP1	Q441*	Hereditary cancer-predisposing syndrome|Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000584646	3	52437840	3	52403824	584646	575709	rs1559587104	NC_000003.12:52403823:G:A
NM_004656.4(BAP1):c.1063C>T (p.Gln355Ter)	BAP1	Q355*	Hereditary cancer-predisposing syndrome|Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224520	3	52439179	3	52405163	224520	226316	rs869312757	NC_000003.12:52405162:G:A
NM_000551.3(VHL):c.304_305dup (p.Pro103fs)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625236	3	10183834 - 10183835	3	10142150 - 10142151	625236	613569	rs1559426145	NC_000003.12:10142150:CC:CCCC
NM_000551.3(VHL):c.294C>G (p.Tyr98Ter)	VHL	Y98*	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625235	3	10183825	3	10142141	625235	613568	rs1559426115	NC_000003.12:10142140:C:G
NM_000551.4(VHL):c.292_295del (p.Tyr98fs)	VHL	Y98fs	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625234	3	10183821 - 10183824	3	10142137 - 10142140	625234	613567	rs1559426095	NC_000003.12:10142136:CCTACC:CC
NM_000551.4(VHL):c.258dup (p.Val87fs)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625230	3	10183786 - 10183787	3	10142102 - 10142103	625230	613563	rs864622545	NC_000003.12:10142102:CCC:CCCC
NM_000551.3(VHL):c.239G>T (p.Ser80Ile)	VHL	S80I	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625229	3	10183770	3	10142086	625229	613562	rs5030805	NC_000003.12:10142085:G:T
NM_000551.3(VHL):c.239_261del (p.Ser80fs)	VHL	S80fs	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625228	3	10183769 - 10183791	3	10142085 - 10142107	625228	613561	rs1559425951	NC_000003.12:10142084:AGTCCGCGCGTCGTGCTGCCCGTA:A
NM_000551.4(VHL):c.233del (p.Asn78fs)	VHL	N78fs	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625227	3	10183763	3	10142079	625227	613560	rs1559425925	NC_000003.12:10142078:AA:A
NM_000551.3(VHL):c.232A>G (p.Asn78Asp)	VHL	N78D	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625226	3	10183763	3	10142079	625226	613559	rs869025621	NC_000003.12:10142078:A:G
NM_000551.3(VHL):c.232A>C (p.Asn78His)	VHL	N78H	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000625225	3	10183763	3	10142079	625225	613558	rs869025621	NC_000003.12:10142078:A:C
NM_000551.3(VHL):c.206dup (p.Glu70fs)	VHL		Von Hippel-Lindau syndrome	Pathogenic	no assertion criteria provided	VCV000478820	3	10183736 - 10183737	3	10142052 - 10142053	478820	472246	rs1553619415	NC_000003.12:10142052:G:GG
NM_000551.3(VHL):c.189_192del (p.Arg64_Ser65insTer)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223205	3	10183720 - 10183723	3	10142036 - 10142039	223205	224890	rs869025647	NC_000003.12:10142035:GCGC:
NM_000551.3(VHL):c.340G>C (p.Gly114Arg)	VHL	G114R, V114L	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223193	3	10183871	3	10142187	223193	224921	rs869025636	NC_000003.12:10142186:G:C
NM_000551.3(VHL):c.340+2_340+6del	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223191	3	10183871 - 10183875	3	10142187 - 10142191	223191	224923	rs869025634	NC_000003.12:10142186:GGTACGG:GG
NM_000551.3(VHL):c.335_340+5del	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223188	3	10183866 - 10183876	3	10142182 - 10142192	223188	224920	rs869025632	NC_000003.12:10142181:ACCGAGGTACG:
NM_000551.3(VHL):c.309dup (p.Gly104fs)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223181	3	10183839 - 10183840	3	10142155 - 10142156	223181	224912	rs869025628	NC_000003.12:10142155:T:TT
NM_000551.3(VHL):c.309del (p.Gly104fs)	VHL	G104fs	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223180	3	10183840	3	10142156	223180	224911	rs869025627	NC_000003.12:10142155:T:
NM_000551.3(VHL):c.300dup (p.Leu101fs)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223179	3	10183830 - 10183831	3	10142146 - 10142147	223179	224910	rs869025626	NC_000003.12:10142146:G:GG
NM_000551.3(VHL):c.296dup (p.Thr100fs)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223178	3	10183824 - 10183825	3	10142140 - 10142141	223178	224909	rs869025625	NC_000003.12:10142140:CCC:CCCC
NM_000551.3(VHL):c.293dup (p.Tyr98Ter)	VHL		Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223177	3	10183823 - 10183824	3	10142139 - 10142140	223177	224908	rs869025624	NC_000003.12:10142139:A:AA
NM_000551.3(VHL):c.293A>G (p.Tyr98Cys)	VHL	Y98C	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223176	3	10183824	3	10142140	223176	224907	rs864321643	NC_000003.12:10142139:A:G
NM_000551.3(VHL):c.277G>T (p.Gly93Cys)	VHL	G93C	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223175	3	10183808	3	10142124	223175	224906	rs5030808	NC_000003.12:10142123:G:T
NM_000551.3(VHL):c.269del (p.Asn90fs)	VHL	N90fs	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223173	3	10183799	3	10142115	223173	224904	rs869025623	NC_000003.12:10142114:AA:A
NM_000551.3(VHL):c.221del (p.Val74fs)	VHL	V74fs	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223165	3	10183752	3	10142068	223165	224896	rs869025620	NC_000003.12:10142067:T:
NM_000551.3(VHL):c.203C>A (p.Ser68Ter)	VHL	S68*	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223162	3	10183734	3	10142050	223162	224893	rs869025617	NC_000003.12:10142049:C:A
NM_000551.3(VHL):c.194C>A (p.Ser65Ter)	VHL	S65*	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000223161	3	10183725	3	10142041	223161	224892	rs5030826	NC_000003.12:10142040:C:A
NM_001163213.1(FGFR3):c.1954A>G (p.Lys652Glu)	FGFR3	K650E, K652E, K538E, K651E	Multiple myeloma|not provided|Thanatophoric dysplasia, type 2|Spermatocytic seminoma|Carcinoma	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000016331	4	1807889	4	1806162	16331	31370	rs78311289	NC_000004.12:1806161:A:G
NM_000440.3(PDE6A):c.1957C>T (p.Arg653Ter)	PDE6A	R653*	Inborn genetic diseases|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437983	5	149264112	5	149884549	437983	431679	rs753942596	NC_000005.10:149884548:G:A
NM_000539.3(RHO):c.403C>T (p.Arg135Trp)	RHO	R135W	Retinitis punctata albescens|not provided|Retinitis pigmentosa 4|Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013028	3	129249760	3	129530917	13028	28067	rs104893775	NC_000003.12:129530916:C:T
NM_172349.2(NSD1):c.1579_1582del (p.Glu527fs)	NSD1	E796fs, E527fs	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159287	5	176637783 - 176637786	5	177210782 - 177210785	159287	168142	rs587784086	NC_000005.10:177210781:AAAGAAA:AAA
NM_004656.4(BAP1):c.65del (p.Phe22fs)	BAP1	F22fs	Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000412414	3	52443732	3	52409716	412414	393755	rs1060503735	NC_000003.12:52409715:AAA:AA
NM_000222.2(KIT):c.1735_1737del (p.Asp579del)	KIT	D579del, D575del	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000409725	4	55593667 - 55593669	4	54727501 - 54727503	409725	394192	rs1060502543	NC_000004.12:54727500:ATGAT:AT
NM_000222.2(KIT):c.1657T>A (p.Tyr553Asn)	KIT	Y553N, Y549N	Cutaneous melanoma|Thymoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375907	4	55593591	4	54727425	375907	362786	rs1057519704	NC_000004.12:54727424:T:A
NM_014159.6(SETD2):c.4457_4460delAGAA	SETD2		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000521901	3	47158239 - 47158242	3	47116749 - 47116752	521901	511493	rs1553699115	NC_000003.12:47116748:TTCTTTCT:TTCT
NM_004321.7(KIF1A):c.920G>A (p.Arg307Gln)	KIF1A	R307Q	Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|not provided|Mental retardation, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418275	2	241715306	2	240775889	418275	405684	rs1064793161	NC_000002.12:240775888:C:T
NM_000551.3(VHL):c.193T>C (p.Ser65Pro)	VHL	S65P	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547829	3	10183724	3	10142040	547829	537735	rs869025616	NC_000003.12:10142039:T:C
NM_198156.3(VHL):c.223_225del (p.Ile75del)	VHL	I75del	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Jun 1, 1995)	no assertion criteria provided	VCV000002214	3	10183752 - 10183754	3	10142068 - 10142070	2214	17253	rs794729660	NC_000003.12:10142067:TCATC:TC
NM_004656.4(BAP1):c.1938T>A (p.Tyr646Ter)	BAP1	Y646*	Hereditary cancer-predisposing syndrome|Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000656678	3	52436840	3	52402824	656678	631702		NC_000003.12:52402823:A:T
NM_004656.4(BAP1):c.1153C>T (p.Arg385Ter)	BAP1	R385*	Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485271	3	52438566	3	52404550	485271	473723	rs1553645164	NC_000003.12:52404549:G:A
NM_004656.4(BAP1):c.1777C>T (p.Gln593Ter)	BAP1	Q593*	Hereditary cancer-predisposing syndrome|not provided|Tumor susceptibility linked to germline BAP1 mutations	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422219	3	52437267	3	52403251	422219	406342	rs1064795638	NC_000003.12:52403250:G:A
NM_002439.5(MSH3):c.2200C>T (p.Arg734Ter)	MSH3	R734*	not provided	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000864573	5	80064769	5	80768950	864573	831106		NC_000005.10:80768949:C:T
NM_002439.5(MSH3):c.256_259AGAA[1] (p.Lys87fs)	MSH3		not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000864272	5	79952247 - 79952250	5	80656428 - 80656431	864272	831002		NC_000005.10:80656427:AAGAAAGAA:AAGAA
NM_002439.5(MSH3):c.2300_2303del (p.Asp767fs)	MSH3	D767fs	not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000864150	5	80071557 - 80071560	5	80775738 - 80775741	864150	831113		NC_000005.10:80775737:TGATTG:TG
NM_002439.5(MSH3):c.1417dup (p.Thr473fs)	MSH3		not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000859595	5	80021347 - 80021348	5	80725528 - 80725529	859595	831072		NC_000005.10:80725528:A:AA
NM_002439.5(MSH3):c.1418_1419del (p.Thr473fs)	MSH3	T473fs	not provided	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000856590	5	80021348 - 80021349	5	80725529 - 80725530	856590	831074		NC_000005.10:80725528:ACA:A
NM_002439.5(MSH3):c.257del (p.Arg86fs)	MSH3	R86fs	not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000855984	5	79952249	5	80656430	855984	831003		NC_000005.10:80656429:G:
NM_002439.5(MSH3):c.2057T>G (p.Leu686Ter)	MSH3	L686*	not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852002	5	80063912	5	80768093	852002	831099		NC_000005.10:80768092:T:G
NM_002439.5(MSH3):c.609del (p.Phe203fs)	MSH3	F203fs	not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000852001	5	79965943	5	80670124	852001	831024		NC_000005.10:80670123:TTT:TT
NM_002439.5(MSH3):c.1499_1502dup (p.Ser502fs)	MSH3		not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000847584	5	80024714 - 80024715	5	80728895 - 80728896	847584	831078		NC_000005.10:80728895:TTTG:TTTGTTTG
NM_002439.5(MSH3):c.1758_1762del (p.Leu587fs)	MSH3	L587fs	not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000846735	5	80040425 - 80040429	5	80744606 - 80744610	846735	831089		NC_000005.10:80744605:TTAAATTAA:TTAA
NM_002439.5(MSH3):c.928del (p.Thr310fs)	MSH3	T310fs	not provided	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000844922	5	79968576	5	80672757	844922	831046		NC_000005.10:80672756:AAA:AA
NM_002439.5(MSH3):c.513del (p.Asp171fs)	MSH3	D171fs	not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000843022	5	79961116	5	80665297	843022	831017		NC_000005.10:80665296:T:
NM_002439.5(MSH3):c.790G>T (p.Glu264Ter)	MSH3	E264*	not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000841131	5	79966126	5	80670307	841131	831038		NC_000005.10:80670306:G:T
NM_002439.5(MSH3):c.1534G>T (p.Glu512Ter)	MSH3	E512*	not provided	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000838651	5	80024750	5	80728931	838651	831079		NC_000005.10:80728930:G:T
NM_002439.5(MSH3):c.703C>T (p.Gln235Ter)	MSH3	Q235*	not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000837189	5	79966039	5	80670220	837189	831031		NC_000005.10:80670219:C:T
NM_002439.5(MSH3):c.2421G>A (p.Trp807Ter)	MSH3	W807*	not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000836979	5	80074641	5	80778822	836979	831120		NC_000005.10:80778821:G:A
NM_002439.5(MSH3):c.2216del (p.Asn739fs)	MSH3	N739fs	not provided	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000835483	5	80064780	5	80768961	835483	831107		NC_000005.10:80768960:AAAAAA:AAAAA
NC_000005.10:g.(?_80725443)_(80741558_?)del	MSH3		not provided	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000833110	5	80021262 - 80037377			833110	819622		
NC_000005.10:g.(?_80744496)_(80744625_?)del	MSH3		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000832983	5	80040315 - 80040444			832983	819626		
NC_000005.10:g.(?_80656401)_(80656541_?)del	MSH3		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832965	5	79952220 - 79952360			832965	819618		
NC_000005.10:g.(?_80725443)_(80761688_?)del	MSH3		not provided	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000832098	5	80021262 - 80057507			832098	819623		
NC_000005.10:g.(?_80775684)_(80778846_?)del	MSH3		not provided	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000831993	5	80071503 - 80074665			831993	819627		
NC_000005.10:g.(?_80665133)_(80665373_?)del	MSH3		not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000831050	5	79960952 - 79961192			831050	819619		
NM_002439.5(MSH3):c.640C>T (p.Gln214Ter)	MSH3	Q214*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000826387	5	79965976	5	80670157	826387	808668		NC_000005.10:80670156:C:T
NM_002439.5(MSH3):c.565C>T (p.Gln189Ter)	MSH3	Q189*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000825881	5	79961168	5	80665349	825881	808665		NC_000005.10:80665348:C:T
NM_002439.5(MSH3):c.303_306AAAG[1] (p.Lys103fs)	MSH3		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000822791	5	79952295 - 79952298	5	80656476 - 80656479	822791	808659		NC_000005.10:80656475:AAAGAAAG:AAAG
NM_002439.5(MSH3):c.2664_2665AG[3] (p.Arg890fs)	MSH3		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000821653	5	80109411 - 80109412	5	80813592 - 80813593	821653	808705		NC_000005.10:80813591:AGAGAGAG:AGAGAG
NM_002439.5(MSH3):c.1772del (p.Asn591fs)	MSH3	N591fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000820032	5	80057371	5	80761552	820032	808693		NC_000005.10:80761551:AAA:AA
NM_002439.5(MSH3):c.1524del (p.Lys508fs)	MSH3	K508fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000819449	5	80024737	5	80728918	819449	808689		NC_000005.10:80728917:AAAA:AAA
NM_002439.5(MSH3):c.2807del (p.Phe936fs)	MSH3	F936fs	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000665540	5	80109551	5	80813732	665540	634387		NC_000005.10:80813731:TTTT:TTT
NM_002439.5(MSH3):c.1586C>G (p.Ser529Ter)	MSH3	S529*	not provided	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000665225	5	80037300	5	80741481	665225	634228		NC_000005.10:80741480:C:G
NC_000005.9:g.(?_80071503)_(80071587_?)del	MSH3		not provided	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000665026	5	80071503 - 80071587	5	80775684 - 80775768	665026	651330		
NM_002439.5(MSH3):c.2803del (p.Ile935fs)	MSH3	I935fs	not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000661402	5	80109550	5	80813731	661402	634385		NC_000005.10:80813730:A:
NM_002439.5(MSH3):c.2179C>T (p.Arg727Ter)	MSH3	R727*	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000660274	5	80064748	5	80768929	660274	634309		NC_000005.10:80768928:C:T
NM_002439.5(MSH3):c.1419_1420AG[1] (p.Glu474fs)	MSH3		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000660042	5	80021350 - 80021351	5	80725531 - 80725532	660042	634217		NC_000005.10:80725530:AGAG:AG
NM_002439.5(MSH3):c.697G>T (p.Glu233Ter)	MSH3	E233*	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000657023	5	79966033	5	80670214	657023	634132		NC_000005.10:80670213:G:T
NM_002439.5(MSH3):c.2874_2875CA[1] (p.Thr959fs)	MSH3		not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000656877	5	80150008 - 80150009	5	80854189 - 80854190	656877	634398		NC_000005.10:80854188:ACACA:ACA
NM_002439.5(MSH3):c.316C>T (p.Gln106Ter)	MSH3	Q106*	not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000652570	5	79952308	5	80656489	652570	634088		NC_000005.10:80656488:C:T
NM_002439.5(MSH3):c.2867_2870TGAC[1] (p.Asp958fs)	MSH3		not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000651493	5	80150000 - 80150003	5	80854181 - 80854184	651493	634395		NC_000005.10:80854180:ACTGACTGAC:ACTGAC
NM_002439.5(MSH3):c.1642del (p.Leu548fs)	MSH3	L548fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000651004	5	80037355	5	80741536	651004	634234		NC_000005.10:80741535:CC:C
NM_002439.5(MSH3):c.2663C>G (p.Ser888Ter)	MSH3	S888*	not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000649390	5	80109410	5	80813591	649390	634361		NC_000005.10:80813590:C:G
NM_002439.5(MSH3):c.2141dup (p.Arg715fs)	MSH3		not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000649279	5	80064704 - 80064705	5	80768885 - 80768886	649279	634300		NC_000005.10:80768885:AAAAAA:AAAAAAA
NM_002439.5(MSH3):c.708C>G (p.Tyr236Ter)	MSH3	Y236*	not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000648027	5	79966044	5	80670225	648027	634133		NC_000005.10:80670224:C:G
NM_002439.5(MSH3):c.2664_2665AG[2] (p.Glu889_Arg890insTer)	MSH3		not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000647814	5	80109411 - 80109414	5	80813592 - 80813595	647814	634362		NC_000005.10:80813591:AGAGAGAG:AGAG
NM_002439.5(MSH3):c.2216dup (p.Asn739fs)	MSH3		not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000647193	5	80064779 - 80064780	5	80768960 - 80768961	647193	634312		NC_000005.10:80768960:AAAAAA:AAAAAAA
NM_002439.5(MSH3):c.1040del (p.Leu347fs)	MSH3	L347fs	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000646031	5	79970814	5	80674995	646031	634173		NC_000005.10:80674994:T:
NM_002439.5(MSH3):c.2695_2696del (p.Met899fs)	MSH3	M899fs	not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000645737	5	80109442 - 80109443	5	80813623 - 80813624	645737	634366		NC_000005.10:80813622:AT:
NM_002439.5(MSH3):c.1060dup (p.Val354fs)	MSH3		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000644085	5	79970833 - 79970834	5	80675014 - 80675015	644085	634175		NC_000005.10:80675014:G:GG
NM_002439.5(MSH3):c.869_872TGTT[1] (p.Val292fs)	MSH3		not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000643770	5	79968139 - 79968142	5	80672320 - 80672323	643770	634150		NC_000005.10:80672319:TGTTTGTT:TGTT
NM_002439.5(MSH3):c.1148dup (p.Asn385fs)	MSH3		not provided	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, single submitter	VCV000643621	5	79970914 - 79970915	5	80675095 - 80675096	643621	634184		NC_000005.10:80675095:AAAAAAAA:AAAAAAAAA
NM_002439.5(MSH3):c.2107_2110del (p.Phe703fs)	MSH3	F703fs	not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000643433	5	80064673 - 80064676	5	80768854 - 80768857	643433	634293		NC_000005.10:80768853:TTATTTA:TTA
NM_002439.5(MSH3):c.586del (p.Thr196fs)	MSH3	T196fs	not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000643370	5	79965921	5	80670102	643370	634117		NC_000005.10:80670101:AA:A
NM_002439.5(MSH3):c.460_461del (p.Glu154fs)	MSH3	E154fs	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000643014	5	79961062 - 79961063	5	80665243 - 80665244	643014	634103		NC_000005.10:80665242:AGA:A
NM_002439.5(MSH3):c.1308_1309AG[1] (p.Glu437fs)	MSH3		not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000642843	5	79974880 - 79974881	5	80679061 - 80679062	642843	634199		NC_000005.10:80679060:AGAG:AG
NM_002439.5(MSH3):c.1256C>G (p.Ser419Ter)	MSH3	S419*	not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000641273	5	79974828	5	80679009	641273	634192		NC_000005.10:80679008:C:G
NM_002439.5(MSH3):c.1935_1936AT[4] (p.His647fs)	MSH3		not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000640350	5	80063788 - 80063789	5	80767969 - 80767970	640350	634273		NC_000005.10:80767969:TATAT:TATATATAT
NM_002439.5(MSH3):c.1545_1546delinsC (p.Leu515fs)	MSH3		not provided	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000639097	5	80024761 - 80024762	5	80728942 - 80728943	639097	634226		NC_000005.10:80728941:GG:C
NM_002439.5(MSH3):c.3001-2A>C	MSH3		Familial adenomatous polyposis 4	Pathogenic(Last reviewed: Aug 31, 2016)	no assertion criteria provided	VCV000253323	5	80160630	5	80864811	253323	247771	rs886037878	NC_000005.10:80864810:A:C
NM_000112.3(SLC26A2):c.1020_1022delTGT	SLC26A2	V341del, V340del	Osteochondrodysplasia|not provided||Diastrophic dysplasia||Achondrogenesis, type IB|Achondrogenesis, type IB|Diastrophic dysplasia||	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065558	5	149360166 - 149360168	5	149980603 - 149980605	65558	76466	rs121908077	NC_000005.10:149980602:TTGTTGTTGTTGT:TTGTTGTTGT
NM_032682.5(FOXP1):c.598C>T (p.Gln200Ter)	FOXP1	Q200*, Q199*, Q99*, Q100*, Q124*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000521240	3	71096159	3	71047008	521240	511512	rs1553709919	NC_000003.12:71047007:G:A
NM_032682.5(FOXP1):c.1507del (p.Arg503fs)	FOXP1	R403fs, R402fs, R427fs, R502fs, R503fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000520738	3	71026115	3	70976964	520738	511510	rs1553667322	NC_000003.12:70976963:GG:G
NM_002439.5(MSH3):c.296dup (p.Lys100fs)	MSH3		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000822397	5	79952283 - 79952284	5	80656464 - 80656465	822397	808658		NC_000005.10:80656464:AAAAA:AAAAAA
NM_002439.5(MSH3):c.1087dup (p.Thr363fs)	MSH3		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000822099	5	79970860 - 79970861	5	80675041 - 80675042	822099	808679		NC_000005.10:80675041:A:AA
NM_002439.5(MSH3):c.1264C>T (p.Gln422Ter)	MSH3	Q422*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000818733	5	79974836	5	80679017	818733	808681		NC_000005.10:80679016:C:T
NM_002439.5(MSH3):c.978_984del (p.Phe326fs)	MSH3	F326fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000657893	5	79968628 - 79968634	5	80672809 - 80672815	657893	634164		NC_000005.10:80672808:TTCCCGG:
NM_002439.5(MSH3):c.1648_1649dup (p.Asn550fs)	MSH3		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654940	5	80037361 - 80037362	5	80741542 - 80741543	654940	634235		NC_000005.10:80741542:AA:AAAA
NM_002439.5(MSH3):c.802C>T (p.Arg268Ter)	MSH3	R268*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000652518	5	79968072	5	80672253	652518	634145		NC_000005.10:80672252:C:T
NM_002439.5(MSH3):c.1360C>T (p.Arg454Ter)	MSH3	R454*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000644460	5	80021291	5	80725472	644460	634206		NC_000005.10:80725471:C:T
NM_002439.5(MSH3):c.574C>T (p.Gln192Ter)	MSH3	Q192*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000643818	5	79961177	5	80665358	643818	634113		NC_000005.10:80665357:C:T
NM_002439.5(MSH3):c.2760del (p.Tyr921fs)	MSH3	Y921fs	not provided|Familial adenomatous polyposis 4	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000253324	5	80109506	5	80813687	253324	247772	rs751326348	NC_000005.10:80813686:CC:C
NM_002439.5(MSH3):c.2686G>T (p.Gly896Ter)	MSH3	G896*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000640896	5	80109433	5	80813614	640896	634364		NC_000005.10:80813613:G:T
NM_002439.5(MSH3):c.1035del (p.Pro346_Leu347insTer)	MSH3		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000809772	5	79970809	5	80674990	809772	795725		NC_000005.10:80674989:T:
NM_002439.5(MSH3):c.2212A>T (p.Lys738Ter)	MSH3	K738*	not provided|Familial adenomatous polyposis 4|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802123	5	80064781	5	80768962	802123	790565		NC_000005.10:80768961:A:T
NM_001370658.1(BTD):c.1552C>T (p.Arg518Cys)	BTD	R538C, R518C, R540C	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001898	3	15686975	3	15645468	1898	16937	rs80338686	NC_000003.12:15645467:C:T
NM_003060.4(SLC22A5):c.695C>T (p.Thr232Met)	SLC22A5	T232M, T256M	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025386	5	131721062	5	132385370	25386	36720	rs114269482	NC_000005.10:132385369:C:T
NM_003060.4(SLC22A5):c.51C>G (p.Phe17Leu)	SLC22A5	F17L	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000025350	5	131705715	5	132370023	25350	36684	rs11568520	NC_000005.10:132370022:C:G
NM_004656.4(BAP1):c.757C>T (p.Gln253Ter)	BAP1	Q253*	Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000472714	3	52440295	3	52406279	472714	452731	rs776240891	NC_000003.12:52406278:G:A
NM_000551.3(VHL):c.313A>C (p.Thr105Pro)	VHL	T105P	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000496055	3	10183844	3	10142160	496055	486951	rs1553619461	NC_000003.12:10142159:A:C
NM_000551.3(VHL):c.238A>C (p.Ser80Arg)	VHL	S80R	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000496052	3	10183769	3	10142085	496052	487011	rs786202787	NC_000003.12:10142084:A:C
NC_000003.11:g.(?_10183319)_(10183871_?)del	VHL		Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000417616	3	10183319 - 10183871	3	10141635 - 10142187	417616	393129		
NM_000551.3(VHL):c.226_227del (p.Phe76fs)	VHL	F76fs	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000411961	3	10183757 - 10183758	3	10142073 - 10142074	411961	393200	rs1060503552	NC_000003.12:10142072:TT:
NM_198156.3(VHL):c.164_171dup (p.Arg60fs)	VHL		not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280053	3	10183692 - 10183693	3	10142008 - 10142009	280053	264141	rs886041345	NC_000003.12:10142008:GGAGGCCGGG:GGAGGCCGGGAGGCCGGG
NM_022455.4(NSD1):c.5304-1G>C	NSD1		Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216978	5	176696602	5	177269601	216978	213558	rs863224905	NC_000005.10:177269600:G:C
NM_022455.4(NSD1):c.6349C>T (p.Arg2117Ter)	NSD1	R2117*, R1848*	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159412	5	176719045	5	177292044	159412	168264	rs587784190	NC_000005.10:177292043:C:T
NM_022455.4(NSD1):c.5303+1G>C	NSD1		Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159362	5	176694720	5	177267719	159362	168214	rs587784141	NC_000005.10:177267718:G:C
NM_022455.4(NSD1):c.4417C>T (p.Arg1473Ter)	NSD1	R1473*, R1204*	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159331	5	176673717	5	177246716	159331	168183	rs587784117	NC_000005.10:177246715:C:T
NM_022455.4(NSD1):c.3964C>T (p.Arg1322Ter)	NSD1	R1322*, R1053*	not provided|Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159318	5	176665280	5	177238279	159318	168170	rs587784107	NC_000005.10:177238278:C:T
NM_022455.4(NSD1):c.6605G>A (p.Cys2202Tyr)	NSD1	C2202Y, C1933Y	Sotos syndrome 1|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000004146	5	176720974	5	177293973	4146	19185	rs121908071	NC_000005.10:177293972:G:A
PDGFRA, ASP846VAL	PDGFRA	D846V	Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal	Pathogenic(Last reviewed: Jul 11, 2019)	no assertion criteria provided	VCV000635778					635778	623609		
PDGFRA, PRO653LEU	PDGFRA	P653L	Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal	Pathogenic(Last reviewed: Jul 11, 2019)	no assertion criteria provided	VCV000635777					635777	623608		
NM_006206.6(PDGFRA):c.2021C>T (p.Thr674Ile)	PDGFRA	T674I, T687I, T699I	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	Pathogenic(Last reviewed: Mar 27, 2003)	no assertion criteria provided	VCV000013550	4	55144547	4	54278380	13550	28589	rs121908587	NC_000004.12:54278379:C:T
NM_006206.6(PDGFRA):c.1664A>G (p.Tyr555Cys)	PDGFRA	Y555C, Y568C, Y580C	Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000013552	4	55141018	4	54274851	13552	28591	rs121908589	NC_000004.12:54274850:A:G
NM_001080522.2(CC2D2A):c.4179+1del	CC2D2A		not provided|Joubert syndrome 9|Postaxial polydactyly type A1|Oligohydramnios|Polycystic kidney dysplasia|Clubfoot|Narrow chest|Microcephaly|Encephalocele|Meckel syndrome type 6|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056312	4	15589552	4	15587929	56312	70951	rs386833760	NC_000004.12:15587928:GG:G
NM_018297.4(NGLY1):c.1405C>T (p.Arg469Ter)	NGLY1	R427*, R469*, R451*	Congenital disorder of deglycosylation|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488990	3	25773830	3	25732339	488990	481686	rs768131676	NC_000003.12:25732338:G:A
NM_002397.5(MEF2C):c.214del (p.Tyr72fs)	MEF2C	Y72fs	History of neurodevelopmental disorder|Inborn genetic diseases	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000521560	5	88100459	5	88804642	521560	511609	rs1554139723	NC_000005.10:88804641:A:
NM_001354689.3(RAF1):c.781C>G (p.Pro261Ala)	RAF1	P261A, P180A, P147A, P228A	Cardiomyopathy, dilated, 1NN|LEOPARD syndrome 2|Noonan syndrome 5|Primary familial hypertrophic cardiomyopathy|not provided|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040605	3	12645688	3	12604189	40605	49075	rs121434594	NC_000003.12:12604188:G:C
NM_006206.6(PDGFRA):c.1696_1713del (p.Ser566_Glu571del)	PDGFRA		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	VCV000013549	4	55141050 - 55141067	4	54274883 - 54274900	13549	28588	rs606231209	NC_000004.12:54274882:AGCCCAGATGGACATGAA:
NM_006206.6(PDGFRA):c.1679_1693del (p.Arg560_Ser564del)	PDGFRA		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	VCV000013548	4	55141032 - 55141046	4	54274865 - 54274879	13548	28587	rs587776795	NC_000004.12:54274864:AGGGTCATTGAATCAA:A
NM_006206.6(PDGFRA):c.1681_1682insAGAGGG (p.Val561_Ile562insGluArg)	PDGFRA		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	VCV000013547	4	55141030 - 55141031	4	54274863 - 54274864	13547	28586	rs587776794	NC_000004.12:54274863:GAGGG:GAGGGAGAGGG
NM_006206.6(PDGFRA):c.2533_2544del (p.His845_Asn848del)	PDGFRA		Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 31, 2003)	no assertion criteria provided	VCV000013545	4	55152101 - 55152112	4	54285934 - 54285945	13545	28584	rs587776793	NC_000004.12:54285933:CATGATTCGAAC:
NM_006206.6(PDGFRA):c.1977C>G (p.Asn659Lys)	PDGFRA	N659K, N684K, N672K	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375902	4	55144148	4	54277981	375902	362781	rs1057519700	NC_000004.12:54277980:C:G
NM_006206.6(PDGFRA):c.1977C>A (p.Asn659Lys)	PDGFRA	N659K, N684K, N672K	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375901	4	55144148	4	54277981	375901	362780	rs1057519700	NC_000004.12:54277980:C:A
NM_000232.4(SGCB):c.341C>T (p.Ser114Phe)	SGCB	S114F	not provided|Qualitative or quantitative defects of beta-sarcoglycan|Autosomal recessive limb-girdle muscular dystrophy type 2E	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042035	4	52895932	4	52029766	42035	51200	rs150518260	NC_000004.12:52029765:G:A
NM_006206.6(PDGFRA):c.2526_2537del (p.Ile843_Asp846del)	PDGFRA		Gastrointestinal stromal tumor	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000013544	4	55152092 - 55152103	4	54285925 - 54285936	13544	28583	rs1553906053	NC_000004.12:54285924:GACATCATGCATGA:GA
NM_000222.2(KIT):c.2458G>C (p.Asp820His)	KIT	D820H, D816H	Cutaneous melanoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375927	4	55599332	4	54733166	375927	362806	rs1057519710	NC_000004.12:54733165:G:C
NM_000222.2(KIT):c.1674G>T (p.Lys558Asn)	KIT	K558N, K554N	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375911	4	55593608	4	54727442	375911	362790	rs200375589	NC_000004.12:54727441:G:T
NM_024577.3(SH3TC2):c.2642A>G (p.Asn881Ser)	SH3TC2	N881S	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000377021	5	148406653	5	149027090	377021	363899	rs80338930	NC_000005.10:149027089:T:C
NM_000551.3(VHL):c.280G>T (p.Glu94Ter)	VHL	E94*	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000584477	3	10183811	3	10142127	584477	575529	rs5030829	NC_000003.12:10142126:G:T
NM_000551.3(VHL):c.278del (p.Gly93fs)	VHL	G93fs	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428811	3	10183808	3	10142124	428811	420441	rs1131690964	NC_000003.12:10142123:GG:G
NM_000551.3(VHL):c.217C>T (p.Gln73Ter)	VHL	Q73*	Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000223164	3	10183748	3	10142064	223164	224895	rs869025619	NC_000003.12:10142063:C:T
NM_000551.3(VHL):c.263G>C (p.Trp88Ser)	VHL	W88S	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000002220	3	10183794	3	10142110	2220	17259	rs119103277	NC_000003.12:10142109:G:C
NM_004168.4(SDHA):c.990del (p.Arg329_Tyr330insTer)	SDHA		not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000280711	5	233686	5	233571	280711	264235	rs886041867	NC_000005.10:233570:C:
NM_004168.4(SDHA):c.691dup (p.Cys231fs)	SDHA		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000826703	5	228368 - 228369	5	228253 - 228254	826703	808606		NC_000005.10:228253:T:TT
NM_004168.4(SDHA):c.484A>T (p.Arg162Ter)	SDHA	R114*, R162*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000825228	5	226025	5	225910	825228	808595		NC_000005.10:225909:A:T
NM_004168.4(SDHA):c.944dup (p.Gly316fs)	SDHA		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000823258	5	233637 - 233638	5	233522 - 233523	823258	808616		NC_000005.10:233522:GGG:GGGG
NM_004168.4(SDHA):c.310C>T (p.Gln104Ter)	SDHA	Q104*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000822909	5	224634	5	224519	822909	808591		NC_000005.10:224518:C:T
NM_004168.4(SDHA):c.267T>A (p.Cys89Ter)	SDHA	C89*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000821669	5	224591	5	224476	821669	808589		NC_000005.10:224475:T:A
NM_004168.4(SDHA):c.558_567del (p.His187fs)	SDHA	H139fs, H187fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000486394	5	226097 - 226106	5	225982 - 225991	486394	474463	rs1553997826	NC_000005.10:225981:GCCCATCGGTGC:GC
NM_004168.4(SDHA):c.308_309CA[3] (p.Gln104fs)	SDHA		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000230564	5	224631 - 224632	5	224516 - 224517	230564	233450	rs876658637	NC_000005.10:224516:CACA:CACACA
NM_004168.4(SDHA):c.1A>C (p.Met1Leu)	SDHA	M1L	Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000008744	5	218471	5	218356	8744	23783	rs1061517	NC_000005.10:218355:A:C
NM_004168.4(SDHA):c.1123C>T (p.Gln375Ter)	SDHA	Q327*, Q375*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000857818	5	235317	5	235202	857818	830814		NC_000005.10:235201:C:T
NM_004168.4(SDHA):c.468T>G (p.Tyr156Ter)	SDHA	Y156*, Y108*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000857526	5	226009	5	225894	857526	830794		NC_000005.10:225893:T:G
NM_004168.4(SDHA):c.1397dup (p.Cys467fs)	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000855920	5	236678 - 236679	5	236563 - 236564	855920	830819		NC_000005.10:236563:C:CC
NM_004168.4(SDHA):c.1656del (p.Phe552fs)	SDHA	F504fs, F552fs	Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000839974	5	251211	5	251096	839974	830826		NC_000005.10:251095:C:
NM_004168.4(SDHA):c.83dup (p.Gly29fs)	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000836479	5	223615 - 223616	5	223500 - 223501	836479	830782		NC_000005.10:223500:C:CC
NM_004168.4(SDHA):c.181G>T (p.Glu61Ter)	SDHA	E61*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000836392	5	224505	5	224390	836392	830784		NC_000005.10:224389:G:T
NM_004168.4(SDHA):c.508C>T (p.Gln170Ter)	SDHA	Q170*, Q122*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000665061	5	226049	5	225934	665061	633861		NC_000005.10:225933:C:T
NM_004168.4(SDHA):c.619_620delinsC (p.Ser208fs)	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000660785	5	226160 - 226161	5	226045 - 226046	660785	633867		NC_000005.10:226044:AG:C
NM_004168.4(SDHA):c.942_945delinsTCC (p.Glu314fs)	SDHA		Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000657145	5	233638 - 233641	5	233523 - 233526	657145	633883		NC_000005.10:233522:GGGA:TCC
NM_004168.4(SDHA):c.28del (p.Leu10fs)	SDHA	L10fs	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000654714	5	218498	5	218383	654714	633849		NC_000005.10:218382:C:
NM_004168.4(SDHA):c.1579del (p.Arg527fs)	SDHA	R527fs, R479fs	Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000653810	5	251133	5	251018	653810	633908		NC_000005.10:251017:CC:C
NM_004168.4(SDHA):c.5C>A (p.Ser2Ter)	SDHA	S2*	Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000644096	5	218475	5	218360	644096	633848		NC_000005.10:218359:C:A
NM_004168.4(SDHA):c.1258C>T (p.Gln420Ter)	SDHA	Q420*, Q372*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000639589	5	235452	5	235337	639589	633895		NC_000005.10:235336:C:T
NM_004168.4(SDHA):c.880C>T (p.Gln294Ter)	SDHA	Q294*, Q246*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000582775	5	231100	5	230985	582775	563121	rs1560992565	NC_000005.10:230984:C:T
NM_004168.4(SDHA):c.253_256dup (p.Asn86delinsIleTer)	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000576450	5	224576 - 224577	5	224461 - 224462	576450	563109	rs1560986132	NC_000005.10:224461:TTTA:TTTATTTA
NM_004168.4(SDHA):c.46_52dup (p.Leu18fs)	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000574154	5	218510 - 218511	5	218395 - 218396	574154	560293	rs1560980939	NC_000005.10:218395:GGCGCCTGGCGC:GGCGCCTGGCGCCTGGCGC
NM_004168.4(SDHA):c.644_645del (p.Tyr215fs)	SDHA	Y215fs, Y167fs	Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000569511	5	228321 - 228322	5	228206 - 228207	569511	565083	rs1560989804	NC_000005.10:228205:TAT:T
NM_004168.4(SDHA):c.722_726del (p.Asp241fs)	SDHA	D193fs, D241fs	Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000539664	5	228398 - 228402	5	228283 - 228287	539664	521112	rs1553998229	NC_000005.10:228282:GGACGGG:GG
NM_004168.4(SDHA):c.1629T>G (p.Tyr543Ter)	SDHA	Y543*, Y495*	Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000539643	5	251184	5	251069	539643	521149	rs747249998	NC_000005.10:251068:T:G
NM_004168.4(SDHA):c.1547dup (p.Lys517fs)	SDHA		Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000539642	5	240586 - 240587	5	240471 - 240472	539642	521736	rs1554000378	NC_000005.10:240471:A:AA
NM_004168.4(SDHA):c.1615dup (p.Ile539fs)	SDHA		Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000412366	5	251166 - 251167	5	251051 - 251052	412366	395069	rs1554001843	NC_000005.10:251051:AAAA:AAAAA
NM_004168.4(SDHA):c.762_770+17del	SDHA		Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000412346	5	228439 - 228464	5	228324 - 228349	412346	395022	rs1041809852	NC_000005.10:228323:TTGCCACAGGGTAGGAATCTCATTTCT:T
NM_004168.4(SDHA):c.356G>A (p.Trp119Ter)	SDHA	W119*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000856810	5	225577	5	225462	856810	830792		NC_000005.10:225461:G:A
NM_004168.4(SDHA):c.995_996del (p.Pro332fs)	SDHA	P284fs, P332fs	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000575469	5	233691 - 233692	5	233576 - 233577	575469	560303	rs1560994766	NC_000005.10:233575:CT:
NM_004168.4(SDHA):c.897_1260+1del	SDHA		Paragangliomas 5	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000545722	5	233588 - 235450	5	233473 - 235335	545722	536214		
NM_004168.4(SDHA):c.1468G>T (p.Glu490Ter)	SDHA	E490*, E442*	Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000472288	5	240508	5	240393	472288	455120	rs1554000360	NC_000005.10:240392:G:T
NM_022455.4(NSD1):c.6014G>A (p.Arg2005Gln)	NSD1	R2005Q, R1736Q	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159395	5	176710792	5	177283791	159395	168247	rs587784174	NC_000005.10:177283790:G:A
NM_004168.4(SDHA):c.64-2A>G	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000835516	5	223595	5	223480	835516	851976		NC_000005.10:223479:A:G
NM_004168.4(SDHA):c.1795-1G>T	SDHA		Mitochondrial complex II deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000691997	5	254507	5	254392	691997	679825		NC_000005.10:254391:G:T
NM_004168.4(SDHA):c.171dup (p.Val58fs)	SDHA		not provided|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545901	5	224494 - 224495	5	224379 - 224380	545901	536309	rs1553997323	NC_000005.10:224379:A:AA
NM_004168.4(SDHA):c.628C>T (p.Arg210Ter)	SDHA	R210*, R162*	Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000539663	5	228306	5	228191	539663	521370	rs775143272	NC_000005.10:228190:C:T
NM_004168.4(SDHA):c.378del (p.Thr126_Val127insTer)	SDHA		Paragangliomas 5|Mitochondrial complex II deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000472290	5	225598	5	225483	472290	455734	rs1553997617	NC_000005.10:225482:CC:C
NM_004168.4(SDHA):c.1054C>T (p.Arg352Ter)	SDHA	R352*, R304*	Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000239634	5	233750	5	233635	239634	239824	rs746165168	NC_000005.10:233634:C:T
NM_004168.4(SDHA):c.615T>A (p.Tyr205Ter)	SDHA	Y205*, Y157*	Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230290	5	226156	5	226041	230290	233453	rs876658486	NC_000005.10:226040:T:A
NM_004656.4(BAP1):c.122+1G>A	BAP1		Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000644428	3	52443569	3	52409553	644428	651235		NC_000003.12:52409552:C:T
NM_000283.3(PDE6B):c.2193+1G>A	PDE6B		Retinitis pigmentosa|Retinal dystrophy|not provided|Retinitis pigmentosa 40	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167440	4	658734	4	664945	167440	177924	rs727504075	NC_000004.12:664944:G:A
NM_000222.2(KIT):c.2485G>C (p.Ala829Pro)	KIT	A829P, A825P	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	VCV000375933	4	55602664	4	54736498	375933	362812	rs1057519713	NC_000004.12:54736497:G:C
NM_004168.4(SDHA):c.553C>T (p.Gln185Ter)	SDHA	Q185*, Q137*	Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480771	5	226094	5	225979	480771	474395	rs775827529	NC_000005.10:225978:C:T
NM_004168.4(SDHA):c.457-2_457del	SDHA		Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000239672	5	225995 - 225997	5	225880 - 225882	239672	239810	rs878854632	NC_000005.10:225879:CAGC:C
NM_004168.4(SDHA):c.1151C>G (p.Ser384Ter)	SDHA	S384*, S336*	Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230877	5	235345	5	235230	230877	233457	rs151170408	NC_000005.10:235229:C:G
NM_004168.4(SDHA):c.1664G>A (p.Gly555Glu)	SDHA	G555E, G507E	Mitochondrial complex II deficiency|Dilated cardiomyopathy 1GG	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000008745	5	251453	5	251338	8745	23784	rs137852768	NC_000005.10:251337:G:A
NM_002439.5(MSH3):c.2319-1G>A	MSH3		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 4|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000253325	5	80074538	5	80778719	253325	247773	rs866260675	NC_000005.10:80778718:G:A
NC_000003.12:g.(?_10141828)_(10146656_?)del	VHL		Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830508	3	10183512 - 10188340			830508	819302		
NM_000551.3(VHL):c.339_340+5del	VHL		Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000639348	3	10183868 - 10183874	3	10142184 - 10142190	639348	651054		NC_000003.12:10142183:CGAGGTACG:CG
NM_000551.3(VHL):c.264G>C (p.Trp88Cys)	VHL	W88C	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000580847	3	10183795	3	10142111	580847	558732	rs869025622	NC_000003.12:10142110:G:C
NM_000551.3(VHL):c.179_192del (p.Arg60fs)	VHL	R60fs	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423409	3	10183707 - 10183720	3	10142023 - 10142036	423409	406063	rs1064796408	NC_000003.12:10142022:CGCGGCCCGTGCTGCGC:CGC
NM_000551.3(VHL):c.258del (p.Val87fs)	VHL	V87fs	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220487	3	10183787	3	10142103	220487	221347	rs864622545	NC_000003.12:10142102:CCC:CC
NM_000551.3(VHL):c.337C>T (p.Arg113Ter)	VHL	R113*	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000220414	3	10183868	3	10142184	220414	221350	rs5030810	NC_000003.12:10142183:C:T
NM_004168.4(SDHA):c.1526_1527delinsGA (p.Ser509Ter)	SDHA		Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418987	5	240566 - 240567	5	240451 - 240452	418987	406740	rs1064793567	NC_000005.10:240450:CG:GA
NM_004168.4(SDHA):c.985C>T (p.Arg329Ter)	SDHA	R329*, R281*	Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412328	5	233681	5	233566	412328	395200	rs771328239	NC_000005.10:233565:C:T
NM_001370658.1(BTD):c.410G>A (p.Arg137His)	BTD	R157H, R137H, R159H	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038290	3	15685833	3	15644326	38290	46845	rs146015592	NC_000003.12:15644325:G:A
NM_001370658.1(BTD):c.1429C>T (p.Pro477Ser)	BTD	P497S, P477S, P499S	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025094	3	15686852	3	15645345	25094	36428	rs138818907	NC_000003.12:15645344:C:T
NM_001145847.2(PROM1):c.1327dup (p.Tyr443fs)	PROM1		PROM1-Related Disorders|Retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 41|Cone-rod dystrophy 12|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372711	4	16008260 - 16008261	4	16006637 - 16006638	372711	359518	rs543698823	NC_000004.12:16006637:AAAAAA:AAAAAAA
NM_022455.4(NSD1):c.6454C>T (p.Arg2152Ter)	NSD1	R2152*, R1883*	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159421	5	176719150	5	177292149	159421	168273	rs587784199	NC_000005.10:177292148:C:T
NM_022455.4(NSD1):c.6049C>T (p.Arg2017Trp)	NSD1	R2017W, R1748W	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159397	5	176710827	5	177283826	159397	168249	rs587784176	NC_000005.10:177283825:C:T
NM_004168.4(SDHA):c.667del (p.Asp223fs)	SDHA	D175fs, D223fs	Paragangliomas 5|Mitochondrial complex II deficiency|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141876	5	228344	5	228229	141876	151590	rs587782077	NC_000005.10:228228:GG:G
NM_000222.2(KIT):c.2465A>T (p.Asn822Ile)	KIT	N822I, N818I	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2014)	no assertion criteria provided	VCV000375930	4	55599339	4	54733173	375930	362809	rs993022333	NC_000004.12:54733172:A:T
NM_000222.2(KIT):c.1679T>G (p.Val560Gly)	KIT	V560G, V556G	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375916	4	55593613	4	54727447	375916	362795	rs121913521	NC_000004.12:54727446:T:G
NM_000222.2(KIT):c.1679T>A (p.Val560Asp)	KIT	V560D, V556D	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375914	4	55593613	4	54727447	375914	362793	rs121913521	NC_000004.12:54727446:T:A
NM_000222.2(KIT):c.1676T>G (p.Val559Gly)	KIT	V559G, V555G	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375912	4	55593610	4	54727444	375912	362791	rs121913517	NC_000004.12:54727443:T:G
NM_007118.4(TRIO):c.2302C>T (p.Gln768Ter)	TRIO	Q768*	Mental retardation, autosomal dominant 44|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000521730	5	14359551	5	14359442	521730	511569	rs1554062562	NC_000005.10:14359441:C:T
NM_000030.3(AGXT):c.33dup (p.Lys12fs)	AGXT		not provided|Primary hyperoxaluria, type I|Primary hyperoxaluria	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140583	2	241808307 - 241808308	2	240868890 - 240868891	140583	150264	rs180177201	NC_000002.12:240868890:CCCCCCCC:CCCCCCCCC
NC_000003.12:g.(?_10141848)_(10142197_?)del	VHL		Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000833198	3	10183532 - 10183881			833198	819303		
NC_000003.12:g.(?_10141848)_(10143024_?)del	VHL		Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830486	3	10183532 - 10184708			830486	819305		
NC_000003.11:g.(?_10183522)_(10183881_?)del	VHL		Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000656836	3	10183522 - 10183881	3	10141838 - 10142197	656836	651028		
NM_000551.3(VHL):c.336C>G (p.Tyr112Ter)	VHL	Y112*	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633015	3	10183867	3	10142183	633015	621144	rs751232153	NC_000003.12:10142182:C:G
NM_000551.3(VHL):c.163dup (p.Glu55fs)	VHL		Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000223159	3	10183692 - 10183693	3	10142008 - 10142009	223159	224889	rs869025615	NC_000003.12:10142008:GG:GGG
NM_000551.3(VHL):c.263G>A (p.Trp88Ter)	VHL	W88*	Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000182978	3	10183794	3	10142110	182978	180116	rs119103277	NC_000003.12:10142109:G:A
NM_000551.3(VHL):c.194C>T (p.Ser65Leu)	VHL	S65L	Von Hippel-Lindau syndrome|Cerebellar hemangioblastoma|Pancreatic cysts|Spinal hemangioblastoma|Retinal capillary hemangioma	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000182975	3	10183725	3	10142041	182975	180112	rs5030826	NC_000003.12:10142040:C:T
NM_000551.3(VHL):c.192del (p.Ser65fs)	VHL	S65fs	Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000182972	3	10183723	3	10142039	182972	180111	rs730882031	NC_000003.12:10142038:C:
NM_001369.2(DNAH5):c.12295del (p.Leu4099fs)	DNAH5	L4099fs	not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000817933	5	13719195	5	13719086	817933	805409		NC_000005.10:13719085:G:
NM_001369.2(DNAH5):c.271G>T (p.Glu91Ter)	DNAH5	E91*	not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000596293	5	13928209	5	13928100	596293	587354	rs750649191	NC_000005.10:13928099:C:A
NM_001369.2(DNAH5):c.4797-1G>C	DNAH5		not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000595076	5	13859715	5	13859606	595076	586138	rs1561449604	NC_000005.10:13859605:C:G
NM_001369.2(DNAH5):c.6688-1G>T	DNAH5		not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000379701	5	13820609	5	13820500	379701	369630	rs1057520697	NC_000005.10:13820499:C:A
NM_001369.2(DNAH5):c.10441C>T (p.Arg3481Ter)	DNAH5	R3481*	not provided	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000265361	5	13754426	5	13754317	265361	259810	rs886039500	NC_000005.10:13754316:G:A
NM_001369.2(DNAH5):c.6605del (p.Phe2201_Leu2202insTer)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000864614	5	13823454	5	13823345	864614	830225		NC_000005.10:13823344:AAAAA:AAAA
NM_001369.2(DNAH5):c.9980del (p.Leu3327fs)	DNAH5	L3327fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000863480	5	13766206	5	13766097	863480	830197		NC_000005.10:13766096:A:
NM_001369.2(DNAH5):c.7540_7543dup (p.Thr2515fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000862156	5	13810233 - 13810234	5	13810124 - 13810125	862156	830219		NC_000005.10:13810124:TCCCT:TCCCTCCCT
NM_001369.2(DNAH5):c.9346C>T (p.Arg3116Ter)	DNAH5	R3116*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000861235	5	13776575	5	13776466	861235	830200		NC_000005.10:13776465:G:A
NM_001369.2(DNAH5):c.13285C>T (p.Arg4429Ter)	DNAH5	R4429*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000856680	5	13708285	5	13708176	856680	830179		NC_000005.10:13708175:G:A
NM_001369.2(DNAH5):c.1054G>T (p.Glu352Ter)	DNAH5	E352*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000855983	5	13917287	5	13917178	855983	830349		NC_000005.10:13917177:C:A
NM_001369.2(DNAH5):c.2734G>T (p.Glu912Ter)	DNAH5	E912*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000854037	5	13886082	5	13885973	854037	830296		NC_000005.10:13885972:C:A
NM_001369.2(DNAH5):c.90_105dup (p.Arg36fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000844653	5	13931305 - 13931306	5	13931196 - 13931197	844653	830356		NC_000005.10:13931196:CGCATCCAAAAGAGCCCGC:CGCATCCAAAAGAGCCCGCATCCAAAAGAGCCCGC
NM_001369.2(DNAH5):c.10930G>T (p.Gly3644Ter)	DNAH5	G3644*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000844652	5	13752341	5	13752232	844652	830192		NC_000005.10:13752231:C:A
NM_001369.2(DNAH5):c.12850dup (p.Tyr4284fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000842179	5	13716654 - 13716655	5	13716545 - 13716546	842179	830181		NC_000005.10:13716545:AAAAA:AAAAAA
NC_000005.10:g.13810167_13810170GTCC[1]	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000842143	5	13810274 - 13810277	5	13810165 - 13810168	842143	830221		NC_000005.10:13810164:CCGTCCGTCC:CCGTCC
NM_001369.2(DNAH5):c.12287G>A (p.Trp4096Ter)	DNAH5	W4096*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000839512	5	13719203	5	13719094	839512	830185		NC_000005.10:13719093:C:T
NM_001369.2(DNAH5):c.6682A>T (p.Arg2228Ter)	DNAH5	R2228*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000839328	5	13823377	5	13823268	839328	830224		NC_000005.10:13823267:T:A
NM_001369.2(DNAH5):c.11070del (p.Phe3690fs)	DNAH5	F3690fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000837715	5	13751328	5	13751219	837715	830191		NC_000005.10:13751218:AAA:AA
NM_001369.2(DNAH5):c.9039dup (p.Thr3014fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000835616	5	13777376 - 13777377	5	13777267 - 13777268	835616	830203		NC_000005.10:13777267:G:GG
NM_001369.2(DNAH5):c.9514dup (p.His3172fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000835399	5	13770948 - 13770949	5	13770839 - 13770840	835399	830199		NC_000005.10:13770839:GGG:GGGG
NC_000005.10:g.(?_13718872)_(13721255_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000833302	5	13718981 - 13721364			833302	819548		
NC_000005.10:g.(?_13691974)_(13944448_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000833192	5	13692083 - 13944557			833192	819547		
NC_000005.10:g.(?_13765966)_(13769625_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000832523	5	13766075 - 13769734			832523	819550		
NC_000005.10:g.(?_13765956)_(13769635_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000832375	5	13766065 - 13769744			832375	819549		
NC_000005.10:g.(?_13830078)_(13842859_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000831792	5	13830187 - 13842968			831792	819553		
NC_000005.10:g.(?_13691964)_(13944458_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000831258	5	13692073 - 13944567			831258	819546		
NM_001369.2(DNAH5):c.9694C>T (p.Gln3232Ter)	DNAH5	Q3232*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000663927	5	13769636	5	13769527	663927	633209		NC_000005.10:13769526:G:A
NC_000005.9:g.(?_13792093)_(13944557_?)dup	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000662867	5	13792093 - 13944557	5	13791984 - 13944448	662867	651226		
NM_001369.2(DNAH5):c.5266G>T (p.Glu1756Ter)	DNAH5	E1756*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000661125	5	13844951	5	13844842	661125	633244		NC_000005.10:13844841:C:A
NM_001369.2(DNAH5):c.12631G>T (p.Glu4211Ter)	DNAH5	E4211*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000660339	5	13717498	5	13717389	660339	633193		NC_000005.10:13717388:C:A
NM_001369.2(DNAH5):c.11804C>A (p.Ser3935Ter)	DNAH5	S3935*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000659274	5	13729627	5	13729518	659274	633197		NC_000005.10:13729517:G:T
NM_001369.2(DNAH5):c.8869del (p.Val2957fs)	DNAH5	V2957fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000658476	5	13781020	5	13780911	658476	633216		NC_000005.10:13780910:CCCC:CCC
NM_001369.2(DNAH5):c.5037T>A (p.Cys1679Ter)	DNAH5	C1679*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000658359	5	13850838	5	13850729	658359	633247		NC_000005.10:13850728:A:T
NM_001369.2(DNAH5):c.9609_9612delGAAT	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000656460	5	13769718 - 13769721	5	13769609 - 13769612	656460	651366		NC_000005.10:13769608:ATTCATTC:ATTC
NM_001369.2(DNAH5):c.8999del (p.Arg3000fs)	DNAH5	R3000fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000656450	5	13777417	5	13777308	656450	633214		NC_000005.10:13777307:C:
NM_001369.2(DNAH5):c.13432_13435del (p.His4478fs)	DNAH5	H4478fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000656057	5	13701449 - 13701452	5	13701340 - 13701343	656057	633189		NC_000005.10:13701339:AGTGAG:AG
NM_001369.2(DNAH5):c.8383C>T (p.Arg2795Ter)	DNAH5	R2795*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000655872	5	13792168	5	13792059	655872	633228		NC_000005.10:13792058:G:A
NM_001369.2(DNAH5):c.46C>T (p.Arg16Ter)	DNAH5	R16*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000654540	5	13944502	5	13944393	654540	633484		NC_000005.10:13944392:G:A
NM_001369.2(DNAH5):c.4400dup (p.Leu1467fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000654148	5	13864701 - 13864702	5	13864592 - 13864593	654148	633253		NC_000005.10:13864592:AAAAAA:AAAAAAA
NM_001369.2(DNAH5):c.5162C>G (p.Ser1721Ter)	DNAH5	S1721*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000653170	5	13845055	5	13844946	653170	633246		NC_000005.10:13844945:G:C
NM_001369.2(DNAH5):c.7436_7450delinsC (p.His2479fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000652693	5	13810327 - 13810341	5	13810218 - 13810232	652693	633234		NC_000005.10:13810217:ACAGCCGCCCCAGGT:G
NM_001369.2(DNAH5):c.10452_10464del (p.His3484fs)	DNAH5	H3484fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000652415	5	13754403 - 13754415	5	13754294 - 13754306	652415	633206		NC_000005.10:13754293:TGTCTGCATCTTGTGTCTGCATC:TGTCTGCATC
NM_001369.2(DNAH5):c.9480T>A (p.Cys3160Ter)	DNAH5	C3160*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000652346	5	13770983	5	13770874	652346	633212		NC_000005.10:13770873:A:T
NM_001369.2(DNAH5):c.9534C>A (p.Tyr3178Ter)	DNAH5	Y3178*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000652322	5	13770929	5	13770820	652322	633210		NC_000005.10:13770819:G:T
NM_001369.2(DNAH5):c.5663_5664CT[1] (p.Leu1889fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000648455	5	13841058 - 13841059	5	13840949 - 13840950	648455	633241		NC_000005.10:13840948:AGAG:AG
NM_001369.2(DNAH5):c.1639del (p.Leu547fs)	DNAH5	L547fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000646752	5	13911500	5	13911391	646752	633467		NC_000005.10:13911390:GG:G
NM_001369.2(DNAH5):c.1722del (p.Lys574fs)	DNAH5	K574fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000644451	5	13902170	5	13902061	644451	633465		NC_000005.10:13902060:TTT:TT
NM_001369.2(DNAH5):c.9124C>T (p.Arg3042Ter)	DNAH5	R3042*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000643375	5	13776797	5	13776688	643375	633213		NC_000005.10:13776687:G:A
NM_001369.2(DNAH5):c.12760_12761AG[1] (p.Arg4254fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000643108	5	13716742 - 13716743	5	13716633 - 13716634	643108	633192		NC_000005.10:13716632:CTCT:CT
NM_001369.2(DNAH5):c.1915C>T (p.Gln639Ter)	DNAH5	Q639*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000642659	5	13901498	5	13901389	642659	633461		NC_000005.10:13901388:G:A
NM_001369.2(DNAH5):c.6419_6420TG[2] (p.Cys2141_Glu2142delinsTer)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000640607	5	13829639 - 13829640	5	13829530 - 13829531	640607	633238		NC_000005.10:13829529:CACACA:CACA
NM_001369.2(DNAH5):c.11853del (p.Lys3951fs)	DNAH5	K3951fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000639711	5	13729578	5	13729469	639711	633196		NC_000005.10:13729468:TTT:TT
NC_000005.9:g.(?_13913832)_(13914087_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000583441	5	13913832 - 13914087	5	13913723 - 13913978	583441	564111		
NM_001369.2(DNAH5):c.3587_3588CT[1] (p.Leu1197fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000579551	5	13871681 - 13871682	5	13871572 - 13871573	579551	562829	rs1561477725	NC_000005.10:13871571:AGAG:AG
NM_001369.2(DNAH5):c.9620del (p.Leu3207fs)	DNAH5	L3207fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000579428	5	13769710	5	13769601	579428	560232	rs769691641	NC_000005.10:13769600:AA:A
NM_001369.2(DNAH5):c.5198C>A (p.Ser1733Ter)	DNAH5	S1733*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000577598	5	13845019	5	13844910	577598	560246	rs146087064	NC_000005.10:13844909:G:T
NM_001369.2(DNAH5):c.5059C>T (p.Gln1687Ter)	DNAH5	Q1687*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000576377	5	13850816	5	13850707	576377	560155	rs1188507108	NC_000005.10:13850706:G:A
NM_001369.2(DNAH5):c.9235C>T (p.Arg3079Ter)	DNAH5	R3079*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000575414	5	13776686	5	13776577	575414	560236	rs1175877764	NC_000005.10:13776576:G:A
NM_001369.2(DNAH5):c.3378_3379insTG (p.Ile1127Ter)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000574046	5	13876810 - 13876811	5	13876701 - 13876702	574046	560159	rs1561487416	NC_000005.10:13876701::CA
NM_001369.2(DNAH5):c.997C>T (p.Arg333Ter)	DNAH5	R333*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000573133	5	13917344	5	13917235	573133	562840	rs771956532	NC_000005.10:13917234:G:A
NM_001369.2(DNAH5):c.13346G>A (p.Trp4449Ter)	DNAH5	W4449*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000571327	5	13701538	5	13701429	571327	560228	rs1561073938	NC_000005.10:13701428:C:T
NM_001369.2(DNAH5):c.13060del (p.Ala4354fs)	DNAH5	A4354fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000568028	5	13714579	5	13714470	568028	560141	rs1370489117	NC_000005.10:13714469:CC:C
NM_001369.2(DNAH5):c.787_790CAGA[1] (p.Thr264fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000566807	5	13920593 - 13920596	5	13920484 - 13920487	566807	562841	rs1391084505	NC_000005.10:13920483:TCTGTCTGT:TCTGT
NM_001369.2(DNAH5):c.11907G>A (p.Trp3969Ter)	DNAH5	W3969*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000566769	5	13727742	5	13727633	566769	562785	rs1561122898	NC_000005.10:13727632:C:T
NM_001369.2(DNAH5):c.8864del (p.Val2955fs)	DNAH5	V2955fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000565985	5	13781025	5	13780916	565985	564739	rs1561241156	NC_000005.10:13780915:A:
NM_001369.2(DNAH5):c.3341_3342del (p.Lys1114fs)	DNAH5	K1114fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000525454	5	13876847 - 13876848	5	13876738 - 13876739	525454	521218	rs768881056	NC_000005.10:13876737:TTT:T
NM_001369.2(DNAH5):c.5881dup (p.Arg1961fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000525430	5	13839465 - 13839466	5	13839356 - 13839357	525430	521020	rs1554072027	NC_000005.10:13839356:T:TT
NM_001369.2(DNAH5):c.3466del (p.Ile1156fs)	DNAH5	I1156fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000525379	5	13871805	5	13871696	525379	521171	rs775866092	NC_000005.10:13871695:T:
NM_001369.2(DNAH5):c.8321_8322insC (p.Trp2774fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000525360	5	13792229 - 13792230	5	13792120 - 13792121	525360	520998	rs1554050517	NC_000005.10:13792120::G
NM_001369.2(DNAH5):c.12586C>T (p.Gln4196Ter)	DNAH5	Q4196*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000525310	5	13717543	5	13717434	525310	520718	rs886059965	NC_000005.10:13717433:G:A
NM_001369.2(DNAH5):c.4702del (p.Arg1568fs)	DNAH5	R1568fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000525285	5	13862751	5	13862642	525285	520768	rs1554081658	NC_000005.10:13862641:GGG:GG
NM_001369.2(DNAH5):c.4157del (p.Thr1386fs)	DNAH5	T1386fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000525276	5	13865975	5	13865866	525276	521217	rs1554082872	NC_000005.10:13865865:G:
NM_001369.2(DNAH5):c.10504del (p.Arg3502fs)	DNAH5	R3502fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000525240	5	13754363	5	13754254	525240	520981	rs1554035330	NC_000005.10:13754253:TTT:TT
NM_001369.2(DNAH5):c.8604_8605CA[1] (p.Thr2869fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000454810	5	13788865 - 13788866	5	13788756 - 13788757	454810	454536	rs1554049087	NC_000005.10:13788755:TGTGT:TGT
NM_001369.2(DNAH5):c.7914dup (p.Arg2639fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000454806	5	13794140 - 13794141	5	13794031 - 13794032	454806	454642	rs749082955	NC_000005.10:13794031:TTT:TTTT
NM_001369.2(DNAH5):c.6932_6935del (p.Asp2311fs)	DNAH5	D2311fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000454796	5	13817710 - 13817713	5	13817601 - 13817604	454796	454643	rs1554062097	NC_000005.10:13817600:CAGTCA:CA
NM_001369.2(DNAH5):c.5482C>T (p.Gln1828Ter)	DNAH5	Q1828*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000454783	5	13841803	5	13841694	454783	455114	rs1354919632	NC_000005.10:13841693:G:A
NM_001369.2(DNAH5):c.5118C>G (p.Tyr1706Ter)	DNAH5	Y1706*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000454780	5	13845099	5	13844990	454780	454577	rs1554074565	NC_000005.10:13844989:G:C
NM_001369.2(DNAH5):c.3943G>T (p.Glu1315Ter)	DNAH5	E1315*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000454773	5	13867993	5	13867884	454773	454585	rs753397685	NC_000005.10:13867883:C:A
NM_001369.2(DNAH5):c.3905del (p.Leu1302fs)	DNAH5	L1302fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000454772	5	13868031	5	13867922	454772	454588	rs754698253	NC_000005.10:13867921:A:
NM_001369.2(DNAH5):c.2772del (p.Thr924_Leu925insTer)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000454761	5	13885309	5	13885200	454761	454679	rs1554090622	NC_000005.10:13885199:GG:G
NM_001369.2(DNAH5):c.2710G>T (p.Glu904Ter)	DNAH5	E904*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000454760	5	13886106	5	13885997	454760	454681	rs1554090927	NC_000005.10:13885996:C:A
NM_001369.2(DNAH5):c.1611C>G (p.Tyr537Ter)	DNAH5	Y537*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000454753	5	13911528	5	13911419	454753	454627	rs367877988	NC_000005.10:13911418:G:C
NM_001369.2(DNAH5):c.1517dup (p.Asp506fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000454749	5	13913870 - 13913871	5	13913761 - 13913762	454749	455437	rs1554101045	NC_000005.10:13913761:T:TT
NM_001369.2(DNAH5):c.1432C>T (p.Arg478Ter)	DNAH5	R478*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000454748	5	13913956	5	13913847	454748	454630	rs747900131	NC_000005.10:13913846:G:A
NM_001369.2(DNAH5):c.13426C>T (p.Arg4476Ter)	DNAH5	R4476*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000454743	5	13701458	5	13701349	454743	455020	rs767716511	NC_000005.10:13701348:G:A
NM_001369.2(DNAH5):c.13338del (p.Ala4447fs)	DNAH5	A4447fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000454742	5	13708232	5	13708123	454742	455023	rs1554017211	NC_000005.10:13708122:TTTTTT:TTTTT
NM_001369.2(DNAH5):c.10858C>T (p.Arg3620Ter)	DNAH5	R3620*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000454728	5	13753356	5	13753247	454728	455350	rs1283070426	NC_000005.10:13753246:G:A
NM_001369.2(DNAH5):c.10849_10852AAAG[1] (p.Glu3618fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000454727	5	13753358 - 13753361	5	13753249 - 13753252	454727	454611	rs1353723750	NC_000005.10:13753248:CTTTCTTT:CTTT
NC_000005.9:g.(?_13824308)_(13830884_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000417569	5	13824308 - 13830884	5	13824199 - 13830775	417569	394282		
NM_001369.2(DNAH5):c.10910del (p.Leu3637fs)	DNAH5	L3637fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000407260	5	13752361	5	13752252	407260	394822	rs769691189	NC_000005.10:13752251:A:
NM_001369.2(DNAH5):c.13331G>A (p.Trp4444Ter)	DNAH5	W4444*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000407247	5	13708239	5	13708130	407247	394977	rs1060501467	NC_000005.10:13708129:C:T
NM_001369.2(DNAH5):c.12599dup (p.Phe4201fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000407238	5	13717529 - 13717530	5	13717420 - 13717421	407238	394816	rs1554020233	NC_000005.10:13717420:TT:TTT
NM_001369.2(DNAH5):c.8024_8025dup (p.Val2676Ter)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000407233	5	13793822 - 13793823	5	13793713 - 13793714	407233	395008	rs1060501459	NC_000005.10:13793713:TAT:TATAT
NM_001369.2(DNAH5):c.2533C>T (p.Gln845Ter)	DNAH5	Q845*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000407232	5	13891129	5	13891020	407232	395031	rs1060501458	NC_000005.10:13891019:G:A
NM_001369.2(DNAH5):c.6273_6274delinsA (p.Glu2092fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000407228	5	13829789 - 13829790	5	13829680 - 13829681	407228	395009	rs1060501457	NC_000005.10:13829679:CC:T
NM_001369.2(DNAH5):c.6304C>T (p.Arg2102Cys)	DNAH5	R2102C	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000407218	5	13829759	5	13829650	407218	394840	rs767019228	NC_000005.10:13829649:G:A
NM_001369.2(DNAH5):c.559G>T (p.Glu187Ter)	DNAH5	E187*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 19, 2016)	criteria provided, single submitter	VCV000407216	5	13922317	5	13922208	407216	395406	rs759059925	NC_000005.10:13922207:C:A
NM_001369.2(DNAH5):c.8465G>A (p.Trp2822Ter)	DNAH5	W2822*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 4, 2016)	criteria provided, single submitter	VCV000407212	5	13789007	5	13788898	407212	395005	rs1060501455	NC_000005.10:13788897:C:T
NM_001369.2(DNAH5):c.278-?_438+?del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000254079	5	13923389 - 13923549	5	13923280 - 13923440	254079	248496		
NM_001369.2(DNAH5):c.7034G>A (p.Trp2345Ter)	DNAH5	W2345*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000238985	5	13814910	5	13814801	238985	239734	rs755596256	NC_000005.10:13814800:C:T
NM_001369.2(DNAH5):c.6508dup (p.Arg2170fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	VCV000238983	5	13824378 - 13824379	5	13824269 - 13824270	238983	239736	rs878854458	NC_000005.10:13824269:TTTTT:TTTTTT
NM_001369.2(DNAH5):c.5290T>C (p.Ser1764Pro)	DNAH5	S1764P	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000238980	5	13841995	5	13841886	238980	239739	rs748763552	NC_000005.10:13841885:A:G
NM_001369.2(DNAH5):c.3291dup (p.Pro1098fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000238968	5	13876897 - 13876898	5	13876788 - 13876789	238968	239748	rs762081081	NC_000005.10:13876788:T:TT
NM_001369.2(DNAH5):c.5557A>T (p.Lys1853Ter)	DNAH5	K1853*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000220581	5	13841167	5	13841058	220581	221599	rs748618094	NC_000005.10:13841057:T:A
NM_001369.2(DNAH5):c.6335_6336insT (p.Gln2112fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000220402	5	13829727 - 13829728	5	13829618 - 13829619	220402	221598	rs779506456	NC_000005.10:13829618::A
NM_001369.2(DNAH5):c.9502C>T (p.Arg3168Ter)	DNAH5	R3168*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000216085	5	13770961	5	13770852	216085	212499	rs863224504	NC_000005.10:13770851:G:A
NM_001369.2(DNAH5):c.(?_-1)_(*1_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000216083					216083	213506		
NM_001369.2(DNAH5):c.8998C>T (p.Arg3000Ter)	DNAH5	R3000*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000188388	5	13777418	5	13777309	188388	186047	rs769054713	NC_000005.10:13777308:G:A
NM_001369.2(DNAH5):c.3139G>A (p.Gly1047Arg)	DNAH5	G1047R	Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039652	5	13883048	5	13882939	39652	48251		NC_000005.10:13882938:C:T
NM_001369.2(DNAH5):c.5130dup (p.Arg1711fs)	DNAH5		Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006481	5	13845086 - 13845087	5	13844977 - 13844978	6481	21520		NC_000005.10:13844977:TTTTTT:TTTTTTT
NM_001369.2(DNAH5):c.1828C>T (p.Gln610Ter)	DNAH5	Q610*	Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006480	5	13901585	5	13901476	6480	21519	rs121908853	NC_000005.10:13901475:G:A
DNAH5, IVS74AS, G-C, -1	DNAH5		Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006479					6479	21518		
NM_001369.2(DNAH5):c.10555G>C (p.Gly3519Arg)	DNAH5	G3519R	Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006478	5	13754312	5	13754203	6478	21517	rs79967166	NC_000005.10:13754202:C:G
DNAH5, 1-BP INS, 5563A	DNAH5		Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006477					6477	21516		
NM_001369.2(DNAH5):c.4360C>T (p.Arg1454Ter)	DNAH5	R1454*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000853579	5	13864742	5	13864633	853579	830237		NC_000005.10:13864632:G:A
NM_001369.2(DNAH5):c.3484C>T (p.Gln1162Ter)	DNAH5	Q1162*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000852814	5	13871787	5	13871678	852814	830240		NC_000005.10:13871677:G:A
NM_001369.2(DNAH5):c.8167C>T (p.Gln2723Ter)	DNAH5	Q2723*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000665164	5	13793681	5	13793572	665164	633229		NC_000005.10:13793571:G:A
NM_001369.2(DNAH5):c.1852C>T (p.Arg618Ter)	DNAH5	R618*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000644218	5	13901561	5	13901452	644218	633463		NC_000005.10:13901451:G:A
NM_001369.2(DNAH5):c.1089+1G>A	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000572984	5	13917251	5	13917142	572984	560260	rs574586008	NC_000005.10:13917141:C:T
NM_001369.2(DNAH5):c.13338+5G>A	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000572293	5	13708227	5	13708118	572293	564698	rs374718437	NC_000005.10:13708117:C:T
NM_001369.2(DNAH5):c.8528T>C (p.Phe2843Ser)	DNAH5	F2843S	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000525375	5	13788944	5	13788835	525375	521144	rs77377082	NC_000005.10:13788834:A:G
NM_001369.2(DNAH5):c.252T>G (p.Tyr84Ter)	DNAH5	Y84*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000525260	5	13928228	5	13928119	525260	520784	rs754982008	NC_000005.10:13928118:A:C
NM_001369.2(DNAH5):c.7896_7897AG[1] (p.Glu2633fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000454805	5	13794154 - 13794157	5	13794045 - 13794048	454805	455400	rs1443540935	NC_000005.10:13794044:CTCTCT:CT
NM_001369.2(DNAH5):c.6343del (p.Ile2114_Ile2115insTer)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000454791	5	13829720	5	13829611	454791	454574	rs1474945018	NC_000005.10:13829610:T:
NM_001369.2(DNAH5):c.13633T>C (p.Trp4545Arg)	DNAH5	W4545R	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000454745	5	13700839	5	13700730	454745	455335	rs1161303371	NC_000005.10:13700729:A:G
NC_000005.10:g.(?_13864387)_(13868002_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000832504	5	13864496 - 13868111			832504	819554		
NM_001369.2(DNAH5):c.3037_3040del (p.Val1014fs)	DNAH5	V1014fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000667393	5	13883147 - 13883150	5	13883038 - 13883041	667393	654366		NC_000005.10:13883037:CGCT:
NM_001369.2(DNAH5):c.11029-2A>T	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000645014	5	13751371	5	13751262	645014	651293		NC_000005.10:13751261:T:A
NM_001369.2(DNAH5):c.2984-2A>C	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000578086	5	13883205	5	13883096	578086	562833	rs757801770	NC_000005.10:13883095:T:G
NM_001369.2(DNAH5):c.9897+1G>C	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000568873	5	13769068	5	13768959	568873	560145	rs914675446	NC_000005.10:13768958:C:G
NM_001369.2(DNAH5):c.2250_2259+674del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000568016	5	13899641 - 13900324	5	13899532 - 13900215	568016	560258	rs1561532139	
NM_001369.2(DNAH5):c.12910-1G>C	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000566788	5	13714730	5	13714621	566788	560143	rs1561097225	NC_000005.10:13714620:C:G
NM_001369.2(DNAH5):c.12617G>A (p.Trp4206Ter)	DNAH5	W4206*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557901	5	13717512	5	13717403	557901	543686	rs372118787	NC_000005.10:13717402:C:T
NC_000005.9:g.(?_13864486)_(13868121_?)del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000525589	5	13864486 - 13868121	5	13864377 - 13868012	525589	520583		
NM_001369.2(DNAH5):c.2283_2284del	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523616	5	13894906 - 13894907	5	13894797 - 13894798	523616	514267	rs1462578042	NC_000005.10:13894796:CTCTCT:CTCT
NM_001369.2(DNAH5):c.6293del (p.Lys2098fs)	DNAH5	K2098fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000407236	5	13829770	5	13829661	407236	394842	rs1060501461	NC_000005.10:13829660:TT:T
NM_001369.2(DNAH5):c.12265C>T (p.Gln4089Ter)	DNAH5	Q4089*	not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000407227	5	13721123	5	13721014	407227	394730	rs1060501456	NC_000005.10:13721013:G:A
NM_001369.2(DNAH5):c.5983C>T (p.Arg1995Ter)	DNAH5	R1995*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000407220	5	13830784	5	13830675	407220	394759	rs773711154	NC_000005.10:13830674:G:A
NM_001369.2(DNAH5):c.5503C>T (p.Gln1835Ter)	DNAH5	Q1835*	not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372356	5	13841221	5	13841112	372356	359652	rs761622153	NC_000005.10:13841111:G:A
NM_001369.2(DNAH5):c.5281C>T (p.Arg1761Ter)	DNAH5	R1761*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000220475	5	13842004	5	13841895	220475	221600	rs148891849	NC_000005.10:13841894:G:A
NM_001369.2(DNAH5):c.4605dup (p.Ile1536fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000220401	5	13862847 - 13862848	5	13862738 - 13862739	220401	221601	rs864622512	NC_000005.10:13862738:A:AA
NM_001369.2(DNAH5):c.13126-2A>C	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000216084	5	13708446	5	13708337	216084	212494	rs863224503	NC_000005.10:13708336:T:G
NM_004168.4(SDHA):c.688del (p.Glu230fs)	SDHA	E182fs, E230fs	Hereditary cancer-predisposing syndrome|Paragangliomas 5|Paragangliomas 5|Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000472291	5	228363	5	228248	472291	454917	rs1553998199	NC_000005.10:228247:GGGG:GGG
NM_004168.4(SDHA):c.1del (p.Met1fs)	SDHA	M1fs	Mitochondrial complex II deficiency|Paragangliomas 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426781	5	218471	5	218356	426781	415003	rs1085307796	NC_000005.10:218355:A:
NM_004168.4(SDHA):c.2T>G (p.Met1Arg)	SDHA	M1R	Mitochondrial complex II deficiency|Paragangliomas 5|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422382	5	218472	5	218357	422382	406737	rs750380279	NC_000005.10:218356:T:G
NM_004168.4(SDHA):c.1432_1432+1del	SDHA		Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000239647	5	236714 - 236715	5	236599 - 236600	239647	239836	rs878854627	NC_000005.10:236598:GG:
NM_004168.4(SDHA):c.1663+1G>T	SDHA		Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231173	5	251219	5	251104	231173	233461	rs766667009	NC_000005.10:251103:G:T
NM_001999.4(FBN2):c.4222+5G>A	FBN2		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000449443	5	127668599	5	128332907	449443	443669	rs1554122550	NC_000005.10:128332906:C:T
GRCh37/hg19 5q23.3(chr5:127744084-127866529)x1	FBN2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253630	5	127744084 - 127866529			253630	248078		
NM_001999.4(FBN2):c.6512-2A>G	FBN2		not provided	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000213345	5	127624946	5	128289254	213345	209701	rs863223580	NC_000005.10:128289253:T:C
NM_001999.4(FBN2):c.3724+2T>C	FBN2		not provided	Pathogenic(Last reviewed: Nov 1, 2013)	criteria provided, single submitter	VCV000213320	5	127671678	5	128335986	213320	209760	rs863223570	NC_000005.10:128335985:A:G
NM_001999.4(FBN2):c.3593G>A (p.Cys1198Tyr)	FBN2	C1198Y	not provided	Pathogenic(Last reviewed: May 24, 2014)	criteria provided, single submitter	VCV000213313	5	127673694	5	128338002	213313	209768	rs863223567	NC_000005.10:128338001:C:T
NM_001999.4(FBN2):c.525T>A (p.Cys175Ter)	FBN2	C175*	not provided	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000213262	5	127863572	5	128527879	213262	209847	rs863223547	NC_000005.10:128527878:A:T
GRCh38/hg38 5q23.3(chr5:128434801-128486349)x1	FBN2		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000152430	5	127770494 - 127822042	5	128434801 - 128486349	152430	162181		
GRCh38/hg38 5q23.3(chr5:128441672-128565049)x1	FBN2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058358	5	127777365 - 127900742	5	128441672 - 128565049	58358	72953		
NM_001999.4(FBN2):c.1171G>A (p.Glu391Lys)	FBN2	E390K, E391K	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Jun 13, 2012)	no assertion criteria provided	VCV000000520	5	127730875	5	128395182	520	15559	rs137852826	NC_000005.10:128395181:C:T
NM_001369.2(DNAH5):c.8404C>T (p.Gln2802Ter)	DNAH5	Q2802*	not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000525390	5	13792147	5	13792038	525390	521198	rs1193586811	NC_000005.10:13792037:G:A
NM_001369.2(DNAH5):c.8498G>A (p.Arg2833His)	DNAH5	R2833H	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000454809	5	13788974	5	13788865	454809	455086	rs753130398	NC_000005.10:13788864:C:T
NM_001369.2(DNAH5):c.6763C>T (p.Arg2255Ter)	DNAH5	R2255*	Ciliary dyskinesia, primary, 3|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000454795	5	13820533	5	13820424	454795	455093	rs745918507	NC_000005.10:13820423:G:A
NM_001369.2(DNAH5):c.6037C>T (p.Arg2013Ter)	DNAH5	R2013*	Ciliary dyskinesia, primary, 3|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000454789	5	13830730	5	13830621	454789	455113	rs1273352530	NC_000005.10:13830620:G:A
NM_001369.2(DNAH5):c.11725C>T (p.Arg3909Ter)	DNAH5	R3909*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407242	5	13735276	5	13735167	407242	394820	rs1060501464	NC_000005.10:13735166:G:A
NM_001369.2(DNAH5):c.5563dup (p.Ile1855fs)	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000407241	5	13841160 - 13841161	5	13841051 - 13841052	407241	394769	rs752925056	NC_000005.10:13841051:TTTTTTT:TTTTTTTT
NM_001369.2(DNAH5):c.8029C>T (p.Arg2677Ter)	DNAH5	R2677*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000238987	5	13793819	5	13793710	238987	239732	rs775946081	NC_000005.10:13793709:G:A
NM_001369.2(DNAH5):c.5114+1G>C	DNAH5		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000238978	5	13850760	5	13850651	238978	239741	rs878854457	NC_000005.10:13850650:C:G
NM_001369.2(DNAH5):c.832del (p.Ala278fs)	DNAH5	A278fs	Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163160	5	13919428	5	13919319	163160	173706	rs727502977	NC_000005.10:13919318:C:
NM_001369.2(DNAH5):c.2261dup (p.Met754fs)	DNAH5		Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000039649	5	13894928 - 13894929	5	13894819 - 13894820	39649	48248	rs672601333	NC_000005.10:13894819:A:AA
NM_001999.4(FBN2):c.5917+5G>A	FBN2		Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000580106	5	127638660	5	128302968	580106	560019	rs1561758622	NC_000005.10:128302967:C:T
NM_001999.4(FBN2):c.4306T>C (p.Cys1436Arg)	FBN2	C1436R	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000411834	5	127666304	5	128330612	411834	394608	rs1060503510	NC_000005.10:128330611:A:G
NM_001999.4(FBN2):c.3777T>A (p.Asn1259Lys)	FBN2	N1259K	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000018402	5	127671217	5	128335525	18402	33441	rs267606802	NC_000005.10:128335524:A:T
NM_001999.4(FBN2):c.3759T>G (p.Cys1253Trp)	FBN2	C1252W, C1253W	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000000527	5	127671235	5	128335543	527	15566	rs28931602	NC_000005.10:128335542:A:C
NM_001999.4(FBN2):c.3425G>T (p.Cys1142Phe)	FBN2	C1141F, C1142F	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000000526	5	127674672	5	128338980	526	15565	rs137852828	NC_000005.10:128338979:C:A
NM_001999.4(FBN2):c.3343G>C (p.Asp1115His)	FBN2	D1114H, D1115H	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000525	5	127680077	5	128344385	525	15564	rs137852827	NC_000005.10:128344384:C:G
NM_001999.4(FBN2):c.3725-15A>G	FBN2		Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000000523	5	127671284	5	128335592	523	15562	rs587776519	NC_000005.10:128335591:T:C
NM_001999.4(FBN2):c.3758G>A (p.Cys1253Tyr)	FBN2	C1252Y, C1253Y	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000000519	5	127671236	5	128335544	519	15558	rs137852825	NC_000005.10:128335543:C:T
NM_001999.4(FBN2):c.827-2A>G	FBN2		Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561010	5	127782301	5	128446608	561010	552083	rs1561461125	NC_000005.10:128446607:T:C
FBN2, IVS30, G-T, -26	FBN2		Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000000524					524	15563		
NM_001999.4(FBN2):c.4346-2A>T	FBN2		Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Oct 10, 2019)	no assertion criteria provided	VCV000000522	5	127664515	5	128328823	522	15561	rs587776518	NC_000005.10:128328822:T:A
NM_001369.2(DNAH5):c.13458dup (p.Asn4487Ter)	DNAH5		Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000350995	5	13701425 - 13701426	5	13701316 - 13701317	350995	295383	rs775696136	NC_000005.10:13701316:AAAAAAA:AAAAAAAA
NM_001369.2(DNAH5):c.8642C>G (p.Ala2881Gly)	DNAH5	A2881G	Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163139	5	13788830	5	13788721	163139	173689	rs727502973	NC_000005.10:13788720:G:C
NM_002439.5(MSH3):c.1148del (p.Lys383fs)	MSH3	K383fs	Familial adenomatous polyposis 4|Hereditary cancer-predisposing syndrome|Endometrial carcinoma|not provided	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008738	5	79970915	5	80675096	8738	23777	rs587776701	NC_000005.10:80675095:AAAAAAAA:AAAAAAA
NM_003242.6(TGFBR2):c.1336G>A (p.Asp446Asn)	TGFBR2	D446N, D471N	Thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265447	3	30715678	3	30674186	265447	259758	rs886039551	NC_000003.12:30674185:G:A
NM_003242.6(TGFBR2):c.1582C>T (p.Arg528Cys)	TGFBR2	R528C, R553C	Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012512	3	30732969	3	30691477	12512	27551	rs104893810	NC_000003.12:30691476:C:T
NM_001369.2(DNAH5):c.2224C>T (p.Arg742Ter)	DNAH5	R742*	Ciliary dyskinesia, primary, 3|not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000454757	5	13900350	5	13900241	454757	455431	rs776686983	NC_000005.10:13900240:G:A
NM_001369.2(DNAH5):c.13194_13197del (p.Asp4398fs)	DNAH5	D4398fs	Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163134	5	13708373 - 13708376	5	13708264 - 13708267	163134	173683	rs727502971	NC_000005.10:13708263:TCTGTCT:TCT
NM_001369.2(DNAH5):c.1730G>C (p.Arg577Thr)	DNAH5	R577T	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065637	5	13902162	5	13902053	65637	76545	rs397515541	NC_000005.10:13902052:C:G
NM_001999.4(FBN2):c.3986G>A (p.Cys1329Tyr)	FBN2	C1329Y	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000844617	5	127670524	5	128334832	844617	829971		NC_000005.10:128334831:C:T
NC_000005.9:g.(?_127664378)_(127666397_?)del	FBN2		Congenital contractural arachnodactyly	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000655237	5	127664378 - 127666397	5	128328686 - 128330705	655237	651300		
NM_022455.4(NSD1):c.6013C>T (p.Arg2005Ter)	NSD1	R2005*, R1736*	Sotos syndrome 1|not provided|Beckwith-Wiedemann syndrome	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159394	5	176710791	5	177283790	159394	168246	rs587784173	NC_000005.10:177283789:C:T
NM_022455.4(NSD1):c.5431C>T (p.Arg1811Ter)	NSD1	R1811*, R1542*	Beckwith-Wiedemann syndrome|Sotos syndrome 1	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159369	5	176696730	5	177269729	159369	168221	rs587784148	NC_000005.10:177269728:C:T
NM_004168.4(SDHA):c.1A>T (p.Met1Leu)	SDHA	M1L	Paragangliomas 5|Mitochondrial complex II deficiency|Paragangliomas 5	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371794	5	218471	5	218356	371794	358789	rs1061517	NC_000005.10:218355:A:T
NM_001369.2(DNAH5):c.5647C>T (p.Arg1883Ter)	DNAH5	R1883*	Primary ciliary dyskinesia|not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430011	5	13841077	5	13840968	430011	421525	rs575017579	NC_000005.10:13840967:G:A
NM_001369.2(DNAH5):c.13486C>T (p.Arg4496Ter)	DNAH5	R4496*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407248	5	13701398	5	13701289	407248	394709	rs200901816	NC_000005.10:13701288:G:A
NM_001369.2(DNAH5):c.5177T>C (p.Leu1726Pro)	DNAH5	L1726P	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369664	5	13845040	5	13844931	369664	353893	rs138890576	NC_000005.10:13844930:A:G
NM_001369.2(DNAH5):c.9365del (p.Ala3121_Leu3122insTer)	DNAH5		Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225341	5	13776556	5	13776447	225341	227278	rs1060501460	NC_000005.10:13776446:AAA:AA
NM_001369.2(DNAH5):c.10616G>A (p.Arg3539His)	DNAH5	R3539H	not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216542	5	13753598	5	13753489	216542	212497	rs769458738	NC_000005.10:13753488:C:T
NM_004321.7(KIF1A):c.296C>T (p.Thr99Met)	KIF1A	T99M	PEHO syndrome|not provided|Mental retardation, autosomal dominant 9|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030169	2	241727535	2	240788118	30169	39125	rs387906799	NC_000002.12:240788117:G:A
NM_000551.3(VHL):c.208G>T (p.Glu70Ter)	VHL	E70*	Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428806	3	10183739	3	10142055	428806	420438	rs5030802	NC_000003.12:10142054:G:T
NM_003060.4(SLC22A5):c.424G>T (p.Ala142Ser)	SLC22A5	A142S, A166S	not provided|Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000025372	5	131714100	5	132378408	25372	36706	rs151231558	NC_000005.10:132378407:G:T
NM_001370658.1(BTD):c.1535C>T (p.Thr512Met)	BTD	T532M, T512M, T534M	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001897	3	15686958	3	15645451	1897	16936	rs104893688	NC_000003.12:15645450:C:T
NM_001369.2(DNAH5):c.5710-2A>G	DNAH5		Ciliary dyskinesia, primary, 3|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000454788	5	13839639	5	13839530	454788	455412	rs548521732	NC_000005.10:13839529:T:C
NM_001369.2(DNAH5):c.10384C>T (p.Gln3462Ter)	DNAH5	Q3462*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000238953	5	13758990	5	13758881	238953	239728	rs571919972	NC_000005.10:13758880:G:A
NM_001369.2(DNAH5):c.4348C>T (p.Gln1450Ter)	DNAH5	Q1450*	Ciliary dyskinesia, primary, 3|Primary ciliary dyskinesia|Kartagener syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000208992	5	13865784	5	13865675	208992	205552	rs771663107	NC_000005.10:13865674:G:A
NM_001369.2(DNAH5):c.9449del (p.Gly3150fs)	DNAH5	G3150fs	not provided|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179339	5	13771014	5	13770905	179339	173688	rs727504802	NC_000005.10:13770904:CCC:CC
NM_001354689.3(RAF1):c.782C>G (p.Pro261Arg)	RAF1	P261R, P147R, P180R, P228R	Noonan syndrome|Noonan syndrome 5|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040606	3	12645687	3	12604188	40606	49076	rs397516828	NC_000003.12:12604187:G:C
NM_001354689.3(RAF1):c.1532C>T (p.Thr511Ile)	RAF1	T491I, T511I, T430I, T410I, T458I, T377I	Cardiovascular phenotype|not provided|Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000021342	3	12627244	3	12585745	21342	34194	rs80338799	NC_000003.12:12585744:G:A
NM_001999.4(FBN2):c.3467G>T (p.Cys1156Phe)	FBN2	C1156F	Congenital contractural arachnodactyly	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547356	5	127674630	5	128338938	547356	537770	rs1206843725	NC_000005.10:128338937:C:A
NM_004656.4(BAP1):c.2050C>T (p.Gln684Ter)	BAP1	Q684*	not provided|Tumor susceptibility linked to germline BAP1 mutations|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030302	3	52436624	3	52402608	30302	39258	rs387906848	NC_000003.12:52402607:G:A
NM_004168.4(SDHA):c.2T>C (p.Met1Thr)	SDHA	M1T	Paragangliomas 5|Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412398	5	218472	5	218357	412398	394857	rs750380279	NC_000005.10:218356:T:C
NM_004168.4(SDHA):c.1534C>T (p.Arg512Ter)	SDHA	R512*, R464*	Paragangliomas 5|Mitochondrial complex II deficiency|not provided|Paragangliomas 5|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371805	5	240574	5	240459	371805	358799	rs748089700	NC_000005.10:240458:C:T
NM_004168.4(SDHA):c.223C>T (p.Arg75Ter)	SDHA	R75*	Paragangliomas 5|Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000209127	5	224547	5	224432	209127	205718	rs781764920	NC_000005.10:224431:C:T
NM_001369.2(DNAH5):c.8440_8447del (p.Lys2813_Glu2814insTer)	DNAH5		Ciliary dyskinesia, primary, 3|Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000454808	5	13792104 - 13792111	5	13791995 - 13792002	454808	455388	rs755136231	NC_000005.10:13791994:TTTGGTTC:
NM_006206.6(PDGFRA):c.1682T>A (p.Val561Asp)	PDGFRA	V561D, V574D, V586D	Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000013546	4	55141036	4	54274869	13546	28585	rs121908586	NC_000004.12:54274868:T:A
NM_001093772.1(KIT):c.1664_1666TTG[1] (p.Val556del)	KIT	V560del, V559del, V555del, V556del	Gastrointestinal stromal tumor, familial|Cutaneous melanoma|Thymoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375913	4	55593609 - 55593611	4	54727443 - 54727445	375913	362792	rs121913685	NC_000004.12:54727442:GTTGTTG:GTTG
NM_000158.4(GBE1):c.691+2T>C	GBE1		Glycogen storage disease, type IV|not provided|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Polyglucosan body disease, adult|Glycogen storage disease, type IV|GBE1-Related Disorders	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208584	3	81698005	3	81648854	208584	205142	rs192044702	NC_000003.12:81648853:A:G
NM_022455.4(NSD1):c.5332C>T (p.Arg1778Ter)	NSD1	R1778*, R1509*	not provided|Sotos syndrome 1|Beckwith-Wiedemann syndrome|Sotos syndrome 1|Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194672	5	176696631	5	177269630	194672	191835	rs794727176	NC_000005.10:177269629:C:T
NC_000003.12:g.(?_10149777)_(10150035_?)del	VHL		Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000833062	3	10191461 - 10191719			833062	819310		
NM_000551.3(VHL):c.320G>A (p.Arg107His)	VHL	R107H	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000223184	3	10183851	3	10142167	223184	224915	rs193922609	NC_000003.12:10142166:G:A
NM_000551.3(VHL):c.334T>A (p.Tyr112Asn)	VHL	Y112N	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002228	3	10183865	3	10142181	2228	17267	rs104893824	NC_000003.12:10142180:T:A
NM_005211.3(CSF1R):c.1441C>T (p.Gln481Ter)	CSF1R	Q481*	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	VCV000520697	5	149449505	5	150069942	520697	511578	rs917027829	NC_000005.10:150069941:G:A
NM_004369.3(COL6A3):c.2985_2988del (p.Ala996fs)	COL6A3	A589fs, A790fs, A996fs, A389fs	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000597337	2	238285497 - 238285500	2	237376854 - 237376857	597337	588398	rs1559253935	NC_000002.12:237376853:TGCA:
NM_004369.3(COL6A3):c.6064-2A>G	COL6A3		not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000501177	2	238270476	2	237361833	501177	492601	rs1553554384	NC_000002.12:237361832:T:C
NM_004369.3(COL6A3):c.4366C>T (p.Arg1456Ter)	COL6A3	R1456*, R849*, R1250*	not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000500906	2	238277740	2	237369097	500906	492330	rs781043870	NC_000002.12:237369096:G:A
NM_004369.3(COL6A3):c.4835C>A (p.Ser1612Ter)	COL6A3	S1612*, S1005*, S1406*	not provided	Pathogenic(Last reviewed: Oct 30, 2016)	criteria provided, single submitter	VCV000498221	2	238277271	2	237368628	498221	489645	rs201532239	NC_000002.12:237368627:G:T
NM_004369.3(COL6A3):c.6156+1G>A	COL6A3		not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000488799	2	238270381	2	237361738	488799	481647	rs1553554298	NC_000002.12:237361737:C:T
NM_004369.3(COL6A3):c.8931del (p.Ala2978fs)	COL6A3	A2371fs, A2772fs, A2978fs	not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000452584	2	238244812	2	237336169	452584	443187	rs1553544667	NC_000002.12:237336168:T:
NM_004369.3(COL6A3):c.6309+3A>G	COL6A3		not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000449325	2	238268002	2	237359359	449325	443193	rs1553553327	NC_000002.12:237359358:T:C
NM_004369.3(COL6A3):c.6604C>T (p.Arg2202Ter)	COL6A3	R2202*, R1595*, R1996*	not provided	Pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000429825	2	238263565	2	237354922	429825	421373	rs774115247	NC_000002.12:237354921:G:A
NM_004369.3(COL6A3):c.9193C>T (p.Gln3065Ter)	COL6A3	Q3065*, Q2859*, Q2458*	not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000288739	2	238243305	2	237334662	288739	272976	rs886043992	NC_000002.12:237334661:G:A
NM_004369.3(COL6A3):c.7542del (p.Phe2515fs)	COL6A3	F2309fs, F2515fs, F1908fs	not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000286919	2	238253119	2	237344476	286919	271156	rs886043519	NC_000002.12:237344475:G:
NM_057164.5(COL6A3):c.92-6634del	COL6A3	G254fs, G48fs	not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000286745	2	238296776	2	237388133	286745	270982	rs780921503	NC_000002.12:237388132:CC:C
NM_004369.3(COL6A3):c.6175G>T (p.Gly2059Cys)	COL6A3	G2059C, G1452C, G1853C	not provided	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000284682	2	238269799	2	237361156	284682	268919	rs758124326	NC_000002.12:237361155:C:A
NM_004369.3(COL6A3):c.6354+1G>T	COL6A3		not provided	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000284484	2	238267848	2	237359205	284484	268721	rs886042883	NC_000002.12:237359204:C:A
NM_004369.3(COL6A3):c.4124del (p.Gln1375fs)	COL6A3	Q1169fs, Q968fs, Q1375fs, Q768fs	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000282652	2	238280536	2	237371893	282652	266889	rs886042447	NC_000002.12:237371892:T:
NM_004369.3(COL6A3):c.5010T>A (p.Tyr1670Ter)	COL6A3	Y1670*, Y1063*, Y1464*	not provided	Pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	VCV000282467	2	238275820	2	237367177	282467	266704	rs886042402	NC_000002.12:237367176:A:T
NM_004369.3(COL6A3):c.6293G>T (p.Gly2098Val)	COL6A3	G2098V, G1892V, G1491V	not provided	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000194849	2	238268021	2	237359378	194849	192012	rs794727206	NC_000002.12:237359377:C:A
NM_004369.3(COL6A3):c.2277T>G (p.Tyr759Ter)	COL6A3	Y759*, Y352*, Y553*	not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634480	2	238287499	2	237378856	634480	622321	rs1559257971	NC_000002.12:237378855:A:C
NM_004369.3(COL6A3):c.6157-2A>C	COL6A3		not provided	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280181	2	238269819	2	237361176	280181	264080	rs886041434	NC_000002.12:237361175:T:G
NM_004369.3(COL6A3):c.6181C>T (p.Arg2061Ter)	COL6A3	R2061*, R1454*, R1855*	Muscular Diseases	Pathogenic(Last reviewed: Apr 28, 2014)	criteria provided, single submitter	VCV000210752	2	238269793	2	237361150	210752	206954	rs797045479	NC_000002.12:237361149:G:A
NM_004369.3(COL6A3):c.6282+1G>A	COL6A3		not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094959	2	238268730	2	237360087	94959	100859	rs398124128	NC_000002.12:237360086:C:T
NM_004369.3(COL6A3):c.6157G>T (p.Gly2053Cys)	COL6A3	G2053C, G1847C, G1446C	not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000595936	2	238269817	2	237361174	595936	586997	rs1559228507	NC_000002.12:237361173:C:A
NM_004369.3(COL6A3):c.7024C>T (p.Arg2342Ter)	COL6A3	R2342*, R2136*, R1735*	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000285477	2	238256455	2	237347812	285477	269714	rs886043113	NC_000002.12:237347811:G:A
NM_004369.4(COL6A3):c.1840C>T (p.Gln614Ter)	COL6A3	Q408*, Q207*, Q614*	Bethlem myopathy 1	Pathogenic	no assertion criteria provided	VCV000816795	2	238289615	2	237380972	816795	804996		NC_000002.12:237380971:G:A
NM_004369.4(COL6A3):c.1825C>T (p.Arg609Ter)	COL6A3	R609*, R202*, R403*	Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000857930	2	238289630	2	237380987	857930	826041		NC_000002.12:237380986:G:A
NM_004369.4(COL6A3):c.4899del (p.Glu1634fs)	COL6A3	E1027fs, E1634fs, E1428fs	Bethlem myopathy 1	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000846414	2	238277207	2	237368564	846414	826022		NC_000002.12:237368563:T:
NM_004369.4(COL6A3):c.7666C>T (p.Gln2556Ter)	COL6A3	Q1949*, Q2350*, Q2556*	Bethlem myopathy 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000844437	2	238252995	2	237344352	844437	826000		NC_000002.12:237344351:G:A
NM_004369.4(COL6A3):c.2162C>G (p.Ser721Ter)	COL6A3	S314*, S515*, S721*	Bethlem myopathy 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000836050	2	238287614	2	237378971	836050	826039		NC_000002.12:237378970:G:C
NM_004369.4(COL6A3):c.7720del (p.Leu2574fs)	COL6A3	L2368fs, L2574fs, L1967fs	Bethlem myopathy 1	Pathogenic	no assertion criteria provided	VCV000816857	2	238250753	2	237342110	816857	804995		NC_000002.12:237342109:GG:G
NM_004369.3(COL6A3):c.6309G>A (p.Lys2103=)	COL6A3		Bethlem myopathy 1	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000659368	2	238268005	2	237359362	659368	629643		NC_000002.12:237359361:C:T
NM_004369.3(COL6A3):c.2431C>T (p.Gln811Ter)	COL6A3	Q605*, Q811*, Q404*	Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000655400	2	238287345	2	237378702	655400	629682		NC_000002.12:237378701:G:A
NM_004369.3(COL6A3):c.1699C>T (p.Gln567Ter)	COL6A3	Q567*, Q361*, Q160*	Bethlem myopathy 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000569352	2	238289756	2	237381113	569352	561192	rs1559261557	NC_000002.12:237381112:G:A
NM_004369.3(COL6A3):c.6212_6309+28del	COL6A3		Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000542995	2	238267977 - 238268801	2	237359334 - 237360158	542995	517975	rs1553553313	
NM_004369.3(COL6A3):c.2620C>T (p.Arg874Ter)	COL6A3	R874*, R668*, R467*, R267*	Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000476512	2	238285865	2	237377222	476512	450588	rs1553561409	NC_000002.12:237377221:G:A
NM_004369.3(COL6A3):c.5177T>G (p.Leu1726Arg)	COL6A3	L1726R, L1119R, L1520R	Bethlem myopathy 1	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000017154	2	238275653	2	237367010	17154	32193	rs121434555	NC_000002.12:237367009:A:C
COL6A3, IVS15DS, GT-TC, +1	COL6A3		Bethlem myopathy 1	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000017153					17153	32192		
NM_004369.3(COL6A3):c.1393C>T (p.Arg465Ter)	COL6A3	R465*, R259*, R58*	Ullrich congenital muscular dystrophy 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000017151	2	238290062	2	237381419	17151	32190	rs121434554	NC_000002.12:237381418:G:A
NM_057166.5(COL6A3):c.5109+5G>A	COL6A3		Ullrich congenital muscular dystrophy 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000017150	2	238257251	2	237348608	17150	32189		NC_000002.12:237348607:C:T
NM_001182.5(ALDH7A1):c.1489+5G>A	ALDH7A1		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280045	5	125885616	5	126549924	280045	264223	rs368820286	NC_000005.10:126549923:C:T
NM_004369.3(COL6A3):c.76C>T (p.Gln26Ter)	COL6A3	Q26*	Bethlem myopathy 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000476558	2	238305385	2	237396742	476558	450703	rs763187844	NC_000002.12:237396741:G:A
NM_003060.4(SLC22A5):c.248G>T (p.Arg83Leu)	SLC22A5	R83L	not provided|Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000025361	5	131705912	5	132370220	25361	36695	rs72552726	NC_000005.10:132370219:G:T
NM_004369.3(COL6A3):c.2506C>T (p.Arg836Ter)	COL6A3	R836*, R229*, R429*, R630*	Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419449	2	238285979	2	237377336	419449	405672	rs761796175	NC_000002.12:237377335:G:A
NM_004369.3(COL6A3):c.7796_7797del (p.Phe2599fs)	COL6A3	F2599fs, F2393fs, F1992fs	not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283441	2	238249762 - 238249763	2	237341119 - 237341120	283441	267678	rs886042623	NC_000002.12:237341118:AAA:A
NM_004415.4(DSP):c.4855del (p.Leu1619fs)	DSP	L1619fs	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000817029	6	7581278	6	7581045	817029	805509		NC_000006.12:7581044:C:
NM_004415.4(DSP):c.3891_3894dup (p.Met1299fs)	DSP		Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802189	6	7580313 - 7580314	6	7580080 - 7580081	802189	790658		NC_000006.12:7580080:GGTC:GGTCGGTC
NM_004415.4(DSP):c.1857C>A (p.Tyr619Ter)	DSP	Y619*	Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000519028	6	7571771	6	7571538	519028	509810	rs1554107097	NC_000006.12:7571537:C:A
NM_004415.4(DSP):c.1087C>T (p.Gln363Ter)	DSP	Q363*	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000518907	6	7567629	6	7567396	518907	509804	rs778856526	NC_000006.12:7567395:C:T
NM_004415.4(DSP):c.2547T>A (p.Tyr849Ter)	DSP	Y849*	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000518471	6	7575638	6	7575405	518471	509817	rs1554107624	NC_000006.12:7575404:T:A
NM_004415.4(DSP):c.4235_4237delinsG (p.Leu1412fs)	DSP		Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000518469	6	7580658 - 7580660	6	7580425 - 7580427	518469	509822	rs1554108280	NC_000006.12:7580424:TGA:G
NM_004415.3(DSP):c.491_492delCCins15 (p.?)	DSP		not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000503972	6	7559527 - 7559528	6	7559294 - 7559295	503972	495291		
NM_004415.4(DSP):c.7899dup (p.Thr2634fs)	DSP		not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000429740	6	7585392 - 7585393	6	7585159 - 7585160	429740	421602	rs1131691561	NC_000006.12:7585159:TT:TTT
NM_004415.4(DSP):c.1A>G (p.Met1Val)	DSP	M1V	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000429736	6	7542149	6	7541916	429736	421599	rs1131691557	NC_000006.12:7541915:A:G
NM_004415.4(DSP):c.3415_3417delinsG (p.Tyr1139fs)	DSP		not provided	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000420657	6	7579838 - 7579840	6	7579605 - 7579607	420657	406920	rs1064794616	NC_000006.12:7579604:TAT:G
NM_004415.4(DSP):c.8014C>T (p.Gln2672Ter)	DSP	Q2672*, Q2073*, Q2229*	not provided	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000419466	6	7585509	6	7585276	419466	406930	rs1064793890	NC_000006.12:7585275:C:T
NM_004415.4(DSP):c.6940G>T (p.Glu2314Ter)	DSP	E2314*, E1715*, E1871*	not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000372958	6	7584435	6	7584202	372958	359756	rs1057518101	NC_000006.12:7584201:G:T
NM_004415.4(DSP):c.3195C>G (p.Tyr1065Ter)	DSP	Y1065*	Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000264512	6	7579618	6	7579385	264512	258450	rs886039178	NC_000006.12:7579384:C:G
NM_004415.4(DSP):c.151C>T (p.Gln51Ter)	DSP	Q51*	not provided	Pathogenic(Last reviewed: Feb 10, 2012)	criteria provided, single submitter	VCV000199942	6	7542299	6	7542066	199942	197018	rs794728156	NC_000006.12:7542065:C:T
NM_004415.4(DSP):c.7873dup (p.Thr2625fs)	DSP		not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000199928	6	7585367 - 7585368	6	7585134 - 7585135	199928	197117	rs794728149	NC_000006.12:7585134:A:AA
NM_004415.4(DSP):c.6398dup (p.Val2134fs)	DSP		not provided	Pathogenic(Last reviewed: Jul 11, 2013)	criteria provided, single submitter	VCV000199926	6	7583888 - 7583889	6	7583655 - 7583656	199926	197107	rs794728147	NC_000006.12:7583655:GGGGG:GGGGGG
NM_004415.4(DSP):c.3733del (p.Glu1245fs)	DSP	E1245fs	not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000199921	6	7580154	6	7579921	199921	197068	rs794728142	NC_000006.12:7579920:GGG:GG
NM_004415.4(DSP):c.3426dup (p.Gln1143fs)	DSP		not provided	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000199920	6	7579848 - 7579849	6	7579615 - 7579616	199920	197063	rs794728141	NC_000006.12:7579615:G:GG
NM_004415.4(DSP):c.3419del (p.Asp1140fs)	DSP	D1140fs	not provided	Pathogenic(Last reviewed: Jul 15, 2013)	criteria provided, single submitter	VCV000199919	6	7579842	6	7579609	199919	197062	rs794728140	NC_000006.12:7579608:A:
NM_004415.4(DSP):c.2865_2869CAATT[1] (p.Asn956_Ser957insTer)	DSP		not provided	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000199918	6	7577263 - 7577267	6	7577030 - 7577034	199918	197058	rs794728139	NC_000006.12:7577029:CAATTCAATT:CAATT
NM_004415.4(DSP):c.243_251del (p.Cys81_Arg84delinsTer)	DSP		not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000199914	6	7556022 - 7556030	6	7555789 - 7555797	199914	197021	rs794728135	NC_000006.12:7555788:GCTTGATGCG:G
NM_004415.4(DSP):c.6850C>T (p.Arg2284Ter)	DSP	R2284*, R1685*, R1841*	not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000199905	6	7584345	6	7584112	199905	197112	rs794728130	NC_000006.12:7584111:C:T
NM_004415.4(DSP):c.4054A>T (p.Arg1352Ter)	DSP	R1352*	not provided	Pathogenic(Last reviewed: Jun 8, 2013)	criteria provided, single submitter	VCV000199882	6	7580477	6	7580244	199882	197074	rs794728121	NC_000006.12:7580243:A:T
NM_004415.4(DSP):c.3961C>T (p.Gln1321Ter)	DSP	Q1321*	not provided	Pathogenic(Last reviewed: Aug 4, 2014)	criteria provided, single submitter	VCV000199876	6	7580384	6	7580151	199876	197072	rs794728119	NC_000006.12:7580150:C:T
NM_004415.4(DSP):c.2644G>T (p.Glu882Ter)	DSP	E882*	not provided	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000199873	6	7576540	6	7576307	199873	197054	rs730880081	NC_000006.12:7576306:G:T
NM_004415.4(DSP):c.1141-2A>G	DSP		not provided	Pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	VCV000199856	6	7568012	6	7567779	199856	197038	rs794728111	NC_000006.12:7567778:A:G
NM_004415.4(DSP):c.888C>G (p.Tyr296Ter)	DSP	Y296*	not provided	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	VCV000199855	6	7565702	6	7565469	199855	197032	rs149701627	NC_000006.12:7565468:C:G
NM_004415.4(DSP):c.273+1G>A	DSP		not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000199847	6	7556054	6	7555821	199847	197023	rs794728106	NC_000006.12:7555820:G:A
NM_004415.4(DSP):c.2528C>A (p.Ser843Ter)	DSP	S843*	Ventricular fibrillation|Sudden cardiac death|Bicuspid aortic valve|Arrhythmia|Aortic dilatation	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000374137	6	7575619	6	7575386	374137	360883	rs1057518920	NC_000006.12:7575385:C:A
NM_004415.4(DSP):c.1865T>C (p.Leu622Pro)	DSP	L622P	Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	Pathogenic(Last reviewed: Nov 22, 2016)	no assertion criteria provided	VCV000372127	6	7571779	6	7571546	372127	359034	rs1554107098	NC_000006.12:7571545:T:C
NM_004415.4(DSP):c.1853A>C (p.His618Pro)	DSP	H618P	Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	Pathogenic(Last reviewed: Nov 22, 2016)	no assertion criteria provided	VCV000372126	6	7571767	6	7571534	372126	359033	rs1554107096	NC_000006.12:7571533:A:C
NM_004415.4(DSP):c.1847A>C (p.Gln616Pro)	DSP	Q616P	Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	Pathogenic(Last reviewed: Nov 22, 2016)	no assertion criteria provided	VCV000372125	6	7571761	6	7571528	372125	359032	rs1184921987	NC_000006.12:7571527:A:C
NM_004415.4(DSP):c.2876_2877+3del	DSP			Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000180180	6	7577272 - 7577276	6	7577039 - 7577043	180180	178363	rs730880023	NC_000006.12:7577038:TAAGGTA:TA
NM_004415.4(DSP):c.1817_1846dup (p.Arg606_Ala615dup)	DSP		Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000157671	6	7571729 - 7571730	6	7571496 - 7571497	157671	167520	rs606231293	NC_000006.12:7571496:CGGAAAATACAGTCTCAGTTCACCGATGCCC:CGGAAAATACAGTCTCAGTTCACCGATGCCCGGAAAATACAGTCTCAGTTCACCGATGCCC
NM_004415.4(DSP):c.7780del (p.Ser2594fs)	DSP	S1995fs, S2594fs, S2151fs	Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060561	6	7585273	6	7585040	60561	75137	rs397514045	NC_000006.12:7585039:TTT:TT
NM_004415.4(DSP):c.7097G>A (p.Arg2366His)	DSP	R2366H, R1767H, R1923H	Skin fragility-woolly hair-palmoplantar keratoderma syndrome	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000029672	6	7584592	6	7584359	29672	38627	rs387906618	NC_000006.12:7584358:G:A
NM_004415.4(DSP):c.1990C>T (p.Gln664Ter)	DSP	Q664*	Skin fragility-woolly hair-palmoplantar keratoderma syndrome	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000016842	6	7572161	6	7571928	16842	31881	rs121912995	NC_000006.12:7571927:C:T
NM_004415.4(DSP):c.2427T>A (p.Cys809Ter)	DSP	C809*	Skin fragility-woolly hair-palmoplantar keratoderma syndrome	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000016840	6	7575019	6	7574786	16840	31879	rs121912994	NC_000006.12:7574785:T:A
NM_004415.4(DSP):c.861T>G (p.Asn287Lys)	DSP	N287K	Skin fragility-woolly hair-palmoplantar keratoderma syndrome	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000016839	6	7565675	6	7565442	16839	31878	rs121912993	NC_000006.12:7565441:T:G
NM_004415.4(DSP):c.991C>T (p.Gln331Ter)	DSP	Q331*	Keratosis palmoplantaris striata II	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000016836	6	7566661	6	7566428	16836	31875	rs121912991	NC_000006.12:7566427:C:T
NM_004415.4(DSP):c.4009del (p.Glu1337fs)	DSP	E1337fs	Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000195754	6	7580431	6	7580198	195754	192915	rs794727381	NC_000006.12:7580197:GG:G
NM_004415.4(DSP):c.423-1G>T	DSP		not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000432430	6	7559458	6	7559225	432430	425703	rs1304410089	NC_000006.12:7559224:G:T
NM_004415.4(DSP):c.7248del (p.Phe2416fs)	DSP	F1817fs, F2416fs, F1973fs	not provided|	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000180181	6	7584738	6	7584505	180181	178364	rs730880024	NC_000006.12:7584504:TTTTTT:TTTTT
NM_004415.4(DSP):c.1691C>T (p.Thr564Ile)	DSP	T564I	Dilated cardiomyopathy with woolly hair and keratoderma|Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000157673	6	7570786	6	7570553	157673	167522	rs606231295	NC_000006.12:7570552:C:T
NM_000297.4(PKD2):c.2614C>T (p.Arg872Ter)	PKD2	R872*	Polycystic kidney disease 2|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448036	4	88996055	4	88074903	448036	440858	rs755226061	NC_000004.12:88074902:C:T
NM_004415.4(DSP):c.3160_3169del (p.Lys1054fs)	DSP	K1054fs	Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000044892	6	7579580 - 7579589	6	7579347 - 7579356	44892	54059	rs397516932	NC_000006.12:7579346:AATAAGAACAAAT:AAT
NM_004415.4(DSP):c.1146del (p.Phe382fs)	DSP	F382fs	Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000044852	6	7568014	6	7567781	44852	54019	rs397516913	NC_000006.12:7567780:TTTTTT:TTTTT
NM_001008844.3(DSP):c.5826del (p.Lys1943fs)	DSP	K1943fs, K2542fs, K2099fs	not provided|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000016837	6	7585117	6	7584884	16837	31876	rs397514039	NC_000006.12:7584883:GG:G
NM_004369.3(COL6A3):c.5838+1G>T	COL6A3		Bethlem myopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000596397	2	238274340	2	237365697	596397	587458	rs1559234260	NC_000002.12:237365696:C:A
NM_004369.3(COL6A3):c.6309+1G>A	COL6A3		Bethlem myopathy 1	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000581383	2	238268004	2	237359361	581383	561116	rs886043919	NC_000002.12:237359360:C:T
NM_004369.3(COL6A3):c.6310-2A>G	COL6A3		Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000571080	2	238267895	2	237359252	571080	560507	rs1559225993	NC_000002.12:237359251:T:C
NM_004369.3(COL6A3):c.6230G>T (p.Gly2077Val)	COL6A3	G2077V, G1470V, G1871V	Bethlem myopathy 1	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000476547	2	238268783	2	237360140	476547	450658	rs1553553646	NC_000002.12:237360139:C:A
NM_004369.3(COL6A3):c.5480del (p.Gly1827fs)	COL6A3	G1220fs, G1621fs, G1827fs	Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419143	2	238275350	2	237366707	419143	405669	rs777304794	NC_000002.12:237366706:CC:C
NM_004369.3(COL6A3):c.6309+1G>T	COL6A3		not provided|Ullrich congenital muscular dystrophy 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000288503	2	238268004	2	237359361	288503	272740	rs886043919	NC_000002.12:237359360:C:A
NM_004415.4(DSP):c.942dup (p.Arg315fs)	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000855556	6	7566611 - 7566612	6	7566378 - 7566379	855556	832456		NC_000006.12:7566378:A:AA
NM_004415.4(DSP):c.3253C>T (p.Gln1085Ter)	DSP	Q1085*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000854238	6	7579676	6	7579443	854238	832483		NC_000006.12:7579442:C:T
NM_004415.4(DSP):c.313C>T (p.Arg105Ter)	DSP	R105*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000853704	6	7558388	6	7558155	853704	832448		NC_000006.12:7558154:C:T
NM_004415.4(DSP):c.1234C>T (p.Gln412Ter)	DSP	Q412*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000843317	6	7568107	6	7567874	843317	832460		NC_000006.12:7567873:C:T
NM_004415.4(DSP):c.2000G>A (p.Trp667Ter)	DSP	W667*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000839375	6	7572171	6	7571938	839375	832473		NC_000006.12:7571937:G:A
NM_004415.4(DSP):c.7559_7562TAGA[1] (p.Asp2521fs)	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000839272	6	7585054 - 7585057	6	7584821 - 7584824	839272	832512		NC_000006.12:7584820:TAGATAGA:TAGA
NM_004415.4(DSP):c.2236del (p.Val746fs)	DSP	V746fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000837892	6	7574424	6	7574191	837892	832477		NC_000006.12:7574190:G:
NM_004415.4(DSP):c.700C>T (p.Gln234Ter)	DSP	Q234*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000836494	6	7562987	6	7562754	836494	832452		NC_000006.12:7562753:C:T
NM_004415.4(DSP):c.1897C>T (p.Gln633Ter)	DSP	Q633*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000836231	6	7571811	6	7571578	836231	832468		NC_000006.12:7571577:C:T
NM_004415.4(DSP):c.827_830del (p.Ile276fs)	DSP	I276fs	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000834988	6	7565638 - 7565641	6	7565405 - 7565408	834988	832454		NC_000006.12:7565404:TCATTCA:TCA
NM_004415.4(DSP):c.925C>T (p.Gln309Ter)	DSP	Q309*	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000692081	6	7565739	6	7565506	692081	679753		NC_000006.12:7565505:C:T
NM_004415.4(DSP):c.1411_1412insT (p.Gln471fs)	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000666177	6	7568814 - 7568815	6	7568581 - 7568582	666177	635258		NC_000006.12:7568581::T
NM_004415.4(DSP):c.2323C>T (p.Gln775Ter)	DSP	Q775*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000662318	6	7574915	6	7574682	662318	635272		NC_000006.12:7574681:C:T
NM_004415.4(DSP):c.4423del (p.Thr1475fs)	DSP	T1475fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000659795	6	7580843	6	7580610	659795	635286		NC_000006.12:7580609:AAAA:AAA
NM_004415.4(DSP):c.330_334del (p.Phe111fs)	DSP	F111fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000658607	6	7558403 - 7558407	6	7558170 - 7558174	658607	635249		NC_000006.12:7558169:TGTTTTG:TG
NM_004415.4(DSP):c.1831C>T (p.Gln611Ter)	DSP	Q611*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000655498	6	7571745	6	7571512	655498	635266		NC_000006.12:7571511:C:T
NM_004415.4(DSP):c.5210del (p.Gly1737fs)	DSP	G1737fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000654195	6	7581632	6	7581399	654195	635290		NC_000006.12:7581398:GG:G
NM_004415.4(DSP):c.1582C>T (p.Gln528Ter)	DSP	Q528*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000579308	6	7570677	6	7570444	579308	561075	rs1267435790	NC_000006.12:7570443:C:T
NM_004415.4(DSP):c.2725C>T (p.Gln909Ter)	DSP	Q909*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000577561	6	7576621	6	7576388	577561	563796	rs1561694696	NC_000006.12:7576387:C:T
NM_004415.4(DSP):c.4357C>T (p.Gln1453Ter)	DSP	Q1453*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000576091	6	7580780	6	7580547	576091	560998	rs1561698750	NC_000006.12:7580546:C:T
NM_004415.4(DSP):c.3126_3127delinsT (p.Arg1042fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000572780	6	7579549 - 7579550	6	7579316 - 7579317	572780	563797	rs1561696970	NC_000006.12:7579315:AC:T
NM_004415.4(DSP):c.2497C>T (p.Gln833Ter)	DSP	Q833*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000572718	6	7575588	6	7575355	572718	565982	rs1561693779	NC_000006.12:7575354:C:T
NM_004415.4(DSP):c.3290_3291dup (p.Asp1098Ter)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000570474	6	7579712 - 7579713	6	7579479 - 7579480	570474	561089	rs1561697181	NC_000006.12:7579479:TA:TATA
NM_004415.4(DSP):c.329_330delinsAA (p.Cys110Ter)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000566602	6	7558404 - 7558405	6	7558171 - 7558172	566602	561055	rs1561680649	NC_000006.12:7558170:GT:AA
NM_004415.4(DSP):c.1282dup (p.Ile428fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000565816	6	7568681 - 7568682	6	7568448 - 7568449	565816	560973	rs1561687796	NC_000006.12:7568448:AAAA:AAAAA
NM_004415.4(DSP):c.6581_6582CA[1] (p.His2195fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000565543	6	7584076 - 7584077	6	7583843 - 7583844	565543	561017	rs1561702771	NC_000006.12:7583842:CACA:CA
NM_004415.4(DSP):c.5460_5466del (p.Val1821fs)	DSP	V1821fs, V1222fs, V1378fs	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000464965	6	7582955 - 7582961	6	7582722 - 7582728	464965	456423	rs1554108610	NC_000006.12:7582721:AGTCCTG:
NM_004415.4(DSP):c.465del (p.Ile156fs)	DSP	I156fs	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000464964	6	7559500	6	7559267	464964	456009	rs1554105911	NC_000006.12:7559266:CC:C
NM_004415.4(DSP):c.3348T>A (p.Tyr1116Ter)	DSP	Y1116*	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000464962	6	7579771	6	7579538	464962	456407	rs772646601	NC_000006.12:7579537:T:A
NM_004415.4(DSP):c.3044_3047dup (p.Phe1016fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000464960	6	7578754 - 7578755	6	7578521 - 7578522	464960	456063	rs1554107916	NC_000006.12:7578521:GGTT:GGTTGGTT
NM_004415.4(DSP):c.2947_2948del (p.Thr983fs)	DSP	T983fs	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000464959	6	7578081 - 7578082	6	7577848 - 7577849	464959	456059	rs1554107839	NC_000006.12:7577847:AC:
NM_004415.4(DSP):c.1058_1059CT[1] (p.Leu354fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000464956	6	7567600 - 7567601	6	7567367 - 7567368	464956	456015	rs1249913357	NC_000006.12:7567366:CTCT:CT
NM_004415.4(DSP):c.2602C>T (p.Gln868Ter)	DSP	Q868*	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 25, 2016)	criteria provided, single submitter	VCV000405248	6	7575693	6	7575460	405248	395444	rs1060500618	NC_000006.12:7575459:C:T
NM_004415.4(DSP):c.1883del (p.Gly628fs)	DSP	G628fs	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000405237	6	7571796	6	7571563	405237	395867	rs1060500613	NC_000006.12:7571562:GG:G
NM_004415.4(DSP):c.5745dup (p.Lys1916Ter)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000405223	6	7583239 - 7583240	6	7583006 - 7583007	405223	395472	rs1060500607	NC_000006.12:7583006:T:TT
NM_004415.4(DSP):c.8156del (p.Pro2719fs)	DSP	P2120fs, P2276fs, P2719fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000199945	6	7585649	6	7585416	199945	197120		NC_000006.12:7585415:CCC:CC
NM_004415.4(DSP):c.8501G>A (p.Arg2834His)	DSP	R2834H, R2235H, R2391H	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Sep 15, 2006)	no assertion criteria provided	VCV000016847	6	7585996	6	7585763	16847	31886	rs121912999	NC_000006.12:7585762:G:A
NM_004415.4(DSP):c.897C>G (p.Ser299Arg)	DSP	S299R	Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000016838	6	7565711	6	7565478	16838	31877	rs121912992	NC_000006.12:7565477:C:G
NM_001369.2(DNAH5):c.6249G>A (p.Met2083Ile)	DNAH5	M2083I	Ciliary dyskinesia, primary, 3|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000228251	5	13830135	5	13830026	228251	229258	rs753614861	NC_000005.10:13830025:C:T
NM_001904.4(CTNNB1):c.101G>A (p.Gly34Glu)	CTNNB1	G34E, G27E	Lung adenocarcinoma|Hepatocellular carcinoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Medulloblastoma|Ovarian Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Adrenocortical carcinoma|Pilomatrixoma	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017584	3	41266104	3	41224613	17584	32623	rs28931589	NC_000003.12:41224612:G:A
NM_001904.4(CTNNB1):c.94G>T (p.Asp32Tyr)	CTNNB1	D32Y, D25Y	Hepatoblastoma|Hepatocellular carcinoma|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Medulloblastoma|Craniopharyngioma|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Pilomatrixoma	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017581	3	41266097	3	41224606	17581	32620	rs28931588	NC_000003.12:41224605:G:T
NM_004415.4(DSP):c.6262del (p.Ala2088fs)	DSP	A1489fs, A1645fs, A2088fs	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000861912	6	7583757	6	7583524	861912	832506		NC_000006.12:7583523:G:
NM_004415.4(DSP):c.2848del (p.Ile950fs)	DSP	I950fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000855123	6	7577241	6	7577008	855123	832480		NC_000006.12:7577007:AAAAAA:AAAAA
NM_004415.2:c.2131_2132del	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000839708					839708	613701		
NM_004415.4(DSP):c.5671_*1792delinsAGAGAAGAACAGTCTT	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000642168			6	7582933 - 7587670	642168	651637		
NC_000006.11:g.(?_7570650)_(7586131_?)del	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000583738	6	7570650 - 7586131	6	7570417 - 7585898	583738	565255		
NM_004415.4(DSP):c.5665_5666GA[4] (p.Lys1892fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: May 26, 2018)	criteria provided, single submitter	VCV000464968	6	7583160 - 7583161	6	7582927 - 7582928	464968	456085	rs1487814687	NC_000006.12:7582926:GAGAGAGAGA:GAGAGAGA
NM_004415.4(DSP):c.1162del (p.Thr388fs)	DSP	T388fs	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000464957	6	7568035	6	7567802	464957	456404	rs1554106742	NC_000006.12:7567801:A:
NM_004415.4(DSP):c.4353_4357del (p.Arg1452fs)	DSP	R1452fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000264015	6	7580776 - 7580780	6	7580543 - 7580547	264015	258447	rs886039009	NC_000006.12:7580542:GAGAC:
NM_004415.4(DSP):c.5550_5557delinsGTG (p.Gln1851fs)	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Mar 31, 2018)	criteria provided, single submitter	VCV000199924	6	7583045 - 7583052	6	7582812 - 7582819	199924	197088	rs1554108621	NC_000006.12:7582811:ACAGCGCC:GTG
NM_004369.3(COL6A3):c.6239G>A (p.Gly2080Asp)	COL6A3	G2080D, G1874D, G1473D	not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000194744	2	238268774	2	237360131	194744	191907	rs794727188	NC_000002.12:237360130:C:T
NM_000551.4(VHL):c.250G>T (p.Val84Leu)	VHL	V84L	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Mar 2, 2012)	criteria provided, single submitter	VCV000002236	3	10183781	3	10142097	2236	17275	rs5030827	NC_000003.12:10142096:G:T
NM_004415.4(DSP):c.1288G>T (p.Glu430Ter)	DSP	E430*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000857798	6	7568691	6	7568458	857798	832461		NC_000006.12:7568457:G:T
NC_000006.12:g.(?_7570427)_(7585888_?)del	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000832649	6	7570660 - 7586121			832649	819750		
NM_004415.4(DSP):c.5771_5772CA[1] (p.Gln1925fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000569376	6	7583265 - 7583266	6	7583032 - 7583033	569376	561101	rs1561701401	NC_000006.12:7583031:ACACA:ACA
NM_004415.4(DSP):c.5321_5322AG[3] (p.Glu1776fs)	DSP		not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545955	6	7581744 - 7581747	6	7581511 - 7581514	545955	536319	rs1394836623	NC_000006.12:7581510:AGAGAGAGAG:AGAGAG
NM_004415.4(DSP):c.3241G>T (p.Glu1081Ter)	DSP	E1081*	not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489339	6	7579664	6	7579431	489339	481771	rs1554108050	NC_000006.12:7579430:G:T
NM_004415.4(DSP):c.5460dup (p.Val1821fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma|not provided	Pathogenic(Last reviewed: May 19, 2018)	criteria provided, single submitter	VCV000464966	6	7582952 - 7582953	6	7582719 - 7582720	464966	456081	rs1554108609	NC_000006.12:7582719:AAA:AAAA
NM_004415.4(DSP):c.250C>T (p.Arg84Ter)	DSP	R84*	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451211	6	7556030	6	7555797	451211	444003	rs768521444	NC_000006.12:7555796:C:T
NM_004415.4(DSP):c.4822C>T (p.Gln1608Ter)	DSP	Q1608*	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000405234	6	7581245	6	7581012	405234	395471	rs1060500610	NC_000006.12:7581011:C:T
NM_004415.4(DSP):c.6510_6511insCT (p.Asn2171fs)	DSP		not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199927	6	7584005 - 7584006	6	7583772 - 7583773	199927	197111	rs794728148	NC_000006.12:7583772::CT
NM_004415.4(DSP):c.273del (p.Glu92fs)	DSP	E92fs	not provided|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000199915	6	7556053	6	7555820	199915	197022	rs794728136	NC_000006.12:7555819:T:
NM_004415.4(DSP):c.3630T>A (p.Tyr1210Ter)	DSP	Y1210*	Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, multiple submitters, no conflicts	VCV000163265	6	7580053	6	7579820	163265	173854	rs727503001	NC_000006.12:7579819:T:A
NM_004415.3(DSP):c.2131_2132delAG (p.Ser711Cysfs)	DSP		not provided|Left ventricular noncompaction cardiomyopathy|Ventricular tachycardia|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000143947	6	7574319 - 7574320	6	7574084 - 7574085	143947	153685	rs587782927	
NM_000030.3(AGXT):c.454T>A (p.Phe152Ile)	AGXT	F152I	Primary hyperoxaluria|Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005645	2	241810796	2	240871379	5645	20684	rs121908524	NC_000002.12:240871378:T:A
NM_004415.4(DSP):c.6767del (p.Gly2256fs)	DSP	G1813fs, G2256fs, G1657fs	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000863260	6	7584260	6	7584027	863260	832509		NC_000006.12:7584026:GGG:GG
NM_004415.4(DSP):c.5269C>T (p.Gln1757Ter)	DSP	Q1757*	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000534275	6	7581692	6	7581459	534275	522209	rs1554108477	NC_000006.12:7581458:C:T
NM_004415.4(DSP):c.3474dup (p.Glu1159fs)	DSP		Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000517147	6	7579896 - 7579897	6	7579663 - 7579664	517147	496579	rs727503000	NC_000006.12:7579663:A:AA
NM_004415.4(DSP):c.1182del (p.Leu395fs)	DSP	L395fs	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000464958	6	7568052	6	7567819	464958	456758	rs1554106743	NC_000006.12:7567818:GGGG:GGG
NM_004415.4(DSP):c.5680_5683del (p.Ser1894fs)	DSP	S1451fs, S1894fs, S1295fs	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000405232	6	7583174 - 7583177	6	7582941 - 7582944	405232	395223	rs774763657	NC_000006.12:7582940:CAGTC:C
NM_057166.5(COL6A3):c.4489-28_4504del	COL6A3		Bethlem myopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498909	2	238267878 - 238267921	2	237359235 - 237359278	498909	490333	rs1553553267	NC_000002.12:237359234:TTTCTCCTACTTCGCCCTAAGAGGGAATAAGGCGGACAGGTAAGT:T
NM_004369.3(COL6A3):c.8966-1G>C	COL6A3		Dystonia 27|Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000192263	2	238243533	2	237334890	192263	190063	rs767517186	NC_000002.12:237334889:C:G
NM_004369.3(COL6A3):c.5036G>A (p.Gly1679Glu)	COL6A3	G1679E, G1072E, G1473E	not provided|Bethlem myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017149	2	238275794	2	237367151	17149	32188	rs121434553	NC_000002.12:237367150:C:T
NM_000404.4(GLB1):c.602G>A (p.Arg201His)	GLB1	R201H, R171H, R249H	GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198077	3	33099712	3	33058220	198077	195238	rs189115557	NC_000003.12:33058219:C:T
NM_003242.6(TGFBR2):c.1378C>T (p.Arg460Cys)	TGFBR2	R460C, R485C	Cardiovascular phenotype|Loeys-Dietz syndrome 2|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012514	3	30715720	3	30674228	12514	27553	rs104893811	NC_000003.12:30674227:C:T
NM_001369.2(DNAH5):c.10815del (p.Pro3606fs)	DNAH5	P3606fs	not provided|Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 3	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000065636	5	13753399	5	13753290	65636	76544	rs397515540	NC_000005.10:13753289:A:
NM_004415.4(DSP):c.939+1del	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000838578	6	7565754	6	7565521	838578	852032		NC_000006.12:7565520:G:
NM_004415.4(DSP):c.1762C>T (p.Gln588Ter)	DSP	Q588*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000658277	6	7571676	6	7571443	658277	635264		NC_000006.12:7571442:C:T
NM_004415.4(DSP):c.4037_4041del (p.Asn1346fs)	DSP	N1346fs	Cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000570298	6	7580458 - 7580462	6	7580225 - 7580229	570298	561095	rs1561698362	NC_000006.12:7580224:AAATGAA:AA
NM_004415.4(DSP):c.4372C>T (p.Arg1458Ter)	DSP	R1458*	Cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000534283	6	7580795	6	7580562	534283	522201	rs28763965	NC_000006.12:7580561:C:T
NM_004415.4(DSP):c.4395T>G (p.Tyr1465Ter)	DSP	Y1465*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 9	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000534281	6	7580818	6	7580585	534281	522217	rs1236464864	NC_000006.12:7580584:T:G
NM_004415.4(DSP):c.6466dup (p.Arg2156fs)	DSP		Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419496	6	7583960 - 7583961	6	7583727 - 7583728	419496	406926	rs1554108859	NC_000006.12:7583727:A:AA
NM_004415.4(DSP):c.3805C>T (p.Arg1269Ter)	DSP	R1269*	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199881	6	7580228	6	7579995	199881	197071	rs767643821	NC_000006.12:7579994:C:T
NM_005859.5(PURA):c.506G>C (p.Arg169Pro)	PURA	R169P	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000521089	5	139494272	5	140114687	521089	511563	rs1554129099	NC_000005.10:140114686:G:C
NM_005859.5(PURA):c.7_11del (p.Asp3fs)	PURA	D3fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000520857	5	139493771 - 139493775	5	140114186 - 140114190	520857	511558	rs1554128999	NC_000005.10:140114185:CGGACCG:CG
NM_005859.5(PURA):c.692T>C (p.Phe231Ser)	PURA	F231S	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000520768	5	139494458	5	140114873	520768	511564	rs1554129113	NC_000005.10:140114872:T:C
NM_004369.3(COL6A3):c.6230G>A (p.Gly2077Asp)	COL6A3	G2077D, G1470D, G1871D	not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476546	2	238268783	2	237360140	476546	450839	rs1553553646	NC_000002.12:237360139:C:T
NM_000094.3(COL7A1):c.1732C>T (p.Arg578Ter)	COL7A1	R578*	not provided|Dystrophic epidermolysis bullosa|Generalized dominant dystrophic epidermolysis bullosa|Pretibial epidermolysis bullosa|Epidermolysis bullosa pruriginosa|Transient bullous dermolysis of the newborn|Nail disorder, nonsyndromic congenital, 8|Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Recessive dystrophic epidermolysis bullosa	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372330	3	48628154	3	48590721	372330	359454	rs144023803	NC_000003.12:48590720:G:A
NM_174889.5(NDUFAF2):c.139C>T (p.Arg47Ter)	NDUFAF2	R45*, R47*	Leigh syndrome|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10|Mitochondrial complex I deficiency, nuclear type 1|Inborn genetic diseases|not specified	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001594	5	60368963	5	61073136	1594	16633	rs137852863	NC_000005.10:61073135:C:T
NM_004415.4(DSP):c.6950_6951AG[2] (p.Gly2319fs)	DSP		Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000518482	6	7584445 - 7584446	6	7584212 - 7584213	518482	509833	rs1554108929	NC_000006.12:7584211:AGAGAG:AGAG
NM_004415.4(DSP):c.5212C>T (p.Arg1738Ter)	DSP	R1738*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000199890	6	7581635	6	7581402	199890	197087	rs794728124	NC_000006.12:7581401:C:T
NM_004415.4(DSP):c.4180C>T (p.Gln1394Ter)	DSP	Q1394*	Arrhythmogenic right ventricular cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162505	6	7580603	6	7580370	162505	172173	rs140474226	NC_000006.12:7580369:C:T
NM_004415.4(DSP):c.4531C>T (p.Gln1511Ter)	DSP	Q1511*	not provided|Arrhythmogenic right ventricular cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044914	6	7580954	6	7580721	44914	54081	rs397516940	NC_000006.12:7580720:C:T
NM_003060.4(SLC22A5):c.760C>T (p.Arg254Ter)	SLC22A5	R254*, R278*	not specified|not provided|Renal carnitine transport defect	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006426	5	131721127	5	132385435	6426	21465	rs121908893	NC_000005.10:132385434:C:T
NC_000003.12:g.(?_10146504)_(10150035_?)del	VHL		Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000832599	3	10188188 - 10191719			832599	819309		
NC_000003.12:g.(?_10141848)_(10150035_?)del	VHL		Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000830987	3	10183532 - 10191719			830987	819306		
NM_000551.3(VHL):c.245G>T (p.Arg82Leu)	VHL	R82L	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000526675	3	10183776	3	10142092	526675	518732	rs794726890	NC_000003.12:10142091:G:T
NM_000551.3(VHL):c.333C>G (p.Ser111Arg)	VHL	S111R	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000223187	3	10183864	3	10142180	223187	224918	rs765978945	NC_000003.12:10142179:C:G
NM_004369.3(COL6A3):c.6220G>A (p.Gly2074Ser)	COL6A3	G2074S, G1467S, G1868S	Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289755	2	238268793	2	237360150	289755	273992	rs886044252	NC_000002.12:237360149:C:T
NM_004369.3(COL6A3):c.6193G>C (p.Gly2065Arg)	COL6A3	G2065R, G1458R, G1859R	not provided|Bethlem myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000284796	2	238269781	2	237361138	284796	269033	rs397515332	NC_000002.12:237361137:C:G
NM_004369.3(COL6A3):c.175C>T (p.Arg59Ter)	COL6A3	R59*	not provided|Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094911	2	238303764	2	237395121	94911	100811	rs398124119	NC_000002.12:237395120:G:A
NM_001904.4(CTNNB1):c.95A>G (p.Asp32Gly)	CTNNB1	D32G, D25G	Hepatocellular carcinoma|Cutaneous melanoma|not provided|Transitional cell carcinoma of the bladder|Medulloblastoma|Uterine cervical neoplasms|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Pilomatrixoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017578	3	41266098	3	41224607	17578	32617	rs121913396	NC_000003.12:41224606:A:G
NM_001145847.2(PROM1):c.1090C>T (p.Arg364Cys)	PROM1	R373C, R364C	Macular dystrophy|Stargardt disease|Retinal dystrophy|Stargardt disease 4|Bull's eye macular dystrophy|Cone-rod dystrophy 12|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005610	4	16014922	4	16013299	5610	20649	rs137853006	NC_000004.12:16013298:G:A
NM_133433.4(NIPBL):c.1435C>T (p.Arg479Ter)	NIPBL	R479*	Cornelia de Lange syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000521020	5	36976444	5	36976342	521020	511597	rs1554015303	NC_000005.10:36976341:C:T
NM_004656.4(BAP1):c.1717del (p.Leu573fs)	BAP1	L573fs	Tumor susceptibility linked to germline BAP1 mutations|BAP1 Cancer Syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000221278	3	52437444	3	52403428	221278	222989	rs869025212	NC_000003.12:52403427:GGGG:GGG
NM_004415.4(DSP):c.523C>T (p.Gln175Ter)	DSP	Q175*	Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000652401	6	7559559	6	7559326	652401	635251		NC_000006.12:7559325:C:T
NM_004415.4(DSP):c.4305_4309del (p.Thr1436fs)	DSP	T1436fs	Arrhythmogenic right ventricular cardiomyopathy, type 8|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000464963	6	7580728 - 7580732	6	7580495 - 7580499	464963	455835	rs1554108287	NC_000006.12:7580494:CACTG:
NM_004415.4(DSP):c.4882_4886delinsTTCT (p.Arg1628fs)	DSP		Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000452266	6	7581305 - 7581309	6	7581072 - 7581076	452266	444012	rs1554108410	NC_000006.12:7581071:AGGAG:TTCT
NM_004415.4(DSP):c.3865C>T (p.Gln1289Ter)	DSP	Q1289*	not provided|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000387849	6	7580288	6	7580055	387849	369053	rs778178956	NC_000006.12:7580054:C:T
NM_004415.4(DSP):c.268C>T (p.Gln90Ter)	DSP	Q90*	not specified|not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265102	6	7556048	6	7555815	265102	259846	rs886039343	NC_000006.12:7555814:C:T
NM_004415.4(DSP):c.1873C>T (p.Gln625Ter)	DSP	Q625*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228253	6	7571787	6	7571554	228253	229493	rs876657638	NC_000006.12:7571553:C:T
NM_004415.4(DSP):c.928dup (p.Glu310fs)	DSP		not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Skin fragility-woolly hair-palmoplantar keratoderma syndrome|Keratosis palmoplantaris striata II|Dilated cardiomyopathy with woolly hair and keratoderma|Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis||Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199916	6	7565740 - 7565741	6	7565507 - 7565508	199916	197033	rs794728137	NC_000006.12:7565507:GG:GGG
NM_004415.4(DSP):c.4198C>T (p.Arg1400Ter)	DSP	R1400*	not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000199884	6	7580621	6	7580388	199884	197076	rs770873593	NC_000006.12:7580387:C:T
NM_000030.3(AGXT):c.731T>C (p.Ile244Thr)	AGXT	I244T	Primary hyperoxaluria, type I|Nephrolithiasis|Nephrocalcinosis|Primary hyperoxaluria|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005646	2	241814576	2	240875159	5646	20685	rs121908525	NC_000002.12:240875158:T:C
NM_004369.3(COL6A3):c.6158G>T (p.Gly2053Val)	COL6A3	G2053V, G1446V, G1847V	Bethlem myopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280028	2	238269816	2	237361173	280028	264078	rs886041329	NC_000002.12:237361172:C:A
NM_003242.6(TGFBR2):c.1570G>A (p.Asp524Asn)	TGFBR2	D524N, D549N	not provided|Thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Loeys-Dietz syndrome|Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180541	3	30732957	3	30691465	180541	178514	rs727504421	NC_000003.12:30691464:G:A
NM_003242.6(TGFBR2):c.1583G>A (p.Arg528His)	TGFBR2	R528H, R553H	Hereditary nonpolyposis colorectal cancer type 6|Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|not provided|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012511	3	30732970	3	30691478	12511	27550	rs104893815	NC_000003.12:30691477:G:A
NM_000094.3(COL7A1):c.6007G>A (p.Gly2003Arg)	COL7A1	G2003R	Dominant dystrophic epidermolysis bullosa with absence of skin|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000017430	3	48612945	3	48575512	17430	32469	rs121912832	NC_000003.12:48575511:C:T
NM_000551.3(VHL):c.278G>A (p.Gly93Asp)	VHL	G93D	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496054	3	10183809	3	10142125	496054	486941	rs1553619440	NC_000003.12:10142124:G:A
NM_000551.3(VHL):c.340+1G>A	VHL		Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000223190	3	10183872	3	10142188	223190	224922	rs730882032	NC_000003.12:10142187:G:A
NM_000551.3(VHL):c.245G>C (p.Arg82Pro)	VHL	R82P	not provided|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193118	3	10183776	3	10142092	193118	190283	rs794726890	NC_000003.12:10142091:G:C
NM_000551.4(VHL):c.194C>G (p.Ser65Trp)	VHL	S65W	Von Hippel-Lindau syndrome|not provided	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000043597	3	10183725	3	10142041	43597	52766	rs5030826	NC_000003.12:10142040:C:G
NM_001370658.1(BTD):c.695A>G (p.Asp232Gly)	BTD	D252G, D232G, D254G	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001901	3	15686118	3	15644611	1901	16940	rs28934601	NC_000003.12:15644610:A:G
NM_000344.3(SMN1):c.815A>G (p.Tyr272Cys)	SMN1	Y272C, Y240C	not provided|Werdnig-Hoffmann disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000009166	5	70241984	5	70946157	9166	24205	rs104893922	NC_000005.10:70946156:A:G
NM_004415.4(DSP):c.4999C>T (p.Gln1667Ter)	DSP	Q1667*	not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488983	6	7581422	6	7581189	488983	481772	rs1554108431	NC_000006.12:7581188:C:T
NM_004415.4(DSP):c.2821C>T (p.Arg941Ter)	DSP	R941*	Cardiac arrest|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180326	6	7577219	6	7576986	180326	178554	rs730880082	NC_000006.12:7576985:C:T
NM_004415.4(DSP):c.2848dup (p.Ile950fs)	DSP		Primary dilated cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044885	6	7577240 - 7577241	6	7577007 - 7577008	44885	54052	rs397516927	NC_000006.12:7577007:AAAAAA:AAAAAAA
NM_000046.5(ARSB):c.629A>G (p.Tyr210Cys)	ARSB	Y210C	Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000885	5	78260300	5	78964477	885	15924	rs118203943	NC_000005.10:78964476:T:C
NM_000406.3(GNRHR):c.317A>G (p.Gln106Arg)	GNRHR	Q106R	Isolated congenital hypogonadotropic hypogonadism|not provided|Hypogonadotropic hypogonadism 7 with or without anosmia|Gonadotropin deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016023	4	68619737	4	67754019	16023	31062	rs104893836	NC_000004.12:67754018:T:C
NM_003042.4(SLC6A1):c.863C>T (p.Ala288Val)	SLC6A1	A288V, A110V, A168V	Myoclonic-atonic epilepsy|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000192372	3	11067472	3	11025786	192372	190159	rs794726860	NC_000003.12:11025785:C:T
NM_000404.4(GLB1):c.176G>A (p.Arg59His)	GLB1	R59H, R107H, R29H	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|not provided||Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000945	3	33114105	3	33072613	945	15984	rs72555392	NC_000003.12:33072612:C:T
NM_000551.3(VHL):c.340G>A (p.Gly114Ser)	VHL	G114S, V114M, V114I	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000583094	3	10183871	3	10142187	583094	559259	rs869025636	NC_000003.12:10142186:G:A
NM_000551.3(VHL):c.250G>C (p.Val84Leu)	VHL	V84L	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000229860	3	10183781	3	10142097	229860	232861	rs5030827	NC_000003.12:10142096:G:C
NM_000551.4(VHL):c.319C>G (p.Arg107Gly)	VHL	R107G	Pheochromocytoma|Renal cell carcinoma, nonpapillary|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043599	3	10183850	3	10142166	43599	52768	rs397516440	NC_000003.12:10142165:C:G
NM_005859.5(PURA):c.153del (p.Leu54fs)	PURA	L54fs	History of neurodevelopmental disorder|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000522145	5	139493919	5	140114334	522145	511560	rs1554129039	NC_000005.10:140114333:A:
NM_004415.4(DSP):c.3133C>T (p.Arg1045Ter)	DSP	R1045*	Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000464961	6	7579556	6	7579323	464961	456069	rs1554108012	NC_000006.12:7579322:C:T
NM_004415.4(DSP):c.5851C>T (p.Arg1951Ter)	DSP	R1951*, R1352*, R1508*	not provided|Arrhythmogenic right ventricular cardiomyopathy, type 8|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222582	6	7583346	6	7583113	222582	224332	rs869025395	NC_000006.12:7583112:C:T
NM_004415.4(DSP):c.5800C>T (p.Arg1934Ter)	DSP	R1934*, R1491*, R1335*	not provided||Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016843	6	7583295	6	7583062	16843	31882	rs121912996	NC_000006.12:7583061:C:T
NM_006206.6(PDGFRA):c.2525A>T (p.Asp842Val)	PDGFRA	D842V, D867V, D855V	Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000013543	4	55152093	4	54285926	13543	28582	rs121908585	NC_000004.12:54285925:A:T
NM_005732.4(RAD50):c.715del (p.Glu239fs)	RAD50	E239fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000826870	5	131915716	5	132580024	826870	808357		NC_000005.10:132580023:GG:G
NM_005732.4(RAD50):c.576del (p.Arg193fs)	RAD50	R193fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000825953	5	131915577	5	132579885	825953	808346		NC_000005.10:132579884:TT:T
NM_005732.4(RAD50):c.423del (p.Ser142fs)	RAD50	S142fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000824710	5	131915066	5	132579374	824710	808333		NC_000005.10:132579373:C:
NM_005732.4(RAD50):c.995_998TAAA[1] (p.Asn333fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000823593	5	131923725 - 131923728	5	132588033 - 132588036	823593	808371		NC_000005.10:132588032:TAAATAAA:TAAA
NM_005732.4(RAD50):c.3271_3272del (p.Glu1091fs)	RAD50	E1091fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000823370	5	131953867 - 131953868	5	132618175 - 132618176	823370	808498		NC_000005.10:132618174:AGA:A
NM_005732.4(RAD50):c.3179T>A (p.Leu1060Ter)	RAD50	L1060*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000823095	5	131953776	5	132618084	823095	808493		NC_000005.10:132618083:T:A
NM_005732.4(RAD50):c.3175A>T (p.Lys1059Ter)	RAD50	K1059*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000823078	5	131953772	5	132618080	823078	808492		NC_000005.10:132618079:A:T
NM_005732.4(RAD50):c.897del (p.Thr300fs)	RAD50	T300fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000822863	5	131923625	5	132587933	822863	808367		NC_000005.10:132587932:GGG:GG
NM_005732.4(RAD50):c.3055C>T (p.Gln1019Ter)	RAD50	Q1019*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000822738	5	131951713	5	132616021	822738	808490		NC_000005.10:132616020:C:T
NM_005732.4(RAD50):c.3040C>T (p.Gln1014Ter)	RAD50	Q1014*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000822693	5	131951698	5	132616006	822693	808486		NC_000005.10:132616005:C:T
NM_005732.4(RAD50):c.2952del (p.Ile984fs)	RAD50	I984fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2017)	criteria provided, single submitter	VCV000822350	5	131945004	5	132609312	822350	808482		NC_000005.10:132609311:A:
NM_005732.4(RAD50):c.1081C>T (p.Gln361Ter)	RAD50	Q361*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000822125	5	131924408	5	132588716	822125	808376		NC_000005.10:132588715:C:T
NM_005732.4(RAD50):c.2876_2877del (p.Lys959fs)	RAD50	K959fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000821940	5	131944854 - 131944855	5	132609162 - 132609163	821940	808478		NC_000005.10:132609161:AAA:A
NM_005732.4(RAD50):c.2209C>T (p.Gln737Ter)	RAD50	Q737*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000820893	5	131938993	5	132603301	820893	808448		NC_000005.10:132603300:C:T
NM_005732.4(RAD50):c.2083C>T (p.Gln695Ter)	RAD50	Q695*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000820680	5	131931378	5	132595686	820680	808440		NC_000005.10:132595685:C:T
NM_005732.4(RAD50):c.2033_2034dup (p.Cys680fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000820565	5	131931327 - 131931328	5	132595635 - 132595636	820565	808435		NC_000005.10:132595635:AG:AGAG
NM_005732.4(RAD50):c.2034_2037dup (p.Cys680fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000820529	5	131931326 - 131931327	5	132595634 - 132595635	820529	808434		NC_000005.10:132595634:CAGTCA:CAGTCAGTCA
NM_005732.4(RAD50):c.1953del (p.Lys651fs)	RAD50	K651fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000820402	5	131930716	5	132595024	820402	808431		NC_000005.10:132595023:AAAAA:AAAA
NM_005732.4(RAD50):c.1813G>T (p.Glu605Ter)	RAD50	E605*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000820128	5	131930580	5	132594888	820128	808424		NC_000005.10:132594887:G:T
NM_005732.4(RAD50):c.1381A>T (p.Lys461Ter)	RAD50	K461*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000819059	5	131925458	5	132589766	819059	808394		NC_000005.10:132589765:A:T
NM_005732.4(RAD50):c.1349_1352TAAG[1] (p.Ser451fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000818961	5	131925426 - 131925429	5	132589734 - 132589737	818961	808392		NC_000005.10:132589733:TAAGTAAG:TAAG
NM_005732.4(RAD50):c.1283_1286AGAT[1] (p.Ile429fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000818805	5	131925360 - 131925363	5	132589668 - 132589671	818805	808389		NC_000005.10:132589667:AGATAGAT:AGAT
NM_005732.4(RAD50):c.1210C>T (p.Gln404Ter)	RAD50	Q404*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000818598	5	131924537	5	132588845	818598	808385		NC_000005.10:132588844:C:T
NM_005732.4(RAD50):c.1174C>T (p.Gln392Ter)	RAD50	Q392*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000818494	5	131924501	5	132588809	818494	808381		NC_000005.10:132588808:C:T
NM_005732.4(RAD50):c.3103G>T (p.Glu1035Ter)	RAD50	E1035*	not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000584475	5	131951761	5	132616069	584475	575540	rs1561650088	NC_000005.10:132616068:G:T
NM_005732.4(RAD50):c.2227A>T (p.Lys743Ter)	RAD50	K743*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000486251	5	131939011	5	132603319	486251	474251	rs1554099081	NC_000005.10:132603318:A:T
NM_005732.4(RAD50):c.2899del (p.Asp967fs)	RAD50	D967fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000484710	5	131944878	5	132609186	484710	474335	rs1554099372	NC_000005.10:132609185:G:
NM_005732.4(RAD50):c.2770C>T (p.Gln924Ter)	RAD50	Q924*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000484705	5	131944358	5	132608666	484705	474312	rs1554099320	NC_000005.10:132608665:C:T
NM_005732.4(RAD50):c.1633A>T (p.Lys545Ter)	RAD50	K545*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000484693	5	131927096	5	132591404	484693	474155	rs1253904315	NC_000005.10:132591403:A:T
NM_005732.4(RAD50):c.2801del (p.Asn934fs)	RAD50	N934fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000484688	5	131944382	5	132608690	484688	474257	rs748536322	NC_000005.10:132608689:AAAAAAAA:AAAAAAA
NM_005732.4(RAD50):c.1826dup (p.Asn609fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000484664	5	131930588 - 131930589	5	132594896 - 132594897	484664	474183	rs1554098584	NC_000005.10:132594896:AAAAA:AAAAAA
NM_005732.4(RAD50):c.648del (p.Gln215_Tyr216insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000484647	5	131915650	5	132579958	484647	474147	rs1554097816	NC_000005.10:132579957:T:
NM_005732.4(RAD50):c.1970-1_1972dup	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000482155	5	131931262 - 131931263	5	132595570 - 132595571	482155	474189	rs1554098661	NC_000005.10:132595570:AGCCA:AGCCAGCCA
NM_005732.4(RAD50):c.1847_1850AAAG[1] (p.Glu619fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000482117	5	131930614 - 131930617	5	132594922 - 132594925	482117	474185	rs1554098588	NC_000005.10:132594921:AAAGAAAG:AAAG
NM_005732.4(RAD50):c.1213G>T (p.Glu405Ter)	RAD50	E405*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	VCV000482087	5	131924540	5	132588848	482087	474128	rs1554098262	NC_000005.10:132588847:G:T
NM_005732.4(RAD50):c.72del (p.Ile25fs)	RAD50	I25fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000480471	5	131893087	5	132557395	480471	473956	rs1554096644	NC_000005.10:132557394:TT:T
NM_005732.4(RAD50):c.1376del (p.Asn459fs)	RAD50	N459fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000480454	5	131925449	5	132589757	480454	474146	rs1554098326	NC_000005.10:132589756:AAAAA:AAAA
NM_005732.4(RAD50):c.1736G>A (p.Trp579Ter)	RAD50	W579*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000480439	5	131927669	5	132591977	480439	474197	rs1554098484	NC_000005.10:132591976:G:A
NM_005732.4(RAD50):c.2314del (p.Glu772fs)	RAD50	E772fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000480433	5	131939098	5	132603406	480433	474211	rs1554099106	NC_000005.10:132603405:G:
NM_005732.4(RAD50):c.2361del (p.Cys788fs)	RAD50	C788fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000480422	5	131939145	5	132603453	480422	474278	rs1554099112	NC_000005.10:132603452:A:
NM_005732.4(RAD50):c.3050G>A (p.Trp1017Ter)	RAD50	W1017*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000480391	5	131951708	5	132616016	480391	474340	rs1554099776	NC_000005.10:132616015:G:A
NM_005732.4(RAD50):c.2284C>T (p.Gln762Ter)	RAD50	Q762*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000234016	5	131939068	5	132603376	234016	233359	rs876660797	NC_000005.10:132603375:C:T
NM_005732.4(RAD50):c.1168_1169del (p.Glu390fs)	RAD50	E390fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000233055	5	131924495 - 131924496	5	132588803 - 132588804	233055	233295	rs876660160	NC_000005.10:132588802:GA:
NM_005732.4(RAD50):c.2744dup (p.Leu915fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000231132	5	131944329 - 131944330	5	132608637 - 132608638	231132	233387	rs876658976	NC_000005.10:132608637:TTT:TTTT
NM_005732.4(RAD50):c.1200_1201GA[6] (p.Gln404fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000187490	5	131924526 - 131924527	5	132588834 - 132588835	187490	182550	rs786203655	NC_000005.10:132588834:GAGAGAGAGA:GAGAGAGAGAGA
NM_005732.4(RAD50):c.1200_1201GA[3] (p.Glu402fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	criteria provided, single submitter	VCV000187339	5	131924527 - 131924530	5	132588835 - 132588838	187339	182549	rs786203655	NC_000005.10:132588834:GAGAGAGAGA:GAGAGA
NM_005732.4(RAD50):c.965del (p.Leu322fs)	RAD50	L322fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000187012	5	131923694	5	132588002	187012	182536	rs786203403	NC_000005.10:132588001:TT:T
NM_005732.4(RAD50):c.2516T>A (p.Leu839Ter)	RAD50	L839*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	VCV000185451	5	131939730	5	132604038	185451	182608	rs776395588	NC_000005.10:132604037:T:A
NM_005732.4(RAD50):c.643C>T (p.Gln215Ter)	RAD50	Q215*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	VCV000141208	5	131915645	5	132579953	141208	150922	rs587781576	NC_000005.10:132579952:C:T
NM_005732.4(RAD50):c.689del (p.Lys230fs)	RAD50	K230fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 24, 2019)	criteria provided, single submitter	VCV000864322	5	131915690	5	132579998	864322	830094		NC_000005.10:132579997:AA:A
NM_005732.4(RAD50):c.1774del (p.Asp592fs)	RAD50	D592fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000860238	5	131927705	5	132592013	860238	830123		NC_000005.10:132592012:GGG:GG
NM_005732.4(RAD50):c.2862_2865del (p.Ile954fs)	RAD50	I954fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000858436	5	131944839 - 131944842	5	132609147 - 132609150	858436	830154		NC_000005.10:132609146:ATTCAT:AT
NM_005732.4(RAD50):c.2944A>T (p.Lys982Ter)	RAD50	K982*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000858174	5	131944996	5	132609304	858174	830155		NC_000005.10:132609303:A:T
NM_005732.4(RAD50):c.2786dup (p.Leu929fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000854484	5	131944372 - 131944373	5	132608680 - 132608681	854484	830151		NC_000005.10:132608680:TT:TTT
NM_005732.4(RAD50):c.1311_1312del (p.Gly438fs)	RAD50	G438fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000849771	5	131925388 - 131925389	5	132589696 - 132589697	849771	830111		NC_000005.10:132589695:TG:
NM_005732.4(RAD50):c.2476C>T (p.Gln826Ter)	RAD50	Q826*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000849115	5	131939690	5	132603998	849115	830143		NC_000005.10:132603997:C:T
NM_005732.4(RAD50):c.52G>T (p.Glu18Ter)	RAD50	E18*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, single submitter	VCV000842928	5	131893068	5	132557376	842928	830078		NC_000005.10:132557375:G:T
NM_005732.4(RAD50):c.1821_1849del (p.Asn607fs)	RAD50	N607fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000841180	5	131930586 - 131930614	5	132594894 - 132594922	841180	830124		NC_000005.10:132594893:AATAAAAATCATATAAATAATGAACTAAAAA:AA
NM_005732.4(RAD50):c.1963C>T (p.Gln655Ter)	RAD50	Q655*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000838210	5	131930730	5	132595038	838210	830131		NC_000005.10:132595037:C:T
NM_005732.4(RAD50):c.3235_3238del (p.Lys1079fs)	RAD50	K1079fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000837926	5	131953830 - 131953833	5	132618138 - 132618141	837926	830162		NC_000005.10:132618137:AGAAAG:AG
NM_005732.4(RAD50):c.1238_1241del (p.Gln413fs)	RAD50	Q413fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000834660	5	131924565 - 131924568	5	132588873 - 132588876	834660	830108		NC_000005.10:132588872:AACT:
NC_000005.10:g.(?_132557325)_(132557463_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000832909	5	131893017 - 131893155			832909	819538		
NC_000005.10:g.(?_132575767)_(132604056_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000832663	5	131911459 - 131939748			832663	819541		
NC_000005.10:g.(?_132637105)_(132638233_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000831137	5	131972797 - 131973925			831137	819544		
NC_000005.10:g.(?_132557315)_(132557463_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000831066	5	131893007 - 131893155			831066	819537		
NM_005732.4(RAD50):c.3372T>G (p.Tyr1124Ter)	RAD50	Y1124*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000823679	5	131953969	5	132618277	823679	808503		NC_000005.10:132618276:T:G
NM_005732.4(RAD50):c.1017dup (p.Asn340fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000818268	5	131923746 - 131923747	5	132588054 - 132588055	818268	808372		NC_000005.10:132588054:C:CC
NM_005732.4(RAD50):c.2668C>T (p.Gln890Ter)	RAD50	Q890*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, single submitter	VCV000656622	5	131940641	5	132604949	656622	633142		NC_000005.10:132604948:C:T
NM_005732.4(RAD50):c.410_411del (p.Asp137fs)	RAD50	D137fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000651741	5	131915053 - 131915054	5	132579361 - 132579362	651741	633086		NC_000005.10:132579360:AC:
NM_005732.4(RAD50):c.2190_2191delinsCT (p.Gly731Ter)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000649615	5	131931485 - 131931486	5	132595793 - 132595794	649615	633128		NC_000005.10:132595792:GG:CT
NM_005732.4(RAD50):c.2299_2311del (p.Asp767fs)	RAD50	D767fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000648327	5	131939077 - 131939089	5	132603385 - 132603397	648327	633135		NC_000005.10:132603384:AAGAACGACATAGAAGAAC:AAGAAC
NM_005732.4(RAD50):c.1391dup (p.Leu464fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2018)	criteria provided, single submitter	VCV000647815	5	131925466 - 131925467	5	132589774 - 132589775	647815	633109		NC_000005.10:132589774:TT:TTT
NM_005732.4(RAD50):c.1360C>T (p.Gln454Ter)	RAD50	Q454*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000645705	5	131925437	5	132589745	645705	633108		NC_000005.10:132589744:C:T
NM_005732.4(RAD50):c.762_765dup (p.Lys256fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000645216	5	131923258 - 131923259	5	132587566 - 132587567	645216	633097		NC_000005.10:132587566:TCTA:TCTATCTA
NM_005732.4(RAD50):c.129+1del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000644625	5	131893145	5	132557453	644625	651275		NC_000005.10:132557452:GG:G
NC_000005.9:g.(?_131911459)_(131911630_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000583678	5	131911459 - 131911630	5	132575767 - 132575938	583678	564101		
NM_005732.4(RAD50):c.1849_1853del (p.Arg617fs)	RAD50	R617fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000583018	5	131930613 - 131930617	5	132594921 - 132594925	583018	560111	rs1561642039	NC_000005.10:132594920:AAAAGAAA:AAA
NM_005732.4(RAD50):c.1648_1651dup (p.Gln551fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 31, 2018)	criteria provided, single submitter	VCV000582987	5	131927580 - 131927581	5	132591888 - 132591889	582987	562733	rs1561641010	NC_000005.10:132591888:GAAC:GAACGAAC
NM_005732.4(RAD50):c.1723C>T (p.Gln575Ter)	RAD50	Q575*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000582373	5	131927656	5	132591964	582373	560196	rs980964237	NC_000005.10:132591963:C:T
NM_005732.4(RAD50):c.1106C>G (p.Ser369Ter)	RAD50	S369*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000578799	5	131924433	5	132588741	578799	560184	rs947142407	NC_000005.10:132588740:C:G
NM_005732.4(RAD50):c.2956C>T (p.Gln986Ter)	RAD50	Q986*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000575716	5	131945008	5	132609316	575716	562754	rs1561647533	NC_000005.10:132609315:C:T
NM_005732.4(RAD50):c.2884G>T (p.Glu962Ter)	RAD50	E962*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000575560	5	131944863	5	132609171	575560	562751	rs1561647410	NC_000005.10:132609170:G:T
NM_005732.4(RAD50):c.1188dup (p.His397fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 2, 2019)	criteria provided, single submitter	VCV000575273	5	131924511 - 131924512	5	132588819 - 132588820	575273	560186	rs770082735	NC_000005.10:132588819:TTTT:TTTTT
NM_005732.4(RAD50):c.2386G>T (p.Glu796Ter)	RAD50	E796*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000575128	5	131939170	5	132603478	575128	562749	rs876658213	NC_000005.10:132603477:G:T
NM_005732.4(RAD50):c.1765C>T (p.Gln589Ter)	RAD50	Q589*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000566732	5	131927698	5	132592006	566732	560109	rs1561641132	NC_000005.10:132592005:C:T
NM_005732.4(RAD50):c.2086G>T (p.Glu696Ter)	RAD50	E696*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527380	5	131931381	5	132595689	527380	521146	rs1388500583	NC_000005.10:132595688:G:T
NM_005732.4(RAD50):c.3277dup (p.Arg1093fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000527375	5	131953873 - 131953874	5	132618181 - 132618182	527375	521097	rs1554099874	NC_000005.10:132618181:C:CC
NM_005732.4(RAD50):c.1850del (p.Arg617fs)	RAD50	R617fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527362	5	131930617	5	132594925	527362	521061	rs1554098589	NC_000005.10:132594924:G:
NM_005732.4(RAD50):c.2054dup (p.Arg686fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000527348	5	131931348 - 131931349	5	132595656 - 132595657	527348	520903	rs1554098683	NC_000005.10:132595656:A:AA
NM_005732.4(RAD50):c.2929G>T (p.Glu977Ter)	RAD50	E977*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527346	5	131944981	5	132609289	527346	521086	rs1554099388	NC_000005.10:132609288:G:T
NM_005732.4(RAD50):c.1432_1433dup (p.Asp478fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000527343	5	131925508 - 131925509	5	132589816 - 132589817	527343	520683	rs1554098333	NC_000005.10:132589816:GA:GAGA
NM_005732.4(RAD50):c.379_383del (p.Val127fs)	RAD50	V127fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 9, 2017)	criteria provided, single submitter	VCV000457470	5	131915020 - 131915024	5	132579328 - 132579332	457470	455185	rs1554097758	NC_000005.10:132579327:AGGTCAG:AG
NM_005732.4(RAD50):c.3353del (p.Asn1118fs)	RAD50	N1118fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000457446	5	131953949	5	132618257	457446	454565	rs1554099888	NC_000005.10:132618256:AA:A
NM_005732.4(RAD50):c.2734del (p.Gln911_Val912insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000457417	5	131944321	5	132608629	457417	455289	rs1297931573	NC_000005.10:132608628:GG:G
NM_005732.4(RAD50):c.1295_1299del (p.Ile432fs)	RAD50	I432fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000457373	5	131925369 - 131925373	5	132589677 - 132589681	457373	455254	rs1554098316	NC_000005.10:132589676:AGATAAGA:AGA
Single allele	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000457358			5	132603294 - 132605005	457358	453875		
NC_000005.9:g.(?_131911469)_(131911620_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000417430	5	131911469 - 131911620	5	132575777 - 132575928	417430	394278		
NC_000005.9:g.(?_131892616)_(131893145_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000417429	5	131892616 - 131893145	5	132556924 - 132557453	417429	394382		
NM_005732.4(RAD50):c.2467C>T (p.Arg823Ter)	RAD50	R823*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000408347	5	131939681	5	132603989	408347	394765	rs1060501936	NC_000005.10:132603988:C:T
NM_005732.4(RAD50):c.3366_3369TATT[1] (p.Tyr1124fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000408329	5	131953963 - 131953966	5	132618271 - 132618274	408329	394682	rs1060501923	NC_000005.10:132618270:TATTTATT:TATT
NM_005732.4(RAD50):c.3266_3273delinsT (p.Lys1089fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000240235	5	131953863 - 131953870	5	132618171 - 132618178	240235	239709	rs878854797	NC_000005.10:132618170:AGAAAGAA:T
NM_005732.4(RAD50):c.3028dup (p.Thr1010fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000240230	5	131945079 - 131945080	5	132609387 - 132609388	240230	239704	rs878854795	NC_000005.10:132609387:A:AA
NM_005732.4(RAD50):c.1293_1299GATAAGA[3] (p.Lys436delinsArgTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127994	5	131925367 - 131925368	5	132589675 - 132589676	127994	133451	rs587780147	NC_000005.10:132589675:GAGATAAGAGATAAGA:GAGATAAGAGATAAGAGATAAGA
NM_005732.4(RAD50):c.731_732del (p.Ser243_Tyr244insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826958	5	131915732 - 131915733	5	132580040 - 132580041	826958	808360		NC_000005.10:132580039:TAT:T
NM_005732.4(RAD50):c.2054_2055AG[2] (p.Arg686fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820618	5	131931349 - 131931350	5	132595657 - 132595658	820618	808437		NC_000005.10:132595656:AGAGAG:AGAG
NM_005732.4(RAD50):c.1704del (p.Tyr569fs)	RAD50	Y569fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000658126	5	131927637	5	132591945	658126	633117		NC_000005.10:132591944:A:
NM_005732.4(RAD50):c.2792del (p.Asn931fs)	RAD50	N931fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000645838	5	131944379	5	132608687	645838	633145		NC_000005.10:132608686:AA:A
NM_005732.4(RAD50):c.471T>A (p.Cys157Ter)	RAD50	C157*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000639622	5	131915114	5	132579422	639622	633088		NC_000005.10:132579421:T:A
NM_005732.4(RAD50):c.2981_2982del (p.Lys994fs)	RAD50	K994fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000583363	5	131945032 - 131945033	5	132609340 - 132609341	583363	560125	rs1561647559	NC_000005.10:132609339:AAA:A
NM_005732.4(RAD50):c.1271_1272del (p.Leu424fs)	RAD50	L424fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000576376	5	131925348 - 131925349	5	132589656 - 132589657	576376	562718	rs769047012	NC_000005.10:132589655:TG:
NM_005732.4(RAD50):c.393_394insTT (p.Lys132fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000576042	5	131915035 - 131915036	5	132579343 - 132579344	576042	560172	rs1458900761	NC_000005.10:132579343:T:TTT
NM_005732.4(RAD50):c.3071del (p.Thr1023_Leu1024insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000574372	5	131951727	5	132616035	574372	560216	rs753950483	NC_000005.10:132616034:TTT:TT
NM_005732.4(RAD50):c.2934_2935del (p.Glu979fs)	RAD50	E979fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572327	5	131944986 - 131944987	5	132609294 - 132609295	572327	564658	rs768522804	NC_000005.10:132609293:TG:
NM_005732.4(RAD50):c.282del (p.Ile94fs)	RAD50	I94fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571863	5	131911537	5	132575845	571863	560168	rs1561634357	NC_000005.10:132575844:A:
NM_005732.4(RAD50):c.2026G>T (p.Glu676Ter)	RAD50	E676*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486238	5	131931321	5	132595629	486238	474290	rs773761143	NC_000005.10:132595628:G:T
NM_005732.4(RAD50):c.2605G>T (p.Glu869Ter)	RAD50	E869*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484658	5	131940578	5	132604886	484658	474224	rs764449224	NC_000005.10:132604885:G:T
NM_005732.4(RAD50):c.1002_1005del (p.Lys334fs)	RAD50	K334fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484646	5	131923730 - 131923733	5	132588038 - 132588041	484646	474219	rs1554098203	NC_000005.10:132588037:AAAGAA:AA
NM_005732.4(RAD50):c.2014C>T (p.Gln672Ter)	RAD50	Q672*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484641	5	131931309	5	132595617	484641	474222	rs142947311	NC_000005.10:132595616:C:T
NM_005732.4(RAD50):c.1620_1621insAG (p.Leu541fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484635	5	131927082 - 131927083	5	132591390 - 132591391	484635	474169	rs764968413	NC_000005.10:132591390:G:GAG
NM_005732.4(RAD50):c.1194del (p.Lys398fs)	RAD50	K398fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480477	5	131924519	5	132588827	480477	474120	rs780230934	NC_000005.10:132588826:AAA:AA
NM_005732.4(RAD50):c.2263C>T (p.Gln755Ter)	RAD50	Q755*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480435	5	131939047	5	132603355	480435	474297	rs765975825	NC_000005.10:132603354:C:T
NM_005732.4(RAD50):c.2534dup (p.Ile846fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480405	5	131940505 - 131940506	5	132604813 - 132604814	480405	474303	rs1281337925	NC_000005.10:132604813:AA:AAA
NM_005732.4(RAD50):c.2801dup (p.Asn934fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000480396	5	131944381 - 131944382	5	132608689 - 132608690	480396	474239	rs748536322	NC_000005.10:132608689:AAAAAAAA:AAAAAAAAA
NM_005732.4(RAD50):c.676C>T (p.Gln226Ter)	RAD50	Q226*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457485	5	131915678	5	132579986	457485	454408	rs377429225	NC_000005.10:132579985:C:T
NM_005732.4(RAD50):c.3067_3070del (p.Leu1022_Thr1023insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457433	5	131951722 - 131951725	5	132616030 - 132616033	457433	454554	rs1554099781	NC_000005.10:132616029:CTTACTT:CTT
NM_005732.4(RAD50):c.1201A>T (p.Arg401Ter)	RAD50	R401*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457365	5	131924528	5	132588836	457365	455230	rs199867309	NC_000005.10:132588835:A:T
NM_005732.4(RAD50):c.2569C>T (p.Gln857Ter)	RAD50	Q857*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408414	5	131940542	5	132604850	408414	394916	rs1060501973	NC_000005.10:132604849:C:T
NM_005732.4(RAD50):c.393dup (p.Lys132Ter)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408379	5	131915035 - 131915036	5	132579343 - 132579344	408379	394859	rs1458900761	NC_000005.10:132579343:T:TT
NM_005732.4(RAD50):c.2938_2942del (p.Glu979_Leu980insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408356	5	131944988 - 131944992	5	132609296 - 132609300	408356	395299	rs1060501942	NC_000005.10:132609295:AACTTAA:AA
NM_005732.4(RAD50):c.474_483delinsAA (p.His158fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408352	5	131915117 - 131915126	5	132579425 - 132579434	408352	394694	rs1064792948	NC_000005.10:132579424:TCAAGAAGAT:AA
NM_005732.4(RAD50):c.1966C>T (p.Arg656Ter)	RAD50	R656*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000240219	5	131930733	5	132595041	240219	239695	rs749466673	NC_000005.10:132595040:C:T
NM_005732.4(RAD50):c.2980A>T (p.Lys994Ter)	RAD50	K994*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233377	5	131945032	5	132609340	233377	233398	rs876660364	NC_000005.10:132609339:A:T
NM_005732.4(RAD50):c.1174del (p.Gln392fs)	RAD50	Q392fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000232871	5	131924501	5	132588809	232871	233297	rs876660039	NC_000005.10:132588808:C:
NM_005732.4(RAD50):c.154del (p.Ile52fs)	RAD50	I52fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000232555	5	131895000	5	132559308	232555	233242	rs876659837	NC_000005.10:132559307:A:
NM_005732.4(RAD50):c.541_542delinsA (p.Ser181fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231601	5	131915184 - 131915185	5	132579492 - 132579493	231601	233265	rs876659255	NC_000005.10:132579491:TC:A
NM_005732.4(RAD50):c.1366G>T (p.Glu456Ter)	RAD50	E456*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231396	5	131925443	5	132589751	231396	233310	rs876659132	NC_000005.10:132589750:G:T
NM_005732.4(RAD50):c.1293_1299GATAAGA[1] (p.Asp434fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230850	5	131925368 - 131925374	5	132589676 - 132589682	230850	233306	rs587780147	NC_000005.10:132589675:GAGATAAGAGATAAGA:GAGATAAGA
NM_005732.4(RAD50):c.1544_1547del (p.Asp515fs)	RAD50	D515fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186695	5	131927005 - 131927008	5	132591313 - 132591316	186695	182560	rs786203151	NC_000005.10:132591312:AGACAG:AG
NM_005732.4(RAD50):c.3209del (p.Asn1070fs)	RAD50	N1070fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185458	5	131953804	5	132618112	185458	182636	rs786202187	NC_000005.10:132618111:AAA:AA
NM_005732.4(RAD50):c.2202del (p.Pro734_Met735insTer)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184917	5	131931495	5	132595803	184917	182596	rs786201789	NC_000005.10:132595802:CCC:CC
NM_005732.4(RAD50):c.541dup (p.Ser181fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184550	5	131915178 - 131915179	5	132579486 - 132579487	184550	182514	rs786201531	NC_000005.10:132579486:TTTTTT:TTTTTTT
NM_005732.4(RAD50):c.1237C>T (p.Gln413Ter)	RAD50	Q413*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184469	5	131924564	5	132588872	184469	182551	rs373428259	NC_000005.10:132588871:C:T
NM_005732.4(RAD50):c.2789_2792del (p.Ile930fs)	RAD50	I930fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141677	5	131944375 - 131944378	5	132608683 - 132608686	141677	151391	rs587781930	NC_000005.10:132608682:AATCAA:AA
NM_005732.4(RAD50):c.354del (p.Thr119fs)	RAD50	T119fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141403	5	131911608	5	132575916	141403	151117	rs587781721	NC_000005.10:132575915:TT:T
NM_005732.4(RAD50):c.94dup (p.Thr32fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141279	5	131893109 - 131893110	5	132557417 - 132557418	141279	150993	rs587781625	NC_000005.10:132557417:A:AA
NM_005732.4(RAD50):c.397_398TG[1] (p.Ala134fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000140899	5	131915039 - 131915040	5	132579347 - 132579348	140899	150613	rs587781355	NC_000005.10:132579346:GTGTG:GTG
NC_000005.10:g.(?_132575767)_(132579512_?)del	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000831468	5	131911459 - 131915204			831468	819540		
NM_005732.4(RAD50):c.1291_1295del (p.Glu431fs)	RAD50	E431fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654483	5	131925364 - 131925368	5	132589672 - 132589676	654483	633107		NC_000005.10:132589671:AGATGAGAT:AGAT
NM_005732.4(RAD50):c.452_453dup (p.Asn152Ter)	RAD50		Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic(Last reviewed: May 27, 2018)	criteria provided, single submitter	VCV000567271	5	131915094 - 131915095	5	132579402 - 132579403	567271	560174	rs1561635887	NC_000005.10:132579402:TA:TATA
NM_005732.4(RAD50):c.832C>T (p.Arg278Ter)	RAD50	R278*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408402	5	131923329	5	132587637	408402	394729	rs766315644	NC_000005.10:132587636:C:T
NM_005732.4(RAD50):c.1253_1254del (p.Phe418fs)	RAD50	F418fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408373	5	131925329 - 131925330	5	132589637 - 132589638	408373	395217	rs1060501954	NC_000005.10:132589636:TTT:T
NM_005732.4(RAD50):c.3229C>T (p.Arg1077Ter)	RAD50	R1077*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231200	5	131953826	5	132618134	231200	233409	rs368980595	NC_000005.10:132618133:C:T
NM_005732.4(RAD50):c.2260_2266del (p.Leu754fs)	RAD50	L754fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220136	5	131939043 - 131939049	5	132603351 - 132603357	220136	221579	rs864622393	NC_000005.10:132603350:ACTGCAGA:A
NM_005732.4(RAD50):c.2707del (p.Arg903fs)	RAD50	R903fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000216096	5	131940680	5	132604988	216096	212480	rs863224509	NC_000005.10:132604987:A:
NM_005732.4(RAD50):c.2517dup (p.Asp840fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185058	5	131939730 - 131939731	5	132604038 - 132604039	185058	182609	rs786201897	NC_000005.10:132604038:A:AA
NM_005732.4(RAD50):c.904G>T (p.Glu302Ter)	RAD50	E302*	Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141896	5	131923634	5	132587942	141896	151610	rs587782090	NC_000005.10:132587941:G:T
NM_005732.4(RAD50):c.2821C>T (p.Gln941Ter)	RAD50	Q941*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037376	5	131944409	5	132608717	37376	45930	rs397507177	NC_000005.10:132608716:C:T
NM_003060.4(SLC22A5):c.136C>T (p.Pro46Ser)	SLC22A5	P46S	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193250	5	131705800	5	132370108	193250	190414	rs202088921	NC_000005.10:132370107:C:T
NM_005732.4(RAD50):c.1174_1177del (p.Gln392fs)	RAD50	Q392fs	Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000482086	5	131924498 - 131924501	5	132588806 - 132588809	482086	474235	rs1554098250	NC_000005.10:132588805:AGACAGA:AGA
NM_005732.4(RAD50):c.2165del (p.Lys722fs)	RAD50	K722fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408407	5	131931452	5	132595760	408407	394669	rs397507178	NC_000005.10:132595759:AAAAAAAAA:AAAAAAAA
NM_005732.4(RAD50):c.2165_2166insT (p.Lys722fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408395	5	131931460 - 131931461	5	132595768 - 132595769	408395	394909	rs587781454	NC_000005.10:132595768::T
NM_005732.4(RAD50):c.2980_2984AAAGA[1] (p.Glu995fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000408368	5	131945032 - 131945036	5	132609340 - 132609344	408368	395301	rs1060501949	NC_000005.10:132609339:AAAGAAAAGA:AAAGA
NM_005732.4(RAD50):c.561dup (p.Ala188fs)	RAD50		Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231180	5	131915560 - 131915561	5	132579868 - 132579869	231180	233267	rs876659005	NC_000005.10:132579868:AAA:AAAA
NM_005732.4(RAD50):c.3372T>A (p.Tyr1124Ter)	RAD50	Y1124*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230674	5	131953969	5	132618277	230674	233415	rs775069541	NC_000005.10:132618276:T:A
NM_005732.4(RAD50):c.412C>T (p.Arg138Ter)	RAD50	R138*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187117	5	131915055	5	132579363	187117	182509	rs786203485	NC_000005.10:132579362:C:T
NM_005732.4(RAD50):c.1722dup (p.Gln575fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142556	5	131927649 - 131927650	5	132591957 - 132591958	142556	152270	rs587782543	NC_000005.10:132591957:AAAAAA:AAAAAAA
NM_005732.4(RAD50):c.1958C>A (p.Ser653Ter)	RAD50	S653*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141646	5	131930725	5	132595033	141646	151360	rs587781904	NC_000005.10:132595032:C:A
NM_005732.4(RAD50):c.2929_2932del (p.Glu977fs)	RAD50	E977fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000128014	5	131944978 - 131944981	5	132609286 - 132609289	128014	133471	rs587780153	NC_000005.10:132609285:AAAGAAA:AAA
NM_005732.4(RAD50):c.1393C>T (p.Gln465Ter)	RAD50	Q465*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000127997	5	131925470	5	132589778	127997	133454	rs587780150	NC_000005.10:132589777:C:T
NM_005732.4(RAD50):c.1093C>T (p.Arg365Ter)	RAD50	R365*	Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480489	5	131924420	5	132588728	480489	474083	rs1247689593	NC_000005.10:132588727:C:T
NM_005732.4(RAD50):c.2116C>T (p.Arg706Ter)	RAD50	R706*	Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457398	5	131931411	5	132595719	457398	454545	rs772468452	NC_000005.10:132595718:C:T
NM_005732.4(RAD50):c.3029_3032del (p.Thr1010fs)	RAD50	T1010fs	Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000408355	5	131945080 - 131945083	5	132609388 - 132609391	408355	394679	rs1060501941	NC_000005.10:132609387:ACACA:A
NM_005732.4(RAD50):c.1268_1269CT[1] (p.Leu424fs)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187444	5	131925345 - 131925346	5	132589653 - 132589654	187444	182554	rs587781327	NC_000005.10:132589652:CTCT:CT
NM_005732.4(RAD50):c.2498_2499del (p.Gln833fs)	RAD50	Q833fs	Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143015	5	131939712 - 131939713	5	132604020 - 132604021	143015	152729	rs587782895	NC_000005.10:132604019:AA:
NM_005732.4(RAD50):c.2983_2986del (p.Glu995fs)	RAD50	E995fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128015	5	131945032 - 131945035	5	132609340 - 132609343	128015	133472	rs587780154	NC_000005.10:132609339:AAAGAAA:AAA
NM_005732.4(RAD50):c.1114C>T (p.Gln372Ter)	RAD50	Q372*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000126999	5	131924441	5	132588749	126999	132512	rs104895046	NC_000005.10:132588748:C:T
NM_005732.3(RAD50):c.2156dupT (p.Glu723Glyfs*5)	RAD50		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037377	5	131931450 - 131931451	5	132595758 - 132595759	37377	45931	rs1554098706	NC_000005.10:132595758:T:TT
NM_004168.4(SDHA):c.1A>G (p.Met1Val)	SDHA	M1V	Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 5	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000239661	5	218471	5	218356	239661	239796	rs1061517	NC_000005.10:218355:A:G
NM_004369.3(COL6A3):c.6210+1G>A	COL6A3		not provided|Ullrich congenital muscular dystrophy 1|Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1, autosomal dominant	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094956	2	238269763	2	237361120	94956	100856	rs398124126	NC_000002.12:237361119:C:T
NM_001904.4(CTNNB1):c.134C>A (p.Ser45Tyr)	CTNNB1	S45Y, S38Y	Hepatocellular carcinoma|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Neoplasm of the large intestine|Malignant melanoma of skin|Malignant neoplasm of body of uterus|Adrenocortical carcinoma|Lung adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375895	3	41266137	3	41224646	375895	362774	rs121913409	NC_000003.12:41224645:C:A
NM_005732.4(RAD50):c.1245+1G>A	RAD50		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000584474	5	131924573	5	132588881	584474	575538	rs1561639636	NC_000005.10:132588880:G:A
NM_004415.4(DSP):c.6496C>T (p.Arg2166Ter)	DSP	R2166*, R1567*, R1723*	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199903	6	7583991	6	7583758	199903	197110	rs141026028	NC_000006.12:7583757:C:T
NM_004415.4(DSP):c.1273C>T (p.Arg425Ter)	DSP	R425*	Cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|DSP-related arrhythmogenic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044856	6	7568676	6	7568443	44856	54023	rs397516915	NC_000006.12:7568442:C:T
NM_000222.2(KIT):c.2466T>G (p.Asn822Lys)	KIT	N822K, N818K	Gastrointestinal stromal tumor|Cutaneous melanoma|Acute myeloid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000375932	4	55599340	4	54733174	375932	362811	rs121913514	NC_000004.12:54733173:T:G
NM_000222.2(KIT):c.1961T>C (p.Val654Ala)	KIT	V654A, V650A	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000375921	4	55594258	4	54728092	375921	362800	rs121913523	NC_000004.12:54728091:T:C
NM_006218.4(PIK3CA):c.1645G>A (p.Asp549Asn)	PIK3CA	D549N	Neoplasm of the breast|Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375900	3	178936103	3	179218315	375900	362779	rs1057519699	NC_000003.12:179218314:G:A
NM_006218.4(PIK3CA):c.1634A>T (p.Glu545Val)	PIK3CA	E545V	Neoplasm of the breast|Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375897	3	178936092	3	179218304	375897	362776	rs121913274	NC_000003.12:179218303:A:T
NM_000551.3(VHL):c.331A>T (p.Ser111Cys)	VHL	S111C	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000565557	3	10183862	3	10142178	565557	561079	rs1559426203	NC_000003.12:10142177:A:T
NM_000551.3(VHL):c.277G>A (p.Gly93Ser)	VHL	G93S	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Pheochromocytoma	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000002237	3	10183808	3	10142124	2237	17276	rs5030808	NC_000003.12:10142123:G:A
NM_001163213.1(FGFR3):c.1955A>C (p.Lys652Thr)	FGFR3	K650T, K652T, K538T, K651T	Hypochondroplasia|Carcinoma of colon|Epidermal nevus|Carcinoma of cervix|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Bladder cancer, somatic|Hypochondroplasia|Levy-Hollister syndrome|Achondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Craniosynostosis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065855	4	1807890	4	1806163	65855	76763	rs121913105	NC_000004.12:1806162:A:C
NM_001163213.1(FGFR3):c.1626C>A (p.Asn542Lys)	FGFR3	N540K, N542K, N428K, N541K	not specified|Hypochondroplasia|not provided|Craniosynostosis|Achondroplasia	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016337	4	1807371	4	1805644	16337	31376	rs28933068	NC_000004.12:1805643:C:A
NM_005732.4(RAD50):c.326_329del (p.Thr109fs)	RAD50	T109fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128017	5	131911578 - 131911581	5	132575886 - 132575889	128017	133474	rs587780155	NC_000005.10:132575885:AGACAGA:AGA
NM_000158.4(GBE1):c.986A>C (p.Tyr329Ser)	GBE1	Y329S	Glycogen storage disease, type IV|Glycogen storage disease IV, nonprogressive hepatic|Polyglucosan body disease, adult|Glycogen storage disease, type IV|Polyglucosan body disease, adult|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|GBE1-Related Disorders|Adult polyglucosan body neuropathy|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002777	3	81691938	3	81642787	2777	17816	rs80338671	NC_000003.12:81642786:T:G
NM_000404.2(GLB1):c.245C>T	GLB1	T82M, T130M, T52M, T82I	Mucopolysaccharidosis, MPS-IV-B||Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B||Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000935	3	33114036	3	33072544	935	15974	rs72555393	NC_000003.12:33072543:G:A
NM_003242.6(TGFBR2):c.1483C>T (p.Arg495Ter)	TGFBR2	R495*, R520*	Loeys-Dietz syndrome 2|Malignant tumor of esophagus|Hereditary nonpolyposis colorectal cancer type 6|Loeys-Dietz syndrome|not provided|Loeys-Dietz syndrome 2|Thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012519	3	30729962	3	30688470	12519	27558	rs104893819	NC_000003.12:30688469:C:T
NM_000203.5(IDUA):c.590-7G>A	IDUA		Mucopolysaccharidosis type 1|Mucopolysaccharidosis, MPS-I-S|Hurler syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222996	4	995460	4	1001672	222996	224715	rs762411583	NC_000004.12:1001671:G:A
NM_000203.5(IDUA):c.979G>C (p.Ala327Pro)	IDUA	A327P, A195P	Hurler syndrome|Mucopolysaccharidosis type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167190	4	996063	4	1002275	167190	177221	rs199801029	NC_000004.12:1002274:G:C
NM_000203.5(IDUA):c.1598C>G (p.Pro533Arg)	IDUA	P533R, P401R	Mucopolysaccharidosis type 1|Hurler syndrome|Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis, MPS-I-S|not provided	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011910	4	997206	4	1003418	11910	26949	rs121965021	NC_000004.12:1003417:C:G
NM_022455.4(NSD1):c.4949_4950del (p.Asn1650fs)	NSD1	N1381fs, N1650fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000521328	5	176684135 - 176684136	5	177257134 - 177257135	521328	511592	rs1554199501	NC_000005.10:177257133:AT:
NM_172349.2(NSD1):c.2642_2643GT[1] (p.Val882fs)	NSD1		Inborn genetic diseases	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000521100	5	176638849 - 176638850	5	177211848 - 177211849	521100	511590	rs1554190262	NC_000005.10:177211847:GTGT:GT
NM_022455.4(NSD1):c.1702_1703insAG (p.Phe568Ter)	NSD1		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000520637	5	176637102 - 176637103	5	177210101 - 177210102	520637	511589	rs1554189042	NC_000005.10:177210101::AG
NM_005732.4(RAD50):c.1875C>G (p.Tyr625Ter)	RAD50	Y625*	Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220719	5	131930642	5	132594950	220719	221577	rs149201802	NC_000005.10:132594949:C:G
NM_005732.4(RAD50):c.2165dup (p.Glu723fs)	RAD50		Hereditary cancer-predisposing syndrome|not provided|Nijmegen breakage syndrome-like disorder	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141045	5	131931451 - 131931452	5	132595759 - 132595760	141045	150759	rs397507178	NC_000005.10:132595759:AAAAAAAAA:AAAAAAAAAA
NM_005732.4(RAD50):c.3G>A (p.Met1Ile)	RAD50	M1I	not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128024	5	131893019	5	132557327	128024	133481	rs377260382	NC_000005.10:132557326:G:A
NM_005732.4(RAD50):c.3277C>T (p.Arg1093Ter)	RAD50	R1093*	Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005872	5	131953874	5	132618182	5872	20911	rs121912628	NC_000005.10:132618181:C:T
NM_004168.4(SDHA):c.1765C>T (p.Arg589Trp)	SDHA	R589W, R541W	Paragangliomas 5|Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030132	5	251554	5	251439	30132	39088	rs387906780	NC_000005.10:251438:C:T
NM_001369.2(DNAH5):c.3598+2T>C	DNAH5		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000520776	5	13871671	5	13871562	520776	511557	rs981267400	NC_000005.10:13871561:A:G
NM_004415.4(DSP):c.3735_3741dup (p.Asp1248fs)	DSP		not provided|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000199923	6	7580155 - 7580156	6	7579922 - 7579923	199923	197069	rs1554108152	NC_000006.12:7579922:GAAAATCGA:GAAAATCGAAAATCGA
NM_001904.4(CTNNB1):c.796C>T (p.Gln266Ter)	CTNNB1	Q266*, Q259*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000521466	3	41267212	3	41225721	521466	511482	rs1553630472	NC_000003.12:41225720:C:T
NM_001904.4(CTNNB1):c.1683G>C (p.Val561=)	CTNNB1		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000520964	3	41275788	3	41234297	520964	511485	rs1553632001	NC_000003.12:41234296:G:C
NM_001904.4(CTNNB1):c.1158del (p.Asn387fs)	CTNNB1	N380fs, N387fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000520963	3	41274907	3	41233416	520963	511484	rs1553631783	NC_000003.12:41233415:GG:G
NM_000551.3(VHL):c.256C>G (p.Pro86Ala)	VHL	P86A	not provided|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000093327	3	10183787	3	10142103	93327	99234	rs398123481	NC_000003.12:10142102:C:G
NM_000404.4(GLB1):c.808T>G (p.Tyr270Asp)	GLB1	Y270D, Y318D, Y139D, Y240D	Infantile GM1 gangliosidosis||GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Inborn genetic diseases|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000284172	3	33093481	3	33051989	284172	268409	rs376663785	NC_000003.12:33051988:A:C
NM_032682.5(FOXP1):c.1541G>A (p.Arg514His)	FOXP1	R514H, R413H, R513H, R414H, R438H	Inborn genetic diseases|not provided|Mental retardation with language impairment and with or without autistic features	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211040	3	71021817	3	70972666	211040	207083	rs797045586	NC_000003.12:70972665:C:T
NM_000551.3(VHL):c.331A>G (p.Ser111Gly)	VHL	S111G	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000633016	3	10183862	3	10142178	633016	621143	rs1559426203	NC_000003.12:10142177:A:G
NM_000551.3(VHL):c.334T>C (p.Tyr112His)	VHL	Y112H	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002222	3	10183865	3	10142181	2222	17261	rs104893824	NC_000003.12:10142180:T:C
NM_022455.4(NSD1):c.2672_2676del (p.Ser891fs)	NSD1	S891fs, S622fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000430048	5	176638068 - 176638072	5	177211067 - 177211071	430048	421541	rs1131691754	NC_000005.10:177211066:TTCTCTTCT:TTCT
NM_001904.4(CTNNB1):c.1923_1924AG[1] (p.Glu642fs)	CTNNB1		not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000503703	3	41277959 - 41277960	3	41236468 - 41236469	503703	495185	rs1553632361	NC_000003.12:41236467:AGAG:AG
NM_001904.4(CTNNB1):c.1759C>T (p.Arg587Ter)	CTNNB1	R587*, R580*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423482	3	41277290	3	41235799	423482	406301	rs1064796453	NC_000003.12:41235798:C:T
NM_000249.4(MLH1):c.1212del (p.Ser405fs)	MLH1	S47fs, S64fs, S164fs, S307fs, S372fs, S405fs	not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000817085	3	37067301	3	37025810	817085	805342		NC_000003.12:37025809:G:
NM_000249.3(MLH1):c.1640T>G (p.Leu547Ter)	MLH1	L547*, L306*, L514*, L189*, L206*, L449*	not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000546007	3	37081758	3	37040267	546007	536280	rs63750300	NC_000003.12:37040266:T:G
NM_000249.3(MLH1):c.735C>G (p.Tyr245Ter)	MLH1	Y245*, Y212*, Y147*, Y4*	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000546001	3	37055980	3	37014489	546001	536275	rs1553645226	NC_000003.12:37014488:C:G
NM_000249.3(MLH1):c.1416dup (p.His473fs)	MLH1		not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000545824	3	37070280 - 37070281	3	37028789 - 37028790	545824	536276	rs1553652883	NC_000003.12:37028789:A:AA
NM_001167618.2(MLH1):c.-157del	MLH1	I157fs, I190fs, I92fs	not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000545811	3	37053332	3	37011841	545811	536273	rs1553644024	NC_000003.12:37011840:C:
NM_001167618.2(MLH1):c.-84del	MLH1	D181fs, D214fs, D116fs	not provided	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000545798	3	37053552	3	37012061	545798	536274	rs1553644194	NC_000003.12:37012060:GG:G
NM_000249.3(MLH1):c.1491dup (p.Arg498fs)	MLH1		not provided	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000545782	3	37070354 - 37070355	3	37028863 - 37028864	545782	536277	rs63751435	NC_000003.12:37028863:GG:GGG
NM_001167617.2(MLH1):c.1220_1221GT[1] (p.Val408fs)	MLH1		not provided	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000545770	3	37070379 - 37070380	3	37028888 - 37028889	545770	536278	rs1553653115	NC_000003.12:37028887:GTGT:GT
NM_001167618.2(MLH1):c.-231del	MLH1	A132fs, A165fs, A67fs	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000545742	3	37050344	3	37008853	545742	536272	rs1553642707	NC_000003.12:37008852:G:
NM_001167617.2(MLH1):c.-446_-442del	MLH1	V24fs	not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000449891	3	37035109 - 37035113	3	36993618 - 36993622	449891	443418	rs1553637293	NC_000003.12:36993617:TTATC:
NM_000249.3(MLH1):c.753C>G (p.Tyr251Ter)	MLH1	Y251*, Y10*, Y153*, Y218*	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000449061	3	37055998	3	37014507	449061	443420	rs63750310	NC_000003.12:37014506:C:G
NM_000249.3(MLH1):c.1334_1335AG[1] (p.Ser446fs)	MLH1		Colon cancer	Pathogenic	no assertion criteria provided	VCV000427760	3	37067423 - 37067424	3	37025932 - 37025933	427760	417649	rs1114167435	NC_000003.12:37025931:AGAG:AG
NM_001167617.2(MLH1):c.1083_1087AGAGA[1] (p.Lys363fs)	MLH1		not provided	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000420649	3	37067466 - 37067470	3	37025975 - 37025979	420649	406235	rs1064794612	NC_000003.12:37025974:AGAGAAGAGA:AGAGA
NM_001167618.2(MLH1):c.-7del	MLH1	F142fs, F207fs, F240fs	not provided	Pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000420251	3	37055961	3	37014470	420251	406219	rs1064794373	NC_000003.12:37014469:CC:C
NM_000249.3(MLH1):c.1182del (p.Asp394fs)	MLH1	D361fs, D36fs, D53fs, D296fs, D153fs, D394fs	not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000420213	3	37067271	3	37025780	420213	406231	rs1064794353	NC_000003.12:37025779:T:
NM_001167617.2(MLH1):c.-140_-137del	MLH1	V51fs	not provided	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	VCV000420207	3	37038142 - 37038145	3	36996651 - 36996654	420207	406201	rs1064794348	NC_000003.12:36996650:TTGTT:T
NM_000249.3(MLH1):c.1637_1641dup (p.Tyr548fs)	MLH1		not provided	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000420067	3	37081753 - 37081754	3	37040262 - 37040263	420067	406244	rs1064794267	NC_000003.12:37040262:AAGTTA:AAGTTAAGTTA
NM_001354621.1(MLH1):c.-139-2763del	MLH1	T37fs, T278fs, T180fs, T245fs	not provided	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000419811	3	37059036	3	37017545	419811	406223	rs1064794122	NC_000003.12:37017544:AAA:AA
NM_000249.3(MLH1):c.1407dup (p.Arg470fs)	MLH1		not provided	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000419707	3	37067492 - 37067493	3	37026001 - 37026002	419707	406237	rs869244899	NC_000003.12:37026001:CCCC:CCCCC
NM_000249.3(MLH1):c.1736_1737insGT (p.Pro579_Ala580insTer)	MLH1		not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419369	3	37089014 - 37089015	3	37047523 - 37047524	419369	406248	rs1064793823	NC_000003.12:37047523::GT
NM_001167617.2(MLH1):c.-423del	MLH1	I32fs	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000419050	3	37035132	3	36993641	419050	406199	rs1064793607	NC_000003.12:36993640:A:
NM_001167617.2(MLH1):c.-89dup	MLH1		not provided	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000419017	3	37038191 - 37038192	3	36996700 - 36996701	419017	406204	rs587778968	NC_000003.12:36996700:GGG:GGGG
NM_001354621.1(MLH1):c.-20del	MLH1	L237fs, L302fs, L94fs, L335fs	not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000418839	3	37061920	3	37020429	418839	406228	rs1064793469	NC_000003.12:37020428:T:
NM_001258271.1(MLH1):c.1896+1320del	MLH1	L664fs, L356fs, L599fs, L666fs, L697fs, L339fs, L456fs, L642fs	not provided	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	VCV000418306	3	37090492	3	37049001	418306	406261	rs1064793177	NC_000003.12:37049000:CCC:CC
NM_000249.3(MLH1):c.1079_1087delinsC (p.Val360fs)	MLH1		not provided	Pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	VCV000418301	3	37067168 - 37067176	3	37025677 - 37025685	418301	406229	rs1064793173	NC_000003.12:37025676:TTAAATCCA:C
NM_000249.3(MLH1):c.1897G>T (p.Glu633Ter)	MLH1	E633*, E578*, E535*, E600*, E275*, E392*, E292*	not provided	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000379514	3	37090008	3	37048517	379514	368455	rs1057520627	NC_000003.12:37048516:G:T
NM_000249.3(MLH1):c.545+1G>T	MLH1		not provided	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	VCV000379286	3	37050397	3	37008906	379286	367409	rs267607765	NC_000003.12:37008905:G:T
NM_000249.3(MLH1):c.1168G>T (p.Glu390Ter)	MLH1	E390*, E357*, E292*, E149*, E32*, E49*	not provided	Pathogenic(Last reviewed: May 11, 2015)	criteria provided, single submitter	VCV000265245	3	37067257	3	37025766	265245	259760	rs886039423	NC_000003.12:37025765:G:T
NM_000249.3(MLH1):c.1698T>A (p.Tyr566Ter)	MLH1	Y566*, Y225*, Y468*, Y208*, Y533*, Y325*	not provided	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000234763	3	37083789	3	37042298	234763	231622	rs876658915	NC_000003.12:37042297:T:A
NM_001354624.1(MLH1):c.-36-5183del	MLH1	F344fs, F103fs, F3fs, F246fs, F311fs	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000234513	3	37061945	3	37020454	234513	231615	rs876661059	NC_000003.12:37020453:C:
NM_000249.3(MLH1):c.392C>G (p.Ser131Ter)	MLH1	S131*, S33*, S98*	not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000234370	3	37048493	3	37007002	234370	231604	rs63749818	NC_000003.12:37007001:C:G
NM_000249.3(MLH1):c.589-?_677+?del	MLH1		not provided	Pathogenic	no assertion criteria provided	VCV000218026					218026	214627		
NM_001167617.2(MLH1):c.1394_1395del (p.Ile465fs)	MLH1	I205fs, I322fs, I465fs, I563fs, I222fs, I530fs	not provided	Pathogenic	no assertion criteria provided	VCV000218016	3	37083778 - 37083779	3	37042287 - 37042288	218016	214637	rs863225376	NC_000003.12:37042286:ATA:A
NM_001167617.2(MLH1):c.-135_-134del	MLH1	K52fs	not provided	Pathogenic(Last reviewed: Aug 5, 2014)	criteria provided, single submitter	VCV000182512	3	37038147 - 37038148	3	36996656 - 36996657	182512	180131	rs63750028	NC_000003.12:36996655:AAA:A
NM_000249.4(MLH1):c.2110dup (p.Val704fs)	MLH1		not provided	Pathogenic(Last reviewed: Aug 11, 2014)	criteria provided, single submitter	VCV000182507	3	37091982 - 37091983	3	37050491 - 37050492	182507	181151	rs1553665514	NC_000003.12:37050491:G:GG
NM_000249.4(MLH1):c.1144del (p.Gln382fs)	MLH1	Q24fs, Q141fs, Q349fs, Q284fs, Q41fs, Q382fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000861841	3	37067232	3	37025741	861841	827950		NC_000003.12:37025740:CC:C
NM_000249.4(MLH1):c.393del (p.Asp132fs)	MLH1	D99fs, D132fs, D34fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000850102	3	37048494	3	37007003	850102	827933		NC_000003.12:37007002:A:
NM_000249.4(MLH1):c.72_82dup (p.Pro28fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000850053	3	37035109 - 37035110	3	36993618 - 36993619	850053	827920		NC_000003.12:36993618:TATCCAGCGGC:TATCCAGCGGCTATCCAGCGGC
NM_000249.4(MLH1):c.1929del (p.Ile643fs)	MLH1	I285fs, I302fs, I545fs, I402fs, I610fs, I588fs, I643fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000848869	3	37090039	3	37048548	848869	827971		NC_000003.12:37048547:TT:T
NM_000249.4(MLH1):c.68_72delinsCTA (p.Glu23fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000848510	3	37035106 - 37035110	3	36993615 - 36993619	848510	827919		NC_000003.12:36993614:AAGTT:CTA
NM_000249.4(MLH1):c.1132del (p.Val378fs)	MLH1	V280fs, V37fs, V137fs, V20fs, V345fs, V378fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000845377	3	37067220	3	37025729	845377	827948		NC_000003.12:37025728:GG:G
NM_000249.4(MLH1):c.1840_1870dup (p.Asp624delinsValSerGluGluGluGlyTer)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000843723	3	37089115 - 37089116	3	37047624 - 37047625	843723	827967		NC_000003.12:37047624:AGTTTCTGAAGAAGAAGGCTGAGATGCTTGCAG:AGTTTCTGAAGAAGAAGGCTGAGATGCTTGCAGTTTCTGAAGAAGAAGGCTGAGATGCTTGCAG
NM_000249.4(MLH1):c.2030dup (p.Ser677fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000842247	3	37090434 - 37090435	3	37048943 - 37048944	842247	827973		NC_000003.12:37048943:G:GG
NC_000003.12:g.(?_37006981)_(37042341_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000832715	3	37048472 - 37083832			832715	819380		
NC_000003.12:g.(?_37014422)_(37014554_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000832289	3	37055913 - 37056045			832289	819387		
NC_000003.12:g.(?_37008800)_(37026017_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000830612	3	37050291 - 37067508			830612	819383		
NM_000249.4(MLH1):c.673dup (p.Ser225fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000826590	3	37053585 - 37053586	3	37012094 - 37012095	826590	807554		NC_000003.12:37012094:A:AA
NM_000249.4(MLH1):c.54del (p.Ile19fs)	MLH1	I19fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000825780	3	37035092	3	36993601	825780	807521		NC_000003.12:36993600:C:
NM_000249.4(MLH1):c.526del (p.Ile176fs)	MLH1	I176fs, I143fs, I78fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000825600	3	37050374	3	37008883	825600	807550		NC_000003.12:37008882:AAAA:AAA
NM_000249.4(MLH1):c.453+2_453+7delinsGATC	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000824979	3	37048556 - 37048561	3	37007065 - 37007070	824979	815302		NC_000003.12:37007064:TAAGAA:GATC
NM_000249.4(MLH1):c.356_357insT (p.Ala120fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000823929	3	37045941 - 37045942	3	37004450 - 37004451	823929	807543		NC_000003.12:37004450::T
NM_000249.4(MLH1):c.290dup (p.Tyr97Ter)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000821975	3	37042527 - 37042528	3	37001036 - 37001037	821975	807540		NC_000003.12:37001036:A:AA
NM_000249.4(MLH1):c.237del (p.Arg79fs)	MLH1	R79fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000821171	3	37042474	3	37000983	821171	807539		NC_000003.12:37000982:GG:G
NM_000249.4(MLH1):c.208-5_262del	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000820683	3	37042439 - 37042498	3	37000948 - 37001007	820683	815300		
NM_000249.4(MLH1):c.2077del (p.Glu693fs)	MLH1	E335fs, E638fs, E660fs, E693fs, E595fs, E352fs, E452fs, E662fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000820665	3	37090482	3	37048991	820665	807629		NC_000003.12:37048990:G:
NM_000249.4(MLH1):c.2071_2072insG (p.Ile691fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000820634	3	37090476 - 37090477	3	37048985 - 37048986	820634	807628		NC_000003.12:37048985::G
NM_000249.4(MLH1):c.1868del (p.Ala623fs)	MLH1	A265fs, A282fs, A382fs, A525fs, A590fs, A623fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000820220	3	37089146	3	37047655	820220	807619		NC_000003.12:37047654:C:
NM_000249.4(MLH1):c.1853del (p.Lys618fs)	MLH1	K260fs, K277fs, K377fs, K520fs, K585fs, K618fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000820160	3	37089130	3	37047639	820160	807618		NC_000003.12:37047638:AA:A
NM_000249.4(MLH1):c.1595del (p.Gly532fs)	MLH1	G191fs, G291fs, G434fs, G499fs, G174fs, G532fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000819618	3	37081711	3	37040220	819618	807605		NC_000003.12:37040219:GGG:GG
NM_000249.4(MLH1):c.1423del (p.Glu475fs)	MLH1	E442fs, E117fs, E475fs, E134fs, E234fs, E377fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000819182	3	37070286	3	37028795	819182	807597		NC_000003.12:37028794:GGG:GG
NM_000249.4(MLH1):c.1342G>T (p.Glu448Ter)	MLH1	E415*, E90*, E107*, E207*, E350*, E448*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000818902	3	37067431	3	37025940	818902	807592		NC_000003.12:37025939:G:T
NM_000249.4(MLH1):c.1261_1262delinsC (p.Ser421fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000818720	3	37067350 - 37067351	3	37025859 - 37025860	818720	807586		NC_000003.12:37025858:AG:C
NM_000249.4(MLH1):c.1233_1254dup (p.Ile419delinsCysHisArgGlyTer)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000818660	3	37067319 - 37067320	3	37025828 - 37025829	818660	807584		NC_000003.12:37025828:ATTGTCACAGAGGATAAGACAGAT:ATTGTCACAGAGGATAAGACAGATTGTCACAGAGGATAAGACAGAT
NM_000249.4(MLH1):c.1230_1232delinsTG (p.Ile411fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000818652	3	37067319 - 37067321	3	37025828 - 37025830	818652	807583		NC_000003.12:37025827:CAT:TG
NM_000249.4(MLH1):c.232_243delinsATGTAAGG (p.Glu78_Thr81delinsMetTer)	MLH1		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000801203	3	37042470 - 37042481	3	37000979 - 37000990	801203	789446		NC_000003.12:37000978:GAAAGGTTCACT:ATGTAAGG
NM_001167617.2(MLH1):c.-454_-435del	MLH1	G22fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000663104	3	37035096 - 37035115	3	36993605 - 36993624	663104	631192		NC_000003.12:36993604:GCGGCGGGGGAAGTTATCCAGCGGC:GCGGC
NM_000249.3(MLH1):c.1333C>T (p.Gln445Ter)	MLH1	Q104*, Q347*, Q412*, Q445*, Q87*, Q204*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000660662	3	37067422	3	37025931	660662	631234		NC_000003.12:37025930:C:T
NM_000249.4(MLH1):c.632del (p.Ala210_Ser211insTer)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000659293	3	37053545	3	37012054	659293	631210		NC_000003.12:37012053:C:
NM_000249.3(MLH1):c.1818delinsCTT (p.Leu607fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, single submitter	VCV000655509	3	37089096	3	37047605	655509	631246		NC_000003.12:37047604:A:CTT
NM_000249.3(MLH1):c.768C>A (p.Cys256Ter)	MLH1	C15*, C256*, C158*, C223*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000655025	3	37056013	3	37014522	655025	631216		NC_000003.12:37014521:C:A
NM_000249.4(MLH1):c.2009dup (p.Glu671fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000653023	3	37090410 - 37090411	3	37048919 - 37048920	653023	631255		NC_000003.12:37048919:AAAA:AAAAA
NM_001354630.1(MLH1):c.1732-985_1732-972del	MLH1	L341fs, L484fs, L549fs, L241fs, L224fs, L582fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000645562	3	37089022 - 37089035	3	37047531 - 37047544	645562	631245		NC_000003.12:37047530:CTCTTTGACCTTGCC:C
NM_001354630.1(MLH1):c.1732-906_1732-905dup	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000641072	3	37089101 - 37089102	3	37047610 - 37047611	641072	631247		NC_000003.12:37047610:TG:TGTG
Single allele	MLH1		Colon cancer	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635950	3	37035001 - 37041000			635950	623763		
NC_000003.11:g.(?_37045882)_(37056045_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000584313	3	37045882 - 37056045	3	37004391 - 37014554	584313	559223		
NC_000003.11:g.(?_37055917)_(37070429_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000583892	3	37055917 - 37070429	3	37014426 - 37028938	583892	561048		
NC_000003.11:g.(?_37089004)_(37089180_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000583801	3	37089004 - 37089180	3	37047513 - 37047689	583801	558708		
NM_001354621.1(MLH1):c.-67_-65delinsT	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000581759	3	37061873 - 37061875	3	37020382 - 37020384	581759	558904	rs1559544064	NC_000003.12:37020381:GGA:T
NM_001167618.2(MLH1):c.-250del	MLH1	N60fs, N125fs, N158fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000580595	3	37050325	3	37008834	580595	561395	rs1559524070	NC_000003.12:37008833:C:
NM_000249.3(MLH1):c.735C>A (p.Tyr245Ter)	MLH1	Y245*, Y147*, Y212*, Y4*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000575912	3	37055980	3	37014489	575912	561413	rs1553645226	NC_000003.12:37014488:C:A
NM_001354624.1(MLH1):c.-28_-26delinsT	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000574009	3	37067136 - 37067138	3	37025645 - 37025647	574009	561417	rs1559551570	NC_000003.12:37025644:ACC:T
NM_001167618.2(MLH1):c.-98del	MLH1	N111fs, N209fs, N176fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 18, 2018)	criteria provided, single submitter	VCV000570158	3	37053538	3	37012047	570158	561409	rs1559530646	NC_000003.12:37012046:AA:A
NM_000249.3(MLH1):c.815T>A (p.Leu272Ter)	MLH1	L272*, L31*, L174*, L239*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000569820	3	37059021	3	37017530	569820	559439	rs63750584	NC_000003.12:37017529:T:A
NM_001354621.1(MLH1):c.-139-2750_-139-2737del	MLH1	A184fs, A41fs, A249fs, A282fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000565757	3	37059051 - 37059064	3	37017560 - 37017573	565757	562699	rs1559539489	NC_000003.12:37017559:CCTATTTGCCCAAA:
NM_001167618.2(MLH1):c.-227dup	MLH1		Colon cancer	Pathogenic(Last reviewed: Apr 8, 2018)	no assertion criteria provided	VCV000560011	3	37050345 - 37050346	3	37008854 - 37008855	560011	550730	rs587779018	NC_000003.12:37008854:TTT:TTTT
NM_001167617.2(MLH1):c.-95delinsATCTT	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000525813	3	37038188	3	36996697	525813	519086	rs1553638868	NC_000003.12:36996696:C:ATCTT
NM_001258271.1(MLH1):c.1896+893_1896+894del	MLH1	L295fs, L312fs, L412fs, L598fs, L653fs, L555fs, L620fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000525596	3	37090067 - 37090068	3	37048576 - 37048577	525596	519104	rs1553663981	NC_000003.12:37048575:AC:
NM_000249.3(MLH1):c.1591del (p.Val531fs)	MLH1	V190fs, V498fs, V173fs, V433fs, V290fs, V531fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000486867	3	37081709	3	37040218	486867	473449	rs1553658009	NC_000003.12:37040217:G:
NM_001258271.1(MLH1):c.1896+1311dup	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000486863	3	37090483 - 37090484	3	37048992 - 37048993	486863	473508	rs1553664617	NC_000003.12:37048992:GG:GGG
NM_001167618.2(MLH1):c.-385del	MLH1	T16fs, T114fs, T81fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000486860	3	37045923	3	37004432	486860	473388	rs1553641295	NC_000003.12:37004431:TT:T
NM_001354621.1(MLH1):c.-140+2438dup	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000486854	3	37056027 - 37056028	3	37014536 - 37014537	486854	473374	rs1553645331	NC_000003.12:37014536:C:CC
NM_000249.3(MLH1):c.958G>T (p.Glu320Ter)	MLH1	E320*, E79*, E222*, E287*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000486847	3	37061874	3	37020383	486847	473559	rs1553648040	NC_000003.12:37020382:G:T
NM_000249.3(MLH1):c.970G>T (p.Glu324Ter)	MLH1	E324*, E83*, E226*, E291*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000485799	3	37061886	3	37020395	485799	473365	rs1553648068	NC_000003.12:37020394:G:T
NM_001354621.1(MLH1):c.-140+2426del	MLH1	F160fs, F17fs, F258fs, F225fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000483596	3	37056016	3	37014525	483596	473353	rs1553645301	NC_000003.12:37014524:C:
NM_000249.3(MLH1):c.1578_1579dup (p.Asn527fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000483575	3	37081694 - 37081695	3	37040203 - 37040204	483575	473414	rs1553657971	NC_000003.12:37040203:ATA:ATATA
NM_000249.3(MLH1):c.1051G>T (p.Gly351Ter)	MLH1	G351*, G110*, G253*, G10*, G318*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000483570	3	37067140	3	37025649	483570	473579	rs1437454428	NC_000003.12:37025648:G:T
NM_000249.3(MLH1):c.1304_1305delinsTGCTGAAGTGGCT (p.Pro435fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000483552	3	37067393 - 37067394	3	37025902 - 37025903	483552	473431	rs1553651299	NC_000003.12:37025901:CA:TGCTGAAGTGGCT
NM_000249.3(MLH1):c.2236dup (p.Leu746fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000483541	3	37092107 - 37092108	3	37050616 - 37050617	483541	473452	rs1553665977	NC_000003.12:37050616:CC:CCC
NM_000249.3(MLH1):c.1883T>A (p.Leu628Ter)	MLH1	L628*, L387*, L287*, L530*, L270*, L595*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000479689	3	37089161	3	37047670	479689	473435	rs1553663159	NC_000003.12:37047669:T:A
NM_001354621.1(MLH1):c.-139-2762_-139-2761dup	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000455456	3	37059037 - 37059038	3	37017546 - 37017547	455456	452105	rs1553646681	NC_000003.12:37017546:ACA:ACACA
NM_001354621.1(MLH1):c.-139-2799del	MLH1	L168fs, L233fs, L25fs, L266fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000455455	3	37059002	3	37017511	455455	452632	rs1553646602	NC_000003.12:37017510:C:
NM_000249.3(MLH1):c.551C>G (p.Ser184Ter)	MLH1	S184*, S151*, S86*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000455446	3	37053316	3	37011825	455446	452375	rs1064796057	NC_000003.12:37011824:C:G
NM_000249.3(MLH1):c.532G>T (p.Glu178Ter)	MLH1	E178*, E145*, E80*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000455443	3	37050383	3	37008892	455443	452625	rs1248251121	NC_000003.12:37008891:G:T
NM_000249.3(MLH1):c.2070C>A (p.Tyr690Ter)	MLH1	Y690*, Y349*, Y659*, Y635*, Y332*, Y449*, Y592*, Y657*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000455414	3	37090475	3	37048984	455414	452146	rs550890395	NC_000003.12:37048983:C:A
NM_000249.3(MLH1):c.1732-2A>C	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000455400	3	37089008	3	37047517	455400	452140	rs267607852	NC_000003.12:37047516:A:C
NM_000249.3(MLH1):c.1526del (p.Leu509fs)	MLH1	L268fs, L509fs, L151fs, L168fs, L411fs, L476fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000455392	3	37070391	3	37028900	455392	452137	rs1553653158	NC_000003.12:37028899:T:
NM_000249.3(MLH1):c.1447del (p.Glu483fs)	MLH1	E483fs, E125fs, E142fs, E385fs, E450fs, E242fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000455387	3	37070311	3	37028820	455387	452671	rs1553652930	NC_000003.12:37028819:GG:G
NM_001167617.2(MLH1):c.967delinsTAT (p.Ser323fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000455381	3	37067350	3	37025859	455381	452384	rs1553651130	NC_000003.12:37025858:A:TAT
NM_001354621.1(MLH1):c.-13_-10delinsAATGTGCA	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000455363	3	37061927 - 37061930	3	37020436 - 37020439	455363	452112	rs1553648195	NC_000003.12:37020435:CAAT:AATGTGCA
NC_000003.11:g.(?_37038104)_(37092150_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000455075	3	37038104 - 37092150			455075	451803		
NM_000249.3(MLH1):c.390C>G (p.Tyr130Ter)	MLH1	Y130*, Y97*, Y32*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000405390	3	37048491	3	37007000	405390	393430	rs1060500689	NC_000003.12:37006999:C:G
NM_001167617.2(MLH1):c.-38del	MLH1	K84fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 20, 2015)	criteria provided, single submitter	VCV000234056	3	37042488	3	37000997	234056	232889	rs876660822	NC_000003.12:37000996:AAA:AA
NM_000249.3(MLH1):c.1656del (p.Thr553fs)	MLH1	T195fs, T455fs, T212fs, T312fs, T520fs, T553fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000233712	3	37081773	3	37040282	233712	232952	rs876660589	NC_000003.12:37040281:CC:C
NM_001354621.1(MLH1):c.-139-2801_-139-2795del	MLH1	R232fs, R265fs, R167fs, R24fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000233519	3	37059000 - 37059006	3	37017509 - 37017515	233519	232914	rs876660458	NC_000003.12:37017508:GTCTGGT:
NM_001354621.1(MLH1):c.-106del	MLH1	N208fs, N273fs, N306fs, N65fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 24, 2015)	criteria provided, single submitter	VCV000233128	3	37061834	3	37020343	233128	232922	rs876660214	NC_000003.12:37020342:T:
NM_000249.3(MLH1):c.1090del (p.Thr364fs)	MLH1	T23fs, T123fs, T266fs, T331fs, T364fs, T6fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2015)	criteria provided, single submitter	VCV000231560	3	37067178	3	37025687	231560	232932	rs876659226	NC_000003.12:37025686:AA:A
NM_001354624.1(MLH1):c.-36-5176del	MLH1	Q105fs, Q5fs, Q248fs, Q313fs, Q346fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000231291	3	37061950	3	37020459	231291	232929	rs876659073	NC_000003.12:37020458:CCC:CC
NM_001167618.2(MLH1):c.-33del	MLH1	I198fs, I231fs, I133fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000230027	3	37055934	3	37014443	230027	232904	rs876658339	NC_000003.12:37014442:AAA:AA
NM_001354621.1(MLH1):c.-54del	MLH1	E226fs, E324fs, E291fs, E83fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	criteria provided, single submitter	VCV000229878	3	37061885	3	37020394	229878	232925	rs876658247	NC_000003.12:37020393:GG:G
NM_000249.3(MLH1):c.1257_1273del (p.Ile419fs)	MLH1	I178fs, I386fs, I419fs, I321fs, I61fs, I78fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	VCV000187648	3	37067346 - 37067362	3	37025855 - 37025871	187648	182267	rs786203893	NC_000003.12:37025854:TTCTAGTGGCAGGGCTA:
NM_000249.3(MLH1):c.2148_2168del21ins5	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	VCV000185561	3	37092021 - 37092041	3	37050530 - 37050550	185561	182303		
NM_001354621.1(MLH1):c.-40_-27del	MLH1	H88fs, H231fs, H296fs, H329fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 14, 2012)	criteria provided, single submitter	VCV000142143	3	37061896 - 37061909	3	37020405 - 37020418	142143	151857	rs587782265	NC_000003.12:37020404:AGCAGCACATCGAGAGCA:AGCA
NM_000249.3(MLH1):c.1401del (p.Ser467fs)	MLH1	S126fs, S434fs, S109fs, S467fs, S226fs, S369fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 12, 2014)	criteria provided, single submitter	VCV000141632	3	37067490	3	37025999	141632	151346	rs587781892	NC_000003.12:37025998:C:
NM_000249.3(MLH1):c.2190del (p.Pro731fs)	MLH1	P490fs, P662fs, P700fs, P731fs, P390fs, P676fs, P373fs, P633fs, P698fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000135851	3	37092063	3	37050572	135851	139563	rs587780683	NC_000003.12:37050571:T:
NM_000249.4(MLH1):c.678-20_693del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000835470	3	37055901 - 37055936	3	37014410 - 37014445	835470	850930		NC_000003.12:37014409:TTCAGAATCTCTTTTCTAATAGAGAACTGATAGAAATT:TT
NC_000003.12:g.(?_37008804)_(37012109_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000832419	3	37050295 - 37053600			832419	819386		
NC_000003.12:g.(?_37008800)_(37012109_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000831745	3	37050291 - 37053600			831745	819382		
NM_000249.4(MLH1):c.755C>G (p.Ser252Ter)	MLH1	S11*, S154*, S219*, S252*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000827123	3	37056000	3	37014509	827123	807560		NC_000003.12:37014508:C:G
NM_000249.4(MLH1):c.688G>T (p.Glu230Ter)	MLH1	E132*, E197*, E230*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000826682	3	37055933	3	37014442	826682	807555		NC_000003.12:37014441:G:T
NM_000249.4(MLH1):c.545+2T>C	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000825746	3	37050398	3	37008907	825746	815303		NC_000003.12:37008906:T:C
NM_000249.4(MLH1):c.2148_2149del (p.Glu717fs)	MLH1	E376fs, E648fs, E662fs, E619fs, E684fs, E686fs, E359fs, E717fs, E476fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000820784	3	37092021 - 37092022	3	37050530 - 37050531	820784	807633		NC_000003.12:37050529:GG:
NM_000249.4(MLH1):c.77del (p.Gln26fs)	MLH1	Q26fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000666013	3	37035115	3	36993624	666013	631193		NC_000003.12:36993623:A:
NM_000249.4(MLH1):c.503del (p.Asn168fs)	MLH1	N135fs, N70fs, N168fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000630044	3	37050349	3	37008858	630044	616850	rs63749959	NC_000003.12:37008857:AAAAAA:AAAAA
NM_000249.4(MLH1):c.1569del (p.Met524fs)	MLH1	M491fs, M183fs, M283fs, M426fs, M524fs, M166fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000628926	3	37081687	3	37040196	628926	616874	rs1559574795	NC_000003.12:37040195:G:
NM_000249.3(MLH1):c.(453+1_454-1)_(545+1_546-1)del	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000584578					584578	575635		
NM_000249.3(MLH1):c.1279C>T (p.Gln427Ter)	MLH1	Q427*, Q86*, Q186*, Q329*, Q394*, Q69*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 25, 2018)	criteria provided, single submitter	VCV000571138	3	37067368	3	37025877	571138	562722	rs1559553501	NC_000003.12:37025876:C:T
NM_001354630.1(MLH1):c.1732-990_1732-977del	MLH1	P240fs, P340fs, P581fs, P223fs, P548fs, P483fs	not provided	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000545815	3	37089017 - 37089030	3	37047526 - 37047539	545815	536281	rs1553662622	NC_000003.12:37047525:CACCGCTCTTTGACC:C
NM_001167618.2(MLH1):c.-227_-226delinsC	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000491711	3	37050348 - 37050349	3	37008857 - 37008858	491711	483588	rs1553642718	NC_000003.12:37008856:TA:C
NM_001354621.1(MLH1):c.-113del	MLH1	D271fs, D304fs, D63fs, D206fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000486865	3	37061827	3	37020336	486865	473553	rs1553647969	NC_000003.12:37020335:A:
NM_001167618.2(MLH1):c.-182del	MLH1	G148fs, G181fs, G83fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000483564	3	37050392	3	37008901	483564	473346	rs1553642777	NC_000003.12:37008900:GG:G
NM_000249.3(MLH1):c.1680del (p.Tyr561fs)	MLH1	Y203fs, Y220fs, Y320fs, Y561fs, Y528fs, Y463fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000479671	3	37083771	3	37042280	479671	473458	rs1553659334	NC_000003.12:37042279:C:
NM_000249.3(MLH1):c.979C>T (p.Gln327Ter)	MLH1	Q327*, Q229*, Q294*, Q86*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000455464	3	37061895	3	37020404	455464	452431	rs587782087	NC_000003.12:37020403:C:T
NC_000003.12:g.(?_37017496)_(37017609_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000833447	3	37058987 - 37059100			833447	819388		
NC_000003.12:g.(?_37006981)_(37007073_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000831418	3	37048472 - 37048564			831418	819379		
NM_000249.3(MLH1):c.207+2T>G	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000525864	3	37038202	3	36996711	525864	519286	rs267607722	NC_000003.12:36996710:T:G
NM_001258271.1(MLH1):c.1896+860del	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000483563	3	37090033	3	37048542	483563	473471	rs1553663834	NC_000003.12:37048541:TT:T
NM_000249.3(MLH1):c.1731+4A>G	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	criteria provided, single submitter	VCV000483547	3	37083826	3	37042335	483547	473428	rs1553659500	NC_000003.12:37042334:A:G
NM_000249.3(MLH1):c.1130dup (p.Val378fs)	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000479697	3	37067217 - 37067218	3	37025726 - 37025727	479697	473391	rs1553650741	NC_000003.12:37025726:AA:AAA
NM_001354621.1(MLH1):c.-84del	MLH1	V281fs, V216fs, V314fs, V73fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000455463	3	37061856	3	37020365	455463	452428	rs1553648023	NC_000003.12:37020364:G:
NM_000249.3(MLH1):c.1785_1786insCCAGATAGTCCAGA (p.Gly596fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000455404	3	37089063 - 37089064	3	37047572 - 37047573	455404	452392	rs1553662800	NC_000003.12:37047572::CCAGATAGTCCAGA
NM_000249.3(MLH1):c.67dup (p.Glu23fs)	MLH1		Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422508	3	37035100 - 37035101	3	36993609 - 36993610	422508	406196	rs63750822	NC_000003.12:36993609:GGGGG:GGGGGG
NM_001167617.2(MLH1):c.-508_-496del	MLH1	F3fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000421747	3	37035044 - 37035056	3	36993553 - 36993565	421747	406195	rs1064795341	NC_000003.12:36993552:GTTCGTGGCAGGGGTT:GTT
NM_001258271.1(MLH1):c.1896+875_1896+882dup	MLH1		Hereditary nonpolyposis colon cancer|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420181	3	37090048 - 37090049	3	37048557 - 37048558	420181	406254	rs1064794331	NC_000003.12:37048557:TGTGCCCC:TGTGCCCCTGTGCCCC
NM_000249.3(MLH1):c.791-2A>T	MLH1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419530	3	37058995	3	37017504	419530	406221	rs267607794	NC_000003.12:37017503:A:T
NM_001354621.1(MLH1):c.-140+2410del	MLH1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418299	3	37056000	3	37014509	418299	406220	rs1064793172	NC_000003.12:37014508:C:
NM_001167617.2(MLH1):c.-470_-464del	MLH1	V16fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231045	3	37035084 - 37035090	3	36993593 - 36993599	231045	232878	rs876658923	NC_000003.12:36993592:GTGAACCG:G
NM_001354621.1(MLH1):c.-139-2802del	MLH1	R265fs, R167fs, R24fs, R232fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000218027	3	37058999	3	37017508	218027	214632	rs863225384	NC_000003.12:37017507:C:
NM_001354630.1(MLH1):c.1732-872del	MLH1	E262fs, E379fs, E587fs, E620fs, E522fs, E279fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187082	3	37089136	3	37047645	187082	182293	rs786203456	NC_000003.12:37047644:G:
NC_000003.12:g.(?_37040176)_(37042341_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831389	3	37081667 - 37083832			831389	819389		
NC_000003.12:g.(?_37048507)_(37049027_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000831361	3	37089998 - 37090518			831361	819394		
NM_000249.4(MLH1):c.460del (p.Asp154fs)	MLH1	D56fs, D121fs, D154fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825040	3	37050310	3	37008819	825040	807545		NC_000003.12:37008818:GG:G
NM_000249.3(MLH1):c.1601del (p.Val534fs)	MLH1	V176fs, V293fs, V534fs, V193fs, V436fs, V501fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619862	3	37081719	3	37040228	619862	611050	rs1559575143	NC_000003.12:37040227:T:
NC_000003.11:g.(?_37053301)_(37056045_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000583941	3	37053301 - 37056045	3	37011810 - 37014554	583941	559225		
NM_000249.3(MLH1):c.453+1G>C	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000525681	3	37048555	3	37007064	525681	519124	rs267607750	NC_000003.12:37007063:G:C
NM_000249.3(MLH1):c.1315G>T (p.Glu439Ter)	MLH1	E439*, E198*, E81*, E98*, E341*, E406*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486846	3	37067404	3	37025913	486846	473436	rs1302248679	NC_000003.12:37025912:G:T
NM_000249.3(MLH1):c.2098C>T (p.Gln700Ter)	MLH1	Q700*, Q459*, Q602*, Q667*, Q359*, Q669*, Q342*, Q645*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000483543	3	37090503	3	37049012	483543	473514	rs1553664702	NC_000003.12:37049011:C:T
NM_000249.3(MLH1):c.1791G>A (p.Trp597Ter)	MLH1	W597*, W356*, W499*, W239*, W256*, W564*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480903	3	37089069	3	37047578	480903	473466	rs1416171624	NC_000003.12:37047577:G:A
NM_000249.3(MLH1):c.404dup (p.Lys136fs)	MLH1		Hereditary nonpolyposis colon cancer|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000455432	3	37048504 - 37048505	3	37007013 - 37007014	455432	452409	rs1553642079	NC_000003.12:37007013:T:TT
NM_000249.3(MLH1):c.1489_1490insCG (p.Arg497fs)	MLH1		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000455391	3	37070354 - 37070355	3	37028863 - 37028864	455391	452458	rs1553653037	NC_000003.12:37028863::CG
NM_000249.3(MLH1):c.34dup (p.Asp12fs)	MLH1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439177	3	37035070 - 37035071	3	36993579 - 36993580	439177	432560	rs1553637196	NC_000003.12:36993579:GG:GGG
NM_000249.3(MLH1):c.2032A>T (p.Lys678Ter)	MLH1	K678*, K337*, K437*, K580*, K645*, K623*, K647*, K320*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439174	3	37090437	3	37048946	439174	432573	rs1553664436	NC_000003.12:37048945:A:T
NM_001167617.2(MLH1):c.1208_1209delinsA (p.Ile403fs)	MLH1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439171	3	37070367 - 37070368	3	37028876 - 37028877	439171	432570	rs1553653084	NC_000003.12:37028875:TT:A
NM_000249.3(MLH1):c.1456dup (p.Ser486fs)	MLH1		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237314	3	37070319 - 37070320	3	37028828 - 37028829	237314	239174	rs878853778	NC_000003.12:37028828:TT:TTT
NM_001354630.1(MLH1):c.1732-840dup	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000185190	3	37089166 - 37089167	3	37047675 - 37047676	185190	182294	rs786201990	NC_000003.12:37047675:TT:TTT
NM_000249.3(MLH1):c.209_215delAAGAAGA	MLH1		not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000182513	3	37042444 - 37042450	3	37000953 - 37000959	182513	180132	rs730881734	NC_000003.12:37000952:AGAAAGAAGA:AGA
NC_000003.12:g.(?_36996608)_(37001063_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000831404	3	37038099 - 37042554			831404	819372		
NC_000003.11:g.(?_37038100)_(37042554_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000583755	3	37038100 - 37042554	3	36996609 - 37001063	583755	558704		
NM_000249.3(MLH1):c.2212G>T (p.Gly738Ter)	MLH1	G738*, G397*, G497*, G669*, G640*, G683*, G705*, G380*, G707*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000525802	3	37092085	3	37050594	525802	519339	rs1553665866	NC_000003.12:37050593:G:T
NM_000249.3(MLH1):c.1997G>A (p.Trp666Ter)	MLH1	W666*, W308*, W611*, W325*, W568*, W425*, W633*, W635*	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265246	3	37090402	3	37048911	265246	259761	rs886039424	NC_000003.12:37048910:G:A
NM_005732.4(RAD50):c.687del (p.Ser229fs)	RAD50	S229fs	Hereditary cancer-predisposing syndrome|Nijmegen breakage syndrome-like disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185010	5	131915689	5	132579997	185010	182523	rs760146707	NC_000005.10:132579996:T:
NM_000249.4(MLH1):c.381-2A>T	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000842811	3	37048480	3	37006989	842811	851556		NC_000003.12:37006988:A:T
NC_000003.12:g.(?_36996608)_(37050653_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000833314	3	37038099 - 37092144			833314	819373		
NC_000003.12:g.(?_37048507)_(37050653_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000831846	3	37089998 - 37092144			831846	819396		
NC_000003.11:g.(?_37038100)_(37092154_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000661730	3	37038100 - 37092154	3	36996609 - 37050663	661730	651034		
NC_000003.11:g.(?_37089998)_(37092154_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000647939	3	37089998 - 37092154	3	37048507 - 37050663	647939	650993		
NM_000249.3(MLH1):c.393_396del (p.Asp132fs)	MLH1	D99fs, D132fs, D34fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000629306	3	37048494 - 37048497	3	37007003 - 37007006	629306	616846	rs1559521039	NC_000003.12:37007002:AGAT:
NM_000249.3(MLH1):c.1400del (p.Ser467fs)	MLH1	S126fs, S434fs, S109fs, S467fs, S226fs, S369fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422036	3	37067489	3	37025998	422036	406236	rs1064795515	NC_000003.12:37025997:G:
NM_000249.3(MLH1):c.1039-2A>C	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000405391	3	37067126	3	37025635	405391	393672	rs267607815	NC_000003.12:37025634:A:C
NM_000249.3(MLH1):c.1746del (p.Phe583fs)	MLH1	F225fs, F242fs, F485fs, F550fs, F342fs, F583fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231279	3	37089024	3	37047533	231279	232956	rs876659068	NC_000003.12:37047532:C:
NM_000249.3(MLH1):c.208-2A>C	MLH1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000186115	3	37042444	3	37000953	186115	182219	rs267607716	NC_000003.12:37000952:A:C
NM_000249.3(MLH1):c.117-1G>A	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000127610	3	37038109	3	36996618	127610	133067	rs587779950	NC_000003.12:36996617:G:A
NM_000551.3(VHL):c.332G>A (p.Ser111Asn)	VHL	S111N	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000223186	3	10183863	3	10142179	223186	224916	rs869025631	NC_000003.12:10142178:G:A
NM_000551.3(VHL):c.266T>C (p.Leu89Pro)	VHL	L89P	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182979	3	10183797	3	10142113	182979	180117	rs5030807	NC_000003.12:10142112:T:C
NC_000003.12:g.(?_37047509)_(37050653_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832869	3	37089000 - 37092144			832869	819392		
NC_000003.12:g.(?_36996609)_(37017609_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000831809	3	37038100 - 37059100			831809	819374		
NM_000249.3(MLH1):c.1989G>C (p.Glu663Asp)	MLH1	E322D, E565D, E630D, E305D, E608D, E422D, E663D	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000639057	3	37090100	3	37048609	639057	631254		NC_000003.12:37048608:G:C
NC_000003.11:g.(?_37089000)_(37092154_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000583723	3	37089000 - 37092154	3	37047509 - 37050663	583723	559229		
NM_000249.3(MLH1):c.2253del (p.Val752fs)	MLH1	V394fs, V654fs, V697fs, V411fs, V683fs, V511fs, V719fs, V721fs, V752fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578789	3	37092124	3	37050633	578789	558916	rs267607901	NC_000003.12:37050632:AAA:AA
NM_000249.3(MLH1):c.1546C>T (p.Gln516Ter)	MLH1	Q516*, Q158*, Q483*, Q175*, Q418*, Q275*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545957	3	37070411	3	37028920	545957	536279	rs1553653195	NC_000003.12:37028919:C:T
NM_000249.3(MLH1):c.2161_2191dup (p.Pro731delinsLeuTer)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000455421	3	37092031 - 37092032	3	37050540 - 37050541	455421	452684	rs1553665683	NC_000003.12:37050540:TCTATAAAGCCTTGCGCTCACACATTCTGCCTC:TCTATAAAGCCTTGCGCTCACACATTCTGCCTCTATAAAGCCTTGCGCTCACACATTCTGCCTC
NM_000249.3(MLH1):c.307-2A>G	MLH1		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234719	3	37045890	3	37004399	234719	231606	rs267607732	NC_000003.12:37004398:A:G
NC_000003.11:g.(?_37061791)_(37092154_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000584338	3	37061791 - 37092154	3	37020300 - 37050663	584338	561050		
NC_000003.11:g.(?_37091971)_(37092150_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000584031	3	37091971 - 37092150	3	37050480 - 37050659	584031	562188		
NM_001167617.2(MLH1):c.1967_1968AG[1] (p.Arg657fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000568558	3	37092133 - 37092134	3	37050642 - 37050643	568558	561441	rs1559597322	NC_000003.12:37050641:GAGAG:GAG
NM_000249.3(MLH1):c.2259del (p.Phe753fs)	MLH1	F722fs, F753fs, F412fs, F684fs, F512fs, F655fs, F698fs, F395fs, F720fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000405405	3	37092130	3	37050639	405405	393526	rs1060500698	NC_000003.12:37050638:TTT:TT
NM_000249.3(MLH1):c.1522_1523del (p.Leu509fs)	MLH1	L168fs, L268fs, L411fs, L151fs, L476fs, L509fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230876	3	37070386 - 37070387	3	37028895 - 37028896	230876	232948	rs876658821	NC_000003.12:37028894:GAG:G
NC_000003.12:g.(?_37040176)_(37050653_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000832635	3	37081667 - 37092144			832635	819390		
NM_000249.3(MLH1):c.320T>A (p.Ile107Lys)	MLH1	I107K, I9K, I74K	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000659950	3	37045905	3	37004414	659950	631199		NC_000003.12:37004413:T:A
NC_000003.11:g.(?_37081667)_(37092154_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000654676	3	37081667 - 37092154	3	37040176 - 37050663	654676	650988		
NM_000249.3(MLH1):c.2215_2218dup (p.Ile740fs)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000646603	3	37092086 - 37092087	3	37050595 - 37050596	646603	631263		NC_000003.12:37050595:AAATA:AAATAAATA
NM_000249.3(MLH1):c.2070C>G (p.Tyr690Ter)	MLH1	Y332*, Y449*, Y592*, Y657*, Y635*, Y659*, Y690*, Y349*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000642710	3	37090475	3	37048984	642710	631257		NC_000003.12:37048983:C:G
NM_000249.3(MLH1):c.1990-1G>C	MLH1		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000628266	3	37090394	3	37048903	628266	619168	rs267607884	NC_000003.12:37048902:G:C
NC_000003.11:g.(?_37081671)_(37092150_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000526007	3	37081671 - 37092150	3	37040180 - 37050659	526007	518891		
NM_001354621.1(MLH1):c.-27_-24del	MLH1	K92fs, K333fs, K300fs, K235fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000483540	3	37061910 - 37061913	3	37020419 - 37020422	483540	473434	rs1553648149	NC_000003.12:37020418:AGCAAGC:AGC
NM_000249.3(MLH1):c.583A>T (p.Lys195Ter)	MLH1	K195*, K162*, K97*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218025	3	37053348	3	37011857	218025	214631	rs863225383	NC_000003.12:37011856:A:T
MLH1, 370-BP DEL	MLH1		Muir-Torré syndrome	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000017083					17083	32122		
NM_001168272.1(ITPR1):c.7615G>A (p.Gly2539Arg)	ITPR1	G2539R, G2491R, G2506R	Gillespie syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235922	3	4856205	3	4814521	235922	237580	rs752281590	NC_000003.12:4814520:G:A
NM_024577.4(SH3TC2):c.3325C>T (p.Arg1109Ter)	SH3TC2	R1109*	Charcot-Marie-Tooth disease, type 4C|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002483	5	148389835	5	149010272	2483	17522	rs80338934	NC_000005.10:149010271:G:A
NM_001904.4(CTNNB1):c.110C>A (p.Ser37Tyr)	CTNNB1	S37Y, S30Y	Neoplasm of stomach|Hepatocellular carcinoma|Uterine cervical neoplasms|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Carcinoma of esophagus|Cutaneous melanoma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Medulloblastoma|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375894	3	41266113	3	41224622	375894	362773	rs121913403	NC_000003.12:41224621:C:A
NM_001904.4(CTNNB1):c.98C>T (p.Ser33Phe)	CTNNB1	S33F, S26F	Lung adenocarcinoma|Hepatocellular carcinoma|Carcinoma of esophagus|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Malignant melanoma of skin|Medulloblastoma|ADRENAL CORTICAL NEOPLASM|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Pilomatrixoma	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017583	3	41266101	3	41224610	17583	32622	rs121913400	NC_000003.12:41224609:C:T
NC_000003.11:g.(?_37089000)_(37089184_?)del	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000659586	3	37089000 - 37089184	3	37047509 - 37047693	659586	651131		
NM_000249.3(MLH1):c.272T>G (p.Leu91Ter)	MLH1	L91*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486851	3	37042510	3	37001019	486851	473333	rs63751137	NC_000003.12:37001018:T:G
NM_001167617.2(MLH1):c.811dup (p.Ser271fs)	MLH1		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000405406	3	37067193 - 37067194	3	37025702 - 37025703	405406	393527	rs1060500699	NC_000003.12:37025702:T:TT
NM_000249.3(MLH1):c.2249dup (p.Tyr750Ter)	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000237334	3	37092121 - 37092122	3	37050630 - 37050631	237334	239191	rs878853787	NC_000003.12:37050630:A:AA
NM_000249.3(MLH1):c.2206G>T (p.Glu736Ter)	MLH1	E736*, E395*, E703*, E638*, E705*, E378*, E495*, E667*, E681*	not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232190	3	37092079	3	37050588	232190	232980	rs876659608	NC_000003.12:37050587:G:T
NM_000249.3(MLH1):c.2059del (p.Arg687fs)	MLH1	R346fs, R446fs, R654fs, R656fs, R687fs, R329fs, R589fs, R632fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000218022	3	37090463	3	37048972	218022	214642	rs863225381	NC_000003.12:37048971:CC:C
NM_000112.3(SLC26A2):c.-26+2T>C	SLC26A2		SLC26A2-Related Disorders||Osteochondrodysplasia|||Diastrophic dysplasia|Achondrogenesis, type IB|||Diastrophic dysplasia|not provided|Achondrogenesis, type IB	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004097	5	149340544	5	149960981	4097	19136	rs386833492	NC_000005.10:149960980:T:C
NM_000112.3(SLC26A2):c.532C>T (p.Arg178Ter)	SLC26A2	R178*	|Osteochondrodysplasia|||Diastrophic dysplasia|SLC26A2-Related Disorders|Achondrogenesis, type IB|Achondrogenesis, type IB|||Diastrophic dysplasia|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004092	5	149357747	5	149978184	4092	19131	rs104893919	NC_000005.10:149978183:C:T
NM_000249.4(MLH1):c.546-2A>T	MLH1		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000853914	3	37053309	3	37011818	853914	850926		NC_000003.12:37011817:A:T
NM_000249.3(MLH1):c.1667+1G>A	MLH1		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Colon cancer	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000455398	3	37081786	3	37040295	455398	452681	rs1434898623	NC_000003.12:37040294:G:A
NM_000249.3(MLH1):c.1667G>A (p.Ser556Asn)	MLH1	S556N, S198N, S523N, S458N, S215N, S315N	Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449776	3	37081785	3	37040294	449776	443423	rs63751596	NC_000003.12:37040293:G:A
NM_000249.3(MLH1):c.2044_2045del (p.Met682fs)	MLH1	M341fs, M649fs, M682fs, M584fs, M324fs, M441fs, M627fs, M651fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237329	3	37090448 - 37090449	3	37048957 - 37048958	237329	239187	rs878853785	NC_000003.12:37048956:TAT:T
NM_022455.4(NSD1):c.6050G>A (p.Arg2017Gln)	NSD1	R2017Q, R1748Q	Sotos syndrome 1|not provided|Scoliosis|High anterior hairline|Hypoplasia of the corpus callosum|Delayed speech and language development|Global developmental delay|Delayed gross motor development|Hypertelorism|Tall stature|Pointed chin|Preeclampsia|Overgrowth|Increased body weight|Delayed speech and language development|Osteopenia|High forehead|Macrocephalus|Beckwith-Wiedemann syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159398	5	176710828	5	177283827	159398	168250	rs587784177	NC_000005.10:177283826:G:A
NM_001369.2(DNAH5):c.7915C>T (p.Arg2639Ter)	DNAH5	R2639*	Inborn genetic diseases|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520775	5	13794140	5	13794031	520775	511556	rs375053470	NC_000005.10:13794030:G:A
NM_001369.2(DNAH5):c.349G>T (p.Glu117Ter)	DNAH5	E117*	Inborn genetic diseases|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000454767	5	13923478	5	13923369	454767	455442	rs116128702	NC_000005.10:13923368:C:A
NM_001369.2(DNAH5):c.8314C>T (p.Arg2772Ter)	DNAH5	R2772*	Primary ciliary dyskinesia|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407217	5	13792237	5	13792128	407217	395365	rs781469274	NC_000005.10:13792127:G:A
NM_001369.2(DNAH5):c.10226G>C (p.Trp3409Ser)	DNAH5	W3409S	Inborn genetic diseases|Primary ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000238952	5	13762886	5	13762777	238952	239729	rs755407407	NC_000005.10:13762776:C:G
NM_001904.4(CTNNB1):c.999C>A (p.Tyr333Ter)	CTNNB1	Y333*, Y326*	Inborn genetic diseases|Hepatocellular carcinoma|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000450550	3	41268761	3	41227270	450550	443454	rs778624338	NC_000003.12:41227269:C:A
NM_001904.4(CTNNB1):c.110C>G (p.Ser37Cys)	CTNNB1	S37C, S30C	Lung adenocarcinoma|Hepatocellular carcinoma|Carcinoma of esophagus|not provided|Neoplasm of ovary|Transitional cell carcinoma of the bladder|Medulloblastoma|Uterine cervical neoplasms|Ovarian Neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Pilomatrixoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017579	3	41266113	3	41224622	17579	32618	rs121913403	NC_000003.12:41224621:C:G
NM_001354689.3(RAF1):c.1897C>G (p.Leu633Val)	RAF1	L613V, L633V, L499V, L580V, L552V, L532V	Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome 5|LEOPARD syndrome 2|not provided|Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013960	3	12626123	3	12584624	13960	28999	rs80338797	NC_000003.12:12584623:G:C
NM_004415.4(DSP):c.699G>A (p.Trp233Ter)	DSP	W233*	Skin fragility-woolly hair-palmoplantar keratoderma syndrome|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis||Keratosis palmoplantaris striata II|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044946	6	7562986	6	7562753	44946	54113	rs397516955	NC_000006.12:7562752:G:A
NM_000222.2(KIT):c.1669T>A (p.Trp557Arg)	KIT	W557R, W553R	Gastrointestinal stromal tumor|Cutaneous melanoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375908	4	55593603	4	54727437	375908	362787	rs121913235	NC_000004.12:54727436:T:A
NM_000551.4(VHL):c.208G>A (p.Glu70Lys)	VHL	E70K, Q195X	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000043598	3	10183739	3	10142055	43598	52767	rs5030802	NC_000003.12:10142054:G:A
NM_024334.3(TMEM43):c.1073C>T (p.Ser358Leu)	TMEM43	S358L	Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 5	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000734	3	14183165	3	14141665	734	15773	rs63750743	NC_000003.12:14141664:C:T
NM_000551.3(VHL):c.257C>G (p.Pro86Arg)	VHL	P86R	Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000223170	3	10183788	3	10142104	223170	224901	rs730882034	NC_000003.12:10142103:C:G
NM_000551.3(VHL):c.293A>C (p.Tyr98Ser)	VHL	Y98S	Pheochromocytoma|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000219160	3	10183824	3	10142140	219160	217068	rs864321643	NC_000003.12:10142139:A:C
NM_000249.3(MLH1):c.381-1G>A	MLH1		not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219740	3	37048481	3	37006990	219740	221382	rs267607744	NC_000003.12:37006989:G:A
NM_001167617.2(MLH1):c.-508del	MLH1	F3fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090462	3	37035047	3	36993556	90462	95936	rs63750745	NC_000003.12:36993555:C:
NM_001354621.1(MLH1):c.-30del	MLH1	S332fs, S91fs, S234fs, S299fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090461	3	37061910	3	37020419	90461	95935	rs63750533	NC_000003.12:37020418:A:
NM_001354621.1(MLH1):c.-70del	MLH1	H220fs, H285fs, H77fs, H318fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090451	3	37061870	3	37020379	90451	95925	rs63749926	NC_000003.12:37020378:C:
NM_001354621.1(MLH1):c.-89dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090448	3	37061850 - 37061851	3	37020359 - 37020360	90448	95922	rs63750319	NC_000003.12:37020359:A:AA
NM_001354621.1(MLH1):c.-96del	MLH1	T310fs, T69fs, T277fs, T212fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090446	3	37061844	3	37020353	90446	95920	rs587779055	NC_000003.12:37020352:A:
NM_001354621.1(MLH1):c.-103_-102dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090443	3	37061836 - 37061837	3	37020345 - 37020346	90443	95917	rs63750962	NC_000003.12:37020345:GC:GCGC
NM_001354621.1(MLH1):c.-123del	MLH1	Q203fs, Q268fs, Q60fs, Q301fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090436	3	37061814	3	37020323	90436	95910	rs587779052	NC_000003.12:37020322:CCCC:CCC
NM_000249.4(MLH1):c.901C>T (p.Gln301Ter)	MLH1	Q301*, Q203*, Q268*, Q60*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090435	3	37061817	3	37020326	90435	95909	rs63750489	NC_000003.12:37020325:C:T
NM_000249.3(MLH1):c.889G>T (p.Glu297Ter)	MLH1	E297*, E199*, E264*, E56*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090434	3	37061805	3	37020314	90434	95908	rs63750736	NC_000003.12:37020313:G:T
NM_001354621.1(MLH1):c.-136del	MLH1	E297fs, E199fs, E56fs, E264fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090432	3	37061804	3	37020313	90432	95906	rs267607809	NC_000003.12:37020312:A:
NM_001354621.1(MLH1):c.-137dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090431	3	37061800 - 37061801	3	37020309 - 37020310	90431	95905	rs63751620	NC_000003.12:37020309:TTT:TTTT
NM_000249.3(MLH1):c.885-?_1731+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090429					90429	95903		
NM_000249.3(MLH1):c.885-?_1038+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090428					90428	95902		
NM_000249.3(MLH1):c.885-?_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090427	3	37061801 - 37092337	3	37020310 - 37050846	90427	95901		
NM_000249.3(MLH1):c.885-594_1038+1123del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090423	3	37061204 - 37063074	3	37019713 - 37021583	90423	95897		
NM_000249.3(MLH1):c.885-493_1039-372del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090422	3	37061308 - 37066756	3	37019817 - 37025265	90422	95896		
NM_000249.3(MLH1):c.885-206_997del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090419	3	37061594 - 37061912	3	37020103 - 37020421	90419	95893	rs1553647795	
NM_000249.3(MLH1):c.884_884+3del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090417	3	37059089 - 37059092	3	37017598 - 37017601	90417	95891	rs587779050	NC_000003.12:37017597:AGGTA:A
NM_001354621.1(MLH1):c.-139-2735AC[5]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090402	3	37059065 - 37059066	3	37017574 - 37017575	90402	95876	rs587779047	NC_000003.12:37017574:ACACACAC:ACACACACAC
NM_001354621.1(MLH1):c.-139-2735AC[3]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090401	3	37059066 - 37059067	3	37017575 - 37017576	90401	95875	rs587779047	NC_000003.12:37017574:ACACACAC:ACACAC
NM_000249.3(MLH1):c.856_857insT (p.Lys286fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090395	3	37059062 - 37059063	3	37017571 - 37017572	90395	95869	rs63750212	NC_000003.12:37017571::T
NM_000249.3(MLH1):c.851T>A (p.Leu284Ter)	MLH1	L284*, L43*, L186*, L251*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090393	3	37059057	3	37017566	90393	95867	rs63750889	NC_000003.12:37017565:T:A
NM_000249.3(MLH1):c.842C>T (p.Ala281Val)	MLH1	A281V, A40V, A183V, A248V	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090390	3	37059048	3	37017557	90390	95864	rs63749950	NC_000003.12:37017556:C:T
NM_000249.3(MLH1):c.840T>A (p.Tyr280Ter)	MLH1	Y280*, Y182*, Y247*, Y39*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090389	3	37059046	3	37017555	90389	95863	rs63750938	NC_000003.12:37017554:T:A
NM_001354621.1(MLH1):c.-139-2774_-139-2771dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090386	3	37059026 - 37059027	3	37017535 - 37017536	90386	95860	rs63751439	NC_000003.12:37017535:AAGC:AAGCAAGC
NM_001354621.1(MLH1):c.-139-2784_-139-2780del	MLH1	S173fs, S238fs, S271fs, S30fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090384	3	37059016 - 37059020	3	37017525 - 37017529	90384	95858	rs587779043	NC_000003.12:37017524:TTCCTT:T
NM_001354621.1(MLH1):c.-139-2787_-139-2784del	MLH1	T270fs, T237fs, T172fs, T29fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090383	3	37059014 - 37059017	3	37017523 - 37017526	90383	95857	rs267607801	NC_000003.12:37017522:ACTT:
NM_001354621.1(MLH1):c.-139-2804_-139-2801del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090379	3	37058996 - 37058999	3	37017505 - 37017508	90379	95853	rs267607799	NC_000003.12:37017504:GATCG:G
NM_000249.3(MLH1):c.791-?_884+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090377					90377	95851		
NM_000249.3(MLH1):c.791-?_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090376					90376	95850		
NM_000249.3(MLH1):c.791-1G>C	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090369	3	37058996	3	37017505	90369	95843	rs267607795	NC_000003.12:37017504:G:C
NM_001167617.2(MLH1):c.-439del	MLH1	Q26fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090354	3	37035116	3	36993625	90354	95828	rs587779040	NC_000003.12:36993624:G:
NM_001354621.1(MLH1):c.-140+2440_-140+2442del	MLH1	I262del	Lynch syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000090352	3	37056027 - 37056029	3	37014536 - 37014538	90352	95826	rs587779039	NC_000003.12:37014535:TCATCA:TCA
NM_001167617.2(MLH1):c.-441del	MLH1	Q26fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090348	3	37035113	3	36993622	90348	95822	rs63749828	NC_000003.12:36993621:CC:C
NM_001354621.1(MLH1):c.-140+2400dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090345	3	37055989 - 37055990	3	37014498 - 37014499	90345	95819	rs63750819	NC_000003.12:37014498:G:GG
NM_001167617.2(MLH1):c.-444del	MLH1	I25fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090344	3	37035111	3	36993620	90344	95818	rs63749839	NC_000003.12:36993619:A:
NM_001167618.2(MLH1):c.-31del	MLH1	I133fs, I198fs, I231fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090334	3	37055937	3	37014446	90334	95808	rs63750764	NC_000003.12:37014445:TT:T
NM_001167618.2(MLH1):c.-41dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090333	3	37055927 - 37055928	3	37014436 - 37014437	90333	95807	rs63751659	NC_000003.12:37014436:T:TT
NM_000249.3(MLH1):c.678-?_884+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090329					90329	95803		
NM_000249.3(MLH1):c.678-?_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090328					90328	95802		
NM_000249.3(MLH1):c.678-9_693del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090327	3	37055912 - 37055936	3	37014421 - 37014445	90327	95801	rs587779036	NC_000003.12:37014420:TTTTCTAATAGAGAACTGATAGAAATT:TT
NM_000249.3(MLH1):c.678-3_678-2del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090326	3	37055919 - 37055920	3	37014428 - 37014429	90326	95800	rs267607783	NC_000003.12:37014427:ATA:A
NM_000249.3(MLH1):c.678-1G>C	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090322	3	37055922	3	37014431	90322	95796	rs267607784	NC_000003.12:37014430:G:C
NM_000249.3(MLH1):c.677_677+1delinsAT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090320	3	37053590 - 37053591	3	37012099 - 37012100	90320	95794	rs587779032	NC_000003.12:37012098:GG:AT
NM_001167617.2(MLH1):c.383+1del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090313	3	37053590	3	37012099	90313	95787	rs267607779	NC_000003.12:37012098:GG:G
NM_001167618.2(MLH1):c.-51_-48del	MLH1	S192fs, S225fs, S127fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090310	3	37053586 - 37053589	3	37012095 - 37012098	90310	95784	rs267607774	NC_000003.12:37012094:AGTC:
NM_001167618.2(MLH1):c.-52del	MLH1	S192fs, S225fs, S127fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090309	3	37053584	3	37012093	90309	95783	rs587779031	NC_000003.12:37012092:TT:T
NM_001167618.2(MLH1):c.-59dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090308	3	37053575 - 37053576	3	37012084 - 37012085	90308	95782	rs63750385	NC_000003.12:37012084:AAA:AAAA
NM_001167618.2(MLH1):c.-75del	MLH1	R184fs, R119fs, R217fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090304	3	37053562	3	37012071	90304	95778	rs63750380	NC_000003.12:37012070:C:
NM_000249.3(MLH1):c.632_633insT (p.Thr212fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090299	3	37053545 - 37053546	3	37012054 - 37012055	90299	95773	rs63750908	NC_000003.12:37012054::T
NM_000249.3(MLH1):c.5C>A (p.Ser2Ter)	MLH1	S2*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090295	3	37035043	3	36993552	90295	95769	rs587779029	NC_000003.12:36993551:C:A
NM_001167618.2(MLH1):c.-131_-130GA[2]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090294	3	37053506 - 37053507	3	37012015 - 37012016	90294	95768	rs63751637	NC_000003.12:37012014:GAGAGA:GAGA
NM_000249.3(MLH1):c.588+1G>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090280	3	37053354	3	37011863	90280	95754	rs267607772	NC_000003.12:37011862:G:T
NM_000249.3(MLH1):c.586A>T (p.Lys196Ter)	MLH1	K196*, K163*, K98*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090279	3	37053351	3	37011860	90279	95753	rs63750500	NC_000003.12:37011859:A:T
NM_000249.3(MLH1):c.578C>G (p.Ser193Ter)	MLH1	S193*, S160*, S95*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090278	3	37053343	3	37011852	90278	95752	rs63751480	NC_000003.12:37011851:C:G
NM_000249.3(MLH1):c.546-?_790+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090271					90271	95745		
NM_000249.3(MLH1):c.546-?_677+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090270					90270	95744		
NM_000249.3(MLH1):c.546-?_1409+?dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090269					90269	95743		
NM_000249.3(MLH1):c.546-361_885-811del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090268	3	37052950 - 37060990	3	37011459 - 37019499	90268	95742		
NM_000249.3(MLH1):c.546-2A>C	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090266	3	37053309	3	37011818	90266	95740	rs267607759	NC_000003.12:37011817:A:C
NM_000249.3(MLH1):c.545G>A (p.Arg182Lys)	MLH1	R182K, R149K, R84K	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090264	3	37050396	3	37008905	90264	95738	rs587779021	NC_000003.12:37008904:G:A
NM_001167618.2(MLH1):c.-193_-192delinsCT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090256	3	37050382 - 37050383	3	37008891 - 37008892	90256	95730	rs63750903	NC_000003.12:37008890:GG:CT
NM_000249.3(MLH1):c.524_525insGA (p.Ile176fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090253	3	37050374 - 37050375	3	37008883 - 37008884	90253	95727	rs587779019	NC_000003.12:37008883:A:AGA
NM_001167618.2(MLH1):c.-211del	MLH1	E74fs, E172fs, E139fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090252	3	37050363	3	37008872	90252	95726	rs63749944	NC_000003.12:37008871:AA:A
NM_001167618.2(MLH1):c.-222_-221del	MLH1	N135fs, N70fs, N168fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090249	3	37050349 - 37050350	3	37008858 - 37008859	90249	95723	rs63749959	NC_000003.12:37008857:AAAAAA:AAAA
NM_001167618.2(MLH1):c.-227del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090247	3	37050346	3	37008855	90247	95721	rs587779018	NC_000003.12:37008854:TTT:TT
NM_000249.3(MLH1):c.497T>A (p.Leu166Ter)	MLH1	L166*, L68*, L133*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090246	3	37050348	3	37008857	90246	95720	rs267607755	NC_000003.12:37008856:T:A
NM_001167618.2(MLH1):c.-236del	MLH1	R130fs, R163fs, R65fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090245	3	37050339	3	37008848	90245	95719	rs267607754	NC_000003.12:37008847:G:
NM_001167618.2(MLH1):c.-256_-255del	MLH1	F58fs, F156fs, F123fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090242	3	37050315 - 37050316	3	37008824 - 37008825	90242	95716	rs63751101	NC_000003.12:37008823:TTTTTT:TTTT
NM_000249.3(MLH1):c.464T>G (p.Leu155Arg)	MLH1	L155R, L122R, L57R	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090241	3	37050315	3	37008824	90241	95715	rs63750891	NC_000003.12:37008823:T:G
NM_000249.3(MLH1):c.454-665_545+49del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090237	3	37049640 - 37050445	3	37008149 - 37008954	90237	95711	rs1553642492	
NM_000249.3(MLH1):c.454-501_546-1098del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090235	3	37049800 - 37052209	3	37008309 - 37010718	90235	95709		
NM_000249.3(MLH1):c.454-466_546-1062del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090234	3	37049839 - 37052249	3	37008348 - 37010758	90234	95708		
NM_000249.3(MLH1):c.454-432_546-1030del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090233	3	37049840 - 37052248	3	37008349 - 37010757	90233	95707		
NM_000249.3(MLH1):c.453+2T>C	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090224	3	37048556	3	37007065	90224	95698	rs267607751	NC_000003.12:37007064:T:C
NM_001167617.2(MLH1):c.-473dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090221	3	37035081 - 37035082	3	36993590 - 36993591	90221	95695	rs63751131	NC_000003.12:36993590:T:TT
NM_000249.3(MLH1):c.445C>T (p.Gln149Ter)	MLH1	Q149*, Q116*, Q51*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090219	3	37048546	3	37007055	90219	95693	rs63751302	NC_000003.12:37007054:C:T
NM_001167618.2(MLH1):c.-296dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090216	3	37048528 - 37048529	3	37007037 - 37007038	90216	95690	rs63751045	NC_000003.12:37007037:C:CC
NM_001167618.2(MLH1):c.-304del	MLH1	K42fs, K140fs, K107fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090214	3	37048519	3	37007028	90214	95688	rs587779015	NC_000003.12:37007027:AAA:AA
NM_001167617.2(MLH1):c.-480_-479GA[3]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090210	3	37035074 - 37035075	3	36993583 - 36993584	90210	95684	rs587779013	NC_000003.12:36993583:GAGA:GAGAGA
NM_000249.3(MLH1):c.397G>T (p.Gly133Ter)	MLH1	G133*, G100*, G35*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090209	3	37048498	3	37007007	90209	95683	rs63751124	NC_000003.12:37007006:G:T
NM_000249.3(MLH1):c.392C>A (p.Ser131Ter)	MLH1	S131*, S33*, S98*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090208	3	37048493	3	37007002	90208	95682	rs63749818	NC_000003.12:37007001:C:A
NM_001167618.2(MLH1):c.-335del	MLH1	Y32fs, Y97fs, Y130fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090206	3	37048490	3	37006999	90206	95680	rs587779012	NC_000003.12:37006998:A:
NM_001167618.2(MLH1):c.-336del	MLH1	Y32fs, Y97fs, Y130fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090204	3	37048488	3	37006997	90204	95678	rs587779009	NC_000003.12:37006996:TT:T
NM_001167618.2(MLH1):c.-339_-338delinsGTT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090202	3	37048486 - 37048487	3	37006995 - 37006996	90202	95676	rs63751710	NC_000003.12:37006994:AG:GTT
NM_000249.4(MLH1):c.382_402delinsT (p.Ala128fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090200	3	37048483 - 37048503	3	37006992 - 37007012	90200	95674	rs267607746	NC_000003.12:37006991:GCAAGTTACTCAGATGGAAAA:T
NM_000249.3(MLH1):c.382G>C (p.Ala128Pro)	MLH1	A128P, A30P, A95P	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090199	3	37048483	3	37006992	90199	95673	rs63750866	NC_000003.12:37006991:G:C
NM_000249.3(MLH1):c.381-?_545+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090198					90198	95672		
NM_000249.3(MLH1):c.381-415_453+733del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090196	3	37048051 - 37049271	3	37006560 - 37007780	90196	95670		
NM_000249.3(MLH1):c.380+2T>A	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090192	3	37045967	3	37004476	90192	95666	rs267607742	NC_000003.12:37004475:T:A
NM_001167617.2(MLH1):c.-480del	MLH1	E13fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090190	3	37035075	3	36993584	90190	95664	rs63750081	NC_000003.12:36993583:G:
NM_001167618.2(MLH1):c.-346del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090187	3	37045963	3	37004472	90187	95661	rs63751607	NC_000003.12:37004471:C:
NM_000249.3(MLH1):c.378C>G (p.Tyr126Ter)	MLH1	Y126*, Y93*, Y28*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090186	3	37045963	3	37004472	90186	95660	rs63751606	NC_000003.12:37004471:C:G
NM_000249.3(MLH1):c.367A>T (p.Lys123Ter)	MLH1	K123*, K90*, K25*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090181	3	37045952	3	37004461	90181	95655	rs63750542	NC_000003.12:37004460:A:T
NM_001167618.2(MLH1):c.-370_-369dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090179	3	37045936 - 37045937	3	37004445 - 37004446	90179	95653	rs63750658	NC_000003.12:37004445:AAAA:AAAAAA
NM_001167618.2(MLH1):c.-378dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090175	3	37045930 - 37045931	3	37004439 - 37004440	90175	95649	rs267607739	NC_000003.12:37004439:A:AA
NM_001167618.2(MLH1):c.-383del	MLH1	T114fs, T16fs, T81fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090173	3	37045926	3	37004435	90173	95647	rs63750645	NC_000003.12:37004434:C:
NM_000249.3(MLH1):c.307-?_545+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090162					90162	95636		
NM_000249.3(MLH1):c.307-?_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090160	3	37045892 - 37092337	3	37004401 - 37050846	90160	95634		
NM_000249.3(MLH1):c.307-820_380+896del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090159	3	37045072 - 37046861	3	37003581 - 37005370	90159	95633		
NM_000249.3(MLH1):c.307-797_677+1061del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090158	3	37045095 - 37054651	3	37003604 - 37013160	90158	95632		
NM_000249.3(MLH1):c.307-245_454-365del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090155	3	37045647 - 37049940	3	37004156 - 37008449	90155	95629		
NM_000249.3(MLH1):c.307-1420_380+624del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090153	3	37044472 - 37046589	3	37002981 - 37005098	90153	95627		
NM_000249.3(MLH1):c.2T>A (p.Met1Lys)	MLH1	M1K	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090134	3	37035040	3	36993549	90134	95608	rs111052004	NC_000003.12:36993548:T:A
NM_000249.3(MLH1):c.265G>T (p.Glu89Ter)	MLH1	E89*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090124	3	37042503	3	37001012	90124	95598	rs11541859	NC_000003.12:37001011:G:T
NM_001167617.2(MLH1):c.-29del	MLH1	F88fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090123	3	37042498	3	37001007	90123	95597	rs267607728	NC_000003.12:37001006:CC:C
NM_000249.3(MLH1):c.256C>T (p.Gln86Ter)	MLH1	Q86*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090121	3	37042494	3	37001003	90121	95595	rs63751421	NC_000003.12:37001002:C:T
NM_001167617.2(MLH1):c.-46dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090117	3	37042481 - 37042482	3	37000990 - 37000991	90117	95591	rs267607729	NC_000003.12:37000990:A:AA
NM_001167617.2(MLH1):c.-61_-60TG[1]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090113	3	37042467 - 37042468	3	37000976 - 37000977	90113	95587	rs63750052	NC_000003.12:37000975:TGTG:TG
NM_001167617.2(MLH1):c.-495dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090111	3	37035059 - 37035060	3	36993568 - 36993569	90111	95585	rs587778996	NC_000003.12:36993568:A:AA
NM_001167617.2(MLH1):c.1975dup (p.Ter659LeuextTer?)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090109	3	37092140 - 37092141	3	37050649 - 37050650	90109	95583	rs1553666143	NC_000003.12:37050649:TT:TTT
NM_001167617.2(MLH1):c.1930del (p.Gln644fs)	MLH1	Q384fs, Q742fs, Q401fs, Q687fs, Q709fs, Q673fs, Q501fs, Q644fs, Q711fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090096	3	37092097	3	37050606	90096	95570	rs267607896	NC_000003.12:37050605:C:
NM_001167617.2(MLH1):c.1929_1939del (p.Gln644fs)	MLH1	Q501fs, Q673fs, Q644fs, Q709fs, Q711fs, Q384fs, Q742fs, Q401fs, Q687fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090093	3	37092096 - 37092106	3	37050605 - 37050615	90093	95567	rs267607897	NC_000003.12:37050604:GCAGCTTGCTA:
NM_000249.3(MLH1):c.2221_2224delCTGCins30 (p.?)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090092	3	37092094 - 37092097	3	37050603 - 37050606	90092	95566		
NM_000249.3(MLH1):c.2163T>A (p.Tyr721Ter)	MLH1	Y721*, Y652*, Y690*, Y380*, Y623*, Y480*, Y688*, Y363*, Y666*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090079	3	37092036	3	37050545	90079	95553	rs63750484	NC_000003.12:37050544:T:A
NM_001167617.2(MLH1):c.1863dup (p.Val622fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090075	3	37092028 - 37092029	3	37050537 - 37050538	90075	95549	rs587778984	NC_000003.12:37050537:TT:TTT
NM_000249.3(MLH1):c.2152_2153CA[1] (p.Ile719fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090072	3	37092024 - 37092025	3	37050533 - 37050534	90072	95546	rs63750971	NC_000003.12:37050532:ACACA:ACA
NM_001167617.2(MLH1):c.1855_1901dup (p.His635fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090070	3	37092021 - 37092022	3	37050530 - 37050531	90070	95544	rs587778982	NC_000003.12:37050530:GAACACATTGTCTATAAAGCCTTGCGCTCACACATTCTGCCTCCTAA:GAACACATTGTCTATAAAGCCTTGCGCTCACACATTCTGCCTCCTAAGAACACATTGTCTATAAAGCCTTGCGCTCACACATTCTGCCTCCTAA
NM_000249.3(MLH1):c.2145_2146TG[1] (p.Val716fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090069	3	37092018 - 37092019	3	37050527 - 37050528	90069	95543	rs587778981	NC_000003.12:37050526:TGTG:TG
NM_000249.3(MLH1):c.2136G>A (p.Trp712Ter)	MLH1	W712*, W354*, W471*, W681*, W614*, W643*, W657*, W679*, W371*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090066	3	37092009	3	37050518	90066	95540	rs63750499	NC_000003.12:37050517:G:A
NM_000249.3(MLH1):c.211G>T (p.Glu71Ter)	MLH1	E71*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090063	3	37042449	3	37000958	90063	95537	rs63749829	NC_000003.12:37000957:G:T
NM_001167617.2(MLH1):c.1817_1823del (p.Val606fs)	MLH1	V463fs, V606fs, V649fs, V671fs, V704fs, V346fs, V363fs, V635fs, V673fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090062	3	37091983 - 37091989	3	37050492 - 37050498	90062	95536	rs587778980	NC_000003.12:37050491:GTGCCTGG:G
NM_001167617.2(MLH1):c.1811_1820del (p.Ser604fs)	MLH1	S633fs, S669fs, S671fs, S461fs, S647fs, S702fs, S344fs, S361fs, S604fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090060	3	37091978 - 37091987	3	37050487 - 37050496	90060	95534	rs587778979	NC_000003.12:37050486:GTGAAGTGCC:
NM_000249.3(MLH1):c.2104-?_*(193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090057	3	37091977 - 37092337	3	37050486 - 37050846	90057	95531		
NM_000249.3(MLH1):c.2104-2A>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090055	3	37091975	3	37050484	90055	95529	rs267607889	NC_000003.12:37050483:A:T
NM_000249.3(MLH1):c.2101C>T (p.Gln701Ter)	MLH1	Q701*, Q360*, Q603*, Q646*, Q668*, Q343*, Q670*, Q460*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090043	3	37090506	3	37049015	90043	95517	rs63750114	NC_000003.12:37049014:C:T
NM_001258271.1(MLH1):c.1896+1330_1896+1333del	MLH1	Q459fs, Q645fs, Q667fs, Q359fs, Q602fs, Q669fs, Q342fs, Q700fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090041	3	37090504 - 37090507	3	37049013 - 37049016	90041	95515	rs63751652	NC_000003.12:37049012:AGCA:
NM_000249.3(MLH1):c.208-?_790+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090037					90037	95511		
NM_000249.3(MLH1):c.208-?_453+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090035					90035	95509		
NM_000249.3(MLH1):c.208-?_306+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090033					90033	95507		
NM_000249.3(MLH1):c.208-2A>G	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090031	3	37042444	3	37000953	90031	95505	rs267607716	NC_000003.12:37000952:A:G
NM_000249.3(MLH1):c.208-1_208del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090030	3	37042444 - 37042445	3	37000953 - 37000954	90030	95504	rs587778973	NC_000003.12:37000952:AGA:A
NM_000249.4(MLH1):c.208-1714_306+641delinsACATAGTA	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090028	3	37040732 - 37043185	3	36999241 - 37001694	90028	95502		
NM_000249.3(MLH1):c.2078_2172del (p.Glu693fs)	MLH1	E693fs, E335fs, E352fs, E638fs, E660fs, E452fs, E595fs, E662fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090026	3	37090481 - 37092043	3	37048990 - 37050552	90026	95500		
NM_001258271.1(MLH1):c.1896+1307_1896+1308del	MLH1	E352fs, E452fs, E662fs, E335fs, E595fs, E693fs, E638fs, E660fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090025	3	37090481 - 37090482	3	37048990 - 37048991	90025	95499	rs63750769	NC_000003.12:37048989:TG:
NM_000249.3(MLH1):c.207+1560_546-871del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090019	3	37039760 - 37052440	3	36998269 - 37010949	90019	95493		
NM_000249.3(MLH1):c.207+1245_884+523dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090018	3	37039445 - 37059613	3	36997954 - 37018122	90018	95492		
NM_001258271.1(MLH1):c.1896+1298_1896+1304del	MLH1	Q591fs, Q689fs, Q348fs, Q448fs, Q634fs, Q656fs, Q331fs, Q658fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090017	3	37090471 - 37090477	3	37048980 - 37048986	90017	95491	rs63750420	NC_000003.12:37048979:AGTACATA:A
NM_001167617.2(MLH1):c.-85del	MLH1	R69fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090015	3	37038198	3	36996707	90015	95489	rs63751704	NC_000003.12:36996706:A:
NM_000249.3(MLH1):c.2011G>T (p.Glu671Ter)	MLH1	E671*, E616*, E640*, E573*, E313*, E330*, E430*, E638*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089999	3	37090416	3	37048925	89999	95473	rs63750663	NC_000003.12:37048924:G:T
NM_001258271.1(MLH1):c.1896+1240del	MLH1	K572fs, K639fs, K637fs, K670fs, K329fs, K429fs, K615fs, K312fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089998	3	37090411	3	37048920	89998	95472	rs63750740	NC_000003.12:37048919:AAAA:AAA
NM_001258271.1(MLH1):c.1896+1231dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089995	3	37090404 - 37090405	3	37048913 - 37048914	89995	95469	rs63750282	NC_000003.12:37048913:A:AA
NM_001167617.2(MLH1):c.-498_-482del	MLH1	V7fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089993	3	37035057 - 37035073	3	36993566 - 36993582	89993	95467	rs267607702	NC_000003.12:36993565:GTTATTCGGCGGCTGGA:
NM_000249.3(MLH1):c.1990-?_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089989	3	37090395 - 37092337	3	37048904 - 37050846	89989	95463		
NM_001167617.2(MLH1):c.-92dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089982	3	37038189 - 37038190	3	36996698 - 36996699	89982	95456	rs587778966	NC_000003.12:36996698:CC:CCC
NM_001258271.1(MLH1):c.1896+925del	MLH1	E608fs, E322fs, E422fs, E663fs, E305fs, E565fs, E630fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089972	3	37090099	3	37048608	89972	95446	rs267607877	NC_000003.12:37048607:A:
NM_000249.3(MLH1):c.1986_1989+1delinsC	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089969	3	37090097 - 37090101	3	37048606 - 37048610	89969	95443	rs267607873	NC_000003.12:37048605:TGAGG:C
NM_001258271.1(MLH1):c.1896+913_1896+914del	MLH1	R604fs, R626fs, R318fs, R659fs, R561fs, R301fs, R418fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089967	3	37090087 - 37090088	3	37048596 - 37048597	89967	95441	rs63751200	NC_000003.12:37048595:GA:
NM_001258271.1(MLH1):c.1896+912_1896+913del	MLH1	R561fs, R301fs, R418fs, R318fs, R626fs, R659fs, R604fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089963	3	37090086 - 37090087	3	37048595 - 37048596	89963	95437	rs63750131	NC_000003.12:37048594:CG:
NM_001258271.1(MLH1):c.1896+908del	MLH1	L300fs, L317fs, L625fs, L658fs, L417fs, L560fs, L603fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089961	3	37090081	3	37048590	89961	95435	rs63750115	NC_000003.12:37048589:TT:T
NM_001167617.2(MLH1):c.-95del	MLH1	T66fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089958	3	37038188	3	36996697	89958	95432	rs267607715	NC_000003.12:36996696:C:
NM_001258271.1(MLH1):c.1896+890_1896+893del	MLH1	E293fs, E310fs, E410fs, E618fs, E553fs, E596fs, E651fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089956	3	37090061 - 37090064	3	37048570 - 37048573	89956	95430	rs63751301	NC_000003.12:37048569:GGAGGGA:GGA
NM_001258271.1(MLH1):c.1896+867del	MLH1	D546fs, D611fs, D303fs, D286fs, D403fs, D589fs, D644fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089950	3	37090041	3	37048550	89950	95424	rs587778962	NC_000003.12:37048549:G:
NM_000249.3(MLH1):c.1920_1921insT (p.Leu641fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089949	3	37090031 - 37090032	3	37048540 - 37048541	89949	95423	rs587778961	NC_000003.12:37048540::T
NM_001167617.2(MLH1):c.-99dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089948	3	37038182 - 37038183	3	36996691 - 36996692	89948	95422	rs63751255	NC_000003.12:36996691:AA:AAA
NM_001258271.1(MLH1):c.1896+853dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089944	3	37090025 - 37090026	3	37048534 - 37048535	89944	95418	rs587778960	NC_000003.12:37048534:TT:TTT
NM_001258271.1(MLH1):c.1896+851_1896+879dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089943	3	37090024 - 37090025	3	37048533 - 37048534	89943	95417	rs587778959	NC_000003.12:37048533:ATTACCCCTTCTGATTGACAACTATGTGC:ATTACCCCTTCTGATTGACAACTATGTGCATTACCCCTTCTGATTGACAACTATGTGC
NM_001167617.2(MLH1):c.-100_-99del	MLH1	N64fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089941	3	37038183 - 37038184	3	36996692 - 36996693	89941	95415	rs63750469	NC_000003.12:36996691:AA:
NM_001258271.1(MLH1):c.1896+841dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089938	3	37090013 - 37090014	3	37048522 - 37048523	89938	95412	rs587778957	NC_000003.12:37048522:AA:AAA
NM_001167617.2(MLH1):c.-499_-483del	MLH1	V7fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089935	3	37035054 - 37035070	3	36993563 - 36993579	89935	95409	rs63751892	NC_000003.12:36993562:GGGGTTATTCGGCGGCTGG:GG
NM_000249.3(MLH1):c.189C>A (p.Asp63Glu)	MLH1	D63E	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089934	3	37038182	3	36996691	89934	95408	rs587778955	NC_000003.12:36996690:C:A
NM_000249.3(MLH1):c.1897-?_1989+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089933					89933	95407		
NM_001354630.1(MLH1):c.1732-837del	MLH1	D598fs, D273fs, D290fs, D390fs, D533fs, D631fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089924	3	37089171	3	37047680	89924	95398	rs587778954	NC_000003.12:37047679:T:
NM_001354630.1(MLH1):c.1732-850_1732-847del	MLH1	S269fs, S386fs, S627fs, S286fs, S529fs, S594fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089921	3	37089157 - 37089160	3	37047666 - 37047669	89921	95395	rs587778953	NC_000003.12:37047665:TCTTT:T
NM_001354630.1(MLH1):c.1732-853_1732-847del	MLH1	F528fs, F593fs, F626fs, F285fs, F268fs, F385fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089916	3	37089153 - 37089159	3	37047662 - 37047668	89916	95390	rs63751594	NC_000003.12:37047661:TTTCTCTTT:TT
NM_000249.3(MLH1):c.1875T>G (p.Tyr625Ter)	MLH1	Y625*, Y527*, Y592*, Y384*, Y267*, Y284*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089914	3	37089153	3	37047662	89914	95388	rs63751415	NC_000003.12:37047661:T:G
NM_001354630.1(MLH1):c.1732-864del	MLH1	A282fs, A590fs, A623fs, A525fs, A265fs, A382fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089912	3	37089143	3	37047652	89912	95386	rs587778950	NC_000003.12:37047651:TT:T
NM_000249.3(MLH1):c.1852A>T (p.Lys618Ter)	MLH1	K618*, K277*, K520*, K260*, K585*, K377*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089904	3	37089130	3	37047639	89904	95378	rs35001569	NC_000003.12:37047638:A:T
NM_001354630.1(MLH1):c.1732-901_1732-898dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089898	3	37089104 - 37089105	3	37047613 - 37047614	89898	95372	rs587778948	NC_000003.12:37047613:ATACAT:ATACATACAT
NM_001354630.1(MLH1):c.1732-909dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089896	3	37089097 - 37089098	3	37047606 - 37047607	89896	95370	rs587778947	NC_000003.12:37047606:TT:TTT
NM_001354630.1(MLH1):c.1732-918dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089894	3	37089087 - 37089088	3	37047596 - 37047597	89894	95368	rs63751240	NC_000003.12:37047596:AAA:AAAA
NM_001354630.1(MLH1):c.1732-930_1732-912del	MLH1	E359fs, E502fs, E567fs, E242fs, E259fs, E600fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089891	3	37089074 - 37089092	3	37047583 - 37047601	89891	95365	rs587778946	NC_000003.12:37047582:AGGAAGATGGTCCCAAAGAAGGA:AGGA
NM_001354630.1(MLH1):c.1732-961del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089885	3	37089046	3	37047555	89885	95359	rs63749979	NC_000003.12:37047554:TT:T
NM_001354630.1(MLH1):c.1732-966del	MLH1	A556fs, A348fs, A231fs, A248fs, A589fs, A491fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089883	3	37089041	3	37047550	89883	95357	rs63751486	NC_000003.12:37047549:TT:T
NM_001167617.2(MLH1):c.-115dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089880	3	37038167 - 37038168	3	36996676 - 36996677	89880	95354	rs587778944	NC_000003.12:36996676:A:AA
NM_001354630.1(MLH1):c.1732-972del	MLH1	M246fs, M346fs, M489fs, M554fs, M587fs, M229fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089878	3	37089035	3	37047544	89878	95352	rs63749863	NC_000003.12:37047543:CC:C
NM_001354630.1(MLH1):c.1732-981del	MLH1	F225fs, F242fs, F550fs, F485fs, F342fs, F583fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089874	3	37089025	3	37047534	89874	95348	rs63750309	NC_000003.12:37047533:TTT:TT
NM_001354630.1(MLH1):c.1732-982_1732-981del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089873	3	37089025 - 37089026	3	37047534 - 37047535	89873	95347	rs63750309	NC_000003.12:37047533:TTT:T
NM_001354630.1(MLH1):c.1732-985del	MLH1	L224fs, L582fs, L549fs, L484fs, L241fs, L341fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089872	3	37089023	3	37047532	89872	95346	rs587778942	NC_000003.12:37047531:T:
NM_000249.3(MLH1):c.1745T>C (p.Leu582Pro)	MLH1	L582P, L484P, L549P, L341P, L224P, L241P	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089871	3	37089023	3	37047532	89871	95345	rs63751616	NC_000003.12:37047531:T:C
NM_000249.3(MLH1):c.1732-?_2103+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089867					89867	95341		
NM_000249.3(MLH1):c.1732-2A>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089862	3	37089008	3	37047517	89862	95336	rs267607852	NC_000003.12:37047516:A:T
NM_000249.3(MLH1):c.1732-2243_1896+404del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089860	3	37086767 - 37089578	3	37045276 - 37048087	89860	95334		
NM_000249.3(MLH1):c.1732-1G>A	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089859	3	37089009	3	37047518	89859	95333	rs267607854	NC_000003.12:37047517:G:A
NM_000249.3(MLH1):c.1731+768_1897-222del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089856	3	37084590 - 37089786	3	37043099 - 37048295	89856	95330		
NM_000249.3(MLH1):c.1731+270_1896+73del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089851	3	37084092 - 37089247	3	37042601 - 37047756	89851	95325		
NM_001167617.2(MLH1):c.1431del (p.Arg477fs)	MLH1	R217fs, R542fs, R334fs, R234fs, R477fs, R575fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089847	3	37083815	3	37042324	89847	95321	rs63751685	NC_000003.12:37042323:GG:G
NM_000249.3(MLH1):c.1715_1716GT[1] (p.Val573fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089845	3	37083806 - 37083807	3	37042315 - 37042316	89845	95319	rs63751709	NC_000003.12:37042314:GTGT:GT
NM_001167617.2(MLH1):c.1395dup (p.Leu466fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089840	3	37083779 - 37083780	3	37042288 - 37042289	89840	95314	rs63750464	NC_000003.12:37042288:A:AA
NM_000249.3(MLH1):c.1684C>T (p.Gln562Ter)	MLH1	Q562*, Q204*, Q464*, Q529*, Q321*, Q221*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089839	3	37083775	3	37042284	89839	95313	rs63751460	NC_000003.12:37042283:C:T
NM_000249.3(MLH1):c.1672G>T (p.Glu558Ter)	MLH1	E558*, E200*, E217*, E317*, E460*, E525*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089835	3	37083763	3	37042272	89835	95309	rs63751081	NC_000003.12:37042271:G:T
NM_001167617.2(MLH1):c.1374del (p.Ser458fs)	MLH1	S523fs, S198fs, S215fs, S458fs, S556fs, S315fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089833	3	37083759	3	37042268	89833	95307	rs587778939	NC_000003.12:37042267:T:
NM_000249.3(MLH1):c.1668-?_1896+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089832					89832	95306		
NM_000249.3(MLH1):c.1668-?_1731+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089831					89831	95305		
NM_000249.3(MLH1):c.1667G>T (p.Ser556Ile)	MLH1	S556I, S315I, S523I, S458I, S198I, S215I	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089825	3	37081785	3	37040294	89825	95299	rs63751596	NC_000003.12:37040293:G:T
NM_000249.3(MLH1):c.1664_1665insAAGT (p.Ser556_Glu557insTer)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089823	3	37081781 - 37081782	3	37040290 - 37040291	89823	95297	rs267607699	NC_000003.12:37040290:T:TAAGT
NM_000249.3(MLH1):c.1644C>G (p.Tyr548Ter)	MLH1	Y548*, Y207*, Y307*, Y450*, Y190*, Y515*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089815	3	37081762	3	37040271	89815	95289	rs63751087	NC_000003.12:37040270:C:G
NM_000249.3(MLH1):c.1640T>A (p.Leu547Ter)	MLH1	L547*, L306*, L514*, L189*, L206*, L449*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089814	3	37081758	3	37040267	89814	95288	rs63750300	NC_000003.12:37040266:T:A
NM_001167617.2(MLH1):c.1328del (p.Ala443fs)	MLH1	A183fs, A300fs, A508fs, A443fs, A200fs, A541fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089808	3	37081740	3	37040249	89808	95282	rs63750824	NC_000003.12:37040248:C:
NM_001167617.2(MLH1):c.1326_1327del (p.Leu442fs)	MLH1	L199fs, L299fs, L540fs, L182fs, L442fs, L507fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089807	3	37081738 - 37081739	3	37040247 - 37040248	89807	95281	rs63750036	NC_000003.12:37040246:GG:
NM_001167617.2(MLH1):c.-129del	MLH1	G54fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089806	3	37038152	3	36996661	89806	95280	rs63751266	NC_000003.12:36996660:GGG:GG
NM_001167617.2(MLH1):c.-133_-130GAGG[1]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089805	3	37038150 - 37038153	3	36996659 - 36996662	89805	95279	rs587778932	NC_000003.12:36996658:GAGGGAGG:GAGG
NM_000249.3(MLH1):c.1614G>A (p.Trp538Ter)	MLH1	W538*, W440*, W180*, W197*, W297*, W505*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089803	3	37081732	3	37040241	89803	95277	rs267607842	NC_000003.12:37040240:G:A
NM_000249.3(MLH1):c.1609C>T (p.Gln537Ter)	MLH1	Q537*, Q296*, Q504*, Q439*, Q179*, Q196*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089801	3	37081727	3	37040236	89801	95275	rs63751277	NC_000003.12:37040235:C:T
NM_001167617.2(MLH1):c.-502_-489del	MLH1	G6fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089800	3	37035050 - 37035063	3	36993559 - 36993572	89800	95274	rs63751891	NC_000003.12:36993558:GGCAGGGGTTATTCGGC:GGC
NM_001167617.2(MLH1):c.1298_1299del (p.Val433fs)	MLH1	V173fs, V290fs, V531fs, V190fs, V433fs, V498fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089799	3	37081709 - 37081710	3	37040218 - 37040219	89799	95273	rs587778931	NC_000003.12:37040217:GTG:G
NM_000249.3(MLH1):c.1574T>A (p.Leu525Ter)	MLH1	L525*, L427*, L184*, L492*, L167*, L284*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089797	3	37081692	3	37040201	89797	95271	rs587778929	NC_000003.12:37040200:T:A
NM_001167617.2(MLH1):c.1279_1280del (p.Leu427fs)	MLH1	L525fs, L184fs, L427fs, L492fs, L167fs, L284fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089796	3	37081691 - 37081692	3	37040200 - 37040201	89796	95270	rs63751613	NC_000003.12:37040199:TT:
NM_001167617.2(MLH1):c.1278_1279del (p.Met426fs)	MLH1	M491fs, M183fs, M283fs, M426fs, M524fs, M166fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089795	3	37081689 - 37081690	3	37040198 - 37040199	89795	95269	rs587778928	NC_000003.12:37040197:TGT:T
NM_000249.3(MLH1):c.1559-?_1731+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089789					89789	95263		
NM_000249.3(MLH1):c.1559-?_1667+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089788					89788	95262		
NM_000249.3(MLH1):c.1559-?_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089787	3	37081677 - 37092337	3	37040186 - 37050846	89787	95261		
NM_000249.3(MLH1):c.1559-2A>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089784	3	37081675	3	37040184	89784	95258	rs267607836	NC_000003.12:37040183:A:T
NM_000249.3(MLH1):c.1559-1322_1668-391del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089778	3	37080354 - 37083367	3	37038863 - 37041876	89778	95252		
NM_000249.3(MLH1):c.1558+1G>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089772	3	37070424	3	37028933	89772	95246	rs267607832	NC_000003.12:37028932:G:T
NM_000249.3(MLH1):c.1557_1558insT (p.Val520fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089769	3	37070422 - 37070423	3	37028931 - 37028932	89769	95243	rs587778926	NC_000003.12:37028931::T
NM_001167617.2(MLH1):c.1258del (p.His420fs)	MLH1	H420fs, H518fs, H277fs, H160fs, H177fs, H485fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089767	3	37070417	3	37028926	89767	95241	rs587778925	NC_000003.12:37028925:C:
NM_000249.3(MLH1):c.1552_1553insT (p.His518fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089766	3	37070417 - 37070418	3	37028926 - 37028927	89766	95240	rs587778924	NC_000003.12:37028926::T
NM_000249.3(MLH1):c.1549G>T (p.Gly517Ter)	MLH1	G517*, G176*, G484*, G419*, G159*, G276*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089765	3	37070414	3	37028923	89765	95239	rs63751705	NC_000003.12:37028922:G:T
NM_001167617.2(MLH1):c.1248dup (p.Glu417Ter)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089764	3	37070406 - 37070407	3	37028915 - 37028916	89764	95238	rs63750317	NC_000003.12:37028915:T:TT
NM_001167617.2(MLH1):c.-137dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089763	3	37038144 - 37038145	3	36996653 - 36996654	89763	95237	rs587778922	NC_000003.12:36996653:TT:TTT
NM_000249.3(MLH1):c.1534G>T (p.Glu512Ter)	MLH1	E512*, E171*, E271*, E154*, E414*, E479*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089762	3	37070399	3	37028908	89762	95236	rs63751472	NC_000003.12:37028907:G:T
NM_001167617.2(MLH1):c.1226dup (p.Leu409fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089759	3	37070381 - 37070382	3	37028890 - 37028891	89759	95233	rs63749916	NC_000003.12:37028890:TTTT:TTTTT
NM_001167617.2(MLH1):c.1226del (p.Val408_Leu409insTer)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089758	3	37070382	3	37028891	89758	95232	rs63749916	NC_000003.12:37028890:TTTT:TTT
NM_001167617.2(MLH1):c.-140dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089756	3	37038141 - 37038142	3	36996650 - 36996651	89756	95230	rs63749956	NC_000003.12:36996650:TT:TTT
NM_001167617.2(MLH1):c.1197del (p.Arg400fs)	MLH1	R140fs, R257fs, R400fs, R465fs, R157fs, R498fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089754	3	37070355	3	37028864	89754	95228	rs63751435	NC_000003.12:37028863:GG:G
NM_000249.3(MLH1):c.146T>A (p.Val49Glu)	MLH1	V49E	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089749	3	37038139	3	36996648	89749	95223	rs63750098	NC_000003.12:36996647:T:A
NM_001167617.2(MLH1):c.1170_1174del (p.Lys390fs)	MLH1	K390fs, K455fs, K130fs, K147fs, K247fs, K488fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089748	3	37070325 - 37070329	3	37028834 - 37028838	89748	95222	rs587778919	NC_000003.12:37028833:GAAAGGAAA:GAAA
NM_001167617.2(MLH1):c.1169del (p.Lys390fs)	MLH1	K390fs, K455fs, K130fs, K147fs, K247fs, K488fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089747	3	37070326	3	37028835	89747	95221	rs63749876	NC_000003.12:37028834:AAA:AA
NM_000249.3(MLH1):c.1462A>T (p.Lys488Ter)	MLH1	K488*, K130*, K390*, K247*, K455*, K147*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089746	3	37070327	3	37028836	89746	95220	rs587778918	NC_000003.12:37028835:A:T
NM_001167617.2(MLH1):c.1155del (p.Asp386fs)	MLH1	D243fs, D451fs, D143fs, D386fs, D126fs, D484fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089740	3	37070313	3	37028822	89740	95214	rs587778915	NC_000003.12:37028821:AA:A
NM_001167617.2(MLH1):c.1126del (p.Arg376fs)	MLH1	R133fs, R233fs, R474fs, R441fs, R116fs, R376fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089736	3	37070285	3	37028794	89736	95210	rs63750482	NC_000003.12:37028793:C:
NM_001167617.2(MLH1):c.1121_1133del (p.Arg374fs)	MLH1	R131fs, R231fs, R374fs, R114fs, R439fs, R472fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089734	3	37070276 - 37070288	3	37028785 - 37028797	89734	95208	rs587778912	NC_000003.12:37028784:AAGAGACATCGGGAAGA:AAGA
NM_001167617.2(MLH1):c.1120dup (p.Arg374fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089731	3	37070278 - 37070279	3	37028787 - 37028788	89731	95205	rs63751468	NC_000003.12:37028787:A:AA
NM_001167617.2(MLH1):c.1119_1122del (p.Lys373fs)	MLH1	K230fs, K130fs, K471fs, K373fs, K113fs, K438fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089730	3	37070277 - 37070280	3	37028786 - 37028789	89730	95204	rs281864936	NC_000003.12:37028785:AGAGA:A
NM_001167617.2(MLH1):c.1118dup (p.Arg374fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089728	3	37070274 - 37070275	3	37028783 - 37028784	89728	95202	rs63751677	NC_000003.12:37028783:AAA:AAAA
NM_000249.3(MLH1):c.1410-?_1731+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089726					89726	95200		
NM_000249.3(MLH1):c.1410-?_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089725					89725	95199		
NM_000249.3(MLH1):c.1410-?_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089724	3	37070275 - 37092337	3	37028784 - 37050846	89724	95198		
NM_000249.3(MLH1):c.1409+1G>C	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089719	3	37067499	3	37026008	89719	95193	rs267607825	NC_000003.12:37026007:G:C
NM_000249.3(MLH1):c.1409+1156_1558+1385del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089717	3	37068654 - 37071808	3	37027163 - 37030317	89717	95191		
NM_000249.3(MLH1):c.1409+1127_1558+4255del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089716	3	37068625 - 37074678	3	37027134 - 37033187	89716	95190		
NM_001167617.2(MLH1):c.1083del (p.Glu362fs)	MLH1	E119fs, E219fs, E102fs, E460fs, E362fs, E427fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089708	3	37067466	3	37025975	89708	95182	rs587778908	NC_000003.12:37025974:A:
NM_001167617.2(MLH1):c.1068dup (p.Thr357fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089707	3	37067447 - 37067448	3	37025956 - 37025957	89707	95181	rs267607821	NC_000003.12:37025956:GGGG:GGGGG
NM_001167617.2(MLH1):c.1060del (p.Thr354fs)	MLH1	T211fs, T111fs, T94fs, T419fs, T452fs, T354fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089704	3	37067442	3	37025951	89704	95178	rs63750071	NC_000003.12:37025950:AA:A
NM_001167617.2(MLH1):c.1054dup (p.Asp352fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089703	3	37067432 - 37067433	3	37025941 - 37025942	89703	95177	rs587778906	NC_000003.12:37025941:GGGGG:GGGGGG
NM_000249.4(MLH1):c.1347_1367delinsTAAA (p.Asp450fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089702	3	37067436 - 37067456	3	37025945 - 37025965	89702	95176	rs587778905	NC_000003.12:37025944:GGATACAACAAAGGGGACTTC:TAAA
NM_001167617.2(MLH1):c.1049del (p.Glu350fs)	MLH1	E415fs, E448fs, E207fs, E350fs, E107fs, E90fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089701	3	37067432	3	37025941	89701	95175	rs63749981	NC_000003.12:37025940:A:
NM_001167617.2(MLH1):c.1040del (p.Gln347fs)	MLH1	Q104fs, Q347fs, Q87fs, Q412fs, Q204fs, Q445fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089699	3	37067423	3	37025932	89699	95173	rs63749845	NC_000003.12:37025931:A:
NM_000249.3(MLH1):c.1325_1346del22ins5	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089697	3	37067414 - 37067435	3	37025923 - 37025944	89697	95171		
NM_001167617.2(MLH1):c.1016del (p.Pro339fs)	MLH1	P196fs, P437fs, P96fs, P79fs, P339fs, P404fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089695	3	37067396	3	37025905	89695	95169	rs63750748	NC_000003.12:37025904:CCCC:CCC
NM_001167617.2(MLH1):c.-162_-159dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089692	3	37038120 - 37038121	3	36996629 - 36996630	89692	95166	rs63751431	NC_000003.12:36996629:AATC:AATCAATC
NM_001167617.2(MLH1):c.967del (p.Ser323fs)	MLH1	S63fs, S323fs, S180fs, S80fs, S388fs, S421fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089689	3	37067350	3	37025859	89689	95163	rs63750293	NC_000003.12:37025858:A:
NM_001167617.2(MLH1):c.924del (p.Gln309fs)	MLH1	Q309fs, Q374fs, Q407fs, Q66fs, Q166fs, Q49fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089681	3	37067307	3	37025816	89681	95155	rs587778900	NC_000003.12:37025815:T:
NM_001167617.2(MLH1):c.923_929dup (p.Gln311fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089680	3	37067305 - 37067306	3	37025814 - 37025815	89680	95154	rs587778899	NC_000003.12:37025814:GTCAGCC:GTCAGCCGTCAGCC
NM_001167617.2(MLH1):c.916dup (p.Leu306fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089679	3	37067295 - 37067296	3	37025804 - 37025805	89679	95153	rs587778898	NC_000003.12:37025804:CCCC:CCCCC
NM_000249.3(MLH1):c.1192C>T (p.Gln398Ter)	MLH1	Q398*, Q157*, Q300*, Q57*, Q365*, Q40*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089674	3	37067281	3	37025790	89674	95148	rs63750483	NC_000003.12:37025789:C:T
NM_000249.3(MLH1):c.117-?_545+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089671					89671	95145		
NM_000249.3(MLH1):c.117-?_380+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089670					89670	95144		
NM_000249.3(MLH1):c.117-?_207+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089668					89668	95142		
NM_000249.3(MLH1):c.117-707_545+1338delinsTCCCGGGTTCAAGCGATTCT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089667	3	37037403 - 37051734	3	36995912 - 37010243	89667	95141		
NM_000249.3(MLH1):c.117-691_306+1011del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089666	3	37037419 - 37043555	3	36995928 - 37002064	89666	95140		
NM_000249.3(MLH1):c.1163_1164ins4	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089660	3	37067252 - 37067253	3	37025761 - 37025762	89660	95134		
NM_001167617.2(MLH1):c.856del (p.Val286fs)	MLH1	V286fs, V384fs, V43fs, V351fs, V143fs, V26fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089652	3	37067238	3	37025747	89652	95126	rs63749965	NC_000003.12:37025746:GG:G
NM_000249.3(MLH1):c.114C>G (p.Asn38Lys)	MLH1	N38K	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089651	3	37035152	3	36993661	89651	95125	rs267607706	NC_000003.12:36993660:C:G
NM_001167617.2(MLH1):c.851dup (p.Met285fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089650	3	37067233 - 37067234	3	37025742 - 37025743	89650	95124	rs587778889	NC_000003.12:37025742:A:AA
NM_001167617.2(MLH1):c.838_840delinsA (p.Val280fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089647	3	37067221 - 37067223	3	37025730 - 37025732	89647	95121	rs587778887	NC_000003.12:37025729:GTC:A
NM_001167617.2(MLH1):c.834_835dup (p.Lys279fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089644	3	37067215 - 37067216	3	37025724 - 37025725	89644	95118	rs63750305	NC_000003.12:37025724:ATA:ATATA
NM_001167617.2(MLH1):c.807del (p.Ser270fs)	MLH1	S10fs, S127fs, S335fs, S368fs, S27fs, S270fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089642	3	37067189	3	37025698	89642	95116	rs63750715	NC_000003.12:37025697:CC:C
NM_000249.3(MLH1):c.109G>T (p.Glu37Ter)	MLH1	E37*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089641	3	37035147	3	36993656	89641	95115	rs63751012	NC_000003.12:36993655:G:T
NM_001354624.1(MLH1):c.-3del	MLH1	E117fs, E325fs, E358fs, E17fs, E260fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089637	3	37067158	3	37025667	89637	95111	rs587778885	NC_000003.12:37025666:GGGG:GGG
NM_001354624.1(MLH1):c.-4_4del (p.Met1fs)	MLH1	M1fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089636	3	37067157 - 37067164	3	37025666 - 37025673	89636	95110	rs587778884	NC_000003.12:37025665:TGGGGAGATGG:TGG
NM_001354624.1(MLH1):c.-14del	MLH1	G256fs, G321fs, G354fs, G113fs, G13fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089635	3	37067149	3	37025658	89635	95109	rs63750472	NC_000003.12:37025657:GG:G
NM_000249.3(MLH1):c.104_105insAA (p.Met35fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089632	3	37035142 - 37035143	3	36993651 - 36993652	89632	95106	rs587778882	NC_000003.12:36993651::AA
NM_000249.3(MLH1):c.1039-?_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089626	3	37067128 - 37092337	3	37025637 - 37050846	89626	95100		
NM_000249.3(MLH1):c.1039-674_1409+27del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089624	3	37066452 - 37067523	3	37024961 - 37026032	89624	95098		
NM_000249.3(MLH1):c.1039-2329_1409+827del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089620	3	37064799 - 37068325	3	37023308 - 37026834	89620	95094		
NM_000249.3(MLH1):c.1038G>T (p.Gln346His)	MLH1	Q346H, Q105H, Q5H, Q248H, Q313H	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089618	3	37061954	3	37020463	89618	95092	rs63751715	NC_000003.12:37020462:G:T
NM_000249.3(MLH1):c.1038G>C (p.Gln346His)	MLH1	Q346H, Q105H, Q5H, Q248H, Q313H	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089617	3	37061954	3	37020463	89617	95091	rs63751715	NC_000003.12:37020462:G:C
NM_000249.3(MLH1):c.1037A>G (p.Gln346Arg)	MLH1	Q346R, Q248R, Q313R, Q105R, Q5R	Lynch syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000089610	3	37061953	3	37020462	89610	95084	rs63751609	NC_000003.12:37020461:A:G
NM_001167617.2(MLH1):c.-417_-416GA[1]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089609	3	37035137 - 37035138	3	36993646 - 36993647	89609	95083	rs63749813	NC_000003.12:36993645:AGAGA:AGA
NM_001354624.1(MLH1):c.-36-5186dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089608	3	37061941 - 37061942	3	37020450 - 37020451	89608	95082	rs587778881	NC_000003.12:37020450:G:GG
NM_001354621.1(MLH1):c.-17del	MLH1	G238fs, G336fs, G303fs, G95fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089602	3	37061921	3	37020430	89602	95076	rs63750434	NC_000003.12:37020429:GGG:GG
NM_000249.3(MLH1):c.-73960_*46597del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089598					89598	95072		
NM_000249.3(MLH1):c.-381_207+606del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089592	3	37034658 - 37038806	3	36993167 - 36997315	89592	95066		
NM_000249.3(MLH1):c.(?_-198)_884+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089583	3	37034841 - 37059090	3	36993350 - 37017599	89583	95057		
NM_000249.3(MLH1):c.(?_-198)_545+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089582	3	37034841 - 37050396	3	36993350 - 37008905	89582	95056		
MLH1:c.(?_-198)_306+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089581	3	37034841 - 37042544	3	36993350 - 37001053	89581	95055		
MLH1:c.(?_-198)_207+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089580	3	37034841 - 37038200	3	36993350 - 36996709	89580	95054		
NM_000249.3(MLH1):c.(?_-198)_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089579	3	37034840 - 37070424	3	36993349 - 37028933	89579	95053		
NM_000249.3(MLH1):c.(?_-198)_(*193_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089576	3	37034841 - 37092337	3	36993350 - 37050846	89576	95050		
NM_004321.7(KIF1A):c.799G>A (p.Glu267Lys)	KIF1A	E267K	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000521233	2	241722526	2	240783109	521233	511411	rs1553637932	NC_000002.12:240783108:C:T
NM_004321.7(KIF1A):c.350G>T (p.Gly117Val)	KIF1A	G117V	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000520815	2	241727481	2	240788064	520815	511413	rs1200817308	NC_000002.12:240788063:C:A
NM_000094.3(COL7A1):c.425A>G (p.Lys142Arg)	COL7A1	K142R	Dystrophic epidermolysis bullosa|Epidermolysis bullosa dystrophica inversa, autosomal recessive|Recessive dystrophic epidermolysis bullosa|Recessive dystrophic epidermolysis bullosa|Dominant dystrophic epidermolysis bullosa with absence of skin|Pretibial epidermolysis bullosa|Nail disorder, nonsyndromic congenital, 8|Transient bullous dermolysis of the newborn|Generalized dominant dystrophic epidermolysis bullosa|Epidermolysis bullosa pruriginosa|Anonychia|Epidermolysis bullosa dystrophica, AD, Epidermolysis bullosa dystrophica, AR|Nail dystrophy|Abnormality of the skin|Skin erosion|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029636	3	48630971	3	48593538	29636	38590	rs121912856	NC_000003.12:48593537:T:C
NM_000112.3(SLC26A2):c.1957T>A (p.Cys653Ser)	SLC26A2	C653S	|Osteochondrodysplasia|||Diastrophic dysplasia|not specified|not provided|Achondrogenesis, type IB|Achondrogenesis, type IB|||Diastrophic dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004098	5	149361113	5	149981550	4098	19137	rs104893924	NC_000005.10:149981549:T:A
NM_004415.4(DSP):c.3337C>T (p.Arg1113Ter)	DSP	R1113*	DSP-Related Disorders|not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Long QT syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000405247	6	7579760	6	7579527	405247	395447	rs746877365	NC_000006.12:7579526:C:T
NM_000249.3(MLH1):c.790+5G>A	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619561	3	37056040	3	37014549	619561	610984	rs267607771	NC_000003.12:37014548:G:A
NM_000249.3(MLH1):c.453+2T>G	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619557	3	37048556	3	37007065	619557	610980	rs267607751	NC_000003.12:37007064:T:G
NM_000249.3(MLH1):c.380+1G>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619556	3	37045966	3	37004475	619556	610979	rs267607745	NC_000003.12:37004474:G:T
NM_000249.3(MLH1):c.1979T>C (p.Leu660Pro)	MLH1	L660P, L319P, L419P, L562P, L627P, L302P, L605P	Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619553	3	37090090	3	37048599	619553	610960	rs1559591546	NC_000003.12:37048598:T:C
NM_000249.3(MLH1):c.2104-1G>A	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619515	3	37091976	3	37050485	619515	610987	rs587778978	NC_000003.12:37050484:G:A
NM_001354621.1(MLH1):c.-139-2802_-139-2801delinsGT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619508	3	37058999 - 37059000	3	37017508 - 37017509	619508	610954	rs1559539068	NC_000003.12:37017507:CG:GT
NM_000249.3(MLH1):c.131C>A (p.Ser44Tyr)	MLH1	S44Y	Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619504	3	37038124	3	36996633	619504	610950	rs63751109	NC_000003.12:36996632:C:A
NM_000249.3(MLH1):c.113A>C (p.Asn38Thr)	MLH1	N38T	Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619503	3	37035151	3	36993660	619503	610949	rs587778888	NC_000003.12:36993659:A:C
NM_001258271.1(MLH1):c.1896+1240_1896+1244del	MLH1	K572fs, K639fs, K637fs, K670fs, K312fs, K329fs, K429fs, K615fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433871	3	37090412 - 37090416	3	37048921 - 37048925	433871	427223	rs1553664353	NC_000003.12:37048920:AAAGGAA:AA
NM_000249.3(MLH1):c.1558+1dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	criteria provided, single submitter	VCV000433868	3	37070421 - 37070422	3	37028930 - 37028931	433868	427220	rs1553653237	NC_000003.12:37028930:GGG:GGGG
NM_000249.3(MLH1):c.1358dup (p.Thr455fs)	MLH1		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433867	3	37067444 - 37067445	3	37025953 - 37025954	433867	427219	rs1553651429	NC_000003.12:37025953:AAA:AAAA
NM_001167617.2(MLH1):c.1031_1052delinsATTTT (p.Ala344fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000433866	3	37067414 - 37067435	3	37025923 - 37025944	433866	427218	rs587778903	NC_000003.12:37025922:CCAAAAATCAGAGCTTGGAGGG:ATTTT
NM_000249.3(MLH1):c.963_1014dup (p.Ser339fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000433861	3	37061878 - 37061879	3	37020387 - 37020388	433861	427213	rs1553648058	
NM_001354621.1(MLH1):c.-118_-117TG[1]	MLH1		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433859	3	37061822 - 37061823	3	37020331 - 37020332	433859	427211	rs1553647947	NC_000003.12:37020330:TGTG:TG
NM_000249.3(MLH1):c.898_908del (p.Pro300fs)	MLH1	P202fs, P267fs, P300fs, P59fs	Lynch syndrome	Pathogenic(Last reviewed: Nov 26, 2014)	criteria provided, single submitter	VCV000433858	3	37061812 - 37061822	3	37020321 - 37020331	433858	427210	rs1553647928	NC_000003.12:37020320:GTCCCCAGAATGT:GT
NM_000249.3(MLH1):c.827_831del (p.Ile276fs)	MLH1	I35fs, I243fs, I276fs, I178fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433857	3	37059032 - 37059036	3	37017541 - 37017545	433857	427209	rs1553646669	NC_000003.12:37017540:ATAGAA:A
NM_001354621.1(MLH1):c.-140+2408_-140+2410del	MLH1		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433855	3	37055998 - 37056000	3	37014507 - 37014509	433855	427207	rs1553645256	NC_000003.12:37014506:CTC:
NM_001167618.2(MLH1):c.-120del	MLH1	A104fs, A169fs, A202fs	Lynch syndrome	Pathogenic(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	VCV000433853	3	37053517	3	37012026	433853	427205	rs1553644155	NC_000003.12:37012025:G:
NM_001167618.2(MLH1):c.-232del	MLH1	A132fs, A67fs, A165fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000433852	3	37050340	3	37008849	433852	427204	rs1553642698	NC_000003.12:37008848:AAAA:AAA
NM_000249.3(MLH1):c.322_335del (p.Ser108fs)	MLH1	S108fs, S10fs, S75fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433850	3	37045906 - 37045919	3	37004415 - 37004428	433850	427201	rs1553641269	NC_000003.12:37004414:AAGCCATGTGGCTCA:A
NM_000249.3(MLH1):c.306+2T>G	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Nov 13, 2012)	criteria provided, single submitter	VCV000433849	3	37042546	3	37001055	433849	427200	rs1553640340	NC_000003.12:37001054:T:G
NM_000249.3(MLH1):c.381-?_677+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000433579	3	37048482 - 37053590			433579	427195		
NM_000249.3(MLH1):c.307-?_1667+?dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 9, 2013)	criteria provided, single submitter	VCV000433578	3	37045892 - 37081785			433578	427194		
NM_000249.3(MLH1):c.1559-?_1667+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000417353	3	37081677 - 37081785	3	37040186 - 37040294	417353	393506		
NM_000249.3(MLH1):c.(?_-198)_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000417352	3	37034841 - 37070423	3	36993350 - 37028932	417352	393134		
NC_000003.11:g.(?_37038110)_(37042544_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000417351	3	37038110 - 37042544	3	36996619 - 37001053	417351	393313		
NM_000249.3(MLH1):c.1410-?_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000417350	3	37070275 - 37070423	3	37028784 - 37028932	417350	393149		
NM_000249.3(MLH1):c.208-?_306+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000417348	3	37042446 - 37042544	3	37000955 - 37001053	417348	393316		
NM_001167617.2(MLH1):c.-161dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000405427	3	37038118 - 37038119	3	36996627 - 36996628	405427	393649	rs63750867	NC_000003.12:36996627:AAAA:AAAAA
NM_001354624.1(MLH1):c.-28dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000405419	3	37067135 - 37067136	3	37025644 - 37025645	405419	393460	rs1060500707	NC_000003.12:37025644:A:AA
NM_000249.3(MLH1):c.2136del (p.Ser711_Trp712insTer)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000405416	3	37092008	3	37050517	405416	393550	rs1060500706	NC_000003.12:37050516:GG:G
NM_001354624.1(MLH1):c.-32del	MLH1	L348fs, L7fs, L315fs, L107fs, L250fs	Lynch syndrome	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000405412	3	37067130	3	37025639	405412	393871	rs1060500703	NC_000003.12:37025638:TTT:TT
NM_001354624.1(MLH1):c.-3_4del (p.Met1fs)	MLH1	E358fs, M1fs, E117fs, E325fs, E260fs, E17fs	Lynch syndrome	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000405395	3	37067159 - 37067165	3	37025668 - 37025674	405395	393880	rs1060500692	NC_000003.12:37025667:GGGAGATGG:GG
NM_001354630.1(MLH1):c.1732-877dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000405386	3	37089129 - 37089130	3	37047638 - 37047639	405386	393896	rs1060500687	NC_000003.12:37047638:AA:AAA
NM_001354621.1(MLH1):c.-65_-64AG[3]	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	VCV000237352	3	37061873 - 37061874	3	37020382 - 37020383	237352	239161	rs878853794	NC_000003.12:37020382:GAGAG:GAGAGAG
NM_001354621.1(MLH1):c.-139-2769dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Nov 27, 2015)	criteria provided, single submitter	VCV000237348	3	37059031 - 37059032	3	37017540 - 37017541	237348	239157	rs878853792	NC_000003.12:37017540:A:AA
NM_001167617.2(MLH1):c.-479dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	VCV000237338	3	37035075 - 37035076	3	36993584 - 36993585	237338	239142	rs63750057	NC_000003.12:36993584:A:AA
NM_000249.3(MLH1):c.1441del (p.Met481fs)	MLH1	M240fs, M123fs, M140fs, M448fs, M383fs, M481fs	Lynch syndrome	Pathogenic(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000237313	3	37070304	3	37028813	237313	239173	rs878853777	NC_000003.12:37028812:AAA:AA
NM_001167618.2(MLH1):c.-18_2del (p.Met1fs)	MLH1	K236fs, M1fs, K138fs, K203fs	Lynch syndrome	Pathogenic(Last reviewed: Jun 13, 2015)	criteria provided, single submitter	VCV000216050	3	37055949 - 37055968	3	37014458 - 37014477	216050	212300	rs863224480	NC_000003.12:37014457:ATAAAACCCTAGCCTTCAAAAT:AT
NM_000249.3(MLH1):c.1912G>T (p.Gly638Ter)	MLH1	G638*, G280*, G583*, G397*, G605*, G297*, G540*	Lynch syndrome	Pathogenic(Last reviewed: May 11, 2015)	criteria provided, single submitter	VCV000216048	3	37090023	3	37048532	216048	212328	rs63750549	NC_000003.12:37048531:G:T
NM_001354621.1(MLH1):c.-139-2735del	MLH1	N254fs, N287fs, N189fs, N46fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090398	3	37059062	3	37017571	90398	95872	rs63750034	NC_000003.12:37017570:AAAAA:AAAA
NM_000249.3(MLH1):c.790+3A>T	MLH1		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000090362	3	37056038	3	37014547	90362	95836	rs267607792	NC_000003.12:37014546:A:T
NM_000249.3(MLH1):c.454-?_1409+?dup	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000090238	3	37050305 - 37067498	3	37008814 - 37026007	90238	95712		
NM_000551.3(VHL):c.262T>C (p.Trp88Arg)	VHL	W88R	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496053	3	10183793	3	10142109	496053	487013	rs1553619431	NC_000003.12:10142108:T:C
NM_001904.4(CTNNB1):c.133T>C (p.Ser45Pro)	CTNNB1	S45P, S38P	Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cutaneous melanoma|Malignant melanoma of skin|Disease|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adrenocortical carcinoma|not provided|Lung adenocarcinoma|Hepatocellular carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017589	3	41266136	3	41224645	17589	32628	rs121913407	NC_000003.12:41224644:T:C
NM_001904.4(CTNNB1):c.134C>T (p.Ser45Phe)	CTNNB1	S45F, S38F	Lung adenocarcinoma|Wilms Tumor|Cutaneous melanoma|Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Malignant melanoma of skin|Disease|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adrenocortical carcinoma|Hepatocellular carcinoma	Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017588	3	41266137	3	41224646	17588	32627	rs121913409	NC_000003.12:41224645:C:T
NM_000249.3(MLH1):c.827T>G (p.Ile276Arg)	MLH1	I276R, I35R, I243R, I178R	Lynch syndrome I	Pathogenic(Last reviewed: Mar 9, 2018)	reviewed by expert panel	VCV000520540	3	37059033	3	37017542	520540	511145	rs1253275403	NC_000003.12:37017541:T:G
NM_001167618.2(MLH1):c.-377del	MLH1	T116fs, T18fs, T83fs	not provided|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234680	3	37045932	3	37004441	234680	231600	rs876661159	NC_000003.12:37004440:C:
NM_000249.3(MLH1):c.2263A>G (p.Arg755Gly)	MLH1	R755G, R414G, R397G, R657G, R514G, R700G, R686G, R722G, R724G	Lynch syndrome I	Pathogenic(Last reviewed: Nov 24, 2015)	reviewed by expert panel	VCV000219292	3	37092136	3	37050645	219292	220983	rs267607900	NC_000003.12:37050644:A:G
NM_001354621.1(MLH1):c.-139-2735dup	MLH1		not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090399	3	37059061 - 37059062	3	37017570 - 37017571	90399	95873	rs63750034	NC_000003.12:37017570:AAAAA:AAAAAA
NM_001354621.1(MLH1):c.-139-2736_-139-2735del	MLH1	N254fs, N46fs, N189fs, N287fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090396	3	37059062 - 37059063	3	37017571 - 37017572	90396	95870	rs63750034	NC_000003.12:37017570:AAAAA:AAA
NM_000249.3(MLH1):c.791-4_795del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090373	3	37058991 - 37058999	3	37017500 - 37017508	90373	95847	rs587779041	NC_000003.12:37017499:GTTTAGATCGT:GT
NM_000249.3(MLH1):c.790+5G>T	MLH1		Lynch syndrome I	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000090364	3	37056040	3	37014549	90364	95838	rs267607771	NC_000003.12:37014548:G:T
NM_000249.3(MLH1):c.779T>G (p.Leu260Arg)	MLH1	L260R, L19R, L162R, L227R	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090350	3	37056024	3	37014533	90350	95824	rs63751283	NC_000003.12:37014532:T:G
NM_000249.3(MLH1):c.76C>T (p.Gln26Ter)	MLH1	Q26*	Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090347	3	37035114	3	36993623	90347	95821	rs63749827	NC_000003.12:36993622:C:T
NM_001167617.2(MLH1):c.-447del	MLH1	V24fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090337	3	37035108	3	36993617	90337	95811	rs63751396	NC_000003.12:36993616:G:
NM_001167618.2(MLH1):c.-59del	MLH1	N189fs, N124fs, N222fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090307	3	37053576	3	37012085	90307	95781	rs63750385	NC_000003.12:37012084:AAA:AA
NM_000249.3(MLH1):c.62C>T (p.Ala21Val)	MLH1	A21V	Lynch syndrome I	Pathogenic(Last reviewed: Nov 24, 2015)	reviewed by expert panel	VCV000090298	3	37035100	3	36993609	90298	95772	rs63750706	NC_000003.12:36993608:C:T
NM_000249.3(MLH1):c.554T>G (p.Val185Gly)	MLH1	V185G, V87G, V152G	Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090272	3	37053319	3	37011828	90272	95746	rs63750515	NC_000003.12:37011827:T:G
NM_001167618.2(MLH1):c.-193_-192delinsAT	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090255	3	37050382 - 37050383	3	37008891 - 37008892	90255	95729	rs63750903	NC_000003.12:37008890:GG:AT
NM_000249.3(MLH1):c.454-?_545+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090239					90239	95713		
NM_000249.3(MLH1):c.38_39insCCCA (p.Glu13fs)	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090207	3	37035075 - 37035076	3	36993584 - 36993585	90207	95681	rs63750057	NC_000003.12:36993584:A:ACCCA
NM_001167618.2(MLH1):c.-342del	MLH1	A30fs, A95fs, A128fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090201	3	37048483	3	37006992	90201	95675	rs63750865	NC_000003.12:37006991:G:
NM_001167618.2(MLH1):c.-354_-353TG[1]	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090182	3	37045954 - 37045955	3	37004463 - 37004464	90182	95656	rs587779006	NC_000003.12:37004462:GTGTG:GTG
NM_000249.3(MLH1):c.306+2dup	MLH1		Lynch syndrome I	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000090143	3	37042545 - 37042546	3	37001054 - 37001055	90143	95617	rs267607738	NC_000003.12:37001054:T:TT
NM_000249.3(MLH1):c.2T>G (p.Met1Arg)	MLH1	M1R	Lynch syndrome I	Pathogenic(Last reviewed: Dec 14, 2016)	reviewed by expert panel	VCV000090136	3	37035040	3	36993549	90136	95610	rs111052004	NC_000003.12:36993548:T:G
NM_000249.3(MLH1):c.2T>C (p.Met1Thr)	MLH1	M1T	Lynch syndrome I	Pathogenic(Last reviewed: Dec 14, 2016)	reviewed by expert panel	VCV000090135	3	37035040	3	36993549	90135	95609	rs111052004	NC_000003.12:36993548:T:C
NM_000249.3(MLH1):c.299G>C (p.Arg100Pro)	MLH1	R100P, E4Q	Lynch syndrome I	Pathogenic(Last reviewed: Mar 9, 2018)	reviewed by expert panel	VCV000090133	3	37042537	3	37001046	90133	95607	rs63750266	NC_000003.12:37001045:G:C
NM_000249.3(MLH1):c.2104_2105delAG	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000090059	3	37091975 - 37091976	3	37050484 - 37050485	90059	95533	rs63751651	NC_000003.12:37050483:AGAG:AG
NM_001258271.1(MLH1):c.1896+1323_1896+1324del	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090039	3	37090494 - 37090495	3	37049003 - 37049004	90039	95513	rs63750859	NC_000003.12:37049002:CTCTC:CTC
NM_000249.3(MLH1):c.208-?_545+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090036					90036	95510		
NM_000249.3(MLH1):c.1998G>A (p.Trp666Ter)	MLH1	W666*, W425*, W633*, W635*, W325*, W568*, W611*, W308*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089991	3	37090403	3	37048912	89991	95465	rs63750639	NC_000003.12:37048911:G:A
NM_000249.3(MLH1):c.1961C>T (p.Pro654Leu)	MLH1	P654L, P413L, P313L, P556L, P599L, P621L, P296L	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089959	3	37090072	3	37048581	89959	95433	rs63750726	NC_000003.12:37048580:C:T
NM_001258271.1(MLH1):c.1896+850_1896+863dup	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089942	3	37090021 - 37090022	3	37048530 - 37048531	89942	95416	rs587778958	NC_000003.12:37048530:TGGATTACCCCTTCTG:TGGATTACCCCTTCTGGATTACCCCTTCTG
NM_001258271.1(MLH1):c.1896+839del	MLH1	N277fs, N635fs, N394fs, N602fs, N294fs, N537fs, N580fs	Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089936	3	37090011	3	37048520	89936	95410	rs587778956	NC_000003.12:37048519:GGG:GG
NM_000249.3(MLH1):c.1865T>C (p.Leu622Pro)	MLH1	L622P, L281P, L589P, L264P, L381P, L524P	Lynch syndrome	Pathogenic(Last reviewed: Feb 21, 2019)	reviewed by expert panel	VCV000089911	3	37089143	3	37047652	89911	95385	rs63750693	NC_000003.12:37047651:T:C
NM_001354630.1(MLH1):c.1732-877delinsTTCTT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089908	3	37089131	3	37047640	89908	95382	rs587778949	NC_000003.12:37047639:A:TTCTT
NM_001354630.1(MLH1):c.1732-899_1732-898del	MLH1	I270fs, I578fs, I253fs, I370fs, I513fs, I611fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089899	3	37089109 - 37089110	3	37047618 - 37047619	89899	95373	rs63750150	NC_000003.12:37047617:AT:
NM_001354630.1(MLH1):c.1732-952_1732-951del	MLH1	P593fs, P352fs, P495fs, P235fs, P252fs, P560fs	Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089887	3	37089056 - 37089057	3	37047565 - 37047566	89887	95361	rs63750375	NC_000003.12:37047564:CA:
NM_000249.3(MLH1):c.1667+2_1667+8delinsATTT	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089824	3	37081787 - 37081793	3	37040296 - 37040302	89824	95298	rs587778938	NC_000003.12:37040295:TAAATCA:ATTT
NM_001167617.2(MLH1):c.1345_1349dup (p.Leu451fs)	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089813	3	37081756 - 37081757	3	37040265 - 37040266	89813	95287	rs587778934	NC_000003.12:37040265:TTATA:TTATATTATA
NM_000249.3(MLH1):c.142C>T (p.Gln48Ter)	MLH1	Q48*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089738	3	37038135	3	36996644	89738	95212	rs587778913	NC_000003.12:36996643:C:T
NM_001167617.2(MLH1):c.1104del (p.Ser369fs)	MLH1	S109fs, S226fs, S369fs, S467fs, S126fs, S434fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089713	3	37067486	3	37025995	89713	95187	rs63750713	NC_000003.12:37025994:CC:C
NM_000249.3(MLH1):c.122A>G (p.Asp41Gly)	MLH1	D41G	Lynch syndrome	Pathogenic(Last reviewed: Dec 19, 2018)	reviewed by expert panel	VCV000089684	3	37038115	3	36996624	89684	95158	rs63751094	NC_000003.12:36996623:A:G
NM_001354624.1(MLH1):c.-25del	MLH1	G351fs, G10fs, G318fs, G253fs, G110fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089633	3	37067139	3	37025648	89633	95107	rs587778883	NC_000003.12:37025647:A:
NM_000249.3(MLH1):c.1039-?_1558+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089628					89628	95102		
NM_000249.3(MLH1):c.1039-?_1409+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089627	3	37067128 - 37067498	3	37025637 - 37026007	89627	95101		
NM_001354621.1(MLH1):c.-7del	MLH1	S242fs, S307fs, S340fs, S99fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089606	3	37061932	3	37020441	89606	95080	rs63750339	NC_000003.12:37020440:CC:C
NM_000249.3(MLH1):c.(?_-198)_116+?del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089577	3	37034841 - 37035154	3	36993350 - 36993663	89577	95051		
MLH1, 11.6-KB DEL	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029655					29655	38610		
MLH1, EPIGENETICALLY SILENCED	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000017102					17102	32141		
MLH1, EX18DEL	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000017101					17101	32140		
MLH1, 3-BP DEL, 213AGA	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000017100					17100	32139		
MLH1, 1-BP DEL, 1784T	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000017086					17086	32125		
NM_000249.3(MLH1):c.1667+1_1667+8delinsATTT	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000017084	3	37081786 - 37081793	3	37040295 - 37040302	17084	32123	rs863223312	NC_000003.12:37040294:GTAAATCA:ATTT
NM_001080517.2(SETD5):c.2347-7A>G	SETD5		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280376	3	9495416	3	9453732	280376	264172	rs886041593	NC_000003.12:9453731:A:G
NM_001182.5(ALDH7A1):c.1279G>C (p.Glu427Gln)	ALDH7A1	E399Q, E390Q, E427Q, E363Q	Seizures|Pyridoxine-dependent epilepsy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000017994	5	125887751	5	126552059	17994	33033	rs121912707	NC_000005.10:126552058:C:G
NM_000297.4(PKD2):c.1319+1G>A	PKD2		Inborn genetic diseases|not provided|Polycystic kidney disease, autosomal dominant|Polycystic kidney disease 2	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430967	4	88964610	4	88043458	430967	424508	rs1131692280	NC_000004.12:88043457:G:A
NM_004415.4(DSP):c.478C>T (p.Arg160Ter)	DSP	R160*	Cardiovascular phenotype|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044922	6	7559514	6	7559281	44922	54089	rs397516943	NC_000006.12:7559280:C:T
NM_000222.2(KIT):c.1676T>A (p.Val559Asp)	KIT	V559D, V555D	Cutaneous melanoma|Gastrointestinal stromal tumor	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000013856	4	55593610	4	54727444	13856	28895	rs121913517	NC_000004.12:54727443:T:A
NM_001904.4(CTNNB1):c.110C>T (p.Ser37Phe)	CTNNB1	S37F, S30F	Lung adenocarcinoma|Hepatocellular carcinoma|Carcinoma of esophagus|Transitional cell carcinoma of the bladder|Cutaneous melanoma|Medulloblastoma|Uterine cervical neoplasms|Ovarian Neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Pilomatrixoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017586	3	41266113	3	41224622	17586	32625	rs121913403	NC_000003.12:41224621:C:T
NM_000249.3(MLH1):c.512_513insAlu	MLH1		Lynch syndrome I	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000617615					617615	609011		
NM_001167617.2(MLH1):c.942_943CA[1] (p.Thr315fs)	MLH1		Lynch syndrome|Colon cancer	Pathogenic(Last reviewed: Jul 30, 2012)	criteria provided, single submitter	VCV000433865	3	37067325 - 37067326	3	37025834 - 37025835	433865	427217	rs1553651073	NC_000003.12:37025833:CACA:CA
NM_001354621.1(MLH1):c.-75del	MLH1	L317fs, L284fs, L219fs, L76fs	Lynch syndrome|not provided	Pathogenic(Last reviewed: Oct 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000433860	3	37061864	3	37020373	433860	427212	rs1553648029	NC_000003.12:37020372:CC:C
NM_001167617.2(MLH1):c.-116_-115delinsT	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234119	3	37038167 - 37038168	3	36996676 - 36996677	234119	232884	rs876660860	NC_000003.12:36996675:GA:T
NM_000249.3(MLH1):c.307-?_380+?del	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000218024	3	37045892 - 37045965	3	37004401 - 37004474	218024	214626		
NM_000249.3(MLH1):c.982C>T (p.Gln328Ter)	MLH1	Q328*, Q295*, Q230*, Q87*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090458	3	37061898	3	37020407	90458	95932	rs587779058	NC_000003.12:37020406:C:T
NM_000249.3(MLH1):c.918T>A (p.Asn306Lys)	MLH1	N306K, N65K, N208K, N273K	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000090441	3	37061834	3	37020343	90441	95915	rs587779054	NC_000003.12:37020342:T:A
NM_000249.3(MLH1):c.86C>G (p.Ala29Gly)	MLH1	A29G	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090403	3	37035124	3	36993633	90403	95877	rs63750216	NC_000003.12:36993632:C:G
NM_001354621.1(MLH1):c.-140+2386_-140+2389del	MLH1	G146fs, G244fs, G3fs, G211fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090341	3	37055976 - 37055979	3	37014485 - 37014488	90341	95815	rs587779037	NC_000003.12:37014484:GTTA:
NM_000249.3(MLH1):c.436C>T (p.Gln146Ter)	MLH1	Q146*, Q113*, Q48*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090217	3	37048537	3	37007046	90217	95691	rs63749820	NC_000003.12:37007045:C:T
NM_001167617.2(MLH1):c.-58del	MLH1	E78fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090114	3	37042470	3	37000979	90114	95588	rs587778997	NC_000003.12:37000978:G:
NM_001167617.2(MLH1):c.-89del	MLH1	I68fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090000	3	37038192	3	36996701	90000	95474	rs587778968	NC_000003.12:36996700:GGG:GG
NM_001354630.1(MLH1):c.1732-972dup	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089879	3	37089034 - 37089035	3	37047543 - 37047544	89879	95353	rs63749863	NC_000003.12:37047543:CC:CCC
NM_001167617.2(MLH1):c.1396_1399del (p.Leu466fs)	MLH1	L206fs, L531fs, L223fs, L323fs, L564fs, L466fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089841	3	37083780 - 37083783	3	37042289 - 37042292	89841	95315	rs267607849	NC_000003.12:37042288:ACTCA:A
NM_001167617.2(MLH1):c.1084_1085GA[1] (p.Lys363fs)	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089711	3	37067466 - 37067467	3	37025975 - 37025976	89711	95185	rs587778909	NC_000003.12:37025974:AGAGA:AGA
NM_001167617.2(MLH1):c.958_959del (p.Asp320fs)	MLH1	D385fs, D418fs, D177fs, D60fs, D320fs, D77fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089686	3	37067340 - 37067341	3	37025849 - 37025850	89686	95160	rs63751118	NC_000003.12:37025848:AGA:A
NM_000249.3(MLH1):c.1039-1G>A	MLH1		not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089619	3	37067127	3	37025636	89619	95093	rs267607819	NC_000003.12:37025635:G:A
MLH1, 3.5-KB DEL	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000017081					17081	32120		
NM_004369.3(COL6A3):c.6238G>C (p.Gly2080Arg)	COL6A3	G2080R, G1473R, G1874R	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000520883	2	238268775	2	237360132	520883	511408	rs1553553625	NC_000002.12:237360131:C:G
NM_000222.2(KIT):c.2446G>T (p.Asp816Tyr)	KIT	D816Y, D812Y	Cutaneous melanoma|Gastrointestinal stromal tumor|MASTOCYTOSIS, CUTANEOUS AND SYSTEMIC, SOMATIC|Hematologic neoplasm|Acute myeloid leukemia	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000013860	4	55599320	4	54733154	13860	28899	rs121913506	NC_000004.12:54733153:G:T
NM_006218.4(PIK3CA):c.353G>A (p.Gly118Asp)	PIK3CA	G118D	Squamous cell carcinoma of the head and neck|Neoplasm of the breast|Cowden syndrome 5|Squamous cell lung carcinoma|Glioblastoma|Neoplasm of brain|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine cervical neoplasms|Adenocarcinoma of stomach|Neoplasm of the thyroid gland|Pancreatic adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000156446	3	178917478	3	179199690	156446	166218	rs587777790	NC_000003.12:179199689:G:A
NM_000249.3(MLH1):c.543C>T (p.Gly181=)	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000633499	3	37050394	3	37008903	633499	621931	rs1481129490	NC_000003.12:37008902:C:T
NM_000249.4(MLH1):c.514G>T (p.Glu172Ter)	MLH1	E172*, E139*, E74*	Lynch syndrome II|Lynch syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000584636	3	37050365	3	37008874	584636	575699	rs1559524405	NC_000003.12:37008873:G:T
NM_000249.3(MLH1):c.1597del (p.Cys533fs)	MLH1	C175fs, C533fs, C292fs, C435fs, C192fs, C500fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569561	3	37081715	3	37040224	569561	561427	rs1559575107	NC_000003.12:37040223:T:
NM_000249.3(MLH1):c.1731+2T>C	MLH1		Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000455399	3	37083824	3	37042333	455399	452139	rs267607856	NC_000003.12:37042332:T:C
NM_001167617.2(MLH1):c.-22del	MLH1	D90fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000405387	3	37042505	3	37001014	405387	393834	rs1060500688	NC_000003.12:37001013:GG:G
NM_001167617.2(MLH1):c.-492_-491delinsTA	MLH1		Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224532	3	37035063 - 37035064	3	36993572 - 36993573	224532	226314	rs869312767	NC_000003.12:36993571:CG:TA
NM_000249.3(MLH1):c.207+5G>C	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141132	3	37038205	3	36996714	141132	150846	rs587781518	NC_000003.12:36996713:G:C
NM_001354621.1(MLH1):c.-85dup	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090449	3	37061853 - 37061854	3	37020362 - 37020363	90449	95923	rs63751259	NC_000003.12:37020362:AA:AAA
NM_001167617.2(MLH1):c.-433del	MLH1	A29fs	Lynch syndrome|Lynch syndrome II	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090392	3	37035122	3	36993631	90392	95866	rs587779045	NC_000003.12:36993630:A:
NM_001167617.2(MLH1):c.-456del	MLH1	A21fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090296	3	37035098	3	36993607	90296	95770	rs63750581	NC_000003.12:36993606:GG:G
NM_001167618.2(MLH1):c.-378del	MLH1	T83fs, T18fs, T116fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090174	3	37045931	3	37004440	90174	95648	rs63750906	NC_000003.12:37004439:A:
NM_001167617.2(MLH1):c.-486del	MLH1	L11fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090166	3	37035069	3	36993578	90166	95640	rs63749816	NC_000003.12:36993577:C:
NM_001167617.2(MLH1):c.1883_1884CA[2] (p.Ile630fs)	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090084	3	37092050 - 37092051	3	37050559 - 37050560	90084	95558	rs267607898	NC_000003.12:37050558:CACACA:CACA
NM_000249.3(MLH1):c.2103+1G>A	MLH1		Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090044	3	37090509	3	37049018	90044	95518	rs267607888	NC_000003.12:37049017:G:A
NM_001258271.1(MLH1):c.1896+1237_1896+1241del	MLH1	E571fs, E636fs, E638fs, E311fs, E428fs, E614fs, E669fs, E328fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089997	3	37090408 - 37090412	3	37048917 - 37048921	89997	95471	rs63750061	NC_000003.12:37048916:AAGAAAAG:AAG
NM_001354630.1(MLH1):c.1732-846_1732-842del	MLH1	L287fs, L270fs, L387fs, L530fs, L595fs, L628fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089922	3	37089162 - 37089166	3	37047671 - 37047675	89922	95396	rs63751639	NC_000003.12:37047670:GGAAA:
NM_000249.3(MLH1):c.1732-?_1896+?del	MLH1		not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089866					89866	95340		
NM_000249.3(MLH1):c.1669G>T (p.Glu557Ter)	MLH1	E557*, E199*, E524*, E216*, E459*, E316*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089834	3	37083760	3	37042269	89834	95308	rs63751244	NC_000003.12:37042268:G:T
NM_001167617.2(MLH1):c.-134dup	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089794	3	37038146 - 37038147	3	36996655 - 36996656	89794	95268	rs63750028	NC_000003.12:36996655:AAA:AAAA
NM_001167617.2(MLH1):c.-135_-132del	MLH1	K52fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089790	3	37038147 - 37038150	3	36996656 - 36996659	89790	95264	rs587778923	NC_000003.12:36996655:AAAGA:A
NM_001167617.2(MLH1):c.1119_1120GA[1] (p.Arg374fs)	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089733	3	37070277 - 37070278	3	37028786 - 37028787	89733	95207	rs281864936	NC_000003.12:37028785:AGAGA:AGA
NM_001167617.2(MLH1):c.1083dup (p.Glu362fs)	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089709	3	37067465 - 37067466	3	37025974 - 37025975	89709	95183	rs63750020	NC_000003.12:37025974:A:AA
NM_001167617.2(MLH1):c.1068del (p.Thr357fs)	MLH1	T214fs, T357fs, T455fs, T97fs, T114fs, T422fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089706	3	37067448	3	37025957	89706	95180	rs267607821	NC_000003.12:37025956:GGGG:GGG
NM_000249.3(MLH1):c.121G>C (p.Asp41His)	MLH1	D41H	not provided|Lynch syndrome I	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000089682	3	37038114	3	36996623	89682	95156	rs267607713	NC_000003.12:36996622:G:C
NM_000249.3(MLH1):c.1171C>T (p.Gln391Ter)	MLH1	Q391*, Q150*, Q50*, Q293*, Q33*, Q358*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089672	3	37067260	3	37025769	89672	95146	rs587778894	NC_000003.12:37025768:C:T
NM_001354621.1(MLH1):c.-13del	MLH1	N305fs, N338fs, N97fs, N240fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089603	3	37061926	3	37020435	89603	95077	rs63750677	NC_000003.12:37020434:CC:C
MLH1, HYPERMETHYLATION	MLH1		Lynch syndrome II	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000017092					17092	32131		
NM_000249.3(MLH1):c.755C>A (p.Ser252Ter)	MLH1	S252*, S219*, S11*, S154*	Lynch syndrome II|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000017078	3	37056000	3	37014509	17078	32117	rs63750198	NC_000003.12:37014508:C:A
NM_001080517.2(SETD5):c.3001C>T (p.Arg1001Ter)	SETD5	R1001*, R903*	Inborn genetic diseases|Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000127104	3	9512419	3	9470735	127104	132613	rs587777327	NC_000003.12:9470734:C:T
NM_000249.3(MLH1):c.456_545+2del	MLH1		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433874	3	37050302 - 37050393	3	37008811 - 37008902	433874	427203	rs1553642657	
NM_000249.3(MLH1):c.1409+1G>T	MLH1		Hereditary nonpolyposis colon cancer|Lynch syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420226	3	37067499	3	37026008	420226	406238	rs267607825	NC_000003.12:37026007:G:T
NM_000249.3(MLH1):c.699T>A (p.Cys233Ter)	MLH1	C233*, C200*, C135*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000405380	3	37055944	3	37014453	405380	393442	rs764085979	NC_000003.12:37014452:T:A
NM_000249.4(MLH1):c.791-5T>G	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090374	3	37058992	3	37017501	90374	95848	rs267607788	NC_000003.12:37017500:T:G
NM_000249.3(MLH1):c.790+1del	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090358	3	37056036	3	37014545	90358	95832	rs267607798	NC_000003.12:37014544:G:
NM_001167618.2(MLH1):c.-320_-317del	MLH1	L102fs, L135fs, L37fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090213	3	37048505 - 37048508	3	37007014 - 37007017	90213	95687	rs587779014	NC_000003.12:37007013:TGAA:
NM_000249.3(MLH1):c.320T>G (p.Ile107Arg)	MLH1	I107R, I74R, I9R	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090167	3	37045905	3	37004414	90167	95641	rs63750507	NC_000003.12:37004413:T:G
NM_000249.3(MLH1):c.306+1G>A	MLH1		Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 24, 2015)	reviewed by expert panel	VCV000090142	3	37042545	3	37001054	90142	95616	rs267607734	NC_000003.12:37001053:G:A
NM_000249.3(MLH1):c.1810A>T (p.Lys604Ter)	MLH1	K604*, K506*, K263*, K363*, K246*, K571*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089893	3	37089088	3	37047597	89893	95367	rs63750386	NC_000003.12:37047596:A:T
NM_000249.3(MLH1):c.1731+5G>A	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000089854	3	37083827	3	37042336	89854	95328	rs267607850	NC_000003.12:37042335:G:A
NM_001167617.2(MLH1):c.1294_1296del (p.Phe432del)	MLH1	F530del, F432del, F497del, F172del, F289del, F189del	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089798	3	37081705 - 37081707	3	37040214 - 37040216	89798	95272	rs587778930	NC_000003.12:37040213:CTTC:C
NM_001167617.2(MLH1):c.-171del	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089676	3	37038110	3	36996619	89676	95150	rs587778896	NC_000003.12:36996618:TTT:TT
NM_000249.3(MLH1):c.1865T>A (p.Leu622His)	MLH1	L622H, L264H, L281H, L589H, L381H, L524H	Lynch syndrome II|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000029657	3	37089143	3	37047652	29657	38612	rs63750693	NC_000003.12:37047651:T:A
NM_000249.3(MLH1):c.131C>T (p.Ser44Phe)	MLH1	S44F	Lynch syndrome|Lynch syndrome II	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017079	3	37038124	3	36996633	17079	32118	rs63751109	NC_000003.12:36996632:C:T
NM_000551.3(VHL):c.257C>T (p.Pro86Leu)	VHL	P86L	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000182977	3	10183788	3	10142104	182977	180115	rs730882034	NC_000003.12:10142103:C:T
NM_006261.4(PROP1):c.301_302del	PROP1		Pituitary hormone deficiency, combined 2|Pituitary hormone deficiency, combined|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008098	5	177421147 - 177421148	5	177994146 - 177994147	8098	23137	rs193922688	NC_000005.10:177994145:CTCTCTC:CTCTC
NM_001370658.1(BTD):c.468G>T (p.Lys156Asn)	BTD	K176N, K156N, K178N	Biotinidase deficiency|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025018	3	15685891	3	15644384	25018	36355	rs397514367	NC_000003.12:15644383:G:T
NM_004415.4(DSP):c.939+1G>A	DSP		Arrhythmogenic right ventricular cardiomyopathy, type 8|Keratosis palmoplantaris striata II|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000178282	6	7565754	6	7565521	178282	173844	rs727504443	NC_000006.12:7565520:G:A
NM_000249.3(MLH1):c.62C>A (p.Ala21Glu)	MLH1	A21E	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090297	3	37035100	3	36993609	90297	95771	rs63750706	NC_000003.12:36993608:C:A
NM_000249.3(MLH1):c.306G>C (p.Glu102Asp)	MLH1	E102D	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090150	3	37042544	3	37001053	90150	95624	rs63751665	NC_000003.12:37001052:G:C
NM_001167617.2(MLH1):c.1858_1859CA[3] (p.Ile621fs)	MLH1		Lynch syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090073	3	37092023 - 37092024	3	37050532 - 37050533	90073	95547	rs63750971	NC_000003.12:37050532:ACACA:ACACACA
NM_000249.3(MLH1):c.2093C>G (p.Ser698Ter)	MLH1	S698*, S357*, S600*, S457*, S665*, S667*, S340*, S643*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090040	3	37090498	3	37049007	90040	95514	rs587778975	NC_000003.12:37049006:C:G
NM_000249.3(MLH1):c.1989+5G>C	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000089977	3	37090105	3	37048614	89977	95451	rs267607878	NC_000003.12:37048613:G:C
NM_001354630.1(MLH1):c.1732-853del	MLH1	F528fs, F593fs, F626fs, F268fs, F285fs, F385fs	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089917	3	37089153	3	37047662	89917	95391	rs63750152	NC_000003.12:37047661:TTT:TT
NM_000249.3(MLH1):c.1732-?_(*193_?)del	MLH1		not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089865	3	37089010 - 37092337	3	37047519 - 37050846	89865	95339		
MLH1, 2-BP DEL, 593AG	MLH1		Lynch syndrome II|Turcot syndrome	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000017104					17104	32143		
MLH1, EX16DEL	MLH1		Lynch syndrome II|Turcot syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000017091					17091	32130		
NM_000222.2(KIT):c.1924A>G (p.Lys642Glu)	KIT	K642E, K638E	Cutaneous melanoma|Malignant melanoma of skin|Adenocarcinoma of stomach|Gastrointestinal stromal tumor|Gastrointestinal stromal tumor, familial|Hematologic neoplasm	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000013866	4	55594221	4	54728055	13866	28905	rs121913512	NC_000004.12:54728054:A:G
NM_000222.2(KIT):c.1676T>C (p.Val559Ala)	KIT	V559A, V555A	Cutaneous melanoma|Thymoma|Gastrointestinal stromal tumor|Cutaneous mastocytosis|Gastrointestinal stromal tumor, familial	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000013865	4	55593610	4	54727444	13865	28904	rs121913517	NC_000004.12:54727443:T:C
NM_000222.2(KIT):c.2446G>C (p.Asp816His)	KIT	D816H, D812H	Dysgerminoma|Cutaneous melanoma|Gastrointestinal stromal tumor|Hematologic neoplasm|not provided|Malignant tumor of testis	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000013863	4	55599320	4	54733154	13863	28902	rs121913506	NC_000004.12:54733153:G:C
NM_000551.3(VHL):c.262T>A (p.Trp88Arg)	VHL	W88R	not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000456577	3	10183793	3	10142109	456577	451870	rs1553619431	NC_000003.12:10142108:T:A
NM_000551.3(VHL):c.191G>C (p.Arg64Pro)	VHL	R64P	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Pheochromocytoma	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002226	3	10183722	3	10142038	2226	17265	rs104893826	NC_000003.12:10142037:G:C
NM_003907.3(EIF2B5):c.338G>A (p.Arg113His)	EIF2B5	R113H	not provided|Leukoencephalopathy with vanishing white matter|Ovarioleukodystrophy	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005945	3	183855425	3	184137637	5945	20984	rs113994049	NC_000003.12:184137636:G:A
NM_001370658.1(BTD):c.1308A>C (p.Gln436His)	BTD	Q456H, Q458H, Q436H	not provided|Biotinidase deficiency	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001902	3	15686731	3	15645224	1902	16941	rs80338685	NC_000003.12:15645223:A:C
NM_000249.3(MLH1):c.(?_1732)_(2271_?)del	MLH1		Lynch syndrome	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000517462	3	37089010 - 37092144	3	37047519 - 37050653	517462	496764		
NM_000249.3(MLH1):c.469dup (p.Tyr157fs)	MLH1		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000491710	3	37050314 - 37050315	3	37008823 - 37008824	491710	483586	rs63751101	NC_000003.12:37008823:TTTTTT:TTTTTTT
NM_000249.3(MLH1):c.1769T>G (p.Leu590Ter)	MLH1	L590*, L249*, L349*, L232*, L492*, L557*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433870	3	37089047	3	37047556	433870	427222	rs1553662753	NC_000003.12:37047555:T:G
NM_000249.4(MLH1):c.791-1G>A	MLH1		Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188509	3	37058996	3	37017505	188509	186317	rs267607795	NC_000003.12:37017504:G:A
NM_001167617.2(MLH1):c.1972_1975dup (p.Ter659LeuextTer?)	MLH1		Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090107	3	37092138 - 37092139	3	37050647 - 37050648	90107	95581	rs267607892	NC_000003.12:37050647:TGTT:TGTTTGTT
NM_000249.3(MLH1):c.1A>G (p.Met1Val)	MLH1	M1V	Hereditary nonpolyposis colon cancer|Lynch syndrome I	Pathogenic(Last reviewed: Jun 30, 2017)	reviewed by expert panel	VCV000089994	3	37035039	3	36993548	89994	95468	rs587778967	NC_000003.12:36993547:A:G
NM_000249.3(MLH1):c.1683C>G (p.Tyr561Ter)	MLH1	Y561*, Y220*, Y463*, Y528*, Y320*, Y203*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089838	3	37083774	3	37042283	89838	95312	rs63751393	NC_000003.12:37042282:C:G
NM_000249.3(MLH1):c.1613G>A (p.Trp538Ter)	MLH1	W538*, W440*, W505*, W180*, W197*, W297*	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089802	3	37081731	3	37040240	89802	95276	rs587778933	NC_000003.12:37040239:G:A
NM_000038.6(APC):c.3366_3369del (p.Asn1122fs)	APC	N1094fs, N1104fs, N996fs, N1031fs, N839fs, N1122fs, N1132fs, N1021fs, N1063fs, N1081fs, N1097fs, N1140fs, N962fs	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000817033	5	112174655 - 112174658	5	112838958 - 112838961	817033	805405		NC_000005.10:112838957:AATCAA:AA
NC_000005.10:g.112827111dup	APC		not specified	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000811396	5	112162803 - 112162804	5	112827106 - 112827107	811396	799389		NC_000005.10:112827106:GGGGG:GGGGGG
NM_000038.6(APC):c.4638_4639del (p.Asn1546fs)	APC	N1263fs, N1386fs, N1455fs, N1487fs, N1505fs, N1518fs, N1528fs, N1546fs, N1556fs, N1564fs, N1420fs, N1445fs, N1521fs	not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000618532	5	112175929 - 112175930	5	112840232 - 112840233	618532	609566	rs1561594148	NC_000005.10:112840231:TG:
NM_000038.6(APC):c.2100dup (p.Met701fs)	APC		not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000618530	5	112173390 - 112173391	5	112837693 - 112837694	618530	609563	rs1561574860	NC_000005.10:112837693:C:CC
NM_000038.6(APC):c.2589C>A (p.Tyr863Ter)	APC	Y845*, Y863*, Y580*, Y737*, Y772*, Y804*, Y835*, Y838*, Y881*, Y703*, Y762*, Y822*, Y873*	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000618529	5	112173880	5	112838183	618529	609564	rs1561578229	NC_000005.10:112838182:C:A
NM_000038.6(APC):c.5971_5972insGCAGCATCTGATGAAAAGTTACAGAATTTTGCTATTGAAAATACTCCGGTTTGCTTTTCTCATAATTCCTCTCTGAGTTCTCTCAGTGACATTGACCAAGAAAACAACAATAAAGAAAATGAACCTATCAAAGAGACTGG (p.Glu1991delinsGlySerIleTer)	APC		not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000617982	5	112177261 - 112177262	5	112841564 - 112841565	617982	609568	rs1561604164	
NM_000038.6(APC):c.2507_2511delinsG (p.Ser835_Ser836insTer)	APC		not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000546059	5	112173798 - 112173802	5	112838101 - 112838105	546059	536297	rs1554084228	NC_000005.10:112838100:CATCA:G
NM_000038.6(APC):c.2853del (p.Pro950_Tyr951insTer)	APC		not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000546047	5	112174144	5	112838447	546047	536298	rs1554084541	NC_000005.10:112838446:T:
NM_000038.6(APC):c.1431dup (p.Leu478fs)	APC		not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000545904	5	112162825 - 112162826	5	112827128 - 112827129	545904	536291	rs1554081640	NC_000005.10:112827128:AA:AAA
NM_000038.6(APC):c.1652del (p.Leu551fs)	APC	L523fs, L551fs, L391fs, L450fs, L510fs, L526fs, L561fs, L268fs, L425fs, L460fs, L492fs, L533fs, L569fs	not provided	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000545895	5	112164576	5	112828879	545895	536293	rs1554082100	NC_000005.10:112828878:TTT:TT
NM_000038.6(APC):c.7946_7955del (p.Pro2649fs)	APC	P2590fs, P2624fs, P2366fs, P2548fs, P2558fs, P2621fs, P2649fs, P2659fs, P2489fs, P2523fs, P2631fs, P2608fs, P2667fs	not provided	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000545875	5	112179236 - 112179245	5	112843539 - 112843548	545875	536306	rs1554088780	NC_000005.10:112843538:CCTGCTGTTTC:C
NM_000038.6(APC):c.2083del (p.Gln695fs)	APC	Q412fs, Q535fs, Q604fs, Q670fs, Q695fs, Q713fs, Q569fs, Q636fs, Q654fs, Q594fs, Q705fs, Q667fs, Q677fs	not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000545865	5	112173373	5	112837676	545865	536296	rs1554083941	NC_000005.10:112837675:CC:C
NM_000038.6(APC):c.2859dup (p.Leu954fs)	APC		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000545858	5	112174147 - 112174148	5	112838450 - 112838451	545858	536299	rs1554084547	NC_000005.10:112838450:AAA:AAAA
NM_000038.6(APC):c.1336del (p.Ile446fs)	APC	I345fs, I418fs, I428fs, I446fs, I286fs, I320fs, I387fs, I163fs, I355fs, I421fs, I456fs	not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000545852	5	112157616	5	112821919	545852	536289	rs1554080688	NC_000005.10:112821918:A:
NM_000038.6(APC):c.4468del (p.His1490fs)	APC	H1207fs, H1330fs, H1389fs, H1399fs, H1500fs, H1508fs, H1449fs, H1364fs, H1431fs, H1462fs, H1465fs, H1472fs, H1490fs	not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000545843	5	112175759	5	112840062	545843	536302	rs1554085898	NC_000005.10:112840061:C:
NM_000038.6(APC):c.1834_1838del (p.Ala612fs)	APC	A452fs, A511fs, A594fs, A329fs, A521fs, A571fs, A486fs, A553fs, A584fs, A587fs, A630fs, A612fs, A622fs	not provided	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000545830	5	112170737 - 112170741	5	112835040 - 112835044	545830	536294	rs1554083160	NC_000005.10:112835039:TGCACT:T
NM_000038.6(APC):c.4969_4970insG (p.Leu1657fs)	APC		not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000545778	5	112176260 - 112176261	5	112840563 - 112840564	545778	536303	rs1554086338	NC_000005.10:112840563::G
NM_000038.6(APC):c.7959_7962del (p.Thr2654fs)	APC	T2553fs, T2595fs, T2494fs, T2563fs, T2626fs, T2613fs, T2636fs, T2654fs, T2664fs, T2672fs, T2371fs, T2528fs, T2629fs	not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000545737	5	112179249 - 112179252	5	112843552 - 112843555	545737	536307	rs1554088793	NC_000005.10:112843551:AAACA:A
NM_000038.6(APC):c.1854_1869del (p.Thr619fs)	APC	T518fs, T578fs, T619fs, T336fs, T493fs, T560fs, T594fs, T601fs, T629fs, T459fs, T528fs, T591fs, T637fs	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000545736	5	112170756 - 112170771	5	112835059 - 112835074	545736	536295	rs1554083164	NC_000005.10:112835058:GGCACTCTTACTTACCGG:GG
NM_000038.6(APC):c.1620del (p.Leu540fs)	APC	L439fs, L449fs, L515fs, L540fs, L558fs, L499fs, L512fs, L257fs, L380fs, L414fs, L481fs, L522fs, L550fs	not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000545735	5	112163697	5	112828000	545735	536292	rs1554081921	NC_000005.10:112827999:A:
NM_000038.6(APC):c.386_387insT (p.Glu129fs)	APC		not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000545734	5	112103051 - 112103052	5	112767354 - 112767355	545734	536288	rs1554069831	NC_000005.10:112767354::T
NM_000038.6(APC):c.3123_3124del (p.Pro1043fs)	APC	P1002fs, P1043fs, P952fs, P984fs, P1015fs, P1025fs, P1061fs, P883fs, P1018fs, P917fs, P1053fs, P760fs, P942fs	not provided	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000545731	5	112174413 - 112174414	5	112838716 - 112838717	545731	536300	rs1554084712	NC_000005.10:112838715:AAA:A
NM_000038.6(APC):c.271del (p.Met91fs)	APC	M32fs, M91fs, M66fs, M101fs	not provided	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000545726	5	112102932	5	112767235	545726	536287	rs1554069710	NC_000005.10:112767234:AAAAA:AAAA
NM_000038.6(APC):c.6381del (p.Ala2128fs)	APC	A2146fs, A1968fs, A2027fs, A2037fs, A2100fs, A2103fs, A2110fs, A2128fs, A2002fs, A2087fs, A1845fs, A2069fs, A2138fs	not provided	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000504055	5	112177671	5	112841974	504055	495218	rs1554087379	NC_000005.10:112841973:AA:A
NM_000038.6(APC):c.2161_2170del (p.Gly721fs)	APC	G561fs, G662fs, G693fs, G703fs, G438fs, G680fs, G721fs, G731fs, G739fs, G620fs, G696fs, G595fs, G630fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000495355	5	112173450 - 112173459	5	112837753 - 112837762	495355	487132	rs1554083981	NC_000005.10:112837752:TGGGAAGTGCTG:TG
NM_000038.6(APC):c.3527del (p.Pro1176fs)	APC	P1176fs, P1016fs, P1085fs, P1158fs, P1075fs, P1117fs, P1148fs, P893fs, P1050fs, P1135fs, P1151fs, P1186fs, P1194fs	not provided	Pathogenic	no assertion criteria provided	VCV000492663	5	112174817	5	112839120	492663	485621	rs1554085084	NC_000005.10:112839119:CC:C
NM_000038.6(APC):c.3264del (p.Lys1088fs)	APC	K962fs, K987fs, K1029fs, K1060fs, K928fs, K997fs, K1063fs, K1047fs, K1070fs, K1088fs, K1098fs, K1106fs, K805fs	not provided	Pathogenic	no assertion criteria provided	VCV000492661	5	112174555	5	112838858	492661	485619	rs1554084885	NC_000005.10:112838857:G:
NM_000038.6(APC):c.2170dup (p.Ala724fs)	APC		not provided	Pathogenic	no assertion criteria provided	VCV000492657	5	112173460 - 112173461	5	112837763 - 112837764	492657	485615	rs1554083984	NC_000005.10:112837763:G:GG
NM_000038.6(APC):c.4585C>T (p.Gln1529Ter)	APC	Q1511*, Q1529*, Q1403*, Q1428*, Q1438*, Q1470*, Q1501*, Q1246*, Q1488*, Q1504*, Q1547*, Q1539*, Q1369*	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000449335	5	112175876	5	112840179	449335	443650	rs1554085992	NC_000005.10:112840178:C:T
NM_000038.6(APC):c.4033G>T (p.Glu1345Ter)	APC	E1327*, E1345*, E1062*, E1185*, E1286*, E1304*, E1317*, E1363*, E1320*, E1355*, E1219*, E1254*, E1244*	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000449334	5	112175324	5	112839627	449334	443649	rs1211642532	NC_000005.10:112839626:G:T
NM_000038.6(APC):c.2077A>T (p.Lys693Ter)	APC	K675*, K693*, K592*, K533*, K602*, K668*, K703*, K410*, K567*, K634*, K652*, K665*, K711*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000449333	5	112173368	5	112837671	449333	443648	rs773985321	NC_000005.10:112837670:A:T
NM_000038.6(APC):c.1263G>A (p.Trp421Ter)	APC	W403*, W421*, W320*, W330*, W362*, W393*, W431*, W261*, W396*, W138*, W295*	not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000449331	5	112154992	5	112819295	449331	443646	rs1554080106	NC_000005.10:112819294:G:A
NM_000038.6(APC):c.834+1G>A	APC		not specified	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000439408	5	112137081	5	112801384	439408	433005	rs1554076225	NC_000005.10:112801383:G:A
NM_000038.6(APC):c.1620dup (p.Gln541fs)	APC		not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000429734	5	112163696 - 112163697	5	112827999 - 112828000	429734	421505	rs1131691555	NC_000005.10:112827999:A:AA
NM_000038.6(APC):c.4059_4060insG (p.Phe1354fs)	APC		not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000422564	5	112175350 - 112175351	5	112839653 - 112839654	422564	406543	rs1064795861	NC_000005.10:112839653::G
NM_000038.6(APC):c.1862del (p.Thr621fs)	APC	T338fs, T562fs, T603fs, T530fs, T639fs, T461fs, T520fs, T596fs, T495fs, T580fs, T593fs, T621fs, T631fs	not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000422457	5	112170766	5	112835069	422457	406511	rs1064795792	NC_000005.10:112835068:C:
NM_000038.6(APC):c.2964_2965delinsT (p.Glu988fs)	APC		not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000422348	5	112174255 - 112174256	5	112838558 - 112838559	422348	406524	rs1064795724	NC_000005.10:112838557:AG:T
NM_000038.6(APC):c.4778_4779insT (p.Lys1593fs)	APC		not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000421962	5	112176069 - 112176070	5	112840372 - 112840373	421962	406549	rs1064795475	NC_000005.10:112840372::T
NM_000038.6(APC):c.2567dup (p.Gly857fs)	APC		not provided	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000421355	5	112173857 - 112173858	5	112838160 - 112838161	421355	406521	rs1554084266	NC_000005.10:112838160:G:GG
NM_000038.6(APC):c.3293_3294GT[1] (p.Val1099fs)	APC		not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000419998	5	112174583 - 112174584	5	112838886 - 112838887	419998	406527	rs1064794228	NC_000005.10:112838885:TGTGT:TGT
NM_000038.6(APC):c.1866C>G (p.Tyr622Ter)	APC	Y604*, Y622*, Y339*, Y462*, Y496*, Y563*, Y640*, Y597*, Y521*, Y531*, Y581*, Y594*, Y632*	not provided	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000419995	5	112170770	5	112835073	419995	406512	rs876658355	NC_000005.10:112835072:C:G
NM_000038.6(APC):c.931A>T (p.Lys311Ter)	APC	K293*, K311*, K252*, K286*, K28*, K283*, K321*	not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000419800	5	112151288	5	112815591	419800	406494	rs1064794114	NC_000005.10:112815590:A:T
NM_000038.6(APC):c.3904del (p.Leu1302fs)	APC	L1019fs, L1176fs, L1274fs, L1284fs, L1312fs, L1201fs, L1211fs, L1320fs, L1142fs, L1243fs, L1277fs, L1302fs, L1261fs	not provided	Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000419687	5	112175193	5	112839496	419687	406539	rs1064794042	NC_000005.10:112839495:CCC:CC
NM_000038.6(APC):c.5839del (p.Thr1947fs)	APC	T1821fs, T1888fs, T1919fs, T1922fs, T1965fs, T1856fs, T1906fs, T1846fs, T1929fs, T1947fs, T1664fs, T1787fs, T1957fs	not provided	Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	VCV000419580	5	112177129	5	112841432	419580	406571	rs1064793969	NC_000005.10:112841431:AA:A
NM_000038.6(APC):c.3335_3336del (p.Thr1112fs)	APC	T1087fs, T1094fs, T986fs, T1011fs, T1053fs, T1071fs, T1112fs, T1122fs, T829fs, T1084fs, T952fs, T1021fs, T1130fs	not provided	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000419301	5	112174625 - 112174626	5	112838928 - 112838929	419301	406530	rs1064793778	NC_000005.10:112838927:ACA:A
NM_000038.6(APC):c.5562del (p.Cys1855fs)	APC	C1572fs, C1695fs, C1754fs, C1764fs, C1814fs, C1830fs, C1855fs, C1729fs, C1827fs, C1865fs, C1796fs, C1837fs, C1873fs	not provided	Pathogenic(Last reviewed: Mar 18, 2015)	criteria provided, single submitter	VCV000418682	5	112176853	5	112841156	418682	406561	rs1064793363	NC_000005.10:112841155:C:
NM_000038.6(APC):c.5764C>T (p.Gln1922Ter)	APC	Q1904*, Q1922*, Q1639*, Q1821*, Q1897*, Q1831*, Q1881*, Q1932*, Q1762*, Q1863*, Q1894*, Q1796*, Q1940*	not provided	Pathogenic(Last reviewed: Oct 27, 2014)	criteria provided, single submitter	VCV000418010	5	112177055	5	112841358	418010	406570	rs1064793024	NC_000005.10:112841357:C:T
NM_000038.6(APC):c.835-8A>G	APC		not provided	Pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	VCV000418007	5	112151184	5	112815487	418007	406489	rs1064793022	NC_000005.10:112815486:A:G
NM_000038.6(APC):c.341del (p.Pro114fs)	APC	P114fs, P124fs, P55fs, P89fs	not provided	Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	VCV000418006	5	112103005	5	112767308	418006	406483	rs1064793021	NC_000005.10:112767307:CC:C
NM_000038.6(APC):c.3427_3428TA[3] (p.Ser1144fs)	APC		not provided	Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	VCV000246198	5	112174717 - 112174718	5	112839020 - 112839021	246198	244429	rs879254148	NC_000005.10:112839020:TATA:TATATA
NM_000038.6(APC):c.2395del (p.Tyr799fs)	APC	Y639fs, Y771fs, Y708fs, Y758fs, Y781fs, Y817fs, Y516fs, Y673fs, Y698fs, Y740fs, Y809fs, Y774fs, Y799fs	not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000246126	5	112173685	5	112837988	246126	244424	rs879254110	NC_000005.10:112837987:TT:T
NM_000038.6(APC):c.3306C>A (p.Tyr1102Ter)	APC	Y1084*, Y1102*, Y819*, Y942*, Y1001*, Y1011*, Y1074*, Y1077*, Y1043*, Y1120*, Y1061*, Y1112*, Y976*	not provided	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000246089	5	112174597	5	112838900	246089	244428	rs879254092	NC_000005.10:112838899:C:A
NM_000038.6(APC):c.3593C>G (p.Ser1198Ter)	APC	S1180*, S1198*, S1072*, S1097*, S1107*, S1170*, S1208*, S1038*, S1157*, S1173*, S1139*, S1216*, S915*	not provided	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000246086	5	112174884	5	112839187	246086	244431	rs879254089	NC_000005.10:112839186:C:G
NM_000038.6(APC):c.423-2A>T	APC		not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000246083	5	112111324	5	112775627	246083	244414	rs879254087	NC_000005.10:112775626:A:T
NM_000038.6(APC):c.4743_4747TGCCA[1] (p.Met1583fs)	APC		not provided	Pathogenic	no assertion criteria provided	VCV000217989	5	112176034 - 112176038	5	112840337 - 112840341	217989	214730	rs863225360	NC_000005.10:112840336:TGCCATGCCA:TGCCA
NM_000038.6(APC):c.2806_2813dup (p.Lys939fs)	APC		not provided	Pathogenic	no assertion criteria provided	VCV000217955	5	112174094 - 112174095	5	112838397 - 112838398	217955	214703	rs863225333	NC_000005.10:112838397:ACAATTTCAC:ACAATTTCACAATTTCAC
NM_000038.6(APC):c.2325del (p.Asn775fs)	APC	N716fs, N734fs, N750fs, N785fs, N615fs, N775fs, N793fs, N649fs, N684fs, N492fs, N674fs, N747fs, N757fs	not provided	Pathogenic	no assertion criteria provided	VCV000217949	5	112173616	5	112837919	217949	214699	rs863225328	NC_000005.10:112837918:T:
NM_000038.5(APC):c.1744-?_1958+?del (p.(?))	APC		not provided	Pathogenic	no assertion criteria provided	VCV000217936					217936	214645		
NM_000038.5(APC):c.1409-?_1743+?del	APC		not provided	Pathogenic	no assertion criteria provided	VCV000217926					217926	214644		
NM_000038.6(APC):c.1297C>T (p.Gln433Ter)	APC	Q415*, Q433*, Q342*, Q374*, Q405*, Q150*, Q273*, Q307*, Q332*, Q408*, Q443*	not provided	Pathogenic	no assertion criteria provided	VCV000217921	5	112155026	5	112819329	217921	214679	rs863225309	NC_000005.10:112819328:C:T
NM_000038.6(APC):c.2557_2558GA[3] (p.Glu855fs)	APC		not provided	Pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	VCV000194584	5	112173848 - 112173849	5	112838151 - 112838152	194584	191747	rs794727160	NC_000005.10:112838150:GAGAGAGA:GAGAGA
NM_000038.6(APC):c.3473_3474insGA (p.Pro1159fs)	APC		not provided	Pathogenic(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	VCV000181834	5	112174764 - 112174765	5	112839067 - 112839068	181834	180201	rs730881272	NC_000005.10:112839067::GA
NM_000038.6(APC):c.3602C>G (p.Ser1201Ter)	APC	S1183*, S1201*, S1142*, S1211*, S1173*, S1075*, S1100*, S1160*, S918*, S1041*, S1110*, S1176*, S1219*	not provided	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000181803	5	112174893	5	112839196	181803	180203	rs730881247	NC_000005.10:112839195:C:G
NM_000038.6(APC):c.531+5G>A	APC		not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000127305	5	112111439	5	112775742	127305	132762	rs587779798	NC_000005.10:112775741:G:A
NM_000038.6(APC):c.4875del (p.Gln1625fs)	APC	Q1342fs, Q1465fs, Q1643fs, Q1524fs, Q1584fs, Q1499fs, Q1566fs, Q1597fs, Q1600fs, Q1607fs, Q1625fs, Q1534fs, Q1635fs	not provided	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000127299	5	112176165	5	112840468	127299	132756	rs587779794	NC_000005.10:112840467:AA:A
NM_000038.6(APC):c.3472A>T (p.Arg1158Ter)	APC	R1158*, R1140*, R1032*, R998*, R1057*, R1168*, R1117*, R1133*, R1176*, R875*, R1067*, R1099*, R1130*	not provided	Pathogenic(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	VCV000127289	5	112174763	5	112839066	127289	132746	rs587779790	NC_000005.10:112839065:A:T
NM_000038.6(APC):c.2805del (p.Thr934_Tyr935insTer)	APC		not provided	Pathogenic(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	VCV000092344	5	112174096	5	112838399	92344	98255	rs398123120	NC_000005.10:112838398:C:
NM_000038.6(APC):c.2731G>T (p.Glu911Ter)	APC	E893*, E911*, E852*, E929*, E870*, E883*, E886*, E921*, E751*, E785*, E810*, E820*, E628*	not provided	Pathogenic(Last reviewed: Mar 14, 2013)	criteria provided, single submitter	VCV000092343	5	112174022	5	112838325	92343	98254	rs398123119	NC_000005.10:112838324:G:T
NM_000038.6(APC):c.7794_7797CAAA[1] (p.Gln2600fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000827255	5	112179085 - 112179088	5	112843388 - 112843391	827255	808268		NC_000005.10:112843387:CAAACAAA:CAAA
NM_000038.6(APC):c.7580_7581AT[1] (p.Ile2528fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000827138	5	112178871 - 112178872	5	112843174 - 112843175	827138	808252		NC_000005.10:112843173:ATAT:AT
NM_000038.6(APC):c.750_751dup (p.Glu251fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000827089	5	112136995 - 112136996	5	112801298 - 112801299	827089	807832		NC_000005.10:112801298:TG:TGTG
NM_000038.6(APC):c.7395_7398del (p.Ser2466fs)	APC	S2183fs, S2340fs, S2407fs, S2441fs, S2365fs, S2448fs, S2466fs, S2306fs, S2375fs, S2425fs, S2438fs, S2476fs, S2484fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000827015	5	112178683 - 112178686	5	112842986 - 112842989	827015	808235		NC_000005.10:112842985:TCTTTCT:TCT
NM_000038.6(APC):c.7295C>G (p.Ser2432Ter)	APC	S2149*, S2306*, S2404*, S2341*, S2373*, S2391*, S2414*, S2432*, S2442*, S2272*, S2331*, S2407*, S2450*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000826949	5	112178586	5	112842889	826949	808230		NC_000005.10:112842888:C:G
NM_000038.6(APC):c.7114C>T (p.Gln2372Ter)	APC	Q2089*, Q2246*, Q2313*, Q2382*, Q2390*, Q2212*, Q2344*, Q2347*, Q2354*, Q2281*, Q2271*, Q2331*, Q2372*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000826849	5	112178405	5	112842708	826849	808225		NC_000005.10:112842707:C:T
NM_000038.6(APC):c.6742A>T (p.Lys2248Ter)	APC	K1965*, K2122*, K2147*, K2223*, K2230*, K2088*, K2248*, K2258*, K2189*, K2220*, K2266*, K2157*, K2207*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000826596	5	112178033	5	112842336	826596	808206		NC_000005.10:112842335:A:T
NM_000038.6(APC):c.6623_6627del (p.Glu2208fs)	APC	E2117fs, E2167fs, E2183fs, E2226fs, E1925fs, E2180fs, E2149fs, E2190fs, E2208fs, E2218fs, E2048fs, E2082fs, E2107fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000826515	5	112177914 - 112177918	5	112842217 - 112842221	826515	808195		NC_000005.10:112842216:AAATT:
NM_000038.6(APC):c.6555_6559del (p.Ser2185fs)	APC	S2025fs, S2126fs, S2144fs, S1902fs, S2084fs, S2094fs, S2157fs, S2160fs, S2185fs, S2203fs, S2059fs, S2167fs, S2195fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000826482	5	112177842 - 112177846	5	112842145 - 112842149	826482	808186		NC_000005.10:112842144:AAAGTAAAG:AAAG
NM_000038.6(APC):c.556A>T (p.Arg186Ter)	APC	R161*, R127*, R196*, R186*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000825835	5	112116511	5	112780814	825835	807820		NC_000005.10:112780813:A:T
NM_000038.6(APC):c.5228_5241del (p.Val1743fs)	APC	V1617fs, V1642fs, V1652fs, V1684fs, V1715fs, V1725fs, V1753fs, V1761fs, V1583fs, V1702fs, V1718fs, V1460fs, V1743fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000825569	5	112176517 - 112176530	5	112840820 - 112840833	825569	808117		NC_000005.10:112840819:TGTGAAAAAGATAATG:TG
NM_000038.6(APC):c.509_516del (p.Asp170fs)	APC	D111fs, D145fs, D170fs, D180fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000825430	5	112111412 - 112111419	5	112775715 - 112775722	825430	807814		NC_000005.10:112775714:ATAGTCTT:
NM_000038.6(APC):c.4604dup (p.Asn1535fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000825037	5	112175893 - 112175894	5	112840196 - 112840197	825037	808079		NC_000005.10:112840196:AA:AAA
NM_000038.6(APC):c.4508del (p.Ser1503fs)	APC	S1220fs, S1462fs, S1475fs, S1503fs, S1402fs, S1412fs, S1444fs, S1343fs, S1377fs, S1485fs, S1513fs, S1478fs, S1521fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000824955	5	112175799	5	112840102	824955	808073		NC_000005.10:112840101:C:
NM_000038.6(APC):c.423-3_456del	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000824702	5	112111321 - 112111357	5	112775624 - 112775660	824702	815322		NC_000005.10:112775623:AATAGGTCATTGCTTCTTGCTGATCTTGACAAAGAAGAA:AA
NM_000038.6(APC):c.4142del (p.Pro1381fs)	APC	P1098fs, P1399fs, P1280fs, P1353fs, P1356fs, P1221fs, P1255fs, P1290fs, P1363fs, P1322fs, P1340fs, P1381fs, P1391fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000824624	5	112175430	5	112839733	824624	808052		NC_000005.10:112839732:CCCC:CCC
NM_000038.6(APC):c.4054_4063dup (p.Ser1355delinsCysTer)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000824541	5	112175343 - 112175344	5	112839646 - 112839647	824541	808044		NC_000005.10:112839646:TGTTGAATTTT:TGTTGAATTTTGTTGAATTTT
NM_000038.6(APC):c.4028_4029del (p.Ser1343fs)	APC	S1217fs, S1302fs, S1060fs, S1284fs, S1325fs, S1252fs, S1315fs, S1318fs, S1343fs, S1353fs, S1361fs, S1183fs, S1242fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000824521	5	112175318 - 112175319	5	112839621 - 112839622	824521	808040		NC_000005.10:112839620:TCT:T
NM_000038.6(APC):c.3892dup (p.Ser1298fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000824346	5	112175181 - 112175182	5	112839484 - 112839485	824346	808029		NC_000005.10:112839484:TT:TTT
NM_000038.6(APC):c.3861dup (p.Gly1288fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000824316	5	112175151 - 112175152	5	112839454 - 112839455	824316	808028		NC_000005.10:112839454:A:AA
NM_000038.6(APC):c.3805dup (p.Ile1269fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000824241	5	112175094 - 112175095	5	112839397 - 112839398	824241	808026		NC_000005.10:112839397:AA:AAA
NM_000038.6(APC):c.3769G>T (p.Glu1257Ter)	APC	E1097*, E1216*, E974*, E1156*, E1239*, E1257*, E1267*, E1131*, E1198*, E1229*, E1232*, E1275*, E1166*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000824181	5	112175060	5	112839363	824181	808024		NC_000005.10:112839362:G:T
NM_000038.6(APC):c.3385_3386del (p.Leu1129fs)	APC	L1028fs, L1104fs, L1111fs, L846fs, L1003fs, L1038fs, L1101fs, L1139fs, L1070fs, L1088fs, L1129fs, L1147fs, L969fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000823696	5	112174675 - 112174676	5	112838978 - 112838979	823696	808004		NC_000005.10:112838977:TTT:T
NM_000038.6(APC):c.3268C>T (p.Gln1090Ter)	APC	Q1031*, Q1062*, Q1065*, Q964*, Q1049*, Q1090*, Q1100*, Q807*, Q999*, Q1108*, Q1072*, Q930*, Q989*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000823353	5	112174559	5	112838862	823353	807993		NC_000005.10:112838861:C:T
NM_000038.6(APC):c.3060del (p.Glu1020fs)	APC	E919fs, E992fs, E961fs, E979fs, E1002fs, E1030fs, E1038fs, E1020fs, E737fs, E860fs, E894fs, E929fs, E995fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000822767	5	112174350	5	112838653	822767	807984		NC_000005.10:112838652:AA:A
NM_000038.6(APC):c.881del (p.Ser294fs)	APC	S269fs, S11fs, S235fs, S266fs, S276fs, S294fs, S304fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000822756	5	112151238	5	112815541	822756	807838		NC_000005.10:112815540:C:
NM_000038.6(APC):c.3060_3062delinsTAATTGG (p.Glu1020fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000822749	5	112174351 - 112174353	5	112838654 - 112838656	822749	807985		NC_000005.10:112838653:ACT:TAATTGG
NM_000038.6(APC):c.277del (p.Leu93fs)	APC	L68fs, L103fs, L34fs, L93fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000821798	5	112102940	5	112767243	821798	807799		NC_000005.10:112767242:CCC:CC
NM_000038.6(APC):c.2681_2683delinsGTATG (p.Val894fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000821672	5	112173972 - 112173974	5	112838275 - 112838277	821672	807960		NC_000005.10:112838274:TGT:GTATG
NM_000038.6(APC):c.2667del (p.Val890fs)	APC	V607fs, V799fs, V865fs, V890fs, V849fs, V900fs, V730fs, V789fs, V862fs, V908fs, V764fs, V831fs, V872fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000821646	5	112173956	5	112838259	821646	807957		NC_000005.10:112838258:AAA:AA
NM_000038.6(APC):c.2303_2304insT (p.Ser770fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000821001	5	112173594 - 112173595	5	112837897 - 112837898	821001	807931		NC_000005.10:112837897::T
NM_000038.6(APC):c.1946del (p.Asn649fs)	APC	N366fs, N548fs, N523fs, N558fs, N590fs, N624fs, N489fs, N608fs, N621fs, N631fs, N649fs, N659fs, N667fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000820395	5	112170848	5	112835151	820395	807917		NC_000005.10:112835150:AAA:AA
NM_000038.6(APC):c.1627-1G>A	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000819698	5	112164552	5	112828855	819698	815329		NC_000005.10:112828854:G:A
NM_000038.6(APC):c.1624C>T (p.Gln542Ter)	APC	Q517*, Q560*, Q259*, Q501*, Q524*, Q552*, Q416*, Q451*, Q514*, Q382*, Q441*, Q483*, Q542*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000819693	5	112163701	5	112828004	819693	807902		NC_000005.10:112828003:C:T
NM_000038.6(APC):c.1525_1527delinsGAGATGTAGCCTTTGAGATGTTGGC (p.Thr509delinsGluMetTer)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000819453	5	112162921 - 112162923	5	112827224 - 112827226	819453	807899		NC_000005.10:112827223:ACT:GAGATGTAGCCTTTGAGATGTTGGC
NM_000038.6(APC):c.145A>T (p.Lys49Ter)	APC	K49*, K24*, K59*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000819274	5	112102032	5	112766335	819274	807792		NC_000005.10:112766334:A:T
NM_000038.6(APC):c.1346del (p.Ala449fs)	APC	A358fs, A390fs, A431fs, A459fs, A166fs, A289fs, A323fs, A348fs, A421fs, A424fs, A449fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000818907	5	112157626	5	112821929	818907	807881		NC_000005.10:112821928:C:
NM_000038.6(APC):c.1286del (p.Pro429fs)	APC	P328fs, P411fs, P303fs, P370fs, P401fs, P439fs, P146fs, P269fs, P338fs, P404fs, P429fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000818804	5	112155014	5	112819317	818804	807875		NC_000005.10:112819316:CC:C
NM_000038.6(APC):c.5986del (p.Gln1996fs)	APC	Q1713fs, Q1836fs, Q1895fs, Q1996fs, Q2006fs, Q1937fs, Q1955fs, Q1968fs, Q1978fs, Q2014fs, Q1870fs, Q1905fs, Q1971fs	not provided	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000801038	5	112177277	5	112841580	801038	789463		NC_000005.10:112841579:C:
NM_000038.6(APC):c.636dup (p.Arg213fs)	APC		not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000619774	5	112116586 - 112116587	5	112780889 - 112780890	619774	611054	rs1561485947	NC_000005.10:112780889:AAAAA:AAAAAA
NM_000038.5(APC):c.(?_-37541)_(-27791_?)del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000495348	5	112036100 - 112045850	5	112700403 - 112710153	495348	487134		
NM_000038.6(APC):c.825del (p.Asn276fs)	APC	N276fs, N251fs, N258fs, N217fs, N286fs, N248fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000486793	5	112137071	5	112801374	486793	473630	rs1554076216	NC_000005.10:112801373:T:
NM_000038.6(APC):c.1606G>T (p.Glu536Ter)	APC	E518*, E536*, E253*, E435*, E495*, E511*, E554*, E376*, E445*, E546*, E477*, E410*, E508*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000486785	5	112163683	5	112827986	486785	473621	rs138098808	NC_000005.10:112827985:G:T
NM_000038.6(APC):c.4067C>G (p.Ser1356Ter)	APC	S1356*, S1338*, S1265*, S1374*, S1331*, S1196*, S1255*, S1297*, S1315*, S1328*, S1366*, S1073*, S1230*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000486783	5	112175358	5	112839661	486783	473764	rs1554085480	NC_000005.10:112839660:C:G
NM_000038.6(APC):c.4770del (p.Ala1591fs)	APC	A1500fs, A1573fs, A1308fs, A1431fs, A1465fs, A1550fs, A1601fs, A1609fs, A1490fs, A1532fs, A1563fs, A1566fs, A1591fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000486781	5	112176059	5	112840362	486781	474054	rs1554086182	NC_000005.10:112840361:AAA:AA
NM_000038.6(APC):c.1358del (p.Leu453fs)	APC	L327fs, L435fs, L170fs, L293fs, L394fs, L362fs, L428fs, L453fs, L352fs, L425fs, L463fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000486779	5	112157638	5	112821941	486779	473577	rs1554080702	NC_000005.10:112821940:T:
NM_000038.6(APC):c.6390_6391del (p.Asp2131fs)	APC	D2040fs, D2103fs, D2090fs, D2149fs, D1848fs, D1971fs, D2072fs, D2113fs, D2141fs, D2005fs, D2030fs, D2106fs, D2131fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000486777	5	112177681 - 112177682	5	112841984 - 112841985	486777	473845	rs1554087390	NC_000005.10:112841983:TG:
NM_000038.6(APC):c.1246_1249del (p.Tyr416fs)	APC	Y133fs, Y398fs, Y290fs, Y325fs, Y426fs, Y256fs, Y388fs, Y416fs, Y315fs, Y357fs, Y391fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000486768	5	112154973 - 112154976	5	112819276 - 112819279	486768	473573	rs1554080089	NC_000005.10:112819275:CTTACT:CT
NM_000038.6(APC):c.2656C>T (p.Gln886Ter)	APC	Q868*, Q886*, Q603*, Q845*, Q858*, Q861*, Q726*, Q785*, Q795*, Q896*, Q904*, Q760*, Q827*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000486755	5	112173947	5	112838250	486755	473713	rs755806668	NC_000005.10:112838249:C:T
NM_000038.6(APC):c.5920del (p.Asp1974fs)	APC	D1814fs, D1848fs, D1883fs, D1933fs, D1984fs, D1915fs, D1946fs, D1949fs, D1974fs, D1992fs, D1691fs, D1873fs, D1956fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000486744	5	112177211	5	112841514	486744	473879	rs1554087070	NC_000005.10:112841513:G:
NM_000038.6(APC):c.4682del (p.Lys1561fs)	APC	K1536fs, K1571fs, K1460fs, K1520fs, K1533fs, K1543fs, K1561fs, K1579fs, K1278fs, K1401fs, K1435fs, K1470fs, K1502fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000485155	5	112175970	5	112840273	485155	473774	rs1114167552	NC_000005.10:112840272:AAAA:AAA
NM_000038.6(APC):c.4141_4142insGGTC (p.Pro1381fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000485143	5	112175431 - 112175432	5	112839734 - 112839735	485143	473761	rs1554085560	NC_000005.10:112839734:C:CGGTC
NM_000038.6(APC):c.7744del (p.Glu2582fs)	APC	E2299fs, E2422fs, E2456fs, E2554fs, E2592fs, E2491fs, E2523fs, E2481fs, E2541fs, E2582fs, E2600fs, E2557fs, E2564fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000482518	5	112179035	5	112843338	482518	474026	rs1554088632	NC_000005.10:112843337:G:
NM_000038.6(APC):c.1431del (p.Glu477fs)	APC	E317fs, E351fs, E495fs, E194fs, E459fs, E436fs, E449fs, E477fs, E376fs, E386fs, E418fs, E452fs, E487fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000482500	5	112162826	5	112827129	482500	473898	rs1554081640	NC_000005.10:112827128:AA:A
NM_000038.6(APC):c.7271C>G (p.Ser2424Ter)	APC	S2424*, S2406*, S2264*, S2333*, S2434*, S2141*, S2298*, S2323*, S2383*, S2442*, S2365*, S2396*, S2399*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000482410	5	112178562	5	112842865	482410	474115	rs1554088206	NC_000005.10:112842864:C:G
NM_000038.6(APC):c.22C>T (p.Gln8Ter)	APC	Q8*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000482401	5	112090609	5	112754912	482401	473772	rs1554067110	NC_000005.10:112754911:C:T
NM_000038.6(APC):c.4950_4951dup (p.Phe1651fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000482332	5	112176240 - 112176241	5	112840543 - 112840544	482332	474062	rs1554086324	NC_000005.10:112840543:CT:CTCT
NM_000038.6(APC):c.1141del (p.Ala381fs)	APC	A353fs, A322fs, A363fs, A381fs, A391fs, A98fs, A356fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	VCV000482328	5	112154868	5	112819171	482328	473890	rs1554080036	NC_000005.10:112819170:GGG:GG
NM_000038.6(APC):c.506_510del (p.Ile169fs)	APC	I144fs, I169fs, I110fs, I179fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000482303	5	112111409 - 112111413	5	112775712 - 112775716	482303	473540	rs1554071607	NC_000005.10:112775711:TAGAT:
NM_000038.6(APC):c.7960del (p.Thr2654fs)	APC	T2563fs, T2626fs, T2629fs, T2613fs, T2371fs, T2494fs, T2528fs, T2595fs, T2553fs, T2636fs, T2654fs, T2664fs, T2672fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 7, 2012)	criteria provided, single submitter	VCV000433678	5	112179248	5	112843551	433678	427315	rs1305971005	NC_000005.10:112843550:AAAA:AAA
NM_000038.6(APC):c.6135del (p.Ala2046fs)	APC	A1945fs, A2021fs, A2046fs, A1763fs, A1920fs, A1955fs, A2028fs, A2056fs, A2064fs, A1886fs, A1987fs, A2005fs, A2018fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433673	5	112177425	5	112841728	433673	427310	rs1554087239	NC_000005.10:112841727:CC:C
NM_000038.6(APC):c.5978del (p.Pro1993fs)	APC	P1833fs, P1902fs, P1952fs, P1965fs, P2003fs, P1934fs, P1867fs, P1975fs, P2011fs, P1710fs, P1892fs, P1968fs, P1993fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433672	5	112177265	5	112841568	433672	427309	rs1554087123	NC_000005.10:112841567:CCCCC:CCCC
NM_000038.6(APC):c.5541del (p.Pro1848fs)	APC	P1688fs, P1757fs, P1830fs, P1565fs, P1807fs, P1820fs, P1848fs, P1747fs, P1789fs, P1722fs, P1823fs, P1858fs, P1866fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Jul 5, 2013)	criteria provided, single submitter	VCV000433671	5	112176832	5	112841135	433671	427308	rs1554086805	NC_000005.10:112841134:G:
NM_000038.6(APC):c.5017G>T (p.Glu1673Ter)	APC	E1655*, E1673*, E1390*, E1547*, E1572*, E1648*, E1683*, E1632*, E1645*, E1513*, E1582*, E1614*, E1691*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	VCV000433670	5	112176308	5	112840611	433670	427307	rs587779796	NC_000005.10:112840610:G:T
NM_000038.6(APC):c.4953_4954del (p.Ser1652fs)	APC	S1551fs, S1561fs, S1611fs, S1624fs, S1652fs, S1670fs, S1492fs, S1627fs, S1369fs, S1662fs, S1526fs, S1593fs, S1634fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433669	5	112176242 - 112176243	5	112840545 - 112840546	433669	427306	rs1554086327	NC_000005.10:112840544:TTTT:TT
NM_000038.6(APC):c.4735_4736del (p.Ile1579fs)	APC	I1538fs, I1554fs, I1579fs, I1589fs, I1488fs, I1551fs, I1597fs, I1296fs, I1419fs, I1453fs, I1478fs, I1520fs, I1561fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433667	5	112176025 - 112176026	5	112840328 - 112840329	433667	427304	rs1554086138	NC_000005.10:112840327:TAT:T
NM_000038.6(APC):c.4726G>T (p.Glu1576Ter)	APC	E1558*, E1576*, E1450*, E1475*, E1551*, E1293*, E1594*, E1485*, E1517*, E1535*, E1548*, E1586*, E1416*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433666	5	112176017	5	112840320	433666	427303	rs1554086134	NC_000005.10:112840319:G:T
NM_000038.6(APC):c.4671del (p.Ile1557fs)	APC	I1532fs, I1557fs, I1397fs, I1456fs, I1498fs, I1431fs, I1466fs, I1529fs, I1575fs, I1274fs, I1516fs, I1539fs, I1567fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433665	5	112175961	5	112840264	433665	427302	rs1554086084	NC_000005.10:112840263:TT:T
NM_000038.6(APC):c.4660G>T (p.Glu1554Ter)	APC	E1536*, E1554*, E1271*, E1513*, E1428*, E1526*, E1564*, E1453*, E1394*, E1463*, E1495*, E1529*, E1572*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433664	5	112175951	5	112840254	433664	427301	rs1392778905	NC_000005.10:112840253:G:T
NM_000038.6(APC):c.4645dup (p.Gln1549fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Oct 10, 2014)	criteria provided, single submitter	VCV000433663	5	112175934 - 112175935	5	112840237 - 112840238	433663	427300	rs1554086036	NC_000005.10:112840237:CC:CCC
NM_000038.6(APC):c.4405C>T (p.Gln1469Ter)	APC	Q1451*, Q1469*, Q1186*, Q1368*, Q1444*, Q1487*, Q1378*, Q1410*, Q1428*, Q1441*, Q1309*, Q1479*, Q1343*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433662	5	112175696	5	112839999	433662	427299	rs1060503288	NC_000005.10:112839998:C:T
NM_000038.6(APC):c.4384_4385del (p.Lys1462fs)	APC	K1302fs, K1403fs, K1179fs, K1336fs, K1361fs, K1437fs, K1371fs, K1444fs, K1462fs, K1480fs, K1421fs, K1434fs, K1472fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Jul 19, 2012)	criteria provided, single submitter	VCV000433661	5	112175673 - 112175674	5	112839976 - 112839977	433661	427298	rs1554085846	NC_000005.10:112839975:AAAA:AA
NM_000038.6(APC):c.4353del (p.Val1452fs)	APC	V1434fs, V1462fs, V1393fs, V1411fs, V1351fs, V1361fs, V1424fs, V1452fs, V1470fs, V1169fs, V1292fs, V1326fs, V1427fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433660	5	112175643	5	112839946	433660	427297	rs1554085817	NC_000005.10:112839945:AA:A
NM_000038.6(APC):c.4241del (p.Val1414fs)	APC	V1373fs, V1389fs, V1131fs, V1288fs, V1313fs, V1396fs, V1432fs, V1254fs, V1323fs, V1355fs, V1386fs, V1414fs, V1424fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433659	5	112175532	5	112839835	433659	427296	rs1554085659	NC_000005.10:112839834:T:
NM_000038.6(APC):c.4060delinsAA (p.Phe1354fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000433657	5	112175351	5	112839654	433657	427294	rs1554085479	NC_000005.10:112839653:T:AA
NM_000038.6(APC):c.3827_3829delinsA (p.Ser1276fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000433655	5	112175118 - 112175120	5	112839421 - 112839423	433655	427292	rs1554085335	NC_000005.10:112839420:CAT:A
NM_000038.6(APC):c.3786_3787del (p.Tyr1262_Cys1263delinsTer)	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433654	5	112175077 - 112175078	5	112839380 - 112839381	433654	427291	rs1554085307	NC_000005.10:112839379:TT:
NM_000038.6(APC):c.3766C>T (p.Gln1256Ter)	APC	Q1238*, Q1256*, Q1228*, Q1266*, Q1096*, Q1155*, Q1165*, Q1215*, Q1231*, Q1274*, Q973*, Q1130*, Q1197*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433653	5	112175057	5	112839360	433653	427290	rs77056664	NC_000005.10:112839359:C:T
NM_000038.6(APC):c.3725del (p.Gln1242fs)	APC	Q1116fs, Q1151fs, Q1201fs, Q1214fs, Q1217fs, Q1252fs, Q1183fs, Q1224fs, Q1260fs, Q1082fs, Q1141fs, Q1242fs, Q959fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433652	5	112175016	5	112839319	433652	427289	rs1554085258	NC_000005.10:112839318:A:
NM_000038.6(APC):c.3707_3708CA[1] (p.Gln1237fs)	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433651	5	112174998 - 112174999	5	112839301 - 112839302	433651	427288	rs1554085246	NC_000005.10:112839300:CACA:CA
NM_000038.6(APC):c.3682C>T (p.Gln1228Ter)	APC	Q1210*, Q1228*, Q1187*, Q1200*, Q1203*, Q1246*, Q945*, Q1102*, Q1137*, Q1169*, Q1068*, Q1127*, Q1238*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 27, 2015)	criteria provided, single submitter	VCV000433650	5	112174973	5	112839276	433650	427287	rs1554085227	NC_000005.10:112839275:C:T
NM_000038.6(APC):c.3567dup (p.Ser1190fs)	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433649	5	112174857 - 112174858	5	112839160 - 112839161	433649	427286	rs1554085117	NC_000005.10:112839160:A:AA
NM_000038.6(APC):c.3542T>A (p.Leu1181Ter)	APC	L1163*, L1181*, L1021*, L1090*, L1140*, L1153*, L1122*, L1199*, L898*, L1055*, L1191*, L1080*, L1156*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000433648	5	112174833	5	112839136	433648	427285	rs1554085102	NC_000005.10:112839135:T:A
NM_000038.6(APC):c.3497_3501del (p.Lys1165_Tyr1166insTer)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000433647	5	112174785 - 112174789	5	112839088 - 112839092	433647	427284	rs1554085053	NC_000005.10:112839087:AATATAAT:AAT
NM_000038.6(APC):c.3467_3470del (p.Glu1156fs)	APC	E1030fs, E1097fs, E1166fs, E1131fs, E1174fs, E996fs, E1128fs, E1138fs, E1055fs, E1065fs, E1115fs, E1156fs, E873fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433646	5	112174758 - 112174761	5	112839061 - 112839064	433646	427283	rs1554085029	NC_000005.10:112839060:AAGA:
NM_000038.6(APC):c.3454C>T (p.Gln1152Ter)	APC	Q1134*, Q1152*, Q1026*, Q1061*, Q1111*, Q1124*, Q1127*, Q1170*, Q1051*, Q1162*, Q992*, Q869*, Q1093*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 28, 2012)	criteria provided, single submitter	VCV000433645	5	112174745	5	112839048	433645	427282	rs1064795228	NC_000005.10:112839047:C:T
NM_000038.6(APC):c.3190G>T (p.Glu1064Ter)	APC	E1046*, E1064*, E1039*, E904*, E973*, E1005*, E938*, E963*, E1023*, E1036*, E1074*, E1082*, E781*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Jan 2, 2013)	criteria provided, single submitter	VCV000433643	5	112174481	5	112838784	433643	427280	rs1462312032	NC_000005.10:112838783:G:T
NM_000038.6(APC):c.3114_3115del (p.Gly1039fs)	APC	G1011fs, G1049fs, G879fs, G938fs, G1021fs, G913fs, G948fs, G980fs, G998fs, G1014fs, G1039fs, G1057fs, G756fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433642	5	112174405 - 112174406	5	112838708 - 112838709	433642	427279	rs1554084698	NC_000005.10:112838707:TG:
NM_000038.6(APC):c.3028del (p.Ser1010fs)	APC	S1010fs, S727fs, S850fs, S884fs, S909fs, S969fs, S1028fs, S985fs, S1020fs, S919fs, S951fs, S982fs, S992fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433640	5	112174319	5	112838622	433640	427277	rs1554084648	NC_000005.10:112838621:A:
NM_000038.6(APC):c.2995C>T (p.Gln999Ter)	APC	Q981*, Q999*, Q716*, Q873*, Q898*, Q940*, Q1017*, Q839*, Q1009*, Q908*, Q958*, Q971*, Q974*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433639	5	112174286	5	112838589	433639	427276	rs75239284	NC_000005.10:112838588:C:T
NM_000038.6(APC):c.2950G>T (p.Glu984Ter)	APC	E966*, E984*, E824*, E883*, E893*, E959*, E994*, E956*, E1002*, E701*, E858*, E925*, E943*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000433638	5	112174241	5	112838544	433638	427275	rs1254176854	NC_000005.10:112838543:G:T
NM_000038.6(APC):c.2938A>T (p.Lys980Ter)	APC	K962*, K980*, K854*, K879*, K921*, K889*, K939*, K952*, K990*, K998*, K697*, K820*, K955*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433637	5	112174229	5	112838532	433637	427274	rs1554084592	NC_000005.10:112838531:A:T
NM_000038.6(APC):c.2895_2896del (p.Asn965fs)	APC	N805fs, N839fs, N937fs, N947fs, N975fs, N682fs, N864fs, N940fs, N965fs, N983fs, N874fs, N906fs, N924fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433636	5	112174185 - 112174186	5	112838488 - 112838489	433636	427273	rs1554084576	NC_000005.10:112838487:ATA:A
NM_000038.6(APC):c.2819del (p.Ser940fs)	APC	S814fs, S915fs, S958fs, S912fs, S950fs, S657fs, S881fs, S922fs, S940fs, S780fs, S839fs, S849fs, S899fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 1, 2013)	criteria provided, single submitter	VCV000433635	5	112174110	5	112838413	433635	427272	rs1554084508	NC_000005.10:112838412:C:
NM_000038.6(APC):c.2694del (p.His898fs)	APC	H615fs, H738fs, H772fs, H857fs, H908fs, H916fs, H797fs, H807fs, H870fs, H873fs, H898fs, H839fs, H880fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433633	5	112173985	5	112838288	433633	427270	rs1554084389	NC_000005.10:112838287:T:
NM_000038.6(APC):c.2186_2187insGCAGCTT (p.Met730fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Jan 24, 2013)	criteria provided, single submitter	VCV000433632	5	112173476 - 112173477	5	112837779 - 112837780	433632	427269	rs1554083998	NC_000005.10:112837779:T:TGCAGCTT
NM_000038.6(APC):c.2093T>G (p.Leu698Ter)	APC	L680*, L698*, L538*, L657*, L597*, L607*, L673*, L716*, L572*, L639*, L670*, L708*, L415*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433631	5	112173384	5	112837687	433631	427268	rs137854582	NC_000005.10:112837686:T:G
NM_000038.6(APC):c.1787C>G (p.Ser596Ter)	APC	S578*, S596*, S606*, S436*, S470*, S495*, S568*, S614*, S313*, S505*, S555*, S537*, S571*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433628	5	112170691	5	112834994	433628	427265	rs1554083134	NC_000005.10:112834993:C:G
NM_000038.6(APC):c.1766_1767dup (p.Ser590Ter)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 17, 2015)	criteria provided, single submitter	VCV000433626	5	112170669 - 112170670	5	112834972 - 112834973	433626	427263	rs1554083122	NC_000005.10:112834972:TG:TGTG
NM_000038.6(APC):c.1605_1606del (p.Glu536fs)	APC	E410fs, E508fs, E253fs, E376fs, E445fs, E495fs, E511fs, E536fs, E546fs, E435fs, E477fs, E518fs, E554fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433624	5	112163682 - 112163683	5	112827985 - 112827986	433624	427261	rs1554081906	NC_000005.10:112827984:TG:
NM_000038.6(APC):c.1409-1G>A	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Jan 23, 2013)	criteria provided, single submitter	VCV000433621	5	112162804	5	112827107	433621	427258	rs863225313	NC_000005.10:112827106:G:A
NM_000038.6(APC):c.1343dup (p.Ala449fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000433618	5	112157621 - 112157622	5	112821924 - 112821925	433618	427255	rs1554080695	NC_000005.10:112821924:CC:CCC
NM_000038.6(APC):c.1213del (p.Arg405fs)	APC	R122fs, R377fs, R387fs, R346fs, R380fs, R405fs, R415fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433617	5	112154941	5	112819244	433617	427254	rs1554080070	NC_000005.10:112819243:CC:C
NM_000038.6(APC):c.889_890AC[2] (p.His298fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: May 12, 2014)	criteria provided, single submitter	VCV000433615	5	112151245 - 112151246	5	112815548 - 112815549	433615	427252	rs1114167567	NC_000005.10:112815547:CACACAC:CACAC
NM_000038.6(APC):c.730-1G>C	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433613	5	112136975	5	112801278	433613	427250	rs1554076129	NC_000005.10:112801277:G:C
NM_000038.6(APC):c.706C>T (p.Gln236Ter)	APC	Q236*, Q177*, Q246*, Q211*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000433612	5	112128203	5	112792506	433612	427249	rs1554074786	NC_000005.10:112792505:C:T
NM_000038.6(APC):c.685delinsTT (p.Leu229fs)	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433611	5	112128182	5	112792485	433611	427248	rs1554074762	NC_000005.10:112792484:C:TT
NM_000038.6(APC):c.646-1G>C	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Jun 1, 2012)	criteria provided, single submitter	VCV000433609	5	112128142	5	112792445	433609	427246	rs78847145	NC_000005.10:112792444:G:C
NM_000038.6(APC):c.594dup (p.Ala199fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Jul 25, 2012)	criteria provided, single submitter	VCV000433607	5	112116547 - 112116548	5	112780850 - 112780851	433607	427244	rs1554072616	NC_000005.10:112780850:TT:TTT
NM_000038.6(APC):c.539T>A (p.Leu180Ter)	APC	L180*, L190*, L155*, L121*	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433606	5	112116494	5	112780797	433606	427243	rs1554072560	NC_000005.10:112780796:T:A
NM_000038.6(APC):c.502del (p.Arg168fs)	APC	R109fs, R178fs, R143fs, R168fs	Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433604	5	112111402	5	112775705	433604	427241	rs1554071602	NC_000005.10:112775704:AAAA:AAA
NM_000038.6(APC):c.492_495del (p.Asn164fs)	APC	N105fs, N164fs, N139fs, N174fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000433603	5	112111395 - 112111398	5	112775698 - 112775701	433603	427240	rs1554071590	NC_000005.10:112775697:TCTC:
NM_000038.6(APC):c.472dup (p.Tyr158fs)	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	VCV000433602	5	112111374 - 112111375	5	112775677 - 112775678	433602	427239	rs1554071555	NC_000005.10:112775677:T:TT
NM_000038.6(APC):c.458del (p.Lys153fs)	APC	K153fs, K128fs, K163fs, K94fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: May 22, 2012)	criteria provided, single submitter	VCV000433601	5	112111358	5	112775661	433601	427238	rs1554071521	NC_000005.10:112775660:AAAA:AAA
NM_000038.6(APC):c.346_359del (p.Gly116fs)	APC	G57fs, G116fs, G126fs, G91fs	Familial adenomatous polyposis	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000433600	5	112103010 - 112103023	5	112767313 - 112767326	433600	427237	rs1554069805	NC_000005.10:112767312:GGGTTCATTTCCAAG:G
NM_000038.6(APC):c.325G>T (p.Glu109Ter)	APC	E109*, E119*, E84*, E50*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000433599	5	112102990	5	112767293	433599	427236	rs1414406816	NC_000005.10:112767292:G:T
NM_000038.6(APC):c.220+1G>A	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 5, 2014)	criteria provided, single submitter	VCV000433598	5	112102108	5	112766411	433598	427235	rs1554069570	NC_000005.10:112766410:G:A
NM_000038.6(APC):c.203T>G (p.Leu68Ter)	APC	L68*, L78*, L43*, L9*	Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, single submitter	VCV000433597	5	112102090	5	112766393	433597	427234	rs1554069549	NC_000005.10:112766392:T:G
NM_000038.5(APC):c.3146-?_8532+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000433572	5	112174437 - 112179823			433572	427585		
NM_000038.5(APC):c.2155-?_3960+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000433571	5	112173446 - 112175251			433571	427584		
NM_000038.5(APC):c.1409-?_1626+?del	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433570					433570	427233		
NM_000038.5(APC):c.1313-?_8532+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Jan 18, 2013)	criteria provided, single submitter	VCV000433569	5	112157593 - 112179823			433569	427583		
NM_000038.5(APC):c.423-?_729+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	VCV000433568					433568	427232		
NM_000038.5(APC):c.1-?_8532+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	VCV000433567	5	112090588 - 112179823			433567	427582		
NM_000038.5(APC):c.1-?_1958+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000433566	5	112090588 - 112170862			433566	427581		
NM_000038.5(APC):c.1-?_1408+?del	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433565	5	112090588 - 112157688			433565	427580		
NM_000038.5(APC):c.-85-?_1743+?del	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433564					433564	427231		
NM_000038.5(APC):c.-85-?_1048+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Mar 18, 2015)	criteria provided, single submitter	VCV000433563	5	112073556 - 112154777			433563	427579		
NM_000038.5(APC):c.-85-?_-19+?del	APC		Familial adenomatous polyposis	Pathogenic	criteria provided, single submitter	VCV000433562					433562	427229		
NM_000038.5(APC):c.-85-?_834+?del	APC		Familial adenomatous polyposis	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000433561					433561	427230		
NM_000038.6(APC):c.4167dup (p.Val1390fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	VCV000429059	5	112175457 - 112175458	5	112839760 - 112839761	429059	421033	rs1131691146	NC_000005.10:112839760:T:TT
NM_000038.6(APC):c.4474del (p.Ala1492fs)	APC	A1401fs, A1492fs, A1502fs, A1391fs, A1433fs, A1467fs, A1510fs, A1366fs, A1474fs, A1209fs, A1332fs, A1451fs, A1464fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000429057	5	112175765	5	112840068	429057	421035	rs1131691144	NC_000005.10:112840067:G:
NM_000038.6(APC):c.2036dup (p.Asn679fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	VCV000429053	5	112173325 - 112173326	5	112837628 - 112837629	429053	421028	rs1131691140	NC_000005.10:112837628:AA:AAA
NM_000038.6(APC):c.2905_2906insC (p.Ser969fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000429051	5	112174196 - 112174197	5	112838499 - 112838500	429051	421031	rs1131691139	NC_000005.10:112838499::C
NM_000038.6(APC):c.1485dup (p.Thr496fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000429048	5	112162879 - 112162880	5	112827182 - 112827183	429048	421025	rs1131691137	NC_000005.10:112827182:TT:TTT
NM_000038.6(APC):c.3386del (p.Leu1129fs)	APC	L1003fs, L1028fs, L1101fs, L1104fs, L1038fs, L1147fs, L969fs, L1070fs, L1088fs, L1139fs, L1111fs, L1129fs, L846fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000428185	5	112174675	5	112838978	428185	419643	rs1114167616	NC_000005.10:112838977:TTT:TT
NM_000038.6(APC):c.1617delinsTGT (p.Leu540fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000428182	5	112163694	5	112827997	428182	419613	rs1114167613	NC_000005.10:112827996:C:TGT
NM_000038.6(APC):c.3300dup (p.Pro1101fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000428177	5	112174590 - 112174591	5	112838893 - 112838894	428177	419641	rs1114167609	NC_000005.10:112838893:T:TT
NM_000038.6(APC):c.762dup (p.His255fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000428173	5	112137007 - 112137008	5	112801310 - 112801311	428173	419598	rs1114167608	NC_000005.10:112801310:A:AA
NM_000038.6(APC):c.1251T>A (p.Cys417Ter)	APC	C399*, C417*, C134*, C316*, C389*, C392*, C427*, C257*, C326*, C291*, C358*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000428172	5	112154980	5	112819283	428172	419605	rs1114167607	NC_000005.10:112819282:T:A
NM_000038.6(APC):c.4890del (p.Ser1631fs)	APC	S1606fs, S1631fs, S1641fs, S1348fs, S1505fs, S1530fs, S1540fs, S1572fs, S1590fs, S1603fs, S1613fs, S1649fs, S1471fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000428170	5	112176180	5	112840483	428170	419663	rs1114167606	NC_000005.10:112840482:TT:T
NM_000038.6(APC):c.6905C>G (p.Ser2302Ter)	APC	S2284*, S2302*, S2142*, S2176*, S2261*, S2019*, S2211*, S2243*, S2277*, S2201*, S2312*, S2320*, S2274*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000428166	5	112178196	5	112842499	428166	419673	rs767372014	NC_000005.10:112842498:C:G
NM_000038.6(APC):c.1464_1467del (p.Thr489fs)	APC	T461fs, T471fs, T388fs, T430fs, T464fs, T489fs, T363fs, T398fs, T448fs, T499fs, T206fs, T329fs, T507fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000428165	5	112162858 - 112162861	5	112827161 - 112827164	428165	419608	rs1114167602	NC_000005.10:112827160:CTTACT:CT
NM_000038.6(APC):c.2185_2336del (p.Leu729fs)	APC	L446fs, L638fs, L711fs, L628fs, L701fs, L704fs, L569fs, L603fs, L729fs, L670fs, L688fs, L739fs, L747fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000428161	5	112173475 - 112173626	5	112837778 - 112837929	428161	419623	rs1554083990	
NM_000038.6(APC):c.3734dup (p.Ala1246fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000428156	5	112175021 - 112175022	5	112839324 - 112839325	428156	419647	rs1114167595	NC_000005.10:112839324:AAAA:AAAAA
NM_000038.6(APC):c.104del (p.Thr35fs)	APC	T35fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 26, 2012)	criteria provided, single submitter	VCV000428154	5	112090691	5	112754994	428154	419589	rs1114167593	NC_000005.10:112754993:C:
NM_000038.6(APC):c.3463_3467del (p.Glu1155fs)	APC	E1029fs, E1165fs, E1173fs, E1096fs, E1114fs, E1127fs, E1130fs, E1137fs, E872fs, E1064fs, E1155fs, E1054fs, E995fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	VCV000428150	5	112174753 - 112174757	5	112839056 - 112839060	428150	419644	rs1114167589	NC_000005.10:112839055:AGAAGA:A
NM_000038.6(APC):c.4737dup (p.Ile1580fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2016)	criteria provided, single submitter	VCV000428148	5	112176026 - 112176027	5	112840329 - 112840330	428148	419662	rs1114167587	NC_000005.10:112840329:TT:TTT
NM_000038.6(APC):c.2129del (p.Leu710fs)	APC	L651fs, L682fs, L710fs, L550fs, L669fs, L692fs, L720fs, L728fs, L427fs, L584fs, L609fs, L619fs, L685fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000428144	5	112173420	5	112837723	428144	419622	rs1114167584	NC_000005.10:112837722:T:
NM_000038.6(APC):c.3183dup (p.Gln1062fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000428141	5	112174470 - 112174471	5	112838773 - 112838774	428141	419638	rs1114167582	NC_000005.10:112838773:AAAA:AAAAA
NM_000038.6(APC):c.4463del (p.Leu1488fs)	APC	L1447fs, L1429fs, L1460fs, L1470fs, L1488fs, L1498fs, L1205fs, L1362fs, L1328fs, L1387fs, L1397fs, L1463fs, L1506fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000428136	5	112175752	5	112840055	428136	419655	rs1114167577	NC_000005.10:112840054:TTT:TT
NM_000038.6(APC):c.2496_2502del (p.Ser833fs)	APC	S673fs, S550fs, S707fs, S732fs, S742fs, S792fs, S805fs, S843fs, S851fs, S774fs, S808fs, S833fs, S815fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 25, 2015)	criteria provided, single submitter	VCV000428133	5	112173785 - 112173791	5	112838088 - 112838094	428133	419626	rs1114167576	NC_000005.10:112838087:CCCAGCTCC:CC
NM_000038.6(APC):c.2426del (p.Asn809fs)	APC	N526fs, N718fs, N784fs, N809fs, N819fs, N649fs, N683fs, N827fs, N708fs, N750fs, N781fs, N768fs, N791fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	VCV000428130	5	112173716	5	112838019	428130	419625	rs1114167573	NC_000005.10:112838018:AA:A
NM_000038.6(APC):c.3757del (p.Ser1253fs)	APC	S1235fs, S1253fs, S1263fs, S1271fs, S1093fs, S1127fs, S1162fs, S1152fs, S1194fs, S1225fs, S1228fs, S1212fs, S970fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000428127	5	112175047	5	112839350	428127	419649	rs1114167571	NC_000005.10:112839349:TT:T
NM_000038.6(APC):c.4054del (p.Val1352fs)	APC	V1251fs, V1334fs, V1352fs, V1192fs, V1226fs, V1311fs, V1327fs, V1370fs, V1261fs, V1069fs, V1362fs, V1293fs, V1324fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 26, 2014)	criteria provided, single submitter	VCV000428120	5	112175345	5	112839648	428120	419653	rs1114167566	NC_000005.10:112839647:G:
NM_000038.6(APC):c.723dup (p.Ala242fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	VCV000428119	5	112128218 - 112128219	5	112792521 - 112792522	428119	419596	rs1114167565	NC_000005.10:112792521:AA:AAA
NM_000038.6(APC):c.2380dup (p.Ser794fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000428118	5	112173668 - 112173669	5	112837971 - 112837972	428118	419624	rs1114167564	NC_000005.10:112837971:AAA:AAAA
NM_000038.6(APC):c.2991_2996del (p.Tyr997_Gln999delinsTer)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000428115	5	112174281 - 112174286	5	112838584 - 112838589	428115	419634	rs1114167562	NC_000005.10:112838583:ATGGTCA:A
NM_000038.6(APC):c.93del (p.Asn32fs)	APC	N32fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	VCV000428113	5	112090679	5	112754982	428113	419588	rs1114167561	NC_000005.10:112754981:CC:C
NM_000038.6(APC):c.2701C>T (p.Gln901Ter)	APC	Q883*, Q901*, Q873*, Q911*, Q775*, Q810*, Q842*, Q860*, Q618*, Q741*, Q800*, Q876*, Q919*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	VCV000428111	5	112173992	5	112838295	428111	419629	rs1114167559	NC_000005.10:112838294:C:T
NM_000038.6(APC):c.5520del (p.Phe1840fs)	APC	F1739fs, F1799fs, F1815fs, F1680fs, F1714fs, F1812fs, F1822fs, F1858fs, F1781fs, F1840fs, F1557fs, F1749fs, F1850fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000428107	5	112176808	5	112841111	428107	419666	rs1114167555	NC_000005.10:112841110:TTTT:TTT
NM_000038.6(APC):c.3347del (p.Gly1116fs)	APC	G1091fs, G1116fs, G1126fs, G833fs, G990fs, G1088fs, G956fs, G1015fs, G1025fs, G1057fs, G1075fs, G1098fs, G1134fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000428105	5	112174636	5	112838939	428105	419642	rs1114167554	NC_000005.10:112838938:GGG:GG
NM_000038.6(APC):c.4682dup (p.Asp1562fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	VCV000428101	5	112175969 - 112175970	5	112840272 - 112840273	428101	419661	rs1114167552	NC_000005.10:112840272:AAAA:AAAAA
NM_000038.6(APC):c.5822dup (p.Asp1942fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2013)	criteria provided, single submitter	VCV000428098	5	112177111 - 112177112	5	112841414 - 112841415	428098	419667	rs1114167549	NC_000005.10:112841414:CC:CCC
NM_000038.6(APC):c.258dup (p.Leu87fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000428095	5	112102919 - 112102920	5	112767222 - 112767223	428095	419590	rs1114167546	NC_000005.10:112767222:AAAA:AAAAA
NM_000038.6(APC):c.1178C>G (p.Ser393Ter)	APC	S375*, S393*, S334*, S368*, S403*, S110*, S365*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000428093	5	112154907	5	112819210	428093	419603	rs1114167545	NC_000005.10:112819209:C:G
NM_000038.6(APC):c.3994dup (p.Thr1332fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2014)	criteria provided, single submitter	VCV000428092	5	112175283 - 112175284	5	112839586 - 112839587	428092	419650	rs1114167544	NC_000005.10:112839586:AA:AAA
NM_000038.6(APC):c.5944A>T (p.Lys1982Ter)	APC	K1964*, K1982*, K1941*, K1954*, K1992*, K1891*, K1822*, K1856*, K1923*, K1957*, K2000*, K1699*, K1881*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000233824	5	112177235	5	112841538	233824	233160	rs876660665	NC_000005.10:112841537:A:T
NM_000038.6(APC):c.2879_2883del (p.Ser959_Ser960insTer)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000233574	5	112174169 - 112174173	5	112838472 - 112838476	233574	233069	rs876660496	NC_000005.10:112838471:TCAAAT:T
NM_000038.6(APC):c.4706_4707del (p.Asp1569fs)	APC	D1541fs, D1544fs, D1551fs, D1286fs, D1528fs, D1478fs, D1579fs, D1409fs, D1443fs, D1468fs, D1510fs, D1569fs, D1587fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000233514	5	112175997 - 112175998	5	112840300 - 112840301	233514	233114	rs876660454	NC_000005.10:112840299:AT:
NM_000038.6(APC):c.875T>A (p.Leu292Ter)	APC	L274*, L292*, L302*, L9*, L233*, L267*, L264*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000233488	5	112151232	5	112815535	233488	233006	rs876660439	NC_000005.10:112815534:T:A
NM_000038.6(APC):c.5158del (p.Glu1720fs)	APC	E1629fs, E1702fs, E1661fs, E1679fs, E1560fs, E1692fs, E1720fs, E1730fs, E1738fs, E1437fs, E1594fs, E1619fs, E1695fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 6, 2015)	criteria provided, single submitter	VCV000232257	5	112176448	5	112840751	232257	233134	rs876659652	NC_000005.10:112840750:GG:G
NM_000038.6(APC):c.1654_1658del (p.Ser552fs)	APC	S493fs, S524fs, S552fs, S451fs, S461fs, S570fs, S269fs, S392fs, S426fs, S511fs, S527fs, S534fs, S562fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000231945	5	112164577 - 112164581	5	112828880 - 112828884	231945	233034	rs876659452	NC_000005.10:112828879:TTGTCTTG:TTG
NM_000038.6(APC):c.6344T>G (p.Leu2115Ter)	APC	L2097*, L2115*, L2087*, L1955*, L2056*, L1832*, L1989*, L2074*, L2133*, L2014*, L2024*, L2090*, L2125*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000231203	5	112177635	5	112841938	231203	233174	rs876659022	NC_000005.10:112841937:T:G
NM_000038.6(APC):c.5973del (p.Glu1991fs)	APC	E1900fs, E1950fs, E2009fs, E1708fs, E1831fs, E1890fs, E1932fs, E1966fs, E1865fs, E1963fs, E1973fs, E1991fs, E2001fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000231195	5	112177264	5	112841567	231195	233162	rs876659015	NC_000005.10:112841566:G:
NM_000038.6(APC):c.1531G>T (p.Gly511Ter)	APC	G493*, G511*, G228*, G521*, G351*, G486*, G385*, G420*, G483*, G410*, G452*, G470*, G529*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000230854	5	112162927	5	112827230	230854	233028	rs876658811	NC_000005.10:112827229:G:T
NM_000038.6(APC):c.1124del (p.Gly375fs)	APC	G316fs, G375fs, G350fs, G385fs, G92fs, G347fs, G357fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000230384	5	112154850	5	112819153	230384	233013	rs876658538	NC_000005.10:112819152:GGGG:GGG
NM_000038.6(APC):c.568_569dup (p.Tyr191fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000229758	5	112116522 - 112116523	5	112780825 - 112780826	229758	232998	rs876658176	NC_000005.10:112780825:GA:GAGA
NM_000038.6(APC):c.541C>T (p.Gln181Ter)	APC	Q181*, Q191*, Q122*, Q156*	not provided	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000217996	5	112116496	5	112780799	217996	214666	rs863225366	NC_000005.10:112780798:C:T
NM_000038.6(APC):c.450_453del (p.Glu151fs)	APC	E92fs, E126fs, E151fs, E161fs	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000217984	5	112111351 - 112111354	5	112775654 - 112775657	217984	214660	rs863225355	NC_000005.10:112775653:AAAGAA:AA
NM_000038.6(APC):c.6126_6141del (p.Ile2043fs)	APC	I1883fs, I2018fs, I2043fs, I1952fs, I1984fs, I2002fs, I1760fs, I1917fs, I2015fs, I2053fs, I1942fs, I2025fs, I2061fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 8, 2014)	criteria provided, single submitter	VCV000186536	5	112177413 - 112177428	5	112841716 - 112841731	186536	182437	rs786203024	NC_000005.10:112841715:AATGTATAAGCTCCGCAATG:AATG
NM_000038.6(APC):c.2971G>T (p.Glu991Ter)	APC	E973*, E991*, E1001*, E708*, E831*, E963*, E1009*, E865*, E900*, E932*, E890*, E950*, E966*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	VCV000186494	5	112174262	5	112838565	186494	182372	rs786202995	NC_000005.10:112838564:G:T
NM_000038.6(APC):c.3484_3485TA[1] (p.Tyr1162_Ser1163delinsTer)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	VCV000185656	5	112174775 - 112174776	5	112839078 - 112839079	185656	182379	rs786202348	NC_000005.10:112839077:TATA:TA
NM_000038.6(APC):c.4824_4827delinsTAC (p.Lys1608fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000185562	5	112176115 - 112176118	5	112840418 - 112840421	185562	182408	rs786202276	NC_000005.10:112840417:ACCA:TAC
NM_000038.5:c.5844_5845delTGAAAAGinsGGAAAA	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000181836					181836	181126		
NM_000038.6(APC):c.1101del (p.Val368fs)	APC	V350fs, V309fs, V340fs, V378fs, V368fs, V85fs, V343fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	VCV000142820	5	112154830	5	112819133	142820	152534	rs587782744	NC_000005.10:112819132:T:
NM_000038.6(APC):c.6373_6376del (p.Ser2125fs)	APC	S1842fs, S2066fs, S2024fs, S2097fs, S2100fs, S2125fs, S2135fs, S2143fs, S1965fs, S1999fs, S2034fs, S2084fs, S2107fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 9, 2013)	criteria provided, single submitter	VCV000142500	5	112177662 - 112177665	5	112841965 - 112841968	142500	152214	rs587782505	NC_000005.10:112841964:TATCTA:TA
NM_000038.6(APC):c.3260_3261del (p.Leu1087fs)	APC	L1062fs, L804fs, L1028fs, L1046fs, L1059fs, L1069fs, L1105fs, L927fs, L961fs, L1097fs, L1087fs, L986fs, L996fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	VCV000142202	5	112174550 - 112174551	5	112838853 - 112838854	142202	151916	rs587782305	NC_000005.10:112838852:CTC:C
NM_000038.6(APC):c.1695del (p.Val566fs)	APC	V475fs, V406fs, V538fs, V566fs, V576fs, V440fs, V507fs, V283fs, V465fs, V525fs, V541fs, V548fs, V584fs	Hepatocellular carcinoma	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	VCV000000840	5	112164620	5	112828923	840	15879	rs397514032	NC_000005.10:112828922:AA:A
APC, 1-BP DEL, 3720T	APC		Desmoid tumor, somatic	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000000838					838	15877		
APC, 4-BP DEL, 7929TCTA	APC		Desmoid disease, hereditary	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000000837					837	15876		
NM_000038.5(APC):c.4575_4576ins337	APC		Desmoid disease, hereditary	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000000833	5	112175866 - 112175867	5	112840169 - 112840170	833	15872		
APC, 2-BP INS, CODON 1924	APC		Desmoid disease, hereditary	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000818					818	15857		
NM_000038.6(APC):c.4183A>T (p.Ser1395Cys)	APC	S1395C, S1377C, S1269C, S1294C, S1370C, S1405C, S1235C, S1354C, S1112C, S1304C, S1336C, S1367C, S1413C	Hepatoblastoma	Pathogenic(Last reviewed: Jul 15, 1996)	no assertion criteria provided	VCV000000817	5	112175474	5	112839777	817	15856	rs137854578	NC_000005.10:112839776:A:T
NM_000038.6(APC):c.4179dup (p.Asp1394Ter)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000824649	5	112175468 - 112175469	5	112839771 - 112839772	824649	808054		NC_000005.10:112839771:TT:TTT
NM_000038.6(APC):c.3058G>T (p.Glu1020Ter)	APC	E860*, E919*, E737*, E979*, E992*, E1030*, E894*, E929*, E1002*, E1020*, E1038*, E961*, E995*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000822747	5	112174349	5	112838652	822747	807983		NC_000005.10:112838651:G:T
NM_000038.6(APC):c.3000C>A (p.Tyr1000Ter)	APC	Y1010*, Y959*, Y840*, Y874*, Y975*, Y1000*, Y1018*, Y717*, Y899*, Y909*, Y941*, Y972*, Y982*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000822551	5	112174291	5	112838594	822551	807981		NC_000005.10:112838593:C:A
NM_000038.6(APC):c.2828C>G (p.Ser943Ter)	APC	S918*, S961*, S660*, S842*, S915*, S953*, S817*, S852*, S902*, S783*, S884*, S925*, S943*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000821863	5	112174119	5	112838422	821863	807969		NC_000005.10:112838421:C:G
NM_000038.6(APC):c.2287G>T (p.Glu763Ter)	APC	E603*, E704*, E745*, E763*, E773*, E738*, E480*, E637*, E662*, E722*, E672*, E735*, E781*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 14, 2018)	criteria provided, single submitter	VCV000821036	5	112173578	5	112837881	821036	807930		NC_000005.10:112837880:G:T
NM_000038.6(APC):c.1529_1530del (p.Phe510fs)	APC	F409fs, F469fs, F492fs, F528fs, F485fs, F350fs, F451fs, F482fs, F510fs, F520fs, F227fs, F384fs, F419fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000819459	5	112162923 - 112162924	5	112827226 - 112827227	819459	807900		NC_000005.10:112827225:TTTT:TT
NM_000038.6(APC):c.26_27insTTTA (p.Leu9fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000630969	5	112090613 - 112090614	5	112754916 - 112754917	630969	617036	rs1561444605	NC_000005.10:112754916::TTTA
NM_000038.6(APC):c.2692_2693insT (p.His898fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000628314	5	112173983 - 112173984	5	112838286 - 112838287	628314	617097	rs1561579040	NC_000005.10:112838286::T
NM_000038.6(APC):c.2390dup (p.Gly797_Asp798insTer)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000628214	5	112173679 - 112173680	5	112837982 - 112837983	628214	617090	rs1561576755	NC_000005.10:112837982:GG:GGG
NM_000038.6(APC):c.3317del (p.Gly1106fs)	APC	G1015fs, G1088fs, G823fs, G946fs, G1078fs, G980fs, G1005fs, G1047fs, G1065fs, G1106fs, G1081fs, G1116fs, G1124fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2018)	criteria provided, single submitter	VCV000628070	5	112174605	5	112838908	628070	617113	rs1561583917	NC_000005.10:112838907:GGGG:GGG
NM_000038.6(APC):c.4634C>A (p.Ser1545Ter)	APC	S1527*, S1545*, S1262*, S1419*, S1555*, S1454*, S1520*, S1563*, S1385*, S1504*, S1517*, S1444*, S1486*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000490280	5	112175925	5	112840228	490280	483832	rs863225356	NC_000005.10:112840227:C:A
NM_000038.6(APC):c.3203C>G (p.Ser1068Ter)	APC	S1050*, S1068*, S1040*, S1043*, S785*, S1009*, S1027*, S1078*, S942*, S1086*, S908*, S967*, S977*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 6, 2016)	criteria provided, single submitter	VCV000490258	5	112174494	5	112838797	490258	483957	rs1554084848	NC_000005.10:112838796:C:G
NM_000038.6(APC):c.154C>T (p.Gln52Ter)	APC	Q52*, Q62*, Q27*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000490213	5	112102041	5	112766344	490213	483785	rs786202584	NC_000005.10:112766343:C:T
NM_000038.6(APC):c.1433del (p.Leu478fs)	APC	L318fs, L387fs, L419fs, L450fs, L488fs, L195fs, L352fs, L377fs, L437fs, L460fs, L453fs, L478fs, L496fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000486782	5	112162828	5	112827131	486782	473663	rs1240024893	NC_000005.10:112827130:TT:T
NM_000038.6(APC):c.4241dup (p.Ser1415fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000482468	5	112175531 - 112175532	5	112839834 - 112839835	482468	473773	rs1554085654	NC_000005.10:112839834:T:TT
NM_000038.6(APC):c.7512G>A (p.Trp2504Ter)	APC	W2486*, W2504*, W2344*, W2463*, W2476*, W2413*, W2514*, W2221*, W2378*, W2445*, W2479*, W2403*, W2522*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000482304	5	112178803	5	112843106	482304	473983	rs1554088413	NC_000005.10:112843105:G:A
NM_000038.6(APC):c.2008_2014delinsTAGTTTTGTA (p.Lys670_His672delinsTer)	APC		not provided	Pathogenic(Last reviewed: Sep 24, 2016)	criteria provided, single submitter	VCV000438872	5	112173299 - 112173305	5	112837602 - 112837608	438872	432582	rs1554083888	NC_000005.10:112837601:AAATCTC:TAGTTTTGTA
NM_000038.6(APC):c.3665C>A (p.Ser1222Ter)	APC	S1204*, S1222*, S1121*, S1194*, S1197*, S1096*, S1232*, S939*, S1062*, S1131*, S1240*, S1163*, S1181*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000428183	5	112174956	5	112839259	428183	419646	rs1114167614	NC_000005.10:112839258:C:A
NM_000038.6(APC):c.1968_1969del (p.Asn659fs)	APC	N499fs, N600fs, N634fs, N641fs, N669fs, N558fs, N568fs, N376fs, N533fs, N618fs, N631fs, N659fs, N677fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000428158	5	112173259 - 112173260	5	112837562 - 112837563	428158	419620	rs1114167597	NC_000005.10:112837561:AA:
NM_000038.6(APC):c.4549C>T (p.Gln1517Ter)	APC	Q1499*, Q1517*, Q1357*, Q1426*, Q1492*, Q1527*, Q1535*, Q1489*, Q1234*, Q1391*, Q1416*, Q1458*, Q1476*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000428157	5	112175840	5	112840143	428157	419658	rs1114167596	NC_000005.10:112840142:C:T
NM_000038.6(APC):c.3002del (p.Pro1001fs)	APC	P1001fs, P1011fs, P910fs, P1019fs, P718fs, P983fs, P875fs, P900fs, P942fs, P841fs, P960fs, P973fs, P976fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000428147	5	112174291	5	112838594	428147	419635	rs1114167586	NC_000005.10:112838593:CCC:CC
NM_000038.6(APC):c.4031C>G (p.Ser1344Ter)	APC	S1326*, S1344*, S1184*, S1253*, S1316*, S1061*, S1243*, S1218*, S1285*, S1303*, S1319*, S1354*, S1362*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000428137	5	112175322	5	112839625	428137	419652	rs1114167578	NC_000005.10:112839624:C:G
NM_000038.6(APC):c.889_890AC[1] (p.His298fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	criteria provided, single submitter	VCV000428121	5	112151245 - 112151248	5	112815548 - 112815551	428121	419600	rs1114167567	NC_000005.10:112815547:CACACAC:CAC
NM_000038.6(APC):c.1548G>A (p.Lys516=)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000428116	5	112162944	5	112827247	428116	419609	rs879254090	NC_000005.10:112827246:G:A
chr5:112154359-112155228 complex variant	APC		Colorectal cancer, susceptibility to	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224516	5	112154359 - 112155228			224516	226372		
NM_000038.6(APC):c.5757del (p.Arg1920fs)	APC	R1760fs, R1829fs, R1920fs, R1892fs, R1895fs, R1930fs, R1637fs, R1819fs, R1861fs, R1879fs, R1902fs, R1794fs, R1938fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000183880	5	112177048	5	112841351	183880	182425	rs786201134	NC_000005.10:112841350:T:
NM_000038.6(APC):c.2093T>A (p.Leu698Ter)	APC	L698*, L680*, L572*, L639*, L657*, L716*, L415*, L597*, L607*, L670*, L708*, L673*, L538*	Gardner syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000000832	5	112173384	5	112837687	832	15871	rs137854582	NC_000005.10:112837686:T:A
NM_000038.6(APC):c.3359G>A (p.Gly1120Glu)	APC	G1120E, G1102E, G1079E, G1130E, G1138E, G960E, G994E, G1019E, G1061E, G1029E, G1092E, G1095E, G837E	Neoplasm of stomach	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000802	5	112174650	5	112838953	802	15841	rs28933379	NC_000005.10:112838952:G:A
NM_000038.6(APC):c.423-11A>G	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000824698	5	112111315	5	112775618	824698	815321		NC_000005.10:112775617:A:G
NM_000038.6(APC):c.2815_2816del (p.Lys939fs)	APC	K914fs, K911fs, K939fs, K656fs, K779fs, K880fs, K957fs, K813fs, K838fs, K848fs, K898fs, K921fs, K949fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000821844	5	112174106 - 112174107	5	112838409 - 112838410	821844	807967		NC_000005.10:112838408:AA:
NM_000038.6(APC):c.1283_1293del (p.Glu428fs)	APC	E145fs, E400fs, E428fs, E302fs, E327fs, E337fs, E369fs, E410fs, E268fs, E403fs, E438fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000818790	5	112155008 - 112155018	5	112819311 - 112819321	818790	807872		NC_000005.10:112819310:CATGAACCAGGCATG:CATG
NM_000038.6(APC):c.1180C>T (p.Gln394Ter)	APC	Q335*, Q366*, Q394*, Q111*, Q376*, Q369*, Q404*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000818506	5	112154909	5	112819212	818506	807862		NC_000005.10:112819211:C:T
NM_000038.6(APC):c.2828C>A (p.Ser943Ter)	APC	S925*, S943*, S842*, S918*, S961*, S660*, S817*, S852*, S884*, S902*, S783*, S915*, S953*	Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000559961	5	112174119	5	112838422	559961	550680	rs1554084512	NC_000005.10:112838421:C:A
NM_000038.6(APC):c.734C>A (p.Ser245Ter)	APC	S227*, S245*, S255*, S186*, S217*, S220*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000492654	5	112136980	5	112801283	492654	485612	rs1554076133	NC_000005.10:112801282:C:A
NM_000038.6(APC):c.1307del (p.Asn436fs)	APC	N335fs, N377fs, N446fs, N310fs, N345fs, N408fs, N411fs, N418fs, N153fs, N276fs, N436fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000487058	5	112155032	5	112819335	487058	473654	rs1554080162	NC_000005.10:112819334:AAAAA:AAAA
NM_000038.6(APC):c.4970dup (p.Ser1658fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000487050	5	112176260 - 112176261	5	112840563 - 112840564	487050	473856	rs1554086340	NC_000005.10:112840563:T:TT
NM_000038.6(APC):c.4778del (p.Lys1593fs)	APC	K1492fs, K1502fs, K1568fs, K1593fs, K1603fs, K1310fs, K1467fs, K1565fs, K1534fs, K1611fs, K1433fs, K1552fs, K1575fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486786	5	112176064	5	112840367	486786	473786	rs1554086185	NC_000005.10:112840366:AAAAAA:AAAAA
NM_000038.6(APC):c.2612del (p.Gly871fs)	APC	G588fs, G745fs, G770fs, G830fs, G846fs, G853fs, G881fs, G711fs, G780fs, G812fs, G843fs, G871fs, G889fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000486750	5	112173902	5	112838205	486750	473683	rs1554084299	NC_000005.10:112838204:GG:G
NM_000038.6(APC):c.3596dup (p.Ser1200fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000482355	5	112174884 - 112174885	5	112839187 - 112839188	482355	473744	rs864622106	NC_000005.10:112839187:AAA:AAAA
NM_000038.6(APC):c.1957A>C (p.Arg653=)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 27, 2016)	criteria provided, single submitter	VCV000482311	5	112170861	5	112835164	482311	473924	rs1114167580	NC_000005.10:112835163:A:C
NM_000038.6(APC):c.3901dup (p.Thr1301fs)	APC		Familial adenomatous polyposis|not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433656	5	112175191 - 112175192	5	112839494 - 112839495	433656	427293	rs1554085382	NC_000005.10:112839494:A:AA
NM_000038.6(APC):c.1048_1141del (p.Ser350fs)	APC	S322fs, S325fs, S350fs, S67fs, S291fs, S332fs, S360fs	Familial adenomatous polyposis|not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000433616	5	112154776 - 112154869	5	112819079 - 112819172	433616	427253	rs1554079988	
NM_000038.6(APC):c.4319del (p.Pro1440fs)	APC	P1157fs, P1440fs, P1399fs, P1415fs, P1450fs, P1280fs, P1339fs, P1349fs, P1422fs, P1458fs, P1314fs, P1381fs, P1412fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429058	5	112175609	5	112839912	429058	421034	rs1131691145	NC_000005.10:112839911:CC:C
NM_000038.6(APC):c.1548+1G>C	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428181	5	112162945	5	112827248	428181	419610	rs1114167599	NC_000005.10:112827247:G:C
NM_000038.6(APC):c.8047del (p.Ile2683fs)	APC	I2557fs, I2592fs, I2642fs, I2655fs, I2701fs, I2523fs, I2582fs, I2624fs, I2658fs, I2693fs, I2400fs, I2665fs, I2683fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2016)	criteria provided, single submitter	VCV000428168	5	112179338	5	112843641	428168	419680	rs1114167604	NC_000005.10:112843640:A:
NM_000038.6(APC):c.1312+2T>C	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000428138	5	112155043	5	112819346	428138	419606	rs1114167579	NC_000005.10:112819345:T:C
NM_000038.6(APC):c.4057G>T (p.Glu1353Ter)	APC	E1335*, E1353*, E1262*, E1294*, E1371*, E1070*, E1252*, E1328*, E1227*, E1363*, E1193*, E1312*, E1325*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000428122	5	112175348	5	112839651	428122	419654	rs1114167568	NC_000005.10:112839650:G:T
NM_000038.6(APC):c.7139_7142AACA[1] (p.Thr2382fs)	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265637	5	112178428 - 112178431	5	112842731 - 112842734	265637	259801	rs886039687	NC_000005.10:112842730:CAAACAAACA:CAAACA
NM_000038.6(APC):c.7931_7937del (p.Ile2644fs)	APC	I2361fs, I2484fs, I2553fs, I2585fs, I2603fs, I2619fs, I2626fs, I2616fs, I2662fs, I2518fs, I2543fs, I2644fs, I2654fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265577	5	112179221 - 112179227	5	112843524 - 112843530	265577	259802	rs886039639	NC_000005.10:112843523:ATTTATCA:A
NM_000038.6(APC):c.6281del (p.Pro2094fs)	APC	P1811fs, P2035fs, P1968fs, P1993fs, P2053fs, P2076fs, P1934fs, P2066fs, P2069fs, P2003fs, P2094fs, P2104fs, P2112fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000234047	5	112177569	5	112841872	234047	233172	rs876660816	NC_000005.10:112841871:CCCC:CCC
NM_000038.6(APC):c.531+2T>C	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000217995	5	112111436	5	112775739	217995	214665	rs863225365	NC_000005.10:112775738:T:C
NM_000038.6(APC):c.531+2T>A	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000217994	5	112111436	5	112775739	217994	214664	rs863225365	NC_000005.10:112775738:T:A
NM_000038.6(APC):c.3688C>T (p.Gln1230Ter)	APC	Q1212*, Q1230*, Q1070*, Q1104*, Q1189*, Q1240*, Q1248*, Q1129*, Q1205*, Q1139*, Q1171*, Q1202*, Q947*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000217969	5	112174979	5	112839282	217969	214715	rs863225344	NC_000005.10:112839281:C:T
NM_000038.6(APC):c.301G>T (p.Gly101Ter)	APC	G101*, G111*, G76*, G42*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jul 30, 2017)	criteria provided, single submitter	VCV000217958	5	112102966	5	112767269	217958	214656	rs863225335	NC_000005.10:112767268:G:T
NM_000038.6(APC):c.2680_2686dup (p.Ala896fs)	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, multiple submitters, no conflicts	VCV000141652	5	112173970 - 112173971	5	112838273 - 112838274	141652	151366	rs587781910	NC_000005.10:112838273:GTGTCAG:GTGTCAGGTGTCAG
NM_000038.6(APC):c.190G>T (p.Gly64Ter)	APC	G64*, G74*, G39*, G5*	Familial colorectal cancer|Familial adenomatous polyposis	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000082875	5	112102077	5	112766380	82875	93766	rs79323615	NC_000005.10:112766379:G:T
NM_000038.6(APC):c.3162del (p.His1054fs)	APC	H1064fs, H963fs, H1054fs, H771fs, H1013fs, H1026fs, H1036fs, H894fs, H928fs, H953fs, H1029fs, H1072fs, H995fs	Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	VCV000042241	5	112174453	5	112838756	42241	51411	rs397515733	NC_000005.10:112838755:C:
NM_000038.6(APC):c.739C>T (p.Gln247Ter)	APC	Q188*, Q222*, Q257*, Q219*, Q229*, Q247*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000827018	5	112136985	5	112801288	827018	807829		NC_000005.10:112801287:C:T
NM_000038.6(APC):c.3367C>T (p.Gln1123Ter)	APC	Q1064*, Q1095*, Q1098*, Q1123*, Q1133*, Q963*, Q1032*, Q1082*, Q997*, Q1022*, Q1105*, Q1141*, Q840*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000823671	5	112174658	5	112838961	823671	808002		NC_000005.10:112838960:C:T
NM_000038.6(APC):c.3121C>T (p.Gln1041Ter)	APC	Q1059*, Q758*, Q915*, Q1000*, Q1051*, Q940*, Q950*, Q1016*, Q1041*, Q982*, Q1013*, Q1023*, Q881*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000822934	5	112174412	5	112838715	822934	807989		NC_000005.10:112838714:C:T
NM_000038.6(APC):c.7709C>G (p.Ser2570Ter)	APC	S2552*, S2570*, S2410*, S2469*, S2542*, S2580*, S2287*, S2529*, S2444*, S2479*, S2511*, S2545*, S2588*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000628123	5	112179000	5	112843303	628123	617262	rs1561617778	NC_000005.10:112843302:C:G
NM_000038.6(APC):c.2336dup (p.Leu779fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000482256	5	112173624 - 112173625	5	112837927 - 112837928	482256	473671	rs1554084079	NC_000005.10:112837927:TTT:TTTT
NM_000038.6(APC):c.4831C>T (p.Gln1611Ter)	APC	Q1593*, Q1611*, Q1328*, Q1451*, Q1570*, Q1629*, Q1485*, Q1520*, Q1583*, Q1621*, Q1510*, Q1552*, Q1586*	Familial adenomatous polyposis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449336	5	112176122	5	112840425	449336	443651	rs774847203	NC_000005.10:112840424:C:T
NM_000038.6(APC):c.5803del (p.Gln1935fs)	APC	Q1809fs, Q1876fs, Q1652fs, Q1775fs, Q1844fs, Q1910fs, Q1953fs, Q1834fs, Q1907fs, Q1917fs, Q1935fs, Q1945fs, Q1894fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000429202	5	112177091	5	112841394	429202	421507	rs1131691253	NC_000005.10:112841393:CCCC:CCC
NM_000038.6(APC):c.1886T>G (p.Leu629Ter)	APC	L611*, L629*, L346*, L503*, L528*, L647*, L469*, L639*, L588*, L604*, L538*, L570*, L601*	Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000429049	5	112170790	5	112835093	429049	421027	rs1019221239	NC_000005.10:112835092:T:G
NM_000038.6(APC):c.4643_4645delinsT (p.Asn1548fs)	APC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000428163	5	112175934 - 112175936	5	112840237 - 112840239	428163	419659	rs1114167601	NC_000005.10:112840236:ACC:T
NM_000038.6(APC):c.4793_4800delinsTGG (p.Ala1598fs)	APC		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265579	5	112176084 - 112176091	5	112840387 - 112840394	265579	259799	rs886039641	NC_000005.10:112840386:CTTCAAAA:TGG
NM_000038.6(APC):c.562C>T (p.Gln188Ter)	APC	Q188*, Q198*, Q129*, Q163*	Familial adenomatous polyposis|Colorectal cancer, susceptibility to	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000224515	5	112116517	5	112780820	224515	226318	rs869312753	NC_000005.10:112780819:C:T
NM_000038.6(APC):c.3336_3340del (p.Asn1113fs)	APC	N1022fs, N1072fs, N1095fs, N1054fs, N1131fs, N1085fs, N1088fs, N1123fs, N830fs, N987fs, N1012fs, N1113fs, N953fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000823623	5	112174626 - 112174630	5	112838929 - 112838933	823623	807998		NC_000005.10:112838928:CAAATC:C
NM_000038.6(APC):c.3730C>T (p.Gln1244Ter)	APC	Q1244*, Q1226*, Q1118*, Q1185*, Q1203*, Q1084*, Q1219*, Q1262*, Q1143*, Q1153*, Q1216*, Q1254*, Q961*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000630045	5	112175021	5	112839324	630045	617129	rs79122263	NC_000005.10:112839323:C:T
NM_000038.6(APC):c.1333C>T (p.Gln445Ter)	APC	Q427*, Q445*, Q344*, Q386*, Q420*, Q162*, Q417*, Q455*, Q285*, Q319*, Q354*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000438865	5	112157613	5	112821916	438865	432575	rs876658802	NC_000005.10:112821915:C:T
NM_000038.6(APC):c.1409-2A>C	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419874	5	112162803	5	112827106	419874	406506	rs1064794163	NC_000005.10:112827105:A:C
NM_000038.6(APC):c.1958+3A>G	APC		Familial adenomatous polyposis|not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000245982	5	112170865	5	112835168	245982	244423	rs879254032	NC_000005.10:112835167:A:G
NM_000038.6(APC):c.6055_6058GTTT[1] (p.Cys2020fs)	APC		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000233077	5	112177346 - 112177349	5	112841649 - 112841652	233077	233164	rs876660174	NC_000005.10:112841648:GTTTGTTT:GTTT
NM_000038.6(APC):c.7715C>G (p.Ser2572Ter)	APC	S2554*, S2572*, S2481*, S2513*, S2289*, S2412*, S2446*, S2471*, S2531*, S2590*, S2547*, S2582*, S2544*	Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231654	5	112179006	5	112843309	231654	233209	rs876659280	NC_000005.10:112843308:C:G
NM_000038.6(APC):c.5038C>T (p.Gln1680Ter)	APC	Q1662*, Q1680*, Q1520*, Q1621*, Q1639*, Q1554*, Q1690*, Q1698*, Q1397*, Q1579*, Q1652*, Q1655*, Q1589*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000230520	5	112176329	5	112840632	230520	233127	rs754122018	NC_000005.10:112840631:C:T
NM_000038.6(APC):c.1959-2A>G	APC		Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000229816	5	112173248	5	112837551	229816	233046	rs876658214	NC_000005.10:112837550:A:G
NM_000038.6(APC):c.3815C>G (p.Ser1272Ter)	APC	S1254*, S1272*, S1282*, S989*, S1112*, S1146*, S1181*, S1247*, S1213*, S1290*, S1171*, S1231*, S1244*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217973	5	112175106	5	112839409	217973	214719	rs863225348	NC_000005.10:112839408:C:G
NM_000038.6(APC):c.1409-1G>T	APC		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217927	5	112162804	5	112827107	217927	214684	rs863225313	NC_000005.10:112827106:G:T
NM_000038.6(APC):c.4621C>T (p.Gln1541Ter)	APC	Q1523*, Q1541*, Q1500*, Q1513*, Q1559*, Q1258*, Q1516*, Q1551*, Q1415*, Q1440*, Q1482*, Q1381*, Q1450*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000184934	5	112175912	5	112840215	184934	182404	rs786201801	NC_000005.10:112840214:C:T
NM_000038.6(APC):c.1659G>A (p.Trp553Ter)	APC	W535*, W553*, W462*, W528*, W393*, W512*, W525*, W563*, W427*, W452*, W494*, W571*, W270*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092340	5	112164585	5	112828888	92340	98251	rs398123116	NC_000005.10:112828887:G:A
NM_000038.6(APC):c.3925G>T (p.Glu1309Ter)	APC	E1183*, E1250*, E1026*, E1208*, E1268*, E1281*, E1291*, E1327*, E1149*, E1319*, E1218*, E1284*, E1309*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000824390	5	112175216	5	112839519	824390	808031		NC_000005.10:112839518:G:T
NM_000038.6(APC):c.4778_4781AGCC[1] (p.Ala1595fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433668	5	112176069 - 112176072	5	112840372 - 112840375	433668	427305	rs1554086196	NC_000005.10:112840371:AGCCAGCC:AGCC
NM_000038.6(APC):c.3749_3750del (p.Lys1250fs)	APC	K1124fs, K1209fs, K1225fs, K1260fs, K1090fs, K1232fs, K967fs, K1159fs, K1191fs, K1250fs, K1268fs, K1149fs, K1222fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000428143	5	112175039 - 112175040	5	112839342 - 112839343	428143	419648	rs1114167583	NC_000005.10:112839341:AAA:A
NM_000038.6(APC):c.311C>G (p.Ser104Ter)	APC	S104*, S114*, S79*, S45*	not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231513	5	112102976	5	112767279	231513	232991	rs74953290	NC_000005.10:112767278:C:G
NM_000038.6(APC):c.2570del (p.Gly857fs)	APC	G697fs, G798fs, G816fs, G756fs, G829fs, G832fs, G875fs, G574fs, G731fs, G766fs, G839fs, G857fs, G867fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, multiple submitters, no conflicts	VCV000230263	5	112173860	5	112838163	230263	233062	rs876658472	NC_000005.10:112838162:GG:G
NM_000038.6(APC):c.4652_4655del (p.Lys1551fs)	APC	K1425fs, K1460fs, K1492fs, K1526fs, K1533fs, K1561fs, K1551fs, K1268fs, K1523fs, K1391fs, K1450fs, K1510fs, K1569fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000217987	5	112175940 - 112175943	5	112840243 - 112840246	217987	214728	rs863225358	NC_000005.10:112840242:AGAAAGA:AGA
NM_000038.6(APC):c.1312+1G>A	APC		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000217923	5	112155042	5	112819345	217923	214681	rs863225310	NC_000005.10:112819344:G:A
NC_000005.9:g.(?_112090588)_(112179768_?)del	APC		Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Feb 5, 2010)	criteria provided, single submitter	VCV000177906	5	112090588 - 112179768	5	112754891 - 112844071	177906	173984		
NM_000038.6(APC):c.2527_2530del (p.Ser843fs)	APC	S752fs, S784fs, S802fs, S560fs, S815fs, S818fs, S825fs, S717fs, S843fs, S853fs, S683fs, S742fs, S861fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246088	5	112173817 - 112173820	5	112838120 - 112838123	246088	244425	rs879254091	NC_000005.10:112838119:TAGTT:T
NM_000038.6(APC):c.3211C>T (p.Gln1071Ter)	APC	Q1053*, Q1071*, Q1012*, Q1030*, Q945*, Q970*, Q980*, Q1089*, Q1043*, Q1046*, Q1081*, Q788*, Q911*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000232078	5	112174502	5	112838805	232078	233080	rs876659539	NC_000005.10:112838804:C:T
NM_000038.6(APC):c.2138C>G (p.Ser713Ter)	APC	S713*, S695*, S587*, S612*, S731*, S430*, S553*, S654*, S622*, S685*, S672*, S688*, S723*	Gardner syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000000800	5	112173429	5	112837732	800	15839	rs137854570	NC_000005.10:112837731:C:G
NM_000038.6(APC):c.3184_3187del (p.Gln1062fs)	APC	Q1037fs, Q1062fs, Q779fs, Q1072fs, Q902fs, Q936fs, Q961fs, Q971fs, Q1003fs, Q1021fs, Q1044fs, Q1080fs, Q1034fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000428100	5	112174472 - 112174475	5	112838775 - 112838778	428100	419639	rs1114167551	NC_000005.10:112838774:AAACAAA:AAA
NM_006218.4(PIK3CA):c.1357G>A (p.Glu453Lys)	PIK3CA	E453K	Hepatocellular carcinoma|Ovarian Neoplasms|Adenocarcinoma of stomach|Squamous cell lung carcinoma|Neoplasm of the breast|Neoplasm of brain||Transitional cell carcinoma of the bladder|Glioblastoma|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000376470	3	178928079	3	179210291	376470	363349	rs1057519925	NC_000003.12:179210290:G:A
NM_000249.3(MLH1):c.1410-2_1410-1delinsCC	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome II	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585224	3	37070273 - 37070274	3	37028782 - 37028783	585224	576258	rs1559558071	NC_000003.12:37028781:AG:CC
NM_000249.3(MLH1):c.1024_1038+1del	MLH1		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495757	3	37061935 - 37061950	3	37020444 - 37020459	495757	486989	rs1553648201	NC_000003.12:37020443:CCAGGATGTACTTCACCCAGG:CCAGG
NM_001167617.2(MLH1):c.-7del	MLH1	S95fs	not provided|Hereditary nonpolyposis colon cancer|Lynch syndrome II	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000421912	3	37042519	3	37001028	421912	406206	rs1064795441	NC_000003.12:37001027:TTT:TT
NM_000249.3(MLH1):c.884G>A (p.Ser295Asn)	MLH1	S295N, S54N, S197N, S262N	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090415	3	37059090	3	37017599	90415	95889	rs63750144	NC_000003.12:37017598:G:A
NM_001167617.2(MLH1):c.-465del	MLH1	R18fs	Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090254	3	37035089	3	36993598	90254	95728	rs63749804	NC_000003.12:36993597:CC:C
NM_000249.3(MLH1):c.37G>T (p.Glu13Ter)	MLH1	E13*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090189	3	37035075	3	36993584	90189	95663	rs587779008	NC_000003.12:36993583:G:T
NM_001167617.2(MLH1):c.1924dup (p.Ile642fs)	MLH1		Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090091	3	37092090 - 37092091	3	37050599 - 37050600	90091	95565	rs587778989	NC_000003.12:37050599:A:AA
NM_000249.3(MLH1):c.1990-2A>G	MLH1		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089987	3	37090393	3	37048902	89987	95461	rs267607883	NC_000003.12:37048901:A:G
NM_000249.3(MLH1):c.1790G>A (p.Trp597Ter)	MLH1	W597*, W499*, W356*, W239*, W256*, W564*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089889	3	37089068	3	37047577	89889	95363	rs63750604	NC_000003.12:37047576:G:A
NM_000249.3(MLH1):c.1528C>T (p.Gln510Ter)	MLH1	Q510*, Q169*, Q152*, Q269*, Q412*, Q477*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089761	3	37070393	3	37028902	89761	95235	rs63749923	NC_000003.12:37028901:C:T
NM_001167617.2(MLH1):c.896del (p.Leu299fs)	MLH1	L156fs, L364fs, L397fs, L39fs, L56fs, L299fs	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089673	3	37067279	3	37025788	89673	95147	rs63750749	NC_000003.12:37025787:T:
NM_001354624.1(MLH1):c.-29dup	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089630	3	37067134 - 37067135	3	37025643 - 37025644	89630	95104	rs267607822	NC_000003.12:37025643:T:TT
NM_001354621.1(MLH1):c.-1del	MLH1	M101fs, M244fs, M309fs, M342fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089607	3	37061938	3	37020447	89607	95081	rs63749837	NC_000003.12:37020446:GG:G
NM_001167617.2(MLH1):c.-413_-412delinsAC	MLH1	M35N	Lynch syndrome|Lynch syndrome II|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017105	3	37035142 - 37035143	3	36993651 - 36993652	17105	32144	rs121912965	NC_000003.12:36993650:TG:AC
NM_000249.3(MLH1):c.199G>T (p.Gly67Trp)	MLH1	G67W	Lynch syndrome|Lynch syndrome II|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017088	3	37038192	3	36996701	17088	32127	rs63750206	NC_000003.12:36996700:G:T
NM_000038.6(APC):c.4132C>T (p.Gln1378Ter)	APC	Q1360*, Q1378*, Q1277*, Q1287*, Q1396*, Q1095*, Q1337*, Q1350*, Q1353*, Q1218*, Q1388*, Q1252*, Q1319*	Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000376061	5	112175423	5	112839726	376061	362940	rs121913329	NC_000005.10:112839725:C:T
NM_000038.6(APC):c.3916G>T (p.Glu1306Ter)	APC	E1288*, E1306*, E1180*, E1247*, E1146*, E1265*, E1205*, E1281*, E1324*, E1023*, E1215*, E1278*, E1316*	not provided|Neoplasm of the large intestine	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000376059	5	112175207	5	112839510	376059	362938	rs121913462	NC_000005.10:112839509:G:T
NM_000038.6(APC):c.622C>T (p.Gln208Ter)	APC	Q208*, Q218*, Q149*, Q183*	Hereditary cancer-predisposing syndrome|Gardner syndrome	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000000839	5	112116577	5	112780880	839	15878	rs137854583	NC_000005.10:112780879:C:T
NM_000222.2(KIT):c.1727T>C (p.Leu576Pro)	KIT	L576P, L572P	Gastrointestinal stromal tumor|Cutaneous melanoma|Non-small cell lung cancer|Thymoma	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000375919	4	55593661	4	54727495	375919	362798	rs121913513	NC_000004.12:54727494:T:C
NM_000038.6(APC):c.4203dup (p.Ala1402fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802142	5	112175492 - 112175493	5	112839795 - 112839796	802142	790501		NC_000005.10:112839795:TT:TTT
NM_000038.6(APC):c.2334_2337del (p.Asn778fs)	APC	N719fs, N750fs, N778fs, N796fs, N495fs, N618fs, N677fs, N753fs, N652fs, N687fs, N737fs, N760fs, N788fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802139	5	112173624 - 112173627	5	112837927 - 112837930	802139	790498		NC_000005.10:112837926:ATTTA:A
NM_000038.6(APC):c.1467_1479del (p.Asn490fs)	APC	N462fs, N500fs, N508fs, N330fs, N364fs, N431fs, N472fs, N389fs, N399fs, N207fs, N449fs, N465fs, N490fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802136	5	112162860 - 112162872	5	112827163 - 112827175	802136	790495		NC_000005.10:112827162:TACTAATGACCACTAC:TAC
NM_000038.6(APC):c.3374dup (p.Ser1126fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584669	5	112174664 - 112174665	5	112838967 - 112838968	584669	575724	rs1561584336	NC_000005.10:112838967:T:TT
NM_000038.6(APC):c.1895_1958+28del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584665	5	112170796 - 112170887	5	112835099 - 112835190	584665	575720	rs1561569140	
NM_000038.6(APC):c.1886T>A (p.Leu629Ter)	APC	L611*, L629*, L346*, L503*, L588*, L604*, L639*, L469*, L538*, L570*, L601*, L528*, L647*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584664	5	112170790	5	112835093	584664	575719	rs1019221239	NC_000005.10:112835092:T:A
NM_000038.6(APC):c.4717del (p.Glu1573fs)	APC	E1290fs, E1514fs, E1545fs, E1555fs, E1573fs, E1591fs, E1447fs, E1548fs, E1482fs, E1583fs, E1413fs, E1472fs, E1532fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 10, 2015)	no assertion criteria provided	VCV000236206	5	112176008	5	112840311	236206	237761	rs878853217	NC_000005.10:112840310:G:
NM_000038.6(APC):c.1369del (p.Ser457fs)	APC	S356fs, S429fs, S457fs, S174fs, S366fs, S297fs, S432fs, S439fs, S331fs, S398fs, S467fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000000795	5	112157647	5	112821950	795	15834	rs387906229	NC_000005.10:112821949:TTT:TT
NM_000038.6(APC):c.559del (p.Arg187fs)	APC	R162fs, R187fs, R197fs, R128fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000862094	5	112116513	5	112780816	862094	829605		NC_000005.10:112780815:AA:A
NM_000038.6(APC):c.530del (p.Asn177fs)	APC	N187fs, N118fs, N152fs, N177fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000858360	5	112111430	5	112775733	858360	829603		NC_000005.10:112775732:AAAA:AAA
NM_000038.6(APC):c.1353T>A (p.Cys451Ter)	APC	C392*, C433*, C168*, C291*, C426*, C350*, C360*, C423*, C461*, C325*, C451*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000857174	5	112157633	5	112821936	857174	829627		NC_000005.10:112821935:T:A
NM_000038.6(APC):c.1809del (p.Ala604fs)	APC	A321fs, A444fs, A579fs, A614fs, A503fs, A513fs, A545fs, A586fs, A478fs, A563fs, A576fs, A604fs, A622fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000856481	5	112170711	5	112835014	856481	829643		NC_000005.10:112835013:AAA:AA
NM_000038.6(APC):c.875del (p.Val291_Leu292insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000856344	5	112151229	5	112815532	856344	829612		NC_000005.10:112815531:TTTT:TTT
NM_000038.6(APC):c.522_523del (p.Leu174fs)	APC	L149fs, L115fs, L174fs, L184fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000851475	5	112111425 - 112111426	5	112775728 - 112775729	851475	829602		NC_000005.10:112775727:AA:
NM_000038.6(APC):c.521T>G (p.Leu174Ter)	APC	L174*, L149*, L115*, L184*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000849001	5	112111424	5	112775727	849001	829601		NC_000005.10:112775726:T:G
NM_000038.6(APC):c.875dup (p.Leu292fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000844696	5	112151228 - 112151229	5	112815531 - 112815532	844696	829613		NC_000005.10:112815531:TTTT:TTTTT
NM_000038.6(APC):c.570_571AT[3] (p.Glu192fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000841971	5	112116524 - 112116525	5	112780827 - 112780828	841971	829606		NC_000005.10:112780827:ATAT:ATATAT
NM_000038.6(APC):c.1496_1511del (p.Arg499fs)	APC	R398fs, R509fs, R339fs, R471fs, R474fs, R499fs, R373fs, R481fs, R517fs, R216fs, R408fs, R440fs, R458fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000841225	5	112162891 - 112162906	5	112827194 - 112827209	841225	829632		NC_000005.10:112827193:CGATATGCTGGAATGGC:C
NM_000038.6(APC):c.1042del (p.Arg348fs)	APC	R320fs, R323fs, R330fs, R348fs, R289fs, R358fs, R65fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000839696	5	112154771	5	112819074	839696	829618		NC_000005.10:112819073:C:
NM_000038.6(APC):c.1717del (p.Met573fs)	APC	M290fs, M482fs, M555fs, M573fs, M413fs, M447fs, M545fs, M583fs, M591fs, M472fs, M514fs, M532fs, M548fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000838384	5	112164643	5	112828946	838384	829639		NC_000005.10:112828945:A:
NC_000005.10:g.(?_112775617)_(112780913_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000833111	5	112111314 - 112116610			833111	819516		
NC_000005.10:g.(?_112707312)_(112755035_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000832064	5	112043009 - 112090732			832064	819505		
NC_000005.10:g.(?_112827098)_(112827257_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000831021	5	112162795 - 112162954			831021	819522		
NM_000038.6(APC):c.1744-6_1744-4delinsAG	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000664704	5	112170642 - 112170644	5	112834945 - 112834947	664704	651254		NC_000005.10:112834944:TAC:AG
NM_000038.6(APC):c.4516del (p.Ser1505_Leu1506insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000662242	5	112175806	5	112840109	662242	632721		NC_000005.10:112840108:CC:C
NM_000038.6(APC):c.6596_6605del (p.Ile2199fs)	APC	I2108fs, I2140fs, I1916fs, I2039fs, I2073fs, I2181fs, I2209fs, I2098fs, I2171fs, I2199fs, I2158fs, I2174fs, I2217fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000657062	5	112177886 - 112177895	5	112842189 - 112842198	657062	632799		NC_000005.10:112842188:ATTACTGGAAA:A
NM_000038.6(APC):c.5777_5778del (p.Ile1926fs)	APC	I1643fs, I1800fs, I1835fs, I1901fs, I1908fs, I1766fs, I1825fs, I1898fs, I1936fs, I1926fs, I1867fs, I1885fs, I1944fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000656752	5	112177067 - 112177068	5	112841370 - 112841371	656752	632771		NC_000005.10:112841369:ATA:A
NM_000038.6(APC):c.156del (p.Gly53fs)	APC	G28fs, G53fs, G63fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000654864	5	112102042	5	112766345	654864	632558		NC_000005.10:112766344:AA:A
NM_000038.6(APC):c.1177dup (p.Ser393fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000653337	5	112154905 - 112154906	5	112819208 - 112819209	653337	632600		NC_000005.10:112819208:T:TT
NM_000038.6(APC):c.1059dup (p.Pro354fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000652299	5	112154786 - 112154787	5	112819089 - 112819090	652299	632597		NC_000005.10:112819089:TT:TTT
NM_000038.6(APC):c.2844_2847dup (p.Pro950fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000652240	5	112174134 - 112174135	5	112838437 - 112838438	652240	632665		NC_000005.10:112838437:TATG:TATGTATG
NM_000038.6(APC):c.1241_1246delinsA (p.Arg414fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000650783	5	112154970 - 112154975	5	112819273 - 112819278	650783	632603		NC_000005.10:112819272:GCGCTT:A
NC_000005.9:g.(?_112043009)_(112116610_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000647956	5	112043009 - 112116610	5	112707312 - 112780913	647956	651214		
NM_000038.6(APC):c.3311C>G (p.Ser1104Ter)	APC	S1076*, S978*, S1003*, S1013*, S1079*, S1114*, S821*, S944*, S1045*, S1063*, S1086*, S1104*, S1122*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000647928	5	112174602	5	112838905	647928	632679		NC_000005.10:112838904:C:G
NC_000005.9:g.(?_112111316)_(112137090_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000642643	5	112111316 - 112137090	5	112775619 - 112801393	642643	651299		
NM_000038.6(APC):c.1323del (p.Val442fs)	APC	V159fs, V282fs, V414fs, V417fs, V442fs, V316fs, V383fs, V452fs, V341fs, V351fs, V424fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000642240	5	112157603	5	112821906	642240	632607		NC_000005.10:112821905:T:
NM_000038.6(APC):c.878del (p.Ser293fs)	APC	S293fs, S275fs, S10fs, S234fs, S268fs, S303fs, S265fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 22, 2018)	criteria provided, single submitter	VCV000641035	5	112151235	5	112815538	641035	632587		NC_000005.10:112815537:G:
NM_000038.6(APC):c.1560del (p.Ser521fs)	APC	S361fs, S420fs, S531fs, S462fs, S539fs, S395fs, S430fs, S480fs, S493fs, S503fs, S521fs, S238fs, S496fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000641011	5	112163637	5	112827940	641011	632617		NC_000005.10:112827939:C:
NM_000038.6(APC):c.974dup (p.His325fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000640245	5	112154702 - 112154703	5	112819005 - 112819006	640245	632590		NC_000005.10:112819005:A:AA
NM_000038.6(APC):c.1479C>A (p.Tyr493Ter)	APC	Y210*, Y434*, Y452*, Y475*, Y493*, Y333*, Y392*, Y402*, Y468*, Y503*, Y367*, Y465*, Y511*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000639528	5	112162875	5	112827178	639528	632613		NC_000005.10:112827177:C:A
NM_000038.6(APC):c.656_659del (p.Ala219fs)	APC	A160fs, A229fs, A194fs, A219fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000639459	5	112128151 - 112128154	5	112792454 - 112792457	639459	632571		NC_000005.10:112792453:AGCCAG:AG
NM_000038.6(APC):c.664C>T (p.Gln222Ter)	APC	Q197*, Q232*, Q163*, Q222*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000638855	5	112128161	5	112792464	638855	632572		NC_000005.10:112792463:C:T
NC_000005.9:g.(?_112151182)_(112170872_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000583455	5	112151182 - 112170872	5	112815485 - 112835175	583455	559954		
NM_000038.6(APC):c.2338del (p.Ser780fs)	APC	S689fs, S721fs, S780fs, S790fs, S620fs, S654fs, S679fs, S752fs, S755fs, S497fs, S762fs, S739fs, S798fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 27, 2018)	criteria provided, single submitter	VCV000582631	5	112173628	5	112837931	582631	562388	rs1561576308	NC_000005.10:112837930:AA:A
NM_000038.6(APC):c.2466_2467insA (p.Ser823fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000580121	5	112173757 - 112173758	5	112838060 - 112838061	580121	559992	rs1561577342	NC_000005.10:112838060::A
NM_000038.6(APC):c.132dup (p.Lys45fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000579756	5	112090718 - 112090719	5	112755021 - 112755022	579756	564172	rs1561445097	NC_000005.10:112755021:G:GG
NM_000038.6(APC):c.4127_4128del (p.Tyr1376fs)	APC	Y1250fs, Y1376fs, Y1386fs, Y1394fs, Y1093fs, Y1216fs, Y1275fs, Y1317fs, Y1335fs, Y1348fs, Y1351fs, Y1358fs, Y1285fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 27, 2015)	no assertion criteria provided	VCV000548663	5	112175417 - 112175418	5	112839720 - 112839721	548663	539131	rs1554085533	NC_000005.10:112839719:TAT:T
NM_000038.6(APC):c.2063C>A (p.Ser688Ter)	APC	S670*, S688*, S528*, S660*, S405*, S663*, S587*, S647*, S706*, S562*, S597*, S629*, S698*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000545723	5	112173354	5	112837657	545723	536215	rs1554083930	NC_000005.10:112837656:C:A
NM_000038.6(APC):c.1616_1623del (p.Asp539fs)	APC	D480fs, D521fs, D539fs, D557fs, D438fs, D448fs, D498fs, D549fs, D256fs, D379fs, D413fs, D511fs, D514fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000537572	5	112163691 - 112163698	5	112827994 - 112828001	537572	520739	rs1554081910	NC_000005.10:112827993:AGACTTACAG:AG
NM_000038.6(APC):c.4363_4365delinsGCTGA (p.Asn1455fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000537553	5	112175654 - 112175656	5	112839957 - 112839959	537553	520335	rs1554085825	NC_000005.10:112839956:AAT:GCTGA
NM_000038.6(APC):c.108del (p.Lys36fs)	APC	K36fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000537502	5	112090692	5	112754995	537502	520643	rs1554067141	NC_000005.10:112754994:AAAA:AAA
NM_000038.6(APC):c.14del (p.Ser5fs)	APC	S5fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000537477	5	112090601	5	112754904	537477	520244	rs1554067104	NC_000005.10:112754903:C:
NM_000038.6(APC):c.1903G>T (p.Gly635Ter)	APC	G617*, G635*, G544*, G576*, G645*, G352*, G475*, G607*, G610*, G653*, G509*, G534*, G594*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000537470	5	112170807	5	112835110	537470	520735	rs1554083205	NC_000005.10:112835109:G:T
NM_000038.6(APC):c.948T>G (p.Tyr316Ter)	APC	Y298*, Y316*, Y33*, Y291*, Y257*, Y288*, Y326*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000470156	5	112154677	5	112818980	470156	454053	rs748010172	NC_000005.10:112818979:T:G
NM_000038.6(APC):c.712dup (p.Gln238fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000470077	5	112128206 - 112128207	5	112792509 - 112792510	470077	454587	rs1554074793	NC_000005.10:112792509:CCC:CCCC
NM_000038.6(APC):c.684_687del (p.Leu229fs)	APC	L170fs, L239fs, L204fs, L229fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000470065	5	112128180 - 112128183	5	112792483 - 112792486	470065	454263	rs1554074759	NC_000005.10:112792482:TACTT:T
NM_000038.6(APC):c.6065C>G (p.Ser2022Ter)	APC	S2004*, S2022*, S1739*, S1896*, S1963*, S1981*, S1994*, S1862*, S1921*, S1931*, S2040*, S2032*, S1997*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000470034	5	112177356	5	112841659	470034	454549	rs1554087174	NC_000005.10:112841658:C:G
NM_000038.6(APC):c.5827_5828insAA (p.Arg1943fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000470023	5	112177117 - 112177118	5	112841420 - 112841421	470023	454034	rs1554087023	NC_000005.10:112841420:A:AAA
NM_000038.6(APC):c.5524del (p.Ser1842fs)	APC	S1817fs, S1783fs, S1852fs, S1682fs, S1716fs, S1741fs, S1751fs, S1801fs, S1842fs, S1559fs, S1814fs, S1824fs, S1860fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000470011	5	112176814	5	112841117	470011	454217	rs1554086794	NC_000005.10:112841116:TT:T
NM_000038.6(APC):c.543_546del (p.Thr182fs)	APC	T182fs, T192fs, T123fs, T157fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000470005	5	112116495 - 112116498	5	112780798 - 112780801	470005	454580	rs1554072562	NC_000005.10:112780797:ACAAACA:ACA
NM_000038.6(APC):c.5384C>G (p.Ser1795Ter)	APC	S1795*, S1777*, S1704*, S1512*, S1669*, S1694*, S1736*, S1754*, S1635*, S1767*, S1813*, S1770*, S1805*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000470004	5	112176675	5	112840978	470004	454831	rs1554086694	NC_000005.10:112840977:C:G
NM_000038.6(APC):c.5341C>T (p.Gln1781Ter)	APC	Q1763*, Q1781*, Q1621*, Q1655*, Q1753*, Q1756*, Q1498*, Q1680*, Q1690*, Q1722*, Q1740*, Q1791*, Q1799*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000469995	5	112176632	5	112840935	469995	453998	rs1554086653	NC_000005.10:112840934:C:T
NM_000038.6(APC):c.4906dup (p.Asp1636fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000469982	5	112176192 - 112176193	5	112840495 - 112840496	469982	454807	rs1554086285	NC_000005.10:112840495:GGGGG:GGGGGG
NM_000038.6(APC):c.4796C>G (p.Ser1599Ter)	APC	S1581*, S1599*, S1508*, S1571*, S1617*, S1473*, S1558*, S1609*, S1316*, S1439*, S1498*, S1574*, S1540*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000469977	5	112176087	5	112840390	469977	454803	rs1554086212	NC_000005.10:112840389:C:G
NM_000038.6(APC):c.4290del (p.Met1431fs)	APC	M1271fs, M1372fs, M1403fs, M1330fs, M1406fs, M1449fs, M1148fs, M1413fs, M1431fs, M1441fs, M1305fs, M1340fs, M1390fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000469960	5	112175580	5	112839883	469960	454190	rs1554085714	NC_000005.10:112839882:CC:C
NM_000038.6(APC):c.4009_4010dup (p.Gln1338fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000469945	5	112175299 - 112175300	5	112839602 - 112839603	469945	454755	rs1554085450	NC_000005.10:112839602:CT:CTCT
NM_000038.6(APC):c.3980C>G (p.Ser1327Ter)	APC	S1309*, S1327*, S1044*, S1167*, S1226*, S1236*, S1268*, S1299*, S1201*, S1337*, S1345*, S1302*, S1286*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000469943	5	112175271	5	112839574	469943	454443	rs1554085429	NC_000005.10:112839573:C:G
NM_000038.6(APC):c.3880C>T (p.Gln1294Ter)	APC	Q1276*, Q1294*, Q1168*, Q1253*, Q1266*, Q1193*, Q1312*, Q1134*, Q1011*, Q1203*, Q1235*, Q1269*, Q1304*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000469942	5	112175171	5	112839474	469942	453972	rs1554085373	NC_000005.10:112839473:C:T
NM_000038.6(APC):c.3629_3630AT[1] (p.Met1211fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000469930	5	112174920 - 112174921	5	112839223 - 112839224	469930	454429	rs1554085190	NC_000005.10:112839222:ATAT:AT
NM_000038.6(APC):c.3343del (p.Val1115fs)	APC	V1014fs, V1115fs, V832fs, V1024fs, V1074fs, V1087fs, V1125fs, V989fs, V1056fs, V1097fs, V1133fs, V955fs, V1090fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000469918	5	112174634	5	112838937	469918	454399	rs1554084945	NC_000005.10:112838936:G:
NM_000038.6(APC):c.3316G>T (p.Gly1106Ter)	APC	G1106*, G1088*, G1078*, G1124*, G823*, G980*, G1015*, G1047*, G1065*, G946*, G1005*, G1081*, G1116*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000469917	5	112174607	5	112838910	469917	453966	rs1554084921	NC_000005.10:112838909:G:T
NM_000038.6(APC):c.3184C>T (p.Gln1062Ter)	APC	Q1044*, Q1062*, Q1021*, Q961*, Q971*, Q936*, Q1003*, Q1034*, Q1037*, Q779*, Q1072*, Q1080*, Q902*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000469912	5	112174475	5	112838778	469912	454389	rs1554084818	NC_000005.10:112838777:C:T
NM_000038.6(APC):c.3090dup (p.Tyr1031fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000469906	5	112174378 - 112174379	5	112838681 - 112838682	469906	454139	rs1554084685	NC_000005.10:112838681:AAA:AAAA
NM_000038.6(APC):c.2991T>G (p.Tyr997Ter)	APC	Y979*, Y997*, Y871*, Y896*, Y906*, Y956*, Y1015*, Y714*, Y837*, Y1007*, Y969*, Y972*, Y938*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000469783	5	112174282	5	112838585	469783	454382	rs864622629	NC_000005.10:112838584:T:G
NM_000038.6(APC):c.2837del (p.Thr946fs)	APC	T786fs, T887fs, T905fs, T921fs, T956fs, T855fs, T928fs, T946fs, T663fs, T820fs, T845fs, T918fs, T964fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000469776	5	112174128	5	112838431	469776	454374	rs1554084529	NC_000005.10:112838430:C:
NM_000038.6(APC):c.2686_2689dup (p.Ile897fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000469766	5	112173974 - 112173975	5	112838277 - 112838278	469766	453932	rs1554084375	NC_000005.10:112838277:CAGCCA:CAGCCAGCCA
NM_000038.6(APC):c.1983T>A (p.Cys661Ter)	APC	C643*, C661*, C378*, C620*, C636*, C671*, C501*, C602*, C535*, C633*, C560*, C570*, C679*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000469727	5	112173274	5	112837577	469727	454091	rs1554083862	NC_000005.10:112837576:T:A
NM_000038.6(APC):c.1643del (p.Val547_Leu548insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000469717	5	112164566	5	112828869	469717	454286	rs1554082091	NC_000005.10:112828868:TTTT:TTT
NM_000038.6(APC):c.1633dup (p.Ala545fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000469715	5	112164558 - 112164559	5	112828861 - 112828862	469715	454079	rs1554082082	NC_000005.10:112828861:G:GG
NM_000038.6(APC):c.1538_1539dup (p.Ala514Ter)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000469711	5	112162933 - 112162934	5	112827236 - 112827237	469711	454076	rs1554081762	NC_000005.10:112827236:TA:TATA
NM_000038.6(APC):c.1447_1448TG[1] (p.Cys483_Glu484delinsTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 16, 2018)	criteria provided, single submitter	VCV000469707	5	112162843 - 112162844	5	112827146 - 112827147	469707	453879	rs1554081669	NC_000005.10:112827145:TGTG:TG
NC_000005.9:g.(?_112163620)_(112179829_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000469693	5	112163620 - 112179829	5	112827923 - 112844132	469693	453612		
NC_000005.9:g.(?_112072721)_(112179829_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000469687	5	112072721 - 112179829	5	112737024 - 112844132	469687	453598		
NC_000005.9:g.(?_112073556)_(112151290_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 7, 2016)	criteria provided, single submitter	VCV000417561	5	112073556 - 112151290	5	112737859 - 112815593	417561	394158		
NC_000005.9:g.(?_112151192)_(112157688_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000417558	5	112151192 - 112157688	5	112815495 - 112821991	417558	394661		
NC_000005.9:g.(?_112116487)_(112181936_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000417557	5	112116487 - 112181936	5	112780790 - 112846239	417557	394378		
NC_000005.9:g.(?_112154663)_(112157688_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000417550	5	112154663 - 112157688	5	112818966 - 112821991	417550	394381		
NM_000038.6(APC):c.4404_4418delinsC (p.Lys1468fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000411550	5	112175695 - 112175709	5	112839998 - 112840012	411550	394526	rs1064792980	NC_000005.10:112839997:GCAAGCTGCAGTAAA:C
NM_000038.6(APC):c.3186_3187del (p.Gln1062_Ser1063insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000411539	5	112174476 - 112174477	5	112838779 - 112838780	411539	394491	rs1060503362	NC_000005.10:112838778:AAA:A
NM_000038.6(APC):c.4357_4363delinsAAT (p.Pro1453fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000411529	5	112175648 - 112175654	5	112839951 - 112839957	411529	394428	rs1064792979	NC_000005.10:112839950:CCTAAAA:AAT
NM_000038.6(APC):c.1402G>T (p.Glu468Ter)	APC	E468*, E450*, E185*, E443*, E478*, E308*, E342*, E367*, E377*, E409*, E440*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000411503	5	112157682	5	112821985	411503	394442	rs1060503340	NC_000005.10:112821984:G:T
NM_000038.6(APC):c.3239_3240AG[1] (p.Ser1081fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000411476	5	112174529 - 112174530	5	112838832 - 112838833	411476	394304	rs1060503327	NC_000005.10:112838831:GAGAG:GAG
NM_000038.6(APC):c.2133del (p.His712fs)	APC	H429fs, H611fs, H653fs, H684fs, H712fs, H722fs, H586fs, H687fs, H730fs, H552fs, H621fs, H671fs, H694fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000411466	5	112173423	5	112837726	411466	394263	rs1060503321	NC_000005.10:112837725:TT:T
NM_000038.6(APC):c.2910_2911del (p.Ser970fs)	APC	S844fs, S810fs, S911fs, S942fs, S945fs, S988fs, S869fs, S879fs, S929fs, S952fs, S687fs, S970fs, S980fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000411441	5	112174200 - 112174201	5	112838503 - 112838504	411441	394828	rs1060503307	NC_000005.10:112838502:GTG:G
NM_000038.6(APC):c.2098del (p.Asp700fs)	APC	D540fs, D659fs, D675fs, D417fs, D609fs, D682fs, D710fs, D574fs, D599fs, D641fs, D672fs, D700fs, D718fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 10, 2016)	criteria provided, single submitter	VCV000411439	5	112173387	5	112837690	411439	394260	rs1060503305	NC_000005.10:112837689:GGG:GG
NM_000038.6(APC):c.3827C>A (p.Ser1276Ter)	APC	S1258*, S1276*, S1150*, S1217*, S1235*, S1251*, S1294*, S1175*, S1286*, S1116*, S1185*, S993*, S1248*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000411428	5	112175118	5	112839421	411428	394342	rs1060503299	NC_000005.10:112839420:C:A
NM_000038.6(APC):c.2635C>T (p.Gln879Ter)	APC	Q861*, Q879*, Q778*, Q838*, Q788*, Q889*, Q897*, Q753*, Q820*, Q851*, Q854*, Q596*, Q719*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000411399	5	112173926	5	112838229	411399	394478	rs1060503287	NC_000005.10:112838228:C:T
NM_000038.6(APC):c.2097G>A (p.Trp699Ter)	APC	W681*, W699*, W416*, W671*, W717*, W539*, W598*, W608*, W674*, W709*, W573*, W640*, W658*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000411387	5	112173388	5	112837691	411387	394464	rs1060503282	NC_000005.10:112837690:G:A
NM_000038.6(APC):c.2240C>G (p.Ser747Ter)	APC	S729*, S747*, S464*, S646*, S688*, S722*, S765*, S587*, S621*, S656*, S706*, S719*, S757*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000411368	5	112173531	5	112837834	411368	394375	rs773020689	NC_000005.10:112837833:C:G
NM_000038.6(APC):c.1759dup (p.Ser587fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000411355	5	112170659 - 112170660	5	112834962 - 112834963	411355	394358	rs1554083100	NC_000005.10:112834962:AAAA:AAAAA
NM_000038.6(APC):c.874_880del (p.Ser293fs)	APC	S265fs, S10fs, S234fs, S268fs, S275fs, S293fs, S303fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000411346	5	112151228 - 112151234	5	112815531 - 112815537	411346	394705	rs1060503263	NC_000005.10:112815530:GTTTTGAGTT:GTT
NM_000038.6(APC):c.1742del (p.Lys581fs)	APC	K563fs, K581fs, K455fs, K556fs, K298fs, K421fs, K480fs, K522fs, K490fs, K540fs, K553fs, K591fs, K599fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000411339	5	112164664	5	112828967	411339	394242	rs1060503259	NC_000005.10:112828966:AAAAA:AAAA
NM_000038.5(APC):c.934-?_*2113+?del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 17, 2016)	criteria provided, single submitter	VCV000236662					236662	239512		
NM_000038.6(APC):c.595dup (p.Ala199fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000236625	5	112116549 - 112116550	5	112780852 - 112780853	236625	239527	rs878853459	NC_000005.10:112780852:G:GG
NM_000038.6(APC):c.5917del (p.Ser1973fs)	APC	S1690fs, S1882fs, S1983fs, S1847fs, S1872fs, S1945fs, S1914fs, S1932fs, S1955fs, S1973fs, S1813fs, S1948fs, S1991fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000236624	5	112177208	5	112841511	236624	239595	rs878853458	NC_000005.10:112841510:A:
NM_000038.6(APC):c.5025dup (p.Arg1676Ter)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000236613	5	112176314 - 112176315	5	112840617 - 112840618	236613	239584	rs878853454	NC_000005.10:112840617:TT:TTT
NM_000038.6(APC):c.4987G>T (p.Glu1663Ter)	APC	E1645*, E1663*, E1604*, E1638*, E1562*, E1572*, E1622*, E1673*, E1681*, E1380*, E1503*, E1635*, E1537*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000236611	5	112176278	5	112840581	236611	239583	rs758987855	NC_000005.10:112840580:G:T
NM_000038.6(APC):c.4701del (p.Asp1568fs)	APC	D1509fs, D1527fs, D1477fs, D1540fs, D1578fs, D1586fs, D1408fs, D1442fs, D1467fs, D1543fs, D1550fs, D1285fs, D1568fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000236605	5	112175992	5	112840295	236605	239578	rs878853449	NC_000005.10:112840294:A:
NM_000038.6(APC):c.3196del (p.Arg1066fs)	APC	R1048fs, R1041fs, R1084fs, R906fs, R1007fs, R1038fs, R783fs, R940fs, R965fs, R975fs, R1025fs, R1066fs, R1076fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 23, 2016)	criteria provided, single submitter	VCV000236586	5	112174485	5	112838788	236586	239561	rs878853436	NC_000005.10:112838787:AAA:AA
NM_000038.6(APC):c.2795C>G (p.Ser932Ter)	APC	S914*, S932*, S806*, S841*, S891*, S907*, S831*, S873*, S942*, S950*, S649*, S772*, S904*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000236581	5	112174086	5	112838389	236581	239556	rs878853432	NC_000005.10:112838388:C:G
NM_000038.6(APC):c.2314del (p.Thr772fs)	APC	T612fs, T754fs, T772fs, T713fs, T747fs, T646fs, T744fs, T790fs, T489fs, T671fs, T681fs, T731fs, T782fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 2, 2016)	criteria provided, single submitter	VCV000236573	5	112173603	5	112837906	236573	239550	rs878853426	NC_000005.10:112837905:AAA:AA
NM_000038.6(APC):c.1866_1867delinsAT (p.Tyr622_Arg623delinsTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 30, 2016)	criteria provided, single submitter	VCV000236564	5	112170770 - 112170771	5	112835073 - 112835074	236564	239542	rs878853419	NC_000005.10:112835072:CC:AT
NM_000038.6(APC):c.3595_3596del (p.Lys1199fs)	APC	K1039fs, K1140fs, K1171fs, K1181fs, K1098fs, K1108fs, K1158fs, K1174fs, K1217fs, K1073fs, K1209fs, K916fs, K1199fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000219466	5	112174885 - 112174886	5	112839188 - 112839189	219466	221509	rs864622106	NC_000005.10:112839187:AAA:A
NM_000038.6(APC):c.3404_3405del (p.Asp1134_Tyr1135insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	VCV000219434	5	112174694 - 112174695	5	112838997 - 112838998	219434	221508	rs864622086	NC_000005.10:112838996:TAT:T
NM_000038.6(APC):c.3921_3924del (p.Ile1307fs)	APC	I1024fs, I1147fs, I1279fs, I1181fs, I1206fs, I1216fs, I1307fs, I1317fs, I1289fs, I1248fs, I1266fs, I1282fs, I1325fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000216016	5	112175212 - 112175215	5	112839515 - 112839518	216016	212425	rs863224457	NC_000005.10:112839514:AAAA:
NM_000038.5(APC):c.1409-?_*(1_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000216013	5	112162805 - 112179824	5	112827108 - 112844127	216013	212382		
NM_000038.6(APC):c.1262G>A (p.Trp421Ter)	APC	W403*, W421*, W138*, W295*, W396*, W320*, W362*, W431*, W261*, W330*, W393*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	VCV000188244	5	112154991	5	112819294	188244	186028	rs559510809	NC_000005.10:112819293:G:A
NM_000038.6(APC):c.4175C>A (p.Ser1392Ter)	APC	S1374*, S1392*, S1109*, S1266*, S1333*, S1402*, S1367*, S1232*, S1301*, S1351*, S1291*, S1364*, S1410*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000188240	5	112175466	5	112839769	188240	186036	rs786204170	NC_000005.10:112839768:C:A
NM_000038.6(APC):c.3830T>G (p.Leu1277Ter)	APC	L1259*, L1277*, L1117*, L1186*, L1218*, L1249*, L1252*, L994*, L1176*, L1236*, L1287*, L1151*, L1295*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 6, 2016)	criteria provided, single submitter	VCV000188239	5	112175121	5	112839424	188239	186035	rs786204169	NC_000005.10:112839423:T:G
NM_000038.6(APC):c.925G>T (p.Gly309Ter)	APC	G291*, G309*, G281*, G26*, G319*, G250*, G284*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 18, 2014)	criteria provided, single submitter	VCV000188167	5	112151282	5	112815585	188167	186027	rs786204118	NC_000005.10:112815584:G:T
NM_000038.6(APC):c.3814del (p.Ser1272fs)	APC	S1171fs, S1231fs, S1272fs, S1290fs, S989fs, S1112fs, S1181fs, S1213fs, S1254fs, S1146fs, S1244fs, S1247fs, S1282fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 24, 2014)	no assertion criteria provided	VCV000156479	5	112175101	5	112839404	156479	166244	rs587783033	NC_000005.10:112839403:TTTTT:TTTT
APC, 5-BP DEL, NT3221	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000000842					842	15881		
NM_000038.6(APC):c.1059_1060insAAGGATGATAT (p.Pro354fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000000836	5	112154787 - 112154788	5	112819090 - 112819091	836	15875	rs1554079996	NC_000005.10:112819090:T:TAAGGATGATAT
APC deletion	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 8, 1999)	no assertion criteria provided	VCV000000834	5	112043201 - 112181937	5	112707504 - 112846240	834	15873		
NM_000038.6(APC):c.1311_1312+1del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000000826	5	112155040 - 112155042	5	112819343 - 112819345	826	15865	rs397514030	NC_000005.10:112819342:AAG:
NM_000038.6(APC):c.470G>A (p.Trp157Ter)	APC	W157*, W167*, W98*, W132*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 20, 2016)	no assertion criteria provided	VCV000000813	5	112111373	5	112775676	813	15852	rs137854576	NC_000005.10:112775675:G:A
NM_000038.6(APC):c.1885_1886insA (p.Leu629fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000000809	5	112170789 - 112170790	5	112835092 - 112835093	809	15848	rs387906233	NC_000005.10:112835092::A
NM_000038.6(APC):c.1069dup (p.Ile357fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000000805	5	112154797 - 112154798	5	112819100 - 112819101	805	15844	rs387906232	NC_000005.10:112819100:A:AA
NM_000038.5(APC):c.730_731delAG (p.Arg244Valfs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 9, 1991)	no assertion criteria provided	VCV000000793	5	112136974 - 112136975	5	112801277 - 112801278	793	15832	rs387906228	NC_000005.10:112801276:AGAG:AG
NM_000249.3(MLH1):c.1297G>T (p.Glu433Ter)	MLH1	E433*, E75*, E92*, E335*, E192*, E400*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451874	3	37067386	3	37025895	451874	443422	rs63750443	NC_000003.12:37025894:G:T
NM_000249.3(MLH1):c.883A>G (p.Ser295Gly)	MLH1	S295G, S54G, S197G, S262G	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090409	3	37059089	3	37017598	90409	95883	rs63751598	NC_000003.12:37017597:A:G
NM_000249.3(MLH1):c.790+2T>A	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000090359	3	37056037	3	37014546	90359	95833	rs267607790	NC_000003.12:37014545:T:A
NM_000249.3(MLH1):c.208-1G>A	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090029	3	37042445	3	37000954	90029	95503	rs267607717	NC_000003.12:37000953:G:A
NM_000249.3(MLH1):c.1989+1G>A	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089973	3	37090101	3	37048610	89973	95447	rs267607879	NC_000003.12:37048609:G:A
NM_001258271.1(MLH1):c.1896+883del	MLH1	P551fs, P291fs, P308fs, P408fs, P594fs, P616fs, P649fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089954	3	37090053	3	37048562	89954	95428	rs281864938	NC_000003.12:37048561:CCCCC:CCCC
NM_001354630.1(MLH1):c.1732-875del	MLH1	A278fs, A378fs, A521fs, A586fs, A261fs, A619fs	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089910	3	37089132	3	37047641	89910	95384	rs63749986	NC_000003.12:37047640:GG:G
NM_000249.3(MLH1):c.1624C>T (p.Gln542Ter)	MLH1	Q542*, Q301*, Q509*, Q184*, Q201*, Q444*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089809	3	37081742	3	37040251	89809	95283	rs63750192	NC_000003.12:37040250:C:T
NM_001167617.2(MLH1):c.1195del (p.Arg399fs)	MLH1	R156fs, R497fs, R399fs, R139fs, R256fs, R464fs	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089752	3	37070349	3	37028858	89752	95226	rs63750855	NC_000003.12:37028857:CCCCCC:CCCCC
NM_001904.4(CTNNB1):c.98C>A (p.Ser33Tyr)	CTNNB1	S33Y, S26Y	Lung adenocarcinoma|Hepatocellular carcinoma|Carcinoma of colon|Carcinoma of esophagus|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Malignant melanoma of skin|Medulloblastoma|Endometrial neoplasm|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Pilomatrixoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000017577	3	41266101	3	41224610	17577	32616	rs121913400	NC_000003.12:41224609:C:A
NM_000038.6(APC):c.2617dup (p.Ser873fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000841422	5	112173906 - 112173907	5	112838209 - 112838210	841422	829658		NC_000005.10:112838209:TT:TTT
NC_000005.10:g.(?_112754891)_(112767400_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000832632	5	112090588 - 112103097			832632	819510		
NC_000005.10:g.(?_112815478)_(112822001_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000832097	5	112151175 - 112157698			832097	819519		
NC_000005.10:g.(?_112815485)_(112822001_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000831835	5	112151182 - 112157698			831835	819521		
NM_000038.6(APC):c.1600A>T (p.Lys534Ter)	APC	K544*, K506*, K509*, K534*, K552*, K374*, K251*, K408*, K433*, K443*, K475*, K493*, K516*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000665501	5	112163677	5	112827980	665501	632619		NC_000005.10:112827979:A:T
NC_000005.9:g.(?_112072721)_(112179833_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000657373	5	112072721 - 112179833	5	112737024 - 112844136	657373	651182		
NM_000038.6(APC):c.516dup (p.Pro173fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000650318	5	112111417 - 112111418	5	112775720 - 112775721	650318	632570		NC_000005.10:112775720:TT:TTT
NM_000038.6(APC):c.712C>T (p.Gln238Ter)	APC	Q179*, Q213*, Q238*, Q248*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000642931	5	112128209	5	112792512	642931	632577		NC_000005.10:112792511:C:T
NM_000038.6(APC):c.1829del (p.Asp610fs)	APC	D569fs, D582fs, D585fs, D620fs, D484fs, D551fs, D327fs, D509fs, D450fs, D519fs, D592fs, D610fs, D628fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000577704	5	112170733	5	112835036	577704	562376	rs1561568510	NC_000005.10:112835035:A:
NM_000038.6(APC):c.989del (p.Met330fs)	APC	M302fs, M305fs, M330fs, M340fs, M271fs, M312fs, M47fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000572638	5	112154718	5	112819021	572638	562341	rs1561540666	NC_000005.10:112819020:T:
NM_000038.6(APC):c.1111G>T (p.Gly371Ter)	APC	G353*, G371*, G312*, G343*, G346*, G88*, G381*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000571193	5	112154840	5	112819143	571193	562345	rs863224535	NC_000005.10:112819142:G:T
NM_000038.6(APC):c.1415dup (p.Gln473fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000566060	5	112162810 - 112162811	5	112827113 - 112827114	566060	564231	rs1561553403	NC_000005.10:112827113:T:TT
NM_000038.6(APC):c.3604_3607del (p.Ser1202fs)	APC	S1101fs, S1212fs, S1220fs, S1177fs, S919fs, S1202fs, S1042fs, S1076fs, S1111fs, S1143fs, S1161fs, S1174fs, S1184fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000537567	5	112174895 - 112174898	5	112839198 - 112839201	537567	520503	rs1408646734	NC_000005.10:112839197:TCTG:
NM_000038.6(APC):c.802G>T (p.Glu268Ter)	APC	E250*, E268*, E209*, E243*, E278*, E240*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000470123	5	112137048	5	112801351	470123	454267	rs1326410920	NC_000005.10:112801350:G:T
NM_000038.6(APC):c.423-9A>G	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000469955	5	112111317	5	112775620	469955	453825	rs1554071494	NC_000005.10:112775619:A:G
NM_000038.6(APC):c.1759del (p.Ser587fs)	APC	S528fs, S559fs, S587fs, S597fs, S605fs, S427fs, S486fs, S546fs, S562fs, S304fs, S496fs, S461fs, S569fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000469718	5	112170660	5	112834963	469718	454287	rs1554083100	NC_000005.10:112834962:AAAA:AAA
NM_000038.6(APC):c.1210del (p.Ile404fs)	APC	I376fs, I379fs, I414fs, I121fs, I386fs, I404fs, I345fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000419993	5	112154937	5	112819240	419993	406498	rs1064794225	NC_000005.10:112819239:AAA:AA
NM_000038.6(APC):c.761C>G (p.Ser254Ter)	APC	S236*, S254*, S229*, S264*, S195*, S226*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000411489	5	112137007	5	112801310	411489	394220	rs1060503334	NC_000005.10:112801309:C:G
NM_001127511.3(APC):c.-192A>T	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 12, 2016)	no assertion criteria provided	VCV000243007	5	112043223	5	112707526	243007	244087	rs879253784	NC_000005.10:112707525:A:T
NM_000038.5(APC):c.792del (p.Gly265Glufs)	APC	G237fs, G240fs, G247fs, G265fs, G275fs, G206fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216018	5	112137037	5	112801340	216018	212394	rs863224459	NC_000005.10:112801339:AA:A
NM_000038.6(APC):c.477del (p.Tyr158_Tyr159insTer)	APC		not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000180587	5	112111380	5	112775683	180587	178765	rs730880250	NC_000005.10:112775682:C:
NM_000038.6(APC):c.5942del (p.Asn1981fs)	APC	N1880fs, N1890fs, N1953fs, N1922fs, N1956fs, N1855fs, N1940fs, N1963fs, N1991fs, N1698fs, N1821fs, N1981fs, N1999fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000820	5	112177232	5	112841535	820	15859	rs397509433	NC_000005.10:112841534:AA:A
NM_000038.6(APC):c.1500T>G (p.Tyr500Ter)	APC	Y482*, Y500*, Y459*, Y374*, Y399*, Y217*, Y340*, Y472*, Y475*, Y518*, Y409*, Y441*, Y510*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000000796	5	112162896	5	112827199	796	15835	rs387906230	NC_000005.10:112827198:T:G
NM_000038.6(APC):c.607del (p.Gln203fs)	APC	Q144fs, Q203fs, Q213fs, Q178fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000860742	5	112116562	5	112780865	860742	829607		NC_000005.10:112780864:C:
NM_000038.6(APC):c.1268G>A (p.Trp423Ter)	APC	W140*, W263*, W332*, W364*, W433*, W297*, W398*, W423*, W322*, W395*, W405*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000851219	5	112154997	5	112819300	851219	829624		NC_000005.10:112819299:G:A
NM_000038.6(APC):c.366del (p.Phe123fs)	APC	F123fs, F64fs, F98fs, F133fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000658616	5	112103029	5	112767332	658616	632564		NC_000005.10:112767331:GGG:GG
NM_000038.6(APC):c.1753del (p.Leu585fs)	APC	L302fs, L425fs, L567fs, L585fs, L595fs, L494fs, L526fs, L544fs, L557fs, L560fs, L459fs, L484fs, L603fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000652107	5	112170655	5	112834958	652107	632625		NC_000005.10:112834957:CCC:CC
NM_000038.6(APC):c.4501del (p.Ser1501fs)	APC	S1375fs, S1410fs, S1483fs, S1341fs, S1442fs, S1473fs, S1400fs, S1476fs, S1501fs, S1511fs, S1218fs, S1460fs, S1519fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000651124	5	112175789	5	112840092	651124	632720		NC_000005.10:112840091:TTTT:TTT
NM_000038.6(APC):c.7803_7807del (p.Ser2601fs)	APC	S2542fs, S2560fs, S2619fs, S2510fs, S2576fs, S2611fs, S2318fs, S2601fs, S2441fs, S2475fs, S2500fs, S2573fs, S2583fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000648862	5	112179090 - 112179094	5	112843393 - 112843397	648862	632843		NC_000005.10:112843392:AAAGTAAAG:AAAG
NM_000038.6(APC):c.7069A>T (p.Lys2357Ter)	APC	K2074*, K2197*, K2231*, K2367*, K2375*, K2266*, K2329*, K2332*, K2298*, K2316*, K2339*, K2357*, K2256*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000639574	5	112178360	5	112842663	639574	632815		NC_000005.10:112842662:A:T
NM_000038.6(APC):c.3871C>T (p.Gln1291Ter)	APC	Q1273*, Q1291*, Q1250*, Q1008*, Q1131*, Q1190*, Q1263*, Q1301*, Q1200*, Q1232*, Q1266*, Q1165*, Q1309*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000575517	5	112175162	5	112839465	575517	562428	rs1561588104	NC_000005.10:112839464:C:T
NM_000038.6(APC):c.74_75del (p.Gln25fs)	APC	Q25fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000470090	5	112090661 - 112090662	5	112754964 - 112754965	470090	454228	rs1554067124	NC_000005.10:112754963:AA:
NM_000038.6(APC):c.1564dup (p.Met522fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000469713	5	112163640 - 112163641	5	112827943 - 112827944	469713	453880	rs1554081884	NC_000005.10:112827943:A:AA
NC_000005.9:g.(?_112043009)_(112116606_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000469683			5	112707312 - 112780909	469683	454375		
NM_000038.6(APC):c.1778G>A (p.Trp593Ter)	APC	W575*, W593*, W611*, W310*, W433*, W552*, W603*, W467*, W502*, W565*, W492*, W534*, W568*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419994	5	112170682	5	112834985	419994	406510	rs1064794226	NC_000005.10:112834984:G:A
NM_000038.6(APC):c.1526del (p.Thr509fs)	APC	T226fs, T418fs, T484fs, T509fs, T383fs, T468fs, T450fs, T481fs, T527fs, T349fs, T408fs, T491fs, T519fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419764	5	112162922	5	112827225	419764	406507	rs1064794092	NC_000005.10:112827224:C:
NM_000038.6(APC):c.956del (p.Leu319fs)	APC	L260fs, L301fs, L319fs, L294fs, L291fs, L36fs, L329fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418926	5	112154684	5	112818987	418926	406495	rs1064793530	NC_000005.10:112818986:TT:T
NM_000038.6(APC):c.1879_1882del (p.Asn627fs)	APC	N501fs, N609fs, N645fs, N536fs, N627fs, N344fs, N526fs, N599fs, N467fs, N568fs, N586fs, N602fs, N637fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000411536	5	112170780 - 112170783	5	112835083 - 112835086	411536	394745	rs1060503360	NC_000005.10:112835082:ACAAACA:ACA
NM_000038.6(APC):c.531+2dup	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000411336	5	112111435 - 112111436	5	112775738 - 112775739	411336	394197	rs1060503257	NC_000005.10:112775738:T:TT
NM_000038.6(APC):c.4901del (p.Pro1634fs)	APC	P1351fs, P1474fs, P1533fs, P1543fs, P1575fs, P1644fs, P1652fs, P1508fs, P1606fs, P1593fs, P1609fs, P1616fs, P1634fs	Adenomatous colonic polyposis|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374105	5	112176191	5	112840494	374105	360864	rs1057518901	NC_000005.10:112840493:CC:C
NM_001127511.3(APC):c.-190G>A	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000243008	5	112043225	5	112707528	243008	244088	rs879253785	NC_000005.10:112707527:G:A
NM_000038.6(APC):c.448A>T (p.Lys150Ter)	APC	K150*, K160*, K91*, K125*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000236598	5	112111351	5	112775654	236598	239523	rs878853444	NC_000005.10:112775653:A:T
NM_000038.5(APC):c.423-?_531+?del (p.(?))	APC		Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000217980					217980	214643		
NM_000038.6(APC):c.3298_3301del (p.Ser1100fs)	APC	S1059fs, S1118fs, S940fs, S1072fs, S1082fs, S1100fs, S974fs, S1041fs, S1075fs, S1110fs, S817fs, S1009fs, S999fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000217965	5	112174589 - 112174592	5	112838892 - 112838895	217965	214711	rs863225341	NC_000005.10:112838891:TCTC:
NM_000038.6(APC):c.1892_1904delinsAAT (p.Ile631fs)	APC		Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jun 25, 2016)	criteria provided, single submitter	VCV000217937	5	112170796 - 112170808	5	112835099 - 112835111	217937	214693	rs863225319	NC_000005.10:112835098:TTATTGAAAGTGG:AAT
NM_000038.6(APC):c.1609del (p.Ser537fs)	APC	S254fs, S411fs, S436fs, S446fs, S478fs, S377fs, S509fs, S537fs, S555fs, S496fs, S512fs, S519fs, S547fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000217932	5	112163684	5	112827987	217932	214689	rs863225317	NC_000005.10:112827986:AAA:AA
NM_000038.6(APC):c.1987C>T (p.Gln663Ter)	APC	Q645*, Q663*, Q562*, Q380*, Q572*, Q638*, Q503*, Q622*, Q635*, Q673*, Q681*, Q537*, Q604*	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000181792	5	112173278	5	112837581	181792	180185	rs730881240	NC_000005.10:112837580:C:T
NM_000038.6(APC):c.1312+3_1312+4del	APC		not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 12, 2015)	criteria provided, multiple submitters, no conflicts	VCV000181775	5	112155043 - 112155044	5	112819346 - 112819347	181775	180179	rs730881228	NC_000005.10:112819345:TAT:T
NM_000038.6(APC):c.2547_2550del (p.Asp849fs)	APC	D689fs, D808fs, D821fs, D824fs, D859fs, D867fs, D723fs, D849fs, D566fs, D748fs, D758fs, D790fs, D831fs	Familial adenomatous polyposis|not specified|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092342	5	112173835 - 112173838	5	112838138 - 112838141	92342	98253	rs398123118	NC_000005.10:112838137:AGATAGA:AGA
NG_008481.4:g.(?_150033)_(158719_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 25, 2016)	criteria provided, single submitter	VCV000000841	5	112173250 - 112181936	5	112837553 - 112846239	841	15880		
NM_000038.6(APC):c.5582_5585del (p.Asp1860_Ser1861insTer)	APC		Familial adenomatous polyposis|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000000821	5	112176871 - 112176874	5	112841174 - 112841177	821	15860	rs587776520	NC_000005.10:112841173:TTCTTT:TT
NM_000249.3(MLH1):c.589C>T (p.Gln197Ter)	MLH1	Q197*, Q99*, Q164*	Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer|Lynch syndrome II	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000479670	3	37053502	3	37012011	479670	473413	rs1553644123	NC_000003.12:37012010:C:T
NM_000249.3(MLH1):c.1667+2T>C	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome II|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237317	3	37081787	3	37040296	237317	239176	rs878853780	NC_000003.12:37040295:T:C
NM_001354630.1(MLH1):c.1732-940_1732-939delinsATCTGGACC	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218018	3	37089068 - 37089069	3	37047577 - 37047578	218018	214639	rs863225378	NC_000003.12:37047576:GG:ATCTGGACC
NM_001354621.1(MLH1):c.-53dup	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141177	3	37061886 - 37061887	3	37020395 - 37020396	141177	150891	rs587781554	NC_000003.12:37020395:A:AA
NM_000249.3(MLH1):c.887T>G (p.Leu296Ter)	MLH1	L296*, L198*, L263*, L55*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090430	3	37061803	3	37020312	90430	95904	rs63750547	NC_000003.12:37020311:T:G
NM_000249.3(MLH1):c.883A>C (p.Ser295Arg)	MLH1	S295R, S262R, S197R, S54R	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090408	3	37059089	3	37017598	90408	95882	rs63751598	NC_000003.12:37017597:A:C
NM_000249.3(MLH1):c.739T>C (p.Ser247Pro)	MLH1	S247P, S214P, S149P, S6P	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090342	3	37055984	3	37014493	90342	95816	rs63750948	NC_000003.12:37014492:T:C
NM_001167618.2(MLH1):c.-136del	MLH1	K196fs, K163fs, K98fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090287	3	37053348	3	37011857	90287	95761	rs63751653	NC_000003.12:37011856:AAAAAA:AAAAA
NM_000249.3(MLH1):c.2084C>A (p.Ser695Ter)	MLH1	S695*, S597*, S662*, S664*, S337*, S454*, S354*, S640*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090038	3	37090489	3	37048998	90038	95512	rs63749995	NC_000003.12:37048997:C:A
NM_000249.3(MLH1):c.1989+1G>T	MLH1		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089975	3	37090101	3	37048610	89975	95449	rs267607879	NC_000003.12:37048609:G:T
NM_001167617.2(MLH1):c.1260dup (p.Glu421Ter)	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089768	3	37070418 - 37070419	3	37028927 - 37028928	89768	95242	rs63751689	NC_000003.12:37028927:T:TT
NM_000249.3(MLH1):c.104T>G (p.Met35Arg)	MLH1	M35R	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089631	3	37035142	3	36993651	89631	95105	rs63749906	NC_000003.12:36993650:T:G
NM_000038.6(APC):c.3472dup (p.Arg1158fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000844657	5	112174762 - 112174763	5	112839065 - 112839066	844657	829698		NC_000005.10:112839065:A:AA
NC_000005.10:g.(?_112801269)_(112844136_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000831467	5	112136966 - 112179833			831467	819518		
NC_000005.10:g.(?_112834941)_(112835175_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000831082	5	112170638 - 112170872			831082	819523		
NM_000038.6(APC):c.532-2A>C	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000666011	5	112116485	5	112780788	666011	651248		NC_000005.10:112780787:A:C
NC_000005.9:g.(?_112043009)_(112179823_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000662855	5	112043009 - 112179823	5	112707312 - 112844126	662855	651296		
NC_000005.9:g.(?_112043009)_(112179833_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000656814	5	112043009 - 112179833	5	112707312 - 112844136	656814	651229		
NM_000038.6(APC):c.7678C>T (p.Arg2560Ter)	APC	R2434*, R2469*, R2501*, R2519*, R2532*, R2570*, R2578*, R2400*, R2459*, R2535*, R2542*, R2560*, R2277*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654491	5	112178969	5	112843272	654491	632838		NC_000005.10:112843271:C:T
NM_000038.6(APC):c.7489dup (p.Ser2497fs)	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000653103	5	112178778 - 112178779	5	112843081 - 112843082	653103	632834		NC_000005.10:112843081:TT:TTT
NM_000038.6(APC):c.1977_1978insTTTCT (p.Asn660fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000652202	5	112173268 - 112173269	5	112837571 - 112837572	652202	632635		NC_000005.10:112837571::TTTCT
NC_000005.9:g.(?_112162795)_(112179833_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000640992	5	112162795 - 112179833	5	112827098 - 112844136	640992	651242		
NM_000038.6(APC):c.2336T>G (p.Leu779Ter)	APC	L779*, L761*, L653*, L720*, L754*, L789*, L496*, L688*, L738*, L619*, L678*, L751*, L797*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000578074	5	112173627	5	112837930	578074	562386	rs1561576302	NC_000005.10:112837929:T:G
NM_000038.6(APC):c.4167del (p.Val1390fs)	APC	V1107fs, V1299fs, V1365fs, V1230fs, V1264fs, V1289fs, V1331fs, V1390fs, V1349fs, V1362fs, V1408fs, V1372fs, V1400fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000569473	5	112175458	5	112839761	569473	559919	rs1561590380	NC_000005.10:112839760:T:
NM_000038.6(APC):c.2999_3005del (p.Tyr1000fs)	APC	Y1018fs, Y874fs, Y909fs, Y1000fs, Y1010fs, Y840fs, Y941fs, Y899fs, Y972fs, Y982fs, Y717fs, Y959fs, Y975fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000568358	5	112174290 - 112174296	5	112838593 - 112838599	568358	560006	rs1561581273	NC_000005.10:112838592:ACCCAGC:
NM_000038.6(APC):c.3488_3492del (p.Ser1163fs)	APC	S1037fs, S1104fs, S1122fs, S1135fs, S1181fs, S880fs, S1003fs, S1138fs, S1062fs, S1145fs, S1163fs, S1173fs, S1072fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000567441	5	112174776 - 112174780	5	112839079 - 112839083	567441	564280	rs1561585111	NC_000005.10:112839078:ATAGCATA:ATA
NM_000038.6(APC):c.2299C>T (p.Gln767Ter)	APC	Q767*, Q749*, Q607*, Q641*, Q666*, Q676*, Q726*, Q708*, Q777*, Q484*, Q739*, Q742*, Q785*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 3, 2018)	criteria provided, single submitter	VCV000567334	5	112173590	5	112837893	567334	562382	rs1561575998	NC_000005.10:112837892:C:T
NM_000038.6(APC):c.266C>A (p.Ser89Ter)	APC	S99*, S89*, S64*, S30*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566516	5	112102931	5	112767234	566516	562314	rs876658846	NC_000005.10:112767233:C:A
NM_000038.6(APC):c.3549T>G (p.Tyr1183Ter)	APC	Y1165*, Y1183*, Y1023*, Y1201*, Y900*, Y1082*, Y1142*, Y1092*, Y1155*, Y1193*, Y1057*, Y1124*, Y1158*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000565402	5	112174840	5	112839143	565402	564281	rs1561585641	NC_000005.10:112839142:T:G
NC_000005.9:g.(?_112170642)_(112170868_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000537704	5	112170642 - 112170868	5	112834945 - 112835171	537704	520154		
NC_000005.9:g.(?_112072721)_(112102113_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000537702	5	112072721 - 112102113	5	112737024 - 112766416	537702	520572		
NM_000038.6(APC):c.2367_2368GA[3] (p.His791fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000537495	5	112173656 - 112173657	5	112837959 - 112837960	537495	520756	rs1554084100	NC_000005.10:112837959:AGAGA:AGAGAGA
NM_000038.6(APC):c.1705del (p.Ser568_Val569insTer)	APC		not provided|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000487422	5	112164631	5	112828934	487422	480465	rs1554082135	NC_000005.10:112828933:G:
NM_000038.6(APC):c.7692dup (p.Arg2565fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000487047	5	112178981 - 112178982	5	112843284 - 112843285	487047	474022	rs1554088600	NC_000005.10:112843284:GG:GGG
NM_000038.6(APC):c.465del (p.Asp156fs)	APC	D97fs, D156fs, D131fs, D166fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486788	5	112111364	5	112775667	486788	473833	rs1554071529	NC_000005.10:112775666:AAAAA:AAAA
NM_000038.6(APC):c.163_164insG (p.Ile55fs)	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486772	5	112102050 - 112102051	5	112766353 - 112766354	486772	473781	rs1554069524	NC_000005.10:112766353::G
NM_000038.6(APC):c.2790_2791delinsGTGT (p.His931fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000469772	5	112174081 - 112174082	5	112838384 - 112838385	469772	453938	rs1554084454	NC_000005.10:112838383:AC:GTGT
NM_000038.6(APC):c.2621C>G (p.Ser874Ter)	APC	S856*, S874*, S815*, S833*, S884*, S591*, S773*, S783*, S714*, S748*, S846*, S849*, S892*	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000469762	5	112173912	5	112838215	469762	454700	rs1554084318	NC_000005.10:112838214:C:G
Single allele	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000469692			5	112827102 - 112844132	469692	454400		
NM_000038.6(APC):c.1370C>A (p.Ser457Ter)	APC	S439*, S457*, S297*, S366*, S432*, S356*, S398*, S429*, S467*, S174*, S331*	Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433620	5	112157650	5	112821953	433620	427257	rs1060503333	NC_000005.10:112821952:C:A
NM_000038.6(APC):c.1348_1349GT[5] (p.Leu453fs)	APC		Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000433619	5	112157626 - 112157627	5	112821929 - 112821930	433619	427256	rs1554080698	NC_000005.10:112821929:TGTGTGTGT:TGTGTGTGTGT
NM_000038.6(APC):c.497_499delinsTT (p.Thr166fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428149	5	112111400 - 112111402	5	112775703 - 112775705	428149	419592	rs1114167588	NC_000005.10:112775702:CTA:TT
NM_000038.6(APC):c.1219del (p.Leu407fs)	APC	L379fs, L417fs, L382fs, L348fs, L389fs, L407fs, L124fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428110	5	112154947	5	112819250	428110	419604	rs1114167558	NC_000005.10:112819249:CC:C
NM_000038.6(APC):c.2096G>A (p.Trp699Ter)	APC	W681*, W699*, W539*, W598*, W709*, W416*, W640*, W717*, W608*, W674*, W573*, W658*, W671*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411494	5	112173387	5	112837690	411494	394257	rs1060503336	NC_000005.10:112837689:G:A
NM_000038.6(APC):c.508_509del (p.Ile169_Asp170insTer)	APC		Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265581	5	112111410 - 112111411	5	112775713 - 112775714	265581	259789	rs886039642	NC_000005.10:112775712:AGA:A
NM_000038.5(APC):c.-85_*2113del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000236555	5	112073556 - 112181936	5	112737859 - 112846239	236555	239511		
NM_000038.6(APC):c.1500T>A (p.Tyr500Ter)	APC	Y482*, Y500*, Y374*, Y399*, Y472*, Y217*, Y340*, Y409*, Y459*, Y510*, Y441*, Y475*, Y518*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000217929	5	112162896	5	112827199	217929	214686	rs387906230	NC_000005.10:112827198:T:A
NM_000038.6(APC):c.423G>T (p.Arg141Ser)	APC	R141S, R151S, R82S, R116S	Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: May 9, 2015)	criteria provided, multiple submitters, no conflicts	VCV000216017	5	112111326	5	112775629	216017	212389	rs863224458	NC_000005.10:112775628:G:T
NM_000038.6(APC):c.4666del (p.Thr1556fs)	APC	T1497fs, T1515fs, T1566fs, T1273fs, T1396fs, T1531fs, T1538fs, T1430fs, T1455fs, T1528fs, T1556fs, T1574fs, T1465fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 24, 2014)	no assertion criteria provided	VCV000156477	5	112175952	5	112840255	156477	166242	rs587783031	NC_000005.10:112840254:AAAAAA:AAAAA
NM_000038.6(APC):c.2107del (p.Ala703fs)	APC	A602fs, A685fs, A703fs, A612fs, A675fs, A420fs, A543fs, A721fs, A577fs, A644fs, A662fs, A678fs, A713fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000156476	5	112173394	5	112837697	156476	166241	rs587783030	NC_000005.10:112837696:GGGGG:GGGG
NM_000038.6(APC):c.3088A>T (p.Lys1030Ter)	APC	K1030*, K1012*, K929*, K1005*, K1048*, K870*, K989*, K747*, K971*, K1002*, K1040*, K904*, K939*	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000127284	5	112174379	5	112838682	127284	132741	rs587779786	NC_000005.10:112838681:A:T
NM_000038.6(APC):c.1458T>G (p.Tyr486Ter)	APC	Y486*, Y468*, Y458*, Y203*, Y360*, Y385*, Y395*, Y427*, Y326*, Y445*, Y461*, Y496*, Y504*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000000825	5	112162854	5	112827157	825	15864	rs2229992	NC_000005.10:112827156:T:G
NM_000203.5(IDUA):c.1205G>A (p.Trp402Ter)	IDUA	W402*, W270*	Mucopolysaccharidosis type 1|Mucopolysaccharidosis, MPS-I-H/S|not provided|Hurler syndrome|Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis, MPS-I-S	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011908	4	996535	4	1002747	11908	26947	rs121965019	NC_000004.12:1002746:G:A
NM_003060.4(SLC22A5):c.1319C>T (p.Thr440Met)	SLC22A5	T440M, T464M	not provided|Renal carnitine transport defect|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025416	5	131728176	5	132392484	25416	36750	rs72552732	NC_000005.10:132392483:C:T
NM_006218.4(PIK3CA):c.1030G>A (p.Val344Met)	PIK3CA	V344M	Malignant melanoma of skin|Uterine cervical neoplasms|Neoplasm of the breast|Squamous cell carcinoma of the head and neck|Cowden syndrome 5|Megalencephaly|Abnormality of the hairline|Intestinal duplication|Diaphragmatic eventration|Hypertelorism|Neoplasm of the large intestine|not provided|Malignant neoplasm of body of uterus|Glioblastoma|Non-Hodgkin lymphoma|Cowden syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000376498	3	178921548	3	179203760	376498	363377	rs1057519942	NC_000003.12:179203759:G:A
NM_004321.7(KIF1A):c.760C>T (p.Arg254Trp)	KIF1A	R254W	not provided|Hereditary sensory and autonomic neuropathy type IIA|Spastic paraplegia 30, autosomal recessive|Mental retardation, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245636	2	241723194	2	240783777	245636	244362	rs879253888	NC_000002.12:240783776:G:A
NM_000038.6(APC):c.531+1G>A	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000860187	5	112111435	5	112775738	860187	850998		NC_000005.10:112775737:G:A
NC_000005.10:g.(?_112815478)_(112844126_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000831864	5	112151175 - 112179823			831864	819520		
NM_000038.6(APC):c.1229del (p.Leu410fs)	APC	L127fs, L351fs, L382fs, L420fs, L385fs, L392fs, L410fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801027	5	112154955	5	112819258	801027	789452		NC_000005.10:112819257:TTTT:TTT
NM_000038.6(APC):c.1968_1971del (p.Glu658fs)	APC	E567fs, E599fs, E658fs, E676fs, E498fs, E532fs, E617fs, E668fs, E375fs, E557fs, E630fs, E633fs, E640fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000646278	5	112173259 - 112173262	5	112837562 - 112837565	646278	632634		NC_000005.10:112837561:AAGA:
NM_000038.6(APC):c.32dup (p.Gln12fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000628229	5	112090616 - 112090617	5	112754919 - 112754920	628229	617037	rs1561444620	NC_000005.10:112754919:AAA:AAAA
NM_000038.6(APC):c.3670_3671dup (p.Asn1224fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000581841	5	112174960 - 112174961	5	112839263 - 112839264	581841	560016	rs1561586671	NC_000005.10:112839263:AA:AAAA
NM_000038.6(APC):c.2652dup (p.Ala885fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000569959	5	112173942 - 112173943	5	112838245 - 112838246	569959	559998	rs1561578684	NC_000005.10:112838245:A:AA
NM_000038.6(APC):c.3782del (p.Thr1261fs)	APC	T1236fs, T1279fs, T1101fs, T1160fs, T1170fs, T1202fs, T1233fs, T1243fs, T1261fs, T1271fs, T1135fs, T1220fs, T978fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000569045	5	112175073	5	112839376	569045	562426	rs1561587604	NC_000005.10:112839375:C:
NM_000038.6(APC):c.5820dup (p.Pro1941fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000566205	5	112177110 - 112177111	5	112841413 - 112841414	566205	560042	rs1561602876	NC_000005.10:112841413:A:AA
NM_000038.6(APC):c.2840_2841del (p.Cys947fs)	APC	C664fs, C856fs, C846fs, C922fs, C947fs, C957fs, C787fs, C821fs, C906fs, C929fs, C888fs, C919fs, C965fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000548662	5	112174130 - 112174131	5	112838433 - 112838434	548662	539130	rs1554084531	NC_000005.10:112838432:TGT:T
NM_000038.6(APC):c.2415dup (p.His806fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000537557	5	112173705 - 112173706	5	112838008 - 112838009	537557	520296	rs1554084141	NC_000005.10:112838008:A:AA
NM_000038.6(APC):c.5860_5863del (p.Phe1954fs)	APC	F1926fs, F1671fs, F1794fs, F1913fs, F1936fs, F1964fs, F1828fs, F1863fs, F1895fs, F1929fs, F1972fs, F1853fs, F1954fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000537536	5	112177151 - 112177154	5	112841454 - 112841457	537536	520807	rs1554087036	NC_000005.10:112841453:TTTG:
NM_000038.6(APC):c.832C>T (p.Gln278Ter)	APC	Q278*, Q260*, Q219*, Q253*, Q250*, Q288*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000470138	5	112137078	5	112801381	470138	454270	rs1554076217	NC_000005.10:112801380:C:T
NC_000005.9:g.(?_112043009)_(112043599_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000429040	5	112043009 - 112043599	5	112707312 - 112707902	429040	420992		
NM_000038.6(APC):c.1098_1099CT[1] (p.Ser367fs)	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000428117	5	112154827 - 112154828	5	112819130 - 112819131	428117	419602	rs387906237	NC_000005.10:112819129:CTCT:CT
NM_000038.6(APC):c.1886del (p.Thr628_Leu629insTer)	APC		not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419996	5	112170788	5	112835091	419996	406514	rs863224817	NC_000005.10:112835090:TTT:TT
NM_000038.6(APC):c.471G>A (p.Trp157Ter)	APC	W157*, W167*, W98*, W132*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000411479	5	112111374	5	112775677	411479	394398	rs1060503328	NC_000005.10:112775676:G:A
NM_000038.6(APC):c.6099_6100CT[1] (p.Asp2033_Ser2034insTer)	APC		Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265576	5	112177390 - 112177391	5	112841693 - 112841694	265576	259800	rs886039638	NC_000005.10:112841692:CTCT:CT
NM_000038.6(APC):c.136-2A>G	APC		Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265561	5	112102021	5	112766324	265561	259788	rs886039625	NC_000005.10:112766323:A:G
NM_000038.6(APC):c.249del (p.Gly84fs)	APC	G94fs, G25fs, G59fs, G84fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000236575	5	112102914	5	112767217	236575	239521	rs878853428	NC_000005.10:112767216:T:
NM_000038.6(APC):c.4645C>T (p.Gln1549Ter)	APC	Q1531*, Q1549*, Q1423*, Q1448*, Q1521*, Q1559*, Q1567*, Q1389*, Q1490*, Q1508*, Q1524*, Q1458*, Q1266*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000217986	5	112175936	5	112840239	217986	214727	rs863225357	NC_000005.10:112840238:C:T
NM_000038.6(APC):c.3469_3470GA[1] (p.Glu1157fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000186532	5	112174759 - 112174762	5	112839062 - 112839065	186532	182378	rs786203020	NC_000005.10:112839061:AGAGAGA:AGA
NM_001168272.1(ITPR1):c.805C>T (p.Arg269Trp)	ITPR1	R269W	Gillespie syndrome|not provided||||Gillespie syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265201	3	4687362	3	4645678	265201	259766	rs886039392	NC_000003.12:4645677:C:T
NM_000249.3(MLH1):c.885-1G>A	MLH1		Turcot syndrome|Muir-Torré syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580133	3	37061800	3	37020309	580133	562700	rs1553647894	NC_000003.12:37020308:G:A
NM_000249.3(MLH1):c.1558+1G>A	MLH1		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220185	3	37070424	3	37028933	220185	221403	rs267607832	NC_000003.12:37028932:G:A
NM_000249.3(MLH1):c.790+4A>G	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000090363	3	37056039	3	37014548	90363	95837	rs267607786	NC_000003.12:37014547:A:G
NM_000249.3(MLH1):c.790+2T>C	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090360	3	37056037	3	37014546	90360	95834	rs267607790	NC_000003.12:37014545:T:C
NM_000249.3(MLH1):c.677+1G>T	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090312	3	37053591	3	37012100	90312	95786	rs267607778	NC_000003.12:37012099:G:T
NM_000249.3(MLH1):c.229T>C (p.Cys77Arg)	MLH1	C77R	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090110	3	37042467	3	37000976	90110	95584	rs63749859	NC_000003.12:37000975:T:C
NM_000249.3(MLH1):c.210_213delAGAA	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090061	3	37042444 - 37042447	3	37000953 - 37000956	90061	95535	rs267607723	NC_000003.12:37000952:AGAAAGAA:AGAA
NM_000249.3(MLH1):c.2040C>A (p.Cys680Ter)	MLH1	C680*, C322*, C647*, C649*, C582*, C625*, C339*, C439*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090009	3	37090445	3	37048954	90009	95483	rs63749867	NC_000003.12:37048953:C:A
NM_000249.3(MLH1):c.1990-1G>A	MLH1		not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089985	3	37090394	3	37048903	89985	95459	rs267607884	NC_000003.12:37048902:G:A
NM_000249.3(MLH1):c.1225C>T (p.Gln409Ter)	MLH1	Q409*, Q376*, Q168*, Q311*, Q51*, Q68*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089683	3	37067314	3	37025823	89683	95157	rs63751153	NC_000003.12:37025822:C:T
NM_000249.3(MLH1):c.116+5G>C	MLH1		not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089658	3	37035159	3	36993668	89658	95132	rs267607710	NC_000003.12:36993667:G:C
NM_000249.3(MLH1):c.113A>G (p.Asn38Ser)	MLH1	N38S	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089648	3	37035151	3	36993660	89648	95122	rs587778888	NC_000003.12:36993659:A:G
NM_000249.3(MLH1):c.112A>C (p.Asn38His)	MLH1	N38H	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089645	3	37035150	3	36993659	89645	95119	rs63750580	NC_000003.12:36993658:A:C
NM_000249.3(MLH1):c.806C>G (p.Ser269Ter)	MLH1	S269*, S236*, S171*, S28*	Lynch syndrome II|Colon cancer|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017098	3	37059012	3	37017521	17098	32137	rs63750691	NC_000003.12:37017520:C:G
NM_198156.3(VHL):c.224_226TCT[1] (p.Phe76del)	VHL	F76del, Q195X	Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000223166	3	10183755 - 10183757	3	10142071 - 10142073	223166	224897	rs5030648	NC_000003.12:10142070:TCTTCT:TCT
NM_000038.6(APC):c.5101C>T (p.Gln1701Ter)	APC	Q1610*, Q1660*, Q1683*, Q1541*, Q1575*, Q1600*, Q1676*, Q1711*, Q1418*, Q1701*, Q1642*, Q1673*, Q1719*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000853623	5	112176392	5	112840695	853623	829746		NC_000005.10:112840694:C:T
NM_000038.6(APC):c.3137del (p.Asn1046fs)	APC	N1021fs, N1056fs, N987fs, N1018fs, N1028fs, N1064fs, N886fs, N1005fs, N1046fs, N920fs, N955fs, N763fs, N945fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 8, 2018)	criteria provided, single submitter	VCV000661528	5	112174427	5	112838730	661528	632674		NC_000005.10:112838729:AA:A
NM_000038.6(APC):c.6201del (p.Asn2067fs)	APC	N1941fs, N2026fs, N2067fs, N1784fs, N1907fs, N1966fs, N2039fs, N2042fs, N1976fs, N2077fs, N2085fs, N2008fs, N2049fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000658413	5	112177492	5	112841795	658413	632785		NC_000005.10:112841794:T:
NM_000038.6(APC):c.2336del (p.Asn778_Leu779insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000656189	5	112173625	5	112837928	656189	632643		NC_000005.10:112837927:TTT:TT
NM_000038.6(APC):c.2530_2531TC[1] (p.Arg845fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000654812	5	112173821 - 112173822	5	112838124 - 112838125	654812	632655		NC_000005.10:112838123:TCTC:TC
NM_000038.6(APC):c.2587_2600del (p.Tyr863fs)	APC	Y822fs, Y835fs, Y838fs, Y881fs, Y703fs, Y737fs, Y772fs, Y804fs, Y845fs, Y863fs, Y873fs, Y580fs, Y762fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000649433	5	112173873 - 112173886	5	112838176 - 112838189	649433	632659		NC_000005.10:112838175:GCAACTACCATCCAGCAAC:GCAAC
NM_000038.6(APC):c.4240del (p.Met1413_Val1414insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000645536	5	112175530	5	112839833	645536	632713		NC_000005.10:112839832:GG:G
NM_000038.6(APC):c.4326del (p.Pro1443fs)	APC	P1160fs, P1352fs, P1342fs, P1384fs, P1402fs, P1415fs, P1283fs, P1418fs, P1317fs, P1425fs, P1443fs, P1453fs, P1461fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000645119	5	112175617	5	112839920	645119	632716		NC_000005.10:112839919:T:
NM_000038.6(APC):c.4397del (p.Gly1466fs)	APC	G1306fs, G1365fs, G1407fs, G1425fs, G1441fs, G1183fs, G1466fs, G1476fs, G1448fs, G1340fs, G1375fs, G1438fs, G1484fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000642089	5	112175687	5	112839990	642089	632719		NC_000005.10:112839989:GG:G
NM_000038.6(APC):c.2485del (p.Thr829fs)	APC	T546fs, T738fs, T804fs, T669fs, T788fs, T801fs, T811fs, T829fs, T839fs, T728fs, T847fs, T703fs, T770fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000571789	5	112173776	5	112838079	571789	562391	rs1561577476	NC_000005.10:112838078:A:
NM_000038.6(APC):c.2894del (p.Asn965fs)	APC	N906fs, N983fs, N839fs, N874fs, N924fs, N937fs, N805fs, N965fs, N682fs, N864fs, N940fs, N947fs, N975fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000537523	5	112174183	5	112838486	537523	520317	rs1554084575	NC_000005.10:112838485:AAA:AA
NM_000038.6(APC):c.2021T>A (p.Leu674Ter)	APC	L656*, L674*, L391*, L633*, L684*, L514*, L583*, L646*, L649*, L692*, L548*, L573*, L615*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	VCV000537472	5	112173312	5	112837615	537472	520753	rs1554083898	NC_000005.10:112837614:T:A
NM_000038.6(APC):c.1102_1103del (p.Val368fs)	APC	V350fs, V340fs, V378fs, V343fs, V309fs, V368fs, V85fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000537469	5	112154830 - 112154831	5	112819133 - 112819134	537469	520725	rs1554080016	NC_000005.10:112819132:TGT:T
NM_000038.6(APC):c.5572C>T (p.Arg1858Ter)	APC	R1840*, R1858*, R1833*, R1876*, R1698*, R1732*, R1767*, R1817*, R1575*, R1799*, R1830*, R1868*, R1757*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486765	5	112176863	5	112841166	486765	473864	rs1270783041	NC_000005.10:112841165:C:T
NM_000038.6(APC):c.697C>T (p.Gln233Ter)	APC	Q233*, Q174*, Q243*, Q208*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000470070	5	112128194	5	112792497	470070	453838	rs1554074772	NC_000005.10:112792496:C:T
NM_000038.6(APC):c.417_418AG[2] (p.Arg141fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000469954	5	112103082 - 112103083	5	112767385 - 112767386	469954	453815	rs1554069850	NC_000005.10:112767384:AGAGAG:AGAG
NM_000038.6(APC):c.3306C>G (p.Tyr1102Ter)	APC	Y1102*, Y1084*, Y1043*, Y1112*, Y1120*, Y976*, Y1061*, Y1074*, Y1077*, Y819*, Y942*, Y1001*, Y1011*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000469916	5	112174597	5	112838900	469916	453964	rs879254092	NC_000005.10:112838899:C:G
NM_000038.6(APC):c.1548+1G>A	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000469712	5	112162945	5	112827248	469712	454285	rs1114167599	NC_000005.10:112827247:G:A
NC_000005.9:g.(?_112173244)_(112179829_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000469694	5	112173244 - 112179829	5	112837547 - 112844132	469694	453614		
NM_000038.6(APC):c.1409-2_1409del	APC		not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449332	5	112162803 - 112162805	5	112827106 - 112827108	449332	443647	rs1554081631	NC_000005.10:112827105:AGG:
NM_000038.6(APC):c.532-1G>A	APC		not specified|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439410	5	112116486	5	112780789	439410	433004	rs1554072547	NC_000005.10:112780788:G:A
NM_000038.6(APC):c.607C>T (p.Gln203Ter)	APC	Q203*, Q213*, Q144*, Q178*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428106	5	112116562	5	112780865	428106	419594	rs141576417	NC_000005.10:112780864:C:T
NM_000038.6(APC):c.2677G>T (p.Glu893Ter)	APC	E875*, E893*, E834*, E868*, E802*, E865*, E733*, E767*, E911*, E610*, E792*, E852*, E903*	not provided|Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000419997	5	112173968	5	112838271	419997	406522	rs199740875	NC_000005.10:112838270:G:T
NM_000038.6(APC):c.298del (p.Glu100fs)	APC	E100fs, E75fs, E110fs, E41fs	Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419991	5	112102961	5	112767264	419991	406482	rs1064794224	NC_000005.10:112767263:GGG:GG
NM_000038.6(APC):c.1246dup (p.Tyr416fs)	APC		Familial adenomatous polyposis 1|not provided|Familial adenomatous polyposis	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411548	5	112154973 - 112154974	5	112819276 - 112819277	411548	394723	rs1060503366	NC_000005.10:112819276:TT:TTT
NM_000038.6(APC):c.1409-5A>G	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000411406	5	112162800	5	112827103	411406	394726	rs768109346	NC_000005.10:112827102:A:G
NM_000038.6(APC):c.1417C>T (p.Gln473Ter)	APC	Q455*, Q473*, Q347*, Q445*, Q313*, Q414*, Q190*, Q382*, Q432*, Q448*, Q483*, Q372*, Q491*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230959	5	112162813	5	112827116	230959	233027	rs876658868	NC_000005.10:112827115:C:T
NM_000038.6(APC):c.266C>G (p.Ser89Ter)	APC	S89*, S99*, S64*, S30*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230927	5	112102931	5	112767234	230927	232988	rs876658846	NC_000005.10:112767233:C:G
NM_000038.6(APC):c.524_531+4del	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217993	5	112111424 - 112111435	5	112775727 - 112775738	217993	214663	rs863225364	NC_000005.10:112775726:TAACTGAAAATGTAA:TAA
NM_000038.6(APC):c.1229dup (p.Leu410fs)	APC		not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217919	5	112154954 - 112154955	5	112819257 - 112819258	217919	214677	rs863225308	NC_000005.10:112819257:TTTT:TTTTT
NM_000038.6(APC):c.1886dup (p.Leu629fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216839	5	112170787 - 112170788	5	112835090 - 112835091	216839	212408	rs863224817	NC_000005.10:112835090:TTT:TTTT
NM_000038.6(APC):c.1072C>T (p.Gln358Ter)	APC	Q340*, Q358*, Q330*, Q333*, Q75*, Q299*, Q368*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216010	5	112154801	5	112819104	216010	212399	rs863224455	NC_000005.10:112819103:C:T
NM_000249.3(MLH1):c.884+4A>G	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090414	3	37059094	3	37017603	90414	95888	rs267607777	NC_000003.12:37017602:A:G
NM_001167618.2(MLH1):c.-1_3AATG[1] (p.Asn2fs)	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090338	3	37055968 - 37055971	3	37014477 - 37014480	90338	95812	rs267607787	NC_000003.12:37014476:AATGAATG:AATG
NM_000249.3(MLH1):c.380G>A (p.Arg127Lys)	MLH1	R127K, R94K, R29K	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000090194	3	37045965	3	37004474	90194	95668	rs63751595	NC_000003.12:37004473:G:A
NM_000249.3(MLH1):c.2135G>A (p.Trp712Ter)	MLH1	W712*, W354*, W471*, W681*, W614*, W643*, W657*, W679*, W371*	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090065	3	37092008	3	37050517	90065	95539	rs63750561	NC_000003.12:37050516:G:A
NM_000249.3(MLH1):c.2035G>T (p.Glu679Ter)	MLH1	E679*, E646*, E648*, E321*, E338*, E438*, E581*, E624*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090005	3	37090440	3	37048949	90005	95479	rs587778971	NC_000003.12:37048948:G:T
NM_001354630.1(MLH1):c.1732-951AG[2]	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089888	3	37089057 - 37089058	3	37047566 - 37047567	89888	95362	rs63750035	NC_000003.12:37047565:AGAGAG:AGAG
NM_000249.3(MLH1):c.1731+1G>A	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089848	3	37083823	3	37042332	89848	95322	rs267607853	NC_000003.12:37042331:G:A
NM_000249.3(MLH1):c.1649T>C (p.Leu550Pro)	MLH1	L550P, L209P, L309P, L517P, L192P, L452P	Lynch syndrome I|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 3, 2016)	reviewed by expert panel	VCV000089818	3	37081767	3	37040276	89818	95292	rs63750193	NC_000003.12:37040275:T:C
NM_000030.3(AGXT):c.508G>A (p.Gly170Arg)	AGXT	G170R	Primary hyperoxaluria|Primary hyperoxaluria, type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040166	2	241810850	2	240871433	40166	38436	rs121908529	NC_000002.12:240871432:G:A
NM_000038.6(APC):c.1861dup (p.Thr621fs)	APC		not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660427	5	112170764 - 112170765	5	112835067 - 112835068	660427	632630		NC_000005.10:112835067:A:AA
NM_000038.6(APC):c.4583_4587del (p.Val1528fs)	APC	V1245fs, V1427fs, V1528fs, V1538fs, V1469fs, V1487fs, V1500fs, V1503fs, V1546fs, V1402fs, V1437fs, V1510fs, V1368fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000654912	5	112175871 - 112175875	5	112840174 - 112840178	654912	632724		NC_000005.10:112840173:CAGTTCAG:CAG
NM_000038.6(APC):c.6137del (p.Ala2046fs)	APC	A2021fs, A1763fs, A1920fs, A1955fs, A2028fs, A2046fs, A2056fs, A2064fs, A1886fs, A1945fs, A1987fs, A2005fs, A2018fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000582306	5	112177428	5	112841731	582306	559941	rs1561605385	NC_000005.10:112841730:C:
NM_000038.6(APC):c.5507del (p.Gly1836fs)	APC	G1553fs, G1735fs, G1745fs, G1811fs, G1846fs, G1676fs, G1777fs, G1836fs, G1818fs, G1710fs, G1795fs, G1808fs, G1854fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000579870	5	112176797	5	112841100	579870	564320	rs1561600715	NC_000005.10:112841099:GG:G
NM_000038.6(APC):c.2884del (p.Asp962fs)	APC	D937fs, D972fs, D836fs, D962fs, D980fs, D802fs, D871fs, D903fs, D679fs, D861fs, D921fs, D934fs, D944fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000575133	5	112174175	5	112838478	575133	559905	rs1561580546	NC_000005.10:112838477:G:
NM_000038.6(APC):c.5293_5296del (p.Leu1765fs)	APC	L1482fs, L1674fs, L1783fs, L1639fs, L1706fs, L1747fs, L1605fs, L1664fs, L1775fs, L1724fs, L1737fs, L1740fs, L1765fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000569926	5	112176582 - 112176585	5	112840885 - 112840888	569926	559935	rs1561599054	NC_000005.10:112840884:AGTTAG:AG
NM_000038.6(APC):c.2863del (p.Glu955fs)	APC	E672fs, E896fs, E914fs, E955fs, E973fs, E854fs, E864fs, E930fs, E829fs, E927fs, E937fs, E795fs, E965fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000469778	5	112174154	5	112838457	469778	453955	rs1554084553	NC_000005.10:112838456:G:
NM_000038.6(APC):c.1970_1971GA[2] (p.Asn659fs)	APC		Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433630	5	112173260 - 112173261	5	112837563 - 112837564	433630	427267	rs863225322	NC_000005.10:112837562:AGAGAGA:AGAGA
NM_000038.6(APC):c.667C>T (p.Gln223Ter)	APC	Q223*, Q233*, Q164*, Q198*	not provided|Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000433610	5	112128164	5	112792467	433610	427247	rs1554074738	NC_000005.10:112792466:C:T
NM_000038.6(APC):c.583C>T (p.Gln195Ter)	APC	Q195*, Q205*, Q170*, Q136*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419992	5	112116538	5	112780841	419992	406486	rs749479682	NC_000005.10:112780840:C:T
NM_000038.6(APC):c.233_236del (p.Asp78fs)	APC	D53fs, D19fs, D78fs, D88fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418005	5	112102895 - 112102898	5	112767198 - 112767201	418005	406480	rs1064793020	NC_000005.10:112767197:TAGATAG:TAG
NM_000038.6(APC):c.3469_3470GA[2] (p.Arg1158fs)	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411546	5	112174759 - 112174760	5	112839062 - 112839063	411546	394425	rs786203020	NC_000005.10:112839061:AGAGAGA:AGAGA
NM_000038.6(APC):c.2795C>A (p.Ser932Ter)	APC	S914*, S932*, S841*, S942*, S649*, S772*, S806*, S891*, S904*, S907*, S831*, S873*, S950*	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000411362	5	112174086	5	112838389	411362	394299	rs878853432	NC_000005.10:112838388:C:A
NM_000038.6(APC):c.2031_2034del (p.Ser678fs)	APC	S577fs, S587fs, S395fs, S552fs, S619fs, S637fs, S650fs, S660fs, S653fs, S518fs, S678fs, S688fs, S696fs	Familial adenomatous polyposis|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000236568	5	112173319 - 112173322	5	112837622 - 112837625	236568	239546	rs878853422	NC_000005.10:112837621:AGTCAGT:AGT
NM_000038.6(APC):c.475dup (p.Tyr159fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217990	5	112111376 - 112111377	5	112775679 - 112775680	217990	214661	rs863225361	NC_000005.10:112775679:TT:TTT
NM_000038.6(APC):c.288T>G (p.Tyr96Ter)	APC	Y106*, Y96*, Y37*, Y71*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217957	5	112102953	5	112767256	217957	214655	rs376213437	NC_000005.10:112767255:T:G
NM_000038.6(APC):c.2805C>G (p.Tyr935Ter)	APC	Y917*, Y935*, Y652*, Y775*, Y834*, Y907*, Y945*, Y809*, Y844*, Y876*, Y910*, Y894*, Y953*	Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186058	5	112174096	5	112838399	186058	182368	rs137854575	NC_000005.10:112838398:C:G
NM_000038.6(APC):c.423-1G>C	APC		Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000181833	5	112111325	5	112775628	181833	180170	rs397514031	NC_000005.10:112775627:G:C
NM_000038.6(APC):c.935dup (p.Glu313fs)	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141040	5	112154663 - 112154664	5	112818966 - 112818967	141040	150754	rs587781451	NC_000005.10:112818966:T:TT
NM_000038.6(APC):c.839C>G (p.Ser280Ter)	APC	S280*, S262*, S255*, S290*, S221*, S252*	Gardner syndrome|Familial adenomatous polyposis|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000799	5	112151196	5	112815499	799	15838	rs137854569	NC_000005.10:112815498:C:G
NM_001370658.1(BTD):c.1270G>C (p.Asp424His)	BTD	D444H, D446H, D424H	not provided|Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001900	3	15686693	3	15645186	1900	16939	rs13078881	NC_000003.12:15645185:G:C
NM_000038.6(APC):c.3379C>T (p.Gln1127Ter)	APC	Q1036*, Q1109*, Q1137*, Q844*, Q1068*, Q967*, Q1001*, Q1026*, Q1099*, Q1145*, Q1086*, Q1102*, Q1127*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000856907	5	112174670	5	112838973	856907	829692		NC_000005.10:112838972:C:T
NM_000038.6(APC):c.2394_2395insG (p.Tyr799fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000854311	5	112173685 - 112173686	5	112837988 - 112837989	854311	829653		NC_000005.10:112837988::G
NM_000038.6(APC):c.5185_5188del (p.Asn1729fs)	APC	N1603fs, N1638fs, N1446fs, N1569fs, N1704fs, N1747fs, N1670fs, N1701fs, N1711fs, N1729fs, N1628fs, N1688fs, N1739fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000852781	5	112176473 - 112176476	5	112840776 - 112840779	852781	829749		NC_000005.10:112840775:ATTAATT:ATT
NM_000038.6(APC):c.3638C>G (p.Ser1213Ter)	APC	S1087*, S1154*, S1231*, S1053*, S1188*, S1195*, S1213*, S1223*, S1122*, S1172*, S1185*, S930*, S1112*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000852583	5	112174929	5	112839232	852583	829704		NC_000005.10:112839231:C:G
NM_000038.6(APC):c.3016del (p.His1006fs)	APC	H846fs, H880fs, H978fs, H1016fs, H915fs, H965fs, H1006fs, H905fs, H947fs, H1024fs, H723fs, H981fs, H988fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000851281	5	112174305	5	112838608	851281	829675		NC_000005.10:112838607:CCC:CC
NM_000038.6(APC):c.2024_2025dup (p.Ile676fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000850080	5	112173313 - 112173314	5	112837616 - 112837617	850080	829647		NC_000005.10:112837616:ACA:ACACA
NM_000038.6(APC):c.7879_7894del (p.Ser2627fs)	APC	S2501fs, S2536fs, S2609fs, S2627fs, S2637fs, S2467fs, S2526fs, S2568fs, S2599fs, S2645fs, S2344fs, S2602fs, S2586fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000844610	5	112179168 - 112179183	5	112843471 - 112843486	844610	829823		NC_000005.10:112843470:CTTCTCAGACCGTTTCCT:CT
NM_000038.6(APC):c.4760C>A (p.Ser1587Ter)	APC	S1496*, S1528*, S1559*, S1605*, S1304*, S1427*, S1461*, S1486*, S1587*, S1546*, S1562*, S1569*, S1597*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000844002	5	112176051	5	112840354	844002	829739		NC_000005.10:112840353:C:A
NM_000038.6(APC):c.4145_4155del (p.Leu1382fs)	APC	L1256fs, L1341fs, L1357fs, L1382fs, L1392fs, L1400fs, L1099fs, L1222fs, L1323fs, L1354fs, L1281fs, L1291fs, L1364fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000843696	5	112175435 - 112175445	5	112839738 - 112839748	843696	829728		NC_000005.10:112839737:CTCATGTTTAGC:C
NM_000038.6(APC):c.2475T>G (p.Tyr825Ter)	APC	Y542*, Y665*, Y734*, Y784*, Y825*, Y699*, Y800*, Y807*, Y835*, Y843*, Y724*, Y766*, Y797*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000840815	5	112173766	5	112838069	840815	829656		NC_000005.10:112838068:T:G
NM_000038.6(APC):c.5979del (p.Asp1994fs)	APC	D1903fs, D1953fs, D1994fs, D1711fs, D1834fs, D1868fs, D1976fs, D2012fs, D2004fs, D1893fs, D1935fs, D1966fs, D1969fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000838960	5	112177270	5	112841573	838960	829773		NC_000005.10:112841572:T:
NM_000038.6(APC):c.5799del (p.Gln1935fs)	APC	Q1834fs, Q1844fs, Q1894fs, Q1907fs, Q1652fs, Q1775fs, Q1809fs, Q1910fs, Q1935fs, Q1876fs, Q1953fs, Q1917fs, Q1945fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000837421	5	112177087	5	112841390	837421	829765		NC_000005.10:112841389:TTTT:TTT
NM_000038.6(APC):c.6090_6093del (p.Ser2031fs)	APC	S1972fs, S2003fs, S2006fs, S2013fs, S2031fs, S1748fs, S1905fs, S1871fs, S1930fs, S1990fs, S2049fs, S1940fs, S2041fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, single submitter	VCV000835847	5	112177380 - 112177383	5	112841683 - 112841686	835847	829777		NC_000005.10:112841682:TTAGT:T
NM_000038.6(APC):c.4398del (p.Pro1467fs)	APC	P1408fs, P1426fs, P1184fs, P1307fs, P1341fs, P1449fs, P1376fs, P1477fs, P1366fs, P1439fs, P1442fs, P1467fs, P1485fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000835680	5	112175689	5	112839992	835680	829734		NC_000005.10:112839991:A:
NM_000038.6(APC):c.3877dup (p.Thr1293fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000663859	5	112175167 - 112175168	5	112839470 - 112839471	663859	632697		NC_000005.10:112839470:A:AA
NM_000038.6(APC):c.6395C>G (p.Ser2132Ter)	APC	S2031*, S2041*, S1972*, S2006*, S2073*, S2104*, S2107*, S2132*, S1849*, S2091*, S2142*, S2150*, S2114*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000662578	5	112177686	5	112841989	662578	632795		NC_000005.10:112841988:C:G
NM_000038.6(APC):c.3935del (p.Gly1312fs)	APC	G1186fs, G1253fs, G1322fs, G1294fs, G1029fs, G1152fs, G1211fs, G1284fs, G1330fs, G1221fs, G1271fs, G1287fs, G1312fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000661934	5	112175225	5	112839528	661934	632700		NC_000005.10:112839527:GG:G
NM_000038.6(APC):c.6091del (p.Ser2031fs)	APC	S1990fs, S1748fs, S1871fs, S1905fs, S1930fs, S2049fs, S2006fs, S2013fs, S1940fs, S1972fs, S2003fs, S2031fs, S2041fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000659568	5	112177382	5	112841685	659568	632783		NC_000005.10:112841684:A:
NM_000038.6(APC):c.1979del (p.Asn660fs)	APC	N660fs, N670fs, N377fs, N534fs, N601fs, N632fs, N678fs, N642fs, N500fs, N559fs, N569fs, N619fs, N635fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000659403	5	112173269	5	112837572	659403	632636		NC_000005.10:112837571:AA:A
NM_000038.6(APC):c.1967_1974del (p.Leu656fs)	APC	L373fs, L628fs, L555fs, L597fs, L631fs, L656fs, L530fs, L674fs, L496fs, L565fs, L615fs, L638fs, L666fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000658165	5	112173258 - 112173265	5	112837561 - 112837568	658165	632633		NC_000005.10:112837560:TAAGAGAG:
NM_000038.6(APC):c.2424_2514dup (p.Gly839Ter)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000656610	5	112173712 - 112173713	5	112838015 - 112838016	656610	632645		
NM_000038.6(APC):c.2536del (p.Ser846fs)	APC	S563fs, S686fs, S755fs, S818fs, S846fs, S745fs, S787fs, S805fs, S821fs, S720fs, S828fs, S856fs, S864fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000654193	5	112173826	5	112838129	654193	632656		NC_000005.10:112838128:TT:T
NM_000038.6(APC):c.4848_4849dup (p.Leu1617fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000650100	5	112176138 - 112176139	5	112840441 - 112840442	650100	632735		NC_000005.10:112840441:AC:ACAC
NM_000038.6(APC):c.3860_3872dup (p.Gln1291delinsHisArgMetTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000648912	5	112175149 - 112175150	5	112839452 - 112839453	648912	632696		NC_000005.10:112839452:ATAGGATGTAATCA:ATAGGATGTAATCATAGGATGTAATCA
NM_000038.6(APC):c.4006A>T (p.Arg1336Ter)	APC	R1235*, R1245*, R1295*, R1311*, R1336*, R1354*, R1210*, R1053*, R1346*, R1176*, R1277*, R1308*, R1318*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000648675	5	112175297	5	112839600	648675	632703		NC_000005.10:112839599:A:T
NM_000038.6(APC):c.5691del (p.His1897fs)	APC	H1737fs, H1915fs, H1771fs, H1806fs, H1879fs, H1796fs, H1838fs, H1856fs, H1897fs, H1614fs, H1869fs, H1872fs, H1907fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000648122	5	112176982	5	112841285	648122	632767		NC_000005.10:112841284:C:
NM_000038.6(APC):c.1993_1994del (p.Leu665fs)	APC	L539fs, L564fs, L683fs, L647fs, L382fs, L574fs, L606fs, L624fs, L637fs, L505fs, L640fs, L665fs, L675fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000647921	5	112173283 - 112173284	5	112837586 - 112837587	647921	632638		NC_000005.10:112837585:TTT:T
NM_000038.6(APC):c.4306del (p.Ser1436fs)	APC	S1276fs, S1377fs, S1436fs, S1446fs, S1335fs, S1418fs, S1153fs, S1310fs, S1345fs, S1395fs, S1408fs, S1411fs, S1454fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000647858	5	112175596	5	112839899	647858	632715		NC_000005.10:112839898:AA:A
NC_000005.9:g.(?_112102013)_(112179833_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, single submitter	VCV000646968	5	112102013 - 112179833	5	112766316 - 112844136	646968	651234		
NM_000038.6(APC):c.2229del (p.Met743fs)	APC	M702fs, M718fs, M725fs, M761fs, M460fs, M715fs, M753fs, M617fs, M684fs, M743fs, M583fs, M642fs, M652fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000644153	5	112173520	5	112837823	644153	632641		NC_000005.10:112837822:G:
NM_000038.6(APC):c.4339del (p.Gln1447fs)	APC	Q1346fs, Q1356fs, Q1388fs, Q1457fs, Q1287fs, Q1406fs, Q1447fs, Q1164fs, Q1419fs, Q1429fs, Q1465fs, Q1321fs, Q1422fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000642084	5	112175630	5	112839933	642084	632717		NC_000005.10:112839932:C:
NM_000038.6(APC):c.4260del (p.Ser1421fs)	APC	S1393fs, S1431fs, S1439fs, S1362fs, S1380fs, S1396fs, S1403fs, S1138fs, S1295fs, S1330fs, S1261fs, S1320fs, S1421fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000640284	5	112175548	5	112839851	640284	632714		NC_000005.10:112839850:CCCC:CCC
NM_000038.6(APC):c.1270C>T (p.Gln424Ter)	APC	Q406*, Q424*, Q333*, Q396*, Q365*, Q298*, Q323*, Q141*, Q264*, Q399*, Q434*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000575787	5	112154999	5	112819302	575787	559869	rs1561542165	NC_000005.10:112819301:C:T
NM_000038.6(APC):c.6011_6012insTT (p.Ser2005fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, single submitter	VCV000575384	5	112177302 - 112177303	5	112841605 - 112841606	575384	560050	rs1561604514	NC_000005.10:112841605::TT
NM_000038.6(APC):c.4670_4671del (p.Ile1557fs)	APC	I1431fs, I1466fs, I1529fs, I1575fs, I1274fs, I1456fs, I1516fs, I1539fs, I1397fs, I1498fs, I1557fs, I1532fs, I1567fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000573000	5	112175961 - 112175962	5	112840264 - 112840265	573000	559929	rs1561594547	NC_000005.10:112840263:TT:
NM_000038.6(APC):c.7498C>T (p.Gln2500Ter)	APC	Q2500*, Q2482*, Q2374*, Q2475*, Q2340*, Q2409*, Q2217*, Q2472*, Q2399*, Q2441*, Q2459*, Q2510*, Q2518*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000572005	5	112178789	5	112843092	572005	559959	rs372535376	NC_000005.10:112843091:C:T
NM_000038.6(APC):c.7930_7934del (p.Ile2644fs)	APC	I2484fs, I2518fs, I2619fs, I2626fs, I2616fs, I2644fs, I2654fs, I2361fs, I2543fs, I2553fs, I2585fs, I2603fs, I2662fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, single submitter	VCV000567733	5	112179219 - 112179223	5	112843522 - 112843526	567733	562546	rs1561619376	NC_000005.10:112843521:TAATTTA:TA
NM_000038.6(APC):c.6871C>T (p.Gln2291Ter)	APC	Q2291*, Q2273*, Q2190*, Q2250*, Q2266*, Q2309*, Q2008*, Q2131*, Q2263*, Q2301*, Q2165*, Q2200*, Q2232*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, single submitter	VCV000565981	5	112178162	5	112842465	565981	560062	rs1561610839	NC_000005.10:112842464:C:T
NM_000038.6(APC):c.4389dup (p.Glu1464fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000537546	5	112175679 - 112175680	5	112839982 - 112839983	537546	520541	rs1554085850	NC_000005.10:112839982:A:AA
NM_000038.6(APC):c.1348_1349GT[3] (p.Val452fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000537527	5	112157627 - 112157628	5	112821930 - 112821931	537527	520276	rs1554080698	NC_000005.10:112821929:TGTGTGTGT:TGTGTGT
NM_000038.6(APC):c.5059C>T (p.Arg1687Ter)	APC	R1669*, R1687*, R1646*, R1705*, R1404*, R1659*, R1697*, R1561*, R1586*, R1527*, R1596*, R1628*, R1662*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000537468	5	112176350	5	112840653	537468	520797	rs1554086415	NC_000005.10:112840652:C:T
NM_000038.6(APC):c.1626+1G>A	APC		not provided|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000492656	5	112163704	5	112828007	492656	485614	rs1554081934	NC_000005.10:112828006:G:A
NC_000005.9:g.(?_112111320)_(112179829_?)del	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 27, 2018)	criteria provided, single submitter	VCV000469690	5	112111320 - 112179829	5	112775623 - 112844132	469690	453868		
NM_000038.6(APC):c.1779G>A (p.Trp593Ter)	APC	W575*, W593*, W502*, W534*, W565*, W568*, W310*, W467*, W552*, W603*, W433*, W492*, W611*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000433627	5	112170683	5	112834986	433627	427264	rs1554083132	NC_000005.10:112834985:G:A
NM_000038.6(APC):c.1548+1G>T	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428160	5	112162945	5	112827248	428160	419611	rs1114167599	NC_000005.10:112827247:G:T
NM_000038.6(APC):c.6247_6250delinsTGT (p.Ile2083fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, single submitter	VCV000411474	5	112177538 - 112177541	5	112841841 - 112841844	411474	394514	rs1064792978	NC_000005.10:112841840:ATAC:TGT
NM_000038.6(APC):c.1958G>T (p.Arg653Met)	APC	R635M, R653M, R370M, R594M, R671M, R663M, R527M, R562M, R625M, R628M, R493M, R552M, R612M	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411463	5	112170862	5	112835165	411463	394463	rs1060503318	NC_000005.10:112835164:G:T
NM_000038.6(APC):c.531+5G>C	APC		Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279681	5	112111439	5	112775742	279681	264174	rs587779798	NC_000005.10:112775741:G:C
NM_000038.6(APC):c.1239dup (p.Arg414fs)	APC		not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000246085	5	112154967 - 112154968	5	112819270 - 112819271	246085	244420	rs879254088	NC_000005.10:112819270:A:AA
NM_000038.6(APC):c.476dup (p.Tyr159Ter)	APC		Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236607	5	112111378 - 112111379	5	112775681 - 112775682	236607	239525	rs878853451	NC_000005.10:112775681:A:AA
NM_000038.6(APC):c.3391C>T (p.Gln1131Ter)	APC	Q1113*, Q1131*, Q1005*, Q1030*, Q1106*, Q1141*, Q971*, Q1072*, Q1103*, Q1090*, Q1149*, Q1040*, Q848*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000236590	5	112174682	5	112838985	236590	239565	rs878853438	NC_000005.10:112838984:C:T
NM_000038.6(APC):c.1234C>T (p.Gln412Ter)	APC	Q394*, Q412*, Q129*, Q353*, Q387*, Q384*, Q422*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234024	5	112154963	5	112819266	234024	233018	rs876660802	NC_000005.10:112819265:C:T
NM_000038.6(APC):c.481C>T (p.Gln161Ter)	APC	Q161*, Q171*, Q102*, Q136*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229997	5	112111384	5	112775687	229997	232995	rs876658325	NC_000005.10:112775686:C:T
NM_000038.6(APC):c.5145del (p.Asp1715fs)	APC	D1589fs, D1624fs, D1656fs, D1715fs, D1432fs, D1555fs, D1687fs, D1690fs, D1725fs, D1733fs, D1697fs, D1614fs, D1674fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217992	5	112176436	5	112840739	217992	214731	rs863225363	NC_000005.10:112840738:C:
NM_000038.6(APC):c.5490_5493del (p.Asn1830fs)	APC	N1739fs, N1805fs, N1848fs, N1789fs, N1812fs, N1547fs, N1704fs, N1670fs, N1729fs, N1771fs, N1802fs, N1830fs, N1840fs	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000181835	5	112176779 - 112176782	5	112841082 - 112841085	181835	180211	rs730881273	NC_000005.10:112841081:AATGAA:AA
NM_000038.6(APC):c.4216C>T (p.Gln1406Ter)	APC	Q1388*, Q1406*, Q1280*, Q1315*, Q1381*, Q1246*, Q1347*, Q1424*, Q1305*, Q1365*, Q1123*, Q1378*, Q1416*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000142519	5	112175507	5	112839810	142519	152233	rs587782518	NC_000005.10:112839809:C:T
NM_000038.6(APC):c.2365C>T (p.Gln789Ter)	APC	Q771*, Q789*, Q506*, Q629*, Q663*, Q761*, Q764*, Q807*, Q698*, Q748*, Q799*, Q688*, Q730*	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092341	5	112173656	5	112837959	92341	98252	rs398123117	NC_000005.10:112837958:C:T
NM_000249.3(MLH1):c.1246A>T (p.Lys416Ter)	MLH1	K416*, K175*, K318*, K383*, K58*, K75*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome II	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220069	3	37067335	3	37025844	220069	221397	rs267607823	NC_000003.12:37025843:A:T
NM_000249.4(MLH1):c.2065C>T (p.Gln689Ter)	MLH1	Q689*, Q448*, Q348*, Q591*, Q634*, Q658*, Q656*, Q331*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182529	3	37090470	3	37048979	182529	180157	rs41542214	NC_000003.12:37048978:C:T
NM_000249.3(MLH1):c.67G>T (p.Glu23Ter)	MLH1	E23*	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090331	3	37035105	3	36993614	90331	95805	rs63750823	NC_000003.12:36993613:G:T
NM_000249.3(MLH1):c.3G>A (p.Met1Ile)	MLH1	M1I	Lynch syndrome I|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 30, 2017)	reviewed by expert panel	VCV000090211	3	37035041	3	36993550	90211	95685	rs72481822	NC_000003.12:36993549:G:A
NM_000249.3(MLH1):c.2103G>C (p.Gln701His)	MLH1	Q701H, Q360H, Q460H, Q670H, Q343H, Q603H, Q646H, Q668H	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090049	3	37090508	3	37049017	90049	95523	rs63750603	NC_000003.12:37049016:G:C
NM_000249.3(MLH1):c.1976G>T (p.Arg659Leu)	MLH1	R659L, R301L, R561L, R626L, R418L, R604L, R318L	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089966	3	37090087	3	37048596	89966	95440	rs63749900	NC_000003.12:37048595:G:T
NM_000249.3(MLH1):c.1559-2A>G	MLH1		not provided|Lynch syndrome|Lynch syndrome II	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089783	3	37081675	3	37040184	89783	95257	rs267607836	NC_000003.12:37040183:A:G
NM_006218.4(PIK3CA):c.1637A>T (p.Gln546Leu)	PIK3CA	Q546L	Uterine cervical neoplasms|Neoplasm of the breast|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Glioblastoma|Neoplasm of brain|Medulloblastoma|Squamous cell carcinoma of the head and neck|Malignant melanoma of skin|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375899	3	178936095	3	179218307	375899	362778	rs397517201	NC_000003.12:179218306:A:T
NM_006218.4(PIK3CA):c.1258T>C (p.Cys420Arg)	PIK3CA	C420R	Neoplasm of ovary|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|Neoplasm of the large intestine|PIK3CA related overgrowth spectrum|Squamous cell lung carcinoma|Ovarian Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Neoplasm of the breast	Pathogenic(Last reviewed: Oct 8, 2010)	criteria provided, single submitter	VCV000031945	3	178927980	3	179210192	31945	40610	rs121913272	NC_000003.12:179210191:T:C
NM_000038.6(APC):c.3441_3442CT[1] (p.Tyr1147_Ser1148insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000862344	5	112174732 - 112174733	5	112839035 - 112839036	862344	829695		NC_000005.10:112839034:CTCT:CT
NM_000038.6(APC):c.3165_3168del (p.Ile1055fs)	APC	I1014fs, I772fs, I954fs, I1027fs, I1030fs, I1037fs, I1055fs, I1073fs, I929fs, I1065fs, I964fs, I996fs, I895fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000861681	5	112174456 - 112174459	5	112838759 - 112838762	861681	829682		NC_000005.10:112838758:AATA:
NM_000038.6(APC):c.4609dup (p.Thr1537fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000858116	5	112175897 - 112175898	5	112840200 - 112840201	858116	829736		NC_000005.10:112840200:AAA:AAAA
NM_000038.6(APC):c.3224del (p.Tyr1075fs)	APC	Y1034fs, Y1085fs, Y1093fs, Y792fs, Y1047fs, Y1050fs, Y1057fs, Y915fs, Y1016fs, Y1075fs, Y949fs, Y974fs, Y984fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000856077	5	112174515	5	112838818	856077	829685		NC_000005.10:112838817:A:
NM_000038.6(APC):c.3329C>A (p.Ser1110Ter)	APC	S1085*, S1120*, S1128*, S827*, S984*, S1082*, S1092*, S1110*, S1051*, S950*, S1009*, S1019*, S1069*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000851718	5	112174620	5	112838923	851718	829690		NC_000005.10:112838922:C:A
NM_000038.6(APC):c.3839del (p.Leu1280fs)	APC	L1120fs, L1179fs, L1239fs, L1290fs, L1154fs, L1255fs, L1280fs, L1189fs, L1221fs, L1298fs, L997fs, L1252fs, L1262fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000850820	5	112175128	5	112839431	850820	829714		NC_000005.10:112839430:TTT:TT
NM_000038.6(APC):c.3466G>T (p.Glu1156Ter)	APC	E1030*, E1065*, E1115*, E1138*, E1156*, E996*, E1097*, E1174*, E873*, E1055*, E1128*, E1131*, E1166*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000848934	5	112174757	5	112839060	848934	829697		NC_000005.10:112839059:G:T
NM_000038.6(APC):c.3845C>G (p.Ser1282Ter)	APC	S1122*, S1223*, S1241*, S1254*, S1181*, S1282*, S999*, S1156*, S1191*, S1257*, S1264*, S1292*, S1300*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000844994	5	112175136	5	112839439	844994	829716		NC_000005.10:112839438:C:G
NM_000038.6(APC):c.2926del (p.Arg976fs)	APC	R958fs, R994fs, R875fs, R885fs, R935fs, R976fs, R917fs, R951fs, R693fs, R816fs, R850fs, R948fs, R986fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000841361	5	112174214	5	112838517	841361	829670		NC_000005.10:112838516:AAAA:AAA
NM_000038.6(APC):c.4027dup (p.Ser1343fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000837594	5	112175317 - 112175318	5	112839620 - 112839621	837594	829720		NC_000005.10:112839620:T:TT
NM_000038.6(APC):c.3544_3548del (p.Lys1182fs)	APC	K1022fs, K1056fs, K1182fs, K1200fs, K1091fs, K1154fs, K899fs, K1081fs, K1123fs, K1141fs, K1157fs, K1164fs, K1192fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000835541	5	112174833 - 112174837	5	112839136 - 112839140	835541	829700		NC_000005.10:112839135:TAAAATA:TA
NM_000038.6(APC):c.4891_4894del (p.Ser1631fs)	APC	S1505fs, S1530fs, S1540fs, S1572fs, S1590fs, S1603fs, S1348fs, S1631fs, S1649fs, S1606fs, S1471fs, S1613fs, S1641fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000664418	5	112176179 - 112176182	5	112840482 - 112840485	664418	632737		NC_000005.10:112840481:GTTAGTT:GTT
NM_000038.6(APC):c.7432del (p.Gln2478fs)	APC	Q2352fs, Q2437fs, Q2195fs, Q2387fs, Q2450fs, Q2460fs, Q2478fs, Q2318fs, Q2377fs, Q2419fs, Q2488fs, Q2496fs, Q2453fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660938	5	112178721	5	112843024	660938	632828		NC_000005.10:112843023:CCC:CC
NM_000038.6(APC):c.4025T>G (p.Leu1342Ter)	APC	L1216*, L1301*, L1314*, L1182*, L1241*, L1283*, L1317*, L1324*, L1352*, L1360*, L1059*, L1342*, L1251*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000645602	5	112175316	5	112839619	645602	632704		NC_000005.10:112839618:T:G
NM_000038.6(APC):c.3211_3212del (p.Gln1071fs)	APC	Q1046fs, Q980fs, Q1071fs, Q1081fs, Q1089fs, Q911fs, Q1030fs, Q1043fs, Q1012fs, Q1053fs, Q788fs, Q945fs, Q970fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000642587	5	112174502 - 112174503	5	112838805 - 112838806	642587	632677		NC_000005.10:112838804:CA:
NM_000038.6(APC):c.6862C>T (p.Gln2288Ter)	APC	Q2260*, Q2288*, Q2197*, Q2247*, Q2298*, Q2128*, Q2162*, Q2187*, Q2229*, Q2263*, Q2306*, Q2005*, Q2270*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000640262	5	112178153	5	112842456	640262	632809		NC_000005.10:112842455:C:T
NM_000038.6(APC):c.2674G>T (p.Glu892Ter)	APC	E874*, E892*, E801*, E864*, E867*, E902*, E766*, E791*, E609*, E732*, E833*, E851*, E910*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000577670	5	112173965	5	112838268	577670	562395	rs1561578889	NC_000005.10:112838267:G:T
NM_000038.6(APC):c.3179_3183del (p.Ile1060fs)	APC	I1032fs, I1060fs, I1070fs, I959fs, I969fs, I1001fs, I777fs, I1019fs, I1035fs, I1042fs, I1078fs, I900fs, I934fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000537504	5	112174467 - 112174471	5	112838770 - 112838774	537504	520497	rs1554084794	NC_000005.10:112838769:AAATAAAA:AAA
NM_000038.6(APC):c.3469_3470GA[4] (p.Pro1159fs)	APC		not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000492662	5	112174758 - 112174759	5	112839061 - 112839062	492662	485620	rs786203020	NC_000005.10:112839061:AGAGAGA:AGAGAGAGA
NM_000038.6(APC):c.1957A>G (p.Arg653Gly)	APC	R635G, R653G, R370G, R527G, R671G, R493G, R562G, R612G, R663G, R594G, R625G, R552G, R628G	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428139	5	112170861	5	112835164	428139	419617	rs1114167580	NC_000005.10:112835163:A:G
NM_000038.6(APC):c.1956C>T (p.His652=)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial adenomatous polyposis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419202	5	112170860	5	112835163	419202	406515	rs1064793716	NC_000005.10:112835162:C:T
NM_000038.6(APC):c.350C>A (p.Ser117Ter)	APC	S117*, S127*, S58*, S92*	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418932	5	112103015	5	112767318	418932	406485	rs1064793535	NC_000005.10:112767317:C:A
NM_000038.6(APC):c.532-8G>A	APC		Familial adenomatous polyposis 1|Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000411469	5	112116479	5	112780782	411469	394685	rs1060503323	NC_000005.10:112780781:G:A
NM_000038.6(APC):c.3956del (p.Pro1319fs)	APC	P1319fs, P1159fs, P1228fs, P1260fs, P1278fs, P1294fs, P1329fs, P1193fs, P1218fs, P1291fs, P1036fs, P1301fs, P1337fs	not provided|Malignant Colorectal Neoplasm|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000371830	5	112175246	5	112839549	371830	358777	rs1057517558	NC_000005.10:112839548:CC:C
NM_000038.6(APC):c.5952_5955del (p.Glu1985fs)	APC	E1702fs, E1825fs, E1859fs, E1926fs, E1957fs, E1967fs, E1995fs, E1894fs, E1985fs, E1944fs, E1960fs, E1884fs, E2003fs	Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371809	5	112177241 - 112177244	5	112841544 - 112841547	371809	358780	rs1057517544	NC_000005.10:112841543:AATGAA:AA
NM_000038.6(APC):c.531+1G>C	APC		not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232758	5	112111435	5	112775738	232758	232997	rs876659973	NC_000005.10:112775737:G:C
NM_000038.6(APC):c.2413C>T (p.Arg805Ter)	APC	R805*, R787*, R679*, R714*, R746*, R777*, R823*, R522*, R704*, R780*, R645*, R764*, R815*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127281	5	112173704	5	112838007	127281	132738	rs587779783	NC_000005.10:112838006:C:T
NM_000038.6(APC):c.423-1G>A	APC		Familial adenomatous polyposis|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000000835	5	112111325	5	112775628	835	15874	rs397514031	NC_000005.10:112775627:G:A
NM_000249.3(MLH1):c.2142G>A (p.Trp714Ter)	MLH1	W714*, W356*, W373*, W616*, W659*, W473*, W645*, W681*, W683*	Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418308	3	37092015	3	37050524	418308	406263	rs63750978	NC_000003.12:37050523:G:A
NM_000249.3(MLH1):c.454-1G>C	MLH1		Lynch syndrome II|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371909	3	37050304	3	37008813	371909	358738	rs193922370	NC_000003.12:37008812:G:C
NM_000249.3(MLH1):c.1896G>A (p.Glu632=)	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089930	3	37089174	3	37047683	89930	95404	rs63751632	NC_000003.12:37047682:G:A
NM_000249.3(MLH1):c.187G>A (p.Asp63Asn)	MLH1	D63N	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000089920	3	37038180	3	36996689	89920	95394	rs63750850	NC_000003.12:36996688:G:A
NM_004321.7(KIF1A):c.946C>T (p.Arg316Trp)	KIF1A	R316W	Mental retardation, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162060	2	241715280	2	240775863	162060	171771	rs672601370	NC_000002.12:240775862:G:A
NM_000038.6(APC):c.3203C>A (p.Ser1068Ter)	APC	S1068*, S1050*, S1040*, S1043*, S1027*, S1078*, S785*, S942*, S967*, S1086*, S908*, S977*, S1009*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000579696	5	112174494	5	112838797	579696	562406	rs1554084848	NC_000005.10:112838796:C:A
NM_000038.6(APC):c.4463dup (p.Leu1488fs)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 31, 2018)	criteria provided, single submitter	VCV000572529	5	112175751 - 112175752	5	112840054 - 112840055	572529	560028	rs1114167577	NC_000005.10:112840054:TTT:TTTT
NM_000038.6(APC):c.7270_7273del (p.Ser2424fs)	APC	S2141fs, S2333fs, S2365fs, S2298fs, S2323fs, S2383fs, S2396fs, S2424fs, S2264fs, S2399fs, S2406fs, S2434fs, S2442fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000492671	5	112178559 - 112178562	5	112842862 - 112842865	492671	485629	rs1469278346	NC_000005.10:112842861:AATCAA:AA
NM_000038.6(APC):c.2825del (p.Asn942fs)	APC	N782fs, N851fs, N914fs, N917fs, N960fs, N816fs, N841fs, N883fs, N942fs, N924fs, N952fs, N659fs, N901fs	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000492659	5	112174113	5	112838416	492659	485617	rs1554084511	NC_000005.10:112838415:AAAA:AAA
NM_000038.6(APC):c.645+1G>T	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000482288	5	112116601	5	112780904	482288	473834	rs863225370	NC_000005.10:112780903:G:T
NM_000038.6(APC):c.3444_3447del (p.Glu1149fs)	APC	E1048fs, E1058fs, E1159fs, E1124fs, E1131fs, E1167fs, E1090fs, E1108fs, E1121fs, E1149fs, E866fs, E989fs, E1023fs	Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433644	5	112174735 - 112174738	5	112839038 - 112839041	433644	427281	rs1554085005	NC_000005.10:112839037:TGAA:
NM_000038.6(APC):c.1657del (p.Trp553fs)	APC	W427fs, W452fs, W553fs, W393fs, W462fs, W512fs, W535fs, W563fs, W494fs, W528fs, W571fs, W270fs, W525fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428155	5	112164582	5	112828885	428155	419614	rs1114167594	NC_000005.10:112828884:TT:T
NM_000038.6(APC):c.6371T>A (p.Leu2124Ter)	APC	L2106*, L2124*, L1998*, L2023*, L2065*, L1964*, L2083*, L2096*, L2099*, L2134*, L1841*, L2033*, L2142*	Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371855	5	112177662	5	112841965	371855	358781	rs1057517568	NC_000005.10:112841964:T:A
NM_000038.6(APC):c.2395dup (p.Tyr799fs)	APC		Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280611	5	112173684 - 112173685	5	112837987 - 112837988	280611	264221	rs879254110	NC_000005.10:112837987:TT:TTT
NM_000038.6(APC):c.3925_3928del (p.Glu1309fs)	APC	E1026fs, E1309fs, E1208fs, E1218fs, E1268fs, E1291fs, E1319fs, E1149fs, E1183fs, E1250fs, E1284fs, E1281fs, E1327fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232247	5	112175213 - 112175216	5	112839516 - 112839519	232247	233089	rs876659647	NC_000005.10:112839515:AAAGAAA:AAA
NM_000038.6(APC):c.5804dup (p.Ser1936fs)	APC		Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217997	5	112177094 - 112177095	5	112841397 - 112841398	217997	214732	rs863225367	NC_000005.10:112841397:A:AA
NM_000038.6(APC):c.3125del (p.Ser1042fs)	APC	S1024fs, S1060fs, S882fs, S951fs, S983fs, S1014fs, S1017fs, S1042fs, S759fs, S916fs, S1001fs, S1052fs, S941fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000217961	5	112174416	5	112838719	217961	214707	rs863225338	NC_000005.10:112838718:G:
NM_000038.6(APC):c.1658G>A (p.Trp553Ter)	APC	W535*, W553*, W427*, W452*, W270*, W393*, W494*, W512*, W525*, W571*, W462*, W528*, W563*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217935	5	112164584	5	112828887	217935	214692	rs863225318	NC_000005.10:112828886:G:A
NM_000038.6(APC):c.6383del (p.Ala2128fs)	APC	A1845fs, A2103fs, A2128fs, A1968fs, A2037fs, A2069fs, A2138fs, A2146fs, A2002fs, A2027fs, A2087fs, A2100fs, A2110fs	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000127311	5	112177674	5	112841977	127311	132768	rs587779803	NC_000005.10:112841976:C:
NM_000249.3(MLH1):c.1219C>T (p.Gln407Ter)	MLH1	Q407*, Q49*, Q166*, Q309*, Q374*, Q66*	Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome II|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371799	3	37067308	3	37025817	371799	358744	rs1057517541	NC_000003.12:37025816:C:T
NM_000249.3(MLH1):c.955G>T (p.Glu319Ter)	MLH1	E319*, E286*, E221*, E78*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome II|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090453	3	37061871	3	37020380	90453	95927	rs63750796	NC_000003.12:37020379:G:T
NM_000249.3(MLH1):c.1976G>C (p.Arg659Pro)	MLH1	R659P, R561P, R604P, R626P, R301P, R318P, R418P	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089965	3	37090087	3	37048596	89965	95439	rs63749900	NC_000003.12:37048595:G:C
NM_001167617.2(MLH1):c.-134del	MLH1	E53fs	not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089793	3	37038147	3	36996656	89793	95267	rs63750028	NC_000003.12:36996655:AAA:AA
NM_001904.4(CTNNB1):c.283C>T (p.Arg95Ter)	CTNNB1	R95*, R88*	Pilomatrixoma|Hepatocellular carcinoma|Carcinoma of colon|Neoplasm of ovary|EXUDATIVE VITREORETINOPATHY 7|Mental retardation, autosomal dominant 19|Medulloblastoma|Mental retardation, autosomal dominant 19|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265443	3	41266486	3	41224995	265443	259764	rs775104326	NC_000003.12:41224994:C:T
NM_000038.6(APC):c.3189_3192del (p.Glu1064fs)	APC	E1036fs, E1082fs, E963fs, E973fs, E1005fs, E1039fs, E1046fs, E1074fs, E938fs, E1023fs, E1064fs, E781fs, E904fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000664591	5	112174478 - 112174481	5	112838781 - 112838784	664591	632676		NC_000005.10:112838780:AGTGAG:AG
NM_000038.6(APC):c.3793_3794insCTT (p.Glu1265delinsAlaTer)	APC		not provided|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000662172	5	112175084 - 112175085	5	112839387 - 112839388	662172	632692		NC_000005.10:112839387::CTT
NM_000038.6(APC):c.2522del (p.Ser840_Leu841insTer)	APC		Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000642670	5	112173812	5	112838115	642670	632654		NC_000005.10:112838114:TT:T
NM_000038.6(APC):c.7438C>T (p.Gln2480Ter)	APC	Q2462*, Q2480*, Q2197*, Q2389*, Q2439*, Q2452*, Q2379*, Q2421*, Q2455*, Q2498*, Q2320*, Q2354*, Q2490*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000537540	5	112178729	5	112843032	537540	520878	rs1554088359	NC_000005.10:112843031:C:T
NM_000038.6(APC):c.4638_4642del (p.Asn1546fs)	APC	N1521fs, N1528fs, N1556fs, N1564fs, N1386fs, N1445fs, N1455fs, N1487fs, N1518fs, N1546fs, N1263fs, N1420fs, N1505fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000537539	5	112175926 - 112175930	5	112840229 - 112840233	537539	520809	rs1554086030	NC_000005.10:112840228:AAATGAAA:AAA
NM_000038.6(APC):c.3783_3784del (p.Tyr1262fs)	APC	Y1221fs, Y979fs, Y1136fs, Y1234fs, Y1244fs, Y1203fs, Y1262fs, Y1280fs, Y1102fs, Y1161fs, Y1171fs, Y1237fs, Y1272fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000537503	5	112175074 - 112175075	5	112839377 - 112839378	537503	520782	rs1554085303	NC_000005.10:112839376:TT:
NM_000038.6(APC):c.5772del (p.Lys1924fs)	APC	K1641fs, K1823fs, K1865fs, K1924fs, K1798fs, K1764fs, K1833fs, K1883fs, K1896fs, K1899fs, K1906fs, K1934fs, K1942fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000537473	5	112177061	5	112841364	537473	520357	rs1554086974	NC_000005.10:112841363:AAA:AA
NM_000038.6(APC):c.3523C>T (p.Gln1175Ter)	APC	Q1175*, Q1157*, Q1049*, Q1074*, Q1185*, Q1084*, Q1134*, Q1116*, Q1147*, Q1193*, Q892*, Q1015*, Q1150*	not specified|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000537459	5	112174814	5	112839117	537459	520499	rs1554085081	NC_000005.10:112839116:C:T
NM_000038.6(APC):c.3786T>G (p.Tyr1262Ter)	APC	Y1244*, Y1262*, Y1102*, Y1203*, Y1237*, Y1280*, Y1136*, Y1161*, Y1221*, Y1272*, Y1171*, Y1234*, Y979*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000537417	5	112175077	5	112839380	537417	520330	rs147411334	NC_000005.10:112839379:T:G
NM_000038.6(APC):c.7932_7935del (p.Tyr2645fs)	APC	Y2554fs, Y2586fs, Y2604fs, Y2627fs, Y2645fs, Y2655fs, Y2485fs, Y2620fs, Y2362fs, Y2519fs, Y2544fs, Y2617fs, Y2663fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000486770	5	112179221 - 112179224	5	112843524 - 112843527	486770	474038	rs1554088762	NC_000005.10:112843523:ATTTAT:AT
NM_000038.6(APC):c.1312+5G>A	APC		not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411416	5	112155046	5	112819349	411416	394347	rs886039507	NC_000005.10:112819348:G:A
NM_000038.6(APC):c.2483del (p.Thr828fs)	APC	T545fs, T668fs, T727fs, T800fs, T803fs, T769fs, T787fs, T810fs, T838fs, T702fs, T737fs, T828fs, T846fs	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000283339	5	112173774	5	112838077	283339	267576	rs886042600	NC_000005.10:112838076:C:
NM_001127511.3(APC):c.-191T>C	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000243005	5	112043224	5	112707527	243005	244085	rs879253783	NC_000005.10:112707526:T:C
NM_000038.6(APC):c.1875_1878del (p.Asn627fs)	APC	N536fs, N627fs, N344fs, N602fs, N609fs, N467fs, N568fs, N586fs, N637fs, N645fs, N501fs, N526fs, N599fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000236565	5	112170777 - 112170780	5	112835080 - 112835083	236565	239543	rs878853420	NC_000005.10:112835079:CAGACA:CA
NM_000038.6(APC):c.1873C>T (p.Gln625Ter)	APC	Q607*, Q625*, Q342*, Q465*, Q534*, Q584*, Q524*, Q597*, Q635*, Q499*, Q600*, Q643*, Q566*	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232045	5	112170777	5	112835080	232045	233044	rs876659517	NC_000005.10:112835079:C:T
NM_000038.6(APC):c.220G>T (p.Glu74Ter)	APC	E74*, E84*, E49*, E15*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial adenomatous polyposis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231074	5	112102107	5	112766410	231074	232984	rs876658941	NC_000005.10:112766409:G:T
NM_000038.6(APC):c.7511G>A (p.Trp2504Ter)	APC	W2486*, W2504*, W2221*, W2403*, W2445*, W2522*, W2378*, W2479*, W2463*, W2476*, W2514*, W2344*, W2413*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, single submitter	VCV000218007	5	112178802	5	112843105	218007	214735	rs755046558	NC_000005.10:112843104:G:A
NM_000038.6(APC):c.1192_1193del (p.Lys398fs)	APC	K339fs, K380fs, K408fs, K115fs, K370fs, K398fs, K373fs	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000828	5	112154921 - 112154922	5	112819224 - 112819225	828	15867	rs387906238	NC_000005.10:112819223:AA:
NM_004369.3(COL6A3):c.6354+1G>A	COL6A3		Inborn genetic diseases|not provided|Bethlem myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285748	2	238267848	2	237359205	285748	269985	rs886042883	NC_000002.12:237359204:C:T
NM_000551.4(VHL):c.256C>T (p.Pro86Ser)	VHL	P86S	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000178692	3	10183787	3	10142103	178692	173736	rs398123481	NC_000003.12:10142102:C:T
NM_000551.3(VHL):c.233A>G (p.Asn78Ser)	VHL	N78S	not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093326	3	10183764	3	10142080	93326	99233	rs5030804	NC_000003.12:10142079:A:G
NM_000249.3(MLH1):c.199G>C (p.Gly67Arg)	MLH1	G67R	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495763	3	37038192	3	36996701	495763	486996	rs63750206	NC_000003.12:36996700:G:C
NM_001167617.2(MLH1):c.-450del	MLH1	E23fs	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090332	3	37035101	3	36993610	90332	95806	rs63750822	NC_000003.12:36993609:GGGGG:GGGG
NM_000249.3(MLH1):c.1411_1414delAAGA	MLH1		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089727	3	37070273 - 37070276	3	37028782 - 37028785	89727	95201	rs63751592	NC_000003.12:37028781:AGAAAGA:AGA
NM_001354621.1(MLH1):c.-13dup	MLH1		not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089604	3	37061925 - 37061926	3	37020434 - 37020435	89604	95078	rs63750677	NC_000003.12:37020434:CC:CCC
NM_000038.6(APC):c.3225T>A (p.Tyr1075Ter)	APC	Y792*, Y1016*, Y1075*, Y1085*, Y915*, Y949*, Y974*, Y1034*, Y1047*, Y1093*, Y984*, Y1050*, Y1057*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000845025	5	112174516	5	112838819	845025	829686		NC_000005.10:112838818:T:A
NM_000038.6(APC):c.6496C>T (p.Arg2166Ter)	APC	R2148*, R2166*, R2107*, R2125*, R2138*, R2141*, R1883*, R2006*, R2176*, R2040*, R2184*, R2065*, R2075*	Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000438883	5	112177787	5	112842090	438883	432593	rs764527706	NC_000005.10:112842089:C:T
NM_000038.6(APC):c.6053del (p.Pro2018fs)	APC	P1858fs, P1917fs, P1959fs, P1990fs, P2018fs, P1892fs, P1927fs, P1977fs, P1993fs, P1735fs, P2000fs, P2028fs, P2036fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429055	5	112177341	5	112841644	429055	421037	rs1131691142	NC_000005.10:112841643:CCCC:CCC
NM_000038.6(APC):c.1958+1G>A	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428125	5	112170863	5	112835166	428125	419619	rs1114167569	NC_000005.10:112835165:G:A
NM_000038.6(APC):c.1370C>G (p.Ser457Ter)	APC	S439*, S457*, S174*, S331*, S356*, S398*, S429*, S467*, S297*, S366*, S432*	not specified|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411488	5	112157650	5	112821953	411488	394439	rs1060503333	NC_000005.10:112821952:C:G
NM_000038.6(APC):c.2309C>G (p.Ser770Ter)	APC	S770*, S752*, S644*, S669*, S711*, S729*, S745*, S742*, S487*, S610*, S679*, S780*, S788*	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411447	5	112173600	5	112837903	411447	394272	rs1060503310	NC_000005.10:112837902:C:G
NM_000038.6(APC):c.477C>G (p.Tyr159Ter)	APC	Y159*, Y169*, Y134*, Y100*	Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000246084	5	112111380	5	112775683	246084	244416	rs863224281	NC_000005.10:112775682:C:G
NM_000038.6(APC):c.6610C>T (p.Arg2204Ter)	APC	R2186*, R2204*, R2078*, R2113*, R2179*, R2145*, R2103*, R2163*, R2214*, R1921*, R2044*, R2176*, R2222*	Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000236632	5	112177901	5	112842204	236632	239601	rs752654519	NC_000005.10:112842203:C:T
NM_000038.6(APC):c.645+1G>A	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218000	5	112116601	5	112780904	218000	214667	rs863225370	NC_000005.10:112780903:G:A
NM_000038.6(APC):c.453del (p.Glu152fs)	APC	E127fs, E162fs, E93fs, E152fs	not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216848	5	112111355	5	112775658	216848	212390	rs863224820	NC_000005.10:112775657:AA:A
NM_000038.6(APC):c.221-2A>G	APC		Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184117	5	112102884	5	112767187	184117	182319	rs786201291	NC_000005.10:112767186:A:G
NM_000038.6(APC):c.2004del (p.His668_Leu669insTer)	APC		not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142199	5	112173295	5	112837598	142199	151913	rs587782303	NC_000005.10:112837597:C:
NM_000249.3(MLH1):c.2070_2071insTT (p.Ile691fs)	MLH1		Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome II|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232298	3	37090475 - 37090476	3	37048984 - 37048985	232298	232970	rs876659681	NC_000003.12:37048984::TT
NM_000249.3(MLH1):c.882C>T (p.Leu294=)	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090407	3	37059088	3	37017597	90407	95881	rs63751707	NC_000003.12:37017596:C:T
NM_000249.3(MLH1):c.544A>G (p.Arg182Gly)	MLH1	R182G, R84G, R149G	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090258	3	37050395	3	37008904	90258	95732	rs63750211	NC_000003.12:37008903:A:G
NM_000249.3(MLH1):c.1559-1G>T	MLH1		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089781	3	37081676	3	37040185	89781	95255	rs267607837	NC_000003.12:37040184:G:T
NM_000249.3(MLH1):c.986A>C (p.His329Pro)	MLH1	H329P, H88P, H231P, H296P	Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017085	3	37061902	3	37020411	17085	32124	rs63750710	NC_000003.12:37020410:A:C
NM_000038.6(APC):c.3827C>G (p.Ser1276Ter)	APC	S1258*, S1276*, S1185*, S1217*, S1235*, S1248*, S1286*, S1116*, S1150*, S1175*, S993*, S1251*, S1294*	not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000492666	5	112175118	5	112839421	492666	485624	rs1060503299	NC_000005.10:112839420:C:G
NM_000038.6(APC):c.2711_2712del (p.Arg904fs)	APC	R778fs, R845fs, R879fs, R886fs, R922fs, R813fs, R621fs, R744fs, R803fs, R863fs, R876fs, R904fs, R914fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000490252	5	112174001 - 112174002	5	112838304 - 112838305	490252	483939	rs1554084403	NC_000005.10:112838303:AGA:A
NM_000038.6(APC):c.3164_3168del (p.Ile1055fs)	APC	I1027fs, I895fs, I1014fs, I1055fs, I772fs, I954fs, I1030fs, I1037fs, I1073fs, I929fs, I1065fs, I964fs, I996fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486749	5	112174454 - 112174458	5	112838757 - 112838761	486749	473700	rs1554084772	NC_000005.10:112838756:ATAATA:A
NM_000038.6(APC):c.1958G>A (p.Arg653Lys)	APC	R635K, R653K, R370K, R552K, R628K, R594K, R625K, R663K, R671K, R612K, R493K, R527K, R562K	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428128	5	112170862	5	112835165	428128	419618	rs1060503318	NC_000005.10:112835164:G:A
NM_000038.6(APC):c.3571C>T (p.Gln1191Ter)	APC	Q1173*, Q1191*, Q1065*, Q1132*, Q1201*, Q1166*, Q1209*, Q1031*, Q1090*, Q1100*, Q1150*, Q1163*, Q908*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428096	5	112174862	5	112839165	428096	419645	rs1114167547	NC_000005.10:112839164:C:T
NM_000038.6(APC):c.5822_5825CAGA[1] (p.Asp1942fs)	APC		not provided|Desmoid disease, hereditary|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000219743	5	112177113 - 112177116	5	112841416 - 112841419	219743	221526	rs864622228	NC_000005.10:112841415:CAGACAGA:CAGA
NM_000038.6(APC):c.3785dup (p.Tyr1262Ter)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217970	5	112175075 - 112175076	5	112839378 - 112839379	217970	214716	rs863225345	NC_000005.10:112839378:A:AA
NM_000038.6(APC):c.3286C>T (p.Gln1096Ter)	APC	Q1078*, Q1096*, Q1037*, Q936*, Q995*, Q1005*, Q1055*, Q813*, Q970*, Q1071*, Q1068*, Q1106*, Q1114*	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156475	5	112174577	5	112838880	156475	166240	rs587783029	NC_000005.10:112838879:C:T
NM_000038.6(APC):c.147_150del (p.Lys49fs)	APC	K59fs, K49fs, K24fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis|not provided	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141368	5	112102032 - 112102035	5	112766335 - 112766338	141368	151082	rs587781694	NC_000005.10:112766334:AAACAA:AA
NM_000038.6(APC):c.894_895CT[1] (p.Ser299fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial multiple polyposis syndrome|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042251	5	112151251 - 112151252	5	112815554 - 112815555	42251	51421	rs397515735	NC_000005.10:112815553:CTCT:CT
NM_006218.4(PIK3CA):c.1637A>C (p.Gln546Pro)	PIK3CA	Q546P	Uterine Carcinosarcoma|Ovarian Neoplasms|Uterine cervical neoplasms|Neoplasm of the large intestine|Neoplasm of the breast|Neoplasm of brain|Adenocarcinoma of stomach|Glioblastoma|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Malignant melanoma of skin|Adenocarcinoma of prostate|Medulloblastoma|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000375898	3	178936095	3	179218307	375898	362777	rs397517201	NC_000003.12:179218306:A:C
NM_000249.3(MLH1):c.117-2A>G	MLH1		Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000142856	3	37038108	3	36996617	142856	152570	rs267607712	NC_000003.12:36996616:A:G
NM_000249.3(MLH1):c.545+3A>G	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome II|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090260	3	37050399	3	37008908	90260	95734	rs267607760	NC_000003.12:37008907:A:G
NM_000249.3(MLH1):c.2194A>T (p.Lys732Ter)	MLH1	K732*, K491*, K677*, K699*, K374*, K663*, K391*, K634*, K701*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090087	3	37092067	3	37050576	90087	95561	rs267607906	NC_000003.12:37050575:A:T
NM_001354630.1(MLH1):c.1732-958_1732-955del	MLH1	D493fs, D558fs, D233fs, D250fs, D350fs, D591fs	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089886	3	37089047 - 37089050	3	37047556 - 37047559	89886	95360	rs63749868	NC_000003.12:37047555:TAGATAG:TAG
NM_001167617.2(MLH1):c.916_917del (p.Leu306fs)	MLH1	L371fs, L46fs, L163fs, L63fs, L306fs, L404fs	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089678	3	37067299 - 37067300	3	37025808 - 37025809	89678	95152	rs63751015	NC_000003.12:37025807:CT:
NM_000249.3(MLH1):c.1038G>A (p.Gln346=)	MLH1		not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089616	3	37061954	3	37020463	89616	95090	rs63751715	NC_000003.12:37020462:G:A
NM_000249.3(MLH1):c.-27C>A	MLH1		not specified|not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000089589	3	37035012	3	36993521	89589	95063	rs587779001	NC_000003.12:36993520:C:A
NM_000249.3(MLH1):c.454-1G>A	MLH1		Lynch syndrome II|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036553	3	37050304	3	37008813	36553	45215	rs193922370	NC_000003.12:37008812:G:A
NM_000038.6(APC):c.3867T>A (p.Cys1289Ter)	APC	C1271*, C1289*, C1006*, C1129*, C1230*, C1248*, C1307*, C1163*, C1198*, C1264*, C1188*, C1261*, C1299*	Carcinoma of colon|Familial adenomatous polyposis 1|Hepatocellular carcinoma|Desmoid disease, hereditary|Neoplasm of stomach|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545962	5	112175158	5	112839461	545962	536301	rs1554085355	NC_000005.10:112839460:T:A
NM_000038.6(APC):c.2107dup (p.Ala703fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000490236	5	112173393 - 112173394	5	112837696 - 112837697	490236	483885	rs587783030	NC_000005.10:112837696:GGGGG:GGGGGG
NM_000038.6(APC):c.7475_7476CT[1] (p.Leu2493fs)	APC		Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000482379	5	112178765 - 112178766	5	112843068 - 112843069	482379	473912	rs1554088391	NC_000005.10:112843067:TCTCT:TCT
NM_000038.6(APC):c.6976C>T (p.Arg2326Ter)	APC	R2326*, R2308*, R2200*, R2267*, R2336*, R2344*, R2043*, R2225*, R2166*, R2235*, R2298*, R2301*, R2285*	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411530	5	112178267	5	112842570	411530	394982	rs1060503355	NC_000005.10:112842569:C:T
NM_000038.6(APC):c.3577_3578del (p.Gln1193fs)	APC	Q1165fs, Q1203fs, Q1092fs, Q1102fs, Q1134fs, Q1152fs, Q1168fs, Q1211fs, Q1033fs, Q1067fs, Q1175fs, Q1193fs, Q910fs	Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000411475	5	112174867 - 112174868	5	112839170 - 112839171	411475	394853	rs1060503326	NC_000005.10:112839169:ACA:A
NM_000038.6(APC):c.1866C>A (p.Tyr622Ter)	APC	Y496*, Y640*, Y521*, Y462*, Y563*, Y597*, Y339*, Y531*, Y581*, Y594*, Y632*, Y604*, Y622*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial adenomatous polyposis|not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233973	5	112170770	5	112835073	233973	233042	rs876658355	NC_000005.10:112835072:C:A
NM_000038.6(APC):c.6709C>T (p.Arg2237Ter)	APC	R2219*, R2237*, R2136*, R2178*, R2196*, R2209*, R1954*, R2077*, R2255*, R2111*, R2247*, R2146*, R2212*	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187612	5	112178000	5	112842303	187612	182452	rs768922431	NC_000005.10:112842302:C:T
NM_000038.6(APC):c.4669_4670del (p.Thr1556_Ile1557insTer)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183857	5	112175959 - 112175960	5	112840262 - 112840263	183857	182406	rs786201118	NC_000005.10:112840261:TAT:T
NM_006218.4(PIK3CA):c.3129G>A (p.Met1043Ile)	PIK3CA	M1043I	Neoplasm of brain|Neoplasm of the large intestine|Glioblastoma|PIK3CA related overgrowth spectrum|Non-small cell lung cancer|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Pancreatic adenocarcinoma|Neoplasm of the breast|Neoplasm of the thyroid gland|Malignant neoplasm of body of uterus|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Cowden syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179173	3	178952074	3	179234286	179173	173901	rs121913283	NC_000003.12:179234285:G:A
NM_006218.4(PIK3CA):c.1636C>G (p.Gln546Glu)	PIK3CA	Q546E	Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Breast adenocarcinoma|Uterine Carcinosarcoma|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Adenocarcinoma of stomach|Glioblastoma|Neoplasm of brain|Neoplasm of the large intestine|Neoplasm of the breast|Medulloblastoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000013654	3	178936094	3	179218306	13654	28693	rs121913286	NC_000003.12:179218305:C:G
NM_000249.3(MLH1):c.731G>A (p.Gly244Asp)	MLH1	G244D, G211D, G146D, G3D	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090339	3	37055976	3	37014485	90339	95813	rs63750303	NC_000003.12:37014484:G:A
NM_000249.3(MLH1):c.2224C>T (p.Gln742Ter)	MLH1	Q742*, Q401*, Q501*, Q644*, Q687*, Q711*, Q709*, Q384*, Q673*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090094	3	37092097	3	37050606	90094	95568	rs587778992	NC_000003.12:37050605:C:T
NM_001167617.2(MLH1):c.-80_-78AGA[1]	MLH1	E71del	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090067	3	37042447 - 37042449	3	37000956 - 37000958	90067	95541	rs63751642	NC_000003.12:37000955:AAGAAGA:AAGA
NM_000249.3(MLH1):c.1989G>A (p.Glu663=)	MLH1		not provided|Hereditary nonpolyposis colon cancer|Lynch syndrome I	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000089979	3	37090100	3	37048609	89979	95453	rs63751662	NC_000003.12:37048608:G:A
NM_006218.4(PIK3CA):c.1624G>C (p.Glu542Gln)	PIK3CA	E542Q	Hepatocellular carcinoma|Papillary renal cell carcinoma, sporadic|Ovarian Neoplasms|Non-small cell lung cancer|Neoplasm of the breast|Neoplasm of brain|Transitional cell carcinoma of the bladder|Uterine cervical neoplasms|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Neoplasm of the large intestine|Squamous cell lung carcinoma|Lung adenocarcinoma|Malignant neoplasm of body of uterus|Glioblastoma|Carcinoma of esophagus|Small cell lung cancer|Squamous cell carcinoma of the head and neck	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000376244	3	178936082	3	179218294	376244	363123	rs121913273	NC_000003.12:179218293:G:C
NM_000038.6(APC):c.487C>T (p.Gln163Ter)	APC	Q163*, Q173*, Q138*, Q104*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided|Familial adenomatous polyposis	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217991	5	112111390	5	112775693	217991	214662	rs863225362	NC_000005.10:112775692:C:T
NM_000038.6(APC):c.288T>A (p.Tyr96Ter)	APC	Y106*, Y96*, Y71*, Y37*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial adenomatous polyposis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181831	5	112102953	5	112767256	181831	180167	rs376213437	NC_000005.10:112767255:T:A
NM_000038.6(APC):c.5936_5939del (p.Asn1979fs)	APC	N1696fs, N1819fs, N1888fs, N1951fs, N1989fs, N1878fs, N1938fs, N1979fs, N1997fs, N1920fs, N1961fs, N1853fs, N1954fs	not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140863	5	112177225 - 112177228	5	112841528 - 112841531	140863	150577	rs587781330	NC_000005.10:112841527:AAACAA:AA
NM_000038.6(APC):c.3202_3205del (p.Ser1068fs)	APC	S942fs, S1043fs, S1086fs, S785fs, S1009fs, S1027fs, S1040fs, S1078fs, S1050fs, S1068fs, S908fs, S967fs, S977fs	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis|not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000088914	5	112174490 - 112174493	5	112838793 - 112838796	88914	94473	rs587779353	NC_000005.10:112838792:CAATCAA:CAA
NM_001354689.3(RAF1):c.781C>T (p.Pro261Ser)	RAF1	P261S, P180S, P147S, P228S	Inborn genetic diseases|Noonan syndrome|Primary familial hypertrophic cardiomyopathy|Noonan syndrome 5|Cardiovascular phenotype|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013958	3	12645688	3	12604189	13958	28997	rs121434594	NC_000003.12:12604188:G:A
NM_000249.3(MLH1):c.790+2dup	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090361	3	37056036 - 37056037	3	37014545 - 37014546	90361	95835	rs267607791	NC_000003.12:37014545:T:TT
NM_000249.3(MLH1):c.55A>T (p.Ile19Phe)	MLH1	I19F	Lynch syndrome I|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000090274	3	37035093	3	36993602	90274	95748	rs63750648	NC_000003.12:36993601:A:T
NM_000249.3(MLH1):c.245C>T (p.Thr82Ile)	MLH1	T82I	Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090118	3	37042483	3	37000992	90118	95592	rs63750005	NC_000003.12:37000991:C:T
NM_000249.3(MLH1):c.2177_2178CA[1] (p.His727fs)	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090083	3	37092050 - 37092053	3	37050559 - 37050562	90083	95557	rs267607898	NC_000003.12:37050558:CACACA:CA
NM_000038.6(APC):c.3577C>T (p.Gln1193Ter)	APC	Q1175*, Q1193*, Q1203*, Q910*, Q1134*, Q1165*, Q1092*, Q1168*, Q1211*, Q1033*, Q1067*, Q1102*, Q1152*	not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492664	5	112174868	5	112839171	492664	485622	rs1554085128	NC_000005.10:112839170:C:T
NM_000038.6(APC):c.1999C>T (p.Gln667Ter)	APC	Q649*, Q667*, Q384*, Q541*, Q566*, Q576*, Q626*, Q642*, Q507*, Q639*, Q608*, Q685*, Q677*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233010	5	112173290	5	112837593	233010	233049	rs876660130	NC_000005.10:112837592:C:T
NM_000038.6(APC):c.220+2T>A	APC		not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141515	5	112102109	5	112766412	141515	151229	rs587781809	NC_000005.10:112766411:T:A
NM_000038.6(APC):c.4473dup (p.Ala1492fs)	APC		Desmoid tumors|not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092347	5	112175760 - 112175761	5	112840063 - 112840064	92347	98258	rs398123122	NC_000005.10:112840063:TTTT:TTTTT
NM_000038.6(APC):c.4612_4613del (p.Glu1538fs)	APC	E1255fs, E1378fs, E1412fs, E1447fs, E1479fs, E1497fs, E1510fs, E1520fs, E1538fs, E1437fs, E1513fs, E1548fs, E1556fs	Familial adenomatous polyposis 1|Gardner syndrome	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000000823	5	112175902 - 112175903	5	112840205 - 112840206	823	15862	rs387906236	NC_000005.10:112840204:AGA:A
NM_000038.6(APC):c.643C>T (p.Gln215Ter)	APC	Q215*, Q225*, Q156*, Q190*	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Brain tumor-polyposis syndrome 2	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000814	5	112116598	5	112780901	814	15853	rs137854577	NC_000005.10:112780900:C:T
NM_000038.6(APC):c.3199C>T (p.Gln1067Ter)	APC	Q1067*, Q1049*, Q1026*, Q1039*, Q784*, Q907*, Q1042*, Q1077*, Q1085*, Q966*, Q976*, Q1008*, Q941*	Neoplasm of stomach|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000803	5	112174490	5	112838793	803	15842	rs137854571	NC_000005.10:112838792:C:T
NM_000249.3(MLH1):c.83C>T (p.Pro28Leu)	MLH1	P28L	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090388	3	37035121	3	36993630	90388	95862	rs63750792	NC_000003.12:36993629:C:T
NM_000249.3(MLH1):c.306+5G>A	MLH1		Hereditary cancer-predisposing syndrome|Muir-Torré syndrome|Lynch syndrome II|Turcot syndrome|Lynch syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090148	3	37042549	3	37001058	90148	95622	rs267607735	NC_000003.12:37001057:G:A
NM_000249.3(MLH1):c.1989G>T (p.Glu663Asp)	MLH1	E663D, E630D, E305D, E322D, E608D, E422D, E565D	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089980	3	37090100	3	37048609	89980	95454	rs63751662	NC_000003.12:37048608:G:T
NM_000249.4(MLH1):c.1276C>T (p.Gln426Ter)	MLH1	Q426*, Q185*, Q68*, Q328*, Q393*, Q85*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089691	3	37067365	3	37025874	89691	95165	rs63750316	NC_000003.12:37025873:C:T
NM_000249.3(MLH1):c.200G>A (p.Gly67Glu)	MLH1	G67E	Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017106	3	37038193	3	36996702	17106	32145	rs63749939	NC_000003.12:36996701:G:A
NM_000249.3(MLH1):c.1942C>T (p.Pro648Ser)	MLH1	P648S, P307S, P407S, P290S, P615S, P550S, P593S	Lynch syndrome|Lynch syndrome II|Turcot syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017097	3	37090053	3	37048562	17097	32136	rs63750899	NC_000003.12:37048561:C:T
NM_000038.6(APC):c.1970_1971GA[1] (p.Glu658fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217940	5	112173260 - 112173263	5	112837563 - 112837566	217940	214695	rs863225322	NC_000005.10:112837562:AGAGAGA:AGA
NM_000038.6(APC):c.3805_3806AT[1] (p.Ile1269fs)	APC		not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187473	5	112175096 - 112175097	5	112839399 - 112839400	187473	182388	rs786203760	NC_000005.10:112839398:ATAT:AT
NM_000038.6(APC):c.1213C>T (p.Arg405Ter)	APC	R405*, R387*, R346*, R377*, R380*, R415*, R122*	Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127275	5	112154942	5	112819245	127275	132732	rs587779780	NC_000005.10:112819244:C:T
NM_000038.6(APC):c.3982C>T (p.Gln1328Ter)	APC	Q1310*, Q1328*, Q1045*, Q1168*, Q1202*, Q1300*, Q1338*, Q1237*, Q1346*, Q1227*, Q1269*, Q1287*, Q1303*	Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092346	5	112175273	5	112839576	92346	98257	rs398123121	NC_000005.10:112839575:C:T
NM_000038.6(APC):c.1690C>T (p.Arg564Ter)	APC	R564*, R546*, R463*, R473*, R505*, R536*, R281*, R574*, R582*, R523*, R404*, R438*, R539*	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000808	5	112164616	5	112828919	808	15847	rs137854574	NC_000005.10:112828918:C:T
NM_000038.6(APC):c.505_508ATAG[1] (p.Asp170fs)	APC		Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000804	5	112111408 - 112111411	5	112775711 - 112775714	804	15843	rs387906231	NC_000005.10:112775710:ATAGATAG:ATAG
NM_001163213.1(FGFR3):c.746C>G (p.Ser249Cys)	FGFR3	S249C	not specified|Transitional cell carcinoma of the bladder|Thanatophoric dysplasia type 1|not provided|Craniosynostosis|Carcinoma|Papillary renal cell carcinoma, sporadic|Keratosis, seborrheic|Bladder cancer, somatic|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Thanatophoric dysplasia, type 2|Hypochondroplasia|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Malignant tumor of testis|Achondroplasia|Carcinoma of cervix|Bladder cancer, somatic|Epidermal nevus|Severe achondroplasia with developmental delay and acanthosis nigricans|Carcinoma of colon|Bladder carcinoma|Squamous cell lung carcinoma|Carcinoma of cervix	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016339	4	1803568	4	1801841	16339	31378	rs121913483	NC_000004.12:1801840:C:G
NM_000249.3(MLH1):c.677+3A>G	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090315	3	37053593	3	37012102	90315	95789	rs267607780	NC_000003.12:37012101:A:G
NM_000249.3(MLH1):c.184C>T (p.Gln62Ter)	MLH1	Q62*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089902	3	37038177	3	36996686	89902	95376	rs63751428	NC_000003.12:36996685:C:T
NM_000038.6(APC):c.3067dup (p.Thr1023fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Familial adenomatous polyposis	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230713	5	112174357 - 112174358	5	112838660 - 112838661	230713	233075	rs876658724	NC_000005.10:112838660:A:AA
NM_000038.6(APC):c.4025dup (p.Leu1342fs)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217976	5	112175313 - 112175314	5	112839616 - 112839617	217976	214722	rs863225351	NC_000005.10:112839616:TTT:TTTT
NM_000038.6(APC):c.3810T>A (p.Cys1270Ter)	APC	C1252*, C1270*, C1169*, C1211*, C1242*, C1245*, C1288*, C1179*, C987*, C1229*, C1280*, C1110*, C1144*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217972	5	112175101	5	112839404	217972	214718	rs863225347	NC_000005.10:112839403:T:A
NM_000038.6(APC):c.2804dup (p.Tyr935Ter)	APC		Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217954	5	112174094 - 112174095	5	112838397 - 112838398	217954	214702	rs863225332	NC_000005.10:112838397:A:AA
NM_000249.3(MLH1):c.588+5G>A	MLH1		Hereditary cancer-predisposing syndrome|Muir-Torré syndrome|Lynch syndrome II|Turcot syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090285	3	37053358	3	37011867	90285	95759	rs267607768	NC_000003.12:37011866:G:A
NM_000249.3(MLH1):c.2246T>C (p.Leu749Pro)	MLH1	L749P, L718P, L391P, L651P, L694P, L408P, L508P, L680P, L716P	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090097	3	37092119	3	37050628	90097	95571	rs267607894	NC_000003.12:37050627:T:C
NM_006218.4(PIK3CA):c.2176G>A (p.Glu726Lys)	PIK3CA	E726K	Uterine cervical neoplasms|Neoplasm of the breast|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Squamous cell lung carcinoma|Neoplasm of the large intestine|Inborn genetic diseases|Squamous cell carcinoma of the head and neck|not provided|Brainstem glioma	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000376476	3	178938934	3	179221146	376476	363355	rs867262025	NC_000003.12:179221145:G:A
NM_006218.4(PIK3CA):c.1637A>G (p.Gln546Arg)	PIK3CA	Q546R	Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Glioblastoma|Neoplasm of ovary|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm of the breast|Neoplasm of brain|Medulloblastoma|Uterine Carcinosarcoma|Ovarian Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Aug 10, 2010)	criteria provided, single submitter	VCV000045466	3	178936095	3	179218307	45466	54633	rs397517201	NC_000003.12:179218306:A:G
NM_173660.5(DOK7):c.1124_1127dup (p.Ala378fs)	DOK7		Myasthenia, limb-girdle, familial|Myasthenia, limb-girdle, familial|Pena-Shokeir syndrome type I|Congenital myasthenic syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001273	4	3494833 - 3494834	4	3493106 - 3493107	1273	16312	rs606231128	NC_000004.12:3493106:GCCTGCC:GCCTGCCTGCC
NM_000038.6(APC):c.3147G>A (p.Trp1049Ter)	APC	W1031*, W1049*, W766*, W923*, W958*, W990*, W1024*, W1059*, W1067*, W948*, W1008*, W1021*, W889*	Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217964	5	112174438	5	112838741	217964	214710	rs863225340	NC_000005.10:112838740:G:A
NM_000038.6(APC):c.1621C>T (p.Gln541Ter)	APC	Q541*, Q523*, Q381*, Q513*, Q516*, Q551*, Q415*, Q440*, Q500*, Q482*, Q559*, Q258*, Q450*	Familial adenomatous polyposis|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Brain tumor-polyposis syndrome 2	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000806	5	112163698	5	112828001	806	15845	rs137854572	NC_000005.10:112828000:C:T
NM_004168.4(SDHA):c.91C>T (p.Arg31Ter)	SDHA	R31*	Leigh syndrome|Paragangliomas 5|Dilated cardiomyopathy 1GG|Mitochondrial complex II deficiency|Paragangliomas 5|Paragangliomas 5|Mitochondrial complex II deficiency|Carney triad|Pilocytic astrocytoma|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142601	5	223624	5	223509	142601	152315	rs142441643	NC_000005.10:223508:C:T
NM_024577.4(SH3TC2):c.2860C>T (p.Arg954Ter)	SH3TC2	R954*	Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|SH3TC2-Related Disorders|Inborn genetic diseases|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002482	5	148406435	5	149026872	2482	17521	rs80338933	NC_000005.10:149026871:G:A
NM_000112.4(SLC26A2):c.835C>T (p.Arg279Trp)	SLC26A2	R279W	Inborn genetic diseases||Osteochondrodysplasia|||Diastrophic dysplasia|SLC26A2-Related Disorders|not specified|Achondrogenesis, type IB|Achondrogenesis, type IB|||Diastrophic dysplasia|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004089	5	149359991	5	149980428	4089	19128	rs104893915	NC_000005.10:149980427:C:T
NM_000038.6(APC):c.1548G>C (p.Lys516Asn)	APC	K498N, K516N, K415N, K475N, K526N, K534N, K390N, K356N, K425N, K457N, K491N, K233N, K488N	Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246087	5	112162944	5	112827247	246087	244422	rs879254090	NC_000005.10:112827246:G:C
NM_000038.6(APC):c.3146G>A (p.Trp1049Ter)	APC	W1031*, W1049*, W766*, W923*, W958*, W990*, W1024*, W1059*, W1008*, W1021*, W889*, W1067*, W948*	not specified|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230610	5	112174437	5	112838740	230610	233077	rs876658667	NC_000005.10:112838739:G:A
NM_000038.6(APC):c.4385_4386AG[3] (p.Glu1464fs)	APC		Familial adenomatous polyposis|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Periampullary adenoma	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000812	5	112175676 - 112175679	5	112839979 - 112839982	812	15851	rs387906234	NC_000005.10:112839978:AGAGAGAGAG:AGAGAG
NM_000249.3(MLH1):c.546-2A>G	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090267	3	37053309	3	37011818	90267	95741	rs267607759	NC_000003.12:37011817:A:G
NM_001167618.2(MLH1):c.-221dup	MLH1		Carcinoma of colon|Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090250	3	37050348 - 37050349	3	37008857 - 37008858	90250	95724	rs63749959	NC_000003.12:37008857:AAAAAA:AAAAAAA
NM_001163213.1(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	R248C	not specified|Lung adenocarcinoma|Multiple myeloma|Transitional cell carcinoma of the bladder|Small for gestational age|Lower limb undergrowth|Skeletal dysplasia|Short stature|Disproportionate short-limb short stature|Femoral bowing|Narrow chest|Growth delay|Bell-shaped thorax|Bowed humerus|Lethal short-limbed short stature|Upper limb undergrowth|Short ribs|not provided|Skeletal dysplasia with acanthosis nigricans|Thanatophoric dysplasia type 1|Epidermal nevus|Carcinoma|Keratosis, seborrheic|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Thanatophoric dysplasia, type 2|Hypochondroplasia|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Malignant tumor of testis|Achondroplasia|Carcinoma of cervix|Bladder cancer, somatic|Epidermal nevus|Severe achondroplasia with developmental delay and acanthosis nigricans|Carcinoma of colon|Squamous cell lung carcinoma	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016332	4	1803564	4	1801837	16332	31371	rs121913482	NC_000004.12:1801836:C:T
NM_000038.6(APC):c.933+1G>A	APC		Hereditary cancer-predisposing syndrome|Desmoid disease, hereditary|Carcinoma of colon|Hepatocellular carcinoma|Neoplasm of stomach|Familial adenomatous polyposis 1|Familial adenomatous polyposis 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233970	5	112151291	5	112815594	233970	233008	rs876660765	NC_000005.10:112815593:G:A
NM_000038.6(APC):c.994C>T (p.Arg332Ter)	APC	R314*, R332*, R304*, R342*, R273*, R307*, R49*	Familial adenomatous polyposis 1|not provided|Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184937	5	112154723	5	112819026	184937	182339	rs775126020	NC_000005.10:112819025:C:T
NM_001167617.2(MLH1):c.1901_1904dup (p.His635fs)	MLH1		Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090088	3	37092066 - 37092067	3	37050575 - 37050576	90088	95562	rs267607903	NC_000003.12:37050575:AAACA:AAACAAACA
NM_000249.3(MLH1):c.230G>A (p.Cys77Tyr)	MLH1	C77Y	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090112	3	37042468	3	37000977	90112	95586	rs63750437	NC_000003.12:37000976:G:A
NM_001167617.2(MLH1):c.1958_1959del (p.Lys653fs)	MLH1	K410fs, K682fs, K696fs, K720fs, K653fs, K393fs, K751fs, K510fs, K718fs	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Lynch syndrome I|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000090101	3	37092124 - 37092125	3	37050633 - 37050634	90101	95575	rs267607901	NC_000003.12:37050632:AAA:A
NM_000249.3(MLH1):c.2141G>A (p.Trp714Ter)	MLH1	W714*, W616*, W659*, W681*, W473*, W645*, W683*, W356*, W373*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090068	3	37092014	3	37050523	90068	95542	rs63751022	NC_000003.12:37050522:G:A
NM_000249.3(MLH1):c.793C>A (p.Arg265Ser)	MLH1	R265S, R167S, R232S, R24S	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000090380	3	37058999	3	37017508	90380	95854	rs63751194	NC_000003.12:37017507:C:A
NM_000249.3(MLH1):c.1975C>T (p.Arg659Ter)	MLH1	R659*, R301*, R418*, R561*, R318*, R604*, R626*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089962	3	37090086	3	37048595	89962	95436	rs63751310	NC_000003.12:37048594:C:T
NM_006218.4(PIK3CA):c.1635G>T (p.Glu545Asp)	PIK3CA	E545D	Small cell lung cancer|Squamous cell lung carcinoma|Lung adenocarcinoma|PIK3CA related overgrowth spectrum|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Brainstem glioma|Glioblastoma|Pancreatic adenocarcinoma|Neoplasm of brain|Carcinoma of gallbladder|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Nasopharyngeal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Malignant melanoma of skin|Hepatocellular carcinoma|Renal cell carcinoma, papillary, 1	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000217293	3	178936093	3	179218305	217293	213943	rs121913275	NC_000003.12:179218304:G:T
NM_000038.6(APC):c.3149del (p.Ala1050fs)	APC	A1009fs, A1032fs, A767fs, A890fs, A991fs, A1022fs, A1025fs, A1050fs, A1068fs, A924fs, A949fs, A959fs, A1060fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183078	5	112174440	5	112838743	183078	181206	rs730882135	NC_000005.10:112838742:C:
NM_001163213.1(FGFR3):c.1178C>A (p.Ala393Glu)	FGFR3	A391E, A393E	Inborn genetic diseases|not provided|Craniosynostosis|Crouzon syndrome with acanthosis nigricans|Carcinoma	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016329	4	1806153	4	1804426	16329	31368	rs28931615	NC_000004.12:1804425:C:A
NM_000249.3(MLH1):c.790+1G>A	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090356	3	37056036	3	37014545	90356	95830	rs267607789	NC_000003.12:37014544:G:A
NM_000038.6(APC):c.426_427del (p.Leu143fs)	APC	L143fs, L153fs, L84fs, L118fs	Familial adenomatous polyposis|not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not specified	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142574	5	112111329 - 112111330	5	112775632 - 112775633	142574	152288	rs587782557	NC_000005.10:112775631:AT:
NM_000249.4(MLH1):c.1381A>T (p.Lys461Ter)	MLH1	K461*, K220*, K363*, K120*, K103*, K428*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome II|Lynch syndrome|Hereditary nonpolyposis colon cancer|Muir-Torré syndrome|Turcot syndrome|Lynch syndrome II	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036540	3	37067470	3	37025979	36540	45202	rs63750540	NC_000003.12:37025978:A:T
NM_000249.3(MLH1):c.589-2A>G	MLH1		Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome II|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090291	3	37053500	3	37012009	90291	95765	rs267607767	NC_000003.12:37012008:A:G
NM_000038.6(APC):c.2802_2805del (p.Tyr935fs)	APC	Y876fs, Y910fs, Y935fs, Y945fs, Y775fs, Y809fs, Y834fs, Y894fs, Y844fs, Y917fs, Y953fs, Y652fs, Y907fs	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis|not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429056	5	112174091 - 112174094	5	112838394 - 112838397	429056	421030	rs1131691143	NC_000005.10:112838393:ACTTAC:AC
NM_000038.6(APC):c.1495C>T (p.Arg499Ter)	APC	R499*, R481*, R373*, R339*, R408*, R474*, R216*, R471*, R517*, R398*, R440*, R458*, R509*	Familial adenomatous polyposis|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Gardner syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000824	5	112162891	5	112827194	824	15863	rs137854580	NC_000005.10:112827193:C:T
NM_000038.6(APC):c.4012C>T (p.Gln1338Ter)	APC	Q1338*, Q1320*, Q1237*, Q1279*, Q1297*, Q1348*, Q1212*, Q1055*, Q1178*, Q1310*, Q1313*, Q1356*, Q1247*	Familial adenomatous polyposis 1|Carcinoma of colon|Neoplasm of the large intestine	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000000801	5	112175303	5	112839606	801	15840	rs121913327	NC_000005.10:112839605:C:T
NM_000551.3(VHL):c.292T>C (p.Tyr98His)	VHL	Y98H	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002223	3	10183823	3	10142139	2223	17262	rs5030809	NC_000003.12:10142138:T:C
NM_006218.4(PIK3CA):c.1636C>A (p.Gln546Lys)	PIK3CA	Q546K	Ovarian epithelial cancer|Carcinoma of colon|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Uterine Carcinosarcoma|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Lung cancer|Adenocarcinoma of stomach|Glioblastoma|PIK3CA related overgrowth spectrum|Neoplasm of brain|Neoplasm of the large intestine|Neoplasm of the breast|Malignant tumor of prostate|Medulloblastoma|Malignant melanoma of skin	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000013657	3	178936094	3	179218306	13657	28696	rs121913286	NC_000003.12:179218305:C:A
NM_000038.6(APC):c.3340C>T (p.Arg1114Ter)	APC	R1096*, R1114*, R1013*, R1023*, R1073*, R1086*, R1089*, R1124*, R1132*, R954*, R988*, R831*, R1055*	Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Lung adenocarcinoma|Neoplasm of the large intestine	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236589	5	112174631	5	112838934	236589	239564	rs121913331	NC_000005.10:112838933:C:T
NM_000038.6(APC):c.904C>T (p.Arg302Ter)	APC	R302*, R284*, R19*, R274*, R277*, R312*, R243*	Gardner syndrome|Familial adenomatous polyposis|Familial adenomatous polyposis 1|not provided|Colorectal cancer, susceptibility to|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000798	5	112151261	5	112815564	798	15837	rs137854568	NC_000005.10:112815563:C:T
NM_001167617.2(MLH1):c.1195dup (p.Arg399fs)	MLH1		not provided|Lynch syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089753	3	37070348 - 37070349	3	37028857 - 37028858	89753	95227	rs63750855	NC_000003.12:37028857:CCCCCC:CCCCCCC
NM_006218.4(PIK3CA):c.1634A>C (p.Glu545Ala)	PIK3CA	E545A	Carcinoma of esophagus|Squamous cell lung carcinoma|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Uterine Carcinosarcoma|Carcinoma of gallbladder|Papillary renal cell carcinoma, sporadic|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach|Glioblastoma|Neoplasm of brain|Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Neoplasm of the breast|Small cell lung cancer|Neoplasm of ovary|Malignant melanoma of skin|Brainstem glioma	Pathogenic(Last reviewed: Dec 23, 2010)	criteria provided, single submitter	VCV000013659	3	178936092	3	179218304	13659	28698	rs121913274	NC_000003.12:179218303:A:C
NM_001354689.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	S257L, S224L, S143L, S176L	Inborn genetic diseases|Noonan syndrome with multiple lentigines|Lung adenocarcinoma|Malignant melanoma of skin|Adenocarcinoma of stomach|Noonan syndrome|Noonan syndrome 5|Neoplasm of the large intestine|Rasopathy|LEOPARD syndrome 2|Noonan syndrome 5|LEOPARD syndrome 2|Cardiomyopathy, dilated, 1NN|Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013957	3	12645699	3	12604200	13957	28996	rs80338796	NC_000003.12:12604199:G:A
NM_000249.4(MLH1):c.677G>A (p.Arg226Gln)	MLH1	R226Q, R128Q, R193Q	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome II|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090318	3	37053590	3	37012099	90318	95792	rs63751711	NC_000003.12:37012098:G:A
NM_000249.3(MLH1):c.1731G>A (p.Ser577=)	MLH1		not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089857	3	37083822	3	37042331	89857	95331	rs63751657	NC_000003.12:37042330:G:A
NM_000249.3(MLH1):c.298C>T (p.Arg100Ter)	MLH1	R100*	Lynch syndrome II|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036550	3	37042536	3	37001045	36550	45212	rs63751221	NC_000003.12:37001044:C:T
NM_000038.6(APC):c.4385_4386AG[4] (p.Ser1465fs)	APC		Familial adenomatous polyposis|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|Periampullary adenoma|Gardner syndrome	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000811	5	112175676 - 112175677	5	112839979 - 112839980	811	15850	rs387906234	NC_000005.10:112839978:AGAGAGAGAG:AGAGAGAG
NM_000249.3(MLH1):c.676C>T (p.Arg226Ter)	MLH1	R226*, R128*, R193*	not provided|Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome|Turcot syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017087	3	37053589	3	37012098	17087	32126	rs63751615	NC_000003.12:37012097:C:T
NM_001163213.1(FGFR3):c.1626C>G (p.Asn542Lys)	FGFR3	N540K, N542K, N541K, N428K	Hypochondroplasia|not provided|Craniosynostosis|Thanatophoric dysplasia type 1|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Thanatophoric dysplasia, type 2|Hypochondroplasia|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Malignant tumor of testis|Achondroplasia|Carcinoma of cervix|Bladder cancer, somatic|Epidermal nevus|Severe achondroplasia with developmental delay and acanthosis nigricans|Carcinoma of colon|Inborn genetic diseases|Short stature	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016338	4	1807371	4	1805644	16338	31377	rs28933068	NC_000004.12:1805643:C:G
NM_006218.4(PIK3CA):c.1633G>C (p.Glu545Gln)	PIK3CA	E545Q	Malignant melanoma of skin|Papillary renal cell carcinoma, sporadic|Uterine cervical neoplasms|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Neoplasm of the breast|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Glioblastoma|Histone Methylation Therapy response|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach|Non-small cell lung cancer|Carcinoma of esophagus|Renal cell carcinoma, papillary, 1|Neoplasm of brain|Neoplasm of the large intestine|Small cell lung cancer|Brainstem glioma|Hepatocellular carcinoma|Head and Neck Neoplasms|Carcinoma of gallbladder|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Nasopharyngeal Neoplasms	Pathogenic/Likely pathogenic, drug response(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000375896	3	178936091	3	179218303	375896	362775	rs104886003	NC_000003.12:179218302:G:C
NM_006218.4(PIK3CA):c.1624G>A (p.Glu542Lys)	PIK3CA	E542K	Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Neoplasm of ovary|Hepatocellular carcinoma|Carcinoma of esophagus|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|Glioblastoma|not provided|Non-small cell lung cancer|Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Small cell lung cancer|Squamous cell lung carcinoma|Papillary renal cell carcinoma, sporadic|Uterine cervical neoplasms|Ovarian Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Neoplasm of the breast|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000031944	3	178936082	3	179218294	31944	40609	rs121913273	NC_000003.12:179218293:G:A
NM_000249.3(MLH1):c.1459C>T (p.Arg487Ter)	MLH1	R487*, R246*, R389*, R129*, R146*, R454*	not provided|Muir-Torré syndrome|Lynch syndrome II|Turcot syndrome|Lynch syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089744	3	37070324	3	37028833	89744	95218	rs63749795	NC_000003.12:37028832:C:T
NM_000038.6(APC):c.1312+3A>G	APC		Neoplasm of stomach|Carcinoma of colon|Desmoid disease, hereditary|Hepatocellular carcinoma|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|not provided|Familial adenomatous polyposis	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217924	5	112155044	5	112819347	217924	214682	rs863225311	NC_000005.10:112819346:A:G
NM_000038.6(APC):c.847C>T (p.Arg283Ter)	APC	R265*, R283*, R255*, R224*, R258*, R293*	Familial adenomatous polyposis 1|Malignant Colorectal Neoplasm|Carcinoma of colon|Neoplasm of stomach|Hepatocellular carcinoma|Desmoid disease, hereditary|Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184999	5	112151204	5	112815507	184999	182336	rs786201856	NC_000005.10:112815506:C:T
NM_000038.6(APC):c.70C>T (p.Arg24Ter)	APC	R24*	not provided|Familial adenomatous polyposis 1|Carcinoma of colon|Neoplasm of stomach|Hepatocellular carcinoma|Desmoid disease, hereditary|Familial adenomatous polyposis 1|Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome|not specified|Familial multiple polyposis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184702	5	112090657	5	112754960	184702	182313	rs145945630	NC_000005.10:112754959:C:T
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly)	PIK3CA	E545G	Carcinoma of esophagus|Cutaneous melanoma|Squamous cell lung carcinoma|Lung adenocarcinoma|Carcinoma of colon|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Epidermal nevus|Carcinoma of gallbladder|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Malignant melanoma of skin|Adenocarcinoma of stomach|Glioblastoma|Neoplasm of brain|Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Neoplasm of the breast|Small cell lung cancer|Brainstem glioma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000013656	3	178936092	3	179218304	13656	28695	rs121913274	NC_000003.12:179218303:A:G
NM_001354630.1(MLH1):c.1732-885GAA[2]	MLH1	K618del, K616del, K375del, K518del, K377del, K520del	not provided|Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome|Turcot syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017080	3	37089130 - 37089132	3	37047632 - 37047634	17080	32119	rs63751247	NC_000003.12:37047631:GAAGAAGAAG:GAAGAAG
NM_006218.4(PIK3CA):c.3139C>T (p.His1047Tyr)	PIK3CA	H1047Y	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Carcinoma of esophagus|Pancreatic adenocarcinoma||Neoplasm of stomach||Congenital macrodactylia|Epidermal nevus|Cowden syndrome 5|Keratosis, seborrheic|Lung cancer|Hepatocellular carcinoma|Familial cancer of breast|Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|Carcinoma of colon|Neoplasm of ovary|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Malignant tumor of floor of mouth|Non-small cell lung cancer|Lung adenocarcinoma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine cervical neoplasms|Ovarian Serous Cystadenocarcinoma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Glioblastoma|Neoplasm of the breast|Transitional cell carcinoma of the bladder|Brainstem glioma|Hepatocellular carcinoma|Medulloblastoma|Neoplasm of the large intestine|Cowden syndrome|Neoplasm of brain|Renal cell carcinoma, papillary, 1|Squamous cell lung carcinoma	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039705	3	178952084	3	179234296	39705	48304	rs121913281	NC_000003.12:179234295:C:T
NM_000038.6(APC):c.637C>T (p.Arg213Ter)	APC	R213*, R223*, R154*, R188*	Carcinoma of colon|Familial adenomatous polyposis 1|Neoplasm of stomach|Desmoid disease, hereditary|Hepatocellular carcinoma|not provided|Familial adenomatous polyposis 1|Familial adenomatous polyposis|Familial multiple polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140952	5	112116592	5	112780895	140952	150666	rs587781392	NC_000005.10:112780894:C:T
NM_000038.6(APC):c.2626C>T (p.Arg876Ter)	APC	R858*, R876*, R785*, R894*, R593*, R775*, R848*, R886*, R835*, R716*, R750*, R817*, R851*	not specified|not provided|Neoplasm of the large intestine|Familial adenomatous polyposis 1|Familial adenomatous polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216014	5	112173917	5	112838220	216014	212414	rs121913333	NC_000005.10:112838219:C:T
NM_000038.6(APC):c.646C>T (p.Arg216Ter)	APC	R216*, R226*, R157*, R191*	Desmoid disease, hereditary|Carcinoma of colon|Neoplasm of stomach|Hepatocellular carcinoma|Familial adenomatous polyposis 1|Familial adenomatous polyposis|not provided|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127312	5	112128143	5	112792446	127312	132769	rs62619935	NC_000005.10:112792445:C:T
NM_000038.6(APC):c.1660C>T (p.Arg554Ter)	APC	R554*, R536*, R394*, R564*, R453*, R526*, R529*, R271*, R463*, R495*, R572*, R428*, R513*	Familial adenomatous polyposis 1|Desmoid disease, hereditary|Familial adenomatous polyposis 1|Neoplasm of stomach|Carcinoma of colon|Hepatocellular carcinoma|not provided|Familial multiple polyposis syndrome|Colorectal cancer, susceptibility to|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000807	5	112164586	5	112828889	807	15846	rs137854573	NC_000005.10:112828888:C:T
NM_001163213.1(FGFR3):c.749C>G (p.Pro250Arg)	FGFR3	P250R	Crouzon syndrome|Coronal craniosynostosis|Unilateral renal agenesis|Infantile axial hypotonia|Seizures|Facial asymmetry|Absence seizures|Inborn genetic diseases|not specified|Hypochondroplasia|not provided|Craniosynostosis|Saethre-Chotzen syndrome|Thanatophoric dysplasia type 1|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Thanatophoric dysplasia, type 2|Hypochondroplasia|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Malignant tumor of testis|Achondroplasia|Carcinoma of cervix|Bladder cancer, somatic|Epidermal nevus|Severe achondroplasia with developmental delay and acanthosis nigricans|Carcinoma of colon|Muenke syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016340	4	1803571	4	1801844	16340	31379	rs4647924	NC_000004.12:1801843:C:G
NM_006218.4(PIK3CA):c.3140A>T (p.His1047Leu)	PIK3CA	H1047L	Carcinoma of esophagus|Squamous cell lung carcinoma|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Non-small cell lung cancer|Hepatocellular carcinoma|Breast adenocarcinoma|Uterine Carcinosarcoma|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Medulloblastoma|Malignant melanoma of skin|Cowden syndrome 1|Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|Adenocarcinoma of stomach|Adrenocortical carcinoma|Glioblastoma|PIK3CA related overgrowth spectrum|Neoplasm of brain|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Neoplasm of the breast|Squamous cell carcinoma of the head and neck|Stroke|Macrodactyly of toe|Brainstem glioma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013653	3	178952085	3	179234297	13653	28692	rs121913279	NC_000003.12:179234296:A:T
NM_000038.6(APC):c.4348C>T (p.Arg1450Ter)	APC	R1432*, R1450*, R1167*, R1290*, R1422*, R1425*, R1349*, R1359*, R1409*, R1460*, R1324*, R1391*, R1468*	Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|not provided|Familial adenomatous polyposis	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194585	5	112175639	5	112839942	194585	191748	rs121913332	NC_000005.10:112839941:C:T
NM_000249.3(MLH1):c.2059C>T (p.Arg687Trp)	MLH1	R687W, R329W, R446W, R589W, R632W, R656W, R346W, R654W	Hereditary cancer-predisposing syndrome|not provided|Muir-Torré syndrome|Lynch syndrome II|Turcot syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome II	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090014	3	37090464	3	37048973	90014	95488	rs63751275	NC_000003.12:37048972:C:T
NM_000249.4(MLH1):c.199G>A (p.Gly67Arg)	MLH1	G67R	not provided|Lynch syndrome|Lynch syndrome II|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089992	3	37038192	3	36996701	89992	95466	rs63750206	NC_000003.12:36996700:G:A
NM_000249.3(MLH1):c.2041G>A (p.Ala681Thr)	MLH1	A681T, A650T, A583T, A340T, A440T, A626T, A648T, A323T	not specified|Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome|not provided|Turcot syndrome|Lynch syndrome II|Muir-Torré syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017099	3	37090446	3	37048955	17099	32138	rs63750217	NC_000003.12:37048954:G:A
NM_006218.4(PIK3CA):c.1633G>A (p.Glu545Lys)	PIK3CA	E545K	Ovarian epithelial cancer|Carcinoma of esophagus|Neoplasm of stomach|Squamous cell lung carcinoma|Lung adenocarcinoma|Carcinoma of colon|Transitional cell carcinoma of the bladder|Non-small cell lung cancer|Hepatocellular carcinoma|Breast adenocarcinoma|Carcinoma of gallbladder|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Neoplasm of brain|Keratosis, seborrheic|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach|Glioblastoma||Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Sarcoma|Neoplasm of the breast|Small cell lung cancer|Brainstem glioma	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000013655	3	178936091	3	179218303	13655	28694	rs104886003	NC_000003.12:179218302:G:A
NM_000038.6(APC):c.694C>T (p.Arg232Ter)	APC	R232*, R173*, R207*, R242*	Familial multiple polyposis syndrome|Familial adenomatous polyposis|Desmoid disease, hereditary|Familial adenomatous polyposis 1|Neoplasm of stomach|Hepatocellular carcinoma|Carcinoma of colon|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042248	5	112128191	5	112792494	42248	51418	rs397515734	NC_000005.10:112792493:C:T
NM_000038.6(APC):c.3183_3187del (p.Lys1061_Gln1062insTer)	APC		Hereditary cancer-predisposing syndrome|Craniopharyngioma|Familial adenomatous polyposis|not provided|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088913	5	112174471 - 112174475	5	112838774 - 112838778	88913	94472	rs587779352	NC_000005.10:112838773:AAAACAAA:AAA
NM_006218.4(PIK3CA):c.3140A>G (p.His1047Arg)	PIK3CA	H1047R	Ovarian epithelial cancer|Neoplasm of stomach|Squamous cell lung carcinoma|Lung adenocarcinoma|Carcinoma of colon|Transitional cell carcinoma of the bladder|Non-small cell lung cancer|Malignant melanoma of skin|Hepatocellular carcinoma|Breast adenocarcinoma|Rosette-forming glioneuronal tumor|Uterine Carcinosarcoma|Ovarian Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Neoplasm of brain|Keratosis, seborrheic|Squamous cell carcinoma of the head and neck|MACRODACTYLY, SOMATIC|Adenocarcinoma of stomach|Adrenocortical carcinoma|Glioblastoma|PIK3CA related overgrowth spectrum|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Neoplasm|Carcinoma of esophagus|Neoplasm of the breast|Medulloblastoma|Neoplasm of ovary|Brainstem glioma	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013652	3	178952085	3	179234297	13652	28691	rs121913279	NC_000003.12:179234296:A:G
NM_000249.4(MLH1):c.793C>T (p.Arg265Cys)	MLH1	R265C, R24C, R232C, R167C	Lynch syndrome II|Lynch syndrome|Carcinoma of colon|Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000029654	3	37058999	3	37017508	29654	38609	rs63751194	NC_000003.12:37017507:C:T
NM_000249.4(MLH1):c.350C>T (p.Thr117Met)	MLH1	T117M, T84M, T19M	not provided|Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017094	3	37045935	3	37004444	17094	32133	rs63750781	NC_000003.12:37004443:C:T
NM_000038.6(APC):c.2805C>A (p.Tyr935Ter)	APC	Y935*, Y917*, Y775*, Y809*, Y876*, Y953*, Y652*, Y834*, Y907*, Y945*, Y844*, Y894*, Y910*	Familial adenomatous polyposis|Familial adenomatous polyposis 1|Desmoid disease, hereditary|Familial adenomatous polyposis 1|Neoplasm of stomach|Carcinoma of colon|Hepatocellular carcinoma|not provided|Colorectal cancer, susceptibility to|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000810	5	112174096	5	112838399	810	15849	rs137854575	NC_000005.10:112838398:C:A
NM_000038.6(APC):c.3922_3926AAAGA[1] (p.Glu1309fs)	APC		Familial adenomatous polyposis|Familial adenomatous polyposis 1|Intestinal polyp|Adenomatous colonic polyposis|Duodenal polyposis|Gastric polyposis|Hyperplastic colonic polyposis|Malignant Colorectal Neoplasm|not provided|Colon adenocarcinoma|Carcinoma of colon|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome|Adenomatous polyposis coli with congenital cholesteatoma|Gardner syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000816	5	112175212 - 112175216	5	112839515 - 112839519	816	15855	rs121913224	NC_000005.10:112839514:AAAAGAAAAGA:AAAAGA
